Citrus Sinensis ID: 011851
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 476 | 2.2.26 [Sep-21-2011] | |||||||
| Q9LFP7 | 493 | Probable receptor-like pr | yes | no | 0.970 | 0.937 | 0.697 | 0.0 | |
| Q9SRH7 | 490 | Receptor-like serine/thre | no | no | 0.926 | 0.9 | 0.718 | 0.0 | |
| Q06548 | 410 | Protein kinase APK1A, chl | no | no | 0.741 | 0.860 | 0.605 | 1e-124 | |
| P46573 | 412 | Protein kinase APK1B, chl | no | no | 0.747 | 0.864 | 0.584 | 1e-120 | |
| P43293 | 389 | Probable serine/threonine | no | no | 0.745 | 0.912 | 0.576 | 1e-120 | |
| Q8GXZ3 | 410 | Serine/threonine-protein | no | no | 0.665 | 0.773 | 0.658 | 1e-119 | |
| O49840 | 426 | Protein kinase 2B, chloro | no | no | 0.766 | 0.856 | 0.578 | 1e-117 | |
| O49839 | 426 | Protein kinase 2A, chloro | no | no | 0.886 | 0.990 | 0.521 | 1e-114 | |
| O48814 | 395 | Serine/threonine-protein | no | no | 0.733 | 0.883 | 0.540 | 1e-111 | |
| Q8H186 | 389 | Probable receptor-like pr | no | no | 0.640 | 0.784 | 0.596 | 1e-107 |
| >sp|Q9LFP7|Y5158_ARATH Probable receptor-like protein kinase At5g15080 OS=Arabidopsis thaliana GN=At5g15080 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 649 bits (1673), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 329/472 (69%), Positives = 376/472 (79%), Gaps = 10/472 (2%)
Query: 6 EDFNGGALNVDKSKSKKKKDGESGVTGCWIKFRFIGGCLSSSPKTDGANSGT-----STQ 60
E+ N N D +KS+ +++ E +GCW+KFRF+ GC+ S D ++S +
Sbjct: 21 ENKNHKKKNGDDNKSRNEEEEEGEASGCWVKFRFMIGCIPSKSDLDASSSSIYGSNCTVT 80
Query: 61 YAESKSTNDTSRGQPVVPIGSSSTTSNAESTTPSTPKIGEELKISPQLRKFSFNELKSAT 120
ESKS N+ S QPV + S++TTSNAES++ STP I EEL IS LRKF+FN+LK +T
Sbjct: 81 TMESKSANEKSNDQPVGQVSSTTTTSNAESSS-STPVISEELNISSHLRKFTFNDLKLST 139
Query: 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNY 180
++FRPE LLGEGGFGCV+KGWI NGTA VKPGTGL VAVKTLN DGLQGHKEWLAE+N+
Sbjct: 140 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNPDGLQGHKEWLAEINF 199
Query: 181 LGGLIHPNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKG 240
LG L+HPNLVKL+G CIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL AAKG
Sbjct: 200 LGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKG 259
Query: 241 LAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYA 300
L+FLHEEA KPVIYRDFKTSNILLD +YNAKLSDFGLAKD P+ KTHVSTRVMGTYGYA
Sbjct: 260 LSFLHEEALKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPDEGKTHVSTRVMGTYGYA 319
Query: 301 APEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRRFYR 360
APEYVMTGHLT+KSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP L ++RRFYR
Sbjct: 320 APEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLLDKRRFYR 379
Query: 361 LIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDMASSSSYVQ 420
L+DP LEG FSIKGA+K QLAA CL+RD K RP+MS+VVEALKPLP+LKDMASSS Y Q
Sbjct: 380 LLDPRLEGHFSIKGAQKVTQLAAQCLSRDPKIRPKMSDVVEALKPLPHLKDMASSSYYFQ 439
Query: 421 AMQAERVRLNLNAKHGSRVPRKGQPTRSLSIPNAPH-VSPYHLNNPHYSPKP 471
MQAER++ N + + R GQ ++PH SPY P SPKP
Sbjct: 440 TMQAERLK-NGSGRSQGFGSRNGQHQPVFRTLSSPHGSSPYRHQIP--SPKP 488
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9SRH7|Y3130_ARATH Receptor-like serine/threonine-protein kinase At3g01300 OS=Arabidopsis thaliana GN=At3g01300 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 634 bits (1635), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 322/448 (71%), Positives = 360/448 (80%), Gaps = 7/448 (1%)
Query: 27 ESGVTGCWIKFRFIGGCLSSSPKTDGANSGTSTQYAESKSTNDTSRGQPVVPIGSSSTTS 86
E GCW+KFR+I C SS+ + + + ST S+S S QPV P+ S++TTS
Sbjct: 42 EEEANGCWVKFRYIVCCASSTSDVETSLT-LSTSTVGSQSAIVQSNDQPVGPVSSTTTTS 100
Query: 87 NAESTTPSTPKIGEELKISPQLRKFSFNELKSATKSFRPECLLGEGGFGCVYKGWINMNG 146
NAES+ STP I EEL I L+KFSF +LK AT++FRPE LLGEGGFGCV+KGW+ NG
Sbjct: 101 NAESSL-STPIISEELNIYSHLKKFSFIDLKLATRNFRPESLLGEGGFGCVFKGWVEENG 159
Query: 147 TATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHPNLVKLIGCCIEDDQRLLVY 206
TA VKPGTGL VAVKTLN DGLQGHKEWLAE+NYLG L+HPNLVKL+G CIEDDQRLLVY
Sbjct: 160 TAPVKPGTGLTVAVKTLNPDGLQGHKEWLAEINYLGNLLHPNLVKLVGYCIEDDQRLLVY 219
Query: 207 EFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDG 266
EFMPRGSLENHLFRRSLPLPWSIRMKIAL AAKGL+FLHEEA KPVIYRDFKTSNILLDG
Sbjct: 220 EFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLSFLHEEALKPVIYRDFKTSNILLDG 279
Query: 267 EYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEM 326
EYNAKLSDFGLAKD P+ KTHVSTRVMGTYGYAAPEYVMTGHLT+KSDVYSFGVVLLEM
Sbjct: 280 EYNAKLSDFGLAKDAPDEGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEM 339
Query: 327 LTGRRSMDKNRPNGEHNLVEWARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCL 386
LTGRRSMDKNRPNGEHNLVEWARP L ++RRFYRL+DP LEG FS+KGA+K QLAA CL
Sbjct: 340 LTGRRSMDKNRPNGEHNLVEWARPHLLDKRRFYRLLDPRLEGHFSVKGAQKVTQLAAQCL 399
Query: 387 NRDQKARPRMSEVVEALKPLPYLKDMASSSSYVQAMQAERVR-LNLNAKHGSRVPRKGQP 445
+RD K RP+MSEVVE LKPLP+LKDMAS+S Y Q MQAER++ + + R GQP
Sbjct: 400 SRDSKIRPKMSEVVEVLKPLPHLKDMASASYYFQTMQAERLKAGSGSGSGRGFGSRNGQP 459
Query: 446 T-RSLSIPNAPH-VSPYHLNNPHYSPKP 471
R+LS P+ SPY P SPKP
Sbjct: 460 VFRTLSSPHGQAGSSPYRHQIP--SPKP 485
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q06548|APK1A_ARATH Protein kinase APK1A, chloroplastic OS=Arabidopsis thaliana GN=APK1A PE=2 SV=1 | Back alignment and function description |
|---|
Score = 445 bits (1144), Expect = e-124, Method: Compositional matrix adjust.
Identities = 226/373 (60%), Positives = 275/373 (73%), Gaps = 20/373 (5%)
Query: 40 IGGCLSSSPKTDGANSGTSTQYAESKSTNDTSRGQPVVPIGSSSTTSNAESTTPSTPKIG 99
+G CLS+ K + +SG ST+Y IGS + +++ S PS P+
Sbjct: 1 MGICLSAQVKAE--SSGASTKYDAKD-------------IGSLGSKASSVSVRPS-PRTE 44
Query: 100 EELKISPQLRKFSFNELKSATKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVA 159
E+ SP L+ FSF ELKSAT++FRP+ +LGEGGFGCV+KGWI+ +PGTGL +A
Sbjct: 45 GEILQSPNLKSFSFAELKSATRNFRPDSVLGEGGFGCVFKGWIDEKSLTASRPGTGLVIA 104
Query: 160 VKTLNHDGLQGHKEWLAEVNYLGGLIHPNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLF 219
VK LN DG QGH+EWLAEVNYLG H +LVKLIG C+ED+ RLLVYEFMPRGSLENHLF
Sbjct: 105 VKKLNQDGWQGHQEWLAEVNYLGQFSHRHLVKLIGYCLEDEHRLLVYEFMPRGSLENHLF 164
Query: 220 RRSL---PLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFG 276
RR L PL W +R+K+AL AAKGLAFLH +E VIYRDFKTSNILLD EYNAKLSDFG
Sbjct: 165 RRGLYFQPLSWKLRLKVALGAAKGLAFLHS-SETRVIYRDFKTSNILLDSEYNAKLSDFG 223
Query: 277 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKN 336
LAKDGP GDK+HVSTRVMGT+GYAAPEY+ TGHLT KSDVYSFGVVLLE+L+GRR++DKN
Sbjct: 224 LAKDGPIGDKSHVSTRVMGTHGYAAPEYLATGHLTTKSDVYSFGVVLLELLSGRRAVDKN 283
Query: 337 RPNGEHNLVEWARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRM 396
RP+GE NLVEWA+P L +R+ +R+ID L+ +S++ A K L+ CL + K RP M
Sbjct: 284 RPSGERNLVEWAKPYLVNKRKIFRVIDNRLQDQYSMEEACKVATLSLRCLTTEIKLRPNM 343
Query: 397 SEVVEALKPLPYL 409
SEVV L+ + L
Sbjct: 344 SEVVSHLEHIQSL 356
|
Possible bi-functional kinase. In vitro, it exhibits serine/threonine activity. In vivo, can phosphorylate tyrosine residues of limited substrates. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P46573|APK1B_ARATH Protein kinase APK1B, chloroplastic OS=Arabidopsis thaliana GN=APK1B PE=2 SV=2 | Back alignment and function description |
|---|
Score = 433 bits (1113), Expect = e-120, Method: Compositional matrix adjust.
Identities = 219/375 (58%), Positives = 269/375 (71%), Gaps = 19/375 (5%)
Query: 40 IGGCLSSSPKTDGANSGTSTQYAESKSTNDTSRGQPVVPIGSSSTTSNAESTTPSTPKIG 99
+G CLS+ K + G S +Y S++ + V I ++ P+
Sbjct: 1 MGICLSAQIK--AVSPGASPKYMSSEANDSLGSKSSSVSIRTN-------------PRTE 45
Query: 100 EELKISPQLRKFSFNELKSATKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVA 159
E+ SP L+ F+F ELK+AT++FRP+ +LGEGGFG V+KGWI+ KPGTG+ +A
Sbjct: 46 GEILQSPNLKSFTFAELKAATRNFRPDSVLGEGGFGSVFKGWIDEQTLTASKPGTGVVIA 105
Query: 160 VKTLNHDGLQGHKEWLAEVNYLGGLIHPNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLF 219
VK LN DG QGH+EWLAEVNYLG HPNLVKLIG C+ED+ RLLVYEFMPRGSLENHLF
Sbjct: 106 VKKLNQDGWQGHQEWLAEVNYLGQFSHPNLVKLIGYCLEDEHRLLVYEFMPRGSLENHLF 165
Query: 220 RRS---LPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFG 276
RR PL W++R+K+AL AAKGLAFLH AE VIYRDFKTSNILLD EYNAKLSDFG
Sbjct: 166 RRGSYFQPLSWTLRLKVALGAAKGLAFLHN-AETSVIYRDFKTSNILLDSEYNAKLSDFG 224
Query: 277 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKN 336
LAKDGP GDK+HVSTR+MGTYGYAAPEY+ TGHLT KSDVYS+GVVLLE+L+GRR++DKN
Sbjct: 225 LAKDGPTGDKSHVSTRIMGTYGYAAPEYLATGHLTTKSDVYSYGVVLLEVLSGRRAVDKN 284
Query: 337 RPNGEHNLVEWARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRM 396
RP GE LVEWARP L +R+ +R+ID L+ +S++ A K LA CL + K RP M
Sbjct: 285 RPPGEQKLVEWARPLLANKRKLFRVIDNRLQDQYSMEEACKVATLALRCLTFEIKLRPNM 344
Query: 397 SEVVEALKPLPYLKD 411
+EVV L+ + L +
Sbjct: 345 NEVVSHLEHIQTLNE 359
|
Possible bi-functional kinase. In vitro, it exhibits serine/threonine activity. In vivo, can phosphorylate tyrosine residues of limited substrates. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P43293|NAK_ARATH Probable serine/threonine-protein kinase NAK OS=Arabidopsis thaliana GN=NAK PE=2 SV=2 | Back alignment and function description |
|---|
Score = 431 bits (1107), Expect = e-120, Method: Compositional matrix adjust.
Identities = 216/375 (57%), Positives = 275/375 (73%), Gaps = 20/375 (5%)
Query: 40 IGGCLSSSPKTDGANSGTSTQYAESKSTNDTSRGQPVVPIGSSSTTSNAESTTPSTPKIG 99
+GGC S+ KTD A +ST + + D S+G SST S + P+
Sbjct: 1 MGGCFSNRIKTDIA---SSTWLSSKFLSRDGSKG--------SSTASFS-----YMPRTE 44
Query: 100 EELKISPQLRKFSFNELKSATKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVA 159
E+ + L+ FS +ELKSAT++FRP+ ++GEGGFGCV+KGWI+ + A KPGTG+ +A
Sbjct: 45 GEILQNANLKNFSLSELKSATRNFRPDSVVGEGGFGCVFKGWIDESSLAPSKPGTGIVIA 104
Query: 160 VKTLNHDGLQGHKEWLAEVNYLGGLIHPNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLF 219
VK LN +G QGH+EWLAE+NYLG L HPNLVKLIG C+E++ RLLVYEFM RGSLENHLF
Sbjct: 105 VKRLNQEGFQGHREWLAEINYLGQLDHPNLVKLIGYCLEEEHRLLVYEFMTRGSLENHLF 164
Query: 220 RRSL---PLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFG 276
RR PL W+ R+++AL AA+GLAFLH A+ VIYRDFK SNILLD YNAKLSDFG
Sbjct: 165 RRGTFYQPLSWNTRVRMALGAARGLAFLHN-AQPQVIYRDFKASNILLDSNYNAKLSDFG 223
Query: 277 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKN 336
LA+DGP GD +HVSTRVMGT GYAAPEY+ TGHL+ KSDVYSFGVVLLE+L+GRR++DKN
Sbjct: 224 LARDGPMGDNSHVSTRVMGTQGYAAPEYLATGHLSVKSDVYSFGVVLLELLSGRRAIDKN 283
Query: 337 RPNGEHNLVEWARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRM 396
+P GEHNLV+WARP L +RR R++DP L+G +S+ A K LA C++ D K+RP M
Sbjct: 284 QPVGEHNLVDWARPYLTNKRRLLRVMDPRLQGQYSLTRALKIAVLALDCISIDAKSRPTM 343
Query: 397 SEVVEALKPLPYLKD 411
+E+V+ ++ L K+
Sbjct: 344 NEIVKTMEELHIQKE 358
|
May play a role in the regulation of plant growth and development. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8GXZ3|Y5102_ARATH Serine/threonine-protein kinase At5g01020 OS=Arabidopsis thaliana GN=At5g01020 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 427 bits (1099), Expect = e-119, Method: Compositional matrix adjust.
Identities = 214/325 (65%), Positives = 259/325 (79%), Gaps = 8/325 (2%)
Query: 86 SNAESTTPSTPKIGEELKIS---PQLRKFSFNELKSATKSFRPECLLGEGGFGCVYKGWI 142
S ++ + PSTP+ ++ + Q+ F+ EL++ TKSFRP+ +LGEGGFG VYKG+I
Sbjct: 29 SVSDLSDPSTPRFRDDSRTPISYAQVIPFTLFELETITKSFRPDYILGEGGFGTVYKGYI 88
Query: 143 NMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHPNLVKLIGCCIEDDQR 202
+ N +K LPVAVK LN +GLQGH+EWL EVN+LG L HPNLVKLIG C EDD R
Sbjct: 89 DDNLRVGLK---SLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHR 145
Query: 203 LLVYEFMPRGSLENHLFRRSL-PLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSN 261
LLVYEFM RGSLENHLFR++ PL WS RM IAL AAKGLAFLH AE+PVIYRDFKTSN
Sbjct: 146 LLVYEFMLRGSLENHLFRKTTAPLSWSRRMMIALGAAKGLAFLHN-AERPVIYRDFKTSN 204
Query: 262 ILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGV 321
ILLD +Y AKLSDFGLAK GP+GD+THVSTRVMGTYGYAAPEYVMTGHLTA+SDVYSFGV
Sbjct: 205 ILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGV 264
Query: 322 VLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQL 381
VLLEMLTGR+S+DK RP+ E NLV+WARP+L ++R+ ++IDP LE +S++ A+K L
Sbjct: 265 VLLEMLTGRKSVDKTRPSKEQNLVDWARPKLNDKRKLLQIIDPRLENQYSVRAAQKACSL 324
Query: 382 AASCLNRDQKARPRMSEVVEALKPL 406
A CL+++ KARP MS+VVE L+PL
Sbjct: 325 AYYCLSQNPKARPLMSDVVETLEPL 349
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O49840|APK2B_ARATH Protein kinase 2B, chloroplastic OS=Arabidopsis thaliana GN=APK2B PE=1 SV=1 | Back alignment and function description |
|---|
Score = 423 bits (1087), Expect = e-117, Method: Compositional matrix adjust.
Identities = 213/368 (57%), Positives = 267/368 (72%), Gaps = 3/368 (0%)
Query: 40 IGGCLSSSPKTDGANSGTSTQYAESKSTNDTSRGQPVVPIGSSSTTSNAESTTPSTPKIG 99
+G CL SS K D ++ A S + + VP S + ++ + P TP+
Sbjct: 1 MGNCLDSSAKVDSSSHSPHANSASLSSRVSSKTSRSTVPSSLSINSYSSVESLP-TPRTE 59
Query: 100 EELKISPQLRKFSFNELKSATKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVA 159
E+ SP L+ F+FNELK+AT++FRP+ LLGEGGFG V+KGWI+ KPG+G+ VA
Sbjct: 60 GEILSSPNLKAFTFNELKNATRNFRPDSLLGEGGFGYVFKGWIDGTTLTASKPGSGIVVA 119
Query: 160 VKTLNHDGLQGHKEWLAEVNYLGGLIHPNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLF 219
VK L +G QGHKEWL EVNYLG L HPNLVKL+G C+E + RLLVYEFMP+GSLENHLF
Sbjct: 120 VKKLKTEGYQGHKEWLTEVNYLGQLSHPNLVKLVGYCVEGENRLLVYEFMPKGSLENHLF 179
Query: 220 RR-SLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLA 278
RR + PL W+IRMK+A+ AAKGL FLH+ A+ VIYRDFK +NILLD E+N+KLSDFGLA
Sbjct: 180 RRGAQPLTWAIRMKVAIGAAKGLTFLHD-AKSQVIYRDFKAANILLDAEFNSKLSDFGLA 238
Query: 279 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRP 338
K GP GDKTHVST+VMGT+GYAAPEYV TG LTAKSDVYSFGVVLLE+L+GRR++DK++
Sbjct: 239 KAGPTGDKTHVSTQVMGTHGYAAPEYVATGRLTAKSDVYSFGVVLLELLSGRRAVDKSKV 298
Query: 339 NGEHNLVEWARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSE 398
E +LV+WA P LG++R+ +R++D L G + KGA LA CLN D K RP+MSE
Sbjct: 299 GMEQSLVDWATPYLGDKRKLFRIMDTRLGGQYPQKGAYTAASLALQCLNPDAKLRPKMSE 358
Query: 399 VVEALKPL 406
V+ L L
Sbjct: 359 VLAKLDQL 366
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O49839|APK2A_ARATH Protein kinase 2A, chloroplastic OS=Arabidopsis thaliana GN=APK2A PE=2 SV=1 | Back alignment and function description |
|---|
Score = 413 bits (1061), Expect = e-114, Method: Compositional matrix adjust.
Identities = 228/437 (52%), Positives = 291/437 (66%), Gaps = 15/437 (3%)
Query: 40 IGGCLSSSPKTDGANSGTSTQYAESKSTNDTSRGQPVVPIGSSSTTSNAESTTPSTPKIG 99
+G CL SS K D +N A S S + + P G S+T+ + +S+ P +
Sbjct: 1 MGNCLDSSAKVDNSNHSPHANSASSGSKVSSKTSRSTGPSGLSTTSYSTDSSFGPLPTLR 60
Query: 100 EELKI--SPQLRKFSFNELKSATKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLP 157
E +I SP L+ F+FNELK+ATK+FR + LLGEGGFGCV+KGWI+ +PG+G+
Sbjct: 61 TEGEILSSPNLKAFTFNELKNATKNFRQDNLLGEGGFGCVFKGWIDQTSLTASRPGSGIV 120
Query: 158 VAVKTLNHDGLQGHKEWLAEVNYLGGLIHPNLVKLIGCCIEDDQRLLVYEFMPRGSLENH 217
VAVK L +G QGHKEWL EVNYLG L HPNLV L+G C E + RLLVYEFMP+GSLENH
Sbjct: 121 VAVKQLKPEGFQGHKEWLTEVNYLGQLSHPNLVLLVGYCAEGENRLLVYEFMPKGSLENH 180
Query: 218 LFRR-SLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFG 276
LFRR + PL W+IRMK+A+ AAKGL FLHE A+ VIYRDFK +NILLD ++NAKLSDFG
Sbjct: 181 LFRRGAQPLTWAIRMKVAVGAAKGLTFLHE-AKSQVIYRDFKAANILLDADFNAKLSDFG 239
Query: 277 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKN 336
LAK GP GD THVST+V+GT+GYAAPEYV TG LTAKSDVYSFGVVLLE+++GRR+MD +
Sbjct: 240 LAKAGPTGDNTHVSTKVIGTHGYAAPEYVATGRLTAKSDVYSFGVVLLELISGRRAMDNS 299
Query: 337 RPNGEHNLVEWARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRM 396
E++LV+WA P LG++R+ +R++D L G + KGA LA CLN D K RP+M
Sbjct: 300 NGGNEYSLVDWATPYLGDKRKLFRIMDTKLGGQYPQKGAFTAANLALQCLNPDAKLRPKM 359
Query: 397 SEVVEALKPLPYLKDMASSSSYVQAMQAERVRLNLNAKHGSRVPRKGQPTRSLSIPNAPH 456
SEV+ L+ L+ +A + M++ R H S V +K P R H
Sbjct: 360 SEVLVTLE---QLESVAKPGTKHTQMESPRF-------HHSSVMQK-SPVRYSHDRPLLH 408
Query: 457 VSPYHLNNPHYSPKPNV 473
++P P Y+ P V
Sbjct: 409 MTPGASPLPSYTQSPRV 425
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O48814|BIK1_ARATH Serine/threonine-protein kinase BIK1 OS=Arabidopsis thaliana GN=BIK1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 402 bits (1033), Expect = e-111, Method: Compositional matrix adjust.
Identities = 200/370 (54%), Positives = 260/370 (70%), Gaps = 21/370 (5%)
Query: 40 IGGCLSSSPKTDGANSGTSTQYAESKSTNDTSRGQPVVPIGSSSTTSNAESTTPSTPKIG 99
+G C SS K D ++G S+ G S ++ + ST + K
Sbjct: 1 MGSCFSSRVKADIFHNGKSSDL-----------------YGLSLSSRKSSSTVAAAQKTE 43
Query: 100 EELKISPQLRKFSFNELKSATKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVA 159
E+ S ++ F+FNELK AT++FRP+ ++GEGGFGCV+KGW++ + KPGTGL +A
Sbjct: 44 GEILSSTPVKSFTFNELKLATRNFRPDSVIGEGGFGCVFKGWLDESTLTPTKPGTGLVIA 103
Query: 160 VKTLNHDGLQGHKEWLAEVNYLGGLIHPNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLF 219
VK LN +G QGH+EWL E+NYLG L HPNLVKLIG C+ED+ RLLVYEFM +GSLENHLF
Sbjct: 104 VKKLNQEGFQGHREWLTEINYLGQLSHPNLVKLIGYCLEDEHRLLVYEFMQKGSLENHLF 163
Query: 220 RRSL---PLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFG 276
RR PLPW +R+ +ALDAAKGLAFLH + K VIYRD K SNILLD +YNAKLSDFG
Sbjct: 164 RRGAYFKPLPWFLRVNVALDAAKGLAFLHSDPVK-VIYRDIKASNILLDADYNAKLSDFG 222
Query: 277 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKN 336
LA+DGP GD ++VSTRVMGTYGYAAPEY+ +GHL A+SDVYSFGV+LLE+L+G+R++D N
Sbjct: 223 LARDGPMGDLSYVSTRVMGTYGYAAPEYMSSGHLNARSDVYSFGVLLLEILSGKRALDHN 282
Query: 337 RPNGEHNLVEWARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRM 396
RP E NLV+WARP L +R+ ++D L+ + + A + +A CL+ + K+RP M
Sbjct: 283 RPAKEENLVDWARPYLTSKRKVLLIVDNRLDTQYLPEEAVRMASVAVQCLSFEPKSRPTM 342
Query: 397 SEVVEALKPL 406
+VV AL+ L
Sbjct: 343 DQVVRALQQL 352
|
Required to activate the resistance responses to necrotrophic pathogens. Phosphorylates FLS2 and BAK1. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8H186|Y3545_ARATH Probable receptor-like protein kinase At3g55450 OS=Arabidopsis thaliana GN=At3g55450 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 388 bits (996), Expect = e-107, Method: Compositional matrix adjust.
Identities = 185/310 (59%), Positives = 234/310 (75%), Gaps = 5/310 (1%)
Query: 101 ELKISPQLRKFSFNELKSATKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAV 160
E+ S ++ FSFNELK AT++FR + ++GEGGFGCV++GW++ K +GL +AV
Sbjct: 39 EILSSTTVKSFSFNELKLATRNFRSDSVVGEGGFGCVFRGWLDETTLTPTKSSSGLVIAV 98
Query: 161 KTLNHDGLQGHKEWLAEVNYLGGLIHPNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLF- 219
K LN DG QGH+EWL E+NYLG L HPNLVKLIG C+ED+QRLLVYEFM +GSLENHLF
Sbjct: 99 KRLNPDGFQGHREWLTEINYLGQLSHPNLVKLIGYCLEDEQRLLVYEFMHKGSLENHLFA 158
Query: 220 ---RRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFG 276
+ PL W +R+K+ALDAAKGLAFLH + K VIYRD K SNILLD ++NAKLSDFG
Sbjct: 159 NGNKDFKPLSWILRIKVALDAAKGLAFLHSDPVK-VIYRDIKASNILLDSDFNAKLSDFG 217
Query: 277 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKN 336
LA+DGP G++++VSTRVMGT+GYAAPEYV TGHL A+SDVYSFGVVLLE+L GR+++D N
Sbjct: 218 LARDGPMGEQSYVSTRVMGTFGYAAPEYVSTGHLNARSDVYSFGVVLLELLCGRQALDHN 277
Query: 337 RPNGEHNLVEWARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRM 396
RP E NLV+WARP L RR+ ++D L + +GA + +A CL+ + K+RP M
Sbjct: 278 RPAKEQNLVDWARPYLTSRRKVLLIVDTRLNSQYKPEGAVRLASIAVQCLSFEPKSRPTM 337
Query: 397 SEVVEALKPL 406
+VV AL L
Sbjct: 338 DQVVRALVQL 347
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 476 | ||||||
| 359488899 | 475 | PREDICTED: probable receptor-like protei | 0.987 | 0.989 | 0.789 | 0.0 | |
| 359473277 | 481 | PREDICTED: probable receptor-like protei | 0.987 | 0.977 | 0.770 | 0.0 | |
| 255558222 | 495 | Protein kinase APK1B, chloroplast precur | 0.993 | 0.955 | 0.742 | 0.0 | |
| 356567562 | 487 | PREDICTED: probable receptor-like protei | 0.926 | 0.905 | 0.793 | 0.0 | |
| 351722951 | 485 | serine/threonine protein kinase-like pro | 0.926 | 0.909 | 0.787 | 0.0 | |
| 356526888 | 487 | PREDICTED: probable receptor-like protei | 0.926 | 0.905 | 0.784 | 0.0 | |
| 356498172 | 491 | PREDICTED: probable receptor-like protei | 0.922 | 0.894 | 0.784 | 0.0 | |
| 147857978 | 495 | hypothetical protein VITISV_008843 [Viti | 0.989 | 0.951 | 0.742 | 0.0 | |
| 357486605 | 492 | Serine/threonine protein kinase-like pro | 0.928 | 0.898 | 0.781 | 0.0 | |
| 449434823 | 488 | PREDICTED: probable receptor-like protei | 0.926 | 0.903 | 0.770 | 0.0 |
| >gi|359488899|ref|XP_003633841.1| PREDICTED: probable receptor-like protein kinase At5g15080-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 758 bits (1957), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 376/476 (78%), Positives = 406/476 (85%), Gaps = 6/476 (1%)
Query: 1 MGLGLEDFNGGALNVDKSKSKKKKDGESGVTGCWIKFRFIGGCLSSSPKTDGANSGTSTQ 60
MGLG + G V SK +KKKD E TGCWIKFRF+G C+S+ K + + S +STQ
Sbjct: 1 MGLGPDAIQVGNWEVGNSKGRKKKDDEEEATGCWIKFRFMGSCMSARSKVESSVSSSSTQ 60
Query: 61 YAESKSTNDTSRGQPVVPIGSSSTTSNAESTTPSTPKIGEELKISPQLRKFSFNELKSAT 120
YAESKSTNDTSR QPV P+ SSSTTSN EST PSTP GEELK++ QLRKF+FNELKSAT
Sbjct: 61 YAESKSTNDTSRDQPVAPVVSSSTTSNGEST-PSTPNTGEELKVASQLRKFTFNELKSAT 119
Query: 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNY 180
++FRPE LLGEGGFGCV+KGWIN GT VKPGTGL VAVKTLNHDGLQGHKEWLAEVN+
Sbjct: 120 RNFRPESLLGEGGFGCVFKGWINGTGTTPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNF 179
Query: 181 LGGLIHPNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKG 240
LG L+HPNLVKLIG CIEDDQRLLVYEFMPRGSLENHLFRR+LPLPWSIRMKIAL AAKG
Sbjct: 180 LGDLLHPNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRALPLPWSIRMKIALGAAKG 239
Query: 241 LAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYA 300
LAFLHEEAE+PVIYRDFKTSNILLD +YNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYA
Sbjct: 240 LAFLHEEAERPVIYRDFKTSNILLDVDYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYA 299
Query: 301 APEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRRFYR 360
APEYVMTGHLT+KSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP LGERRRFYR
Sbjct: 300 APEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYR 359
Query: 361 LIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDMASSSSYVQ 420
L+DP LEG FSIKGA+K QLAA CL+RD KARP MSEVVEALKPLP LKDMASSSS+ Q
Sbjct: 360 LLDPRLEGRFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPNLKDMASSSSFFQ 419
Query: 421 AMQAERVRLNLNAKHGSR-----VPRKGQPTRSLSIPNAPHVSPYHLNNPHYSPKP 471
MQAER N++ G R + R GQP RSLS+PN PH SPY+ NNPH SPKP
Sbjct: 420 TMQAERTGSTPNSRSGIRAQAGFLSRNGQPNRSLSMPNGPHASPYNHNNPHRSPKP 475
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359473277|ref|XP_003631281.1| PREDICTED: probable receptor-like protein kinase At5g15080-like [Vitis vinifera] gi|296086431|emb|CBI32020.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 736 bits (1899), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 370/480 (77%), Positives = 403/480 (83%), Gaps = 10/480 (2%)
Query: 1 MGLGLEDFNGGALNVDKSKSKKKKDGESGVTGC-WIKFRFIGGCLSSSPKTDGANSGTST 59
MGLG D + V KSK +KKKDG TGC W+K RF+ C+SS K D + SGTST
Sbjct: 1 MGLGGNDVKVESWEVGKSKGRKKKDGGEEETGCCWVKLRFMASCISSRSKVDSSISGTST 60
Query: 60 QYAESKSTNDTSRGQPVVPIGSSSTTSNAESTTPSTPKIGEELKISPQLRKFSFNELKSA 119
Y E++STNDTSR QPV P+ SS+TTSNAES + ST K+ EELK++ +LRKFSFN+LK A
Sbjct: 61 HY-ENRSTNDTSRDQPVAPVVSSTTTSNAESNS-STSKLEEELKVASRLRKFSFNDLKMA 118
Query: 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVN 179
T++FRPE LLGEGGFGCV+KGWI NGTA VKPGTGL VAVKTLNHDGLQGHKEWLAEVN
Sbjct: 119 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVN 178
Query: 180 YLGGLIHPNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAK 239
+LG LIHPNLVKLIG CIEDDQRLLVYEFMPRGSLENHLFRR+LPLPW+IRMKIAL AAK
Sbjct: 179 FLGDLIHPNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRALPLPWAIRMKIALGAAK 238
Query: 240 GLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGY 299
GLAFLHEEAE+PVIYRDFKTSNILLD EYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGY
Sbjct: 239 GLAFLHEEAERPVIYRDFKTSNILLDAEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGY 298
Query: 300 AAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRRFY 359
AAPEYVMTGHLT++SDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP LGERRRFY
Sbjct: 299 AAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFY 358
Query: 360 RLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDMASSSSYV 419
RLIDP LEG FSIKGA+K QLAA CL+RD K RP MSEVVEALKPLP LKDMASSS Y
Sbjct: 359 RLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKVRPLMSEVVEALKPLPNLKDMASSSYYF 418
Query: 420 QAMQAERVRLNLNAKHGSR-----VPRKG-QPTRSLSIPNAPHVSPYHLNN-PHYSPKPN 472
Q MQAER+ + NA++G R + R G Q RSLSIPN H SPYH N P+ SPKPN
Sbjct: 419 QTMQAERIGSSPNARNGVRTQQGILSRNGHQQQRSLSIPNGSHASPYHQNQYPYQSPKPN 478
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255558222|ref|XP_002520138.1| Protein kinase APK1B, chloroplast precursor, putative [Ricinus communis] gi|223540630|gb|EEF42193.1| Protein kinase APK1B, chloroplast precursor, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 726 bits (1875), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 369/497 (74%), Positives = 400/497 (80%), Gaps = 24/497 (4%)
Query: 1 MGLGLEDFNGGALNV-----DKSKSKKKKDG-------------ESGVTGCWIKFRFIGG 42
MGLG ED N + K ++KKK+D E TGCW KFRFIG
Sbjct: 1 MGLGSEDGNRAKASSWEVCKPKGRNKKKQDVSNSSGGASPGDVVEEAETGCWFKFRFIGS 60
Query: 43 CLSSSPKTDGANSGTSTQYAESKSTNDTSRGQPVVPIGSSSTTSNAESTTPSTPKIGEEL 102
C+SS K D + SGTST + ESKSTNDTSR QP P SS+TTSNAES + ST K+ EEL
Sbjct: 61 CISSRSKVDSSVSGTST-HCESKSTNDTSRDQPTAPTISSTTTSNAESNS-STSKLEEEL 118
Query: 103 KISPQLRKFSFNELKSATKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKT 162
KI+ +LRKF+FN+LK AT++FRPE LLGEGGFGCV+KGWI NGTA VKPGTGL VAVKT
Sbjct: 119 KIASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKT 178
Query: 163 LNHDGLQGHKEWLAEVNYLGGLIHPNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRS 222
LNHDGLQGHKEWLAEVNYLG L+HPNLVKLIG CIEDDQRLLVYEFMPRGSLENHLFRRS
Sbjct: 179 LNHDGLQGHKEWLAEVNYLGDLVHPNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS 238
Query: 223 LPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGP 282
LPLPWSIRMKIAL AAKGLAFLHEEAE+PVIYRDFKTSNILLD +YNAKLSDFGLAKDGP
Sbjct: 239 LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGP 298
Query: 283 EGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEH 342
EGDKTHVSTRVMGTYGYAAPEYVMTGHLT++SDVYSFGVVLLEM+TGRRSMDKNRP GEH
Sbjct: 299 EGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMITGRRSMDKNRPIGEH 358
Query: 343 NLVEWARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEA 402
NLVEWARP LGERRRFYRLIDP LEG FSIKGA+K QLAA CL+RD KARP MSEVVE
Sbjct: 359 NLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEV 418
Query: 403 LKPLPYLKDMASSSSYVQAMQAERVRLNLNAKHGSRVP----RKGQPTRSLSIPNAPHVS 458
LKPLP LKDMASSS Y Q+MQA+++ + NAK +R R GQ RSLSIPN H S
Sbjct: 419 LKPLPNLKDMASSSYYFQSMQADKIASSPNAKSSNRTQGGLLRNGQQQRSLSIPNGSHAS 478
Query: 459 PYHLNNPHYSPKPNVSQ 475
PYH P SPKPN Q
Sbjct: 479 PYHHQYPFQSPKPNGKQ 495
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356567562|ref|XP_003551987.1| PREDICTED: probable receptor-like protein kinase At5g15080-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 723 bits (1865), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 354/446 (79%), Positives = 381/446 (85%), Gaps = 5/446 (1%)
Query: 31 TGCWIKFRFIGGCLSSSPKTDGANSGTSTQYAESKSTNDTSRGQPVVPIGSSSTTSNAES 90
TGCW + RFIG C+SS K D + SGTST YAESKST DTSR QP VP+ SS+TTSNAES
Sbjct: 40 TGCWFRLRFIGSCISSRSKVDSSVSGTSTNYAESKSTIDTSRDQPTVPVVSSTTTSNAES 99
Query: 91 TTPSTPKIGEELKISPQLRKFSFNELKSATKSFRPECLLGEGGFGCVYKGWINMNGTATV 150
+ ST K+ EE K+S +LRKF+FN+LK AT++FRPE LLGEGGFGCV+KGWI NGTA V
Sbjct: 100 NS-STSKLEEEFKVSSRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPV 158
Query: 151 KPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHPNLVKLIGCCIEDDQRLLVYEFMP 210
KPGTGL VAVKTLNHDGLQGHKEWLAEVNYLG L+HP+LVKLIG CIEDDQRLLVYEFMP
Sbjct: 159 KPGTGLTVAVKTLNHDGLQGHKEWLAEVNYLGDLVHPHLVKLIGYCIEDDQRLLVYEFMP 218
Query: 211 RGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNA 270
RGSLENHLFRRSLPLPWSIRMKIAL AAKGLAFLHEEAE+PVIYRDFKTSNILLD EYNA
Sbjct: 219 RGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAEYNA 278
Query: 271 KLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGR 330
KLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLT++SDVYSFGVVLLEMLTGR
Sbjct: 279 KLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 338
Query: 331 RSMDKNRPNGEHNLVEWARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQ 390
RSMDKNRPNGEHNLVEWARP LGERRRFYRLIDP LEG FSIKGA+K LAA CL+RD
Sbjct: 339 RSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAHLAAHCLSRDP 398
Query: 391 KARPRMSEVVEALKPLPYLKDMASSSSYVQAMQAERVRLNLNAK----HGSRVPRKGQPT 446
KARP MSEVVEALKPLP LKDMASSS Y Q MQA+R + N + G+ + R GQ
Sbjct: 399 KARPLMSEVVEALKPLPNLKDMASSSYYFQTMQADRFSASPNTRNGRTQGALLTRNGQQQ 458
Query: 447 RSLSIPNAPHVSPYHLNNPHYSPKPN 472
RSLSIP+ H SPYH P SPKPN
Sbjct: 459 RSLSIPHGTHASPYHHQFPQPSPKPN 484
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|351722951|ref|NP_001235470.1| serine/threonine protein kinase-like protein [Glycine max] gi|223452506|gb|ACM89580.1| serine/threonine protein kinase-like protein [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 721 bits (1862), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 352/447 (78%), Positives = 382/447 (85%), Gaps = 6/447 (1%)
Query: 32 GCWIKFRFIGGCLSSSPKTDGA--NSGTSTQYAESKSTNDTSRGQPVVPIGSSSTTSNAE 89
GCW++ RFIG C+SS K D + SGTST YAESKSTNDTSR QP P SS+TTSNAE
Sbjct: 36 GCWVRLRFIGSCISSRSKVDTSVSGSGTSTHYAESKSTNDTSRDQPTAPAVSSTTTSNAE 95
Query: 90 STTPSTPKIGEELKISPQLRKFSFNELKSATKSFRPECLLGEGGFGCVYKGWINMNGTAT 149
S + ST K+ EELKI+ +LRKFSFNELK AT++FRPE LGEGGFGCV+KGWI NGTA
Sbjct: 96 SNSSSTSKLEEELKIASRLRKFSFNELKLATRNFRPESFLGEGGFGCVFKGWIEENGTAP 155
Query: 150 VKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHPNLVKLIGCCIEDDQRLLVYEFM 209
VKPGTGL VAVKTLNHDGLQGHKEWLAEVN+LG L+HPNLVKL+G CIE+DQRLLVYEFM
Sbjct: 156 VKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHPNLVKLVGYCIEEDQRLLVYEFM 215
Query: 210 PRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYN 269
PRGSLENHLFRRS+PLPWSIRMKIAL AAKGLAFLHEEAE+PVIYRDFKTSNILLD EYN
Sbjct: 216 PRGSLENHLFRRSIPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAEYN 275
Query: 270 AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTG 329
AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLT+KSDVYSFGVVLLEMLTG
Sbjct: 276 AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 335
Query: 330 RRSMDKNRPNGEHNLVEWARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRD 389
RRSMDK+RPNGEHNLVEWARP LGERRRFYRLIDP LEG FS+KGA+K LAA CL+RD
Sbjct: 336 RRSMDKHRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSVKGAQKAALLAAHCLSRD 395
Query: 390 QKARPRMSEVVEALKPLPYLKDMASSSSYVQAMQAERVRLNLNAK----HGSRVPRKGQP 445
KARP MSEVVEALKPLP LKDMASSS Y QAMQA+R+ + N + G+ + R GQ
Sbjct: 396 PKARPLMSEVVEALKPLPNLKDMASSSYYFQAMQADRIGASPNTRNGRMQGALLTRNGQQ 455
Query: 446 TRSLSIPNAPHVSPYHLNNPHYSPKPN 472
RSLSIPN + SPYH P SPKPN
Sbjct: 456 QRSLSIPNGTYASPYHHQFPQPSPKPN 482
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356526888|ref|XP_003532048.1| PREDICTED: probable receptor-like protein kinase At5g15080-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 717 bits (1850), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 350/446 (78%), Positives = 382/446 (85%), Gaps = 5/446 (1%)
Query: 31 TGCWIKFRFIGGCLSSSPKTDGANSGTSTQYAESKSTNDTSRGQPVVPIGSSSTTSNAES 90
TGCW + RFIG C+SS K D + SGTST YAESKST DTSR QP + + SS+TTSNAES
Sbjct: 40 TGCWFRLRFIGSCISSRSKVDSSVSGTSTNYAESKSTIDTSRDQPTLRVVSSTTTSNAES 99
Query: 91 TTPSTPKIGEELKISPQLRKFSFNELKSATKSFRPECLLGEGGFGCVYKGWINMNGTATV 150
+ ST K+ EELK++ +LRKF+FN+LK AT++FRPE LLGEGGFGCV+KGWI NGTA V
Sbjct: 100 NS-STSKLEEELKVASRLRKFAFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPV 158
Query: 151 KPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHPNLVKLIGCCIEDDQRLLVYEFMP 210
KPGTGL VAVKTLNHDGLQGHKEWLAEVNYLG L+HP+LVKLIG CIEDDQRLLVYEFMP
Sbjct: 159 KPGTGLTVAVKTLNHDGLQGHKEWLAEVNYLGDLVHPHLVKLIGYCIEDDQRLLVYEFMP 218
Query: 211 RGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNA 270
RGSLENHLFRRSLPLPWSIRMKIAL AAKGLAFLHEEAE+PVIYRDFKTSNILLD EYN+
Sbjct: 219 RGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAEYNS 278
Query: 271 KLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGR 330
KLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLT++SDVYSFGVVLLEMLTGR
Sbjct: 279 KLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 338
Query: 331 RSMDKNRPNGEHNLVEWARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQ 390
RSMDKNRPNGEHNLVEWARP LGERRRFY+LIDP LEG FSIKGA+K LAA CL+RD
Sbjct: 339 RSMDKNRPNGEHNLVEWARPHLGERRRFYKLIDPRLEGHFSIKGAQKAAHLAAHCLSRDP 398
Query: 391 KARPRMSEVVEALKPLPYLKDMASSSSYVQAMQAERVRLNLNAK----HGSRVPRKGQPT 446
KARP MSEVVEALKPLP LKDMASSS Y Q MQA+R ++ N + G+ + R GQ
Sbjct: 399 KARPLMSEVVEALKPLPNLKDMASSSYYFQTMQADRFSVSPNTRNGRTQGALLTRNGQQQ 458
Query: 447 RSLSIPNAPHVSPYHLNNPHYSPKPN 472
RSLSIP+ H SPYH P SPKPN
Sbjct: 459 RSLSIPHGTHASPYHHQFPQPSPKPN 484
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356498172|ref|XP_003517927.1| PREDICTED: probable receptor-like protein kinase At5g15080-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 714 bits (1843), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 350/446 (78%), Positives = 381/446 (85%), Gaps = 7/446 (1%)
Query: 33 CWIKFRFIGGCLSSSPKTDGA--NSGTSTQYAESKSTNDTSRGQPVVPIGSSSTTSNAES 90
CW++ RFIG C+SS K D + SG ST YAESKSTNDTSR QP P SS+TTSNAES
Sbjct: 44 CWVRLRFIGSCISSRSKVDTSVSASGISTHYAESKSTNDTSRDQPTAPAVSSTTTSNAES 103
Query: 91 TTPSTPKIGEELKISPQLRKFSFNELKSATKSFRPECLLGEGGFGCVYKGWINMNGTATV 150
+ ST K+ EELKI+ +LRKFSFN+LKSAT++FRPE LGEGGFGCV+KGWI NGTA V
Sbjct: 104 NS-STSKLEEELKIASRLRKFSFNDLKSATRNFRPESFLGEGGFGCVFKGWIEENGTAPV 162
Query: 151 KPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHPNLVKLIGCCIEDDQRLLVYEFMP 210
KPGTGL VAVKTLNHDGLQGHKEWLAEVN+LG L+HPNLVKL+G CIEDDQRLLVYEFMP
Sbjct: 163 KPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHPNLVKLVGYCIEDDQRLLVYEFMP 222
Query: 211 RGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNA 270
RGSLENHLFRRS+PLPWSIRMKIAL AAKGLAFLHEEAE+PVIYRDFKTSNILLD +YNA
Sbjct: 223 RGSLENHLFRRSMPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNA 282
Query: 271 KLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGR 330
KLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLT+KSDVYSFGVVLLEMLTGR
Sbjct: 283 KLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGR 342
Query: 331 RSMDKNRPNGEHNLVEWARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQ 390
RSMDK+RPNGEHNLVEWARP LGERRRFYRLIDP LEG FS+KGA+K QLAA CL+RD
Sbjct: 343 RSMDKHRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSVKGAQKAAQLAAHCLSRDP 402
Query: 391 KARPRMSEVVEALKPLPYLKDMASSSSYVQAMQAERVRLNLNAK----HGSRVPRKGQPT 446
K+RP MSEVVEALKPLP LKDMASSS Y QAMQA+R + N + G+ + R GQ
Sbjct: 403 KSRPLMSEVVEALKPLPSLKDMASSSYYFQAMQADRFGASPNTRNGRMQGALLTRNGQQQ 462
Query: 447 RSLSIPNAPHVSPYHLNNPHYSPKPN 472
RSLSIPN + SPYH P SPKPN
Sbjct: 463 RSLSIPNGTYASPYHHQFPQPSPKPN 488
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147857978|emb|CAN82516.1| hypothetical protein VITISV_008843 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 714 bits (1843), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 366/493 (74%), Positives = 398/493 (80%), Gaps = 22/493 (4%)
Query: 1 MGLGLEDFNGGALNVDKSKSKKKKDGESGVTGC-WIKFRFIGGCLSSSPKTDGANSGTST 59
MGLG D + V KSK +KKKDG TGC W+K RF+ C+SS K D + SGTST
Sbjct: 1 MGLGGNDVKVESWEVGKSKGRKKKDGGEEETGCCWVKLRFMASCISSRSKVDSSISGTST 60
Query: 60 QY-------AESKSTN------DTSRGQPVVPIGSSSTTSNAESTTPSTPKIGEELKISP 106
Y E +S N R QPV P+ SS+TTSNAES + ST K+ EELK++
Sbjct: 61 HYDLGVXFDVEPRSLNVFWCDFGLCRDQPVAPVVSSTTTSNAESNS-STSKLEEELKVAS 119
Query: 107 QLRKFSFNELKSATKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHD 166
+LRKFSFN+LK AT++FRPE LLGEGGFGCV+KGWI NGTA VKPGTGL VAVKTLNHD
Sbjct: 120 RLRKFSFNDLKMATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD 179
Query: 167 GLQGHKEWLAEVNYLGGLIHPNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLP 226
GLQGHKEWLAEVN+LG LIHPNLVKLIG CIEDDQRLLVYEFMPRGSLENHLFRR+LPLP
Sbjct: 180 GLQGHKEWLAEVNFLGDLIHPNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRALPLP 239
Query: 227 WSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDK 286
W+IRMKIAL AAKGLAFLHEEAE+PVIYRDFKTSNILLD EYNAKLSDFGLAKDGPEGDK
Sbjct: 240 WAIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAEYNAKLSDFGLAKDGPEGDK 299
Query: 287 THVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVE 346
THVSTRVMGTYGYAAPEYVMTGHLT++SDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVE
Sbjct: 300 THVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVE 359
Query: 347 WARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPL 406
WARP LGERRRFYRLIDP LEG FSIKGA+K QLAA CL+RD K RP MSEVVEALKPL
Sbjct: 360 WARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKVRPLMSEVVEALKPL 419
Query: 407 PYLKDMASSSSYVQAMQAERVRLNLNAKHGSR-----VPRKG-QPTRSLSIPNAPHVSPY 460
P LKDMASSS Y Q MQAER+ + NA++G R + R G Q RSLSIPN H SPY
Sbjct: 420 PNLKDMASSSYYFQTMQAERIGSSPNARNGVRTQQGILSRNGHQQQRSLSIPNGSHASPY 479
Query: 461 HLNN-PHYSPKPN 472
H N P+ SPKPN
Sbjct: 480 HQNQYPYQSPKPN 492
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357486605|ref|XP_003613590.1| Serine/threonine protein kinase-like protein [Medicago truncatula] gi|355514925|gb|AES96548.1| Serine/threonine protein kinase-like protein [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 709 bits (1830), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 351/449 (78%), Positives = 382/449 (85%), Gaps = 7/449 (1%)
Query: 31 TGCWIKFRFIGGCLSSSPKTDGANSGTST--QYAESKSTNDTSRGQPVVPIGSSSTTSNA 88
TGCW+ RFIG C+SS K D + SG+ T YAESKSTNDTSRGQ P+ SS+TTSNA
Sbjct: 43 TGCWVGLRFIGSCISSRSKVDSSVSGSGTSTHYAESKSTNDTSRGQRTAPVISSTTTSNA 102
Query: 89 ESTTPSTPKIGEELKISPQLRKFSFNELKSATKSFRPECLLGEGGFGCVYKGWINMNGTA 148
ES + ST K+ EELKI+ +LRKFSFNELK AT++FRPE LGEGGFGCV+KGWI NGTA
Sbjct: 103 ESNS-STTKLEEELKIASRLRKFSFNELKLATRNFRPESFLGEGGFGCVFKGWIEENGTA 161
Query: 149 TVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHPNLVKLIGCCIEDDQRLLVYEF 208
VKPGTGL VAVKTLNHDGLQGHKEWLAEVN+LG L+H NLVKLIG CIEDDQRLLVYEF
Sbjct: 162 PVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHQNLVKLIGYCIEDDQRLLVYEF 221
Query: 209 MPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEY 268
MPRGSLENHLFRRS+PLPWSIRMKIAL AAKGLAFLHEEAE+PVIYRDFKTSNILLD +Y
Sbjct: 222 MPRGSLENHLFRRSMPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADY 281
Query: 269 NAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLT 328
NAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLT+KSDVYSFGVVLLEM++
Sbjct: 282 NAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMIS 341
Query: 329 GRRSMDKNRPNGEHNLVEWARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNR 388
GRRSMDK+RPNGEHNLVEWARP LGERRRFYRLIDP LEG FS+KGA+K QLA CL+R
Sbjct: 342 GRRSMDKHRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSVKGAQKAAQLAHHCLSR 401
Query: 389 DQKARPRMSEVVEALKPLPYLKDMASSSSYVQAMQAERVRLNLNAK----HGSRVPRKGQ 444
D KARP MSEVVEAL PLP LKDMASSS Y Q+MQAER + N++ G+ + R GQ
Sbjct: 402 DPKARPLMSEVVEALMPLPNLKDMASSSYYFQSMQAERFGASPNSRSVHAQGASLARNGQ 461
Query: 445 PTRSLSIPNAPHVSPYHLNNPHYSPKPNV 473
RSLSIPN HVSPYH P SPKPNV
Sbjct: 462 QRRSLSIPNGAHVSPYHHKYPQQSPKPNV 490
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449434823|ref|XP_004135195.1| PREDICTED: probable receptor-like protein kinase At5g15080-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 702 bits (1813), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 346/449 (77%), Positives = 376/449 (83%), Gaps = 8/449 (1%)
Query: 32 GCWIKFRFIGGCLSSSPKTDGANSGTSTQYAESKSTNDTSRGQPVVPIGSSSTTS--NAE 89
GCWI R G C+SS K D + SGTS YAESKST D+SR QP SS+ TS N E
Sbjct: 39 GCWIALRIFGSCISSRSKVDSSISGTSINYAESKSTADSSRDQPTPREISSTNTSMSNGE 98
Query: 90 STTPSTPKIGEELKISPQLRKFSFNELKSATKSFRPECLLGEGGFGCVYKGWINMNGTAT 149
S + ST K+ EELKISP LRKFSFN+LK AT++FRPE LLGEGGFGCV+KGW+ NGTA
Sbjct: 99 SNS-STSKLEEELKISPHLRKFSFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAP 157
Query: 150 VKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHPNLVKLIGCCIEDDQRLLVYEFM 209
VKPGTGL VAVKTLNHDGLQGHKEW+AEVN+L L HPNLV+LIG C EDDQRLLVYEFM
Sbjct: 158 VKPGTGLTVAVKTLNHDGLQGHKEWMAEVNFLSDLKHPNLVRLIGYCNEDDQRLLVYEFM 217
Query: 210 PRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYN 269
PRGSLENHLFRRSLPLPWSIRMKIAL AAKGLAFLHEEA++PVIYRDFKTSNILLD EYN
Sbjct: 218 PRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAKRPVIYRDFKTSNILLDAEYN 277
Query: 270 AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTG 329
AKLSDFGLAKDGP+GDKTHVSTRVMGTYGYAAPEYVMTGHLT++SDVYSFGVVLLEMLTG
Sbjct: 278 AKLSDFGLAKDGPDGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 337
Query: 330 RRSMDKNRPNGEHNLVEWARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRD 389
RRSMDKNRPNGEHNLVEWARP LGE++RFYRLIDP LEG FSIKGA+K +QLAA CL+RD
Sbjct: 338 RRSMDKNRPNGEHNLVEWARPYLGEKKRFYRLIDPRLEGHFSIKGAQKAVQLAAQCLSRD 397
Query: 390 QKARPRMSEVVEALKPLPYLKDMASSSSYVQAMQAERVRLNLNAKHG-----SRVPRKGQ 444
QK RP MSEVVEALKPLP LKDMASSS Y Q MQA+RVR + A++G +VP+ GQ
Sbjct: 398 QKVRPLMSEVVEALKPLPNLKDMASSSYYFQTMQADRVRSSPMARNGYHTAAGQVPKNGQ 457
Query: 445 PTRSLSIPNAPHVSPYHLNNPHYSPKPNV 473
RS SI N H SPYH PH SPKPNV
Sbjct: 458 QLRSYSIANGSHASPYHHQQPHPSPKPNV 486
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 476 | ||||||
| TAIR|locus:2147805 | 493 | AT5G15080 [Arabidopsis thalian | 0.966 | 0.933 | 0.677 | 5e-163 | |
| TAIR|locus:2100282 | 490 | AT3G01300 [Arabidopsis thalian | 0.924 | 0.897 | 0.703 | 4e-161 | |
| TAIR|locus:2095517 | 453 | AT3G28690 [Arabidopsis thalian | 0.930 | 0.977 | 0.668 | 7e-157 | |
| TAIR|locus:2012492 | 426 | APK2A "protein kinase 2A" [Ara | 0.886 | 0.990 | 0.514 | 4.3e-109 | |
| TAIR|locus:2058847 | 426 | APK2B "protein kinase 2B" [Ara | 0.888 | 0.992 | 0.523 | 5.5e-109 | |
| TAIR|locus:2053240 | 423 | PK1B "protein kinase 1B" [Arab | 0.661 | 0.744 | 0.652 | 5.5e-109 | |
| TAIR|locus:2180127 | 389 | NAK [Arabidopsis thaliana (tax | 0.764 | 0.935 | 0.554 | 6.3e-108 | |
| TAIR|locus:2150019 | 410 | AT5G01020 [Arabidopsis thalian | 0.621 | 0.721 | 0.694 | 1e-107 | |
| TAIR|locus:2039772 | 395 | BIK1 "botrytis-induced kinase1 | 0.642 | 0.774 | 0.607 | 1.4e-103 | |
| TAIR|locus:2205050 | 387 | AT1G69790 [Arabidopsis thalian | 0.796 | 0.979 | 0.523 | 1.4e-101 |
| TAIR|locus:2147805 AT5G15080 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1587 (563.7 bits), Expect = 5.0e-163, P = 5.0e-163
Identities = 321/474 (67%), Positives = 359/474 (75%)
Query: 6 EDFNGGALNVDXXXXXXXXDGESGVTGCWIKFRFIGGCLSSSPKTDGANS---GTSTQYA 62
E+ N N D + E +GCW+KFRF+ GC+ S D ++S G++
Sbjct: 21 ENKNHKKKNGDDNKSRNEEEEEGEASGCWVKFRFMIGCIPSKSDLDASSSSIYGSNCTVT 80
Query: 63 --ESKSTNDTSRGQPVVPIGXXXXXXXXXXXXXXXPKIGEELKISPQLRKFSFNELKSAT 120
ESKS N+ S QPV + P I EEL IS LRKF+FN+LK +T
Sbjct: 81 TMESKSANEKSNDQPVGQVSSTTTTSNAESSSST-PVISEELNISSHLRKFTFNDLKLST 139
Query: 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNY 180
++FRPE LLGEGGFGCV+KGWI NGTA VKPGTGL VAVKTLN DGLQGHKEWLAE+N+
Sbjct: 140 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNPDGLQGHKEWLAEINF 199
Query: 181 LGGLIHPNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKG 240
LG L+HPNLVKL+G CIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL AAKG
Sbjct: 200 LGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKG 259
Query: 241 LAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYA 300
L+FLHEEA KPVIYRDFKTSNILLD +YNAKLSDFGLAKD P+ KTHVSTRVMGTYGYA
Sbjct: 260 LSFLHEEALKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPDEGKTHVSTRVMGTYGYA 319
Query: 301 APEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRRFYR 360
APEYVMTGHLT+KSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP L ++RRFYR
Sbjct: 320 APEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLLDKRRFYR 379
Query: 361 LIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDMASSSSYVQ 420
L+DP LEG FSIKGA+K QLAA CL+RD K RP+MS+VVEALKPLP+LKDMASSS Y Q
Sbjct: 380 LLDPRLEGHFSIKGAQKVTQLAAQCLSRDPKIRPKMSDVVEALKPLPHLKDMASSSYYFQ 439
Query: 421 AMQAERVRLNLNAKHGSRVPRKGQ--PT-RSLSIPNAPHVSPYHLNNPHYSPKP 471
MQAER++ G R GQ P R+LS P+ SPY P SPKP
Sbjct: 440 TMQAERLKNGSGRSQGFG-SRNGQHQPVFRTLSSPHGS--SPYRHQIP--SPKP 488
|
|
| TAIR|locus:2100282 AT3G01300 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1569 (557.4 bits), Expect = 4.0e-161, P = 4.0e-161
Identities = 316/449 (70%), Positives = 348/449 (77%)
Query: 27 ESGVTGCWIKFRFIGGCLSSSPKTDGANSGT-STQYAESKSTNDTSRGQPVVPIGXXXXX 85
E GCW+KFR+I C SS+ +D S T ST S+S S QPV P+
Sbjct: 42 EEEANGCWVKFRYIVCCASST--SDVETSLTLSTSTVGSQSAIVQSNDQPVGPVSSTTTT 99
Query: 86 XXXXXXXXXXPKIGEELKISPQLRKFSFNELKSATKSFRPECLLGEGGFGCVYKGWINMN 145
P I EEL I L+KFSF +LK AT++FRPE LLGEGGFGCV+KGW+ N
Sbjct: 100 SNAESSLST-PIISEELNIYSHLKKFSFIDLKLATRNFRPESLLGEGGFGCVFKGWVEEN 158
Query: 146 GTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHPNLVKLIGCCIEDDQRLLV 205
GTA VKPGTGL VAVKTLN DGLQGHKEWLAE+NYLG L+HPNLVKL+G CIEDDQRLLV
Sbjct: 159 GTAPVKPGTGLTVAVKTLNPDGLQGHKEWLAEINYLGNLLHPNLVKLVGYCIEDDQRLLV 218
Query: 206 YEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLD 265
YEFMPRGSLENHLFRRSLPLPWSIRMKIAL AAKGL+FLHEEA KPVIYRDFKTSNILLD
Sbjct: 219 YEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLSFLHEEALKPVIYRDFKTSNILLD 278
Query: 266 GEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLE 325
GEYNAKLSDFGLAKD P+ KTHVSTRVMGTYGYAAPEYVMTGHLT+KSDVYSFGVVLLE
Sbjct: 279 GEYNAKLSDFGLAKDAPDEGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLE 338
Query: 326 MLTGRRSMDKNRPNGEHNLVEWARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASC 385
MLTGRRSMDKNRPNGEHNLVEWARP L ++RRFYRL+DP LEG FS+KGA+K QLAA C
Sbjct: 339 MLTGRRSMDKNRPNGEHNLVEWARPHLLDKRRFYRLLDPRLEGHFSVKGAQKVTQLAAQC 398
Query: 386 LNRDQKARPRMSEVVEALKPLPYLKDMASSSSYVQAMQAERVRLNLNAKHGSRV-PRKGQ 444
L+RD K RP+MSEVVE LKPLP+LKDMAS+S Y Q MQAER++ + G R GQ
Sbjct: 399 LSRDSKIRPKMSEVVEVLKPLPHLKDMASASYYFQTMQAERLKAGSGSGSGRGFGSRNGQ 458
Query: 445 PT-RSLSIPNAPH-VSPYHLNNPHYSPKP 471
P R+LS P+ SPY P SPKP
Sbjct: 459 PVFRTLSSPHGQAGSSPYRHQIP--SPKP 485
|
|
| TAIR|locus:2095517 AT3G28690 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1529 (543.3 bits), Expect = 7.0e-157, P = 7.0e-157
Identities = 302/452 (66%), Positives = 343/452 (75%)
Query: 25 DGESGVTGCWIKFRFIGGCLSSSPKTDGANSGTSTQYAESKSTNDTSRGQPVVPIGXXXX 84
DG+ +G W +F+FI C+SS K D + + T+ AE K + G P P
Sbjct: 11 DGDESESGFWFRFKFIFSCISSRSKVDSSMNATAV-IAEPKKVIEKLEGHPA-P----TK 64
Query: 85 XXXXXXXXXXXPKIGEELKISPQLRKFSFNELKSATKSFRPECLLGEGGFGCVYKGWINM 144
P + ELK S +LR F FN+LK AT++FRPE LLGEGGFGCV+KGWI
Sbjct: 65 DTGCAESGSSTPLMSGELKYSSKLRIFMFNDLKLATRNFRPESLLGEGGFGCVFKGWIEE 124
Query: 145 NGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHPNLVKLIGCCIEDDQRLL 204
NGTA VKPGTGL VAVKTLN DGLQGHKEWLAE+N+LG L+HP+LVKL+G C+E+DQRLL
Sbjct: 125 NGTAPVKPGTGLTVAVKTLNPDGLQGHKEWLAEINFLGNLVHPSLVKLVGYCMEEDQRLL 184
Query: 205 VYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILL 264
VYEFMPRGSLENHLFRR+LPLPWS+RMKIAL AAKGLAFLHEEAEKPVIYRDFKTSNILL
Sbjct: 185 VYEFMPRGSLENHLFRRTLPLPWSVRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILL 244
Query: 265 DGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLL 324
DGEYNAKLSDFGLAKD P+ K+HVSTRVMGTYGYAAPEYVMTGHLT KSDVYSFGVVLL
Sbjct: 245 DGEYNAKLSDFGLAKDAPDEKKSHVSTRVMGTYGYAAPEYVMTGHLTTKSDVYSFGVVLL 304
Query: 325 EMLTGRRSMDKNRPNGEHNLVEWARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAAS 384
E+LTGRRS+DK+RPNGE NLVEW RP L +++RFYRL+DP LEG +SIKGA+K Q+AA
Sbjct: 305 EILTGRRSVDKSRPNGEQNLVEWVRPHLLDKKRFYRLLDPRLEGHYSIKGAQKATQVAAQ 364
Query: 385 CLNRDQKARPRMSEVVEALKPLPYLKDMASSSSYVQAMQAERVRLNLNAKHGSRVPRKGQ 444
CLNRD KARP+MSEVVEALKPLP LKD ASSSS Q MQ + + + G V R G
Sbjct: 365 CLNRDSKARPKMSEVVEALKPLPNLKDFASSSSSFQTMQPV-AKNGVRTQGGGFVSRNGP 423
Query: 445 PTRSLSIPNAPHVSPYHLNNPHYSPKPNVSQP 476
P RSLS N P SPY SPKP +P
Sbjct: 424 PMRSLSSLNLPQASPYRY--ARQSPKPKGKEP 453
|
|
| TAIR|locus:2012492 APK2A "protein kinase 2A" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1078 (384.5 bits), Expect = 4.3e-109, P = 4.3e-109
Identities = 225/437 (51%), Positives = 282/437 (64%)
Query: 40 IGGCLSSSPKTDGANSGTSTQYAESKSTNDTSRGQPVVPIGXXXXXXXXXXXXXXXPKIG 99
+G CL SS K D +N A S S + + P G P +
Sbjct: 1 MGNCLDSSAKVDNSNHSPHANSASSGSKVSSKTSRSTGPSGLSTTSYSTDSSFGPLPTLR 60
Query: 100 EELKI--SPQLRKFSFNELKSATKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLP 157
E +I SP L+ F+FNELK+ATK+FR + LLGEGGFGCV+KGWI+ +PG+G+
Sbjct: 61 TEGEILSSPNLKAFTFNELKNATKNFRQDNLLGEGGFGCVFKGWIDQTSLTASRPGSGIV 120
Query: 158 VAVKTLNHDGLQGHKEWLAEVNYLGGLIHPNLVKLIGCCIEDDQRLLVYEFMPRGSLENH 217
VAVK L +G QGHKEWL EVNYLG L HPNLV L+G C E + RLLVYEFMP+GSLENH
Sbjct: 121 VAVKQLKPEGFQGHKEWLTEVNYLGQLSHPNLVLLVGYCAEGENRLLVYEFMPKGSLENH 180
Query: 218 LFRRSL-PLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFG 276
LFRR PL W+IRMK+A+ AAKGL FLHE A+ VIYRDFK +NILLD ++NAKLSDFG
Sbjct: 181 LFRRGAQPLTWAIRMKVAVGAAKGLTFLHE-AKSQVIYRDFKAANILLDADFNAKLSDFG 239
Query: 277 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKN 336
LAK GP GD THVST+V+GT+GYAAPEYV TG LTAKSDVYSFGVVLLE+++GRR+MD +
Sbjct: 240 LAKAGPTGDNTHVSTKVIGTHGYAAPEYVATGRLTAKSDVYSFGVVLLELISGRRAMDNS 299
Query: 337 RPNGEHNLVEWARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRM 396
E++LV+WA P LG++R+ +R++D L G + KGA LA CLN D K RP+M
Sbjct: 300 NGGNEYSLVDWATPYLGDKRKLFRIMDTKLGGQYPQKGAFTAANLALQCLNPDAKLRPKM 359
Query: 397 SEVVEALKPLPYLKDMASSSSYVQAMQAERVRLNLNAKHGSRVPRKGQPTRSLSIPNAPH 456
SEV+ L+ L + +A + M++ R H S V +K P R H
Sbjct: 360 SEVLVTLEQL---ESVAKPGTKHTQMESPRF-------HHSSVMQKS-PVRYSHDRPLLH 408
Query: 457 VSPYHLNNPHYSPKPNV 473
++P P Y+ P V
Sbjct: 409 MTPGASPLPSYTQSPRV 425
|
|
| TAIR|locus:2058847 APK2B "protein kinase 2B" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1077 (384.2 bits), Expect = 5.5e-109, P = 5.5e-109
Identities = 226/432 (52%), Positives = 283/432 (65%)
Query: 40 IGGCLSSSPKTDGANSGTSTQYAESKSTNDTSRGQPVVPIGXXXXXXXXXXXXXXXPKIG 99
+G CL SS K D ++ A S + + VP P+
Sbjct: 1 MGNCLDSSAKVDSSSHSPHANSASLSSRVSSKTSRSTVP-SSLSINSYSSVESLPTPRTE 59
Query: 100 EELKISPQLRKFSFNELKSATKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVA 159
E+ SP L+ F+FNELK+AT++FRP+ LLGEGGFG V+KGWI+ KPG+G+ VA
Sbjct: 60 GEILSSPNLKAFTFNELKNATRNFRPDSLLGEGGFGYVFKGWIDGTTLTASKPGSGIVVA 119
Query: 160 VKTLNHDGLQGHKEWLAEVNYLGGLIHPNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLF 219
VK L +G QGHKEWL EVNYLG L HPNLVKL+G C+E + RLLVYEFMP+GSLENHLF
Sbjct: 120 VKKLKTEGYQGHKEWLTEVNYLGQLSHPNLVKLVGYCVEGENRLLVYEFMPKGSLENHLF 179
Query: 220 RRSL-PLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLA 278
RR PL W+IRMK+A+ AAKGL FLH+ A+ VIYRDFK +NILLD E+N+KLSDFGLA
Sbjct: 180 RRGAQPLTWAIRMKVAIGAAKGLTFLHD-AKSQVIYRDFKAANILLDAEFNSKLSDFGLA 238
Query: 279 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRP 338
K GP GDKTHVST+VMGT+GYAAPEYV TG LTAKSDVYSFGVVLLE+L+GRR++DK++
Sbjct: 239 KAGPTGDKTHVSTQVMGTHGYAAPEYVATGRLTAKSDVYSFGVVLLELLSGRRAVDKSKV 298
Query: 339 NGEHNLVEWARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSE 398
E +LV+WA P LG++R+ +R++D L G + KGA LA CLN D K RP+MSE
Sbjct: 299 GMEQSLVDWATPYLGDKRKLFRIMDTRLGGQYPQKGAYTAASLALQCLNPDAKLRPKMSE 358
Query: 399 VVEALKPLPYLKDMASSSSYVQAMQAERVRLNLNAKHGSRVPRKGQPTRSLSIPNAPHVS 458
V+ L L K + QA Q + R N + PR+ R L + P S
Sbjct: 359 VLAKLDQLESTKPGTGVGNR-QA-QIDSPR-GSNGSIVQKSPRRYSYDRPL-LHITPGAS 414
Query: 459 PYHLNNPHYSPK 470
P +N +SP+
Sbjct: 415 PLPTHN--HSPR 424
|
|
| TAIR|locus:2053240 PK1B "protein kinase 1B" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1077 (384.2 bits), Expect = 5.5e-109, P = 5.5e-109
Identities = 208/319 (65%), Positives = 249/319 (78%)
Query: 96 PKIGEELKISPQLRKFSFNELKSATKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTG 155
P+ E+ SP L+ F+F ELK+AT++FRP+ +LGEGGFG V+KGWI+ KPGTG
Sbjct: 53 PRTEGEILQSPNLKSFTFAELKAATRNFRPDSVLGEGGFGSVFKGWIDEQTLTASKPGTG 112
Query: 156 LPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHPNLVKLIGCCIEDDQRLLVYEFMPRGSLE 215
+ +AVK LN DG QGH+EWLAEVNYLG HPNLVKLIG C+ED+ RLLVYEFMPRGSLE
Sbjct: 113 VVIAVKKLNQDGWQGHQEWLAEVNYLGQFSHPNLVKLIGYCLEDEHRLLVYEFMPRGSLE 172
Query: 216 NHLFRRSL---PLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKL 272
NHLFRR PL W++R+K+AL AAKGLAFLH AE VIYRDFKTSNILLD EYNAKL
Sbjct: 173 NHLFRRGSYFQPLSWTLRLKVALGAAKGLAFLHN-AETSVIYRDFKTSNILLDSEYNAKL 231
Query: 273 SDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRS 332
SDFGLAKDGP GDK+HVSTR+MGTYGYAAPEY+ TGHLT KSDVYS+GVVLLE+L+GRR+
Sbjct: 232 SDFGLAKDGPTGDKSHVSTRIMGTYGYAAPEYLATGHLTTKSDVYSYGVVLLEVLSGRRA 291
Query: 333 MDKNRPNGEHNLVEWARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKA 392
+DKNRP GE LVEWARP L +R+ +R+ID L+ +S++ A K LA CL + K
Sbjct: 292 VDKNRPPGEQKLVEWARPLLANKRKLFRVIDNRLQDQYSMEEACKVATLALRCLTFEIKL 351
Query: 393 RPRMSEVVEALKPLPYLKD 411
RP M+EVV L+ + L +
Sbjct: 352 RPNMNEVVSHLEHIQTLNE 370
|
|
| TAIR|locus:2180127 NAK [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1067 (380.7 bits), Expect = 6.3e-108, P = 6.3e-108
Identities = 213/384 (55%), Positives = 272/384 (70%)
Query: 40 IGGCLSSSPKTDGANSGTSTQYAESKSTNDTSRGQPVVPIGXXXXXXXXXXXXXXXPKIG 99
+GGC S+ KTD A+S T + + D S+G P+
Sbjct: 1 MGGCFSNRIKTDIASS---TWLSSKFLSRDGSKGS-------------STASFSYMPRTE 44
Query: 100 EELKISPQLRKFSFNELKSATKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVA 159
E+ + L+ FS +ELKSAT++FRP+ ++GEGGFGCV+KGWI+ + A KPGTG+ +A
Sbjct: 45 GEILQNANLKNFSLSELKSATRNFRPDSVVGEGGFGCVFKGWIDESSLAPSKPGTGIVIA 104
Query: 160 VKTLNHDGLQGHKEWLAEVNYLGGLIHPNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLF 219
VK LN +G QGH+EWLAE+NYLG L HPNLVKLIG C+E++ RLLVYEFM RGSLENHLF
Sbjct: 105 VKRLNQEGFQGHREWLAEINYLGQLDHPNLVKLIGYCLEEEHRLLVYEFMTRGSLENHLF 164
Query: 220 RRSL---PLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFG 276
RR PL W+ R+++AL AA+GLAFLH A+ VIYRDFK SNILLD YNAKLSDFG
Sbjct: 165 RRGTFYQPLSWNTRVRMALGAARGLAFLHN-AQPQVIYRDFKASNILLDSNYNAKLSDFG 223
Query: 277 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKN 336
LA+DGP GD +HVSTRVMGT GYAAPEY+ TGHL+ KSDVYSFGVVLLE+L+GRR++DKN
Sbjct: 224 LARDGPMGDNSHVSTRVMGTQGYAAPEYLATGHLSVKSDVYSFGVVLLELLSGRRAIDKN 283
Query: 337 RPNGEHNLVEWARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRM 396
+P GEHNLV+WARP L +RR R++DP L+G +S+ A K LA C++ D K+RP M
Sbjct: 284 QPVGEHNLVDWARPYLTNKRRLLRVMDPRLQGQYSLTRALKIAVLALDCISIDAKSRPTM 343
Query: 397 SEVVEALKPLPYLKDMASSSSYVQ 420
+E+V+ ++ L K+ + Q
Sbjct: 344 NEIVKTMEELHIQKEASKEQQNPQ 367
|
|
| TAIR|locus:2150019 AT5G01020 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1065 (380.0 bits), Expect = 1.0e-107, P = 1.0e-107
Identities = 209/301 (69%), Positives = 247/301 (82%)
Query: 107 QLRKFSFNELKSATKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHD 166
Q+ F+ EL++ TKSFRP+ +LGEGGFG VYKG+I+ N +K LPVAVK LN +
Sbjct: 53 QVIPFTLFELETITKSFRPDYILGEGGFGTVYKGYIDDNLRVGLK---SLPVAVKVLNKE 109
Query: 167 GLQGHKEWLAEVNYLGGLIHPNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSL-PL 225
GLQGH+EWL EVN+LG L HPNLVKLIG C EDD RLLVYEFM RGSLENHLFR++ PL
Sbjct: 110 GLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMLRGSLENHLFRKTTAPL 169
Query: 226 PWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGD 285
WS RM IAL AAKGLAFLH AE+PVIYRDFKTSNILLD +Y AKLSDFGLAK GP+GD
Sbjct: 170 SWSRRMMIALGAAKGLAFLHN-AERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGD 228
Query: 286 KTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV 345
+THVSTRVMGTYGYAAPEYVMTGHLTA+SDVYSFGVVLLEMLTGR+S+DK RP+ E NLV
Sbjct: 229 ETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLEMLTGRKSVDKTRPSKEQNLV 288
Query: 346 EWARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKP 405
+WARP+L ++R+ ++IDP LE +S++ A+K LA CL+++ KARP MS+VVE L+P
Sbjct: 289 DWARPKLNDKRKLLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEP 348
Query: 406 L 406
L
Sbjct: 349 L 349
|
|
| TAIR|locus:2039772 BIK1 "botrytis-induced kinase1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1002 (357.8 bits), Expect = 1.4e-103, Sum P(2) = 1.4e-103
Identities = 189/311 (60%), Positives = 241/311 (77%)
Query: 99 GEELKISPQLRKFSFNELKSATKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPV 158
GE L +P ++ F+FNELK AT++FRP+ ++GEGGFGCV+KGW++ + KPGTGL +
Sbjct: 44 GEILSSTP-VKSFTFNELKLATRNFRPDSVIGEGGFGCVFKGWLDESTLTPTKPGTGLVI 102
Query: 159 AVKTLNHDGLQGHKEWLAEVNYLGGLIHPNLVKLIGCCIEDDQRLLVYEFMPRGSLENHL 218
AVK LN +G QGH+EWL E+NYLG L HPNLVKLIG C+ED+ RLLVYEFM +GSLENHL
Sbjct: 103 AVKKLNQEGFQGHREWLTEINYLGQLSHPNLVKLIGYCLEDEHRLLVYEFMQKGSLENHL 162
Query: 219 FRRSL---PLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDF 275
FRR PLPW +R+ +ALDAAKGLAFLH + K VIYRD K SNILLD +YNAKLSDF
Sbjct: 163 FRRGAYFKPLPWFLRVNVALDAAKGLAFLHSDPVK-VIYRDIKASNILLDADYNAKLSDF 221
Query: 276 GLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDK 335
GLA+DGP GD ++VSTRVMGTYGYAAPEY+ +GHL A+SDVYSFGV+LLE+L+G+R++D
Sbjct: 222 GLARDGPMGDLSYVSTRVMGTYGYAAPEYMSSGHLNARSDVYSFGVLLLEILSGKRALDH 281
Query: 336 NRPNGEHNLVEWARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPR 395
NRP E NLV+WARP L +R+ ++D L+ + + A + +A CL+ + K+RP
Sbjct: 282 NRPAKEENLVDWARPYLTSKRKVLLIVDNRLDTQYLPEEAVRMASVAVQCLSFEPKSRPT 341
Query: 396 MSEVVEALKPL 406
M +VV AL+ L
Sbjct: 342 MDQVVRALQQL 352
|
|
| TAIR|locus:2205050 AT1G69790 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1007 (359.5 bits), Expect = 1.4e-101, P = 1.4e-101
Identities = 201/384 (52%), Positives = 259/384 (67%)
Query: 40 IGGCLSSSPKTDGANSGTSTQYAESKSTNDTSRGQPVVPIGXXXXXXXXXXXXXXXPKIG 99
+G CL SS + S S+ N +SR + P+
Sbjct: 1 MGNCLDSSARVGNRESTFGGSSRISRKPNQSSRLSSLTIPSYSNNSFTTSSWSNLTPRSE 60
Query: 100 EELKISPQLRKFSFNELKSATKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVA 159
EL SP L+ F+FNELK+AT++F+P ++GEGGFGCVYKGWI + KPG+G+ VA
Sbjct: 61 GELLPSPTLKAFTFNELKTATRNFKPNSMIGEGGFGCVYKGWIGERSLSPSKPGSGMVVA 120
Query: 160 VKTLNHDGLQGHKEWLAEVNYLGGLIHPNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLF 219
VK L +G QGHKEWL EV+YLG L H NLVKLIG C+E ++RLLVYE+MP+GSLENHLF
Sbjct: 121 VKKLKSEGFQGHKEWLTEVHYLGRLHHMNLVKLIGYCLEGEKRLLVYEYMPKGSLENHLF 180
Query: 220 RRSL-PLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLA 278
RR P+PW RMK+A AA+GL+FLHE VIYRDFK SNILLD ++NAKLSDFGLA
Sbjct: 181 RRGAEPIPWKTRMKVAFSAARGLSFLHEAK---VIYRDFKASNILLDVDFNAKLSDFGLA 237
Query: 279 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRP 338
K GP GD+THV+T+V+GT GYAAPEY+ TG LT+KSDVYSFGVVLLE+L+GR ++DK++
Sbjct: 238 KAGPTGDRTHVTTQVIGTQGYAAPEYIATGRLTSKSDVYSFGVVLLELLSGRPTLDKSKV 297
Query: 339 NGEHNLVEWARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSE 398
E NLV+WA P L +RR+ +R++D L G + KGA +A CLN + K RP M++
Sbjct: 298 GVERNLVDWAIPYLVDRRKVFRIMDTKLGGQYPHKGACAAANIALRCLNTEPKLRPDMAD 357
Query: 399 VVEALKPLPYL-KDMASSSSYVQA 421
V+ L+ L K M S+ + V +
Sbjct: 358 VLSTLQQLETSSKKMGSTQNIVMS 381
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q9LFP7 | Y5158_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.6970 | 0.9705 | 0.9371 | yes | no |
| Q9SRH7 | Y3130_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.7187 | 0.9264 | 0.9 | no | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.991 |
| 3rd Layer | 2.7.11 | 0.976 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 476 | |||
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 7e-58 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-57 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-56 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-55 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 1e-52 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-52 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 5e-49 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-39 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 7e-38 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 5e-37 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 4e-34 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 4e-32 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 4e-30 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 9e-30 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-29 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 2e-29 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-29 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 6e-29 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 1e-28 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 1e-28 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-28 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 2e-27 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 1e-26 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-26 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 2e-26 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-26 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 6e-26 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 6e-26 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 6e-26 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 7e-26 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 1e-25 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-25 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 2e-25 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-25 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 4e-25 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 6e-25 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 8e-25 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 9e-25 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 3e-24 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 3e-24 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 4e-24 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 5e-24 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 1e-23 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 1e-23 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 3e-23 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 3e-23 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 6e-23 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 7e-23 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 1e-22 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-22 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 1e-22 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 3e-22 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 3e-22 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 4e-22 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 8e-22 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 1e-21 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 2e-21 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 3e-21 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 4e-21 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 4e-21 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 5e-21 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 7e-21 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 1e-20 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 1e-20 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-20 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 1e-20 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 2e-20 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-20 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 2e-20 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 3e-20 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 3e-20 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 4e-20 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 4e-20 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 5e-20 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 5e-20 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 6e-20 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 6e-20 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 1e-19 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 1e-19 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-19 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 2e-19 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-19 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 3e-19 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 3e-19 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 3e-19 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 4e-19 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 5e-19 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 5e-19 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 6e-19 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 1e-18 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 1e-18 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 2e-18 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-18 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 2e-18 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 5e-18 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 6e-18 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 6e-18 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 6e-18 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 7e-18 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 8e-18 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 8e-18 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 1e-17 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 2e-17 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 2e-17 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-17 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-17 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 3e-17 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 3e-17 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 3e-17 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 3e-17 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 3e-17 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 4e-17 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 7e-17 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 1e-16 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 1e-16 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 1e-16 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 2e-16 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 2e-16 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-16 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 2e-16 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 3e-16 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 3e-16 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 3e-16 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 4e-16 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 4e-16 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 4e-16 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 5e-16 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 6e-16 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 6e-16 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 7e-16 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 7e-16 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 7e-16 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 8e-16 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 8e-16 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 8e-16 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 8e-16 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 9e-16 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 9e-16 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 1e-15 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 1e-15 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 1e-15 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 2e-15 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 2e-15 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 2e-15 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-15 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 3e-15 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 3e-15 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 3e-15 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 4e-15 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 4e-15 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 5e-15 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 5e-15 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 6e-15 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 7e-15 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 7e-15 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 8e-15 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 1e-14 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 1e-14 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 1e-14 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 1e-14 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-14 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 2e-14 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 3e-14 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 4e-14 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 4e-14 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 5e-14 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 5e-14 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 6e-14 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 8e-14 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 9e-14 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 9e-14 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 1e-13 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-13 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-13 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 2e-13 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 2e-13 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 3e-13 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 3e-13 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 3e-13 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 4e-13 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 4e-13 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 5e-13 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 6e-13 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 6e-13 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 7e-13 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 7e-13 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 7e-13 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 1e-12 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 1e-12 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 1e-12 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 1e-12 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 1e-12 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 2e-12 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-12 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 2e-12 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 3e-12 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 4e-12 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 5e-12 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 6e-12 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 7e-12 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 7e-12 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 8e-12 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 8e-12 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 1e-11 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 1e-11 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 2e-11 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 2e-11 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 2e-11 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-11 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 3e-11 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 3e-11 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 4e-11 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 4e-11 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 5e-11 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 5e-11 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 7e-11 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 9e-11 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 9e-11 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 1e-10 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 1e-10 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-10 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 2e-10 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 2e-10 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 3e-10 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 3e-10 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 3e-10 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 3e-10 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 3e-10 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 4e-10 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 5e-10 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 8e-10 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 8e-10 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 8e-10 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 1e-09 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 1e-09 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 1e-09 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-09 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 2e-09 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 2e-09 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 3e-09 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 3e-09 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 3e-09 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 3e-09 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 4e-09 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 4e-09 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 4e-09 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 8e-09 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 8e-09 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 1e-08 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 1e-08 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 1e-08 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 1e-08 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 1e-08 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 2e-08 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-08 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 2e-08 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 2e-08 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 2e-08 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 2e-08 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 3e-08 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 4e-08 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 4e-08 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 6e-08 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 7e-08 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 9e-08 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 9e-08 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 1e-07 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 1e-07 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 1e-07 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 2e-07 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 3e-07 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 3e-07 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 5e-07 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 5e-07 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 5e-07 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 9e-07 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 1e-06 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 1e-06 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 1e-06 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 2e-06 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 2e-06 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 2e-06 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 2e-06 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 2e-06 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 2e-06 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 4e-06 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 4e-06 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 4e-06 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 5e-06 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 5e-06 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 8e-06 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 9e-06 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 1e-05 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 3e-05 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 4e-05 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 4e-05 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 5e-05 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 5e-05 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 5e-05 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 9e-05 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 1e-04 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 2e-04 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 4e-04 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 4e-04 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 0.004 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 191 bits (488), Expect = 7e-58
Identities = 93/276 (33%), Positives = 127/276 (46%), Gaps = 26/276 (9%)
Query: 129 LGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHD-GLQGHKEWLAEVNYLGGLIHP 187
LGEG FG VYKG + G + VAVKTL D Q +E+L E + L HP
Sbjct: 7 LGEGAFGEVYKGKLKGKG-----GKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHP 61
Query: 188 NLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEE 247
N+VKL+G C E++ +V E+M G L ++L + L S + AL A+G+ +L
Sbjct: 62 NVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLE-- 119
Query: 248 AEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT 307
K I+RD N L+ K+SDFGL++D + D + APE +
Sbjct: 120 -SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGG-KLPIRWMAPESLKE 177
Query: 308 GHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRRFYRLIDPCLE 367
G T+KSDV+SFGV+L E+ T P + E L YRL P
Sbjct: 178 GKFTSKSDVWSFGVLLWEIFTLGEQ-----PYPGMSNEE-VLEYLKNG---YRL--PQPP 226
Query: 368 GCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEAL 403
C + L C D + RP SE+VE L
Sbjct: 227 NC-----PPELYDLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 190 bits (485), Expect = 2e-57
Identities = 97/277 (35%), Positives = 133/277 (48%), Gaps = 27/277 (9%)
Query: 129 LGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHD-GLQGHKEWLAEVNYLGGLIHP 187
LGEG FG VYKG + G G + VAVKTL D Q +E+L E + L HP
Sbjct: 7 LGEGAFGEVYKGTLKGKG-----DGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHP 61
Query: 188 NLVKLIGCCIEDDQRLLVYEFMPRGSLENHL-FRRSLPLPWSIRMKIALDAAKGLAFLHE 246
N+VKL+G C E++ ++V E+MP G L ++L R L S + AL A+G+ +L
Sbjct: 62 NIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLE- 120
Query: 247 EAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM 306
K I+RD N L+ K+SDFGL++D + D V + APE +
Sbjct: 121 --SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGG-KLPIRWMAPESLK 177
Query: 307 TGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRRFYRLIDPCL 366
G T+KSDV+SFGV+L E+ T P + E L + YRL P
Sbjct: 178 EGKFTSKSDVWSFGVLLWEIFTLGEE-----PYPGMSNAE-VLEYLKKG---YRL--PKP 226
Query: 367 EGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEAL 403
C + +L C D + RP SE+VE L
Sbjct: 227 PNC-----PPELYKLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 186 bits (475), Expect = 1e-56
Identities = 79/278 (28%), Positives = 113/278 (40%), Gaps = 66/278 (23%)
Query: 129 LGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKE-WLAEVNYLGGLIHP 187
LGEGGFG VY TG VA+K + + E L E+ L L HP
Sbjct: 1 LGEGGFGTVYLARDK---------KTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHP 51
Query: 188 NLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEE 247
N+VKL G +++ LV E+ GSL++ L L ++I L +GL +LH
Sbjct: 52 NIVKLYGVFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLH-- 109
Query: 248 AEKPVIYRDFKTSNILLD-GEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM 306
+I+RD K NILLD KL+DFGL+K ++GT Y APE ++
Sbjct: 110 -SNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSL--LKTIVGTPAYMAPEVLL 166
Query: 307 -TGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRRFYRLIDPC 365
G+ + KSD++S GV+L E+
Sbjct: 167 GKGYYSEKSDIWSLGVILYEL--------------------------------------- 187
Query: 366 LEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEAL 403
+ L L +D + RP E++E L
Sbjct: 188 ----------PELKDLIRKMLQKDPEKRPSAKEILEHL 215
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 185 bits (471), Expect = 2e-55
Identities = 93/282 (32%), Positives = 132/282 (46%), Gaps = 37/282 (13%)
Query: 129 LGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHD-GLQGHKEWLAEVNYLGGLIHP 187
LGEG FG VYKG + GT VAVKTL + +E+L E + + L HP
Sbjct: 7 LGEGAFGEVYKGTLKG-----DGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHP 61
Query: 188 NLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEE 247
N+V+L+G C + + +V E+MP G L + L + L +++AL AKG+ +L
Sbjct: 62 NIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLE-- 119
Query: 248 AEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVST------RVMGTYGYAA 301
K ++RD N L+ K+SDFGL++D E D + M A
Sbjct: 120 -SKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWM------A 172
Query: 302 PEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRRFYRL 361
PE + G T+KSDV+SFGV+L E+ T P + E L + YRL
Sbjct: 173 PESLKDGKFTSKSDVWSFGVLLWEIFTLGEQ-----PYPGMSNEE-VLELLEDG---YRL 223
Query: 362 IDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEAL 403
P E C ++ +L C D + RP SE+VE L
Sbjct: 224 --PRPENC-----PDELYELMLQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 178 bits (453), Expect = 1e-52
Identities = 93/278 (33%), Positives = 125/278 (44%), Gaps = 33/278 (11%)
Query: 129 LGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL--QGHKEWLAEVNYLGGLIH 186
LG G FG VYK GTG VAVK L + + E+ L L H
Sbjct: 7 LGSGSFGTVYKA---------KHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSH 57
Query: 187 PNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHE 246
PN+V+LI + D LV E+ G L R PL KIAL +GL +LH
Sbjct: 58 PNIVRLIDAFEDKDHLYLVMEYCEGGDL-FDYLSRGGPLSEDEAKKIALQILRGLEYLHS 116
Query: 247 EAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM 306
+I+RD K NILLD K++DFGLAK + ++T V GT Y APE ++
Sbjct: 117 NG---IIHRDLKPENILLDENGVVKIADFGLAKKL-LKSSSSLTTFV-GTPWYMAPEVLL 171
Query: 307 TG-HLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRRFYRLIDPC 365
G K DV+S GV+L E+LTG+ L + + R++ P
Sbjct: 172 GGNGYGPKVDVWSLGVILYELLTGK-------------PPFSGENILDQLQLIRRILGPP 218
Query: 366 LEGCF--SIKGAEKTIQLAASCLNRDQKARPRMSEVVE 401
LE G+E+ L CLN+D RP E+++
Sbjct: 219 LEFDEPKWSSGSEEAKDLIKKCLNKDPSKRPTAEEILQ 256
|
Length = 260 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 177 bits (451), Expect = 2e-52
Identities = 96/299 (32%), Positives = 136/299 (45%), Gaps = 62/299 (20%)
Query: 129 LGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL-QGHKEWLAEVNYLGGLIHP 187
LGEG FG VYKG K G VAVKTL D + K++L E + L HP
Sbjct: 3 LGEGAFGEVYKG------KLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHP 56
Query: 188 NLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLP--------LPWSIRMKIALDAAK 239
N+V+L+G C E++ LV E+M G L ++L + L + A+ AK
Sbjct: 57 NVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAK 116
Query: 240 GLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVST------RV 293
G+ +L K ++RD N L+ + K+SDFGL++D + D T R
Sbjct: 117 GMEYLA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRW 173
Query: 294 MGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGE--------HNLV 345
M APE + G T+KSDV+SFGV+L E+ T G ++
Sbjct: 174 M------APESLKDGIFTSKSDVWSFGVLLWEIFT----------LGATPYPGLSNEEVL 217
Query: 346 EWARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALK 404
E+ R+ YRL P E C ++ +L SC D + RP SE+VE L+
Sbjct: 218 EYL-------RKGYRL--PKPEYCP-----DELYELMLSCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 168 bits (427), Expect = 5e-49
Identities = 81/282 (28%), Positives = 119/282 (42%), Gaps = 35/282 (12%)
Query: 123 FRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKE-WLAEVNYL 181
+ LGEG FG VY TG VA+K + ++ +E L E+ L
Sbjct: 1 YEILEKLGEGSFGKVYLA---------RDKKTGKLVAIKVIKKKKIKKDRERILREIKIL 51
Query: 182 GGLIHPNLVKLIGCCIEDDQRLLVYEFMPRGSLENHL-FRRSLPLPWSIRMKIALDAAKG 240
L HPN+V+L ++D+ LV E+ G L + L R L R
Sbjct: 52 KKLKHPNIVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDE-AR-FYLRQILSA 109
Query: 241 LAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYA 300
L +LH K +++RD K NILLD + + KL+DFGLA+ G+K T V GT Y
Sbjct: 110 LEYLHS---KGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLT--TFV-GTPEYM 163
Query: 301 APEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRP-NGEHNLVEWARPQLGERRRFY 359
APE ++ D++S GV+L E+LTG+ P G+ L+E + + F
Sbjct: 164 APEVLLGKGYGKAVDIWSLGVILYELLTGK------PPFPGDDQLLELFKKIGKPKPPFP 217
Query: 360 RLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVE 401
L L +D + R E ++
Sbjct: 218 PPEWDISPEA---------KDLIRKLLVKDPEKRLTAEEALQ 250
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 142 bits (361), Expect = 2e-39
Identities = 62/208 (29%), Positives = 101/208 (48%), Gaps = 15/208 (7%)
Query: 123 FRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLG 182
F +G+GGFG VYK TG VA+K + + + ++ + E+ L
Sbjct: 2 FEILEKIGKGGFGEVYKARHKR---------TGKEVAIKVIKLESKEKKEKIINEIQILK 52
Query: 183 GLIHPNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLA 242
HPN+VK G ++ D+ +V EF GSL++ L + L S + + KGL
Sbjct: 53 KCKHPNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLE 112
Query: 243 FLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAP 302
+LH +I+RD K +NILL + KL DFGL+ + + ++GT + AP
Sbjct: 113 YLH---SNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARN---TMVGTPYWMAP 166
Query: 303 EYVMTGHLTAKSDVYSFGVVLLEMLTGR 330
E + K+D++S G+ +E+ G+
Sbjct: 167 EVINGKPYDYKADIWSLGITAIELAEGK 194
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 138 bits (350), Expect = 7e-38
Identities = 66/215 (30%), Positives = 109/215 (50%), Gaps = 19/215 (8%)
Query: 122 SFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKT--LNHDGLQGHKEWLAEVN 179
+ LLG G FG VY ++ + TG +AVK+ L+ D + + E+
Sbjct: 1 EWTRGELLGRGSFGSVYLA-LDKD--------TGELMAVKSVELSGDSEEELEALEREIR 51
Query: 180 YLGGLIHPNLVKLIGCCIEDDQR-LLVY-EFMPRGSLENHLFRRSLPLPWS-IRMKIALD 236
L L HPN+V+ G ++++ L ++ E++ GSL + L ++ LP IR K
Sbjct: 52 ILSSLQHPNIVRYYGSERDEEKNTLNIFLEYVSGGSL-SSLLKKFGKLPEPVIR-KYTRQ 109
Query: 237 AAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGT 296
+GLA+LH +++RD K +NIL+D + KL+DFG AK + + + V GT
Sbjct: 110 ILEGLAYLHS---NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGT 166
Query: 297 YGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRR 331
+ APE + +D++S G ++EM TG+
Sbjct: 167 PYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKP 201
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 137 bits (346), Expect = 5e-37
Identities = 71/206 (34%), Positives = 102/206 (49%), Gaps = 16/206 (7%)
Query: 129 LGEGGFGCVYKG-WINMNGTATVKPGTGLPVAVKTLNHDGLQGH-KEWLAEVNYLGGLIH 186
LGEG FG V + + TG VAVK+LNH G + H ++ E+ L L H
Sbjct: 12 LGEGHFGKVELCRYDPLGD------NTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDH 65
Query: 187 PNLVKLIGCCIEDDQR--LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFL 244
N+VK G C + R L+ E++P GSL ++L R + + + KG+ +L
Sbjct: 66 ENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYL 125
Query: 245 HEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVST--RVMGTYGYAAP 302
+ I+RD NIL++ E K+SDFGLAK PE + + Y AP
Sbjct: 126 GS---QRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY-AP 181
Query: 303 EYVMTGHLTAKSDVYSFGVVLLEMLT 328
E + T ++ SDV+SFGV L E+ T
Sbjct: 182 ECLRTSKFSSASDVWSFGVTLYELFT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 4e-34
Identities = 70/206 (33%), Positives = 104/206 (50%), Gaps = 17/206 (8%)
Query: 127 CLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKT--LNHDGLQGHKEWLAEVNYLGGL 184
L+G G FG VYKG +N+ TG VA+K L + K + E++ L L
Sbjct: 6 DLIGRGAFGVVYKG-LNLE--------TGDFVAIKQISLEKIKEEALKSIMQEIDLLKNL 56
Query: 185 IHPNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFL 244
HPN+VK IG D ++ E+ GSL + ++ P P S+ +GLA+L
Sbjct: 57 KHPNIVKYIGSIETSDSLYIILEYAENGSLRQ-IIKKFGPFPESLVAVYVYQVLQGLAYL 115
Query: 245 HEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEY 304
HE+ VI+RD K +NIL + KL+DFG+A + K V+GT + APE
Sbjct: 116 HEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD--DASVVGTPYWMAPEV 170
Query: 305 VMTGHLTAKSDVYSFGVVLLEMLTGR 330
+ + SD++S G ++E+LTG
Sbjct: 171 IEMSGASTASDIWSLGCTVIELLTGN 196
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 122 bits (309), Expect = 4e-32
Identities = 80/278 (28%), Positives = 124/278 (44%), Gaps = 30/278 (10%)
Query: 128 LLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKE-WLAEVNYLGGLIH 186
+G+G FG VYKG + VAVKT K +L E L H
Sbjct: 2 KIGKGNFGDVYKGVLK----------GNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDH 51
Query: 187 PNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHE 246
PN+VKLIG C++ +V E +P GSL L ++ L ++++LDAA G+ +L
Sbjct: 52 PNIVKLIGVCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLE- 110
Query: 247 EAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM 306
K I+RD N L+ K+SDFG++++ G T + APE +
Sbjct: 111 --SKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALN 168
Query: 307 TGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRRFYRLIDPCL 366
G T++SDV+S+G++L E + + N + R ++ YR+ P
Sbjct: 169 YGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQ------TRERI---ESGYRM--PAP 217
Query: 367 EGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALK 404
+ C E+ +L C D + RP SE+ L+
Sbjct: 218 QLC-----PEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 4e-30
Identities = 65/210 (30%), Positives = 102/210 (48%), Gaps = 17/210 (8%)
Query: 129 LGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHK-EWLAEVNYLGGLIHP 187
LG+G FG VY+G VK VA+KT+N + + E+L E + +
Sbjct: 14 LGQGSFGMVYEG----LAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCH 69
Query: 188 NLVKLIGCCIEDDQRLLVYEFMPRGSLENHL--------FRRSLPLPWSIRM-KIALDAA 238
++V+L+G L+V E M +G L+++L L P + ++A + A
Sbjct: 70 HVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIA 129
Query: 239 KGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYG 298
G+A+L A K ++RD N ++ + K+ DFG+ +D E D + +
Sbjct: 130 DGMAYL---AAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 186
Query: 299 YAAPEYVMTGHLTAKSDVYSFGVVLLEMLT 328
+ APE + G T KSDV+SFGVVL EM T
Sbjct: 187 WMAPESLKDGVFTTKSDVWSFGVVLWEMAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 9e-30
Identities = 69/208 (33%), Positives = 107/208 (51%), Gaps = 28/208 (13%)
Query: 128 LLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHP 187
+G+G FG V G G VAVK L D +LAE + + L HP
Sbjct: 13 TIGKGEFGDVMLGDYR-----------GQKVAVKCLKDDSTAAQA-FLAEASVMTTLRHP 60
Query: 188 NLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLP-LPWSIRMKIALDAAKGLAFLHE 246
NLV+L+G ++ + +V E+M +GSL ++L R + + ++ ALD +G+ +L
Sbjct: 61 NLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLE- 119
Query: 247 EAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKD---GPEGDKTHVSTRVMGTYGYAAPE 303
EK ++RD N+L+ + AK+SDFGLAK+ G + K V + APE
Sbjct: 120 --EKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPVK--------WTAPE 169
Query: 304 YVMTGHLTAKSDVYSFGVVLLEMLT-GR 330
+ + KSDV+SFG++L E+ + GR
Sbjct: 170 ALREKKFSTKSDVWSFGILLWEIYSFGR 197
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 119 bits (297), Expect = 2e-29
Identities = 96/383 (25%), Positives = 139/383 (36%), Gaps = 49/383 (12%)
Query: 122 SFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEW---LAEV 178
S+R LGEG FG VY VA+K L KE L E+
Sbjct: 1 SYRILRKLGEGSFGEVYLARDRK------------LVALKVLAKKLESKSKEVERFLREI 48
Query: 179 NYLGGLIHP-NLVKLIGCCIEDDQRLLVYEFMPRGSLENHL--FRRSLPLPWSIRMKIAL 235
L L HP N+VKL ++ LV E++ GSLE+ L R PL S + I
Sbjct: 49 QILASLNHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILA 108
Query: 236 DAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYN-AKLSDFGLAK----DGPEGDKTHVS 290
L +LH K +I+RD K NILLD + KL DFGLAK G +
Sbjct: 109 QILSALEYLHS---KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALP 165
Query: 291 TRVMGTYGYAAPEYVM---TGHLTAKSDVYSFGVVLLEMLTGRR-SMDKNRPNGEHNLVE 346
+ +GT GY APE ++ + ++ SD++S G+ L E+LTG + + ++
Sbjct: 166 STSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLK 225
Query: 347 WARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEA---- 402
++ L L +D K R S +
Sbjct: 226 IILELPTPSLASPLSPS------NPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLA 279
Query: 403 ---------LKPLPYLKDMASSSSYVQAMQAERVRLNLNAKHGSRVPRKGQPTRSLSIPN 453
L S +++A LN A GS + PN
Sbjct: 280 HLKLKESDLSDLLKPDDSAPLRLSLPPSLEALISSLNSLAISGSDLKLDDSNFSKELAPN 339
Query: 454 APHVSPYHLNNPHYSPKPNVSQP 476
SP++ ++ S +
Sbjct: 340 GVSSSPHNSSSLLLSTASSKRSS 362
|
Length = 384 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 116 bits (291), Expect = 2e-29
Identities = 91/286 (31%), Positives = 134/286 (46%), Gaps = 28/286 (9%)
Query: 129 LGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKE-WLAEVNYLGGLIHP 187
LGEG FG V ++ GTG VAVKTL + Q + W E+N L L H
Sbjct: 12 LGEGHFGKV-----SLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHE 66
Query: 188 NLVKLIGCCIEDDQR--LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLH 245
N+VK GCC E + L+ E++P GSL ++L + L L + + A +G+A+LH
Sbjct: 67 NIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNL--AQLLLFAQQICEGMAYLH 124
Query: 246 EEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTH-VSTRVMGTYGYAAPEY 304
+ I+RD N+LLD + K+ DFGLAK PEG + + V + A E
Sbjct: 125 S---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVEC 181
Query: 305 VMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERR------RF 358
+ + SDV+SFGV L E+LT ++ P ++ + Q+ R R
Sbjct: 182 LKENKFSYASDVWSFGVTLYELLT-HCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERG 240
Query: 359 YRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALK 404
RL PC + C ++ L +C + K RP ++ LK
Sbjct: 241 MRL--PCPKNC-----PQEVYILMKNCWETEAKFRPTFRSLIPILK 279
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 2e-29
Identities = 68/207 (32%), Positives = 98/207 (47%), Gaps = 19/207 (9%)
Query: 128 LLGEGGFGCVYKG-WINMNGTATVKPGTGLPVAVKTLNHDGLQG-HKEWLAEVNYLGGLI 185
LG+G FG V +G W G +PVAVK L D L ++L E + L
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKV-------IPVAVKCLKSDKLSDIMDDFLKEAAIMHSLD 54
Query: 186 HPNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLP-LPWSIRMKIALDAAKGLAFL 244
H NL++L G + ++V E P GSL + L + +L S A+ A G+ +L
Sbjct: 55 HENLIRLYGVVL-THPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYL 113
Query: 245 HEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVST---RVMGTYGYAA 301
K I+RD NILL + K+ DFGL + P+ + +V +V + + A
Sbjct: 114 ES---KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKV--PFAWCA 168
Query: 302 PEYVMTGHLTAKSDVYSFGVVLLEMLT 328
PE + T + SDV+ FGV L EM T
Sbjct: 169 PESLRTRTFSHASDVWMFGVTLWEMFT 195
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 6e-29
Identities = 70/213 (32%), Positives = 103/213 (48%), Gaps = 24/213 (11%)
Query: 121 KSFRPECLLGEGGFGCVYKG-WINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVN 179
+ F E LG G FG V++G W N + VA+K L D L +++ EV
Sbjct: 6 EEFTLERKLGSGYFGEVWEGLWKNR-----------VRVAIKILKSDDLLKQQDFQKEVQ 54
Query: 180 YLGGLIHPNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFR----RSLPLPWSIRMKIAL 235
L L H +L+ L C + ++ E M +GSL R + LP+ I M A
Sbjct: 55 ALKRLRHKHLISLFAVCSVGEPVYIITELMEKGSLL-AFLRSPEGQVLPVASLIDM--AC 111
Query: 236 DAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMG 295
A+G+A+L E+ I+RD NIL+ + K++DFGLA+ E ++
Sbjct: 112 QVAEGMAYLE---EQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKI-- 166
Query: 296 TYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLT 328
Y + APE G + KSDV+SFG++L EM T
Sbjct: 167 PYKWTAPEAASHGTFSTKSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 1e-28
Identities = 93/288 (32%), Positives = 133/288 (46%), Gaps = 41/288 (14%)
Query: 129 LGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTL-NHDGLQGHKEWLAEVNYLGGLIHP 187
LG G FG V KG M K G + VAVKTL G KE+L E + + L HP
Sbjct: 3 LGHGNFGSVVKGVYLM------KSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHP 56
Query: 188 NLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEE 247
+V+LIG C + +LV E P G L +L +R +P S ++A A G+A+L
Sbjct: 57 CIVRLIGVCKGE-PLMLVMELAPLGPLLKYLKKRRE-IPVSDLKELAHQVAMGMAYLES- 113
Query: 248 AEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYG-----YAAP 302
K ++RD N+LL + AK+SDFG+++ G + +T T G + AP
Sbjct: 114 --KHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRAT----TAGRWPLKWYAP 167
Query: 303 EYVMTGHLTAKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVE-WARPQLGERRRFYR 360
E + G ++KSDV+S+GV L E + G +P GE E A + GER
Sbjct: 168 ECINYGKFSSKSDVWSYGVTLWEAFSYG------AKPYGEMKGAEVIAMLESGERL---- 217
Query: 361 LIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPY 408
P E C ++ + SC + RP SE+ + P
Sbjct: 218 ---PRPEEC-----PQEIYSIMLSCWKYRPEDRPTFSELESTFRRDPE 257
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 1e-28
Identities = 82/287 (28%), Positives = 133/287 (46%), Gaps = 48/287 (16%)
Query: 129 LGEGGFGCVYKG-WINMNGTATVKPGTGLPVAVKTLNHD-GLQGHKEWLAEVNYLGGLIH 186
LG G FG VYKG WI VK +PVA+K L + + +KE L E + + H
Sbjct: 15 LGSGAFGTVYKGVWIPEG--EKVK----IPVAIKVLREETSPKANKEILDEAYVMASVDH 68
Query: 187 PNLVKLIGCCIEDDQRLLVYEFMPRGSLENHL------FRRSLPLPWSIRMKIALDAAKG 240
P++V+L+G C+ Q L+ + MP G L +++ L W +++ AKG
Sbjct: 69 PHVVRLLGICL-SSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQI------AKG 121
Query: 241 LAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYA 300
+++L E K +++RD N+L+ + K++DFGLAK +K + + +
Sbjct: 122 MSYLEE---KRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWM 178
Query: 301 APEYVMTGHLTAKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPQLGERRRFY 359
A E ++ T KSDV+S+GV + E++T G + + +L+E GE
Sbjct: 179 ALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLE-----KGE----- 228
Query: 360 RLIDPCLEGCFSIKGAEKTIQ---LAASCLNRDQKARPRMSEVVEAL 403
RL P C TI + C D ++RP E++
Sbjct: 229 RLPQP--PIC--------TIDVYMVLVKCWMIDAESRPTFKELINEF 265
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 2e-28
Identities = 72/207 (34%), Positives = 98/207 (47%), Gaps = 22/207 (10%)
Query: 129 LGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEW---LAEVNYLGGLI 185
LG+G FG V K TG A+K L + KE L E N L +
Sbjct: 1 LGKGSFGKVL---------LVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRIN 51
Query: 186 HPNLVKLIGCCIEDDQRL-LVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALDAAKGLAF 243
HP +VKL + +++L LV E+ P G L +HL + R A + L +
Sbjct: 52 HPFIVKLH-YAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEER-ARFYAA-EIVLALEY 108
Query: 244 LHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPE 303
LH +IYRD K NILLD + + KL+DFGLAK+ + +T GT Y APE
Sbjct: 109 LHS---LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-SRTNTFC-GTPEYLAPE 163
Query: 304 YVMTGHLTAKSDVYSFGVVLLEMLTGR 330
++ D +S GV+L EMLTG+
Sbjct: 164 VLLGKGYGKAVDWWSLGVLLYEMLTGK 190
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 2e-27
Identities = 90/278 (32%), Positives = 125/278 (44%), Gaps = 54/278 (19%)
Query: 129 LGEGGFGCVYKG-WINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHP 187
LG G FG V+ G W NGT VAVKTL G + +L E + L H
Sbjct: 14 LGAGQFGEVWMGTW---NGT--------TKVAVKTLK-PGTMSPEAFLQEAQIMKKLRHD 61
Query: 188 NLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALDAAKGLAFL 244
LV+L C E++ +V E+M +GSL + L + L LP + M A A+G+A+L
Sbjct: 62 KLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDM--AAQIAEGMAYL 119
Query: 245 HEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAK-------DGPEGDKTHVSTRVMGTY 297
+ I+RD NIL+ K++DFGLA+ EG K +
Sbjct: 120 ES---RNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIK------- 169
Query: 298 GYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRP-NGEHNLVEWARPQLGERR 356
+ APE G T KSDV+SFG++L E++T R P G N R L +
Sbjct: 170 -WTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRV-----PYPGMTN-----REVLEQVE 218
Query: 357 RFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARP 394
R YR+ P C E+ L C ++D + RP
Sbjct: 219 RGYRM--PRPPNC-----PEELYDLMLQCWDKDPEERP 249
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 1e-26
Identities = 67/218 (30%), Positives = 104/218 (47%), Gaps = 31/218 (14%)
Query: 129 LGEGGFGCVYKGWINMNGTATVKPGTGLP---VAVKTL--NHDGLQGHKEWLAEVNYLGG 183
LGEG FG VYKG + P L VA+KTL N + + +E+ E +
Sbjct: 13 LGEGAFGKVYKGEL-------TGPNERLSATSVAIKTLKENAEP-KVQQEFRQEAELMSD 64
Query: 184 LIHPNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRS---------------LPLPWS 228
L HPN+V L+G C ++ +++E++ G L L R S L S
Sbjct: 65 LQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCS 124
Query: 229 IRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTH 288
+ IA+ A G+ +L + ++RD N L+ K+SDFGL++D D
Sbjct: 125 DFLHIAIQIAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYR 181
Query: 289 VSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEM 326
V ++ + + PE ++ G T +SD++SFGVVL E+
Sbjct: 182 VQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 2e-26
Identities = 72/282 (25%), Positives = 122/282 (43%), Gaps = 38/282 (13%)
Query: 129 LGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEW--LAEVNYLGGLIH 186
+G G FG V +G + + G + VA+KTL G + L E + +G H
Sbjct: 12 IGGGEFGEVCRGRLKLPGKKEI------DVAIKTL-KAGSSDKQRLDFLTEASIMGQFDH 64
Query: 187 PNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHE 246
PN+++L G + +++ E+M GSL+ L + + A G+ +L
Sbjct: 65 PNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYL-- 122
Query: 247 EAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAK--DGPEGDKTHVSTRVMGTYGYAAPEY 304
+E ++RD NIL++ K+SDFGL++ + E T ++ + APE
Sbjct: 123 -SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKI--PIRWTAPEA 179
Query: 305 VMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQ-LGERRRFYRLID 363
+ T+ SDV+SFG+V+ E+++ GE + + + YRL
Sbjct: 180 IAYRKFTSASDVWSFGIVMWEVMS----------YGERPYWDMSNQDVIKAVEDGYRLPP 229
Query: 364 P--CLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEAL 403
P C + QL C +D+ RP S++V L
Sbjct: 230 PMDCPSALY---------QLMLDCWQKDRNERPTFSQIVSTL 262
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 2e-26
Identities = 89/278 (32%), Positives = 127/278 (45%), Gaps = 54/278 (19%)
Query: 129 LGEGGFGCVYKG-WINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHP 187
LG G FG V++G W N T PVAVKTL + K++LAE + L HP
Sbjct: 14 LGAGQFGEVWEGLW---NNTT--------PVAVKTLKPGTMDP-KDFLAEAQIMKKLRHP 61
Query: 188 NLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALDAAKGLAFL 244
L++L C ++ +V E M GSL +L R+L LP I M A A G+A+L
Sbjct: 62 KLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDM--AAQVASGMAYL 119
Query: 245 HEEAEKPVIYRDFKTSNILLDGEYN-AKLSDFGLAK-------DGPEGDKTHVSTRVMGT 296
+ I+RD N+L+ GE N K++DFGLA+ + EG K +
Sbjct: 120 EAQN---YIHRDLAARNVLV-GENNICKVADFGLARVIKEDIYEAREGAKFPIK------ 169
Query: 297 YGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERR 356
+ APE + + KSDV+SFG++L E++T R N E L +
Sbjct: 170 --WTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAE---------VLQQVD 218
Query: 357 RFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARP 394
+ YR+ PC GC ++ + C D RP
Sbjct: 219 QGYRM--PCPPGC-----PKELYDIMLDCWKEDPDDRP 249
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 2e-26
Identities = 71/269 (26%), Positives = 115/269 (42%), Gaps = 34/269 (12%)
Query: 129 LGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQG--HKEWLAEVNYLGGLIH 186
+G+G FG V+K V+ A+K ++ + +E + E L L
Sbjct: 8 IGKGSFGVVFK---------VVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDS 58
Query: 187 PNLVKLIGCCIEDDQRLLVYEFMPRGSLENHL-FRRSLPLPWSIRMKIALDAAKGLAFLH 245
+++ ++ + +V E+ G L L +R PLP + + GLA LH
Sbjct: 59 SYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLH 118
Query: 246 EEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYV 305
K +++RD K+ N+ LD N K+ D G+AK D T+ + ++GT Y +PE
Sbjct: 119 S---KKILHRDIKSLNLFLDAYDNVKIGDLGVAK--LLSDNTNFANTIVGTPYYLSPELC 173
Query: 306 MTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRRFYRLIDPC 365
KSDV++ GVVL E TG+ D A Q + R + P
Sbjct: 174 EDKPYNEKSDVWALGVVLYECCTGKHPFD-------------ANNQGALILKIIRGVFPP 220
Query: 366 LEGCFSIKGAEKTIQLAASCLNRDQKARP 394
+ +S ++ QL CL +D + RP
Sbjct: 221 VSQMYS----QQLAQLIDQCLTKDYRQRP 245
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 6e-26
Identities = 75/215 (34%), Positives = 110/215 (51%), Gaps = 22/215 (10%)
Query: 128 LLGEGGFGCVYKGWINMNGTATVKPGTG-LPVAVKTLNHDGL-QGHKEWLAEVNYLGGLI 185
LG G FG VY+G T + PG+G + VAVKTL Q KE+L E + +
Sbjct: 2 FLGSGAFGEVYEG----TATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFN 57
Query: 186 HPNLVKLIGCCIEDDQRLLVYEFMPRGSLENHL-------FRRSLPLPWSIRMKIALDAA 238
HPN+VKL+G C+ ++ + ++ E M G L ++L F L L + I LD A
Sbjct: 58 HPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPL-LTLKELLDICLDVA 116
Query: 239 KGLAFLHEEAEKPVIYRDFKTSNILL-----DGEYNAKLSDFGLAKDGPEGDKTHVSTRV 293
KG +L + I+RD N L+ D + K+ DFGLA+D + D
Sbjct: 117 KGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEG 173
Query: 294 MGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLT 328
+ + APE ++ G T +SDV+SFGV++ E+LT
Sbjct: 174 LLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILT 208
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 6e-26
Identities = 68/215 (31%), Positives = 97/215 (45%), Gaps = 23/215 (10%)
Query: 129 LGEGGFGCVYKGWINMNGTATVKPGTGLP-VAVKTLNHDGL-QGHKEWLAEVNYLGGLIH 186
LGEG FG V+ G ++P VAVKTL K++ E L H
Sbjct: 13 LGEGAFGKVFLGEC-----YHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQH 67
Query: 187 PNLVKLIGCCIEDDQRLLVYEFMPRGSLENHL------FRRSL-------PLPWSIRMKI 233
N+VK G C E D ++V+E+M G L L L S ++I
Sbjct: 68 ENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQI 127
Query: 234 ALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRV 293
A+ A G+ +L A + ++RD T N L+ + K+ DFG+++D D V
Sbjct: 128 AVQIASGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHT 184
Query: 294 MGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLT 328
M + PE +M T +SDV+SFGVVL E+ T
Sbjct: 185 MLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 6e-26
Identities = 70/289 (24%), Positives = 115/289 (39%), Gaps = 60/289 (20%)
Query: 128 LLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKT--LNHDGLQGHKEWLAEVNYLGGLI 185
+G+G FG VY +G +K L++ + ++ L EV L L
Sbjct: 7 QIGKGSFGKVYLVRRKSDGK---------LYVLKEIDLSNMSEKEREDALNEVKILKKLN 57
Query: 186 HPNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSL---PLP----WSIRMKIALDAA 238
HPN++K E + +V E+ G L + ++ P P +++ L
Sbjct: 58 HPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCL--- 114
Query: 239 KGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYG 298
L +LH + +++RD K NI L KL DFG++K T V GT
Sbjct: 115 -ALKYLHS---RKILHRDIKPQNIFLTSNGLVKLGDFGISKV-LSSTVDLAKTVV-GTPY 168
Query: 299 YAAPE------YVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQL 352
Y +PE Y KSD++S G VL E+ T + + NL +L
Sbjct: 169 YLSPELCQNKPY------NYKSDIWSLGCVLYELCTLKHPFEGE------NL-----LEL 211
Query: 353 GER--RRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEV 399
+ + Y I +S + L +S L +D + RP ++++
Sbjct: 212 ALKILKGQYPPIPS----QYS----SELRNLVSSLLQKDPEERPSIAQI 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 7e-26
Identities = 85/304 (27%), Positives = 138/304 (45%), Gaps = 51/304 (16%)
Query: 129 LGEGGFGCVY-------KGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHK-EWLAEVNY 180
LGEG FG V+ + + V+ G L VAVK L D + + ++L EV
Sbjct: 13 LGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKI 72
Query: 181 LGGLIHPNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSL---------------PL 225
L L PN+++L+G C+++D ++ E+M G L L L L
Sbjct: 73 LSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCL 132
Query: 226 P---WSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGP 282
P +S + +AL A G+ +L + ++RD T N L+ K++DFG++++
Sbjct: 133 PAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMSRNLY 189
Query: 283 EGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGE- 341
GD + R + + A E ++ G T SDV++FGV L E+L + K +P GE
Sbjct: 190 AGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEIL----MLCKEQPYGEL 245
Query: 342 ------HNLVEWARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPR 395
N E+ R Q R+ + PC +G + +L C +RD + RP
Sbjct: 246 TDEQVIENAGEFFRDQ--GRQVYLFRPPPCPQGLY---------ELMLQCWSRDCRERPS 294
Query: 396 MSEV 399
S++
Sbjct: 295 FSDI 298
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 1e-25
Identities = 80/297 (26%), Positives = 132/297 (44%), Gaps = 48/297 (16%)
Query: 128 LLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGH--KEWLAEVNYLGGLI 185
+LGEG FG V +G ++ + + +K VAVKT+ D +E+L+E +
Sbjct: 6 ILGEGEFGSVMEGQLSQDDGSQLK------VAVKTMKLDIHTYSEIEEFLSEAACMKDFD 59
Query: 186 HPNLVKLIGCCIEDDQR------LLVYEFMPRGSLENHLFRRSLP-----LPWSIRMKIA 234
HPN++KLIG C E +++ FM G L + L L LP +K
Sbjct: 60 HPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFM 119
Query: 235 LDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGD---KTHVST 291
+D A G+ +L + + I+RD N +L + ++DFGL+K GD + ++
Sbjct: 120 VDIALGMEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAK 176
Query: 292 RVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQ 351
+ + A E + T+KSDV++FGV + E+ T R H + ++
Sbjct: 177 MPVK---WIAIESLADRVYTSKSDVWAFGVTMWEIAT--RGQTPYPGVENHEIYDYL--- 228
Query: 352 LGERRRFYRLIDP--CLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPL 406
R RL P CL+ + + SC D K RP +++ E L+ +
Sbjct: 229 ----RHGNRLKQPEDCLDELYDL---------MYSCWRADPKDRPTFTKLREVLENI 272
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 2e-25
Identities = 87/282 (30%), Positives = 127/282 (45%), Gaps = 35/282 (12%)
Query: 128 LLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWL-AEVNYLGGLIH 186
+LG+G +G VY G N VK V + T N + E L EV+ L L H
Sbjct: 7 VLGKGAYGTVYCGLTNQGQLIAVKQ-----VELDTSNVLAAEKEYEKLQEEVDLLKSLKH 61
Query: 187 PNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHE 246
N+V+ +G C++D+ + EF+P GS+ + L R PLP + K G+A+LH
Sbjct: 62 VNIVQYLGTCLDDNTISIFMEFVPGGSISSIL-NRFGPLPEPVFCKYTKQILDGVAYLHN 120
Query: 247 EAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKD----GPEGDKTHVSTRVMGTYGYAAP 302
V++RD K +N++L KL DFG A+ G G +++ + GT + AP
Sbjct: 121 NC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAP 177
Query: 303 EYVMTGHLTAKSDVYSFGVVLLEMLTGR---RSMDKNRPNGEHNLVEWARPQLGERRRFY 359
E + KSD++S G + EM TG+ SMD+ A +G R
Sbjct: 178 EVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLA----------AMFYIGAHRGLM 227
Query: 360 RLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVE 401
P L FS I SCL RDQ RP +++
Sbjct: 228 ----PRLPDSFS----AAAIDFVTSCLTRDQHERPSALQLLR 261
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 2e-25
Identities = 77/225 (34%), Positives = 106/225 (47%), Gaps = 21/225 (9%)
Query: 129 LGEGGFGCVYKG-WINMNGTATVKPGTGLPVAVKTLNHDGL-QGHKEWLAEVNYLGGLIH 186
LG G FG VY+G + +G A L VAVKTL Q ++L E + H
Sbjct: 14 LGHGAFGEVYEGLYRGRDGDAV-----ELQVAVKTLPESCSEQDESDFLMEALIMSKFNH 68
Query: 187 PNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPL---PWSIRMK----IALDAAK 239
N+V+LIG E R ++ E M G L++ L R + P P S+ MK A D AK
Sbjct: 69 QNIVRLIGVSFERLPRFILLELMAGGDLKSFL-RENRPRPERPSSLTMKDLLFCARDVAK 127
Query: 240 GLAFLHEEAEKPVIYRDFKTSNILLDGE---YNAKLSDFGLAKDGPEGDKTHVSTRVMGT 296
G +L E I+RD N LL + AK++DFG+A+D R M
Sbjct: 128 GCKYLE---ENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLP 184
Query: 297 YGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGE 341
+ PE + G T+K+DV+SFGV+L E+ + R N E
Sbjct: 185 IKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQE 229
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 2e-25
Identities = 76/278 (27%), Positives = 123/278 (44%), Gaps = 50/278 (17%)
Query: 129 LGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDG-LQGHKEWLAEVNYLGGLIHP 187
LG+G G VYK KP TG A+K ++ DG + K+ L E+ L P
Sbjct: 9 LGQGSSGVVYK--------VRHKP-TGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESP 59
Query: 188 NLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEE 247
+VK G ++ + +V E+M GSL + L ++ +P + IA KGL +LH
Sbjct: 60 YVVKCYGAFYKEGEISIVLEYMDGGSLAD-LLKKVGKIPEPVLAYIARQILKGLDYLH-- 116
Query: 248 AEKPVIYRDFKTSNILLDGEYNAKLSDFGLAK---DGPEGDKTHVSTRVMGTYGYAAPEY 304
++ +I+RD K SN+L++ + K++DFG++K + + T V GT Y +PE
Sbjct: 117 TKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV-----GTVTYMSPER 171
Query: 305 VMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRRFYRLID- 363
+ + +D++S G+ LLE G+ F+ L+
Sbjct: 172 IQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPS-----------------FFELMQA 214
Query: 364 ------PCL-EGCFSIKGAEKTIQLAASCLNRDQKARP 394
P L FS + ++CL +D K RP
Sbjct: 215 ICDGPPPSLPAEEFS----PEFRDFISACLQKDPKKRP 248
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 4e-25
Identities = 64/214 (29%), Positives = 105/214 (49%), Gaps = 17/214 (7%)
Query: 129 LGEGGFGCVYKG-WINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHP 187
+G G FG V+ G W+ VA+KT+ +G ++++ E + L HP
Sbjct: 12 IGSGQFGLVWLGYWLEKR-----------KVAIKTI-REGAMSEEDFIEEAQVMMKLSHP 59
Query: 188 NLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEE 247
LV+L G C E LV+EFM G L ++L + + + LD +G+A+L
Sbjct: 60 KLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESS 119
Query: 248 AEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT 307
VI+RD N L+ K+SDFG+ + + D+ ST +++PE
Sbjct: 120 N---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLD-DQYTSSTGTKFPVKWSSPEVFSF 175
Query: 308 GHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGE 341
++KSDV+SFGV++ E+ + ++ +NR N E
Sbjct: 176 SKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSE 209
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 6e-25
Identities = 92/279 (32%), Positives = 140/279 (50%), Gaps = 35/279 (12%)
Query: 128 LLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHK-EWLAEVNYLGGLIH 186
LLG+G FG V+KG T+K T PVAVKT D Q K ++L+E L H
Sbjct: 2 LLGKGNFGEVFKG--------TLKDKT--PVAVKTCKEDLPQELKIKFLSEARILKQYDH 51
Query: 187 PNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHE 246
PN+VKLIG C + +V E +P G + L ++ L +K ALDAA G+A+L
Sbjct: 52 PNIVKLIGVCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLE- 110
Query: 247 EAEKPVIYRDFKTSNILLDGEYNA-KLSDFGLAKDGPEGDKTHVSTRVMGT-YGYAAPEY 304
K I+RD N L+ GE N K+SDFG+++ E D + S+ + + APE
Sbjct: 111 --SKNCIHRDLAARNCLV-GENNVLKISDFGMSRQ--EDDGIYSSSGLKQIPIKWTAPEA 165
Query: 305 VMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRRFYRLIDP 364
+ G +++SDV+S+G++L E S+ G N + AR Q+ + YR+
Sbjct: 166 LNYGRYSSESDVWSYGILLWETF----SLGVCPYPGMTN--QQAREQV---EKGYRM--S 214
Query: 365 CLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEAL 403
C + C + ++ C + + RP+ SE+ + L
Sbjct: 215 CPQKC-----PDDVYKVMQRCWDYKPENRPKFSELQKEL 248
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 8e-25
Identities = 71/212 (33%), Positives = 98/212 (46%), Gaps = 24/212 (11%)
Query: 129 LGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLN-HDGLQG-HKEWLAEVNYLGGLIH 186
+G G FG VY +N++ TG +AVK + D KE E+ L L H
Sbjct: 8 IGGGTFGKVYTA-VNLD--------TGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKH 58
Query: 187 PNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHE 246
PNLVK G + ++ + E+ G+LE L L + L +GLA+LH
Sbjct: 59 PNLVKYYGVEVHREKVYIFMEYCSGGTLEE-LLEHGRILDEHVIRVYTLQLLEGLAYLH- 116
Query: 247 EAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRV---MGTYGYAAPE 303
+++RD K +NI LD KL DFG A T + V GT Y APE
Sbjct: 117 --SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNN-TTTMGEEVQSLAGTPAYMAPE 173
Query: 304 YV----MTGHLTAKSDVYSFGVVLLEMLTGRR 331
+ GH A +D++S G V+LEM TG+R
Sbjct: 174 VITGGKGKGHGRA-ADIWSLGCVVLEMATGKR 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 9e-25
Identities = 75/279 (26%), Positives = 118/279 (42%), Gaps = 39/279 (13%)
Query: 129 LGEGGFGCVYKG-WINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHP 187
LG G FG V+ G W + VA+K + +G +++ E + L HP
Sbjct: 12 LGSGQFGVVHLGKWRGK-----------IDVAIKMI-REGAMSEDDFIEEAKVMMKLSHP 59
Query: 188 NLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEE 247
NLV+L G C + +V E+M G L N+L R L + + D + + +L
Sbjct: 60 NLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLE-- 117
Query: 248 AEKPVIYRDFKTSNILLDGEYNAKLSDFGLAK---DGPEGDKTHVSTRVMGTYGYAAPEY 304
I+RD N L+ + K+SDFGLA+ D D+ S +A PE
Sbjct: 118 -SNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLD----DQYTSSQGTKFPVKWAPPEV 172
Query: 305 VMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRRFYRLIDP 364
++KSDV+SFGV++ E+ + + + N E +VE G YRL P
Sbjct: 173 FDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSE--VVE--SVSAG-----YRLYRP 223
Query: 365 CLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEAL 403
L + + SC + + RP +++ L
Sbjct: 224 KL-------APTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 3e-24
Identities = 64/210 (30%), Positives = 97/210 (46%), Gaps = 24/210 (11%)
Query: 128 LLGEGGFGCVYKGWINMNGT-ATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIH 186
LLG G FG VY+G +G VK V++ G + K+ E+ L L H
Sbjct: 7 LLGSGSFGSVYEGLNLDDGDFFAVKE-----VSLADDGQTGQEAVKQLEQEIALLSKLQH 61
Query: 187 PNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHE 246
PN+V+ +G E+D + E +P GSL L ++ P + GL +LH+
Sbjct: 62 PNIVQYLGTEREEDNLYIFLELVPGGSLAK-LLKKYGSFPEPVIRLYTRQILLGLEYLHD 120
Query: 247 EAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVM-----GTYGYAA 301
+ ++RD K +NIL+D KL+DFG+AK V G+ + A
Sbjct: 121 ---RNTVHRDIKGANILVDTNGVVKLADFGMAK--------QVVEFSFAKSFKGSPYWMA 169
Query: 302 PEYVM-TGHLTAKSDVYSFGVVLLEMLTGR 330
PE + G +D++S G +LEM TG+
Sbjct: 170 PEVIAQQGGYGLAADIWSLGCTVLEMATGK 199
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 3e-24
Identities = 66/239 (27%), Positives = 96/239 (40%), Gaps = 53/239 (22%)
Query: 123 FRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGH---------KE 173
F+ ++GEG F V A K T A+K L+ L KE
Sbjct: 3 FKFGKIIGEGSFSTVVL--------AKEK-ETNKEYAIKILDKRQLIKEKKVKYVKIEKE 53
Query: 174 WLAEVNYLGGLIHPNLVKLIGCCIEDDQRL-LVYEFMPRGSLENHL-FRRSLPLPWSIRM 231
L L G HP ++KL +D++ L V E+ P G L ++ SL R
Sbjct: 54 VL---TRLNG--HPGIIKLY-YTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKC-TRF 106
Query: 232 KIA--LDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHV 289
A L A L +LH K +I+RD K NILLD + + K++DFG AK
Sbjct: 107 YAAEILLA---LEYLHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPES 160
Query: 290 STRVM------------------GTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGR 330
+ GT Y +PE + SD+++ G ++ +MLTG+
Sbjct: 161 NKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 4e-24
Identities = 70/207 (33%), Positives = 107/207 (51%), Gaps = 17/207 (8%)
Query: 128 LLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNH-DGLQGHKEWLAEVNYLGGLIH 186
++G+G FGCVY +GT G + AVK+LN L+ +++L E + H
Sbjct: 2 VIGKGHFGCVY------HGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSH 55
Query: 187 PNLVKLIGCCIEDD-QRLLVYEFMPRGSLENHLFRRSLPLPWSIR--MKIALDAAKGLAF 243
PN++ L+G C+ + L+V +M G L N F RS +++ + L AKG+ +
Sbjct: 56 PNVLSLLGICLPSEGSPLVVLPYMKHGDLRN--FIRSETHNPTVKDLIGFGLQVAKGMEY 113
Query: 244 LHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKD--GPEGDKTHVSTRVMGTYGYAA 301
L A K ++RD N +LD + K++DFGLA+D E H T + A
Sbjct: 114 L---ASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMA 170
Query: 302 PEYVMTGHLTAKSDVYSFGVVLLEMLT 328
E + T T KSDV+SFGV+L E++T
Sbjct: 171 LESLQTQKFTTKSDVWSFGVLLWELMT 197
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 5e-24
Identities = 81/303 (26%), Positives = 128/303 (42%), Gaps = 52/303 (17%)
Query: 129 LGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLA--EVNYLGGLIH 186
+GEG G VYK AT + TG VA+K + L+ + L E+ + H
Sbjct: 27 IGEGASGEVYK--------ATDR-ATGKEVAIKKMR---LRKQNKELIINEILIMKDCKH 74
Query: 187 PNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHE 246
PN+V + D+ +V E+M GSL + + + + + + + +GL +LH
Sbjct: 75 PNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHS 134
Query: 247 EAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM 306
+ VI+RD K+ NILL + + KL+DFG A + S V+GT + APE V+
Sbjct: 135 ---QNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNS--VVGTPYWMAPE-VI 188
Query: 307 TGHL-TAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGER--RRFYRLID 363
K D++S G++ +EM G P P L E R + +
Sbjct: 189 KRKDYGPKVDIWSLGIMCIEMAEG-------EP-----------PYLREPPLRALFLITT 230
Query: 364 PCLEGCFSIKGAEKTIQL----AASCLNRDQKARPRMSEVVEALKPLPYLKDMASSSSYV 419
+G +K EK CL +D + RP E L+ P+LK +
Sbjct: 231 ---KGIPPLKNPEKWSPEFKDFLNKCLVKDPEKRP---SAEELLQ-HPFLKKACPKEEFA 283
Query: 420 QAM 422
+
Sbjct: 284 PLI 286
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 99.7 bits (249), Expect = 1e-23
Identities = 68/211 (32%), Positives = 99/211 (46%), Gaps = 32/211 (15%)
Query: 129 LGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDG-LQGHKEWLAEVNYLGGLIHP 187
LG G G V K +P TG +AVKT+ + K+ L E++ L P
Sbjct: 9 LGAGNSGVVSK--------VLHRP-TGKIMAVKTIRLEINEAIQKQILRELDILHKCNSP 59
Query: 188 NLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEE 247
+V G + + E+M GSL+ L +P I KIA+ KGL +LHE+
Sbjct: 60 YIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEK 119
Query: 248 AEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVM--------GTYGY 299
+ +I+RD K SNIL++ KL DFG VS +++ GT Y
Sbjct: 120 HK--IIHRDVKPSNILVNSRGQIKLCDFG------------VSGQLVNSLAKTFVGTSSY 165
Query: 300 AAPEYVMTGHLTAKSDVYSFGVVLLEMLTGR 330
APE + + KSD++S G+ L+E+ TGR
Sbjct: 166 MAPERIQGNDYSVKSDIWSLGLSLIELATGR 196
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 99 bits (249), Expect = 1e-23
Identities = 63/222 (28%), Positives = 100/222 (45%), Gaps = 29/222 (13%)
Query: 129 LGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDG-LQGHKEWLAEVNYLGGLIHP 187
+G+G FG V++ G +P T VAVK L + ++ E + HP
Sbjct: 13 IGQGAFGRVFQA--RAPGLLPYEPFT--MVAVKMLKEEASADMQADFQREAALMAEFDHP 68
Query: 188 NLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRS---------------------LPLP 226
N+VKL+G C L++E+M G L L RS LPL
Sbjct: 69 NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLS 128
Query: 227 WSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDK 286
+ ++ IA A G+A+L +E+ ++RD T N L+ K++DFGL+++ D
Sbjct: 129 CTEQLCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADY 185
Query: 287 THVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLT 328
S + PE + T +SDV+++GVVL E+ +
Sbjct: 186 YKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 98.9 bits (246), Expect = 3e-23
Identities = 70/232 (30%), Positives = 115/232 (49%), Gaps = 17/232 (7%)
Query: 128 LLGEGGFGCVYKG-WINMNGTATVKPGTGLPVAVKTL-NHDGLQGHKEWLAEVNYLGGLI 185
LLG G FG V+KG WI + + PVA+KT+ + G Q +E + +G L
Sbjct: 14 LLGSGVFGTVHKGIWIPEGDSIKI------PVAIKTIQDRSGRQTFQEITDHMLAMGSLD 67
Query: 186 HPNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLH 245
H +V+L+G C LV + P GSL +H+ + L + + AKG+ +L
Sbjct: 68 HAYIVRLLGIC-PGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLE 126
Query: 246 EEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYV 305
E +++R+ NILL + +++DFG+A DK + + + A E +
Sbjct: 127 EHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESI 183
Query: 306 MTGHLTAKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVE----WARPQL 352
+ G T +SDV+S+GV + EM++ G RP+ +L+E A+PQ+
Sbjct: 184 LFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGERLAQPQI 235
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 98.9 bits (246), Expect = 3e-23
Identities = 82/295 (27%), Positives = 131/295 (44%), Gaps = 34/295 (11%)
Query: 129 LGEGGFG----CVYKGWINMNG-TATVKPGTGLPVAVKTLNHDGLQ-GHKEWLAEVNYLG 182
LGEG FG C +G G A G + VAVK L D + ++L E+ +
Sbjct: 13 LGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMS 72
Query: 183 GLIHPNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKI--------- 233
L +PN+++L+G C+ DD ++ E+M G L L +R + ++ I
Sbjct: 73 RLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLL 132
Query: 234 --ALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVST 291
A+ A G+ +L A ++RD T N L+ Y K++DFG++++ GD +
Sbjct: 133 YMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQG 189
Query: 292 RVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEH---NLVEWA 348
R + + A E ++ G T SDV++FGV L EM T + + + E N E+
Sbjct: 190 RAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQVIENTGEFF 249
Query: 349 RPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEAL 403
R Q R+ Y P +L C +RD K RP +++ L
Sbjct: 250 RNQ---GRQIYLSQTPLCPS--------PVFKLMMRCWSRDIKDRPTFNKIHHFL 293
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 98.3 bits (245), Expect = 6e-23
Identities = 92/297 (30%), Positives = 134/297 (45%), Gaps = 43/297 (14%)
Query: 128 LLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHP 187
LG+G FG V + ++ TG VAVK L H + +++ E+ L L H
Sbjct: 11 QLGKGNFGSV-----ELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHD 65
Query: 188 NLVKLIGCCIEDDQR--LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLH 245
N+VK G C +R LV E++P GSL ++L + L + A KG+ +L
Sbjct: 66 NIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYL- 124
Query: 246 EEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMG---TYGYAAP 302
K ++RD T NIL++ E K+ DFGL K P+ DK + R G + Y AP
Sbjct: 125 --GSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQ-DKEYYKVREPGESPIFWY-AP 180
Query: 303 EYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRR----F 358
E + + SDV+SFGVVL E+ T DK+ E+ R +G ++
Sbjct: 181 ESLTESKFSVASDVWSFGVVLYELFT---YSDKSCSPPA----EFMR-MMGNDKQGQMIV 232
Query: 359 YRLID--------PCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEV---VEALK 404
Y LI+ P GC + + C N D RP SE+ VEA++
Sbjct: 233 YHLIELLKNNGRLPAPPGC-----PAEIYAIMKECWNNDPSQRPSFSELALQVEAIR 284
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 98.2 bits (245), Expect = 7e-23
Identities = 82/303 (27%), Positives = 122/303 (40%), Gaps = 57/303 (18%)
Query: 129 LGEGGFGCVY-------------KGWINMNGTATVKPGTGLPVAVKTLNHDG-LQGHKEW 174
LGEG FG V+ N N A V VAVK L D +++
Sbjct: 13 LGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVL------VAVKVLRPDASDNAREDF 66
Query: 175 LAEVNYLGGLIHPNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRR----------SLP 224
L EV L L PN+ +L+G C D ++ E+M G L L + S
Sbjct: 67 LKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKS 126
Query: 225 LPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEG 284
L +S + +A A G+ +L ++RD T N L+ Y K++DFG++++
Sbjct: 127 LSFSTLLYMATQIASGMRYL---ESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSS 183
Query: 285 DKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLT-GRRSMDKNRPNGE-- 341
D V R + A E V+ G T KSDV++FGV L E+LT R +P
Sbjct: 184 DYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCRE-----QPYEHLT 238
Query: 342 -----HNLVEWARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRM 396
N + R R+ + C + + +L C RD++ RP
Sbjct: 239 DQQVIENAGHFFRDD--GRQIYLPRPPNCPKDIY---------ELMLECWRRDEEDRPTF 287
Query: 397 SEV 399
E+
Sbjct: 288 REI 290
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 96.6 bits (241), Expect = 1e-22
Identities = 63/210 (30%), Positives = 97/210 (46%), Gaps = 16/210 (7%)
Query: 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNY 180
+ F LGEG +G VYK I+ TG VA+K + + +E + E++
Sbjct: 3 EVFDILEKLGEGSYGSVYKA-IHKE--------TGQVVAIKVVPVEE--DLQEIIKEISI 51
Query: 181 LGGLIHPNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKG 240
L P +VK G ++ +V E+ GS+ + + + L I KG
Sbjct: 52 LKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKG 111
Query: 241 LAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYA 300
L +LH I+RD K NILL+ E AKL+DFG++ G D V+GT +
Sbjct: 112 LEYLHS---NKKIHRDIKAGNILLNEEGQAKLADFGVS--GQLTDTMAKRNTVIGTPFWM 166
Query: 301 APEYVMTGHLTAKSDVYSFGVVLLEMLTGR 330
APE + K+D++S G+ +EM G+
Sbjct: 167 APEVIQEIGYNNKADIWSLGITAIEMAEGK 196
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 1e-22
Identities = 89/287 (31%), Positives = 133/287 (46%), Gaps = 32/287 (11%)
Query: 122 SFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLN-HDGLQGHKEWLAEVNY 180
S + E ++ G G YKG NG V VK +N + + +E+
Sbjct: 691 SLKEENVISRGKKGASYKGKSIKNGMQFV---------VKEINDVNSIP-----SSEIAD 736
Query: 181 LGGLIHPNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKG 240
+G L HPN+VKLIG C + L++E++ +L L L W R KIA+ AK
Sbjct: 737 MGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVL----RNLSWERRRKIAIGIAKA 792
Query: 241 LAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYA 300
L FLH V+ + I++DG+ L L+ G T+ + Y
Sbjct: 793 LRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR---LSLPGL----LCTDTKCFISSAYV 845
Query: 301 APEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEH-NLVEWARPQLGERRRFY 359
APE T +T KSD+Y FG++L+E+LTG+ D G H ++VEWAR +
Sbjct: 846 APETRETKDITEKSDIYGFGLILIELLTGKSPADAE--FGVHGSIVEWARYCYSD-CHLD 902
Query: 360 RLIDPCLEGCFSIKGAE--KTIQLAASCLNRDQKARPRMSEVVEALK 404
IDP + G S+ E + + LA C D ARP ++V++ L+
Sbjct: 903 MWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLE 949
|
Length = 968 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 96.6 bits (240), Expect = 1e-22
Identities = 87/279 (31%), Positives = 131/279 (46%), Gaps = 43/279 (15%)
Query: 129 LGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHPN 188
+GEG FG V +G TG VAVK + D + +L E + L H N
Sbjct: 14 IGEGEFGAVLQG-----------EYTGQKVAVKNIKCDVTA--QAFLEETAVMTKLHHKN 60
Query: 189 LVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRM-KIALDAAKGLAFLHEE 247
LV+L+G I + +V E M +G+L N L R L I++ + +LD A+G+ +L
Sbjct: 61 LVRLLGV-ILHNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLES- 118
Query: 248 AEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEG-DKTHVSTRVMGTYGYAAPEYVM 306
K +++RD NIL+ + AK+SDFGLA+ G G D + + + + APE +
Sbjct: 119 --KKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVK------WTAPEALK 170
Query: 307 TGHLTAKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPQLGERRRFYRLIDPC 365
++KSDV+S+GV+L E+ + GR K VE + YR+ P
Sbjct: 171 HKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVE----------KGYRMEPP- 219
Query: 366 LEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALK 404
EGC L SC + K RP ++ E L+
Sbjct: 220 -EGC-----PADVYVLMTSCWETEPKKRPSFHKLREKLE 252
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 95.6 bits (238), Expect = 3e-22
Identities = 63/216 (29%), Positives = 105/216 (48%), Gaps = 25/216 (11%)
Query: 128 LLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTL--------NHDGLQGH--KEWLAE 177
L+G+G +G VY + +N T TG +AVK + HD Q K +E
Sbjct: 8 LIGKGTYGRVY---LALNVT------TGEMMAVKQVELPATIAGRHDSRQKDMVKALRSE 58
Query: 178 VNYLGGLIHPNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDA 237
+ L L H N+V+ +G ++ + E++P GS+ + R +
Sbjct: 59 IETLKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGS-CLRTYGRFEEQLVRFFTEQV 117
Query: 238 AKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTY 297
+GLA+LH K +++RD K N+L+D + K+SDFG++K + + + G+
Sbjct: 118 LEGLAYLHS---KGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSV 174
Query: 298 GYAAPEYVMTGH--LTAKSDVYSFGVVLLEMLTGRR 331
+ APE + + +AK D++S G V+LEM GRR
Sbjct: 175 FWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRR 210
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 95.7 bits (238), Expect = 3e-22
Identities = 78/288 (27%), Positives = 129/288 (44%), Gaps = 49/288 (17%)
Query: 129 LGEGGFGCVYKG-WINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHP 187
LG G +G VY+G W + T VAVKTL D ++ E+L E + + HP
Sbjct: 14 LGGGQYGEVYEGVWKKYSLT----------VAVKTLKEDTMEVE-EFLKEAAVMKEIKHP 62
Query: 188 NLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFR--RSLPLPWSIRMKIALDAAKGLAFLH 245
NLV+L+G C + ++ EFM G+L ++L R + + + +A + + +L
Sbjct: 63 NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE-VNAVVLLYMATQISSAMEYLE 121
Query: 246 EEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAK-------DGPEGDKTHVSTRVMGTYG 298
+K I+RD N L+ + K++DFGL++ G K +
Sbjct: 122 ---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK-------- 170
Query: 299 YAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRRF 358
+ APE + + KSDV++FGV+L E+ T S P + + V +
Sbjct: 171 WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMS---PYPGIDLSQV------YELLEKG 221
Query: 359 YRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPL 406
YR+ P EGC K +L +C + RP +E+ +A + +
Sbjct: 222 YRMERP--EGC-----PPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 96.1 bits (239), Expect = 4e-22
Identities = 77/292 (26%), Positives = 131/292 (44%), Gaps = 35/292 (11%)
Query: 129 LGEGGFG----CVYKG---WINMNGTATVKPGTGLPVAVKTLNHDGLQGHK-EWLAEVNY 180
LGEG FG C +G +++ + + V + VAVK L D + + ++L E+
Sbjct: 13 LGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKI 72
Query: 181 LGGLIHPNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLP----------WSIR 230
+ L PN+++L+ CI D ++ E+M G L L R +S
Sbjct: 73 MSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTL 132
Query: 231 MKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVS 290
+ +A A G+ +L + ++RD T N L+ Y K++DFG++++ GD +
Sbjct: 133 IFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQ 189
Query: 291 TRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEH---NLVEW 347
R + + + E ++ G T SDV++FGV L E+LT + ++ + E N E+
Sbjct: 190 GRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQVIENTGEF 249
Query: 348 ARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEV 399
R Q R+ Y C + +L SC R+ K RP E+
Sbjct: 250 FRDQ---GRQVYLPKPAL---C-----PDSLYKLMLSCWRRNAKERPSFQEI 290
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 94.1 bits (234), Expect = 8e-22
Identities = 83/278 (29%), Positives = 122/278 (43%), Gaps = 55/278 (19%)
Query: 129 LGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHPN 188
LG G FG V+ G+ N + VA+K+L G + +LAE N + L HP
Sbjct: 14 LGAGQFGEVWMGYYNGH----------TKVAIKSLK-QGSMSPEAFLAEANLMKQLQHPR 62
Query: 189 LVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRS---LPLPWSIRMKIALDAAKGLAFLH 245
LV+L + + ++ E+M GSL + L L + I M A A+G+AF+
Sbjct: 63 LVRLYAV-VTQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDM--AAQIAEGMAFIE 119
Query: 246 EEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAK-------DGPEGDKTHVSTRVMGTYG 298
K I+RD + +NIL+ K++DFGLA+ EG K +
Sbjct: 120 R---KNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIK-------- 168
Query: 299 YAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGE--HNLVEWARPQLGERR 356
+ APE + G T KSDV+SFG++L E++T R N E NL
Sbjct: 169 WTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNL-----------E 217
Query: 357 RFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARP 394
R YR+ P + C E+ +L C + RP
Sbjct: 218 RGYRM--PRPDNC-----PEELYELMRLCWKEKPEERP 248
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 94.7 bits (235), Expect = 1e-21
Identities = 68/217 (31%), Positives = 98/217 (45%), Gaps = 26/217 (11%)
Query: 129 LGEGGFGCVYKG-WINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHP 187
LGEG FG V+ N++ T + VAVK L L K++ E L L H
Sbjct: 13 LGEGAFGKVFLAECYNLSPT-----KDKMLVAVKALKDPTLAARKDFQREAELLTNLQHE 67
Query: 188 NLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLP----------------LPWSIRM 231
++VK G C + D ++V+E+M G L N R P L S +
Sbjct: 68 HIVKFYGVCGDGDPLIMVFEYMKHGDL-NKFLRAHGPDAMILVDGQPRQAKGELGLSQML 126
Query: 232 KIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVST 291
IA A G+ +L A + ++RD T N L+ K+ DFG+++D D V
Sbjct: 127 HIASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGG 183
Query: 292 RVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLT 328
M + PE +M T +SDV+SFGV+L E+ T
Sbjct: 184 HTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 220
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 93.3 bits (232), Expect = 2e-21
Identities = 57/201 (28%), Positives = 93/201 (46%), Gaps = 12/201 (5%)
Query: 128 LLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKE-WLAEVNYLGGLIH 186
+GEG FG VY+G + VAVKT + +E +L E + H
Sbjct: 13 CIGEGQFGDVYQG------VYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDH 66
Query: 187 PNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHE 246
P++VKLIG ++ +V E P G L ++L L + + + + LA+L
Sbjct: 67 PHIVKLIGVI-TENPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLES 125
Query: 247 EAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM 306
K ++RD N+L+ KL DFGL++ E + + +++ + APE +
Sbjct: 126 ---KRFVHRDIAARNVLVSSPDCVKLGDFGLSR-YLEDESYYKASKGKLPIKWMAPESIN 181
Query: 307 TGHLTAKSDVYSFGVVLLEML 327
T+ SDV+ FGV + E+L
Sbjct: 182 FRRFTSASDVWMFGVCMWEIL 202
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.2 bits (232), Expect = 3e-21
Identities = 66/211 (31%), Positives = 96/211 (45%), Gaps = 30/211 (14%)
Query: 129 LGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEW-----LAEVNYLGG 183
+GEG +G VYK + G VA+K + L+ E L E+ L
Sbjct: 7 IGEGTYGVVYKARDKLTGEI---------VAIKKIK---LRFESEGIPKTALREIKLLKE 54
Query: 184 LIHPNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAF 243
L HPN++KL+ LV+EFM L + R LP S+ +GLAF
Sbjct: 55 LNHPNIIKLLDVFRHKGDLYLVFEFM-DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAF 113
Query: 244 LHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAK--DGPEGDKTH-VSTRVMGTYGYA 300
H +++RD K N+L++ E KL+DFGLA+ P TH V TR Y
Sbjct: 114 CHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTR-----WYR 165
Query: 301 APEYVMT-GHLTAKSDVYSFGVVLLEMLTGR 330
APE ++ + D++S G + E+L+ R
Sbjct: 166 APELLLGDKGYSTPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.9 bits (232), Expect = 4e-21
Identities = 66/208 (31%), Positives = 107/208 (51%), Gaps = 24/208 (11%)
Query: 129 LGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTL----NHDGLQGHKEWLAEVNYLGGL 184
LGEG +G VYK + TG VA+K + +G+ L E++ L L
Sbjct: 7 LGEGTYGVVYKAR-DKK--------TGEIVALKKIRLDNEEEGIP--STALREISLLKEL 55
Query: 185 IHPNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFL 244
HPN+VKL+ + + LV+E+ L+ +L +R PL ++ I +GLA+
Sbjct: 56 KHPNIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYC 114
Query: 245 HEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEY 304
H +++RD K NIL++ + KL+DFGLA+ +T+ + V+ T Y APE
Sbjct: 115 HS---HRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTY-THEVV-TLWYRAPE- 168
Query: 305 VMTG--HLTAKSDVYSFGVVLLEMLTGR 330
++ G H + D++S G + EM+TG+
Sbjct: 169 ILLGSKHYSTAVDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 92.7 bits (231), Expect = 4e-21
Identities = 60/208 (28%), Positives = 95/208 (45%), Gaps = 23/208 (11%)
Query: 129 LGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLN----HDGLQGHKEWLAEVNYLGGL 184
+GEG G V+K A + TG VA+K + G+ + L E+ L
Sbjct: 8 IGEGAHGIVFK--------AKDR-ETGETVALKKVALRRLEGGIP--NQALREIKALQAC 56
Query: 185 IHPNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFL 244
HP +VKL+ +LV E+MP L L PLP + KG+A++
Sbjct: 57 QHPYVVKLLDVFPHGSGFVLVMEYMPS-DLSEVLRDEERPLPEAQVKSYMRMLLKGVAYM 115
Query: 245 HEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEY 304
H +++RD K +N+L+ + K++DFGLA+ E + S +V T Y APE
Sbjct: 116 HANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQV-ATRWYRAPE- 170
Query: 305 VMTG--HLTAKSDVYSFGVVLLEMLTGR 330
++ G D+++ G + E+L G
Sbjct: 171 LLYGARKYDPGVDLWAVGCIFAELLNGS 198
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 5e-21
Identities = 89/285 (31%), Positives = 130/285 (45%), Gaps = 53/285 (18%)
Query: 121 KSFRPECLLGEGGFGCVYKG-WINMNGTA-----TVKPGTGLPVAVKTLNHDGLQGHKEW 174
+S R + LG+G FG V+ G W NGT T+KPGT +P A +
Sbjct: 6 ESLRLDVKLGQGCFGEVWMGTW---NGTTKVAIKTLKPGTMMPEA--------------F 48
Query: 175 LAEVNYLGGLIHPNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRM 231
L E + L H LV L + ++ +V EFM +GSL + L + L LP + M
Sbjct: 49 LQEAQIMKKLRHDKLVPLYAV-VSEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDM 107
Query: 232 KIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVST 291
A A G+A++ I+RD + +NIL+ K++DFGLA+ + + T
Sbjct: 108 --AAQIADGMAYIER---MNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT---A 159
Query: 292 RVMGTY--GYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR 349
R + + APE + G T KSDV+SFG++L E++T R N R
Sbjct: 160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVN---------R 210
Query: 350 PQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARP 394
L + R YR+ PC +GC E +L C +D RP
Sbjct: 211 EVLEQVERGYRM--PCPQGC-----PESLHELMKLCWKKDPDERP 248
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 91.6 bits (228), Expect = 7e-21
Identities = 78/270 (28%), Positives = 116/270 (42%), Gaps = 35/270 (12%)
Query: 147 TATVKPGTGLP----VAVKTLNHDGLQGH-KEWLAEVNYLGGLIHPNLVKLIGCCIEDDQ 201
TA V LP VA+K ++ + Q E EV + HPN+VK + D+
Sbjct: 14 TAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDE 73
Query: 202 RLLVYEFMPRGSLENHLFRRSLP---LPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFK 258
LV ++ GSL + + S P L +I + + KGL +LH + I+RD K
Sbjct: 74 LWLVMPYLSGGSLL-DIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQ---IHRDIK 129
Query: 259 TSNILLDGEYNAKLSDFG----LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGH--LTA 312
NILL + + K++DFG LA G V +GT + APE VM
Sbjct: 130 AGNILLGEDGSVKIADFGVSASLADGG--DRTRKVRKTFVGTPCWMAPE-VMEQVHGYDF 186
Query: 313 KSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRRFYRLIDPCLEGCFSI 372
K+D++SFG+ +E+ TG K P L P P LE
Sbjct: 187 KADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDP-------------PSLETGADY 233
Query: 373 KGAEKTI-QLAASCLNRDQKARPRMSEVVE 401
K K+ ++ + CL +D RP E+++
Sbjct: 234 KKYSKSFRKMISLCLQKDPSKRPTAEELLK 263
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 92.4 bits (230), Expect = 1e-20
Identities = 71/215 (33%), Positives = 95/215 (44%), Gaps = 35/215 (16%)
Query: 128 LLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHD---------GLQGHKEWLAEV 178
+LG+G FG V A +K GT AVK L D K LA
Sbjct: 2 VLGKGSFGKVL--------LAELK-GTDELYAVKVLKKDVILQDDDVECTMTEKRVLALA 52
Query: 179 NYLGGLIHPNLVKLIGCCIEDDQRL-LVYEFMPRGSLENHLFR-RSLPLPWSIRMKIALD 236
HP L +L C + RL V E++ G L H+ R P + A +
Sbjct: 53 GK-----HPFLTQLH-SCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFY--AAE 104
Query: 237 AAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDG-PEGDKTHVSTRVMG 295
GL FLHE + +IYRD K N+LLD E + K++DFG+ K+G G T + G
Sbjct: 105 IVLGLQFLHE---RGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTT---STFCG 158
Query: 296 TYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGR 330
T Y APE + D ++ GV+L EML G+
Sbjct: 159 TPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQ 193
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 1e-20
Identities = 73/288 (25%), Positives = 127/288 (44%), Gaps = 41/288 (14%)
Query: 129 LGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTL-NHDGLQGHKEWLAEVNYLGGLIHP 187
LGE FG +YKG + + G + VA+KTL + + Q E+ E + + L HP
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQL-----VAIKTLKDINNPQQWGEFQQEASLMAELHHP 67
Query: 188 NLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRS----------------LPLPWSIRM 231
N+V L+G ++ +++E++ +G L L RS L +
Sbjct: 68 NIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFL 127
Query: 232 KIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVST 291
IA+ A G+ +L + +++D NIL+ + + K+SD GL+++ D V
Sbjct: 128 HIAIQIAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQP 184
Query: 292 RVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQ 351
+ + + PE +M G ++ SD++SFGVVL E+ + G ++ +
Sbjct: 185 KSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS----------FGLQPYYGFSNQE 234
Query: 352 LGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEV 399
+ E R +L+ PC E C + L C RPR ++
Sbjct: 235 VIEMVRKRQLL-PCSEDC-----PPRMYSLMTECWQEGPSRRPRFKDI 276
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.5 bits (228), Expect = 1e-20
Identities = 61/215 (28%), Positives = 100/215 (46%), Gaps = 35/215 (16%)
Query: 129 LGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKE-----WLAEVNYLGG 183
+GEG +G VYK N TG VA+K + ++ KE + E+ L
Sbjct: 7 IGEGTYGQVYKA---RNKK------TGELVALKKIR---MENEKEGFPITAIREIKLLQK 54
Query: 184 LIHPNLVKLIGCCIEDDQR--LLVYEFMP---RGSLENHLFRRSLPLPWSIR--MKIALD 236
L HPN+V+L + +V+E+M G L++ + + I+ MK L
Sbjct: 55 LRHPNIVRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTES---QIKCYMKQLL- 110
Query: 237 AAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGT 296
+GL +LH +++RD K SNIL++ + KL+DFGLA+ + T + T
Sbjct: 111 --EGLQYLHS---NGILHRDIKGSNILINNDGVLKLADFGLARP-YTKRNSADYTNRVIT 164
Query: 297 YGYAAPEYVM-TGHLTAKSDVYSFGVVLLEMLTGR 330
Y PE ++ + D++S G +L E+ G+
Sbjct: 165 LWYRPPELLLGATRYGPEVDMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 91.3 bits (227), Expect = 1e-20
Identities = 63/209 (30%), Positives = 95/209 (45%), Gaps = 24/209 (11%)
Query: 129 LGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHD-GLQGHKEWLAEVNYLGGLIHP 187
LGEG G V K + TG+ A+KT+ D K+ L E+ P
Sbjct: 9 LGEGAGGSVTKCRL---------KNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSP 59
Query: 188 NLVKLIGCCIEDDQRLL--VYEFMPRGSLEN---HLFRRSLPLPWSIRMKIALDAAKGLA 242
+VK G +++ + E+ GSL++ + +R + + KIA KGL+
Sbjct: 60 YIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLS 119
Query: 243 FLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKD-GPEGDKTHVSTRVMGTYGYAA 301
+LH + +I+RD K SNILL + KL DFG++ + T GT Y A
Sbjct: 120 YLHS---RKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFT-----GTSFYMA 171
Query: 302 PEYVMTGHLTAKSDVYSFGVVLLEMLTGR 330
PE + + SDV+S G+ LLE+ R
Sbjct: 172 PERIQGKPYSITSDVWSLGLTLLEVAQNR 200
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 2e-20
Identities = 69/210 (32%), Positives = 104/210 (49%), Gaps = 25/210 (11%)
Query: 128 LLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGH--KEWLA---EVNYLG 182
LLG+G FG VY TG +AVK + D KE A E+ L
Sbjct: 9 LLGQGAFGRVY---------LCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLK 59
Query: 183 GLIHPNLVKLIGCCIEDDQRLLVY-EFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGL 241
L H +V+ GC + DD+ L ++ E+MP GS+++ L + L ++ K +G+
Sbjct: 60 NLQHERIVQYYGC-LRDDETLSIFMEYMPGGSVKDQL-KAYGALTETVTRKYTRQILEGV 117
Query: 242 AFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAK--DGPEGDKTHVSTRVMGTYGY 299
+LH +++RD K +NIL D N KL DFG +K T + + V GT +
Sbjct: 118 EYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKS-VTGTPYW 173
Query: 300 AAPEYVMTGHLTA-KSDVYSFGVVLLEMLT 328
+PE V++G K+DV+S G ++EMLT
Sbjct: 174 MSPE-VISGEGYGRKADVWSVGCTVVEMLT 202
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 2e-20
Identities = 64/206 (31%), Positives = 86/206 (41%), Gaps = 19/206 (9%)
Query: 129 LGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL---QGHKEWLAEVNYLGGLI 185
LG+GGFG V A TG A K L+ L +G + L E L +
Sbjct: 1 LGKGGFGEVC---------ACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVS 51
Query: 186 HPNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLP-LPWSIRMKIALDAAKGLAFL 244
+V L D LV M G L+ H++ P P + + A GL L
Sbjct: 52 SRFIVSLAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHL 111
Query: 245 HEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEY 304
H+ ++YRD K N+LLD N ++SD GLA + G K GT GY APE
Sbjct: 112 HQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRA---GTPGYMAPEV 165
Query: 305 VMTGHLTAKSDVYSFGVVLLEMLTGR 330
+ D ++ G L EM+ GR
Sbjct: 166 LQGEVYDFSVDWFALGCTLYEMIAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 89.9 bits (223), Expect = 2e-20
Identities = 78/277 (28%), Positives = 130/277 (46%), Gaps = 35/277 (12%)
Query: 129 LGEGGFGCVYKG-WINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHP 187
LG G FG V+ G W A +K VA+K +N +G ++++ E + L HP
Sbjct: 12 LGSGQFGVVHLGKW-----RAQIK------VAIKAIN-EGAMSEEDFIEEAKVMMKLSHP 59
Query: 188 NLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEE 247
LV+L G C + +V EFM G L N+L +R L + + + D +G+ +L
Sbjct: 60 KLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERN 119
Query: 248 AEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT 307
+ I+RD N L+ K+SDFG+ + + D+ S+ ++ PE
Sbjct: 120 S---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLD-DEYTSSSGAKFPVKWSPPEVFNF 175
Query: 308 GHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRRFYRLIDPCLE 367
++KSDV+SFGV++ E+ T + + + N E +VE + R YR P L
Sbjct: 176 SKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYE--VVE----MISRGFRLYR---PKL- 225
Query: 368 GCFSIKGAEKTI-QLAASCLNRDQKARPRMSEVVEAL 403
A T+ ++ SC + + RP +E++ A+
Sbjct: 226 -------ASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 90.5 bits (224), Expect = 3e-20
Identities = 68/214 (31%), Positives = 97/214 (45%), Gaps = 23/214 (10%)
Query: 129 LGEGGFGCVYKGWINMNGTATVKPGTG-LPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHP 187
LGEG FG V+ + + P + VAVKTL K++ E L L H
Sbjct: 13 LGEGAFGKVF-----LAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHE 67
Query: 188 NLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLP-------------LPWSIRMKIA 234
++VK G C+E D ++V+E+M G L N R P L S + IA
Sbjct: 68 HIVKFYGVCVEGDPLIMVFEYMKHGDL-NKFLRAHGPDAVLMAEGNRPAELTQSQMLHIA 126
Query: 235 LDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVM 294
A G+ +L A + ++RD T N L+ K+ DFG+++D D V M
Sbjct: 127 QQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTM 183
Query: 295 GTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLT 328
+ PE +M T +SDV+S GVVL E+ T
Sbjct: 184 LPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFT 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 90.5 bits (224), Expect = 3e-20
Identities = 60/203 (29%), Positives = 106/203 (52%), Gaps = 12/203 (5%)
Query: 128 LLGEGGFGCVYKG-WINMNGTATVKPGTGLPVAVKTLNHD-GLQGHKEWLAEVNYLGGLI 185
+LG G FG VYKG W+ T + PVA+K LN G + + E++ E + +
Sbjct: 14 VLGSGAFGTVYKGIWVPEGETVKI------PVAIKILNETTGPKANVEFMDEALIMASMD 67
Query: 186 HPNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLH 245
HP+LV+L+G C+ +L V + MP G L +++ + + + + AKG+ +L
Sbjct: 68 HPHLVRLLGVCLSPTIQL-VTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLE 126
Query: 246 EEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYV 305
E + +++RD N+L+ + K++DFGLA+ +K + + + A E +
Sbjct: 127 E---RRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECI 183
Query: 306 MTGHLTAKSDVYSFGVVLLEMLT 328
T +SDV+S+GV + E++T
Sbjct: 184 HYRKFTHQSDVWSYGVTIWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.6 bits (223), Expect = 4e-20
Identities = 57/213 (26%), Positives = 97/213 (45%), Gaps = 23/213 (10%)
Query: 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLA-EVN 179
+ F +G+G FG VYK T VA+K ++ + + E + E+
Sbjct: 1 ELFTLLECIGKGSFGEVYKAIDK---------RTNQVVAIKVIDLEEAEDEIEDIQQEIQ 51
Query: 180 YLGGLIHPNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAK 239
+L P + K G ++ + ++ E+ GS + L + L + I +
Sbjct: 52 FLSQCRSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLL--KPGKLDETYIAFILREVLL 109
Query: 240 GLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTR---VMGT 296
GL +LHEE I+RD K +NILL E + KL+DFG++ G T ++ +GT
Sbjct: 110 GLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVS-----GQLTSTMSKRNTFVGT 161
Query: 297 YGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTG 329
+ APE + K+D++S G+ +E+ G
Sbjct: 162 PFWMAPEVIKQSGYDEKADIWSLGITAIELAKG 194
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 90.0 bits (223), Expect = 4e-20
Identities = 67/212 (31%), Positives = 107/212 (50%), Gaps = 21/212 (9%)
Query: 129 LGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDG-LQGHKEWLAEVNYLGGLIHP 187
LG+G FG VY+G N +K VAVKT+N L+ E+L E + + G
Sbjct: 14 LGQGSFGMVYEG----NARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCH 69
Query: 188 NLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSL----------PLPWSIRM-KIALD 236
++V+L+G + L+V E M G L+++L RSL P P M ++A +
Sbjct: 70 HVVRLLGVVSKGQPTLVVMELMAHGDLKSYL--RSLRPEAENNPGRPPPTLQEMIQMAAE 127
Query: 237 AAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGT 296
A G+A+L+ K ++RD N ++ ++ K+ DFG+ +D E D + +
Sbjct: 128 IADGMAYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 184
Query: 297 YGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLT 328
+ APE + G T SD++SFGVVL E+ +
Sbjct: 185 VRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 5e-20
Identities = 73/256 (28%), Positives = 121/256 (47%), Gaps = 36/256 (14%)
Query: 155 GLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHPNLVKLIGCCIEDDQRL-LVYEFMPRGS 213
G VAVK + +D + +LAE + + L H NLV+L+G +E+ L +V E+M +GS
Sbjct: 29 GNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGS 86
Query: 214 LENHLFRRSLP-LPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKL 272
L ++L R L +K +LD + + +L EA ++RD N+L+ + AK+
Sbjct: 87 LVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL--EANN-FVHRDLAARNVLVSEDNVAKV 143
Query: 273 SDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRS 332
SDFGL K E T + ++ + APE + + KSDV+SFG++L E+ + R
Sbjct: 144 SDFGLTK---EASSTQDTGKL--PVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGR- 197
Query: 333 MDKNRPNGEHNLVEWARPQLGE----RRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNR 388
V + R L + + Y++ P +GC + C +
Sbjct: 198 ------------VPYPRIPLKDVVPRVEKGYKMDAP--DGC-----PPVVYDVMKQCWHL 238
Query: 389 DQKARPRMSEVVEALK 404
D RP ++ E L+
Sbjct: 239 DAATRPSFLQLREQLE 254
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 89.8 bits (223), Expect = 5e-20
Identities = 68/224 (30%), Positives = 103/224 (45%), Gaps = 34/224 (15%)
Query: 127 CLLGEGGFGCV----YKGWINMNGTATVKPGTGLPVAVKTLNHDGL-QGHKEWLAEVNYL 181
LGEG FG V G N N T+TV AVK L D + + ++E+ +
Sbjct: 18 KPLGEGAFGQVVKAEAVGLDNPNETSTV--------AVKMLKDDATEKDLSDLVSEMEMM 69
Query: 182 GGLI--HPNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRR-------SLPLPWSIRMK 232
+I H N++ L+G C ++ +V E+ G+L + L R S P
Sbjct: 70 K-MIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEET 128
Query: 233 I--------ALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEG 284
+ A A+G+ FL A K I+RD N+L+ ++ K++DFGLA+D
Sbjct: 129 LTQKDLVSFAYQVARGMEFL---ASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHI 185
Query: 285 DKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLT 328
D +T + APE + T +SDV+SFGV+L E+ T
Sbjct: 186 DYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 6e-20
Identities = 64/216 (29%), Positives = 94/216 (43%), Gaps = 25/216 (11%)
Query: 129 LGEGGFGCVYKGWINMNGTATVKPGTG-LPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHP 187
LGEG FG V+ + + P + VAVK L +++ E L L H
Sbjct: 13 LGEGAFGKVF-----LAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQ 67
Query: 188 NLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLP---------------LPWSIRMK 232
++V+ G C E L+V+E+M G L N R P L +
Sbjct: 68 HIVRFYGVCTEGRPLLMVFEYMRHGDL-NRFLRSHGPDAKILAGGEDVAPGQLTLGQMLA 126
Query: 233 IALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTR 292
IA A G+ +L A ++RD T N L+ K+ DFG+++D D V R
Sbjct: 127 IASQIASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGR 183
Query: 293 VMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLT 328
M + PE ++ T +SD++SFGVVL E+ T
Sbjct: 184 TMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 6e-20
Identities = 74/284 (26%), Positives = 132/284 (46%), Gaps = 33/284 (11%)
Query: 128 LLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHK-EWLAEVNYLGGLIH 186
++G G FG V++G + M G V VA+KTL + + ++L+E + +G H
Sbjct: 12 VIGAGEFGEVFRGILKMPGRKEV------AVAIKTLKPGYTEKQRQDFLSEASIMGQFSH 65
Query: 187 PNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHE 246
N+++L G + +++ E+M G+L+ +L + + A G+ +L
Sbjct: 66 HNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYL-- 123
Query: 247 EAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAK---DGPEGDKTHVSTRVMGTYGYAAPE 303
++ ++RD NIL++ K+SDFGL++ D PEG T ++ + APE
Sbjct: 124 -SDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKI--PIRWTAPE 180
Query: 304 YVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGER-RRFYRLI 362
+ T+ SDV+SFG+V+ E+++ GE + + ++ + +RL
Sbjct: 181 AIAYRKFTSASDVWSFGIVMWEVMS----------FGERPYWDMSNHEVMKAINDGFRL- 229
Query: 363 DPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPL 406
P C S QL C +D+ RPR ++V L L
Sbjct: 230 -PAPMDCPS-----AVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 88.4 bits (219), Expect = 1e-19
Identities = 73/286 (25%), Positives = 130/286 (45%), Gaps = 31/286 (10%)
Query: 126 ECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHD-GLQGHKEWLAEVNYLGGL 184
E ++G G FG V +G + + G + VA+KTL + +++L+E + +G
Sbjct: 9 EEVIGAGEFGEVCRGRLKLPGKREI------FVAIKTLKSGYTEKQRRDFLSEASIMGQF 62
Query: 185 IHPNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFL 244
HPN++ L G + +++ EFM G+L++ L + + + A G+ +L
Sbjct: 63 DHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYL 122
Query: 245 HEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMG---TYGYAA 301
+E ++RD NIL++ K+SDFGL++ + T +G + A
Sbjct: 123 ---SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTA 179
Query: 302 PEYVMTGHLTAKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPQLGERRRFYR 360
PE + T+ SDV+S+G+V+ E+++ G R N +E + YR
Sbjct: 180 PEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIE----------QDYR 229
Query: 361 LIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPL 406
L P C + QL C +D+ ARP+ ++V L +
Sbjct: 230 LPPP--MDCPTA-----LHQLMLDCWQKDRNARPKFGQIVSTLDKM 268
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 88.1 bits (219), Expect = 1e-19
Identities = 61/216 (28%), Positives = 92/216 (42%), Gaps = 30/216 (13%)
Query: 129 LGEGGFGCVYKGWINMNGTATVK-PGTGLPVAVKTLNHDGLQGH-KEWL-AEVNYLGGLI 185
+G+G FG V K V+ G + K +++ + K+ L +EVN L L
Sbjct: 8 IGKGSFGTVRK----------VRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELK 57
Query: 186 HPNLVKLIGCCIEDDQRLL--VYEFMPRGSLENHLFRRS----LPLPWSIRMKIALDAAK 239
HPN+V+ I+ + L V E+ G L L ++ + +I
Sbjct: 58 HPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQ-LIQKCKKERKYIEEEFIWRILTQLLL 116
Query: 240 GLAFLH--EEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGD---KTHVSTRVM 294
L H + V++RD K +NI LD N KL DFGLAK KT+V
Sbjct: 117 ALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYV----- 171
Query: 295 GTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGR 330
GT Y +PE + KSD++S G ++ E+
Sbjct: 172 GTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALS 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.1 bits (219), Expect = 2e-19
Identities = 73/295 (24%), Positives = 110/295 (37%), Gaps = 51/295 (17%)
Query: 127 CLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTL--NHDGLQGHKEWLAEVNYLGGL 184
++GEG +G V K K TG VA+K + D K L EV L L
Sbjct: 7 GVVGEGAYGVVLK--------CRNK-ATGEIVAIKKFKESEDDEDVKKTALREVKVLRQL 57
Query: 185 IHPNLVKLIGCCIEDDQRLLVYEFMPRGSLEN-HLFRRSLPLPWSIRMKIALDAAKGLAF 243
H N+V L + LV+E++ R LE LP P ++R + +A+
Sbjct: 58 RHENIVNLKEAFRRKGRLYLVFEYVERTLLELLEASPGGLP-PDAVR-SYIWQLLQAIAY 115
Query: 244 LHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPE 303
H +I+RD K NIL+ KL DFG A+ + ++ V T Y APE
Sbjct: 116 CHS---HNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYV-ATRWYRAPE 171
Query: 304 ----YVMTGHLTAKSDVYSFGVVLLEMLTGR----------------RSMDKNRPNGEHN 343
G DV++ G ++ E+L G + + P H
Sbjct: 172 LLVGDTNYG---KPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPP--SHQ 226
Query: 344 LVEWARPQLGERRRFYRLIDP----CLEGCFSIKGAEKTIQLAASCLNRDQKARP 394
+ + P+ +P LE + K + + +CL D K R
Sbjct: 227 ELFSSNPRF----AGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERL 277
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 88.1 bits (218), Expect = 2e-19
Identities = 70/205 (34%), Positives = 102/205 (49%), Gaps = 14/205 (6%)
Query: 129 LGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWL-AEVNYLGGLIHP 187
LGEG FG V + G TG VAVK+L + H L E+ L L H
Sbjct: 12 LGEGHFGKVELCRYDPEGD-----NTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHE 66
Query: 188 NLVKLIGCCIEDDQR--LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLH 245
N+VK G C ED L+ EF+P GSL+ +L R + ++K A+ KG+ +L
Sbjct: 67 NIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYL- 125
Query: 246 EEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTR--VMGTYGYAAPE 303
+ ++RD N+L++ E+ K+ DFGL K E DK + + + + + APE
Sbjct: 126 --GSRQYVHRDLAARNVLVESEHQVKIGDFGLTK-AIETDKEYYTVKDDLDSPVFWYAPE 182
Query: 304 YVMTGHLTAKSDVYSFGVVLLEMLT 328
++ SDV+SFGV L E+LT
Sbjct: 183 CLIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 2e-19
Identities = 73/249 (29%), Positives = 114/249 (45%), Gaps = 29/249 (11%)
Query: 129 LGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEW---LAEVNYLGGLI 185
+G G FG VY N T VAVK +++ G Q +++W + EV +L L
Sbjct: 29 IGHGSFGAVY---FATNSH------TNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLK 79
Query: 186 HPNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLH 245
HPN ++ GC +++ LV E+ GS + L PL I A +GLA+LH
Sbjct: 80 HPNTIEYKGCYLKEHTAWLVMEYC-LGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLH 138
Query: 246 EEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYV 305
+I+RD K NILL KL+DFG A K+ + +GT + APE +
Sbjct: 139 SHN---MIHRDIKAGNILLTEPGQVKLADFGSAS------KSSPANSFVGTPYWMAPEVI 189
Query: 306 MT---GHLTAKSDVYSFGVVLLEMLTGRRSM-DKNRPNGEHNLVEWARPQLGERR---RF 358
+ G K DV+S G+ +E+ + + + N + +++ + P L F
Sbjct: 190 LAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSF 249
Query: 359 YRLIDPCLE 367
+D CL+
Sbjct: 250 RGFVDYCLQ 258
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 87.7 bits (217), Expect = 3e-19
Identities = 69/226 (30%), Positives = 104/226 (46%), Gaps = 35/226 (15%)
Query: 129 LGEGGFGCVYKGWINMNGTATVKPGTG--LPVAVKTLNHDGLQGH-KEWLAEVNYLGGLI 185
LGEG FG V K TA G VAVK L + ++ L+E N L +
Sbjct: 8 LGEGEFGKVVKA------TAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVN 61
Query: 186 HPNLVKLIGCCIEDDQRLLVYEFMPRGSLENHL---------------FRRSLPL----- 225
HP+++KL G C +D LL+ E+ GSL + L R S L
Sbjct: 62 HPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDE 121
Query: 226 -PWSIRMKI--ALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGP 282
++ I A ++G+ +L AE +++RD N+L+ K+SDFGL++D
Sbjct: 122 RALTMGDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVY 178
Query: 283 EGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLT 328
E D ++ + A E + T +SDV+SFGV+L E++T
Sbjct: 179 EEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 87.6 bits (218), Expect = 3e-19
Identities = 69/214 (32%), Positives = 97/214 (45%), Gaps = 41/214 (19%)
Query: 129 LGEGGFGCV----YKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKE---WLAEVNYL 181
LG G FG V +KG +G A+K L+ + K+ L E L
Sbjct: 9 LGTGSFGRVMLVRHKG-------------SGKYYALKILSKAKIVKLKQVEHVLNEKRIL 55
Query: 182 GGLIHPNLVKLIGCCIEDDQRL-LVYEFMPRGSLENHLFR-RSLPLPWSIRMKIALDAAK 239
+ HP LV L G +DD L LV E++P G L +HL + P P + A
Sbjct: 56 QSIRHPFLVNLYGS-FQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVA--RFYAAQVVL 112
Query: 240 GLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVM---GT 296
L +LH ++YRD K N+LLD + K++DFG AK V R GT
Sbjct: 113 ALEYLHS---LDIVYRDLKPENLLLDSDGYIKITDFGFAK--------RVKGRTYTLCGT 161
Query: 297 YGYAAPEYVM-TGHLTAKSDVYSFGVVLLEMLTG 329
Y APE ++ G+ A D ++ G+++ EML G
Sbjct: 162 PEYLAPEIILSKGYGKA-VDWWALGILIYEMLAG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 3e-19
Identities = 86/272 (31%), Positives = 127/272 (46%), Gaps = 43/272 (15%)
Query: 129 LGEGGFGCVYKG-WINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHP 187
LG G FG V+ G W NG V AVKTL G + +L E + L H
Sbjct: 14 LGNGQFGEVWMGTW---NGNTKV--------AVKTLK-PGTMSPESFLEEAQIMKKLRHD 61
Query: 188 NLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALDAAKGLAFL 244
LV+L + ++ +V E+M +GSL + L R+L LP + M A A G+A++
Sbjct: 62 KLVQLYAV-VSEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDM--AAQVAAGMAYI 118
Query: 245 HEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTY--GYAAP 302
I+RD +++NIL+ K++DFGLA+ + + T R + + AP
Sbjct: 119 ER---MNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT---ARQGAKFPIKWTAP 172
Query: 303 EYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRRFYRLI 362
E + G T KSDV+SFG++L E++T R N R L + R YR+
Sbjct: 173 EAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNN---------REVLEQVERGYRM- 222
Query: 363 DPCLEGCFSIKGAEKTIQLAASCLNRDQKARP 394
PC + C I E +Q C +D + RP
Sbjct: 223 -PCPQDC-PISLHELMLQ----CWKKDPEERP 248
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 4e-19
Identities = 65/212 (30%), Positives = 108/212 (50%), Gaps = 21/212 (9%)
Query: 129 LGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDG-LQGHKEWLAEVNYLGGLIHP 187
LG+G FG VY+G G +P T VA+KT+N ++ E+L E + +
Sbjct: 14 LGQGSFGMVYEGI--AKGVVKDEPET--RVAIKTVNEAASMRERIEFLNEASVMKEFNCH 69
Query: 188 NLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSL-----------PLPWSIRMKIALD 236
++V+L+G + L++ E M RG L+++L RSL P +++A +
Sbjct: 70 HVVRLLGVVSQGQPTLVIMELMTRGDLKSYL--RSLRPEMENNPVQAPPSLKKMIQMAGE 127
Query: 237 AAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGT 296
A G+A+L+ A K ++RD N ++ ++ K+ DFG+ +D E D + +
Sbjct: 128 IADGMAYLN--ANK-FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 184
Query: 297 YGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLT 328
+ +PE + G T SDV+SFGVVL E+ T
Sbjct: 185 VRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.7 bits (215), Expect = 5e-19
Identities = 58/208 (27%), Positives = 94/208 (45%), Gaps = 21/208 (10%)
Query: 129 LGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHPN 188
LG+G FG VYK TGL A K + + + ++++ E++ L HPN
Sbjct: 13 LGDGAFGKVYK---------AQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPN 63
Query: 189 LVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEA 248
+V L +++ ++ EF G+L++ + L + + L FLH
Sbjct: 64 IVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHS-- 121
Query: 249 EKPVIYRDFKTSNILLDGEYNAKLSDFGL-AKDGPEGDKTHVSTRVMGTYGYAAPEYVMT 307
VI+RD K NILL + + KL+DFG+ AK+ K +GT + APE V
Sbjct: 122 -HKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDT---FIGTPYWMAPEVVAC 177
Query: 308 GHLT-----AKSDVYSFGVVLLEMLTGR 330
K+D++S G+ L+E+
Sbjct: 178 ETFKDNPYDYKADIWSLGITLIELAQME 205
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 5e-19
Identities = 64/217 (29%), Positives = 105/217 (48%), Gaps = 28/217 (12%)
Query: 128 LLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVK-----TLNHDGLQGHKEWLA----EV 178
L+G G FG VY G MN + +G +AVK +++ + L E+
Sbjct: 7 LIGSGSFGSVYLG---MNAS------SGELMAVKQVELPSVSASSKDRKRSMLDALAREI 57
Query: 179 NYLGGLIHPNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAA 238
L L H N+V+ +G ++ D + E++P GS+ L ++
Sbjct: 58 ALLKELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAA-LLNNYGAFEETLVRNFVRQIL 116
Query: 239 KGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTR-----V 293
KGL +LH + +I+RD K +NIL+D + K+SDFG++K E + T +
Sbjct: 117 KGLNYLHN---RGIIHRDIKGANILVDNKGGIKISDFGISKK-LEANSLSTKTNGARPSL 172
Query: 294 MGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGR 330
G+ + APE V T K+D++S G +++EMLTG+
Sbjct: 173 QGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGK 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 86.3 bits (213), Expect = 6e-19
Identities = 86/285 (30%), Positives = 127/285 (44%), Gaps = 53/285 (18%)
Query: 121 KSFRPECLLGEGGFGCVYKG-WINMNGTA-----TVKPGTGLPVAVKTLNHDGLQGHKEW 174
+S R E LG+G FG V+ G W NGT T+KPGT P A +
Sbjct: 6 ESLRLEVKLGQGCFGEVWMGTW---NGTTRVAIKTLKPGTMSPEA--------------F 48
Query: 175 LAEVNYLGGLIHPNLVKLIGCCIEDDQRLLVYEFMPRGSLENHL---FRRSLPLPWSIRM 231
L E + L H LV+L + ++ +V E+M +GSL + L + L LP + M
Sbjct: 49 LQEAQVMKKLRHEKLVQLYAV-VSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDM 107
Query: 232 KIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVST 291
A A G+A++ ++RD + +NIL+ K++DFGLA+ + + T
Sbjct: 108 --AAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT---A 159
Query: 292 RVMGTY--GYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR 349
R + + APE + G T KSDV+SFG++L E+ T R N R
Sbjct: 160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN---------R 210
Query: 350 PQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARP 394
L + R YR+ PC C E L C ++ + RP
Sbjct: 211 EVLDQVERGYRM--PCPPEC-----PESLHDLMCQCWRKEPEERP 248
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 85.4 bits (212), Expect = 1e-18
Identities = 72/284 (25%), Positives = 109/284 (38%), Gaps = 38/284 (13%)
Query: 130 GEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLN---HDGLQGHKEWLAEVNYLGGLIH 186
G+G FG V I K T A+K +N + L E L L H
Sbjct: 9 GKGAFGKV---CI------VQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNH 59
Query: 187 PNLVKLIGCCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLH 245
P LV L +D++ + LV + + G L HL ++ ++ I + L +LH
Sbjct: 60 PFLVNLWYS-FQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWIC-EIVLALEYLH 117
Query: 246 EEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYV 305
K +I+RD K NILLD + + ++DF +A T T GT GY APE +
Sbjct: 118 S---KGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLT---TSTSGTPGYMAPEVL 171
Query: 306 MTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRRFYRLIDPC 365
+ D +S GV E L G+R + + + R + Y
Sbjct: 172 CRQGYSVAVDWWSLGVTAYECLRGKRPYRGHS----RTIRDQIRAKQETADVLYPATWS- 226
Query: 366 LEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYL 409
+ I L RD + R+ + ++ LK PY
Sbjct: 227 ----------TEAIDAINKLLERD--PQKRLGDNLKDLKNHPYF 258
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 89.1 bits (221), Expect = 1e-18
Identities = 57/193 (29%), Positives = 91/193 (47%), Gaps = 18/193 (9%)
Query: 154 TGLPVAVKTLNHDGLQGHKE---WLAEVNYLGGLIHPNLVKLI--GCCIEDDQRLLVYEF 208
TG VA+K L D + + + E L HPN+V L+ G V+E+
Sbjct: 2 TGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEA-PPGLLFAVFEY 60
Query: 209 MPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILL---D 265
+P +L L LP ++ L LA H + +++RD K NI++
Sbjct: 61 VPGRTLREVLAADG-ALPAGETGRLMLQVLDALACAHNQG---IVHRDLKPQNIMVSQTG 116
Query: 266 GEYNAKLSDFGLAKDGP---EGDKTHVS--TRVMGTYGYAAPEYVMTGHLTAKSDVYSFG 320
+AK+ DFG+ P + D ++ T V+GT Y APE + +T SD+Y++G
Sbjct: 117 VRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWG 176
Query: 321 VVLLEMLTGRRSM 333
++ LE LTG+R +
Sbjct: 177 LIFLECLTGQRVV 189
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 2e-18
Identities = 81/291 (27%), Positives = 129/291 (44%), Gaps = 43/291 (14%)
Query: 129 LGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHD--GLQGHKEWLAEVNYLGGLIH 186
LGEG FG V +G +N + + L VAVKT+ +++L+E + H
Sbjct: 7 LGEGEFGSVMEGQLNQDDSI-------LKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDH 59
Query: 187 PNLVKLIGCCIEDDQR------LLVYEFMPRGSLENHLFRRSLP-----LPWSIRMKIAL 235
PN+++LIG C++ + +++ FM G L + L L LP + +K
Sbjct: 60 PNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMT 119
Query: 236 DAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMG 295
D A G+ +L + K I+RD N +L+ N ++DFGL+K GD
Sbjct: 120 DIASGMEYL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKM 176
Query: 296 TYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGER 355
+ A E + T KSDV+SFGV + E+ T ++ N E + ++
Sbjct: 177 PVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSE--IYDYL------- 227
Query: 356 RRFYRLIDP--CLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALK 404
R+ RL P CL+G +S L +SC + K RP + L+
Sbjct: 228 RQGNRLKQPPDCLDGLYS---------LMSSCWLLNPKDRPSFETLRCELE 269
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 2e-18
Identities = 67/210 (31%), Positives = 103/210 (49%), Gaps = 34/210 (16%)
Query: 129 LGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHPN 188
LG G FG V+ G+ N N T VAVKTL G + +L E N + L H
Sbjct: 14 LGAGQFGEVWMGYYN-NSTK---------VAVKTLK-PGTMSVQAFLEEANLMKTLQHDK 62
Query: 189 LVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRS---LPLPWSIRMKIALDAAKGLAFLH 245
LV+L +++ ++ E+M +GSL + L + LP I + A+G+A++
Sbjct: 63 LVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQI--AEGMAYIE 120
Query: 246 EEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAK-------DGPEGDKTHVSTRVMGTYG 298
K I+RD + +N+L+ K++DFGLA+ EG K +
Sbjct: 121 R---KNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIK-------- 169
Query: 299 YAAPEYVMTGHLTAKSDVYSFGVVLLEMLT 328
+ APE + G T KSDV+SFG++L E++T
Sbjct: 170 WTAPEAINFGSFTIKSDVWSFGILLYEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 2e-18
Identities = 68/210 (32%), Positives = 98/210 (46%), Gaps = 24/210 (11%)
Query: 129 LGEGGFGCVYKGWINMNGTA--TVKPGTGLPVAVKTLNHDGLQGHKEWLAE----VNYLG 182
LG G FG V + TA K + VAVK L +E L +++LG
Sbjct: 43 LGAGAFGKV------VEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLG 96
Query: 183 GLIHPNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFR-RSLPLPWSIRMKIALDAAKGL 241
H N+V L+G C L++ E+ G L N L R R L + + AKG+
Sbjct: 97 N--HENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGM 154
Query: 242 AFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHV---STRVMGTYG 298
AFL A K I+RD N+LL K+ DFGLA+D D +V + R+
Sbjct: 155 AFL---ASKNCIHRDLAARNVLLTHGKIVKICDFGLARD-IMNDSNYVVKGNARL--PVK 208
Query: 299 YAAPEYVMTGHLTAKSDVYSFGVVLLEMLT 328
+ APE + T +SDV+S+G++L E+ +
Sbjct: 209 WMAPESIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 5e-18
Identities = 61/205 (29%), Positives = 102/205 (49%), Gaps = 21/205 (10%)
Query: 129 LGEGGFGCVYKGWINMNGTATVKP-GTGLPVAVKTLNHDGLQG-HKEWLAEVNYLGGLIH 186
LG G G V K VK TG +A K ++ K+ L E+ +
Sbjct: 13 LGAGNGGSVSK----------VKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRS 62
Query: 187 PNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHE 246
P +V G + ++ + EFM GSL+ ++++ P+P I KIA+ +GL +L+
Sbjct: 63 PYIVSFYGAFLNENNICMCMEFMDCGSLDR-IYKKGGPIPVEILGKIAVAVVEGLTYLYN 121
Query: 247 EAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTH-VSTRVMGTYGYAAPEYV 305
+++RD K SNIL++ KL DFG++ G+ + ++ +GT Y +PE +
Sbjct: 122 VHR--IMHRDIKPSNILVNSRGQIKLCDFGVS-----GELINSIADTFVGTSTYMSPERI 174
Query: 306 MTGHLTAKSDVYSFGVVLLEMLTGR 330
G T KSDV+S G+ ++E+ G+
Sbjct: 175 QGGKYTVKSDVWSLGISIIELALGK 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 6e-18
Identities = 58/203 (28%), Positives = 99/203 (48%), Gaps = 15/203 (7%)
Query: 129 LGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQG-HKEWLAEVNYLGGLIHP 187
LG G FGCV KG M + VA+K L ++ + E + E + L +P
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQ-------IDVAIKVLKNENEKSVRDEMMREAEIMHQLDNP 55
Query: 188 NLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEE 247
+V++IG C E + +LV E G L L + + S +++ + G+ +L
Sbjct: 56 YIVRMIGVC-EAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEG- 113
Query: 248 AEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTY--GYAAPEYV 305
K ++RD N+LL ++ AK+SDFGL+K D ++ R G + + APE +
Sbjct: 114 --KNFVHRDLAARNVLLVNQHYAKISDFGLSK-ALGADDSYYKARSAGKWPLKWYAPECI 170
Query: 306 MTGHLTAKSDVYSFGVVLLEMLT 328
+++SDV+S+G+ + E +
Sbjct: 171 NFRKFSSRSDVWSYGITMWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.7 bits (208), Expect = 6e-18
Identities = 65/218 (29%), Positives = 100/218 (45%), Gaps = 44/218 (20%)
Query: 129 LGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEW-----LAEVNYLGG 183
LG+G FG VY G VA+K + + W L EV L
Sbjct: 7 LGDGTFGSVYLARNKETGEL---------VAIKKMK----KKFYSWEECMNLREVKSLRK 53
Query: 184 L-IHPNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLF-----RRSLPLPWSIRMKIALDA 237
L HPN+VKL E+D+ V+E+M E +L+ R+ P S+ I
Sbjct: 54 LNEHPNIVKLKEVFRENDELYFVFEYM-----EGNLYQLMKDRKGKPFSESVIRSIIYQI 108
Query: 238 AKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKD----GPEGDKTHVSTRV 293
+GLA +H+ +RD K N+L+ G K++DFGLA++ P D +VSTR
Sbjct: 109 LQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTD--YVSTR- 162
Query: 294 MGTYGYAAPEYVM-TGHLTAKSDVYSFGVVLLEMLTGR 330
Y APE ++ + ++ D+++ G ++ E+ T R
Sbjct: 163 ----WYRAPEILLRSTSYSSPVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 83.4 bits (206), Expect = 6e-18
Identities = 62/215 (28%), Positives = 102/215 (47%), Gaps = 28/215 (13%)
Query: 128 LLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTL----NHDGLQGH--KEWLAEVNYL 181
LG G F Y VK GT + AVK + N Q + E+ +
Sbjct: 7 QLGTGAFSSCY-------QARDVKTGTLM--AVKQVTYVRNTSSEQEEVVEALRKEIRLM 57
Query: 182 GGLIHPNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGL 241
L HP++++++G ED L E+M GS+ +HL + ++ + +GL
Sbjct: 58 ARLNHPHIIRMLGATCEDSHFNLFVEWMAGGSV-SHLLSKYGAFKEAVIINYTEQLLRGL 116
Query: 242 AFLHEEAEKPVIYRDFKTSNILLDGE-YNAKLSDFG----LAKDGPEGDKTHVSTRVMGT 296
++LH E +I+RD K +N+L+D +++DFG LA G + +++GT
Sbjct: 117 SYLH---ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGE--FQGQLLGT 171
Query: 297 YGYAAPEYVMTGHLTAKS-DVYSFGVVLLEMLTGR 330
+ APE V+ G +S DV+S G V++EM T +
Sbjct: 172 IAFMAPE-VLRGEQYGRSCDVWSVGCVIIEMATAK 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 83.0 bits (205), Expect = 7e-18
Identities = 58/217 (26%), Positives = 96/217 (44%), Gaps = 31/217 (14%)
Query: 128 LLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLA--EVNYLGGLI 185
++G G FG V + V +K + + + + A E L L
Sbjct: 7 VVGRGAFGIV---HLCRRKADQKL------VIIKQIPVEQMTKDERLAAQNECQVLKLLS 57
Query: 186 HPNLVKLIGCCIEDDQRLLVYEFMPRGSLE-------NHLFRRSLPLPWSIRMKIALDAA 238
HPN+++ +ED ++V E+ P G+L N L L + +++ +A
Sbjct: 58 HPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLA---- 113
Query: 239 KGLAFLHEEAEKPVIYRDFKTSNILLDGEYN-AKLSDFGLAKDGPEGDKTHVSTRVMGTY 297
LH K +++RD KT NILLD K+ DFG++K K+ T V+GT
Sbjct: 114 -----LHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKI--LSSKSKAYT-VVGTP 165
Query: 298 GYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMD 334
Y +PE KSD+++ G VL E+ + +R+ +
Sbjct: 166 CYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFE 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 8e-18
Identities = 60/166 (36%), Positives = 83/166 (50%), Gaps = 20/166 (12%)
Query: 186 HPNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFR-RSLPLP----WSIRMKIALDAAKG 240
HP LV L C + + V EF+ G L H+ R R LP +S + +AL+
Sbjct: 55 HPFLVGLHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALN---- 110
Query: 241 LAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDG-PEGDKTHVSTRVMGTYGY 299
FLHE + +IYRD K N+LLD E + KL+D+G+ K+G GD T ST GT Y
Sbjct: 111 --FLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTT--ST-FCGTPNY 162
Query: 300 AAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMD--KNRPNGEHN 343
APE + D ++ GV++ EM+ GR D N + N
Sbjct: 163 IAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQN 208
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 8e-18
Identities = 81/285 (28%), Positives = 130/285 (45%), Gaps = 42/285 (14%)
Query: 128 LLGEGGFGCVYKG-WINMNGTATVKPGTGLPVAVKTLNHD-GLQGHKEWLAEVNYLGGLI 185
+LG G FG VYKG WI VK +PVA+K L + + +KE L E + G+
Sbjct: 14 VLGSGAFGTVYKGIWIP--DGENVK----IPVAIKVLRENTSPKANKEILDEAYVMAGVG 67
Query: 186 HPNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLH 245
P + +L+G C+ +L V + MP G L +++ + + + AKG+++L
Sbjct: 68 SPYVCRLLGICLTSTVQL-VTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLE 126
Query: 246 EEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAK----DGPE--GDKTHVSTRVMGTYGY 299
E +++RD N+L+ + K++DFGLA+ D E D V + M
Sbjct: 127 EVR---LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWM----- 178
Query: 300 AAPEYVMTGHLTAKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPQLGERRRF 358
A E ++ T +SDV+S+GV + E++T G + D +L+E GE
Sbjct: 179 -ALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLE-----KGE---- 228
Query: 359 YRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEAL 403
RL P + C + C D + RPR E+V+
Sbjct: 229 -RLPQPPI--C-----TIDVYMIMVKCWMIDSECRPRFRELVDEF 265
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 1e-17
Identities = 73/279 (26%), Positives = 124/279 (44%), Gaps = 45/279 (16%)
Query: 129 LGEGGFGCV-YKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHP 187
LG G FG V Y W VA+K + +G E++ E + L H
Sbjct: 12 LGTGQFGVVKYGKWRGQYD-----------VAIKMIK-EGSMSEDEFIEEAKVMMKLSHE 59
Query: 188 NLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEE 247
LV+L G C + +V E+M G L N+L S +++ D +G+A+L
Sbjct: 60 KLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLE-- 117
Query: 248 AEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGT---YGYAAPEY 304
K I+RD N L+D + K+SDFGL++ D + S+ +G+ ++ PE
Sbjct: 118 -SKQFIHRDLAARNCLVDDQGCVKVSDFGLSR--YVLDDEYTSS--VGSKFPVRWSPPEV 172
Query: 305 VMTGHLTAKSDVYSFGVVLLEMLT-GRRSMDK--NRPNGEHNLVEWARPQLGERRRFYRL 361
++ ++KSDV++FGV++ E+ + G+ ++ N E + + R YR
Sbjct: 173 LLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEK---------VSQGLRLYR- 222
Query: 362 IDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVV 400
P L +EK + SC + + RP +++
Sbjct: 223 --PHL-------ASEKVYAIMYSCWHEKAEERPTFQQLL 252
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 2e-17
Identities = 71/285 (24%), Positives = 114/285 (40%), Gaps = 32/285 (11%)
Query: 128 LLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNH-DGLQGHKEWLAEVNYLGGLIH 186
LG G FG V+ + G V VK L E+ E++ L H
Sbjct: 12 TLGRGEFGEVFLAKAK----GIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSH 67
Query: 187 PNLVKLIGCCIEDDQRLLVYEFMPRGSLENHL--------FRRSLPLPWSIRMKIALDAA 238
N+V+L+G C E + ++ E+ G L+ L + PL ++ + A
Sbjct: 68 KNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIA 127
Query: 239 KGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYG 298
G+ L + ++RD N L+ + K+S L+KD + + +
Sbjct: 128 LGMDHL---SNARFVHRDLAARNCLVSSQREVKVSLLSLSKD-VYNSEYYKLRNALIPLR 183
Query: 299 YAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRRF 358
+ APE V + KSDV+SFGV++ E+ T GE + ++ R +
Sbjct: 184 WLAPEAVQEDDFSTKSDVWSFGVLMWEVFT----------QGELPFYGLSDEEVLNRLQA 233
Query: 359 YRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEAL 403
+L P EGC + +L C + K RP SE+V AL
Sbjct: 234 GKLELPVPEGC-----PSRLYKLMTRCWAVNPKDRPSFSELVSAL 273
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 2e-17
Identities = 66/224 (29%), Positives = 110/224 (49%), Gaps = 35/224 (15%)
Query: 123 FRPECLLGEGGFGCVYKG-WINMNGTATVKPGTGLPVAVKTL-NHDGLQGHKEWLAEVNY 180
LL EG FG ++ G I+ KPG V VKT+ +H L E
Sbjct: 8 VTLSDLLQEGTFGRIFYGILID------EKPGKEEEVFVKTVKDHASEIQVTLLLQESCL 61
Query: 181 LGGLIHPNLVKLIGCCIED-DQRLLVYEFMPRGSLENHLFRRSLPL-----PWSIRMK-- 232
L GL H N++ ++ CIED + ++Y +M G+L+ LF + L P ++ +
Sbjct: 62 LYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLK--LFLQQCRLGEANNPQALSTQQL 119
Query: 233 --IALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKD-GPE-----G 284
+A+ A G+++LH+ + VI++D N ++D E K++D L++D P G
Sbjct: 120 VHMAIQIACGMSYLHK---RGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLG 176
Query: 285 DKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLT 328
D + + M A E ++ ++ SDV+SFGV+L E++T
Sbjct: 177 DNENRPVKWM------ALESLVNKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 2e-17
Identities = 81/290 (27%), Positives = 129/290 (44%), Gaps = 51/290 (17%)
Query: 128 LLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEW----------LAE 177
LG G FGCVYK K +A+K +N K+ ++E
Sbjct: 7 HLGSGAFGCVYK--------VRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSE 58
Query: 178 VNYLG-GLIHPNLVKLIGCCIEDDQRLLVYEFM---PRGSLENHLFRRSLPLP----WSI 229
V + L HPN+V+ +E+D+ +V + + P G N L + W+I
Sbjct: 59 VTIIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNI 118
Query: 230 RMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHV 289
+++ L L +LH+E K +++RD +NI+L + ++DFGLAK K
Sbjct: 119 FVQMVL----ALRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKL-- 170
Query: 290 STRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR 349
T V+GT Y+ PE V K+DV++FG +L +M T P N++ A
Sbjct: 171 -TSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCT------LQPPFYSTNMLSLAT 223
Query: 350 PQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEV 399
++ E + +P EG +S E + SCL D +ARP + +V
Sbjct: 224 -KIVE-----AVYEPLPEGMYS----EDVTDVITSCLTPDAEARPDIIQV 263
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 81.5 bits (201), Expect = 2e-17
Identities = 77/292 (26%), Positives = 130/292 (44%), Gaps = 41/292 (14%)
Query: 124 RPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKE-----WLAEV 178
+ E ++G G FG V G + + G + PVA+KTL G+ E +L+E
Sbjct: 7 KIEKVIGAGEFGEVCSGRLKLPGKREI------PVAIKTLK----AGYTEKQRRDFLSEA 56
Query: 179 NYLGGLIHPNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAA 238
+ +G HPN++ L G + ++V E+M GSL+ L + + + A
Sbjct: 57 SIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIA 116
Query: 239 KGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAK---DGPEGDKTHVSTRVMG 295
G+ +L ++ ++RD NIL++ K+SDFGL++ D PE T ++
Sbjct: 117 SGMKYL---SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI-- 171
Query: 296 TYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA-RPQLGE 354
+ APE + T+ SDV+S+G+V+ E+++ GE E + + +
Sbjct: 172 PIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMS----------YGERPYWEMSNQDVIKA 221
Query: 355 RRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPL 406
YRL P C QL C +D+ RP+ ++V L L
Sbjct: 222 IEEGYRLPAPM--DC-----PAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 3e-17
Identities = 77/278 (27%), Positives = 119/278 (42%), Gaps = 33/278 (11%)
Query: 129 LGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHK-EWLAEVNYLGGLIHP 187
+G G FG V+ G + + T PVAVK+ K ++L E L HP
Sbjct: 3 IGRGNFGEVFSGRLRADNT---------PVAVKSCRETLPPDLKAKFLQEARILKQYSHP 53
Query: 188 NLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEE 247
N+V+LIG C + +V E + G L L +++ +AA G+ +L
Sbjct: 54 NIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLE-- 111
Query: 248 AEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGT--YGYAAPEYV 305
K I+RD N L+ + K+SDFG++++ E D + ST M + APE +
Sbjct: 112 -SKHCIHRDLAARNCLVTEKNVLKISDFGMSRE--EEDGVYASTGGMKQIPVKWTAPEAL 168
Query: 306 MTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRRFYRLIDPC 365
G +++SDV+SFG++L E + N N + R + + R PC
Sbjct: 169 NYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQ------TREAIEQGVRL-----PC 217
Query: 366 LEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEAL 403
E C + +L C D RP S V + L
Sbjct: 218 PELC-----PDAVYRLMERCWEYDPGQRPSFSTVHQEL 250
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 3e-17
Identities = 57/207 (27%), Positives = 103/207 (49%), Gaps = 10/207 (4%)
Query: 123 FRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNH-DGLQGHKEWLAEVNYL 181
F+ +LG G FG VYKG G +PVA+K L + +KE L E +
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWIPEGE-----KVKIPVAIKELREATSPKANKEILDEAYVM 63
Query: 182 GGLIHPNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGL 241
+ +P++ +L+G C+ +L + + MP G L +++ + + + AKG+
Sbjct: 64 ASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGM 122
Query: 242 AFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAA 301
+L E + +++RD N+L+ + K++DFGLAK +K + + + A
Sbjct: 123 NYLEE---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMA 179
Query: 302 PEYVMTGHLTAKSDVYSFGVVLLEMLT 328
E ++ T +SDV+S+GV + E++T
Sbjct: 180 LESILHRIYTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 82.0 bits (203), Expect = 3e-17
Identities = 54/146 (36%), Positives = 70/146 (47%), Gaps = 11/146 (7%)
Query: 186 HPNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKI-ALDAAKGLAFL 244
HP LV L C +D V E+ G L H+ P R A GL +L
Sbjct: 61 HPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEP---RAVFYAACVVLGLQYL 117
Query: 245 HEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGP-EGDKTHVSTRVMGTYGYAAPE 303
HE ++YRD K N+LLD E K++DFGL K+G GD+T ST GT + APE
Sbjct: 118 HE---NKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRT--ST-FCGTPEFLAPE 171
Query: 304 YVMTGHLTAKSDVYSFGVVLLEMLTG 329
+ T D + GV++ EML G
Sbjct: 172 VLTETSYTRAVDWWGLGVLIYEMLVG 197
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 3e-17
Identities = 62/204 (30%), Positives = 91/204 (44%), Gaps = 25/204 (12%)
Query: 129 LGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEW---LAEVNYLGGLI 185
+G G FG VY VA+K +++ G Q +++W + EV +L L
Sbjct: 23 IGHGSFGAVYFARDVRTNEV---------VAIKKMSYSGKQSNEKWQDIIKEVRFLQQLR 73
Query: 186 HPNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLH 245
HPN ++ GC + + LV E+ GS + L PL I A +GLA+LH
Sbjct: 74 HPNTIEYKGCYLREHTAWLVMEYC-LGSASDILEVHKKPLQEVEIAAICHGALQGLAYLH 132
Query: 246 EEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYV 305
I+RD K NILL KL+DFG A + +GT + APE +
Sbjct: 133 SHER---IHRDIKAGNILLTEPGTVKLADFGSAS------LVSPANSFVGTPYWMAPEVI 183
Query: 306 MT---GHLTAKSDVYSFGVVLLEM 326
+ G K DV+S G+ +E+
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 82.0 bits (203), Expect = 3e-17
Identities = 72/238 (30%), Positives = 101/238 (42%), Gaps = 43/238 (18%)
Query: 118 SATKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVK-TLNHDGLQG-HKEWL 175
S + + LGEG FG VYK G VA+K L H+ G L
Sbjct: 5 SKLRDYEILGKLGEGTFGEVYKARQIKTGRV---------VALKKILMHNEKDGFPITAL 55
Query: 176 AEVNYLGGLIHPNLVKLIGCCIE-----DDQRLLVYEFMP------RGSLENHLFRRSLP 224
E+ L L HPN+V LI +E +R VY P G LEN + +
Sbjct: 56 REIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTES 115
Query: 225 LPWSIR--MKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAK--- 279
I+ M L+ G+ +LHE +++RD K +NIL+D + K++DFGLA+
Sbjct: 116 ---QIKCYMLQLLE---GINYLHE---NHILHRDIKAANILIDNQGILKIADFGLARPYD 166
Query: 280 ------DGPEGDKTHVSTRVMGTYGYAAPEYVM-TGHLTAKSDVYSFGVVLLEMLTGR 330
G G T T ++ T Y PE ++ T D++ G V EM T R
Sbjct: 167 GPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRR 224
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 81.1 bits (200), Expect = 4e-17
Identities = 62/215 (28%), Positives = 106/215 (49%), Gaps = 16/215 (7%)
Query: 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKE--WLAEV 178
KS + E +LG G FG + +G + + LPVA+ TL G + +LAE
Sbjct: 5 KSIKIERILGTGRFGELCRGCLKLPSKRE------LPVAIHTL-RAGCSDKQRRGFLAEA 57
Query: 179 NYLGGLIHPNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAA 238
LG H N+V+L G + ++V E+M G+L++ L + L M + A
Sbjct: 58 LTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLA 117
Query: 239 KGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFG-LAKDGPEGDKTHVSTRVMGTY 297
G+ +L +E +++ +L++ + K+S F L +D E T +S + +
Sbjct: 118 SGMKYL---SEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLW 174
Query: 298 GYAAPEYVMTGHLTAKSDVYSFGVVLLEMLT-GRR 331
AAPE + H ++ SDV+SFG+V+ E+++ G R
Sbjct: 175 --AAPEAIQYHHFSSASDVWSFGIVMWEVMSYGER 207
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 80.7 bits (200), Expect = 7e-17
Identities = 70/222 (31%), Positives = 101/222 (45%), Gaps = 37/222 (16%)
Query: 123 FRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKT--LNH-----DGLQGHKEWL 175
+ LGEG + VYK A K TG VA+K L DG+ + L
Sbjct: 2 YEKGKKLGEGTYAVVYK--------ARDKE-TGRIVAIKKIKLGERKEAKDGI--NFTAL 50
Query: 176 AEVNYLGGLIHPNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPL-PWSIR--MK 232
E+ L L HPN++ L+ LV+EFM LE + +S+ L P I+ M
Sbjct: 51 REIKLLQELKHPNIIGLLDVFGHKSNINLVFEFME-TDLEKVIKDKSIVLTPADIKSYML 109
Query: 233 IALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKD--GPEGDKTH-V 289
+ L +GL +LH +++RD K +N+L+ + KL+DFGLA+ P TH V
Sbjct: 110 MTL---RGLEYLHS---NWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQV 163
Query: 290 STRVMGTYGYAAPEYVM-TGHLTAKSDVYSFGVVLLEMLTGR 330
TR Y APE + H D++S G + E+L
Sbjct: 164 VTRW-----YRAPELLFGARHYGVGVDMWSVGCIFAELLLRV 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 1e-16
Identities = 66/223 (29%), Positives = 109/223 (48%), Gaps = 36/223 (16%)
Query: 126 ECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQG-HKEWLAEVNYLGGL 184
E ++GEG FG V + I K G + A+K L + H+++ E+ L L
Sbjct: 7 EDVIGEGNFGQVIRAMIK-------KDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKL 59
Query: 185 -IHPNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPL---PWSIR---------- 230
HPN++ L+G C + E+ P G+L + L R+S L P +
Sbjct: 60 GHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFL-RKSRVLETDPAFAKEHGTASTLTS 118
Query: 231 ---MKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKT 287
++ A D A G+ +L +EK I+RD N+L+ +K++DFGL++ G++
Sbjct: 119 QQLLQFASDVATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSR----GEEV 171
Query: 288 HVSTRVMGTYG--YAAPEYVMTGHLTAKSDVYSFGVVLLEMLT 328
+V + MG + A E + T KSDV+SFGV+L E+++
Sbjct: 172 YVK-KTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 80.1 bits (198), Expect = 1e-16
Identities = 68/211 (32%), Positives = 97/211 (45%), Gaps = 28/211 (13%)
Query: 127 CLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVK--TLNHDGLQGHKEWLAEVNYLGGL 184
+GEG +G V+K TG VA+K + D K L E+ L L
Sbjct: 7 SKIGEGSYGVVFK---------CRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQL 57
Query: 185 IHPNLVKLIGCCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAF 243
HPNLV LI ++L LV+E+ ++ N L + +P + KI + + F
Sbjct: 58 KHPNLVNLIEV-FRRKRKLHLVFEYCDH-TVLNELEKNPRGVPEHLIKKIIWQTLQAVNF 115
Query: 244 LHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAK--DGPEGDKT-HVSTRVMGTYGYA 300
H+ I+RD K NIL+ + KL DFG A+ GP D T +V+TR Y
Sbjct: 116 CHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATR-----WYR 167
Query: 301 APEYVMTGHLTAKS--DVYSFGVVLLEMLTG 329
APE ++ G DV++ G V E+LTG
Sbjct: 168 APE-LLVGDTQYGPPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 79.2 bits (195), Expect = 1e-16
Identities = 60/214 (28%), Positives = 93/214 (43%), Gaps = 22/214 (10%)
Query: 128 LLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGH--KEWLAEVNYLGGLI 185
+LG+G FG V + + G+ VAVK L D +E+L E +
Sbjct: 6 MLGKGEFGSVREAQLKSED------GSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFD 59
Query: 186 HPNLVKLIGCCIED--DQRL----LVYEFMPRGSLENHLFRRSL-----PLPWSIRMKIA 234
HPN++KLIG + RL ++ FM G L L + LP ++
Sbjct: 60 HPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFM 119
Query: 235 LDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVM 294
+D A G+ +L + K I+RD N +L+ ++DFGL+K GD
Sbjct: 120 IDIASGMEYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASK 176
Query: 295 GTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLT 328
+ A E + T SDV++FGV + E++T
Sbjct: 177 LPVKWLALESLADNVYTTHSDVWAFGVTMWEIMT 210
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 2e-16
Identities = 76/276 (27%), Positives = 115/276 (41%), Gaps = 47/276 (17%)
Query: 128 LLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGH-KEWLAEVNYLGGLIH 186
L+G G +G VY+G TG VA+K +N D + EV L L
Sbjct: 8 LIGRGAYGAVYRGKHVP---------TGRVVALKIINLDTPDDDVSDIQREVALLSQLRQ 58
Query: 187 ---PNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK----IALDAAK 239
PN+ K G ++ + ++ E+ GS+ R+L I K I +
Sbjct: 59 SQPPNITKYYGSYLKGPRLWIIMEYAEGGSV------RTLMKAGPIAEKYISVIIREVLV 112
Query: 240 GLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGY 299
L ++H+ VI+RD K +NIL+ N KL DFG+A + ST V GT +
Sbjct: 113 ALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKR-STFV-GTPYW 167
Query: 300 AAPEYVMTGHL-TAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRRF 358
APE + G K+D++S G+ + EM TG L+ ++P
Sbjct: 168 MAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKP-------- 219
Query: 359 YRLIDPCLEGCFSIKGAEKTIQ-LAASCLNRDQKAR 393
P LE G K ++ A+CL+ + K R
Sbjct: 220 -----PRLED----NGYSKLLREFVAACLDEEPKER 246
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 78.8 bits (195), Expect = 2e-16
Identities = 68/223 (30%), Positives = 89/223 (39%), Gaps = 55/223 (24%)
Query: 129 LGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHD-----GLQGH----KEWLAEVN 179
LG GGFG V VK A+K + G Q H KE L E N
Sbjct: 1 LGVGGFGRVEL--------VKVKS-KNRTFALKCVKKRHIVETGQQEHIFSEKEILEECN 51
Query: 180 YLGGLIHPNLVKLIGCCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSI-RMKIALDA 237
HP +VKL +D + + ++ E+ G L W+I R + D
Sbjct: 52 ------HPFIVKLY-RTFKDKKYIYMLMEYCLGGEL------------WTILRDRGLFDE 92
Query: 238 AKG----------LAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKT 287
+LH + +IYRD K N+LLD KL DFG AK G KT
Sbjct: 93 YTARFYIACVVLAFEYLHN---RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKT 149
Query: 288 HVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGR 330
GT Y APE ++ D +S G++L E+LTGR
Sbjct: 150 WT---FCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGR 189
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 2e-16
Identities = 64/224 (28%), Positives = 99/224 (44%), Gaps = 42/224 (18%)
Query: 128 LLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKE---WLAEVNYLGGL 184
LG+G +G VYK + A+K ++ G KE + E+ L +
Sbjct: 7 KLGKGSYGSVYKVKRLSDNQF---------YALKEVDL-GSMSQKEREDAVNEIRILASV 56
Query: 185 IHPNLVK-----LIGC--CIEDDQRLLVYEFMPRGSLENHLFRRSL---PLPWSIRMKIA 234
HPN++ L G CI V E+ P G L + +R +P +I
Sbjct: 57 NHPNIISYKEAFLDGNKLCI-------VMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIF 109
Query: 235 LDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVM 294
+ +GL LHE+ +++RD K++NILL K+ D G++K K +++ +
Sbjct: 110 IQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVL----KKNMAKTQI 162
Query: 295 GTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGR-----RSM 333
GT Y APE + KSD++S G +L EM T RSM
Sbjct: 163 GTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSM 206
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 79.4 bits (195), Expect = 2e-16
Identities = 82/285 (28%), Positives = 130/285 (45%), Gaps = 33/285 (11%)
Query: 93 PSTPKIGEELKISPQLRKFSFNELKSATKSFRPECLLGEGGFGCVYKGWINMNGTATVKP 152
PST + G LK P++ + F E K F +G G FG VY + T V
Sbjct: 1 PSTSRAGS-LK-DPEIAELFFKE--DPEKLFTDLREIGHGSFGAVY--FARDVRTNEV-- 52
Query: 153 GTGLPVAVKTLNHDGLQGHKEW---LAEVNYLGGLIHPNLVKLIGCCIEDDQRLLVYEFM 209
VA+K +++ G Q +++W + EV +L + HPN ++ GC + + LV E+
Sbjct: 53 -----VAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYC 107
Query: 210 PRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYN 269
GS + L PL I A +GLA+LH +I+RD K NILL
Sbjct: 108 -LGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQ 163
Query: 270 AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT---GHLTAKSDVYSFGVVLLEM 326
KL+DFG A + +GT + APE ++ G K DV+S G+ +E+
Sbjct: 164 VKLADFGSASIASPANS------FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 217
Query: 327 LTGRRSM-DKNRPNGEHNLVEWARPQL--GERRRFYR-LIDPCLE 367
+ + + N + +++ + P L E ++R +D CL+
Sbjct: 218 AERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFVDSCLQ 262
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 3e-16
Identities = 63/201 (31%), Positives = 97/201 (48%), Gaps = 17/201 (8%)
Query: 129 LGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQG--HKEWLAEVNYLGGLIH 186
LG G FG V KG M + VAVK L +D E L E N + L +
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEK-------TVAVKILKNDNNDPALKDELLREANVMQQLDN 55
Query: 187 PNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHE 246
P +V++IG C E + +LV E G L L + +I ++ + G+ +L E
Sbjct: 56 PYIVRMIGIC-EAESWMLVMELAELGPLNKFLQKNKHVTEKNI-TELVHQVSMGMKYLEE 113
Query: 247 EAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTY--GYAAPEY 304
++RD N+LL ++ AK+SDFGL+K D+ + + G + + APE
Sbjct: 114 TN---FVHRDLAARNVLLVTQHYAKISDFGLSK-ALGADENYYKAKTHGKWPVKWYAPEC 169
Query: 305 VMTGHLTAKSDVYSFGVVLLE 325
+ ++KSDV+SFGV++ E
Sbjct: 170 MNYYKFSSKSDVWSFGVLMWE 190
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 3e-16
Identities = 66/231 (28%), Positives = 107/231 (46%), Gaps = 27/231 (11%)
Query: 115 ELKSATKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQG--HK 172
E+ +T F E LGE FG VYKG ++ GTA + VA+KTL D +G +
Sbjct: 1 EINLSTVRFMEE--LGEDRFGKVYKG--HLFGTAPGEQTQA--VAIKTLK-DKAEGPLRE 53
Query: 173 EWLAEVNYLGGLIHPNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRS---------- 222
E+ E L HPN+V L+G ++ +++ + L L RS
Sbjct: 54 EFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDD 113
Query: 223 -----LPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGL 277
L + + I A G+ FL + V+++D T N+L+ + N K+SD GL
Sbjct: 114 DKTVKSTLEPADFVHIVTQIAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGL 170
Query: 278 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLT 328
++ D + + + +PE +M G + SD++S+GVVL E+ +
Sbjct: 171 FREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 78.0 bits (192), Expect = 3e-16
Identities = 60/213 (28%), Positives = 91/213 (42%), Gaps = 24/213 (11%)
Query: 129 LGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDG-LQGHKEWLAEVNYLGGLIHP 187
+G G FG V G + G + + V VK L +L EV L HP
Sbjct: 3 IGNGWFGKVLLGEAH-RGMSKAR------VVVKELRASATPDEQLLFLQEVQPYRELNHP 55
Query: 188 NLVKLIGCCIEDDQRLLVYEFMPRGSLENHL-----FRRSLPLPWSIRMKIALDAAKGLA 242
N+++ +G CIE LLV EF P G L+N+L + + ++A + A GL
Sbjct: 56 NVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQK-DVLQRMACEVASGLL 114
Query: 243 FLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAP 302
+LH+ I+ D N L + + K+ D+GLA + D + AP
Sbjct: 115 WLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAP 171
Query: 303 EYV-------MTGHLTAKSDVYSFGVVLLEMLT 328
E V + T KS+++S GV + E+ T
Sbjct: 172 ELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFT 204
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.3 bits (196), Expect = 4e-16
Identities = 70/239 (29%), Positives = 98/239 (41%), Gaps = 57/239 (23%)
Query: 128 LLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKE---WLAEVNYLGGL 184
++G G FG V+ TG A+K L + + AE + L
Sbjct: 8 VIGRGAFGEVWLVR---------DKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADA 58
Query: 185 IHPNLVKLIGCCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIR-----MKIALDAA 238
P +VKL +D++ L LV E+MP G L N L R+ + + R + +ALD+
Sbjct: 59 DSPWIVKLY-YSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSV 117
Query: 239 KGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKT----------- 287
L F+H RD K NIL+D + + KL+DFGL K +
Sbjct: 118 HKLGFIH---------RDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLL 168
Query: 288 -----------HVSTRVM-----GTYGYAAPEYVMTGH-LTAKSDVYSFGVVLLEMLTG 329
H RV GT Y APE V+ G + D +S GV+L EML G
Sbjct: 169 FRDNVLVRRRDHKQRRVRANSTVGTPDYIAPE-VLRGTPYGLECDWWSLGVILYEMLYG 226
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.1 bits (193), Expect = 4e-16
Identities = 67/224 (29%), Positives = 94/224 (41%), Gaps = 44/224 (19%)
Query: 128 LLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLI-H 186
++GEG +G VYK + TG VA+K ++ +E E N L H
Sbjct: 13 VIGEGTYGKVYKA-RHKK--------TGQLVAIKIMDIIE-DEEEEIKEEYNILRKYSNH 62
Query: 187 PNLVKLIGC------CIEDDQRLLVYEFMPRGSLEN-----HLFRRSLPLPWSIRMKIAL 235
PN+ G DDQ LV E GS+ + + L W IA
Sbjct: 63 PNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEW-----IAY 117
Query: 236 ---DAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAK--DGPEGDKTHVS 290
+ +GLA+LHE VI+RD K NILL KL DFG++ D G + +
Sbjct: 118 ILRETLRGLAYLHE---NKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLG-RRNTF 173
Query: 291 TRVMGTYGYAAPEYVM-----TGHLTAKSDVYSFGVVLLEMLTG 329
GT + APE + A+SDV+S G+ +E+ G
Sbjct: 174 I---GTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADG 214
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 4e-16
Identities = 71/299 (23%), Positives = 124/299 (41%), Gaps = 50/299 (16%)
Query: 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHK---EWLA 176
+F+ E +G+G F VYK ++G VA+K + + K + L
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDG---------RVVALKKVQIFEMMDAKARQDCLK 51
Query: 177 EVNYLGGLIHPNLVKLIGCCIEDDQRLLVYEFMPRGSLE---NHLFRRSLPLP----WSI 229
E++ L L HPN++K + IE+++ +V E G L H ++ +P W
Sbjct: 52 EIDLLKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKY 111
Query: 230 RMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHV 289
+++ L +H K +++RD K +N+ + KL D GL + KT
Sbjct: 112 FVQL----CSALEHMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSS--KTTA 162
Query: 290 STRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR 349
+ ++GT Y +PE + KSD++S G +L EM
Sbjct: 163 AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEM------------------AALQS 204
Query: 350 PQLGERRRFYRLIDPCLEGCFSIKGAEKTIQ----LAASCLNRDQKARPRMSEVVEALK 404
P G++ Y L + + A+ + L + C+N D + RP +S V++ K
Sbjct: 205 PFYGDKMNLYSLCKKIEKCDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAK 263
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 5e-16
Identities = 66/221 (29%), Positives = 106/221 (47%), Gaps = 36/221 (16%)
Query: 128 LLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQG-HKEWLAEVNYLGGL-I 185
++GEG FG V K I K G + A+K + + H+++ E+ L L
Sbjct: 2 VIGEGNFGQVLKARIK-------KDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 54
Query: 186 HPNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPL---PWSIR------------ 230
HPN++ L+G C L E+ P G+L + L R+S L P
Sbjct: 55 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFL-RKSRVLETDPAFAIANSTASTLSSQQ 113
Query: 231 -MKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHV 289
+ A D A+G+ +L ++K I+RD NIL+ Y AK++DFGL++ G + +V
Sbjct: 114 LLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR----GQEVYV 166
Query: 290 STRVMGTYG--YAAPEYVMTGHLTAKSDVYSFGVVLLEMLT 328
+ MG + A E + T SDV+S+GV+L E+++
Sbjct: 167 K-KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 6e-16
Identities = 60/243 (24%), Positives = 99/243 (40%), Gaps = 45/243 (18%)
Query: 175 LAEVNYLGGLIHPNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 234
L E+ L L HPN++ ++D+ L+ E+ G+L + + R+ L + M +
Sbjct: 47 LNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQL-FEEEMVLW 105
Query: 235 L--DAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTR 292
++++H+ +++RD KT NI L KL DFG++K G + ++
Sbjct: 106 YLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKI--LGSEYSMAET 160
Query: 293 VMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQL 352
V+GT Y +PE KSD+++ G VL E+LT +R+ D P
Sbjct: 161 VVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNP-------------- 206
Query: 353 GERRRFYRLIDPCLEGCFSIKGAEKT----------IQLAASCLNRDQKARPRMSEVVEA 402
L I T I L S L +D + RP EV++
Sbjct: 207 -------------LNLVVKIVQGNYTPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQ 253
Query: 403 LKP 405
Sbjct: 254 PLL 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 6e-16
Identities = 60/205 (29%), Positives = 99/205 (48%), Gaps = 23/205 (11%)
Query: 129 LGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHPN 188
LG+G FG VYK TG A K + + ++++ E+ L HP
Sbjct: 20 LGDGAFGKVYKA---------KNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPY 70
Query: 189 LVKLIGCCIEDDQRLLVYEFMPRGSLENHLFR--RSLPLPWSIRMKIALDAAKGLAFLHE 246
+VKL+G D + ++ EF P G+++ + R L P I++ I + L +LH
Sbjct: 71 IVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEP-QIQV-ICRQMLEALQYLHS 128
Query: 247 EAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM 306
+I+RD K N+LL + + KL+DFG++ + + S +GT + APE VM
Sbjct: 129 ---MKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDS--FIGTPYWMAPEVVM 183
Query: 307 TGHLTA-----KSDVYSFGVVLLEM 326
+ K+D++S G+ L+EM
Sbjct: 184 CETMKDTPYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 7e-16
Identities = 72/211 (34%), Positives = 102/211 (48%), Gaps = 28/211 (13%)
Query: 128 LLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQ--------GHKEWLAEVN 179
+LG+G FG V+ P G A+K L L+ ++ LAEVN
Sbjct: 3 VLGQGSFGKVFLV------RKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVN 56
Query: 180 YLGGLIHPNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAK 239
HP +VKL + + L+ +F+ G L L + + ++ +A + A
Sbjct: 57 ------HPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLA-ELAL 109
Query: 240 GLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGY 299
L LH +IYRD K NILLD E + KL+DFGL+K+ + +K S GT Y
Sbjct: 110 ALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGTVEY 164
Query: 300 AAPEYV-MTGHLTAKSDVYSFGVVLLEMLTG 329
APE V GH T +D +SFGV++ EMLTG
Sbjct: 165 MAPEVVNRRGH-TQSADWWSFGVLMFEMLTG 194
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 7e-16
Identities = 64/217 (29%), Positives = 97/217 (44%), Gaps = 22/217 (10%)
Query: 129 LGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLI--H 186
LGEG FG V G KP + VAVK L D L + +I H
Sbjct: 20 LGEGCFGQVVMA--EAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKH 77
Query: 187 PNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLP---------------LPWSIRM 231
N++ L+G C +D ++ E+ +G+L +L R P L + +
Sbjct: 78 KNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLV 137
Query: 232 KIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVST 291
A A+G+ +L A + I+RD N+L+ + K++DFGLA+D D +T
Sbjct: 138 SCAYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTT 194
Query: 292 RVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLT 328
+ APE + T +SDV+SFGV+L E+ T
Sbjct: 195 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 7e-16
Identities = 54/163 (33%), Positives = 80/163 (49%), Gaps = 8/163 (4%)
Query: 186 HPNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLH 245
+P LV L C + LV E++ G L H+ +R LP A + L FLH
Sbjct: 55 NPFLVGLHSCFQTTSRLFLVIEYVNGGDLMFHM-QRQRKLPEEHARFYAAEICIALNFLH 113
Query: 246 EEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDG-PEGDKTHVSTRVMGTYGYAAPEY 304
E + +IYRD K N+LLD + + KL+D+G+ K+G GD T + GT Y APE
Sbjct: 114 E---RGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTT---STFCGTPNYIAPEI 167
Query: 305 VMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEW 347
+ D ++ GV++ EM+ GR D N + N ++
Sbjct: 168 LRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDY 210
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 8e-16
Identities = 65/217 (29%), Positives = 97/217 (44%), Gaps = 22/217 (10%)
Query: 129 LGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLI--H 186
LGEG FG V G KP VAVK L D + L + +I H
Sbjct: 26 LGEGCFGQVVMA--EAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 83
Query: 187 PNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLP---------------LPWSIRM 231
N++ L+G C +D ++ E+ +G+L +L R P L + +
Sbjct: 84 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLV 143
Query: 232 KIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVST 291
A A+G+ +L A K I+RD N+L+ + K++DFGLA+D D +T
Sbjct: 144 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 200
Query: 292 RVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLT 328
+ APE + T +SDV+SFGV+L E+ T
Sbjct: 201 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 8e-16
Identities = 72/207 (34%), Positives = 93/207 (44%), Gaps = 23/207 (11%)
Query: 129 LGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEW---LAEVNYL-GGL 184
+G+G FG V G AVK L + KE +AE N L +
Sbjct: 3 IGKGSFGKVLL---------AKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNV 53
Query: 185 IHPNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFR-RSLPLPWSIRMKI-ALDAAKGLA 242
HP LV L D+ V +++ G L HL R RS P P R + A + A L
Sbjct: 54 KHPFLVGLHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEP---RARFYAAEIASALG 110
Query: 243 FLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAP 302
+LH +IYRD K NILLD + + L+DFGL K+G E KT ++ GT Y AP
Sbjct: 111 YLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKT--TSTFCGTPEYLAP 165
Query: 303 EYVMTGHLTAKSDVYSFGVVLLEMLTG 329
E + D + G VL EML G
Sbjct: 166 EVLRKQPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 8e-16
Identities = 45/166 (27%), Positives = 71/166 (42%), Gaps = 15/166 (9%)
Query: 187 PNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHE 246
P + KL D LV E++ G + L + LP + + G+ LH+
Sbjct: 57 PYVAKLYYSFQSKDYLYLVMEYLNGGDCAS-LIKTLGGLPEDWAKQYIAEVVLGVEDLHQ 115
Query: 247 EAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM 306
+I+RD K N+L+D + KL+DFGL+++G + + +GT Y APE ++
Sbjct: 116 RG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNG------LENKKFVGTPDYLAPETIL 166
Query: 307 TGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRP-----NGEHNLVEW 347
SD +S G V+ E L G P N + W
Sbjct: 167 GVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINW 212
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 76.9 bits (190), Expect = 8e-16
Identities = 57/208 (27%), Positives = 89/208 (42%), Gaps = 24/208 (11%)
Query: 132 GGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGH---KEWLAEVNYLGGLIHPN 188
G +G V+ K TG A+K + + + L E + L P
Sbjct: 4 GAYGRVFLA---------KKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPY 54
Query: 189 LVKLIGCCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEE 247
+VKL + + L LV E++P G L L L + + L +LH
Sbjct: 55 VVKLY-YSFQGKKNLYLVMEYLPGGDLA-SLLENVGSLDEDVARIYIAEIVLALEYLHSN 112
Query: 248 AEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVS------TRVMGTYGYAA 301
+I+RD K NIL+D + KL+DFGL+K G + +++ R++GT Y A
Sbjct: 113 G---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIA 169
Query: 302 PEYVMTGHLTAKSDVYSFGVVLLEMLTG 329
PE ++ + D +S G +L E L G
Sbjct: 170 PEVILGQGHSKTVDWWSLGCILYEFLVG 197
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 9e-16
Identities = 59/171 (34%), Positives = 89/171 (52%), Gaps = 19/171 (11%)
Query: 176 AEVNYLGGLIHPNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 235
AE N L + HP +V LI + L+ E++ G L HL R + + + ++
Sbjct: 49 AERNILEAVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLS- 107
Query: 236 DAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDG-PEGDKTHVSTRVM 294
+ + L LH++ +IYRD K NILLD + + KL+DFGL K+ EG TH
Sbjct: 108 EISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHT---FC 161
Query: 295 GTYGYAAPEYVM-TGHLTAKSDVYSFGVVLLEMLTG---------RRSMDK 335
GT Y APE +M +GH A D +S G ++ +MLTG ++++DK
Sbjct: 162 GTIEYMAPEILMRSGHGKA-VDWWSLGALMYDMLTGAPPFTAENRKKTIDK 211
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 9e-16
Identities = 54/145 (37%), Positives = 75/145 (51%), Gaps = 8/145 (5%)
Query: 186 HPNLVKLIGCCIEDDQRLL-VYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFL 244
HP L +L CC + RL V EF+ G L H+ ++S + A + L FL
Sbjct: 55 HPFLTQLY-CCFQTPDRLFFVMEFVNGGDLMFHI-QKSRRFDEARARFYAAEITSALMFL 112
Query: 245 HEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEY 304
H+ K +IYRD K N+LLD E + KL+DFG+ K+G KT ++ GT Y APE
Sbjct: 113 HD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKT--TSTFCGTPDYIAPEI 167
Query: 305 VMTGHLTAKSDVYSFGVVLLEMLTG 329
+ D ++ GV+L EML G
Sbjct: 168 LQEMLYGPSVDWWAMGVLLYEMLCG 192
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 1e-15
Identities = 51/150 (34%), Positives = 75/150 (50%), Gaps = 8/150 (5%)
Query: 186 HPNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLH 245
HP LV L C + + V E++ G L H+ +R LP + + + L +LH
Sbjct: 55 HPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHM-QRQRKLPEEHARFYSAEISLALNYLH 113
Query: 246 EEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPE-GDKTHVSTRVMGTYGYAAPEY 304
E +IYRD K N+LLD E + KL+D+G+ K+G GD T + GT Y APE
Sbjct: 114 ERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT---STFCGTPNYIAPEI 167
Query: 305 VMTGHLTAKSDVYSFGVVLLEMLTGRRSMD 334
+ D ++ GV++ EM+ GR D
Sbjct: 168 LRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 1e-15
Identities = 64/207 (30%), Positives = 104/207 (50%), Gaps = 21/207 (10%)
Query: 129 LGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEW-LAEVNYLGGLIHP 187
LGEG + VYKG N T TG VA+K ++ D +G + E++ + L H
Sbjct: 8 LGEGTYATVYKG---RNRT------TGEIVALKEIHLDAEEGTPSTAIREISLMKELKHE 58
Query: 188 NLVKLIGCCIEDDQRLLVYEFMP---RGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFL 244
N+V+L +++ +LV+E+M + ++ H R +L + KG+AF
Sbjct: 59 NIVRLHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDP--NTVKSFTYQLLKGIAFC 116
Query: 245 HEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEY 304
HE V++RD K N+L++ KL+DFGLA+ T + V T Y AP+
Sbjct: 117 HENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV--TLWYRAPDV 171
Query: 305 VMTGHLTAKS-DVYSFGVVLLEMLTGR 330
++ + S D++S G ++ EM+TGR
Sbjct: 172 LLGSRTYSTSIDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 1e-15
Identities = 54/154 (35%), Positives = 76/154 (49%), Gaps = 18/154 (11%)
Query: 187 PNLVKLIGCCIEDDQRLLVYEFMPRGSLENHL-----FRRSLPLPWSIRMKIALDAAKGL 241
P L +L C D+ V E++ G L H+ F+ + + A + A GL
Sbjct: 61 PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFY------AAEIAIGL 114
Query: 242 AFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVM-GTYGYA 300
FLH K +IYRD K N++LD E + K++DFG+ K+ G KT TR GT Y
Sbjct: 115 FFLHS---KGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKT---TRTFCGTPDYI 168
Query: 301 APEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMD 334
APE + D ++FGV+L EML G+ D
Sbjct: 169 APEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 76.2 bits (188), Expect = 2e-15
Identities = 85/305 (27%), Positives = 124/305 (40%), Gaps = 48/305 (15%)
Query: 128 LLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVK--TLNHDGLQGHKEWLAEVNYLGGLI 185
+G G FG V K +GT +AVK D + K L +++ +
Sbjct: 11 EIGRGAFGTVNKMLHKPSGTI---------MAVKRIRSTVDEKE-QKRLLMDLDVVMRSS 60
Query: 186 H-PNLVKLIGCCIEDDQRLLVYEFMPRGSLEN-----HLFRRSLPLPWSIRMKIALDAAK 239
P +VK G + + E M SL+ + +S+ +P I KIA+ K
Sbjct: 61 DCPYIVKFYGALFREGDCWICMELMDI-SLDKFYKYVYEVLKSV-IPEEILGKIAVATVK 118
Query: 240 GLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGY 299
L +L EE + +I+RD K SNILLD N KL DFG++ G D TR G Y
Sbjct: 119 ALNYLKEELK--IIHRDVKPSNILLDRNGNIKLCDFGIS--GQLVDSI-AKTRDAGCRPY 173
Query: 300 AAPEYVMTGHLTA---KSDVYSFGVVLLEMLTGRRSMDKNRPNGEH--NLVEWARPQLGE 354
APE + +SDV+S G+ L E+ TG+ K + +V+ P L
Sbjct: 174 MAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPIL-- 231
Query: 355 RRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDMAS 414
E FS + CL +D+ RP+ E L P++KD
Sbjct: 232 --------SNSEEREFSP----SFVNFINLCLIKDESKRPKYKE----LLEHPFIKDYEE 275
Query: 415 SSSYV 419
+ V
Sbjct: 276 RNVDV 280
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 2e-15
Identities = 66/221 (29%), Positives = 105/221 (47%), Gaps = 36/221 (16%)
Query: 128 LLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQG-HKEWLAEVNYLGGL-I 185
++GEG FG V K I K G + A+K + + H+++ E+ L L
Sbjct: 14 VIGEGNFGQVLKARIK-------KDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 66
Query: 186 HPNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA----------- 234
HPN++ L+G C L E+ P G+L + L R+S L IA
Sbjct: 67 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFL-RKSRVLETDPAFAIANSTASTLSSQQ 125
Query: 235 -----LDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHV 289
D A+G+ +L ++K I+RD NIL+ Y AK++DFGL++ G + +V
Sbjct: 126 LLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR----GQEVYV 178
Query: 290 STRVMGTYG--YAAPEYVMTGHLTAKSDVYSFGVVLLEMLT 328
+ MG + A E + T SDV+S+GV+L E+++
Sbjct: 179 K-KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 2e-15
Identities = 59/182 (32%), Positives = 90/182 (49%), Gaps = 16/182 (8%)
Query: 153 GTGLPVAVKTLNHDGLQGHKE---WLAEVNYLGGLIHPNLVKLIGCCIEDDQRL-LVYEF 208
GTG A+K L + K+ E + L L HP +V ++ C +D+ R+ + EF
Sbjct: 41 GTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMM-CSFQDENRVYFLLEF 99
Query: 209 MPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEY 268
+ G L HL R++ P + + +LH K +IYRD K N+LLD +
Sbjct: 100 VVGGELFTHL-RKAGRFPNDVAKFYHAELVLAFEYLHS---KDIIYRDLKPENLLLDNKG 155
Query: 269 NAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTAKSDVYSFGVVLLEML 327
+ K++DFG AK P+ T + GT Y APE + + GH A D ++ GV+L E +
Sbjct: 156 HVKVTDFGFAKKVPDRTFT-----LCGTPEYLAPEVIQSKGHGKA-VDWWTMGVLLYEFI 209
Query: 328 TG 329
G
Sbjct: 210 AG 211
|
Length = 329 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 2e-15
Identities = 57/203 (28%), Positives = 95/203 (46%), Gaps = 19/203 (9%)
Query: 129 LGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHPN 188
LG+G FG VYK TG+ A K ++ + ++++ E++ L HPN
Sbjct: 13 LGDGAFGKVYKAQ---------NKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPN 63
Query: 189 LVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEA 248
+VKL+ ++ ++ EF G+++ + PL + + L +LHE
Sbjct: 64 IVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENK 123
Query: 249 EKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG 308
+I+RD K NIL + + KL+DFG++ + S +GT + APE VM
Sbjct: 124 ---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS--FIGTPYWMAPEVVMCE 178
Query: 309 H-----LTAKSDVYSFGVVLLEM 326
K+DV+S G+ L+EM
Sbjct: 179 TSKDRPYDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 3e-15
Identities = 65/216 (30%), Positives = 98/216 (45%), Gaps = 33/216 (15%)
Query: 123 FRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLG 182
+G G FG V+ ++ +P ++ + K L EV+
Sbjct: 3 LERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVS--- 59
Query: 183 GLIHPNLVKLIGCCIEDDQRLL--VYEFMPRGSLENHL-----FRRSLPLPWSIRMKIAL 235
HP +++L E DQR L + E++P G L ++L F S L ++ + AL
Sbjct: 60 ---HPFIIRLF--WTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCAL 114
Query: 236 DAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVM- 294
+ +LH K ++YRD K NILLD E + KL+DFG AK K T +
Sbjct: 115 E------YLHS---KEIVYRDLKPENILLDKEGHIKLTDFGFAK------KLRDRTWTLC 159
Query: 295 GTYGYAAPEYVM-TGHLTAKSDVYSFGVVLLEMLTG 329
GT Y APE + GH A D ++ G+++ EML G
Sbjct: 160 GTPEYLAPEVIQSKGHNKA-VDWWALGILIYEMLVG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 3e-15
Identities = 72/274 (26%), Positives = 121/274 (44%), Gaps = 34/274 (12%)
Query: 129 LGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLA-EVNYLGGLIHP 187
+G+G FG V+KG N T VA+K ++ + + E + E+ L P
Sbjct: 12 IGKGSFGEVFKGIDNR---------TQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 62
Query: 188 NLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEE 247
+ K G ++D + ++ E++ GS + L PL + I + KGL +LH E
Sbjct: 63 YVTKYYGSYLKDTKLWIIMEYLGGGSALDLL--EPGPLDETQIATILREILKGLDYLHSE 120
Query: 248 AEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT 307
+ I+RD K +N+LL KL+DFG+A G D +GT + APE +
Sbjct: 121 KK---IHRDIKAANVLLSEHGEVKLADFGVA--GQLTDTQIKRNTFVGTPFWMAPEVIKQ 175
Query: 308 GHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRRFYRLIDPCLE 367
+K+D++S G+ +E+ G + P L+ P P LE
Sbjct: 176 SAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNP-------------PTLE 222
Query: 368 GCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVE 401
G +S + + +CLN++ RP E+++
Sbjct: 223 GNYS----KPLKEFVEACLNKEPSFRPTAKELLK 252
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 75.9 bits (186), Expect = 3e-15
Identities = 69/249 (27%), Positives = 109/249 (43%), Gaps = 29/249 (11%)
Query: 129 LGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEW---LAEVNYLGGLI 185
+G G FG VY N VA+K +++ G Q +++W + EV +L L
Sbjct: 23 IGHGSFGAVYFARDVRNSEV---------VAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73
Query: 186 HPNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLH 245
HPN ++ GC + + LV E+ GS + L PL + A +GLA+LH
Sbjct: 74 HPNTIQYRGCYLREHTAWLVMEYC-LGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH 132
Query: 246 EEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYV 305
+I+RD K NILL KL DFG A + +GT + APE +
Sbjct: 133 SHN---MIHRDVKAGNILLSEPGLVKLGDFGSAS------IMAPANXFVGTPYWMAPEVI 183
Query: 306 MT---GHLTAKSDVYSFGVVLLEMLTGRRSM-DKNRPNGEHNLVEWARPQLGERR---RF 358
+ G K DV+S G+ +E+ + + + N + +++ + P L F
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYF 243
Query: 359 YRLIDPCLE 367
+D CL+
Sbjct: 244 RNFVDSCLQ 252
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 4e-15
Identities = 72/221 (32%), Positives = 108/221 (48%), Gaps = 36/221 (16%)
Query: 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNY 180
+S + E LG G FG V+ N + VAVKT+ G + +LAE N
Sbjct: 6 ESLKLEKKLGAGQFGEVWMATYNKH----------TKVAVKTMK-PGSMSVEAFLAEANV 54
Query: 181 LGGLIHPNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRS---LPLPWSIRMKIALDA 237
+ L H LVKL + + ++ EFM +GSL + L PLP I +
Sbjct: 55 MKTLQHDKLVKL-HAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQI-- 111
Query: 238 AKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAK-------DGPEGDKTHVS 290
A+G+AF+ + + I+RD + +NIL+ K++DFGLA+ EG K +
Sbjct: 112 AEGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIK 168
Query: 291 TRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLT-GR 330
+ APE + G T KSDV+SFG++L+E++T GR
Sbjct: 169 --------WTAPEAINFGSFTIKSDVWSFGILLMEIVTYGR 201
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 75.5 bits (186), Expect = 4e-15
Identities = 73/236 (30%), Positives = 105/236 (44%), Gaps = 30/236 (12%)
Query: 102 LKISPQLRKFSFNELKSATKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVK 161
L I Q N+L++ +G G G VYK K TG +AVK
Sbjct: 3 LTIDGQKYPADLNDLEN-------LGEIGSGTCGQVYK--------MRFKK-TGHVMAVK 46
Query: 162 TLNHDG-LQGHKEWLAEVNYLGGLIH--PNLVKLIGCCIEDDQRLLVYEFMPRGSLENHL 218
+ G + +K L +++ + H P +VK G I D + E M L+ L
Sbjct: 47 QMRRTGNKEENKRILMDLDVVL-KSHDCPYIVKCYGYFITDSDVFICMELMST-CLDKLL 104
Query: 219 FRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLA 278
R P+P I K+ + K L +L E+ VI+RD K SNILLD N KL DFG++
Sbjct: 105 KRIQGPIPEDILGKMTVAIVKALHYLKEK--HGVIHRDVKPSNILLDASGNVKLCDFGIS 162
Query: 279 KDGPEGDKTHVSTRVMGTYGYAAPEYV----MTGHLTAKSDVYSFGVVLLEMLTGR 330
+ K TR G Y APE + ++DV+S G+ L+E+ TG+
Sbjct: 163 GRLVD-SKAK--TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQ 215
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 5e-15
Identities = 75/294 (25%), Positives = 122/294 (41%), Gaps = 44/294 (14%)
Query: 122 SFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL---QGHKEWLAEV 178
+FR E +G G F VY+ ++G PVA+K + L + + + E+
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGV---------PVALKKVQIFDLMDAKARADCIKEI 53
Query: 179 NYLGGLIHPNLVKLIGCCIEDDQRLLVYEFMPRGSLEN---HLFRRSLPLPWSIRMKIAL 235
+ L L HPN++K IED++ +V E G L H ++ +P K +
Sbjct: 54 DLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFV 113
Query: 236 DAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMG 295
L +H + V++RD K +N+ + KL D GL + KT + ++G
Sbjct: 114 QLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFF--SSKTTAAHSLVG 168
Query: 296 TYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGER 355
T Y +PE + KSD++S G +L EM P G++
Sbjct: 169 TPYYMSPERIHENGYNFKSDIWSLGCLLYEM------------------AALQSPFYGDK 210
Query: 356 RRFYRLIDPCLEGCF-----SIKGAEKTIQLAASCLNRDQKARPRMSEVVEALK 404
Y L +E C S +E+ QL C+N D + RP ++ V + K
Sbjct: 211 MNLYSLCKK-IEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAK 263
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 5e-15
Identities = 72/274 (26%), Positives = 120/274 (43%), Gaps = 34/274 (12%)
Query: 129 LGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLA-EVNYLGGLIHP 187
+G+G FG VYKG N VA+K ++ + + E + E+ L P
Sbjct: 12 IGKGSFGEVYKGIDNRTKEV---------VAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 62
Query: 188 NLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEE 247
+ + G ++ + ++ E++ GS + L + PL + I + KGL +LH E
Sbjct: 63 YITRYYGSYLKGTKLWIIMEYLGGGSALDLL--KPGPLEETYIATILREILKGLDYLHSE 120
Query: 248 AEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT 307
+ I+RD K +N+LL + + KL+DFG+A G D +GT + APE +
Sbjct: 121 RK---IHRDIKAANVLLSEQGDVKLADFGVA--GQLTDTQIKRNTFVGTPFWMAPEVIKQ 175
Query: 308 GHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRRFYRLIDPCLE 367
K+D++S G+ +E+ G P L+ P P LE
Sbjct: 176 SAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSP-------------PTLE 222
Query: 368 GCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVE 401
G +S E +CLN+D + RP E+++
Sbjct: 223 GQYSKPFKE----FVEACLNKDPRFRPTAKELLK 252
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 6e-15
Identities = 69/246 (28%), Positives = 115/246 (46%), Gaps = 25/246 (10%)
Query: 129 LGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLA-EVNYLGGLIHP 187
+G+G G VY TA + TG VA+K +N Q KE + E+ + HP
Sbjct: 27 IGQGASGTVY--------TA-IDVATGQEVAIKQMNLQQ-QPKKELIINEILVMRENKHP 76
Query: 188 NLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEE 247
N+V + + D+ +V E++ GSL + + + + + + L FLH
Sbjct: 77 NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDE--GQIAAVCRECLQALEFLHSN 134
Query: 248 AEKPVIYRDFKTSNILLDGEYNAKLSDFGL-AKDGPEGDKTHVSTRVMGTYGYAAPEYVM 306
VI+RD K+ NILL + + KL+DFG A+ PE K + ++GT + APE V
Sbjct: 135 Q---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK---RSTMVGTPYWMAPEVVT 188
Query: 307 TGHLTAKSDVYSFGVVLLEMLTGRRS-MDKNRPNGEHNLVEWARPQLGERRR----FYRL 361
K D++S G++ +EM+ G +++N + + P+L + F
Sbjct: 189 RKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDF 248
Query: 362 IDPCLE 367
++ CLE
Sbjct: 249 LNRCLE 254
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 7e-15
Identities = 68/211 (32%), Positives = 97/211 (45%), Gaps = 27/211 (12%)
Query: 128 LLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKE---WLAEVNYLG-G 183
+LG+G FG V+ A +K GT A+K L D + + + E L
Sbjct: 2 MLGKGSFGKVF--------LAELK-GTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLA 52
Query: 184 LIHPNLVKLIGCCIEDDQRLL-VYEFMPRGSLENHL---FRRSLPLPWSIRMKIALDAAK 239
HP L L C + + L V E++ G L H+ + LP +I
Sbjct: 53 WEHPFLTHLY-CTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIIC---- 107
Query: 240 GLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGY 299
GL FLH K ++YRD K NILLD + + K++DFG+ K+ GD + GT Y
Sbjct: 108 GLQFLHS---KGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAK--TCTFCGTPDY 162
Query: 300 AAPEYVMTGHLTAKSDVYSFGVVLLEMLTGR 330
APE ++ D +SFGV+L EML G+
Sbjct: 163 IAPEILLGQKYNTSVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 7e-15
Identities = 52/146 (35%), Positives = 70/146 (47%), Gaps = 8/146 (5%)
Query: 186 HPNLVKLIGCCIEDDQRLL-VYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFL 244
HP L L CC + RL V E++ G L + +RS A + L FL
Sbjct: 55 HPFLTALH-CCFQTKDRLFFVMEYVNGGDLMFQI-QRSRKFDEPRSRFYAAEVTLALMFL 112
Query: 245 HEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEY 304
H VIYRD K NILLD E + KL+DFG+ K+G T +T GT Y APE
Sbjct: 113 HRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVT--TTTFCGTPDYIAPEI 167
Query: 305 VMTGHLTAKSDVYSFGVVLLEMLTGR 330
+ D ++ GV++ EM+ G+
Sbjct: 168 LQELEYGPSVDWWALGVLMYEMMAGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 8e-15
Identities = 63/217 (29%), Positives = 98/217 (45%), Gaps = 22/217 (10%)
Query: 129 LGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLI--H 186
LGEG FG V G KP + VAVK L D + L + +I H
Sbjct: 23 LGEGCFGQVVMA--EALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 80
Query: 187 PNLVKLIGCCIEDDQRLLVYEFMPRGSLENHL-FRRSLPLPWSIRMKIALDA-------- 237
N++ L+G C +D ++ E+ +G+L +L RR + +S + D
Sbjct: 81 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLV 140
Query: 238 ------AKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVST 291
A+G+ +L A + I+RD N+L+ K++DFGLA+D D +T
Sbjct: 141 SCTYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTT 197
Query: 292 RVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLT 328
+ APE + T +SDV+SFGV++ E+ T
Sbjct: 198 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 1e-14
Identities = 50/146 (34%), Positives = 74/146 (50%), Gaps = 8/146 (5%)
Query: 186 HPNLVKLIGCCIEDDQRLL-VYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFL 244
HP L L C + + L V E++ G L H+ + S + A + GL FL
Sbjct: 55 HPFLTHLF-CTFQTKEHLFFVMEYLNGGDLMFHI-QSSGRFDEARARFYAAEIICGLQFL 112
Query: 245 HEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEY 304
H+ K +IYRD K N+LLD + + K++DFG+ K+ G+ ++ GT Y APE
Sbjct: 113 HK---KGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGK--ASTFCGTPDYIAPEI 167
Query: 305 VMTGHLTAKSDVYSFGVVLLEMLTGR 330
+ D +SFGV+L EML G+
Sbjct: 168 LKGQKYNESVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 1e-14
Identities = 48/144 (33%), Positives = 80/144 (55%), Gaps = 7/144 (4%)
Query: 187 PNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHE 246
P +V G D + + E M GSL+ L +++ +P +I KI++ +GL +L E
Sbjct: 59 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVL-KKAGRIPENILGKISIAVLRGLTYLRE 117
Query: 247 EAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM 306
+ + +++RD K SNIL++ KL DFG++ G D ++ +GT Y +PE +
Sbjct: 118 KHK--IMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDS--MANSFVGTRSYMSPERLQ 171
Query: 307 TGHLTAKSDVYSFGVVLLEMLTGR 330
H T +SD++S G+ L+EM GR
Sbjct: 172 GTHYTVQSDIWSLGLSLVEMAIGR 195
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 1e-14
Identities = 78/295 (26%), Positives = 116/295 (39%), Gaps = 65/295 (22%)
Query: 129 LGEGGFGCVYKGWINMNGTATVKPGTGLPVAVK----TLNHDGLQGHKEWLAEVNYLGGL 184
LG G +G V K TG +AVK T+N Q K L +++
Sbjct: 9 LGRGAYGVVDK---------MRHVPTGTIMAVKRIRATVNS---QEQKRLLMDLDISMRS 56
Query: 185 IH-PNLVKLIGCCIEDDQRLLVYEFMPRGSLEN---HLFRRSLPLPWSIRMKIALDAAKG 240
+ P V G + + E M SL+ ++ + L +P I KIA+ K
Sbjct: 57 VDCPYTVTFYGALFREGDVWICMEVM-DTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKA 115
Query: 241 LAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFG--------LAKDGPEGDKTHVSTR 292
L +LH + VI+RD K SN+L++ KL DFG +AK G K
Sbjct: 116 LEYLHSKLS--VIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTIDAGCKP----- 168
Query: 293 VMGTYGYAAPEYV----MTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEH--NLVE 346
Y APE + KSDV+S G+ ++E+ TGR D + + +VE
Sbjct: 169 ------YMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVE 222
Query: 347 WARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVE 401
PQL + FS + CL ++ K RP E+++
Sbjct: 223 EPSPQLPAEK-------------FS----PEFQDFVNKCLKKNYKERPNYPELLQ 260
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 73.2 bits (179), Expect = 1e-14
Identities = 63/209 (30%), Positives = 98/209 (46%), Gaps = 17/209 (8%)
Query: 128 LLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLA---EVNYLGGL 184
LLG+G FG VY + V G L + + + KE A E+ L L
Sbjct: 9 LLGQGAFGRVYLCY-------DVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNL 61
Query: 185 IHPNLVKLIGCCIEDDQRLLV--YEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLA 242
H +V+ GC + ++ L E+MP GS+++ L + L S+ K +G++
Sbjct: 62 QHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQL-KAYGALTESVTRKYTRQILEGMS 120
Query: 243 FLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTR-VMGTYGYAA 301
+LH +++RD K +NIL D N KL DFG +K + R V GT + +
Sbjct: 121 YLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMS 177
Query: 302 PEYVMTGHLTAKSDVYSFGVVLLEMLTGR 330
PE + K+DV+S G ++EMLT +
Sbjct: 178 PEVISGEGYGRKADVWSLGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 2e-14
Identities = 64/208 (30%), Positives = 89/208 (42%), Gaps = 23/208 (11%)
Query: 129 LGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQ---GHKEWLAEVNYLGGLI 185
LG+GGFG V A TG A K L+ L+ G K L E L +
Sbjct: 1 LGKGGFGEV---------CAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVN 51
Query: 186 HPNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLF---RRSLPLPWSIRMKIALDAAKGLA 242
P +V L LV M G L+ H++ R L + I + G+
Sbjct: 52 SPFIVNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQI--TCGIL 109
Query: 243 FLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAP 302
LH ++YRD K N+LLD + N +LSD GLA + +G T+ GT GY AP
Sbjct: 110 HLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTI---TQRAGTNGYMAP 163
Query: 303 EYVMTGHLTAKSDVYSFGVVLLEMLTGR 330
E + + D ++ G + EM+ GR
Sbjct: 164 EILKEEPYSYPVDWFAMGCSIYEMVAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 2e-14
Identities = 52/148 (35%), Positives = 75/148 (50%), Gaps = 13/148 (8%)
Query: 187 PNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHE 246
P LV L D + L+ +++ G L HL++R +R+ IA + L LH+
Sbjct: 65 PFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIA-EIVLALDHLHQ 123
Query: 247 EAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKD--GPEGDKTHVSTRVMGTYGYAAPEY 304
+IYRD K NILLD E + L+DFGL+K+ E ++ + GT Y APE
Sbjct: 124 LG---IIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAY---SFCGTIEYMAPEV 177
Query: 305 VMT---GHLTAKSDVYSFGVVLLEMLTG 329
+ GH A D +S GV+ E+LTG
Sbjct: 178 IRGGSGGHDKA-VDWWSLGVLTFELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 3e-14
Identities = 56/203 (27%), Positives = 96/203 (47%), Gaps = 22/203 (10%)
Query: 129 LGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHD-GLQGHKEWLAEVNYLGGLIHP 187
LG G G VYK + T +AVK + D ++ K+ ++E+ L P
Sbjct: 9 LGHGNGGTVYKAYH---------LLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSP 59
Query: 188 NLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEE 247
++ G +++ + EFM GSL+ ++R+ +P + +IA+ KGL +L
Sbjct: 60 YIIGFYGAFFVENRISICTEFMDGGSLD--VYRK---IPEHVLGRIAVAVVKGLTYLWS- 113
Query: 248 AEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT 307
+++RD K SN+L++ KL DFG++ ++ +GT Y APE +
Sbjct: 114 --LKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS----IAKTYVGTNAYMAPERISG 167
Query: 308 GHLTAKSDVYSFGVVLLEMLTGR 330
SDV+S G+ +E+ GR
Sbjct: 168 EQYGIHSDVWSLGISFMELALGR 190
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 4e-14
Identities = 62/211 (29%), Positives = 99/211 (46%), Gaps = 36/211 (17%)
Query: 129 LGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHPN 188
+GEG G V AT K TG VAVK ++ Q + EV + HPN
Sbjct: 27 IGEGSTGIVC--------IATDK-STGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPN 77
Query: 189 LVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK------IALDAAKGLA 242
+V++ + D+ +V EF+ G+L + + RM + L K L+
Sbjct: 78 IVEMYSSYLVGDELWVVMEFLEGGALTD--------IVTHTRMNEEQIATVCLAVLKALS 129
Query: 243 FLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFG----LAKDGPEGDKTHVSTRVMGTYG 298
FLH + VI+RD K+ +ILL + KLSDFG ++K+ P ++GT
Sbjct: 130 FLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPR------RKSLVGTPY 180
Query: 299 YAAPEYVMTGHLTAKSDVYSFGVVLLEMLTG 329
+ APE + + D++S G++++EM+ G
Sbjct: 181 WMAPEVISRLPYGTEVDIWSLGIMVIEMVDG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 4e-14
Identities = 65/216 (30%), Positives = 103/216 (47%), Gaps = 31/216 (14%)
Query: 128 LLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTL--NHDGLQGHKEWLA---EVNYLG 182
LLG+G FG VY + TG +AVK + + + + KE A E+ L
Sbjct: 9 LLGQGAFGRVYLCY---------DADTGRELAVKQVQFDPESPETSKEVNALECEIQLLK 59
Query: 183 GLIHPNLVKLIGCCIEDDQRLL--VYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKG 240
L+H +V+ GC + +R L E MP GS+++ L + L ++ K +G
Sbjct: 60 NLLHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQL-KSYGALTENVTRKYTRQILEG 118
Query: 241 LAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKD------GPEGDKTHVSTRVM 294
+++LH +++RD K +NIL D N KL DFG +K G K+ V
Sbjct: 119 VSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKS-----VT 170
Query: 295 GTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGR 330
GT + +PE + K+D++S G ++EMLT +
Sbjct: 171 GTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 5e-14
Identities = 58/217 (26%), Positives = 96/217 (44%), Gaps = 22/217 (10%)
Query: 129 LGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLI--H 186
LGEG FG V + G +P + VAVK L + L L LI H
Sbjct: 20 LGEGCFGQVVRA--EAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKH 77
Query: 187 PNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLP---------------WSIRM 231
N++ L+G C ++ ++ E+ +G+L L R P P + +
Sbjct: 78 KNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLV 137
Query: 232 KIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVST 291
A A+G+ +L + I+RD N+L+ + K++DFGLA+ + D ++
Sbjct: 138 SCAYQVARGMEYL---ESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTS 194
Query: 292 RVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLT 328
+ APE + T +SDV+SFG+++ E+ T
Sbjct: 195 NGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.6 bits (176), Expect = 5e-14
Identities = 62/211 (29%), Positives = 96/211 (45%), Gaps = 37/211 (17%)
Query: 129 LGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHPN 188
+G G +G VYK A TG VA+K + + + E++ L HPN
Sbjct: 11 IGSGTYGDVYK--------ARDIA-TGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPN 61
Query: 189 LVKLIGCCIEDDQRLLVYEFMPRGSLEN--HLFRRSLPLPWSIRMKIAL---DAAKGLAF 243
+V G + D+ +V E+ GSL++ + R L +IA + KGLA+
Sbjct: 62 IVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSEL-----QIAYVCRETLKGLAY 116
Query: 244 LHEEAEKPVIYRDFKTSNILL--DGEYNAKLSDFGLAKDGPEGDKTHVSTR---VMGTYG 298
LHE I+RD K +NILL DG+ KL+DFG++ T + +GT
Sbjct: 117 LHE---TGKIHRDIKGANILLTEDGD--VKLADFGVS-----AQLTATIAKRKSFIGTPY 166
Query: 299 YAAPEYV---MTGHLTAKSDVYSFGVVLLEM 326
+ APE G K D+++ G+ +E+
Sbjct: 167 WMAPEVAAVERKGGYDGKCDIWALGITAIEL 197
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 6e-14
Identities = 63/217 (29%), Positives = 105/217 (48%), Gaps = 19/217 (8%)
Query: 115 ELKSATKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQG-HKE 173
ELK F LG G G V K KP +GL +A K ++ + +
Sbjct: 1 ELKD--DDFERISELGAGNGGVVTK--------VQHKP-SGLIMARKLIHLEIKPAIRNQ 49
Query: 174 WLAEVNYLGGLIHPNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKI 233
+ E+ L P +V G D + + E M GSL+ + + + +P I K+
Sbjct: 50 IIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLD-QVLKEAKRIPEEILGKV 108
Query: 234 ALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRV 293
++ +GLA+L E+ + +++RD K SNIL++ KL DFG++ G D ++
Sbjct: 109 SIAVLRGLAYLREKHQ--IMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDS--MANSF 162
Query: 294 MGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGR 330
+GT Y +PE + H + +SD++S G+ L+E+ GR
Sbjct: 163 VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGR 199
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 8e-14
Identities = 64/212 (30%), Positives = 91/212 (42%), Gaps = 28/212 (13%)
Query: 129 LGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL---QGHKEWLAEVNYLGGLI 185
LG+GGFG V +A TG A K LN L +G++ + E L +
Sbjct: 1 LGKGGFGEV---------SACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAK-V 50
Query: 186 HPNLVKLIGCCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAK---GL 241
H + + + L LV M G L H++ P + A+ GL
Sbjct: 51 HSRFIVSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGL 110
Query: 242 AFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLA---KDGPEGDKTHVSTRVMGTYG 298
LH+ + +IYRD K N+LLD + N ++SD GLA KDG K + GT G
Sbjct: 111 EHLHQ---RRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYA-----GTPG 162
Query: 299 YAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGR 330
+ APE + D ++ GV L EM+ R
Sbjct: 163 FMAPELLQGEEYDFSVDYFALGVTLYEMIAAR 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 9e-14
Identities = 50/153 (32%), Positives = 71/153 (46%), Gaps = 22/153 (14%)
Query: 186 HPNLVKLIGCCIEDDQRLLVYEFMPRGSLENH--------LFRRSLPLPWSIRMKIALDA 237
+P L L + V EF+ G L H L+R + A +
Sbjct: 55 NPFLTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATF---------YAAEI 105
Query: 238 AKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTY 297
GL FLH K +IYRD K N++LD + + K++DFG+ K+ GD ++ GT
Sbjct: 106 VCGLQFLHS---KGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNR--ASTFCGTP 160
Query: 298 GYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGR 330
Y APE + T D +SFGV+L EML G+
Sbjct: 161 DYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 9e-14
Identities = 75/291 (25%), Positives = 123/291 (42%), Gaps = 40/291 (13%)
Query: 129 LGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLA-EVNYLGGLIHP 187
+G+G FG V+KG N VA+K ++ + + E + E+ L P
Sbjct: 12 IGKGSFGEVFKGIDNRTQQV---------VAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 62
Query: 188 NLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEE 247
+ K G ++ + ++ E++ GS + L R+ P + + KGL +LH E
Sbjct: 63 YVTKYYGSYLKGTKLWIIMEYLGGGSALDLL--RAGPFDEFQIATMLKEILKGLDYLHSE 120
Query: 248 AEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT 307
+ I+RD K +N+LL + + KL+DFG+A G D +GT + APE +
Sbjct: 121 KK---IHRDIKAANVLLSEQGDVKLADFGVA--GQLTDTQIKRNTFVGTPFWMAPEVIQQ 175
Query: 308 GHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRRFYRLIDPCLE 367
+K+D++S G+ +E+ G P L+ P P L
Sbjct: 176 SAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNP-------------PTLT 222
Query: 368 GCFSIKGAEKTIQLAASCLNRDQKARPRMSE------VVEALKPLPYLKDM 412
G FS E +CLN+D RP E +V+ K YL ++
Sbjct: 223 GEFSKPFKEFI----DACLNKDPSFRPTAKELLKHKFIVKNAKKTSYLTEL 269
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 1e-13
Identities = 64/212 (30%), Positives = 103/212 (48%), Gaps = 30/212 (14%)
Query: 129 LGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLA-----EVNYLGG 183
+GEG +G VYKG TG VA+K + L+ +E + E++ L
Sbjct: 8 IGEGTYGVVYKG---------RNKKTGQIVAMKKIR---LESEEEGVPSTAIREISLLKE 55
Query: 184 LIHPNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSI---RMKIAL-DAAK 239
L HPN+V L +++ + L++EF+ L+ +L SLP + +K L +
Sbjct: 56 LQHPNIVCLQDVLMQESRLYLIFEFLSM-DLKKYL--DSLPKGQYMDAELVKSYLYQILQ 112
Query: 240 GLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGY 299
G+ F H + V++RD K N+L+D + KL+DFGLA+ G V T + T Y
Sbjct: 113 GILFCHS---RRVLHRDLKPQNLLIDNKGVIKLADFGLAR--AFGIPVRVYTHEVVTLWY 167
Query: 300 AAPEYVMTGHLTAKS-DVYSFGVVLLEMLTGR 330
APE ++ + D++S G + EM T +
Sbjct: 168 RAPEVLLGSPRYSTPVDIWSIGTIFAEMATKK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 2e-13
Identities = 70/207 (33%), Positives = 94/207 (45%), Gaps = 21/207 (10%)
Query: 128 LLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEW---LAEVN-YLGG 183
++G+G FG V ++G AVK L + KE +AE N L
Sbjct: 2 VIGKGSFGKVLLAKRKLDGKC---------YAVKVLQKKIVLNRKEQKHIMAERNVLLKN 52
Query: 184 LIHPNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFR-RSLPLPWSIRMKIALDAAKGLA 242
+ HP LV L ++ V +F+ G L HL R RS P P + R A + A L
Sbjct: 53 VKHPFLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRA-RFYAA-EIASALG 110
Query: 243 FLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAP 302
+LH ++YRD K NILLD + + L+DFGL K+G T +T GT Y AP
Sbjct: 111 YLHS---INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDT--TTTFCGTPEYLAP 165
Query: 303 EYVMTGHLTAKSDVYSFGVVLLEMLTG 329
E + D + G VL EML G
Sbjct: 166 EVIRKQPYDNTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 2e-13
Identities = 71/265 (26%), Positives = 116/265 (43%), Gaps = 51/265 (19%)
Query: 75 PVVPIGSSSTTSNAESTT-PSTPKIGEELKISPQLRKFSFNELKSATKSFRPECLLGEGG 133
P SSS++S++ S + PS K S +EL+ + +G G
Sbjct: 48 PPPSSSSSSSSSSSASGSAPSAAK--------------SLSELERVNR-------IGSGA 86
Query: 134 FGCVYKGWINMNGTATVKPGTGLPVAVKTL--NHDGLQGHKEWLAEVNYLGGLIHPNLVK 191
G VYK + TG A+K + NH+ ++ E+ L + HPN+VK
Sbjct: 87 GGTVYK---------VIHRPTGRLYALKVIYGNHED-TVRRQICREIEILRDVNHPNVVK 136
Query: 192 LIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKP 251
+ + ++ EFM GSLE L +A G+A+LH +
Sbjct: 137 CHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLA-----DVARQILSGIAYLHR---RH 188
Query: 252 VIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEG-DKTHVSTRVMGTYGYAAPEYVMTGHL 310
+++RD K SN+L++ N K++DFG+++ + D + S +GT Y +PE + T
Sbjct: 189 IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSS---VGTIAYMSPERINTDLN 245
Query: 311 TAK-----SDVYSFGVVLLEMLTGR 330
D++S GV +LE GR
Sbjct: 246 HGAYDGYAGDIWSLGVSILEFYLGR 270
|
Length = 353 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 2e-13
Identities = 66/219 (30%), Positives = 98/219 (44%), Gaps = 23/219 (10%)
Query: 122 SFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKE---WLAEV 178
F +LG+G FG V A K GT A+K L D + + + E
Sbjct: 1 DFNFLMVLGKGSFGKVM--------LAERK-GTDELYAIKILKKDVVIQDDDVECTMVEK 51
Query: 179 NYLGGLIHPNLVKLIGCCIEDDQRL-LVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALD 236
L P + + C + RL V E++ G L H+ + P ++ A +
Sbjct: 52 RVLALQDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFY--AAE 109
Query: 237 AAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVM-G 295
+ GL FLH + +IYRD K N++LD E + K++DFG+ K E V+TR G
Sbjct: 110 ISVGLFFLHR---RGIIYRDLKLDNVMLDSEGHIKIADFGMCK---EHMVDGVTTRTFCG 163
Query: 296 TYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMD 334
T Y APE + D +++GV+L EML G+ D
Sbjct: 164 TPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 2e-13
Identities = 83/296 (28%), Positives = 118/296 (39%), Gaps = 34/296 (11%)
Query: 122 SFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQ---GHKEWLAEV 178
+FR +LG+GGFG V A TG A K L ++ G L E
Sbjct: 1 TFRQYRVLGKGGFGEV---------CACQVRATGKMYACKRLEKKRIKKRKGESMALNEK 51
Query: 179 NYLGGLIHPNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKI-ALDA 237
L + +V L D LV M G L+ H++ P R A +
Sbjct: 52 QILEKVNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEI 111
Query: 238 AKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTY 297
GL LH E +YRD K NILLD + ++SD GLA PEG+ + RV GT
Sbjct: 112 LCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES--IRGRV-GTV 165
Query: 298 GYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRR 357
GY APE + T D + G ++ EM+ G+ + + V+ RR
Sbjct: 166 GYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVD---------RR 216
Query: 358 FYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEA-LKPLPYLKDM 412
E +S K +E+ + L +D K R E +K P+ ++M
Sbjct: 217 VLE-----TEEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNM 267
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 3e-13
Identities = 66/213 (30%), Positives = 104/213 (48%), Gaps = 28/213 (13%)
Query: 129 LGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHD----GLQGHKEWLAEVNYLGGL 184
+GEG +G VYK A K TG VA+K + D G+ + E++ L L
Sbjct: 8 IGEGTYGVVYK--------ARNKL-TGEVVALKKIRLDTETEGVPSTA--IREISLLKEL 56
Query: 185 IHPNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLP---LPWSIRMKIALDAAKGL 241
HPN+VKL+ +++ LV+EF+ + F + P +P + +GL
Sbjct: 57 NHPNIVKLLDVIHTENKLYLVFEFL---HQDLKKFMDASPLSGIPLPLIKSYLFQLLQGL 113
Query: 242 AFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAA 301
AF H V++RD K N+L++ E KL+DFGLA+ G T + T Y A
Sbjct: 114 AFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLAR--AFGVPVRTYTHEVVTLWYRA 168
Query: 302 PEYVM-TGHLTAKSDVYSFGVVLLEMLTGRRSM 333
PE ++ + + D++S G + EM+T RR++
Sbjct: 169 PEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 69.8 bits (170), Expect = 3e-13
Identities = 68/260 (26%), Positives = 120/260 (46%), Gaps = 29/260 (11%)
Query: 129 LGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHPN 188
+G+G G V+ TA TG VA+K +N + + E+ + L +PN
Sbjct: 27 IGQGASGTVF--------TAI-DVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPN 77
Query: 189 LVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL---DAAKGLAFLH 245
+V + + D+ +V E++ GSL + + + +IA + + L FLH
Sbjct: 78 IVNFLDSFLVGDELFVVMEYLAGGSLTDVVTETCMD-----EAQIAAVCRECLQALEFLH 132
Query: 246 EEAEKPVIYRDFKTSNILLDGEYNAKLSDFGL-AKDGPEGDKTHVSTRVMGTYGYAAPEY 304
VI+RD K+ N+LL + + KL+DFG A+ PE K + ++GT + APE
Sbjct: 133 ANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK---RSTMVGTPYWMAPEV 186
Query: 305 VMTGHLTAKSDVYSFGVVLLEMLTGRRS-MDKNRPNGEHNLVEWARPQLGERRR----FY 359
V K D++S G++ +EM+ G +++N + + P+L + F
Sbjct: 187 VTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFR 246
Query: 360 RLIDPCLEGCFSIKGAEKTI 379
++ CLE +G+ K +
Sbjct: 247 DFLNRCLEMDVEKRGSAKEL 266
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 3e-13
Identities = 70/229 (30%), Positives = 97/229 (42%), Gaps = 19/229 (8%)
Query: 122 SFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQ---GHKEWLAEV 178
+FR +LG+GGFG V A TG A K L ++ G L E
Sbjct: 1 TFRQYRVLGKGGFGEV---------CACQVRATGKMYACKKLEKKRIKKRKGESMALNEK 51
Query: 179 NYLGGLIHPNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALDA 237
L + +V L D LV M G L+ H++ + A +
Sbjct: 52 QILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEI 111
Query: 238 AKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTY 297
GL LH+E ++YRD K NILLD + ++SD GLA PEG + RV GT
Sbjct: 112 CCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT--IKGRV-GTV 165
Query: 298 GYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVE 346
GY APE V T D ++ G +L EM+ G+ + + + VE
Sbjct: 166 GYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVE 214
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 4e-13
Identities = 46/144 (31%), Positives = 79/144 (54%), Gaps = 7/144 (4%)
Query: 187 PNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHE 246
P +V G D + + E M GSL+ + +++ +P I K+++ KGL +L E
Sbjct: 63 PYIVGFYGAFYSDGEISICMEHMDGGSLD-QVLKKAGRIPEQILGKVSIAVIKGLTYLRE 121
Query: 247 EAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM 306
+ + +++RD K SNIL++ KL DFG++ G D ++ +GT Y +PE +
Sbjct: 122 KHK--IMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDS--MANSFVGTRSYMSPERLQ 175
Query: 307 TGHLTAKSDVYSFGVVLLEMLTGR 330
H + +SD++S G+ L+EM GR
Sbjct: 176 GTHYSVQSDIWSMGLSLVEMAIGR 199
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 69.9 bits (172), Expect = 4e-13
Identities = 62/228 (27%), Positives = 95/228 (41%), Gaps = 55/228 (24%)
Query: 128 LLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNH--DGLQGHKEWLAEVNYLGGLI 185
+G G +G V V TG VA+K +++ D L K L E+ L L
Sbjct: 7 PIGSGAYGVVCSA---------VDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLR 57
Query: 186 HPNLVKLIGCCIEDDQRL------LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAA- 238
H N++ L+ + +V E M E L + I+ L
Sbjct: 58 HENIIGLLDI-LRPPSPEDFNDVYIVTELM-----ETDLHK-------VIKSPQPLTDDH 104
Query: 239 ---------KGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAK-DGPEGDKT- 287
+GL +LH VI+RD K SNIL++ + K+ DFGLA+ P+ D+
Sbjct: 105 IQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKG 161
Query: 288 ----HVSTRVMGTYGYAAPEYVMTG-HLTAKSDVYSFGVVLLEMLTGR 330
+V TR Y APE +++ T D++S G + E+LT +
Sbjct: 162 FLTEYVVTRW-----YRAPELLLSSSRYTKAIDIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 5e-13
Identities = 67/221 (30%), Positives = 98/221 (44%), Gaps = 39/221 (17%)
Query: 129 LGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEW-----LAEVNYLGG 183
+GEG +G VYK TG VA+K + L KE + E+ L
Sbjct: 15 IGEGTYGQVYKA---------RDKDTGELVALKKVR---LDNEKEGFPITAIREIKILRQ 62
Query: 184 LIHPNLVKLIGCCIEDDQRL----------LVYEFMPR---GSLENHLFRRSLPLPWSIR 230
L H N+V L + L LV+E+M G LE+ L S S
Sbjct: 63 LNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSF- 121
Query: 231 MKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVS 290
MK L+ GL + H+ K ++RD K SNILL+ + KL+DFGLA+ + +
Sbjct: 122 MKQLLE---GLNYCHK---KNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYT 175
Query: 291 TRVMGTYGYAAPEYVMTGHLTAKS-DVYSFGVVLLEMLTGR 330
+V+ T Y PE ++ + DV+S G +L E+ T +
Sbjct: 176 NKVI-TLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKK 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 6e-13
Identities = 51/152 (33%), Positives = 73/152 (48%), Gaps = 20/152 (13%)
Query: 187 PNLVKLIGCCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPW----SIRMKIALDAAKGL 241
P +V+L C +DD+ L +V E+MP G L N + +P W + + +ALDA +
Sbjct: 103 PWVVQLF-CAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHSM 161
Query: 242 AFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAA 301
+H RD K N+LLD + KL+DFG E T V GT Y +
Sbjct: 162 GLIH---------RDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAV-GTPDYIS 211
Query: 302 PEYVMT----GHLTAKSDVYSFGVVLLEMLTG 329
PE + + G+ + D +S GV L EML G
Sbjct: 212 PEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 6e-13
Identities = 66/225 (29%), Positives = 101/225 (44%), Gaps = 26/225 (11%)
Query: 128 LLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL---QGHKEWLAEVNYLGGL 184
++G GGFG VY K TG A+K L+ + QG L E L L
Sbjct: 1 IIGRGGFGEVY---------GCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLS-L 50
Query: 185 IHPNLVKLIGCCI----EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKG 240
+ I C D+ + + M G L HL + + +R A + G
Sbjct: 51 VSTGDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRF-YATEIILG 109
Query: 241 LAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYA 300
L +H + V+YRD K +NILLD + ++SD GLA D + K H S +GT+GY
Sbjct: 110 LEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSK-KKPHAS---VGTHGYM 162
Query: 301 APEYVMTG-HLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNL 344
APE + G + +D +S G +L ++L G +++ +H +
Sbjct: 163 APEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI 207
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 7e-13
Identities = 64/214 (29%), Positives = 101/214 (47%), Gaps = 31/214 (14%)
Query: 128 LLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTL--NHDGLQGHKEWLA---EVNYLG 182
LLG G FG VY + TG +AVK + + D + KE A E+ L
Sbjct: 9 LLGRGAFGEVYLCY---------DADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLK 59
Query: 183 GLIHPNLVKLIGCCIEDDQRLL--VYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKG 240
L H +V+ GC + +++ L E+MP GS+++ L + L ++ + +G
Sbjct: 60 NLRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQL-KAYGALTENVTRRYTRQILQG 118
Query: 241 LAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKD------GPEGDKTHVSTRVM 294
+++LH +++RD K +NIL D N KL DFG +K G K+ V
Sbjct: 119 VSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKS-----VT 170
Query: 295 GTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLT 328
GT + +PE + K+DV+S ++EMLT
Sbjct: 171 GTPYWMSPEVISGEGYGRKADVWSVACTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 7e-13
Identities = 69/213 (32%), Positives = 95/213 (44%), Gaps = 19/213 (8%)
Query: 122 SFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHK-EWLA--EV 178
+FR +LG+GGFG V A TG A K L ++ K E +A E
Sbjct: 1 TFRHYRVLGKGGFGEV---------CACQVRATGKMYACKKLEKKRIKKRKGEAMALNEK 51
Query: 179 NYLGGLIHPNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLP-LPWSIRMKIALDA 237
L + +V L D LV M G L+ H++ P + A +
Sbjct: 52 QILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEI 111
Query: 238 AKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTY 297
GL LH E ++YRD K NILLD + ++SD GLA + PEG+ + RV GT
Sbjct: 112 TCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET--IRGRV-GTV 165
Query: 298 GYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGR 330
GY APE V T D + G ++ EM+ G+
Sbjct: 166 GYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGK 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 69.1 bits (170), Expect = 7e-13
Identities = 53/160 (33%), Positives = 76/160 (47%), Gaps = 30/160 (18%)
Query: 186 HPNLVKLIGCCIEDDQR--LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAK---- 239
HPN+VKL+ ++ + LV+E+M E L IR I D K
Sbjct: 66 HPNIVKLLNVIKAENDKDIYLVFEYM-----ETDLHA-------VIRANILEDVHKRYIM 113
Query: 240 -----GLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAK---DGPEGDKTHVST 291
L ++H VI+RD K SNILL+ + KL+DFGLA+ + E + V T
Sbjct: 114 YQLLKALKYIHS-GN--VIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLT 170
Query: 292 RVMGTYGYAAPEYVMTGHLTAKS-DVYSFGVVLLEMLTGR 330
+ T Y APE ++ K D++S G +L EML G+
Sbjct: 171 DYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.5 bits (168), Expect = 1e-12
Identities = 61/232 (26%), Positives = 95/232 (40%), Gaps = 62/232 (26%)
Query: 130 GEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQG---HKEWLAEVNYLGGLIH 186
G G +G VYK G A+K D Q + E+ L L H
Sbjct: 9 GRGTYGRVYKAK-------RKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKH 61
Query: 187 PNLVKLIGCCIEDDQRL--LVYEFMPRGSLENHLF----------RRSLP------LPWS 228
N+V L+ +E + L++++ E+ L+ R S+P L W
Sbjct: 62 ENVVSLVEVFLEHADKSVYLLFDYA-----EHDLWQIIKFHRQAKRVSIPPSMVKSLLWQ 116
Query: 229 IRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNA----KLSDFGLAK--DGP 282
I L+ G+ +LH V++RD K +NIL+ GE K+ D GLA+ + P
Sbjct: 117 I-----LN---GVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAP 165
Query: 283 -----EGDKTHVSTRVMGTYGYAAPEYVMTG-HLTAKSDVYSFGVVLLEMLT 328
+ D V+ T Y APE ++ H T D+++ G + E+LT
Sbjct: 166 LKPLADLDP------VVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 1e-12
Identities = 65/210 (30%), Positives = 98/210 (46%), Gaps = 26/210 (12%)
Query: 129 LGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTL----NHDGLQGHKEWLAEVNYLGGL 184
+GEG +G VY+ T +G VA+K + DG+ L E+ L L
Sbjct: 15 IGEGTYGIVYRA------RDTT---SGEIVALKKVRMDNERDGIPISS--LREITLLLNL 63
Query: 185 IHPNLVKLIGCCIED--DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLA 242
HPN+V+L + D LV E+ + L + L P S + L +GL
Sbjct: 64 RHPNIVELKEVVVGKHLDSIFLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQ 122
Query: 243 FLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAP 302
+LHE +I+RD K SN+LL + K++DFGLA+ G T + T Y AP
Sbjct: 123 YLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLAR--TYGLPAKPMTPKVVTLWYRAP 177
Query: 303 EYV--MTGHLTAKSDVYSFGVVLLEMLTGR 330
E + T + TA D+++ G +L E+L +
Sbjct: 178 ELLLGCTTYTTA-IDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 1e-12
Identities = 65/206 (31%), Positives = 90/206 (43%), Gaps = 17/206 (8%)
Query: 128 LLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKE---WLAEVNYLGGL 184
LLG+G FG V + TG A+K L + + E L E L
Sbjct: 2 LLGKGTFGKV---------ILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS 52
Query: 185 IHPNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFL 244
HP L L D+ V E+ G L HL R + R A + L +L
Sbjct: 53 RHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGA-EIVSALDYL 111
Query: 245 HEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEY 304
H +EK V+YRD K N++LD + + K++DFGL K+G + T + GT Y APE
Sbjct: 112 H--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT--FCGTPEYLAPEV 167
Query: 305 VMTGHLTAKSDVYSFGVVLLEMLTGR 330
+ D + GVV+ EM+ GR
Sbjct: 168 LEDNDYGRAVDWWGLGVVMYEMMCGR 193
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 1e-12
Identities = 61/175 (34%), Positives = 82/175 (46%), Gaps = 10/175 (5%)
Query: 159 AVKTLNHDGLQGHKEW---LAEVN-YLGGLIHPNLVKLIGCCIEDDQRLLVYEFMPRGSL 214
AVK L + KE +AE N L L HP LV L ++ V +++ G L
Sbjct: 24 AVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGGEL 83
Query: 215 ENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSD 274
HL R L R A + A + +LH +IYRD K NILLD + + L+D
Sbjct: 84 FFHLQRERCFLEPRARF-YAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTD 139
Query: 275 FGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTG 329
FGL K+G E ++T ++ GT Y APE + D + G VL EML G
Sbjct: 140 FGLCKEGVEPEET--TSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 1e-12
Identities = 59/213 (27%), Positives = 97/213 (45%), Gaps = 29/213 (13%)
Query: 128 LLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHP 187
+LG+G +G VY A T + +A+K + + + E+ L H
Sbjct: 15 VLGKGTYGIVY---------AARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHR 65
Query: 188 NLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKI--ALDAAKGLAFLH 245
N+V+ +G E+ + E +P GSL L + PL + + I +GL +LH
Sbjct: 66 NIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLH 125
Query: 246 EEAEKPVIYRDFKTSNILLDGEYNA--KLSDFG----LAKDGPEGDKTHVSTRVMGTYGY 299
+ +++RD K N+L++ Y+ K+SDFG LA P + GT Y
Sbjct: 126 DNQ---IVHRDIKGDNVLVN-TYSGVVKISDFGTSKRLAGINP------CTETFTGTLQY 175
Query: 300 AAPEYVMTGH--LTAKSDVYSFGVVLLEMLTGR 330
APE + G A +D++S G ++EM TG+
Sbjct: 176 MAPEVIDKGPRGYGAPADIWSLGCTIVEMATGK 208
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 2e-12
Identities = 48/148 (32%), Positives = 70/148 (47%), Gaps = 27/148 (18%)
Query: 195 CCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSI----RMKIALDAAKGLAFLHEEAE 249
+DD+ L +V E+MP G L N + +P W+ + +ALDA + F+H
Sbjct: 110 YAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPEKWARFYTAEVVLALDAIHSMGFIH---- 165
Query: 250 KPVIYRDFKTSNILLDGEYNAKLSDFG----LAKDGPEGDKTHVSTRVMGTYGYAAPEYV 305
RD K N+LLD + KL+DFG + +G T V GT Y +PE +
Sbjct: 166 -----RDVKPDNMLLDKSGHLKLADFGTCMKMDANG----MVRCDTAV-GTPDYISPEVL 215
Query: 306 MT----GHLTAKSDVYSFGVVLLEMLTG 329
+ G+ + D +S GV L EML G
Sbjct: 216 KSQGGDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 2e-12
Identities = 66/257 (25%), Positives = 116/257 (45%), Gaps = 23/257 (8%)
Query: 129 LGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHPN 188
+G+G G VY + TG VA+K +N + + E+ + +PN
Sbjct: 27 IGQGASGTVY---------TAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPN 77
Query: 189 LVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEA 248
+V + + D+ +V E++ GSL + + + + + + L FLH
Sbjct: 78 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMD--EGQIAAVCRECLQALDFLHSNQ 135
Query: 249 EKPVIYRDFKTSNILLDGEYNAKLSDFGL-AKDGPEGDKTHVSTRVMGTYGYAAPEYVMT 307
VI+RD K+ NILL + + KL+DFG A+ PE K + ++GT + APE V
Sbjct: 136 ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK---RSTMVGTPYWMAPEVVTR 189
Query: 308 GHLTAKSDVYSFGVVLLEMLTGRRS-MDKNRPNGEHNLVEWARPQLGERRR----FYRLI 362
K D++S G++ +EM+ G +++N + + P+L R F +
Sbjct: 190 KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRDFL 249
Query: 363 DPCLEGCFSIKGAEKTI 379
+ CLE +G+ K +
Sbjct: 250 NRCLEMDVDRRGSAKEL 266
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 67.0 bits (164), Expect = 2e-12
Identities = 79/307 (25%), Positives = 116/307 (37%), Gaps = 65/307 (21%)
Query: 128 LLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTL--NHDGLQGHKEWLAEVNYLGGLI 185
L+GEG +G V K TG VA+K + D K + E+ L L
Sbjct: 8 LVGEGSYGMVMK---------CKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLR 58
Query: 186 HPNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLH 245
H NLV LI + LV+EF+ L + L + L S K +G+ F H
Sbjct: 59 HENLVNLIEVFRRKKRLYLVFEFVDHTVL-DDLEKYPNGLDESRVRKYLFQILRGIEFCH 117
Query: 246 EEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAK--DGPEGDKT-HVSTRVMGTYGYAAP 302
+I+RD K NIL+ KL DFG A+ P T +V+TR Y AP
Sbjct: 118 SHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATR-----WYRAP 169
Query: 303 EYVMTGHLTAKS-DVYSFGVVLLEMLTG---------------------------RRSMD 334
E ++ ++ D+++ G ++ EMLTG +
Sbjct: 170 ELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQ 229
Query: 335 KNRPNGEHNLVEWARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARP 394
KN L E + +RF +L + + LA CL D RP
Sbjct: 230 KNPLFAGMRLPE-VKEIEPLEKRFPKL-------------SGLVLDLAKQCLRIDPDDRP 275
Query: 395 RMSEVVE 401
S+++
Sbjct: 276 SSSQLLH 282
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 3e-12
Identities = 69/222 (31%), Positives = 96/222 (43%), Gaps = 23/222 (10%)
Query: 122 SFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQ---GHKEWLAEV 178
+FR +LG+GGFG V A TG A K L ++ G L E
Sbjct: 1 TFRHYRVLGKGGFGEV---------CACQVRATGKMYACKKLEKKRIKKRKGEAMALNEK 51
Query: 179 NYLGGLIHPNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAA 238
L + +V L D LV M G L+ H++ ++ P + AA
Sbjct: 52 RILEKVNSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIY--NMGNPGFDEQRAIFYAA 109
Query: 239 K---GLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMG 295
+ GL L E ++YRD K NILLD + ++SD GLA PEG+ V RV G
Sbjct: 110 ELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET--VRGRV-G 163
Query: 296 TYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNR 337
T GY APE + T D + G ++ EM+ G+ K +
Sbjct: 164 TVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRK 205
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 4e-12
Identities = 49/154 (31%), Positives = 74/154 (48%), Gaps = 18/154 (11%)
Query: 187 PNLVKLIGCCIEDDQRLLVYEFMPRGSLENHL-----FRRSLPLPWSIRMKIALDAAKGL 241
P L +L C D+ V E++ G L + F+ + ++ + I GL
Sbjct: 61 PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAI------GL 114
Query: 242 AFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVM-GTYGYA 300
FLH K +IYRD K N++LD E + K++DFG+ K E V+T+ GT Y
Sbjct: 115 FFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCK---ENMWDGVTTKTFCGTPDYI 168
Query: 301 APEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMD 334
APE + D ++FGV+L EML G+ +
Sbjct: 169 APEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 5e-12
Identities = 62/206 (30%), Positives = 87/206 (42%), Gaps = 18/206 (8%)
Query: 128 LLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKE---WLAEVNYLGGL 184
LLG+G FG V + TG A+K L + + E + E L
Sbjct: 2 LLGKGTFGKV---------ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT 52
Query: 185 IHPNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFL 244
HP L L D+ V E+ G L HL R + R A + L +L
Sbjct: 53 RHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGA-EIVSALEYL 111
Query: 245 HEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEY 304
H + V+YRD K N++LD + + K++DFGL K+G T + GT Y APE
Sbjct: 112 HS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT--FCGTPEYLAPEV 166
Query: 305 VMTGHLTAKSDVYSFGVVLLEMLTGR 330
+ D + GVV+ EM+ GR
Sbjct: 167 LEDNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 6e-12
Identities = 55/204 (26%), Positives = 92/204 (45%), Gaps = 17/204 (8%)
Query: 151 KPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHPNLVKLIGCCIEDDQRLLVYEFMP 210
KPG PV +K G +G L E L + HP+++++ + +V +P
Sbjct: 87 KPGQPDPVVLKI----GQKGTT--LIEAMLLQNVNHPSVIRMKDTLVSGAITCMV---LP 137
Query: 211 --RGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEY 268
L +L +RS PLP + I +GL +LH + +I+RD KT NI ++
Sbjct: 138 HYSSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVD 194
Query: 269 NAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLT 328
+ D G A+ P + + GT APE + +K+D++S G+VL EML
Sbjct: 195 QVCIGDLGAAQ-FPVVAPAFLG--LAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLA 251
Query: 329 GRRSMDKNRPNGEHNLVEWARPQL 352
++ ++ P+ V+ L
Sbjct: 252 YPSTIFEDPPSTPEEYVKSCHSHL 275
|
Length = 357 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 7e-12
Identities = 53/211 (25%), Positives = 96/211 (45%), Gaps = 20/211 (9%)
Query: 122 SFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL---QGHKEWLAEV 178
+F+ E +G G F VY+ ++ PVA+K + + + ++ + E+
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRK---------PVALKKVQIFEMMDAKARQDCVKEI 53
Query: 179 NYLGGLIHPNLVKLIGCCIEDDQRLLVYEFMPRGSLEN---HLFRRSLPLPWSIRMKIAL 235
+ L L HPN++K + IED++ +V E G L + ++ +P K +
Sbjct: 54 DLLKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFV 113
Query: 236 DAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMG 295
+ +H + V++RD K +N+ + KL D GL + KT + ++G
Sbjct: 114 QLCSAVEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFF--SSKTTAAHSLVG 168
Query: 296 TYGYAAPEYVMTGHLTAKSDVYSFGVVLLEM 326
T Y +PE + KSD++S G +L EM
Sbjct: 169 TPYYMSPERIHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 7e-12
Identities = 78/310 (25%), Positives = 129/310 (41%), Gaps = 55/310 (17%)
Query: 129 LGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHPN 188
+GEG G V ATVK +G VAVK ++ Q + EV + H N
Sbjct: 28 IGEGSTGIVC--------IATVK-SSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHEN 78
Query: 189 LVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK------IALDAAKGLA 242
+V++ + D+ +V EF+ G+L + + RM + L K L+
Sbjct: 79 VVEMYNSYLVGDELWVVMEFLEGGALTD--------IVTHTRMNEEQIAAVCLAVLKALS 130
Query: 243 FLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFG----LAKDGPEGDKTHVSTRVMGTYG 298
LH + VI+RD K+ +ILL + KLSDFG ++K+ P ++GT
Sbjct: 131 VLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR------RKSLVGTPY 181
Query: 299 YAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRRF 358
+ APE + + D++S G++++EM+ G P ++ R L + +
Sbjct: 182 WMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI---RDNLPPKLKN 238
Query: 359 YRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDMASSSSY 418
+ P L+G L RD R +E+++ P+L S
Sbjct: 239 LHKVSPSLKGFLD------------RLLVRDPAQRATAAELLKH----PFLAKAGPPSCI 282
Query: 419 VQAMQAERVR 428
V M+ R+R
Sbjct: 283 VPLMRQNRMR 292
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 8e-12
Identities = 64/252 (25%), Positives = 99/252 (39%), Gaps = 58/252 (23%)
Query: 128 LLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQG----HKEWLAEVNYLGG 183
L+G+GG G VY + P VA+K + D L K +L E
Sbjct: 9 LIGKGGMGEVYLAY---------DPVCSRRVALKKIRED-LSENPLLKKRFLREAKIAAD 58
Query: 184 LIHPNLVKLIGCCIEDDQRLLVYEFMP--RGSLENHLFR-----RSLPLPWSIR------ 230
LIHP +V + C + D VY MP G L + SL + +
Sbjct: 59 LIHPGIVPVYSICSDGD---PVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAF 115
Query: 231 MKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLA--KDGPEGDKTH 288
+ I + ++H K V++RD K NILL + D+G A K E D
Sbjct: 116 LSIFHKICATIEYVHS---KGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLD 172
Query: 289 VST--------------RVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLT------ 328
+ +++GT Y APE ++ + +D+Y+ GV+L +MLT
Sbjct: 173 IDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYR 232
Query: 329 ---GRRSMDKNR 337
GR+ ++
Sbjct: 233 RKKGRKISYRDV 244
|
Length = 932 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 65.5 bits (159), Expect = 8e-12
Identities = 55/202 (27%), Positives = 95/202 (47%), Gaps = 18/202 (8%)
Query: 129 LGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHPN 188
+G+G G VY + TG VA++ +N + + E+ + +PN
Sbjct: 28 IGQGASGTVY---------TAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 189 LVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEA 248
+V + + D+ +V E++ GSL + + + + + + L FLH
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMD--EGQIAAVCRECLQALEFLHSNQ 136
Query: 249 EKPVIYRDFKTSNILLDGEYNAKLSDFGL-AKDGPEGDKTHVSTRVMGTYGYAAPEYVMT 307
VI+RD K+ NILL + + KL+DFG A+ PE K + ++GT + APE V
Sbjct: 137 ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK---RSTMVGTPYWMAPEVVTR 190
Query: 308 GHLTAKSDVYSFGVVLLEMLTG 329
K D++S G++ +EM+ G
Sbjct: 191 KAYGPKVDIWSLGIMAIEMIEG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.0 bits (159), Expect = 1e-11
Identities = 60/211 (28%), Positives = 97/211 (45%), Gaps = 29/211 (13%)
Query: 129 LGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEW-----LAEVNYLGG 183
+GEG +G VYK + G VA+K + L+ E + E++ L
Sbjct: 7 IGEGTYGVVYKARDKLTGEI---------VALKKIR---LETEDEGVPSTAIREISLLKE 54
Query: 184 LIHPNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLP---LPWSIRMKIALDAAKG 240
L HPN+V+L+ +++ LV+EF+ L+ + S P L + +G
Sbjct: 55 LNHPNIVRLLDVVHSENKLYLVFEFL---DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQG 111
Query: 241 LAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYA 300
+A+ H V++RD K N+L+D E KL+DFGLA+ G T + T Y
Sbjct: 112 IAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLAR--AFGVPVRTYTHEVVTLWYR 166
Query: 301 APEYVMTG-HLTAKSDVYSFGVVLLEMLTGR 330
APE ++ + D++S G + EM+ R
Sbjct: 167 APEILLGSRQYSTPVDIWSIGCIFAEMVNRR 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 1e-11
Identities = 69/255 (27%), Positives = 97/255 (38%), Gaps = 56/255 (21%)
Query: 129 LGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNY-------L 181
+G+GG+G V+ K TG VA+K + L L EV + L
Sbjct: 9 VGQGGYGQVF---------LAKKKDTGEIVALKRMKKSLLF----KLNEVRHVLTERDIL 55
Query: 182 GGLIHPNLVKLIGCCIEDDQRL-LVYEFMP----------RGSLENHLFRRSLPLPWSIR 230
LVKL+ +DD+ L L E++P G L R +
Sbjct: 56 TTTKSEWLVKLL-YAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYM-----AE 109
Query: 231 MKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVS 290
M A+DA L ++H RD K N L+D + KL+DFGL+K +
Sbjct: 110 MFEAVDALHELGYIH---------RDLKPENFLIDASGHIKLTDFGLSKGIVT-----YA 155
Query: 291 TRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEH-NLVEWA- 348
V+G+ Y APE + D +S G +L E L G + PN NL W
Sbjct: 156 NSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKE 215
Query: 349 ---RPQLGERRRFYR 360
RP + R
Sbjct: 216 TLQRPVYDDPRFNLS 230
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 2e-11
Identities = 49/184 (26%), Positives = 83/184 (45%), Gaps = 19/184 (10%)
Query: 157 PVAVKTLNHDGLQGHKEWLA----EVNYLGGLIHPNLVKLIGCCIEDDQRL----LVYEF 208
V ++T +GHK + E+ L + N++K+ G I+ L L+ E+
Sbjct: 45 EVIIRTFKKFH-KGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103
Query: 209 MPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEY 268
RG L L + L + ++ +A+D KGL L++ KP Y++ + + L+ Y
Sbjct: 104 CTRGYLREVL-DKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKP--YKNLTSVSFLVTENY 160
Query: 269 NAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT--GHLTAKSDVYSFGVVLLEM 326
K+ GL K +V+ V Y + + + T K D+YS GVVL E+
Sbjct: 161 KLKIICHGLEKILSSPPFKNVNFMV-----YFSYKMLNDIFSEYTIKDDIYSLGVVLWEI 215
Query: 327 LTGR 330
TG+
Sbjct: 216 FTGK 219
|
Length = 283 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 2e-11
Identities = 67/228 (29%), Positives = 105/228 (46%), Gaps = 32/228 (14%)
Query: 128 LLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHK-EWLAEVNYLGGLIH 186
++G GGFG VY K TG A+K L+ ++ + E LA L I
Sbjct: 1 IIGRGGFGEVY---------GCRKADTGKMYAMKCLDKKRIKMKQGETLA----LNERIM 47
Query: 187 PNLVKLIGC----CIE-----DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDA 237
+LV C C+ D+ + + M G L HL + + +R A +
Sbjct: 48 LSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRF-YAAEI 106
Query: 238 AKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTY 297
GL +H + V+YRD K +NILLD + ++SD GLA D + K H S +GT+
Sbjct: 107 ILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSK-KKPHAS---VGTH 159
Query: 298 GYAAPEYVMTG-HLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNL 344
GY APE + G + +D +S G +L ++L G +++ +H +
Sbjct: 160 GYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI 207
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 2e-11
Identities = 64/214 (29%), Positives = 98/214 (45%), Gaps = 28/214 (13%)
Query: 129 LGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHD-GLQGHKEWLAEVNYLGGLIHP 187
+G G FG V G +N T V VK L +Q ++L E L H
Sbjct: 3 IGNGWFGKVILGEVNSGYTPA-------QVVVKELRVSASVQEQMKFLEEAQPYRSLQHS 55
Query: 188 NLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRS-------LPLPWSIRMKIALDAAKG 240
NL++ +G C E LLV EF P G L+ +L RS P P +++ ++A + A G
Sbjct: 56 NLLQCLGQCTEVTPYLLVMEFCPLGDLKGYL--RSCRKAELMTPDPTTLQ-RMACEIALG 112
Query: 241 LAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYA 300
L LH+ I+ D N LL + K+ D+GL+ + + D ++ +
Sbjct: 113 LLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWI 169
Query: 301 APEYV--MTGHL-----TAKSDVYSFGVVLLEML 327
APE V + G+L T +S+V+S GV + E+
Sbjct: 170 APELVDEVHGNLLVVDQTKESNVWSLGVTIWELF 203
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 64.2 bits (157), Expect = 2e-11
Identities = 63/225 (28%), Positives = 101/225 (44%), Gaps = 48/225 (21%)
Query: 126 ECL--LGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKE-----WLAEV 178
E L + EG +G VY+ + TG VA+K L + KE L E+
Sbjct: 8 EKLNRIEEGTYGVVYRA---RDKK------TGEIVALKKLKMEK---EKEGFPITSLREI 55
Query: 179 NYLGGLIHPNLVKL----IGCCIEDDQRLLVYEFMP---RGSLENHLFRRSLPLPWSIR- 230
N L L HPN+V + +G + D+ +V E++ + +E P+
Sbjct: 56 NILLKLQHPNIVTVKEVVVGSNL--DKIYMVMEYVEHDLKSLMETM------KQPFLQSE 107
Query: 231 ----MKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDK 286
M L G+A LH+ +++RD KTSN+LL+ K+ DFGLA+ G
Sbjct: 108 VKCLMLQLLS---GVAHLHD---NWILHRDLKTSNLLLNNRGILKICDFGLAR--EYGSP 159
Query: 287 THVSTRVMGTYGYAAPEYVM-TGHLTAKSDVYSFGVVLLEMLTGR 330
T+++ T Y APE ++ + D++S G + E+LT +
Sbjct: 160 LKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKK 204
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 3e-11
Identities = 59/175 (33%), Positives = 80/175 (45%), Gaps = 10/175 (5%)
Query: 159 AVKTLNHDGLQGHKE---WLAEVN-YLGGLIHPNLVKLIGCCIEDDQRLLVYEFMPRGSL 214
AVK L + KE ++E N L + HP LV L D+ V +++ G L
Sbjct: 24 AVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGEL 83
Query: 215 ENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSD 274
HL R L R A + A L +LH ++YRD K NILLD + + L+D
Sbjct: 84 FYHLQRERCFLEPRARF-YAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTD 139
Query: 275 FGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTG 329
FGL K+ E + T ++ GT Y APE + D + G VL EML G
Sbjct: 140 FGLCKENIEHNGT--TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.9 bits (156), Expect = 3e-11
Identities = 36/94 (38%), Positives = 54/94 (57%), Gaps = 5/94 (5%)
Query: 239 KGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAK-DGPEGDKTHVSTRVMGTY 297
+GL ++H V++RD K SN+LL+ + K+ DFGLA+ PE D T T + T
Sbjct: 117 RGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATR 173
Query: 298 GYAAPEYVMTGHLTAKS-DVYSFGVVLLEMLTGR 330
Y APE ++ K+ D++S G +L EML+ R
Sbjct: 174 WYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 4e-11
Identities = 47/161 (29%), Positives = 72/161 (44%), Gaps = 24/161 (14%)
Query: 187 PNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLP------WSIRMKIALDAAKG 240
PN+V L + +D LV + G L +H+ + L +P W+ M +ALDA
Sbjct: 45 PNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKF-LNIPEECVKRWAAEMVVALDA--- 100
Query: 241 LAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKD-GPEGDKTHVSTRVMGTYGY 299
LH E ++ RD +NILLD + +L+ F + D V Y
Sbjct: 101 ---LHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENM------Y 148
Query: 300 AAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNG 340
APE T D +S G +L E+LTG +++ + P+G
Sbjct: 149 CAPEVGGISEETEACDWWSLGAILFELLTG-KTLVECHPSG 188
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 4e-11
Identities = 63/207 (30%), Positives = 86/207 (41%), Gaps = 20/207 (9%)
Query: 128 LLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKE---WLAEVNYLGGL 184
LLG+G FG V + TG A+K L + + E L E L
Sbjct: 2 LLGKGTFGKV---------ILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNT 52
Query: 185 IHPNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFL 244
HP L L D+ V E+ G L HL R + R A + L +L
Sbjct: 53 RHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGA-EIVSALGYL 111
Query: 245 HEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDG-PEGDKTHVSTRVMGTYGYAAPE 303
H V+YRD K N++LD + + K++DFGL K+G +G GT Y APE
Sbjct: 112 HS---CDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATM---KTFCGTPEYLAPE 165
Query: 304 YVMTGHLTAKSDVYSFGVVLLEMLTGR 330
+ D + GVV+ EM+ GR
Sbjct: 166 VLEDNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 5e-11
Identities = 65/217 (29%), Positives = 92/217 (42%), Gaps = 28/217 (12%)
Query: 129 LGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEW---LAEVNYLGGLI 185
LG G FG V AT K PVA+K + K+ +E L +
Sbjct: 38 LGTGSFGRVI--------LATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYIN 89
Query: 186 HPNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLH 245
HP V L G ++ LV EF+ G L RR+ P + AA+ +
Sbjct: 90 HPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFL-RRNKRFPNDVG---CFYAAQIVLIFE 145
Query: 246 EEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTR---VMGTYGYAAP 302
++YRD K N+LLD + K++DFG AK V TR + GT Y AP
Sbjct: 146 YLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKV--------VDTRTYTLCGTPEYIAP 197
Query: 303 EYVMT-GHLTAKSDVYSFGVVLLEMLTGRRSMDKNRP 338
E ++ GH A +D ++ G+ + E+L G N P
Sbjct: 198 EILLNVGHGKA-ADWWTLGIFIYEILVGCPPFYANEP 233
|
Length = 340 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 5e-11
Identities = 65/223 (29%), Positives = 100/223 (44%), Gaps = 47/223 (21%)
Query: 186 HPNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPL--PWSIRMKIALDAAKGLAF 243
H ++V L G C+ D + ++V EF+ G L+ + R+S L PW + K+A A L++
Sbjct: 63 HKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPW--KFKVAKQLASALSY 120
Query: 244 LHEEAEKPVIYRDFKTSNILL-----DGEYNA--KLSDFGLAKDGPEGDKTHVSTR--VM 294
L +K +++ + T NILL DGE KLSD G+ V +R +
Sbjct: 121 LE---DKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIP--------ITVLSRQECV 169
Query: 295 GTYGYAAPEYVM-TGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLG 353
+ APE V + +L+ +D +SFG L E+ NGE L + L
Sbjct: 170 ERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICY----------NGEIPLKD---KTLA 216
Query: 354 ERRRFYRLIDPCLEGCFSI--KGAEKTIQLAASCLNRDQKARP 394
E+ RFY EG + ++ L C+N D RP
Sbjct: 217 EKERFY-------EGQCMLVTPSCKELADLMTHCMNYDPNQRP 252
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 7e-11
Identities = 63/217 (29%), Positives = 97/217 (44%), Gaps = 29/217 (13%)
Query: 123 FRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTL----NHDGLQ-GHKEWLAE 177
+ P +G G +G VYK P +G VA+K++ N DGL +A
Sbjct: 2 YEPVAEIGVGAYGTVYKA---------RDPHSGHFVALKSVRVQTNEDGLPLSTVREVAL 52
Query: 178 VNYLGGLIHPNLVKLIGCC--IEDDQRL---LVYEFMPRGSLENHLFRRSLP-LPWSIRM 231
+ L HPN+V+L+ C D+ LV+E + + L +L + P LP
Sbjct: 53 LKRLEAFDHPNIVRLMDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIK 111
Query: 232 KIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVS- 290
+ +GL FLH +++RD K NIL+ KL+DFGLA+ ++
Sbjct: 112 DLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIY----SCQMAL 164
Query: 291 TRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEML 327
T V+ T Y APE ++ D++S G + EM
Sbjct: 165 TPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF 201
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 9e-11
Identities = 42/125 (33%), Positives = 57/125 (45%), Gaps = 4/125 (3%)
Query: 221 RSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKD 280
RS PLP + I + LA+LH + +I+RD KT NI LD NA L DFG A
Sbjct: 178 RSGPLPLEQAITIQRRLLEALAYLHG---RGIIHRDVKTENIFLDEPENAVLGDFGAACK 234
Query: 281 GPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSM-DKNRPN 339
T GT +PE + AK+D++S G+VL EM ++ K +
Sbjct: 235 LDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKS 294
Query: 340 GEHNL 344
L
Sbjct: 295 SSSQL 299
|
Length = 392 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 9e-11
Identities = 47/141 (33%), Positives = 68/141 (48%), Gaps = 19/141 (13%)
Query: 198 EDDQRL-LVYEFMPRGSLENHLFRRSLPLPW----SIRMKIALDAAKGLAFLHEEAEKPV 252
+DD+ L +V E+MP G L N + +P W + + +ALDA + F+H
Sbjct: 113 QDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIH------- 165
Query: 253 IYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT----G 308
RD K N+LLD + KL+DFG + T V GT Y +PE + + G
Sbjct: 166 --RDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISPEVLKSQGGDG 222
Query: 309 HLTAKSDVYSFGVVLLEMLTG 329
+ + D +S GV L EML G
Sbjct: 223 YYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 1e-10
Identities = 61/206 (29%), Positives = 87/206 (42%), Gaps = 18/206 (8%)
Query: 128 LLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKE---WLAEVNYLGGL 184
LLG+G FG V + +G A+K L + + E L E L
Sbjct: 2 LLGKGTFGKV---------ILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNT 52
Query: 185 IHPNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFL 244
HP L L D+ V E++ G L HL R + R A + L +L
Sbjct: 53 RHPFLTSLKYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGA-EIVSALDYL 111
Query: 245 HEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEY 304
H ++YRD K N++LD + + K++DFGL K+G T + GT Y APE
Sbjct: 112 HS---GKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKT--FCGTPEYLAPEV 166
Query: 305 VMTGHLTAKSDVYSFGVVLLEMLTGR 330
+ D + GVV+ EM+ GR
Sbjct: 167 LEDNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 1e-10
Identities = 70/225 (31%), Positives = 94/225 (41%), Gaps = 36/225 (16%)
Query: 175 LAEVNYLGGLIHPNLVKLIGCCIEDDQRLLVYEFMPRGSLENHL-----FRRSLPLPWSI 229
LAE L + P +V L ++ LV F+ G L +HL F S ++
Sbjct: 41 LAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTA 100
Query: 230 RMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAK-DGPEGDKTH 288
+ AL+ LH+ VIYRD K NILLD + + L DFGL K + + DKT+
Sbjct: 101 ELLCALEN------LHK---FNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTN 151
Query: 289 VSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA 348
GT Y APE ++ T D ++ GV+L EMLTG P + N+ E
Sbjct: 152 T---FCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGL------PPFYDENVNEMY 202
Query: 349 RPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKAR 393
R L E RF D L L+RD R
Sbjct: 203 RKILQEPLRFPDGFD------------RDAKDLLIGLLSRDPTRR 235
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 2e-10
Identities = 57/205 (27%), Positives = 99/205 (48%), Gaps = 19/205 (9%)
Query: 129 LGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHK-EWLAEVNYLGGLIHP 187
LGEG + VYKG +NG VA+K ++ +G + E + L GL H
Sbjct: 13 LGEGSYATVYKGISRINGQL---------VALKVISMKTEEGVPFTAIREASLLKGLKHA 63
Query: 188 NLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPL-PWSIRMKIALDAAKGLAFLHE 246
N+V L + V+E+M L ++ + L P+++R+ +GLA++H
Sbjct: 64 NIVLLHDIIHTKETLTFVFEYM-HTDLAQYMIQHPGGLHPYNVRL-FMFQLLRGLAYIHG 121
Query: 247 EAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM 306
+ +++RD K N+L+ KL+DFGLA+ +T+ S V T Y P+ ++
Sbjct: 122 QH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV--TLWYRPPDVLL 176
Query: 307 -TGHLTAKSDVYSFGVVLLEMLTGR 330
++ D++ G + +EML G+
Sbjct: 177 GATDYSSALDIWGAGCIFIEMLQGQ 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 2e-10
Identities = 59/211 (27%), Positives = 98/211 (46%), Gaps = 36/211 (17%)
Query: 129 LGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHPN 188
+GEG G V AT K TG VAVK ++ Q + EV + H N
Sbjct: 30 IGEGSTGIVC--------IATEK-HTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHEN 80
Query: 189 LVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK------IALDAAKGLA 242
+V + + D+ +V EF+ G+L + + RM + L + L+
Sbjct: 81 VVDMYNSYLVGDELWVVMEFLEGGALTD--------IVTHTRMNEEQIATVCLSVLRALS 132
Query: 243 FLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFG----LAKDGPEGDKTHVSTRVMGTYG 298
+LH + VI+RD K+ +ILL + KLSDFG ++K+ P+ ++GT
Sbjct: 133 YLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPK------RKSLVGTPY 183
Query: 299 YAAPEYVMTGHLTAKSDVYSFGVVLLEMLTG 329
+ APE + + D++S G++++EM+ G
Sbjct: 184 WMAPEVISRLPYGTEVDIWSLGIMVIEMIDG 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 2e-10
Identities = 60/224 (26%), Positives = 96/224 (42%), Gaps = 32/224 (14%)
Query: 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWL----- 175
+ + +GEG +G V+K NG G VA+K + +Q +E +
Sbjct: 1 QQYECVAEIGEGAYGKVFKARDLKNG--------GRFVALKRVR---VQTGEEGMPLSTI 49
Query: 176 ---AEVNYLGGLIHPNLVKLIGCCI-----EDDQRLLVYEFMPRGSLENHLFRRSLP-LP 226
A + +L HPN+V+L C + + LV+E + + L +L + P +P
Sbjct: 50 REVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVP 108
Query: 227 WSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDK 286
+ +GL FLH V++RD K NIL+ KL+DFGLA+
Sbjct: 109 TETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARI---YSF 162
Query: 287 THVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGR 330
T V+ T Y APE ++ D++S G + EM +
Sbjct: 163 QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 3e-10
Identities = 49/146 (33%), Positives = 72/146 (49%), Gaps = 9/146 (6%)
Query: 187 PNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHE 246
P LV L D + L+ +++ G L HL +R +++ + L LH+
Sbjct: 65 PFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSG-EIVLALEHLHK 123
Query: 247 EAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM 306
+IYRD K NILLD + L+DFGL+K+ E D+ + GT Y AP+ V
Sbjct: 124 LG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFHE-DEVERAYSFCGTIEYMAPDIVR 179
Query: 307 ---TGHLTAKSDVYSFGVVLLEMLTG 329
GH A D +S GV++ E+LTG
Sbjct: 180 GGDGGHDKA-VDWWSMGVLMYELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 3e-10
Identities = 64/214 (29%), Positives = 104/214 (48%), Gaps = 30/214 (14%)
Query: 129 LGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHK--EWLAEVNYLGGLIH 186
LG+G +G VYK +P TG+ +A+K + + L K + + E++ L +
Sbjct: 9 LGKGNYGSVYK--------VLHRP-TGVTMAMKEIRLE-LDESKFNQIIMELDILHKAVS 58
Query: 187 PNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLP---LPWSIRMKIALDAAKGLAF 243
P +V G + + E+M GSL+ L+ + +P + +I KGL F
Sbjct: 59 PYIVDFYGAFFIEGAVYMCMEYMDAGSLDK-LYAGGVATEGIPEDVLRRITYAVVKGLKF 117
Query: 244 LHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEG-DKTHVSTRVMGTYGYAAP 302
L EE +I+RD K +N+L++G KL DFG++ + KT++ G Y AP
Sbjct: 118 LKEEHN--IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNI-----GCQSYMAP 170
Query: 303 EYVMTGHLTA------KSDVYSFGVVLLEMLTGR 330
E + +G +SDV+S G+ +LEM GR
Sbjct: 171 ERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGR 204
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 3e-10
Identities = 49/168 (29%), Positives = 77/168 (45%), Gaps = 19/168 (11%)
Query: 177 EVNYLGGLIHPNLVKLIGCCIEDDQRLLVYEFMPRGSLENH-------LFRRSLPLPWSI 229
EV L + HPN+V E+ + +V E+ G L LF L W +
Sbjct: 49 EVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFV 108
Query: 230 RMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGE-YNAKLSDFGLAKDGPEGDKTH 288
+I+L GL +H+ + +++RD K+ NI L AKL DFG+A+ D
Sbjct: 109 --QISL----GLKHIHD---RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQ--LNDSME 157
Query: 289 VSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKN 336
++ +GT Y +PE K+D++S G VL E+ T + + N
Sbjct: 158 LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGN 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 61.2 bits (149), Expect = 3e-10
Identities = 60/241 (24%), Positives = 95/241 (39%), Gaps = 64/241 (26%)
Query: 122 SFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNH--DGLQGHKEWLAEVN 179
++P +G G +G V + +G VA+K + H D K L E+
Sbjct: 6 RYKPIENIGSGAYGVVCSA---------IDTRSGKKVAIKKIPHAFDVPTLAKRTLRELK 56
Query: 180 YLGGLIHPNLVKLIGCCIEDDQR---------LLVYEFM---------PRGSLENHLFRR 221
L H N++ I D R +V + M L R
Sbjct: 57 ILRHFKHDNII-----AIRDILRPPGADFKDVYVVMDLMESDLHHIIHSDQPLTEEHIRY 111
Query: 222 SLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAK-- 279
L + + +GL ++H VI+RD K SN+L++ + ++ DFG+A+
Sbjct: 112 FL---YQL--------LRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGL 157
Query: 280 -DGPEGDKT----HVSTRVMGTYGYAAPE--YVMTGHLTAKSDVYSFGVVLLEMLTGRRS 332
P K +V+TR Y APE + + TA D++S G + EML GRR
Sbjct: 158 SSSPTEHKYFMTEYVATR-----WYRAPELLLSLPEYTTA-IDMWSVGCIFAEML-GRRQ 210
Query: 333 M 333
+
Sbjct: 211 L 211
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 3e-10
Identities = 64/214 (29%), Positives = 99/214 (46%), Gaps = 33/214 (15%)
Query: 129 LGEGGFGCVYKG-WINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLA---EVNYLGGL 184
LG+G F +YKG + V PG + V +K L H++ LA + + L
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLG----SDHRDSLAFFETASLMSQL 58
Query: 185 IHPNLVKLIGCCIEDDQRLLVYEFMPRGSLEN--HLFRRSLPLPWSIRMKIALDAAKGLA 242
H +LVKL G C+ D + ++V E++ G L+ H + ++ L W LD AK LA
Sbjct: 59 SHKHLVKLYGVCVRD-ENIMVEEYVKFGPLDVFLHREKNNVSLHWK------LDVAKQLA 111
Query: 243 F-LHEEAEKPVIYRDFKTSNILL-----DGEYN--AKLSDFGLAKDGPEGDKTHVSTRVM 294
LH +K +++ + NIL+ + Y KLSD G+ + R+
Sbjct: 112 SALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPI--TVLSREERVERI- 168
Query: 295 GTYGYAAPEYVMTGH--LTAKSDVYSFGVVLLEM 326
+ APE + G LT +D +SFG LLE+
Sbjct: 169 ---PWIAPECIRNGQASLTIAADKWSFGTTLLEI 199
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 4e-10
Identities = 42/128 (32%), Positives = 66/128 (51%), Gaps = 8/128 (6%)
Query: 204 LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNIL 263
L+ +++ G + HL++R +R + L LH+ ++YRD K NIL
Sbjct: 82 LILDYVSGGEMFTHLYQRDNFSEDEVRFYSG-EIILALEHLHKLG---IVYRDIKLENIL 137
Query: 264 LDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYV--MTGHLTAKSDVYSFGV 321
LD E + L+DFGL+K+ +K + GT Y APE + GH A D +S G+
Sbjct: 138 LDSEGHVVLTDFGLSKEFLSEEKERTYS-FCGTIEYMAPEIIRGKGGHGKA-VDWWSLGI 195
Query: 322 VLLEMLTG 329
++ E+LTG
Sbjct: 196 LIFELLTG 203
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 5e-10
Identities = 58/214 (27%), Positives = 101/214 (47%), Gaps = 34/214 (15%)
Query: 129 LGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEW-----LAEVNYLGG 183
+GEG +G VYK + T +A+K + L+ E + E++ L
Sbjct: 10 IGEGTYGVVYKARDRV---------TNETIALKKIR---LEQEDEGVPSTAIREISLLKE 57
Query: 184 LIHPNLVKLIGCCIEDDQRLLVYEFMPRGSLENHL-----FRRSLPLPWSIRMKIALDAA 238
+ H N+V+L + + LV+E++ L+ H+ F ++ L + +I
Sbjct: 58 MQHGNIVRLQDVVHSEKRLYLVFEYLDL-DLKKHMDSSPDFAKNPRLIKTYLYQIL---- 112
Query: 239 KGLAFLHEEAEKPVIYRDFKTSNILLDGEYNA-KLSDFGLAKDGPEGDKTHVSTRVMGTY 297
+G+A+ H V++RD K N+L+D NA KL+DFGLA+ G T + T
Sbjct: 113 RGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLAR--AFGIPVRTFTHEVVTL 167
Query: 298 GYAAPEYVM-TGHLTAKSDVYSFGVVLLEMLTGR 330
Y APE ++ + H + D++S G + EM+ +
Sbjct: 168 WYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.6 bits (145), Expect = 8e-10
Identities = 65/249 (26%), Positives = 93/249 (37%), Gaps = 59/249 (23%)
Query: 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEW---LAE 177
K F+ LLG+G G V+ +K GTG A+K L+ + + L E
Sbjct: 1 KHFKKIKLLGKGDVGRVF--------LVRLK-GTGKLFALKVLDKKEMIKRNKVKRVLTE 51
Query: 178 VNYLGGLIHPNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDA 237
L L HP L L + LV ++ P G L + P ++ +
Sbjct: 52 QEILATLDHPFLPTLYASFQTETYLCLVMDYCPGGEL--FRLLQRQP-----GKCLSEEV 104
Query: 238 AK--------GLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAK---------- 279
A+ L +LH ++YRD K NILL + LSDF L+K
Sbjct: 105 ARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVS 161
Query: 280 ----DGPEGDKTH----------VSTRVM---GTYGYAAPEYVM-TGHLTAKSDVYSFGV 321
G + S R GT Y APE + GH + D ++ G+
Sbjct: 162 KALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGH-GSAVDWWTLGI 220
Query: 322 VLLEMLTGR 330
+L EML G
Sbjct: 221 LLYEMLYGT 229
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 8e-10
Identities = 49/183 (26%), Positives = 90/183 (49%), Gaps = 21/183 (11%)
Query: 154 TGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHPNLVKLIGCCIEDDQRLLVYEFMPRGS 213
+G VAVK ++ Q + EV + H N+V++ + ++ ++ EF+ G+
Sbjct: 45 SGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGA 104
Query: 214 LENHLFRRSLPLPWSIRMKIAL---DAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNA 270
L + + + L +IA + L +LH + VI+RD K+ +ILL +
Sbjct: 105 LTDIVSQTRLN-----EEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRV 156
Query: 271 KLSDFG----LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEM 326
KLSDFG ++KD P+ ++GT + APE + + D++S G++++EM
Sbjct: 157 KLSDFGFCAQISKDVPK------RKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEM 210
Query: 327 LTG 329
+ G
Sbjct: 211 VDG 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 60.0 bits (146), Expect = 8e-10
Identities = 32/94 (34%), Positives = 52/94 (55%), Gaps = 11/94 (11%)
Query: 239 KGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYG 298
+GL ++H +I+RD K SNI ++ + K+ DFGLA+ + +V+TR
Sbjct: 129 RGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMTGYVATR-----W 180
Query: 299 YAAPEYVMT--GHLTAKSDVYSFGVVLLEMLTGR 330
Y APE +M H D++S G ++ E+LTG+
Sbjct: 181 YRAPE-IMLNWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 1e-09
Identities = 43/145 (29%), Positives = 68/145 (46%), Gaps = 26/145 (17%)
Query: 222 SLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDG 281
S PL ++ + A+G+ FL A K I+RD N+LL AK+ DFGLA+D
Sbjct: 206 SWPLDLDDLLRFSSQVAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLARD- 261
Query: 282 PEGDKTHVSTRVMGT----YGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNR 337
D +V V G + APE + T +SDV+S+G++L E+ S+ K+
Sbjct: 262 IMNDSNYV---VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIF----SLGKS- 313
Query: 338 PNGEHNLVEWARPQLGERRRFYRLI 362
P + +FY+++
Sbjct: 314 ----------PYPGILVNSKFYKMV 328
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 1e-09
Identities = 52/181 (28%), Positives = 79/181 (43%), Gaps = 15/181 (8%)
Query: 154 TGLPVAVKTLNH--DGLQGHKEWLAEVNYLGGLIHPNLVKLIGCCIEDDQRL-LVYEFMP 210
TG VA+K + K E+ L L H N++ L I + + V E +
Sbjct: 34 TGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTELL- 92
Query: 211 RGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNA 270
+ H S PL +GL ++H V++RD K SNIL++ +
Sbjct: 93 --GTDLHRLLTSRPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDL 147
Query: 271 KLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGH-LTAKSDVYSFGVVLLEMLTG 329
K+ DFGLA+ +VSTR Y APE ++T + D++S G + EML G
Sbjct: 148 KICDFGLARIQDPQMTGYVSTRY-----YRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEG 202
Query: 330 R 330
+
Sbjct: 203 K 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 58.6 bits (141), Expect = 1e-09
Identities = 77/260 (29%), Positives = 115/260 (44%), Gaps = 40/260 (15%)
Query: 128 LLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIH- 186
L+G G +G VYKG VK TG A+K ++ G + +E E+N L H
Sbjct: 13 LVGNGTYGQVYKG-------RHVK--TGQLAAIKVMDVTGDE-EEEIKQEINMLKKYSHH 62
Query: 187 PNLVKLIGCCIE------DDQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALDA 237
N+ G I+ DDQ LV EF GS+ + + +L W I +
Sbjct: 63 RNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWI--AYICREI 120
Query: 238 AKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTR--VMG 295
+GL+ LH+ VI+RD K N+LL KL DFG++ + D+T V R +G
Sbjct: 121 LRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSA---QLDRT-VGRRNTFIG 173
Query: 296 TYGYAAPEYVMTGH-----LTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEW-AR 349
T + APE + KSD++S G+ +EM G + P L+
Sbjct: 174 TPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPA 233
Query: 350 PQLGER---RRFYRLIDPCL 366
P+L + ++F I+ CL
Sbjct: 234 PRLKSKKWSKKFQSFIESCL 253
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 58.4 bits (142), Expect = 2e-09
Identities = 62/214 (28%), Positives = 94/214 (43%), Gaps = 40/214 (18%)
Query: 129 LGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLI--- 185
+GEG F V K + K TG A+K + H + L +VN L +
Sbjct: 7 IGEGTFSEVLK-------AQSRK--TGKYYAIKCMKK-----HFKSLEQVNNLREIQALR 52
Query: 186 ----HPNLVKLIGCCIEDDQ-RL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAK 239
HPN+++LI + RL LV+E M +L + R PLP K
Sbjct: 53 RLSPHPNILRLIEVLFDRKTGRLALVFELM-DMNLYELIKGRKRPLPEKRVKSYMYQLLK 111
Query: 240 GLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAK----DGPEGDKTHVSTRVMG 295
L +H + +RD K NIL+ + KL+DFG + P + ++STR
Sbjct: 112 SLDHMHR---NGIFHRDIKPENILIKDD-ILKLADFGSCRGIYSKPPYTE--YISTR--- 162
Query: 296 TYGYAAPEYVMT-GHLTAKSDVYSFGVVLLEMLT 328
Y APE ++T G+ K D+++ G V E+L+
Sbjct: 163 --WYRAPECLLTDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 2e-09
Identities = 67/217 (30%), Positives = 91/217 (41%), Gaps = 33/217 (15%)
Query: 129 LGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLN--HDGLQGHKEWLAEVNYLGGLI- 185
+G+G +G V+K NG+ AVK L+ HD +E AE N L L
Sbjct: 26 IGKGTYGKVFKVLNKKNGSKA---------AVKILDPIHDI---DEEIEAEYNILKALSD 73
Query: 186 HPNLVKLIGC-----CIEDDQRLLVYEFMPRGS---LENHLFRRSLPLPWSIRMKIALDA 237
HPN+VK G DQ LV E GS L +R + I I +A
Sbjct: 74 HPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEA 133
Query: 238 AKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTY 297
GL LH I+RD K +NILL E KL DFG++ +GT
Sbjct: 134 LMGLQHLHVNK---TIHRDVKGNNILLTTEGGVKLVDFGVSAQ--LTSTRLRRNTSVGTP 188
Query: 298 GYAAPEYV-----MTGHLTAKSDVYSFGVVLLEMLTG 329
+ APE + + A+ DV+S G+ +E+ G
Sbjct: 189 FWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDG 225
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 2e-09
Identities = 37/101 (36%), Positives = 50/101 (49%), Gaps = 6/101 (5%)
Query: 240 GLAFL------HEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRV 293
GL F+ H K +I+RD K++NILL KL DFG +K V
Sbjct: 146 GLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTF 205
Query: 294 MGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMD 334
GT Y APE + K+D++S GV+L E+LT +R D
Sbjct: 206 CGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFD 246
|
Length = 496 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 3e-09
Identities = 47/157 (29%), Positives = 77/157 (49%), Gaps = 2/157 (1%)
Query: 176 AEVNYLGGLIHPNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIA 234
+E++ L H +VK DD+ LL+ E+ G L + +R LP+ ++
Sbjct: 114 SELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQ-EYEVG 172
Query: 235 LDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVM 294
L + + L E + +++RD K++NI L KL DFG +K + V++
Sbjct: 173 LLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFC 232
Query: 295 GTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRR 331
GT Y APE + K+D++S GV+L E+LT R
Sbjct: 233 GTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHR 269
|
Length = 478 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 3e-09
Identities = 55/216 (25%), Positives = 87/216 (40%), Gaps = 38/216 (17%)
Query: 129 LGEGGFGCVYKGWINMNGTATVKPGTGLPVAVK--TLNHDGLQGHKEWLAEVNYLGGLIH 186
+GEG +G V+K T VA+K L+ D L E+ L L H
Sbjct: 8 IGEGTYGTVFKA---------KNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKH 58
Query: 187 PNLVKLIGCCIEDDQRLLVYEFMP----------RGSLENHLFRRSLPLPWSIRMKIALD 236
N+V+L D + LV+E+ G ++ + + +
Sbjct: 59 KNIVRLYDVLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFM-----------FQ 107
Query: 237 AAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGT 296
KGLAF H V++RD K N+L++ KL+DFGLA+ G + + T
Sbjct: 108 LLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLAR--AFGIPVRCYSAEVVT 162
Query: 297 YGYAAPEYVMTGHLTAKS-DVYSFGVVLLEMLTGRR 331
Y P+ + L + S D++S G + E+ R
Sbjct: 163 LWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGR 198
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 58.1 bits (141), Expect = 3e-09
Identities = 50/188 (26%), Positives = 78/188 (41%), Gaps = 25/188 (13%)
Query: 158 VAVKTLNHDGLQGHKEWL---AEVNYLGGLIHPNLVKLIGCCIEDDQRLLVYEFMPRGSL 214
VAVK +N D ++ E+ L HPN++ + I D + +V M GS
Sbjct: 28 VAVKKINLDS-CSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSC 86
Query: 215 ENHLFRRSLP--LPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKL 272
E+ L + P LP I D L ++H K I+R K S+ILL G+ L
Sbjct: 87 ED-LLKTHFPEGLPELAIAFILKDVLNALDYIH---SKGFIHRSVKASHILLSGDGKVVL 142
Query: 273 SDFGLAKDGPEGDKTHV--------STRVMGTYGYAAPEYV---MTGHLTAKSDVYSFGV 321
S + + K S + + + +PE + + G+ KSD+YS G+
Sbjct: 143 SGLRYSVSMIKHGKRQRVVHDFPKSSVKNL---PWLSPEVLQQNLQGY-NEKSDIYSVGI 198
Query: 322 VLLEMLTG 329
E+ G
Sbjct: 199 TACELANG 206
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.6 bits (140), Expect = 3e-09
Identities = 64/216 (29%), Positives = 101/216 (46%), Gaps = 39/216 (18%)
Query: 128 LLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKT----LNHDGLQGHKEWLAEVNYLGG 183
+GEG +G VYK ++N TG VA+K L+ +G+ L E+ L
Sbjct: 6 EIGEGAYGTVYKA-RDLN--------TGRFVALKKVRVPLSEEGIP--LSTLREIALLKQ 54
Query: 184 LI---HPNLVKLIGCC--IEDDQRL---LVYEFMPR---GSLENHLFRRSLPLPWSIR-- 230
L HPN+V+L+ C D+ L LV+E + + L + LP P +I+
Sbjct: 55 LESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCP-KPGLP-PETIKDL 112
Query: 231 MKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVS 290
M+ L +G+ FLH +++RD K NIL+ + K++DFGLA+
Sbjct: 113 MRQLL---RGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLAR---IYSFEMAL 163
Query: 291 TRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEM 326
T V+ T Y APE ++ D++S G + E+
Sbjct: 164 TSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 4e-09
Identities = 78/298 (26%), Positives = 117/298 (39%), Gaps = 53/298 (17%)
Query: 129 LGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKE---WLAEVNYLGGLI 185
+G+G FG VY+ K T A+K L+ + KE + E N L +
Sbjct: 1 IGKGTFGQVYQ---------VRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTL 51
Query: 186 H---PNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLA 242
P +V L D LV ++M G L HL + + IA + L
Sbjct: 52 LDESPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIA-ELVLALE 110
Query: 243 FLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAP 302
LH+ ++YRD K NILLD + L DFGL+K +KT + GT Y AP
Sbjct: 111 HLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKT--TNTFCGTTEYLAP 165
Query: 303 EYVM--TGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRRFYR 360
E ++ G+ T D +S GV++ EM G W+ + ++ YR
Sbjct: 166 EVLLDEKGY-TKHVDFWSLGVLVFEMCCG-----------------WSPFYAEDTQQMYR 207
Query: 361 LIDPCLEGCF-SIKGAEKTI-----QLAASCLNRDQKARPRMSEVVEALKPLPYLKDM 412
I F ++ + + Q LNR+ + R LK P+ D+
Sbjct: 208 NI------AFGKVRFPKNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFADI 259
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 4e-09
Identities = 54/176 (30%), Positives = 77/176 (43%), Gaps = 24/176 (13%)
Query: 234 ALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHV---S 290
+ A+G+ FL A + I+RD NILL K+ DFGLA+D + D +V S
Sbjct: 180 SFQVARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYK-DPDYVRKGS 235
Query: 291 TRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP 350
R+ + APE + T +SDV+SFGV+L E+ + S P + N R
Sbjct: 236 ARL--PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGAS---PYPGVQINEEFCQRL 290
Query: 351 QLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPL 406
+ G R R P + + +C D K RP S +VE L L
Sbjct: 291 KDGTRMRAPENATPEIYR------------IMLACWQGDPKERPTFSALVEILGDL 334
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 4e-09
Identities = 47/168 (27%), Positives = 73/168 (43%), Gaps = 26/168 (15%)
Query: 238 AKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTY 297
AKG++FL A K I+RD NILL K+ DFGLA+D V
Sbjct: 224 AKGMSFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPV 280
Query: 298 GYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRR 357
+ APE + T +SDV+S+G++L E+ + L P + +
Sbjct: 281 KWMAPESIFNCVYTFESDVWSYGILLWEIFS---------------LGSSPYPGMPVDSK 325
Query: 358 FYRLIDPCLEGCFSIKGAE----KTIQLAASCLNRDQKARPRMSEVVE 401
FY++I EG + + E + + SC + D RP ++V+
Sbjct: 326 FYKMIK---EG-YRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQ 369
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.0 bits (138), Expect = 8e-09
Identities = 65/264 (24%), Positives = 96/264 (36%), Gaps = 84/264 (31%)
Query: 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLN-----HDGLQGH---- 171
F ++G G FG V K TG A+K L H
Sbjct: 1 DDFESIKVIGRGAFGEV---------RLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAE 51
Query: 172 KEWLAEVNYLGGLIHPNLVKLIGCCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIR 230
++ LAE + +P +VKL +D+ L L+ E++P G + L ++ R
Sbjct: 52 RDILAEAD------NPWVVKLY-YSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETR 104
Query: 231 MKI-----ALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEG- 284
I A+D+ L ++H RD K N+LLD + + KLSDFGL G
Sbjct: 105 FYIAETILAIDSIHKLGYIH---------RDIKPDNLLLDAKGHIKLSDFGLCT----GL 151
Query: 285 DKTHVST----------------------------------RVM-----GTYGYAAPEYV 305
K+H + R + GT Y APE
Sbjct: 152 KKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVF 211
Query: 306 MTGHLTAKSDVYSFGVVLLEMLTG 329
+ + D +S GV++ EML G
Sbjct: 212 LQTGYNKECDWWSLGVIMYEMLVG 235
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 8e-09
Identities = 74/260 (28%), Positives = 110/260 (42%), Gaps = 40/260 (15%)
Query: 128 LLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIH- 186
++G G +G VYKG VK G + V + D +E E+N L H
Sbjct: 23 VVGNGTYGQVYKG-------RHVKTGQLAAIKVMDVTEDE---EEEIKLEINMLKKYSHH 72
Query: 187 PNLVKLIGCCIE------DDQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALDA 237
N+ G I+ DDQ LV EF GS+ + + +L W I +
Sbjct: 73 RNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWI--AYICREI 130
Query: 238 AKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTR--VMG 295
+GLA LH VI+RD K N+LL KL DFG++ + D+T V R +G
Sbjct: 131 LRGLAHLHAHK---VIHRDIKGQNVLLTENAEVKLVDFGVSA---QLDRT-VGRRNTFIG 183
Query: 296 TYGYAAPEYVMTGH-----LTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEW-AR 349
T + APE + +SD++S G+ +EM G + P L+
Sbjct: 184 TPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPP 243
Query: 350 PQLGER---RRFYRLIDPCL 366
P+L + ++F I+ CL
Sbjct: 244 PKLKSKKWSKKFIDFIEGCL 263
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 1e-08
Identities = 70/221 (31%), Positives = 94/221 (42%), Gaps = 41/221 (18%)
Query: 129 LGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWL-AEVNYLGGLI-H 186
+G+G +G VYK K G+ AVK L D + E + AE N L L H
Sbjct: 30 IGKGTYGKVYK-------VTNKKDGS--LAAVKIL--DPISDVDEEIEAEYNILQSLPNH 78
Query: 187 PNLVKLIGCCIEDD-----QRLLVYEFMPRGS---LENHLFRRSLPLPWSIRMKIALDAA 238
PN+VK G + D Q LV E GS L L L ++ I A
Sbjct: 79 PNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGAL 138
Query: 239 KGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRV----- 293
GL LH +I+RD K +NILL E KL DFG++ STR+
Sbjct: 139 LGLQHLHNNR---IIHRDVKGNNILLTTEGGVKLVDFGVSAQ-------LTSTRLRRNTS 188
Query: 294 MGTYGYAAPEYVMTGH-----LTAKSDVYSFGVVLLEMLTG 329
+GT + APE + A+ DV+S G+ +E+ G
Sbjct: 189 VGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDG 229
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 1e-08
Identities = 40/157 (25%), Positives = 70/157 (44%), Gaps = 19/157 (12%)
Query: 184 LIHPNLVKLIGCCIEDDQRLLVYEFMPRGSLENHL------FRRSLPLPWSIRMKIALDA 237
L HPN+++ +G C+E LLV+E+ G L+++L R S L + ++A +
Sbjct: 52 LQHPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLL---LLQRMACEI 108
Query: 238 AKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTY 297
A G+ +H+ ++ D N L + K+ D+G+ + D
Sbjct: 109 AAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPL 165
Query: 298 GYAAPEYV-------MTGHLTAKSDVYSFGVVLLEML 327
+ APE V +T T S+V++ GV L E+
Sbjct: 166 RWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELF 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 1e-08
Identities = 57/205 (27%), Positives = 98/205 (47%), Gaps = 19/205 (9%)
Query: 129 LGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHK-EWLAEVNYLGGLIHP 187
LGEG + V+KG + T VA+K + + +G + EV+ L L H
Sbjct: 14 LGEGTYATVFKGRSKL---------TENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHA 64
Query: 188 NLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL-DAAKGLAFLHE 246
N+V L D LV+E++ + L+ ++ + +KI L +GLA+ H
Sbjct: 65 NIVTLHDIVHTDKSLTLVFEYLDK-DLKQYMDDCGNIMSMH-NVKIFLYQILRGLAYCHR 122
Query: 247 EAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM 306
+ V++RD K N+L++ KL+DFGLA+ KT+ + V T Y P+ ++
Sbjct: 123 ---RKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV--TLWYRPPDVLL 177
Query: 307 -TGHLTAKSDVYSFGVVLLEMLTGR 330
+ + + D++ G + EM +GR
Sbjct: 178 GSSEYSTQIDMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 1e-08
Identities = 54/204 (26%), Positives = 95/204 (46%), Gaps = 17/204 (8%)
Query: 129 LGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHK-EWLAEVNYLGGLIHP 187
LGEG + V+KG + T VA+K + + +G + EV+ L L H
Sbjct: 13 LGEGTYATVFKGRSKL---------TENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHA 63
Query: 188 NLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEE 247
N+V L + LV+E++ L+ +L + +GL++ H+
Sbjct: 64 NIVTLHDIIHTERCLTLVFEYL-DSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHK- 121
Query: 248 AEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM- 306
+ +++RD K N+L++ + KL+DFGLA+ KT+ + V T Y P+ ++
Sbjct: 122 --RKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV--TLWYRPPDVLLG 177
Query: 307 TGHLTAKSDVYSFGVVLLEMLTGR 330
+ + D++ G +L EM TGR
Sbjct: 178 STEYSTPIDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 55.9 bits (134), Expect = 1e-08
Identities = 52/204 (25%), Positives = 99/204 (48%), Gaps = 19/204 (9%)
Query: 129 LGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHK-EWLAEVNYLGGLIHP 187
LGEG + VYKG +NG VA+K + +G + E + L GL H
Sbjct: 13 LGEGSYATVYKGKSKVNGKL---------VALKVIRLQEEEGTPFTAIREASLLKGLKHA 63
Query: 188 NLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPL-PWSIRMKIALDAAKGLAFLHE 246
N+V L + LV+E++ L ++ + L P ++++ + +GL+++H+
Sbjct: 64 NIVLLHDIIHTKETLTLVFEYV-HTDLCQYMDKHPGGLHPENVKLFL-FQLLRGLSYIHQ 121
Query: 247 EAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM 306
+ +++RD K N+L+ KL+DFGLA+ + +H + + T Y P+ ++
Sbjct: 122 ---RYILHRDLKPQNLLISDTGELKLADFGLAR--AKSVPSHTYSNEVVTLWYRPPDVLL 176
Query: 307 -TGHLTAKSDVYSFGVVLLEMLTG 329
+ + D++ G + +EM+ G
Sbjct: 177 GSTEYSTCLDMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 2e-08
Identities = 45/159 (28%), Positives = 67/159 (42%), Gaps = 18/159 (11%)
Query: 177 EVNYLGGLIHPNLVKLIGCCIEDDQRLLVYEFMPRGSL-------ENHLFRRSLPLPWSI 229
EV L + HPN+V+ E+ +V ++ G L LF L W +
Sbjct: 49 EVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFV 108
Query: 230 RMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHV 289
++ +AL LH RD K+ NI L + KL DFG+A+ +
Sbjct: 109 QICLALKHVHDRKILH---------RDIKSQNIFLTKDGTIKLGDFGIAR--VLNSTVEL 157
Query: 290 STRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLT 328
+ +GT Y +PE KSD+++ G VL EM T
Sbjct: 158 ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCT 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 2e-08
Identities = 31/93 (33%), Positives = 52/93 (55%), Gaps = 5/93 (5%)
Query: 239 KGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYG 298
+GL +LH +++RD K N+L++ K+ DFGLA+ + H++ V+ Y
Sbjct: 114 RGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQY- 169
Query: 299 YAAPEYVM-TGHLTAKSDVYSFGVVLLEMLTGR 330
Y APE +M + H T+ D++S G + E+L R
Sbjct: 170 YRAPEILMGSRHYTSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 2e-08
Identities = 59/216 (27%), Positives = 94/216 (43%), Gaps = 37/216 (17%)
Query: 127 CLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVK--TLNHDGLQGHK-EWLAEVNYLGG 183
LGEG + VYKG + G VA+K L H+ +G + E + L
Sbjct: 11 DKLGEGSYATVYKGRSKLTGQL---------VALKEIRLEHE--EGAPFTAIREASLLKD 59
Query: 184 LIHPNLVKLIGCCIEDDQRLLVYEFMPRG---SLENHLFRRSLPLPWSIRM---KIAL-D 236
L H N+V L LV+E++ +++ + M ++ L
Sbjct: 60 LKHANIVTLHDIIHTKKTLTLVFEYLDTDLKQYMDDC--------GGGLSMHNVRLFLFQ 111
Query: 237 AAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGT 296
+GLA+ H+ + V++RD K N+L+ KL+DFGLA+ KT+ + V T
Sbjct: 112 LLRGLAYCHQ---RRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVV--T 166
Query: 297 YGYAAPEYVMTG--HLTAKSDVYSFGVVLLEMLTGR 330
Y P+ V+ G + D++ G + EM TGR
Sbjct: 167 LWYRPPD-VLLGSTEYSTSLDMWGVGCIFYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 2e-08
Identities = 32/93 (34%), Positives = 50/93 (53%), Gaps = 9/93 (9%)
Query: 239 KGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYG 298
KGL ++H +I+RD K N+ ++ + K+ DFGLA+ +V TR
Sbjct: 129 KGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMTGYVVTR-----W 180
Query: 299 YAAPEYVMTG-HLTAKSDVYSFGVVLLEMLTGR 330
Y APE ++ H T D++S G ++ EMLTG+
Sbjct: 181 YRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 2e-08
Identities = 31/93 (33%), Positives = 52/93 (55%), Gaps = 9/93 (9%)
Query: 239 KGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYG 298
+GL ++H +I+RD K SN+ ++ + K+ DFGLA+ + +V+TR
Sbjct: 131 RGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----W 182
Query: 299 YAAPEYVMTG-HLTAKSDVYSFGVVLLEMLTGR 330
Y APE ++ H D++S G ++ E+LTGR
Sbjct: 183 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 2e-08
Identities = 60/225 (26%), Positives = 104/225 (46%), Gaps = 31/225 (13%)
Query: 117 KSATKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLA 176
+S KS++ ++G G FG VY+ + T VA+K + D ++E L
Sbjct: 62 RSPNKSYKLGNIIGNGSFGVVYEA---------ICIDTSEKVAIKKVLQDPQYKNRELLI 112
Query: 177 EVNYLGGLIHPNLVKL-----IGCCIEDDQRL---LVYEFMPRG--SLENHLFRRSLPLP 226
N L H N++ L C ++++ + +V EF+P+ H R + LP
Sbjct: 113 MKN----LNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALP 168
Query: 227 WSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLD-GEYNAKLSDFGLAKDGPEGD 285
+ + + LA++H K + +RD K N+L+D + KL DFG AK+ G
Sbjct: 169 LFLVKLYSYQLCRALAYIH---SKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQ 225
Query: 286 KTHVSTRVMGTYGYAAPEYVM-TGHLTAKSDVYSFGVVLLEMLTG 329
+ S + + Y APE ++ + T D++S G ++ EM+ G
Sbjct: 226 R---SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILG 267
|
Length = 440 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 3e-08
Identities = 51/185 (27%), Positives = 80/185 (43%), Gaps = 21/185 (11%)
Query: 175 LAEVNYLGGLIHPNLVKLIGCCIEDDQR--------LLVYEFMPR---GSLENHLFRRSL 223
L E+ L L H N+V LI C LV+EF G L N + +L
Sbjct: 59 LREIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTL 118
Query: 224 PLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAK--DG 281
+ MK+ L+ GL ++H +++RD K +NIL+ + KL+DFGLA+
Sbjct: 119 SEIKKV-MKMLLN---GLYYIHRNK---ILHRDMKAANILITKDGILKLADFGLARAFSL 171
Query: 282 PEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNG 340
+ K + T + T Y PE ++ D++ G ++ EM T M N
Sbjct: 172 SKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQH 231
Query: 341 EHNLV 345
+ L+
Sbjct: 232 QLTLI 236
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 4e-08
Identities = 55/204 (26%), Positives = 93/204 (45%), Gaps = 17/204 (8%)
Query: 129 LGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHK-EWLAEVNYLGGLIHP 187
LGEG + VYKG + T VA+K + + +G + EV+ L L H
Sbjct: 14 LGEGTYATVYKGRSKL---------TDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHA 64
Query: 188 NLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEE 247
N+V L + LV+E++ + L+ +L + +GL + H
Sbjct: 65 NIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHR- 122
Query: 248 AEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM- 306
+ V++RD K N+L++ KL+DFGLA+ KT+ + V T Y P+ ++
Sbjct: 123 --RKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV--TLWYRPPDILLG 178
Query: 307 TGHLTAKSDVYSFGVVLLEMLTGR 330
+ + + D++ G + EM TGR
Sbjct: 179 STDYSTQIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 4e-08
Identities = 52/201 (25%), Positives = 92/201 (45%), Gaps = 18/201 (8%)
Query: 129 LGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHPN 188
+G G +G VYK N+N TG A+K + + + E+ + H N
Sbjct: 17 IGSGTYGDVYKAR-NVN--------TGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSN 67
Query: 189 LVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEA 248
+V G + D+ + EF GSL++ ++ + PL S ++ + +GL +LH +
Sbjct: 68 IVAYFGSYLRRDKLWICMEFCGGGSLQD-IYHVTGPLSESQIAYVSRETLQGLYYLHSKG 126
Query: 249 EKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT- 307
+ ++RD K +NILL + KL+DFG++ S +GT + APE
Sbjct: 127 K---MHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKS--FIGTPYWMAPEVAAVE 181
Query: 308 --GHLTAKSDVYSFGVVLLEM 326
G D+++ G+ +E+
Sbjct: 182 RKGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 6e-08
Identities = 63/236 (26%), Positives = 99/236 (41%), Gaps = 24/236 (10%)
Query: 114 NELKSATKSFRP-ECLLGEGGFGCVYKGWINMNGTAT----VKPGTGLPVAVKTLNHDGL 168
N S ++ + LGEG +G V K + + G VK K G+
Sbjct: 1 NMSFSISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGM 60
Query: 169 QG-HKEWLAEVNYLGGLIHPNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPW 227
G H L E+ + + H N++ L+ +E D LV + M L+ + R + L
Sbjct: 61 CGIHFTTLRELKIMNEIKHENIMGLVDVYVEGDFINLVMDIM-ASDLKK-VVDRKIRLTE 118
Query: 228 SIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAK-------- 279
S I L GL LH+ ++RD +NI ++ + K++DFGLA+
Sbjct: 119 SQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYS 175
Query: 280 DGPEGDKTHVSTRVMG----TYGYAAPEYVMTGHLTAKS-DVYSFGVVLLEMLTGR 330
D D+T M T Y APE +M + D++S G + E+LTG+
Sbjct: 176 DTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 7e-08
Identities = 37/99 (37%), Positives = 54/99 (54%), Gaps = 11/99 (11%)
Query: 234 ALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNA-KLSDFGLAKDGPEGDKTHV--- 289
+ A+G+ FL A + I+RD NILL E N K+ DFGLA+D + D +V
Sbjct: 179 SFQVARGMEFL---ASRKCIHRDLAARNILLS-ENNVVKICDFGLARDIYK-DPDYVRKG 233
Query: 290 STRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLT 328
R+ + APE + T +SDV+SFGV+L E+ +
Sbjct: 234 DARL--PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 9e-08
Identities = 48/179 (26%), Positives = 83/179 (46%), Gaps = 8/179 (4%)
Query: 177 EVNYLGGLIHPNLVKLIGCCI-EDDQRLLVYEFMPRGSLENHLF-RRSLPLPWSIRMKIA 234
E L L HPN+V ED +V F G L + L ++ LP + ++
Sbjct: 49 EAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWF 108
Query: 235 LDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVM 294
+ A L +LHE K +++RD KT N+ L K+ D G+A+ ++ +++ ++
Sbjct: 109 VQIAMALQYLHE---KHILHRDLKTQNVFLTRTNIIKVGDLGIAR--VLENQCDMASTLI 163
Query: 295 GTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNG-EHNLVEWARPQL 352
GT Y +PE KSDV++ G + EM T + + + N + ++E P +
Sbjct: 164 GTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPM 222
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 9e-08
Identities = 54/177 (30%), Positives = 77/177 (43%), Gaps = 26/177 (14%)
Query: 234 ALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHV---S 290
+ AKG+ FL A + I+RD NILL K+ DFGLA+D + D +V
Sbjct: 185 SFQVAKGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYK-DPDYVRKGD 240
Query: 291 TRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA-R 349
R+ + APE + T +SDV+SFGV+L E+ S+ + G E+ R
Sbjct: 241 ARL--PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF----SLGASPYPGVKIDEEFCRR 294
Query: 350 PQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPL 406
+ G R R P + Q C + + RP SE+VE L L
Sbjct: 295 LKEGTRMRAPDYTTP------------EMYQTMLDCWHGEPSQRPTFSELVEHLGNL 339
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 1e-07
Identities = 30/93 (32%), Positives = 48/93 (51%), Gaps = 9/93 (9%)
Query: 239 KGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYG 298
GL ++H +I+RD K N+ ++ + K+ DFGLA+ +V TR
Sbjct: 128 CGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTR-----W 179
Query: 299 YAAPEYVMTG-HLTAKSDVYSFGVVLLEMLTGR 330
Y APE ++ H D++S G ++ EMLTG+
Sbjct: 180 YRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 1e-07
Identities = 61/237 (25%), Positives = 99/237 (41%), Gaps = 43/237 (18%)
Query: 115 ELKSATKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEW 174
+L S RP LG G G V+ + V VAVK + Q K
Sbjct: 2 DLGSRYMDLRP---LGCGSNGLVF---------SAVDSDCDKRVAVKKIVLTDPQSVKHA 49
Query: 175 LAEVNYLGGLIHPNLVKL--------------IGCCIEDDQRLLVYEFMPRGSLENHLFR 220
L E+ + L H N+VK+ +G E + +V E+M E L
Sbjct: 50 LREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYM-----ETDL-A 103
Query: 221 RSL---PLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGE-YNAKLSDFG 276
L PL +GL ++H V++RD K +N+ ++ E K+ DFG
Sbjct: 104 NVLEQGPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLKIGDFG 160
Query: 277 LAK--DGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTAKSDVYSFGVVLLEMLTGR 330
LA+ D K ++S ++ + Y +P +++ + T D+++ G + EMLTG+
Sbjct: 161 LARIVDPHYSHKGYLSEGLVTKW-YRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 1e-07
Identities = 50/169 (29%), Positives = 69/169 (40%), Gaps = 22/169 (13%)
Query: 177 EVNYLGGLIHPNLVKLIGCCIEDDQRLLVYEFMPRGSL-------ENHLFRRSLPLPWSI 229
E L + HPN+V D +V E+ G L LF L W +
Sbjct: 48 EAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFV 107
Query: 230 RMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAK--DGPEGDKT 287
+M + G+ +HE K V++RD K+ NI L KL DFG A+ P
Sbjct: 108 QMCL------GVQHIHE---KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSP---GA 155
Query: 288 HVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKN 336
+ T V GT Y PE KSD++S G +L E+ T + N
Sbjct: 156 YACTYV-GTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQAN 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 2e-07
Identities = 55/220 (25%), Positives = 95/220 (43%), Gaps = 39/220 (17%)
Query: 129 LGEGGFGCVYKGWINMNGTATVKPGTGLPVAVK----TLNHDGLQGHKEWLAEVNYLGGL 184
+GEG +G VYK + TG VA+K ++ +G+ L E++ L L
Sbjct: 9 IGEGTYGKVYKA---RDKN------TGKLVALKKTRLEMDEEGIPPTA--LREISLLQML 57
Query: 185 IH-PNLVKLIGCCIEDDQR-------LLVYEFMP---RGSLENHLFRRSLPLPWSIRMKI 233
+V+L+ +E + LV+E++ + ++++ PLP
Sbjct: 58 SESIYIVRLL--DVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSF 115
Query: 234 ALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNA-KLSDFGLAKDG--PEGDKTHVS 290
KG+A H+ V++RD K N+L+D + K++D GL + P TH
Sbjct: 116 MYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTH-- 170
Query: 291 TRVMGTYGYAAPEYVMTG-HLTAKSDVYSFGVVLLEMLTG 329
+ T Y APE ++ H + D++S G + EM
Sbjct: 171 --EIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRK 208
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 3e-07
Identities = 43/150 (28%), Positives = 68/150 (45%), Gaps = 20/150 (13%)
Query: 195 CCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSI-RMKIALDAAKGLAFLHEEAEKPV 252
C E + L +V E++ G L + LP + RM A + L +LH +
Sbjct: 68 CSFETKRHLCMVMEYVEGGDCAT-LLKNIGALPVDMARMYFA-ETVLALEYLHNYG---I 122
Query: 253 IYRDFKTSNILLDGEYNAKLSDFGLAKDG--------PEGD-----KTHVSTRVMGTYGY 299
++RD K N+L+ + KL+DFGL+K G EG + + +V GT Y
Sbjct: 123 VHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEY 182
Query: 300 AAPEYVMTGHLTAKSDVYSFGVVLLEMLTG 329
APE ++ D ++ G++L E L G
Sbjct: 183 IAPEVILRQGYGKPVDWWAMGIILYEFLVG 212
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 3e-07
Identities = 54/221 (24%), Positives = 95/221 (42%), Gaps = 30/221 (13%)
Query: 123 FRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNH--DGLQGHKEWLAEVNY 180
++ + ++G+G +G V + + TG VA+K +N + + L E+
Sbjct: 2 YKIQEVIGKGSYGVV---------CSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKL 52
Query: 181 LGGLIHPNLVKLIGCCIEDDQR-----LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 235
L L HP++V++ + +R +V+E M S + + + + L
Sbjct: 53 LRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELM--ESDLHQVIKANDDLTPEHHQFFLY 110
Query: 236 DAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAK----DGPEGDKTHVST 291
+ L ++H V +RD K NIL + + K+ DFGLA+ D P T
Sbjct: 111 QLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAFNDTP---TAIFWT 164
Query: 292 RVMGTYGYAAPEYVMT--GHLTAKSDVYSFGVVLLEMLTGR 330
+ T Y APE + T D++S G + E+LTG+
Sbjct: 165 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 5e-07
Identities = 46/171 (26%), Positives = 67/171 (39%), Gaps = 48/171 (28%)
Query: 198 EDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKI-----ALDAAKGLAFLHEEAEKP 251
+D + L L+ EF+P G + L ++ + + I A+DA L F+H
Sbjct: 71 QDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIH------ 124
Query: 252 VIYRDFKTSNILLDGEYNAKLSDFGLA---------------KDGPEGD----------- 285
RD K N+LLD + + KLSDFGL P D
Sbjct: 125 ---RDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRK 181
Query: 286 -------KTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTG 329
+ ++ +GT Y APE M D +S GV++ EML G
Sbjct: 182 AETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 51.2 bits (123), Expect = 5e-07
Identities = 52/187 (27%), Positives = 81/187 (43%), Gaps = 19/187 (10%)
Query: 154 TGLPVAVKTLNH--DGLQGHKEWLAEVNYLGGLIHPNLVKLIGCCIEDDQR------LLV 205
T VA+K + + D K L E+ L L H N++ + + R +V
Sbjct: 29 TNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDI-MPPPHREAFNDVYIV 87
Query: 206 YEFMPRGSLENH-LFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILL 264
YE M + H + R S L +GL ++H V++RD K SN+LL
Sbjct: 88 YELM---DTDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLL 141
Query: 265 DGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTAKSDVYSFGVVL 323
+ + K+ DFGLA+ +K T + T Y APE ++ T DV+S G +
Sbjct: 142 NANCDLKICDFGLAR--TTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIF 199
Query: 324 LEMLTGR 330
E+L +
Sbjct: 200 AELLGRK 206
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 5e-07
Identities = 40/133 (30%), Positives = 60/133 (45%), Gaps = 10/133 (7%)
Query: 204 LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNIL 263
LV E+ P G L + L R + A+ + +H + ++RD K N+L
Sbjct: 78 LVMEYQPGGDLLSLLNRYEDQFDEDM---AQFYLAELVLAIHSVHQMGYVHRDIKPENVL 134
Query: 264 LDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKS------DVY 317
+D + KL+DFG A +K S +GT Y APE + T + K D +
Sbjct: 135 IDRTGHIKLADFGSAA-RLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWW 193
Query: 318 SFGVVLLEMLTGR 330
S GV+ EM+ GR
Sbjct: 194 SLGVIAYEMIYGR 206
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 9e-07
Identities = 42/164 (25%), Positives = 62/164 (37%), Gaps = 47/164 (28%)
Query: 204 LVYEFMPRGSLENHLFRRSLPLPWSIRMKIA-----LDAAKGLAFLHEEAEKPVIYRDFK 258
L+ EF+P G + L ++ + IA +D+ L F+H RD K
Sbjct: 78 LIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIH---------RDIK 128
Query: 259 TSNILLDGEYNAKLSDFGLAKDGPEGDKT------------------------------- 287
N+LLD + + KLSDFGL + +T
Sbjct: 129 PDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRN 188
Query: 288 --HVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTG 329
++ +GT Y APE M D +S GV++ EML G
Sbjct: 189 RRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 1e-06
Identities = 28/93 (30%), Positives = 51/93 (54%), Gaps = 9/93 (9%)
Query: 239 KGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYG 298
+GL ++H +I+RD K SN+ ++ + ++ DFGLA+ + +V+TR
Sbjct: 129 RGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGYVATR-----W 180
Query: 299 YAAPEYVMTG-HLTAKSDVYSFGVVLLEMLTGR 330
Y APE ++ H D++S G ++ E+L G+
Sbjct: 181 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 1e-06
Identities = 51/207 (24%), Positives = 91/207 (43%), Gaps = 14/207 (6%)
Query: 129 LGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHPN 188
LG+G F ++KG G T V +K L+ + + + + L H +
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKT--EVLLKVLDKSHRNYSESFFEAASMMSQLSHKH 60
Query: 189 LVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRR--SLPLPWSIRMKIALDAAKGLAF-LH 245
LV G C+ D+ ++V E++ GSL+ +L + + + W L+ AK LA+ LH
Sbjct: 61 LVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWK------LEVAKQLAWALH 114
Query: 246 EEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGT--YGYAAPE 303
+K + + + N+LL E + K + K G V + + + PE
Sbjct: 115 FLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLERIPWVPPE 174
Query: 304 YVMTG-HLTAKSDVYSFGVVLLEMLTG 329
+ +L+ +D +SFG L E+ +G
Sbjct: 175 CIENPQNLSLAADKWSFGTTLWEIFSG 201
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 1e-06
Identities = 46/172 (26%), Positives = 72/172 (41%), Gaps = 23/172 (13%)
Query: 238 AKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVST-RVMGT 296
A+G+ FL A K ++RD N+LL K+ DFGLA+D D +VS
Sbjct: 247 ARGMEFL---ASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMH-DSNYVSKGSTFLP 302
Query: 297 YGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERR 356
+ APE + T SDV+S+G++L E+ + L P +
Sbjct: 303 VKWMAPESIFDNLYTTLSDVWSYGILLWEIFS---------------LGGTPYPGMIVDS 347
Query: 357 RFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPR---MSEVVEALKP 405
FY I ++ + C N + + RP +S++VE+L P
Sbjct: 348 TFYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 2e-06
Identities = 40/160 (25%), Positives = 71/160 (44%), Gaps = 12/160 (7%)
Query: 177 EVNYLGGLIHPNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLF---RRSLPLPWSIRMKI 233
E + L + HP++++L G + L+ +PR + + + +R++ + + I
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLI---LPRYKTDLYCYLAAKRNIAI--CDILAI 187
Query: 234 ALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRV 293
+ + +LHE +I+RD K NI ++ + L DFG A P +
Sbjct: 188 ERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFG-AACFPVDINANKYYGW 243
Query: 294 MGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSM 333
GT APE + D++S G+VL EM T S+
Sbjct: 244 AGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSL 283
|
Length = 391 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 2e-06
Identities = 54/208 (25%), Positives = 91/208 (43%), Gaps = 22/208 (10%)
Query: 128 LLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTL-NHDGLQGHKEW-LAEVNYLGGLI 185
++GEG +G V K T VA+K + + + KE L E+ L L
Sbjct: 8 VVGEGAYGVVLK---------CRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLK 58
Query: 186 HPNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLP---LPWSIRMKIALDAAKGLA 242
N+V+L + LV+E++ + LE +P P +R I K +
Sbjct: 59 QENIVELKEAFRRRGKLYLVFEYVEKNMLE---LLEEMPNGVPPEKVRSYI-YQLIKAIH 114
Query: 243 FLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAP 302
+ H+ +++RD K N+L+ KL DFG A++ EG + T + T Y +P
Sbjct: 115 WCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANY-TEYVATRWYRSP 170
Query: 303 EYVMTGHLTAKSDVYSFGVVLLEMLTGR 330
E ++ D++S G +L E+ G+
Sbjct: 171 ELLLGAPYGKAVDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 49.3 bits (118), Expect = 2e-06
Identities = 33/102 (32%), Positives = 57/102 (55%), Gaps = 9/102 (8%)
Query: 240 GLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAK---DGPEGDKTHVSTRVMGT 296
GL ++H V++RD K N+L++ + K+ DFGLA+ + P + + T + T
Sbjct: 117 GLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFM-TEYVAT 172
Query: 297 YGYAAPEYVMTGHLTAKS-DVYSFGVVLLEMLTGRRSMDKNR 337
Y APE +++ K+ DV+S G +L E+L GR+ + K +
Sbjct: 173 RWYRAPEIMLSFQSYTKAIDVWSVGCILAELL-GRKPVFKGK 213
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 2e-06
Identities = 58/222 (26%), Positives = 96/222 (43%), Gaps = 37/222 (16%)
Query: 127 CLLGEGGFGCVYKGWINMNGTATVKPGTG-LPVAVKTLNHDGLQGHKEWLAEVNYLGGLI 185
C +G G +G VYK A K G A+K + G+ E+ L L
Sbjct: 7 CKVGRGTYGHVYK--------AKRKDGKDEKEYALKQIEGTGIS--MSACREIALLRELK 56
Query: 186 HPNLVKLIGCCIEDDQR--LLVYEFMP----------RGSLENHLFRRSLPLPWSIRMKI 233
HPN++ L + R L++++ R S N ++ + LP S+ +
Sbjct: 57 HPNVIALQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKAN---KKPMQLPRSMVKSL 113
Query: 234 ALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGE----YNAKLSDFGLAK--DGPEGDKT 287
G+ +LH V++RD K +NIL+ GE K++D G A+ + P
Sbjct: 114 LYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLA 170
Query: 288 HVSTRVMGTYGYAAPEYVMTG-HLTAKSDVYSFGVVLLEMLT 328
+ V+ T+ Y APE ++ H T D+++ G + E+LT
Sbjct: 171 DLDPVVV-TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 2e-06
Identities = 54/207 (26%), Positives = 84/207 (40%), Gaps = 51/207 (24%)
Query: 168 LQGHKEWLAEVNYLGGLIHPNLVKLIGCCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLP 226
+ G +W+ ++Y +D+ L LV ++ G L L + LP
Sbjct: 56 VNGDNQWITTLHY---------------AFQDENNLYLVMDYYVGGDLLTLLSKFEDRLP 100
Query: 227 ------WSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFG---- 276
+ M IA+D+ L ++H RD K NIL+D + +L+DFG
Sbjct: 101 EDMARFYLAEMVIAIDSVHQLHYVH---------RDIKPDNILMDMNGHIRLADFGSCLK 151
Query: 277 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-----GHLTAKSDVYSFGVVLLEMLTGRR 331
L +DG T S+ +GT Y +PE + G + D +S GV + EML G
Sbjct: 152 LMEDG-----TVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGE- 205
Query: 332 SMDKNRPNGEHNLVEWARPQLGERRRF 358
P +LVE + + RF
Sbjct: 206 -----TPFYAESLVETYGKIMNHKERF 227
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 49.3 bits (118), Expect = 2e-06
Identities = 29/91 (31%), Positives = 47/91 (51%), Gaps = 6/91 (6%)
Query: 240 GLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGY 299
G+ LH +I+RD K SNI++ + K+ DFGLA+ G ++ V+ Y Y
Sbjct: 130 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRY-Y 183
Query: 300 AAPEYVMTGHLTAKSDVYSFGVVLLEMLTGR 330
APE ++ D++S G ++ EM+ G
Sbjct: 184 RAPEVILGMGYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 4e-06
Identities = 32/92 (34%), Positives = 47/92 (51%), Gaps = 5/92 (5%)
Query: 238 AKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVST-RVMGT 296
A G+ FL A K ++RD N+L+ K+ DFGLA+D D ++S
Sbjct: 249 ANGMEFL---ASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMR-DSNYISKGSTFLP 304
Query: 297 YGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLT 328
+ APE + T SDV+SFG++L E+ T
Sbjct: 305 LKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 4e-06
Identities = 54/208 (25%), Positives = 89/208 (42%), Gaps = 27/208 (12%)
Query: 129 LGEGGFGCVYKGWINMNGTATVKPGTGLPV----AVKTLN-HDGLQGHKEWLAEVNYLGG 183
LG+G FG VY + L V V LN ++ +Q ++ E L
Sbjct: 8 LGKGSFGTVY-----LVKDKKAVAEERLKVLKEIPVGELNPNETVQANQ----EAQLLSK 58
Query: 184 LIHPNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFR-----RSLPLPWSIRMKIALDAA 238
L HP +VK +E D ++ E+ L+ L ++L I L
Sbjct: 59 LDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQL--L 116
Query: 239 KGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYG 298
G+ ++H ++ +++RD K NI L K+ DFG+++ ++T GT
Sbjct: 117 LGVHYMH---QRRILHRDLKAKNIFLKNNL-LKIGDFGVSR--LLMGSCDLATTFTGTPY 170
Query: 299 YAAPEYVMTGHLTAKSDVYSFGVVLLEM 326
Y +PE + +KSD++S G +L EM
Sbjct: 171 YMSPEALKHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 4e-06
Identities = 35/108 (32%), Positives = 50/108 (46%), Gaps = 23/108 (21%)
Query: 231 MKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFG----LAKDGPEGDK 286
M +A+D+ L ++H RD K N+LLD + +L+DFG L DG
Sbjct: 111 MVLAIDSVHQLGYVH---------RDIKPDNVLLDKNGHIRLADFGSCLRLLADG----- 156
Query: 287 THVSTRVMGTYGYAAPEYVM-----TGHLTAKSDVYSFGVVLLEMLTG 329
T S +GT Y +PE + G + D +S GV + EML G
Sbjct: 157 TVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 5e-06
Identities = 53/220 (24%), Positives = 86/220 (39%), Gaps = 58/220 (26%)
Query: 176 AEVNYLGGLIHPNLVKLIGCCIEDDQRLLVYEFMPRGSLENHL-----FRRSLPLPWSIR 230
AE + L + +VKL + D V +++P G + + L F L +
Sbjct: 50 AERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAE 109
Query: 231 MKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGL---------AKDG 281
+ A+++ + F+H RD K NIL+D + + KL+DFGL +K
Sbjct: 110 LTCAIESVHKMGFIH---------RDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY 160
Query: 282 PEGDKTHVS---------------------------TRVM-----GTYGYAAPEYVM-TG 308
+GD R + GT Y APE ++ TG
Sbjct: 161 QKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTG 220
Query: 309 HLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNG-EHNLVEW 347
+ T D +S GV+L EML G+ + P + ++ W
Sbjct: 221 Y-TQLCDWWSVGVILYEMLVGQPPFLADTPAETQLKVINW 259
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 5e-06
Identities = 50/201 (24%), Positives = 87/201 (43%), Gaps = 18/201 (8%)
Query: 129 LGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHPN 188
+G G +G VYK TG AVK + + E+ + H N
Sbjct: 17 VGSGTYGDVYKA---------RNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCN 67
Query: 189 LVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEA 248
+V G + ++ + E+ GSL++ ++ + PL + + +GLA+LH +
Sbjct: 68 IVAYFGSYLSREKLWICMEYCGGGSLQD-IYHVTGPLSELQIAYVCRETLQGLAYLHSKG 126
Query: 249 EKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-- 306
+ ++RD K +NILL + KL+DFG+A S +GT + APE
Sbjct: 127 K---MHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKS--FIGTPYWMAPEVAAVE 181
Query: 307 -TGHLTAKSDVYSFGVVLLEM 326
G D+++ G+ +E+
Sbjct: 182 KNGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 8e-06
Identities = 49/191 (25%), Positives = 80/191 (41%), Gaps = 34/191 (17%)
Query: 155 GLPVAVKTLNHD-GLQGH-KEWLAEVNYLGGLIHPNLVKLIGCCIEDDQRLLVYEFMPRG 212
G+ VAVK L+ Q H K E+ L + H N++ L+ F P+
Sbjct: 46 GINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNV------------FTPQK 93
Query: 213 SLEN----HLFRRSLPLPWSIRMKIALDAAK----------GLAFLHEEAEKPVIYRDFK 258
SLE +L + + + LD + G+ LH +I+RD K
Sbjct: 94 SLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLK 150
Query: 259 TSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYS 318
SNI++ + K+ DFGLA+ + T + T Y APE ++ D++S
Sbjct: 151 PSNIVVKSDCTLKILDFGLAR---TACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWS 207
Query: 319 FGVVLLEMLTG 329
G ++ E++ G
Sbjct: 208 VGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 9e-06
Identities = 57/222 (25%), Positives = 96/222 (43%), Gaps = 37/222 (16%)
Query: 127 CLLGEGGFGCVYKGWINMNGTATVKPGTG-LPVAVKTLNHDGLQGHKEWLAEVNYLGGLI 185
C +G G +G VYK A K G A+K + G+ E+ L L
Sbjct: 7 CKVGRGTYGHVYK--------AKRKDGKDDRDYALKQIEGTGIS--MSACREIALLRELK 56
Query: 186 HPNLVKLIGCCIE--DDQRLLVYEFMP----------RGSLENHLFRRSLPLPWSIRMKI 233
HPN++ L + D + L++++ R S N ++ + LP + +
Sbjct: 57 HPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKAN---KKPVQLPRGMVKSL 113
Query: 234 ALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGE----YNAKLSDFGLAK--DGPEGDKT 287
G+ +LH V++RD K +NIL+ GE K++D G A+ + P
Sbjct: 114 LYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLA 170
Query: 288 HVSTRVMGTYGYAAPEYVMTG-HLTAKSDVYSFGVVLLEMLT 328
+ V+ T+ Y APE ++ H T D+++ G + E+LT
Sbjct: 171 DLDPVVV-TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 1e-05
Identities = 29/91 (31%), Positives = 47/91 (51%), Gaps = 6/91 (6%)
Query: 240 GLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGY 299
G+ LH +I+RD K SNI++ + K+ DFGLA+ G ++ V+ Y Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRY-Y 191
Query: 300 AAPEYVMTGHLTAKSDVYSFGVVLLEMLTGR 330
APE ++ D++S G ++ EM+ G
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 3e-05
Identities = 63/255 (24%), Positives = 97/255 (38%), Gaps = 71/255 (27%)
Query: 129 LGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWL---AEVNYLGGLI 185
LG G FG V K T A+KTL + + AE + L
Sbjct: 9 LGIGAFGEV---------CLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEAD 59
Query: 186 HPNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFR-----RSLPLPWSIRMKIALDAAKG 240
+ +VKL + D V +++P G + + L R L + + +A+++
Sbjct: 60 NEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHK 119
Query: 241 LAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLA-------------------KDG 281
+ F+H RD K NIL+D + + KL+DFGL +D
Sbjct: 120 MGFIH---------RDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDS 170
Query: 282 PE-------------GD----------KTH---VSTRVMGTYGYAAPEYVMTGHLTAKSD 315
E GD K H ++ ++GT Y APE ++ T D
Sbjct: 171 MEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCD 230
Query: 316 VYSFGVVLLEMLTGR 330
+S GV+L EML G+
Sbjct: 231 WWSVGVILFEMLVGQ 245
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 4e-05
Identities = 34/115 (29%), Positives = 52/115 (45%), Gaps = 3/115 (2%)
Query: 211 RGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNA 270
R L +L R PL + +A + ++H E +I+RD KT N+L++G +
Sbjct: 243 RSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDI 299
Query: 271 KLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLE 325
L DFG A T + GT APE + T D++S G+V+ E
Sbjct: 300 CLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 4e-05
Identities = 67/265 (25%), Positives = 93/265 (35%), Gaps = 81/265 (30%)
Query: 123 FRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTL------NHDGLQGHKEWLA 176
F ++G+G FG V K TG A+KTL D L K A
Sbjct: 3 FHTVKVIGKGAFGEV---------RLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVK---A 50
Query: 177 EVNYLGGLIHPNLVKLIGCCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIA- 234
E + L P +V L +D Q L L+ EF+P G L L + R +A
Sbjct: 51 ERDVLAESDSPWVVSLY-YSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAE 109
Query: 235 ----LDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGL------------- 277
++A L F+H RD K NIL+D + KLSDFGL
Sbjct: 110 CVLAIEAVHKLGFIH---------RDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYY 160
Query: 278 --------AKDGPEGDKTHV-------------------STRVM-----GTYGYAAPEYV 305
K+ + + + R+M GT Y APE +
Sbjct: 161 QKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPE-I 219
Query: 306 MTGH-LTAKSDVYSFGVVLLEMLTG 329
+ D +S G ++ E L G
Sbjct: 220 FLQQGYGQECDWWSLGAIMFECLIG 244
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 5e-05
Identities = 42/148 (28%), Positives = 66/148 (44%), Gaps = 30/148 (20%)
Query: 198 EDDQRL-LVYEFMPRGSLENHLFRRSLPLP------WSIRMKIALDAAKGLAFLHEEAEK 250
+D+ L LV ++ G L L + LP + M +A+ + L ++H
Sbjct: 71 QDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVH----- 125
Query: 251 PVIYRDFKTSNILLDGEYNAKLSDFG----LAKDGPEGDKTHVSTRVMGTYGYAAPEYVM 306
RD K N+LLD + +L+DFG + +DG T S+ +GT Y +PE +
Sbjct: 126 ----RDIKPDNVLLDMNGHIRLADFGSCLKMNQDG-----TVQSSVAVGTPDYISPEILQ 176
Query: 307 T-----GHLTAKSDVYSFGVVLLEMLTG 329
G + D +S GV + EML G
Sbjct: 177 AMEDGMGKYGPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 45.5 bits (107), Expect = 5e-05
Identities = 43/162 (26%), Positives = 73/162 (45%), Gaps = 21/162 (12%)
Query: 177 EVNYLGGLIHPNLVKLIGCCIEDDQRLLV--------YEFMPRGSLENHLFRRSLPLPWS 228
E+ LG L H N++K+ + ++ Y FM + + + PL
Sbjct: 213 EILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFD----WKDRPLLKQ 268
Query: 229 IR--MKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDK 286
R MK L A + ++H+ K +I+RD K NI L+ + L DFG A E ++
Sbjct: 269 TRAIMKQLLCA---VEYIHD---KKLIHRDIKLENIFLNCDGKIVLGDFGTAMPF-EKER 321
Query: 287 THVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLT 328
+GT +PE + +D++S G++LL+ML+
Sbjct: 322 EAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 45.1 bits (106), Expect = 5e-05
Identities = 28/88 (31%), Positives = 46/88 (52%), Gaps = 6/88 (6%)
Query: 240 GLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGY 299
G+ LH +I+RD K SNI++ + K+ DFGLA+ G ++ V+ Y Y
Sbjct: 131 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRY-Y 184
Query: 300 AAPEYVMTGHLTAKSDVYSFGVVLLEML 327
APE ++ D++S G ++ EM+
Sbjct: 185 RAPEVILGMGYKENVDIWSVGCIMGEMV 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 9e-05
Identities = 42/183 (22%), Positives = 67/183 (36%), Gaps = 59/183 (32%)
Query: 198 EDDQRLLVYEFMPRGSLENHL-----FRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPV 252
+ D V +++P G + + L F L + + A+++ + F+H
Sbjct: 72 DKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIH------- 124
Query: 253 IYRDFKTSNILLDGEYNAKLSDFGL--------------AKDGPEGDKTHVSTR------ 292
RD K NIL+D + + KL+DFGL + D D S
Sbjct: 125 --RDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPAN 182
Query: 293 -------------------------VMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEML 327
++GT Y APE ++ T D +S GV+L EML
Sbjct: 183 CRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 242
Query: 328 TGR 330
G+
Sbjct: 243 VGQ 245
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 1e-04
Identities = 40/167 (23%), Positives = 72/167 (43%), Gaps = 14/167 (8%)
Query: 121 KSFRPECLLGEGGFGCVYK------GWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEW 174
K ++ + L+G GGFGCVY+ IN A ++ + ++TL ++ + +
Sbjct: 12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIY-DIDK 70
Query: 175 LAEVNYLGGLIHPNLVKLIGCCIEDDQRLLVYEFMPRGSL---ENHLFRRSLPLPWSIRM 231
+A + + H + K GC R+ Y F+ L +F+R +
Sbjct: 71 IALWKNIHNIDHLGIPKYYGCGSFKRCRMY-YRFILLEKLVENTKEIFKRIKCKNKKLIK 129
Query: 232 KIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLA 278
I D L ++HE + + D K NI++DG + D+G+A
Sbjct: 130 NIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGNNRGYIIDYGIA 173
|
Length = 294 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 2e-04
Identities = 44/158 (27%), Positives = 73/158 (46%), Gaps = 21/158 (13%)
Query: 186 HPNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLP--LPWSIRMKIALDAAKGLAF 243
HPN++ ++ FM GS N L + P + ++ I A +GL +
Sbjct: 58 HPNIMTSWTVFTTGSWLWVISPFMAYGS-ANSLLKTYFPEGMSEALIGNILFGALRGLNY 116
Query: 244 LHEEAEKPVIYRDFKTSNILLDGEYNAKLSD----FGLAKDGPEG----DKTHVSTRVMG 295
LH+ I+R+ K S+IL+ G+ LS + L ++G + D ST V+
Sbjct: 117 LHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLP 173
Query: 296 TYGYAAPEYV---MTGHLTAKSDVYSFGVVLLEMLTGR 330
+ +PE + + G+ KSD+YS G+ E+ TGR
Sbjct: 174 ---WLSPELLRQDLYGY-NVKSDIYSVGITACELATGR 207
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 4e-04
Identities = 53/197 (26%), Positives = 88/197 (44%), Gaps = 31/197 (15%)
Query: 186 HPNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLH 245
H +L + G C+ + ++V EF+ G L+ L + +P + ++ +A A L++L
Sbjct: 75 HIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLE 134
Query: 246 EEAEKPVIYRDFKTSNILL------DGEYN-AKLSDFGLAKDGPEGDKTHVSTRVMGTYG 298
+K +++ + NILL +G KLSD G++ ++ RV
Sbjct: 135 ---DKNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSREE-----RV-ERIP 185
Query: 299 YAAPEYVMTG-HLTAKSDVYSFGVVLLEM-------LTGRRSMDKNR-PNGEHNLVEWAR 349
+ APE V G L+ +D +SFG LLE+ L R +K R +H L E +
Sbjct: 186 WIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKERFYEKKHRLPEPSC 245
Query: 350 PQLGERRRFYRLIDPCL 366
+L LI CL
Sbjct: 246 KELAT------LISQCL 256
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.8 bits (100), Expect = 4e-04
Identities = 53/207 (25%), Positives = 97/207 (46%), Gaps = 37/207 (17%)
Query: 161 KTLNHDGLQGHK--EWLAEVNYLGGLIHPNLVKLIGCCIED-DQRL-LVYEFMPRGSLEN 216
K +++ GL+ + + + EVN + L H N+V+ I + +Q+L ++ EF G L
Sbjct: 44 KAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSR 103
Query: 217 HLFRRSLPLPWSIRMKIALDAAK----GLAFLHEEAEKP----VIYRDFKTSNILL---- 264
++ ++ + I +D + LA+ H + P V++RD K NI L
Sbjct: 104 NI-QKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGI 162
Query: 265 -------------DGEYNAKLSDFGLAKD-GPEGDKTHVSTRVMGTYGYAAPEYVM--TG 308
+G AK+ DFGL+K+ G E ++ +GT Y +PE ++ T
Sbjct: 163 RHIGKITAQANNLNGRPIAKIGDFGLSKNIGIES----MAHSCVGTPYYWSPELLLHETK 218
Query: 309 HLTAKSDVYSFGVVLLEMLTGRRSMDK 335
KSD+++ G ++ E+ +G+ K
Sbjct: 219 SYDDKSDMWALGCIIYELCSGKTPFHK 245
|
Length = 1021 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 38.7 bits (91), Expect = 0.004
Identities = 41/148 (27%), Positives = 66/148 (44%), Gaps = 17/148 (11%)
Query: 186 HPNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLH 245
+PN +KL +L+ +++ G L + L ++ L + KI + L LH
Sbjct: 68 NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFD-LLKKEGKLSEAEVKKIIRQLVEALNDLH 126
Query: 246 EEAEKPVIYRDFKTSNILLDG-EYNAKLSDFGLAKDGPEGDKTHVSTRVM--GTYGYAAP 302
+ +I+ D K N+L D + L D+GL K + T GT Y +P
Sbjct: 127 K---HNIIHNDIKLENVLYDRAKDRIYLCDYGLCK--------IIGTPSCYDGTLDYFSP 175
Query: 303 EYVMTGHLTAKS-DVYSFGVVLLEMLTG 329
E + GH S D ++ GV+ E+LTG
Sbjct: 176 EKI-KGHNYDVSFDWWAVGVLTYELLTG 202
|
Length = 267 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 476 | |||
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 100.0 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.98 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.98 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.97 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.97 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.97 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.96 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.95 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.95 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.95 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.95 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.94 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.94 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.94 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.92 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.91 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.89 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.89 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.88 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.88 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.88 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.88 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.87 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.87 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.86 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.85 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.85 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.81 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.8 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.8 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.8 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.79 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.78 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.77 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.72 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.7 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.69 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.62 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.56 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.49 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.49 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.46 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.46 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.41 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.38 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.34 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.3 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.27 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.24 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.2 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.0 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.98 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.97 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.92 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.83 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.74 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.72 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.71 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.63 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.59 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.52 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.45 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.42 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.37 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.36 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.29 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.23 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.16 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.15 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 98.13 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.12 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.07 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.91 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.9 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.89 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.81 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.71 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.7 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.64 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.62 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.58 | |
| PLN02236 | 344 | choline kinase | 97.18 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.12 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.1 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.02 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.96 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.8 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 96.77 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.77 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 96.72 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 96.63 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 96.59 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.57 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.47 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 96.41 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.21 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.19 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 95.93 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 95.9 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 95.8 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 95.34 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 95.33 | |
| PTZ00384 | 383 | choline kinase; Provisional | 94.27 |
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-55 Score=422.44 Aligned_cols=264 Identities=27% Similarity=0.387 Sum_probs=216.1
Q ss_pred hccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccC-------HHHHHHHHHHHhCCCCCceee
Q 011851 119 ATKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQG-------HKEWLAEVNYLGGLIHPNLVK 191 (476)
Q Consensus 119 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~-------~~~~~~E~~~l~~l~hpnIv~ 191 (476)
....|.+.+.||+|+||.|-+|. ++.||+.||||++++..... ...+.+|++||++|+|||||+
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~---------e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~ 240 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAY---------EKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVR 240 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEE---------EcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEE
Confidence 44568999999999999999874 55799999999998754332 223579999999999999999
Q ss_pred EEEEEEeCCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCC---C
Q 011851 192 LIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGE---Y 268 (476)
Q Consensus 192 l~~~~~~~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~---~ 268 (476)
++++|+..+..||||||++||+|++.+..+ ..+.+..-..+++|++.||.|||++| |+||||||+|||+..+ .
T Consensus 241 ~~d~f~~~ds~YmVlE~v~GGeLfd~vv~n-k~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~ 316 (475)
T KOG0615|consen 241 IKDFFEVPDSSYMVLEYVEGGELFDKVVAN-KYLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDC 316 (475)
T ss_pred EeeeeecCCceEEEEEEecCccHHHHHHhc-cccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcce
Confidence 999999999999999999999999999654 56888889999999999999999999 9999999999999766 7
Q ss_pred ceEEeecCCcCCCCCCCccceeeeeecCCCCCCcchhhcCC---CCccchhhhhHHHHHHHHhCCCCCCCCCCCC-cchh
Q 011851 269 NAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGH---LTAKSDVYSFGVVLLEMLTGRRSMDKNRPNG-EHNL 344 (476)
Q Consensus 269 ~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DiwslGv~l~elltG~~pf~~~~~~~-~~~~ 344 (476)
.+||+|||+|+...++ ..+.++||||.|.|||++.... +..++|||||||+||-+|+|.+||....... ....
T Consensus 317 llKItDFGlAK~~g~~---sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQ 393 (475)
T KOG0615|consen 317 LLKITDFGLAKVSGEG---SFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQ 393 (475)
T ss_pred EEEecccchhhccccc---eehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHH
Confidence 8999999999986532 3455699999999999998764 4458899999999999999999998654433 2222
Q ss_pred HHhhhhhhccccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCcccccCcc
Q 011851 345 VEWARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDMASSS 416 (476)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~~~~~~ 416 (476)
+...+... .. + .-...+++..+||.+||..||++|||+.|+|+| |||++....+
T Consensus 394 I~~G~y~f------~p---~-----~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h----pW~~~~~~~s 447 (475)
T KOG0615|consen 394 ILKGRYAF------GP---L-----QWDRISEEALDLINWMLVVDPENRPSADEALNH----PWFKDAPCLS 447 (475)
T ss_pred HhcCcccc------cC---h-----hhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC----hhhhcccccc
Confidence 21111111 00 0 112347899999999999999999999999998 9999876433
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-53 Score=423.21 Aligned_cols=287 Identities=58% Similarity=0.965 Sum_probs=252.0
Q ss_pred cccccChhHHHHhccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCCCC
Q 011851 107 QLRKFSFNELKSATKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIH 186 (476)
Q Consensus 107 ~~~~~~~~~~~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~h 186 (476)
..+.|++.++..+|++|....+||+|+||.||+|... .|..||||.+.....+..++|..|+++|.+++|
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~----------~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H 130 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLS----------DGTVVAVKRLSSNSGQGEREFLNEVEILSRLRH 130 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEEC----------CCCEEEEEEecCCCCcchhHHHHHHHHHhcCCC
Confidence 4678999999999999999999999999999999875 346799998876544314669999999999999
Q ss_pred CceeeEEEEEEeCC-eeEEEEEecCCCCHHHHHhhcCC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeee
Q 011851 187 PNLVKLIGCCIEDD-QRLLVYEFMPRGSLENHLFRRSL-PLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILL 264 (476)
Q Consensus 187 pnIv~l~~~~~~~~-~~~lV~E~~~~g~L~~~l~~~~~-~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl 264 (476)
||+|+|+|||.+.+ +.+||+||+++|+|.++|+.... +++|..+++|+.++|+||+|||.....+|||||||++||||
T Consensus 131 ~Nlv~LlGyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILL 210 (361)
T KOG1187|consen 131 PNLVKLLGYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILL 210 (361)
T ss_pred cCcccEEEEEecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeE
Confidence 99999999999999 59999999999999999987766 89999999999999999999999887789999999999999
Q ss_pred cCCCceEEeecCCcCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchh
Q 011851 265 DGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNL 344 (476)
Q Consensus 265 ~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~ 344 (476)
|+++++||+|||+|+..... .....+...||.+|+|||++..+..+.++|||||||+|+||+||+.+.+...+.....+
T Consensus 211 D~~~~aKlsDFGLa~~~~~~-~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l 289 (361)
T KOG1187|consen 211 DEDFNAKLSDFGLAKLGPEG-DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSL 289 (361)
T ss_pred CCCCCEEccCccCcccCCcc-ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccH
Confidence 99999999999999775541 12111111799999999999999999999999999999999999999987766666778
Q ss_pred HHhhhhhhccccccccccCcccC-CCCCh-HHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 011851 345 VEWARPQLGERRRFYRLIDPCLE-GCFSI-KGAEKTIQLAASCLNRDQKARPRMSEVVEALKP 405 (476)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~d~~l~-~~~~~-~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~ 405 (476)
+.|..+.+.+. .+.+++|+.+. +.+.. .....+..+..+|++.+|.+||+|.+|++.|+.
T Consensus 290 ~~w~~~~~~~~-~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~ 351 (361)
T KOG1187|consen 290 VEWAKPLLEEG-KLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEG 351 (361)
T ss_pred HHHHHHHHHCc-chhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHh
Confidence 99987777665 78999999987 66664 567789999999999999999999999998744
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-54 Score=430.71 Aligned_cols=253 Identities=28% Similarity=0.435 Sum_probs=218.6
Q ss_pred cCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCcc---CHHHHHHHHHHHhCCCCCceeeEEEEEE
Q 011851 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQ---GHKEWLAEVNYLGGLIHPNLVKLIGCCI 197 (476)
Q Consensus 121 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~---~~~~~~~E~~~l~~l~hpnIv~l~~~~~ 197 (476)
.+|...++||+|+|+.||++++. .+|+.||+|++.+.... ..+.+.+||+|.+.|+|||||+++++|+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~---------~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FE 88 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDL---------DTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFE 88 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEc---------CCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEee
Confidence 56999999999999999998763 48889999999875433 3456889999999999999999999999
Q ss_pred eCCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCC
Q 011851 198 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGL 277 (476)
Q Consensus 198 ~~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~ 277 (476)
+.+++|||+|+|..++|..++. +..+++|.++++++.||+.||.|||+++ |||||||..|+||+++.+|||+||||
T Consensus 89 Ds~nVYivLELC~~~sL~el~K-rrk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGL 164 (592)
T KOG0575|consen 89 DSNNVYIVLELCHRGSLMELLK-RRKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGL 164 (592)
T ss_pred cCCceEEEEEecCCccHHHHHH-hcCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccce
Confidence 9999999999999999998885 6678999999999999999999999988 99999999999999999999999999
Q ss_pred cCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhccccc
Q 011851 278 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRR 357 (476)
Q Consensus 278 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 357 (476)
|..+...+.. ..+.||||.|+|||++....++..+||||+||+||.||+|++||+...-.+....+.....
T Consensus 165 At~le~~~Er--k~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y------- 235 (592)
T KOG0575|consen 165 ATQLEYDGER--KKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEY------- 235 (592)
T ss_pred eeeecCcccc--cceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCc-------
Confidence 9987654332 3458999999999999999999999999999999999999999986543333222221111
Q ss_pred cccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCcc
Q 011851 358 FYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLK 410 (476)
Q Consensus 358 ~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~ 410 (476)
.++...+.++.+||.++|+.||.+|||+++||.| +||+
T Consensus 236 -----------~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h----~Ff~ 273 (592)
T KOG0575|consen 236 -----------SMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDH----PFFK 273 (592)
T ss_pred -----------ccccccCHHHHHHHHHHhcCCcccCCCHHHHhcC----Hhhh
Confidence 1223447899999999999999999999999998 8883
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-54 Score=411.05 Aligned_cols=263 Identities=28% Similarity=0.374 Sum_probs=217.6
Q ss_pred ccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCH---HHHHHHHHHHhCCCCCceeeEEEEE
Q 011851 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGH---KEWLAEVNYLGGLIHPNLVKLIGCC 196 (476)
Q Consensus 120 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~---~~~~~E~~~l~~l~hpnIv~l~~~~ 196 (476)
.++|+++++||+|+||+||.++. +.|++.||+|++++...-.. +....|..||.+++||+||+++..|
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk---------~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysF 94 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRK---------KDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSF 94 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEE---------cccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEec
Confidence 34699999999999999999654 46899999999988755443 4567899999999999999999999
Q ss_pred EeCCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecC
Q 011851 197 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFG 276 (476)
Q Consensus 197 ~~~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG 276 (476)
++.+.+|||+||+.||.|+.+|.+ .+.+++..+..++.+|+.||.|||+.+ ||||||||+|||||.+|+++|+|||
T Consensus 95 Qt~~kLylVld~~~GGeLf~hL~~-eg~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFg 170 (357)
T KOG0598|consen 95 QTEEKLYLVLDYLNGGELFYHLQR-EGRFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFG 170 (357)
T ss_pred ccCCeEEEEEeccCCccHHHHHHh-cCCcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccc
Confidence 999999999999999999999954 457999999999999999999999988 9999999999999999999999999
Q ss_pred CcCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhcccc
Q 011851 277 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERR 356 (476)
Q Consensus 277 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~ 356 (476)
+++....... .+.++|||+.|||||++.+.+|+.++|+|||||++|||++|.+||...+.....+.+....
T Consensus 171 L~k~~~~~~~--~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k------- 241 (357)
T KOG0598|consen 171 LCKEDLKDGD--ATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGK------- 241 (357)
T ss_pred cchhcccCCC--ccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCc-------
Confidence 9996443322 2445899999999999999999999999999999999999999998765432222211111
Q ss_pred ccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCcccccC
Q 011851 357 RFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDMAS 414 (476)
Q Consensus 357 ~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~~~~ 414 (476)
...++.-.+.++.+|+.++|..||++|.....=.+.++.+|||+++..
T Consensus 242 ----------~~~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~inW 289 (357)
T KOG0598|consen 242 ----------LPLPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKGINW 289 (357)
T ss_pred ----------CCCCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcCcccccCCH
Confidence 000111236789999999999999999743333344777899998764
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-53 Score=400.57 Aligned_cols=264 Identities=27% Similarity=0.407 Sum_probs=217.5
Q ss_pred CCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCc-cCHHHHHHHHHHHhCCCCCceeeEEEEEEeCC
Q 011851 122 SFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL-QGHKEWLAEVNYLGGLIHPNLVKLIGCCIEDD 200 (476)
Q Consensus 122 ~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 200 (476)
+.+.++.||+|..|+||++.+ +.|++.+|+|++..... ...+++.+|+++++.++|||||.+|++|..++
T Consensus 80 dle~~~~lG~G~gG~V~kv~H---------k~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~ 150 (364)
T KOG0581|consen 80 DLERLGVLGSGNGGTVYKVRH---------KPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNG 150 (364)
T ss_pred HhhhhhhcccCCCcEEEEEEE---------cCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCC
Confidence 345667899999999999755 46889999999954433 33578999999999999999999999999999
Q ss_pred -eeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCCeeecCCCceEEeecCCc
Q 011851 201 -QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHE-EAEKPVIYRDFKTSNILLDGEYNAKLSDFGLA 278 (476)
Q Consensus 201 -~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~-~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a 278 (476)
.++|+||||++|+|++++... +.+++.....++.+|++||.|||+ ++ ||||||||+||||+..|.|||||||.+
T Consensus 151 ~~isI~mEYMDgGSLd~~~k~~-g~i~E~~L~~ia~~VL~GL~YLh~~~~---IIHRDIKPsNlLvNskGeVKicDFGVS 226 (364)
T KOG0581|consen 151 EEISICMEYMDGGSLDDILKRV-GRIPEPVLGKIARAVLRGLSYLHEERK---IIHRDIKPSNLLVNSKGEVKICDFGVS 226 (364)
T ss_pred ceEEeehhhcCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhhccC---eeeccCCHHHeeeccCCCEEecccccc
Confidence 499999999999999988544 679999999999999999999996 55 999999999999999999999999999
Q ss_pred CCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCC--CcchhHHhhhhhhcccc
Q 011851 279 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPN--GEHNLVEWARPQLGERR 356 (476)
Q Consensus 279 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~--~~~~~~~~~~~~~~~~~ 356 (476)
+...+. ...+++||..|||||.+.+..|+.++||||||++++||++|+.||....+. ....+..+.. .+.
T Consensus 227 ~~lvnS----~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv---~~p- 298 (364)
T KOG0581|consen 227 GILVNS----IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIV---DEP- 298 (364)
T ss_pred HHhhhh----hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHh---cCC-
Confidence 887553 345689999999999999999999999999999999999999999765221 1112221111 100
Q ss_pred ccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCcccccCcchHH
Q 011851 357 RFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDMASSSSYV 419 (476)
Q Consensus 357 ~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~~~~~~~~~ 419 (476)
.|.+... ..++++++||..||++||.+||++.++++| ||+++........
T Consensus 299 ------pP~lP~~---~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H----pfi~~~~~~~vd~ 348 (364)
T KOG0581|consen 299 ------PPRLPEG---EFSPEFRSFVSCCLRKDPSERPSAKQLLQH----PFIKKFEDPNVDM 348 (364)
T ss_pred ------CCCCCcc---cCCHHHHHHHHHHhcCCcccCCCHHHHhcC----HHHhhcccccccH
Confidence 0111111 247899999999999999999999999998 9999876655443
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-52 Score=408.40 Aligned_cols=265 Identities=26% Similarity=0.352 Sum_probs=221.7
Q ss_pred HHhccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccC---HHHHHHHHHHHhCC-CCCceeeE
Q 011851 117 KSATKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQG---HKEWLAEVNYLGGL-IHPNLVKL 192 (476)
Q Consensus 117 ~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~---~~~~~~E~~~l~~l-~hpnIv~l 192 (476)
+...++|.+++.||+|+|++||+|+.. .+++.||||++.+..... .+.+..|-++|.+| .||.|++|
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~---------~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkL 139 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREK---------ATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKL 139 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeec---------CCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEE
Confidence 455678999999999999999998654 588999999997754332 34567899999999 79999999
Q ss_pred EEEEEeCCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEE
Q 011851 193 IGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKL 272 (476)
Q Consensus 193 ~~~~~~~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl 272 (476)
|..|.++..+|+|+||+++|+|.++|.+- +.|++..++.++.||+.||+|||++| ||||||||+|||||+|+++||
T Consensus 140 y~TFQD~~sLYFvLe~A~nGdll~~i~K~-Gsfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikI 215 (604)
T KOG0592|consen 140 YFTFQDEESLYFVLEYAPNGDLLDLIKKY-GSFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKI 215 (604)
T ss_pred EEEeecccceEEEEEecCCCcHHHHHHHh-CcchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEE
Confidence 99999999999999999999999999554 67999999999999999999999999 999999999999999999999
Q ss_pred eecCCcCCCCCCCcc---------cee--eeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCc
Q 011851 273 SDFGLAKDGPEGDKT---------HVS--TRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGE 341 (476)
Q Consensus 273 ~DFG~a~~~~~~~~~---------~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~ 341 (476)
+|||.|+.+...... ... ..++||..|++||++..+..++.+|||+||||||+|+.|.+||.+.++...
T Consensus 216 TDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Neyli 295 (604)
T KOG0592|consen 216 TDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLI 295 (604)
T ss_pred eeccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHH
Confidence 999999876542221 111 459999999999999999999999999999999999999999987654322
Q ss_pred chhHHhhhhhhccccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCcccccCcc
Q 011851 342 HNLVEWARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDMASSS 416 (476)
Q Consensus 342 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~~~~~~ 416 (476)
..-+. + +.-.|+...++.+.+||+++|..||.+|+|+++|.+| |||.++....
T Consensus 296 FqkI~----------------~--l~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H----pFF~~Vdw~n 348 (604)
T KOG0592|consen 296 FQKIQ----------------A--LDYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAH----PFFEGVDWEN 348 (604)
T ss_pred HHHHH----------------H--hcccCCCCCCHHHHHHHHHHHccCccccccHHHHhhC----cccccCChhh
Confidence 21111 1 1112334446889999999999999999999887776 9999887644
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-52 Score=397.89 Aligned_cols=252 Identities=30% Similarity=0.457 Sum_probs=206.1
Q ss_pred ccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCC--ccCHHHHHHHHHHHhCCCCCceeeEEEEEE
Q 011851 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDG--LQGHKEWLAEVNYLGGLIHPNLVKLIGCCI 197 (476)
Q Consensus 120 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~ 197 (476)
..+|.+.+.||+|+||+||+|+++ .++..||||.+.+.. .+..+.+..|+.||+.++|||||.|++++.
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~---------~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~ 79 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHK---------KSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIE 79 (429)
T ss_pred cccceehhhccCcceEEEEEeEec---------cCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEe
Confidence 346889999999999999999876 356789999998774 334456788999999999999999999999
Q ss_pred eCCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCC------CceE
Q 011851 198 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGE------YNAK 271 (476)
Q Consensus 198 ~~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~------~~vk 271 (476)
.++.+|||||||.||+|.++|+++ +.+++..++.++.||+.||++||+++ ||||||||+||||+.. -.+|
T Consensus 80 ~~~~i~lVMEyC~gGDLs~yi~~~-~~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LK 155 (429)
T KOG0595|consen 80 DDDFIYLVMEYCNGGDLSDYIRRR-GRLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLK 155 (429)
T ss_pred cCCeEEEEEEeCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEE
Confidence 999999999999999999999665 47999999999999999999999988 9999999999999764 4689
Q ss_pred EeecCCcCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhh
Q 011851 272 LSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQ 351 (476)
Q Consensus 272 l~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~ 351 (476)
|+|||+|+.+..+. ...+.||++.|||||+++...|+.|+|+||+|++||+|++|+.||+.....+....++.....
T Consensus 156 IADFGfAR~L~~~~---~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~ 232 (429)
T KOG0595|consen 156 IADFGFARFLQPGS---MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEI 232 (429)
T ss_pred ecccchhhhCCchh---HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccc
Confidence 99999999986543 234589999999999999999999999999999999999999999876554333222211111
Q ss_pred hccccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011851 352 LGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEA 402 (476)
Q Consensus 352 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~ 402 (476)
+ ..++...+..+.+|+...|+++|.+|-+..+-..+
T Consensus 233 ~---------------~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~ 268 (429)
T KOG0595|consen 233 V---------------PVLPAELSNPLRELLISLLQRNPKDRISFEDFFDH 268 (429)
T ss_pred c---------------CchhhhccCchhhhhhHHHhcCccccCchHHhhhh
Confidence 1 11111223455577888888888888777776654
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-51 Score=379.49 Aligned_cols=271 Identities=26% Similarity=0.332 Sum_probs=216.9
Q ss_pred CCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCc-c-CHHHHHHHHHHHhCCCCCceeeEEEEEEeC
Q 011851 122 SFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL-Q-GHKEWLAEVNYLGGLIHPNLVKLIGCCIED 199 (476)
Q Consensus 122 ~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~-~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~ 199 (476)
.|+.+.++|+|+||+||++++ +.||+.||||.+..... . -.+-.++|+++|++|+|+|+|.|+++|...
T Consensus 3 kYE~LgkvGEGSYGvV~KCrn---------k~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrk 73 (396)
T KOG0593|consen 3 KYEKLGKVGEGSYGVVMKCRN---------KDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRK 73 (396)
T ss_pred HHhhhhccccCcceEEEEecc---------CCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhc
Confidence 578888999999999999755 46899999999865543 2 234568999999999999999999999999
Q ss_pred CeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCcC
Q 011851 200 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAK 279 (476)
Q Consensus 200 ~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~ 279 (476)
..++||+|||+. ++.+.|.+....++...+.++++|++.|+.|||+++ +|||||||+||||+.+|.+||||||+|+
T Consensus 74 rklhLVFE~~dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR 149 (396)
T KOG0593|consen 74 RKLHLVFEYCDH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFAR 149 (396)
T ss_pred ceeEEEeeecch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhH
Confidence 999999999976 555566666667999999999999999999999998 9999999999999999999999999999
Q ss_pred CCCCCCccceeeeeecCCCCCCcchhhc-CCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhcc----
Q 011851 280 DGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGE---- 354 (476)
Q Consensus 280 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~---- 354 (476)
.... .....+.++.|.+|+|||++.+ -.|+..+||||+||++.||++|.+-|.+....+....+......+.-
T Consensus 150 ~L~~--pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~ 227 (396)
T KOG0593|consen 150 TLSA--PGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQS 227 (396)
T ss_pred hhcC--CcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHH
Confidence 8763 2233566889999999999998 48999999999999999999999999887665554444332222211
Q ss_pred ----ccccccccCcccC------CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCcccc
Q 011851 355 ----RRRFYRLIDPCLE------GCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDM 412 (476)
Q Consensus 355 ----~~~~~~~~d~~l~------~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~~ 412 (476)
...|.-+.-|... ..|+ ..+.-+.+|++.||..||++|++.++++.| +||.+.
T Consensus 228 iF~~N~~F~Gv~lP~~~~~epLe~k~p-~~s~~~ld~~k~cL~~dP~~R~sc~qll~H----~yFd~~ 290 (396)
T KOG0593|consen 228 IFSSNPFFHGVRLPEPEHPEPLERKYP-KISNVLLDLLKKCLKMDPDDRLSCEQLLHH----PYFDGF 290 (396)
T ss_pred HhccCCceeeeecCCCCCccchhhhcc-cchHHHHHHHHHHhcCCccccccHHHHhcC----hHHHHH
Confidence 1111111111111 1111 235578999999999999999999999998 888653
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-51 Score=400.98 Aligned_cols=268 Identities=25% Similarity=0.355 Sum_probs=217.8
Q ss_pred hccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCH---HHHHHHHHHHhCCCCCceeeEEEE
Q 011851 119 ATKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGH---KEWLAEVNYLGGLIHPNLVKLIGC 195 (476)
Q Consensus 119 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~---~~~~~E~~~l~~l~hpnIv~l~~~ 195 (476)
..++|.++++||+|+||.||+|+ ++.||..||+|++++...... +-++.|-++|...++|+||+||..
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLar---------Kk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYs 209 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLAR---------KKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYS 209 (550)
T ss_pred CcccchhheeeccccceeEEEEE---------EccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEE
Confidence 34679999999999999999964 557999999999998765443 446789999999999999999999
Q ss_pred EEeCCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeec
Q 011851 196 CIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDF 275 (476)
Q Consensus 196 ~~~~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DF 275 (476)
|++.+++||||||++||++..+|.+. +.|++..++.++.+++.||+.||+.| +|||||||+|+|||..|++||+||
T Consensus 210 FQD~~~LYLiMEylPGGD~mTLL~~~-~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDF 285 (550)
T KOG0605|consen 210 FQDKEYLYLIMEYLPGGDMMTLLMRK-DTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDF 285 (550)
T ss_pred ecCCCeeEEEEEecCCccHHHHHHhc-CcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccc
Confidence 99999999999999999999999654 57999999999999999999999999 999999999999999999999999
Q ss_pred CCcCCCCC----------------------CCcc----ce-------------------eeeeecCCCCCCcchhhcCCC
Q 011851 276 GLAKDGPE----------------------GDKT----HV-------------------STRVMGTYGYAAPEYVMTGHL 310 (476)
Q Consensus 276 G~a~~~~~----------------------~~~~----~~-------------------~~~~~gt~~y~aPE~~~~~~~ 310 (476)
||+.-... .+.. .. ....+|||.|||||++.+..|
T Consensus 286 GLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY 365 (550)
T KOG0605|consen 286 GLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGY 365 (550)
T ss_pred cccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCC
Confidence 99852111 0000 00 113689999999999999999
Q ss_pred CccchhhhhHHHHHHHHhCCCCCCCCCCCCcch-hHHhhhhhhccccccccccCcccCCCCChHHHHHHHHHHHHhcccC
Q 011851 311 TAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHN-LVEWARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRD 389 (476)
Q Consensus 311 ~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~d 389 (476)
+..+|+||||||+||||.|.+||....+..... ++.|... + ...-....+.+++|||.+||. |
T Consensus 366 ~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~-l--------------~fP~~~~~s~eA~DLI~rll~-d 429 (550)
T KOG0605|consen 366 GKECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRET-L--------------KFPEEVDLSDEAKDLITRLLC-D 429 (550)
T ss_pred CccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhh-c--------------cCCCcCcccHHHHHHHHHHhc-C
Confidence 999999999999999999999999887755432 2333211 1 111112236899999999999 9
Q ss_pred CCCCCCHHHHHHHhcCCCCcccccCcc
Q 011851 390 QKARPRMSEVVEALKPLPYLKDMASSS 416 (476)
Q Consensus 390 P~~RPt~~ell~~L~~~~~~~~~~~~~ 416 (476)
|++|.- ..=+++++.+|||+++....
T Consensus 430 ~~~RLG-~~G~~EIK~HPfF~~v~W~~ 455 (550)
T KOG0605|consen 430 PENRLG-SKGAEEIKKHPFFKGVDWDH 455 (550)
T ss_pred HHHhcC-cccHHHHhcCCccccCCcch
Confidence 999976 33344466679999876543
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-51 Score=376.07 Aligned_cols=258 Identities=28% Similarity=0.362 Sum_probs=216.2
Q ss_pred cCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHH---HHHHHHHHHhCCCCCceeeEEEEEE
Q 011851 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHK---EWLAEVNYLGGLIHPNLVKLIGCCI 197 (476)
Q Consensus 121 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~---~~~~E~~~l~~l~hpnIv~l~~~~~ 197 (476)
.+|+.++.||.|+||.|.+++.+ .+|..||+|++.+...-..+ ...+|..+|+.+.||+++++++.|.
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k---------~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~ 114 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREK---------HSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFK 114 (355)
T ss_pred hhhhheeeeccCccceEEEEEEc---------cCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeec
Confidence 46889999999999999997654 57888999999887654443 3567999999999999999999999
Q ss_pred eCCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCC
Q 011851 198 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGL 277 (476)
Q Consensus 198 ~~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~ 277 (476)
+.+++||||||++||.|+.++++ .+++++..++.++.||+.||+|||+.+ |++|||||+|||||.+|.+||+|||+
T Consensus 115 d~~~lymvmeyv~GGElFS~Lrk-~~rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGF 190 (355)
T KOG0616|consen 115 DNSNLYMVMEYVPGGELFSYLRK-SGRFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGF 190 (355)
T ss_pred cCCeEEEEEeccCCccHHHHHHh-cCCCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccc
Confidence 99999999999999999999955 457999999999999999999999988 99999999999999999999999999
Q ss_pred cCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhccccc
Q 011851 278 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRR 357 (476)
Q Consensus 278 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 357 (476)
|+..... +.+.||||.|+|||++...+|+.++|+|||||++|||+.|.+||...++....+.+ ....-
T Consensus 191 AK~v~~r-----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI------~~~~v- 258 (355)
T KOG0616|consen 191 AKRVSGR-----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKI------LEGKV- 258 (355)
T ss_pred eEEecCc-----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHH------HhCcc-
Confidence 9986542 44589999999999999999999999999999999999999999877652211111 11111
Q ss_pred cccccCcccCCCCChHHHHHHHHHHHHhcccCCCCC-CCHHHHHHHhcCCCCcccccC
Q 011851 358 FYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKAR-PRMSEVVEALKPLPYLKDMAS 414 (476)
Q Consensus 358 ~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~R-Pt~~ell~~L~~~~~~~~~~~ 414 (476)
.|+...+.++.+|+.++|+.|-.+| -++..=.+.++.+|||++...
T Consensus 259 -----------~fP~~fs~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v~W 305 (355)
T KOG0616|consen 259 -----------KFPSYFSSDAKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKGVDW 305 (355)
T ss_pred -----------cCCcccCHHHHHHHHHHHhhhhHhhhcCcCCCccccccCcccccccH
Confidence 1344446789999999999999999 334333444666799997653
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-51 Score=374.67 Aligned_cols=255 Identities=25% Similarity=0.363 Sum_probs=204.8
Q ss_pred cCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCcc--CHHHHHHHHHHHhCCCCCceeeEEE-EEE
Q 011851 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQ--GHKEWLAEVNYLGGLIHPNLVKLIG-CCI 197 (476)
Q Consensus 121 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~l~~-~~~ 197 (476)
.+|+++++||+|.||.||++... .+|..||.|.+.-.... ..+.+..|+.+|++|+|||||++|+ .|.
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~---------~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~ 89 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCL---------LDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFI 89 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeec---------cCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhh
Confidence 35889999999999999997544 57888999998754433 3456889999999999999999999 455
Q ss_pred eCCe-eEEEEEecCCCCHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHHhcCC-CCeEecCCCCCCeeecCCCceEE
Q 011851 198 EDDQ-RLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALDAAKGLAFLHEEAE-KPVIYRDFKTSNILLDGEYNAKL 272 (476)
Q Consensus 198 ~~~~-~~lV~E~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~al~~lH~~~~-~~ivHrDlKp~NILl~~~~~vkl 272 (476)
++.. ++||||||.+|+|...|.. ....+++..+++++.|++.||..||+.-. ..|+||||||.||+|+.+|.|||
T Consensus 90 ~~~evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKL 169 (375)
T KOG0591|consen 90 EDNEVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKL 169 (375)
T ss_pred ccchhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceee
Confidence 5555 8999999999999998853 45679999999999999999999999431 12999999999999999999999
Q ss_pred eecCCcCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhh
Q 011851 273 SDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQL 352 (476)
Q Consensus 273 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~ 352 (476)
+|||+++.+... +......+|||+||+||.+.+.+|+.++||||+||++|||+.-+.||.+.+ +.+.... +
T Consensus 170 GDfGL~r~l~s~--~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n------~~~L~~K-I 240 (375)
T KOG0591|consen 170 GDFGLGRFLSSK--TTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDN------LLSLCKK-I 240 (375)
T ss_pred ccchhHhHhcch--hHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCccccc------HHHHHHH-H
Confidence 999999987542 333456899999999999999999999999999999999999999998762 1111111 0
Q ss_pred ccccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011851 353 GERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEA 402 (476)
Q Consensus 353 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~ 402 (476)
... . ..+++ ....+.++..||..|+..||+.||+...++..
T Consensus 241 ~qg-d----~~~~p----~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~d 281 (375)
T KOG0591|consen 241 EQG-D----YPPLP----DEHYSTDLRELINMCIAVDPEQRPDTVPYVQD 281 (375)
T ss_pred HcC-C----CCCCc----HHHhhhHHHHHHHHHccCCcccCCCcchHHHH
Confidence 000 0 01111 23457899999999999999999985444443
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-50 Score=390.89 Aligned_cols=273 Identities=26% Similarity=0.355 Sum_probs=219.6
Q ss_pred hccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHH--HHHHHHHHhCCC-CCceeeEEEE
Q 011851 119 ATKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKE--WLAEVNYLGGLI-HPNLVKLIGC 195 (476)
Q Consensus 119 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~--~~~E~~~l~~l~-hpnIv~l~~~ 195 (476)
.-++|.++++||.|+||.||+|... .+|..||||.+++.... .++ -++|+..|++|+ |||||+|.++
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~---------~~~~~VAIK~MK~Kf~s-~ee~~nLREvksL~kln~hpniikL~Ev 77 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSK---------ETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNPHPNIIKLKEV 77 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeec---------CCCceeeHHHHHhhhcc-HHHHHHHHHHHHHHhcCCCCcchhhHHH
Confidence 3467999999999999999998655 46778999999765443 344 368999999999 9999999999
Q ss_pred EEeCC-eeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEee
Q 011851 196 CIEDD-QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSD 274 (476)
Q Consensus 196 ~~~~~-~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~D 274 (476)
+.+.+ .+|+||||| ..+|++++..++..|++..++.|+.||++||+|+|.+| +.||||||||||+.....|||+|
T Consensus 78 i~d~~~~L~fVfE~M-d~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaD 153 (538)
T KOG0661|consen 78 IRDNDRILYFVFEFM-DCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIAD 153 (538)
T ss_pred hhccCceEeeeHHhh-hhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEecc
Confidence 99988 999999999 55999999888999999999999999999999999999 99999999999999899999999
Q ss_pred cCCcCCCCCCCccceeeeeecCCCCCCcchhhc-CCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHH-hh-hhh
Q 011851 275 FGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVE-WA-RPQ 351 (476)
Q Consensus 275 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~-~~-~~~ 351 (476)
||+|+....... .+.++.|.+|+|||++.. +.|+.+.||||+|||++|+++-++.|.+.++.+....+. .. .+.
T Consensus 154 FGLARev~SkpP---YTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~ 230 (538)
T KOG0661|consen 154 FGLAREVRSKPP---YTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPD 230 (538)
T ss_pred cccccccccCCC---cchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCc
Confidence 999998765443 456889999999999876 579999999999999999999999998876544332211 10 011
Q ss_pred hccc-----------cccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCccccc
Q 011851 352 LGER-----------RRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDMA 413 (476)
Q Consensus 352 ~~~~-----------~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~~~ 413 (476)
.... .++.....-.+...++. .+.++.+||.+||.+||++|||+.++|++ |||+...
T Consensus 231 ~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~-~s~~~~~li~~ll~WDP~kRpTA~~al~~----pffq~~~ 298 (538)
T KOG0661|consen 231 KDSWPEGYNLASAMNFRFPQVKPSPLKDLLPN-ASSEAASLIERLLAWDPDKRPTASQALQH----PFFQVGR 298 (538)
T ss_pred cccchhHHHHHHHhccCCCcCCCCChHHhCcc-cCHHHHHHHHHHhcCCCccCccHHHHhcC----ccccccc
Confidence 0000 01111111112222222 57899999999999999999999999998 9998543
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-49 Score=377.43 Aligned_cols=268 Identities=26% Similarity=0.320 Sum_probs=217.8
Q ss_pred ccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHH---HHHHHHHHHhCCCCCceeeEEEEE
Q 011851 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHK---EWLAEVNYLGGLIHPNLVKLIGCC 196 (476)
Q Consensus 120 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~---~~~~E~~~l~~l~hpnIv~l~~~~ 196 (476)
.++|++++.||.|.-|+||++++. +++..+|+|++.+......+ +...|-+||+.++||.++.||..|
T Consensus 76 l~~f~llk~LG~GdiG~VyL~~l~---------~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~f 146 (459)
T KOG0610|consen 76 LRHFRLLKRLGCGDIGTVYLVELR---------GTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASF 146 (459)
T ss_pred HHHHHHHHHcCCCCceeEEEEEec---------CCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhhee
Confidence 346889999999999999998776 45678999999987665443 456799999999999999999999
Q ss_pred EeCCeeEEEEEecCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeec
Q 011851 197 IEDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDF 275 (476)
Q Consensus 197 ~~~~~~~lV~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DF 275 (476)
+.+...|||||||+||+|..+++++ +..+++..++.++.+|+.||+|||..| ||+|||||+||||-++|+|.|+||
T Consensus 147 et~~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDF 223 (459)
T KOG0610|consen 147 ETDKYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDF 223 (459)
T ss_pred eccceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeec
Confidence 9999999999999999999988765 567999999999999999999999999 999999999999999999999999
Q ss_pred CCcCCCCC---------------------------------CCc---------------------cceeeeeecCCCCCC
Q 011851 276 GLAKDGPE---------------------------------GDK---------------------THVSTRVMGTYGYAA 301 (476)
Q Consensus 276 G~a~~~~~---------------------------------~~~---------------------~~~~~~~~gt~~y~a 301 (476)
.++..+.. ... ...+..++||.+|+|
T Consensus 224 DLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlA 303 (459)
T KOG0610|consen 224 DLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLA 303 (459)
T ss_pred cccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCcccccccccccccc
Confidence 98643210 000 011234899999999
Q ss_pred cchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhccccccccccCcccCCCCChHHHHHHHHH
Q 011851 302 PEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQL 381 (476)
Q Consensus 302 PE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l 381 (476)
||++.+...+.++|||+|||+|||||.|..||.+.+.......+ +-..+.-......+-.+.||
T Consensus 304 PEvI~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NI----------------v~~~l~Fp~~~~vs~~akDL 367 (459)
T KOG0610|consen 304 PEVIRGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNI----------------VGQPLKFPEEPEVSSAAKDL 367 (459)
T ss_pred ceeeecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHH----------------hcCCCcCCCCCcchhHHHHH
Confidence 99999999999999999999999999999999987654433222 22222211122346789999
Q ss_pred HHHhcccCCCCCCCHHHHHHHhcCCCCcccccCc
Q 011851 382 AASCLNRDQKARPRMSEVVEALKPLPYLKDMASS 415 (476)
Q Consensus 382 i~~cL~~dP~~RPt~~ell~~L~~~~~~~~~~~~ 415 (476)
|+++|.+||.+|.....=...++.+|||+++.+.
T Consensus 368 Ir~LLvKdP~kRlg~~rGA~eIK~HpFF~gVnWa 401 (459)
T KOG0610|consen 368 IRKLLVKDPSKRLGSKRGAAEIKRHPFFEGVNWA 401 (459)
T ss_pred HHHHhccChhhhhccccchHHhhcCccccCCChh
Confidence 9999999999999833333334555999998753
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-49 Score=392.62 Aligned_cols=256 Identities=27% Similarity=0.362 Sum_probs=213.2
Q ss_pred hccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCC----Cc-cCHHHHHHHHHHHhCCC-CCceeeE
Q 011851 119 ATKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHD----GL-QGHKEWLAEVNYLGGLI-HPNLVKL 192 (476)
Q Consensus 119 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~----~~-~~~~~~~~E~~~l~~l~-hpnIv~l 192 (476)
....|.+.+.||+|+||+|++|++. .+|+.||+|++.+. .. ...+.+.+|+.+++++. ||||+++
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~---------~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l 85 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHR---------LTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRL 85 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeec---------cCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEE
Confidence 3567999999999999999998765 46788999988764 12 22345678999999999 9999999
Q ss_pred EEEEEeCCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCC-CceE
Q 011851 193 IGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGE-YNAK 271 (476)
Q Consensus 193 ~~~~~~~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~-~~vk 271 (476)
++++.....+|+|||||.||+|++++.+ .+++.+..+..++.||+.||+|||+++ |+||||||+|||++.+ +++|
T Consensus 86 ~ev~~t~~~~~ivmEy~~gGdL~~~i~~-~g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~K 161 (370)
T KOG0583|consen 86 LEVFATPTKIYIVMEYCSGGDLFDYIVN-KGRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLK 161 (370)
T ss_pred EEEEecCCeEEEEEEecCCccHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEE
Confidence 9999999999999999999999999977 678999999999999999999999998 9999999999999999 9999
Q ss_pred EeecCCcCCCCCCCccceeeeeecCCCCCCcchhhcCC-CC-ccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhh
Q 011851 272 LSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGH-LT-AKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR 349 (476)
Q Consensus 272 l~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~ 349 (476)
|+|||++..... ........|||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||+........ .
T Consensus 162 l~DFG~s~~~~~--~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~------~ 233 (370)
T KOG0583|consen 162 LSDFGLSAISPG--EDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLY------R 233 (370)
T ss_pred EeccccccccCC--CCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHH------H
Confidence 999999998631 112244589999999999999977 86 7899999999999999999999873221111 1
Q ss_pred hhhccccccccccCcccCCCCChHH-HHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCccc
Q 011851 350 PQLGERRRFYRLIDPCLEGCFSIKG-AEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKD 411 (476)
Q Consensus 350 ~~~~~~~~~~~~~d~~l~~~~~~~~-~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~ 411 (476)
........+ +... +.++.+|+.+||..||.+|+++.+|++| |||+.
T Consensus 234 ki~~~~~~~------------p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h----~w~~~ 280 (370)
T KOG0583|consen 234 KIRKGEFKI------------PSYLLSPEARSLIEKMLVPDPSTRITLLEILEH----PWFQK 280 (370)
T ss_pred HHhcCCccC------------CCCcCCHHHHHHHHHHcCCCcccCCCHHHHhhC----hhhcc
Confidence 111111111 1112 6789999999999999999999999976 99986
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-49 Score=390.08 Aligned_cols=253 Identities=37% Similarity=0.578 Sum_probs=208.0
Q ss_pred CCccccccccCCccEEEEEEccCCceeeeCCCCce-EEEEEecCCCccC--HHHHHHHHHHHhCCCCCceeeEEEEEEeC
Q 011851 123 FRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLP-VAVKTLNHDGLQG--HKEWLAEVNYLGGLIHPNLVKLIGCCIED 199 (476)
Q Consensus 123 y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~-vAiK~~~~~~~~~--~~~~~~E~~~l~~l~hpnIv~l~~~~~~~ 199 (476)
..+.+.||+|+||+||+|.+. |+. ||||++....... .++|.+|+.+|.+++|||||+++|++.+.
T Consensus 43 l~~~~~iG~G~~g~V~~~~~~-----------g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~ 111 (362)
T KOG0192|consen 43 LPIEEVLGSGSFGTVYKGKWR-----------GTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSP 111 (362)
T ss_pred hhhhhhcccCCceeEEEEEeC-----------CceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence 344556999999999999885 445 9999998654333 45899999999999999999999999988
Q ss_pred C-eeEEEEEecCCCCHHHHHhh-cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCC-ceEEeecC
Q 011851 200 D-QRLLVYEFMPRGSLENHLFR-RSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEY-NAKLSDFG 276 (476)
Q Consensus 200 ~-~~~lV~E~~~~g~L~~~l~~-~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~-~vkl~DFG 276 (476)
. .++|||||+++|+|.+++.+ ....+++..++.++.||++||+|||+++. ||||||||+||||+.++ ++||+|||
T Consensus 112 ~~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFG 189 (362)
T KOG0192|consen 112 PGSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFG 189 (362)
T ss_pred CCceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCc
Confidence 7 79999999999999999987 47889999999999999999999999774 99999999999999998 99999999
Q ss_pred CcCCCCCCCccceeeeeecCCCCCCcchhh--cCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhcc
Q 011851 277 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVM--TGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGE 354 (476)
Q Consensus 277 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~ 354 (476)
+++...... ...+...||+.|||||++. ...|+.++|||||||+||||+||+.||...........+. ....
T Consensus 190 lsr~~~~~~--~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~----~~~~ 263 (362)
T KOG0192|consen 190 LSREKVISK--TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVV----VGGL 263 (362)
T ss_pred cceeecccc--ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHH----hcCC
Confidence 998754321 2233378999999999999 5699999999999999999999999998765421111110 0011
Q ss_pred ccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011851 355 RRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPL 406 (476)
Q Consensus 355 ~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~ 406 (476)
...++...+..+..|+.+||..||..||++.+++..|+.+
T Consensus 264 ------------Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~ 303 (362)
T KOG0192|consen 264 ------------RPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESI 303 (362)
T ss_pred ------------CCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHH
Confidence 1111222467899999999999999999999999987643
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-49 Score=385.00 Aligned_cols=272 Identities=24% Similarity=0.311 Sum_probs=217.6
Q ss_pred ccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCcc--CHHHHHHHHHHHhCCCCCceeeEEEEEE
Q 011851 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQ--GHKEWLAEVNYLGGLIHPNLVKLIGCCI 197 (476)
Q Consensus 120 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~l~~~~~ 197 (476)
.+.|+.+++||+|+||.||+|++. .||+.||+|.++.+..+ ...-..+||.||++|+||||++|.+...
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~---------~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt 186 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDL---------ETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVT 186 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeec---------ccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEE
Confidence 345888899999999999998765 47888999999876533 3455789999999999999999999988
Q ss_pred eC--CeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeec
Q 011851 198 ED--DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDF 275 (476)
Q Consensus 198 ~~--~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DF 275 (476)
+. ..+|||+|||+. +|.-++....-.|++.++..++.||+.||+|||.++ |+|||||.+|||||.+|.+||+||
T Consensus 187 ~~~~~siYlVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDF 262 (560)
T KOG0600|consen 187 SKLSGSIYLVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADF 262 (560)
T ss_pred ecCCceEEEEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccc
Confidence 76 689999999976 888888777778999999999999999999999988 999999999999999999999999
Q ss_pred CCcCCCCCCCccceeeeeecCCCCCCcchhhcC-CCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhh-hc
Q 011851 276 GLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQ-LG 353 (476)
Q Consensus 276 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~-~~ 353 (476)
|||+.+....... .+..+-|.+|+|||++++. .|+.++|+||+||||.||++|++.|.+.........+-..... ..
T Consensus 263 GLAr~y~~~~~~~-~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e 341 (560)
T KOG0600|consen 263 GLARFYTPSGSAP-YTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTE 341 (560)
T ss_pred cceeeccCCCCcc-cccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCCh
Confidence 9999765544333 4456779999999999986 7999999999999999999999999987765544433211110 01
Q ss_pred ccccccc-----cc------CcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCcc
Q 011851 354 ERRRFYR-----LI------DPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLK 410 (476)
Q Consensus 354 ~~~~~~~-----~~------d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~ 410 (476)
+.+...+ .+ ..++.+.| ...+..+++|+..+|..||.+|.|+.++|+. .||.
T Consensus 342 ~~W~~~kLP~~~~~kp~~~y~r~l~E~~-~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s----eyF~ 404 (560)
T KOG0600|consen 342 DYWPVSKLPHATIFKPQQPYKRRLRETF-KDFPASALDLLEKLLSLDPDKRGTASSALQS----EYFT 404 (560)
T ss_pred hccccccCCcccccCCCCcccchHHHHh-ccCCHHHHHHHHHHhccCccccccHHHHhcC----cccc
Confidence 1111001 11 11222211 1125678999999999999999999999997 7774
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-49 Score=357.73 Aligned_cols=274 Identities=26% Similarity=0.390 Sum_probs=220.8
Q ss_pred cCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccC--HHHHHHHHHHHhCCCCCceeeEEEEEEe
Q 011851 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQG--HKEWLAEVNYLGGLIHPNLVKLIGCCIE 198 (476)
Q Consensus 121 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~--~~~~~~E~~~l~~l~hpnIv~l~~~~~~ 198 (476)
.+|..+++||+|.||+||+|++. .||+.||||.++.....+ ....++|++.|+.++|+||+.|+++|.+
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~---------~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~ 72 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDT---------ETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPH 72 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEec---------CCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccC
Confidence 46888899999999999999754 588999999998765442 2457899999999999999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCc
Q 011851 199 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLA 278 (476)
Q Consensus 199 ~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a 278 (476)
.+.+.||+||++ .+|+..|..+...++...+..++.++++||+|||.+. |+||||||.|+|++.+|.+||+|||+|
T Consensus 73 ~~~l~lVfEfm~-tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLA 148 (318)
T KOG0659|consen 73 KSNLSLVFEFMP-TDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLA 148 (318)
T ss_pred CCceEEEEEecc-ccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccch
Confidence 999999999995 4999999888889999999999999999999999988 999999999999999999999999999
Q ss_pred CCCCCCCccceeeeeecCCCCCCcchhhcC-CCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHh--hhhhhccc
Q 011851 279 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEW--ARPQLGER 355 (476)
Q Consensus 279 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~--~~~~~~~~ 355 (476)
+.+...+.. .+..+-|.+|+|||++.+. .|+..+||||.|||+.||+-|.+-|.+.+.-+....+-. ..+....+
T Consensus 149 r~f~~p~~~--~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~W 226 (318)
T KOG0659|consen 149 RFFGSPNRI--QTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQW 226 (318)
T ss_pred hccCCCCcc--cccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccC
Confidence 987654433 2333779999999999986 799999999999999999999988887655433322211 11111111
Q ss_pred ---------cccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCcccccC
Q 011851 356 ---------RRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDMAS 414 (476)
Q Consensus 356 ---------~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~~~~ 414 (476)
..+...-.+.+...| ...+.++.||+.+||..||.+|++++|+++| +||+..+.
T Consensus 227 P~~~~lpdY~~~~~~P~~~~~~lf-~aas~d~ldLl~~m~~ynP~~Rita~qaL~~----~yf~~~P~ 289 (318)
T KOG0659|consen 227 PEMTSLPDYVKIQQFPKPPLNNLF-PAASSDALDLLSKMLTYNPKKRITASQALKH----PYFKSLPL 289 (318)
T ss_pred ccccccccHHHHhcCCCCcccccc-ccccHHHHHHHHhhhccCchhcccHHHHhcc----hhhhcCCC
Confidence 111111112222233 3446677999999999999999999999998 99887544
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-49 Score=391.28 Aligned_cols=268 Identities=26% Similarity=0.363 Sum_probs=225.5
Q ss_pred cCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCCCCCceeeEEEEEEeCC
Q 011851 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHPNLVKLIGCCIEDD 200 (476)
Q Consensus 121 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 200 (476)
..|....+||+|+-|.||.|.. ..+++.||||.+........+-+++|+.+|+.++|+|||++++.|..++
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~---------~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~d 343 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARK---------ISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGD 343 (550)
T ss_pred hhhcchhhhccccccceeeeee---------ccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccc
Confidence 4588889999999999999754 4578889999999887777777899999999999999999999999999
Q ss_pred eeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCcCC
Q 011851 201 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKD 280 (476)
Q Consensus 201 ~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~ 280 (476)
.+|+||||++||+|.|.+... .+++.++..|+++++.||+|||.++ |+|||||.+|||++.+|.+||+|||++..
T Consensus 344 eLWVVMEym~ggsLTDvVt~~--~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaq 418 (550)
T KOG0578|consen 344 ELWVVMEYMEGGSLTDVVTKT--RMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQ 418 (550)
T ss_pred eeEEEEeecCCCchhhhhhcc--cccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeec
Confidence 999999999999999988543 4999999999999999999999998 99999999999999999999999999988
Q ss_pred CCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhcccccccc
Q 011851 281 GPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRRFYR 360 (476)
Q Consensus 281 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 360 (476)
...... .....+|||+|||||++....|+.++||||||++++||+-|.+||...++.....++....
T Consensus 419 i~~~~~--KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng----------- 485 (550)
T KOG0578|consen 419 ISEEQS--KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNG----------- 485 (550)
T ss_pred cccccC--ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcC-----------
Confidence 765432 3455899999999999999999999999999999999999999998655543333222110
Q ss_pred ccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCcccccCcchHHHHHH
Q 011851 361 LIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDMASSSSYVQAMQ 423 (476)
Q Consensus 361 ~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~~~~~~~~~~~~~ 423 (476)
.+.-......+..+.+|+.+||+.|+++|+++.|||+| ||++...........+.
T Consensus 486 ----~P~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H----pFl~~a~p~ssL~pLi~ 540 (550)
T KOG0578|consen 486 ----TPKLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLEH----PFLKMAKPESSLNPLIL 540 (550)
T ss_pred ----CCCcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhcC----hhhhhcCCHHHhHHHHH
Confidence 01111233447899999999999999999999999998 99976655444443333
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-49 Score=396.36 Aligned_cols=253 Identities=27% Similarity=0.375 Sum_probs=213.2
Q ss_pred CCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCc---cCHHHHHHHHHHHhCCCCCceeeEEEEEEe
Q 011851 122 SFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL---QGHKEWLAEVNYLGGLIHPNLVKLIGCCIE 198 (476)
Q Consensus 122 ~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~ 198 (476)
-|++++-||.|+-|+|.+|++. .||+.+|||++.+... .....+.+|+-||+.|.||||+++|++|++
T Consensus 13 pwkLgkTLG~Gstg~vrlakh~---------~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~ 83 (786)
T KOG0588|consen 13 PWKLGKTLGKGSTGCVRLAKHA---------ETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWEN 83 (786)
T ss_pred ceeccccccCCCCceehhhhcc---------cccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeecc
Confidence 4889999999999999998654 5999999999987621 123457899999999999999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCc
Q 011851 199 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLA 278 (476)
Q Consensus 199 ~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a 278 (476)
..++|||+||++||.|++++.++ +++++.++.++++||+.|+.|||..+ |+||||||+|+|||..++|||+|||+|
T Consensus 84 ~~~lylvlEyv~gGELFdylv~k-G~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMA 159 (786)
T KOG0588|consen 84 KQHLYLVLEYVPGGELFDYLVRK-GPLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMA 159 (786)
T ss_pred CceEEEEEEecCCchhHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeecccee
Confidence 99999999999999999999655 57999999999999999999999988 999999999999999999999999999
Q ss_pred CCCCCCCccceeeeeecCCCCCCcchhhcCCCC-ccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhccccc
Q 011851 279 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLT-AKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRR 357 (476)
Q Consensus 279 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 357 (476)
..-.++.- -.+-||+|.|.|||++++.+|+ .++||||+|||||.||||+.||++.+-......+......+
T Consensus 160 sLe~~gkl---LeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f~M----- 231 (786)
T KOG0588|consen 160 SLEVPGKL---LETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVFEM----- 231 (786)
T ss_pred ecccCCcc---ccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcccC-----
Confidence 87544322 3347999999999999999885 78999999999999999999998544322222222211111
Q ss_pred cccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCcccc
Q 011851 358 FYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDM 412 (476)
Q Consensus 358 ~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~~ 412 (476)
+...+.++.+||.+||..||+.|.|++||++| ||+.+.
T Consensus 232 -------------Ps~Is~eaQdLLr~ml~VDp~~RiT~~eI~kH----P~l~g~ 269 (786)
T KOG0588|consen 232 -------------PSNISSEAQDLLRRMLDVDPSTRITTEEILKH----PFLSGY 269 (786)
T ss_pred -------------CCcCCHHHHHHHHHHhccCccccccHHHHhhC----chhhcC
Confidence 12337799999999999999999999999998 887654
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-48 Score=374.64 Aligned_cols=262 Identities=31% Similarity=0.478 Sum_probs=208.8
Q ss_pred cCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCCCCCceeeEEEEEEeCC
Q 011851 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHPNLVKLIGCCIEDD 200 (476)
Q Consensus 121 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 200 (476)
.+|...+.||+|+||.||++.+. .+|..+|||.+........+.+.+|+.+|++|+|||||++++......
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~---------~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~ 87 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNK---------KTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRE 87 (313)
T ss_pred chhhhhccccCccceEEEEEEec---------CCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCcccccc
Confidence 35777889999999999998654 357889999987664333566889999999999999999999855444
Q ss_pred --eeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecC-CCceEEeecCC
Q 011851 201 --QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDG-EYNAKLSDFGL 277 (476)
Q Consensus 201 --~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~-~~~vkl~DFG~ 277 (476)
.+++.|||+++|+|.+++.+.++.+++..++.+++||++||.|||+++ ||||||||+||||+. ++.+||+|||+
T Consensus 88 ~~~~~i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~ 164 (313)
T KOG0198|consen 88 NDEYNIFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGL 164 (313)
T ss_pred CeeeEeeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCcc
Confidence 699999999999999999776558999999999999999999999988 999999999999999 79999999999
Q ss_pred cCCCCC-CCccceeeeeecCCCCCCcchhhcCC-CCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhccc
Q 011851 278 AKDGPE-GDKTHVSTRVMGTYGYAAPEYVMTGH-LTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGER 355 (476)
Q Consensus 278 a~~~~~-~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~ 355 (476)
++.... .........+.||+.|||||++..+. ...++|||||||++.||+||+.||... ......+..... .
T Consensus 165 a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-~~~~~~~~~ig~----~- 238 (313)
T KOG0198|consen 165 AKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF-FEEAEALLLIGR----E- 238 (313)
T ss_pred ccccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh-cchHHHHHHHhc----c-
Confidence 987653 11112233478999999999999643 345999999999999999999999764 000001111000 0
Q ss_pred cccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCccccc
Q 011851 356 RRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDMA 413 (476)
Q Consensus 356 ~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~~~ 413 (476)
. ....++...+.++.+++.+||..||++|||++++|+| ||++...
T Consensus 239 --------~-~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~h----pf~~~~~ 283 (313)
T KOG0198|consen 239 --------D-SLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEH----PFLKQNS 283 (313)
T ss_pred --------C-CCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhC----hhhhccc
Confidence 0 0012333457899999999999999999999999998 8876543
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-48 Score=372.57 Aligned_cols=271 Identities=26% Similarity=0.337 Sum_probs=218.1
Q ss_pred ccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCH-HHHHHHHHHHhCCCCCceeeEEEEEEe
Q 011851 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGH-KEWLAEVNYLGGLIHPNLVKLIGCCIE 198 (476)
Q Consensus 120 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~-~~~~~E~~~l~~l~hpnIv~l~~~~~~ 198 (476)
...|++.++||.|.-++||+|+.. .+++.||||+++.+..... +.+.+|+..|+.++||||++++..|..
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~---------p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv 95 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCI---------PTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVV 95 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeec---------ccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEe
Confidence 346999999999999999998754 4678899999998776654 788999999999999999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCC
Q 011851 199 DDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGL 277 (476)
Q Consensus 199 ~~~~~lV~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~ 277 (476)
+..+|+||.||.+|++.+++... ...+++..+..|++++++||.|||.+| .||||||+.||||+.+|.|||+|||.
T Consensus 96 ~~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgv 172 (516)
T KOG0582|consen 96 DSELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGV 172 (516)
T ss_pred cceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCcee
Confidence 99999999999999999999653 345999999999999999999999999 99999999999999999999999998
Q ss_pred cCCCCCCC-cccee-eeeecCCCCCCcchhhcC--CCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhc
Q 011851 278 AKDGPEGD-KTHVS-TRVMGTYGYAAPEYVMTG--HLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLG 353 (476)
Q Consensus 278 a~~~~~~~-~~~~~-~~~~gt~~y~aPE~~~~~--~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~ 353 (476)
+....... ..... ..++||++|||||+++.. .|+.|+||||||++..||.+|..||....+-..........+...
T Consensus 173 sa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~ 252 (516)
T KOG0582|consen 173 SASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTL 252 (516)
T ss_pred eeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCc
Confidence 76543322 22222 457999999999997654 799999999999999999999999987765432211111111000
Q ss_pred cccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCcccccC
Q 011851 354 ERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDMAS 414 (476)
Q Consensus 354 ~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~~~~ 414 (476)
. -..+...-....+..+..+|..||+.||.+|||+++++++ +||+....
T Consensus 253 ~--------t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh----~FFk~~k~ 301 (516)
T KOG0582|consen 253 L--------TSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH----AFFKKAKS 301 (516)
T ss_pred c--------cccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc----HHHhhccc
Confidence 0 0001111112235689999999999999999999999998 89886543
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-48 Score=391.64 Aligned_cols=259 Identities=26% Similarity=0.413 Sum_probs=216.4
Q ss_pred HhccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccC---HHHHHHHHHHHhCCC-CCceeeEE
Q 011851 118 SATKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQG---HKEWLAEVNYLGGLI-HPNLVKLI 193 (476)
Q Consensus 118 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~---~~~~~~E~~~l~~l~-hpnIv~l~ 193 (476)
....+|+++++||+|.||+|++|..+ .+++.||||++++...-. .+..+.|.+|+.... ||.+++|+
T Consensus 365 ~~l~~F~~l~vLGkGsFGkV~lae~k---------~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~ 435 (694)
T KOG0694|consen 365 LTLDDFRLLAVLGRGSFGKVLLAELK---------GTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLF 435 (694)
T ss_pred ccccceEEEEEeccCcCceEEEEEEc---------CCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecc
Confidence 34568999999999999999998765 578889999999876543 445677888888774 99999999
Q ss_pred EEEEeCCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEe
Q 011851 194 GCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLS 273 (476)
Q Consensus 194 ~~~~~~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~ 273 (476)
.+|+..+++|+||||+.||++..+ .+...+++..+..++..|+.||.|||+++ |||||||.+|||||.+|++||+
T Consensus 436 ~~fQT~~~l~fvmey~~Ggdm~~~--~~~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiA 510 (694)
T KOG0694|consen 436 SCFQTKEHLFFVMEYVAGGDLMHH--IHTDVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIA 510 (694)
T ss_pred cccccCCeEEEEEEecCCCcEEEE--EecccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEec
Confidence 999999999999999999995433 34457999999999999999999999998 9999999999999999999999
Q ss_pred ecCCcCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhc
Q 011851 274 DFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLG 353 (476)
Q Consensus 274 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~ 353 (476)
|||+++....... .+.++||||.|||||++.+..|+.++|||||||+|||||.|..||.+.+..+..+.+..
T Consensus 511 DFGlcKe~m~~g~--~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~------ 582 (694)
T KOG0694|consen 511 DFGLCKEGMGQGD--RTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVN------ 582 (694)
T ss_pred ccccccccCCCCC--ccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhc------
Confidence 9999998653222 35669999999999999999999999999999999999999999987765433322211
Q ss_pred cccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCH-----HHHHHHhcCCCCcccccC
Q 011851 354 ERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRM-----SEVVEALKPLPYLKDMAS 414 (476)
Q Consensus 354 ~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~-----~ell~~L~~~~~~~~~~~ 414 (476)
+ +-.|+.-.+.++.++++++|.+||++|.-+ .+|.+ +|||+.+..
T Consensus 583 d------------~~~yP~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~----hpFFr~i~w 632 (694)
T KOG0694|consen 583 D------------EVRYPRFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKK----HPFFRSIDW 632 (694)
T ss_pred C------------CCCCCCcccHHHHHHHHHHhccCcccccCCCCCCchhhhh----CCccccCCH
Confidence 1 112455558899999999999999999765 45544 599998763
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-49 Score=386.98 Aligned_cols=253 Identities=30% Similarity=0.406 Sum_probs=216.8
Q ss_pred cCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCcc--CHHHHHHHHHHHhCCCCCceeeEEEEEEe
Q 011851 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQ--GHKEWLAEVNYLGGLIHPNLVKLIGCCIE 198 (476)
Q Consensus 121 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~l~~~~~~ 198 (476)
++|.+.+.||+|+||+||+|+.+ .|.+.||||.+.+.... +.+.+.+|++|++.|+|||||.++++|+.
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK---------~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt 72 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRK---------YTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFET 72 (808)
T ss_pred cchhHHHHhcCCccceeeecccc---------cceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcc
Confidence 46889999999999999998644 68889999999876543 34568899999999999999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCc
Q 011851 199 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLA 278 (476)
Q Consensus 199 ~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a 278 (476)
..++|+|.|||.| +|+.+| ..+..++++.+..++.|++.||.|||+++ |+|||+||.||||+..|.+|+||||+|
T Consensus 73 ~~~~~vVte~a~g-~L~~il-~~d~~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~A 147 (808)
T KOG0597|consen 73 SAHLWVVTEYAVG-DLFTIL-EQDGKLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLA 147 (808)
T ss_pred cceEEEEehhhhh-hHHHHH-HhccCCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhh
Confidence 9999999999976 999988 45568999999999999999999999988 999999999999999999999999999
Q ss_pred CCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhcccccc
Q 011851 279 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRRF 358 (476)
Q Consensus 279 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 358 (476)
+.... .+.+.+++.|||.|||||++.+.+|+..+|+||||||+|||++|++||.... ...++.....
T Consensus 148 r~m~~--~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~s---i~~Lv~~I~~-------- 214 (808)
T KOG0597|consen 148 RAMST--NTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARS---ITQLVKSILK-------- 214 (808)
T ss_pred hhccc--CceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHH---HHHHHHHHhc--------
Confidence 97544 4556677899999999999999999999999999999999999999997532 1222221111
Q ss_pred ccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCccc
Q 011851 359 YRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKD 411 (476)
Q Consensus 359 ~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~ 411 (476)
|+. .++...+..+.+|++.+|.+||.+|.+-.+++.| ||.++
T Consensus 215 ----d~v---~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H----pF~k~ 256 (808)
T KOG0597|consen 215 ----DPV---KPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGH----PFWKG 256 (808)
T ss_pred ----CCC---CCcccccHHHHHHHHHHhhcChhhcccHHHHhcC----hHHhh
Confidence 111 1234567899999999999999999999999987 77664
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-48 Score=368.45 Aligned_cols=248 Identities=23% Similarity=0.357 Sum_probs=211.3
Q ss_pred ccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHH---HHHHHHHHhCCCCCceeeEEEEE
Q 011851 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKE---WLAEVNYLGGLIHPNLVKLIGCC 196 (476)
Q Consensus 120 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~---~~~E~~~l~~l~hpnIv~l~~~~ 196 (476)
..+|++.+.||+|.||.|-+|+.. ..|+.||||.++++..++.++ +.+|++||..|+||||+.+|++|
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~---------~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVF 122 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEH---------KSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVF 122 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhc---------cCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhh
Confidence 467999999999999999997643 578899999999988776554 67899999999999999999999
Q ss_pred EeCCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecC
Q 011851 197 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFG 276 (476)
Q Consensus 197 ~~~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG 276 (476)
+..+.+.|||||..+|.|+||+.++ +.+++.+++.+++||+.|+.|||.++ |+|||||.+|||||.++++||+|||
T Consensus 123 ENkdKIvivMEYaS~GeLYDYiSer-~~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFG 198 (668)
T KOG0611|consen 123 ENKDKIVIVMEYASGGELYDYISER-GSLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFG 198 (668)
T ss_pred cCCceEEEEEEecCCccHHHHHHHh-ccccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccc
Confidence 9999999999999999999999654 57999999999999999999999988 9999999999999999999999999
Q ss_pred CcCCCCCCCccceeeeeecCCCCCCcchhhcCCC-CccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhccc
Q 011851 277 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHL-TAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGER 355 (476)
Q Consensus 277 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~ 355 (476)
++..+.... ...++||+|-|.+||++.+.+| ++.+|-|||||+||.|+.|..||++.+-.- ++. ++...
T Consensus 199 LSNly~~~k---fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~---lvr----QIs~G 268 (668)
T KOG0611|consen 199 LSNLYADKK---FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKR---LVR----QISRG 268 (668)
T ss_pred hhhhhcccc---HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHH---HHH----Hhhcc
Confidence 998765432 2345999999999999999988 578999999999999999999998764321 111 11100
Q ss_pred cccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011851 356 RRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEA 402 (476)
Q Consensus 356 ~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~ 402 (476)
..+....+..+.-||.+||..||++|.|+.+|..|
T Consensus 269 ------------aYrEP~~PSdA~gLIRwmLmVNP~RRATieDiAsH 303 (668)
T KOG0611|consen 269 ------------AYREPETPSDASGLIRWMLMVNPERRATIEDIASH 303 (668)
T ss_pred ------------cccCCCCCchHHHHHHHHHhcCcccchhHHHHhhh
Confidence 01112224567789999999999999999999987
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-48 Score=373.74 Aligned_cols=264 Identities=26% Similarity=0.386 Sum_probs=223.4
Q ss_pred cCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccC-HHHHHHHHHHHhCCCCCceeeEEEEEEeC
Q 011851 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQG-HKEWLAEVNYLGGLIHPNLVKLIGCCIED 199 (476)
Q Consensus 121 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~-~~~~~~E~~~l~~l~hpnIv~l~~~~~~~ 199 (476)
..|+..++||+|.||.||+|.+. .|++.||+|++..+..++ .+++.+|+.+|.+++++||.++|+.|..+
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~---------~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g 83 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDN---------KTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKG 83 (467)
T ss_pred cccccchhccccccceeeeeeec---------cccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeec
Confidence 35788899999999999999765 478889999998766554 56788999999999999999999999999
Q ss_pred CeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCcC
Q 011851 200 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAK 279 (476)
Q Consensus 200 ~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~ 279 (476)
..+|++||||.||++.+.+ +.+..+.+..+..++++++.||.|||.++ .+|||||+.|||+..+|.+||+|||.+.
T Consensus 84 ~~LwiiMey~~gGsv~~lL-~~~~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ 159 (467)
T KOG0201|consen 84 TKLWIIMEYCGGGSVLDLL-KSGNILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAG 159 (467)
T ss_pred ccHHHHHHHhcCcchhhhh-ccCCCCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceee
Confidence 9999999999999999988 44555688889999999999999999988 9999999999999999999999999998
Q ss_pred CCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhccccccc
Q 011851 280 DGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRRFY 359 (476)
Q Consensus 280 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 359 (476)
........ ...++|||.|||||++.+..|+.++||||||++.|||++|.+|+....+.....++ .
T Consensus 160 ql~~~~~r--r~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflI-------------p 224 (467)
T KOG0201|consen 160 QLTNTVKR--RKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLI-------------P 224 (467)
T ss_pred eeechhhc--cccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEec-------------c
Confidence 76553332 25689999999999999989999999999999999999999999877663322222 1
Q ss_pred cccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCcccccCcchHHH
Q 011851 360 RLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDMASSSSYVQ 420 (476)
Q Consensus 360 ~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~~~~~~~~~~ 420 (476)
+-..|.+.+. .+..+++||..||+.||+.||++.++|+| .|++.....+....
T Consensus 225 k~~PP~L~~~----~S~~~kEFV~~CL~k~P~~RpsA~~LLKh----~FIk~a~k~s~L~~ 277 (467)
T KOG0201|consen 225 KSAPPRLDGD----FSPPFKEFVEACLDKNPEFRPSAKELLKH----KFIKRAKKTSELKE 277 (467)
T ss_pred CCCCCccccc----cCHHHHHHHHHHhhcCcccCcCHHHHhhh----HHHHhcCCchHHHH
Confidence 2223444443 36789999999999999999999999998 88888654444433
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-47 Score=361.97 Aligned_cols=276 Identities=25% Similarity=0.334 Sum_probs=216.5
Q ss_pred hccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEec--CCCccCHHHHHHHHHHHhCCCCCceeeEEEEE
Q 011851 119 ATKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLN--HDGLQGHKEWLAEVNYLGGLIHPNLVKLIGCC 196 (476)
Q Consensus 119 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~--~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~ 196 (476)
....|...+.||+|+||.|..|.+. .||+.||||.+. .......++.++|+.+|+.++|+||+.+++++
T Consensus 20 i~~~y~~~~~iG~GAyGvVcsA~~~---------~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~ 90 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAYGVVCSAKDK---------RTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIF 90 (359)
T ss_pred ccceecccccccCcceeeEEEEEEc---------CCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeec
Confidence 3456777899999999999997554 678899999987 34444567889999999999999999999998
Q ss_pred Ee-----CCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceE
Q 011851 197 IE-----DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAK 271 (476)
Q Consensus 197 ~~-----~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vk 271 (476)
.. -..+|+|+|+| +.+|.+.| +.+..++...+..+++||++||+|+|+.+ |+||||||.|+|++.++.+|
T Consensus 91 ~p~~~~~f~DvYiV~elM-etDL~~ii-k~~~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lK 165 (359)
T KOG0660|consen 91 RPPSRDKFNDVYLVFELM-ETDLHQII-KSQQDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLK 165 (359)
T ss_pred ccccccccceeEEehhHH-hhHHHHHH-HcCccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEE
Confidence 75 34689999999 66888877 55556999999999999999999999988 99999999999999999999
Q ss_pred EeecCCcCCCCCCCccceeeeeecCCCCCCcchhhc-CCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhh
Q 011851 272 LSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP 350 (476)
Q Consensus 272 l~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~ 350 (476)
|||||+|+...........+..+-|.+|+|||++.. ..|+.+.||||+|||+.||++|++-|.+.+......++.....
T Consensus 166 I~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lG 245 (359)
T KOG0660|consen 166 ICDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLG 245 (359)
T ss_pred eccccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcC
Confidence 999999998754333334567889999999998865 5899999999999999999999999988766544433321111
Q ss_pred hhccc--------------cccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCccccc
Q 011851 351 QLGER--------------RRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDMA 413 (476)
Q Consensus 351 ~~~~~--------------~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~~~ 413 (476)
...+. ..+.......+...|+ ..+..+.+|+++||.+||.+|+|++|+|+| ||+....
T Consensus 246 tP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp-~a~p~AidLlekmL~fdP~kRita~eAL~h----PYl~~~h 317 (359)
T KOG0660|consen 246 TPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFP-NANPLAIDLLEKMLVFDPKKRITAEEALAH----PYLAPYH 317 (359)
T ss_pred CCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcC-CCCHHHHHHHHHHhccCccccCCHHHHhcC----hhhhhhc
Confidence 11000 0000000001111122 346789999999999999999999999998 8887654
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-46 Score=351.09 Aligned_cols=274 Identities=23% Similarity=0.297 Sum_probs=216.4
Q ss_pred cCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccC--HHHHHHHHHHHhCCCCCceeeEEEEEEe
Q 011851 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQG--HKEWLAEVNYLGGLIHPNLVKLIGCCIE 198 (476)
Q Consensus 121 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~--~~~~~~E~~~l~~l~hpnIv~l~~~~~~ 198 (476)
+.|..+..|++|+||.||+|+++ .|++.||+|.++.+.... .---++||.+|.+++|||||.+-++...
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk---------~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG 146 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDK---------KTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVG 146 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccC---------CcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEec
Confidence 35788899999999999998654 578889999997654221 1235799999999999999999988764
Q ss_pred --CCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecC
Q 011851 199 --DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFG 276 (476)
Q Consensus 199 --~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG 276 (476)
-+.+|||||||+. +|..++..-..++...++..++.|++.||+|||.+. |+|||||++|+|++..|.+||+|||
T Consensus 147 ~~~d~iy~VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFG 222 (419)
T KOG0663|consen 147 SNMDKIYIVMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFG 222 (419)
T ss_pred cccceeeeeHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccc
Confidence 4579999999976 899999877789999999999999999999999999 9999999999999999999999999
Q ss_pred CcCCCCCCCccceeeeeecCCCCCCcchhhcC-CCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhh--hhhhc
Q 011851 277 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA--RPQLG 353 (476)
Q Consensus 277 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~--~~~~~ 353 (476)
+|+.+... ....+..+-|.+|+|||++.+. .|+.++|+||+|||+.||+++++.|.+.......+.+-.. .+.-.
T Consensus 223 LAR~ygsp--~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~ 300 (419)
T KOG0663|consen 223 LAREYGSP--LKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEA 300 (419)
T ss_pred hhhhhcCC--cccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccc
Confidence 99987654 2234567889999999999986 6999999999999999999999999887664443322111 11111
Q ss_pred ccccccc-----------ccCcccCCCCChH-HHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCccccc
Q 011851 354 ERRRFYR-----------LIDPCLEGCFSIK-GAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDMA 413 (476)
Q Consensus 354 ~~~~~~~-----------~~d~~l~~~~~~~-~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~~~ 413 (476)
.+..+.+ ..-..+...|... .++...+|+..+|..||.+|.|+++.|+| .||.+.+
T Consensus 301 iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h----~~F~e~P 368 (419)
T KOG0663|consen 301 IWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH----EYFRETP 368 (419)
T ss_pred cCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc----cccccCC
Confidence 1111111 1111122222222 35788999999999999999999999998 9998743
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-47 Score=367.22 Aligned_cols=263 Identities=26% Similarity=0.368 Sum_probs=208.6
Q ss_pred HHHHhccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCcc--------------CHHHHHHHHHH
Q 011851 115 ELKSATKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQ--------------GHKEWLAEVNY 180 (476)
Q Consensus 115 ~~~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~--------------~~~~~~~E~~~ 180 (476)
+.....++|++.+.||+|.||.|-+|++.. +++.||||++.+.... ..+.+.+||.|
T Consensus 91 ~~~k~lNqy~l~~eiG~G~yGkVkLar~~~---------~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIai 161 (576)
T KOG0585|consen 91 QDRKQLNQYELIKEIGSGQYGKVKLARDEV---------DGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAI 161 (576)
T ss_pred ccceehhheehhhhhcCCccceEEEEeecC---------CCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHH
Confidence 344567889999999999999999998763 6778999999764221 13468899999
Q ss_pred HhCCCCCceeeEEEEEEe--CCeeEEEEEecCCCCHHHHHhhcCCC-CCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCC
Q 011851 181 LGGLIHPNLVKLIGCCIE--DDQRLLVYEFMPRGSLENHLFRRSLP-LPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDF 257 (476)
Q Consensus 181 l~~l~hpnIv~l~~~~~~--~~~~~lV~E~~~~g~L~~~l~~~~~~-l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDl 257 (476)
|++|+|||||+|+++..+ .+.+|||+|||..|.+... ....+ +++.++++|+++++.||+|||.++ ||||||
T Consensus 162 lKkl~H~nVV~LiEvLDDP~s~~~YlVley~s~G~v~w~--p~d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDI 236 (576)
T KOG0585|consen 162 LKKLHHPNVVKLIEVLDDPESDKLYLVLEYCSKGEVKWC--PPDKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDI 236 (576)
T ss_pred HHhcCCcCeeEEEEeecCcccCceEEEEEeccCCccccC--CCCcccccHHHHHHHHHHHHHHHHHHHhcC---eecccc
Confidence 999999999999999875 4689999999999887532 23345 999999999999999999999999 999999
Q ss_pred CCCCeeecCCCceEEeecCCcCCCCCCCc---cceeeeeecCCCCCCcchhhcCC----CCccchhhhhHHHHHHHHhCC
Q 011851 258 KTSNILLDGEYNAKLSDFGLAKDGPEGDK---THVSTRVMGTYGYAAPEYVMTGH----LTAKSDVYSFGVVLLEMLTGR 330 (476)
Q Consensus 258 Kp~NILl~~~~~vkl~DFG~a~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DiwslGv~l~elltG~ 330 (476)
||+|+||+.+|+|||+|||.+.....+.. .....+.+|||.|+|||++.++. .+.+.||||+||+||.|+.|+
T Consensus 237 KPsNLLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~ 316 (576)
T KOG0585|consen 237 KPSNLLLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQ 316 (576)
T ss_pred chhheEEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhcc
Confidence 99999999999999999999986532211 11122368999999999998742 356889999999999999999
Q ss_pred CCCCCCCCCCcchhHHhhhhhhccccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCcc
Q 011851 331 RSMDKNRPNGEHNLVEWARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLK 410 (476)
Q Consensus 331 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~ 410 (476)
.||.+...... +.++++..+.-.-..+..+.+.+||++||.+||++|.+..+|..| ||+.
T Consensus 317 ~PF~~~~~~~l----------------~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~H----pwvt 376 (576)
T KOG0585|consen 317 LPFFDDFELEL----------------FDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLH----PWVT 376 (576)
T ss_pred CCcccchHHHH----------------HHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheec----ceec
Confidence 99976532211 122333333322222347889999999999999999999998777 8875
Q ss_pred c
Q 011851 411 D 411 (476)
Q Consensus 411 ~ 411 (476)
.
T Consensus 377 ~ 377 (576)
T KOG0585|consen 377 R 377 (576)
T ss_pred c
Confidence 4
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-47 Score=374.56 Aligned_cols=253 Identities=34% Similarity=0.492 Sum_probs=208.8
Q ss_pred CCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCCCCCceeeEEEEEEeCCe
Q 011851 122 SFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHPNLVKLIGCCIEDDQ 201 (476)
Q Consensus 122 ~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~ 201 (476)
.+++++.||+|.||.||+|.++.. ..||+|.++... ...+.|++|+++|++|+|+|||++++++..++.
T Consensus 207 ~l~l~~~LG~G~FG~V~~g~~~~~----------~~vavk~ik~~~-m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~p 275 (468)
T KOG0197|consen 207 ELKLIRELGSGQFGEVWLGKWNGS----------TKVAVKTIKEGS-MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEP 275 (468)
T ss_pred HHHHHHHhcCCccceEEEEEEcCC----------CcccceEEeccc-cChhHHHHHHHHHHhCcccCeEEEEEEEecCCc
Confidence 356778999999999999998743 259999997653 345788999999999999999999999999989
Q ss_pred eEEEEEecCCCCHHHHHhh-cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCcCC
Q 011851 202 RLLVYEFMPRGSLENHLFR-RSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKD 280 (476)
Q Consensus 202 ~~lV~E~~~~g~L~~~l~~-~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~ 280 (476)
+|||||||+.|+|.++|.. .+..+...+.+.++.|||+|++||++++ +|||||...||||+++..+||+|||+|+.
T Consensus 276 iyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~ 352 (468)
T KOG0197|consen 276 IYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARL 352 (468)
T ss_pred eEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccccc
Confidence 9999999999999999986 5667899999999999999999999988 99999999999999999999999999995
Q ss_pred CCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhhccccccc
Q 011851 281 GPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPQLGERRRFY 359 (476)
Q Consensus 281 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 359 (476)
..+ +.+.....-.-...|.|||.+..+.++.++|||||||+||||+| |+.||...........++ ...+
T Consensus 353 ~~d-~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le-------~GyR-- 422 (468)
T KOG0197|consen 353 IGD-DEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLE-------RGYR-- 422 (468)
T ss_pred cCC-CceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHh-------ccCc--
Confidence 443 33322222233567999999999999999999999999999999 777877654433222222 1222
Q ss_pred cccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011851 360 RLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPL 406 (476)
Q Consensus 360 ~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~ 406 (476)
+ +++.+ ++.++.+|+..||..+|++|||++.+...|+.+
T Consensus 423 -l--p~P~~-----CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~ 461 (468)
T KOG0197|consen 423 -L--PRPEG-----CPDEVYELMKSCWHEDPEDRPTFETLREVLEDF 461 (468)
T ss_pred -C--CCCCC-----CCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHh
Confidence 1 23333 378999999999999999999999988877643
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-48 Score=349.25 Aligned_cols=260 Identities=24% Similarity=0.357 Sum_probs=215.0
Q ss_pred ccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCc--cCHHHHHHHHHHHhCCCCCceeeEEEEEE
Q 011851 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL--QGHKEWLAEVNYLGGLIHPNLVKLIGCCI 197 (476)
Q Consensus 120 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~ 197 (476)
.+.|.+.++||+|.|+.||+ |++..||+.+|+|+++.... .+.+++.+|++|.+.|+|||||+|.+.+.
T Consensus 10 ~d~y~l~e~igkG~FSvVrR---------c~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~ 80 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRR---------CVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQ 80 (355)
T ss_pred chhhhHHHHHccCchHHHHH---------HHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhc
Confidence 45688899999999999997 67778999999999875433 35678899999999999999999999999
Q ss_pred eCCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeec---CCCceEEee
Q 011851 198 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLD---GEYNAKLSD 274 (476)
Q Consensus 198 ~~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~---~~~~vkl~D 274 (476)
+....|||+|++.|++|..-|.++ ..+++..+-.+++||+++|.|||.++ |||||+||+|+||. ...-+||+|
T Consensus 81 ~~~~~ylvFe~m~G~dl~~eIV~R-~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~ 156 (355)
T KOG0033|consen 81 EESFHYLVFDLVTGGELFEDIVAR-EFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLAD 156 (355)
T ss_pred ccceeEEEEecccchHHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecc
Confidence 999999999999999998877655 45788999999999999999999988 99999999999994 344699999
Q ss_pred cCCcCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhcc
Q 011851 275 FGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGE 354 (476)
Q Consensus 275 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~ 354 (476)
||+|.....+. .-..++|||.|||||++...+|+..+|||+.||+||-||.|.+||.+.+.......+.....
T Consensus 157 FGvAi~l~~g~---~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~y---- 229 (355)
T KOG0033|consen 157 FGLAIEVNDGE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAY---- 229 (355)
T ss_pred cceEEEeCCcc---ccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhcccc----
Confidence 99999876322 34457899999999999999999999999999999999999999987543222211111111
Q ss_pred ccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCccccc
Q 011851 355 RRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDMA 413 (476)
Q Consensus 355 ~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~~~ 413 (476)
++-.+.+. ..++++.+|+.+||..||.+|.|+.|.|+| ||+++-.
T Consensus 230 -----d~~~~~w~-----~is~~Ak~LvrrML~~dP~kRIta~EAL~H----pWi~~r~ 274 (355)
T KOG0033|consen 230 -----DYPSPEWD-----TVTPEAKSLIRRMLTVNPKKRITADEALKH----PWICNRE 274 (355)
T ss_pred -----CCCCcccC-----cCCHHHHHHHHHHhccChhhhccHHHHhCC----chhcchH
Confidence 11111111 236789999999999999999999999998 9998643
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-47 Score=341.73 Aligned_cols=254 Identities=25% Similarity=0.373 Sum_probs=215.1
Q ss_pred ccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCcc---CHHHHHHHHHHHhCCCCCceeeEEEEE
Q 011851 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQ---GHKEWLAEVNYLGGLIHPNLVKLIGCC 196 (476)
Q Consensus 120 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~---~~~~~~~E~~~l~~l~hpnIv~l~~~~ 196 (476)
.++|++++.||+|.||.||+|+.+ .++-.||+|++.+.... ...++.+|++|-..|+||||+++|++|
T Consensus 21 l~dfeigr~LgkgkFG~vYlarek---------ks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~f 91 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREK---------KSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYF 91 (281)
T ss_pred hhhccccccccCCccccEeEeeec---------cCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhhe
Confidence 346999999999999999999765 46778999999776543 246788999999999999999999999
Q ss_pred EeCCeeEEEEEecCCCCHHHHHhh-cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeec
Q 011851 197 IEDDQRLLVYEFMPRGSLENHLFR-RSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDF 275 (476)
Q Consensus 197 ~~~~~~~lV~E~~~~g~L~~~l~~-~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DF 275 (476)
.++..+||++||..+|+|+..|.. ....+++.....++.|++.||.|||..+ ||||||||+|+|++.++.+||+||
T Consensus 92 hd~~riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdf 168 (281)
T KOG0580|consen 92 HDSKRIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADF 168 (281)
T ss_pred eccceeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCC
Confidence 999999999999999999999964 3556999999999999999999999977 999999999999999999999999
Q ss_pred CCcCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhccc
Q 011851 276 GLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGER 355 (476)
Q Consensus 276 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~ 355 (476)
|.+...... .....|||..|.+||++.+..++..+|+|++|++.||++.|.+||..........-+. .
T Consensus 169 GwsV~~p~~----kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~--k------ 236 (281)
T KOG0580|consen 169 GWSVHAPSN----KRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIR--K------ 236 (281)
T ss_pred CceeecCCC----CceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHH--H------
Confidence 999875422 2345899999999999999999999999999999999999999998655221111110 0
Q ss_pred cccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCccc
Q 011851 356 RRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKD 411 (476)
Q Consensus 356 ~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~ 411 (476)
.++ .++...+..+.|||.+||..+|.+|.+..|+++| ||+..
T Consensus 237 ---~~~-------~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h----pwI~a 278 (281)
T KOG0580|consen 237 ---VDL-------KFPSTISGGAADLISRLLVKNPIERLALTEVMDH----PWIVA 278 (281)
T ss_pred ---ccc-------cCCcccChhHHHHHHHHhccCccccccHHHHhhh----HHHHh
Confidence 011 1233447889999999999999999999999998 88754
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-46 Score=366.65 Aligned_cols=256 Identities=24% Similarity=0.360 Sum_probs=220.2
Q ss_pred cCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCH--HHHHHHHHHHhCCCCCceeeEEEEEEe
Q 011851 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGH--KEWLAEVNYLGGLIHPNLVKLIGCCIE 198 (476)
Q Consensus 121 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~--~~~~~E~~~l~~l~hpnIv~l~~~~~~ 198 (476)
.-|.+.+-||+|.|++|-+|++- -||+.||||++.+...... ..+.+|++.|+.++|||||+||++...
T Consensus 18 GLYDLekTlG~GHFAVVKLArHV---------FTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDT 88 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHV---------FTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDT 88 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhh---------cccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcc
Confidence 45888999999999999998754 3899999999988766543 458899999999999999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeee-cCCCceEEeecCC
Q 011851 199 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILL-DGEYNAKLSDFGL 277 (476)
Q Consensus 199 ~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl-~~~~~vkl~DFG~ 277 (476)
...+|||+|+=++|+|+|+|.+....+.+..+.+++.||+.|+.|||+.. ||||||||+||.+ ..-|-|||.|||+
T Consensus 89 QTKlyLiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGF 165 (864)
T KOG4717|consen 89 QTKLYLILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGF 165 (864)
T ss_pred cceEEEEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccc
Confidence 99999999999999999999998888999999999999999999999988 9999999999866 5668999999999
Q ss_pred cCCCCCCCccceeeeeecCCCCCCcchhhcCCCC-ccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhcccc
Q 011851 278 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLT-AKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERR 356 (476)
Q Consensus 278 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~ 356 (476)
+..+..+.. .+..||+..|-|||++.+..|+ +++||||||||||.|++|++||+..+..+..-.+
T Consensus 166 SNkf~PG~k---L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmI----------- 231 (864)
T KOG4717|consen 166 SNKFQPGKK---LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMI----------- 231 (864)
T ss_pred cccCCCcch---hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhh-----------
Confidence 988876654 3458999999999999999987 5799999999999999999999876554332221
Q ss_pred ccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCccccc
Q 011851 357 RFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDMA 413 (476)
Q Consensus 357 ~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~~~ 413 (476)
+| ..-..+...+.++.+||..||..||++|.+.++|..+ +|++...
T Consensus 232 -----mD--CKYtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~----~Wlq~~D 277 (864)
T KOG4717|consen 232 -----MD--CKYTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVST----SWLQAGD 277 (864)
T ss_pred -----hc--ccccCchhhhHHHHHHHHHHHhcCchhhccHHHHhcc----ccccCCC
Confidence 11 1112345668999999999999999999999998887 8887543
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-46 Score=370.23 Aligned_cols=250 Identities=28% Similarity=0.372 Sum_probs=204.2
Q ss_pred ccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCc---cCHHHHHHHHHHHhCCCCCceeeEEEEEEeCCeeE
Q 011851 127 CLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL---QGHKEWLAEVNYLGGLIHPNLVKLIGCCIEDDQRL 203 (476)
Q Consensus 127 ~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 203 (476)
+.||+|+||.||+|.+. .+|+.||||+++.... .....+.+|+.+|++++||||+++++++..++.+|
T Consensus 1 ~~lG~G~~g~Vy~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~ 71 (323)
T cd05571 1 KLLGKGTFGKVILVREK---------ATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLC 71 (323)
T ss_pred CeeeeCCCeEEEEEEEC---------CCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEE
Confidence 46999999999998654 4678899999975432 22345778999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCcCCCCC
Q 011851 204 LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPE 283 (476)
Q Consensus 204 lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~ 283 (476)
|||||+++++|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++....
T Consensus 72 lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~ 147 (323)
T cd05571 72 FVMEYANGGELFFHLSR-ERVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIS 147 (323)
T ss_pred EEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCccccc
Confidence 99999999999998854 457899999999999999999999988 99999999999999999999999999975322
Q ss_pred CCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhccccccccccC
Q 011851 284 GDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRRFYRLID 363 (476)
Q Consensus 284 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 363 (476)
... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||...........+ .....
T Consensus 148 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~------~~~~~------- 212 (323)
T cd05571 148 DGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI------LMEEI------- 212 (323)
T ss_pred CCC--cccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHH------HcCCC-------
Confidence 111 123468999999999999999999999999999999999999999754321111110 00000
Q ss_pred cccCCCCChHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHhcCCCCccccc
Q 011851 364 PCLEGCFSIKGAEKTIQLAASCLNRDQKARP-----RMSEVVEALKPLPYLKDMA 413 (476)
Q Consensus 364 ~~l~~~~~~~~~~~~~~li~~cL~~dP~~RP-----t~~ell~~L~~~~~~~~~~ 413 (476)
.++...+.++.+||.+||+.||++|| ++.++++| |||....
T Consensus 213 -----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h----~~f~~~~ 258 (323)
T cd05571 213 -----RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH----RFFASIN 258 (323)
T ss_pred -----CCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC----CCcCCCC
Confidence 11223367889999999999999999 79998887 9998754
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-46 Score=366.42 Aligned_cols=253 Identities=25% Similarity=0.312 Sum_probs=208.1
Q ss_pred cCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCc---cCHHHHHHHHHHHhCCCCCceeeEEEEEE
Q 011851 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL---QGHKEWLAEVNYLGGLIHPNLVKLIGCCI 197 (476)
Q Consensus 121 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~l~~~~~ 197 (476)
++|++.+.||+|+||.||+|.+. .+|+.||+|++..... ...+.+.+|+.+|++++||||+++++++.
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 71 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDR---------ISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEH 71 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEc---------CCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhc
Confidence 36899999999999999998654 4678899999975432 23456788999999999999999999999
Q ss_pred eCCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCC
Q 011851 198 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGL 277 (476)
Q Consensus 198 ~~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~ 277 (476)
+++.+|+||||+++++|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 72 ~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~ 147 (291)
T cd05612 72 DQRFLYMLMEYVPGGELFSYLRN-SGRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGF 147 (291)
T ss_pred cCCeEEEEEeCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCc
Confidence 99999999999999999999954 457899999999999999999999988 99999999999999999999999999
Q ss_pred cCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhccccc
Q 011851 278 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRR 357 (476)
Q Consensus 278 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 357 (476)
++..... ....+||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+ .....
T Consensus 148 ~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i------~~~~~- 215 (291)
T cd05612 148 AKKLRDR-----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKI------LAGKL- 215 (291)
T ss_pred chhccCC-----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH------HhCCc-
Confidence 9865432 12357999999999999999999999999999999999999999764322111111 00000
Q ss_pred cccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHHhcCCCCccccc
Q 011851 358 FYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPR-----MSEVVEALKPLPYLKDMA 413 (476)
Q Consensus 358 ~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt-----~~ell~~L~~~~~~~~~~ 413 (476)
.++...+..+.+||.+||+.||.+||+ ++++++| ||++...
T Consensus 216 -----------~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h----~~~~~~~ 261 (291)
T cd05612 216 -----------EFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH----RWFKSVD 261 (291)
T ss_pred -----------CCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC----ccccCCC
Confidence 011122567899999999999999995 8888776 9998654
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-46 Score=372.16 Aligned_cols=253 Identities=27% Similarity=0.408 Sum_probs=207.7
Q ss_pred cCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCc---cCHHHHHHHHHHHhCCCCCceeeEEEEEE
Q 011851 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL---QGHKEWLAEVNYLGGLIHPNLVKLIGCCI 197 (476)
Q Consensus 121 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~l~~~~~ 197 (476)
++|++.+.||+|+||.||+|.+. .+++.||+|++..... ...+.+.+|+.+|++++||||+++++++.
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 88 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHK---------GTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQ 88 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEEC---------CCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence 46899999999999999998764 4678899999975432 23456889999999999999999999999
Q ss_pred eCCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCC
Q 011851 198 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGL 277 (476)
Q Consensus 198 ~~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~ 277 (476)
+++.+|+||||+++++|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+
T Consensus 89 ~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~ 164 (329)
T PTZ00263 89 DENRVYFLLEFVVGGELFTHLRKA-GRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGF 164 (329)
T ss_pred cCCEEEEEEcCCCCChHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccC
Confidence 999999999999999999999554 56899999999999999999999988 99999999999999999999999999
Q ss_pred cCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhccccc
Q 011851 278 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRR 357 (476)
Q Consensus 278 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 357 (476)
++...... ...+||+.|+|||++.+..++.++|||||||++|||++|+.||....... .... .......
T Consensus 165 ~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~---~~~~---i~~~~~~ 233 (329)
T PTZ00263 165 AKKVPDRT-----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFR---IYEK---ILAGRLK 233 (329)
T ss_pred ceEcCCCc-----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHH---HHHH---HhcCCcC
Confidence 98654321 23679999999999999999999999999999999999999997543211 1110 0000000
Q ss_pred cccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHHhcCCCCccccc
Q 011851 358 FYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPR-----MSEVVEALKPLPYLKDMA 413 (476)
Q Consensus 358 ~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt-----~~ell~~L~~~~~~~~~~ 413 (476)
++...+..+.+||.+||+.||.+|++ +.+++.| |||++..
T Consensus 234 ------------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h----p~f~~~~ 278 (329)
T PTZ00263 234 ------------FPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH----PYFHGAN 278 (329)
T ss_pred ------------CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC----CccCCCC
Confidence 11112567889999999999999997 5776666 9998743
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-45 Score=368.30 Aligned_cols=258 Identities=26% Similarity=0.344 Sum_probs=218.8
Q ss_pred ccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccC---HHHHHHHHHHHhCCC-CCceeeEEEE
Q 011851 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQG---HKEWLAEVNYLGGLI-HPNLVKLIGC 195 (476)
Q Consensus 120 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~---~~~~~~E~~~l~~l~-hpnIv~l~~~ 195 (476)
...|.+.+.||+|.||.||++. ++.||+.+|+|++.+..... ...+.+|+.+|+++. |||||.++++
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~---------~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~ 104 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCR---------EKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDA 104 (382)
T ss_pred cccEEehhhhCCCCceEEEEEE---------ecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEE
Confidence 4568899999999999999965 45679999999998776643 357899999999998 9999999999
Q ss_pred EEeCCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecC----CCceE
Q 011851 196 CIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDG----EYNAK 271 (476)
Q Consensus 196 ~~~~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~----~~~vk 271 (476)
|++.+.+++|||+|.||.|++.|... .+++..+..++.||+.++.|||+.+ |+||||||+|+|+.. ++.+|
T Consensus 105 ~e~~~~~~lvmEL~~GGeLfd~i~~~--~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik 179 (382)
T KOG0032|consen 105 FEDPDSVYLVMELCEGGELFDRIVKK--HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIK 179 (382)
T ss_pred EEcCCeEEEEEEecCCchHHHHHHHc--cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEE
Confidence 99999999999999999999999777 3999999999999999999999988 999999999999943 35799
Q ss_pred EeecCCcCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhh
Q 011851 272 LSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQ 351 (476)
Q Consensus 272 l~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~ 351 (476)
++|||++..... .......+||+.|+|||++....|+..+||||+||++|.|++|..||...........+.....
T Consensus 180 ~~DFGla~~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~- 255 (382)
T KOG0032|consen 180 LIDFGLAKFIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDF- 255 (382)
T ss_pred EeeCCCceEccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCC-
Confidence 999999998765 2234568999999999999999999999999999999999999999987765443332211111
Q ss_pred hccccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCcccc
Q 011851 352 LGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDM 412 (476)
Q Consensus 352 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~~ 412 (476)
++.++.+. ..+..+.++|.+||..||.+|+|+.++|+| ||++..
T Consensus 256 --------~f~~~~w~-----~is~~akd~i~~ll~~dp~~R~ta~~~L~H----pWi~~~ 299 (382)
T KOG0032|consen 256 --------DFTSEPWD-----DISESAKDFIRKLLEFDPRKRLTAAQALQH----PWIKSI 299 (382)
T ss_pred --------CCCCCCcc-----ccCHHHHHHHHHhcccCcccCCCHHHHhcC----ccccCC
Confidence 11122222 237889999999999999999999999997 999875
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-45 Score=359.51 Aligned_cols=259 Identities=29% Similarity=0.408 Sum_probs=209.1
Q ss_pred CCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCcc---CHHHHHHHHHHHhCCCCCceeeEEEEEEe
Q 011851 122 SFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQ---GHKEWLAEVNYLGGLIHPNLVKLIGCCIE 198 (476)
Q Consensus 122 ~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~---~~~~~~~E~~~l~~l~hpnIv~l~~~~~~ 198 (476)
.|+..+.||+|+||.||+|.+. .+|+.||+|.+...... ....+.+|+.+|++++|+||+++++++.+
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~---------~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~ 71 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVR---------ATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYET 71 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEe---------cCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEcc
Confidence 3778899999999999998754 46788999998754332 23357789999999999999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCC
Q 011851 199 DDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGL 277 (476)
Q Consensus 199 ~~~~~lV~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~ 277 (476)
++..++||||+++|+|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 72 ~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~ 148 (285)
T cd05631 72 KDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGL 148 (285)
T ss_pred CCeEEEEEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCC
Confidence 99999999999999999887543 346899999999999999999999988 99999999999999999999999999
Q ss_pred cCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhccccc
Q 011851 278 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRR 357 (476)
Q Consensus 278 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 357 (476)
+........ .....||+.|+|||++.+..++.++|||||||++|||++|+.||...........+.. ....
T Consensus 149 ~~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~---~~~~--- 219 (285)
T cd05631 149 AVQIPEGET---VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDR---RVKE--- 219 (285)
T ss_pred cEEcCCCCe---ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHH---Hhhc---
Confidence 986543221 2335799999999999999999999999999999999999999986543221111110 0000
Q ss_pred cccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHHhcCCCCccccc
Q 011851 358 FYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPR-----MSEVVEALKPLPYLKDMA 413 (476)
Q Consensus 358 ~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt-----~~ell~~L~~~~~~~~~~ 413 (476)
....++...+.++.+|+.+||+.||++||+ ++++++| |||++..
T Consensus 220 --------~~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h----~~~~~~~ 268 (285)
T cd05631 220 --------DQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH----PIFKNIN 268 (285)
T ss_pred --------ccccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC----HhhcCCC
Confidence 001122233678899999999999999997 7888776 9988754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-45 Score=368.61 Aligned_cols=263 Identities=29% Similarity=0.416 Sum_probs=204.7
Q ss_pred ccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCc-cCHHHHHHHHHHHhCC-CCCceeeEEEEEE
Q 011851 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL-QGHKEWLAEVNYLGGL-IHPNLVKLIGCCI 197 (476)
Q Consensus 120 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~-~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~ 197 (476)
.++|++.++||+|+||.||+|.+... .+..+++.||||++..... ...+.+.+|+.+|.++ +||||+++++++.
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~----~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~ 81 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGI----DKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACT 81 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEecc----CCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEec
Confidence 35799999999999999999976421 1224567899999975432 2245688999999999 8999999999887
Q ss_pred eC-CeeEEEEEecCCCCHHHHHhhcC------------------------------------------------------
Q 011851 198 ED-DQRLLVYEFMPRGSLENHLFRRS------------------------------------------------------ 222 (476)
Q Consensus 198 ~~-~~~~lV~E~~~~g~L~~~l~~~~------------------------------------------------------ 222 (476)
.. +.+++||||+++|+|.+++....
T Consensus 82 ~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (338)
T cd05102 82 KPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQ 161 (338)
T ss_pred CCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccch
Confidence 64 46899999999999999986421
Q ss_pred -------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCcCCCCCCCccceeeeeec
Q 011851 223 -------LPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMG 295 (476)
Q Consensus 223 -------~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~g 295 (476)
.++++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...............+
T Consensus 162 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~ 238 (338)
T cd05102 162 ETDDLWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARL 238 (338)
T ss_pred hccccccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCC
Confidence 24778888999999999999999988 99999999999999999999999999986533222222223456
Q ss_pred CCCCCCcchhhcCCCCccchhhhhHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhhccccccccccCcccCCCCChHH
Q 011851 296 TYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPQLGERRRFYRLIDPCLEGCFSIKG 374 (476)
Q Consensus 296 t~~y~aPE~~~~~~~~~~~DiwslGv~l~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 374 (476)
++.|+|||++.+..++.++|||||||++|||++ |..||........ ... .+..... . ..+...
T Consensus 239 ~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~--~~~----~~~~~~~-~---------~~~~~~ 302 (338)
T cd05102 239 PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEE--FCQ----RLKDGTR-M---------RAPENA 302 (338)
T ss_pred CccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHH--HHH----HHhcCCC-C---------CCCCCC
Confidence 788999999999999999999999999999997 9999976433211 111 0000000 0 011123
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 011851 375 AEKTIQLAASCLNRDQKARPRMSEVVEALKP 405 (476)
Q Consensus 375 ~~~~~~li~~cL~~dP~~RPt~~ell~~L~~ 405 (476)
+..+.+|+.+||+.||++|||+.+|++.|+.
T Consensus 303 ~~~l~~li~~cl~~dp~~RPs~~el~~~l~~ 333 (338)
T cd05102 303 TPEIYRIMLACWQGDPKERPTFSALVEILGD 333 (338)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 5678999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=369.05 Aligned_cols=268 Identities=26% Similarity=0.416 Sum_probs=213.9
Q ss_pred ChhHHHHhccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccC--HHHHHHHHHHHhCCCCCce
Q 011851 112 SFNELKSATKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQG--HKEWLAEVNYLGGLIHPNL 189 (476)
Q Consensus 112 ~~~~~~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~--~~~~~~E~~~l~~l~hpnI 189 (476)
+.+++....+.+.+...||+|.||+||+|++..+ ||||+++.+.... .+.|..|+..|++-+|.||
T Consensus 383 s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whGd------------VAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NI 450 (678)
T KOG0193|consen 383 SLEEWEIPPEEVLLGERIGSGSFGTVYRGRWHGD------------VAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENI 450 (678)
T ss_pred cccccccCHHHhhccceeccccccceeecccccc------------eEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhh
Confidence 3344445556677889999999999999998754 9999998766543 4679999999999999999
Q ss_pred eeEEEEEEeCCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCc
Q 011851 190 VKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYN 269 (476)
Q Consensus 190 v~l~~~~~~~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~ 269 (476)
+-++||+..... .||..+|+|-+|+.+|+.....|.....+.|+.||++|+.|||..+ |||||||..||+|.+++.
T Consensus 451 lLFMG~~~~p~~-AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~k 526 (678)
T KOG0193|consen 451 LLFMGACMNPPL-AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLK 526 (678)
T ss_pred eeeehhhcCCce-eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCc
Confidence 999999998877 9999999999999999887788999999999999999999999988 999999999999999999
Q ss_pred eEEeecCCcCCCCCCCccceeeeeecCCCCCCcchhhc---CCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHH
Q 011851 270 AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT---GHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVE 346 (476)
Q Consensus 270 vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~ 346 (476)
|||+|||++................|...|||||+++. .+|+..+|||||||++|||+||..||...........+
T Consensus 527 VkIgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmV- 605 (678)
T KOG0193|consen 527 VKIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMV- 605 (678)
T ss_pred EEEecccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEe-
Confidence 99999999865332211111223468889999999975 37999999999999999999999999844333222111
Q ss_pred hhhhhhccccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCC
Q 011851 347 WARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPY 408 (476)
Q Consensus 347 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~ 408 (476)
+... -..|... ...+.++++.+|+..||..++++||.+.+|+..|+.++-
T Consensus 606 ------GrG~---l~pd~s~---~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~ 655 (678)
T KOG0193|consen 606 ------GRGY---LMPDLSK---IRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP 655 (678)
T ss_pred ------cccc---cCccchh---hhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence 1110 0111111 112347799999999999999999999999997665533
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-45 Score=356.75 Aligned_cols=270 Identities=24% Similarity=0.328 Sum_probs=207.6
Q ss_pred cCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCcc-CHHHHHHHHHHHhCCCCCceeeEEEEEEeC
Q 011851 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQ-GHKEWLAEVNYLGGLIHPNLVKLIGCCIED 199 (476)
Q Consensus 121 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~ 199 (476)
++|++.++||+|+||.||+|++. .+++.||+|+++..... ....+.+|+.++++++||||+++++++.++
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 75 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSK---------LTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTE 75 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEEC---------CCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCC
Confidence 46999999999999999998654 46788999999754322 234677899999999999999999999999
Q ss_pred CeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCcC
Q 011851 200 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAK 279 (476)
Q Consensus 200 ~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~ 279 (476)
+..++||||+++ +|.+++......+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 76 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~ 151 (288)
T cd07871 76 RCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLAR 151 (288)
T ss_pred CeEEEEEeCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCccee
Confidence 999999999965 999988766667899999999999999999999988 9999999999999999999999999997
Q ss_pred CCCCCCccceeeeeecCCCCCCcchhhc-CCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhh--------h
Q 011851 280 DGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR--------P 350 (476)
Q Consensus 280 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~--------~ 350 (476)
........ .....|++.|+|||++.+ ..++.++|||||||++|+|++|+.||...........+.... +
T Consensus 152 ~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (288)
T cd07871 152 AKSVPTKT--YSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWP 229 (288)
T ss_pred eccCCCcc--ccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhh
Confidence 64332211 223568999999998876 468999999999999999999999997654332221111000 0
Q ss_pred hhccccccccccCcccCCC----CChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCc
Q 011851 351 QLGERRRFYRLIDPCLEGC----FSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYL 409 (476)
Q Consensus 351 ~~~~~~~~~~~~d~~l~~~----~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~ 409 (476)
.......+.....+..... .....+.++.+||.+||+.||.+|||+.|+++| |||
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h----p~f 288 (288)
T cd07871 230 GITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH----SYF 288 (288)
T ss_pred ccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC----CCC
Confidence 0000011111111111000 001225678999999999999999999999987 886
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-45 Score=366.90 Aligned_cols=260 Identities=24% Similarity=0.334 Sum_probs=210.9
Q ss_pred cCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCc---cCHHHHHHHHHHHhCCCCCceeeEEEEEE
Q 011851 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL---QGHKEWLAEVNYLGGLIHPNLVKLIGCCI 197 (476)
Q Consensus 121 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~l~~~~~ 197 (476)
++|++.+.||+|+||.||+|.+. .+++.||||++..... .....+..|+++|..++||||+++++++.
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~ 71 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKK---------DTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQ 71 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEEC---------CCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEE
Confidence 36899999999999999998764 4678899999975432 23456788999999999999999999999
Q ss_pred eCCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCC
Q 011851 198 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGL 277 (476)
Q Consensus 198 ~~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~ 277 (476)
+.+..||||||+++++|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 72 ~~~~~~lv~e~~~g~~L~~~l~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~ 147 (333)
T cd05600 72 DDEYLYLAMEYVPGGDFRTLLNN-LGVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGL 147 (333)
T ss_pred cCCEEEEEEeCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcC
Confidence 99999999999999999999854 457899999999999999999999988 99999999999999999999999999
Q ss_pred cCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhccccc
Q 011851 278 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRR 357 (476)
Q Consensus 278 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 357 (476)
+..... .....+||+.|+|||++.+..++.++|||||||++|||++|..||...........+....
T Consensus 148 a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~-------- 214 (333)
T cd05600 148 SKGIVT-----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWK-------- 214 (333)
T ss_pred Cccccc-----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhcc--------
Confidence 986543 1234679999999999999999999999999999999999999997654322111111000
Q ss_pred cccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCcccc
Q 011851 358 FYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDM 412 (476)
Q Consensus 358 ~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~~ 412 (476)
..+............+.++.+||.+||..+|++||++.++++| |||++.
T Consensus 215 --~~~~~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h----~~~~~~ 263 (333)
T cd05600 215 --ETLQRPVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH----PFFKEV 263 (333)
T ss_pred --ccccCCCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC----cccCCC
Confidence 0000000000011236789999999999999999999999997 888864
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-45 Score=363.10 Aligned_cols=273 Identities=24% Similarity=0.351 Sum_probs=211.0
Q ss_pred ccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCc-cCHHHHHHHHHHHhCCCCCceeeEEEEEEe
Q 011851 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL-QGHKEWLAEVNYLGGLIHPNLVKLIGCCIE 198 (476)
Q Consensus 120 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~ 198 (476)
.++|++.+.||+|+||.||++.+. .+|..||+|++..... .....+.+|+++|++++||||+++++++..
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 74 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHK---------PSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS 74 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEEC---------CCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE
Confidence 357999999999999999998654 4678899999976432 224568899999999999999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCc
Q 011851 199 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLA 278 (476)
Q Consensus 199 ~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a 278 (476)
++.+++||||+++++|.+++... ..+++..+..++.|++.||.|||+.+ +|+||||||+|||++.++.+||+|||++
T Consensus 75 ~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~ 151 (331)
T cd06649 75 DGEISICMEHMDGGSLDQVLKEA-KRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVS 151 (331)
T ss_pred CCEEEEEeecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccc
Confidence 99999999999999999998543 46899999999999999999999853 2999999999999999999999999999
Q ss_pred CCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhcc-c--
Q 011851 279 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGE-R-- 355 (476)
Q Consensus 279 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~-~-- 355 (476)
....... .....||+.|+|||++.+..++.++|||||||++|||++|+.||............. .+.... .
T Consensus 152 ~~~~~~~----~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~--~~~~~~~~~~ 225 (331)
T cd06649 152 GQLIDSM----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFG--RPVVDGEEGE 225 (331)
T ss_pred ccccccc----cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhc--ccccccccCC
Confidence 7653321 233579999999999999999999999999999999999999996543211100000 000000 0
Q ss_pred -------------------------cccccccC----cccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011851 356 -------------------------RRFYRLID----PCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPL 406 (476)
Q Consensus 356 -------------------------~~~~~~~d----~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~ 406 (476)
......++ ...........+.++.+||.+||+.||++|||+.+|++|
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h---- 301 (331)
T cd06649 226 PHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNH---- 301 (331)
T ss_pred ccccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcC----
Confidence 00000000 000000011235789999999999999999999999997
Q ss_pred CCcccccC
Q 011851 407 PYLKDMAS 414 (476)
Q Consensus 407 ~~~~~~~~ 414 (476)
||++....
T Consensus 302 ~~~~~~~~ 309 (331)
T cd06649 302 TFIKRSEV 309 (331)
T ss_pred hHHhhccc
Confidence 99886543
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-45 Score=356.87 Aligned_cols=271 Identities=22% Similarity=0.282 Sum_probs=207.1
Q ss_pred cCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCc--cCHHHHHHHHHHHhCCCCCceeeEEEEEEe
Q 011851 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL--QGHKEWLAEVNYLGGLIHPNLVKLIGCCIE 198 (476)
Q Consensus 121 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~ 198 (476)
++|++.+.||+|+||.||+|++. .+++.||+|++..... ...+.+.+|+.+++.++||||+++++++..
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~---------~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 71 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHK---------ETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRR 71 (287)
T ss_pred CCceEEEEecccCCEEEEEEEEC---------CCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEec
Confidence 46999999999999999998764 4678899999875432 234567889999999999999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCc
Q 011851 199 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLA 278 (476)
Q Consensus 199 ~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a 278 (476)
++..|+||||++++.|.. +......+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 72 ~~~~~lv~e~~~~~~l~~-~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~ 147 (287)
T cd07848 72 RGKLYLVFEYVEKNMLEL-LEEMPNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFA 147 (287)
T ss_pred CCEEEEEEecCCCCHHHH-HHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCc
Confidence 999999999998876654 4344567999999999999999999999988 999999999999999999999999999
Q ss_pred CCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhc-----
Q 011851 279 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLG----- 353 (476)
Q Consensus 279 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~----- 353 (476)
......... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...........+........
T Consensus 148 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (287)
T cd07848 148 RNLSEGSNA-NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMK 226 (287)
T ss_pred ccccccccc-cccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHH
Confidence 875432221 12335799999999999998999999999999999999999999976543221111110000000
Q ss_pred ---cccccccccCcccCC------CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCc
Q 011851 354 ---ERRRFYRLIDPCLEG------CFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYL 409 (476)
Q Consensus 354 ---~~~~~~~~~d~~l~~------~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~ 409 (476)
....+.....+.... .+....+.++.+||.+||+.||++|||++++++| |||
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h----p~f 287 (287)
T cd07848 227 LFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH----PAF 287 (287)
T ss_pred hhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC----CCC
Confidence 000000000000000 0111235679999999999999999999999987 886
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-46 Score=341.50 Aligned_cols=262 Identities=26% Similarity=0.396 Sum_probs=213.7
Q ss_pred HHHhccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCc----cCH----HHHHHHHHHHhCC-CC
Q 011851 116 LKSATKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL----QGH----KEWLAEVNYLGGL-IH 186 (476)
Q Consensus 116 ~~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~----~~~----~~~~~E~~~l~~l-~h 186 (476)
.+...+.|...+.||+|..++|.+ |+++.||.++|+|++..... +.. +.-.+|+.||+++ .|
T Consensus 12 a~~fy~~y~pkeilgrgvss~vrR---------ci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GH 82 (411)
T KOG0599|consen 12 AKGFYAKYEPKEILGRGVSSVVRR---------CIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGH 82 (411)
T ss_pred HhhHHhhcChHHHhcccchhhhhh---------hhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCC
Confidence 344556788999999999999987 56778999999999864221 112 2346799999999 59
Q ss_pred CceeeEEEEEEeCCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecC
Q 011851 187 PNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDG 266 (476)
Q Consensus 187 pnIv~l~~~~~~~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~ 266 (476)
|+|+.+.++|+.+...++|+|.|+.|.|+|+|. ....++++..+.|++|+++|++|||..+ ||||||||+|||+|+
T Consensus 83 P~II~l~D~yes~sF~FlVFdl~prGELFDyLt-s~VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILldd 158 (411)
T KOG0599|consen 83 PYIIDLQDVYESDAFVFLVFDLMPRGELFDYLT-SKVTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDD 158 (411)
T ss_pred CcEEEeeeeccCcchhhhhhhhcccchHHHHhh-hheeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeecc
Confidence 999999999999999999999999999999994 4457999999999999999999999988 999999999999999
Q ss_pred CCceEEeecCCcCCCCCCCccceeeeeecCCCCCCcchhhc------CCCCccchhhhhHHHHHHHHhCCCCCCCCCCCC
Q 011851 267 EYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT------GHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNG 340 (476)
Q Consensus 267 ~~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~ 340 (476)
+.++||+|||+++....+... ...||||+|+|||.+.. ..|+..+|+|++|||+|.||.|.+||.....-.
T Consensus 159 n~~i~isDFGFa~~l~~GekL---relCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQml 235 (411)
T KOG0599|consen 159 NMNIKISDFGFACQLEPGEKL---RELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQML 235 (411)
T ss_pred ccceEEeccceeeccCCchhH---HHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHH
Confidence 999999999999998776653 45899999999998864 368889999999999999999999996432211
Q ss_pred cchhHHhhhhhhccccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCccc
Q 011851 341 EHNLVEWARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKD 411 (476)
Q Consensus 341 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~ 411 (476)
+.+..+... +.+-.+.+.+ .+....+||.+||+.||.+|.|+.|+|+| |||..
T Consensus 236 ------MLR~ImeGk---yqF~speWad-----is~~~KdLIsrlLqVdp~~Ritake~LaH----pff~q 288 (411)
T KOG0599|consen 236 ------MLRMIMEGK---YQFRSPEWAD-----ISATVKDLISRLLQVDPTKRITAKEALAH----PFFIQ 288 (411)
T ss_pred ------HHHHHHhcc---cccCCcchhh-----ccccHHHHHHHHHeeCchhcccHHHHhcC----hHHHH
Confidence 111111111 1222333332 36788999999999999999999999998 88854
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-45 Score=366.75 Aligned_cols=254 Identities=25% Similarity=0.332 Sum_probs=207.5
Q ss_pred cCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCc---cCHHHHHHHHHHHhCCCCCceeeEEEEEE
Q 011851 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL---QGHKEWLAEVNYLGGLIHPNLVKLIGCCI 197 (476)
Q Consensus 121 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~l~~~~~ 197 (476)
++|.+.+.||+|+||.||+|.+... .+..||+|++..... ...+.+.+|+.+|+.++||||+++++++.
T Consensus 30 ~~y~~~~~ig~G~~g~Vy~a~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~ 101 (340)
T PTZ00426 30 EDFNFIRTLGTGSFGRVILATYKNE--------DFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFK 101 (340)
T ss_pred hhcEEEEEEeecCCeEEEEEEEECC--------CCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEE
Confidence 4699999999999999999875421 235799999865422 23456788999999999999999999999
Q ss_pred eCCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCC
Q 011851 198 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGL 277 (476)
Q Consensus 198 ~~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~ 277 (476)
+.+.+||||||+++|+|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 102 ~~~~~~lv~Ey~~~g~L~~~i~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~ 177 (340)
T PTZ00426 102 DESYLYLVLEFVIGGEFFTFLRRN-KRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGF 177 (340)
T ss_pred eCCEEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCC
Confidence 999999999999999999998544 56999999999999999999999988 99999999999999999999999999
Q ss_pred cCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhccccc
Q 011851 278 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRR 357 (476)
Q Consensus 278 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 357 (476)
+...... ....+||+.|+|||++.+..++.++|||||||++|||++|..||....+......+ .....
T Consensus 178 a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i------~~~~~- 245 (340)
T PTZ00426 178 AKVVDTR-----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKI------LEGII- 245 (340)
T ss_pred CeecCCC-----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHH------hcCCC-
Confidence 9865321 22467999999999999989999999999999999999999999764332111100 00000
Q ss_pred cccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHhcCCCCccccc
Q 011851 358 FYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARP-----RMSEVVEALKPLPYLKDMA 413 (476)
Q Consensus 358 ~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RP-----t~~ell~~L~~~~~~~~~~ 413 (476)
.++...+..+.++|.+||+.||++|+ +++++++| |||++..
T Consensus 246 -----------~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h----p~f~~~~ 291 (340)
T PTZ00426 246 -----------YFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH----PWFGNID 291 (340)
T ss_pred -----------CCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC----CCcCCCC
Confidence 01122356788999999999999995 78888776 9998754
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-45 Score=362.77 Aligned_cols=263 Identities=28% Similarity=0.368 Sum_probs=208.1
Q ss_pred CCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCc----cCHHHHHHHHHHHhCC-CCCceeeEEEEE
Q 011851 122 SFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL----QGHKEWLAEVNYLGGL-IHPNLVKLIGCC 196 (476)
Q Consensus 122 ~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~----~~~~~~~~E~~~l~~l-~hpnIv~l~~~~ 196 (476)
+|++.+.||+|+||.||+++... ...+++.||+|++.+... ...+.+..|+.+|..+ +|+||+++++++
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~------~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~ 74 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVT------GHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAF 74 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcc------cCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEE
Confidence 48899999999999999987532 334788999999975322 2234577899999999 599999999999
Q ss_pred EeCCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecC
Q 011851 197 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFG 276 (476)
Q Consensus 197 ~~~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG 276 (476)
..++.+|+||||+++|+|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||
T Consensus 75 ~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG 150 (332)
T cd05614 75 QTEAKLHLILDYVSGGEMFTHLYQR-DNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFG 150 (332)
T ss_pred ecCCEEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCc
Confidence 9999999999999999999998554 46899999999999999999999988 9999999999999999999999999
Q ss_pred CcCCCCCCCccceeeeeecCCCCCCcchhhcC-CCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhccc
Q 011851 277 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGER 355 (476)
Q Consensus 277 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~ 355 (476)
+++........ .....+||+.|+|||++.+. .++.++|||||||++|||++|+.||...........+. .....
T Consensus 151 ~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~--~~~~~-- 225 (332)
T cd05614 151 LSKEFLSEEKE-RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVS--RRILK-- 225 (332)
T ss_pred CCccccccCCC-ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHH--HHHhc--
Confidence 99865332221 12346799999999999865 48899999999999999999999997543322111111 00000
Q ss_pred cccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHhcCCCCccccc
Q 011851 356 RRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARP-----RMSEVVEALKPLPYLKDMA 413 (476)
Q Consensus 356 ~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RP-----t~~ell~~L~~~~~~~~~~ 413 (476)
.++. ++...+..+.+|+.+||+.||++|| +++++++| |||++..
T Consensus 226 ------~~~~----~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h----~~~~~~~ 274 (332)
T cd05614 226 ------CDPP----FPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH----PFFKGLD 274 (332)
T ss_pred ------CCCC----CCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC----CCcCCCC
Confidence 0111 1122356789999999999999999 67788776 9998753
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-44 Score=361.39 Aligned_cols=254 Identities=24% Similarity=0.345 Sum_probs=199.3
Q ss_pred CCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCcc-CHHHHHHHHHHHhCCCCCceeeEEEEEEeCC
Q 011851 122 SFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQ-GHKEWLAEVNYLGGLIHPNLVKLIGCCIEDD 200 (476)
Q Consensus 122 ~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 200 (476)
+|...+.||+|+||.||+|.+. .+++.||||++...... ....+.+|+++|+.++|+||+++++++.+++
T Consensus 75 ~~~~~~~lg~G~~g~V~~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 145 (353)
T PLN00034 75 ELERVNRIGSGAGGTVYKVIHR---------PTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNG 145 (353)
T ss_pred HHhhhhhccCCCCeEEEEEEEC---------CCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCC
Confidence 4677889999999999998654 46788999999654322 2356889999999999999999999999999
Q ss_pred eeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCcCC
Q 011851 201 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKD 280 (476)
Q Consensus 201 ~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~ 280 (476)
.+|+||||+++++|.+.. ...+..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++.
T Consensus 146 ~~~lv~e~~~~~~L~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~ 217 (353)
T PLN00034 146 EIQVLLEFMDGGSLEGTH-----IADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRI 217 (353)
T ss_pred eEEEEEecCCCCcccccc-----cCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccccccee
Confidence 999999999999986532 3567788899999999999999988 99999999999999999999999999986
Q ss_pred CCCCCccceeeeeecCCCCCCcchhhc-----CCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhccc
Q 011851 281 GPEGDKTHVSTRVMGTYGYAAPEYVMT-----GHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGER 355 (476)
Q Consensus 281 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~ 355 (476)
...... ......||..|+|||++.. ..++.++|||||||++|||++|+.||................ ...
T Consensus 218 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~--~~~- 292 (353)
T PLN00034 218 LAQTMD--PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAIC--MSQ- 292 (353)
T ss_pred cccccc--cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHh--ccC-
Confidence 543211 1233579999999998753 234568999999999999999999997432221111111000 000
Q ss_pred cccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCcccc
Q 011851 356 RRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDM 412 (476)
Q Consensus 356 ~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~~ 412 (476)
........+.++.+||.+||+.||++||++.|+++| ||+.+.
T Consensus 293 -----------~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h----p~~~~~ 334 (353)
T PLN00034 293 -----------PPEAPATASREFRHFISCCLQREPAKRWSAMQLLQH----PFILRA 334 (353)
T ss_pred -----------CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC----cccccC
Confidence 000112236789999999999999999999999997 998764
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-45 Score=358.49 Aligned_cols=276 Identities=21% Similarity=0.305 Sum_probs=208.6
Q ss_pred ccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCcc-CHHHHHHHHHHHhCCCCCceeeEEEEEEe
Q 011851 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQ-GHKEWLAEVNYLGGLIHPNLVKLIGCCIE 198 (476)
Q Consensus 120 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~~ 198 (476)
.++|++.+.||+|+||.||+|.+. .+++.||||++...... ....+.+|+.+++.++||||+++++++.+
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 74 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSK---------VNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHT 74 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEEC---------CCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEec
Confidence 467999999999999999998764 46778999999754332 23457789999999999999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCc
Q 011851 199 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLA 278 (476)
Q Consensus 199 ~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a 278 (476)
++..|+||||+. ++|.+++......+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 75 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~ 150 (303)
T cd07869 75 KETLTLVFEYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLA 150 (303)
T ss_pred CCeEEEEEECCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcc
Confidence 999999999995 6888888776677999999999999999999999988 999999999999999999999999998
Q ss_pred CCCCCCCccceeeeeecCCCCCCcchhhcC-CCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcc-hhHHhh--hhhhcc
Q 011851 279 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEH-NLVEWA--RPQLGE 354 (476)
Q Consensus 279 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~-~~~~~~--~~~~~~ 354 (476)
........ ......||+.|+|||++.+. .++.++|||||||++|||++|..||......... ..+... .+....
T Consensus 151 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 228 (303)
T cd07869 151 RAKSVPSH--TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDT 228 (303)
T ss_pred eeccCCCc--cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhh
Confidence 75432211 12335689999999998764 6889999999999999999999999764321110 000000 000000
Q ss_pred ccccc---cc--------cCcccCCCC-ChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCcccccC
Q 011851 355 RRRFY---RL--------IDPCLEGCF-SIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDMAS 414 (476)
Q Consensus 355 ~~~~~---~~--------~d~~l~~~~-~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~~~~ 414 (476)
..... .. ....+...+ ....+..+.+|+.+||+.||++|||+.++++| |||++...
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h----~~f~~~~~ 296 (303)
T cd07869 229 WPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSH----EYFSDLPP 296 (303)
T ss_pred ccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcC----cccccCCh
Confidence 00000 00 000000000 00113578899999999999999999999987 99987643
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-45 Score=363.21 Aligned_cols=250 Identities=26% Similarity=0.360 Sum_probs=203.3
Q ss_pred ccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCc---cCHHHHHHHHHHHhCCCCCceeeEEEEEEeCCeeE
Q 011851 127 CLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL---QGHKEWLAEVNYLGGLIHPNLVKLIGCCIEDDQRL 203 (476)
Q Consensus 127 ~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 203 (476)
+.||+|+||.||++.+. .+|+.||+|++..... .....+.+|+.+|+.++||||+++++++..++.+|
T Consensus 1 ~~lG~G~~g~Vy~~~~~---------~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 71 (328)
T cd05593 1 KLLGKGTFGKVILVREK---------ASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLC 71 (328)
T ss_pred CeeeeCCCEEEEEEEEC---------CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEE
Confidence 46999999999998654 4678899999976432 23356788999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCcCCCCC
Q 011851 204 LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPE 283 (476)
Q Consensus 204 lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~ 283 (476)
|||||+++++|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++....
T Consensus 72 lv~Ey~~~g~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~ 147 (328)
T cd05593 72 FVMEYVNGGELFFHLSR-ERVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGIT 147 (328)
T ss_pred EEEeCCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCC
Confidence 99999999999988854 457999999999999999999999988 99999999999999999999999999876432
Q ss_pred CCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhccccccccccC
Q 011851 284 GDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRRFYRLID 363 (476)
Q Consensus 284 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 363 (476)
... .....+||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+ .....
T Consensus 148 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~------~~~~~------- 212 (328)
T cd05593 148 DAA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI------LMEDI------- 212 (328)
T ss_pred ccc--ccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHh------ccCCc-------
Confidence 111 123467999999999999999999999999999999999999999754321111100 00000
Q ss_pred cccCCCCChHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHhcCCCCccccc
Q 011851 364 PCLEGCFSIKGAEKTIQLAASCLNRDQKARP-----RMSEVVEALKPLPYLKDMA 413 (476)
Q Consensus 364 ~~l~~~~~~~~~~~~~~li~~cL~~dP~~RP-----t~~ell~~L~~~~~~~~~~ 413 (476)
.++...+.++.+||.+||+.||++|+ ++.++++| +||.+..
T Consensus 213 -----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h----~~~~~~~ 258 (328)
T cd05593 213 -----KFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH----SFFTGVN 258 (328)
T ss_pred -----cCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC----CCcCCCC
Confidence 11222367889999999999999997 89998887 8987653
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-46 Score=353.02 Aligned_cols=271 Identities=24% Similarity=0.339 Sum_probs=210.6
Q ss_pred cCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCCCCCceeeEEEEEEeCC
Q 011851 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHPNLVKLIGCCIEDD 200 (476)
Q Consensus 121 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 200 (476)
-.|+..+++|+|+||.||+|.... +++.||||..-.+.. .-.+|+++|+.++|||||+|..+|....
T Consensus 24 i~~~~~~liG~GsFg~Vyq~~~~e---------~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~ 90 (364)
T KOG0658|consen 24 ISYEAVRLIGSGSFGVVYQAKLRE---------TEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSST 90 (364)
T ss_pred EEEEeeEEEeecccceEEEEEEcC---------CCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecC
Confidence 357788999999999999998763 477899998854432 2247999999999999999999887532
Q ss_pred -----eeEEEEEecCCCCHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCC-CceE
Q 011851 201 -----QRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGE-YNAK 271 (476)
Q Consensus 201 -----~~~lV~E~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~-~~vk 271 (476)
++.|||||++. +|.+.+.. .+..++...++-+.+||++||.|||+.+ |+||||||.|+|+|.+ |.+|
T Consensus 91 ~~d~~~lnlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LK 166 (364)
T KOG0658|consen 91 ESDEVYLNLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLK 166 (364)
T ss_pred CCchhHHHHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEE
Confidence 35689999966 89988863 3567889999999999999999999988 9999999999999977 8999
Q ss_pred EeecCCcCCCCCCCccceeeeeecCCCCCCcchhhcC-CCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhh-
Q 011851 272 LSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR- 349 (476)
Q Consensus 272 l~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~- 349 (476)
|||||.|+....++.. ....-|..|+|||++.+. .|+.+.||||.||++.||+-|++-|.+.+.......+-...
T Consensus 167 icDFGSAK~L~~~epn---iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG 243 (364)
T KOG0658|consen 167 ICDFGSAKVLVKGEPN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLG 243 (364)
T ss_pred eccCCcceeeccCCCc---eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhC
Confidence 9999999988765543 346678899999999986 79999999999999999999999998865543332211100
Q ss_pred -hhh-------cc--ccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCcccccCc
Q 011851 350 -PQL-------GE--RRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDMASS 415 (476)
Q Consensus 350 -~~~-------~~--~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~~~~~ 415 (476)
+.. .+ ...+..+....+...+....+.++.+|+.++|..+|.+|.++.|++.| |||+.....
T Consensus 244 ~Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h----~fFdelr~~ 315 (364)
T KOG0658|consen 244 TPTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH----PFFDELRDP 315 (364)
T ss_pred CCCHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc----hhhHHhhCc
Confidence 000 00 111222222222222344457899999999999999999999999998 888876543
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-45 Score=367.98 Aligned_cols=261 Identities=25% Similarity=0.335 Sum_probs=204.9
Q ss_pred cCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCc---cCHHHHHHHHHHHhCCCCCceeeEEEEEE
Q 011851 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL---QGHKEWLAEVNYLGGLIHPNLVKLIGCCI 197 (476)
Q Consensus 121 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~l~~~~~ 197 (476)
++|++.+.||+|+||+||+|.+. .+++.||||++++... .....+.+|+.++.+++|+||+++++.+.
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~ 71 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKK---------DTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQ 71 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEEC---------CCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEe
Confidence 36899999999999999998654 4688899999975432 22345778999999999999999999999
Q ss_pred eCCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCC
Q 011851 198 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGL 277 (476)
Q Consensus 198 ~~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~ 277 (476)
+...+|||||||++|+|.+++.+. ..+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+
T Consensus 72 ~~~~~~lv~E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGl 147 (363)
T cd05628 72 DKLNLYLIMEFLPGGDMMTLLMKK-DTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGL 147 (363)
T ss_pred cCCeEEEEEcCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccC
Confidence 999999999999999999999654 57999999999999999999999988 99999999999999999999999999
Q ss_pred cCCCCCCCcc---------------------------------ceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHH
Q 011851 278 AKDGPEGDKT---------------------------------HVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLL 324 (476)
Q Consensus 278 a~~~~~~~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~ 324 (476)
++........ ......+||+.|+|||++.+..++.++|||||||++|
T Consensus 148 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ 227 (363)
T cd05628 148 CTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMY 227 (363)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHH
Confidence 8754321100 0112358999999999999999999999999999999
Q ss_pred HHHhCCCCCCCCCCCCcchhHHhhhhhhccccccccccCcccCCCCChHHHHHHHHHHHHhcccCCC---CCCCHHHHHH
Q 011851 325 EMLTGRRSMDKNRPNGEHNLVEWARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQK---ARPRMSEVVE 401 (476)
Q Consensus 325 elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~---~RPt~~ell~ 401 (476)
||++|+.||...........+. ..... . .+.+ . ...+.++.+||.+++. +|. .||++++|++
T Consensus 228 ell~G~~Pf~~~~~~~~~~~i~------~~~~~-~-~~p~----~--~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~ 292 (363)
T cd05628 228 EMLIGYPPFCSETPQETYKKVM------NWKET-L-IFPP----E--VPISEKAKDLILRFCC-EWEHRIGAPGVEEIKT 292 (363)
T ss_pred HHHhCCCCCCCCCHHHHHHHHH------cCcCc-c-cCCC----c--CCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhC
Confidence 9999999997654321111100 00000 0 0000 0 1125678899988665 444 4689999988
Q ss_pred HhcCCCCccccc
Q 011851 402 ALKPLPYLKDMA 413 (476)
Q Consensus 402 ~L~~~~~~~~~~ 413 (476)
| |||++..
T Consensus 293 h----p~f~~~~ 300 (363)
T cd05628 293 N----PFFEGVD 300 (363)
T ss_pred C----CCCCCCC
Confidence 7 9998764
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-45 Score=360.21 Aligned_cols=247 Identities=30% Similarity=0.349 Sum_probs=201.1
Q ss_pred ccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCC---ccCHHHHHHHHHHHhCCCCCceeeEEEEEEeCCeeEEE
Q 011851 129 LGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDG---LQGHKEWLAEVNYLGGLIHPNLVKLIGCCIEDDQRLLV 205 (476)
Q Consensus 129 LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV 205 (476)
||+|+||.||+|++. .+++.||+|++.... ......+.+|+.+|++++||||+++++++.+.+..|+|
T Consensus 1 lg~G~~g~Vy~~~~~---------~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 71 (312)
T cd05585 1 IGKGSFGKVMQVRKR---------DTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLV 71 (312)
T ss_pred CCcCCCeEEEEEEEC---------CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEE
Confidence 799999999998754 467789999997532 22345678899999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCcCCCCCCC
Q 011851 206 YEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGD 285 (476)
Q Consensus 206 ~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~ 285 (476)
|||+++|+|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 72 ~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~ 147 (312)
T cd05585 72 LAFINGGELFHHLQR-EGRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD 147 (312)
T ss_pred EcCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccCC
Confidence 999999999999955 456999999999999999999999988 9999999999999999999999999997643222
Q ss_pred ccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhccccccccccCcc
Q 011851 286 KTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRRFYRLIDPC 365 (476)
Q Consensus 286 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 365 (476)
......+||+.|+|||++.+..++.++|||||||++|||++|+.||...... ...........
T Consensus 148 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~------~~~~~~~~~~~--------- 210 (312)
T cd05585 148 --DKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVN------EMYRKILQEPL--------- 210 (312)
T ss_pred --CccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHH------HHHHHHHcCCC---------
Confidence 1233467999999999999999999999999999999999999999754321 11111111100
Q ss_pred cCCCCChHHHHHHHHHHHHhcccCCCCCCC---HHHHHHHhcCCCCcccc
Q 011851 366 LEGCFSIKGAEKTIQLAASCLNRDQKARPR---MSEVVEALKPLPYLKDM 412 (476)
Q Consensus 366 l~~~~~~~~~~~~~~li~~cL~~dP~~RPt---~~ell~~L~~~~~~~~~ 412 (476)
.++...+.++.+||.+||+.||++||+ +.+++.| |||.+.
T Consensus 211 ---~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~h----p~~~~~ 253 (312)
T cd05585 211 ---RFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNH----PFFSQL 253 (312)
T ss_pred ---CCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcC----CCcCCC
Confidence 112223578899999999999999975 5677766 999875
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-45 Score=362.63 Aligned_cols=250 Identities=28% Similarity=0.369 Sum_probs=203.0
Q ss_pred ccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCc---cCHHHHHHHHHHHhCCCCCceeeEEEEEEeCCeeE
Q 011851 127 CLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL---QGHKEWLAEVNYLGGLIHPNLVKLIGCCIEDDQRL 203 (476)
Q Consensus 127 ~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 203 (476)
+.||+|+||.||++.+. .+|..||+|+++.... .....+.+|+.+++.++||||++++++|..++.+|
T Consensus 1 ~~lG~G~~g~Vy~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~ 71 (323)
T cd05595 1 KLLGKGTFGKVILVREK---------ATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC 71 (323)
T ss_pred CeeeeCCCEEEEEEEEC---------CCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEE
Confidence 46999999999998654 4678899999975432 22345678999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCcCCCCC
Q 011851 204 LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPE 283 (476)
Q Consensus 204 lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~ 283 (476)
|||||+++++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 72 lv~E~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~ 147 (323)
T cd05595 72 FVMEYANGGELFFHLSRE-RVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 147 (323)
T ss_pred EEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccC
Confidence 999999999999888543 57899999999999999999999988 99999999999999999999999999875422
Q ss_pred CCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhccccccccccC
Q 011851 284 GDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRRFYRLID 363 (476)
Q Consensus 284 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 363 (476)
... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...........+ .....
T Consensus 148 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~------~~~~~------- 212 (323)
T cd05595 148 DGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI------LMEEI------- 212 (323)
T ss_pred CCC--ccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHH------hcCCC-------
Confidence 211 122367999999999999999999999999999999999999999754322111110 00000
Q ss_pred cccCCCCChHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHhcCCCCccccc
Q 011851 364 PCLEGCFSIKGAEKTIQLAASCLNRDQKARP-----RMSEVVEALKPLPYLKDMA 413 (476)
Q Consensus 364 ~~l~~~~~~~~~~~~~~li~~cL~~dP~~RP-----t~~ell~~L~~~~~~~~~~ 413 (476)
.++...+.++.+||.+||+.||++|+ ++.++++| +||....
T Consensus 213 -----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h----~~~~~~~ 258 (323)
T cd05595 213 -----RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH----RFFLSIN 258 (323)
T ss_pred -----CCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC----CCcCCCC
Confidence 01122367889999999999999998 88998887 8988654
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-44 Score=353.07 Aligned_cols=271 Identities=27% Similarity=0.437 Sum_probs=207.9
Q ss_pred cCCCccccccccCCccEEEEEEccCCce-------eeeCCCCceEEEEEecCCCcc-CHHHHHHHHHHHhCCCCCceeeE
Q 011851 121 KSFRPECLLGEGGFGCVYKGWINMNGTA-------TVKPGTGLPVAVKTLNHDGLQ-GHKEWLAEVNYLGGLIHPNLVKL 192 (476)
Q Consensus 121 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~-------~~~~~~g~~vAiK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l 192 (476)
++|++.++||+|+||.||+|.+...... ..+..++..||+|++...... ...++.+|+++|.+++||||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 4689999999999999999987543211 123446678999999764322 34568899999999999999999
Q ss_pred EEEEEeCCeeEEEEEecCCCCHHHHHhhcC------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEe
Q 011851 193 IGCCIEDDQRLLVYEFMPRGSLENHLFRRS------------------LPLPWSIRMKIALDAAKGLAFLHEEAEKPVIY 254 (476)
Q Consensus 193 ~~~~~~~~~~~lV~E~~~~g~L~~~l~~~~------------------~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivH 254 (476)
++++.+.+..+|||||+++++|.+++.... ..+++..+..++.||+.||.|||+.+ |+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---ivH 161 (304)
T cd05096 85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FVH 161 (304)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---ccc
Confidence 999999999999999999999999985421 24678889999999999999999988 999
Q ss_pred cCCCCCCeeecCCCceEEeecCCcCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHh--CCCC
Q 011851 255 RDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLT--GRRS 332 (476)
Q Consensus 255 rDlKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~ellt--G~~p 332 (476)
|||||+|||++.++.+||+|||+++...............++..|+|||++.++.++.++|||||||++|||++ +..|
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p 241 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP 241 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence 99999999999999999999999986544333222333456889999999999999999999999999999987 5567
Q ss_pred CCCCCCCCcchhHHhhhhhhccccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 011851 333 MDKNRPNGEHNLVEWARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALK 404 (476)
Q Consensus 333 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~ 404 (476)
|....... .............. .. ....+...+..+.+|+.+||+.||++|||+.+|.+.|+
T Consensus 242 ~~~~~~~~---~~~~~~~~~~~~~~--~~-----~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 242 YGELTDEQ---VIENAGEFFRDQGR--QV-----YLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred CCcCCHHH---HHHHHHHHhhhccc--cc-----cccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 76543221 11111111100000 00 00011123568899999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-45 Score=362.42 Aligned_cols=251 Identities=26% Similarity=0.368 Sum_probs=213.0
Q ss_pred cCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccC--HHHHHHHHHHHhCCCCCceeeEEEEEEe
Q 011851 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQG--HKEWLAEVNYLGGLIHPNLVKLIGCCIE 198 (476)
Q Consensus 121 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~--~~~~~~E~~~l~~l~hpnIv~l~~~~~~ 198 (476)
.+|..++++|+|+||.+++.+++ ..+..|++|.++...... .....+|+.+++++.|||||.+++.|++
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk---------~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~ 74 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHK---------SDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEE 74 (426)
T ss_pred chhhhhhhcCccccchhhhhhhc---------cCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhc
Confidence 46899999999999999986554 456679999998765543 3357889999999999999999999999
Q ss_pred CCe-eEEEEEecCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecC
Q 011851 199 DDQ-RLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFG 276 (476)
Q Consensus 199 ~~~-~~lV~E~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG 276 (476)
++. ++|||+||+||+|.+.|.+.. ..++++.+..|+.|++.||.|||+.. |+|||||+.||+++.++.|||+|||
T Consensus 75 ~~~~l~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfG 151 (426)
T KOG0589|consen 75 DGQLLCIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFG 151 (426)
T ss_pred CCceEEEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchh
Confidence 998 999999999999999997754 77999999999999999999999877 9999999999999999999999999
Q ss_pred CcCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhcccc
Q 011851 277 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERR 356 (476)
Q Consensus 277 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~ 356 (476)
+|+...... .....++||+.||.||++.+.+|+.++|||||||++|||++-+++|...+......-+ .
T Consensus 152 laK~l~~~~--~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki---~------- 219 (426)
T KOG0589|consen 152 LAKILNPED--SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKI---N------- 219 (426)
T ss_pred hhhhcCCch--hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHH---h-------
Confidence 999876543 2344589999999999999999999999999999999999999999876543221111 0
Q ss_pred ccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011851 357 RFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEA 402 (476)
Q Consensus 357 ~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~ 402 (476)
...++| .+...+.++..||+.||..+|..||++.++|.+
T Consensus 220 --~~~~~P-----lp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 220 --RGLYSP-----LPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred --hccCCC-----CCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 111222 223347899999999999999999999999997
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-44 Score=367.12 Aligned_cols=261 Identities=23% Similarity=0.310 Sum_probs=204.6
Q ss_pred cCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCc---cCHHHHHHHHHHHhCCCCCceeeEEEEEE
Q 011851 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL---QGHKEWLAEVNYLGGLIHPNLVKLIGCCI 197 (476)
Q Consensus 121 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~l~~~~~ 197 (476)
++|++.+.||+|+||.||+|.+. .+++.||||++..... ...+.+.+|+++|++++||||+++++++.
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~ 71 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKK---------DTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQ 71 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEEC---------CCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEE
Confidence 36899999999999999998654 4778899999865422 22346778999999999999999999999
Q ss_pred eCCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCC
Q 011851 198 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGL 277 (476)
Q Consensus 198 ~~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~ 277 (476)
+++.+||||||+++|+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 72 ~~~~~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGl 147 (377)
T cd05629 72 DAQYLYLIMEFLPGGDLMTMLIK-YDTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGL 147 (377)
T ss_pred cCCeeEEEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeeccc
Confidence 99999999999999999999854 457899999999999999999999988 99999999999999999999999999
Q ss_pred cCCCCCCCcc---------------------------------------------ceeeeeecCCCCCCcchhhcCCCCc
Q 011851 278 AKDGPEGDKT---------------------------------------------HVSTRVMGTYGYAAPEYVMTGHLTA 312 (476)
Q Consensus 278 a~~~~~~~~~---------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~ 312 (476)
++........ ......+||+.|+|||++.+..++.
T Consensus 148 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 227 (377)
T cd05629 148 STGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQ 227 (377)
T ss_pred ccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCC
Confidence 8632210000 0001257999999999999999999
Q ss_pred cchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhccccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCC
Q 011851 313 KSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKA 392 (476)
Q Consensus 313 ~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~ 392 (476)
++|||||||++|||++|..||...........+ ...... .. +.. ....+.++.+||.+||. +|.+
T Consensus 228 ~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i------~~~~~~-~~-----~p~--~~~~s~~~~dli~~lL~-~~~~ 292 (377)
T cd05629 228 ECDWWSLGAIMFECLIGWPPFCSENSHETYRKI------INWRET-LY-----FPD--DIHLSVEAEDLIRRLIT-NAEN 292 (377)
T ss_pred ceeeEecchhhhhhhcCCCCCCCCCHHHHHHHH------HccCCc-cC-----CCC--CCCCCHHHHHHHHHHhc-CHhh
Confidence 999999999999999999999754432111100 000000 00 000 01225688999999998 7776
Q ss_pred C---CCHHHHHHHhcCCCCccccc
Q 011851 393 R---PRMSEVVEALKPLPYLKDMA 413 (476)
Q Consensus 393 R---Pt~~ell~~L~~~~~~~~~~ 413 (476)
| +++.+++.| |||++..
T Consensus 293 r~~r~~~~~~l~h----p~~~~~~ 312 (377)
T cd05629 293 RLGRGGAHEIKSH----PFFRGVD 312 (377)
T ss_pred cCCCCCHHHHhcC----CCcCCCC
Confidence 5 599999987 9998653
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-45 Score=362.91 Aligned_cols=250 Identities=27% Similarity=0.360 Sum_probs=202.1
Q ss_pred ccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCc---cCHHHHHHHHHHHhCCCCCceeeEEEEEEeCCeeE
Q 011851 127 CLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL---QGHKEWLAEVNYLGGLIHPNLVKLIGCCIEDDQRL 203 (476)
Q Consensus 127 ~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 203 (476)
+.||+|+||.||++.+. .+|+.||+|++..... .....+..|++++..++||||+++++++..++.+|
T Consensus 1 ~~lG~G~~g~V~~~~~~---------~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~ 71 (325)
T cd05594 1 KLLGKGTFGKVILVKEK---------ATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLC 71 (325)
T ss_pred CeeeeCCCEEEEEEEEC---------CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEE
Confidence 46999999999998654 4788899999976432 22345678999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCCeeecCCCceEEeecCCcCCCC
Q 011851 204 LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHE-EAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGP 282 (476)
Q Consensus 204 lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~-~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~ 282 (476)
|||||+++++|.+++.. ...+++..+..++.||+.||.|||+ .+ |+||||||+|||++.++.+||+|||+++...
T Consensus 72 lv~E~~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~ 147 (325)
T cd05594 72 FVMEYANGGELFFHLSR-ERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGI 147 (325)
T ss_pred EEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecC
Confidence 99999999999988854 4578999999999999999999997 56 9999999999999999999999999987533
Q ss_pred CCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhcccccccccc
Q 011851 283 EGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRRFYRLI 362 (476)
Q Consensus 283 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 362 (476)
.... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||...........+. ....
T Consensus 148 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~------~~~~------ 213 (325)
T cd05594 148 KDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELIL------MEEI------ 213 (325)
T ss_pred CCCc--ccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHh------cCCC------
Confidence 2111 1223679999999999999999999999999999999999999997543211111110 0000
Q ss_pred CcccCCCCChHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHhcCCCCccccc
Q 011851 363 DPCLEGCFSIKGAEKTIQLAASCLNRDQKARP-----RMSEVVEALKPLPYLKDMA 413 (476)
Q Consensus 363 d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RP-----t~~ell~~L~~~~~~~~~~ 413 (476)
.++...+.++.+||.+||+.||++|+ ++.++++| +||.+..
T Consensus 214 ------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h----~~~~~~~ 259 (325)
T cd05594 214 ------RFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH----KFFAGIV 259 (325)
T ss_pred ------CCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC----CCcCCCC
Confidence 01112356889999999999999996 89999987 8988654
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=368.14 Aligned_cols=261 Identities=24% Similarity=0.341 Sum_probs=205.2
Q ss_pred CCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCcc---CHHHHHHHHHHHhCCCCCceeeEEEEEEe
Q 011851 122 SFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQ---GHKEWLAEVNYLGGLIHPNLVKLIGCCIE 198 (476)
Q Consensus 122 ~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~---~~~~~~~E~~~l~~l~hpnIv~l~~~~~~ 198 (476)
.|++++.||+|+||+||+|.+. .+++.||||++...... ....+.+|+++|++++||||+++++++.+
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~---------~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~ 72 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKV---------DTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQD 72 (381)
T ss_pred CceEEEEEeecCCEEEEEEEEC---------CCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEec
Confidence 5889999999999999998654 47888999999764322 23467889999999999999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCc
Q 011851 199 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLA 278 (476)
Q Consensus 199 ~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a 278 (476)
.+++||||||+++|+|.+++.+. ..+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||++
T Consensus 73 ~~~~~lv~E~~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~ 148 (381)
T cd05626 73 KDNLYFVMDYIPGGDMMSLLIRM-EVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLC 148 (381)
T ss_pred CCEEEEEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCC
Confidence 99999999999999999998554 46899999999999999999999988 999999999999999999999999997
Q ss_pred CCCCCCCc---------------------------------------------cceeeeeecCCCCCCcchhhcCCCCcc
Q 011851 279 KDGPEGDK---------------------------------------------THVSTRVMGTYGYAAPEYVMTGHLTAK 313 (476)
Q Consensus 279 ~~~~~~~~---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~ 313 (476)
........ .......+||+.|+|||++.+..++.+
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~ 228 (381)
T cd05626 149 TGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQL 228 (381)
T ss_pred cccccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCc
Confidence 54311000 001123579999999999999999999
Q ss_pred chhhhhHHHHHHHHhCCCCCCCCCCCCcch-hHHhhhhhhccccccccccCcccCCCCChHHHHHHHHHHHHhc--ccCC
Q 011851 314 SDVYSFGVVLLEMLTGRRSMDKNRPNGEHN-LVEWARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCL--NRDQ 390 (476)
Q Consensus 314 ~DiwslGv~l~elltG~~pf~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL--~~dP 390 (476)
+|||||||++|||++|..||.......... +..+. ... .+ + .....+.++.+||.+|| ..++
T Consensus 229 ~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~-----~~~---~~--~-----~~~~~s~~~~dli~~ll~~~~~~ 293 (381)
T cd05626 229 CDWWSVGVILFEMLVGQPPFLAPTPTETQLKVINWE-----NTL---HI--P-----PQVKLSPEAVDLITKLCCSAEER 293 (381)
T ss_pred cceeehhhHHHHHHhCCCCCcCCCHHHHHHHHHccc-----ccc---CC--C-----CCCCCCHHHHHHHHHHccCcccc
Confidence 999999999999999999997654321111 00000 000 00 0 01123578889999855 5556
Q ss_pred CCCCCHHHHHHHhcCCCCcccccC
Q 011851 391 KARPRMSEVVEALKPLPYLKDMAS 414 (476)
Q Consensus 391 ~~RPt~~ell~~L~~~~~~~~~~~ 414 (476)
..|+++.++++| |||.+...
T Consensus 294 ~~R~~~~~~l~h----p~f~~~~~ 313 (381)
T cd05626 294 LGRNGADDIKAH----PFFSEVDF 313 (381)
T ss_pred cCCCCHHHHhcC----cccCCCCh
Confidence 669999999987 99987543
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-45 Score=368.13 Aligned_cols=261 Identities=23% Similarity=0.353 Sum_probs=207.5
Q ss_pred cCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCc---cCHHHHHHHHHHHhCCCCCceeeEEEEEE
Q 011851 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL---QGHKEWLAEVNYLGGLIHPNLVKLIGCCI 197 (476)
Q Consensus 121 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~l~~~~~ 197 (476)
++|++.+.||+|+||.||+|.+. .+|+.||||++..... .....+.+|+.+|..++||||+++++++.
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~ 71 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKK---------DTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQ 71 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEEC---------CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEE
Confidence 46899999999999999998764 4678899999975432 22345778999999999999999999999
Q ss_pred eCCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCC
Q 011851 198 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGL 277 (476)
Q Consensus 198 ~~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~ 277 (476)
+++.+|||||||++|+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 72 ~~~~~~lv~E~~~~g~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 147 (364)
T cd05599 72 DENYLYLIMEYLPGGDMMTLLMKK-DTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGL 147 (364)
T ss_pred cCCeEEEEECCCCCcHHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeeccc
Confidence 999999999999999999998654 46999999999999999999999988 99999999999999999999999999
Q ss_pred cCCCCCCCccc------------------------------------eeeeeecCCCCCCcchhhcCCCCccchhhhhHH
Q 011851 278 AKDGPEGDKTH------------------------------------VSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGV 321 (476)
Q Consensus 278 a~~~~~~~~~~------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv 321 (476)
+.......... .....+||+.|+|||++.+..++.++|||||||
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~ 227 (364)
T cd05599 148 CTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGV 227 (364)
T ss_pred ceeccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchh
Confidence 87542211000 011246999999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCCCCCCcchhHHhhhhhhccccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCC---HHH
Q 011851 322 VLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPR---MSE 398 (476)
Q Consensus 322 ~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt---~~e 398 (476)
++|||++|..||...........+ ......+ .. + .....++++.+||.+||. +|.+|++ +.+
T Consensus 228 il~el~~G~~Pf~~~~~~~~~~~i------~~~~~~~-~~--~-----~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ 292 (364)
T cd05599 228 IMYEMLVGYPPFCSDNPQETYRKI------INWKETL-QF--P-----DEVPLSPEAKDLIKRLCC-EAERRLGNNGVNE 292 (364)
T ss_pred HHHHhhcCCCCCCCCCHHHHHHHH------HcCCCcc-CC--C-----CCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHH
Confidence 999999999999765432111000 0000000 00 0 001225788999999997 9999998 999
Q ss_pred HHHHhcCCCCccccc
Q 011851 399 VVEALKPLPYLKDMA 413 (476)
Q Consensus 399 ll~~L~~~~~~~~~~ 413 (476)
+++| |||++..
T Consensus 293 ll~h----~~~~~~~ 303 (364)
T cd05599 293 IKSH----PFFKGVD 303 (364)
T ss_pred HhcC----CCcCCCC
Confidence 8887 9998764
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-44 Score=373.53 Aligned_cols=275 Identities=21% Similarity=0.330 Sum_probs=201.5
Q ss_pred HHHHhccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCCC------CCc
Q 011851 115 ELKSATKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLI------HPN 188 (476)
Q Consensus 115 ~~~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~------hpn 188 (476)
++...+++|++.++||+|+||+||+|++. .+++.||||+++... .....+..|+.++..+. |.+
T Consensus 123 ~~~~~~~~y~i~~~lG~G~fg~V~~a~~~---------~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~ 192 (467)
T PTZ00284 123 DIDVSTQRFKILSLLGEGTFGKVVEAWDR---------KRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFP 192 (467)
T ss_pred ccccCCCcEEEEEEEEeccCEEEEEEEEc---------CCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcc
Confidence 33445678999999999999999998764 467789999996532 12234455666666554 456
Q ss_pred eeeEEEEEEeC-CeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCCeeecC
Q 011851 189 LVKLIGCCIED-DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHE-EAEKPVIYRDFKTSNILLDG 266 (476)
Q Consensus 189 Iv~l~~~~~~~-~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~-~~~~~ivHrDlKp~NILl~~ 266 (476)
|++++++|..+ .++|||||++ +++|.+++.+. ..+++..+..|+.||+.||.|||+ .+ ||||||||+||||+.
T Consensus 193 i~~i~~~~~~~~~~~~iv~~~~-g~~l~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~ 267 (467)
T PTZ00284 193 LMKIQRYFQNETGHMCIVMPKY-GPCLLDWIMKH-GPFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMET 267 (467)
T ss_pred eeeeEEEEEcCCceEEEEEecc-CCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEec
Confidence 89999998764 5789999998 77899888554 579999999999999999999997 47 999999999999987
Q ss_pred CC----------------ceEEeecCCcCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCC
Q 011851 267 EY----------------NAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGR 330 (476)
Q Consensus 267 ~~----------------~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~ 330 (476)
++ .+||+|||++..... .....+||+.|+|||++.+..|+.++|||||||++|||++|+
T Consensus 268 ~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~~-----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~ 342 (467)
T PTZ00284 268 SDTVVDPVTNRALPPDPCRVRICDLGGCCDERH-----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGK 342 (467)
T ss_pred CCcccccccccccCCCCceEEECCCCccccCcc-----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCC
Confidence 65 499999998865322 123468999999999999999999999999999999999999
Q ss_pred CCCCCCCCCCcchhHHhhhhhhccc----------ccccc---ccCcccCC-----------CCChHHHHHHHHHHHHhc
Q 011851 331 RSMDKNRPNGEHNLVEWARPQLGER----------RRFYR---LIDPCLEG-----------CFSIKGAEKTIQLAASCL 386 (476)
Q Consensus 331 ~pf~~~~~~~~~~~~~~~~~~~~~~----------~~~~~---~~d~~l~~-----------~~~~~~~~~~~~li~~cL 386 (476)
.||...........+......+... ..+.. .+.++... .........+.+||.+||
T Consensus 343 ~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL 422 (467)
T PTZ00284 343 LLYDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLL 422 (467)
T ss_pred CCCCCCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhC
Confidence 9998655432222211110000000 00000 00000000 000112456789999999
Q ss_pred ccCCCCCCCHHHHHHHhcCCCCccccc
Q 011851 387 NRDQKARPRMSEVVEALKPLPYLKDMA 413 (476)
Q Consensus 387 ~~dP~~RPt~~ell~~L~~~~~~~~~~ 413 (476)
+.||++|||+.|+|+| |||....
T Consensus 423 ~~dP~~R~ta~e~L~H----p~~~~~~ 445 (467)
T PTZ00284 423 HYDRQKRLNARQMTTH----PYVLKYY 445 (467)
T ss_pred CcChhhCCCHHHHhcC----ccccccC
Confidence 9999999999999998 9998643
|
|
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-44 Score=357.19 Aligned_cols=253 Identities=27% Similarity=0.422 Sum_probs=201.0
Q ss_pred CCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCc---cCHHHHHHHHHH---HhCCCCCceeeEEEEE
Q 011851 123 FRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL---QGHKEWLAEVNY---LGGLIHPNLVKLIGCC 196 (476)
Q Consensus 123 y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~---~~~~~~~~E~~~---l~~l~hpnIv~l~~~~ 196 (476)
|++.+.||+|+||.||+|.+. .+|+.||||+++.... ...+.+.+|+++ ++.++||||+++++++
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~ 71 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYK---------KTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACF 71 (324)
T ss_pred CeEEEEEeecCCEEEEEEEEC---------CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEE
Confidence 678899999999999998654 4678899999975421 223445666555 4677899999999999
Q ss_pred EeCCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecC
Q 011851 197 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFG 276 (476)
Q Consensus 197 ~~~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG 276 (476)
.+.+..|+||||+++++|..++.. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 72 ~~~~~~~lv~E~~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg 146 (324)
T cd05589 72 QTEDHVCFVMEYAAGGDLMMHIHT--DVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFG 146 (324)
T ss_pred EcCCEEEEEEcCCCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCccc
Confidence 999999999999999999988743 46899999999999999999999988 9999999999999999999999999
Q ss_pred CcCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhcccc
Q 011851 277 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERR 356 (476)
Q Consensus 277 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~ 356 (476)
+++....... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||...........+ .....
T Consensus 147 ~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i------~~~~~ 218 (324)
T cd05589 147 LCKEGMGFGD--RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSI------VNDEV 218 (324)
T ss_pred CCccCCCCCC--cccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHH------HhCCC
Confidence 9875432211 123467999999999999999999999999999999999999999754322111100 00000
Q ss_pred ccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHhcCCCCccccc
Q 011851 357 RFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARP-----RMSEVVEALKPLPYLKDMA 413 (476)
Q Consensus 357 ~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RP-----t~~ell~~L~~~~~~~~~~ 413 (476)
.++...+..+.++|.+||+.||.+|| ++.+++++ |||++..
T Consensus 219 ------------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~----~~f~~~~ 264 (324)
T cd05589 219 ------------RYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQ----PFFRDIN 264 (324)
T ss_pred ------------CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhC----CCcCCCC
Confidence 01122367788999999999999999 46666654 9998764
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-44 Score=357.96 Aligned_cols=275 Identities=24% Similarity=0.353 Sum_probs=210.3
Q ss_pred ccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCcc-CHHHHHHHHHHHhCCCCCceeeEEEEEEe
Q 011851 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQ-GHKEWLAEVNYLGGLIHPNLVKLIGCCIE 198 (476)
Q Consensus 120 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~~ 198 (476)
.++|++.+.||+|+||.||+|.+. .++..+|+|++...... ....+.+|+++|++++|+||++++++|.+
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~---------~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 74 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHK---------PSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS 74 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEEC---------CCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEE
Confidence 357999999999999999998654 46788999998764322 23568899999999999999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeEecCCCCCCeeecCCCceEEeecCC
Q 011851 199 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEE-AEKPVIYRDFKTSNILLDGEYNAKLSDFGL 277 (476)
Q Consensus 199 ~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~-~~~~ivHrDlKp~NILl~~~~~vkl~DFG~ 277 (476)
++.+||||||+++++|.+++.. ...+++..+..++.|++.||.|||+. + |+||||||+|||++.++.+||+|||+
T Consensus 75 ~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~ 150 (333)
T cd06650 75 DGEISICMEHMDGGSLDQVLKK-AGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGV 150 (333)
T ss_pred CCEEEEEEecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChhhEEEcCCCCEEEeeCCc
Confidence 9999999999999999999855 34689999999999999999999974 5 99999999999999999999999999
Q ss_pred cCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhc----
Q 011851 278 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLG---- 353 (476)
Q Consensus 278 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~---- 353 (476)
+....... .....||..|+|||++.+..++.++|||||||++|+|++|+.||....................
T Consensus 151 ~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (333)
T cd06650 151 SGQLIDSM----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESE 226 (333)
T ss_pred chhhhhhc----cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccc
Confidence 87643321 2235789999999999988999999999999999999999999975432211110000000000
Q ss_pred ------------------cc--cccccccCcccC---CCC-ChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCc
Q 011851 354 ------------------ER--RRFYRLIDPCLE---GCF-SIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYL 409 (476)
Q Consensus 354 ------------------~~--~~~~~~~d~~l~---~~~-~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~ 409 (476)
.+ .....+.+.... ..+ ....+.++.+|+.+||+.||++|||+.++++| +|+
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h----~~~ 302 (333)
T cd06650 227 TSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVH----AFI 302 (333)
T ss_pred cCcccCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhC----HHH
Confidence 00 000000000000 000 00124678999999999999999999999987 999
Q ss_pred ccccCc
Q 011851 410 KDMASS 415 (476)
Q Consensus 410 ~~~~~~ 415 (476)
+.....
T Consensus 303 ~~~~~~ 308 (333)
T cd06650 303 KRSEAE 308 (333)
T ss_pred hcCccc
Confidence 876443
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-44 Score=360.05 Aligned_cols=274 Identities=24% Similarity=0.366 Sum_probs=204.2
Q ss_pred CCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCC--ccCHHHHHHHHHHHhCCCCCceeeEEEEEEeC
Q 011851 122 SFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDG--LQGHKEWLAEVNYLGGLIHPNLVKLIGCCIED 199 (476)
Q Consensus 122 ~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~ 199 (476)
+|++.++||+|+||.||+|.+. .+|+.||||++.... .....++.+|+++|++++||||+++++++...
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 71 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDT---------HTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPP 71 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEEC---------CCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEecc
Confidence 5889999999999999998654 467889999987432 22345688999999999999999999988643
Q ss_pred -----CeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEee
Q 011851 200 -----DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSD 274 (476)
Q Consensus 200 -----~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~D 274 (476)
..+|+||||| +++|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|
T Consensus 72 ~~~~~~~~~lv~e~~-~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~D 146 (338)
T cd07859 72 SRREFKDIYVVFELM-ESDLHQVIKA-NDDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICD 146 (338)
T ss_pred CCCCCceEEEEEecC-CCCHHHHHHh-cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEcc
Confidence 2589999999 4689988854 456999999999999999999999988 99999999999999999999999
Q ss_pred cCCcCCCCCCCc-cceeeeeecCCCCCCcchhhc--CCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhh--
Q 011851 275 FGLAKDGPEGDK-THVSTRVMGTYGYAAPEYVMT--GHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR-- 349 (476)
Q Consensus 275 FG~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~-- 349 (476)
||+++....... .......+||+.|+|||++.+ ..++.++|||||||++|||++|+.||...........+....
T Consensus 147 fg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~ 226 (338)
T cd07859 147 FGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGT 226 (338)
T ss_pred CccccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCC
Confidence 999986432221 111234679999999999876 678999999999999999999999997643221111100000
Q ss_pred ------hhh--ccccccccccCcc----cCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCcccccC
Q 011851 350 ------PQL--GERRRFYRLIDPC----LEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDMAS 414 (476)
Q Consensus 350 ------~~~--~~~~~~~~~~d~~----l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~~~~ 414 (476)
..+ .....+...+.+. +...+ ...+..+.+++.+||+.||++|||++++++| |||++...
T Consensus 227 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h----p~f~~~~~ 298 (338)
T cd07859 227 PSPETISRVRNEKARRYLSSMRKKQPVPFSQKF-PNADPLALRLLERLLAFDPKDRPTAEEALAD----PYFKGLAK 298 (338)
T ss_pred CCHHHHHHhhhhhHHHHHHhhcccCCCchHHhc-CCCChHHHHHHHHHcCcCcccCCCHHHHhcC----chhhhcCc
Confidence 000 0000000000000 00000 0124578899999999999999999999997 99987544
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-44 Score=358.09 Aligned_cols=259 Identities=25% Similarity=0.377 Sum_probs=205.3
Q ss_pred CCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCc---cCHHHHHHHHHHHhCCCC-CceeeEEEEEE
Q 011851 122 SFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL---QGHKEWLAEVNYLGGLIH-PNLVKLIGCCI 197 (476)
Q Consensus 122 ~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~---~~~~~~~~E~~~l~~l~h-pnIv~l~~~~~ 197 (476)
+|++.+.||+|+||.||+|.+. .+++.||||++..... ...+.+..|++++..+.| ++|+.+++++.
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~---------~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~ 71 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERK---------GTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQ 71 (324)
T ss_pred CceEEEEEeeccCeEEEEEEEC---------CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEE
Confidence 4889999999999999998654 4677899999975422 234567789999999976 46889999999
Q ss_pred eCCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCC
Q 011851 198 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGL 277 (476)
Q Consensus 198 ~~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~ 277 (476)
+.+.+|+||||+++|+|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 72 ~~~~~~lv~E~~~~g~L~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~ 147 (324)
T cd05587 72 TMDRLYFVMEYVNGGDLMYHIQQV-GKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGM 147 (324)
T ss_pred cCCEEEEEEcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCc
Confidence 999999999999999999988543 46899999999999999999999988 99999999999999999999999999
Q ss_pred cCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhccccc
Q 011851 278 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRR 357 (476)
Q Consensus 278 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 357 (476)
+........ .....+||+.|+|||++.+..++.++|||||||++|||++|+.||........ .... ....
T Consensus 148 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~---~~~i---~~~~-- 217 (324)
T cd05587 148 CKENIFGGK--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDEL---FQSI---MEHN-- 217 (324)
T ss_pred ceecCCCCC--ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHH---HHHH---HcCC--
Confidence 875322221 12346799999999999999999999999999999999999999975432111 1100 0000
Q ss_pred cccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHH-HHHHHhcCCCCccccc
Q 011851 358 FYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMS-EVVEALKPLPYLKDMA 413 (476)
Q Consensus 358 ~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~-ell~~L~~~~~~~~~~ 413 (476)
..++...+.++.+++.+||..||.+|++.. +..+.+..+|||+...
T Consensus 218 ----------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~~~ 264 (324)
T cd05587 218 ----------VSYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFFRRID 264 (324)
T ss_pred ----------CCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCCcCCCC
Confidence 011222367889999999999999999862 2333445569998754
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-44 Score=358.43 Aligned_cols=252 Identities=28% Similarity=0.403 Sum_probs=202.9
Q ss_pred ccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCc----cCHHHHHHHHHHHhCCCCCceeeEEEEEEeCCee
Q 011851 127 CLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL----QGHKEWLAEVNYLGGLIHPNLVKLIGCCIEDDQR 202 (476)
Q Consensus 127 ~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~----~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~ 202 (476)
+.||+|+||.||+++... ...+++.||+|++..... .....+..|+++|+.++||||+++++++..++.+
T Consensus 2 ~~lg~G~~g~V~~~~~~~------~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~ 75 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVT------GADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKL 75 (323)
T ss_pred ceeeecCCeEEEEEEEcc------cCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeE
Confidence 679999999999987642 224788999999975322 2234567899999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCcCCCC
Q 011851 203 LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGP 282 (476)
Q Consensus 203 ~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~ 282 (476)
|+||||+++++|.+++.+ ...+.+..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 76 ~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 151 (323)
T cd05584 76 YLILEYLSGGELFMHLER-EGIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESI 151 (323)
T ss_pred EEEEeCCCCchHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecc
Confidence 999999999999999854 456889999999999999999999988 9999999999999999999999999987543
Q ss_pred CCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhcccccccccc
Q 011851 283 EGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRRFYRLI 362 (476)
Q Consensus 283 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 362 (476)
.... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||........ .. .......
T Consensus 152 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~---~~---~~~~~~~------ 217 (323)
T cd05584 152 HEGT--VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKT---ID---KILKGKL------ 217 (323)
T ss_pred cCCC--cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHH---HH---HHHcCCC------
Confidence 2221 12336799999999999998999999999999999999999999975432111 10 0000000
Q ss_pred CcccCCCCChHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHhcCCCCcccc
Q 011851 363 DPCLEGCFSIKGAEKTIQLAASCLNRDQKARP-----RMSEVVEALKPLPYLKDM 412 (476)
Q Consensus 363 d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RP-----t~~ell~~L~~~~~~~~~ 412 (476)
.++...+.++.+||.+||+.||++|| ++.++++| ||++..
T Consensus 218 ------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h----~~~~~~ 262 (323)
T cd05584 218 ------NLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH----PFFRHV 262 (323)
T ss_pred ------CCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC----CCcCCC
Confidence 01122356789999999999999999 78888776 998764
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=368.15 Aligned_cols=261 Identities=25% Similarity=0.298 Sum_probs=204.8
Q ss_pred CCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCc---cCHHHHHHHHHHHhCCCCCceeeEEEEEEe
Q 011851 122 SFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL---QGHKEWLAEVNYLGGLIHPNLVKLIGCCIE 198 (476)
Q Consensus 122 ~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~ 198 (476)
+|+++++||+|+||+||+|++. .+++.||||++..... .....+.+|+++|++++|+||+++++++.+
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~---------~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~ 72 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKV---------DTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQD 72 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEEC---------CCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEe
Confidence 5889999999999999998654 4678899999975432 223467889999999999999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCc
Q 011851 199 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLA 278 (476)
Q Consensus 199 ~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a 278 (476)
++.+|||||||++|+|.+++.+. ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 73 ~~~~~lv~E~~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla 148 (382)
T cd05625 73 KDNLYFVMDYIPGGDMMSLLIRM-GIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLC 148 (382)
T ss_pred CCEEEEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCC
Confidence 99999999999999999998554 56899999999999999999999988 999999999999999999999999997
Q ss_pred CCCCCCC---------------------------------------------ccceeeeeecCCCCCCcchhhcCCCCcc
Q 011851 279 KDGPEGD---------------------------------------------KTHVSTRVMGTYGYAAPEYVMTGHLTAK 313 (476)
Q Consensus 279 ~~~~~~~---------------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 313 (476)
....... ........+||+.|+|||++.+..|+.+
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~ 228 (382)
T cd05625 149 TGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQL 228 (382)
T ss_pred ccccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCe
Confidence 5321000 0001123579999999999999999999
Q ss_pred chhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhccccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCC
Q 011851 314 SDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKAR 393 (476)
Q Consensus 314 ~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~R 393 (476)
+|||||||++|||++|+.||....+......+ . ... ..+........+.++.++|.+|+ .+|.+|
T Consensus 229 ~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i------~-~~~-------~~~~~p~~~~~s~~~~~li~~l~-~~p~~R 293 (382)
T cd05625 229 CDWWSVGVILYEMLVGQPPFLAQTPLETQMKV------I-NWQ-------TSLHIPPQAKLSPEASDLIIKLC-RGPEDR 293 (382)
T ss_pred eeEEechHHHHHHHhCCCCCCCCCHHHHHHHH------H-ccC-------CCcCCCCcccCCHHHHHHHHHHc-cCHhHc
Confidence 99999999999999999999765432111000 0 000 00000001122567889998876 599999
Q ss_pred CC---HHHHHHHhcCCCCcccccC
Q 011851 394 PR---MSEVVEALKPLPYLKDMAS 414 (476)
Q Consensus 394 Pt---~~ell~~L~~~~~~~~~~~ 414 (476)
++ +.++++| |||+....
T Consensus 294 ~~~~~~~ei~~h----p~f~~~~~ 313 (382)
T cd05625 294 LGKNGADEIKAH----PFFKTIDF 313 (382)
T ss_pred CCCCCHHHHhcC----CCcCCcCh
Confidence 87 8887776 99987643
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-45 Score=364.95 Aligned_cols=261 Identities=27% Similarity=0.348 Sum_probs=211.1
Q ss_pred cCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCc---cCHHHHHHHHHHHhCCCCCceeeEEEEEE
Q 011851 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL---QGHKEWLAEVNYLGGLIHPNLVKLIGCCI 197 (476)
Q Consensus 121 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~l~~~~~ 197 (476)
++|++.+.||+|+||.||+|.+. .+|+.||||+++.... .....+..|+++|..++|+||+++++++.
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~ 71 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDK---------DTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQ 71 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEEC---------CCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhhee
Confidence 46999999999999999998764 4688899999975432 23456788999999999999999999999
Q ss_pred eCCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCC
Q 011851 198 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGL 277 (476)
Q Consensus 198 ~~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~ 277 (476)
+++++|+||||+++++|.+++.+. ..+++..++.++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+
T Consensus 72 ~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~ 147 (350)
T cd05573 72 DEEHLYLVMEYMPGGDLMNLLIRK-DVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGL 147 (350)
T ss_pred cCCeEEEEEcCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCC
Confidence 999999999999999999999655 67999999999999999999999988 99999999999999999999999999
Q ss_pred cCCCCCCC---------------------------ccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCC
Q 011851 278 AKDGPEGD---------------------------KTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGR 330 (476)
Q Consensus 278 a~~~~~~~---------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~ 330 (476)
+....... .........||+.|+|||++.+..++.++|||||||++|||++|+
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~ 227 (350)
T cd05573 148 CKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGF 227 (350)
T ss_pred CccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCC
Confidence 98654332 001123357999999999999999999999999999999999999
Q ss_pred CCCCCCCCCCcchhHHhhhhhhccccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCC-HHHHHHHhcCCCCc
Q 011851 331 RSMDKNRPNGEHNLVEWARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPR-MSEVVEALKPLPYL 409 (476)
Q Consensus 331 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt-~~ell~~L~~~~~~ 409 (476)
.||........... ...... .+.-......+.++.+||.+||. ||.+||+ +.++++| ||+
T Consensus 228 ~Pf~~~~~~~~~~~------i~~~~~--------~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h----p~~ 288 (350)
T cd05573 228 PPFYSDTLQETYNK------IINWKE--------SLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH----PFF 288 (350)
T ss_pred CCCCCCCHHHHHHH------HhccCC--------cccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC----CCc
Confidence 99976542211100 000000 00000001136789999999997 9999999 9999997 999
Q ss_pred cccc
Q 011851 410 KDMA 413 (476)
Q Consensus 410 ~~~~ 413 (476)
++..
T Consensus 289 ~~~~ 292 (350)
T cd05573 289 KGID 292 (350)
T ss_pred CCCC
Confidence 8754
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-44 Score=342.00 Aligned_cols=274 Identities=26% Similarity=0.364 Sum_probs=211.4
Q ss_pred CCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCcc--CHHHHHHHHHHHhCCCCCc-eeeEEEEEEe
Q 011851 122 SFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQ--GHKEWLAEVNYLGGLIHPN-LVKLIGCCIE 198 (476)
Q Consensus 122 ~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~--~~~~~~~E~~~l~~l~hpn-Iv~l~~~~~~ 198 (476)
.|..+++||+|+||+||+|+.. .+|+.||+|.++....+ ......+|+.+|+.|+|+| ||+|++++..
T Consensus 12 ~~~~~eklGeGtyg~Vykar~~---------~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~ 82 (323)
T KOG0594|consen 12 DYEKVEKLGEGTYGVVYKARSK---------RTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHT 82 (323)
T ss_pred HHHHHHHhCCCCceEEEEEEEe---------cCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeee
Confidence 4666788999999999998765 47788999999876542 2345689999999999999 9999999998
Q ss_pred CC------eeEEEEEecCCCCHHHHHhhcC---CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCc
Q 011851 199 DD------QRLLVYEFMPRGSLENHLFRRS---LPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYN 269 (476)
Q Consensus 199 ~~------~~~lV~E~~~~g~L~~~l~~~~---~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~ 269 (476)
.+ .++||+||+ .-+|..++.... ..++...++.+++||+.||+|||+++ |+||||||+||||+.+|.
T Consensus 83 ~~~~~~~~~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~ 158 (323)
T KOG0594|consen 83 SNNHRGIGKLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGV 158 (323)
T ss_pred cccccccceEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCc
Confidence 77 899999999 559999997655 45888899999999999999999999 999999999999999999
Q ss_pred eEEeecCCcCCCCCCCccceeeeeecCCCCCCcchhhcC-CCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhH-Hh
Q 011851 270 AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV-EW 347 (476)
Q Consensus 270 vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~-~~ 347 (476)
+||+|||+|+...-... ..+..++|..|+|||++.+. .|+...||||+|||++||++++.-|.+.........+ ..
T Consensus 159 lKlaDFGlAra~~ip~~--~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~ 236 (323)
T KOG0594|consen 159 LKLADFGLARAFSIPMR--TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRL 236 (323)
T ss_pred EeeeccchHHHhcCCcc--cccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHH
Confidence 99999999996543222 23456899999999999987 7999999999999999999999999876652222111 00
Q ss_pred -hhhhhcccc----------ccccccCcc-cCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCcccccCc
Q 011851 348 -ARPQLGERR----------RFYRLIDPC-LEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDMASS 415 (476)
Q Consensus 348 -~~~~~~~~~----------~~~~~~d~~-l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~~~~~ 415 (476)
..+....+. .+..+-.+. +....+ .......+++.+||+.+|.+|.|+..+++| |||......
T Consensus 237 lGtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~-~~~~~~~dll~~~L~y~p~~R~Sa~~al~h----~yf~~~~~~ 311 (323)
T KOG0594|consen 237 LGTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILP-KLDPDGIELLSKLLQYDPAKRISAKGALTH----PYFSELPEK 311 (323)
T ss_pred cCCCCccCCCCccccccccccCcCCCCccchHHhcc-ccCccHHHHHHHHhccCcccCcCHHHHhcC----hhhcccccc
Confidence 000000000 001110000 000000 012478899999999999999999999998 998877543
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-44 Score=364.18 Aligned_cols=269 Identities=20% Similarity=0.222 Sum_probs=204.4
Q ss_pred ccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCCCCCceeeEEEEEEeC
Q 011851 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHPNLVKLIGCCIED 199 (476)
Q Consensus 120 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~ 199 (476)
.++|.+.+.||+|+||.||+|.+. .+++.||||.... ..+.+|+++|++|+||||++++++|..+
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~---------~~~~~vaiK~~~~------~~~~~E~~il~~l~HpnIv~~~~~~~~~ 155 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDN---------KTCEHVVIKAGQR------GGTATEAHILRAINHPSIIQLKGTFTYN 155 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEEC---------CCCCEEEEechhh------hhhHHHHHHHHhCCCCCCCCEeEEEEEC
Confidence 357999999999999999998654 5788899997532 3467899999999999999999999999
Q ss_pred CeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCcC
Q 011851 200 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAK 279 (476)
Q Consensus 200 ~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~ 279 (476)
...++|||++ +++|..++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 156 ~~~~lv~e~~-~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~ 230 (391)
T PHA03212 156 KFTCLILPRY-KTDLYCYLAAK-RNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAAC 230 (391)
T ss_pred CeeEEEEecC-CCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCccc
Confidence 9999999999 46898888543 46899999999999999999999988 9999999999999999999999999997
Q ss_pred CCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcc----hhHHhhhhhhcc-
Q 011851 280 DGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEH----NLVEWARPQLGE- 354 (476)
Q Consensus 280 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~----~~~~~~~~~~~~- 354 (476)
........ .....+||+.|+|||++.+..++.++|||||||++|||++|+.||......... ..+.......+.
T Consensus 231 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~ 309 (391)
T PHA03212 231 FPVDINAN-KYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTH 309 (391)
T ss_pred cccccccc-ccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCC
Confidence 53322111 123468999999999999999999999999999999999999887543221100 000000000000
Q ss_pred --c------ccccccc---------CcccCCCC--ChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCccccc
Q 011851 355 --R------RRFYRLI---------DPCLEGCF--SIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDMA 413 (476)
Q Consensus 355 --~------~~~~~~~---------d~~l~~~~--~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~~~ 413 (476)
. ..+...+ .+.....+ ....+.++.+||.+||+.||++|||+.|+++| |||+...
T Consensus 310 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~h----p~f~~~~ 383 (391)
T PHA03212 310 PNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDF----AAFQDIP 383 (391)
T ss_pred hhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcC----hhhccCC
Confidence 0 0000000 00000000 01235678999999999999999999999997 9987653
|
|
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=368.01 Aligned_cols=260 Identities=24% Similarity=0.285 Sum_probs=205.8
Q ss_pred CCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCc---cCHHHHHHHHHHHhCCCCCceeeEEEEEEe
Q 011851 122 SFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL---QGHKEWLAEVNYLGGLIHPNLVKLIGCCIE 198 (476)
Q Consensus 122 ~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~ 198 (476)
+|++++.||+|+||.||+|.+. .+++.||||++..... .....+.+|+++|++++|+||+++++.+.+
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~---------~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~ 72 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKV---------DTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQD 72 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEEC---------CCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEc
Confidence 6899999999999999998654 4678899999965322 223557789999999999999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCc
Q 011851 199 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLA 278 (476)
Q Consensus 199 ~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a 278 (476)
++.+|||||||++|+|.+++.+. ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 73 ~~~~~lv~E~~~~g~L~~~i~~~-~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a 148 (376)
T cd05598 73 KDNLYFVMDYIPGGDMMSLLIRL-GIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLC 148 (376)
T ss_pred CCEEEEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCC
Confidence 99999999999999999999554 56899999999999999999999988 999999999999999999999999997
Q ss_pred CCCCCCC-----------------------------------------ccceeeeeecCCCCCCcchhhcCCCCccchhh
Q 011851 279 KDGPEGD-----------------------------------------KTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVY 317 (476)
Q Consensus 279 ~~~~~~~-----------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diw 317 (476)
....... ........+||+.|+|||++.+..++.++|||
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diw 228 (376)
T cd05598 149 TGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWW 228 (376)
T ss_pred ccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeee
Confidence 5321000 00011235799999999999999999999999
Q ss_pred hhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhccccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCC---
Q 011851 318 SFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARP--- 394 (476)
Q Consensus 318 slGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RP--- 394 (476)
||||++|||++|+.||...........+. ....... .+ .....+.++.++|.+|+ .+|.+|+
T Consensus 229 SlGvilyell~G~~Pf~~~~~~~~~~~i~-------~~~~~~~--~~-----~~~~~s~~~~~li~~l~-~~p~~R~~~~ 293 (376)
T cd05598 229 SVGVILYEMLVGQPPFLADTPAETQLKVI-------NWETTLH--IP-----SQAKLSREASDLILRLC-CGAEDRLGKN 293 (376)
T ss_pred eccceeeehhhCCCCCCCCCHHHHHHHHh-------ccCcccc--CC-----CCCCCCHHHHHHHHHHh-cCHhhcCCCC
Confidence 99999999999999997654322111100 0000000 00 01123567889999976 5999999
Q ss_pred CHHHHHHHhcCCCCccccc
Q 011851 395 RMSEVVEALKPLPYLKDMA 413 (476)
Q Consensus 395 t~~ell~~L~~~~~~~~~~ 413 (476)
++.++++| |||++..
T Consensus 294 t~~ell~h----~~~~~~~ 308 (376)
T cd05598 294 GADEIKAH----PFFKGID 308 (376)
T ss_pred CHHHHhCC----CCcCCCC
Confidence 89999887 9998764
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-44 Score=356.52 Aligned_cols=250 Identities=28% Similarity=0.423 Sum_probs=199.6
Q ss_pred ccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCc---cCHHHHHHHHHHHhC-CCCCceeeEEEEEEeCCee
Q 011851 127 CLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL---QGHKEWLAEVNYLGG-LIHPNLVKLIGCCIEDDQR 202 (476)
Q Consensus 127 ~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~---~~~~~~~~E~~~l~~-l~hpnIv~l~~~~~~~~~~ 202 (476)
++||+|+||.||+|.+. .+|+.||+|+++.... .....+..|..++.. ++||||+++++++.+++++
T Consensus 1 ~~lg~G~~g~V~~~~~~---------~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~ 71 (316)
T cd05620 1 KVLGKGSFGKVLLAELK---------GKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHL 71 (316)
T ss_pred CeeeeCCCeEEEEEEEC---------CCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEE
Confidence 46999999999998754 4678899999975421 233456678888775 4899999999999999999
Q ss_pred EEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCcCCCC
Q 011851 203 LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGP 282 (476)
Q Consensus 203 ~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~ 282 (476)
||||||+++++|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 72 ~lv~E~~~~g~L~~~i~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~ 147 (316)
T cd05620 72 FFVMEFLNGGDLMFHIQD-KGRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENV 147 (316)
T ss_pred EEEECCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecc
Confidence 999999999999998855 456899999999999999999999988 9999999999999999999999999987532
Q ss_pred CCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhcccccccccc
Q 011851 283 EGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRRFYRLI 362 (476)
Q Consensus 283 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 362 (476)
.... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||....... +...... .
T Consensus 148 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~---~~~~~~~---~-------- 211 (316)
T cd05620 148 FGDN--RASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDE---LFESIRV---D-------- 211 (316)
T ss_pred cCCC--ceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH---HHHHHHh---C--------
Confidence 2221 2334689999999999999999999999999999999999999997543221 1111100 0
Q ss_pred CcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHH-HHHHHhcCCCCccccc
Q 011851 363 DPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMS-EVVEALKPLPYLKDMA 413 (476)
Q Consensus 363 d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~-ell~~L~~~~~~~~~~ 413 (476)
.+. ++...+.++.+||.+||+.||++||++. ++++| |||+...
T Consensus 212 ~~~----~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h----~~f~~~~ 255 (316)
T cd05620 212 TPH----YPRWITKESKDILEKLFERDPTRRLGVVGNIRGH----PFFKTIN 255 (316)
T ss_pred CCC----CCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcC----CCcCCCC
Confidence 000 1111256788999999999999999984 55555 9998754
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-44 Score=357.51 Aligned_cols=250 Identities=27% Similarity=0.427 Sum_probs=200.7
Q ss_pred ccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCC---ccCHHHHHHHHHHHhCC-CCCceeeEEEEEEeCCee
Q 011851 127 CLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDG---LQGHKEWLAEVNYLGGL-IHPNLVKLIGCCIEDDQR 202 (476)
Q Consensus 127 ~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~---~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~ 202 (476)
++||+|+||.||+|.+. .+++.||||++.... ......+..|+.++..+ +||||+++++++...+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~ 71 (320)
T cd05590 1 RVLGKGSFGKVMLARLK---------ESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRL 71 (320)
T ss_pred CeeeeCCCeEEEEEEEc---------CCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEE
Confidence 46999999999998754 467789999997542 12334567788888876 699999999999999999
Q ss_pred EEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCcCCCC
Q 011851 203 LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGP 282 (476)
Q Consensus 203 ~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~ 282 (476)
||||||+++++|.+++.+. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 72 ~iv~Ey~~~g~L~~~i~~~-~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~ 147 (320)
T cd05590 72 FFVMEFVNGGDLMFHIQKS-RRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGI 147 (320)
T ss_pred EEEEcCCCCchHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecC
Confidence 9999999999999988544 56999999999999999999999988 9999999999999999999999999987543
Q ss_pred CCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhcccccccccc
Q 011851 283 EGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRRFYRLI 362 (476)
Q Consensus 283 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 362 (476)
.... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||........ ... ......
T Consensus 148 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~---~~~---i~~~~~------ 213 (320)
T cd05590 148 FNGK--TTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDL---FEA---ILNDEV------ 213 (320)
T ss_pred cCCC--cccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHH---HHH---HhcCCC------
Confidence 2211 22346799999999999999999999999999999999999999976432211 111 000000
Q ss_pred CcccCCCCChHHHHHHHHHHHHhcccCCCCCCCH------HHHHHHhcCCCCccccc
Q 011851 363 DPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRM------SEVVEALKPLPYLKDMA 413 (476)
Q Consensus 363 d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~------~ell~~L~~~~~~~~~~ 413 (476)
.++...+.++.+|+.+||+.||++||++ .++++| |||+...
T Consensus 214 ------~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h----~~f~~~~ 260 (320)
T cd05590 214 ------VYPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRH----PFFKELD 260 (320)
T ss_pred ------CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcC----CCcCCCC
Confidence 0111235688999999999999999998 666655 9998754
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-44 Score=372.94 Aligned_cols=257 Identities=25% Similarity=0.289 Sum_probs=206.7
Q ss_pred ccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCCC-CCceeeEEEE-EE
Q 011851 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLI-HPNLVKLIGC-CI 197 (476)
Q Consensus 120 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~-~~ 197 (476)
..++++.+.|.+|||+.||+|.+.. .|..||+|++-..+....+.+.+|+++|++|. |+|||.+++. ..
T Consensus 36 ~~~v~V~~vLAEGGFa~VYla~~~~---------~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~ 106 (738)
T KOG1989|consen 36 SHRVTVEKVLAEGGFAQVYLAQDVK---------GGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAI 106 (738)
T ss_pred CEEEEEEEEEccCCcEEEEEEEecC---------CCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccc
Confidence 4568899999999999999998763 33779999987777777788999999999997 9999999993 32
Q ss_pred eC------CeeEEEEEecCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCce
Q 011851 198 ED------DQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNA 270 (476)
Q Consensus 198 ~~------~~~~lV~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~v 270 (476)
.. -+++|+||||.||.|.|++.++ ...|++.++++|+.|+++||.+||... .+|||||||-|||||..+|..
T Consensus 107 ~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~~g~~ 185 (738)
T KOG1989|consen 107 NRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSADGNY 185 (738)
T ss_pred cccCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcCCCCE
Confidence 21 2578999999999999999754 445999999999999999999999987 779999999999999999999
Q ss_pred EEeecCCcCCCCCCCccce-------eeeeecCCCCCCcchhh---cCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCC
Q 011851 271 KLSDFGLAKDGPEGDKTHV-------STRVMGTYGYAAPEYVM---TGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNG 340 (476)
Q Consensus 271 kl~DFG~a~~~~~~~~~~~-------~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~ 340 (476)
||||||.|........... .-...-|+.|+|||++. +.+++.|+|||+|||+||-|+....||+......
T Consensus 186 KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~la 265 (738)
T KOG1989|consen 186 KLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLA 265 (738)
T ss_pred EeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCccee
Confidence 9999999875332221100 00134689999999875 6689999999999999999999999998654332
Q ss_pred cchhHHhhhhhhccccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011851 341 EHNLVEWARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPL 406 (476)
Q Consensus 341 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~ 406 (476)
..+ ....--.....+..+.+||..||+.||++||++-+++..+..+
T Consensus 266 Iln--------------------g~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l 311 (738)
T KOG1989|consen 266 ILN--------------------GNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFEL 311 (738)
T ss_pred EEe--------------------ccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHH
Confidence 211 1111111135688999999999999999999999999986533
|
|
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-46 Score=340.97 Aligned_cols=259 Identities=26% Similarity=0.367 Sum_probs=219.9
Q ss_pred CCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCCCCCceeeEEEEEEeCCee
Q 011851 123 FRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHPNLVKLIGCCIEDDQR 202 (476)
Q Consensus 123 y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~ 202 (476)
|.++.+||+|+||.||+| +++.+|+.+|||.+..+ .+.+++..|+.||++++.|+||++|+.|.....+
T Consensus 35 FDi~~KLGEGSYGSV~KA---------IH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDL 103 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKA---------IHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDL 103 (502)
T ss_pred HHHHHHhcCCcchHHHHH---------HHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCce
Confidence 778899999999999996 45568999999998765 4568899999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCcCCCC
Q 011851 203 LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGP 282 (476)
Q Consensus 203 ~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~ 282 (476)
|+|||||..|++.|.++.++.++.+.++..+++..++||+|||... -||||||..||||+.+|..||+|||.|-.+.
T Consensus 104 WIVMEYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLT 180 (502)
T KOG0574|consen 104 WIVMEYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLT 180 (502)
T ss_pred EeehhhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhh
Confidence 9999999999999999989999999999999999999999999987 7999999999999999999999999997764
Q ss_pred CCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhcccccccccc
Q 011851 283 EGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRRFYRLI 362 (476)
Q Consensus 283 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 362 (476)
+. ....+.+.|||.|||||++..-.|+.++||||||++..||..|++||....+-.....+- .
T Consensus 181 DT--MAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIP---------------T 243 (502)
T KOG0574|consen 181 DT--MAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIP---------------T 243 (502)
T ss_pred hh--HHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEecc---------------C
Confidence 42 223456899999999999999999999999999999999999999997654422111110 0
Q ss_pred CcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCcccccCcc
Q 011851 363 DPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDMASSS 416 (476)
Q Consensus 363 d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~~~~~~ 416 (476)
.|...-.-+..-+.++.|++++||..+|++|.|+.++++| +|++....-.
T Consensus 244 ~PPPTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H----~FiknA~g~~ 293 (502)
T KOG0574|consen 244 KPPPTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH----TFIKNAPGCD 293 (502)
T ss_pred CCCCCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh----hhhcCCCccc
Confidence 1111111233447889999999999999999999999998 8888765433
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-44 Score=364.12 Aligned_cols=262 Identities=26% Similarity=0.398 Sum_probs=205.8
Q ss_pred cCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCc-cCHHHHHHHHHHHhCC-CCCceeeEEEEEEe
Q 011851 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL-QGHKEWLAEVNYLGGL-IHPNLVKLIGCCIE 198 (476)
Q Consensus 121 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~-~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~ 198 (476)
++|++.+.||+|+||.||+|.+.. ..+..++..||||+++.... ...+.+.+|+.+|..+ +||||+++++++.+
T Consensus 35 ~~~~~~~~LG~G~fG~V~~~~~~~----~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~ 110 (375)
T cd05104 35 NRLSFGKTLGAGAFGKVVEATAYG----LFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTV 110 (375)
T ss_pred HHeehhheecCCccceEEEEEEec----cccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeecc
Confidence 468999999999999999997531 11234677899999975432 2345688999999999 89999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHHhhcC--------------------------------------------------------
Q 011851 199 DDQRLLVYEFMPRGSLENHLFRRS-------------------------------------------------------- 222 (476)
Q Consensus 199 ~~~~~lV~E~~~~g~L~~~l~~~~-------------------------------------------------------- 222 (476)
.+..++|||||++|+|.+++....
T Consensus 111 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (375)
T cd05104 111 GGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVR 190 (375)
T ss_pred CCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccc
Confidence 999999999999999999985422
Q ss_pred ------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCcCCCCCC
Q 011851 223 ------------------LPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEG 284 (476)
Q Consensus 223 ------------------~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~ 284 (476)
..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~ 267 (375)
T cd05104 191 SGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRND 267 (375)
T ss_pred cceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCc
Confidence 24788889999999999999999988 999999999999999999999999999865433
Q ss_pred CccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhhccccccccccC
Q 011851 285 DKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPQLGERRRFYRLID 363 (476)
Q Consensus 285 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 363 (476)
..........++..|+|||++.+..++.++|||||||++|||++ |..||....... ........ .. ...
T Consensus 268 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~--~~~~~~~~----~~---~~~- 337 (375)
T cd05104 268 SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS--KFYKMIKE----GY---RML- 337 (375)
T ss_pred ccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH--HHHHHHHh----Cc---cCC-
Confidence 22222222345678999999999999999999999999999998 888986543221 11111110 00 000
Q ss_pred cccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 011851 364 PCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKP 405 (476)
Q Consensus 364 ~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~ 405 (476)
.+...+.++.+|+.+||+.||++||++.+|++.|+.
T Consensus 338 ------~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~ 373 (375)
T cd05104 338 ------SPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ 373 (375)
T ss_pred ------CCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence 011125689999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=361.21 Aligned_cols=261 Identities=25% Similarity=0.309 Sum_probs=209.8
Q ss_pred cCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCc---cCHHHHHHHHHHHhCCCCCceeeEEEEEE
Q 011851 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL---QGHKEWLAEVNYLGGLIHPNLVKLIGCCI 197 (476)
Q Consensus 121 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~l~~~~~ 197 (476)
++|.+.+.||+|+||.||+|.+. .+|+.||+|+++.... ...+.+.+|+.+++.++|+||+++++++.
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~ 71 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREK---------ATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQ 71 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEEC---------CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEe
Confidence 36899999999999999998654 4678899999976432 23455788999999999999999999999
Q ss_pred eCCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCC
Q 011851 198 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGL 277 (476)
Q Consensus 198 ~~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~ 277 (476)
+++..||||||+++++|.+++.+....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 72 ~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~ 148 (330)
T cd05601 72 DKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGS 148 (330)
T ss_pred cCCeEEEEECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCC
Confidence 999999999999999999999776568999999999999999999999988 99999999999999999999999999
Q ss_pred cCCCCCCCccceeeeeecCCCCCCcchhh------cCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhh
Q 011851 278 AKDGPEGDKTHVSTRVMGTYGYAAPEYVM------TGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQ 351 (476)
Q Consensus 278 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~ 351 (476)
+......... ......||+.|+|||++. ...++.++|||||||++|||++|+.||.......... .
T Consensus 149 a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~-------~ 220 (330)
T cd05601 149 AARLTANKMV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYN-------N 220 (330)
T ss_pred CeECCCCCce-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHH-------H
Confidence 9865432221 223357999999999987 4568899999999999999999999997543221110 0
Q ss_pred hccccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCccccc
Q 011851 352 LGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDMA 413 (476)
Q Consensus 352 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~~~ 413 (476)
+.......... .....+.++.+|+.+||+ ||++||++.++++| |||....
T Consensus 221 i~~~~~~~~~~-------~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h----~~~~~~~ 270 (330)
T cd05601 221 IMNFQRFLKFP-------EDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH----PFFSKID 270 (330)
T ss_pred HHcCCCccCCC-------CCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC----CCcCCCC
Confidence 00000000000 011236788999999998 99999999999887 9998653
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-44 Score=355.46 Aligned_cols=250 Identities=28% Similarity=0.426 Sum_probs=198.6
Q ss_pred ccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCc---cCHHHHHHHHHHHhC-CCCCceeeEEEEEEeCCee
Q 011851 127 CLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL---QGHKEWLAEVNYLGG-LIHPNLVKLIGCCIEDDQR 202 (476)
Q Consensus 127 ~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~---~~~~~~~~E~~~l~~-l~hpnIv~l~~~~~~~~~~ 202 (476)
++||+|+||.||+|.+. .+++.||||+++.... ...+.+..|..++.. ++||||+++++++..++.+
T Consensus 1 ~~lG~G~~g~Vy~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~ 71 (316)
T cd05592 1 KVLGKGSFGKVMLAELK---------GTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHL 71 (316)
T ss_pred CeeeeCCCeEEEEEEEC---------CCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEE
Confidence 46999999999998764 4678899999975422 223445667777764 4899999999999999999
Q ss_pred EEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCcCCCC
Q 011851 203 LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGP 282 (476)
Q Consensus 203 ~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~ 282 (476)
|+||||+++|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 72 ~lv~e~~~gg~L~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~ 147 (316)
T cd05592 72 FFVMEYLNGGDLMFHIQS-SGRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENM 147 (316)
T ss_pred EEEEcCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECC
Confidence 999999999999998854 456999999999999999999999988 9999999999999999999999999997643
Q ss_pred CCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhcccccccccc
Q 011851 283 EGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRRFYRLI 362 (476)
Q Consensus 283 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 362 (476)
... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||....... +... .....
T Consensus 148 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~---~~~~---i~~~~------- 212 (316)
T cd05592 148 NGE--GKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDE---LFDS---ILNDR------- 212 (316)
T ss_pred CCC--CccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHH---HHHH---HHcCC-------
Confidence 322 12334679999999999999999999999999999999999999997643211 1110 00000
Q ss_pred CcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHH-HHHHHhcCCCCccccc
Q 011851 363 DPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMS-EVVEALKPLPYLKDMA 413 (476)
Q Consensus 363 d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~-ell~~L~~~~~~~~~~ 413 (476)
..++...+.++.+|+.+||+.||++||++. ++++| ||++...
T Consensus 213 -----~~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h----~~~~~~~ 255 (316)
T cd05592 213 -----PHFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQH----PFFRGID 255 (316)
T ss_pred -----CCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcC----cccCCCC
Confidence 011222356788999999999999999875 55554 8987653
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=359.74 Aligned_cols=257 Identities=28% Similarity=0.378 Sum_probs=205.4
Q ss_pred ccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCcc--CHHHHHHHHHHHhCCCCCceeeEEEEEEeCCeeEE
Q 011851 127 CLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQ--GHKEWLAEVNYLGGLIHPNLVKLIGCCIEDDQRLL 204 (476)
Q Consensus 127 ~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 204 (476)
+.||+|+||.||+++.. ....+|+.||+|++...... ....+..|+++|++++||||+++++++.+++.+||
T Consensus 2 ~~lg~G~~g~Vy~~~~~------~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 75 (318)
T cd05582 2 KVLGQGSFGKVFLVRKI------TGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYL 75 (318)
T ss_pred ceeeeCCCEEEEEEEEe------ccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEE
Confidence 57999999999998753 23357899999999764322 23456789999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCcCCCCCC
Q 011851 205 VYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEG 284 (476)
Q Consensus 205 V~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~ 284 (476)
||||+++++|.+++.+ ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 76 v~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~ 151 (318)
T cd05582 76 ILDFLRGGDLFTRLSK-EVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDH 151 (318)
T ss_pred EEcCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCC
Confidence 9999999999999854 456899999999999999999999988 999999999999999999999999999865432
Q ss_pred CccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhccccccccccCc
Q 011851 285 DKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRRFYRLIDP 364 (476)
Q Consensus 285 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 364 (476)
.. ......||+.|+|||++.+..++.++|||||||++|||++|+.||....... .... ......
T Consensus 152 ~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~---~~~~---i~~~~~-------- 215 (318)
T cd05582 152 EK--KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKE---TMTM---ILKAKL-------- 215 (318)
T ss_pred CC--ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHH---HHHH---HHcCCC--------
Confidence 11 2234679999999999998899999999999999999999999997543211 1110 000000
Q ss_pred ccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHH-HHHHhcCCCCccccc
Q 011851 365 CLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSE-VVEALKPLPYLKDMA 413 (476)
Q Consensus 365 ~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~e-ll~~L~~~~~~~~~~ 413 (476)
.++...+..+.+||.+||+.||++||++.+ .++.+..++||+...
T Consensus 216 ----~~p~~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~~~~~~~~ 261 (318)
T cd05582 216 ----GMPQFLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFFSTID 261 (318)
T ss_pred ----CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCCCCcCCCC
Confidence 011123567889999999999999999655 244455569998753
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-44 Score=356.28 Aligned_cols=250 Identities=27% Similarity=0.430 Sum_probs=200.7
Q ss_pred ccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCc---cCHHHHHHHHHHHhCC-CCCceeeEEEEEEeCCee
Q 011851 127 CLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL---QGHKEWLAEVNYLGGL-IHPNLVKLIGCCIEDDQR 202 (476)
Q Consensus 127 ~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~---~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~ 202 (476)
++||+|+||.||+|.+. .+++.||||++..... .....+..|.+++..+ +||||+++++++.+.+.+
T Consensus 1 ~~lG~G~~g~Vy~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~ 71 (321)
T cd05591 1 KVLGKGSFGKVMLAELK---------GTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRL 71 (321)
T ss_pred CccccCCCeEEEEEEEC---------CCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeE
Confidence 46999999999998654 4678899999976422 2234567788888865 799999999999999999
Q ss_pred EEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCcCCCC
Q 011851 203 LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGP 282 (476)
Q Consensus 203 ~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~ 282 (476)
||||||+++++|.+++.+. ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++....
T Consensus 72 ~lv~E~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~ 147 (321)
T cd05591 72 FFVMEYVNGGDLMFQIQRS-RKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGI 147 (321)
T ss_pred EEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecc
Confidence 9999999999999888544 56899999999999999999999988 9999999999999999999999999987543
Q ss_pred CCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhcccccccccc
Q 011851 283 EGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRRFYRLI 362 (476)
Q Consensus 283 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 362 (476)
.... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||....... ..... .....
T Consensus 148 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~---~~~~i---~~~~~------ 213 (321)
T cd05591 148 LNGV--TTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDD---LFESI---LHDDV------ 213 (321)
T ss_pred cCCc--cccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHH---HHHHH---HcCCC------
Confidence 2221 1234679999999999999999999999999999999999999997654221 11110 00000
Q ss_pred CcccCCCCChHHHHHHHHHHHHhcccCCCCCC-------CHHHHHHHhcCCCCccccc
Q 011851 363 DPCLEGCFSIKGAEKTIQLAASCLNRDQKARP-------RMSEVVEALKPLPYLKDMA 413 (476)
Q Consensus 363 d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RP-------t~~ell~~L~~~~~~~~~~ 413 (476)
.++...+.++.+|+.+||+.||++|| ++.++++| |||....
T Consensus 214 ------~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h----p~~~~~~ 261 (321)
T cd05591 214 ------LYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH----PFFKEID 261 (321)
T ss_pred ------CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC----CccCCCC
Confidence 01112257889999999999999999 77777765 9997653
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-44 Score=364.06 Aligned_cols=262 Identities=26% Similarity=0.398 Sum_probs=205.8
Q ss_pred cCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCcc-CHHHHHHHHHHHhCC-CCCceeeEEEEEEe
Q 011851 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQ-GHKEWLAEVNYLGGL-IHPNLVKLIGCCIE 198 (476)
Q Consensus 121 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~-~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~ 198 (476)
++|.+.+.||+|+||.||+|.+...+ +..++..||||+++..... ....+.+|+++|+.+ +|+||+++++++.+
T Consensus 38 ~~~~~~~~LG~G~fg~V~~~~~~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~ 113 (374)
T cd05106 38 DNLQFGKTLGAGAFGKVVEATAFGLG----KEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTH 113 (374)
T ss_pred HHceehheecCCCcccEEEEEEecCC----cccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecC
Confidence 46899999999999999999864322 1235668999999764332 234678999999999 89999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHHhhcC--------------------------------------------------------
Q 011851 199 DDQRLLVYEFMPRGSLENHLFRRS-------------------------------------------------------- 222 (476)
Q Consensus 199 ~~~~~lV~E~~~~g~L~~~l~~~~-------------------------------------------------------- 222 (476)
.+..|||||||++|+|.+++....
T Consensus 114 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (374)
T cd05106 114 GGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQ 193 (374)
T ss_pred CCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccc
Confidence 999999999999999999985421
Q ss_pred -------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCcCCCCCCCccce
Q 011851 223 -------------LPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHV 289 (476)
Q Consensus 223 -------------~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~ 289 (476)
.++++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++..........
T Consensus 194 ~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~ 270 (374)
T cd05106 194 SSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVV 270 (374)
T ss_pred cccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcceee
Confidence 24788889999999999999999988 99999999999999999999999999986543322222
Q ss_pred eeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhhccccccccccCcccCC
Q 011851 290 STRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPQLGERRRFYRLIDPCLEG 368 (476)
Q Consensus 290 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 368 (476)
.....++..|+|||++.+..++.++|||||||++|||++ |+.||........ ....... .. ..
T Consensus 271 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~--~~~~~~~----~~---~~------- 334 (374)
T cd05106 271 KGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSK--FYKMVKR----GY---QM------- 334 (374)
T ss_pred ccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHH--HHHHHHc----cc---Cc-------
Confidence 222345678999999999999999999999999999997 9999976433211 1111000 00 00
Q ss_pred CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 011851 369 CFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKP 405 (476)
Q Consensus 369 ~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~ 405 (476)
..+...+.++.+++.+||+.||++|||+.+|++.|+.
T Consensus 335 ~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~ 371 (374)
T cd05106 335 SRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQR 371 (374)
T ss_pred cCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 0111125789999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-43 Score=359.11 Aligned_cols=273 Identities=24% Similarity=0.235 Sum_probs=209.6
Q ss_pred ccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCCCCCceeeEEEEEEeC
Q 011851 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHPNLVKLIGCCIED 199 (476)
Q Consensus 120 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~ 199 (476)
..+|++.+.||+|+||.||+|.... ..+++.||+|.+... ....+|+++|++++||||+++++++...
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~-------~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~ 158 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHG-------DEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWK 158 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcC-------CccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeC
Confidence 4579999999999999999986542 235678999988643 2346899999999999999999999999
Q ss_pred CeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCcC
Q 011851 200 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAK 279 (476)
Q Consensus 200 ~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~ 279 (476)
...|+|||++. ++|.+++ .....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.++|+|||+++
T Consensus 159 ~~~~lv~e~~~-~~l~~~l-~~~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~ 233 (392)
T PHA03207 159 STVCMVMPKYK-CDLFTYV-DRSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAAC 233 (392)
T ss_pred CEEEEEehhcC-CCHHHHH-HhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCcccc
Confidence 99999999994 6898888 44567999999999999999999999988 9999999999999999999999999997
Q ss_pred CCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhcc-cccc
Q 011851 280 DGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGE-RRRF 358 (476)
Q Consensus 280 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~ 358 (476)
...............||+.|+|||++.+..|+.++|||||||++|||++|+.||..................+.. ...+
T Consensus 234 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~ 313 (392)
T PHA03207 234 KLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEF 313 (392)
T ss_pred ccCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCcccc
Confidence 655433332233467999999999999999999999999999999999999999765543221111100000000 0000
Q ss_pred c--------c---ccCcccCCCC-------ChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCccccc
Q 011851 359 Y--------R---LIDPCLEGCF-------SIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDMA 413 (476)
Q Consensus 359 ~--------~---~~d~~l~~~~-------~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~~~ 413 (476)
. . .+.......+ ....+.++.++|.+||..||++|||+.+++.| |||....
T Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~----p~f~~~~ 382 (392)
T PHA03207 314 PQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL----PLFTKEP 382 (392)
T ss_pred CCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC----chhhccc
Confidence 0 0 0000000000 01124578899999999999999999999998 9997643
|
|
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-44 Score=356.62 Aligned_cols=254 Identities=29% Similarity=0.393 Sum_probs=200.3
Q ss_pred ccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCc---cCHHHHHHHHH-HHhCCCCCceeeEEEEEEeCCee
Q 011851 127 CLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL---QGHKEWLAEVN-YLGGLIHPNLVKLIGCCIEDDQR 202 (476)
Q Consensus 127 ~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~---~~~~~~~~E~~-~l~~l~hpnIv~l~~~~~~~~~~ 202 (476)
+.||+|+||+||+|.+. .+|+.||||++..... ...+++..|.. +++.++||||+++++++.+.+..
T Consensus 1 ~~lg~G~~g~V~~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~ 71 (323)
T cd05575 1 KVIGKGSFGKVLLAKHK---------ADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKL 71 (323)
T ss_pred CeeeeCCCeEEEEEEEC---------CCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEE
Confidence 46999999999998764 4688899999975432 12234555554 56789999999999999999999
Q ss_pred EEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCcCCCC
Q 011851 203 LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGP 282 (476)
Q Consensus 203 ~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~ 282 (476)
|+||||+++++|.+++.+ ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 72 ~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~ 147 (323)
T cd05575 72 YFVLDYVNGGELFFHLQR-ERSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGI 147 (323)
T ss_pred EEEEcCCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccc
Confidence 999999999999998854 457899999999999999999999988 9999999999999999999999999987643
Q ss_pred CCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhcccccccccc
Q 011851 283 EGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRRFYRLI 362 (476)
Q Consensus 283 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 362 (476)
.... .....+||+.|+|||++.+..++.++|||||||++|||++|..||....... ... .....
T Consensus 148 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~---~~~---~i~~~-------- 211 (323)
T cd05575 148 EHSK--TTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAE---MYD---NILNK-------- 211 (323)
T ss_pred cCCC--ccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHH---HHH---HHHcC--------
Confidence 2221 2334679999999999999999999999999999999999999997543211 110 00000
Q ss_pred CcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCccccc
Q 011851 363 DPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDMA 413 (476)
Q Consensus 363 d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~~~ 413 (476)
.+. .....+..+.++|.+||+.||.+||++.+.+..+..+|||....
T Consensus 212 --~~~--~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~~~~~~~~ 258 (323)
T cd05575 212 --PLR--LKPNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSSIN 258 (323)
T ss_pred --CCC--CCCCCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcCCCcCCCC
Confidence 000 11122678899999999999999999865444455569998653
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-44 Score=353.09 Aligned_cols=250 Identities=27% Similarity=0.461 Sum_probs=199.8
Q ss_pred ccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCc---cCHHHHHHHHHHHhC-CCCCceeeEEEEEEeCCee
Q 011851 127 CLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL---QGHKEWLAEVNYLGG-LIHPNLVKLIGCCIEDDQR 202 (476)
Q Consensus 127 ~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~---~~~~~~~~E~~~l~~-l~hpnIv~l~~~~~~~~~~ 202 (476)
+.||+|+||.||+|.+. .+++.||||+++.... .....+..|..++.. ++||||+++++++.+.+.+
T Consensus 1 ~~lG~G~~g~Vy~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~ 71 (316)
T cd05619 1 KMLGKGSFGKVFLAELK---------GTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENL 71 (316)
T ss_pred CeeeeCCCEEEEEEEEC---------CCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEE
Confidence 46999999999998765 4678899999976421 223456678888875 4899999999999999999
Q ss_pred EEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCcCCCC
Q 011851 203 LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGP 282 (476)
Q Consensus 203 ~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~ 282 (476)
||||||+++|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 72 ~lv~ey~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~ 147 (316)
T cd05619 72 FFVMEYLNGGDLMFHIQS-CHKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENM 147 (316)
T ss_pred EEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECC
Confidence 999999999999998854 356899999999999999999999988 9999999999999999999999999987533
Q ss_pred CCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhcccccccccc
Q 011851 283 EGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRRFYRLI 362 (476)
Q Consensus 283 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 362 (476)
.... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||....... +...... .
T Consensus 148 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~---~~~~i~~---~-------- 211 (316)
T cd05619 148 LGDA--KTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEE---LFQSIRM---D-------- 211 (316)
T ss_pred CCCC--ceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHH---HHHHHHh---C--------
Confidence 2221 1234679999999999999999999999999999999999999997643221 1111100 0
Q ss_pred CcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHH-HHHHHhcCCCCccccc
Q 011851 363 DPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMS-EVVEALKPLPYLKDMA 413 (476)
Q Consensus 363 d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~-ell~~L~~~~~~~~~~ 413 (476)
.+. ++...+.++.+|+.+||+.||++||++. ++++| |||+...
T Consensus 212 ~~~----~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~h----~~~~~~~ 255 (316)
T cd05619 212 NPC----YPRWLTREAKDILVKLFVREPERRLGVKGDIRQH----PFFREID 255 (316)
T ss_pred CCC----CCccCCHHHHHHHHHHhccCHhhcCCChHHHHcC----cccCCCC
Confidence 010 1112256788999999999999999997 66555 9998754
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-44 Score=354.96 Aligned_cols=259 Identities=25% Similarity=0.359 Sum_probs=204.6
Q ss_pred CCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCcc---CHHHHHHHHHHHhCC-CCCceeeEEEEEE
Q 011851 122 SFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQ---GHKEWLAEVNYLGGL-IHPNLVKLIGCCI 197 (476)
Q Consensus 122 ~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~---~~~~~~~E~~~l~~l-~hpnIv~l~~~~~ 197 (476)
+|++.+.||+|+||.||+|.+. .+++.||||++.+.... ....+..|..++..+ +|++|+++++++.
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~ 71 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERK---------GTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQ 71 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEEC---------CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEe
Confidence 4888999999999999998654 46788999999764322 233466788888777 5899999999999
Q ss_pred eCCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCC
Q 011851 198 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGL 277 (476)
Q Consensus 198 ~~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~ 277 (476)
+.+.+||||||+++|+|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 72 ~~~~~~lv~E~~~~g~L~~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~ 147 (323)
T cd05616 72 TMDRLYFVMEYVNGGDLMYQIQQV-GRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGM 147 (323)
T ss_pred cCCEEEEEEcCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCC
Confidence 999999999999999999988544 46899999999999999999999988 99999999999999999999999999
Q ss_pred cCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhccccc
Q 011851 278 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRR 357 (476)
Q Consensus 278 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 357 (476)
++....... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||....... +.... ....
T Consensus 148 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~---~~~~i---~~~~-- 217 (323)
T cd05616 148 CKENMWDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE---LFQSI---MEHN-- 217 (323)
T ss_pred ceecCCCCC--ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHH---HHHHH---HhCC--
Confidence 975432111 1234679999999999999999999999999999999999999997643221 11110 0000
Q ss_pred cccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHH-HHHHHhcCCCCccccc
Q 011851 358 FYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMS-EVVEALKPLPYLKDMA 413 (476)
Q Consensus 358 ~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~-ell~~L~~~~~~~~~~ 413 (476)
..++...+.++.+|+.+||+.||++|++.. +..+.+..++||+...
T Consensus 218 ----------~~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~~~ 264 (323)
T cd05616 218 ----------VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYID 264 (323)
T ss_pred ----------CCCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcCCCcCCCC
Confidence 011223367889999999999999999852 2233344559998653
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-44 Score=373.00 Aligned_cols=253 Identities=23% Similarity=0.288 Sum_probs=205.7
Q ss_pred CCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCCCCCceeeEEEEEEeCCe
Q 011851 122 SFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHPNLVKLIGCCIEDDQ 201 (476)
Q Consensus 122 ~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~ 201 (476)
.|.+.+.||+|+||.||+|....+ .++.||+|.+..........+.+|+.+|+.++||||+++++++..++.
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~--------~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~ 139 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSD--------PKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDK 139 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCC--------CCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCE
Confidence 388999999999999999865421 266799998765544444567889999999999999999999999999
Q ss_pred eEEEEEecCCCCHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCc
Q 011851 202 RLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLA 278 (476)
Q Consensus 202 ~~lV~E~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a 278 (476)
+||||||+++|+|.+++.. ...++++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||++
T Consensus 140 ~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla 216 (478)
T PTZ00267 140 LLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFS 216 (478)
T ss_pred EEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCc
Confidence 9999999999999988753 3457899999999999999999999988 999999999999999999999999999
Q ss_pred CCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhcccccc
Q 011851 279 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRRF 358 (476)
Q Consensus 279 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 358 (476)
+..............+||+.|+|||++.+..++.++|||||||++|||++|+.||....... +...... ..
T Consensus 217 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~---~~~~~~~--~~---- 287 (478)
T PTZ00267 217 KQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQRE---IMQQVLY--GK---- 287 (478)
T ss_pred eecCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHh--CC----
Confidence 87644332223345689999999999999999999999999999999999999997543211 1110000 00
Q ss_pred ccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011851 359 YRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEA 402 (476)
Q Consensus 359 ~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~ 402 (476)
.++ ++...+.++.+||.+||..||++||++.+++.+
T Consensus 288 ---~~~-----~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~ 323 (478)
T PTZ00267 288 ---YDP-----FPCPVSSGMKALLDPLLSKNPALRPTTQQLLHT 323 (478)
T ss_pred ---CCC-----CCccCCHHHHHHHHHHhccChhhCcCHHHHHhC
Confidence 000 111235689999999999999999999999875
|
|
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=354.07 Aligned_cols=257 Identities=26% Similarity=0.399 Sum_probs=201.7
Q ss_pred ccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCc---cCHHHHHHHHHHHhCC-CCCceeeEEEEEEeCCee
Q 011851 127 CLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL---QGHKEWLAEVNYLGGL-IHPNLVKLIGCCIEDDQR 202 (476)
Q Consensus 127 ~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~---~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~ 202 (476)
++||+|+||.||+|.+. .+++.||+|+++.... .....+..|..++..+ +||||+++++++.+.+.+
T Consensus 1 ~~lG~G~~g~V~~~~~~---------~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~ 71 (329)
T cd05588 1 RVIGRGSYAKVLLVELK---------KTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRL 71 (329)
T ss_pred CeEeeCCCeEEEEEEEC---------CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEE
Confidence 46999999999998654 4678899999976432 2234577899999888 699999999999999999
Q ss_pred EEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCcCCCC
Q 011851 203 LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGP 282 (476)
Q Consensus 203 ~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~ 282 (476)
||||||+++++|.+++.+. ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 72 ~lv~e~~~~g~L~~~~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~ 147 (329)
T cd05588 72 FFVIEFVSGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGI 147 (329)
T ss_pred EEEEeCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccc
Confidence 9999999999999888543 57999999999999999999999988 9999999999999999999999999987532
Q ss_pred CCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCC--cchhHHhhhhhhcccccccc
Q 011851 283 EGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNG--EHNLVEWARPQLGERRRFYR 360 (476)
Q Consensus 283 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 360 (476)
.... .....+||+.|+|||++.+..++.++|||||||++|+|++|+.||....... ......+....+..
T Consensus 148 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~------ 219 (329)
T cd05588 148 RPGD--TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILE------ 219 (329)
T ss_pred cCCC--ccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHc------
Confidence 2111 1234689999999999999999999999999999999999999997432211 11111111111100
Q ss_pred ccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCC------HHHHHHHhcCCCCccccc
Q 011851 361 LIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPR------MSEVVEALKPLPYLKDMA 413 (476)
Q Consensus 361 ~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt------~~ell~~L~~~~~~~~~~ 413 (476)
... .++...+.++.+||.+||+.||.+|++ +.++++| |||....
T Consensus 220 ---~~~--~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h----p~~~~~~ 269 (329)
T cd05588 220 ---KQI--RIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSH----PFFRNID 269 (329)
T ss_pred ---CCC--CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcC----CCCCCCC
Confidence 000 011123567899999999999999998 5677665 9997643
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-45 Score=340.07 Aligned_cols=258 Identities=26% Similarity=0.347 Sum_probs=215.8
Q ss_pred ccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHH---HHHHHHHhCCCCCceeeEEEEE
Q 011851 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEW---LAEVNYLGGLIHPNLVKLIGCC 196 (476)
Q Consensus 120 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~---~~E~~~l~~l~hpnIv~l~~~~ 196 (476)
-++|..+++||+|.||+|.++ .++.||+.||||+++++..-...+. +.|-++|+..+||.+..|-..|
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~---------rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsF 237 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILC---------REKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSF 237 (516)
T ss_pred cchhhHHHHhcCCccceEEEE---------eecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhh
Confidence 356889999999999999985 4667999999999998766655543 5689999999999999999999
Q ss_pred EeCCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecC
Q 011851 197 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFG 276 (476)
Q Consensus 197 ~~~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG 276 (476)
+..+++|+||||..||.|+-+|.+ ...+++...+.+...|+.||.|||+++ ||+||||.+|+|||.+|++||+|||
T Consensus 238 Qt~drlCFVMeyanGGeLf~HLsr-er~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFG 313 (516)
T KOG0690|consen 238 QTQDRLCFVMEYANGGELFFHLSR-ERVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFG 313 (516)
T ss_pred ccCceEEEEEEEccCceEeeehhh-hhcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecc
Confidence 999999999999999999998855 456899999999999999999999988 9999999999999999999999999
Q ss_pred CcCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhcccc
Q 011851 277 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERR 356 (476)
Q Consensus 277 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~ 356 (476)
+++.... .......+||||.|+|||++....|+.++|+|.+||++|||++|+.||...+......++.... .
T Consensus 314 LCKE~I~--~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed------~ 385 (516)
T KOG0690|consen 314 LCKEEIK--YGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMED------L 385 (516)
T ss_pred cchhccc--ccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhh------c
Confidence 9986433 2233556999999999999999999999999999999999999999998655443333322111 1
Q ss_pred ccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHhcCCCCcccccC
Q 011851 357 RFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARP-----RMSEVVEALKPLPYLKDMAS 414 (476)
Q Consensus 357 ~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RP-----t~~ell~~L~~~~~~~~~~~ 414 (476)
.|+...++++..|+..+|..||.+|. .+.||.+| +||.++..
T Consensus 386 ------------kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h----~FF~~v~W 432 (516)
T KOG0690|consen 386 ------------KFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRH----RFFASVDW 432 (516)
T ss_pred ------------cCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhh----hhhccCCH
Confidence 13444578999999999999999995 35555555 88887754
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=346.53 Aligned_cols=244 Identities=21% Similarity=0.316 Sum_probs=198.3
Q ss_pred ccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccC---HHHHHHHHHHHhCCCCCceeeEEEEEEe----C
Q 011851 127 CLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQG---HKEWLAEVNYLGGLIHPNLVKLIGCCIE----D 199 (476)
Q Consensus 127 ~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~---~~~~~~E~~~l~~l~hpnIv~l~~~~~~----~ 199 (476)
..||+|++|.||+|.+ +|+.||||.++...... .+.+.+|+.+|++++||||+++++++.+ .
T Consensus 26 ~~i~~g~~~~v~~~~~-----------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~ 94 (283)
T PHA02988 26 VLIKENDQNSIYKGIF-----------NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDL 94 (283)
T ss_pred eEEeeCCceEEEEEEE-----------CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCC
Confidence 5799999999999975 46789999997654433 3567799999999999999999999877 3
Q ss_pred CeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeEecCCCCCCeeecCCCceEEeecCCc
Q 011851 200 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEE-AEKPVIYRDFKTSNILLDGEYNAKLSDFGLA 278 (476)
Q Consensus 200 ~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~-~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a 278 (476)
..+++||||+++|+|.+++... ..+++.....++.|++.||.|||+. + ++||||||+|||++.++.+||+|||++
T Consensus 95 ~~~~lv~Ey~~~g~L~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~~~~~~kl~dfg~~ 170 (283)
T PHA02988 95 PRLSLILEYCTRGYLREVLDKE-KDLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVTENYKLKIICHGLE 170 (283)
T ss_pred CceEEEEEeCCCCcHHHHHhhC-CCCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEECCCCcEEEcccchH
Confidence 4789999999999999999654 5789999999999999999999984 5 889999999999999999999999999
Q ss_pred CCCCCCCccceeeeeecCCCCCCcchhhc--CCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhcccc
Q 011851 279 KDGPEGDKTHVSTRVMGTYGYAAPEYVMT--GHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERR 356 (476)
Q Consensus 279 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~ 356 (476)
+...... ....|+..|+|||++.+ ..++.++|||||||++|||++|+.||........ .... .....
T Consensus 171 ~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~---~~~i---~~~~~ 239 (283)
T PHA02988 171 KILSSPP-----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEI---YDLI---INKNN 239 (283)
T ss_pred hhhcccc-----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHH---HHHH---HhcCC
Confidence 8653321 22468899999999976 6899999999999999999999999976532211 1110 00000
Q ss_pred ccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011851 357 RFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPL 406 (476)
Q Consensus 357 ~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~ 406 (476)
. ..++...+.++.+|+.+||+.||++|||+.++++.|+.+
T Consensus 240 ~----------~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~ 279 (283)
T PHA02988 240 S----------LKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLY 279 (283)
T ss_pred C----------CCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence 0 011223467899999999999999999999999998765
|
|
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-45 Score=361.57 Aligned_cols=265 Identities=24% Similarity=0.395 Sum_probs=219.9
Q ss_pred cCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCCCCCceeeEEEEEEeCC
Q 011851 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHPNLVKLIGCCIEDD 200 (476)
Q Consensus 121 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 200 (476)
+.|.|+..||.|+||.||+|..+ .++...|-|+|.....+..++++-||+||..++||+||+|++.|..++
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nk---------et~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~en 102 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNK---------ETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFEN 102 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcc---------cchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccC
Confidence 34788889999999999998654 466678899998777677788999999999999999999999999999
Q ss_pred eeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCcCC
Q 011851 201 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKD 280 (476)
Q Consensus 201 ~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~ 280 (476)
.+||+.|||.||.+...+..-+.+|++.++..+++|++.||.|||+++ |||||||..|||++-+|.|+|+|||.+..
T Consensus 103 kLwiliEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAK 179 (1187)
T KOG0579|consen 103 KLWILIEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAK 179 (1187)
T ss_pred ceEEEEeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeeccccccc
Confidence 999999999999999999888889999999999999999999999988 99999999999999999999999999865
Q ss_pred CCCCCccceeeeeecCCCCCCcchhhc-----CCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhccc
Q 011851 281 GPEGDKTHVSTRVMGTYGYAAPEYVMT-----GHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGER 355 (476)
Q Consensus 281 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~ 355 (476)
... .......++|||+|||||+++. .+|++++||||||++|.||..+.+|....++-- .++..+....
T Consensus 180 n~~--t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMR--VllKiaKSeP--- 252 (1187)
T KOG0579|consen 180 NKS--TRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMR--VLLKIAKSEP--- 252 (1187)
T ss_pred chh--HHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHH--HHHHHhhcCC---
Confidence 322 1222345899999999999874 589999999999999999999999976544321 1122211111
Q ss_pred cccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCcccccCcchH
Q 011851 356 RRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDMASSSSY 418 (476)
Q Consensus 356 ~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~~~~~~~~ 418 (476)
..++. +...+..+.|++++||..||..||++.+|++| ||+....+....
T Consensus 253 ---PTLlq-------PS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H----pfv~~~~SnK~i 301 (1187)
T KOG0579|consen 253 ---PTLLQ-------PSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH----PFVQNAPSNKMI 301 (1187)
T ss_pred ---CcccC-------cchhhhHHHHHHHHHHhcCCccCCCHHHHhhC----cccccCCcchHH
Confidence 11111 22336788999999999999999999999998 999987766433
|
|
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=352.59 Aligned_cols=256 Identities=25% Similarity=0.387 Sum_probs=200.6
Q ss_pred ccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCc---cCHHHHHHHHHHHhCC-CCCceeeEEEEEEeCCee
Q 011851 127 CLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL---QGHKEWLAEVNYLGGL-IHPNLVKLIGCCIEDDQR 202 (476)
Q Consensus 127 ~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~---~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~ 202 (476)
+.||+|+||.||+|.+. .+++.||+|++.+... .....+..|+.++.++ +||||+++++++.+.+.+
T Consensus 1 ~~lG~G~~g~V~~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~ 71 (329)
T cd05618 1 RVIGRGSYAKVLLVRLK---------KTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRL 71 (329)
T ss_pred CeeeeCCCeEEEEEEEC---------CCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEE
Confidence 46999999999998755 4678899999976432 2234567888888776 799999999999999999
Q ss_pred EEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCcCCCC
Q 011851 203 LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGP 282 (476)
Q Consensus 203 ~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~ 282 (476)
||||||+++++|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 72 ~lv~E~~~~~~L~~~~~~-~~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~ 147 (329)
T cd05618 72 FFVIEYVNGGDLMFHMQR-QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 147 (329)
T ss_pred EEEEeCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCcccccc
Confidence 999999999999988854 457999999999999999999999988 9999999999999999999999999997532
Q ss_pred CCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCc--chhHHhhhhhhcccccccc
Q 011851 283 EGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGE--HNLVEWARPQLGERRRFYR 360 (476)
Q Consensus 283 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~ 360 (476)
.... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||........ .....+....+..
T Consensus 148 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~------ 219 (329)
T cd05618 148 RPGD--TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE------ 219 (329)
T ss_pred CCCC--ccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhc------
Confidence 2111 12346799999999999999999999999999999999999999964222111 1111111111100
Q ss_pred ccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCH------HHHHHHhcCCCCcccc
Q 011851 361 LIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRM------SEVVEALKPLPYLKDM 412 (476)
Q Consensus 361 ~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~------~ell~~L~~~~~~~~~ 412 (476)
.. ..++...+.++.+||.+||+.||++||++ .++++| |||+..
T Consensus 220 ---~~--~~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~h----p~f~~~ 268 (329)
T cd05618 220 ---KQ--IRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH----PFFRNV 268 (329)
T ss_pred ---CC--CCCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcC----CCCCCC
Confidence 00 01222335788899999999999999984 677665 999875
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=357.56 Aligned_cols=238 Identities=29% Similarity=0.450 Sum_probs=200.7
Q ss_pred cccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCCCCCceeeEEEEEEeCCeeEEE
Q 011851 126 ECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHPNLVKLIGCCIEDDQRLLV 205 (476)
Q Consensus 126 ~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV 205 (476)
++-||+|+.|.||+|++. ++.||||.++.-. ..+|+-|++|+||||+.+.++|.....+|||
T Consensus 129 LeWlGSGaQGAVF~Grl~-----------netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIi 190 (904)
T KOG4721|consen 129 LEWLGSGAQGAVFLGRLH-----------NETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCYCII 190 (904)
T ss_pred hhhhccCcccceeeeecc-----------CceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCceeEEe
Confidence 466999999999999875 5679999875432 2478889999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCcCCCCCCC
Q 011851 206 YEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGD 285 (476)
Q Consensus 206 ~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~ 285 (476)
||||..|-|...| +...+++......|..+|+.|+.|||.+. |||||||.-||||..+..|||+|||-++...+.
T Consensus 191 MEfCa~GqL~~VL-ka~~~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~- 265 (904)
T KOG4721|consen 191 MEFCAQGQLYEVL-KAGRPITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKELSDK- 265 (904)
T ss_pred eeccccccHHHHH-hccCccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHhhhhh-
Confidence 9999999999999 55668999999999999999999999988 999999999999999999999999999876553
Q ss_pred ccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhccccccccccCcc
Q 011851 286 KTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRRFYRLIDPC 365 (476)
Q Consensus 286 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 365 (476)
.+ ...++||..|||||++.+.+.+.|+|||||||+|||||||..||......... |.... ..
T Consensus 266 ST--kMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAII----wGVGs------------Ns 327 (904)
T KOG4721|consen 266 ST--KMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAII----WGVGS------------NS 327 (904)
T ss_pred hh--hhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeE----EeccC------------Cc
Confidence 12 33489999999999999999999999999999999999999999765432221 11111 01
Q ss_pred cCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 011851 366 LEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALK 404 (476)
Q Consensus 366 l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~ 404 (476)
|.-..+..+++-+.-||++||+..|..||++++|+.||.
T Consensus 328 L~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~Hld 366 (904)
T KOG4721|consen 328 LHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLD 366 (904)
T ss_pred ccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHh
Confidence 111123345778889999999999999999999999976
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-44 Score=362.80 Aligned_cols=268 Identities=23% Similarity=0.309 Sum_probs=208.0
Q ss_pred CCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCCC-C-----CceeeEEEE
Q 011851 122 SFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLI-H-----PNLVKLIGC 195 (476)
Q Consensus 122 ~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~-h-----pnIv~l~~~ 195 (476)
+|.+.++||+|+||.|.+|++. +|++.||||+++... .-..+...|+.||..|+ | -|||+++++
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~---------~T~e~VAIKIiKN~k-~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~ 256 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDH---------KTGEIVAIKIIKNKK-RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDY 256 (586)
T ss_pred EEEEEEEecccccceeEEEEec---------CCCcEEEEEeeccCh-HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeec
Confidence 6889999999999999998654 689999999997652 33456677999999886 4 389999999
Q ss_pred EEeCCeeEEEEEecCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCC--CceEE
Q 011851 196 CIEDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGE--YNAKL 272 (476)
Q Consensus 196 ~~~~~~~~lV~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~--~~vkl 272 (476)
|...+++|||+|++ +.+|+++|... ...++...++.++.||+.||.+||+.+ |||+|||||||||..- ..|||
T Consensus 257 F~fr~HlciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKV 332 (586)
T KOG0667|consen 257 FYFRNHLCIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKV 332 (586)
T ss_pred cccccceeeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeE
Confidence 99999999999999 66999999654 456899999999999999999999988 9999999999999543 37999
Q ss_pred eecCCcCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhh-
Q 011851 273 SDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQ- 351 (476)
Q Consensus 273 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~- 351 (476)
+|||.+......-. ..+.+..|+|||++.+.+|+.+.||||||||++||++|.+.|.+.+..+....+.-....
T Consensus 333 IDFGSSc~~~q~vy-----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~P 407 (586)
T KOG0667|consen 333 IDFGSSCFESQRVY-----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLP 407 (586)
T ss_pred EecccccccCCcce-----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCC
Confidence 99999987543222 467788899999999999999999999999999999999888877654433221100000
Q ss_pred ----hccccccccccCc----------------------------------------ccCCCCChHHHHHHHHHHHHhcc
Q 011851 352 ----LGERRRFYRLIDP----------------------------------------CLEGCFSIKGAEKTIQLAASCLN 387 (476)
Q Consensus 352 ----~~~~~~~~~~~d~----------------------------------------~l~~~~~~~~~~~~~~li~~cL~ 387 (476)
+....+...+++. .+...+.......+.+++++||.
T Consensus 408 p~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~ 487 (586)
T KOG0667|consen 408 PPKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLE 487 (586)
T ss_pred CHHHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhc
Confidence 0000000001110 00001111224578999999999
Q ss_pred cCCCCCCCHHHHHHHhcCCCCcccc
Q 011851 388 RDQKARPRMSEVVEALKPLPYLKDM 412 (476)
Q Consensus 388 ~dP~~RPt~~ell~~L~~~~~~~~~ 412 (476)
+||.+|+|..++|+| ||+.+.
T Consensus 488 ~dP~~R~tp~qal~H----pfl~~~ 508 (586)
T KOG0667|consen 488 WDPAERITPAQALNH----PFLTGT 508 (586)
T ss_pred cCchhcCCHHHHhcC----cccccc
Confidence 999999999999998 998854
|
|
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-44 Score=356.34 Aligned_cols=254 Identities=28% Similarity=0.377 Sum_probs=202.4
Q ss_pred ccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCc---cCHHHHHHHHH-HHhCCCCCceeeEEEEEEeCCee
Q 011851 127 CLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL---QGHKEWLAEVN-YLGGLIHPNLVKLIGCCIEDDQR 202 (476)
Q Consensus 127 ~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~---~~~~~~~~E~~-~l~~l~hpnIv~l~~~~~~~~~~ 202 (476)
++||+|+||+||+|.+. .+|+.||+|++..... .....+..|.. +++.++||||+++++++..++.+
T Consensus 1 ~~lG~G~~g~V~~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~ 71 (325)
T cd05604 1 KVIGKGSFGKVLLAKRK---------LDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKL 71 (325)
T ss_pred CceeeCCCeEEEEEEEC---------CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEE
Confidence 46999999999998654 4678899999975422 22334555554 57789999999999999999999
Q ss_pred EEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCcCCCC
Q 011851 203 LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGP 282 (476)
Q Consensus 203 ~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~ 282 (476)
|+||||+++++|..++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 72 ~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~ 147 (325)
T cd05604 72 YFVLDFVNGGELFFHLQR-ERSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGI 147 (325)
T ss_pred EEEEcCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCC
Confidence 999999999999988854 457999999999999999999999988 9999999999999999999999999987543
Q ss_pred CCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhcccccccccc
Q 011851 283 EGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRRFYRLI 362 (476)
Q Consensus 283 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 362 (476)
.... .....+||+.|+|||++.+..++.++|||||||++|||++|..||........ .. .....
T Consensus 148 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~---~~---~~~~~-------- 211 (325)
T cd05604 148 AQSD--TTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEM---YD---NILHK-------- 211 (325)
T ss_pred CCCC--CcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHH---HH---HHHcC--------
Confidence 2221 12346799999999999999999999999999999999999999975432211 11 00000
Q ss_pred CcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCccccc
Q 011851 363 DPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDMA 413 (476)
Q Consensus 363 d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~~~ 413 (476)
.+ .+....+..+.+++.+||+.||.+||++.+.++.+..+|||....
T Consensus 212 --~~--~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h~~f~~~~ 258 (325)
T cd05604 212 --PL--VLRPGASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFESLS 258 (325)
T ss_pred --Cc--cCCCCCCHHHHHHHHHHhccCHHhcCCCCCCHHHHhcCCCcCCCC
Confidence 00 011123567889999999999999999987676777779998753
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=346.05 Aligned_cols=270 Identities=24% Similarity=0.313 Sum_probs=200.0
Q ss_pred cCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCcc--CHHHHHHHHHHHhCC---CCCceeeEEEE
Q 011851 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQ--GHKEWLAEVNYLGGL---IHPNLVKLIGC 195 (476)
Q Consensus 121 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~--~~~~~~~E~~~l~~l---~hpnIv~l~~~ 195 (476)
++|++.+.||+|+||.||+|.+.. .+++.||+|+++..... ....+.+|+.+++.+ +||||++++++
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~--------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~ 72 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLK--------NGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDV 72 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcC--------CCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEE
Confidence 369999999999999999987642 24677999998754322 223456677776655 69999999999
Q ss_pred EEe-----CCeeEEEEEecCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCc
Q 011851 196 CIE-----DDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYN 269 (476)
Q Consensus 196 ~~~-----~~~~~lV~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~ 269 (476)
+.. ...+++||||++ ++|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.
T Consensus 73 ~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~ 148 (290)
T cd07862 73 CTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQ 148 (290)
T ss_pred EecccCCCCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCC
Confidence 863 456899999995 6899988653 345899999999999999999999988 999999999999999999
Q ss_pred eEEeecCCcCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhH-Hhh
Q 011851 270 AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV-EWA 348 (476)
Q Consensus 270 vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~-~~~ 348 (476)
+||+|||+++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...........+ ...
T Consensus 149 ~kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~ 225 (290)
T cd07862 149 IKLADFGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVI 225 (290)
T ss_pred EEEccccceEeccCCc---ccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHh
Confidence 9999999997654321 223467999999999999999999999999999999999999999865432211111 100
Q ss_pred hhhhc-cccccc----cccCcccCC---CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCc
Q 011851 349 RPQLG-ERRRFY----RLIDPCLEG---CFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYL 409 (476)
Q Consensus 349 ~~~~~-~~~~~~----~~~d~~l~~---~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~ 409 (476)
..... ...... ..+.+.... ......+..+.+|+.+||+.||++|||+.++++| |||
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~h----p~f 290 (290)
T cd07862 226 GLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH----PYF 290 (290)
T ss_pred CCCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcC----CCC
Confidence 00000 000000 000000000 0011235678899999999999999999999987 886
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=344.27 Aligned_cols=253 Identities=26% Similarity=0.402 Sum_probs=201.5
Q ss_pred ccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCcc---CHHHHHHHHHHHhCCCCCceeeEEEEEEeCCeeEEE
Q 011851 129 LGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQ---GHKEWLAEVNYLGGLIHPNLVKLIGCCIEDDQRLLV 205 (476)
Q Consensus 129 LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~---~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV 205 (476)
||+|+||+||++.+. .+++.||+|.+...... ..+.+..|+++|+.++|+||+++++++..+...|+|
T Consensus 1 lg~G~~g~Vy~~~~~---------~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv 71 (280)
T cd05608 1 LGKGGFGEVSACQMR---------ATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLV 71 (280)
T ss_pred CCCCCceeEEEEEEc---------cCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEE
Confidence 799999999997654 46788999998754332 234567899999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCcCCCC
Q 011851 206 YEFMPRGSLENHLFR---RSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGP 282 (476)
Q Consensus 206 ~E~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~ 282 (476)
|||+++|+|.+++.. ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.++|+|||++....
T Consensus 72 ~e~~~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~ 148 (280)
T cd05608 72 MTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELK 148 (280)
T ss_pred EeCCCCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecC
Confidence 999999999888743 3456899999999999999999999988 9999999999999999999999999997654
Q ss_pred CCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhcccccccccc
Q 011851 283 EGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRRFYRLI 362 (476)
Q Consensus 283 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 362 (476)
..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||........... ..... .
T Consensus 149 ~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~--~~~~~----------~ 214 (280)
T cd05608 149 DGQSK--TKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKE--LKQRI----------L 214 (280)
T ss_pred CCCcc--ccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHH--HHHhh----------c
Confidence 43221 2335799999999999999999999999999999999999999975433211110 00000 0
Q ss_pred CcccCCCCChHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHhcCCCCccccc
Q 011851 363 DPCLEGCFSIKGAEKTIQLAASCLNRDQKARP-----RMSEVVEALKPLPYLKDMA 413 (476)
Q Consensus 363 d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RP-----t~~ell~~L~~~~~~~~~~ 413 (476)
.... .++...+..+.+++.+||+.||++|| +++++++| |||++..
T Consensus 215 ~~~~--~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h----~~~~~~~ 264 (280)
T cd05608 215 NDSV--TYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH----PLFRDLN 264 (280)
T ss_pred ccCC--CCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC----hhhhcCC
Confidence 0000 11223467889999999999999999 66666665 9998743
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-44 Score=360.57 Aligned_cols=261 Identities=25% Similarity=0.338 Sum_probs=205.3
Q ss_pred cCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCC---ccCHHHHHHHHHHHhCCCCCceeeEEEEEE
Q 011851 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDG---LQGHKEWLAEVNYLGGLIHPNLVKLIGCCI 197 (476)
Q Consensus 121 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~ 197 (476)
++|++.+.||+|+||.||+|.+. .+++.||||+++... ......+.+|+.++..++|+||+++++.+.
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~ 71 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKK---------DTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQ 71 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEEC---------CCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence 36889999999999999998654 467889999997532 223456778999999999999999999999
Q ss_pred eCCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCC
Q 011851 198 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGL 277 (476)
Q Consensus 198 ~~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~ 277 (476)
+++.+||||||+++|+|.+++.+ ...+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+
T Consensus 72 ~~~~~~lv~E~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~ 147 (360)
T cd05627 72 DKRNLYLIMEFLPGGDMMTLLMK-KDTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGL 147 (360)
T ss_pred cCCEEEEEEeCCCCccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccC
Confidence 99999999999999999999854 456899999999999999999999988 99999999999999999999999999
Q ss_pred cCCCCCCCcc---------------------------------ceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHH
Q 011851 278 AKDGPEGDKT---------------------------------HVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLL 324 (476)
Q Consensus 278 a~~~~~~~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~ 324 (476)
+......... ......+||+.|+|||++.+..++.++|||||||++|
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvily 227 (360)
T cd05627 148 CTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMY 227 (360)
T ss_pred CcccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceee
Confidence 8754321100 0012357999999999999999999999999999999
Q ss_pred HHHhCCCCCCCCCCCCcchhHHhhhhhhccccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCC---HHHHHH
Q 011851 325 EMLTGRRSMDKNRPNGEHNLVEWARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPR---MSEVVE 401 (476)
Q Consensus 325 elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt---~~ell~ 401 (476)
||++|+.||....+......+. ..... . .+.+ ....+.++.+||.+|+ .||.+|++ +.++++
T Consensus 228 el~tG~~Pf~~~~~~~~~~~i~------~~~~~-~-~~p~------~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~ 292 (360)
T cd05627 228 EMLIGYPPFCSETPQETYRKVM------NWKET-L-VFPP------EVPISEKAKDLILRFC-TDSENRIGSNGVEEIKS 292 (360)
T ss_pred ecccCCCCCCCCCHHHHHHHHH------cCCCc-e-ecCC------CCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhc
Confidence 9999999997654322111110 00000 0 0000 0112568889999977 49999985 667666
Q ss_pred HhcCCCCccccc
Q 011851 402 ALKPLPYLKDMA 413 (476)
Q Consensus 402 ~L~~~~~~~~~~ 413 (476)
| |||++..
T Consensus 293 h----p~f~~~~ 300 (360)
T cd05627 293 H----PFFEGVD 300 (360)
T ss_pred C----CCCCCCC
Confidence 5 9999864
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=341.74 Aligned_cols=259 Identities=26% Similarity=0.417 Sum_probs=207.0
Q ss_pred ccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCcc-CHHHHHHHHHHHhCCCCCceeeEEEEEEe
Q 011851 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQ-GHKEWLAEVNYLGGLIHPNLVKLIGCCIE 198 (476)
Q Consensus 120 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~~ 198 (476)
.++|++.+.||+|+||.||+|++... ...+..||+|.++..... ....+.+|+.+|++++||||+++++++..
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~------~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 77 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLP------SKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITR 77 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecC------CCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEec
Confidence 34689999999999999999986532 235678999999765332 23468899999999999999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCc
Q 011851 199 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLA 278 (476)
Q Consensus 199 ~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a 278 (476)
++..+|||||+++++|.+++......+++..++.++.||+.||+|||+++ ++||||||+|||++.++.++|+|||.+
T Consensus 78 ~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~ 154 (266)
T cd05064 78 GNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRL 154 (266)
T ss_pred CCCcEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCccc
Confidence 99999999999999999999776667999999999999999999999988 999999999999999999999999987
Q ss_pred CCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhhccccc
Q 011851 279 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPQLGERRR 357 (476)
Q Consensus 279 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 357 (476)
........ .......++..|+|||++.+..++.++|||||||++|||++ |..||........ .... .....
T Consensus 155 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~---~~~~----~~~~~ 226 (266)
T cd05064 155 QEDKSEAI-YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDV---IKAV----EDGFR 226 (266)
T ss_pred ccccccch-hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHH---HHHH----HCCCC
Confidence 65422111 11112345678999999999999999999999999999775 9999976533211 1110 01000
Q ss_pred cccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 011851 358 FYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKP 405 (476)
Q Consensus 358 ~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~ 405 (476)
. + .+...+..+.+++.+||+.+|++||++.+|++.|..
T Consensus 227 ---~--~-----~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~ 264 (266)
T cd05064 227 ---L--P-----APRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSK 264 (266)
T ss_pred ---C--C-----CCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHh
Confidence 0 0 112235678999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=352.42 Aligned_cols=250 Identities=28% Similarity=0.441 Sum_probs=201.9
Q ss_pred ccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCc---cCHHHHHHHHHHHhCC-CCCceeeEEEEEEeCCee
Q 011851 127 CLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL---QGHKEWLAEVNYLGGL-IHPNLVKLIGCCIEDDQR 202 (476)
Q Consensus 127 ~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~---~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~ 202 (476)
+.||+|+||.||+|.+. .+++.||||++++... .....+..|..++..+ +||||+++++++...+.+
T Consensus 1 ~~lG~G~~g~V~~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~ 71 (318)
T cd05570 1 KVLGKGSFGKVLLAELK---------GTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRL 71 (318)
T ss_pred CeeeeCCCeEEEEEEEC---------CCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEE
Confidence 46999999999998654 4677899999976432 2334567888999877 699999999999999999
Q ss_pred EEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCcCCCC
Q 011851 203 LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGP 282 (476)
Q Consensus 203 ~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~ 282 (476)
|+||||+++++|.+++.+. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 72 ~lv~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 147 (318)
T cd05570 72 FFVMEYVNGGDLMFHIQRS-GRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGI 147 (318)
T ss_pred EEEEcCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecC
Confidence 9999999999999888544 57999999999999999999999988 9999999999999999999999999987532
Q ss_pred CCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhcccccccccc
Q 011851 283 EGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRRFYRLI 362 (476)
Q Consensus 283 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 362 (476)
.... .....+||+.|+|||++.+..++.++|||||||++|+|++|+.||...... ..... ......
T Consensus 148 ~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~---~~~~~---i~~~~~------ 213 (318)
T cd05570 148 LGGV--TTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDED---ELFQS---ILEDEV------ 213 (318)
T ss_pred cCCC--cccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHH---HHHHH---HHcCCC------
Confidence 2221 123467999999999999999999999999999999999999999754321 11110 000000
Q ss_pred CcccCCCCChHHHHHHHHHHHHhcccCCCCCCCH-----HHHHHHhcCCCCccccc
Q 011851 363 DPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRM-----SEVVEALKPLPYLKDMA 413 (476)
Q Consensus 363 d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~-----~ell~~L~~~~~~~~~~ 413 (476)
.++...+.++.+||.+||+.||++||++ .+++++ ||++...
T Consensus 214 ------~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~----~~~~~~~ 259 (318)
T cd05570 214 ------RYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH----PFFREID 259 (318)
T ss_pred ------CCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC----CCcCCCC
Confidence 0112235788999999999999999999 888776 9998753
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-43 Score=341.54 Aligned_cols=256 Identities=27% Similarity=0.389 Sum_probs=204.7
Q ss_pred ccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCcc---CHHHHHHHHHHHhCCCCCceeeEEEEEEeCCeeEEE
Q 011851 129 LGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQ---GHKEWLAEVNYLGGLIHPNLVKLIGCCIEDDQRLLV 205 (476)
Q Consensus 129 LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~---~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV 205 (476)
||+|+||.||++... .+|+.||+|.+...... ..+.+..|+++|++++||||+++++++.++..+|+|
T Consensus 1 lg~G~~g~Vy~~~~~---------~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv 71 (277)
T cd05607 1 LGKGGFGEVCAVQVK---------NTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLV 71 (277)
T ss_pred CCCCCceEEEEEEEc---------cCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEE
Confidence 799999999998654 46888999998653322 223456799999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCcCCCCCC
Q 011851 206 YEFMPRGSLENHLFRR-SLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEG 284 (476)
Q Consensus 206 ~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~ 284 (476)
|||+++++|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.++|+|||++......
T Consensus 72 ~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~ 148 (277)
T cd05607 72 MSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG 148 (277)
T ss_pred EecCCCCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCC
Confidence 9999999999888543 346889999999999999999999988 999999999999999999999999998765432
Q ss_pred CccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhccccccccccCc
Q 011851 285 DKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRRFYRLIDP 364 (476)
Q Consensus 285 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 364 (476)
. ......|+..|+|||++.+..++.++|||||||++|||++|+.||......... ..........
T Consensus 149 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~--~~~~~~~~~~---------- 213 (277)
T cd05607 149 K---TITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAK--EELKRRTLED---------- 213 (277)
T ss_pred c---eeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhH--HHHHHHhhcc----------
Confidence 2 123356899999999999989999999999999999999999999754322111 1111111100
Q ss_pred ccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCcccc
Q 011851 365 CLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDM 412 (476)
Q Consensus 365 ~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~~ 412 (476)
.... .....+.++.+|+.+||+.||++||++.|+++.+..++||+..
T Consensus 214 ~~~~-~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~h~~f~~~ 260 (277)
T cd05607 214 EVKF-EHQNFTEESKDICRLFLAKKPEDRLGSREKNDDPRKHEFFKTI 260 (277)
T ss_pred cccc-ccccCCHHHHHHHHHHhccCHhhCCCCccchhhhhcChhhcCC
Confidence 0000 0012356789999999999999999999888888888999875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-44 Score=361.42 Aligned_cols=262 Identities=23% Similarity=0.283 Sum_probs=207.8
Q ss_pred hccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCc---cCHHHHHHHHHHHhCCCCCceeeEEEE
Q 011851 119 ATKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL---QGHKEWLAEVNYLGGLIHPNLVKLIGC 195 (476)
Q Consensus 119 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~l~~~ 195 (476)
..++|++.+.||+|+||.||+|.+. .+++.||+|++..... .....+.+|+.+|+.++||||++++++
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~ 111 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHK---------SSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYA 111 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEEC---------CCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEE
Confidence 3457999999999999999998654 4678899999975322 223456789999999999999999999
Q ss_pred EEeCCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeec
Q 011851 196 CIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDF 275 (476)
Q Consensus 196 ~~~~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DF 275 (476)
+.+++.+||||||+++|+|.+++... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+||
T Consensus 112 ~~~~~~~~lv~Ey~~gg~L~~~l~~~--~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~Df 186 (370)
T cd05596 112 FQDDKYLYMVMEYMPGGDLVNLMSNY--DIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADF 186 (370)
T ss_pred EecCCEEEEEEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEec
Confidence 99999999999999999999988543 5888999999999999999999988 999999999999999999999999
Q ss_pred CCcCCCCCCCccceeeeeecCCCCCCcchhhcC----CCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhh
Q 011851 276 GLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG----HLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQ 351 (476)
Q Consensus 276 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~ 351 (476)
|++........ ......+||+.|+|||++.+. .++.++|||||||++|||++|+.||...........+
T Consensus 187 G~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i------ 259 (370)
T cd05596 187 GTCMKMDANGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKI------ 259 (370)
T ss_pred cceeeccCCCc-ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHH------
Confidence 99976533221 112346799999999998753 4789999999999999999999999765432111100
Q ss_pred hccccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCC--CCCHHHHHHHhcCCCCccccc
Q 011851 352 LGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKA--RPRMSEVVEALKPLPYLKDMA 413 (476)
Q Consensus 352 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~--RPt~~ell~~L~~~~~~~~~~ 413 (476)
...... +........+.++.+||.+||+.+|++ |+++.++++| |||++..
T Consensus 260 ~~~~~~--------~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h----~~~~~~~ 311 (370)
T cd05596 260 MDHKNS--------LTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH----PFFKNDQ 311 (370)
T ss_pred HcCCCc--------CCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC----cccCCCC
Confidence 000000 000001123678999999999999988 9999999998 9998643
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-43 Score=351.76 Aligned_cols=267 Identities=22% Similarity=0.306 Sum_probs=201.8
Q ss_pred ccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCCCCCceeeEEEEEEeC
Q 011851 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHPNLVKLIGCCIED 199 (476)
Q Consensus 120 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~ 199 (476)
..+|++.+.||+|+||.||+|.+. .+++.||+|+.... ....|+.+|++++|+||+++++++.+.
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~---------~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~ 129 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKP---------GQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSG 129 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEEC---------CCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeC
Confidence 457999999999999999998754 46678999985432 234699999999999999999999999
Q ss_pred CeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCcC
Q 011851 200 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAK 279 (476)
Q Consensus 200 ~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~ 279 (476)
+..++||||+ .++|.+++......+++..++.|+.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 130 ~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~ 205 (357)
T PHA03209 130 AITCMVLPHY-SSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQ 205 (357)
T ss_pred CeeEEEEEcc-CCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCcccc
Confidence 9999999999 56899988777778999999999999999999999988 9999999999999999999999999997
Q ss_pred CCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchh--------HHhhhhh
Q 011851 280 DGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNL--------VEWARPQ 351 (476)
Q Consensus 280 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~--------~~~~~~~ 351 (476)
...... ......||+.|+|||++.+..++.++|||||||++|||+++..++....+...... .......
T Consensus 206 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~ 282 (357)
T PHA03209 206 FPVVAP---AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTL 282 (357)
T ss_pred ccccCc---ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHh
Confidence 532211 12346799999999999999999999999999999999987665533322211110 0000000
Q ss_pred hccccccc---------cccC--cccCC---CC----ChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCcccc
Q 011851 352 LGERRRFY---------RLID--PCLEG---CF----SIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDM 412 (476)
Q Consensus 352 ~~~~~~~~---------~~~d--~~l~~---~~----~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~~ 412 (476)
......+. .+++ ..... .+ ....+..+.+||.+||+.||++|||+.|+++| |||+++
T Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~h----p~f~~~ 357 (357)
T PHA03209 283 KVHPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNY----PMFAQL 357 (357)
T ss_pred ccChhhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcC----chhccC
Confidence 00000000 0000 00000 00 01124466789999999999999999999998 999863
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=359.14 Aligned_cols=262 Identities=23% Similarity=0.294 Sum_probs=206.0
Q ss_pred hccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCc---cCHHHHHHHHHHHhCCCCCceeeEEEE
Q 011851 119 ATKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL---QGHKEWLAEVNYLGGLIHPNLVKLIGC 195 (476)
Q Consensus 119 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~l~~~ 195 (476)
..++|++.+.||+|+||.||+|.+. .+++.||+|++.+... .....+.+|+.+++.++||||++++++
T Consensus 41 ~~~~y~~~~~lG~G~fg~Vy~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~ 111 (370)
T cd05621 41 KAEDYDVVKVIGRGAFGEVQLVRHK---------SSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCA 111 (370)
T ss_pred CHHHCeEEEEEEecCCeEEEEEEEC---------CCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence 3568999999999999999998654 4678899999865322 223457789999999999999999999
Q ss_pred EEeCCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeec
Q 011851 196 CIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDF 275 (476)
Q Consensus 196 ~~~~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DF 275 (476)
+.+++.+|+|||||++|+|.+++... .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+||
T Consensus 112 ~~~~~~~~lv~Ey~~gg~L~~~l~~~--~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DF 186 (370)
T cd05621 112 FQDDKYLYMVMEYMPGGDLVNLMSNY--DVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADF 186 (370)
T ss_pred EEcCCEEEEEEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEec
Confidence 99999999999999999999988543 5889999999999999999999988 999999999999999999999999
Q ss_pred CCcCCCCCCCccceeeeeecCCCCCCcchhhcC----CCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhh
Q 011851 276 GLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG----HLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQ 351 (476)
Q Consensus 276 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~ 351 (476)
|++........ ......+||+.|+|||++.+. .++.++|||||||++|||++|+.||........... .
T Consensus 187 G~a~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~------i 259 (370)
T cd05621 187 GTCMKMDETGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSK------I 259 (370)
T ss_pred ccceecccCCc-eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHH------H
Confidence 99986543221 112346799999999999764 378899999999999999999999975432111100 0
Q ss_pred hccccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCC--CCCHHHHHHHhcCCCCccccc
Q 011851 352 LGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKA--RPRMSEVVEALKPLPYLKDMA 413 (476)
Q Consensus 352 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~--RPt~~ell~~L~~~~~~~~~~ 413 (476)
...... +........+..+.+++.+||..++.+ |+++.++++| |||+...
T Consensus 260 ~~~~~~--------~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h----p~~~~~~ 311 (370)
T cd05621 260 MDHKNS--------LNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH----PFFKNDQ 311 (370)
T ss_pred HhCCcc--------cCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC----cccCCCC
Confidence 000000 000001123678889999999865543 8999999997 9998643
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-43 Score=350.52 Aligned_cols=263 Identities=20% Similarity=0.253 Sum_probs=205.3
Q ss_pred cCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCc---cCHHHHHHHHHHHhCCCCCceeeEEEEEE
Q 011851 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL---QGHKEWLAEVNYLGGLIHPNLVKLIGCCI 197 (476)
Q Consensus 121 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~l~~~~~ 197 (476)
++|++.+.||+|+||.||++++. .+++.||+|++.+... .....+.+|+.++..++|+||+++++++.
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~ 71 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMK---------HTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQ 71 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEEC---------CCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence 46999999999999999998654 4677899999875321 12344778999999999999999999999
Q ss_pred eCCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCC
Q 011851 198 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGL 277 (476)
Q Consensus 198 ~~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~ 277 (476)
+++..||||||++||+|.+++.+....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 72 ~~~~~~lv~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~ 148 (331)
T cd05624 72 DENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGS 148 (331)
T ss_pred cCCEEEEEEeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccc
Confidence 999999999999999999999775667999999999999999999999988 99999999999999999999999999
Q ss_pred cCCCCCCCccceeeeeecCCCCCCcchhhc-----CCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhh
Q 011851 278 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-----GHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQL 352 (476)
Q Consensus 278 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~ 352 (476)
++....... ......+||+.|+|||++.+ +.++.++|||||||++|||++|+.||........... ..
T Consensus 149 a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~------i~ 221 (331)
T cd05624 149 CLKMNQDGT-VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGK------IM 221 (331)
T ss_pred eeeccCCCc-eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHH------HH
Confidence 976543221 11233579999999999876 5688999999999999999999999975432211100 00
Q ss_pred ccccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCC--CCCHHHHHHHhcCCCCccccc
Q 011851 353 GERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKA--RPRMSEVVEALKPLPYLKDMA 413 (476)
Q Consensus 353 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~--RPt~~ell~~L~~~~~~~~~~ 413 (476)
.....+ . +...+ ...++++.+|+.+||..++++ |++++++++| +||+...
T Consensus 222 ~~~~~~-~-~p~~~-----~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h----~~f~~~~ 273 (331)
T cd05624 222 NHEERF-Q-FPSHI-----TDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH----AFFEGID 273 (331)
T ss_pred cCCCcc-c-CCCcc-----ccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC----CCcCCCC
Confidence 000000 0 00111 122578999999999876554 4678887776 9998754
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-43 Score=342.26 Aligned_cols=261 Identities=29% Similarity=0.475 Sum_probs=209.8
Q ss_pred cCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCcc-CHHHHHHHHHHHhCCCCCceeeEEEEEEeC
Q 011851 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQ-GHKEWLAEVNYLGGLIHPNLVKLIGCCIED 199 (476)
Q Consensus 121 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~ 199 (476)
++|++.+.||+|+||.||+|.+..... ..+...||+|.+...... ...++.+|+.++.+++||||+++++++...
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~----~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~ 80 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNE----RLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKE 80 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCC----CcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCC
Confidence 368899999999999999998764321 234567999998754332 235688999999999999999999999999
Q ss_pred CeeEEEEEecCCCCHHHHHhhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeee
Q 011851 200 DQRLLVYEFMPRGSLENHLFRRS---------------LPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILL 264 (476)
Q Consensus 200 ~~~~lV~E~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl 264 (476)
+..|++|||+++++|.+++.... ..+++..++.++.||+.||.|||+.+ |+||||||+|||+
T Consensus 81 ~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~ 157 (283)
T cd05048 81 QPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLV 157 (283)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEE
Confidence 99999999999999999996531 45788999999999999999999988 9999999999999
Q ss_pred cCCCceEEeecCCcCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHh-CCCCCCCCCCCCcch
Q 011851 265 DGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHN 343 (476)
Q Consensus 265 ~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~ellt-G~~pf~~~~~~~~~~ 343 (476)
+.++.++|+|||+++...............+++.|+|||++.+..++.++|||||||++|||++ |..||.......
T Consensus 158 ~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~--- 234 (283)
T cd05048 158 GEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQE--- 234 (283)
T ss_pred cCCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHH---
Confidence 9999999999999986544333223334567889999999998899999999999999999998 999997654321
Q ss_pred hHHhhhhhhccccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 011851 344 LVEWARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKP 405 (476)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~ 405 (476)
+...... . .....+...+.++.+|+.+||+.||++||++.+|+++|+.
T Consensus 235 ~~~~i~~----~----------~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 235 VIEMIRS----R----------QLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred HHHHHHc----C----------CcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 1111100 0 0001122336789999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-43 Score=350.16 Aligned_cols=257 Identities=25% Similarity=0.378 Sum_probs=202.7
Q ss_pred ccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCcc---CHHHHHHHHHHHhCC-CCCceeeEEEEEEeCCee
Q 011851 127 CLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQ---GHKEWLAEVNYLGGL-IHPNLVKLIGCCIEDDQR 202 (476)
Q Consensus 127 ~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~---~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~ 202 (476)
++||+|+||.||+|.+. .+++.||+|++...... ..+.+..|+.++.++ +||||+.+++++.+.+.+
T Consensus 1 ~~lG~G~~g~V~~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~ 71 (327)
T cd05617 1 RVIGRGSYAKVLLVRLK---------KNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRL 71 (327)
T ss_pred CeeeeCCCeEEEEEEEC---------CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEE
Confidence 46999999999998765 46778999999864322 234577899999888 699999999999999999
Q ss_pred EEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCcCCCC
Q 011851 203 LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGP 282 (476)
Q Consensus 203 ~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~ 282 (476)
||||||+++++|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 72 ~lv~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~ 147 (327)
T cd05617 72 FLVIEYVNGGDLMFHMQRQ-RKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGL 147 (327)
T ss_pred EEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceecc
Confidence 9999999999999888543 46999999999999999999999988 9999999999999999999999999987532
Q ss_pred CCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhcccccccccc
Q 011851 283 EGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRRFYRLI 362 (476)
Q Consensus 283 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 362 (476)
.... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||......................
T Consensus 148 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~------- 218 (327)
T cd05617 148 GPGD--TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEK------- 218 (327)
T ss_pred CCCC--ceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhC-------
Confidence 2111 2234689999999999999999999999999999999999999997543332222111111111100
Q ss_pred CcccCCCCChHHHHHHHHHHHHhcccCCCCCCCH------HHHHHHhcCCCCccccc
Q 011851 363 DPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRM------SEVVEALKPLPYLKDMA 413 (476)
Q Consensus 363 d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~------~ell~~L~~~~~~~~~~ 413 (476)
.. .++...+..+.+++.+||+.||++|+++ .++++| |||+.+.
T Consensus 219 --~~--~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h----~~f~~~~ 267 (327)
T cd05617 219 --PI--RIPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSH----TFFRSID 267 (327)
T ss_pred --CC--CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcC----CCCCCCC
Confidence 00 0112235678899999999999999985 466655 9998764
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-43 Score=348.66 Aligned_cols=263 Identities=20% Similarity=0.266 Sum_probs=205.7
Q ss_pred cCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCc---cCHHHHHHHHHHHhCCCCCceeeEEEEEE
Q 011851 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL---QGHKEWLAEVNYLGGLIHPNLVKLIGCCI 197 (476)
Q Consensus 121 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~l~~~~~ 197 (476)
++|++.++||+|+||.||++.+. .+++.||+|++.+... .....+..|+.++..++|+||+++++++.
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~ 71 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLK---------NADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQ 71 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEEC---------CCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEe
Confidence 36899999999999999998764 4677899999864321 12334778999999999999999999999
Q ss_pred eCCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCC
Q 011851 198 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGL 277 (476)
Q Consensus 198 ~~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~ 277 (476)
+.+.+||||||+++|+|.+++.+....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 72 ~~~~~~lv~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~ 148 (332)
T cd05623 72 DENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGS 148 (332)
T ss_pred cCCEEEEEEeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecch
Confidence 999999999999999999999775667999999999999999999999988 99999999999999999999999999
Q ss_pred cCCCCCCCccceeeeeecCCCCCCcchhh-----cCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhh
Q 011851 278 AKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQL 352 (476)
Q Consensus 278 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~ 352 (476)
+........ ......+||+.|+|||++. ...++.++|||||||++|||++|+.||...........+ .
T Consensus 149 a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i------~ 221 (332)
T cd05623 149 CLKLMEDGT-VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI------M 221 (332)
T ss_pred heecccCCc-ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHH------h
Confidence 876433221 1223357999999999986 346889999999999999999999999754321111110 0
Q ss_pred ccccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCC--CCCHHHHHHHhcCCCCccccc
Q 011851 353 GERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKA--RPRMSEVVEALKPLPYLKDMA 413 (476)
Q Consensus 353 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~--RPt~~ell~~L~~~~~~~~~~ 413 (476)
.....+ . +.. .....+.++.+|+.+||..++++ |+++.++++| |||.+..
T Consensus 222 ~~~~~~-~-~p~-----~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h----~~f~~~~ 273 (332)
T cd05623 222 NHKERF-Q-FPA-----QVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH----PFFTGID 273 (332)
T ss_pred CCCccc-c-CCC-----ccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC----CCcCCCC
Confidence 000000 0 000 01123678899999999765554 6899999887 9998764
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=367.29 Aligned_cols=269 Identities=23% Similarity=0.371 Sum_probs=201.0
Q ss_pred ccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCCCCCceeeEEEEEEeC
Q 011851 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHPNLVKLIGCCIED 199 (476)
Q Consensus 120 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~ 199 (476)
..+|++.++||+|+||.||+|.+. .+++.||||.+.... ....+|+.+|+.++||||+++++++...
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~---------~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~ 131 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICI---------DTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTE 131 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEEC---------CCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeec
Confidence 457999999999999999998654 467889999886432 2345799999999999999999987532
Q ss_pred --------CeeEEEEEecCCCCHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCC
Q 011851 200 --------DQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEY 268 (476)
Q Consensus 200 --------~~~~lV~E~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~ 268 (476)
..+++||||+++ +|.+++.. ....+++..++.++.||+.||.|||+.+ |+||||||+||||+.++
T Consensus 132 ~~~~~~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~ 207 (440)
T PTZ00036 132 CFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNT 207 (440)
T ss_pred ccccCCCceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCC
Confidence 246799999965 77776642 4567999999999999999999999988 99999999999998665
Q ss_pred -ceEEeecCCcCCCCCCCccceeeeeecCCCCCCcchhhcC-CCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcch-hH
Q 011851 269 -NAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHN-LV 345 (476)
Q Consensus 269 -~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~-~~ 345 (476)
.+||+|||+++....... .....||+.|+|||++.+. .|+.++|||||||++|||++|.+||.+........ ++
T Consensus 208 ~~vkL~DFGla~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~ 284 (440)
T PTZ00036 208 HTLKLCDFGSAKNLLAGQR---SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRII 284 (440)
T ss_pred CceeeeccccchhccCCCC---cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence 699999999987543322 2235789999999998764 69999999999999999999999997654322111 11
Q ss_pred Hhhh-hhhcc---------ccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCcccc
Q 011851 346 EWAR-PQLGE---------RRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDM 412 (476)
Q Consensus 346 ~~~~-~~~~~---------~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~~ 412 (476)
.... +.... ...+.......+...++...+.++.+||.+||+.||.+|||+.++++| |||+..
T Consensus 285 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h----p~f~~~ 357 (440)
T PTZ00036 285 QVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD----PFFDDL 357 (440)
T ss_pred HHhCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC----hhHHhh
Confidence 1000 00000 000000000111111222335789999999999999999999999998 888654
|
|
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-43 Score=343.05 Aligned_cols=258 Identities=29% Similarity=0.416 Sum_probs=207.8
Q ss_pred CCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCcc---CHHHHHHHHHHHhCCCCCceeeEEEEEEe
Q 011851 122 SFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQ---GHKEWLAEVNYLGGLIHPNLVKLIGCCIE 198 (476)
Q Consensus 122 ~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~---~~~~~~~E~~~l~~l~hpnIv~l~~~~~~ 198 (476)
+|++.++||+|+||.||++.+. .+++.||+|++...... ....+.+|+.+++.++||||+++++++..
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 71 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVR---------ATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYET 71 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEc---------CCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecC
Confidence 4888999999999999998654 46788999999754322 22456789999999999999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCC
Q 011851 199 DDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGL 277 (476)
Q Consensus 199 ~~~~~lV~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~ 277 (476)
++.+|+||||+++++|.+++... ...+++..+..++.|++.||.|||+.+ |+||||||+||++++++.++|+|||+
T Consensus 72 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~ 148 (285)
T cd05605 72 KDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGL 148 (285)
T ss_pred CCeEEEEEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCC
Confidence 99999999999999999888654 346899999999999999999999988 99999999999999999999999999
Q ss_pred cCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhccccc
Q 011851 278 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRR 357 (476)
Q Consensus 278 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 357 (476)
+........ ....+|++.|+|||++.+..++.++|||||||++|||++|..||...........+. ..+..
T Consensus 149 ~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~---~~~~~--- 219 (285)
T cd05605 149 AVEIPEGET---IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVE---RRVKE--- 219 (285)
T ss_pred ceecCCCCc---cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHH---HHhhh---
Confidence 976533221 223579999999999998899999999999999999999999997643321111110 00000
Q ss_pred cccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHhcCCCCcccc
Q 011851 358 FYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARP-----RMSEVVEALKPLPYLKDM 412 (476)
Q Consensus 358 ~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RP-----t~~ell~~L~~~~~~~~~ 412 (476)
....++...+..+.+|+.+||+.||++|| ++.++++| +||...
T Consensus 220 --------~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~----~~~~~~ 267 (285)
T cd05605 220 --------DQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH----PFFRTA 267 (285)
T ss_pred --------cccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC----cCccCC
Confidence 00111223367889999999999999999 78888877 998764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-43 Score=351.04 Aligned_cols=263 Identities=21% Similarity=0.277 Sum_probs=205.6
Q ss_pred cCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCc---cCHHHHHHHHHHHhCCCCCceeeEEEEEE
Q 011851 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL---QGHKEWLAEVNYLGGLIHPNLVKLIGCCI 197 (476)
Q Consensus 121 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~l~~~~~ 197 (476)
++|++.+.||+|+||.||++.+. .+++.||+|++.+... ...+.+.+|+.++..++|+||+++++++.
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~ 71 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMK---------NTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQ 71 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEEC---------CCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEe
Confidence 46999999999999999998654 4677899999975321 22345788999999999999999999999
Q ss_pred eCCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCC
Q 011851 198 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGL 277 (476)
Q Consensus 198 ~~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~ 277 (476)
+++++|+||||+++++|.+++.+....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 72 ~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~ 148 (331)
T cd05597 72 DENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGS 148 (331)
T ss_pred cCCeEEEEEecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCc
Confidence 999999999999999999999765667999999999999999999999988 99999999999999999999999999
Q ss_pred cCCCCCCCccceeeeeecCCCCCCcchhhc-----CCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhh
Q 011851 278 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-----GHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQL 352 (476)
Q Consensus 278 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~ 352 (476)
+........ ......+||+.|+|||++.. ..++.++|||||||++|||++|+.||.......... ...
T Consensus 149 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~------~i~ 221 (331)
T cd05597 149 CLRLLADGT-VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYG------KIM 221 (331)
T ss_pred eeecCCCCC-ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHH------HHH
Confidence 876543222 11223579999999999873 457889999999999999999999997543211110 000
Q ss_pred ccccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCC--CCCHHHHHHHhcCCCCccccc
Q 011851 353 GERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKA--RPRMSEVVEALKPLPYLKDMA 413 (476)
Q Consensus 353 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~--RPt~~ell~~L~~~~~~~~~~ 413 (476)
..... ..+ .+. ....+..+.+||.+||..++++ |+++.++++| |||.+..
T Consensus 222 ~~~~~-~~~-~~~-----~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h----p~~~~~~ 273 (331)
T cd05597 222 NHKEH-FQF-PPD-----VTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH----PFFEGID 273 (331)
T ss_pred cCCCc-ccC-CCc-----cCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC----CCCCCCC
Confidence 00000 000 000 0113678899999988664443 7899999988 9998754
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=352.17 Aligned_cols=253 Identities=26% Similarity=0.346 Sum_probs=200.9
Q ss_pred ccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCc---cCHHHHHHHHH-HHhCCCCCceeeEEEEEEeCCee
Q 011851 127 CLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL---QGHKEWLAEVN-YLGGLIHPNLVKLIGCCIEDDQR 202 (476)
Q Consensus 127 ~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~---~~~~~~~~E~~-~l~~l~hpnIv~l~~~~~~~~~~ 202 (476)
+.||+|+||+||+|++. .+++.||+|++..... .....+..|.. +++.++||||+++++++.+.+.+
T Consensus 1 ~~lg~G~fg~V~~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~ 71 (325)
T cd05602 1 KVIGKGSFGKVLLARHK---------AEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKL 71 (325)
T ss_pred CeeeeCCCeEEEEEEEC---------CCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeE
Confidence 46999999999998764 4677899999975422 12234444444 56889999999999999999999
Q ss_pred EEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCcCCCC
Q 011851 203 LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGP 282 (476)
Q Consensus 203 ~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~ 282 (476)
|+||||+++++|.+++.. ...+.+..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 72 ~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~ 147 (325)
T cd05602 72 YFVLDYINGGELFYHLQR-ERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENI 147 (325)
T ss_pred EEEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccc
Confidence 999999999999998855 456888999999999999999999988 9999999999999999999999999997543
Q ss_pred CCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhcccccccccc
Q 011851 283 EGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRRFYRLI 362 (476)
Q Consensus 283 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 362 (476)
.... .....+||+.|+|||++.+..++.++|||||||++|||++|..||........ .... ...
T Consensus 148 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~---~~~i---~~~-------- 211 (325)
T cd05602 148 EHNG--TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEM---YDNI---LNK-------- 211 (325)
T ss_pred cCCC--CcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHH---HHHH---HhC--------
Confidence 2221 23346799999999999999999999999999999999999999975432211 1110 000
Q ss_pred CcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCcccc
Q 011851 363 DPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDM 412 (476)
Q Consensus 363 d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~~ 412 (476)
.+ .+....+..+.++|.+||+.||.+|+++.+.+..+..++|+...
T Consensus 212 --~~--~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~~~~~~~~ 257 (325)
T cd05602 212 --PL--QLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFFSPI 257 (325)
T ss_pred --Cc--CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCHHHHhcCcccCCC
Confidence 00 01122367889999999999999999998777777778998654
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-44 Score=371.59 Aligned_cols=260 Identities=30% Similarity=0.475 Sum_probs=218.3
Q ss_pred CCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCcc-CHHHHHHHHHHHhCCCCCceeeEEEEEEeCC
Q 011851 122 SFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQ-GHKEWLAEVNYLGGLIHPNLVKLIGCCIEDD 200 (476)
Q Consensus 122 ~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 200 (476)
+.+..+.||+|+||+||+|+...-. -.+..+.||||.++..... ..++|.+|+++|..|+|||||+|+|+|.+++
T Consensus 487 ~i~~~~eLGegaFGkVf~a~~~~l~----p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~ 562 (774)
T KOG1026|consen 487 DIVFKEELGEGAFGKVFLAEAYGLL----PGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGD 562 (774)
T ss_pred heeehhhhcCchhhhhhhhhccCCC----CCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCC
Confidence 4556788999999999999865322 1134567999999877665 5778999999999999999999999999999
Q ss_pred eeEEEEEecCCCCHHHHHhhc---------C----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCC
Q 011851 201 QRLLVYEFMPRGSLENHLFRR---------S----LPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGE 267 (476)
Q Consensus 201 ~~~lV~E~~~~g~L~~~l~~~---------~----~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~ 267 (476)
.+|||+|||..|+|.++|... + .+++..+.+.|+.||+.|++||-++. +|||||...|+||.++
T Consensus 563 P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge~ 639 (774)
T KOG1026|consen 563 PLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGEN 639 (774)
T ss_pred eeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceeccc
Confidence 999999999999999999632 2 23889999999999999999999988 9999999999999999
Q ss_pred CceEEeecCCcCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHh-CCCCCCCCCCCCcchhHH
Q 011851 268 YNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVE 346 (476)
Q Consensus 268 ~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~ellt-G~~pf~~~~~~~~~~~~~ 346 (476)
..|||+|||+++..-..+++....+-.-...||+||.|+.+.|+.++|||||||+|||+++ |+.||.+....+....+.
T Consensus 640 l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~ 719 (774)
T KOG1026|consen 640 LVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIR 719 (774)
T ss_pred eEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHHHH
Confidence 9999999999998877776665544445678999999999999999999999999999998 888998766544433332
Q ss_pred hhhhhhccccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 011851 347 WARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKP 405 (476)
Q Consensus 347 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~ 405 (476)
.. . +-++.+++ +.+++.|+..||+.+|++||+++||-..|+.
T Consensus 720 ~g-----------~-lL~~Pe~C-----P~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~ 761 (774)
T KOG1026|consen 720 AG-----------Q-LLSCPENC-----PTEVYSLMLECWNENPKRRPSFKEIHSRLQA 761 (774)
T ss_pred cC-----------C-cccCCCCC-----CHHHHHHHHHHhhcCcccCCCHHHHHHHHHH
Confidence 11 1 13444444 7899999999999999999999999988763
|
|
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-43 Score=360.34 Aligned_cols=267 Identities=24% Similarity=0.275 Sum_probs=204.4
Q ss_pred ccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCCCCCceeeEEEEEEeC
Q 011851 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHPNLVKLIGCCIED 199 (476)
Q Consensus 120 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~ 199 (476)
...|.+.+.||+|+||.||+|.+. .+++.||||.... ..+.+|+++|++|+|+|||++++++..+
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~---------~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~ 232 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHP---------DYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVG 232 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEEC---------CCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEEC
Confidence 447999999999999999998654 4677899996432 3456899999999999999999999999
Q ss_pred CeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCcC
Q 011851 200 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAK 279 (476)
Q Consensus 200 ~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~ 279 (476)
+..+||||++ .++|.+++......+++..++.|+.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++
T Consensus 233 ~~~~lv~e~~-~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~ 308 (461)
T PHA03211 233 GLTCLVLPKY-RSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAAC 308 (461)
T ss_pred CEEEEEEEcc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCce
Confidence 9999999999 56899988766667999999999999999999999988 9999999999999999999999999998
Q ss_pred CCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCc-----chhHHhhhhhhcc
Q 011851 280 DGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGE-----HNLVEWARPQLGE 354 (476)
Q Consensus 280 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~-----~~~~~~~~~~~~~ 354 (476)
...............||+.|+|||++.+..++.++|||||||+||||++|..++........ ..+..........
T Consensus 309 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~ 388 (461)
T PHA03211 309 FARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVH 388 (461)
T ss_pred ecccccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccc
Confidence 65433222223346799999999999999999999999999999999999876543221110 1111111100000
Q ss_pred ccccccc---------------------cCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCccc
Q 011851 355 RRRFYRL---------------------IDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKD 411 (476)
Q Consensus 355 ~~~~~~~---------------------~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~ 411 (476)
...+... ..+.+... ...+..+.+||.+||+.||.+|||+.|+|+| |||+.
T Consensus 389 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~dli~~mL~~DP~~RPsa~elL~h----p~f~~ 460 (461)
T PHA03211 389 VDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRY--YKLDLDVEYLVCRALTFDGARRPSAAELLRL----PLFQS 460 (461)
T ss_pred cccCCCCcchHHHHHHHhhhhcccCCccCCcchhhh--ccccchHHHHHHHHcccChhhCcCHHHHhhC----cccCC
Confidence 0000000 00000000 0124578899999999999999999999998 99864
|
|
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=351.12 Aligned_cols=254 Identities=28% Similarity=0.367 Sum_probs=198.6
Q ss_pred ccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCc---cCHHHHHHHHH-HHhCCCCCceeeEEEEEEeCCee
Q 011851 127 CLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL---QGHKEWLAEVN-YLGGLIHPNLVKLIGCCIEDDQR 202 (476)
Q Consensus 127 ~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~---~~~~~~~~E~~-~l~~l~hpnIv~l~~~~~~~~~~ 202 (476)
++||+|+||.||+|++. .+++.||+|++.+... .....+..|.. +++.++||||+++++++.+.+..
T Consensus 1 ~~lg~G~~g~Vy~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~ 71 (321)
T cd05603 1 KVIGKGSFGKVLLAKRK---------SDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKL 71 (321)
T ss_pred CeeeeCCCEEEEEEEEC---------CCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEE
Confidence 46999999999998764 4677899999975432 12334555554 67889999999999999999999
Q ss_pred EEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCcCCCC
Q 011851 203 LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGP 282 (476)
Q Consensus 203 ~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~ 282 (476)
|+||||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++...
T Consensus 72 ~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~ 147 (321)
T cd05603 72 YFVLDYVNGGELFFHLQR-ERCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGV 147 (321)
T ss_pred EEEEcCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCC
Confidence 999999999999988854 456889999999999999999999988 9999999999999999999999999987532
Q ss_pred CCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhcccccccccc
Q 011851 283 EGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRRFYRLI 362 (476)
Q Consensus 283 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 362 (476)
.... .....+||+.|+|||++.+..++.++|||||||++|||++|..||....... ... ......
T Consensus 148 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~~~---~i~~~~------- 212 (321)
T cd05603 148 EPEE--TTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQ---MYD---NILHKP------- 212 (321)
T ss_pred CCCC--ccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHH---HHH---HHhcCC-------
Confidence 2221 2334679999999999999899999999999999999999999997543211 111 000000
Q ss_pred CcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCccccc
Q 011851 363 DPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDMA 413 (476)
Q Consensus 363 d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~~~ 413 (476)
+ .++...+..+.+++.+||+.||.+||++..-+..+..++|+....
T Consensus 213 ---~--~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~~~~~~~~ 258 (321)
T cd05603 213 ---L--QLPGGKTVAACDLLVGLLHKDQRRRLGAKADFLEIKNHVFFSPIN 258 (321)
T ss_pred ---C--CCCCCCCHHHHHHHHHHccCCHhhcCCCCCCHHHHhCCCCcCCCC
Confidence 0 011223567899999999999999998753344455568887643
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-43 Score=350.66 Aligned_cols=259 Identities=24% Similarity=0.373 Sum_probs=204.8
Q ss_pred CCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCc---cCHHHHHHHHHHHhCCC-CCceeeEEEEEE
Q 011851 122 SFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL---QGHKEWLAEVNYLGGLI-HPNLVKLIGCCI 197 (476)
Q Consensus 122 ~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~---~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~ 197 (476)
+|+..+.||+|+||.||+|.+. .+|+.||||++..... ...+.+..|+.++..+. |++|+++++++.
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~ 71 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERK---------GTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQ 71 (323)
T ss_pred CceEEEEEEecCCeEEEEEEEC---------CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEe
Confidence 4778899999999999998654 4678899999975422 22345778889988885 577889999999
Q ss_pred eCCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCC
Q 011851 198 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGL 277 (476)
Q Consensus 198 ~~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~ 277 (476)
+.+.+||||||+++|+|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 72 ~~~~~~lv~Ey~~~g~L~~~i~~-~~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~ 147 (323)
T cd05615 72 TVDRLYFVMEYVNGGDLMYHIQQ-VGKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGM 147 (323)
T ss_pred cCCEEEEEEcCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEecccc
Confidence 99999999999999999998854 356999999999999999999999988 99999999999999999999999999
Q ss_pred cCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhccccc
Q 011851 278 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRR 357 (476)
Q Consensus 278 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 357 (476)
++....... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||....... ..... .....
T Consensus 148 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~---~~~~i---~~~~~- 218 (323)
T cd05615 148 CKEHMVDGV--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDE---LFQSI---MEHNV- 218 (323)
T ss_pred ccccCCCCc--cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHH---HHHHH---HhCCC-
Confidence 875432211 1233679999999999999999999999999999999999999997653211 11110 00000
Q ss_pred cccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHH-HHHHHhcCCCCccccc
Q 011851 358 FYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMS-EVVEALKPLPYLKDMA 413 (476)
Q Consensus 358 ~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~-ell~~L~~~~~~~~~~ 413 (476)
.++...+.++.+++.+||+.||.+|++.. +..+.+..+|||+...
T Consensus 219 -----------~~p~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~~ 264 (323)
T cd05615 219 -----------SYPKSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREHAFFRRID 264 (323)
T ss_pred -----------CCCccCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcCcccCCCC
Confidence 01122356789999999999999999853 2344456669998754
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-43 Score=346.75 Aligned_cols=274 Identities=23% Similarity=0.338 Sum_probs=208.9
Q ss_pred cCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCcc-CHHHHHHHHHHHhCCCCCceeeEEEEEEeC
Q 011851 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQ-GHKEWLAEVNYLGGLIHPNLVKLIGCCIED 199 (476)
Q Consensus 121 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~ 199 (476)
++|.+.+.||+|+||.||+|++. .+++.||+|.++..... ....+.+|+.++++++||||+++++++..+
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 76 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSK---------LTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTD 76 (309)
T ss_pred CceEEEEEecccCCEEEEEEEec---------CCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeC
Confidence 46999999999999999998654 46778999998754332 234577899999999999999999999999
Q ss_pred CeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCcC
Q 011851 200 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAK 279 (476)
Q Consensus 200 ~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~ 279 (476)
+..|+||||+++ +|.+++......+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 77 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~ 152 (309)
T cd07872 77 KSLTLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLAR 152 (309)
T ss_pred CeEEEEEeCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccce
Confidence 999999999965 898888776667899999999999999999999988 9999999999999999999999999997
Q ss_pred CCCCCCccceeeeeecCCCCCCcchhhc-CCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhh--------h
Q 011851 280 DGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR--------P 350 (476)
Q Consensus 280 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~--------~ 350 (476)
....... ......+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||...........+.... +
T Consensus 153 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (309)
T cd07872 153 AKSVPTK--TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWP 230 (309)
T ss_pred ecCCCcc--ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Confidence 6433221 1223568999999998875 468999999999999999999999997654432222111100 0
Q ss_pred hhccccccccccCcccC--CC--CChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCccccc
Q 011851 351 QLGERRRFYRLIDPCLE--GC--FSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDMA 413 (476)
Q Consensus 351 ~~~~~~~~~~~~d~~l~--~~--~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~~~ 413 (476)
.+.....+...-.+... .. .....+.++.+||.+||+.||.+|||+.|+++| |||+...
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h----~~~~~~~ 293 (309)
T cd07872 231 GISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKH----AYFRSLG 293 (309)
T ss_pred hhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcC----hhhhhcc
Confidence 00000000000000000 00 001235678899999999999999999999997 9988654
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-43 Score=369.48 Aligned_cols=257 Identities=26% Similarity=0.329 Sum_probs=206.2
Q ss_pred HHhccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCcc--CHHHHHHHHHHHhCCCCCceeeEEE
Q 011851 117 KSATKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQ--GHKEWLAEVNYLGGLIHPNLVKLIG 194 (476)
Q Consensus 117 ~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~l~~ 194 (476)
....++|++.+.||+|+||+||+|++. .+|+.||||++...... ....+.+|+.+|..++|+||+++++
T Consensus 28 ~~~~~rY~i~~~LG~G~fG~Vy~a~~~---------~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~ 98 (496)
T PTZ00283 28 KEQAKKYWISRVLGSGATGTVLCAKRV---------SDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHE 98 (496)
T ss_pred cccCCCEEEEEEEecCCCEEEEEEEEc---------CCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeec
Confidence 344578999999999999999998654 46788999999765432 2346788999999999999999988
Q ss_pred EEEeCC--------eeEEEEEecCCCCHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCee
Q 011851 195 CCIEDD--------QRLLVYEFMPRGSLENHLFRR---SLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNIL 263 (476)
Q Consensus 195 ~~~~~~--------~~~lV~E~~~~g~L~~~l~~~---~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NIL 263 (476)
.+...+ .+++||||+++|+|.+++... ...+++..+..++.|++.||.|||+.+ |+||||||+|||
T Consensus 99 ~~~~~~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NIL 175 (496)
T PTZ00283 99 DFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANIL 175 (496)
T ss_pred ceecccccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEE
Confidence 776432 368999999999999998642 456899999999999999999999988 999999999999
Q ss_pred ecCCCceEEeecCCcCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcch
Q 011851 264 LDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHN 343 (476)
Q Consensus 264 l~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~ 343 (476)
|+.++.+||+|||+++..............+||+.|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus 176 l~~~~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~--- 252 (496)
T PTZ00283 176 LCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEE--- 252 (496)
T ss_pred EeCCCCEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH---
Confidence 99999999999999986543222222344689999999999999999999999999999999999999997543211
Q ss_pred hHHhhhhhhccccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011851 344 LVEWARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEA 402 (476)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~ 402 (476)
+.. ..... ..++ ++...+.++.+|+.+||+.||++||++.+++++
T Consensus 253 ~~~---~~~~~------~~~~-----~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 253 VMH---KTLAG------RYDP-----LPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred HHH---HHhcC------CCCC-----CCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 111 00000 0011 122336789999999999999999999999987
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-43 Score=338.73 Aligned_cols=260 Identities=29% Similarity=0.438 Sum_probs=207.7
Q ss_pred cCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCcc-CHHHHHHHHHHHhCCCCCceeeEEEEEEeC
Q 011851 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQ-GHKEWLAEVNYLGGLIHPNLVKLIGCCIED 199 (476)
Q Consensus 121 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~ 199 (476)
.+|.+.+.||+|+||.||+|.+... ....+++.||||.+...... ..+.+.+|+++|+.++|+||+++++++...
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~----~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 80 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHL----EPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEG 80 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccc----cCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecC
Confidence 4588899999999999999976432 11235678999999765443 346788999999999999999999999999
Q ss_pred CeeEEEEEecCCCCHHHHHhhcC-------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecC
Q 011851 200 DQRLLVYEFMPRGSLENHLFRRS-------------LPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDG 266 (476)
Q Consensus 200 ~~~~lV~E~~~~g~L~~~l~~~~-------------~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~ 266 (476)
...++||||+++++|.+++.... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.
T Consensus 81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~ 157 (280)
T cd05049 81 DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGY 157 (280)
T ss_pred CCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcC
Confidence 99999999999999999996432 34788899999999999999999988 999999999999999
Q ss_pred CCceEEeecCCcCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHh-CCCCCCCCCCCCcchhH
Q 011851 267 EYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLV 345 (476)
Q Consensus 267 ~~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~ellt-G~~pf~~~~~~~~~~~~ 345 (476)
++.+||+|||+++...............+++.|+|||++.+..++.++|||||||++|||++ |..||....... ..
T Consensus 158 ~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~---~~ 234 (280)
T cd05049 158 DLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE---VI 234 (280)
T ss_pred CCeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHH---HH
Confidence 99999999999976433222222223456788999999999999999999999999999998 999987543321 11
Q ss_pred HhhhhhhccccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 011851 346 EWARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALK 404 (476)
Q Consensus 346 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~ 404 (476)
..... ... . ..+...+..+.+++.+||+.||++||++.|+++.|+
T Consensus 235 ~~~~~-----~~~----~-----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 235 ECITQ-----GRL----L-----QRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred HHHHc-----CCc----C-----CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 11110 000 0 011123578899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-43 Score=355.61 Aligned_cols=263 Identities=22% Similarity=0.356 Sum_probs=206.4
Q ss_pred ccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCcc-CHHHHHHHHHHHhCCC-CCceeeEEEEEE
Q 011851 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQ-GHKEWLAEVNYLGGLI-HPNLVKLIGCCI 197 (476)
Q Consensus 120 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~-~~~~~~~E~~~l~~l~-hpnIv~l~~~~~ 197 (476)
.++|++.++||+|+||.||+|.+.... ...++..||||++...... ..+.+.+|+++|+++. ||||+++++++.
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~----~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~ 111 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLS----RSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACT 111 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccC----CCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEc
Confidence 457899999999999999999864221 2234567999999754332 2356889999999996 999999999999
Q ss_pred eCCeeEEEEEecCCCCHHHHHhhcC-------------------------------------------------------
Q 011851 198 EDDQRLLVYEFMPRGSLENHLFRRS------------------------------------------------------- 222 (476)
Q Consensus 198 ~~~~~~lV~E~~~~g~L~~~l~~~~------------------------------------------------------- 222 (476)
+.+.+|||||||++|+|.++|.+..
T Consensus 112 ~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (400)
T cd05105 112 KSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPM 191 (400)
T ss_pred cCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchh
Confidence 9999999999999999999885421
Q ss_pred ----------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCe
Q 011851 223 ----------------------------------------LPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNI 262 (476)
Q Consensus 223 ----------------------------------------~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NI 262 (476)
..+++..+..++.||+.||.|||+.+ |+||||||+||
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Ni 268 (400)
T cd05105 192 LEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNV 268 (400)
T ss_pred hhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhE
Confidence 24778888999999999999999988 99999999999
Q ss_pred eecCCCceEEeecCCcCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHh-CCCCCCCCCCCCc
Q 011851 263 LLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLT-GRRSMDKNRPNGE 341 (476)
Q Consensus 263 Ll~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~ellt-G~~pf~~~~~~~~ 341 (476)
|++.++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||........
T Consensus 269 ll~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~ 348 (400)
T cd05105 269 LLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDST 348 (400)
T ss_pred EEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHH
Confidence 999999999999999986543222222223457788999999999999999999999999999997 9999875422111
Q ss_pred chhHHhhhhhhccccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 011851 342 HNLVEWARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKP 405 (476)
Q Consensus 342 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~ 405 (476)
.... +...... ..+...+.++.+++.+||+.||++||++.+|.+.|+.
T Consensus 349 --~~~~----~~~~~~~----------~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~ 396 (400)
T cd05105 349 --FYNK----IKSGYRM----------AKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVES 396 (400)
T ss_pred --HHHH----HhcCCCC----------CCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHH
Confidence 1100 0000000 0112235788999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-43 Score=338.49 Aligned_cols=262 Identities=26% Similarity=0.420 Sum_probs=205.7
Q ss_pred hccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCc-cCHHHHHHHHHHHhCCCCCceeeEEEEEE
Q 011851 119 ATKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL-QGHKEWLAEVNYLGGLIHPNLVKLIGCCI 197 (476)
Q Consensus 119 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~ 197 (476)
..++|++.+.||+|+||.||+|.+... ....++..||+|.+..... ....++.+|+.+++.++||||+++++++.
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~----~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~ 79 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGV----VKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS 79 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccC----CCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEc
Confidence 356799999999999999999986532 2234567899999865332 23456889999999999999999999999
Q ss_pred eCCeeEEEEEecCCCCHHHHHhhcC---------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCC
Q 011851 198 EDDQRLLVYEFMPRGSLENHLFRRS---------LPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEY 268 (476)
Q Consensus 198 ~~~~~~lV~E~~~~g~L~~~l~~~~---------~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~ 268 (476)
+....++||||+++++|.+++.... ..+++..+..++.|++.||.|||+.+ ++||||||+|||++.++
T Consensus 80 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~ 156 (277)
T cd05062 80 QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDF 156 (277)
T ss_pred CCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCC
Confidence 9999999999999999999986422 23577889999999999999999988 99999999999999999
Q ss_pred ceEEeecCCcCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHh-CCCCCCCCCCCCcchhHHh
Q 011851 269 NAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEW 347 (476)
Q Consensus 269 ~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~ellt-G~~pf~~~~~~~~~~~~~~ 347 (476)
.++|+|||+++...............+++.|+|||++.+..++.++|||||||++|||++ |..||....... ....
T Consensus 157 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~---~~~~ 233 (277)
T cd05062 157 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQ---VLRF 233 (277)
T ss_pred CEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHH
Confidence 999999999976543222211222345778999999999999999999999999999999 788886543221 1111
Q ss_pred hhhhhccccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 011851 348 ARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALK 404 (476)
Q Consensus 348 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~ 404 (476)
.. .. .+.. .+...+..+.+++.+||+.||++|||+.+++++|+
T Consensus 234 ~~----~~-~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 234 VM----EG-GLLD---------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred HH----cC-CcCC---------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 00 00 0000 11122567899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-43 Score=346.18 Aligned_cols=260 Identities=26% Similarity=0.426 Sum_probs=204.7
Q ss_pred cCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCc-cCHHHHHHHHHHHhCCCCCceeeEEEEEEeC
Q 011851 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL-QGHKEWLAEVNYLGGLIHPNLVKLIGCCIED 199 (476)
Q Consensus 121 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~ 199 (476)
.+|++.+.||+|+||.||+|.+..++. .....||+|+++.... ...+++.+|+.+++.++||||+++++++...
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~ 81 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGE-----KVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS 81 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCC-----ccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC
Confidence 469999999999999999998754322 1244599999875432 3345788999999999999999999998764
Q ss_pred CeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCcC
Q 011851 200 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAK 279 (476)
Q Consensus 200 ~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~ 279 (476)
..++|+||+++|+|.+++......+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 82 -~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~ 157 (316)
T cd05108 82 -TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAK 157 (316)
T ss_pred -CceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEccccccc
Confidence 578999999999999999776667899999999999999999999988 9999999999999999999999999998
Q ss_pred CCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhhcccccc
Q 011851 280 DGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPQLGERRRF 358 (476)
Q Consensus 280 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 358 (476)
...............++..|+|||++.+..++.++|||||||++|||++ |..||....... +..... ....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~---~~~~~~----~~~~- 229 (316)
T cd05108 158 LLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---ISSILE----KGER- 229 (316)
T ss_pred cccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH---HHHHHh----CCCC-
Confidence 7654332221222334678999999999999999999999999999998 999997543211 111100 0000
Q ss_pred ccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011851 359 YRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPL 406 (476)
Q Consensus 359 ~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~ 406 (476)
. + .+...+.++.+++.+||..||++||++.+++.+|..+
T Consensus 230 --~--~-----~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~ 268 (316)
T cd05108 230 --L--P-----QPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 268 (316)
T ss_pred --C--C-----CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 0 0 0111245788999999999999999999999986543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-43 Score=349.43 Aligned_cols=262 Identities=27% Similarity=0.399 Sum_probs=204.8
Q ss_pred cCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCc-cCHHHHHHHHHHHhCC-CCCceeeEEEEEEe
Q 011851 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL-QGHKEWLAEVNYLGGL-IHPNLVKLIGCCIE 198 (476)
Q Consensus 121 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~-~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~ 198 (476)
++|++.++||+|+||.||+|.+...+ +..+++.||+|+++.... ...+.+..|+.++.++ +|+||+++++++..
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~----~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~ 82 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIE----KSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTK 82 (337)
T ss_pred HHhhhhcccccCcCceEEeccccccc----cccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEec
Confidence 46999999999999999999754221 224678899999875432 2235678899999999 89999999998765
Q ss_pred -CCeeEEEEEecCCCCHHHHHhhcC-------------------------------------------------------
Q 011851 199 -DDQRLLVYEFMPRGSLENHLFRRS------------------------------------------------------- 222 (476)
Q Consensus 199 -~~~~~lV~E~~~~g~L~~~l~~~~------------------------------------------------------- 222 (476)
+..++++|||+++++|.+++....
T Consensus 83 ~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (337)
T cd05054 83 PGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEG 162 (337)
T ss_pred CCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhh
Confidence 457889999999999999885421
Q ss_pred -----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCcCCCCCCCccceeeeeecCC
Q 011851 223 -----LPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTY 297 (476)
Q Consensus 223 -----~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~ 297 (476)
..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.++|+|||++................++.
T Consensus 163 ~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~ 239 (337)
T cd05054 163 DELYKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPL 239 (337)
T ss_pred hHHhhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCc
Confidence 26889999999999999999999988 9999999999999999999999999998754333222222345677
Q ss_pred CCCCcchhhcCCCCccchhhhhHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhhccccccccccCcccCCCCChHHHH
Q 011851 298 GYAAPEYVMTGHLTAKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPQLGERRRFYRLIDPCLEGCFSIKGAE 376 (476)
Q Consensus 298 ~y~aPE~~~~~~~~~~~DiwslGv~l~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~ 376 (476)
.|+|||++.+..++.++|||||||++|||++ |..||........ +.. .+..... . ..+...+.
T Consensus 240 ~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~--~~~----~~~~~~~---~-------~~~~~~~~ 303 (337)
T cd05054 240 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE--FCR----RLKEGTR---M-------RAPEYATP 303 (337)
T ss_pred cccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHH--HHH----HHhccCC---C-------CCCccCCH
Confidence 8999999999999999999999999999998 9999975432211 111 1111000 0 00112256
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 011851 377 KTIQLAASCLNRDQKARPRMSEVVEALKP 405 (476)
Q Consensus 377 ~~~~li~~cL~~dP~~RPt~~ell~~L~~ 405 (476)
++.+++.+||+.+|++||++.+|+++|+.
T Consensus 304 ~~~~l~~~cl~~~p~~RPs~~ell~~l~~ 332 (337)
T cd05054 304 EIYSIMLDCWHNNPEDRPTFSELVEILGD 332 (337)
T ss_pred HHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 78999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=332.98 Aligned_cols=251 Identities=28% Similarity=0.453 Sum_probs=202.2
Q ss_pred cCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCCCCCceeeEEEEEEeCC
Q 011851 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHPNLVKLIGCCIEDD 200 (476)
Q Consensus 121 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 200 (476)
++|++.+.||+|+||.||++.+. .+..+|+|.+.... .....+.+|+.+|++++||||+++++++.+++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~----------~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 72 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWR----------AQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQK 72 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEec----------cCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCC
Confidence 35888899999999999998764 34569999886543 33467889999999999999999999999999
Q ss_pred eeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCcCC
Q 011851 201 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKD 280 (476)
Q Consensus 201 ~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~ 280 (476)
..++||||+++++|.+++......+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++.
T Consensus 73 ~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~ 149 (256)
T cd05114 73 PLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRY 149 (256)
T ss_pred CEEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccc
Confidence 999999999999999999765567899999999999999999999988 99999999999999999999999999986
Q ss_pred CCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhhccccccc
Q 011851 281 GPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPQLGERRRFY 359 (476)
Q Consensus 281 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 359 (476)
....... ......++..|+|||++.+..++.++||||||+++|||++ |+.||....... ....... ..
T Consensus 150 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~---~~~~i~~----~~--- 218 (256)
T cd05114 150 VLDDEYT-SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYE---VVEMISR----GF--- 218 (256)
T ss_pred cCCCcee-ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHH---HHHHHHC----CC---
Confidence 5332211 1112345668999999998899999999999999999999 899996543221 1111110 00
Q ss_pred cccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011851 360 RLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEAL 403 (476)
Q Consensus 360 ~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L 403 (476)
....+ ...+..+.+++.+||+.||++||++.++++.|
T Consensus 219 ~~~~~-------~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 219 RLYRP-------KLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred CCCCC-------CCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 01111 11256789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-44 Score=353.14 Aligned_cols=258 Identities=28% Similarity=0.403 Sum_probs=213.7
Q ss_pred CCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccC---HHHHHHHHHHHhCCCCCceeeEEEEEEe
Q 011851 122 SFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQG---HKEWLAEVNYLGGLIHPNLVKLIGCCIE 198 (476)
Q Consensus 122 ~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~---~~~~~~E~~~l~~l~hpnIv~l~~~~~~ 198 (476)
.|.-++.||.|+||.||-|++. .+.+.||||.+.-...+. ..+++.|+..|++|.|||+|.+-++|..
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~---------~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLr 97 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDV---------RNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLR 97 (948)
T ss_pred HHHHHHHhcCCccceeEEeecc---------CccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeec
Confidence 3666788999999999998765 467789999998766554 4578999999999999999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCc
Q 011851 199 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLA 278 (476)
Q Consensus 199 ~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a 278 (476)
+...||||||| -|+-.|++.-...++.+..+..|+.+.+.||.|||+++ .||||||..||||++.|.|||+|||.|
T Consensus 98 e~TaWLVMEYC-lGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSA 173 (948)
T KOG0577|consen 98 EHTAWLVMEYC-LGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSA 173 (948)
T ss_pred cchHHHHHHHH-hccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccch
Confidence 99999999999 56888888777788999999999999999999999998 999999999999999999999999999
Q ss_pred CCCCCCCccceeeeeecCCCCCCcchhh---cCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhccc
Q 011851 279 KDGPEGDKTHVSTRVMGTYGYAAPEYVM---TGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGER 355 (476)
Q Consensus 279 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~ 355 (476)
..... .+.++|||+|||||++. .+.|+-++|||||||+..||...++|+...+.-.....+....
T Consensus 174 si~~P------AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNe------ 241 (948)
T KOG0577|consen 174 SIMAP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNE------ 241 (948)
T ss_pred hhcCc------hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcC------
Confidence 77543 23589999999999986 4689999999999999999999999986543321111111000
Q ss_pred cccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCcccccCcchH
Q 011851 356 RRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDMASSSSY 418 (476)
Q Consensus 356 ~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~~~~~~~~ 418 (476)
.|.|. ....+..+..|+..||+.-|.+|||..++++| +|+.....+...
T Consensus 242 -------sPtLq---s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H----~fv~R~Rp~tvi 290 (948)
T KOG0577|consen 242 -------SPTLQ---SNEWSDYFRNFVDSCLQKIPQERPTSEELLKH----RFVLRERPPTVI 290 (948)
T ss_pred -------CCCCC---CchhHHHHHHHHHHHHhhCcccCCcHHHHhhc----chhccCCCchHH
Confidence 11111 22347899999999999999999999999998 887765554433
|
|
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=340.16 Aligned_cols=262 Identities=29% Similarity=0.431 Sum_probs=208.4
Q ss_pred cCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCCCCCceeeEEEEEEeCC
Q 011851 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHPNLVKLIGCCIEDD 200 (476)
Q Consensus 121 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 200 (476)
++|.+.+.||+|+||.||++..... ....++..+|+|.+........+.+.+|+++|++++||||+++++++...+
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~----~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 80 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNL----CPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGD 80 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccC----CCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCC
Confidence 4688999999999999999875321 122456779999997665555567899999999999999999999999999
Q ss_pred eeEEEEEecCCCCHHHHHhhcC------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCC
Q 011851 201 QRLLVYEFMPRGSLENHLFRRS------------LPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEY 268 (476)
Q Consensus 201 ~~~lV~E~~~~g~L~~~l~~~~------------~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~ 268 (476)
.+++||||+++++|.+++.... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~ 157 (288)
T cd05093 81 PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENL 157 (288)
T ss_pred ccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCC
Confidence 9999999999999999986432 34899999999999999999999988 99999999999999999
Q ss_pred ceEEeecCCcCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHh-CCCCCCCCCCCCcchhHHh
Q 011851 269 NAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEW 347 (476)
Q Consensus 269 ~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~ellt-G~~pf~~~~~~~~~~~~~~ 347 (476)
.+||+|||+++...............++..|+|||++.+..++.++|||||||++|+|++ |..||........ ...
T Consensus 158 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~---~~~ 234 (288)
T cd05093 158 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEV---IEC 234 (288)
T ss_pred cEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH---HHH
Confidence 999999999986543222222223446788999999998899999999999999999998 8999865543211 111
Q ss_pred hhhhhccccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011851 348 ARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPL 406 (476)
Q Consensus 348 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~ 406 (476)
.. . .... .. +...+.++.+|+.+||+.||.+|||+.++++.|+.+
T Consensus 235 i~----~-~~~~-----~~----~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~ 279 (288)
T cd05093 235 IT----Q-GRVL-----QR----PRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNL 279 (288)
T ss_pred HH----c-CCcC-----CC----CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHH
Confidence 00 0 0000 00 111246789999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=333.56 Aligned_cols=260 Identities=26% Similarity=0.454 Sum_probs=208.6
Q ss_pred cCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCcc-CHHHHHHHHHHHhCCCCCceeeEEEEEEeC
Q 011851 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQ-GHKEWLAEVNYLGGLIHPNLVKLIGCCIED 199 (476)
Q Consensus 121 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~ 199 (476)
++|++.+.||+|+||.||+|.+...+ .+...||||.++..... ....+.+|+.++++++||||+++++++.+.
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~------~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 77 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPG------KKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKS 77 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCC------CCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecC
Confidence 46899999999999999999875331 23567999998755433 235688899999999999999999999999
Q ss_pred CeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCcC
Q 011851 200 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAK 279 (476)
Q Consensus 200 ~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~ 279 (476)
+..++||||+++++|.+++......+++..++.++.|++.||.|||+++ |+||||||+|||++.++.++|+|||+++
T Consensus 78 ~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~ 154 (266)
T cd05033 78 RPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSR 154 (266)
T ss_pred CceEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhh
Confidence 9999999999999999999776667999999999999999999999988 9999999999999999999999999998
Q ss_pred CCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhhcccccc
Q 011851 280 DGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPQLGERRRF 358 (476)
Q Consensus 280 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 358 (476)
...............++..|+|||.+.+..++.++||||||+++|+|++ |..||....... ..... .....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~---~~~~~----~~~~~- 226 (266)
T cd05033 155 RLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQD---VIKAV----EDGYR- 226 (266)
T ss_pred cccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHH---HHHHH----HcCCC-
Confidence 7642222222222345678999999998899999999999999999998 999986533211 11111 00000
Q ss_pred ccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011851 359 YRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPL 406 (476)
Q Consensus 359 ~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~ 406 (476)
.+ .+...+..+.+|+.+||+.+|++||++.+|+++|+.+
T Consensus 227 ----~~-----~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 227 ----LP-----PPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred ----CC-----CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 01 1112357889999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-43 Score=353.64 Aligned_cols=264 Identities=22% Similarity=0.270 Sum_probs=205.3
Q ss_pred HHHhccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCc---cCHHHHHHHHHHHhCCCCCceeeE
Q 011851 116 LKSATKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL---QGHKEWLAEVNYLGGLIHPNLVKL 192 (476)
Q Consensus 116 ~~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~l 192 (476)
+....++|++.+.||+|+||.||+|.+. .+++.||+|++..... .....+.+|+.+++.++||||+++
T Consensus 38 ~~~~~~~y~i~~~lG~G~fg~Vy~~~~~---------~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~ 108 (371)
T cd05622 38 LRMKAEDYEVVKVIGRGAFGEVQLVRHK---------STRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL 108 (371)
T ss_pred cCcchhhcEEEEEEeecCCeEEEEEEEC---------CCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeE
Confidence 3344578999999999999999998654 4778899999865322 223456789999999999999999
Q ss_pred EEEEEeCCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEE
Q 011851 193 IGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKL 272 (476)
Q Consensus 193 ~~~~~~~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl 272 (476)
++++.+++.+|+||||+++|+|.+++... .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||
T Consensus 109 ~~~~~~~~~~~lv~Ey~~gg~L~~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL 183 (371)
T cd05622 109 FYAFQDDRYLYMVMEYMPGGDLVNLMSNY--DVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKL 183 (371)
T ss_pred EEEEEcCCEEEEEEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEE
Confidence 99999999999999999999999988543 4889999999999999999999988 999999999999999999999
Q ss_pred eecCCcCCCCCCCccceeeeeecCCCCCCcchhhcC----CCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhh
Q 011851 273 SDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG----HLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA 348 (476)
Q Consensus 273 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~ 348 (476)
+|||+++....... ......+||+.|+|||++.+. .++.++|||||||++|||++|+.||...........
T Consensus 184 ~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~---- 258 (371)
T cd05622 184 ADFGTCMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSK---- 258 (371)
T ss_pred EeCCceeEcCcCCc-ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHH----
Confidence 99999986543221 112346799999999998754 378999999999999999999999976432111110
Q ss_pred hhhhccccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCC--CCCHHHHHHHhcCCCCcccc
Q 011851 349 RPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKA--RPRMSEVVEALKPLPYLKDM 412 (476)
Q Consensus 349 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~--RPt~~ell~~L~~~~~~~~~ 412 (476)
....... ..+. .....+..+.+||.+||..++.+ |+++.++++| +||++.
T Consensus 259 --i~~~~~~-~~~~-------~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h----~~~~~~ 310 (371)
T cd05622 259 --IMNHKNS-LTFP-------DDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH----LFFKND 310 (371)
T ss_pred --HHcCCCc-ccCC-------CcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcC----cccCCC
Confidence 0000000 0000 01123678899999999844433 7899998887 888764
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=353.08 Aligned_cols=273 Identities=25% Similarity=0.353 Sum_probs=205.8
Q ss_pred CCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCC--ccCHHHHHHHHHHHhCCCCCceeeEEEEEEeC
Q 011851 122 SFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDG--LQGHKEWLAEVNYLGGLIHPNLVKLIGCCIED 199 (476)
Q Consensus 122 ~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~ 199 (476)
+|++.+.||+|+||.||+|.+. .+|+.||||.+.... ....+++.+|+++|+.++|+||+++++++...
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 71 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDP---------RDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPP 71 (372)
T ss_pred CCcccceeeeCCCEEEEEEEEC---------CCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCC
Confidence 4788999999999999998654 467889999986532 22345788999999999999999999999877
Q ss_pred C-----eeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEee
Q 011851 200 D-----QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSD 274 (476)
Q Consensus 200 ~-----~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~D 274 (476)
+ ..|+||||+. ++|.+.+.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|
T Consensus 72 ~~~~~~~~~lv~e~~~-~~l~~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~D 146 (372)
T cd07853 72 HIDPFEEIYVVTELMQ-SDLHKIIVS-PQPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICD 146 (372)
T ss_pred CccccceEEEEeeccc-cCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEecc
Confidence 6 7899999995 588887743 457999999999999999999999988 99999999999999999999999
Q ss_pred cCCcCCCCCCCccceeeeeecCCCCCCcchhhcC-CCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhh--h
Q 011851 275 FGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP--Q 351 (476)
Q Consensus 275 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~--~ 351 (476)
||+++....... .......+|+.|+|||++.+. .++.++|||||||++|||++|+.||....+......+..... .
T Consensus 147 fg~a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~ 225 (372)
T cd07853 147 FGLARVEEPDES-KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPS 225 (372)
T ss_pred ccceeecccCcc-ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCC
Confidence 999986433221 112335689999999998874 589999999999999999999999986554322111110000 0
Q ss_pred hc--------ccccccc-ccC-cccCC--CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCccccc
Q 011851 352 LG--------ERRRFYR-LID-PCLEG--CFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDMA 413 (476)
Q Consensus 352 ~~--------~~~~~~~-~~d-~~l~~--~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~~~ 413 (476)
.. ....+.. ... +.... .+....++++.+||.+||+.||++|||+.++++| ||+++..
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h----p~~~~~~ 295 (372)
T cd07853 226 LEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH----PYLDEGR 295 (372)
T ss_pred HHHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC----HhhCCCc
Confidence 00 0000000 000 00000 0111225788999999999999999999999998 8988753
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=336.58 Aligned_cols=260 Identities=28% Similarity=0.483 Sum_probs=205.8
Q ss_pred cCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCc-cCHHHHHHHHHHHhCCCCCceeeEEEEEEeC
Q 011851 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL-QGHKEWLAEVNYLGGLIHPNLVKLIGCCIED 199 (476)
Q Consensus 121 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~ 199 (476)
.+|++.+.||+|+||.||+|.+...+ ..++..||+|.+..... .....+.+|++++++++||||+++++++...
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~-----~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 79 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPG-----MDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQE 79 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCC-----CCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecC
Confidence 35888899999999999999864322 23677899999975332 2235688899999999999999999999999
Q ss_pred CeeEEEEEecCCCCHHHHHhhc----------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCee
Q 011851 200 DQRLLVYEFMPRGSLENHLFRR----------------SLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNIL 263 (476)
Q Consensus 200 ~~~~lV~E~~~~g~L~~~l~~~----------------~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NIL 263 (476)
+..|+||||+++++|.+++... ...+++..+..++.|++.||.|||+++ |+||||||+|||
T Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nil 156 (283)
T cd05090 80 QPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNIL 156 (283)
T ss_pred CceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEE
Confidence 9999999999999999998532 134788899999999999999999988 999999999999
Q ss_pred ecCCCceEEeecCCcCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHh-CCCCCCCCCCCCcc
Q 011851 264 LDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEH 342 (476)
Q Consensus 264 l~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~ellt-G~~pf~~~~~~~~~ 342 (476)
++.++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||......
T Consensus 157 i~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~--- 233 (283)
T cd05090 157 IGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQ--- 233 (283)
T ss_pred EcCCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH---
Confidence 99999999999999986543332222233456778999999988889999999999999999998 99998654321
Q ss_pred hhHHhhhhhhccccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 011851 343 NLVEWARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKP 405 (476)
Q Consensus 343 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~ 405 (476)
.+.+.... .. . .+ .+...+.++.+++.+||+.||++||++.+|+++|..
T Consensus 234 ~~~~~~~~----~~----~-~~-----~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 234 EVIEMVRK----RQ----L-LP-----CSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred HHHHHHHc----CC----c-CC-----CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 11111110 00 0 00 111225688999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-42 Score=336.99 Aligned_cols=263 Identities=26% Similarity=0.406 Sum_probs=212.3
Q ss_pred cCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCCCCCceeeEEEEEEeCC
Q 011851 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHPNLVKLIGCCIEDD 200 (476)
Q Consensus 121 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 200 (476)
+.|++.++||.|+||.||+|.+. .+++.||+|++........+.+.+|+.+++.++|+||+++++++..++
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~---------~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 82 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNK---------ETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDG 82 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEEC---------CCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCC
Confidence 56999999999999999998765 367789999998765555667889999999999999999999999999
Q ss_pred eeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCcCC
Q 011851 201 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKD 280 (476)
Q Consensus 201 ~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~ 280 (476)
..|+||||+++++|..++.+....+++..+..++.|++.+|.|||+.+ |+||||||+||+++.++.++|+|||++..
T Consensus 83 ~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~ 159 (292)
T cd06644 83 KLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAK 159 (292)
T ss_pred eEEEEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCcccee
Confidence 999999999999999888766667999999999999999999999988 99999999999999999999999999875
Q ss_pred CCCCCccceeeeeecCCCCCCcchhh-----cCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhccc
Q 011851 281 GPEGDKTHVSTRVMGTYGYAAPEYVM-----TGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGER 355 (476)
Q Consensus 281 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~ 355 (476)
..... .......+++.|+|||++. ...++.++|||||||++|||++|..||....... ........
T Consensus 160 ~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~--~~~~~~~~----- 230 (292)
T cd06644 160 NVKTL--QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR--VLLKIAKS----- 230 (292)
T ss_pred ccccc--cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHH--HHHHHhcC-----
Confidence 43211 1123356899999999885 3457889999999999999999999997543211 11111000
Q ss_pred cccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCcccccCcc
Q 011851 356 RRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDMASSS 416 (476)
Q Consensus 356 ~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~~~~~~ 416 (476)
..+.. ..+...+.++.+++.+||..||++||++.+++++ ||+..+....
T Consensus 231 ------~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~----~~~~~~~~~~ 279 (292)
T cd06644 231 ------EPPTL--SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEH----PFVSSVTSNR 279 (292)
T ss_pred ------CCccC--CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcC----ccccccccch
Confidence 00000 0111235678899999999999999999999987 9988766554
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=352.07 Aligned_cols=253 Identities=26% Similarity=0.333 Sum_probs=194.9
Q ss_pred ccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCcc---CHHHHHHHHHHHhCC---CCCceeeEEEEEEeCCee
Q 011851 129 LGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQ---GHKEWLAEVNYLGGL---IHPNLVKLIGCCIEDDQR 202 (476)
Q Consensus 129 LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~---~~~~~~~E~~~l~~l---~hpnIv~l~~~~~~~~~~ 202 (476)
||+|+||+||+|++. .+++.||||++.+.... ....+..|..++..+ .||||+.+++++.+.+.+
T Consensus 1 lG~G~~g~Vy~~~~~---------~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~ 71 (330)
T cd05586 1 IGKGTFGQVYQVRKK---------DTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDL 71 (330)
T ss_pred CCCCCceEEEEEEEC---------CCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeE
Confidence 799999999998754 46788999999654322 123345577777655 699999999999999999
Q ss_pred EEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCcCCCC
Q 011851 203 LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGP 282 (476)
Q Consensus 203 ~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~ 282 (476)
||||||+++++|.+++.+ ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 72 ~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~ 147 (330)
T cd05586 72 YLVTDYMSGGELFWHLQK-EGRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANL 147 (330)
T ss_pred EEEEcCCCCChHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCC
Confidence 999999999999998854 457999999999999999999999988 9999999999999999999999999997643
Q ss_pred CCCccceeeeeecCCCCCCcchhhcC-CCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhccccccccc
Q 011851 283 EGDKTHVSTRVMGTYGYAAPEYVMTG-HLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRRFYRL 361 (476)
Q Consensus 283 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 361 (476)
.... .....+||+.|+|||++.+. .++.++|||||||++|+|++|+.||...........+. .... .+
T Consensus 148 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~------~~~~---~~ 216 (330)
T cd05586 148 TDNK--TTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIA------FGKV---RF 216 (330)
T ss_pred CCCC--CccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHH------cCCC---CC
Confidence 2221 12346799999999998765 58999999999999999999999997543211111000 0000 00
Q ss_pred cCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCccccc
Q 011851 362 IDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDMA 413 (476)
Q Consensus 362 ~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~~~ 413 (476)
. . ...+.++.+||.+||+.||++||++.+.++.|..+|||++..
T Consensus 217 ~----~----~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~~~~~~~ 260 (330)
T cd05586 217 P----K----NVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFADID 260 (330)
T ss_pred C----C----ccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCccccCCC
Confidence 0 0 112567889999999999999995444344444459998654
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=339.51 Aligned_cols=262 Identities=27% Similarity=0.432 Sum_probs=209.8
Q ss_pred cCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCCCCCceeeEEEEEEeCC
Q 011851 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHPNLVKLIGCCIEDD 200 (476)
Q Consensus 121 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 200 (476)
.+|.+.+.||+|+||.||+|.+.... ...++..+++|.+........+.+.+|++++++++|+||+++++++...+
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~----~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 80 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLS----PTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGD 80 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccC----CCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCC
Confidence 35888899999999999999754321 12356679999987766555667889999999999999999999999999
Q ss_pred eeEEEEEecCCCCHHHHHhhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeec
Q 011851 201 QRLLVYEFMPRGSLENHLFRRS---------------LPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLD 265 (476)
Q Consensus 201 ~~~lV~E~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~ 265 (476)
..++||||+++++|.+++.... ..+++..++.++.||+.||.|||+++ |+||||||+|||++
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~ 157 (291)
T cd05094 81 PLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVG 157 (291)
T ss_pred ceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEc
Confidence 9999999999999999996432 34789999999999999999999988 99999999999999
Q ss_pred CCCceEEeecCCcCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHh-CCCCCCCCCCCCcchh
Q 011851 266 GEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNL 344 (476)
Q Consensus 266 ~~~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~ellt-G~~pf~~~~~~~~~~~ 344 (476)
.++.++|+|||++................++..|+|||++.+..++.++|||||||++|||++ |+.||....... .
T Consensus 158 ~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~---~ 234 (291)
T cd05094 158 ANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE---V 234 (291)
T ss_pred cCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---H
Confidence 999999999999976544332222233557889999999999999999999999999999999 999986543321 1
Q ss_pred HHhhhhhhccccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011851 345 VEWARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPL 406 (476)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~ 406 (476)
...... ..... .....+..+.+++.+||+.||++||++.++++.|+.+
T Consensus 235 ~~~~~~-----~~~~~---------~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~ 282 (291)
T cd05094 235 IECITQ-----GRVLE---------RPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHAL 282 (291)
T ss_pred HHHHhC-----CCCCC---------CCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHH
Confidence 111100 00000 0112256789999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=333.38 Aligned_cols=255 Identities=24% Similarity=0.321 Sum_probs=203.8
Q ss_pred cCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCCCCCceeeEEEEEEeCC
Q 011851 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHPNLVKLIGCCIEDD 200 (476)
Q Consensus 121 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 200 (476)
.+|++.+.||+|+||.||+|.+. .+++.||+|++..........+.+|+.++++++||||+++++++..++
T Consensus 9 ~~y~~~~~lg~g~~g~vy~~~~~---------~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~ 79 (267)
T cd06646 9 HDYELIQRVGSGTYGDVYKARNL---------HTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSRE 79 (267)
T ss_pred hhcchhheeecCCCeEEEEEEEC---------CCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCC
Confidence 46999999999999999998654 467789999997655445566788999999999999999999999999
Q ss_pred eeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCcCC
Q 011851 201 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKD 280 (476)
Q Consensus 201 ~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~ 280 (476)
.+|+||||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++..
T Consensus 80 ~~~iv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~ 155 (267)
T cd06646 80 KLWICMEYCGGGSLQDIYHV-TGPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAK 155 (267)
T ss_pred EEEEEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCcccee
Confidence 99999999999999998854 457899999999999999999999988 99999999999999999999999999986
Q ss_pred CCCCCccceeeeeecCCCCCCcchhh---cCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhccccc
Q 011851 281 GPEGDKTHVSTRVMGTYGYAAPEYVM---TGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRR 357 (476)
Q Consensus 281 ~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 357 (476)
...... ......|+..|+|||.+. ...++.++|||||||++|||++|+.||....+........ . .
T Consensus 156 ~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~--~------~- 224 (267)
T cd06646 156 ITATIA--KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMS--K------S- 224 (267)
T ss_pred eccccc--ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeee--c------C-
Confidence 532211 112356889999999885 3457889999999999999999999996543321111000 0 0
Q ss_pred cccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011851 358 FYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEAL 403 (476)
Q Consensus 358 ~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L 403 (476)
.+..+.+.. ....+..+.++|.+||+.||++||++++|+++|
T Consensus 225 --~~~~~~~~~--~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 225 --NFQPPKLKD--KTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred --CCCCCCCcc--ccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 000111111 112356889999999999999999999999873
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-42 Score=336.34 Aligned_cols=258 Identities=30% Similarity=0.414 Sum_probs=206.7
Q ss_pred CCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccC---HHHHHHHHHHHhCCCCCceeeEEEEEEe
Q 011851 122 SFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQG---HKEWLAEVNYLGGLIHPNLVKLIGCCIE 198 (476)
Q Consensus 122 ~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~---~~~~~~E~~~l~~l~hpnIv~l~~~~~~ 198 (476)
.|+..++||+|+||.||+|.+. .+++.||+|.+....... ...+..|+.++++++|+||+.+++.+.+
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~---------~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~ 71 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVR---------ATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYET 71 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEc---------CCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEec
Confidence 3778899999999999998655 477889999987543322 2356789999999999999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCC
Q 011851 199 DDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGL 277 (476)
Q Consensus 199 ~~~~~lV~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~ 277 (476)
++..|+||||+++++|.+++... ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||+
T Consensus 72 ~~~~~lv~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~ 148 (285)
T cd05630 72 KDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGL 148 (285)
T ss_pred CCEEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccc
Confidence 99999999999999999988543 346899999999999999999999988 99999999999999999999999999
Q ss_pred cCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhccccc
Q 011851 278 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRR 357 (476)
Q Consensus 278 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 357 (476)
+........ .....|+..|+|||++.+..++.++|||||||++|+|++|+.||...................
T Consensus 149 ~~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~----- 220 (285)
T cd05630 149 AVHVPEGQT---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV----- 220 (285)
T ss_pred eeecCCCcc---ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhh-----
Confidence 876533221 123479999999999999999999999999999999999999997643221111110000000
Q ss_pred cccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHHhcCCCCcccc
Q 011851 358 FYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPR-----MSEVVEALKPLPYLKDM 412 (476)
Q Consensus 358 ~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt-----~~ell~~L~~~~~~~~~ 412 (476)
...+....+.++.+|+.+||+.||++||| +.++++| |||+..
T Consensus 221 ---------~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h----~~~~~~ 267 (285)
T cd05630 221 ---------QEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEH----PLFKQI 267 (285)
T ss_pred ---------hhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcC----hhhhcc
Confidence 00111223567899999999999999999 8898887 998764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-42 Score=339.90 Aligned_cols=267 Identities=23% Similarity=0.362 Sum_probs=193.2
Q ss_pred cccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCCCCCceeeEEEEEEe--CCeeE
Q 011851 126 ECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHPNLVKLIGCCIE--DDQRL 203 (476)
Q Consensus 126 ~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~--~~~~~ 203 (476)
.++||+|+||+||+|.+.. ..+++.||+|.+..... ...+.+|+.+|++++||||+++++++.. +..+|
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~-------~~~~~~~aiK~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 76 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKD-------GKDDRDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVW 76 (317)
T ss_pred ccccccCCCeEEEEEEEcc-------CCCCceEEEEEECCCCC--cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEE
Confidence 4679999999999997642 13567899999875432 3457789999999999999999999864 45689
Q ss_pred EEEEecCCCCHHHHHhhc--------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeee----cCCCceE
Q 011851 204 LVYEFMPRGSLENHLFRR--------SLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILL----DGEYNAK 271 (476)
Q Consensus 204 lV~E~~~~g~L~~~l~~~--------~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl----~~~~~vk 271 (476)
+||||+. ++|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+|||+ +.++.+|
T Consensus 77 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~k 152 (317)
T cd07868 77 LLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVK 152 (317)
T ss_pred EEEeccC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEE
Confidence 9999995 5888877421 235899999999999999999999988 9999999999999 4567899
Q ss_pred EeecCCcCCCCCCCcc-ceeeeeecCCCCCCcchhhcC-CCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcc------h
Q 011851 272 LSDFGLAKDGPEGDKT-HVSTRVMGTYGYAAPEYVMTG-HLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEH------N 343 (476)
Q Consensus 272 l~DFG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~------~ 343 (476)
|+|||+++........ .......||+.|+|||++.+. .++.++|||||||++|||++|+.||......... .
T Consensus 153 l~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~ 232 (317)
T cd07868 153 IADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHD 232 (317)
T ss_pred EeecCceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHH
Confidence 9999999865432211 112346789999999999874 6899999999999999999999999754332110 0
Q ss_pred hHHhhhhh--------------hccccccccccC-----cc-cCC---CCChHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 011851 344 LVEWARPQ--------------LGERRRFYRLID-----PC-LEG---CFSIKGAEKTIQLAASCLNRDQKARPRMSEVV 400 (476)
Q Consensus 344 ~~~~~~~~--------------~~~~~~~~~~~d-----~~-l~~---~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell 400 (476)
........ ..+.......+. .+ +.. ......+.++.+||.+||+.||++|||++|++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l 312 (317)
T cd07868 233 QLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAM 312 (317)
T ss_pred HHHHHHHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHh
Confidence 00000000 000000000000 00 000 00001134688999999999999999999999
Q ss_pred HHhcCCCCc
Q 011851 401 EALKPLPYL 409 (476)
Q Consensus 401 ~~L~~~~~~ 409 (476)
+| |||
T Consensus 313 ~h----p~f 317 (317)
T cd07868 313 QD----PYF 317 (317)
T ss_pred cC----CCC
Confidence 97 886
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-42 Score=330.50 Aligned_cols=256 Identities=26% Similarity=0.374 Sum_probs=205.5
Q ss_pred cCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCcc-----CHHHHHHHHHHHhCCCCCceeeEEEE
Q 011851 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQ-----GHKEWLAEVNYLGGLIHPNLVKLIGC 195 (476)
Q Consensus 121 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~-----~~~~~~~E~~~l~~l~hpnIv~l~~~ 195 (476)
++|.+.+.||+|+||.||+|.+. .+++.||+|.+...... ..+.+.+|++++++++||||++++++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~---------~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~ 72 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDV---------DTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGC 72 (263)
T ss_pred CcccccceecCCCceEEEEEEEc---------CCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEE
Confidence 46899999999999999998654 46788999998754321 23457889999999999999999999
Q ss_pred EEeCCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeec
Q 011851 196 CIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDF 275 (476)
Q Consensus 196 ~~~~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DF 275 (476)
+.+++..++||||+++++|.+++... ..+++..+..++.|++.||.|||+.+ |+||||+|+||+++.++.++|+||
T Consensus 73 ~~~~~~~~~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~df 148 (263)
T cd06625 73 LRDDETLSIFMEYMPGGSVKDQLKAY-GALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDF 148 (263)
T ss_pred EccCCeEEEEEEECCCCcHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeec
Confidence 99999999999999999999988543 46899999999999999999999988 999999999999999999999999
Q ss_pred CCcCCCCCCCccce-eeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhcc
Q 011851 276 GLAKDGPEGDKTHV-STRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGE 354 (476)
Q Consensus 276 G~a~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~ 354 (476)
|+++.......... .....|+..|+|||++.+..++.++|||||||++|||++|+.||........ ..... .
T Consensus 149 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~--~~~~~-----~ 221 (263)
T cd06625 149 GASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAA--IFKIA-----T 221 (263)
T ss_pred ccceeccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHH--HHHHh-----c
Confidence 99876533221111 1235688899999999998999999999999999999999999965422111 00000 0
Q ss_pred ccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCc
Q 011851 355 RRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYL 409 (476)
Q Consensus 355 ~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~ 409 (476)
......++...+..+.+++.+||..+|++|||+.+++++ +||
T Consensus 222 ---------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~----~~~ 263 (263)
T cd06625 222 ---------QPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH----FFV 263 (263)
T ss_pred ---------cCCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC----CCC
Confidence 000011222336688999999999999999999999997 664
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-42 Score=333.72 Aligned_cols=260 Identities=25% Similarity=0.386 Sum_probs=206.4
Q ss_pred CCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCc-cCHHHHHHHHHHHhCCCCCceeeEEEEEEeCC
Q 011851 122 SFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL-QGHKEWLAEVNYLGGLIHPNLVKLIGCCIEDD 200 (476)
Q Consensus 122 ~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 200 (476)
+|++.++||+|+||.||+|.+. .+++.||+|++..... ...+++.+|++++++++||||+++++++..++
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 72 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHL---------LTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVEN 72 (279)
T ss_pred cchheeeeccCCCeEEEEEEEc---------CCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECC
Confidence 5888899999999999998654 4678899999875422 23456889999999999999999999999999
Q ss_pred eeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCcCC
Q 011851 201 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKD 280 (476)
Q Consensus 201 ~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~ 280 (476)
..++||||+++++|..+. .+++..+..++.|++.||.|||+.+ |+|+||||+|||++.++.++|+|||++..
T Consensus 73 ~~~lv~e~~~~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~ 144 (279)
T cd06619 73 RISICTEFMDGGSLDVYR-----KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQ 144 (279)
T ss_pred EEEEEEecCCCCChHHhh-----cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCccee
Confidence 999999999999986542 4788899999999999999999988 99999999999999999999999999976
Q ss_pred CCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcch-hHHhhhhhhccccccc
Q 011851 281 GPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHN-LVEWARPQLGERRRFY 359 (476)
Q Consensus 281 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~-~~~~~~~~~~~~~~~~ 359 (476)
..... ....+||..|+|||++.+..++.++|||||||++|+|++|+.||.......... ............
T Consensus 145 ~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~---- 216 (279)
T cd06619 145 LVNSI----AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDED---- 216 (279)
T ss_pred ccccc----ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccC----
Confidence 53321 223579999999999999999999999999999999999999997533221111 011110000000
Q ss_pred cccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCcccccCcc
Q 011851 360 RLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDMASSS 416 (476)
Q Consensus 360 ~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~~~~~~ 416 (476)
.+.+ .....+.++.+++.+||+.||++||++++++++ ||+.......
T Consensus 217 ---~~~~---~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~----~~~~~~~~~~ 263 (279)
T cd06619 217 ---PPVL---PVGQFSEKFVHFITQCMRKQPKERPAPENLMDH----PFIVQYNDGN 263 (279)
T ss_pred ---CCCC---CCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC----cccccccCcc
Confidence 0000 011225678999999999999999999999987 9988765443
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-42 Score=339.39 Aligned_cols=272 Identities=25% Similarity=0.379 Sum_probs=208.4
Q ss_pred cCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCcc-CHHHHHHHHHHHhCCCCCceeeEEEEEEeC
Q 011851 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQ-GHKEWLAEVNYLGGLIHPNLVKLIGCCIED 199 (476)
Q Consensus 121 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~ 199 (476)
++|++.+.||+|+||.||++.+. .++..+|+|.+...... ...++.+|++++++++||||+++++++.++
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~---------~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 71 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHR---------PSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSD 71 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEc---------CCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeC
Confidence 36899999999999999998654 46778999998754322 234688999999999999999999999999
Q ss_pred CeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCCeeecCCCceEEeecCCc
Q 011851 200 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHE-EAEKPVIYRDFKTSNILLDGEYNAKLSDFGLA 278 (476)
Q Consensus 200 ~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~-~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a 278 (476)
+.+|+||||+++++|.+++.+. ..+++..+..++.||+.||.|||+ .+ |+||||||+|||++.++.+||+|||++
T Consensus 72 ~~~~lv~ey~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~ 147 (308)
T cd06615 72 GEISICMEHMDGGSLDQVLKKA-GRIPENILGKISIAVLRGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVS 147 (308)
T ss_pred CEEEEEeeccCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhhCC---EEECCCChHHEEEecCCcEEEccCCCc
Confidence 9999999999999999999554 578999999999999999999997 46 999999999999999999999999998
Q ss_pred CCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhccc---
Q 011851 279 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGER--- 355 (476)
Q Consensus 279 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~--- 355 (476)
....... .....|+..|+|||++.+..++.++|||||||++|+|++|+.||......................
T Consensus 148 ~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (308)
T cd06615 148 GQLIDSM----ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESH 223 (308)
T ss_pred ccccccc----cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCc
Confidence 7643321 233578999999999988889999999999999999999999996543221111110000000000
Q ss_pred -------------cccccccCcccC---CCC-ChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCccccc
Q 011851 356 -------------RRFYRLIDPCLE---GCF-SIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDMA 413 (476)
Q Consensus 356 -------------~~~~~~~d~~l~---~~~-~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~~~ 413 (476)
....+..+.... ... ....+.++.+|+.+||..||++||++.+|+++ ||+.+..
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~----~~~~~~~ 294 (308)
T cd06615 224 RPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH----PFIKRAE 294 (308)
T ss_pred ccccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC----hhhhhcc
Confidence 000000000000 000 01135678999999999999999999999998 9987643
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-42 Score=335.33 Aligned_cols=271 Identities=27% Similarity=0.382 Sum_probs=210.4
Q ss_pred cCCCccccccccCCccEEEEEEccCCcee-------eeCCCCceEEEEEecCCCcc-CHHHHHHHHHHHhCCCCCceeeE
Q 011851 121 KSFRPECLLGEGGFGCVYKGWINMNGTAT-------VKPGTGLPVAVKTLNHDGLQ-GHKEWLAEVNYLGGLIHPNLVKL 192 (476)
Q Consensus 121 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~-------~~~~~g~~vAiK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l 192 (476)
.+|++.+.||+|+||.||+|.+...+... .....+..||+|++...... ..+.+.+|+++|++++||||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~ 84 (296)
T cd05051 5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARL 84 (296)
T ss_pred hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence 47999999999999999999876543221 23345677999998765432 34578899999999999999999
Q ss_pred EEEEEeCCeeEEEEEecCCCCHHHHHhhcC----------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCe
Q 011851 193 IGCCIEDDQRLLVYEFMPRGSLENHLFRRS----------LPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNI 262 (476)
Q Consensus 193 ~~~~~~~~~~~lV~E~~~~g~L~~~l~~~~----------~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NI 262 (476)
++++..++..++||||+++++|.+++.+.. ..+++..++.++.|++.||.|||+.+ |+||||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~Ni 161 (296)
T cd05051 85 LGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRNC 161 (296)
T ss_pred EEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhce
Confidence 999999999999999999999999986543 26899999999999999999999988 99999999999
Q ss_pred eecCCCceEEeecCCcCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHh--CCCCCCCCCCCC
Q 011851 263 LLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLT--GRRSMDKNRPNG 340 (476)
Q Consensus 263 Ll~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~ellt--G~~pf~~~~~~~ 340 (476)
+++.++.++|+|||+++...............+++.|+|||++.+..++.++|||||||++|||++ |..||......
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~- 240 (296)
T cd05051 162 LVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQ- 240 (296)
T ss_pred eecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChH-
Confidence 999999999999999986544332222334557788999999998899999999999999999998 67777543321
Q ss_pred cchhHHhhhhhhccccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 011851 341 EHNLVEWARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALK 404 (476)
Q Consensus 341 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~ 404 (476)
........... ..........+...+.++.+|+.+||+.||++|||+.+|++.|+
T Consensus 241 --~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 241 --QVIENAGHFFR-------DDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred --HHHHHHHhccc-------cccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 11111110000 00000000011223578999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-42 Score=336.43 Aligned_cols=268 Identities=25% Similarity=0.335 Sum_probs=198.3
Q ss_pred CCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCcc--CHHHHHHHHHHHhCC---CCCceeeEEEEE
Q 011851 122 SFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQ--GHKEWLAEVNYLGGL---IHPNLVKLIGCC 196 (476)
Q Consensus 122 ~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~--~~~~~~~E~~~l~~l---~hpnIv~l~~~~ 196 (476)
+|++.+.||+|+||.||+|.+. .+++.||+|.++..... ....+.+|+.+++.+ +||||+++++++
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~ 71 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDP---------HSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVC 71 (288)
T ss_pred CceEeeEEeecCCeEEEEEEEC---------CCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeee
Confidence 4889999999999999998654 47888999998754322 123455677766655 799999999988
Q ss_pred Ee-----CCeeEEEEEecCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCce
Q 011851 197 IE-----DDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNA 270 (476)
Q Consensus 197 ~~-----~~~~~lV~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~v 270 (476)
.. ...+++||||+. ++|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+
T Consensus 72 ~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~ 147 (288)
T cd07863 72 ATSRTDRETKVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQV 147 (288)
T ss_pred ccccCCCCceEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCE
Confidence 64 345899999996 4888888654 345899999999999999999999988 9999999999999999999
Q ss_pred EEeecCCcCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcch-hHHhhh
Q 011851 271 KLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHN-LVEWAR 349 (476)
Q Consensus 271 kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~-~~~~~~ 349 (476)
||+|||+++....... .....||..|+|||++.+..++.++|||||||++|+|++|++||.......... +.....
T Consensus 148 kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~ 224 (288)
T cd07863 148 KLADFGLARIYSCQMA---LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIG 224 (288)
T ss_pred EECccCccccccCccc---CCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhC
Confidence 9999999986543221 223578999999999999999999999999999999999999997543322111 111000
Q ss_pred h-hhcccc---cc-ccccCcccC---CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCc
Q 011851 350 P-QLGERR---RF-YRLIDPCLE---GCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYL 409 (476)
Q Consensus 350 ~-~~~~~~---~~-~~~~d~~l~---~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~ 409 (476)
. ...... .. ...+.+... .......++++.+|+.+||+.||++|||+.+++.| |||
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h----p~f 288 (288)
T cd07863 225 LPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH----PFF 288 (288)
T ss_pred CCChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC----CCC
Confidence 0 000000 00 000000000 00011235678999999999999999999999987 886
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-42 Score=329.52 Aligned_cols=249 Identities=26% Similarity=0.416 Sum_probs=197.5
Q ss_pred ccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCc-cCHHHHHHHHHHHhCCCCCceeeEEEEEEeCCeeEEE
Q 011851 127 CLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL-QGHKEWLAEVNYLGGLIHPNLVKLIGCCIEDDQRLLV 205 (476)
Q Consensus 127 ~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV 205 (476)
+.||+|+||.||+|.+. .+++.||+|.+..... .....+.+|++++++++||||+++++++......|+|
T Consensus 1 ~~lg~g~~g~vy~~~~~---------~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 71 (252)
T cd05084 1 ERIGRGNFGEVFSGRLR---------ADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIV 71 (252)
T ss_pred CccCcccCccEEEEEEe---------cCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEE
Confidence 46999999999998764 3577899998865432 2235688999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCcCCCCCCC
Q 011851 206 YEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGD 285 (476)
Q Consensus 206 ~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~ 285 (476)
|||+++++|.+++......+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 72 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~ 148 (252)
T cd05084 72 MELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGV 148 (252)
T ss_pred EeeccCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCccccccc
Confidence 9999999999999766667899999999999999999999988 9999999999999999999999999987644321
Q ss_pred ccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhhccccccccccCc
Q 011851 286 KTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPQLGERRRFYRLIDP 364 (476)
Q Consensus 286 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 364 (476)
.........++..|+|||.+.++.++.++|||||||++|||++ |..||...........+. ..
T Consensus 149 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~-------~~--------- 212 (252)
T cd05084 149 YASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIE-------QG--------- 212 (252)
T ss_pred ccccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHH-------cC---------
Confidence 1111111123456999999999899999999999999999998 888886443211111000 00
Q ss_pred ccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 011851 365 CLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALK 404 (476)
Q Consensus 365 ~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~ 404 (476)
.....+...+..+.+|+.+||+.||++|||+.++++.|+
T Consensus 213 -~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 213 -VRLPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred -CCCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 000111223578899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=333.02 Aligned_cols=254 Identities=24% Similarity=0.346 Sum_probs=203.5
Q ss_pred cCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCCCCCceeeEEEEEEeCC
Q 011851 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHPNLVKLIGCCIEDD 200 (476)
Q Consensus 121 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 200 (476)
++|.+.+.||+|+||.||+|.+. .+++.||+|+++.........+.+|+.+++.++||||+++++++..++
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~---------~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~ 79 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNV---------NTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRD 79 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEc---------CCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCC
Confidence 46888999999999999998654 467789999997665444556788999999999999999999999999
Q ss_pred eeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCcCC
Q 011851 201 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKD 280 (476)
Q Consensus 201 ~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~ 280 (476)
.+|+||||+++++|.+++.. ...+++..++.++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||++..
T Consensus 80 ~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~ 155 (267)
T cd06645 80 KLWICMEFCGGGSLQDIYHV-TGPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQ 155 (267)
T ss_pred EEEEEEeccCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeE
Confidence 99999999999999998854 457999999999999999999999988 99999999999999999999999999876
Q ss_pred CCCCCccceeeeeecCCCCCCcchhh---cCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhccccc
Q 011851 281 GPEGDKTHVSTRVMGTYGYAAPEYVM---TGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRR 357 (476)
Q Consensus 281 ~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 357 (476)
..... .......|+..|+|||++. ...++.++|||||||++|+|++|..||....+........ ..
T Consensus 156 ~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~--~~------- 224 (267)
T cd06645 156 ITATI--AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMT--KS------- 224 (267)
T ss_pred ccCcc--cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhh--cc-------
Confidence 43211 1123357999999999875 4568899999999999999999999986544322111100 00
Q ss_pred cccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011851 358 FYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEA 402 (476)
Q Consensus 358 ~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~ 402 (476)
....+.+.. ....+..+.++|.+||+.||++||++++|++|
T Consensus 225 --~~~~~~~~~--~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 225 --NFQPPKLKD--KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred --CCCCCcccc--cCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence 000011111 01124678899999999999999999999987
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=341.51 Aligned_cols=270 Identities=22% Similarity=0.284 Sum_probs=213.7
Q ss_pred hccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCC--CccCHHHHHHHHHHHhCCC-CCceeeEEEE
Q 011851 119 ATKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHD--GLQGHKEWLAEVNYLGGLI-HPNLVKLIGC 195 (476)
Q Consensus 119 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~--~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~ 195 (476)
....|+++++||+||.+.||++... ..+.||+|.+... +.+...-+..|+..|.+|+ |.+||+||+|
T Consensus 359 kg~~Yeilk~iG~GGSSkV~kV~~s----------~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DY 428 (677)
T KOG0596|consen 359 KGREYEILKQIGSGGSSKVFKVLNS----------DKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDY 428 (677)
T ss_pred CcchhhHHHhhcCCCcceeeeeecC----------CCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeee
Confidence 3457999999999999999997644 3345777765432 2233456899999999995 9999999999
Q ss_pred EEeCCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeec
Q 011851 196 CIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDF 275 (476)
Q Consensus 196 ~~~~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DF 275 (476)
-..++.+||||||= ..+|..+|.+....++...++.+..|++.|+.++|.++ |||.||||.|+|+- .|.+||+||
T Consensus 429 Ev~d~~lYmvmE~G-d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlV-kG~LKLIDF 503 (677)
T KOG0596|consen 429 EVTDGYLYMVMECG-DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLV-KGRLKLIDF 503 (677)
T ss_pred eccCceEEEEeecc-cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEE-eeeEEeeee
Confidence 99999999999975 56999999877666665588899999999999999999 99999999999986 678999999
Q ss_pred CCcCCCCCCCccceeeeeecCCCCCCcchhhcCC-----------CCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchh
Q 011851 276 GLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGH-----------LTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNL 344 (476)
Q Consensus 276 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-----------~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~ 344 (476)
|+|...............+||+.||+||.+.... .+.++||||||||||+|+.|+.||.....
T Consensus 504 GIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n------ 577 (677)
T KOG0596|consen 504 GIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN------ 577 (677)
T ss_pred chhcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH------
Confidence 9999877765555566689999999999987432 46789999999999999999999964311
Q ss_pred HHhhhhhhccccccccccCcccCCCCChHH-HHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCcccccCcchHHHHH
Q 011851 345 VEWARPQLGERRRFYRLIDPCLEGCFSIKG-AEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDMASSSSYVQAM 422 (476)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~-~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~~~~~~~~~~~~ 422 (476)
...++..+.||..+-.|+... ..++.++++.||++||++||++.+||+| ||+.....+.......
T Consensus 578 ---------~~aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh----pFl~~~~i~~~~m~~~ 643 (677)
T KOG0596|consen 578 ---------QIAKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH----PFLQIQPIPVEQMAKL 643 (677)
T ss_pred ---------HHHHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC----cccccccccchHHHHH
Confidence 112334555554333333222 3349999999999999999999999998 9988766555544433
|
|
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-43 Score=353.95 Aligned_cols=252 Identities=26% Similarity=0.392 Sum_probs=212.2
Q ss_pred cccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCCCCCceeeEEEEEEeCCeeEEEEE
Q 011851 128 LLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHPNLVKLIGCCIEDDQRLLVYE 207 (476)
Q Consensus 128 ~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E 207 (476)
+||+|.||+||.|++. .|..++|||.+........+-+..|+.+.++|+|.|||+++|.+.+++++-|.||
T Consensus 582 VLGKGTYG~VYA~RD~---------~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFME 652 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDM---------DTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFME 652 (1226)
T ss_pred EeecCceeEEEeeccc---------cceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEee
Confidence 6999999999999866 4667799999988777777778999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCCC--CHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeec-CCCceEEeecCCcCCCCCC
Q 011851 208 FMPRGSLENHLFRRSLPL--PWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLD-GEYNAKLSDFGLAKDGPEG 284 (476)
Q Consensus 208 ~~~~g~L~~~l~~~~~~l--~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~-~~~~vkl~DFG~a~~~~~~ 284 (476)
-++||+|.++|...-+++ .+...-.+.+||++||.|||++. |||||||-+||||+ -.|.+||+|||-++.+...
T Consensus 653 qVPGGSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgi 729 (1226)
T KOG4279|consen 653 QVPGGSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGI 729 (1226)
T ss_pred cCCCCcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhccC
Confidence 999999999998888888 88889999999999999999988 99999999999995 5689999999999886543
Q ss_pred CccceeeeeecCCCCCCcchhhcC--CCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhcccccccccc
Q 011851 285 DKTHVSTRVMGTYGYAAPEYVMTG--HLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRRFYRLI 362 (476)
Q Consensus 285 ~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 362 (476)
+. .+.++.||..|||||++..+ .|+.++|||||||++.||.||++||........ +.-. -.+++.-
T Consensus 730 nP--~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqA------AMFk----VGmyKvH 797 (1226)
T KOG4279|consen 730 NP--CTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQA------AMFK----VGMYKVH 797 (1226)
T ss_pred Cc--cccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhH------hhhh----hcceecC
Confidence 33 34558899999999999876 699999999999999999999999975432211 0001 1112211
Q ss_pred CcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCcccc
Q 011851 363 DPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDM 412 (476)
Q Consensus 363 d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~~ 412 (476)
. ..+...+.++..+|.+|+..||.+||++.++|.. ||++..
T Consensus 798 P-----~iPeelsaeak~FilrcFepd~~~R~sA~~LL~D----pFlq~~ 838 (1226)
T KOG4279|consen 798 P-----PIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQD----PFLQHN 838 (1226)
T ss_pred C-----CCcHHHHHHHHHHHHHHcCCCcccCccHHHhccC----cccccC
Confidence 1 1344568899999999999999999999999987 887754
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-42 Score=347.38 Aligned_cols=270 Identities=23% Similarity=0.307 Sum_probs=202.0
Q ss_pred hccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCC--ccCHHHHHHHHHHHhCCCCCceeeEEEEE
Q 011851 119 ATKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDG--LQGHKEWLAEVNYLGGLIHPNLVKLIGCC 196 (476)
Q Consensus 119 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~ 196 (476)
..++|++.+.||+|+||.||+|.+. .+|+.||+|++.... ......+.+|+.+++.++||||+++++++
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 89 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDT---------VLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVF 89 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEc---------CCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeee
Confidence 3568999999999999999998654 468889999996542 22345678999999999999999999998
Q ss_pred EeCC------eeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCce
Q 011851 197 IEDD------QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNA 270 (476)
Q Consensus 197 ~~~~------~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~v 270 (476)
...+ .+|+||||+++ +|.+.+.. .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+
T Consensus 90 ~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~ 162 (359)
T cd07876 90 TPQKSLEEFQDVYLVMELMDA-NLCQVIHM---ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTL 162 (359)
T ss_pred ccCCCccccceeEEEEeCCCc-CHHHHHhc---cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCE
Confidence 7543 57999999965 67666632 4788999999999999999999988 9999999999999999999
Q ss_pred EEeecCCcCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcch-hH----
Q 011851 271 KLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHN-LV---- 345 (476)
Q Consensus 271 kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~-~~---- 345 (476)
||+|||+++...... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.......... ..
T Consensus 163 kl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~ 239 (359)
T cd07876 163 KILDFGLARTACTNF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLG 239 (359)
T ss_pred EEecCCCccccccCc---cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC
Confidence 999999997643211 1233578999999999999999999999999999999999999997653211100 00
Q ss_pred -------Hhh----hhhhccccc-----cccccCccc---CCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011851 346 -------EWA----RPQLGERRR-----FYRLIDPCL---EGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPL 406 (476)
Q Consensus 346 -------~~~----~~~~~~~~~-----~~~~~d~~l---~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~ 406 (476)
... ......... +.+.+.... ........+.++.+||.+||+.||++|||+.|+++|
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h---- 315 (359)
T cd07876 240 TPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH---- 315 (359)
T ss_pred CCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC----
Confidence 000 000000000 000000000 000011124678999999999999999999999998
Q ss_pred CCccc
Q 011851 407 PYLKD 411 (476)
Q Consensus 407 ~~~~~ 411 (476)
||+..
T Consensus 316 p~~~~ 320 (359)
T cd07876 316 PYITV 320 (359)
T ss_pred chhhh
Confidence 88764
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-42 Score=334.48 Aligned_cols=260 Identities=26% Similarity=0.408 Sum_probs=206.9
Q ss_pred cCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCCCCCceeeEEEEEEeCC
Q 011851 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHPNLVKLIGCCIEDD 200 (476)
Q Consensus 121 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 200 (476)
.+|++.++||+|+||.||++..... ....++..+|+|.+..........+.+|+++++.++|+||+++++++.+.+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~----~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 80 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNL----LPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGR 80 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecC----CCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCC
Confidence 4688899999999999999865321 223467789999987665555667899999999999999999999999999
Q ss_pred eeEEEEEecCCCCHHHHHhhcC--------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecC
Q 011851 201 QRLLVYEFMPRGSLENHLFRRS--------------LPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDG 266 (476)
Q Consensus 201 ~~~lV~E~~~~g~L~~~l~~~~--------------~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~ 266 (476)
..++||||+++++|.+++.... ..+++..++.++.||+.||.|||+.+ |+||||||+|||+++
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~ 157 (280)
T cd05092 81 PLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQ 157 (280)
T ss_pred ceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcC
Confidence 9999999999999999986532 34789999999999999999999988 999999999999999
Q ss_pred CCceEEeecCCcCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHh-CCCCCCCCCCCCcchhH
Q 011851 267 EYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLV 345 (476)
Q Consensus 267 ~~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~ellt-G~~pf~~~~~~~~~~~~ 345 (476)
++.+||+|||++................+++.|+|||++.+..++.++|||||||++|||++ |..||............
T Consensus 158 ~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~ 237 (280)
T cd05092 158 GLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECI 237 (280)
T ss_pred CCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHH
Confidence 99999999999976533222122222345788999999999999999999999999999998 89998654322111111
Q ss_pred HhhhhhhccccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 011851 346 EWARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALK 404 (476)
Q Consensus 346 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~ 404 (476)
. .... . ..+...+..+.+|+.+||+.||.+||++.+|++.|+
T Consensus 238 ~-------~~~~---~-------~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 238 T-------QGRE---L-------ERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred H-------cCcc---C-------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 0 0000 0 001122567889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-42 Score=329.52 Aligned_cols=252 Identities=26% Similarity=0.417 Sum_probs=202.6
Q ss_pred cCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCCCCCceeeEEEEEEeCC
Q 011851 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHPNLVKLIGCCIEDD 200 (476)
Q Consensus 121 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 200 (476)
.+|++.+.||+|+||.||+|.+. .+..+|+|.+..... ....+.+|+.++++++||||+++++++.+.+
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~----------~~~~~aik~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 72 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWR----------GQYDVAIKMIKEGSM-SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQR 72 (256)
T ss_pred HHeEEeeEecCcccceEEEEEec----------CCCcEEEEEcCCCcc-cHHHHHHHHHHHhcCCCCCeeeEEEEEccCC
Confidence 35888999999999999998654 234599999875433 3467899999999999999999999999999
Q ss_pred eeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCcCC
Q 011851 201 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKD 280 (476)
Q Consensus 201 ~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~ 280 (476)
..|+||||+.+++|.+++......+++..++.++.||+.||.|||+.+ |+|+||||+|||++.++.+||+|||+++.
T Consensus 73 ~~~lv~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~ 149 (256)
T cd05113 73 PIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRY 149 (256)
T ss_pred CcEEEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCcccee
Confidence 999999999999999999765557899999999999999999999988 99999999999999999999999999876
Q ss_pred CCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhhccccccc
Q 011851 281 GPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPQLGERRRFY 359 (476)
Q Consensus 281 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 359 (476)
...... .......++..|+|||++.+..++.++|||||||++|+|++ |..||....... ...... .....
T Consensus 150 ~~~~~~-~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~---~~~~~~----~~~~~- 220 (256)
T cd05113 150 VLDDEY-TSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSE---TVEKVS----QGLRL- 220 (256)
T ss_pred cCCCce-eecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH---HHHHHh----cCCCC-
Confidence 543221 11112345678999999998889999999999999999998 999986543211 111110 00000
Q ss_pred cccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 011851 360 RLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALK 404 (476)
Q Consensus 360 ~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~ 404 (476)
..+...+..+.+++.+||+.||.+||++.+|++.|+
T Consensus 221 ---------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 221 ---------YRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred ---------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 001112578899999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-42 Score=333.18 Aligned_cols=259 Identities=29% Similarity=0.431 Sum_probs=202.7
Q ss_pred cCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCc-cCHHHHHHHHHHHhCCCCCceeeEEEEEEeC
Q 011851 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL-QGHKEWLAEVNYLGGLIHPNLVKLIGCCIED 199 (476)
Q Consensus 121 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~ 199 (476)
.+|++.+.||+|+||+||+|.+..++.. ....|++|.+..... ....++..|+.+++++.||||+++++++. +
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~-----~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~ 80 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDS-----IKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-G 80 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCc-----eeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-C
Confidence 3688899999999999999987543221 123588888754322 22356778888999999999999999875 4
Q ss_pred CeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCcC
Q 011851 200 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAK 279 (476)
Q Consensus 200 ~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~ 279 (476)
...++++||+++|+|.+++......+++..+..++.||+.||.|||+.+ ++||||||+|||++.++.+||+|||+++
T Consensus 81 ~~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~ 157 (279)
T cd05111 81 ASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVAD 157 (279)
T ss_pred CccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccce
Confidence 5678999999999999999776678999999999999999999999988 9999999999999999999999999998
Q ss_pred CCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhhcccccc
Q 011851 280 DGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPQLGERRRF 358 (476)
Q Consensus 280 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 358 (476)
...............++..|+|||++.+..++.++|||||||++|||++ |..||..........++. ...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~-------~~~-- 228 (279)
T cd05111 158 LLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLE-------KGE-- 228 (279)
T ss_pred eccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-------CCC--
Confidence 6544332222334567788999999998999999999999999999998 999997654322111111 000
Q ss_pred ccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 011851 359 YRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKP 405 (476)
Q Consensus 359 ~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~ 405 (476)
....+ ...+..+.+++.+||..||++|||+.++++.|..
T Consensus 229 -~~~~~-------~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~ 267 (279)
T cd05111 229 -RLAQP-------QICTIDVYMVMVKCWMIDENVRPTFKELANEFTR 267 (279)
T ss_pred -cCCCC-------CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHH
Confidence 00001 0124567889999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-43 Score=317.93 Aligned_cols=273 Identities=27% Similarity=0.409 Sum_probs=217.4
Q ss_pred cCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCC-ccCHHHHHHHHHHHhCCC-CCceeeEEEEEEe
Q 011851 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDG-LQGHKEWLAEVNYLGGLI-HPNLVKLIGCCIE 198 (476)
Q Consensus 121 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~-~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~ 198 (476)
++...+..||.|+.|+|++++.. .+|...|||.++... .+..+++++.++++...+ +|+||+.+|||..
T Consensus 92 ndl~~l~dlGsGtcG~V~k~~~r---------s~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~ 162 (391)
T KOG0983|consen 92 NDLENLGDLGSGTCGQVWKMRFR---------STGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFIT 162 (391)
T ss_pred HHhhhHHhhcCCCccceEEEEEc---------ccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEee
Confidence 34456678999999999997654 578889999997654 445678888888877665 8999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCc
Q 011851 199 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLA 278 (476)
Q Consensus 199 ~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a 278 (476)
+...++.||.| ...++.++.+-.+++++..+-++...++.||.||.+.++ |+|||+||+|||||+.|++||||||++
T Consensus 163 n~dV~IcMelM-s~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~--viHRDvKPSNILlDe~GniKlCDFGIs 239 (391)
T KOG0983|consen 163 NTDVFICMELM-STCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHG--VIHRDVKPSNILLDERGNIKLCDFGIS 239 (391)
T ss_pred CchHHHHHHHH-HHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcc--eeecccCccceEEccCCCEEeeccccc
Confidence 99999999998 556777776667889999999999999999999988553 999999999999999999999999999
Q ss_pred CCCCCCCccceeeeeecCCCCCCcchhhc---CCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhccc
Q 011851 279 KDGPEGDKTHVSTRVMGTYGYAAPEYVMT---GHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGER 355 (476)
Q Consensus 279 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~ 355 (476)
-...+.. ..++-.|-+.|||||.+.- ..|+.++||||||++|+||.||..||.+....- ....... .
T Consensus 240 GrlvdSk---AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdF--e~ltkvl---n-- 309 (391)
T KOG0983|consen 240 GRLVDSK---AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDF--EVLTKVL---N-- 309 (391)
T ss_pred ceeeccc---ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccH--HHHHHHH---h--
Confidence 8765433 2345679999999998864 479999999999999999999999998754321 1111110 0
Q ss_pred cccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCcccccCcchHHHHHHHHH
Q 011851 356 RRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDMASSSSYVQAMQAER 426 (476)
Q Consensus 356 ~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~~~~~~~~~~~~~~~~ 426 (476)
-..|+|.+.- ..+..+.+++..||..|+.+||...++|+| ||.+..+.-...+..+....
T Consensus 310 -----~ePP~L~~~~--gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h----~Fi~~ye~a~~dVa~WF~dV 369 (391)
T KOG0983|consen 310 -----EEPPLLPGHM--GFSPDFQSFVKDCLTKDHRKRPKYNKLLEH----PFIKRYETAEVDVASWFKDV 369 (391)
T ss_pred -----cCCCCCCccc--CcCHHHHHHHHHHhhcCcccCcchHHHhcC----cceeecchhhccHHHHHHHH
Confidence 0113333221 247889999999999999999999999998 99998877665555554443
|
|
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=334.97 Aligned_cols=260 Identities=25% Similarity=0.350 Sum_probs=211.5
Q ss_pred ccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCCCCCceeeEEEEEEeC
Q 011851 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHPNLVKLIGCCIED 199 (476)
Q Consensus 120 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~ 199 (476)
..+|++.+.||+|+||.||+|.+. .+++.||+|.+........+.+.+|+.+++.+.|+||+++++.+..+
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~---------~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~ 89 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDV---------ATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVG 89 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEEC---------CCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeC
Confidence 357999999999999999998654 46778999999876666667788999999999999999999999999
Q ss_pred CeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCcC
Q 011851 200 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAK 279 (476)
Q Consensus 200 ~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~ 279 (476)
.+.|+||||+++++|.+++.. ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++.
T Consensus 90 ~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~ 164 (296)
T cd06654 90 DELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCA 164 (296)
T ss_pred CEEEEeecccCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccch
Confidence 999999999999999998854 35889999999999999999999988 9999999999999999999999999987
Q ss_pred CCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhccccccc
Q 011851 280 DGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRRFY 359 (476)
Q Consensus 280 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 359 (476)
........ .....|++.|+|||.+.+..++.++|||||||++|+|++|+.||....+.... ..+.. ...
T Consensus 165 ~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~--~~~~~----~~~--- 233 (296)
T cd06654 165 QITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRAL--YLIAT----NGT--- 233 (296)
T ss_pred hccccccc--cCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhH--HHHhc----CCC---
Confidence 64332211 22356899999999999888999999999999999999999999754432111 11000 000
Q ss_pred cccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCcccccC
Q 011851 360 RLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDMAS 414 (476)
Q Consensus 360 ~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~~~~ 414 (476)
+.+ ..+...+..+.+|+.+||..||++||++.+++++ +|+.....
T Consensus 234 ----~~~--~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~----~~~~~~~~ 278 (296)
T cd06654 234 ----PEL--QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH----QFLKIAKP 278 (296)
T ss_pred ----CCC--CCccccCHHHHHHHHHHCcCCcccCcCHHHHhhC----hhhhccCC
Confidence 000 0112235678899999999999999999999997 88875544
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-42 Score=328.31 Aligned_cols=250 Identities=27% Similarity=0.416 Sum_probs=201.5
Q ss_pred CCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCCCCCceeeEEEEEEeCCe
Q 011851 122 SFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHPNLVKLIGCCIEDDQ 201 (476)
Q Consensus 122 ~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~ 201 (476)
+|++.+.||+|+||.||+|.+. ++..+|+|++..... ....+.+|++++++++|+||+++++++.+.+.
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~----------~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 73 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWR----------GKIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRP 73 (256)
T ss_pred HcchhhhhccCCCceEEEeEec----------CCccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCc
Confidence 5888999999999999998654 345699999865433 34568889999999999999999999999999
Q ss_pred eEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCcCCC
Q 011851 202 RLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDG 281 (476)
Q Consensus 202 ~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~ 281 (476)
.|+||||+++++|.+++......+++..++.++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||+++..
T Consensus 74 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~ 150 (256)
T cd05059 74 IFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYV 150 (256)
T ss_pred eEEEEecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceec
Confidence 99999999999999999766567899999999999999999999988 999999999999999999999999999765
Q ss_pred CCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhhcccccccc
Q 011851 282 PEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPQLGERRRFYR 360 (476)
Q Consensus 282 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 360 (476)
...... ......++..|+|||++.+..++.++|||||||++|+|++ |+.||....... ...... ....
T Consensus 151 ~~~~~~-~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~~~~~----~~~~--- 219 (256)
T cd05059 151 LDDQYT-SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSE---VVESVS----AGYR--- 219 (256)
T ss_pred cccccc-ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHH---HHHHHH----cCCc---
Confidence 432111 1111223457999999999999999999999999999999 899997543321 111100 0000
Q ss_pred ccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011851 361 LIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEAL 403 (476)
Q Consensus 361 ~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L 403 (476)
. ..+...+.++.+++.+||..+|++|||+.++++.|
T Consensus 220 ~-------~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 220 L-------YRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred C-------CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 0 01112367899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-42 Score=330.54 Aligned_cols=254 Identities=26% Similarity=0.392 Sum_probs=205.0
Q ss_pred CCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCCCCCceeeEEEEEEeCCe
Q 011851 122 SFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHPNLVKLIGCCIEDDQ 201 (476)
Q Consensus 122 ~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~ 201 (476)
+|.+.+.||+|+||.||+|.+. .++..||+|++.... ....++.+|++++++++|+||+++++++..++.
T Consensus 7 ~~~~~~~ig~g~~~~v~~~~~~---------~~~~~~~~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 76 (263)
T cd05052 7 DITMKHKLGGGQYGEVYEGVWK---------KYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP 76 (263)
T ss_pred HeEEeeecCCcccceEEEEEEe---------cCCceEEEEEecCCc-hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCC
Confidence 4788899999999999998764 357789999987543 335678899999999999999999999999999
Q ss_pred eEEEEEecCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCcCC
Q 011851 202 RLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKD 280 (476)
Q Consensus 202 ~~lV~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~ 280 (476)
+++||||+++++|.+++... ...+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 77 ~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~ 153 (263)
T cd05052 77 FYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRL 153 (263)
T ss_pred cEEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCccccc
Confidence 99999999999999998654 346899999999999999999999988 99999999999999999999999999987
Q ss_pred CCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhhccccccc
Q 011851 281 GPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPQLGERRRFY 359 (476)
Q Consensus 281 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 359 (476)
....... ......++..|+|||.+.+..++.++|||||||++|||++ |..||....... ...... .
T Consensus 154 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~---~~~~~~----~----- 220 (263)
T cd05052 154 MTGDTYT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ---VYELLE----K----- 220 (263)
T ss_pred cccceee-ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHHHH----C-----
Confidence 5442211 1111234667999999999999999999999999999998 999987543211 111100 0
Q ss_pred cccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011851 360 RLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPL 406 (476)
Q Consensus 360 ~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~ 406 (476)
......+...+.++.+++.+||+.||++||++.++++.|+.+
T Consensus 221 -----~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 221 -----GYRMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred -----CCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 000111222367899999999999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-42 Score=335.32 Aligned_cols=269 Identities=26% Similarity=0.423 Sum_probs=209.4
Q ss_pred ccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCc-cCHHHHHHHHHHHhCCCCCceeeEEEEEEe
Q 011851 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL-QGHKEWLAEVNYLGGLIHPNLVKLIGCCIE 198 (476)
Q Consensus 120 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~ 198 (476)
.++|++.++||+|+||.||+|..... .....+..||+|.+..... .....+.+|+.+++.++||||+++++++.+
T Consensus 5 ~~~~~i~~~lg~G~~g~Vy~~~~~~~----~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 80 (288)
T cd05061 5 REKITLLRELGQGSFGMVYEGNARDI----IKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSK 80 (288)
T ss_pred HHHceeeeeecCCCCcEEEEEEEecc----CCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC
Confidence 46799999999999999999976531 1122456799999865432 223457889999999999999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHHhhcC---------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCc
Q 011851 199 DDQRLLVYEFMPRGSLENHLFRRS---------LPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYN 269 (476)
Q Consensus 199 ~~~~~lV~E~~~~g~L~~~l~~~~---------~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~ 269 (476)
.+..|+||||+++|+|.+++.... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.
T Consensus 81 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~ 157 (288)
T cd05061 81 GQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFT 157 (288)
T ss_pred CCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCc
Confidence 999999999999999999996421 23567788899999999999999988 999999999999999999
Q ss_pred eEEeecCCcCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHh-CCCCCCCCCCCCcchhHHhh
Q 011851 270 AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWA 348 (476)
Q Consensus 270 vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~ellt-G~~pf~~~~~~~~~~~~~~~ 348 (476)
++|+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||....... .....
T Consensus 158 ~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~---~~~~~ 234 (288)
T cd05061 158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQ---VLKFV 234 (288)
T ss_pred EEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHH
Confidence 99999999986533222211222345778999999999999999999999999999999 788886543211 11110
Q ss_pred hhhhccccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC--CCCcccc
Q 011851 349 RPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKP--LPYLKDM 412 (476)
Q Consensus 349 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~--~~~~~~~ 412 (476)
. ... .. ..+...+..+.+++.+||+.||++|||+.++++.|+. +|+|+++
T Consensus 235 ~----~~~-~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~~ 286 (288)
T cd05061 235 M----DGG-YL---------DQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEV 286 (288)
T ss_pred H----cCC-CC---------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCCC
Confidence 0 000 00 0111225689999999999999999999999999887 7777764
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-42 Score=334.03 Aligned_cols=259 Identities=25% Similarity=0.411 Sum_probs=208.8
Q ss_pred CCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCCCCCceeeEEEEEEeCCee
Q 011851 123 FRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHPNLVKLIGCCIEDDQR 202 (476)
Q Consensus 123 y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~ 202 (476)
|++.+.||+|+||.||+|.+. .++..+++|.+........+.+.+|+++++.++||||+++++++..++..
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~---------~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~ 77 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNK---------ETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNL 77 (282)
T ss_pred HHHHhhcccCCCeEEEEEEEC---------CCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEE
Confidence 678899999999999998765 46778999999766555566788999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCcCCCC
Q 011851 203 LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGP 282 (476)
Q Consensus 203 ~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~ 282 (476)
|+||||+++++|..++.+...++++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 78 ~~v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~ 154 (282)
T cd06643 78 WILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNT 154 (282)
T ss_pred EEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEcccccccccc
Confidence 9999999999999988766678999999999999999999999988 9999999999999999999999999987643
Q ss_pred CCCccceeeeeecCCCCCCcchhh-----cCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhccccc
Q 011851 283 EGDKTHVSTRVMGTYGYAAPEYVM-----TGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRR 357 (476)
Q Consensus 283 ~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 357 (476)
... .......|++.|+|||++. +..++.++|||||||++|||++|+.||........ ....... ..
T Consensus 155 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~--~~~~~~~---~~-- 225 (282)
T cd06643 155 RTI--QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRV--LLKIAKS---EP-- 225 (282)
T ss_pred ccc--cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHH--HHHHhhc---CC--
Confidence 221 1123357899999999984 34578899999999999999999999975432111 1111000 00
Q ss_pred cccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCcccccC
Q 011851 358 FYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDMAS 414 (476)
Q Consensus 358 ~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~~~~ 414 (476)
.... .+...+.++.+||.+||+.||.+||++.+++++ ||++....
T Consensus 226 -~~~~-------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~----~~~~~~~~ 270 (282)
T cd06643 226 -PTLA-------QPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQH----PFVTVNSN 270 (282)
T ss_pred -CCCC-------CccccCHHHHHHHHHHccCChhhCcCHHHHhcC----CCEeccCC
Confidence 0000 111235688999999999999999999999987 99886533
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-42 Score=329.71 Aligned_cols=253 Identities=26% Similarity=0.433 Sum_probs=204.3
Q ss_pred cCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCCCCCceeeEEEEEEeCC
Q 011851 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHPNLVKLIGCCIEDD 200 (476)
Q Consensus 121 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 200 (476)
++|++.++||+|+||.||+|.+. ++..||+|.+..... ..+.+.+|+.+++.++|+||+++++++.+.+
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~----------~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 74 (261)
T cd05072 6 ESIKLVKKLGAGQFGEVWMGYYN----------NSTKVAVKTLKPGTM-SVQAFLEEANLMKTLQHDKLVRLYAVVTKEE 74 (261)
T ss_pred HHeEEeeecCCcCCceEEEEEec----------CCceEEEEEccCCch-hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 46899999999999999999754 345699999865432 3567889999999999999999999999999
Q ss_pred eeEEEEEecCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCcC
Q 011851 201 QRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAK 279 (476)
Q Consensus 201 ~~~lV~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~ 279 (476)
..++||||+++++|.+++... ...+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||++.
T Consensus 75 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~ 151 (261)
T cd05072 75 PIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLAR 151 (261)
T ss_pred CcEEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccce
Confidence 999999999999999998653 456889999999999999999999988 9999999999999999999999999998
Q ss_pred CCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhhcccccc
Q 011851 280 DGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPQLGERRRF 358 (476)
Q Consensus 280 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 358 (476)
........ ......++..|+|||++....++.++|||||||++|+|++ |..||....... ...... ....
T Consensus 152 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~---~~~~~~----~~~~- 222 (261)
T cd05072 152 VIEDNEYT-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSD---VMSALQ----RGYR- 222 (261)
T ss_pred ecCCCcee-ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHH---HHHHHH----cCCC-
Confidence 75432211 1122346678999999998899999999999999999998 999996543221 111110 0000
Q ss_pred ccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 011851 359 YRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKP 405 (476)
Q Consensus 359 ~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~ 405 (476)
.+.. ...+.++.+++.+||..+|++||+++++++.|+.
T Consensus 223 ----~~~~-----~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 223 ----MPRM-----ENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred ----CCCC-----CCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 0001 1225678999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-42 Score=330.34 Aligned_cols=254 Identities=29% Similarity=0.445 Sum_probs=208.5
Q ss_pred ccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCCCCCceeeEEEEEEeC
Q 011851 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHPNLVKLIGCCIED 199 (476)
Q Consensus 120 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~ 199 (476)
..+|++.++||.|+||.||+|.+. .+..+|+|++..........+..|+.+++.++|+||+++++++.+.
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~----------~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 74 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWK----------NRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVG 74 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEec----------CCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecC
Confidence 346899999999999999998765 2567999999877665667888999999999999999999999999
Q ss_pred CeeEEEEEecCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCc
Q 011851 200 DQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLA 278 (476)
Q Consensus 200 ~~~~lV~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a 278 (476)
+..++||||+++++|.+++... ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 75 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~ 151 (261)
T cd05148 75 EPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLA 151 (261)
T ss_pred CCeEEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccch
Confidence 9999999999999999999653 456899999999999999999999988 999999999999999999999999999
Q ss_pred CCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhhccccc
Q 011851 279 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPQLGERRR 357 (476)
Q Consensus 279 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 357 (476)
......... .....++..|+|||++....++.++||||||+++|+|++ |+.||....... ........
T Consensus 152 ~~~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~---~~~~~~~~------ 220 (261)
T cd05148 152 RLIKEDVYL--SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHE---VYDQITAG------ 220 (261)
T ss_pred hhcCCcccc--ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHH---HHHHHHhC------
Confidence 765432211 122346678999999998899999999999999999998 899997544211 11111100
Q ss_pred cccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 011851 358 FYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKP 405 (476)
Q Consensus 358 ~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~ 405 (476)
.....+...++.+.+++.+||+.||++|||+.++++.|+.
T Consensus 221 --------~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 221 --------YRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred --------CcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 0001112335788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-42 Score=333.72 Aligned_cols=277 Identities=26% Similarity=0.344 Sum_probs=206.0
Q ss_pred cCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCCCCCceeeEEEEEEe--
Q 011851 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHPNLVKLIGCCIE-- 198 (476)
Q Consensus 121 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~-- 198 (476)
.+|++.+.||+|+||.||+|.... ....+++.||+|.+........+.+.+|+++|++++||||+++++++..
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~-----~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 78 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDP-----LQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG 78 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecC-----CcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCC
Confidence 478999999999999999987541 2345788999999977655556678899999999999999999998754
Q ss_pred CCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCc
Q 011851 199 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLA 278 (476)
Q Consensus 199 ~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a 278 (476)
...+++||||+++++|.+++.+....+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 79 ~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~ 155 (284)
T cd05081 79 RRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLT 155 (284)
T ss_pred CCceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCccc
Confidence 34689999999999999999766667899999999999999999999988 999999999999999999999999999
Q ss_pred CCCCCCCcccee-eeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhccccc
Q 011851 279 KDGPEGDKTHVS-TRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRR 357 (476)
Q Consensus 279 ~~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 357 (476)
............ ....++..|+|||++.+..++.++|||||||++|||++|..++....... ................
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 234 (284)
T cd05081 156 KVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEF-MRMMGNDKQGQMIVYH 234 (284)
T ss_pred ccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhh-hhhcccccccccchHH
Confidence 876443221111 11223456999999998899999999999999999999887764322110 0000000000000000
Q ss_pred cccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011851 358 FYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPL 406 (476)
Q Consensus 358 ~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~ 406 (476)
+.+.+............+.++.+|+.+||..+|++|||+.+|++.|+.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 235 LIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred HHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 0000000000011122356899999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-42 Score=333.69 Aligned_cols=261 Identities=27% Similarity=0.421 Sum_probs=211.6
Q ss_pred ccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCCCCCceeeEEEEEEeC
Q 011851 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHPNLVKLIGCCIED 199 (476)
Q Consensus 120 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~ 199 (476)
.++|++.+.||.|+||.||+|.+. .++..||+|++........+.+..|++++++++|+||+++++++..+
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~---------~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 74 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHK---------ETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYE 74 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEc---------CCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecC
Confidence 346899999999999999998764 36778999999766555556788999999999999999999999999
Q ss_pred CeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCcC
Q 011851 200 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAK 279 (476)
Q Consensus 200 ~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~ 279 (476)
...|+||||+++++|.+++.+....+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||++.
T Consensus 75 ~~~~lv~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~ 151 (280)
T cd06611 75 NKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSA 151 (280)
T ss_pred CeEEEEeeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccch
Confidence 9999999999999999998776677999999999999999999999988 9999999999999999999999999987
Q ss_pred CCCCCCccceeeeeecCCCCCCcchhhc-----CCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhcc
Q 011851 280 DGPEGDKTHVSTRVMGTYGYAAPEYVMT-----GHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGE 354 (476)
Q Consensus 280 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~ 354 (476)
....... ......|++.|+|||++.. ..++.++|||||||++|+|++|+.||........ ...+.. ..
T Consensus 152 ~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~--~~~~~~---~~ 224 (280)
T cd06611 152 KNKSTLQ--KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRV--LLKILK---SE 224 (280)
T ss_pred hhccccc--ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHH--HHHHhc---CC
Confidence 6433221 1234678999999999853 4578899999999999999999999975432211 111100 00
Q ss_pred ccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCccccc
Q 011851 355 RRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDMA 413 (476)
Q Consensus 355 ~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~~~ 413 (476)
.+.+. .+...+.++.+++.+||+.||.+||++.+++++ +|+.+..
T Consensus 225 --------~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~----~~~~~~~ 269 (280)
T cd06611 225 --------PPTLD--QPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH----PFVSDQS 269 (280)
T ss_pred --------CCCcC--CcccCCHHHHHHHHHHhccChhhCcCHHHHhcC----hhhcccc
Confidence 00000 111235678899999999999999999999998 9988764
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-42 Score=334.99 Aligned_cols=258 Identities=29% Similarity=0.419 Sum_probs=205.5
Q ss_pred CCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccC---HHHHHHHHHHHhCCCCCceeeEEEEEEeC
Q 011851 123 FRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQG---HKEWLAEVNYLGGLIHPNLVKLIGCCIED 199 (476)
Q Consensus 123 y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~---~~~~~~E~~~l~~l~hpnIv~l~~~~~~~ 199 (476)
|+..++||+|+||+||+|.+. .+++.||+|.+....... ...+.+|+++|+.++|+||+.+++++..+
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~ 72 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVR---------ATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETK 72 (285)
T ss_pred ceEEEEEecCCCeEEEEEEEC---------CCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecC
Confidence 777889999999999998765 467889999987543322 23467899999999999999999999999
Q ss_pred CeeEEEEEecCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCc
Q 011851 200 DQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLA 278 (476)
Q Consensus 200 ~~~~lV~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a 278 (476)
+..|+||||+++++|.+++... ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++
T Consensus 73 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~ 149 (285)
T cd05632 73 DALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLA 149 (285)
T ss_pred CEEEEEEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcc
Confidence 9999999999999999888653 346999999999999999999999988 999999999999999999999999998
Q ss_pred CCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhcccccc
Q 011851 279 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRRF 358 (476)
Q Consensus 279 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 358 (476)
........ .....|+..|+|||++.+..++.++|||||||++|+|++|..||...........+. .....
T Consensus 150 ~~~~~~~~---~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~---~~~~~---- 219 (285)
T cd05632 150 VKIPEGES---IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVD---RRVLE---- 219 (285)
T ss_pred eecCCCCc---ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH---Hhhhc----
Confidence 76433221 123579999999999998999999999999999999999999997543221111111 00000
Q ss_pred ccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHHhcCCCCccccc
Q 011851 359 YRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPR-----MSEVVEALKPLPYLKDMA 413 (476)
Q Consensus 359 ~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt-----~~ell~~L~~~~~~~~~~ 413 (476)
. ...+....+.++.+|+.+||+.||++||+ +.+++++ +||+.+.
T Consensus 220 --~-----~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~----~~~~~~~ 268 (285)
T cd05632 220 --T-----EEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH----PFFRNMN 268 (285)
T ss_pred --c-----ccccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC----hhhhcCC
Confidence 0 00111223567889999999999999999 5565554 9988764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-42 Score=332.06 Aligned_cols=256 Identities=29% Similarity=0.423 Sum_probs=203.7
Q ss_pred hccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCC-CCCceeeEEEEEE
Q 011851 119 ATKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGL-IHPNLVKLIGCCI 197 (476)
Q Consensus 119 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~ 197 (476)
+++.|++.+.||+|+||.||+|.+. .+++.||+|++.... .....+..|+.+++++ +|+||+++++++.
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~---------~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~ 73 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHV---------KTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFI 73 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEc---------CCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEe
Confidence 4567899999999999999998654 467789999997553 3446788899999998 6999999999987
Q ss_pred eC------CeeEEEEEecCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCce
Q 011851 198 ED------DQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNA 270 (476)
Q Consensus 198 ~~------~~~~lV~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~v 270 (476)
.. ..+|+||||+++++|.+++... ...+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+
T Consensus 74 ~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~ 150 (272)
T cd06637 74 KKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEV 150 (272)
T ss_pred ecCCCCCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCE
Confidence 53 4689999999999999998753 456899999999999999999999988 9999999999999999999
Q ss_pred EEeecCCcCCCCCCCccceeeeeecCCCCCCcchhh-----cCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhH
Q 011851 271 KLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV 345 (476)
Q Consensus 271 kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~ 345 (476)
+|+|||++........ ......|++.|+|||++. +..++.++|||||||++|||++|..||............
T Consensus 151 ~l~Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~ 228 (272)
T cd06637 151 KLVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI 228 (272)
T ss_pred EEccCCCceecccccc--cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHH
Confidence 9999999976533211 123367999999999986 346888999999999999999999999654321111000
Q ss_pred HhhhhhhccccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCc
Q 011851 346 EWARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYL 409 (476)
Q Consensus 346 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~ 409 (476)
.. .. ...+ .....+.++.+|+.+||..||.+|||+.++++| |||
T Consensus 229 -------~~-~~-----~~~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~----~~~ 272 (272)
T cd06637 229 -------PR-NP-----APRL---KSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKH----PFI 272 (272)
T ss_pred -------hc-CC-----CCCC---CCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhC----CCC
Confidence 00 00 0000 011225678999999999999999999999997 875
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=347.47 Aligned_cols=270 Identities=23% Similarity=0.290 Sum_probs=202.6
Q ss_pred hccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCc--cCHHHHHHHHHHHhCCCCCceeeEEEEE
Q 011851 119 ATKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL--QGHKEWLAEVNYLGGLIHPNLVKLIGCC 196 (476)
Q Consensus 119 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~ 196 (476)
..++|++.+.||+|+||.||+|.+. .+++.||||.+..... .....+.+|+.+++.++||||+++++++
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 85 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDA---------VLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVF 85 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEec---------CCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeee
Confidence 4578999999999999999998654 4678899999975432 2345678899999999999999999998
Q ss_pred EeC------CeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCce
Q 011851 197 IED------DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNA 270 (476)
Q Consensus 197 ~~~------~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~v 270 (476)
... ...|+||||+++ +|.+.+.. .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+
T Consensus 86 ~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~ 158 (355)
T cd07874 86 TPQKSLEEFQDVYLVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTL 158 (355)
T ss_pred eccccccccceeEEEhhhhcc-cHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCE
Confidence 654 357999999965 67776633 4889999999999999999999988 9999999999999999999
Q ss_pred EEeecCCcCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchh-HHh--
Q 011851 271 KLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNL-VEW-- 347 (476)
Q Consensus 271 kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~-~~~-- 347 (476)
||+|||+++...... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||........... +..
T Consensus 159 kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~ 235 (355)
T cd07874 159 KILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLG 235 (355)
T ss_pred EEeeCcccccCCCcc---ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence 999999998643321 12335799999999999999999999999999999999999999976432111100 000
Q ss_pred -------------hhhhhccccccc-----cccCccc---CCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011851 348 -------------ARPQLGERRRFY-----RLIDPCL---EGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPL 406 (476)
Q Consensus 348 -------------~~~~~~~~~~~~-----~~~d~~l---~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~ 406 (476)
............ ..+...+ ........+.++.+||.+||+.||++|||+.|+++|
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h---- 311 (355)
T cd07874 236 TPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH---- 311 (355)
T ss_pred CCCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC----
Confidence 000000000000 0000000 000111224678999999999999999999999998
Q ss_pred CCccc
Q 011851 407 PYLKD 411 (476)
Q Consensus 407 ~~~~~ 411 (476)
||+..
T Consensus 312 p~~~~ 316 (355)
T cd07874 312 PYINV 316 (355)
T ss_pred cchhc
Confidence 88863
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-42 Score=332.62 Aligned_cols=272 Identities=31% Similarity=0.449 Sum_probs=204.5
Q ss_pred CCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCc-cCHHHHHHHHHHHhCCCCCceeeEEEEEEeC--
Q 011851 123 FRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL-QGHKEWLAEVNYLGGLIHPNLVKLIGCCIED-- 199 (476)
Q Consensus 123 y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~-- 199 (476)
|.+.+.||+|+||+||++.... ....++..||+|+++.... .....+.+|+++|++++||||+++++++...
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~-----~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 80 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDP-----ANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGG 80 (283)
T ss_pred ceeceecccCCCcEEEEeeEcc-----ccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence 3888999999999999876542 2335788899999976533 2345688999999999999999999987754
Q ss_pred CeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCcC
Q 011851 200 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAK 279 (476)
Q Consensus 200 ~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~ 279 (476)
..+++||||+++++|.+++... .+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.++|+|||+++
T Consensus 81 ~~~~lv~e~~~~~~l~~~~~~~--~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~ 155 (283)
T cd05080 81 KGLQLIMEYVPLGSLRDYLPKH--KLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAK 155 (283)
T ss_pred ceEEEEecCCCCCCHHHHHHHc--CCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeeccccc
Confidence 4689999999999999998553 4899999999999999999999988 9999999999999999999999999998
Q ss_pred CCCCCCccc-eeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhcccccc
Q 011851 280 DGPEGDKTH-VSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRRF 358 (476)
Q Consensus 280 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 358 (476)
......... ......++..|+|||++.+..++.++|||||||++|||++|..||....... ........... ....+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~-~~~~~~~~~~~-~~~~~ 233 (283)
T cd05080 156 AVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKF-EEMIGPKQGQM-TVVRL 233 (283)
T ss_pred ccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchh-hhhhccccccc-chhhh
Confidence 754432211 1112345667999999988899999999999999999999999986543211 01110000000 00000
Q ss_pred ccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011851 359 YRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPL 406 (476)
Q Consensus 359 ~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~ 406 (476)
...++.......+...+.++.+++.+||+.||++|||++++++.|+.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~ 281 (283)
T cd05080 234 IELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM 281 (283)
T ss_pred hhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHh
Confidence 111111111111223357899999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-42 Score=332.69 Aligned_cols=261 Identities=28% Similarity=0.393 Sum_probs=204.1
Q ss_pred ccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCcc-CHHHHHHHHHHHhCCCCCceeeEEEEEEe
Q 011851 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQ-GHKEWLAEVNYLGGLIHPNLVKLIGCCIE 198 (476)
Q Consensus 120 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~~ 198 (476)
.++|.+.+.||+|+||.||+|.+..... ..++..||+|.+...... ....+..|+.+++.++|+||+++++++.+
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~----~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 80 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDG----DAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFE 80 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCC----CCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEcc
Confidence 3568999999999999999998753211 125678999988754332 23468889999999999999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHHhhcC------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCC---c
Q 011851 199 DDQRLLVYEFMPRGSLENHLFRRS------LPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEY---N 269 (476)
Q Consensus 199 ~~~~~lV~E~~~~g~L~~~l~~~~------~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~---~ 269 (476)
.+..++||||+++++|.+++.... ..+++..++.++.||+.||+|||+.+ ++||||||+|||++.++ .
T Consensus 81 ~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~ 157 (277)
T cd05036 81 RLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRV 157 (277)
T ss_pred CCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcc
Confidence 999999999999999999986542 25899999999999999999999988 99999999999998654 5
Q ss_pred eEEeecCCcCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHh-CCCCCCCCCCCCcchhHHhh
Q 011851 270 AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWA 348 (476)
Q Consensus 270 vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~ellt-G~~pf~~~~~~~~~~~~~~~ 348 (476)
+||+|||+++................+..|+|||++.+..++.++|||||||++|||++ |..||...........+.
T Consensus 158 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~-- 235 (277)
T cd05036 158 AKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVT-- 235 (277)
T ss_pred eEeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH--
Confidence 99999999987533222111112234567999999999999999999999999999997 999997543321111110
Q ss_pred hhhhccccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 011851 349 RPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALK 404 (476)
Q Consensus 349 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~ 404 (476)
.. ....++...+..+.+++.+||+.||++||++.+|+++|+
T Consensus 236 -----~~----------~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 236 -----GG----------GRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred -----cC----------CcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 00 001112223578899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-42 Score=336.50 Aligned_cols=273 Identities=23% Similarity=0.339 Sum_probs=208.3
Q ss_pred cCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCcc-CHHHHHHHHHHHhCCCCCceeeEEEEEEeC
Q 011851 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQ-GHKEWLAEVNYLGGLIHPNLVKLIGCCIED 199 (476)
Q Consensus 121 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~ 199 (476)
++|.+.+.||+|+||.||+|.+. .+++.||+|.++..... ....+.+|+.+++.++||||+++++++..+
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~ 76 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSK---------LTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTE 76 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEc---------CCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecC
Confidence 46999999999999999998654 46778999998754332 234677899999999999999999999999
Q ss_pred CeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCcC
Q 011851 200 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAK 279 (476)
Q Consensus 200 ~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~ 279 (476)
+..|+||||++ ++|.+++......+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.
T Consensus 77 ~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~ 152 (301)
T cd07873 77 KSLTLVFEYLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLAR 152 (301)
T ss_pred CeEEEEEeccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchh
Confidence 99999999996 5999988776667899999999999999999999988 9999999999999999999999999997
Q ss_pred CCCCCCccceeeeeecCCCCCCcchhhcC-CCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhh--------h
Q 011851 280 DGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR--------P 350 (476)
Q Consensus 280 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~--------~ 350 (476)
........ .....+++.|+|||++.+. .++.++|||||||++|||++|+.||...........+.... +
T Consensus 153 ~~~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (301)
T cd07873 153 AKSIPTKT--YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWP 230 (301)
T ss_pred ccCCCCCc--ccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhch
Confidence 64332211 2234578999999988764 58889999999999999999999997654321111100000 0
Q ss_pred hhcccccc-----ccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCccccc
Q 011851 351 QLGERRRF-----YRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDMA 413 (476)
Q Consensus 351 ~~~~~~~~-----~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~~~ 413 (476)
.......+ ......++. ......+..+.+||.+||+.||.+|||+.++++| |||+...
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h----~~f~~~~ 293 (301)
T cd07873 231 GILSNEEFKSYNYPKYRADCLH-NHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKH----PYFHCLG 293 (301)
T ss_pred hhhccccccccccCccccccHH-hhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcC----ccccccc
Confidence 00000000 000000000 0011225678999999999999999999999998 9997654
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=350.63 Aligned_cols=259 Identities=30% Similarity=0.467 Sum_probs=208.0
Q ss_pred cCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCC---ccCHHHHHHHHHHHhCCCCCceeeEEEEEE
Q 011851 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDG---LQGHKEWLAEVNYLGGLIHPNLVKLIGCCI 197 (476)
Q Consensus 121 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~ 197 (476)
++-.+.++||+|+||.||+|.+...+.. ....||||..+... ....+++++|.++|++++|||||++||+..
T Consensus 157 ~~v~l~kkLGeGaFGeV~~G~l~~~~~~-----~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~ 231 (474)
T KOG0194|consen 157 SDIELGKKLGEGAFGEVFKGKLKLKNGF-----KVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAV 231 (474)
T ss_pred cCccccceeecccccEEEEEEEEecCCc-----eeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence 4455668999999999999987643221 11229999998533 344678999999999999999999999999
Q ss_pred eCCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCC
Q 011851 198 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGL 277 (476)
Q Consensus 198 ~~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~ 277 (476)
....++||||+|.||+|.++|.+....++..+...++.+.+.||+|||+.+ +|||||-..|+|++.++.+||+|||+
T Consensus 232 ~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKISDFGL 308 (474)
T KOG0194|consen 232 LEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKISDFGL 308 (474)
T ss_pred CCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeCcccc
Confidence 999999999999999999999877667999999999999999999999988 99999999999999999999999999
Q ss_pred cCCCCCCCccceee-eeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhhccc
Q 011851 278 AKDGPEGDKTHVST-RVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPQLGER 355 (476)
Q Consensus 278 a~~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~ 355 (476)
++.... ..... ...-...|+|||.+....|+.++|||||||++||+++ |..||.+.........+. .+.
T Consensus 309 s~~~~~---~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~------~~~ 379 (474)
T KOG0194|consen 309 SRAGSQ---YVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIV------KNG 379 (474)
T ss_pred ccCCcc---eeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHH------hcC
Confidence 987531 11111 1124567999999999999999999999999999999 888997765432111110 111
Q ss_pred cccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011851 356 RRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPL 406 (476)
Q Consensus 356 ~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~ 406 (476)
.+ -..+...+.++..++.+||..||++||+|.++.+.|+.+
T Consensus 380 ~r----------~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~ 420 (474)
T KOG0194|consen 380 YR----------MPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEAL 420 (474)
T ss_pred cc----------CCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHH
Confidence 00 011223478889999999999999999999999987654
|
|
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=333.10 Aligned_cols=256 Identities=32% Similarity=0.518 Sum_probs=204.9
Q ss_pred CCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHH--HHHHHHHHHhCCCCCceeeEEEEEEeCC
Q 011851 123 FRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHK--EWLAEVNYLGGLIHPNLVKLIGCCIEDD 200 (476)
Q Consensus 123 y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~--~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 200 (476)
|++.+.||+|+||+||++.+. .+++.||+|++......... ...+|+.++++++||||+++++++.+..
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~---------~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~ 71 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNK---------KNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDN 71 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEET---------TTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESS
T ss_pred CEEeEEEEeCCCEEEEEEEEC---------CCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccccc
Confidence 678899999999999998655 56778999999877554332 2356999999999999999999999999
Q ss_pred eeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCcCC
Q 011851 201 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKD 280 (476)
Q Consensus 201 ~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~ 280 (476)
..++||||+++++|.+++. ....+++..+..++.||+.||.+||+.+ |+|+||||+|||++.++.++|+|||++..
T Consensus 72 ~~~~v~~~~~~~~L~~~l~-~~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~ 147 (260)
T PF00069_consen 72 YLYIVMEYCPGGSLQDYLQ-KNKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVK 147 (260)
T ss_dssp EEEEEEEEETTEBHHHHHH-HHSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEE
T ss_pred ccccccccccccccccccc-cccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccc
Confidence 9999999999999999996 4456899999999999999999999988 99999999999999999999999999975
Q ss_pred CCCCCccceeeeeecCCCCCCcchhh-cCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhh-hhcccccc
Q 011851 281 GPEGDKTHVSTRVMGTYGYAAPEYVM-TGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP-QLGERRRF 358 (476)
Q Consensus 281 ~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~ 358 (476)
... .........++..|+|||++. +..++.++||||||+++|+|++|..||................. ......
T Consensus 148 ~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~-- 223 (260)
T PF00069_consen 148 LSE--NNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSS-- 223 (260)
T ss_dssp STS--TTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHT--
T ss_pred ccc--cccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccc--
Confidence 311 122233467899999999998 78899999999999999999999999986521111111111110 000000
Q ss_pred ccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCc
Q 011851 359 YRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYL 409 (476)
Q Consensus 359 ~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~ 409 (476)
. .......++.+++.+||+.||++||++.+++++ |||
T Consensus 224 -------~---~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~----~~~ 260 (260)
T PF00069_consen 224 -------Q---QSREKSEELRDLIKKMLSKDPEQRPSAEELLKH----PWF 260 (260)
T ss_dssp -------T---SHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTS----GGG
T ss_pred -------c---ccchhHHHHHHHHHHHccCChhHCcCHHHHhcC----CCC
Confidence 0 000013789999999999999999999999997 775
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-42 Score=328.48 Aligned_cols=254 Identities=29% Similarity=0.429 Sum_probs=204.2
Q ss_pred ccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCCCCCceeeEEEEEEeC
Q 011851 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHPNLVKLIGCCIED 199 (476)
Q Consensus 120 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~ 199 (476)
.++|++.+.||+|+||.||+|.+. +++.||+|.++.... ..+++.+|+.++++++|+||+++++++...
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~----------~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 73 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWN----------NTTPVAVKTLKPGTM-DPKDFLAEAQIMKKLRHPKLIQLYAVCTLE 73 (261)
T ss_pred hhheeeEEEecccCCccEEEEEec----------CCeEEEEEeeCCCcc-cHHHHHHHHHHHHHCCCCCccceeEEEecC
Confidence 356899999999999999998754 345699999976543 356788999999999999999999999999
Q ss_pred CeeEEEEEecCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCc
Q 011851 200 DQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLA 278 (476)
Q Consensus 200 ~~~~lV~E~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a 278 (476)
+..|+||||+++++|.+++.... ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++
T Consensus 74 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~ 150 (261)
T cd05068 74 EPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLA 150 (261)
T ss_pred CCeeeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceE
Confidence 99999999999999999996543 56899999999999999999999988 999999999999999999999999999
Q ss_pred CCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhhccccc
Q 011851 279 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPQLGERRR 357 (476)
Q Consensus 279 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 357 (476)
+........ .......+..|+|||++.+..++.++||||||+++|||++ |+.||....... ... .+.....
T Consensus 151 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~----~~~~~~~ 222 (261)
T cd05068 151 RVIKEDIYE-AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAE---VLQ----QVDQGYR 222 (261)
T ss_pred EEccCCccc-ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHH---HHH----HHHcCCC
Confidence 875422111 1111223457999999998899999999999999999999 999997543211 111 1100000
Q ss_pred cccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 011851 358 FYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKP 405 (476)
Q Consensus 358 ~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~ 405 (476)
. ..+...+..+.+++.+||+.+|++||++.++++.|+.
T Consensus 223 ---~-------~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 223 ---M-------PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred ---C-------CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 0 0112235789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=341.86 Aligned_cols=264 Identities=30% Similarity=0.438 Sum_probs=215.4
Q ss_pred cCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCcc---CHHHHHHHHHHHhCCCCCceeeEEEEEE
Q 011851 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQ---GHKEWLAEVNYLGGLIHPNLVKLIGCCI 197 (476)
Q Consensus 121 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~---~~~~~~~E~~~l~~l~hpnIv~l~~~~~ 197 (476)
+.|+.-++||+|+||.||-+ ....||+.||.|.+.+.... ...-.+.|-.||.+++.+.||.+-.+|+
T Consensus 185 n~F~~~RvlGkGGFGEV~ac---------qvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfe 255 (591)
T KOG0986|consen 185 NTFRVYRVLGKGGFGEVCAC---------QVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFE 255 (591)
T ss_pred cceeeeEEEecccccceeEE---------EEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeec
Confidence 56889999999999999975 45568999999998765433 2234678999999999999999999999
Q ss_pred eCCeeEEEEEecCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecC
Q 011851 198 EDDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFG 276 (476)
Q Consensus 198 ~~~~~~lV~E~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG 276 (476)
..+.+||||..|.||+|.-+|...+ ..+++..++.++.+|+.||++||+.. ||+|||||+|||||+.|+|+|+|+|
T Consensus 256 Tkd~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLG 332 (591)
T KOG0986|consen 256 TKDALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLG 332 (591)
T ss_pred CCCceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccc
Confidence 9999999999999999998886643 46999999999999999999999988 9999999999999999999999999
Q ss_pred CcCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhcccc
Q 011851 277 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERR 356 (476)
Q Consensus 277 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~ 356 (476)
+|....++... ...+||.+|||||++.++.|+...|+|||||+||||+.|+.||..........-++ +.....
T Consensus 333 LAvei~~g~~~---~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvd--rr~~~~-- 405 (591)
T KOG0986|consen 333 LAVEIPEGKPI---RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVD--RRTLED-- 405 (591)
T ss_pred eEEecCCCCcc---ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHH--HHHhcc--
Confidence 99988776543 23489999999999999999999999999999999999999997654332221111 111111
Q ss_pred ccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHH-HHHHHhcCCCCccccc
Q 011851 357 RFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMS-EVVEALKPLPYLKDMA 413 (476)
Q Consensus 357 ~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~-ell~~L~~~~~~~~~~ 413 (476)
...|+...++++.+|.+.+|..||.+|.... +=.+.++.+|||+++.
T Consensus 406 ----------~~ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~ln 453 (591)
T KOG0986|consen 406 ----------PEEYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLN 453 (591)
T ss_pred ----------hhhcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCcccccCC
Confidence 1124455688999999999999999997655 2333344559999864
|
|
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=329.85 Aligned_cols=258 Identities=29% Similarity=0.472 Sum_probs=202.6
Q ss_pred CCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCcc--CHHHHHHHHHHHhCCCCCceeeEEEEEEeCC
Q 011851 123 FRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQ--GHKEWLAEVNYLGGLIHPNLVKLIGCCIEDD 200 (476)
Q Consensus 123 y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 200 (476)
|.+.+.||+|+||.||+|.+..+. .++..||+|.++..... ....+.+|+++++.++||||+++++++.+.+
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~------~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 74 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDD------GSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEAS 74 (273)
T ss_pred CccccccCcCCCceEEEEEEecCC------CCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCC
Confidence 577899999999999999875322 25678999998754332 2356889999999999999999999887655
Q ss_pred e------eEEEEEecCCCCHHHHHhhc-----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCc
Q 011851 201 Q------RLLVYEFMPRGSLENHLFRR-----SLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYN 269 (476)
Q Consensus 201 ~------~~lV~E~~~~g~L~~~l~~~-----~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~ 269 (476)
. .++||||+++++|..++... ...+++..+..++.|++.||.|||+.+ |+||||||+||++++++.
T Consensus 75 ~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~ 151 (273)
T cd05035 75 SLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMT 151 (273)
T ss_pred ccccCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCe
Confidence 4 79999999999999888542 235899999999999999999999988 999999999999999999
Q ss_pred eEEeecCCcCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHh-CCCCCCCCCCCCcchhHHhh
Q 011851 270 AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWA 348 (476)
Q Consensus 270 vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~ellt-G~~pf~~~~~~~~~~~~~~~ 348 (476)
+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||...... ......
T Consensus 152 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~---~~~~~~ 228 (273)
T cd05035 152 VCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENH---EIYDYL 228 (273)
T ss_pred EEECCccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHH
Confidence 99999999986543322211222345678999999988899999999999999999999 88898654321 111111
Q ss_pred hhhhccccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011851 349 RPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPL 406 (476)
Q Consensus 349 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~ 406 (476)
... .. ...+...+.++.+++.+||+.||++||++.+++++|+.+
T Consensus 229 ~~~--~~------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 229 RHG--NR------------LKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred HcC--CC------------CCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 100 00 001122356899999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-42 Score=333.59 Aligned_cols=260 Identities=27% Similarity=0.408 Sum_probs=205.3
Q ss_pred CCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccC-HHHHHHHHHHHhCCCCCceeeEEEEEEeCC
Q 011851 122 SFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQG-HKEWLAEVNYLGGLIHPNLVKLIGCCIEDD 200 (476)
Q Consensus 122 ~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~-~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 200 (476)
+|++.+.||+|+||.||+|.+.... ....++.||||+++...... ...+.+|+.++..++||||+++++++.+.+
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~----~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~ 81 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTA----PGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQ 81 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCC----CCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCC
Confidence 4788899999999999999765321 12346789999997554322 345788999999999999999999999999
Q ss_pred eeEEEEEecCCCCHHHHHhhc---------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeec
Q 011851 201 QRLLVYEFMPRGSLENHLFRR---------------SLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLD 265 (476)
Q Consensus 201 ~~~lV~E~~~~g~L~~~l~~~---------------~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~ 265 (476)
..++++||+.+++|.+++... ...+++..+..++.|++.||.|||+++ |+||||||+|||++
T Consensus 82 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~ 158 (283)
T cd05091 82 PLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVF 158 (283)
T ss_pred ceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEec
Confidence 999999999999999998521 235788899999999999999999988 99999999999999
Q ss_pred CCCceEEeecCCcCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHh-CCCCCCCCCCCCcchh
Q 011851 266 GEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNL 344 (476)
Q Consensus 266 ~~~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~ellt-G~~pf~~~~~~~~~~~ 344 (476)
+++.+||+|||+++...............+++.|+|||++.+..++.++|||||||++|||++ |..||...... ..
T Consensus 159 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~---~~ 235 (283)
T cd05091 159 DKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ---DV 235 (283)
T ss_pred CCCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHH---HH
Confidence 999999999999886544332222233456789999999998899999999999999999998 88888654321 11
Q ss_pred HHhhhhhhccccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 011851 345 VEWARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKP 405 (476)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~ 405 (476)
..... ... ..+ .+...+..+.+|+.+||+.+|++||++.+|+..|+.
T Consensus 236 ~~~i~----~~~-----~~~-----~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 236 IEMIR----NRQ-----VLP-----CPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred HHHHH----cCC-----cCC-----CCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 11110 000 001 112236778999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-43 Score=315.52 Aligned_cols=265 Identities=27% Similarity=0.345 Sum_probs=209.5
Q ss_pred HhccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCCCCCceeeEEEEEE
Q 011851 118 SATKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHPNLVKLIGCCI 197 (476)
Q Consensus 118 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~ 197 (476)
...++|++.++||+|+|+-||++.. ..++..||+|.+.-...++.+..++|++..++++||||++++++..
T Consensus 18 In~~Ryri~~~LgeGGfsfv~LV~~---------~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l 88 (302)
T KOG2345|consen 18 INNKRYRIQRLLGEGGFSFVDLVKG---------LSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQL 88 (302)
T ss_pred EcCceEEEeeeecCCCceeeeeecc---------cCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHH
Confidence 3467899999999999999999753 3578889999998777778888999999999999999999998865
Q ss_pred eCC-----eeEEEEEecCCCCHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCc
Q 011851 198 EDD-----QRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYN 269 (476)
Q Consensus 198 ~~~-----~~~lV~E~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~ 269 (476)
.+. ..||+++|...|+|.+.+.. .+..+++.+.+.|+.+|++||++||+.. .++.||||||.|||+.+.+.
T Consensus 89 ~~~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~ 167 (302)
T KOG2345|consen 89 REEKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGL 167 (302)
T ss_pred HhhccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCc
Confidence 433 48999999999999999865 3457999999999999999999999977 57999999999999999999
Q ss_pred eEEeecCCcCCCCCCCccc-------eeeeeecCCCCCCcchhhcC---CCCccchhhhhHHHHHHHHhCCCCCCCCCCC
Q 011851 270 AKLSDFGLAKDGPEGDKTH-------VSTRVMGTYGYAAPEYVMTG---HLTAKSDVYSFGVVLLEMLTGRRSMDKNRPN 339 (476)
Q Consensus 270 vkl~DFG~a~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwslGv~l~elltG~~pf~~~~~~ 339 (476)
++|.|||.+....-.-... .-.....|..|+|||++.-. ..+.++|||||||+||+|+.|..||+..-..
T Consensus 168 ~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~ 247 (302)
T KOG2345|consen 168 PVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQ 247 (302)
T ss_pred eEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhc
Confidence 9999999987642211100 00113458889999988744 5789999999999999999999999754433
Q ss_pred CcchhHHhhhhhhccccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011851 340 GEHNLVEWARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPL 406 (476)
Q Consensus 340 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~ 406 (476)
+..-........ +.-.-....++.+.+||++||+.||.+||++.+++.++..+
T Consensus 248 GgSlaLAv~n~q--------------~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L 300 (302)
T KOG2345|consen 248 GGSLALAVQNAQ--------------ISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL 300 (302)
T ss_pred CCeEEEeeeccc--------------cccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence 222111111111 10001112378999999999999999999999999987653
|
|
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-42 Score=336.84 Aligned_cols=262 Identities=25% Similarity=0.370 Sum_probs=207.4
Q ss_pred cCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCcc-CHHHHHHHHHHHhCC-CCCceeeEEEEEEe
Q 011851 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQ-GHKEWLAEVNYLGGL-IHPNLVKLIGCCIE 198 (476)
Q Consensus 121 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~-~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~ 198 (476)
++|.+.+.||+|+||.||+|.+... ....++..||+|+++..... ..+.+.+|+.+++++ +|+||+++++++..
T Consensus 35 ~~~~~~~~ig~G~~g~V~~~~~~~~----~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 110 (302)
T cd05055 35 NNLSFGKTLGAGAFGKVVEATAYGL----SKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTI 110 (302)
T ss_pred HHeEEcceeeccCCeeEEEEEEecC----CCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEec
Confidence 4699999999999999999976321 12345678999998755322 235688999999999 79999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCC
Q 011851 199 DDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGL 277 (476)
Q Consensus 199 ~~~~~lV~E~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~ 277 (476)
.+..|+||||+++++|.+++.... ..+++..+..++.||+.||.|||+++ |+|+||||+|||++.++.++|+|||+
T Consensus 111 ~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg~ 187 (302)
T cd05055 111 GGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGL 187 (302)
T ss_pred CCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCcc
Confidence 999999999999999999996543 34899999999999999999999988 99999999999999999999999999
Q ss_pred cCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhhcccc
Q 011851 278 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPQLGERR 356 (476)
Q Consensus 278 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~ 356 (476)
++...............++..|+|||++.+..++.++|||||||++|||++ |..||........ ...... ...
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~--~~~~~~----~~~ 261 (302)
T cd05055 188 ARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSK--FYKLIK----EGY 261 (302)
T ss_pred cccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHH--HHHHHH----cCC
Confidence 986544322111222346788999999999999999999999999999998 9999875433211 111100 000
Q ss_pred ccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 011851 357 RFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKP 405 (476)
Q Consensus 357 ~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~ 405 (476)
....+...+.++.+++.+||+.+|++||++.++++.|+.
T Consensus 262 ----------~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~ 300 (302)
T cd05055 262 ----------RMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGK 300 (302)
T ss_pred ----------cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHh
Confidence 000111225689999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-42 Score=346.69 Aligned_cols=269 Identities=23% Similarity=0.286 Sum_probs=202.4
Q ss_pred ccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCC--ccCHHHHHHHHHHHhCCCCCceeeEEEEEE
Q 011851 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDG--LQGHKEWLAEVNYLGGLIHPNLVKLIGCCI 197 (476)
Q Consensus 120 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~ 197 (476)
.++|++.+.||+|+||.||+|.+. .+++.||||++.... ....+.+.+|+.+++.++||||+++++++.
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~ 93 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDA---------ILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFT 93 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEEC---------CCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeec
Confidence 467999999999999999998654 467789999997543 223456788999999999999999999876
Q ss_pred eC------CeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceE
Q 011851 198 ED------DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAK 271 (476)
Q Consensus 198 ~~------~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vk 271 (476)
.. ..+|+||||+++ +|.+.+.. .+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+|
T Consensus 94 ~~~~~~~~~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~k 166 (364)
T cd07875 94 PQKSLEEFQDVYIVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLK 166 (364)
T ss_pred ccccccccCeEEEEEeCCCC-CHHHHHHh---cCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEE
Confidence 43 357999999964 77777743 4788999999999999999999988 99999999999999999999
Q ss_pred EeecCCcCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHh----
Q 011851 272 LSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEW---- 347 (476)
Q Consensus 272 l~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~---- 347 (476)
|+|||+++...... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+..
T Consensus 167 L~DfG~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~ 243 (364)
T cd07875 167 ILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGT 243 (364)
T ss_pred EEeCCCccccCCCC---cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence 99999998653321 12335789999999999999999999999999999999999999976543211111000
Q ss_pred --------h----hhhhccccccc-----cccCccc---CCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCC
Q 011851 348 --------A----RPQLGERRRFY-----RLIDPCL---EGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLP 407 (476)
Q Consensus 348 --------~----~~~~~~~~~~~-----~~~d~~l---~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~ 407 (476)
. ......+..+. .++...+ ........+.++.+||.+||+.||.+|||+.++++| |
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h----p 319 (364)
T cd07875 244 PCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH----P 319 (364)
T ss_pred CCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC----c
Confidence 0 00000000000 0000000 000111124578999999999999999999999998 8
Q ss_pred Cccc
Q 011851 408 YLKD 411 (476)
Q Consensus 408 ~~~~ 411 (476)
|+..
T Consensus 320 ~~~~ 323 (364)
T cd07875 320 YINV 323 (364)
T ss_pred cccc
Confidence 8863
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=328.62 Aligned_cols=259 Identities=27% Similarity=0.404 Sum_probs=212.1
Q ss_pred cCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCC-ccCHHHHHHHHHHHhCCCCCceeeEEEEEEeC
Q 011851 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDG-LQGHKEWLAEVNYLGGLIHPNLVKLIGCCIED 199 (476)
Q Consensus 121 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~ 199 (476)
++|++.+.||.|+||.||+|.+. .+++.||+|++.... ......+.+|+++++.++|+||+++++++.++
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~---------~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 71 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDK---------RTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKG 71 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEEC---------CCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEEC
Confidence 36889999999999999998764 367889999987654 23345678899999999999999999999999
Q ss_pred CeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCcC
Q 011851 200 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAK 279 (476)
Q Consensus 200 ~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~ 279 (476)
..+|+|+||+++++|.+++... ++++..+..++.|++.||.|||+.+ |+||||+|+||+++.++.++|+|||+++
T Consensus 72 ~~~~~v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~ 146 (274)
T cd06609 72 SKLWIIMEYCGGGSCLDLLKPG--KLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSG 146 (274)
T ss_pred CeEEEEEEeeCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccce
Confidence 9999999999999999998654 7899999999999999999999988 9999999999999999999999999998
Q ss_pred CCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhccccccc
Q 011851 280 DGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRRFY 359 (476)
Q Consensus 280 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 359 (476)
...... .......|++.|+|||++.+..++.++|||||||++|+|++|+.||....+......+.
T Consensus 147 ~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~------------- 211 (274)
T cd06609 147 QLTSTM--SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIP------------- 211 (274)
T ss_pred eecccc--cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhh-------------
Confidence 764322 11233578899999999999889999999999999999999999997544221110000
Q ss_pred cccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCcccccCc
Q 011851 360 RLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDMASS 415 (476)
Q Consensus 360 ~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~~~~~ 415 (476)
....+.+... ..+..+.+++.+||..||++|||+++++++ +|+......
T Consensus 212 ~~~~~~~~~~---~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~----~~~~~~~~~ 260 (274)
T cd06609 212 KNNPPSLEGN---KFSKPFKDFVSLCLNKDPKERPSAKELLKH----KFIKKAKKT 260 (274)
T ss_pred hcCCCCCccc---ccCHHHHHHHHHHhhCChhhCcCHHHHhhC----hhhcCCCcc
Confidence 0000111111 135678999999999999999999999997 999886655
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=326.32 Aligned_cols=255 Identities=26% Similarity=0.359 Sum_probs=208.8
Q ss_pred cCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCCCCCceeeEEEEEEeCC
Q 011851 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHPNLVKLIGCCIEDD 200 (476)
Q Consensus 121 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 200 (476)
++|++.+.||.|+||.||+|.+. .+++.+++|++........+.+.+|++++++++||||+++++++.+.+
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~---------~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~ 73 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDI---------ATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRD 73 (262)
T ss_pred cceEEEEEecCCCceEEEEeEec---------CCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCC
Confidence 46899999999999999998654 356789999998766556678899999999999999999999999999
Q ss_pred eeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCcCC
Q 011851 201 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKD 280 (476)
Q Consensus 201 ~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~ 280 (476)
.+|++|||+++++|.+++......+++..+..++.|++.||.|||+++ |+|+||||+||+++.++.+||+|||++..
T Consensus 74 ~~~l~~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~ 150 (262)
T cd06613 74 KLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQ 150 (262)
T ss_pred EEEEEEeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchh
Confidence 999999999999999998766568999999999999999999999988 99999999999999999999999999876
Q ss_pred CCCCCccceeeeeecCCCCCCcchhhcC---CCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhccccc
Q 011851 281 GPEGDKTHVSTRVMGTYGYAAPEYVMTG---HLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRR 357 (476)
Q Consensus 281 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 357 (476)
...... ......++..|+|||++.+. .++.++|||||||++|+|++|+.||........... .... .
T Consensus 151 ~~~~~~--~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~--~~~~------~ 220 (262)
T cd06613 151 LTATIA--KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFL--ISKS------N 220 (262)
T ss_pred hhhhhh--ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH--HHhc------c
Confidence 543211 12235788999999999876 889999999999999999999999976443211111 0000 0
Q ss_pred cccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011851 358 FYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEA 402 (476)
Q Consensus 358 ~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~ 402 (476)
+....+ ......+.++.+++.+||..||.+|||+.+|+.+
T Consensus 221 ---~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 260 (262)
T cd06613 221 ---FPPPKL--KDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQH 260 (262)
T ss_pred ---CCCccc--cchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000001 1122346789999999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=325.44 Aligned_cols=254 Identities=28% Similarity=0.404 Sum_probs=209.7
Q ss_pred cCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCCCCCceeeEEEEEEeCC
Q 011851 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHPNLVKLIGCCIEDD 200 (476)
Q Consensus 121 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 200 (476)
++|++.+.||+|+||.||+|.+. .+++.|++|.+..... .+++.+|++++++++|+||+++++++.++.
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~---------~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~ 71 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHK---------ETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNT 71 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEc---------CCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCC
Confidence 57999999999999999998765 3567899999876533 578899999999999999999999999999
Q ss_pred eeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCcCC
Q 011851 201 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKD 280 (476)
Q Consensus 201 ~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~ 280 (476)
..|++|||+++++|.+++......+++..++.++.|++.||.|||+.+ |+|+||+|+||+++.++.++|+|||++..
T Consensus 72 ~~~l~~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~ 148 (256)
T cd06612 72 DLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQ 148 (256)
T ss_pred cEEEEEecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchh
Confidence 999999999999999999766778999999999999999999999988 99999999999999999999999999987
Q ss_pred CCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhcccccccc
Q 011851 281 GPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRRFYR 360 (476)
Q Consensus 281 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 360 (476)
...... ......|+..|+|||++.+..++.++|||||||++|+|++|+.||....+......+. .
T Consensus 149 ~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~-------~------ 213 (256)
T cd06612 149 LTDTMA--KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIP-------N------ 213 (256)
T ss_pred cccCcc--ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhc-------c------
Confidence 544321 1233568899999999998899999999999999999999999997543322111000 0
Q ss_pred ccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCc
Q 011851 361 LIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYL 409 (476)
Q Consensus 361 ~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~ 409 (476)
...+.+ ..+...+.++.+++.+||+.||++|||+.+++++ |||
T Consensus 214 ~~~~~~--~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~----~~~ 256 (256)
T cd06612 214 KPPPTL--SDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQH----PFI 256 (256)
T ss_pred CCCCCC--CchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcC----CCC
Confidence 000000 0112235688999999999999999999999997 775
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=325.81 Aligned_cols=250 Identities=26% Similarity=0.409 Sum_probs=205.1
Q ss_pred CCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCc--cCHHHHHHHHHHHhCCCCCceeeEEEEEEeC
Q 011851 122 SFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL--QGHKEWLAEVNYLGGLIHPNLVKLIGCCIED 199 (476)
Q Consensus 122 ~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~ 199 (476)
+|.+.+.||+|+||.||+|.+. .+++.|++|.+..... ....++.+|++++++++||||+++++++.++
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~---------~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 71 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRK---------ADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDK 71 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEc---------CCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccC
Confidence 4778899999999999998654 4677899999875432 2345688899999999999999999999999
Q ss_pred CeeEEEEEecCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCc
Q 011851 200 DQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLA 278 (476)
Q Consensus 200 ~~~~lV~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a 278 (476)
+..|+||||+++++|.+++... ...+++..++.++.||+.||.|||+.+ |+|+||||+||+++.++.++|+|||++
T Consensus 72 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~ 148 (256)
T cd08529 72 GKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVA 148 (256)
T ss_pred CEEEEEEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccc
Confidence 9999999999999999999764 467899999999999999999999988 999999999999999999999999998
Q ss_pred CCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhcccccc
Q 011851 279 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRRF 358 (476)
Q Consensus 279 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 358 (476)
+....... ......|++.|+|||++.+..++.++|||||||++|+|++|+.||...... ........
T Consensus 149 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~~~~~-------- 215 (256)
T cd08529 149 KLLSDNTN--FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQG---ALILKIIR-------- 215 (256)
T ss_pred eeccCccc--hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHc--------
Confidence 86543221 123357899999999999999999999999999999999999999754321 11111000
Q ss_pred ccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011851 359 YRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEA 402 (476)
Q Consensus 359 ~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~ 402 (476)
....+ .....+..+.+++.+||+.+|++||++.+++++
T Consensus 216 -~~~~~-----~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 216 -GVFPP-----VSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred -CCCCC-----CccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 00000 111235789999999999999999999999987
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=333.10 Aligned_cols=254 Identities=35% Similarity=0.555 Sum_probs=197.2
Q ss_pred ccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCc-cCHHHHHHHHHHHhCCCCCceeeEEEEEEeCCeeE
Q 011851 125 PECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL-QGHKEWLAEVNYLGGLIHPNLVKLIGCCIEDDQRL 203 (476)
Q Consensus 125 ~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 203 (476)
+.+.||.|.||.||+|.+.. .....+..|+||+++.... ...+.+.+|+++|++++||||+++++++...+..+
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~-----~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~ 77 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQ-----KDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLF 77 (259)
T ss_dssp EEEEEEEESSEEEEEEEEES-----TTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEE
T ss_pred EeeEEccCCCcEEEEEEEEc-----ccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccc
Confidence 45789999999999999873 2234677899999965332 23578999999999999999999999999888899
Q ss_pred EEEEecCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCcCCCC
Q 011851 204 LVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGP 282 (476)
Q Consensus 204 lV~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~ 282 (476)
+||||+++|+|.++|... ...+++..+..|+.||+.||.|||+.+ |+|+||+++|||++.++.+||+|||++....
T Consensus 78 lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~ 154 (259)
T PF07714_consen 78 LVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPIS 154 (259)
T ss_dssp EEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETT
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccc
Confidence 999999999999999776 677999999999999999999999988 9999999999999999999999999998763
Q ss_pred CCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhhccccccccc
Q 011851 283 EGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPQLGERRRFYRL 361 (476)
Q Consensus 283 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 361 (476)
............+...|+|||.+.+..++.++||||||+++|||++ |+.||..... ..+.... .+....
T Consensus 155 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~---~~~~~~~----~~~~~~--- 224 (259)
T PF07714_consen 155 EKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDN---EEIIEKL----KQGQRL--- 224 (259)
T ss_dssp TSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCH---HHHHHHH----HTTEET---
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccc---ccccccc----cccccc---
Confidence 3332222223456778999999999999999999999999999999 7788865422 1111111 010100
Q ss_pred cCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011851 362 IDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEAL 403 (476)
Q Consensus 362 ~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L 403 (476)
..+...+..+.++|.+||..||++||++.+|++.|
T Consensus 225 -------~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 225 -------PIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp -------TSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred -------eeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 01112267789999999999999999999999875
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=333.67 Aligned_cols=260 Identities=27% Similarity=0.390 Sum_probs=204.4
Q ss_pred CCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCc-cCHHHHHHHHHHHhCCCCCceeeEEEEEEeCC
Q 011851 122 SFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL-QGHKEWLAEVNYLGGLIHPNLVKLIGCCIEDD 200 (476)
Q Consensus 122 ~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 200 (476)
+|++.+.||+|+||.||+|.+.... .......+|+|.+..... ....++.+|+.+++.++||||+++++.+..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~----~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 76 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLK----GRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDG 76 (290)
T ss_pred CccccccccCcCCcceEEEEEecCC----CCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCC
Confidence 4788899999999999999865321 112345799998875432 22456888999999999999999999999999
Q ss_pred eeEEEEEecCCCCHHHHHhhc-----------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCC
Q 011851 201 QRLLVYEFMPRGSLENHLFRR-----------------------SLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDF 257 (476)
Q Consensus 201 ~~~lV~E~~~~g~L~~~l~~~-----------------------~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDl 257 (476)
..++||||+.+++|.+++... ...+++..++.++.|++.||.|||+.+ |+||||
T Consensus 77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~di 153 (290)
T cd05045 77 PLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDL 153 (290)
T ss_pred CcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhh
Confidence 999999999999999988532 135788999999999999999999988 999999
Q ss_pred CCCCeeecCCCceEEeecCCcCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHh-CCCCCCCC
Q 011851 258 KTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLT-GRRSMDKN 336 (476)
Q Consensus 258 Kp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~ellt-G~~pf~~~ 336 (476)
||+|||+++++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..||...
T Consensus 154 kp~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~ 233 (290)
T cd05045 154 AARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI 233 (290)
T ss_pred hhheEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCC
Confidence 99999999999999999999986533222211223456778999999988899999999999999999998 99999654
Q ss_pred CCCCcchhHHhhhhhhccccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 011851 337 RPNGEHNLVEWARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKP 405 (476)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~ 405 (476)
.+.. +....... .....+...+.++.+++.+||+.||++||++.++++.|+.
T Consensus 234 ~~~~---~~~~~~~~--------------~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~ 285 (290)
T cd05045 234 APER---LFNLLKTG--------------YRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEK 285 (290)
T ss_pred CHHH---HHHHHhCC--------------CCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHH
Confidence 3221 11111100 0000111235689999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=326.72 Aligned_cols=258 Identities=24% Similarity=0.362 Sum_probs=206.1
Q ss_pred cCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCcc---CHHHHHHHHHHHhCCCCCceeeEEEEEE
Q 011851 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQ---GHKEWLAEVNYLGGLIHPNLVKLIGCCI 197 (476)
Q Consensus 121 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~---~~~~~~~E~~~l~~l~hpnIv~l~~~~~ 197 (476)
++|++.+.||+|+||.||+|+.. .+++.||||.+...... ....+.+|+++++.++||||+++++++.
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~---------~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 72 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCL---------LDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFI 72 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEe---------CCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEE
Confidence 46899999999999999998765 36778999988653322 2345788999999999999999999999
Q ss_pred eCCeeEEEEEecCCCCHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEee
Q 011851 198 EDDQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSD 274 (476)
Q Consensus 198 ~~~~~~lV~E~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~D 274 (476)
+.+..++||||+++++|.+++.. ....+++..+..++.||+.||.|||+++ |+|+||||+|||++.++.++|+|
T Consensus 73 ~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d 149 (267)
T cd08228 73 EDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGD 149 (267)
T ss_pred ECCeEEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECc
Confidence 99999999999999999988853 3455889999999999999999999988 99999999999999999999999
Q ss_pred cCCcCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhcc
Q 011851 275 FGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGE 354 (476)
Q Consensus 275 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~ 354 (476)
||++........ ......|++.|+|||.+.+..++.++|+||||+++|||++|+.||....... ........ .
T Consensus 150 ~g~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~-~~~~~~~~----~ 222 (267)
T cd08228 150 LGLGRFFSSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL-FSLCQKIE----Q 222 (267)
T ss_pred cccceeccchhH--HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccH-HHHHHHHh----c
Confidence 999886543221 1123568899999999998889999999999999999999999996543211 11111100 0
Q ss_pred ccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011851 355 RRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPL 406 (476)
Q Consensus 355 ~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~ 406 (476)
... .+. .....+..+.+++.+||+.+|++||++.++++.|+.+
T Consensus 223 -~~~----~~~----~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 223 -CDY----PPL----PTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred -CCC----CCC----ChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 000 000 1112357799999999999999999999999987654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-42 Score=343.59 Aligned_cols=271 Identities=23% Similarity=0.347 Sum_probs=203.2
Q ss_pred hccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCc--cCHHHHHHHHHHHhCCCCCceeeEEEEE
Q 011851 119 ATKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL--QGHKEWLAEVNYLGGLIHPNLVKLIGCC 196 (476)
Q Consensus 119 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~ 196 (476)
..++|.+.+.||+|+||.||+|.+. .+++.||||++..... ...+.+.+|+.+|++++||||+++++++
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 83 (343)
T cd07878 13 VPERYQNLTPVGSGAYGSVCSAYDT---------RLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVF 83 (343)
T ss_pred hhhhhhhheecccCCCeEEEEEEEC---------CCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhh
Confidence 4568999999999999999998654 4678899999875432 2235577899999999999999999987
Q ss_pred EeC------CeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCce
Q 011851 197 IED------DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNA 270 (476)
Q Consensus 197 ~~~------~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~v 270 (476)
... ...|++||++ +++|.+++.. ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+
T Consensus 84 ~~~~~~~~~~~~~~~~~~~-~~~l~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~ 157 (343)
T cd07878 84 TPATSIENFNEVYLVTNLM-GADLNNIVKC--QKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCEL 157 (343)
T ss_pred cccccccccCcEEEEeecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCE
Confidence 643 3578999998 7899887743 46999999999999999999999988 9999999999999999999
Q ss_pred EEeecCCcCCCCCCCccceeeeeecCCCCCCcchhhc-CCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhH-Hhh
Q 011851 271 KLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV-EWA 348 (476)
Q Consensus 271 kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~-~~~ 348 (476)
||+|||+++..... ....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...........+ ...
T Consensus 158 kl~Dfg~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~ 232 (343)
T cd07878 158 RILDFGLARQADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVV 232 (343)
T ss_pred EEcCCccceecCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHh
Confidence 99999999865432 223578999999999877 57899999999999999999999999754321111000 000
Q ss_pred hhh-------hc--ccccccc----ccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCcccccC
Q 011851 349 RPQ-------LG--ERRRFYR----LIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDMAS 414 (476)
Q Consensus 349 ~~~-------~~--~~~~~~~----~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~~~~ 414 (476)
... +. ....+.. .....+...+ ...++.+.+||.+||+.||++|||+.++++| |||.....
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~mL~~dp~~R~s~~ell~h----p~~~~~~~ 306 (343)
T cd07878 233 GTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIF-RGANPLAIDLLEKMLVLDSDKRISASEALAH----PYFSQYHD 306 (343)
T ss_pred CCCCHHHHHhcchhhHHHHhhccccccchhHHHhc-cCCCHHHHHHHHHHcCCChhhCCCHHHHhcC----cchhccCC
Confidence 000 00 0000000 0000000000 0113467899999999999999999999987 99986543
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-42 Score=334.82 Aligned_cols=264 Identities=27% Similarity=0.381 Sum_probs=207.1
Q ss_pred hccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCc-cCHHHHHHHHHHHhCC-CCCceeeEEEEE
Q 011851 119 ATKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL-QGHKEWLAEVNYLGGL-IHPNLVKLIGCC 196 (476)
Q Consensus 119 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~-~~~~~~~~E~~~l~~l-~hpnIv~l~~~~ 196 (476)
..++|++.+.||+|+||.||+|.+..... ......+|+|.+..... ....++.+|++++.++ +|+||+++++++
T Consensus 10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~----~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~ 85 (293)
T cd05053 10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDN----PNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVC 85 (293)
T ss_pred CHhHeEEeeEecccccccEEEEEEecCCC----CCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 34568999999999999999997653211 23456799999875432 2234678899999999 799999999999
Q ss_pred EeCCeeEEEEEecCCCCHHHHHhhc---------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCC
Q 011851 197 IEDDQRLLVYEFMPRGSLENHLFRR---------------SLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSN 261 (476)
Q Consensus 197 ~~~~~~~lV~E~~~~g~L~~~l~~~---------------~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~N 261 (476)
..++.+++||||+++++|.+++... ...+++..++.++.||+.||.|||+.+ |+||||||+|
T Consensus 86 ~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~N 162 (293)
T cd05053 86 TQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARN 162 (293)
T ss_pred cCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceee
Confidence 9999999999999999999998532 346889999999999999999999988 9999999999
Q ss_pred eeecCCCceEEeecCCcCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHh-CCCCCCCCCCCC
Q 011851 262 ILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLT-GRRSMDKNRPNG 340 (476)
Q Consensus 262 ILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~ellt-G~~pf~~~~~~~ 340 (476)
||++.++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||.......
T Consensus 163 il~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~ 242 (293)
T cd05053 163 VLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE 242 (293)
T ss_pred EEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHH
Confidence 9999999999999999987544322221222335678999999998999999999999999999997 999986543221
Q ss_pred cchhHHhhhhhhccccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011851 341 EHNLVEWARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPL 406 (476)
Q Consensus 341 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~ 406 (476)
..... .... ....+...+..+.+|+.+||..||++|||+.++++.|+.+
T Consensus 243 ~~~~~-------~~~~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~ 291 (293)
T cd05053 243 LFKLL-------KEGY----------RMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRM 291 (293)
T ss_pred HHHHH-------HcCC----------cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHh
Confidence 11110 0000 0011122356889999999999999999999999997643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=331.92 Aligned_cols=271 Identities=27% Similarity=0.427 Sum_probs=204.3
Q ss_pred cCCCccccccccCCccEEEEEEccCCce-----eeeCCCCceEEEEEecCCCcc-CHHHHHHHHHHHhCCCCCceeeEEE
Q 011851 121 KSFRPECLLGEGGFGCVYKGWINMNGTA-----TVKPGTGLPVAVKTLNHDGLQ-GHKEWLAEVNYLGGLIHPNLVKLIG 194 (476)
Q Consensus 121 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~-----~~~~~~g~~vAiK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~ 194 (476)
++|++.+.||+|+||.||++++...+.. .....+...||+|.++..... ....+.+|+++|++++|+||+++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 4799999999999999999876532110 011223456999999764322 2346889999999999999999999
Q ss_pred EEEeCCeeEEEEEecCCCCHHHHHhhcC-----------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCee
Q 011851 195 CCIEDDQRLLVYEFMPRGSLENHLFRRS-----------LPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNIL 263 (476)
Q Consensus 195 ~~~~~~~~~lV~E~~~~g~L~~~l~~~~-----------~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NIL 263 (476)
++..++..++||||+++++|.+++.... ..+++..++.++.|++.||.|||+.+ ++||||||+|||
T Consensus 85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil 161 (295)
T cd05097 85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNCL 161 (295)
T ss_pred EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhEE
Confidence 9999999999999999999999985432 23688899999999999999999988 999999999999
Q ss_pred ecCCCceEEeecCCcCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHh--CCCCCCCCCCCCc
Q 011851 264 LDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLT--GRRSMDKNRPNGE 341 (476)
Q Consensus 264 l~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~ellt--G~~pf~~~~~~~~ 341 (476)
++.++.+||+|||++................++..|+|||++.+..++.++|||||||++|+|++ |..||.......
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~- 240 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ- 240 (295)
T ss_pred EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHH-
Confidence 99999999999999976543322222223445778999999998999999999999999999998 566776543211
Q ss_pred chhHHhhhhhhccccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 011851 342 HNLVEWARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALK 404 (476)
Q Consensus 342 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~ 404 (476)
.+............ ... ...+...+..+.+|+.+||+.||++||++.+|++.|+
T Consensus 241 --~~~~~~~~~~~~~~--~~~-----~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 241 --VIENTGEFFRNQGR--QIY-----LSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred --HHHHHHHhhhhccc--ccc-----CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 11111000000000 000 0011112578999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-42 Score=317.68 Aligned_cols=260 Identities=24% Similarity=0.294 Sum_probs=206.3
Q ss_pred hccCCCcc-ccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCC-CCCceeeEEEEE
Q 011851 119 ATKSFRPE-CLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGL-IHPNLVKLIGCC 196 (476)
Q Consensus 119 ~~~~y~~~-~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~ 196 (476)
.+++|.+. ++||-|-.|.|.. |+++.||+.+|+|++... ...++|+++.-.. .|||||.++++|
T Consensus 59 itedY~is~qvLG~GinGkV~~---------C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVy 124 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQ---------CVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVY 124 (400)
T ss_pred chhhheehhhhhccccCCceEE---------EEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhh
Confidence 45667665 5799999999987 566789999999998643 4456788865544 599999999998
Q ss_pred Ee----CCeeEEEEEecCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecC---CC
Q 011851 197 IE----DDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDG---EY 268 (476)
Q Consensus 197 ~~----~~~~~lV~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~---~~ 268 (476)
+. ...+.+|||.|+||.|+..|..+ ...+++.++..|+.||+.|+.|||+.+ |.||||||+|+|... |.
T Consensus 125 eNs~~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na 201 (400)
T KOG0604|consen 125 ENSYQGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNA 201 (400)
T ss_pred hhhccCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCc
Confidence 64 45688999999999999999765 457999999999999999999999988 999999999999954 55
Q ss_pred ceEEeecCCcCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhh
Q 011851 269 NAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA 348 (476)
Q Consensus 269 ~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~ 348 (476)
.+||+|||+|+..... ....+.|-||+|.|||++....|+..+|+||+||++|-||+|.+||.........--..
T Consensus 202 ~lKLtDfGFAK~t~~~---~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk-- 276 (400)
T KOG0604|consen 202 PLKLTDFGFAKETQEP---GDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK-- 276 (400)
T ss_pred ceEecccccccccCCC---ccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHH--
Confidence 7999999999975431 12334788999999999999999999999999999999999999998654422111000
Q ss_pred hhhhccccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCcccc
Q 011851 349 RPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDM 412 (476)
Q Consensus 349 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~~ 412 (476)
. .+ +...+++-++.+. ..++.+.++|+.+|..+|.+|.|+.++++| ||+.+.
T Consensus 277 ~-rI--~~gqy~FP~pEWs-----~VSe~aKdlIR~LLkt~PteRlTI~~~m~h----pwi~~~ 328 (400)
T KOG0604|consen 277 R-RI--RTGQYEFPEPEWS-----CVSEAAKDLIRKLLKTEPTERLTIEEVMDH----PWINQY 328 (400)
T ss_pred h-Hh--hccCccCCChhHh-----HHHHHHHHHHHHHhcCCchhheeHHHhhcC----chhccc
Confidence 0 00 0111233333332 348899999999999999999999999998 888754
|
|
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=331.58 Aligned_cols=260 Identities=25% Similarity=0.349 Sum_probs=212.0
Q ss_pred ccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCCCCCceeeEEEEEEeC
Q 011851 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHPNLVKLIGCCIED 199 (476)
Q Consensus 120 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~ 199 (476)
..+|++.+.||+|+||.||+|.+. .+++.||+|.+........+.+.+|+.+++.++|+||+++++++..+
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~ 88 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDI---------ATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVG 88 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEEC---------CCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence 367999999999999999998654 46788999999766555566788999999999999999999999999
Q ss_pred CeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCcC
Q 011851 200 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAK 279 (476)
Q Consensus 200 ~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~ 279 (476)
+..|+||||+++++|.+++.+ ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.++|+|||++.
T Consensus 89 ~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~ 163 (297)
T cd06656 89 DELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCA 163 (297)
T ss_pred CEEEEeecccCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccce
Confidence 999999999999999998854 35889999999999999999999988 9999999999999999999999999987
Q ss_pred CCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhccccccc
Q 011851 280 DGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRRFY 359 (476)
Q Consensus 280 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 359 (476)
....... ......|++.|+|||.+.+..++.++|||||||++|+|++|..||....+........ .
T Consensus 164 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~--~---------- 229 (297)
T cd06656 164 QITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA--T---------- 229 (297)
T ss_pred EccCCcc--CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeec--c----------
Confidence 6433221 1223568999999999999899999999999999999999999997644322111000 0
Q ss_pred cccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCcccccC
Q 011851 360 RLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDMAS 414 (476)
Q Consensus 360 ~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~~~~ 414 (476)
........+...+..+.+|+.+||..||++||++.+++++ ||++....
T Consensus 230 ---~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~----~~~~~~~~ 277 (297)
T cd06656 230 ---NGTPELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQH----PFLKLAKP 277 (297)
T ss_pred ---CCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC----chhccccc
Confidence 0000000112235678899999999999999999999997 99876543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=330.50 Aligned_cols=260 Identities=26% Similarity=0.420 Sum_probs=203.0
Q ss_pred ccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCcc-CHHHHHHHHHHHhCCCCCceeeEEEEEEe
Q 011851 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQ-GHKEWLAEVNYLGGLIHPNLVKLIGCCIE 198 (476)
Q Consensus 120 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~~ 198 (476)
.++|++.++||+|+||+||+|.+..++.. ....||+|++...... ...++.+|+.+++.++|+||+++++++..
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~-----~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~ 80 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGEN-----VKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT 80 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCc-----cceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC
Confidence 34688999999999999999986543321 1235899998754332 34568889999999999999999999875
Q ss_pred CCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCc
Q 011851 199 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLA 278 (476)
Q Consensus 199 ~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a 278 (476)
...+++|||+++|+|.+++......+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 81 -~~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~ 156 (279)
T cd05109 81 -STVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLA 156 (279)
T ss_pred -CCcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCce
Confidence 4578999999999999999766667999999999999999999999988 999999999999999999999999999
Q ss_pred CCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhhccccc
Q 011851 279 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPQLGERRR 357 (476)
Q Consensus 279 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 357 (476)
+...............+++.|+|||.+.+..++.++|||||||++|||++ |..||........ ..+... ...
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~---~~~~~~----~~~ 229 (279)
T cd05109 157 RLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREI---PDLLEK----GER 229 (279)
T ss_pred eecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH---HHHHHC----CCc
Confidence 87643222111112235678999999999999999999999999999998 8999865432111 111110 000
Q ss_pred cccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 011851 358 FYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKP 405 (476)
Q Consensus 358 ~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~ 405 (476)
. + .+...+.++.+++.+||+.||++||++.++++.|+.
T Consensus 230 ~-----~-----~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~ 267 (279)
T cd05109 230 L-----P-----QPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSR 267 (279)
T ss_pred C-----C-----CCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 0 0 011225678899999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-41 Score=330.97 Aligned_cols=271 Identities=27% Similarity=0.425 Sum_probs=205.4
Q ss_pred cCCCccccccccCCccEEEEEEccCCcee-------eeCCCCceEEEEEecCCCcc-CHHHHHHHHHHHhCCCCCceeeE
Q 011851 121 KSFRPECLLGEGGFGCVYKGWINMNGTAT-------VKPGTGLPVAVKTLNHDGLQ-GHKEWLAEVNYLGGLIHPNLVKL 192 (476)
Q Consensus 121 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~-------~~~~~g~~vAiK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l 192 (476)
++|++.+.||+|+||.||++.+....... ....++..||+|++...... ....+.+|+.+|+.++|+||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 46999999999999999998654321100 12334567999999765322 34578899999999999999999
Q ss_pred EEEEEeCCeeEEEEEecCCCCHHHHHhhcC----------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCe
Q 011851 193 IGCCIEDDQRLLVYEFMPRGSLENHLFRRS----------LPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNI 262 (476)
Q Consensus 193 ~~~~~~~~~~~lV~E~~~~g~L~~~l~~~~----------~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NI 262 (476)
++++..++..++||||+++++|.+++.... ..+++..+..++.||+.||+|||+.+ |+||||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~Ni 161 (296)
T cd05095 85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRNC 161 (296)
T ss_pred EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChheE
Confidence 999999999999999999999999986532 23677889999999999999999988 99999999999
Q ss_pred eecCCCceEEeecCCcCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHh--CCCCCCCCCCCC
Q 011851 263 LLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLT--GRRSMDKNRPNG 340 (476)
Q Consensus 263 Ll~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~ellt--G~~pf~~~~~~~ 340 (476)
|++.++.++|+|||+++...............++..|+|||+..++.++.++|||||||++|||++ |..||.......
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~ 241 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ 241 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHH
Confidence 999999999999999986543322222223345678999999988899999999999999999998 778886543321
Q ss_pred cchhHHhhhhhhccccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 011851 341 EHNLVEWARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALK 404 (476)
Q Consensus 341 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~ 404 (476)
. +........... .....+. +...+..+.+|+.+||+.||++||++.+|++.|+
T Consensus 242 ~---~~~~~~~~~~~~--~~~~~~~-----~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 242 V---IENTGEFFRDQG--RQVYLPK-----PALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred H---HHHHHHHHhhcc--ccccCCC-----CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 1 111000000000 0000011 1122468899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=329.53 Aligned_cols=261 Identities=28% Similarity=0.418 Sum_probs=207.0
Q ss_pred ccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCc-cCHHHHHHHHHHHhCCCCCceeeEEEEEEe
Q 011851 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL-QGHKEWLAEVNYLGGLIHPNLVKLIGCCIE 198 (476)
Q Consensus 120 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~ 198 (476)
.++|++.+.||+|+||.||+|.+.... ...++..||+|.+..... .....+.+|+.+|+.++|+||+++++++..
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~----~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~ 80 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVV----KGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVST 80 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccC----CCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcC
Confidence 346899999999999999999875321 124567899999865432 234567899999999999999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHHhhc---------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCc
Q 011851 199 DDQRLLVYEFMPRGSLENHLFRR---------SLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYN 269 (476)
Q Consensus 199 ~~~~~lV~E~~~~g~L~~~l~~~---------~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~ 269 (476)
....|+||||+++++|.+++... ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.
T Consensus 81 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~ 157 (277)
T cd05032 81 GQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLT 157 (277)
T ss_pred CCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCC
Confidence 99999999999999999998642 124688899999999999999999988 999999999999999999
Q ss_pred eEEeecCCcCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHh-CCCCCCCCCCCCcchhHHhh
Q 011851 270 AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWA 348 (476)
Q Consensus 270 vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~ellt-G~~pf~~~~~~~~~~~~~~~ 348 (476)
+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||........ ....
T Consensus 158 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~---~~~~ 234 (277)
T cd05032 158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEV---LKFV 234 (277)
T ss_pred EEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHH---HHHH
Confidence 99999999976543322222223456788999999998899999999999999999998 9999965433211 1111
Q ss_pred hhhhccccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 011851 349 RPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALK 404 (476)
Q Consensus 349 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~ 404 (476)
. ... .. .++...+.++.+++.+||+.+|++|||+.++++.|+
T Consensus 235 ~----~~~-~~---------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 235 I----DGG-HL---------DLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred h----cCC-CC---------CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 1 000 00 011122678899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=329.53 Aligned_cols=249 Identities=23% Similarity=0.405 Sum_probs=194.5
Q ss_pred cccccCCccEEEEEEccCCcee---------------eeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCCCCCceeeE
Q 011851 128 LLGEGGFGCVYKGWINMNGTAT---------------VKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHPNLVKL 192 (476)
Q Consensus 128 ~LG~G~fg~Vy~a~~~~~~~~~---------------~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l 192 (476)
+||+|+||.||+|.+...+... .+......||+|++.........++.+|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 6999999999999865322111 1223345699999876544444568889999999999999999
Q ss_pred EEEEEeCCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCC----
Q 011851 193 IGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEY---- 268 (476)
Q Consensus 193 ~~~~~~~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~---- 268 (476)
++++.++...+|||||+++++|..++.+....+++..+..++.||+.||+|||+.+ |+||||||+|||++..+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~~~~ 158 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLAEG 158 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCcccC
Confidence 99999999999999999999999998766667899999999999999999999987 99999999999997644
Q ss_pred ---ceEEeecCCcCCCCCCCccceeeeeecCCCCCCcchhhc-CCCCccchhhhhHHHHHHHH-hCCCCCCCCCCCCcch
Q 011851 269 ---NAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTAKSDVYSFGVVLLEML-TGRRSMDKNRPNGEHN 343 (476)
Q Consensus 269 ---~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGv~l~ell-tG~~pf~~~~~~~~~~ 343 (476)
.+||+|||++...... ....++..|+|||++.+ ..++.++|||||||++|||+ +|+.||....+.....
T Consensus 159 ~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~ 232 (274)
T cd05076 159 TSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKER 232 (274)
T ss_pred ccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHH
Confidence 3899999998654221 12357888999998876 56899999999999999994 7999997654322111
Q ss_pred hHHhhhhhhccccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 011851 344 LVEWARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALK 404 (476)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~ 404 (476)
... .... ++......+.++|.+||+.+|++|||+.+|+++|.
T Consensus 233 ~~~-------~~~~------------~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 233 FYE-------KKHR------------LPEPSCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred HHH-------hccC------------CCCCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 110 0000 01111357889999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-42 Score=336.85 Aligned_cols=263 Identities=26% Similarity=0.372 Sum_probs=205.0
Q ss_pred cCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCc-cCHHHHHHHHHHHhCC-CCCceeeEEEEEEe
Q 011851 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL-QGHKEWLAEVNYLGGL-IHPNLVKLIGCCIE 198 (476)
Q Consensus 121 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~-~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~ 198 (476)
++|.+.+.||+|+||.||+|.+....+ ....++..+|+|.+..... ....++..|+++++.+ +|+||+++++++..
T Consensus 18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~--~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (307)
T cd05098 18 DRLVLGKPLGEGCFGQVVMAEAIGLDK--EKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 95 (307)
T ss_pred HHeEEeeeeccCCCeeEEEeEEeccCC--cccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEec
Confidence 469999999999999999997643211 1112456799999976432 2345678899999999 79999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHHhhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCee
Q 011851 199 DDQRLLVYEFMPRGSLENHLFRRS---------------LPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNIL 263 (476)
Q Consensus 199 ~~~~~lV~E~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NIL 263 (476)
++..|+||||+++++|.+++.... ..+++..++.++.||+.||+|||+++ ++||||||+|||
T Consensus 96 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nil 172 (307)
T cd05098 96 DGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVL 172 (307)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheE
Confidence 999999999999999999996532 24889999999999999999999988 999999999999
Q ss_pred ecCCCceEEeecCCcCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHh-CCCCCCCCCCCCcc
Q 011851 264 LDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEH 342 (476)
Q Consensus 264 l~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~ellt-G~~pf~~~~~~~~~ 342 (476)
++.++.+||+|||+++...............+++.|+|||++.+..++.++|||||||++|||++ |..||.......
T Consensus 173 l~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~-- 250 (307)
T cd05098 173 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE-- 250 (307)
T ss_pred EcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHH--
Confidence 99999999999999976543222111122234568999999999899999999999999999998 888886543211
Q ss_pred hhHHhhhhhhccccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 011851 343 NLVEWARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKP 405 (476)
Q Consensus 343 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~ 405 (476)
+..... ... ....+...+.++.+|+.+||..+|++||++.++++.|+.
T Consensus 251 -~~~~~~----~~~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~ 298 (307)
T cd05098 251 -LFKLLK----EGH----------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR 298 (307)
T ss_pred -HHHHHH----cCC----------CCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHH
Confidence 111100 000 000112235788999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=325.49 Aligned_cols=254 Identities=27% Similarity=0.460 Sum_probs=204.1
Q ss_pred CCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccC---------HHHHHHHHHHHhCCCCCceeeE
Q 011851 122 SFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQG---------HKEWLAEVNYLGGLIHPNLVKL 192 (476)
Q Consensus 122 ~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~---------~~~~~~E~~~l~~l~hpnIv~l 192 (476)
+|.+.+.||+|+||.||+|.+. .+++.||+|.+....... .+.+.+|+.++++++||||+++
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~---------~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~ 71 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNA---------SSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQY 71 (267)
T ss_pred CccccceeecCCCeEEEEEEec---------CCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeE
Confidence 4788899999999999998754 356789999886543321 1457789999999999999999
Q ss_pred EEEEEeCCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEE
Q 011851 193 IGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKL 272 (476)
Q Consensus 193 ~~~~~~~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl 272 (476)
++++.+.+..++||||+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++||||+|+||+++.++.++|
T Consensus 72 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l 147 (267)
T cd06628 72 LGSSLDADHLNIFLEYVPGGSVAALLNNY-GAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKI 147 (267)
T ss_pred EEEEEeCCccEEEEEecCCCCHHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEe
Confidence 99999999999999999999999999543 56899999999999999999999988 999999999999999999999
Q ss_pred eecCCcCCCCCCCc----cceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhh
Q 011851 273 SDFGLAKDGPEGDK----THVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA 348 (476)
Q Consensus 273 ~DFG~a~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~ 348 (476)
+|||+++....... ........|+..|+|||++.+..++.++|||||||++|+|++|+.||....... ....
T Consensus 148 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--~~~~-- 223 (267)
T cd06628 148 SDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQ--AIFK-- 223 (267)
T ss_pred cccCCCcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHH--HHHH--
Confidence 99999986642111 111123568899999999998889999999999999999999999997542211 0000
Q ss_pred hhhhccccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCc
Q 011851 349 RPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYL 409 (476)
Q Consensus 349 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~ 409 (476)
.. ....+ .++...+..+.++|.+||+.||++||++.+++++ +||
T Consensus 224 ---~~------~~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~----~~~ 267 (267)
T cd06628 224 ---IG------ENASP----EIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKH----PFL 267 (267)
T ss_pred ---Hh------ccCCC----cCCcccCHHHHHHHHHHccCCchhCcCHHHHhhC----CCC
Confidence 00 00011 1122336788999999999999999999999997 775
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=337.22 Aligned_cols=271 Identities=19% Similarity=0.221 Sum_probs=201.1
Q ss_pred cccccccc--CCccEEEEEEccCCceeeeCCCCceEEEEEecCCCcc--CHHHHHHHHHHHhCCCCCceeeEEEEEEeCC
Q 011851 125 PECLLGEG--GFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQ--GHKEWLAEVNYLGGLIHPNLVKLIGCCIEDD 200 (476)
Q Consensus 125 ~~~~LG~G--~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 200 (476)
++++||+| +|++||++.+. .+|+.||+|.++..... ....+.+|+++++.++||||+++++++..++
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~ 72 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYK---------PTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADN 72 (327)
T ss_pred hhhhccccccceEEEEEEeec---------ccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECC
Confidence 46789999 68899997654 57888999999765332 2345678999999999999999999999999
Q ss_pred eeEEEEEecCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCcC
Q 011851 201 QRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAK 279 (476)
Q Consensus 201 ~~~lV~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~ 279 (476)
..|+||||+++++|.+++... ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.++++||+.+.
T Consensus 73 ~~~lv~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~ 149 (327)
T cd08227 73 ELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNL 149 (327)
T ss_pred EEEEEEeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhh
Confidence 999999999999999998653 345899999999999999999999988 9999999999999999999999998754
Q ss_pred CCCCCCcc-----ceeeeeecCCCCCCcchhhc--CCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhh
Q 011851 280 DGPEGDKT-----HVSTRVMGTYGYAAPEYVMT--GHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQL 352 (476)
Q Consensus 280 ~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~ 352 (476)
........ .......++..|+|||++.+ ..++.++|||||||++|||++|+.||........ .........
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~~~~~~~ 227 (327)
T cd08227 150 SMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM--LLEKLNGTV 227 (327)
T ss_pred ccccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHH--HHHHhcCCc
Confidence 33211110 00112356778999999976 4689999999999999999999999975332110 000000000
Q ss_pred ccc---------------------cccccc---------cCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011851 353 GER---------------------RRFYRL---------IDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEA 402 (476)
Q Consensus 353 ~~~---------------------~~~~~~---------~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~ 402 (476)
... ..+... ........+....+..+.+|+.+||+.||++|||++++++|
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~ 307 (327)
T cd08227 228 PCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 307 (327)
T ss_pred cccccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcC
Confidence 000 000000 00000001112235688999999999999999999999987
Q ss_pred hcCCCCccccc
Q 011851 403 LKPLPYLKDMA 413 (476)
Q Consensus 403 L~~~~~~~~~~ 413 (476)
|||+.+.
T Consensus 308 ----p~f~~~~ 314 (327)
T cd08227 308 ----SFFKQIK 314 (327)
T ss_pred ----hhhhhcc
Confidence 9998653
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-42 Score=342.64 Aligned_cols=248 Identities=24% Similarity=0.319 Sum_probs=210.6
Q ss_pred hccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCH--HHHHHHHHHHhCCCCCceeeEEEEE
Q 011851 119 ATKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGH--KEWLAEVNYLGGLIHPNLVKLIGCC 196 (476)
Q Consensus 119 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~--~~~~~E~~~l~~l~hpnIv~l~~~~ 196 (476)
....|.+.+.||+|.|+.|.+|++. -|+..||||++.+...... ..+.+|+++|+.|+|||||+++.+.
T Consensus 54 ~vg~y~i~~tig~g~f~~V~La~~~---------~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~ 124 (596)
T KOG0586|consen 54 SVGLYVIIKTIGKGNFAKVKLARHI---------LTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVI 124 (596)
T ss_pred cccceeeeeeeccceeEEEEeeEec---------CCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeee
Confidence 3456999999999999999998765 4788899999988765432 3478999999999999999999999
Q ss_pred EeCCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecC
Q 011851 197 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFG 276 (476)
Q Consensus 197 ~~~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG 276 (476)
+....+|+||||+.+|.+++++.+.+ .+.+..+..++.|++.|++|||+++ |||||||.+||||+.+.++||+|||
T Consensus 125 ~t~~~lylV~eya~~ge~~~yl~~~g-r~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfg 200 (596)
T KOG0586|consen 125 ETEATLYLVMEYASGGELFDYLVKHG-RMKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFG 200 (596)
T ss_pred eecceeEEEEEeccCchhHHHHHhcc-cchhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccc
Confidence 99999999999999999999996654 5666999999999999999999988 9999999999999999999999999
Q ss_pred CcCCCCCCCccceeeeeecCCCCCCcchhhcCCC-CccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhccc
Q 011851 277 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHL-TAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGER 355 (476)
Q Consensus 277 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~ 355 (476)
++..+..+. ....+||++.|.|||++.+..| ++.+|+||+|++||-|+.|..||++..-.....
T Consensus 201 fS~~~~~~~---~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~------------ 265 (596)
T KOG0586|consen 201 FSTFFDYGL---MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRP------------ 265 (596)
T ss_pred cceeecccc---cccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccc------------
Confidence 998875432 3455899999999999999876 578999999999999999999998764332211
Q ss_pred cccccccCcccCCCC--ChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011851 356 RRFYRLIDPCLEGCF--SIKGAEKTIQLAASCLNRDQKARPRMSEVVEA 402 (476)
Q Consensus 356 ~~~~~~~d~~l~~~~--~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~ 402 (476)
+++.+.+ +.-.+.++.+||+++|.++|.+|++++++.++
T Consensus 266 --------rvl~gk~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~ 306 (596)
T KOG0586|consen 266 --------RVLRGKYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKD 306 (596)
T ss_pred --------hheeeeecccceeechhHHHHHHhhccCccccCCHHHhhhh
Confidence 1111111 12236788999999999999999999999887
|
|
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=328.81 Aligned_cols=269 Identities=24% Similarity=0.336 Sum_probs=201.7
Q ss_pred CCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCcc--CHHHHHHHHHHHhCCCCCceeeEEEEEEeC
Q 011851 122 SFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQ--GHKEWLAEVNYLGGLIHPNLVKLIGCCIED 199 (476)
Q Consensus 122 ~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~ 199 (476)
+|++.+.||+|+||.||+|.+. .+++.||||.++..... ..+.+.+|+.++++++||||+++++++.++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~---------~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 71 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNK---------KTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQE 71 (285)
T ss_pred CceEeeEecccCceEEEEEEEC---------CCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeC
Confidence 4888999999999999998754 46788999998654322 245678899999999999999999999999
Q ss_pred CeeEEEEEecCCCCHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCC
Q 011851 200 DQRLLVYEFMPRGSLENHLFRR--SLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGL 277 (476)
Q Consensus 200 ~~~~lV~E~~~~g~L~~~l~~~--~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~ 277 (476)
+.+|+||||++ ++|.+++... ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.++|+|||+
T Consensus 72 ~~~~~v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~ 147 (285)
T cd07861 72 SRLYLIFEFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGL 147 (285)
T ss_pred CeEEEEEecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccc
Confidence 99999999996 5888888543 356899999999999999999999988 99999999999999999999999999
Q ss_pred cCCCCCCCccceeeeeecCCCCCCcchhhcC-CCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchh-HHhh-hh----
Q 011851 278 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNL-VEWA-RP---- 350 (476)
Q Consensus 278 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~-~~~~-~~---- 350 (476)
+....... .......+++.|+|||++.+. .++.++|||||||++|+|++|+.||........... .... ..
T Consensus 148 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (285)
T cd07861 148 ARAFGIPV--RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDV 225 (285)
T ss_pred eeecCCCc--ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhh
Confidence 87543221 112234678899999988764 578999999999999999999999975432111100 0000 00
Q ss_pred --hhccccccccccCcccCCC---CChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCc
Q 011851 351 --QLGERRRFYRLIDPCLEGC---FSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYL 409 (476)
Q Consensus 351 --~~~~~~~~~~~~d~~l~~~---~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~ 409 (476)
.......+...+....... .....+.++.+||.+||+.||++|||+.+|+++ |||
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~----~~~ 285 (285)
T cd07861 226 WPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH----PYF 285 (285)
T ss_pred hhcchhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC----CCC
Confidence 0000000000000000000 001135688899999999999999999999987 775
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=330.94 Aligned_cols=269 Identities=23% Similarity=0.295 Sum_probs=201.9
Q ss_pred CCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCcc--CHHHHHHHHHHHhCCCCCceeeEEEEEEeC
Q 011851 122 SFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQ--GHKEWLAEVNYLGGLIHPNLVKLIGCCIED 199 (476)
Q Consensus 122 ~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~ 199 (476)
+|++.+.||+|+||.||+|.+. .+|+.||+|.+...... ....+.+|+.++++++||||+++++++.+.
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~---------~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~ 71 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNR---------ETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSD 71 (284)
T ss_pred CceeEEEecccCCeEEEEEEEC---------CCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccC
Confidence 4888999999999999998654 46788999998754322 234577899999999999999999999999
Q ss_pred CeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCcC
Q 011851 200 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAK 279 (476)
Q Consensus 200 ~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~ 279 (476)
+.+|+||||++ ++|.+++......+++..++.++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||+++
T Consensus 72 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~ 147 (284)
T cd07839 72 KKLTLVFEYCD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLAR 147 (284)
T ss_pred CceEEEEecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhh
Confidence 99999999996 5888888666677999999999999999999999988 9999999999999999999999999998
Q ss_pred CCCCCCccceeeeeecCCCCCCcchhhcC-CCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcc-hhH-Hh-------hh
Q 011851 280 DGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEH-NLV-EW-------AR 349 (476)
Q Consensus 280 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~-~~~-~~-------~~ 349 (476)
........ .....+++.|+|||++.+. .++.++|||||||++|+|++|..||......... ..+ .. ..
T Consensus 148 ~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (284)
T cd07839 148 AFGIPVRC--YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESW 225 (284)
T ss_pred ccCCCCCC--cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHh
Confidence 65332211 1234678999999998775 4789999999999999999999986533221100 000 00 00
Q ss_pred hhhcccccc--ccccCcccC-CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCc
Q 011851 350 PQLGERRRF--YRLIDPCLE-GCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYL 409 (476)
Q Consensus 350 ~~~~~~~~~--~~~~d~~l~-~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~ 409 (476)
+........ ......... .......+.++.+||.+||+.||.+|||+.++++| |||
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h----~~f 284 (284)
T cd07839 226 PGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH----PYF 284 (284)
T ss_pred HHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC----CCC
Confidence 000000000 000000000 00011235788999999999999999999999997 775
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=326.33 Aligned_cols=260 Identities=25% Similarity=0.441 Sum_probs=206.0
Q ss_pred cCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCc-cCHHHHHHHHHHHhCCCCCceeeEEEEEEeC
Q 011851 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL-QGHKEWLAEVNYLGGLIHPNLVKLIGCCIED 199 (476)
Q Consensus 121 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~ 199 (476)
++|+..+.||+|+||.||+|.+..++ .....+|+|.+..... ...+.+..|++++++++|+||+++++++.+.
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~------~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 78 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPG------RKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKF 78 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCC------CCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccC
Confidence 46888899999999999999875322 1234799999875532 2345688999999999999999999999999
Q ss_pred CeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCcC
Q 011851 200 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAK 279 (476)
Q Consensus 200 ~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~ 279 (476)
+..|+||||+++++|.+++......+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++.
T Consensus 79 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~ 155 (268)
T cd05063 79 KPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSR 155 (268)
T ss_pred CCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccce
Confidence 9999999999999999999776677999999999999999999999988 9999999999999999999999999998
Q ss_pred CCCCCCcccee-eeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhhccccc
Q 011851 280 DGPEGDKTHVS-TRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPQLGERRR 357 (476)
Q Consensus 280 ~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 357 (476)
........... .....+..|+|||++.+..++.++|||||||++|||++ |+.||....... ...... ....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~---~~~~i~----~~~~ 228 (268)
T cd05063 156 VLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHE---VMKAIN----DGFR 228 (268)
T ss_pred ecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHH---HHHHHh----cCCC
Confidence 65432221111 11223457999999998899999999999999999997 999996543211 111110 0000
Q ss_pred cccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011851 358 FYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPL 406 (476)
Q Consensus 358 ~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~ 406 (476)
.+ .....+..+.+++.+||+.+|++||++.+|++.|+.+
T Consensus 229 -----~~-----~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 229 -----LP-----APMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred -----CC-----CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 01 1112356789999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-42 Score=370.46 Aligned_cols=260 Identities=24% Similarity=0.333 Sum_probs=202.7
Q ss_pred HhccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCcc--CHHHHHHHHHHHhCCCCCceeeEEEE
Q 011851 118 SATKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQ--GHKEWLAEVNYLGGLIHPNLVKLIGC 195 (476)
Q Consensus 118 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~l~~~ 195 (476)
...++|++++.||+|+||+||+|.+. .++..||+|++...... ....+..|+.+|++|+|||||+++++
T Consensus 10 ~~l~~YeIl~kLG~GgFGtVYLAkdk---------~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~ 80 (1021)
T PTZ00266 10 SRLNEYEVIKKIGNGRFGEVFLVKHK---------RTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDR 80 (1021)
T ss_pred cccCCEEEEEEEecCCCeEEEEEEEC---------CCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEE
Confidence 34568999999999999999998764 46778999998754332 24568899999999999999999999
Q ss_pred EEeC--CeeEEEEEecCCCCHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHHHhcCC----CCeEecCCCCCCeeecC
Q 011851 196 CIED--DQRLLVYEFMPRGSLENHLFRR---SLPLPWSIRMKIALDAAKGLAFLHEEAE----KPVIYRDFKTSNILLDG 266 (476)
Q Consensus 196 ~~~~--~~~~lV~E~~~~g~L~~~l~~~---~~~l~~~~~~~i~~qi~~al~~lH~~~~----~~ivHrDlKp~NILl~~ 266 (476)
|.+. ..+||||||+++++|.++|... ...+++..++.|+.||+.||.|||+.+. .+||||||||+||||+.
T Consensus 81 f~de~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s 160 (1021)
T PTZ00266 81 FLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLST 160 (1021)
T ss_pred EEecCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeec
Confidence 8653 5689999999999999998642 3579999999999999999999998541 34999999999999964
Q ss_pred -----------------CCceEEeecCCcCCCCCCCccceeeeeecCCCCCCcchhhc--CCCCccchhhhhHHHHHHHH
Q 011851 267 -----------------EYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT--GHLTAKSDVYSFGVVLLEML 327 (476)
Q Consensus 267 -----------------~~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslGv~l~ell 327 (476)
.+.+||+|||++....... .....+||+.|+|||++.+ ..++.++||||||||||||+
T Consensus 161 ~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s---~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELL 237 (1021)
T PTZ00266 161 GIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIES---MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELC 237 (1021)
T ss_pred CccccccccccccccCCCCceEEccCCccccccccc---cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHH
Confidence 2358999999998653322 1234679999999999865 45889999999999999999
Q ss_pred hCCCCCCCCCCCCcchhHHhhhhhhccccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCC
Q 011851 328 TGRRSMDKNRPNGEHNLVEWARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLP 407 (476)
Q Consensus 328 tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~ 407 (476)
+|..||....... .++.. +.... ...+ ...+.++.+||..||+.+|.+||++.++|.+ +
T Consensus 238 TGk~PF~~~~~~~--qli~~----lk~~p------~lpi-----~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h----~ 296 (1021)
T PTZ00266 238 SGKTPFHKANNFS--QLISE----LKRGP------DLPI-----KGKSKELNILIKNLLNLSAKERPSALQCLGY----Q 296 (1021)
T ss_pred HCCCCCCcCCcHH--HHHHH----HhcCC------CCCc-----CCCCHHHHHHHHHHhcCChhHCcCHHHHhcc----H
Confidence 9999997543211 11110 00000 0000 1125689999999999999999999999975 5
Q ss_pred Ccc
Q 011851 408 YLK 410 (476)
Q Consensus 408 ~~~ 410 (476)
|++
T Consensus 297 ~ik 299 (1021)
T PTZ00266 297 IIK 299 (1021)
T ss_pred HHh
Confidence 554
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-42 Score=367.54 Aligned_cols=260 Identities=32% Similarity=0.447 Sum_probs=212.3
Q ss_pred CCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCC-ccCHHHHHHHHHHHhCCCCCceeeEEEEEEeCC
Q 011851 122 SFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDG-LQGHKEWLAEVNYLGGLIHPNLVKLIGCCIEDD 200 (476)
Q Consensus 122 ~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 200 (476)
+-.+.+.||+|+||.||+|......... ....||||.+++.. .+...+|++|..+|++++|||||+++|++.+..
T Consensus 693 ~v~l~~~lG~G~FG~VY~g~~~~~~~~~----~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~ 768 (1025)
T KOG1095|consen 693 NVTLLRVLGKGAFGEVYEGTYSDVPGSV----SPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSG 768 (1025)
T ss_pred heEeeeeeccccccceEEEEEecCCCCc----cceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCC
Confidence 3456678999999999999876432210 14569999997653 344568999999999999999999999999999
Q ss_pred eeEEEEEecCCCCHHHHHhhc------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEee
Q 011851 201 QRLLVYEFMPRGSLENHLFRR------SLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSD 274 (476)
Q Consensus 201 ~~~lV~E~~~~g~L~~~l~~~------~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~D 274 (476)
..+|++|||+||+|..+|++. ...++....+.++.||++|++||++++ +|||||...|+||+....|||+|
T Consensus 769 ~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaD 845 (1025)
T KOG1095|consen 769 PPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIAD 845 (1025)
T ss_pred CcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcc
Confidence 999999999999999999876 667899999999999999999999988 99999999999999999999999
Q ss_pred cCCcCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhhc
Q 011851 275 FGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPQLG 353 (476)
Q Consensus 275 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~ 353 (476)
||+|++....+.+....+-.-...|||||.+..+.++.++|||||||+|||++| |..||...+.......+.
T Consensus 846 FGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~------- 918 (1025)
T KOG1095|consen 846 FGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVL------- 918 (1025)
T ss_pred cchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHH-------
Confidence 999997666555544333233468999999999999999999999999999999 778887655433322111
Q ss_pred cccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 011851 354 ERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKP 405 (476)
Q Consensus 354 ~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~ 405 (476)
+..++ + .+..+++.+++|+.+||+.+|++||++..|++.+..
T Consensus 919 ~ggRL----~------~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~ 960 (1025)
T KOG1095|consen 919 EGGRL----D------PPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPA 960 (1025)
T ss_pred hCCcc----C------CCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhh
Confidence 11111 0 223347889999999999999999999999997553
|
|
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-41 Score=332.49 Aligned_cols=266 Identities=23% Similarity=0.357 Sum_probs=192.4
Q ss_pred ccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCCCCCceeeEEEEEEe--CCeeEE
Q 011851 127 CLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHPNLVKLIGCCIE--DDQRLL 204 (476)
Q Consensus 127 ~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~--~~~~~l 204 (476)
.+||+|+||.||+|..... .++..||+|.+..... ...+.+|+.+|++++||||+++++++.. +...|+
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~-------~~~~~~a~k~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~l 77 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDG-------KDEKEYALKQIEGTGI--SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWL 77 (317)
T ss_pred eEeccCCCeeEEEEEecCC-------CccceEEEEEecCCCC--cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEE
Confidence 5799999999999976432 3567899999875432 3457789999999999999999999854 567899
Q ss_pred EEEecCCCCHHHHHhh--------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeee----cCCCceEE
Q 011851 205 VYEFMPRGSLENHLFR--------RSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILL----DGEYNAKL 272 (476)
Q Consensus 205 V~E~~~~g~L~~~l~~--------~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl----~~~~~vkl 272 (476)
||||++ ++|.+++.. ....+++..++.++.||+.||.|||+.+ |+||||||+|||+ +.++.+||
T Consensus 78 v~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl 153 (317)
T cd07867 78 LFDYAE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKI 153 (317)
T ss_pred EEeeeC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEE
Confidence 999995 578777642 1235889999999999999999999988 9999999999999 56678999
Q ss_pred eecCCcCCCCCCCcc-ceeeeeecCCCCCCcchhhcC-CCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcc-------h
Q 011851 273 SDFGLAKDGPEGDKT-HVSTRVMGTYGYAAPEYVMTG-HLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEH-------N 343 (476)
Q Consensus 273 ~DFG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~-------~ 343 (476)
+|||+++........ .......||+.|+|||++.+. .++.++|||||||++|||+||+.||......... .
T Consensus 154 ~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~ 233 (317)
T cd07867 154 ADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQ 233 (317)
T ss_pred eeccceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHH
Confidence 999999865432211 112335789999999998764 5899999999999999999999999754322110 0
Q ss_pred hHHhhh----------hhhccccccccccCcc---------c---CCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 011851 344 LVEWAR----------PQLGERRRFYRLIDPC---------L---EGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVE 401 (476)
Q Consensus 344 ~~~~~~----------~~~~~~~~~~~~~d~~---------l---~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~ 401 (476)
+..... ........+....... + ...........+.+|+.+||+.||.+|||+.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~ 313 (317)
T cd07867 234 LDRIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQ 313 (317)
T ss_pred HHHHHHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhc
Confidence 000000 0000000000000000 0 00001112356889999999999999999999999
Q ss_pred HhcCCCCc
Q 011851 402 ALKPLPYL 409 (476)
Q Consensus 402 ~L~~~~~~ 409 (476)
| |||
T Consensus 314 h----p~f 317 (317)
T cd07867 314 D----PYF 317 (317)
T ss_pred C----CCC
Confidence 7 886
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=334.96 Aligned_cols=265 Identities=26% Similarity=0.380 Sum_probs=206.7
Q ss_pred ccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCC-ccCHHHHHHHHHHHhCC-CCCceeeEEEEEE
Q 011851 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDG-LQGHKEWLAEVNYLGGL-IHPNLVKLIGCCI 197 (476)
Q Consensus 120 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~ 197 (476)
..+|.+.+.||+|+||.||+|.+..... ....++..||+|.+.... ......+.+|+.+++.+ +||||+++++++.
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~--~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 91 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDK--DKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 91 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCC--CCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence 3468899999999999999997542111 112345679999987542 23345788999999999 8999999999999
Q ss_pred eCCeeEEEEEecCCCCHHHHHhhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCe
Q 011851 198 EDDQRLLVYEFMPRGSLENHLFRRS---------------LPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNI 262 (476)
Q Consensus 198 ~~~~~~lV~E~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NI 262 (476)
.....|+||||+++++|.+++.... ..+++..+..++.||+.||.|||+++ |+||||||+||
T Consensus 92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Ni 168 (304)
T cd05101 92 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNV 168 (304)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceE
Confidence 9999999999999999999996531 34788889999999999999999988 99999999999
Q ss_pred eecCCCceEEeecCCcCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHh-CCCCCCCCCCCCc
Q 011851 263 LLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLT-GRRSMDKNRPNGE 341 (476)
Q Consensus 263 Ll~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~ellt-G~~pf~~~~~~~~ 341 (476)
|++.++.+||+|||+++...............+++.|+|||++.+..++.++|||||||++|+|++ |..||.......
T Consensus 169 li~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~- 247 (304)
T cd05101 169 LVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE- 247 (304)
T ss_pred EEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH-
Confidence 999999999999999987644332222223446778999999998899999999999999999998 788886543211
Q ss_pred chhHHhhhhhhccccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011851 342 HNLVEWARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPL 406 (476)
Q Consensus 342 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~ 406 (476)
+... +..... ...+...+.++.+|+.+||+.+|++||++.++++.|+.+
T Consensus 248 --~~~~----~~~~~~----------~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~ 296 (304)
T cd05101 248 --LFKL----LKEGHR----------MDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRI 296 (304)
T ss_pred --HHHH----HHcCCc----------CCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHH
Confidence 1111 000000 001122367899999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=346.28 Aligned_cols=263 Identities=24% Similarity=0.381 Sum_probs=205.3
Q ss_pred cCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccC-HHHHHHHHHHHhCCC-CCceeeEEEEEEe
Q 011851 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQG-HKEWLAEVNYLGGLI-HPNLVKLIGCCIE 198 (476)
Q Consensus 121 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~-~~~~~~E~~~l~~l~-hpnIv~l~~~~~~ 198 (476)
++|.+.+.||+|+||.||+|++.... ...++..||||+++...... .+.+.+|+++|.++. ||||+++++++..
T Consensus 37 ~~~~~~~~lG~G~fG~Vy~~~~~~~~----~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~ 112 (401)
T cd05107 37 DNLVLGRTLGSGAFGRVVEATAHGLS----HSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTK 112 (401)
T ss_pred HHeehhhhccCCCceeEEEEEEcCCC----CCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEcc
Confidence 35888899999999999999875321 22356789999997653332 346889999999997 9999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHHhhcC--------------------------------------------------------
Q 011851 199 DDQRLLVYEFMPRGSLENHLFRRS-------------------------------------------------------- 222 (476)
Q Consensus 199 ~~~~~lV~E~~~~g~L~~~l~~~~-------------------------------------------------------- 222 (476)
.+..+||||||++|+|.+++.+..
T Consensus 113 ~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (401)
T cd05107 113 GGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPM 192 (401)
T ss_pred CCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccch
Confidence 999999999999999999996431
Q ss_pred -----------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCC
Q 011851 223 -----------------------------------------LPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSN 261 (476)
Q Consensus 223 -----------------------------------------~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~N 261 (476)
..+++..+..++.||+.||.|||+.+ |+||||||+|
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~N 269 (401)
T cd05107 193 QDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAARN 269 (401)
T ss_pred hcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcce
Confidence 13567778899999999999999987 9999999999
Q ss_pred eeecCCCceEEeecCCcCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHh-CCCCCCCCCCCC
Q 011851 262 ILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLT-GRRSMDKNRPNG 340 (476)
Q Consensus 262 ILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~ellt-G~~pf~~~~~~~ 340 (476)
||++.++.+||+|||+++...............+++.|+|||++.+..++.++|||||||++|||++ |..||.......
T Consensus 270 iLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~ 349 (401)
T cd05107 270 VLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNE 349 (401)
T ss_pred EEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchH
Confidence 9999999999999999986433222111223457889999999998899999999999999999998 888986543221
Q ss_pred cchhHHhhhhhhccccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011851 341 EHNLVEWARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPL 406 (476)
Q Consensus 341 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~ 406 (476)
. .... +..... . ..+...+.++.+|+.+||..+|.+||++++|++.|+.+
T Consensus 350 ~--~~~~----~~~~~~---~-------~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~ 399 (401)
T cd05107 350 Q--FYNA----IKRGYR---M-------AKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDL 399 (401)
T ss_pred H--HHHH----HHcCCC---C-------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 1 0000 000000 0 01112357899999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-43 Score=369.69 Aligned_cols=265 Identities=24% Similarity=0.297 Sum_probs=216.2
Q ss_pred HHHHhccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCcc---CHHHHHHHHHHHhCCCCCceee
Q 011851 115 ELKSATKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQ---GHKEWLAEVNYLGGLIHPNLVK 191 (476)
Q Consensus 115 ~~~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~---~~~~~~~E~~~l~~l~hpnIv~ 191 (476)
+++-...+|.++++||+|+||.|.+.+ .+.|++.||+|++++...- ....|..|-++|..-+.+.|++
T Consensus 69 ~lrl~~~DfeilKvIGrGaFGEV~lVr---------~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~ 139 (1317)
T KOG0612|consen 69 ELRLKAEDFEILKVIGRGAFGEVALVR---------HKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQ 139 (1317)
T ss_pred HHhCCHHhhHHHHHhcccccceeEEEE---------eeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHH
Confidence 344456789999999999999999854 4578899999999874332 3345888999999999999999
Q ss_pred EEEEEEeCCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceE
Q 011851 192 LIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAK 271 (476)
Q Consensus 192 l~~~~~~~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vk 271 (476)
++.+|.++.++||||||++||+|..++.+.. ++++..++.++..|+.||..||+.| +|||||||+|||||..|+||
T Consensus 140 LhyAFQD~~~LYlVMdY~pGGDlltLlSk~~-~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHik 215 (1317)
T KOG0612|consen 140 LHYAFQDERYLYLVMDYMPGGDLLTLLSKFD-RLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIK 215 (1317)
T ss_pred HHHHhcCccceEEEEecccCchHHHHHhhcC-CChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEe
Confidence 9999999999999999999999999996665 8999999999999999999999999 99999999999999999999
Q ss_pred EeecCCcCCCCCCCccceeeeeecCCCCCCcchhhc-----CCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHH
Q 011851 272 LSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-----GHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVE 346 (476)
Q Consensus 272 l~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~ 346 (476)
|+|||.+..... +....+...+|||.|++||++.. +.|+..+||||+||++|||+.|..||....-.+...
T Consensus 216 LADFGsClkm~~-dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~--- 291 (1317)
T KOG0612|consen 216 LADFGSCLKMDA-DGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYG--- 291 (1317)
T ss_pred eccchhHHhcCC-CCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHH---
Confidence 999999877653 33444556789999999999862 579999999999999999999999997543221111
Q ss_pred hhhhhhccccccccccCcccCCCCC--hHHHHHHHHHHHHhcccCCCCCCC---HHHHHHHhcCCCCcccccC
Q 011851 347 WARPQLGERRRFYRLIDPCLEGCFS--IKGAEKTIQLAASCLNRDQKARPR---MSEVVEALKPLPYLKDMAS 414 (476)
Q Consensus 347 ~~~~~~~~~~~~~~~~d~~l~~~~~--~~~~~~~~~li~~cL~~dP~~RPt---~~ell~~L~~~~~~~~~~~ 414 (476)
++++-.-.-.|+ .+.++++.+||.+.+. +|+.|.. ++++-.| |||.+..+
T Consensus 292 -------------KIm~hk~~l~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~H----pFF~g~~W 346 (1317)
T KOG0612|consen 292 -------------KIMNHKESLSFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNH----PFFEGIDW 346 (1317)
T ss_pred -------------HHhchhhhcCCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhC----ccccCCCh
Confidence 111110001122 3458899999999885 7888877 8887666 99998876
|
|
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=340.13 Aligned_cols=262 Identities=28% Similarity=0.380 Sum_probs=201.7
Q ss_pred cCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCcc-CHHHHHHHHHHHhCC-CCCceeeEEEEEEe
Q 011851 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQ-GHKEWLAEVNYLGGL-IHPNLVKLIGCCIE 198 (476)
Q Consensus 121 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~-~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~ 198 (476)
++|++.+.||+|+||.||+|.+... .+..+++.||||+++..... ....+.+|+.+|.++ +|+||+++++++..
T Consensus 7 ~~~~~~~~lG~G~fg~V~~~~~~~~----~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~ 82 (343)
T cd05103 7 DRLKLGKPLGRGAFGQVIEADAFGI----DKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK 82 (343)
T ss_pred hHhcccccccCCccceEEEEeeccC----CccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeec
Confidence 4799999999999999999976421 12346788999999764322 235678899999999 68999999998765
Q ss_pred C-CeeEEEEEecCCCCHHHHHhhcC-------------------------------------------------------
Q 011851 199 D-DQRLLVYEFMPRGSLENHLFRRS------------------------------------------------------- 222 (476)
Q Consensus 199 ~-~~~~lV~E~~~~g~L~~~l~~~~------------------------------------------------------- 222 (476)
. ...++|||||++|+|.+++....
T Consensus 83 ~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (343)
T cd05103 83 PGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVE 162 (343)
T ss_pred CCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccch
Confidence 4 56889999999999999986421
Q ss_pred -----------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCcCCCCCCCccceee
Q 011851 223 -----------LPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVST 291 (476)
Q Consensus 223 -----------~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~ 291 (476)
..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.............
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 239 (343)
T cd05103 163 EEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKG 239 (343)
T ss_pred hhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcC
Confidence 23678888999999999999999988 9999999999999999999999999998653322211122
Q ss_pred eeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhhccccccccccCcccCCCC
Q 011851 292 RVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPQLGERRRFYRLIDPCLEGCF 370 (476)
Q Consensus 292 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 370 (476)
...++..|+|||++.+..++.++|||||||++|+|++ |..||....... ..... ...... .. .
T Consensus 240 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--~~~~~----~~~~~~---~~---~---- 303 (343)
T cd05103 240 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE--EFCRR----LKEGTR---MR---A---- 303 (343)
T ss_pred CCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccH--HHHHH----HhccCC---CC---C----
Confidence 2345678999999999999999999999999999997 999986543211 11110 000000 00 0
Q ss_pred ChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 011851 371 SIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKP 405 (476)
Q Consensus 371 ~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~ 405 (476)
+...+.++.+++.+||+.||++||++.+|+++|+.
T Consensus 304 ~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~ 338 (343)
T cd05103 304 PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 338 (343)
T ss_pred CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 00124578899999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-41 Score=322.69 Aligned_cols=250 Identities=27% Similarity=0.387 Sum_probs=197.3
Q ss_pred cccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCcc--CHHHHHHHHHHHhCCCCCceeeEEEEEEeCCeeEEE
Q 011851 128 LLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQ--GHKEWLAEVNYLGGLIHPNLVKLIGCCIEDDQRLLV 205 (476)
Q Consensus 128 ~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV 205 (476)
.||+|+||.||+|.+.. ..++..+|+|+++..... ..+++..|+.+++.++||||+++++++. .+..++|
T Consensus 2 ~lg~G~~g~v~~~~~~~-------~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv 73 (257)
T cd05116 2 ELGSGNFGTVKKGMYKM-------KKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLV 73 (257)
T ss_pred cCCCcCCcceEEeEEec-------CCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEE
Confidence 58999999999996542 246778999998754322 2456889999999999999999999875 4577999
Q ss_pred EEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCcCCCCCCC
Q 011851 206 YEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGD 285 (476)
Q Consensus 206 ~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~ 285 (476)
|||+++++|.+++... ..+++..+..++.|++.||.|||+++ |+||||||.|||++.++.+||+|||++.......
T Consensus 74 ~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~ 149 (257)
T cd05116 74 MELAELGPLNKFLQKN-KHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADE 149 (257)
T ss_pred EecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCC
Confidence 9999999999998543 46899999999999999999999988 9999999999999999999999999998654322
Q ss_pred ccc-eeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhhccccccccccC
Q 011851 286 KTH-VSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPQLGERRRFYRLID 363 (476)
Q Consensus 286 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 363 (476)
... ......++..|+|||++....++.++|||||||++|||++ |..||....... +..... ...
T Consensus 150 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~~i~----~~~------- 215 (257)
T cd05116 150 NYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNE---VTQMIE----SGE------- 215 (257)
T ss_pred CeeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHH----CCC-------
Confidence 211 1112234578999999988889999999999999999998 999997543321 111111 000
Q ss_pred cccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011851 364 PCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPL 406 (476)
Q Consensus 364 ~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~ 406 (476)
....+...+.++.+||.+||+.||++||++.+|.+.|+..
T Consensus 216 ---~~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 216 ---RMECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred ---CCCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 0001122367899999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=332.61 Aligned_cols=257 Identities=26% Similarity=0.393 Sum_probs=210.5
Q ss_pred cCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCCCCCceeeEEEEEEeCC
Q 011851 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHPNLVKLIGCCIEDD 200 (476)
Q Consensus 121 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 200 (476)
.+|++.+.||.|+||.||+|.+. .+++.||+|.+........+.+.+|+.+++.++||||+++++++...+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~---------~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 89 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDV---------ATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGD 89 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEc---------CCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCc
Confidence 46999999999999999998654 467889999997665555677889999999999999999999999999
Q ss_pred eeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCcCC
Q 011851 201 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKD 280 (476)
Q Consensus 201 ~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~ 280 (476)
.+|+||||+++++|.+++... .+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++..
T Consensus 90 ~~~lv~e~~~~~~L~~~~~~~--~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~ 164 (296)
T cd06655 90 ELFVVMEYLAGGSLTDVVTET--CMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQ 164 (296)
T ss_pred eEEEEEEecCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchh
Confidence 999999999999999988543 5899999999999999999999988 99999999999999999999999999876
Q ss_pred CCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhcccccccc
Q 011851 281 GPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRRFYR 360 (476)
Q Consensus 281 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 360 (476)
....... .....|+..|+|||.+.+..++.++|||||||++|+|++|+.||...........+ .. ...
T Consensus 165 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~--~~---~~~----- 232 (296)
T cd06655 165 ITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI--AT---NGT----- 232 (296)
T ss_pred ccccccc--CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--Hh---cCC-----
Confidence 5432211 22356899999999999888999999999999999999999999765432111110 00 000
Q ss_pred ccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCcccc
Q 011851 361 LIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDM 412 (476)
Q Consensus 361 ~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~~ 412 (476)
+.+. .+...+..+.++|.+||..||++||++.+++.+ ||++..
T Consensus 233 ---~~~~--~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~----~~~~~~ 275 (296)
T cd06655 233 ---PELQ--NPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQH----PFLKLA 275 (296)
T ss_pred ---cccC--CcccCCHHHHHHHHHHhhcChhhCCCHHHHhhC----hHhhhc
Confidence 0000 111235678899999999999999999999997 888754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-41 Score=322.42 Aligned_cols=251 Identities=25% Similarity=0.413 Sum_probs=198.4
Q ss_pred cccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCcc-CHHHHHHHHHHHhCCCCCceeeEEEEEEeCCeeEEEE
Q 011851 128 LLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQ-GHKEWLAEVNYLGGLIHPNLVKLIGCCIEDDQRLLVY 206 (476)
Q Consensus 128 ~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~ 206 (476)
.||+|+||.||+|.+... .++..||+|++...... ..+.+.+|+.++++++|+||+++++++. .+..++||
T Consensus 2 ~ig~G~~g~v~~~~~~~~-------~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~ 73 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMR-------KKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVM 73 (257)
T ss_pred ccCCCCcccEEEEEEecC-------CCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEE
Confidence 389999999999976422 24567999998765332 2356889999999999999999999875 45789999
Q ss_pred EecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCcCCCCCCCc
Q 011851 207 EFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDK 286 (476)
Q Consensus 207 E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~~ 286 (476)
||+++++|.+++......+++..++.++.||+.||.|||+++ ++||||||+|||++.++.+||+|||++........
T Consensus 74 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~ 150 (257)
T cd05115 74 EMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDS 150 (257)
T ss_pred EeCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCcc
Confidence 999999999999766667999999999999999999999988 99999999999999999999999999976543322
Q ss_pred cce-eeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhhccccccccccCc
Q 011851 287 THV-STRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPQLGERRRFYRLIDP 364 (476)
Q Consensus 287 ~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 364 (476)
... .....++..|+|||++.+..++.++|||||||++|||++ |..||...........+. ..
T Consensus 151 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-------~~--------- 214 (257)
T cd05115 151 YYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIE-------QG--------- 214 (257)
T ss_pred ceeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHH-------CC---------
Confidence 111 111223578999999988889999999999999999996 999997553321111110 00
Q ss_pred ccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011851 365 CLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPL 406 (476)
Q Consensus 365 ~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~ 406 (476)
.....+...+.++.+++.+||..||++||++.+|++.|+.+
T Consensus 215 -~~~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 215 -KRLDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred -CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 00011223367899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=325.23 Aligned_cols=255 Identities=30% Similarity=0.461 Sum_probs=203.3
Q ss_pred CCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCcc------CHHHHHHHHHHHhCCCCCceeeEEEE
Q 011851 122 SFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQ------GHKEWLAEVNYLGGLIHPNLVKLIGC 195 (476)
Q Consensus 122 ~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~------~~~~~~~E~~~l~~l~hpnIv~l~~~ 195 (476)
+|++.+.||.|+||.||+|... +++.+|+|.+...... ....+.+|+++|++++|+||++++++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~----------~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~ 70 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTN----------QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGT 70 (265)
T ss_pred CccccceEeccCCeEEEEEEEc----------CCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeE
Confidence 4788999999999999998642 5778999998654221 12457889999999999999999999
Q ss_pred EEeCCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeec
Q 011851 196 CIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDF 275 (476)
Q Consensus 196 ~~~~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DF 275 (476)
+.+.+..++||||+++++|.+++.+. ..+++..+..++.|++.||+|||+.+ |+|+||+|+||+++.++.++|+||
T Consensus 71 ~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~df 146 (265)
T cd06631 71 CLDDNTISIFMEFVPGGSISSILNRF-GPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDF 146 (265)
T ss_pred eecCCeEEEEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccc
Confidence 99999999999999999999999543 46899999999999999999999988 999999999999999999999999
Q ss_pred CCcCCCCCCC----ccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhh
Q 011851 276 GLAKDGPEGD----KTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQ 351 (476)
Q Consensus 276 G~a~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~ 351 (476)
|++....... .........|+..|+|||++.+..++.++|||||||++|+|++|..||.......... ...
T Consensus 147 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~--~~~--- 221 (265)
T cd06631 147 GCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMF--YIG--- 221 (265)
T ss_pred hhhHhhhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHH--Hhh---
Confidence 9987542211 1111223568999999999998899999999999999999999999997543211110 000
Q ss_pred hccccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCc
Q 011851 352 LGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYL 409 (476)
Q Consensus 352 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~ 409 (476)
... . ..+. .+...+.++.++|.+||+.+|++||++.+++++ |||
T Consensus 222 --~~~---~-~~~~----~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~----~~~ 265 (265)
T cd06631 222 --AHR---G-LMPR----LPDSFSAAAIDFVTSCLTRDQHERPSALQLLRH----DFL 265 (265)
T ss_pred --hcc---C-CCCC----CCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcC----CCC
Confidence 000 0 0011 112236788999999999999999999999987 775
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-41 Score=324.67 Aligned_cols=257 Identities=23% Similarity=0.343 Sum_probs=204.3
Q ss_pred ccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCCCCCceeeEEEEEEeC
Q 011851 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHPNLVKLIGCCIED 199 (476)
Q Consensus 120 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~ 199 (476)
++.+.....||+|+||.||+|.+. .++..||+|.+........+.+.+|+.++++++|+||+++++++..+
T Consensus 7 ~~~~~~~~~lg~g~~g~v~~~~~~---------~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 77 (268)
T cd06624 7 YDENGERVVLGKGTYGIVYAARDL---------STQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSEN 77 (268)
T ss_pred cccCCceEEEecCCceEEEEeEec---------CCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccC
Confidence 445555678999999999998654 36778999998776655567789999999999999999999999999
Q ss_pred CeeEEEEEecCCCCHHHHHhhcCCCC--CHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecC-CCceEEeecC
Q 011851 200 DQRLLVYEFMPRGSLENHLFRRSLPL--PWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDG-EYNAKLSDFG 276 (476)
Q Consensus 200 ~~~~lV~E~~~~g~L~~~l~~~~~~l--~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~-~~~vkl~DFG 276 (476)
+..++||||+++++|.+++......+ ++..+..++.||+.||.|||+.+ |+||||||+||+++. ++.++|+|||
T Consensus 78 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg 154 (268)
T cd06624 78 GFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFG 154 (268)
T ss_pred CEEEEEEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecch
Confidence 99999999999999999997654556 88889999999999999999988 999999999999976 6799999999
Q ss_pred CcCCCCCCCccceeeeeecCCCCCCcchhhcCC--CCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhcc
Q 011851 277 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGH--LTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGE 354 (476)
Q Consensus 277 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~ 354 (476)
++........ ......|++.|+|||++.+.. ++.++||||||+++|+|++|+.||........ ..+......
T Consensus 155 ~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~---~~~~~~~~~- 228 (268)
T cd06624 155 TSKRLAGINP--CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQA---AMFKVGMFK- 228 (268)
T ss_pred hheecccCCC--ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhh---hHhhhhhhc-
Confidence 9876533221 122346899999999987653 78899999999999999999999965322111 001000000
Q ss_pred ccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCc
Q 011851 355 RRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYL 409 (476)
Q Consensus 355 ~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~ 409 (476)
....++...++++.+++.+||+.+|++|||+.++++| ||+
T Consensus 229 -----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~----~~~ 268 (268)
T cd06624 229 -----------IHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQD----PFL 268 (268)
T ss_pred -----------cCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC----CCC
Confidence 0011122335788999999999999999999999998 875
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=328.65 Aligned_cols=260 Identities=27% Similarity=0.435 Sum_probs=206.1
Q ss_pred CCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCc-cCHHHHHHHHHHHhCCCCCceeeEEEEEEeCC
Q 011851 122 SFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL-QGHKEWLAEVNYLGGLIHPNLVKLIGCCIEDD 200 (476)
Q Consensus 122 ~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 200 (476)
+|++.+.||+|+||.||+|.+. .+++.||+|.+..... .....+.+|++++++++|+||+++++++..++
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~---------~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~ 72 (286)
T cd06622 2 EIEVLDELGKGNYGSVYKVLHR---------PTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEG 72 (286)
T ss_pred hhhhhhhhcccCCeEEEEEEEc---------CCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCC
Confidence 6889999999999999998654 4677899999865422 22457889999999999999999999999999
Q ss_pred eeEEEEEecCCCCHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeEecCCCCCCeeecCCCceEEeecCC
Q 011851 201 QRLLVYEFMPRGSLENHLFRR--SLPLPWSIRMKIALDAAKGLAFLHEE-AEKPVIYRDFKTSNILLDGEYNAKLSDFGL 277 (476)
Q Consensus 201 ~~~lV~E~~~~g~L~~~l~~~--~~~l~~~~~~~i~~qi~~al~~lH~~-~~~~ivHrDlKp~NILl~~~~~vkl~DFG~ 277 (476)
.+|+||||+++++|..++... ...+++..+..++.||+.||.|||+. + |+||||||+||+++.++.+||+|||+
T Consensus 73 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~ 149 (286)
T cd06622 73 AVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN---IIHRDVKPTNVLVNGNGQVKLCDFGV 149 (286)
T ss_pred eEEEEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCC---EeeCCCCHHHEEECCCCCEEEeecCC
Confidence 999999999999998888553 33689999999999999999999973 6 99999999999999999999999999
Q ss_pred cCCCCCCCccceeeeeecCCCCCCcchhhcC------CCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhh
Q 011851 278 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG------HLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQ 351 (476)
Q Consensus 278 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~ 351 (476)
+....... .....|++.|+|||++.+. .++.++|||||||++|+|++|+.||..............
T Consensus 150 ~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~---- 221 (286)
T cd06622 150 SGNLVASL----AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSA---- 221 (286)
T ss_pred cccccCCc----cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHH----
Confidence 87643221 2235688899999998554 358899999999999999999999965432211111100
Q ss_pred hccccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCcccccCc
Q 011851 352 LGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDMASS 415 (476)
Q Consensus 352 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~~~~~ 415 (476)
+.+.. ....+...+.++.+||.+||+.+|++||++.+++++ ||+......
T Consensus 222 ---------~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~----~~~~~~~~~ 271 (286)
T cd06622 222 ---------IVDGD-PPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH----PWLVKYKNA 271 (286)
T ss_pred ---------HhhcC-CCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcC----hhhhhccCC
Confidence 00000 001122346788999999999999999999999987 998765444
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-41 Score=321.81 Aligned_cols=252 Identities=35% Similarity=0.513 Sum_probs=205.7
Q ss_pred ccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccC-HHHHHHHHHHHhCCCCCceeeEEEEEEeCCeeEEE
Q 011851 127 CLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQG-HKEWLAEVNYLGGLIHPNLVKLIGCCIEDDQRLLV 205 (476)
Q Consensus 127 ~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~-~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV 205 (476)
+.||+|+||.||+|.+.... .++..||+|++....... .+.+.+|+++++.++|+||+++++++.++..+++|
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~------~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv 74 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKD------GKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLV 74 (262)
T ss_pred CccccCCceEEEEEEEecCC------CCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEE
Confidence 46999999999999875321 347789999998765443 56788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhc--------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCC
Q 011851 206 YEFMPRGSLENHLFRR--------SLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGL 277 (476)
Q Consensus 206 ~E~~~~g~L~~~l~~~--------~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~ 277 (476)
|||+++++|.+++... ...+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||.
T Consensus 75 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~ 151 (262)
T cd00192 75 LEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGL 151 (262)
T ss_pred EEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccc
Confidence 9999999999999765 477999999999999999999999988 99999999999999999999999999
Q ss_pred cCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhhcccc
Q 011851 278 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPQLGERR 356 (476)
Q Consensus 278 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~ 356 (476)
+................++..|+|||.+....++.++|||||||++|+|++ |..||....... +..... ...
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~~~~~----~~~ 224 (262)
T cd00192 152 SRDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEE---VLEYLR----KGY 224 (262)
T ss_pred ccccccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHH---HHHHHH----cCC
Confidence 987654332222334567889999999998899999999999999999999 699997653211 111110 000
Q ss_pred ccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 011851 357 RFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALK 404 (476)
Q Consensus 357 ~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~ 404 (476)
. ...+...+.++.+++.+||+.||++||++.+++++|+
T Consensus 225 ---~-------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 225 ---R-------LPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred ---C-------CCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 0 0111222678999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=331.01 Aligned_cols=253 Identities=28% Similarity=0.413 Sum_probs=207.7
Q ss_pred cCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCc---cCHHHHHHHHHHHhCCCCCceeeEEEEEE
Q 011851 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL---QGHKEWLAEVNYLGGLIHPNLVKLIGCCI 197 (476)
Q Consensus 121 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~l~~~~~ 197 (476)
++|++.+.||+|+||.||++.+. .+++.||+|++..... ...+.+.+|+++|++++||||+++++++.
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 71 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHK---------GSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQ 71 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEc---------CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEE
Confidence 36889999999999999998765 3678899999875432 23456788999999999999999999999
Q ss_pred eCCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCC
Q 011851 198 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGL 277 (476)
Q Consensus 198 ~~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~ 277 (476)
+++.+|+||||+++++|.+++... ..+++..+..++.||+.||.|||+.+ |+|+||+|+|||++.++.+||+|||+
T Consensus 72 ~~~~~~~v~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~ 147 (290)
T cd05580 72 DDSNLYLVMEYVPGGELFSHLRKS-GRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGF 147 (290)
T ss_pred cCCeEEEEEecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCC
Confidence 999999999999999999998554 57999999999999999999999988 99999999999999999999999999
Q ss_pred cCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhccccc
Q 011851 278 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRR 357 (476)
Q Consensus 278 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 357 (476)
+...... .....|++.|+|||.+.+..++.++||||||+++|+|++|+.||...... ..... ......
T Consensus 148 ~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~~---~~~~~~- 215 (290)
T cd05580 148 AKRVKGR-----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPI---QIYEK---ILEGKV- 215 (290)
T ss_pred ccccCCC-----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH---HHHHH---HhcCCc-
Confidence 9876443 22357899999999998888999999999999999999999999754421 11110 000000
Q ss_pred cccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHhcCCCCccccc
Q 011851 358 FYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARP-----RMSEVVEALKPLPYLKDMA 413 (476)
Q Consensus 358 ~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RP-----t~~ell~~L~~~~~~~~~~ 413 (476)
.++...+..+.+++.+||..||.+|+ ++.++++| |||+...
T Consensus 216 -----------~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~----~~~~~~~ 261 (290)
T cd05580 216 -----------RFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNH----PWFAGID 261 (290)
T ss_pred -----------cCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcC----cccccCC
Confidence 01112257888999999999999998 77777765 9987754
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-41 Score=325.61 Aligned_cols=256 Identities=28% Similarity=0.432 Sum_probs=197.4
Q ss_pred CCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCc--cCHHHHHHHHHHHhCCCCCceeeEEEEEEeC-
Q 011851 123 FRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL--QGHKEWLAEVNYLGGLIHPNLVKLIGCCIED- 199 (476)
Q Consensus 123 y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~- 199 (476)
|.+.+.||+|+||.||+|.+...+ ....||+|.++.... ...+.+.+|+.+++.++|+||+++++++...
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~-------~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 73 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDD-------SILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTV 73 (272)
T ss_pred CccccccCcccCceEEEeEEccCC-------CeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCC
Confidence 456789999999999999875332 123699999875432 2345688899999999999999999987532
Q ss_pred -----CeeEEEEEecCCCCHHHHHhh-----cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCc
Q 011851 200 -----DQRLLVYEFMPRGSLENHLFR-----RSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYN 269 (476)
Q Consensus 200 -----~~~~lV~E~~~~g~L~~~l~~-----~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~ 269 (476)
...++||||+++++|.+++.. ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.
T Consensus 74 ~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~ 150 (272)
T cd05075 74 ESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMN 150 (272)
T ss_pred cccCCCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCC
Confidence 246899999999999988743 2345889999999999999999999988 999999999999999999
Q ss_pred eEEeecCCcCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHh-CCCCCCCCCCCCcchhHHhh
Q 011851 270 AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWA 348 (476)
Q Consensus 270 vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~ellt-G~~pf~~~~~~~~~~~~~~~ 348 (476)
+||+|||+++...............+++.|+|||++.+..++.++|||||||++|||++ |+.||...... ......
T Consensus 151 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---~~~~~~ 227 (272)
T cd05075 151 VCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENS---EIYDYL 227 (272)
T ss_pred EEECCCCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHH---HHHHHH
Confidence 99999999987543322111122346778999999999999999999999999999999 88898653321 111111
Q ss_pred hhhhccccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 011851 349 RPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKP 405 (476)
Q Consensus 349 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~ 405 (476)
. ..... ......+..+.++|.+||+.||++|||+.+|+++|+.
T Consensus 228 ~----~~~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~ 270 (272)
T cd05075 228 R----QGNRL----------KQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEK 270 (272)
T ss_pred H----cCCCC----------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence 0 10000 0111225678999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=326.56 Aligned_cols=258 Identities=26% Similarity=0.459 Sum_probs=204.1
Q ss_pred CCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCC-ccCHHHHHHHHHHHhCCCCCceeeEEEEEEeCC
Q 011851 122 SFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDG-LQGHKEWLAEVNYLGGLIHPNLVKLIGCCIEDD 200 (476)
Q Consensus 122 ~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 200 (476)
.|++.+.||+|+||.||+|.+...+. ++..||||++.... .....++..|+.++++++||||+++++++.+++
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~ 78 (269)
T cd05065 5 CVKIEEVIGAGEFGEVCRGRLKLPGK------REIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSR 78 (269)
T ss_pred HeEEEeEecCCCCCeEEEEEEecCCC------CceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCC
Confidence 57889999999999999998764322 24569999987542 223457889999999999999999999999999
Q ss_pred eeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCcCC
Q 011851 201 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKD 280 (476)
Q Consensus 201 ~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~ 280 (476)
..++||||+++++|.+++......+++..++.++.|++.||.|||+++ ++||||||+|||++.++.+||+|||++..
T Consensus 79 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~ 155 (269)
T cd05065 79 PVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRF 155 (269)
T ss_pred ceEEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCccccc
Confidence 999999999999999999766667899999999999999999999988 99999999999999999999999999876
Q ss_pred CCCCCccceeee-ee--cCCCCCCcchhhcCCCCccchhhhhHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhhcccc
Q 011851 281 GPEGDKTHVSTR-VM--GTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPQLGERR 356 (476)
Q Consensus 281 ~~~~~~~~~~~~-~~--gt~~y~aPE~~~~~~~~~~~DiwslGv~l~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~ 356 (476)
............ .. .+..|+|||++.+..++.++|||||||++|||++ |..||...... ....+... ..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~---~~~~~i~~----~~ 228 (269)
T cd05065 156 LEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ---DVINAIEQ----DY 228 (269)
T ss_pred cccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH---HHHHHHHc----CC
Confidence 543222111111 11 2457999999999999999999999999999886 99999754322 11111110 00
Q ss_pred ccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 011851 357 RFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKP 405 (476)
Q Consensus 357 ~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~ 405 (476)
. . + .+...+..+.+++.+||+.+|++||++.+|+..|+.
T Consensus 229 ~---~--~-----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 267 (269)
T cd05065 229 R---L--P-----PPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDK 267 (269)
T ss_pred c---C--C-----CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence 0 0 0 111225678899999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-41 Score=323.92 Aligned_cols=249 Identities=23% Similarity=0.361 Sum_probs=194.9
Q ss_pred ccccccCCccEEEEEEccCCce---eeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCCCCCceeeEEEEEEeCCeeE
Q 011851 127 CLLGEGGFGCVYKGWINMNGTA---TVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHPNLVKLIGCCIEDDQRL 203 (476)
Q Consensus 127 ~~LG~G~fg~Vy~a~~~~~~~~---~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 203 (476)
+.||+|+||.||+|........ .........|++|++..........+.+|+.+++.++||||+++++++..+...+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 3689999999999986432211 1112345569999987655444557888999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCc-------eEEeecC
Q 011851 204 LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYN-------AKLSDFG 276 (476)
Q Consensus 204 lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~-------vkl~DFG 276 (476)
+||||+++++|..++......+++..++.++.||+.||.|||+.+ |+||||||+|||++.++. ++++|||
T Consensus 81 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g 157 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLSDPG 157 (262)
T ss_pred EEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeCCCC
Confidence 999999999999888766677999999999999999999999988 999999999999987664 8999999
Q ss_pred CcCCCCCCCccceeeeeecCCCCCCcchhh-cCCCCccchhhhhHHHHHHHH-hCCCCCCCCCCCCcchhHHhhhhhhcc
Q 011851 277 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-TGHLTAKSDVYSFGVVLLEML-TGRRSMDKNRPNGEHNLVEWARPQLGE 354 (476)
Q Consensus 277 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslGv~l~ell-tG~~pf~~~~~~~~~~~~~~~~~~~~~ 354 (476)
++...... ....++..|+|||++. +..++.++|||||||++|||+ +|..||........... . ..
T Consensus 158 ~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~---~----~~ 224 (262)
T cd05077 158 IPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERF---Y----EG 224 (262)
T ss_pred CCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHHH---H----hc
Confidence 98764321 1245788999999887 467899999999999999998 58888764322111000 0 00
Q ss_pred ccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011851 355 RRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEAL 403 (476)
Q Consensus 355 ~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L 403 (476)
. ... ......++.+||.+||+.||++||++.+|+++|
T Consensus 225 --~-~~~---------~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 225 --Q-CML---------VTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred --C-ccC---------CCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 0 000 011246789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-41 Score=323.19 Aligned_cols=250 Identities=22% Similarity=0.300 Sum_probs=203.2
Q ss_pred CCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCC-ccCHHHHHHHHHHHhCCCCCceeeEEEEEEeCC
Q 011851 122 SFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDG-LQGHKEWLAEVNYLGGLIHPNLVKLIGCCIEDD 200 (476)
Q Consensus 122 ~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 200 (476)
+|++.+.||+|+||.||++.+. .+++.||+|.++... ....+.+..|+.+++.++|+||+++++.+.+++
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~---------~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 71 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHV---------NSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADG 71 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEc---------CCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECC
Confidence 4788999999999999998654 467889999986543 233456788999999999999999999999999
Q ss_pred eeEEEEEecCCCCHHHHHhh-cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCcC
Q 011851 201 QRLLVYEFMPRGSLENHLFR-RSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAK 279 (476)
Q Consensus 201 ~~~lV~E~~~~g~L~~~l~~-~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~ 279 (476)
.+|+||||+++++|.+++.. ....+++..++.++.||+.||.|||+++ |+|+||||+||+++.++.++|+|||++.
T Consensus 72 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~ 148 (255)
T cd08219 72 HLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSAR 148 (255)
T ss_pred EEEEEEeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcce
Confidence 99999999999999998865 3456899999999999999999999988 9999999999999999999999999997
Q ss_pred CCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhccccccc
Q 011851 280 DGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRRFY 359 (476)
Q Consensus 280 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 359 (476)
....... ......|++.|+|||++.+..++.++|+||||+++|+|++|..||........ ... ... ..
T Consensus 149 ~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~---~~~----~~~-~~-- 216 (255)
T cd08219 149 LLTSPGA--YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNL---ILK----VCQ-GS-- 216 (255)
T ss_pred eeccccc--ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHH---HHH----Hhc-CC--
Confidence 6543221 12346789999999999988999999999999999999999999975432111 100 000 00
Q ss_pred cccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011851 360 RLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEA 402 (476)
Q Consensus 360 ~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~ 402 (476)
..+ .+...+..+.+||.+||+.||++||++.+++..
T Consensus 217 --~~~-----~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 217 --YKP-----LPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred --CCC-----CCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 000 111235678899999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-41 Score=326.84 Aligned_cols=270 Identities=27% Similarity=0.352 Sum_probs=205.1
Q ss_pred cCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCc--cCHHHHHHHHHHHhCCCCCceeeEEEEEEe
Q 011851 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL--QGHKEWLAEVNYLGGLIHPNLVKLIGCCIE 198 (476)
Q Consensus 121 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~ 198 (476)
++|++.+.||+|+||.||+|.+. .+|+.||+|++..... ...+.+.+|+.++++++|+||+++++++..
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~---------~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~ 71 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNR---------ETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRR 71 (286)
T ss_pred CceeeeeeecccCCeEEEEEEEC---------CCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEee
Confidence 36889999999999999998764 4678899999865432 223567889999999999999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCc
Q 011851 199 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLA 278 (476)
Q Consensus 199 ~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a 278 (476)
+...++||||++++.|..++ .....+++..++.++.||+.||.|||+.+ |+||||||+||+++.++.++|+|||++
T Consensus 72 ~~~~~~v~e~~~~~~l~~~~-~~~~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~ 147 (286)
T cd07847 72 KRKLHLVFEYCDHTVLNELE-KNPRGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFA 147 (286)
T ss_pred CCEEEEEEeccCccHHHHHH-hCCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccc
Confidence 99999999999988777666 44456999999999999999999999988 999999999999999999999999999
Q ss_pred CCCCCCCccceeeeeecCCCCCCcchhhc-CCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhh-cc--
Q 011851 279 KDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQL-GE-- 354 (476)
Q Consensus 279 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~-~~-- 354 (476)
........ ......++..|+|||++.+ ..++.++|||||||++|+|++|+.||...........+....... ..
T Consensus 148 ~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (286)
T cd07847 148 RILTGPGD--DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQ 225 (286)
T ss_pred eecCCCcc--cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHh
Confidence 87644321 1223567889999999876 468899999999999999999999997654322211111000000 00
Q ss_pred ----cccc-ccccCcccCCCCC-----hHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCc
Q 011851 355 ----RRRF-YRLIDPCLEGCFS-----IKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYL 409 (476)
Q Consensus 355 ----~~~~-~~~~d~~l~~~~~-----~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~ 409 (476)
...+ ..+..+......+ ...+..+.+|+.+||+.||++||++.+++.| |||
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~----~~f 286 (286)
T cd07847 226 QIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH----PYF 286 (286)
T ss_pred hhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC----CCC
Confidence 0000 0000111110000 1125678999999999999999999999987 775
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-41 Score=325.17 Aligned_cols=259 Identities=26% Similarity=0.462 Sum_probs=205.9
Q ss_pred cCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCcc-CHHHHHHHHHHHhCCCCCceeeEEEEEEeC
Q 011851 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQ-GHKEWLAEVNYLGGLIHPNLVKLIGCCIED 199 (476)
Q Consensus 121 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~ 199 (476)
.+|++.+.||+|+||.||+|.+...+ ..+..+|+|.++..... ..+.+.+|+.++++++||||+++++++.++
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~------~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 77 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPG------KREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKS 77 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCC------CCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecC
Confidence 46889999999999999999765322 13457999998754322 245688899999999999999999999999
Q ss_pred CeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCcC
Q 011851 200 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAK 279 (476)
Q Consensus 200 ~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~ 279 (476)
+..|+||||+++++|.+++......+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.++|+|||++.
T Consensus 78 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~ 154 (267)
T cd05066 78 KPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSR 154 (267)
T ss_pred CccEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCccc
Confidence 9999999999999999999776667899999999999999999999988 9999999999999999999999999998
Q ss_pred CCCCCCccce-eeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhhccccc
Q 011851 280 DGPEGDKTHV-STRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPQLGERRR 357 (476)
Q Consensus 280 ~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 357 (476)
.......... .....++..|+|||++.+..++.++|+|||||++|||++ |..||........ ..... ....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~---~~~~~----~~~~ 227 (267)
T cd05066 155 VLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDV---IKAIE----EGYR 227 (267)
T ss_pred ccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHH---HHHHh----CCCc
Confidence 7544322111 111233567999999998899999999999999999886 9999975533211 11111 0000
Q ss_pred cccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 011851 358 FYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKP 405 (476)
Q Consensus 358 ~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~ 405 (476)
. + .....+..+.+++.+||+.+|.+||++.++++.|+.
T Consensus 228 ~-----~-----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 265 (267)
T cd05066 228 L-----P-----APMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDK 265 (267)
T ss_pred C-----C-----CCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHh
Confidence 0 0 011225678999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-41 Score=323.88 Aligned_cols=258 Identities=27% Similarity=0.375 Sum_probs=206.3
Q ss_pred cCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCcc---CHHHHHHHHHHHhCCCCCceeeEEEEEE
Q 011851 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQ---GHKEWLAEVNYLGGLIHPNLVKLIGCCI 197 (476)
Q Consensus 121 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~---~~~~~~~E~~~l~~l~hpnIv~l~~~~~ 197 (476)
.+|++.+.||+|+||.||+|.+. .++..||||.+...... ...++.+|+.+++.++|+||+++++++.
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~---------~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~ 72 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCL---------LDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFI 72 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeec---------CCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeE
Confidence 46888999999999999998754 35778999988654322 2346788999999999999999999999
Q ss_pred eCCeeEEEEEecCCCCHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEee
Q 011851 198 EDDQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSD 274 (476)
Q Consensus 198 ~~~~~~lV~E~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~D 274 (476)
+++..++||||+++++|.+++.. ....+++..++.++.||+.||.|||+++ |+|+||||+||+++.++.++|+|
T Consensus 73 ~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~d 149 (267)
T cd08229 73 EDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGD 149 (267)
T ss_pred eCCeEEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECc
Confidence 99999999999999999998853 2456899999999999999999999988 99999999999999999999999
Q ss_pred cCCcCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhcc
Q 011851 275 FGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGE 354 (476)
Q Consensus 275 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~ 354 (476)
||++........ ......|+..|+|||++.+..++.++||||||+++|+|++|..||....... .......
T Consensus 150 fg~~~~~~~~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~------ 220 (267)
T cd08229 150 LGLGRFFSSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL-YSLCKKI------ 220 (267)
T ss_pred chhhhccccCCc--ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchH-HHHhhhh------
Confidence 999876543221 1223578999999999998899999999999999999999999996533211 1111000
Q ss_pred ccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011851 355 RRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPL 406 (476)
Q Consensus 355 ~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~ 406 (476)
.....+.. .....+.++.+++.+||+.||++|||+.+|++.++++
T Consensus 221 ----~~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~ 265 (267)
T cd08229 221 ----EQCDYPPL---PSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM 265 (267)
T ss_pred ----hcCCCCCC---CcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence 00000000 1112367899999999999999999999999987653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-41 Score=333.71 Aligned_cols=261 Identities=27% Similarity=0.357 Sum_probs=207.9
Q ss_pred cCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCcc---CHHHHHHHHHHHhCCCCCceeeEEEEEE
Q 011851 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQ---GHKEWLAEVNYLGGLIHPNLVKLIGCCI 197 (476)
Q Consensus 121 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~---~~~~~~~E~~~l~~l~hpnIv~l~~~~~ 197 (476)
++|++.+.||+|+||.||+|.+. .+++.||+|.+...... ..+.+..|+++++.++|+||+++++.+.
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 71 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLK---------GTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQ 71 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEc---------CCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeee
Confidence 36889999999999999998654 36788999999765443 3456788999999999999999999999
Q ss_pred eCCeeEEEEEecCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecC
Q 011851 198 EDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFG 276 (476)
Q Consensus 198 ~~~~~~lV~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG 276 (476)
+.+..|+||||+.+++|.+++.+. ...+++..+..++.||+.||.|||+.+ |+|+||||+||+++.++.++|+|||
T Consensus 72 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg 148 (316)
T cd05574 72 TETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFD 148 (316)
T ss_pred cCCEEEEEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecc
Confidence 999999999999999999998653 457899999999999999999999988 9999999999999999999999999
Q ss_pred CcCCCCCCCcc---------------------------ceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhC
Q 011851 277 LAKDGPEGDKT---------------------------HVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTG 329 (476)
Q Consensus 277 ~a~~~~~~~~~---------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG 329 (476)
++......... .......||..|+|||++.+..++.++|||||||++|+|++|
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g 228 (316)
T cd05574 149 LSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYG 228 (316)
T ss_pred hhhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhC
Confidence 98754321110 011235789999999999988899999999999999999999
Q ss_pred CCCCCCCCCCCcchhHHhhhhhhccccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCC----HHHHHHHhcC
Q 011851 330 RRSMDKNRPNGEHNLVEWARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPR----MSEVVEALKP 405 (476)
Q Consensus 330 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt----~~ell~~L~~ 405 (476)
+.||......... .. +.+....-......+..+.+++.+||+.||++||+ +.+++.|
T Consensus 229 ~~pf~~~~~~~~~--~~--------------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~--- 289 (316)
T cd05574 229 TTPFKGSNRDETF--SN--------------ILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQH--- 289 (316)
T ss_pred CCCCCCCchHHHH--HH--------------HhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcC---
Confidence 9999754432111 00 00000000001113678999999999999999999 6666664
Q ss_pred CCCccccc
Q 011851 406 LPYLKDMA 413 (476)
Q Consensus 406 ~~~~~~~~ 413 (476)
|||++..
T Consensus 290 -~~~~~~~ 296 (316)
T cd05574 290 -PFFRGVN 296 (316)
T ss_pred -chhhcCC
Confidence 9987643
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=331.46 Aligned_cols=256 Identities=26% Similarity=0.397 Sum_probs=199.6
Q ss_pred cCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCC-ccCHHHHHHHHHHHhCC-CCCceeeEEEEEEe
Q 011851 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDG-LQGHKEWLAEVNYLGGL-IHPNLVKLIGCCIE 198 (476)
Q Consensus 121 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~ 198 (476)
++|++.++||+|+||.||+|++..++ ....+++|.++... ....+.+.+|+.++.++ +||||+++++++.+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~-------~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 74 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDG-------LKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACEN 74 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCC-------CcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEcc
Confidence 46899999999999999999765332 22347888886432 22345688899999999 79999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHHhhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCee
Q 011851 199 DDQRLLVYEFMPRGSLENHLFRRS---------------LPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNIL 263 (476)
Q Consensus 199 ~~~~~lV~E~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NIL 263 (476)
.+.+|+||||+++++|.+++.... ..+++..++.++.||+.||+|||+++ |+||||||+|||
T Consensus 75 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil 151 (297)
T cd05089 75 RGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVL 151 (297)
T ss_pred CCcceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEE
Confidence 999999999999999999996432 35889999999999999999999988 999999999999
Q ss_pred ecCCCceEEeecCCcCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHh-CCCCCCCCCCCCcc
Q 011851 264 LDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEH 342 (476)
Q Consensus 264 l~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~ellt-G~~pf~~~~~~~~~ 342 (476)
++.++.+||+|||++........ ......+..|+|||++.+..++.++|||||||++|||++ |..||.......
T Consensus 152 l~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~-- 226 (297)
T cd05089 152 VGENLASKIADFGLSRGEEVYVK---KTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAE-- 226 (297)
T ss_pred ECCCCeEEECCcCCCccccceec---cCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH--
Confidence 99999999999999864321111 111223457999999998899999999999999999997 999997543221
Q ss_pred hhHHhhhhhhccccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011851 343 NLVEWARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPL 406 (476)
Q Consensus 343 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~ 406 (476)
..... ... .....+...+..+.+|+.+||+.||.+||++.++++.|+.+
T Consensus 227 -~~~~~----~~~----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 275 (297)
T cd05089 227 -LYEKL----PQG----------YRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRM 275 (297)
T ss_pred -HHHHH----hcC----------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 11100 000 00001112356889999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-41 Score=323.18 Aligned_cols=255 Identities=26% Similarity=0.356 Sum_probs=194.2
Q ss_pred ccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCcc-CHHHHHHHHHHHhCCCCCceeeEEEEEEeCCeeEEE
Q 011851 127 CLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQ-GHKEWLAEVNYLGGLIHPNLVKLIGCCIEDDQRLLV 205 (476)
Q Consensus 127 ~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV 205 (476)
+.||+|+||.||+|.+.. ..++..+|+|.++..... ....+.+|+.++++++||||+++++++.+....++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~-------~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 73 (269)
T cd05087 1 KEIGNGWFGKVILGEVNS-------GYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLV 73 (269)
T ss_pred CcccccCCceEEEEEEcC-------CCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEE
Confidence 368999999999997642 235667999998765432 234688899999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhc----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCcCCC
Q 011851 206 YEFMPRGSLENHLFRR----SLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDG 281 (476)
Q Consensus 206 ~E~~~~g~L~~~l~~~----~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~ 281 (476)
|||+++++|.+++... ....++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++..
T Consensus 74 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~ 150 (269)
T cd05087 74 MEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNK 150 (269)
T ss_pred EECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccc
Confidence 9999999999998642 234567788899999999999999988 999999999999999999999999999764
Q ss_pred CCCCccceeeeeecCCCCCCcchhhcC-------CCCccchhhhhHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhhc
Q 011851 282 PEGDKTHVSTRVMGTYGYAAPEYVMTG-------HLTAKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPQLG 353 (476)
Q Consensus 282 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~DiwslGv~l~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~ 353 (476)
.............|+..|+|||++.+. .++.++|||||||++|||++ |..||........ ..... ..
T Consensus 151 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~---~~~~~--~~ 225 (269)
T cd05087 151 YKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQV---LTYTV--RE 225 (269)
T ss_pred cCcceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHH---HHHHh--hc
Confidence 332222222235678889999988642 35789999999999999996 9999965433211 11100 00
Q ss_pred cccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 011851 354 ERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALK 404 (476)
Q Consensus 354 ~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~ 404 (476)
. ...+.++.+. ...++.+.+++..|| .+|++|||+++|+..|+
T Consensus 226 ~---~~~~~~~~~~----~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 226 Q---QLKLPKPRLK----LPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred c---cCCCCCCccC----CCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 0 0111122221 122567889999999 68999999999998764
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=320.88 Aligned_cols=258 Identities=25% Similarity=0.377 Sum_probs=207.0
Q ss_pred cCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCc---cCHHHHHHHHHHHhCCCCCceeeEEEEEE
Q 011851 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL---QGHKEWLAEVNYLGGLIHPNLVKLIGCCI 197 (476)
Q Consensus 121 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~l~~~~~ 197 (476)
++|++.+.||+|+||.||+|.+. .+|+.||+|.++.... ...+.+.+|++++++++|+||+++++++.
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~---------~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~ 72 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICL---------LDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFI 72 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEc---------CCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeee
Confidence 57999999999999999998654 4678899998864322 23457889999999999999999999999
Q ss_pred eCCeeEEEEEecCCCCHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEee
Q 011851 198 EDDQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSD 274 (476)
Q Consensus 198 ~~~~~~lV~E~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~D 274 (476)
+++..++||||+++++|.+++.. ....+++..++.++.||+.||.|||+.+ |+||||+|+||+++.++.++|+|
T Consensus 73 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d 149 (267)
T cd08224 73 ENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGD 149 (267)
T ss_pred cCCeEEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEec
Confidence 99999999999999999998853 2456899999999999999999999988 99999999999999999999999
Q ss_pred cCCcCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhcc
Q 011851 275 FGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGE 354 (476)
Q Consensus 275 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~ 354 (476)
||++........ ......|+..|+|||.+.+..++.++|||||||++|+|++|+.||...... ......... .
T Consensus 150 ~~~~~~~~~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~~~~~~-~ 222 (267)
T cd08224 150 LGLGRFFSSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LYSLCKKIE-K 222 (267)
T ss_pred cceeeeccCCCc--ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCcc----HHHHHhhhh-c
Confidence 999876533221 122356899999999999889999999999999999999999999644321 111100000 0
Q ss_pred ccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011851 355 RRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPL 406 (476)
Q Consensus 355 ~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~ 406 (476)
. ...+. .....+..+.++|.+||..+|++||++.+|++.|+.+
T Consensus 223 -~----~~~~~----~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~ 265 (267)
T cd08224 223 -C----DYPPL----PADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM 265 (267)
T ss_pred -C----CCCCC----ChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence 0 00000 0113356889999999999999999999999987654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-41 Score=324.42 Aligned_cols=261 Identities=31% Similarity=0.409 Sum_probs=210.4
Q ss_pred CCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCc-cCHHHHHHHHHHHhCCCCCceeeEEEEEEeCC
Q 011851 122 SFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL-QGHKEWLAEVNYLGGLIHPNLVKLIGCCIEDD 200 (476)
Q Consensus 122 ~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 200 (476)
+|++.+.||+|+||.||+|.+. .+++.||+|.+..... ...+++.+|++++++++||||+++++++..++
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~---------~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~ 72 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHR---------PTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNG 72 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEc---------CCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCC
Confidence 5788899999999999998654 4678899999876543 33456889999999999999999999999999
Q ss_pred eeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCCeeecCCCceEEeecCCcC
Q 011851 201 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHE-EAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAK 279 (476)
Q Consensus 201 ~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~-~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~ 279 (476)
.+++||||+++++|.+++......+++..+..++.|++.||.|||+ .+ ++|+||||+||+++.++.++|+|||.+.
T Consensus 73 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~ 149 (265)
T cd06605 73 DISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSG 149 (265)
T ss_pred EEEEEEEecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccch
Confidence 9999999999999999997655789999999999999999999999 77 9999999999999999999999999987
Q ss_pred CCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhccccccc
Q 011851 280 DGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRRFY 359 (476)
Q Consensus 280 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 359 (476)
....... ....++..|+|||++.+..++.++||||||+++|+|++|+.||......... ............
T Consensus 150 ~~~~~~~----~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~-~~~~~~~~~~~~---- 220 (265)
T cd06605 150 QLVNSLA----KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDG-IFELLQYIVNEP---- 220 (265)
T ss_pred hhHHHHh----hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccccccc-HHHHHHHHhcCC----
Confidence 6432111 1267889999999999999999999999999999999999999754321111 111111111000
Q ss_pred cccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCccccc
Q 011851 360 RLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDMA 413 (476)
Q Consensus 360 ~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~~~ 413 (476)
.+.+ .....+.++.++|.+||..||++|||+.+++.+ |||+...
T Consensus 221 ---~~~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~----~~~~~~~ 264 (265)
T cd06605 221 ---PPRL---PSGKFSPDFQDFVNLCLIKDPRERPSYKELLEH----PFIKKYE 264 (265)
T ss_pred ---CCCC---ChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC----chhhccc
Confidence 0000 011136778999999999999999999999997 9997653
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-41 Score=352.85 Aligned_cols=285 Identities=18% Similarity=0.234 Sum_probs=196.4
Q ss_pred hccCCCccccccccCCccEEEEEEccCCceeee------CCCCceE----EEEEecCCCccCHHHHHHHHHHHhCCCCCc
Q 011851 119 ATKSFRPECLLGEGGFGCVYKGWINMNGTATVK------PGTGLPV----AVKTLNHDGLQGHKEWLAEVNYLGGLIHPN 188 (476)
Q Consensus 119 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~------~~~g~~v----AiK~~~~~~~~~~~~~~~E~~~l~~l~hpn 188 (476)
...+|++++.||+|+||+||+|.+......... ...+... +.|.+.. .......+.+|+++|++++|||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~-~~~~~~~~~~Ei~il~~l~Hpn 224 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKA-GSRAAIQLENEILALGRLNHEN 224 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhc-chHHHHHHHHHHHHHHhCCCCC
Confidence 456899999999999999999876432111000 0001111 1111111 1112345788999999999999
Q ss_pred eeeEEEEEEeCCeeEEEEEecCCCCHHHHHhhcC----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeee
Q 011851 189 LVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRS----LPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILL 264 (476)
Q Consensus 189 Iv~l~~~~~~~~~~~lV~E~~~~g~L~~~l~~~~----~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl 264 (476)
|+++++++.+.+..|+|||++ +++|.+++.... .......+..++.||+.||.|||+++ ||||||||+||||
T Consensus 225 Iv~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NILl 300 (501)
T PHA03210 225 ILKIEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIFL 300 (501)
T ss_pred cCcEeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEE
Confidence 999999999999999999999 557877775431 22345667889999999999999988 9999999999999
Q ss_pred cCCCceEEeecCCcCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCC-CCCCCCCCcch
Q 011851 265 DGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRS-MDKNRPNGEHN 343 (476)
Q Consensus 265 ~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~p-f~~~~~~~~~~ 343 (476)
+.++.+||+|||+++....... ......+||+.|+|||++.+..++.++|||||||++|||++|..+ |..........
T Consensus 301 ~~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~ 379 (501)
T PHA03210 301 NCDGKIVLGDFGTAMPFEKERE-AFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQ 379 (501)
T ss_pred CCCCCEEEEeCCCceecCcccc-cccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHH
Confidence 9999999999999987643222 122346799999999999999999999999999999999999864 43322221112
Q ss_pred hHHhhhhhhcccc-------ccccccCcc-c---CCCC-----ChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCC
Q 011851 344 LVEWARPQLGERR-------RFYRLIDPC-L---EGCF-----SIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLP 407 (476)
Q Consensus 344 ~~~~~~~~~~~~~-------~~~~~~d~~-l---~~~~-----~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~ 407 (476)
+............ .+..+++.. . ...+ ....+..+.++|.+||+.||++|||+.|++.| |
T Consensus 380 ~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h----p 455 (501)
T PHA03210 380 LLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL----P 455 (501)
T ss_pred HHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC----h
Confidence 1111110000000 000010000 0 0000 00113467888999999999999999999997 9
Q ss_pred Cccccc
Q 011851 408 YLKDMA 413 (476)
Q Consensus 408 ~~~~~~ 413 (476)
||....
T Consensus 456 ~f~~~~ 461 (501)
T PHA03210 456 LFSAEE 461 (501)
T ss_pred hhhcCC
Confidence 998654
|
|
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=333.07 Aligned_cols=255 Identities=26% Similarity=0.410 Sum_probs=198.8
Q ss_pred cCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCc-cCHHHHHHHHHHHhCC-CCCceeeEEEEEEe
Q 011851 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL-QGHKEWLAEVNYLGGL-IHPNLVKLIGCCIE 198 (476)
Q Consensus 121 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~-~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~ 198 (476)
++|.+.+.||+|+||.||+|.+..++ ....+|+|.+..... .....+.+|++++.++ +|+||+++++++.+
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~-------~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~ 79 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDG-------LRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH 79 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCC-------ceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECC
Confidence 46889999999999999999875322 123467887754322 2345678899999999 89999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHHhhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCee
Q 011851 199 DDQRLLVYEFMPRGSLENHLFRRS---------------LPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNIL 263 (476)
Q Consensus 199 ~~~~~lV~E~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NIL 263 (476)
++.+|+||||+++++|.+++.+.. ..+++..++.++.||+.||+|||+++ |+||||||+|||
T Consensus 80 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nil 156 (303)
T cd05088 80 RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNIL 156 (303)
T ss_pred CCCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEE
Confidence 999999999999999999996432 25789999999999999999999988 999999999999
Q ss_pred ecCCCceEEeecCCcCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHh-CCCCCCCCCCCCcc
Q 011851 264 LDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEH 342 (476)
Q Consensus 264 l~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~ellt-G~~pf~~~~~~~~~ 342 (476)
++.++.+||+|||++....... ......++..|+|||++.+..++.++|||||||++|||+| |..||.......
T Consensus 157 i~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~-- 231 (303)
T cd05088 157 VGENYVAKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE-- 231 (303)
T ss_pred ecCCCcEEeCccccCcccchhh---hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHH--
Confidence 9999999999999986432111 1111234667999999988889999999999999999998 999996543221
Q ss_pred hhHHhhhhhhccccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 011851 343 NLVEWARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKP 405 (476)
Q Consensus 343 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~ 405 (476)
..... .... ....+...+..+.+|+.+||+.+|++||++.++++.|+.
T Consensus 232 -~~~~~----~~~~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~ 279 (303)
T cd05088 232 -LYEKL----PQGY----------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNR 279 (303)
T ss_pred -HHHHH----hcCC----------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 11110 0000 000111225678999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-41 Score=323.28 Aligned_cols=252 Identities=29% Similarity=0.401 Sum_probs=200.7
Q ss_pred cCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCCCCCceeeEEEEEEeCC
Q 011851 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHPNLVKLIGCCIEDD 200 (476)
Q Consensus 121 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 200 (476)
++|++.++||+|+||.||+|.+.. ...||+|+++.... ..+++.+|++++++++|+||+++++++. .+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~----------~~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~ 73 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNG----------TTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EE 73 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecC----------CceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEEC-CC
Confidence 469999999999999999997642 23599999976433 3467889999999999999999999874 45
Q ss_pred eeEEEEEecCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCcC
Q 011851 201 QRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAK 279 (476)
Q Consensus 201 ~~~lV~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~ 279 (476)
..|+||||+++++|.+++.+. ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++.
T Consensus 74 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~ 150 (262)
T cd05071 74 PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLAR 150 (262)
T ss_pred CcEEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCcee
Confidence 689999999999999999653 345889999999999999999999988 9999999999999999999999999997
Q ss_pred CCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhhcccccc
Q 011851 280 DGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPQLGERRRF 358 (476)
Q Consensus 280 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 358 (476)
........ ......++..|+|||++.+..++.++|||||||++|||++ |..||...........+ .....
T Consensus 151 ~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~-------~~~~~- 221 (262)
T cd05071 151 LIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV-------ERGYR- 221 (262)
T ss_pred eccccccc-cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHH-------hcCCC-
Confidence 65433221 1122346678999999988899999999999999999999 88888654322111100 00000
Q ss_pred ccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 011851 359 YRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKP 405 (476)
Q Consensus 359 ~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~ 405 (476)
.......+..+.+|+.+||+.||++||++.++++.|+.
T Consensus 222 ---------~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~ 259 (262)
T cd05071 222 ---------MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLED 259 (262)
T ss_pred ---------CCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHH
Confidence 00112336788999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-41 Score=327.65 Aligned_cols=266 Identities=29% Similarity=0.399 Sum_probs=204.6
Q ss_pred CCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCC-ccCHHHHHHHHHHHhCCCCCceeeEEEEEEeC-
Q 011851 122 SFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDG-LQGHKEWLAEVNYLGGLIHPNLVKLIGCCIED- 199 (476)
Q Consensus 122 ~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~- 199 (476)
.|.+.+.||+|+||.||+|.+... ...++..||+|.++... ......+.+|+.++++++||||+++++++.+.
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~-----~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 79 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPE-----GDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDG 79 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccC-----CCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCC
Confidence 478899999999999999976422 23478889999987543 22345688999999999999999999998875
Q ss_pred -CeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCc
Q 011851 200 -DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLA 278 (476)
Q Consensus 200 -~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a 278 (476)
...++||||+++++|.+++.+....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.++|+|||++
T Consensus 80 ~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~ 156 (284)
T cd05079 80 GNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLT 156 (284)
T ss_pred CCceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCccc
Confidence 5689999999999999999665557899999999999999999999988 999999999999999999999999999
Q ss_pred CCCCCCCcc-ceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCC--------CcchhHHhhh
Q 011851 279 KDGPEGDKT-HVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPN--------GEHNLVEWAR 349 (476)
Q Consensus 279 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~--------~~~~~~~~~~ 349 (476)
+........ .......++..|+|||++.+..++.++|||||||++|||+++..|+...... ..........
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd05079 157 KAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLV 236 (284)
T ss_pred cccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHH
Confidence 865432221 1112345777899999999889999999999999999999987765321110 0000000000
Q ss_pred hhhccccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 011851 350 PQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKP 405 (476)
Q Consensus 350 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~ 405 (476)
........ . + .....+..+.+|+.+||+.||++||++.++++.|+.
T Consensus 237 ~~~~~~~~----~-~-----~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~ 282 (284)
T cd05079 237 RVLEEGKR----L-P-----RPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEA 282 (284)
T ss_pred HHHHcCcc----C-C-----CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHh
Confidence 00000000 0 0 111236789999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=321.19 Aligned_cols=252 Identities=29% Similarity=0.408 Sum_probs=200.9
Q ss_pred cCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCCCCCceeeEEEEEEeCC
Q 011851 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHPNLVKLIGCCIEDD 200 (476)
Q Consensus 121 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 200 (476)
++|++.+.||+|+||.||+|.+. .+..||+|.+..... ..+.+.+|+.++++++|+||+++++++. .+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~----------~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~ 73 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWN----------GNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EE 73 (260)
T ss_pred HHhhhhheeccccCceEEEEEec----------CCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CC
Confidence 46899999999999999998654 345699999876543 3467889999999999999999999875 55
Q ss_pred eeEEEEEecCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCcC
Q 011851 201 QRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAK 279 (476)
Q Consensus 201 ~~~lV~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~ 279 (476)
..|+||||+++++|.+++... ...+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++.
T Consensus 74 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~ 150 (260)
T cd05070 74 PIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLAR 150 (260)
T ss_pred CcEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeee
Confidence 689999999999999998653 345899999999999999999999988 9999999999999999999999999997
Q ss_pred CCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhhcccccc
Q 011851 280 DGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPQLGERRRF 358 (476)
Q Consensus 280 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 358 (476)
........ ......++..|+|||++.+..++.++||||||+++|+|++ |..||....... ...... ....
T Consensus 151 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~---~~~~~~----~~~~- 221 (260)
T cd05070 151 LIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNRE---VLEQVE----RGYR- 221 (260)
T ss_pred eccCcccc-cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHH---HHHHHH----cCCC-
Confidence 65432211 1112345667999999988899999999999999999999 889996543211 111110 0000
Q ss_pred ccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 011851 359 YRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKP 405 (476)
Q Consensus 359 ~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~ 405 (476)
...+...+..+.+|+.+||..||++|||+.++++.|+.
T Consensus 222 ---------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 222 ---------MPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred ---------CCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 00112235689999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=320.90 Aligned_cols=260 Identities=26% Similarity=0.376 Sum_probs=208.8
Q ss_pred cCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCc-cCHHHHHHHHHHHhCCCCCceeeEEEEEEeC
Q 011851 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL-QGHKEWLAEVNYLGGLIHPNLVKLIGCCIED 199 (476)
Q Consensus 121 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~ 199 (476)
++|++.+.||.|+||+||+|... .++..+|+|++..... ...+.+.+|+++|+.++|+||+++++.+..+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~---------~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 71 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICL---------PNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVG 71 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEc---------CCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeC
Confidence 46899999999999999998654 3677899999975443 2456788999999999999999999999999
Q ss_pred CeeEEEEEecCCCCHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCC
Q 011851 200 DQRLLVYEFMPRGSLENHLFRR--SLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGL 277 (476)
Q Consensus 200 ~~~~lV~E~~~~g~L~~~l~~~--~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~ 277 (476)
+..|+||||+++++|.+++... ...+++..+..++.|++.||.|||+.+ |+||||+|+||++++++.++|+|||+
T Consensus 72 ~~~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~ 148 (267)
T cd06610 72 DELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGV 148 (267)
T ss_pred CEEEEEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccch
Confidence 9999999999999999999653 246899999999999999999999988 99999999999999999999999999
Q ss_pred cCCCCCCCccc--eeeeeecCCCCCCcchhhcC-CCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhcc
Q 011851 278 AKDGPEGDKTH--VSTRVMGTYGYAAPEYVMTG-HLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGE 354 (476)
Q Consensus 278 a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~ 354 (476)
+.......... ......|+..|+|||++... .++.++|+|||||++|+|++|+.||......... .......
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~--~~~~~~~--- 223 (267)
T cd06610 149 SASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVL--MLTLQND--- 223 (267)
T ss_pred HHHhccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhH--HHHhcCC---
Confidence 87654432221 22335789999999998877 7899999999999999999999999755432211 1111100
Q ss_pred ccccccccCcccCCCC-ChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCc
Q 011851 355 RRRFYRLIDPCLEGCF-SIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYL 409 (476)
Q Consensus 355 ~~~~~~~~d~~l~~~~-~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~ 409 (476)
.+.+.... ....+..+.+++.+||..||++||++.+|++| |||
T Consensus 224 --------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~----p~~ 267 (267)
T cd06610 224 --------PPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH----KFF 267 (267)
T ss_pred --------CCCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhC----CCC
Confidence 00011000 11235788999999999999999999999997 875
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-41 Score=321.61 Aligned_cols=253 Identities=28% Similarity=0.451 Sum_probs=203.0
Q ss_pred ccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCCCCCceeeEEEEEEeC
Q 011851 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHPNLVKLIGCCIED 199 (476)
Q Consensus 120 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~ 199 (476)
.++|++.++||+|+||.||+|... +++.||+|.+..... ....+.+|+.++++++|+||+++++++ .+
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~----------~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~ 72 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYN----------GHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVV-TQ 72 (260)
T ss_pred hHHceeeeeeccCccceEEeeecC----------CCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEE-cc
Confidence 356899999999999999998653 467799999976543 356788999999999999999999986 45
Q ss_pred CeeEEEEEecCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCc
Q 011851 200 DQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLA 278 (476)
Q Consensus 200 ~~~~lV~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a 278 (476)
+..++||||+++++|.+++... ...+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||++
T Consensus 73 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~ 149 (260)
T cd05067 73 EPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLA 149 (260)
T ss_pred CCcEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcce
Confidence 6789999999999999998653 456899999999999999999999988 999999999999999999999999999
Q ss_pred CCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhhccccc
Q 011851 279 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPQLGERRR 357 (476)
Q Consensus 279 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 357 (476)
......... ......++..|+|||++....++.++||||||+++|||++ |+.||....... ..... .....
T Consensus 150 ~~~~~~~~~-~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~~~~----~~~~~ 221 (260)
T cd05067 150 RLIEDNEYT-AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPE---VIQNL----ERGYR 221 (260)
T ss_pred eecCCCCcc-cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHH---HHHHH----HcCCC
Confidence 765432211 1122346778999999998899999999999999999999 999997543221 11110 00000
Q ss_pred cccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 011851 358 FYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKP 405 (476)
Q Consensus 358 ~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~ 405 (476)
.+ .+...+.++.+++.+||+.+|++||++++++..|+.
T Consensus 222 -----~~-----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 222 -----MP-----RPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred -----CC-----CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 00 011225689999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=323.48 Aligned_cols=261 Identities=25% Similarity=0.374 Sum_probs=212.2
Q ss_pred CCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCc-cCHHHHHHHHHHHhCCCCCceeeEEEEEEeCC
Q 011851 122 SFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL-QGHKEWLAEVNYLGGLIHPNLVKLIGCCIEDD 200 (476)
Q Consensus 122 ~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 200 (476)
.|...+.||.|+||.||+|.+. .++..||+|++..... .....+.+|+.+++++.|+||+++++++.++.
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 75 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDN---------RTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGT 75 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEc---------cCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC
Confidence 5788899999999999998654 3677899999875432 33456888999999999999999999999999
Q ss_pred eeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCcCC
Q 011851 201 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKD 280 (476)
Q Consensus 201 ~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~ 280 (476)
..|+||||+++++|.+++.. .++++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++..
T Consensus 76 ~~~lv~e~~~~~~L~~~i~~--~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~ 150 (277)
T cd06640 76 KLWIIMEYLGGGSALDLLRA--GPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQ 150 (277)
T ss_pred EEEEEEecCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEccccccee
Confidence 99999999999999998854 46889999999999999999999988 99999999999999999999999999976
Q ss_pred CCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhcccccccc
Q 011851 281 GPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRRFYR 360 (476)
Q Consensus 281 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 360 (476)
...... ......++..|+|||++.+..++.++|+|||||++|||++|..||....+......+.
T Consensus 151 ~~~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~-------------- 214 (277)
T cd06640 151 LTDTQI--KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIP-------------- 214 (277)
T ss_pred ccCCcc--ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhh--------------
Confidence 543221 1223568889999999998889999999999999999999999997544322111100
Q ss_pred ccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCcccccCcchHH
Q 011851 361 LIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDMASSSSYV 419 (476)
Q Consensus 361 ~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~~~~~~~~~ 419 (476)
...........+..+.+++.+||+.+|++||++.+++.+ +|+........+.
T Consensus 215 ---~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~----~~~~~~~~~~~~~ 266 (277)
T cd06640 215 ---KNNPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH----KFIVKNAKKTSYL 266 (277)
T ss_pred ---cCCCCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC----hHhhhcchhhhHH
Confidence 000111223446788999999999999999999999998 8887665544443
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-41 Score=320.85 Aligned_cols=252 Identities=29% Similarity=0.446 Sum_probs=201.8
Q ss_pred ccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCc-cCHHHHHHHHHHHhCCCCCceeeEEEEEEeCCeeEEE
Q 011851 127 CLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL-QGHKEWLAEVNYLGGLIHPNLVKLIGCCIEDDQRLLV 205 (476)
Q Consensus 127 ~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV 205 (476)
++||+|+||.||+|.+... ..+...||||.+..... ...+.+.+|+.++++++||||+++++++.+ ...++|
T Consensus 1 ~~ig~g~~~~v~~~~~~~~------~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v 73 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTS------GGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMV 73 (257)
T ss_pred CcCCccCcccEEeeeEecC------CCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEE
Confidence 4689999999999987532 12345699999987766 455678899999999999999999999988 889999
Q ss_pred EEecCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCcCCCCCC
Q 011851 206 YEFMPRGSLENHLFRRS-LPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEG 284 (476)
Q Consensus 206 ~E~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~ 284 (476)
|||+++++|.+++.... ..+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||+++.....
T Consensus 74 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~ 150 (257)
T cd05040 74 TELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQN 150 (257)
T ss_pred EEecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEecccccccccccc
Confidence 99999999999997654 57899999999999999999999988 999999999999999999999999999876442
Q ss_pred Ccc-ceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhhcccccccccc
Q 011851 285 DKT-HVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPQLGERRRFYRLI 362 (476)
Q Consensus 285 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 362 (476)
... .......++..|+|||++.+..++.++|||||||++|||++ |+.||....... ....... ... ...
T Consensus 151 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~~~~~---~~~---~~~ 221 (257)
T cd05040 151 EDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQ---ILKKIDK---EGE---RLE 221 (257)
T ss_pred ccceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHHh---cCC---cCC
Confidence 221 11122457788999999998899999999999999999998 999996543221 1111100 000 000
Q ss_pred CcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 011851 363 DPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALK 404 (476)
Q Consensus 363 d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~ 404 (476)
.+...+..+.+++.+||+.+|++||++.++++.|.
T Consensus 222 -------~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 222 -------RPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred -------CCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 11122568899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-41 Score=320.71 Aligned_cols=253 Identities=32% Similarity=0.516 Sum_probs=199.3
Q ss_pred ccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCcc-CHHHHHHHHHHHhCCCCCceeeEEEEEEeCCeeEEE
Q 011851 127 CLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQ-GHKEWLAEVNYLGGLIHPNLVKLIGCCIEDDQRLLV 205 (476)
Q Consensus 127 ~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV 205 (476)
++||+|+||.||+|.+... ..++..||+|.+...... ..+++.+|+.+++.++|+||+++++++. .+..++|
T Consensus 1 ~~ig~G~~g~v~~~~~~~~------~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v 73 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMK------SGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLV 73 (257)
T ss_pred CccCccCceeEEEeEeecc------CCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEE
Confidence 4699999999999976432 124578999999866543 3456889999999999999999999876 5578999
Q ss_pred EEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCcCCCCCCC
Q 011851 206 YEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGD 285 (476)
Q Consensus 206 ~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~ 285 (476)
|||+++++|.+++.... .+++..+..++.|++.||.|||..+ |+||||||+|||++.++.+||+|||+++......
T Consensus 74 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~ 149 (257)
T cd05060 74 MELAPLGPLLKYLKKRR-EIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGS 149 (257)
T ss_pred EEeCCCCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCC
Confidence 99999999999996543 7899999999999999999999988 9999999999999999999999999998654332
Q ss_pred ccce-eeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhhccccccccccC
Q 011851 286 KTHV-STRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPQLGERRRFYRLID 363 (476)
Q Consensus 286 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 363 (476)
.... .....++..|+|||.+.+..++.++|||||||++|+|++ |..||...... .+...... ... .
T Consensus 150 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~---~~~~~~~~----~~~---~-- 217 (257)
T cd05060 150 DYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGA---EVIAMLES----GER---L-- 217 (257)
T ss_pred cccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHH---HHHHHHHc----CCc---C--
Confidence 2111 111223567999999998899999999999999999998 99999754321 11111111 000 0
Q ss_pred cccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCC
Q 011851 364 PCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLP 407 (476)
Q Consensus 364 ~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~ 407 (476)
+ .+...+..+.++|.+||..||++||++.++++.|+.++
T Consensus 218 ~-----~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 218 P-----RPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred C-----CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 0 11122568899999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-41 Score=327.21 Aligned_cols=262 Identities=29% Similarity=0.419 Sum_probs=205.1
Q ss_pred hhHHHHhccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCC-CCCceee
Q 011851 113 FNELKSATKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGL-IHPNLVK 191 (476)
Q Consensus 113 ~~~~~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~ 191 (476)
..++....+.|++.+.||.|+||.||+|.+. .+++.||+|++.... ....++..|+.+++++ +|+||++
T Consensus 8 ~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~---------~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~ 77 (282)
T cd06636 8 LSALRDPAGIFELVEVVGNGTYGQVYKGRHV---------KTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIAT 77 (282)
T ss_pred hhhhcChhhhhhhheeeccCCCeEEEEEEEc---------CCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEE
Confidence 3344455678999999999999999998764 367789999986543 2335678899999988 6999999
Q ss_pred EEEEEEe------CCeeEEEEEecCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeee
Q 011851 192 LIGCCIE------DDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILL 264 (476)
Q Consensus 192 l~~~~~~------~~~~~lV~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl 264 (476)
+++++.. ...+|+||||+++++|.+++... ...+++..+..++.||+.||.|||+.+ |+|+||||+||++
T Consensus 78 ~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili 154 (282)
T cd06636 78 YYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLL 154 (282)
T ss_pred EeeehhcccccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEE
Confidence 9999863 46789999999999999988653 456889999999999999999999988 9999999999999
Q ss_pred cCCCceEEeecCCcCCCCCCCccceeeeeecCCCCCCcchhh-----cCCCCccchhhhhHHHHHHHHhCCCCCCCCCCC
Q 011851 265 DGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPN 339 (476)
Q Consensus 265 ~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~ 339 (476)
+.++.++|+|||++........ ......|++.|+|||++. ...++.++|||||||++|||++|..||....+.
T Consensus 155 ~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~ 232 (282)
T cd06636 155 TENAEVKLVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPM 232 (282)
T ss_pred CCCCCEEEeeCcchhhhhcccc--CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHH
Confidence 9999999999999875432111 122357899999999886 346888999999999999999999999654322
Q ss_pred CcchhHHhhhhhhccccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCc
Q 011851 340 GEHNLVEWARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYL 409 (476)
Q Consensus 340 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~ 409 (476)
....... ....+.+ .....+.++.+||.+||+.||.+||++.+|+++ |||
T Consensus 233 ~~~~~~~-------------~~~~~~~---~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~----~~~ 282 (282)
T cd06636 233 RALFLIP-------------RNPPPKL---KSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKH----PFI 282 (282)
T ss_pred hhhhhHh-------------hCCCCCC---cccccCHHHHHHHHHHhCCChhhCcCHHHHhcC----CCC
Confidence 1111000 0000000 011235689999999999999999999999987 775
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-41 Score=320.87 Aligned_cols=253 Identities=25% Similarity=0.343 Sum_probs=203.6
Q ss_pred CCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCc--cCHHHHHHHHHHHhCCCCCceeeEEEEEEe-
Q 011851 122 SFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL--QGHKEWLAEVNYLGGLIHPNLVKLIGCCIE- 198 (476)
Q Consensus 122 ~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~- 198 (476)
.|++.+.||+|+||.||++.+. .+++.||+|.+..... ...+.+.+|++++++++|+||+++++.+..
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~---------~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 71 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHR---------TDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGE 71 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEc---------CCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCC
Confidence 4889999999999999998654 4577899999875433 234567889999999999999999998764
Q ss_pred CCeeEEEEEecCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCC
Q 011851 199 DDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGL 277 (476)
Q Consensus 199 ~~~~~lV~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~ 277 (476)
+..+|+||||+++++|.+++... ...+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||+
T Consensus 72 ~~~~~lv~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~ 148 (257)
T cd08223 72 DGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGI 148 (257)
T ss_pred CCEEEEEecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccc
Confidence 44689999999999999998653 456899999999999999999999988 99999999999999999999999999
Q ss_pred cCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhccccc
Q 011851 278 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRR 357 (476)
Q Consensus 278 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 357 (476)
+....... .......|++.|+|||++.+..++.++|||||||++|+|++|+.||....... .. ......
T Consensus 149 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~---~~---~~~~~~--- 217 (257)
T cd08223 149 ARVLENQC--DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNS---LV---YRIIEG--- 217 (257)
T ss_pred eEEecccC--CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHH---HH---HHHHhc---
Confidence 87653321 12234578999999999999999999999999999999999999997432111 10 000000
Q ss_pred cccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCc
Q 011851 358 FYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYL 409 (476)
Q Consensus 358 ~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~ 409 (476)
.+ ...+...+..+.+++.+||+.||++||++.+++++ |||
T Consensus 218 ---~~-----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~----~~~ 257 (257)
T cd08223 218 ---KL-----PPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ----PYI 257 (257)
T ss_pred ---CC-----CCCccccCHHHHHHHHHHhccCcccCCCHHHHhcC----CCC
Confidence 00 01112335789999999999999999999999997 775
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=332.99 Aligned_cols=261 Identities=25% Similarity=0.350 Sum_probs=209.2
Q ss_pred CCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCCCCCceeeEEEEEEeCCee
Q 011851 123 FRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHPNLVKLIGCCIEDDQR 202 (476)
Q Consensus 123 y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~ 202 (476)
|.....||+|+||.||++.+. .++..||||.+........+.+.+|+.+++.++|+||+++++.+...+..
T Consensus 24 ~~~~~~lg~g~~g~v~~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~ 94 (292)
T cd06658 24 LDSFIKIGEGSTGIVCIATEK---------HTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDEL 94 (292)
T ss_pred HhhhhcccCCCCeEEEEEEEC---------CCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeE
Confidence 444567999999999998654 36778999998765555556788999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCcCCCC
Q 011851 203 LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGP 282 (476)
Q Consensus 203 ~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~ 282 (476)
|+||||+++++|.+++.. ..+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.++|+|||++....
T Consensus 95 ~lv~e~~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~ 169 (292)
T cd06658 95 WVVMEFLEGGALTDIVTH--TRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVS 169 (292)
T ss_pred EEEEeCCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhcc
Confidence 999999999999998743 35899999999999999999999988 9999999999999999999999999987543
Q ss_pred CCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhcccccccccc
Q 011851 283 EGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRRFYRLI 362 (476)
Q Consensus 283 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 362 (476)
.... ......|+..|+|||++.+..++.++|||||||++|||++|+.||........... .. ..+
T Consensus 170 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~---~~----------~~~ 234 (292)
T cd06658 170 KEVP--KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRR---IR----------DNL 234 (292)
T ss_pred cccc--cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HH----------hcC
Confidence 2221 12335789999999999888999999999999999999999999975432211110 00 011
Q ss_pred CcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCcccccCcchH
Q 011851 363 DPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDMASSSSY 418 (476)
Q Consensus 363 d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~~~~~~~~ 418 (476)
.+.+.. ....+..+.+++.+||..||.+|||+.+++++ +||+....+...
T Consensus 235 ~~~~~~--~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~----~~~~~~~~~~~~ 284 (292)
T cd06658 235 PPRVKD--SHKVSSVLRGFLDLMLVREPSQRATAQELLQH----PFLKLAGPPSCI 284 (292)
T ss_pred CCcccc--ccccCHHHHHHHHHHccCChhHCcCHHHHhhC----hhhhccCCcccc
Confidence 111111 11225678899999999999999999999997 999877665543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=318.45 Aligned_cols=248 Identities=30% Similarity=0.460 Sum_probs=199.3
Q ss_pred ccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCcc-CHHHHHHHHHHHhCCCCCceeeEEEEEEeCCeeEEE
Q 011851 127 CLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQ-GHKEWLAEVNYLGGLIHPNLVKLIGCCIEDDQRLLV 205 (476)
Q Consensus 127 ~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV 205 (476)
++||.|+||.||+|.+. . ++.||+|.+...... ....+.+|++++++++|+||+++++++.+....++|
T Consensus 1 ~~lg~g~~g~v~~~~~~---------~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 70 (251)
T cd05041 1 EKIGKGNFGDVYKGVLK---------G-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIV 70 (251)
T ss_pred CccccCCCceEEEEEEe---------C-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEE
Confidence 46999999999998654 2 677999998765443 345788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCcCCCCCCC
Q 011851 206 YEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGD 285 (476)
Q Consensus 206 ~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~ 285 (476)
|||+++++|.+++......+++..+..++.+++.||.|||+++ ++||||||+|||++.++.+||+|||++.......
T Consensus 71 ~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~ 147 (251)
T cd05041 71 MELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGI 147 (251)
T ss_pred EEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCc
Confidence 9999999999999766667899999999999999999999988 9999999999999999999999999998654222
Q ss_pred ccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhhccccccccccCc
Q 011851 286 KTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPQLGERRRFYRLIDP 364 (476)
Q Consensus 286 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 364 (476)
.........++..|+|||++.+..++.++|||||||++|||++ |..||...........+. ...
T Consensus 148 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~-------~~~-------- 212 (251)
T cd05041 148 YTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIE-------SGY-------- 212 (251)
T ss_pred ceeccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHh-------cCC--------
Confidence 1111111234567999999998899999999999999999999 888886543321111110 000
Q ss_pred ccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 011851 365 CLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALK 404 (476)
Q Consensus 365 ~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~ 404 (476)
....+...+.++.+++.+||+.+|++|||+.++++.|+
T Consensus 213 --~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 213 --RMPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred --CCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 00011223568999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-42 Score=336.46 Aligned_cols=253 Identities=26% Similarity=0.350 Sum_probs=206.9
Q ss_pred cccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCcc--CHHHHHHHHHHHhCCCCCceeeEEEEEEeCCeeE
Q 011851 126 ECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQ--GHKEWLAEVNYLGGLIHPNLVKLIGCCIEDDQRL 203 (476)
Q Consensus 126 ~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 203 (476)
.++||+|.||+||-|.++ .+|+.||||++.+.... ...++++|+.||++++||.||.|...|+..+.++
T Consensus 569 devLGSGQFG~VYgg~hR---------ktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervF 639 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHR---------KTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVF 639 (888)
T ss_pred HhhccCCcceeeecceec---------ccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEE
Confidence 478999999999987554 68999999999875543 3456889999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCC---CceEEeecCCcCC
Q 011851 204 LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGE---YNAKLSDFGLAKD 280 (476)
Q Consensus 204 lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~---~~vkl~DFG~a~~ 280 (476)
+|||-+.|.-|+-.|....+.+++.....++.||+.||.|||..+ |+|+||||+||||... -.+||||||+|+.
T Consensus 640 VVMEKl~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARi 716 (888)
T KOG4236|consen 640 VVMEKLHGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARI 716 (888)
T ss_pred EEehhhcchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceee
Confidence 999999665555555556788999999999999999999999988 9999999999999543 4699999999998
Q ss_pred CCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhcccccccc
Q 011851 281 GPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRRFYR 360 (476)
Q Consensus 281 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 360 (476)
..+.. ....++|||.|+|||++.+..|+..-|+||+|||+|--|+|..||..... ..+.++.+.-..
T Consensus 717 IgEks---FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEd--IndQIQNAaFMy-------- 783 (888)
T KOG4236|consen 717 IGEKS---FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDED--INDQIQNAAFMY-------- 783 (888)
T ss_pred cchhh---hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccc--hhHHhhcccccc--------
Confidence 76533 24458999999999999999999999999999999999999999964322 122222111111
Q ss_pred ccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCccccc
Q 011851 361 LIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDMA 413 (476)
Q Consensus 361 ~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~~~ 413 (476)
.+... .+.+.++.|||..+|+..-.+|-+.+..+.| ||+++..
T Consensus 784 --Pp~PW----~eis~~AidlIn~LLqVkm~kRysvdk~lsh----~Wlq~yq 826 (888)
T KOG4236|consen 784 --PPNPW----SEISPEAIDLINNLLQVKMRKRYSVDKSLSH----PWLQDYQ 826 (888)
T ss_pred --CCCch----hhcCHHHHHHHHHHHHHHHHHhcchHhhccc----hhhhcch
Confidence 00000 1236789999999999999999999999887 9999864
|
|
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-41 Score=331.65 Aligned_cols=263 Identities=25% Similarity=0.381 Sum_probs=203.8
Q ss_pred cCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCc-cCHHHHHHHHHHHhCC-CCCceeeEEEEEEe
Q 011851 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL-QGHKEWLAEVNYLGGL-IHPNLVKLIGCCIE 198 (476)
Q Consensus 121 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~-~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~ 198 (476)
.+|.+.+.||+|+||.||+|....... ........||+|.++.... .....+..|+++++++ +||||+++++++.+
T Consensus 12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~--~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 89 (314)
T cd05099 12 DRLVLGKPLGEGCFGQVVRAEAYGIDK--SRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQ 89 (314)
T ss_pred HHeeeeeeecCCCcccEEEeeecccCC--ccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEcc
Confidence 468899999999999999997542111 1123456799999875432 2245678899999999 69999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHHhhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCee
Q 011851 199 DDQRLLVYEFMPRGSLENHLFRRS---------------LPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNIL 263 (476)
Q Consensus 199 ~~~~~lV~E~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NIL 263 (476)
++.+|+||||+++++|.+++.... ..+++..+..++.||+.||.|||+++ |+||||||+|||
T Consensus 90 ~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nil 166 (314)
T cd05099 90 EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVL 166 (314)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEE
Confidence 999999999999999999996531 35889999999999999999999988 999999999999
Q ss_pred ecCCCceEEeecCCcCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHh-CCCCCCCCCCCCcc
Q 011851 264 LDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEH 342 (476)
Q Consensus 264 l~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~ellt-G~~pf~~~~~~~~~ 342 (476)
++.++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|+|++ |..||........
T Consensus 167 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~- 245 (314)
T cd05099 167 VTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEEL- 245 (314)
T ss_pred EcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHH-
Confidence 99999999999999986543222111112234567999999999999999999999999999999 8889865432211
Q ss_pred hhHHhhhhhhccccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 011851 343 NLVEWARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKP 405 (476)
Q Consensus 343 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~ 405 (476)
..... .... ...+...+.++.+|+.+||..||++||++.++++.|..
T Consensus 246 --~~~~~----~~~~----------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~ 292 (314)
T cd05099 246 --FKLLR----EGHR----------MDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDK 292 (314)
T ss_pred --HHHHH----cCCC----------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHH
Confidence 11110 0000 00112235688899999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-41 Score=322.30 Aligned_cols=259 Identities=23% Similarity=0.367 Sum_probs=206.0
Q ss_pred CCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCcc------CHHHHHHHHHHHhCCCCCceeeEEEE
Q 011851 122 SFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQ------GHKEWLAEVNYLGGLIHPNLVKLIGC 195 (476)
Q Consensus 122 ~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~------~~~~~~~E~~~l~~l~hpnIv~l~~~ 195 (476)
+|+..+.||+|+||.||+|.+. .+++.||+|++...... ..+.+.+|+.+|++++|+||++++++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~---------~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 71 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDV---------KTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGA 71 (268)
T ss_pred CccccceecCcCceEEEEEEEc---------CCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhce
Confidence 4788899999999999998653 46788999998754321 23568889999999999999999999
Q ss_pred EEeCCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCC-ceEEee
Q 011851 196 CIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEY-NAKLSD 274 (476)
Q Consensus 196 ~~~~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~-~vkl~D 274 (476)
+.+.+..++||||+++++|.+++.+ ..++++..+..++.||+.||.|||+.+ ++|+||||+||+++.++ .+||+|
T Consensus 72 ~~~~~~~~~v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~d 147 (268)
T cd06630 72 TCEDSHFNLFVEWMAGGSVSHLLSK-YGAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIAD 147 (268)
T ss_pred eccCCeEEEEEeccCCCcHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEcc
Confidence 9999999999999999999998854 457899999999999999999999988 99999999999998776 599999
Q ss_pred cCCcCCCCCCCc--cceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhh
Q 011851 275 FGLAKDGPEGDK--THVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQL 352 (476)
Q Consensus 275 FG~a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~ 352 (476)
||++........ ........|+..|+|||++.+..++.++|||||||++|+|++|..||...........+.....
T Consensus 148 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-- 225 (268)
T cd06630 148 FGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIAS-- 225 (268)
T ss_pred cccccccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhc--
Confidence 999876543211 1112235688999999999888999999999999999999999999965432211111110000
Q ss_pred ccccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCcc
Q 011851 353 GERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLK 410 (476)
Q Consensus 353 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~ 410 (476)
......++...+.++.+++.+||..+|++||++.+++++ |||+
T Consensus 226 -----------~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~----~~~~ 268 (268)
T cd06630 226 -----------ATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKH----PVFR 268 (268)
T ss_pred -----------cCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcC----cccC
Confidence 000111223346789999999999999999999999987 8864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-41 Score=326.43 Aligned_cols=269 Identities=26% Similarity=0.374 Sum_probs=206.6
Q ss_pred CCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCc--cCHHHHHHHHHHHhCCCCCceeeEEEEEEeC
Q 011851 122 SFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL--QGHKEWLAEVNYLGGLIHPNLVKLIGCCIED 199 (476)
Q Consensus 122 ~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~ 199 (476)
+|++.+.||+|+||.||+|.+. .+|..||+|++..... ...+.+.+|+.++++++||||+++++++..+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~---------~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~ 71 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDR---------ETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHG 71 (286)
T ss_pred CceEEeecccCCCcEEEEEEEC---------CCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecC
Confidence 4888999999999999998764 3577899999876543 2245788999999999999999999999999
Q ss_pred CeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCcC
Q 011851 200 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAK 279 (476)
Q Consensus 200 ~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~ 279 (476)
...|+||||+ +++|.+++......+++..++.++.||+.||.|||+.+ |+|+||||+||+++.++.++|+|||++.
T Consensus 72 ~~~~~v~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~ 147 (286)
T cd07832 72 SGFVLVMEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLAR 147 (286)
T ss_pred CeeEEEeccc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecc
Confidence 9999999999 99999999776678999999999999999999999988 9999999999999999999999999998
Q ss_pred CCCCCCccceeeeeecCCCCCCcchhhcC-CCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhH-Hhh-------hh
Q 011851 280 DGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV-EWA-------RP 350 (476)
Q Consensus 280 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~-~~~-------~~ 350 (476)
....... .......|+..|+|||++.+. .++.++|||||||++|||++|.++|...........+ ... .+
T Consensus 148 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (286)
T cd07832 148 LFSEEEP-RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWP 226 (286)
T ss_pred cccCCCC-CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHh
Confidence 7644322 112235689999999988754 5689999999999999999998888654321111000 000 00
Q ss_pred hhccccccccccCc-----ccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCc
Q 011851 351 QLGERRRFYRLIDP-----CLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYL 409 (476)
Q Consensus 351 ~~~~~~~~~~~~d~-----~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~ 409 (476)
..........+..+ .+...+ ...+..+.+||.+||+.||++||+++++++| |||
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h----~~~ 285 (286)
T cd07832 227 GLTSLPDYNKITFPESKPIPLEEIF-PDASPEALDLLKGLLVYDPSKRLSAAEALRH----PYF 285 (286)
T ss_pred hccCcchhhcccCCCCCcchHHHhC-CCccHHHHHHHHHHhccChhhCCCHHHHhhC----cCc
Confidence 00000000000000 000000 1225789999999999999999999999998 886
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=326.57 Aligned_cols=270 Identities=24% Similarity=0.341 Sum_probs=201.9
Q ss_pred cCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCcc-CHHHHHHHHHHHhCCCCCceeeEEEEEEeC
Q 011851 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQ-GHKEWLAEVNYLGGLIHPNLVKLIGCCIED 199 (476)
Q Consensus 121 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~ 199 (476)
++|++.+.||+|+||.||+|.+. .+++.||||.+...... ....+.+|++++++++|+||+++++++.++
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~---------~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 75 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSK---------LTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTK 75 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEc---------CCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecC
Confidence 57999999999999999998754 35778999998754322 234567899999999999999999999999
Q ss_pred CeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCcC
Q 011851 200 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAK 279 (476)
Q Consensus 200 ~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~ 279 (476)
+..|+||||+.+ +|.+++.+....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 76 ~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~ 151 (291)
T cd07844 76 KTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLAR 151 (291)
T ss_pred CeEEEEEecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECcccccc
Confidence 999999999974 999988776667899999999999999999999988 9999999999999999999999999987
Q ss_pred CCCCCCccceeeeeecCCCCCCcchhhc-CCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcc-hhHHhh--------h
Q 011851 280 DGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEH-NLVEWA--------R 349 (476)
Q Consensus 280 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~-~~~~~~--------~ 349 (476)
........ .....++..|+|||++.+ ..++.++|||||||++|+|++|+.||......... ..+... .
T Consensus 152 ~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (291)
T cd07844 152 AKSVPSKT--YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETW 229 (291)
T ss_pred ccCCCCcc--ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhh
Confidence 54321111 122356889999999876 46899999999999999999999999654311100 000000 0
Q ss_pred hhhccccccc----ccc-CcccCCCC-ChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCc
Q 011851 350 PQLGERRRFY----RLI-DPCLEGCF-SIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYL 409 (476)
Q Consensus 350 ~~~~~~~~~~----~~~-d~~l~~~~-~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~ 409 (476)
.......... ... ...+.... ......++.+++.+||+.||++||++.+++++ |||
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~----~~f 291 (291)
T cd07844 230 PGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKH----PYF 291 (291)
T ss_pred hhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcC----CCC
Confidence 0000000000 000 00000000 01112678899999999999999999999987 775
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-41 Score=326.75 Aligned_cols=262 Identities=27% Similarity=0.356 Sum_probs=203.9
Q ss_pred cChhHHHHhccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCC-CCCce
Q 011851 111 FSFNELKSATKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGL-IHPNL 189 (476)
Q Consensus 111 ~~~~~~~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l-~hpnI 189 (476)
+.++.+....++|++.+.||+|+||.||+|.+. .+++.+|+|++.... ....++.+|+.+++.+ +||||
T Consensus 8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~---------~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i 77 (286)
T cd06638 8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNK---------KNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNV 77 (286)
T ss_pred EEeecCCCcccceeeeeeeccCCCcEEEEEEEC---------CCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCe
Confidence 344555667789999999999999999998654 467789999986532 2235677899999999 69999
Q ss_pred eeEEEEEE-----eCCeeEEEEEecCCCCHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCC
Q 011851 190 VKLIGCCI-----EDDQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSN 261 (476)
Q Consensus 190 v~l~~~~~-----~~~~~~lV~E~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~N 261 (476)
+++++++. .++..++||||+++++|.+++.. ....+++..+..++.|++.||.|||+.+ |+||||||+|
T Consensus 78 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~n 154 (286)
T cd06638 78 VKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNN 154 (286)
T ss_pred eeeeeeeeecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHh
Confidence 99999874 34578999999999999988753 3456889999999999999999999988 9999999999
Q ss_pred eeecCCCceEEeecCCcCCCCCCCccceeeeeecCCCCCCcchhhc-----CCCCccchhhhhHHHHHHHHhCCCCCCCC
Q 011851 262 ILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-----GHLTAKSDVYSFGVVLLEMLTGRRSMDKN 336 (476)
Q Consensus 262 ILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslGv~l~elltG~~pf~~~ 336 (476)
|+++.++.+||+|||+++....... ......|++.|+|||++.. ..++.++|||||||++|||++|+.||...
T Consensus 155 ili~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~ 232 (286)
T cd06638 155 ILLTTEGGVKLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADL 232 (286)
T ss_pred EEECCCCCEEEccCCceeecccCCC--ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCC
Confidence 9999999999999999876533211 1223568999999998853 45788999999999999999999999754
Q ss_pred CCCCcchhHHhhhhhhccccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011851 337 RPNGEHNLVEWARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEA 402 (476)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~ 402 (476)
...... .... . .......+ +...+.++.+|+.+||+.||++|||+.+|+++
T Consensus 233 ~~~~~~--~~~~-----~-~~~~~~~~-------~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 233 HPMRAL--FKIP-----R-NPPPTLHQ-------PELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred chhHHH--hhcc-----c-cCCCcccC-------CCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 322111 0000 0 00000111 11124578899999999999999999999998
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=321.88 Aligned_cols=256 Identities=26% Similarity=0.392 Sum_probs=200.7
Q ss_pred cCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCcc-----CHHHHHHHHHHHhCCCCCceeeEEEE
Q 011851 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQ-----GHKEWLAEVNYLGGLIHPNLVKLIGC 195 (476)
Q Consensus 121 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~-----~~~~~~~E~~~l~~l~hpnIv~l~~~ 195 (476)
.+|...+.||+|+||.||+|.+. .++..||+|.+...... ....+.+|+.++++++||||++++++
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~---------~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 72 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDV---------DTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGC 72 (266)
T ss_pred CCccccceecCCCCEEEEEEEEc---------CCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEE
Confidence 46899999999999999998654 46788999998654321 23457789999999999999999999
Q ss_pred EEe--CCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEe
Q 011851 196 CIE--DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLS 273 (476)
Q Consensus 196 ~~~--~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~ 273 (476)
+.+ ...++++|||+++++|.+++... ..+++...+.++.|++.||.|||+.+ |+||||||+||+++.++.+||+
T Consensus 73 ~~~~~~~~~~l~~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~ 148 (266)
T cd06651 73 LRDRAEKTLTIFMEYMPGGSVKDQLKAY-GALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLG 148 (266)
T ss_pred EEcCCCCEEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEc
Confidence 876 35788999999999999998543 46899999999999999999999988 9999999999999999999999
Q ss_pred ecCCcCCCCCCCcc-ceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhh
Q 011851 274 DFGLAKDGPEGDKT-HVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQL 352 (476)
Q Consensus 274 DFG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~ 352 (476)
|||+++........ .......++..|+|||++.+..++.++|||||||++|||++|+.||........ + .. ..
T Consensus 149 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~---~--~~-~~ 222 (266)
T cd06651 149 DFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAA---I--FK-IA 222 (266)
T ss_pred cCCCccccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHH---H--HH-Hh
Confidence 99998764321111 111235688999999999988899999999999999999999999975422110 0 00 00
Q ss_pred ccccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCcc
Q 011851 353 GERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLK 410 (476)
Q Consensus 353 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~ 410 (476)
. ......++...++.+.+++ +||..+|++||++.+|++| |||+
T Consensus 223 ~----------~~~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~h----p~~~ 265 (266)
T cd06651 223 T----------QPTNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLRH----PFAQ 265 (266)
T ss_pred c----------CCCCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcC----cccc
Confidence 0 0001112223356777888 6888999999999999998 8875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-41 Score=327.14 Aligned_cols=262 Identities=25% Similarity=0.389 Sum_probs=210.5
Q ss_pred CCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCc-cCHHHHHHHHHHHhCCCCCceeeEEEEEEeCC
Q 011851 122 SFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL-QGHKEWLAEVNYLGGLIHPNLVKLIGCCIEDD 200 (476)
Q Consensus 122 ~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 200 (476)
.|+..+.||+|+||.||+|.+. .+++.||+|.+..... ...+.+.+|++++++++||||+++++++..++
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 75 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDN---------RTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGT 75 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEc---------CCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCC
Confidence 3677788999999999998664 3577899999875432 22356889999999999999999999999999
Q ss_pred eeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCcCC
Q 011851 201 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKD 280 (476)
Q Consensus 201 ~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~ 280 (476)
..|+||||+++++|.+++.. ..+++..+..++.||+.||.|||+.+ |+|+||+|+||+++.++.++|+|||++..
T Consensus 76 ~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~ 150 (277)
T cd06642 76 KLWIIMEYLGGGSALDLLKP--GPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQ 150 (277)
T ss_pred ceEEEEEccCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEcccccccc
Confidence 99999999999999998843 46899999999999999999999988 99999999999999999999999999976
Q ss_pred CCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhcccccccc
Q 011851 281 GPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRRFYR 360 (476)
Q Consensus 281 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 360 (476)
...... ......|+..|+|||++.+..++.++|||||||++|||++|+.||....+..... . ...
T Consensus 151 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~---~----~~~------ 215 (277)
T cd06642 151 LTDTQI--KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLF---L----IPK------ 215 (277)
T ss_pred ccCcch--hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHh---h----hhc------
Confidence 543221 1223568899999999998899999999999999999999999986543221110 0 000
Q ss_pred ccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCcccccCcchHHH
Q 011851 361 LIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDMASSSSYVQ 420 (476)
Q Consensus 361 ~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~~~~~~~~~~ 420 (476)
...+ ......+.++.+++.+||+.+|++||++.+++++ +|+........+..
T Consensus 216 ~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~----~~~~~~~~~~~~~~ 267 (277)
T cd06642 216 NSPP----TLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKH----KFITRYTKKTSFLT 267 (277)
T ss_pred CCCC----CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHh----HHHHHHhhhHHHHH
Confidence 0001 1112235678999999999999999999999998 88877665555543
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=319.03 Aligned_cols=250 Identities=26% Similarity=0.371 Sum_probs=204.9
Q ss_pred CCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCC--ccCHHHHHHHHHHHhCCCCCceeeEEEEEEeC
Q 011851 122 SFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDG--LQGHKEWLAEVNYLGGLIHPNLVKLIGCCIED 199 (476)
Q Consensus 122 ~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~ 199 (476)
+|+..+.||.|+||.||.+... .+++.+++|.+.... ....+++.+|+++|++++|+||+++++++.+.
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~---------~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~ 71 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRT---------EDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDD 71 (256)
T ss_pred CceEeeEecccCCceEEEEEEc---------CCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecC
Confidence 5889999999999999997654 467789999986543 23345788999999999999999999999999
Q ss_pred CeeEEEEEecCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCc
Q 011851 200 DQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLA 278 (476)
Q Consensus 200 ~~~~lV~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a 278 (476)
+.+++||||+++++|.+++.+. ...+++..+..++.|++.+|.|||+.+ ++|+||+|+||+++.++.+||+|||++
T Consensus 72 ~~~~~~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~ 148 (256)
T cd08221 72 NTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGIS 148 (256)
T ss_pred CeEEEEEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcce
Confidence 9999999999999999999664 456899999999999999999999988 999999999999999999999999999
Q ss_pred CCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhcccccc
Q 011851 279 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRRF 358 (476)
Q Consensus 279 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 358 (476)
........ ......|++.|+|||++.+..++.++||||||+++|||++|..||...........+ .. ..
T Consensus 149 ~~~~~~~~--~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~------~~--~~- 217 (256)
T cd08221 149 KILGSEYS--MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKI------VQ--GN- 217 (256)
T ss_pred EEcccccc--cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHH------Hc--CC-
Confidence 76543221 223457899999999998888999999999999999999999999754322111100 00 00
Q ss_pred ccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011851 359 YRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEA 402 (476)
Q Consensus 359 ~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~ 402 (476)
..+ .....+.++.+++.+||..+|++||++.+++++
T Consensus 218 ---~~~-----~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~ 253 (256)
T cd08221 218 ---YTP-----VVSVYSSELISLVHSLLQQDPEKRPTADEVLDQ 253 (256)
T ss_pred ---CCC-----CccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence 000 011235688999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-41 Score=325.09 Aligned_cols=260 Identities=27% Similarity=0.422 Sum_probs=206.0
Q ss_pred cCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCcc-CHHHHHHHHHHHhCCCCCceeeEEEEEEeC
Q 011851 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQ-GHKEWLAEVNYLGGLIHPNLVKLIGCCIED 199 (476)
Q Consensus 121 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~ 199 (476)
.+|++.+.||+|+||.||+|.+..++. .....||+|.+...... ...++.+|+.++++++||||+++++++..
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~-----~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~- 80 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGE-----KVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS- 80 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCC-----CcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-
Confidence 468899999999999999998754332 12346999998765432 34568889999999999999999999887
Q ss_pred CeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCcC
Q 011851 200 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAK 279 (476)
Q Consensus 200 ~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~ 279 (476)
...++||||+++++|.+++......+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 81 ~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~ 157 (279)
T cd05057 81 SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAK 157 (279)
T ss_pred CceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCcccc
Confidence 7899999999999999999776667999999999999999999999988 9999999999999999999999999998
Q ss_pred CCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhhcccccc
Q 011851 280 DGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPQLGERRRF 358 (476)
Q Consensus 280 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 358 (476)
...............++..|+|||.+....++.++|||||||++|||++ |+.||...........+ . ....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~---~----~~~~- 229 (279)
T cd05057 158 LLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLL---E----KGER- 229 (279)
T ss_pred cccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH---h----CCCC-
Confidence 7653322211112234568999999988899999999999999999998 99999765432111111 0 0000
Q ss_pred ccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011851 359 YRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPL 406 (476)
Q Consensus 359 ~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~ 406 (476)
. ..+...+..+.+++.+||..||++||++.++++.|+.+
T Consensus 230 --~-------~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~ 268 (279)
T cd05057 230 --L-------PQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKM 268 (279)
T ss_pred --C-------CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 0 01111246788999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-41 Score=326.90 Aligned_cols=261 Identities=26% Similarity=0.406 Sum_probs=204.2
Q ss_pred ccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCc-cCHHHHHHHHHHHhCCCCCceeeEEEEEEe
Q 011851 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL-QGHKEWLAEVNYLGGLIHPNLVKLIGCCIE 198 (476)
Q Consensus 120 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~ 198 (476)
.++|++.+.||+|+||.||+|.+... ....++..||+|++..... ....++.+|+.++++++||||+++++++.+
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~----~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~ 79 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGL----LPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAV 79 (288)
T ss_pred hHhceecccccccccccEEEEEEccc----CCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcC
Confidence 35799999999999999999976421 1223567899999875433 224568889999999999999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHHhhcC---------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCC
Q 011851 199 DDQRLLVYEFMPRGSLENHLFRRS---------------------LPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDF 257 (476)
Q Consensus 199 ~~~~~lV~E~~~~g~L~~~l~~~~---------------------~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDl 257 (476)
++..|+||||+++++|.+++.... ..+++..++.++.||+.||.|||+.+ ++||||
T Consensus 80 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl 156 (288)
T cd05050 80 GKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDL 156 (288)
T ss_pred CCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccc
Confidence 999999999999999999996421 24788889999999999999999988 999999
Q ss_pred CCCCeeecCCCceEEeecCCcCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHh-CCCCCCCC
Q 011851 258 KTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLT-GRRSMDKN 336 (476)
Q Consensus 258 Kp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~ellt-G~~pf~~~ 336 (476)
||+|||++.++.++|+|||++................++..|+|||.+.+..++.++|||||||++|||++ |..||...
T Consensus 157 ~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~ 236 (288)
T cd05050 157 ATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGM 236 (288)
T ss_pred cHhheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999999875433221111122335667999999998999999999999999999998 88888654
Q ss_pred CCCCcchhHHhhhhhhccccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 011851 337 RPNGEHNLVEWARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALK 404 (476)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~ 404 (476)
.... ...... . .. . .+ .+...+.++.+|+.+||+.||++|||+.|+++.|+
T Consensus 237 ~~~~---~~~~~~----~-~~---~-~~-----~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~ 287 (288)
T cd05050 237 AHEE---VIYYVR----D-GN---V-LS-----CPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQ 287 (288)
T ss_pred CHHH---HHHHHh----c-CC---C-CC-----CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhh
Confidence 3211 111100 0 00 0 00 01122578999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-41 Score=326.09 Aligned_cols=276 Identities=28% Similarity=0.367 Sum_probs=208.7
Q ss_pred cCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCcc-CHHHHHHHHHHHhCCCCCceeeEEEEEEe-
Q 011851 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQ-GHKEWLAEVNYLGGLIHPNLVKLIGCCIE- 198 (476)
Q Consensus 121 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~~- 198 (476)
..|.+.+.||+|+||.||+|.+...+ ..++..||+|++...... ..+.+.+|+++++.+.|+||+++++++..
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~-----~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~ 78 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLG-----DNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKP 78 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCC-----CCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecC
Confidence 35788899999999999999875332 346888999999765443 35678999999999999999999999887
Q ss_pred -CCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCC
Q 011851 199 -DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGL 277 (476)
Q Consensus 199 -~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~ 277 (476)
....++||||+++++|.+++......+++..+..++.|++.||.|||+.+ |+|+||||+|||++.++.++|+|||+
T Consensus 79 ~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~ 155 (284)
T cd05038 79 GGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGL 155 (284)
T ss_pred CCCceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEccccc
Confidence 55789999999999999999776657999999999999999999999988 99999999999999999999999999
Q ss_pred cCCCCCCCccc-eeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhcccc
Q 011851 278 AKDGPEGDKTH-VSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERR 356 (476)
Q Consensus 278 a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~ 356 (476)
+.......... ......++..|+|||.+.+..++.++|||||||++|||++|..|+............. . .......
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~-~-~~~~~~~ 233 (284)
T cd05038 156 AKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGI-A-QGQMIVT 233 (284)
T ss_pred ccccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhcccccc-c-cccccHH
Confidence 98765322211 1111334567999999988899999999999999999999999986532211000000 0 0000000
Q ss_pred ccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011851 357 RFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPL 406 (476)
Q Consensus 357 ~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~ 406 (476)
.+.+.+........+...+.++.+|+.+||+.+|++|||+.+|++.|+.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 234 RLLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHHHHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 00000000000011122356899999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=317.65 Aligned_cols=247 Identities=31% Similarity=0.472 Sum_probs=197.1
Q ss_pred ccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccC-HHHHHHHHHHHhCCCCCceeeEEEEEEeCCeeEEE
Q 011851 127 CLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQG-HKEWLAEVNYLGGLIHPNLVKLIGCCIEDDQRLLV 205 (476)
Q Consensus 127 ~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~-~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV 205 (476)
++||+|+||.||+|... ++..||+|.++...... ...+.+|++++++++||||+++++++...+..++|
T Consensus 1 ~~ig~g~~g~vy~~~~~----------~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 70 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK----------DKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIV 70 (250)
T ss_pred CccCCCCCceEEEEEec----------CCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEE
Confidence 36999999999998643 45679999987654322 34578899999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCcCCCCCCC
Q 011851 206 YEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGD 285 (476)
Q Consensus 206 ~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~ 285 (476)
|||+++++|.+++......+++..+..++.|++.+|.|||+.+ ++||||||+||+++.++.+||+|||++.......
T Consensus 71 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 147 (250)
T cd05085 71 MELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGI 147 (250)
T ss_pred EECCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceeccccc
Confidence 9999999999998766667899999999999999999999988 9999999999999999999999999987543221
Q ss_pred ccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhhccccccccccCc
Q 011851 286 KTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPQLGERRRFYRLIDP 364 (476)
Q Consensus 286 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 364 (476)
.. ......++..|+|||++.+..++.++||||||+++|+|++ |..||....... .... ......
T Consensus 148 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~---~~~~----~~~~~~------- 212 (250)
T cd05085 148 YS-SSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQ---AREQ----VEKGYR------- 212 (250)
T ss_pred cc-cCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHH---HHHH----HHcCCC-------
Confidence 11 1111234667999999998899999999999999999998 999996543211 1110 000000
Q ss_pred ccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 011851 365 CLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALK 404 (476)
Q Consensus 365 ~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~ 404 (476)
...+...+..+.+++.+||+.+|++||++.++++.|.
T Consensus 213 ---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 213 ---MSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred ---CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 0111123578999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=319.19 Aligned_cols=248 Identities=30% Similarity=0.490 Sum_probs=203.7
Q ss_pred cCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCCCCCceeeEEEEEEeCC
Q 011851 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHPNLVKLIGCCIEDD 200 (476)
Q Consensus 121 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 200 (476)
++|++.+.||.|+||.||+|.. .|+.||+|.+..... ..+++.+|+.+++.++|+||+++++++.+.+
T Consensus 6 ~~~~~~~~ig~g~~g~v~~~~~-----------~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 73 (256)
T cd05039 6 KELKLGATIGKGEFGDVMLGDY-----------RGQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGN 73 (256)
T ss_pred hhccceeeeecCCCceEEEEEe-----------cCcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCC
Confidence 4688999999999999999864 367799999976644 4567899999999999999999999999999
Q ss_pred eeEEEEEecCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCcC
Q 011851 201 QRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAK 279 (476)
Q Consensus 201 ~~~lV~E~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~ 279 (476)
..|+||||+++++|.+++.... ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++
T Consensus 74 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~ 150 (256)
T cd05039 74 PLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAK 150 (256)
T ss_pred CeEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEccccccc
Confidence 9999999999999999996543 36899999999999999999999988 9999999999999999999999999998
Q ss_pred CCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhhcccccc
Q 011851 280 DGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPQLGERRRF 358 (476)
Q Consensus 280 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 358 (476)
....... ...++..|+|||.+....++.++||||||+++|||++ |..||....... +..... ....
T Consensus 151 ~~~~~~~-----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~~~~~----~~~~- 217 (256)
T cd05039 151 EASQGQD-----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVPHVE----KGYR- 217 (256)
T ss_pred ccccccc-----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHH---HHHHHh----cCCC-
Confidence 7532211 2334667999999988899999999999999999997 999986543211 111110 0000
Q ss_pred ccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 011851 359 YRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKP 405 (476)
Q Consensus 359 ~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~ 405 (476)
...+...+..+.++|.+||..+|++||++.++++.|+.
T Consensus 218 ---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 218 ---------MEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred ---------CCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 00111225788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-41 Score=326.75 Aligned_cols=271 Identities=26% Similarity=0.356 Sum_probs=206.1
Q ss_pred cCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCC--ccCHHHHHHHHHHHhCCCCCceeeEEEEEEe
Q 011851 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDG--LQGHKEWLAEVNYLGGLIHPNLVKLIGCCIE 198 (476)
Q Consensus 121 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~ 198 (476)
++|++.+.||+|+||.||+|.+. .+++.||+|+++... ....+.+.+|++++++++|+||+++++++..
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~---------~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 71 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNK---------ATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRR 71 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeC---------CCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEE
Confidence 36899999999999999998654 467789999987543 2234678899999999999999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCc
Q 011851 199 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLA 278 (476)
Q Consensus 199 ~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a 278 (476)
++..++||||++++.|..++ .....+++..+..++.||+.||.|||+.+ |+||||+|+||+++.++.+||+|||++
T Consensus 72 ~~~~~iv~e~~~~~~l~~~~-~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~ 147 (288)
T cd07833 72 KGRLYLVFEYVERTLLELLE-ASPGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFA 147 (288)
T ss_pred CCEEEEEEecCCCCHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecc
Confidence 99999999999886665544 44556899999999999999999999988 999999999999999999999999999
Q ss_pred CCCCCCCccceeeeeecCCCCCCcchhhcC-CCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhc----
Q 011851 279 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLG---- 353 (476)
Q Consensus 279 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~---- 353 (476)
......... ......++..|+|||++.+. .++.++||||||+++|+|++|+.||....................
T Consensus 148 ~~~~~~~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (288)
T cd07833 148 RALRARPAS-PLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQ 226 (288)
T ss_pred cccCCCccc-cccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHh
Confidence 876543321 22346788999999999888 889999999999999999999999975432211110000000000
Q ss_pred ----ccc-----ccccccCc-ccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCc
Q 011851 354 ----ERR-----RFYRLIDP-CLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYL 409 (476)
Q Consensus 354 ----~~~-----~~~~~~d~-~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~ 409 (476)
... .+....++ .+...++...+.++.+||++||..+|++||++++++++ +||
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~----~~f 288 (288)
T cd07833 227 ELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH----PYF 288 (288)
T ss_pred hhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC----CCC
Confidence 000 00000000 00011122236789999999999999999999999987 775
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=319.47 Aligned_cols=247 Identities=28% Similarity=0.425 Sum_probs=198.6
Q ss_pred cCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCCCCCceeeEEEEEE-eC
Q 011851 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHPNLVKLIGCCI-ED 199 (476)
Q Consensus 121 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~-~~ 199 (476)
.+|.+.+.||+|+||.||++.. .|..||+|.+.... ..+.+.+|+.++++++|+||+++++++. ++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~-----------~~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 72 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDY-----------RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEK 72 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEE-----------cCCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCC
Confidence 3688999999999999999854 36679999986543 3467889999999999999999999765 45
Q ss_pred CeeEEEEEecCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCc
Q 011851 200 DQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLA 278 (476)
Q Consensus 200 ~~~~lV~E~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a 278 (476)
+..|+||||+++++|.+++.... ..+++..+..++.||+.||.|||+++ |+||||||+||+++.++.+||+|||++
T Consensus 73 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~ 149 (256)
T cd05082 73 GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLT 149 (256)
T ss_pred CceEEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccc
Confidence 67899999999999999996643 34889999999999999999999988 999999999999999999999999998
Q ss_pred CCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhhccccc
Q 011851 279 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPQLGERRR 357 (476)
Q Consensus 279 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 357 (476)
....... ....++..|+|||++.+..++.++|||||||++|+|++ |+.||...... .+.... ....
T Consensus 150 ~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~---~~~~~~----~~~~- 216 (256)
T cd05082 150 KEASSTQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK---DVVPRV----EKGY- 216 (256)
T ss_pred eeccccC-----CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHH----hcCC-
Confidence 7643321 12345667999999998899999999999999999998 99998643221 111110 0000
Q ss_pred cccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 011851 358 FYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKP 405 (476)
Q Consensus 358 ~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~ 405 (476)
........+..+.+++.+||+.+|++|||+.+++++|+.
T Consensus 217 ---------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 217 ---------KMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH 255 (256)
T ss_pred ---------CCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence 000111235788999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-41 Score=323.41 Aligned_cols=248 Identities=22% Similarity=0.351 Sum_probs=194.9
Q ss_pred ccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCCCCCceeeEEEEEEeCCeeEEEE
Q 011851 127 CLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHPNLVKLIGCCIEDDQRLLVY 206 (476)
Q Consensus 127 ~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~ 206 (476)
+.||+|+||.||+|.....+.. .......||+|.+........+.+.+|+.+++.++||||+++++++..++..++||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~--~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 78 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDY--GELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQ 78 (258)
T ss_pred CCCCcccchhheeeeecccccc--cccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEE
Confidence 4699999999999987532211 01234568999887655444567888999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCc--------eEEeecCCc
Q 011851 207 EFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYN--------AKLSDFGLA 278 (476)
Q Consensus 207 E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~--------vkl~DFG~a 278 (476)
||+++|+|.+++......+++..++.++.||+.||+|||+.+ |+||||||+|||++.++. ++++|||++
T Consensus 79 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~ 155 (258)
T cd05078 79 EYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS 155 (258)
T ss_pred ecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEecccccc
Confidence 999999999999766667899999999999999999999988 999999999999987765 699999998
Q ss_pred CCCCCCCccceeeeeecCCCCCCcchhhcC-CCCccchhhhhHHHHHHHHhCC-CCCCCCCCCCcchhHHhhhhhhcccc
Q 011851 279 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTAKSDVYSFGVVLLEMLTGR-RSMDKNRPNGEHNLVEWARPQLGERR 356 (476)
Q Consensus 279 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGv~l~elltG~-~pf~~~~~~~~~~~~~~~~~~~~~~~ 356 (476)
...... ....++..|+|||++.+. .++.++|||||||++|||++|. .||........... .....
T Consensus 156 ~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~-------~~~~~ 222 (258)
T cd05078 156 ITVLPK------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQF-------YEDRH 222 (258)
T ss_pred cccCCc------hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHH-------HHccc
Confidence 754321 225688899999999874 5899999999999999999995 55543322111000 00000
Q ss_pred ccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 011851 357 RFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALK 404 (476)
Q Consensus 357 ~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~ 404 (476)
.++.....++.+|+.+||+.||++|||++++++.|.
T Consensus 223 ------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 223 ------------QLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred ------------cCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 011122467899999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=324.61 Aligned_cols=271 Identities=24% Similarity=0.336 Sum_probs=203.2
Q ss_pred ccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccC-HHHHHHHHHHHhCCCCCceeeEEEEEEe
Q 011851 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQG-HKEWLAEVNYLGGLIHPNLVKLIGCCIE 198 (476)
Q Consensus 120 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~-~~~~~~E~~~l~~l~hpnIv~l~~~~~~ 198 (476)
+++|++.+.||+|+||.||+|.+. .+|..||+|++....... ...+.+|+++|+.++|+||+++++++..
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~---------~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~ 74 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISR---------INGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHT 74 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEc---------CCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEec
Confidence 567999999999999999998654 467789999987554332 3457789999999999999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCc
Q 011851 199 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLA 278 (476)
Q Consensus 199 ~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a 278 (476)
++..|+||||+. ++|.+++......+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.++|+|||++
T Consensus 75 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~ 150 (291)
T cd07870 75 KETLTFVFEYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLA 150 (291)
T ss_pred CCeEEEEEeccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccc
Confidence 999999999995 6888777665567888999999999999999999988 999999999999999999999999999
Q ss_pred CCCCCCCccceeeeeecCCCCCCcchhhcC-CCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhc----
Q 011851 279 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLG---- 353 (476)
Q Consensus 279 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~---- 353 (476)
+........ .....+++.|+|||++.+. .++.++|||||||++|+|++|..||.............+......
T Consensus 151 ~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~ 228 (291)
T cd07870 151 RAKSIPSQT--YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDT 228 (291)
T ss_pred cccCCCCCC--CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhh
Confidence 764322211 2234578999999998764 588899999999999999999999975543211100000000000
Q ss_pred -----ccccc-ccccCcccCCCC-----ChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCc
Q 011851 354 -----ERRRF-YRLIDPCLEGCF-----SIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYL 409 (476)
Q Consensus 354 -----~~~~~-~~~~d~~l~~~~-----~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~ 409 (476)
..... ..+...+....+ ....+..+.+++.+||..||.+|||+.+++.| |||
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h----~~~ 291 (291)
T cd07870 229 WPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLH----PYF 291 (291)
T ss_pred hhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcC----CCC
Confidence 00000 000000000000 00114578899999999999999999999987 775
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=322.21 Aligned_cols=259 Identities=25% Similarity=0.402 Sum_probs=202.5
Q ss_pred CCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCcc----------CHHHHHHHHHHHhCCCCCceee
Q 011851 122 SFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQ----------GHKEWLAEVNYLGGLIHPNLVK 191 (476)
Q Consensus 122 ~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~----------~~~~~~~E~~~l~~l~hpnIv~ 191 (476)
+|.+.+.||.|+||.||+|... .+|+.||+|.++..... ..+.+..|+.+++.++|+||++
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~---------~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~ 72 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNV---------TTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQ 72 (272)
T ss_pred ceeecceecccCceEEEEEeec---------CCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcce
Confidence 4788899999999999998654 36788999988642111 1235678999999999999999
Q ss_pred EEEEEEeCCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceE
Q 011851 192 LIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAK 271 (476)
Q Consensus 192 l~~~~~~~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vk 271 (476)
+++++...+..++||||+++++|.+++.+. ..+++..+..++.||+.||.|||+.+ ++||||+|+||+++.++.++
T Consensus 73 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~ 148 (272)
T cd06629 73 YLGFETTEEYLSIFLEYVPGGSIGSCLRTY-GRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICK 148 (272)
T ss_pred EEEEeccCCceEEEEecCCCCcHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEE
Confidence 999999999999999999999999998654 57899999999999999999999988 99999999999999999999
Q ss_pred EeecCCcCCCCCCCccceeeeeecCCCCCCcchhhcCC--CCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhh
Q 011851 272 LSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGH--LTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR 349 (476)
Q Consensus 272 l~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~ 349 (476)
|+|||+++...............|+..|+|||++.... ++.++|+||||+++|+|++|..||....... ......
T Consensus 149 l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~--~~~~~~- 225 (272)
T cd06629 149 ISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIA--AMFKLG- 225 (272)
T ss_pred EeeccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHH--HHHHhh-
Confidence 99999997654322111123356899999999988754 8899999999999999999999996432211 010000
Q ss_pred hhhccccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCc
Q 011851 350 PQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYL 409 (476)
Q Consensus 350 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~ 409 (476)
.. . ....+. .......+.++.+++.+||..+|++||++.++++| ||+
T Consensus 226 ---~~-~-~~~~~~----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~----~~~ 272 (272)
T cd06629 226 ---NK-R-SAPPIP----PDVSMNLSPVALDFLNACFTINPDNRPTARELLQH----PFI 272 (272)
T ss_pred ---cc-c-cCCcCC----ccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC----CCC
Confidence 00 0 000011 11111235789999999999999999999999998 774
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=329.97 Aligned_cols=262 Identities=29% Similarity=0.471 Sum_probs=215.7
Q ss_pred cCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccC-HHHHHHHHHHHhCCCCCceeeEEEEEEeC
Q 011851 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQG-HKEWLAEVNYLGGLIHPNLVKLIGCCIED 199 (476)
Q Consensus 121 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~-~~~~~~E~~~l~~l~hpnIv~l~~~~~~~ 199 (476)
....+.++||+|-||.|.++... .+..||+|.++...... .++|.+|+++|.+|+|||||+|+++|..+
T Consensus 538 s~L~~~ekiGeGqFGEVhLCeve----------g~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~D 607 (807)
T KOG1094|consen 538 SRLRFKEKIGEGQFGEVHLCEVE----------GPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQD 607 (807)
T ss_pred hheehhhhhcCcccceeEEEEec----------CceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecC
Confidence 45678899999999999998764 35789999998776554 47899999999999999999999999999
Q ss_pred CeeEEEEEecCCCCHHHHHhhcCCCC-CHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCc
Q 011851 200 DQRLLVYEFMPRGSLENHLFRRSLPL-PWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLA 278 (476)
Q Consensus 200 ~~~~lV~E~~~~g~L~~~l~~~~~~l-~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a 278 (476)
+.++||+||+++|+|.+++.+...+. .......|+.||+.|++||.+.+ +|||||.+.|+|+++++++||+|||++
T Consensus 608 ePicmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgms 684 (807)
T KOG1094|consen 608 DPLCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMS 684 (807)
T ss_pred CchHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCcccc
Confidence 99999999999999999998764443 55566779999999999999988 999999999999999999999999999
Q ss_pred CCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHh--CCCCCCCCCCCCcchhHHhhhhhhcccc
Q 011851 279 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLT--GRRSMDKNRPNGEHNLVEWARPQLGERR 356 (476)
Q Consensus 279 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~ellt--G~~pf~~~~~~~~~~~~~~~~~~~~~~~ 356 (476)
+.+-.++.+....+.+-...|||+|.+..+.++.++|+|+||+++||+++ ...||....... .++..........
T Consensus 685 R~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~---vven~~~~~~~~~ 761 (807)
T KOG1094|consen 685 RNLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQ---VVENAGEFFRDQG 761 (807)
T ss_pred cccccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHH---HHHhhhhhcCCCC
Confidence 98888888888888888899999999999999999999999999999865 667886543322 2221111111111
Q ss_pred ccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 011851 357 RFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKP 405 (476)
Q Consensus 357 ~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~ 405 (476)
...+-. -+.-++..+.+|+.+||..|-++||+++++..+|+.
T Consensus 762 --~~~~l~-----~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~ 803 (807)
T KOG1094|consen 762 --RQVVLS-----RPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQE 803 (807)
T ss_pred --cceecc-----CCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHH
Confidence 011111 122336789999999999999999999999988764
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=316.37 Aligned_cols=273 Identities=26% Similarity=0.328 Sum_probs=212.1
Q ss_pred cChhHHHHhccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCCC-CCce
Q 011851 111 FSFNELKSATKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLI-HPNL 189 (476)
Q Consensus 111 ~~~~~~~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~-hpnI 189 (476)
-.|+++...+. +.||+|+++.|-- |+...||.+||||++.+..-..+.++.+|++++.+++ |+||
T Consensus 73 g~F~d~YkLt~-----e~LGeGAyasVqt---------cv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~ni 138 (463)
T KOG0607|consen 73 GKFEDMYKLTS-----ELLGEGAYASVQT---------CVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNI 138 (463)
T ss_pred chHHHHHHhHH-----HHhcCccceeeee---------eeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccH
Confidence 34666666554 6799999999976 4555789999999999886666788999999999995 9999
Q ss_pred eeEEEEEEeCCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCC-
Q 011851 190 VKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEY- 268 (476)
Q Consensus 190 v~l~~~~~~~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~- 268 (476)
++|+++|++++..|||||-|.||.|..+|.++ ..+++.++..++.+|+.||.|||..+ |.||||||+|||-..-.
T Consensus 139 lqLiefFEdd~~FYLVfEKm~GGplLshI~~~-~~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~ 214 (463)
T KOG0607|consen 139 LQLIEFFEDDTRFYLVFEKMRGGPLLSHIQKR-KHFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNK 214 (463)
T ss_pred HHHHHHhcccceEEEEEecccCchHHHHHHHh-hhccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCC
Confidence 99999999999999999999999999999655 46999999999999999999999988 99999999999986543
Q ss_pred --ceEEeecCCcCCCCCCCc-----cceeeeeecCCCCCCcchhh---c--CCCCccchhhhhHHHHHHHHhCCCCCCCC
Q 011851 269 --NAKLSDFGLAKDGPEGDK-----THVSTRVMGTYGYAAPEYVM---T--GHLTAKSDVYSFGVVLLEMLTGRRSMDKN 336 (476)
Q Consensus 269 --~vkl~DFG~a~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~---~--~~~~~~~DiwslGv~l~elltG~~pf~~~ 336 (476)
-||||||.++.-...... +....+.+|+..|||||++. + ..|+.++|.||||||||-||+|.+||.+.
T Consensus 215 vsPvKiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~ 294 (463)
T KOG0607|consen 215 VSPVKICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGH 294 (463)
T ss_pred cCceeeeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCc
Confidence 489999998753221111 11123478999999999874 2 36899999999999999999999999865
Q ss_pred CCCCcc--------hhHHhhhhhhccccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCC
Q 011851 337 RPNGEH--------NLVEWARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPY 408 (476)
Q Consensus 337 ~~~~~~--------~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~ 408 (476)
-...-- ...+.....+.+ .-+++.|..+. ..+.+..+||..+|..|+.+|.++.+++.| ||
T Consensus 295 Cg~dCGWdrGe~Cr~CQ~~LFesIQE--GkYeFPdkdWa-----hIS~eakdlisnLlvrda~~rlsa~~vlnh----Pw 363 (463)
T KOG0607|consen 295 CGADCGWDRGEVCRVCQNKLFESIQE--GKYEFPDKDWA-----HISSEAKDLISNLLVRDAKQRLSAAQVLNH----PW 363 (463)
T ss_pred cCCcCCccCCCccHHHHHHHHHHHhc--cCCcCChhhhH-----HhhHHHHHHHHHHHhccHHhhhhhhhccCC----cc
Confidence 331110 011111111111 11233333332 237889999999999999999999999987 88
Q ss_pred cccc
Q 011851 409 LKDM 412 (476)
Q Consensus 409 ~~~~ 412 (476)
++..
T Consensus 364 ~~~~ 367 (463)
T KOG0607|consen 364 VQRC 367 (463)
T ss_pred cccc
Confidence 8754
|
|
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=327.52 Aligned_cols=274 Identities=24% Similarity=0.323 Sum_probs=207.1
Q ss_pred CCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCcc-----CHHHHHHHHHHHhCCCCCceeeEEEEE
Q 011851 122 SFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQ-----GHKEWLAEVNYLGGLIHPNLVKLIGCC 196 (476)
Q Consensus 122 ~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~-----~~~~~~~E~~~l~~l~hpnIv~l~~~~ 196 (476)
+|.+.+.||+|+||.||+|.+. .+|+.||||.++..... ....+..|++++++++|+||+++++++
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~---------~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~ 71 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDK---------ETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVF 71 (298)
T ss_pred CceeeeeeeeccccEEEEEEEC---------CCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhhee
Confidence 4788899999999999998754 35778999999765433 234567899999999999999999999
Q ss_pred EeCCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecC
Q 011851 197 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFG 276 (476)
Q Consensus 197 ~~~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG 276 (476)
.+.+..++||||+ +++|.+++......+++..++.++.||++||.|||+.+ |+|+||||+|||++.++.++|+|||
T Consensus 72 ~~~~~~~lv~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg 147 (298)
T cd07841 72 GHKSNINLVFEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFG 147 (298)
T ss_pred ecCCEEEEEEccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccce
Confidence 9999999999999 88999999655447999999999999999999999988 9999999999999999999999999
Q ss_pred CcCCCCCCCccceeeeeecCCCCCCcchhhc-CCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhH-Hhh-hhhhc
Q 011851 277 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV-EWA-RPQLG 353 (476)
Q Consensus 277 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~-~~~-~~~~~ 353 (476)
++......... .....+++.|+|||++.+ ..++.++|||||||++|||++|.++|............ ... .+...
T Consensus 148 ~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (298)
T cd07841 148 LARSFGSPNRK--MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEE 225 (298)
T ss_pred eeeeccCCCcc--ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchh
Confidence 99875443211 122456888999998865 46789999999999999999998888654332111100 000 00000
Q ss_pred ccc---ccccccCcccC-----CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCcccccC
Q 011851 354 ERR---RFYRLIDPCLE-----GCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDMAS 414 (476)
Q Consensus 354 ~~~---~~~~~~d~~l~-----~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~~~~ 414 (476)
... ........... .......+.++.++|.+||+.||++|||+.+++++ +||++...
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~----~~~~~~~~ 290 (298)
T cd07841 226 NWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH----PYFSNDPA 290 (298)
T ss_pred hhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC----ccccCCCC
Confidence 000 00000000000 00011235788999999999999999999999997 99887543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-41 Score=325.80 Aligned_cols=260 Identities=27% Similarity=0.395 Sum_probs=206.5
Q ss_pred cCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCc-cCHHHHHHHHHHHhCCCCCceeeEEEEEEeC
Q 011851 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL-QGHKEWLAEVNYLGGLIHPNLVKLIGCCIED 199 (476)
Q Consensus 121 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~ 199 (476)
++|++.+.||+|+||+||++.+. .+|+.||+|++..... ...+.+.+|+++++.++||||+++++++...
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~---------~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 75 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHI---------PTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNE 75 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEc---------CCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecC
Confidence 46889999999999999998654 3677899999865432 2346788999999999999999999999999
Q ss_pred CeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCCeeecCCCceEEeecCCc
Q 011851 200 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHE-EAEKPVIYRDFKTSNILLDGEYNAKLSDFGLA 278 (476)
Q Consensus 200 ~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~-~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a 278 (476)
+.+||||||+++++|.+++.+ ...+++..+..++.+++.||.|||+ .+ |+||||||+||+++.++.++|+|||++
T Consensus 76 ~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~d~gl~ 151 (284)
T cd06620 76 NNICMCMEFMDCGSLDRIYKK-GGPIPVEILGKIAVAVVEGLTYLYNVHR---IMHRDIKPSNILVNSRGQIKLCDFGVS 151 (284)
T ss_pred CEEEEEEecCCCCCHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHHhcC---eeccCCCHHHEEECCCCcEEEccCCcc
Confidence 999999999999999988854 4578999999999999999999997 45 999999999999999999999999998
Q ss_pred CCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCc-----chhHHhhhhhhc
Q 011851 279 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGE-----HNLVEWARPQLG 353 (476)
Q Consensus 279 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~-----~~~~~~~~~~~~ 353 (476)
....... .....|+..|+|||++.+..++.++|||||||++|+|++|..||........ ..+..+......
T Consensus 152 ~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (284)
T cd06620 152 GELINSI----ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQ 227 (284)
T ss_pred cchhhhc----cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhh
Confidence 6542211 1235789999999999888999999999999999999999999986543211 111111111110
Q ss_pred cccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCccc
Q 011851 354 ERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKD 411 (476)
Q Consensus 354 ~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~ 411 (476)
.. .+.+ .....+.++.+|+.+||+.||++|||+.+++++ +|+..
T Consensus 228 ~~-------~~~~---~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~----~~~~~ 271 (284)
T cd06620 228 EP-------PPRL---PSSDFPEDLRDFVDACLLKDPTERPTPQQLCAM----PPFIQ 271 (284)
T ss_pred cc-------CCCC---CchhcCHHHHHHHHHHhcCCcccCcCHHHHhcC----ccccc
Confidence 00 0000 011135678999999999999999999999987 55543
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-40 Score=319.67 Aligned_cols=268 Identities=28% Similarity=0.372 Sum_probs=209.9
Q ss_pred cCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCc-cCHHHHHHHHHHHhCCCCCceeeEEEEEEeC
Q 011851 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL-QGHKEWLAEVNYLGGLIHPNLVKLIGCCIED 199 (476)
Q Consensus 121 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~ 199 (476)
++|+..+.||.|++|.||++.+. .+++.||+|.+..... ....++.+|++++++++||||++++++|.+.
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~---------~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 71 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLK---------NTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDE 71 (287)
T ss_pred CceEEEEEeccCCceEEEEEEEC---------CCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcc
Confidence 36888899999999999998765 3678899999875433 2345688999999999999999999998653
Q ss_pred --CeeEEEEEecCCCCHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEee
Q 011851 200 --DQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSD 274 (476)
Q Consensus 200 --~~~~lV~E~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~D 274 (476)
+.+|+||||+++++|.+++.. ....+++..+..++.||+.||.|||+.+ ++|+||+|+||+++.++.++|+|
T Consensus 72 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d 148 (287)
T cd06621 72 SSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCD 148 (287)
T ss_pred CCCeEEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEee
Confidence 478999999999999887643 3456899999999999999999999988 99999999999999999999999
Q ss_pred cCCcCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCC--CcchhHHhhhhhh
Q 011851 275 FGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPN--GEHNLVEWARPQL 352 (476)
Q Consensus 275 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~--~~~~~~~~~~~~~ 352 (476)
||++....... .....++..|+|||.+.+..++.++|||||||++|+|++|..||...... .......+....
T Consensus 149 fg~~~~~~~~~----~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~- 223 (287)
T cd06621 149 FGVSGELVNSL----AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNM- 223 (287)
T ss_pred ccccccccccc----cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcC-
Confidence 99987643321 12356788999999999999999999999999999999999999765331 111121111110
Q ss_pred ccccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCcccccCcc
Q 011851 353 GERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDMASSS 416 (476)
Q Consensus 353 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~~~~~~ 416 (476)
.. . .+..... .....++.+.+++.+||..||.+|||+.|++++ +|++....+.
T Consensus 224 -~~---~-~~~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~----~~~~~~~~~~ 276 (287)
T cd06621 224 -PN---P-ELKDEPG--NGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEH----PWIKAQMKKK 276 (287)
T ss_pred -Cc---h-hhccCCC--CCCchHHHHHHHHHHHcCCCcccCCCHHHHHhC----ccccccccch
Confidence 00 0 0010110 001236789999999999999999999999998 9997766544
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=324.76 Aligned_cols=262 Identities=27% Similarity=0.418 Sum_probs=206.7
Q ss_pred ccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCc-cCHHHHHHHHHHHhCCCCCceeeEEEEEEe
Q 011851 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL-QGHKEWLAEVNYLGGLIHPNLVKLIGCCIE 198 (476)
Q Consensus 120 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~ 198 (476)
.++|.+.+.||+|+||.||+|.+.... ..++..|++|.+..... .....+.+|+.+|++++|+||+++++++.+
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~-----~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~ 79 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEK-----PGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIE 79 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCC-----CCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec
Confidence 457899999999999999999876421 12467899999865422 234567889999999999999999998776
Q ss_pred -CCeeEEEEEecCCCCHHHHHhhcC-------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCce
Q 011851 199 -DDQRLLVYEFMPRGSLENHLFRRS-------LPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNA 270 (476)
Q Consensus 199 -~~~~~lV~E~~~~g~L~~~l~~~~-------~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~v 270 (476)
+...++++||+++++|.+++.... ..+++..+..++.||+.||.|||+.+ ++||||||+|||++.++.+
T Consensus 80 ~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~ 156 (280)
T cd05043 80 DGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQV 156 (280)
T ss_pred CCCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcE
Confidence 567899999999999999986532 45899999999999999999999988 9999999999999999999
Q ss_pred EEeecCCcCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHh-CCCCCCCCCCCCcchhHHhhh
Q 011851 271 KLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWAR 349 (476)
Q Consensus 271 kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~ellt-G~~pf~~~~~~~~~~~~~~~~ 349 (476)
||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |+.||....+.. +..+..
T Consensus 157 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~~~~~ 233 (280)
T cd05043 157 KITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFE---MAAYLK 233 (280)
T ss_pred EECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHH---HHHHHH
Confidence 9999999986544332222223456778999999998899999999999999999999 999997643321 111111
Q ss_pred hhhccccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011851 350 PQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPL 406 (476)
Q Consensus 350 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~ 406 (476)
. .. .+. .....+.++.+++.+||..||++|||+.++++.|+.+
T Consensus 234 ~----~~---~~~-------~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~ 276 (280)
T cd05043 234 D----GY---RLA-------QPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDF 276 (280)
T ss_pred c----CC---CCC-------CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 0 00 000 1112256889999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-41 Score=334.03 Aligned_cols=264 Identities=27% Similarity=0.385 Sum_probs=205.1
Q ss_pred cCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCc-cCHHHHHHHHHHHhCC-CCCceeeEEEEEEe
Q 011851 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL-QGHKEWLAEVNYLGGL-IHPNLVKLIGCCIE 198 (476)
Q Consensus 121 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~-~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~ 198 (476)
.+|.+.+.||+|+||.||+|.+...++. ....+..||+|.+..... ...+++.+|+++++++ +||||+++++++.+
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~--~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 89 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKD--KPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 89 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCc--cCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEcc
Confidence 3689999999999999999976532211 112345799998875432 2345788999999999 79999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHHhhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCee
Q 011851 199 DDQRLLVYEFMPRGSLENHLFRRS---------------LPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNIL 263 (476)
Q Consensus 199 ~~~~~lV~E~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NIL 263 (476)
++..++||||+++++|.+++.+.. ..+++..+..++.||+.||.|||+++ |+||||||+|||
T Consensus 90 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nil 166 (334)
T cd05100 90 DGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARNVL 166 (334)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEE
Confidence 999999999999999999986531 24788899999999999999999988 999999999999
Q ss_pred ecCCCceEEeecCCcCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHh-CCCCCCCCCCCCcc
Q 011851 264 LDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEH 342 (476)
Q Consensus 264 l~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~ellt-G~~pf~~~~~~~~~ 342 (476)
++.++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||.........
T Consensus 167 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~ 246 (334)
T cd05100 167 VTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELF 246 (334)
T ss_pred EcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHH
Confidence 99999999999999986543322211222334567999999999999999999999999999998 88888654321111
Q ss_pred hhHHhhhhhhccccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011851 343 NLVEWARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPL 406 (476)
Q Consensus 343 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~ 406 (476)
..+ ..... ...+...+.++.+|+.+||+.+|++||++.+++++|+.+
T Consensus 247 ~~~-------~~~~~----------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~ 293 (334)
T cd05100 247 KLL-------KEGHR----------MDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRV 293 (334)
T ss_pred HHH-------HcCCC----------CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHH
Confidence 110 00000 001112356889999999999999999999999997654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=318.72 Aligned_cols=254 Identities=30% Similarity=0.434 Sum_probs=204.5
Q ss_pred ccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCCCCCceeeEEEEEEeC
Q 011851 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHPNLVKLIGCCIED 199 (476)
Q Consensus 120 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~ 199 (476)
.++|++.+.||+|+||.||+|.+. .++.||||.+..... ..+++.+|+.++++++|+||+++++++..+
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~----------~~~~~~vK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 73 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWN----------GTTKVAVKTLKPGTM-SPEAFLQEAQIMKKLRHDKLVQLYAVCSEE 73 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEc----------CCceEEEEEecCCcc-CHHHHHHHHHHHhhCCCCCEeeeeeeeecC
Confidence 457999999999999999998754 345699999876543 456789999999999999999999999998
Q ss_pred CeeEEEEEecCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCc
Q 011851 200 DQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLA 278 (476)
Q Consensus 200 ~~~~lV~E~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a 278 (476)
...++||||+++++|.+++.... ..+++..+..++.||+.||.|||+++ |+|+||||+||+++.++.+||+|||++
T Consensus 74 ~~~~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~ 150 (261)
T cd05034 74 EPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLA 150 (261)
T ss_pred CceEEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccc
Confidence 99999999999999999996643 56899999999999999999999988 999999999999999999999999999
Q ss_pred CCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhhccccc
Q 011851 279 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPQLGERRR 357 (476)
Q Consensus 279 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 357 (476)
........ .......++..|+|||.+.+..++.++|||||||++|+|++ |+.||....... ....... ..
T Consensus 151 ~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~---~~~~~~~----~~- 221 (261)
T cd05034 151 RLIEDDEY-TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNRE---VLEQVER----GY- 221 (261)
T ss_pred eeccchhh-hhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHHc----CC-
Confidence 76543211 11112334568999999998899999999999999999999 999996543211 1111000 00
Q ss_pred cccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 011851 358 FYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKP 405 (476)
Q Consensus 358 ~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~ 405 (476)
.. ..+...+.++.+++.+||+.+|++||++.++++.|+.
T Consensus 222 --~~-------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 222 --RM-------PRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred --CC-------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 00 0111125688999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=328.16 Aligned_cols=257 Identities=23% Similarity=0.340 Sum_probs=206.1
Q ss_pred CCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCCCCCceeeEEEEEEeCCee
Q 011851 123 FRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHPNLVKLIGCCIEDDQR 202 (476)
Q Consensus 123 y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~ 202 (476)
|.....||+|+||.||+|.+. .+++.||+|++........+.+.+|+.+++.++||||+++++++..++..
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~---------~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~ 93 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREK---------HSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEEL 93 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEc---------CCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeE
Confidence 344457999999999998654 36778999999765555566788999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCcCCCC
Q 011851 203 LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGP 282 (476)
Q Consensus 203 ~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~ 282 (476)
|+||||+++++|.+++.. ..+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 94 ~iv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~ 168 (297)
T cd06659 94 WVLMEFLQGGALTDIVSQ--TRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQIS 168 (297)
T ss_pred EEEEecCCCCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhcc
Confidence 999999999999987743 45899999999999999999999988 9999999999999999999999999987543
Q ss_pred CCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhcccccccccc
Q 011851 283 EGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRRFYRLI 362 (476)
Q Consensus 283 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 362 (476)
.... ......|+..|+|||++.+..++.++|||||||++|||++|+.||.......... ......
T Consensus 169 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~---~~~~~~---------- 233 (297)
T cd06659 169 KDVP--KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMK---RLRDSP---------- 233 (297)
T ss_pred cccc--cccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHhccC----------
Confidence 3221 1233678999999999998899999999999999999999999997543221111 100000
Q ss_pred CcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCcccccC
Q 011851 363 DPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDMAS 414 (476)
Q Consensus 363 d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~~~~ 414 (476)
.+.+. .....+..+.++|.+||+.+|++||++.+++++ +|+.+...
T Consensus 234 ~~~~~--~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~----~~~~~~~~ 279 (297)
T cd06659 234 PPKLK--NAHKISPVLRDFLERMLTREPQERATAQELLDH----PFLLQTGL 279 (297)
T ss_pred CCCcc--ccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC----hhhccCCC
Confidence 00000 011225678899999999999999999999997 88776543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=320.22 Aligned_cols=253 Identities=28% Similarity=0.452 Sum_probs=193.9
Q ss_pred ccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCC-ccCHHHHHHHHHHHhCCCCCceeeEEEEEE-eCCeeEE
Q 011851 127 CLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDG-LQGHKEWLAEVNYLGGLIHPNLVKLIGCCI-EDDQRLL 204 (476)
Q Consensus 127 ~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~-~~~~~~l 204 (476)
+.||+|+||.||+|.+... ...+..||||.+.... ....+.+.+|+.+++.++||||+++++++. .++..++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~------~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~l 74 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDS------DGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLV 74 (262)
T ss_pred CcccccCCceEEEEEEecC------CCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEE
Confidence 4689999999999986432 1245679999985432 233457888999999999999999999776 4556899
Q ss_pred EEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCcCCCCCC
Q 011851 205 VYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEG 284 (476)
Q Consensus 205 V~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~ 284 (476)
||||+.+++|.+++.+....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 75 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~ 151 (262)
T cd05058 75 VLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDK 151 (262)
T ss_pred EEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCC
Confidence 99999999999999766556788888999999999999999988 999999999999999999999999999764332
Q ss_pred Cccc--eeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhC-CCCCCCCCCCCcchhHHhhhhhhccccccccc
Q 011851 285 DKTH--VSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTG-RRSMDKNRPNGEHNLVEWARPQLGERRRFYRL 361 (476)
Q Consensus 285 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 361 (476)
.... ......++..|+|||.+.+..++.++|||||||++|||++| .+||...... ....... ...
T Consensus 152 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~---~~~~~~~----~~~----- 219 (262)
T cd05058 152 EYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSF---DITVYLL----QGR----- 219 (262)
T ss_pred cceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHH---HHHHHHh----cCC-----
Confidence 1110 11124467789999999888999999999999999999995 5556533211 1111100 000
Q ss_pred cCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 011851 362 IDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKP 405 (476)
Q Consensus 362 ~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~ 405 (476)
... .+...+..+.+++.+||..+|++||++.++++.|+.
T Consensus 220 -~~~----~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~ 258 (262)
T cd05058 220 -RLL----QPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQ 258 (262)
T ss_pred -CCC----CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHH
Confidence 000 011125678899999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=318.22 Aligned_cols=252 Identities=27% Similarity=0.471 Sum_probs=202.4
Q ss_pred cCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCCCCCceeeEEEEEEeCC
Q 011851 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHPNLVKLIGCCIEDD 200 (476)
Q Consensus 121 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 200 (476)
.+|++.+.||+|+||.||+|.+. .+..+|+|.+..... ....+.+|++++++++||||+++++++....
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~----------~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 72 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWL----------EKRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTERS 72 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEe----------CCCeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEccCC
Confidence 35788899999999999998764 345699999875433 3457889999999999999999999999999
Q ss_pred eeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCcCC
Q 011851 201 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKD 280 (476)
Q Consensus 201 ~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~ 280 (476)
..++||||+++++|.+++......+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++..
T Consensus 73 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~ 149 (256)
T cd05112 73 PICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRF 149 (256)
T ss_pred ceEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceee
Confidence 999999999999999999766667899999999999999999999988 99999999999999999999999999876
Q ss_pred CCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhhccccccc
Q 011851 281 GPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPQLGERRRFY 359 (476)
Q Consensus 281 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 359 (476)
...... .......++..|+|||++.++.++.++|||||||++|||++ |..||...... ...... ... .
T Consensus 150 ~~~~~~-~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~---~~~~~~----~~~---~ 218 (256)
T cd05112 150 VLDDQY-TSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNS---EVVETI----NAG---F 218 (256)
T ss_pred cccCcc-cccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHH---HHHHHH----hCC---C
Confidence 533211 11112335678999999998899999999999999999998 99999653321 111110 000 0
Q ss_pred cccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 011851 360 RLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALK 404 (476)
Q Consensus 360 ~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~ 404 (476)
....+. ..+..+.+|+.+||+.+|++||++.++++.|.
T Consensus 219 ~~~~~~-------~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 219 RLYKPR-------LASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred CCCCCC-------CCCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 111111 12578999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=319.71 Aligned_cols=255 Identities=25% Similarity=0.366 Sum_probs=201.0
Q ss_pred cCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCc-----cCHHHHHHHHHHHhCCCCCceeeEEEE
Q 011851 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL-----QGHKEWLAEVNYLGGLIHPNLVKLIGC 195 (476)
Q Consensus 121 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~-----~~~~~~~~E~~~l~~l~hpnIv~l~~~ 195 (476)
++|++.+.||+|+||.||+|.+. .+|..||||.+..... ...+.+.+|+.++++++||||++++++
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~---------~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~ 72 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDA---------DTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGC 72 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEc---------CCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeE
Confidence 46899999999999999998654 4678899998864321 123467789999999999999999999
Q ss_pred EEeC--CeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEe
Q 011851 196 CIED--DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLS 273 (476)
Q Consensus 196 ~~~~--~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~ 273 (476)
+.+. ..+++||||+++++|.+++... ..+++..+..++.|++.||.|||+.+ |+|+||||+|||++.++.++|+
T Consensus 73 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~ 148 (265)
T cd06652 73 LRDPMERTLSIFMEHMPGGSIKDQLKSY-GALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLG 148 (265)
T ss_pred eccCCCceEEEEEEecCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEEC
Confidence 8764 4688999999999999998544 46889999999999999999999988 9999999999999999999999
Q ss_pred ecCCcCCCCCCCcc-ceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhh
Q 011851 274 DFGLAKDGPEGDKT-HVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQL 352 (476)
Q Consensus 274 DFG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~ 352 (476)
|||++......... .......|+..|+|||++.+..++.++|||||||++|+|++|+.||........ ... . .
T Consensus 149 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~--~~~---~-~ 222 (265)
T cd06652 149 DFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAA--IFK---I-A 222 (265)
T ss_pred cCccccccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHH--HHH---H-h
Confidence 99999764321111 112235689999999999988899999999999999999999999964321110 000 0 0
Q ss_pred ccccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCc
Q 011851 353 GERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYL 409 (476)
Q Consensus 353 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~ 409 (476)
. .......+...+..+.+++.+||. +|++||++++|+++ +|+
T Consensus 223 ~----------~~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~----~~~ 264 (265)
T cd06652 223 T----------QPTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH----TFV 264 (265)
T ss_pred c----------CCCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC----ccc
Confidence 0 000111233446788899999994 99999999999987 775
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=325.24 Aligned_cols=266 Identities=29% Similarity=0.382 Sum_probs=207.3
Q ss_pred cChhHHHHhccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCC-CCCce
Q 011851 111 FSFNELKSATKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGL-IHPNL 189 (476)
Q Consensus 111 ~~~~~~~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l-~hpnI 189 (476)
+.+.++...+++|.+.+.||+|+||.||+|... .+++.+|+|++.... .....+.+|+.+++++ +||||
T Consensus 12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~---------~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni 81 (291)
T cd06639 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNK---------KDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNV 81 (291)
T ss_pred hhcccCCCCCCCeEEEEEeecCCCeEEEEEEEC---------CCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCe
Confidence 334455566788999999999999999998654 467889999986542 2235677899999998 79999
Q ss_pred eeEEEEEEeC-----CeeEEEEEecCCCCHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCC
Q 011851 190 VKLIGCCIED-----DQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSN 261 (476)
Q Consensus 190 v~l~~~~~~~-----~~~~lV~E~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~N 261 (476)
+++++++... +..|+||||+++++|.+++.. ....+++..++.++.|++.||.|||+.+ |+||||||+|
T Consensus 82 ~~~~~~~~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~n 158 (291)
T cd06639 82 VKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNN 158 (291)
T ss_pred EEEEEEEEeccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHH
Confidence 9999998754 358999999999999998853 3457899999999999999999999988 9999999999
Q ss_pred eeecCCCceEEeecCCcCCCCCCCccceeeeeecCCCCCCcchhhcC-----CCCccchhhhhHHHHHHHHhCCCCCCCC
Q 011851 262 ILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-----HLTAKSDVYSFGVVLLEMLTGRRSMDKN 336 (476)
Q Consensus 262 ILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DiwslGv~l~elltG~~pf~~~ 336 (476)
|+++.++.+||+|||++......... .....|+..|+|||++... .++.++|||||||++|||++|+.||...
T Consensus 159 ili~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~ 236 (291)
T cd06639 159 ILLTTEGGVKLVDFGVSAQLTSTRLR--RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDM 236 (291)
T ss_pred EEEcCCCCEEEeecccchhccccccc--ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCC
Confidence 99999999999999998865432211 1235688999999988643 3688999999999999999999999754
Q ss_pred CCCCcchhHHhhhhhhccccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCcc
Q 011851 337 RPNGEHNLVEWARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLK 410 (476)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~ 410 (476)
..... +..+... ....+.+ .......+.+||.+||+.||++||++.++++| |||+
T Consensus 237 ~~~~~--~~~~~~~------~~~~~~~-------~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~----~~~~ 291 (291)
T cd06639 237 HPVKT--LFKIPRN------PPPTLLH-------PEKWCRSFNHFISQCLIKDFEARPSVTHLLEH----PFIK 291 (291)
T ss_pred cHHHH--HHHHhcC------CCCCCCc-------ccccCHHHHHHHHHHhhcChhhCcCHHHHhcC----cccC
Confidence 32111 1111000 0000111 11224578999999999999999999999998 8874
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=358.72 Aligned_cols=257 Identities=23% Similarity=0.307 Sum_probs=199.8
Q ss_pred cCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCcc---CHHHHHHHHHHHhCCCCCceeeEEEEEE
Q 011851 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQ---GHKEWLAEVNYLGGLIHPNLVKLIGCCI 197 (476)
Q Consensus 121 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~---~~~~~~~E~~~l~~l~hpnIv~l~~~~~ 197 (476)
++|++.++||+|+||.||+|.+. .+|+.||||+++..... ..+++.+|++++++++||||+++++++.
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~---------~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~ 72 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDP---------VCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICS 72 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEEC---------CCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEe
Confidence 47999999999999999998654 46888999999754322 2356889999999999999999999999
Q ss_pred eCCeeEEEEEecCCCCHHHHHhhc----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCC
Q 011851 198 EDDQRLLVYEFMPRGSLENHLFRR----------SLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGE 267 (476)
Q Consensus 198 ~~~~~~lV~E~~~~g~L~~~l~~~----------~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~ 267 (476)
+++..|+||||++|++|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.+
T Consensus 73 d~~~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~d 149 (932)
T PRK13184 73 DGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLF 149 (932)
T ss_pred eCCEEEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCC
Confidence 999999999999999999988531 123566778899999999999999988 9999999999999999
Q ss_pred CceEEeecCCcCCCCCCCc----------------cceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCC
Q 011851 268 YNAKLSDFGLAKDGPEGDK----------------THVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRR 331 (476)
Q Consensus 268 ~~vkl~DFG~a~~~~~~~~----------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~ 331 (476)
+.+||+|||+++....... .......+||+.|+|||++.+..++.++|||||||++|||+||+.
T Consensus 150 g~vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~ 229 (932)
T PRK13184 150 GEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSF 229 (932)
T ss_pred CCEEEEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCC
Confidence 9999999999986521110 001123579999999999999999999999999999999999999
Q ss_pred CCCCCCCCCcchhHHhhhhhhccccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCC-HHHHHHHhc
Q 011851 332 SMDKNRPNGEHNLVEWARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPR-MSEVVEALK 404 (476)
Q Consensus 332 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt-~~ell~~L~ 404 (476)
||........... ... .++... ......+..+.+++.+||+.||++|++ ++++++.|+
T Consensus 230 PF~~~~~~ki~~~-----~~i---------~~P~~~-~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le 288 (932)
T PRK13184 230 PYRRKKGRKISYR-----DVI---------LSPIEV-APYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLE 288 (932)
T ss_pred CCCCcchhhhhhh-----hhc---------cChhhc-cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 9975332111100 000 000000 000122567889999999999999964 556666554
|
|
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=317.63 Aligned_cols=252 Identities=30% Similarity=0.430 Sum_probs=200.0
Q ss_pred cCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCCCCCceeeEEEEEEeCC
Q 011851 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHPNLVKLIGCCIEDD 200 (476)
Q Consensus 121 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 200 (476)
++|++.+.||+|+||.||+|.+. .+..+|+|.+.... ...+.+.+|+.++++++|+||+++++++. .+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~----------~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~ 73 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWN----------GTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EE 73 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEc----------CCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CC
Confidence 45889999999999999998764 22359999886543 23467889999999999999999999875 45
Q ss_pred eeEEEEEecCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCcC
Q 011851 201 QRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAK 279 (476)
Q Consensus 201 ~~~lV~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~ 279 (476)
..++||||+++++|.+++... ...+++..+..++.||+.||.|||+.+ |+|+||||+||++++++.++|+|||++.
T Consensus 74 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~ 150 (260)
T cd05069 74 PIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLAR 150 (260)
T ss_pred CcEEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccce
Confidence 789999999999999999653 345889999999999999999999988 9999999999999999999999999997
Q ss_pred CCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhhcccccc
Q 011851 280 DGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPQLGERRRF 358 (476)
Q Consensus 280 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 358 (476)
........ ......++..|+|||.+.+..++.++|||||||++|||++ |..||....... ...... ....
T Consensus 151 ~~~~~~~~-~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~~~~----~~~~- 221 (260)
T cd05069 151 LIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNRE---VLEQVE----RGYR- 221 (260)
T ss_pred EccCCccc-ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHH----cCCC-
Confidence 65332211 1122346678999999988899999999999999999999 899997543211 111110 0000
Q ss_pred ccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 011851 359 YRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKP 405 (476)
Q Consensus 359 ~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~ 405 (476)
. + .+...+..+.+++.+||..||++||+++++++.|+.
T Consensus 222 --~--~-----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 222 --M--P-----CPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred --C--C-----CCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 0 0 111236789999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=326.59 Aligned_cols=263 Identities=22% Similarity=0.302 Sum_probs=204.0
Q ss_pred cCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCcc---CHHHHHHHHHHHhCCCCCceeeEEEEEE
Q 011851 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQ---GHKEWLAEVNYLGGLIHPNLVKLIGCCI 197 (476)
Q Consensus 121 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~---~~~~~~~E~~~l~~l~hpnIv~l~~~~~ 197 (476)
++|.+.+.||+|+||.||++.+. .+++.||+|.+...... ....+.+|+++++.++||||+++++.+.
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~---------~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~ 71 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHK---------ETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFE 71 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEEC---------CCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEe
Confidence 36889999999999999998654 46788999998765432 2346778999999999999999999999
Q ss_pred eCCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCC
Q 011851 198 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGL 277 (476)
Q Consensus 198 ~~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~ 277 (476)
.++++|+||||++|++|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||+
T Consensus 72 ~~~~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~ 147 (305)
T cd05609 72 TKRHLCMVMEYVEGGDCATLLKNI-GALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGL 147 (305)
T ss_pred cCCEEEEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCC
Confidence 999999999999999999998544 57899999999999999999999988 99999999999999999999999999
Q ss_pred cCCCCCCCc-------------cceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchh
Q 011851 278 AKDGPEGDK-------------THVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNL 344 (476)
Q Consensus 278 a~~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~ 344 (476)
++....... ........|+..|+|||.+.+..++.++|||||||++|||++|..||.+..... +
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~---~ 224 (305)
T cd05609 148 SKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE---L 224 (305)
T ss_pred ccccCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---H
Confidence 874211100 001112467889999999998899999999999999999999999997543221 1
Q ss_pred HHhhhhhhccccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCcccc
Q 011851 345 VEWARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDM 412 (476)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~~ 412 (476)
.... ... ....+... ...+.++.++|.+||+.||++||++.++++.|+ +||+...
T Consensus 225 ~~~~---~~~-----~~~~~~~~----~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~-~~~~~~~ 279 (305)
T cd05609 225 FGQV---ISD-----DIEWPEGD----EALPADAQDLISRLLRQNPLERLGTGGAFEVKQ-HRFFLGL 279 (305)
T ss_pred HHHH---Hhc-----ccCCCCcc----ccCCHHHHHHHHHHhccChhhccCccCHHHHHh-CccccCC
Confidence 1100 000 00001111 022567899999999999999999654444333 3888653
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=318.50 Aligned_cols=253 Identities=23% Similarity=0.344 Sum_probs=205.3
Q ss_pred CCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCc--cCHHHHHHHHHHHhCCCCCceeeEEEEEEeC
Q 011851 122 SFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL--QGHKEWLAEVNYLGGLIHPNLVKLIGCCIED 199 (476)
Q Consensus 122 ~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~ 199 (476)
+|++.+.||+|+||.||++... .+|+.||+|.+..... ...+++.+|+.++++++||||+++++++...
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~---------~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 71 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSK---------EDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEEN 71 (256)
T ss_pred CceEEEEeccCCceEEEEEEEc---------CCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCC
Confidence 4889999999999999998654 3577899999875432 2345788999999999999999999999999
Q ss_pred CeeEEEEEecCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCc
Q 011851 200 DQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLA 278 (476)
Q Consensus 200 ~~~~lV~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a 278 (476)
+..|+||||+++++|.+++... ...+++..++.++.|++.||.|||+++ ++|+||+|+|||++.++.++|+|||++
T Consensus 72 ~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~ 148 (256)
T cd08218 72 GNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIA 148 (256)
T ss_pred CeEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccce
Confidence 9999999999999999998654 346899999999999999999999988 999999999999999999999999999
Q ss_pred CCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhcccccc
Q 011851 279 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRRF 358 (476)
Q Consensus 279 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 358 (476)
........ ......|++.|+|||++.+..++.++|+|||||++|+|++|+.||....... ... .....
T Consensus 149 ~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~---~~~---~~~~~---- 216 (256)
T cd08218 149 RVLNSTVE--LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKN---LVL---KIIRG---- 216 (256)
T ss_pred eecCcchh--hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHH---HHH---HHhcC----
Confidence 76543221 1223568899999999998889999999999999999999999996432211 110 00000
Q ss_pred ccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCc
Q 011851 359 YRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYL 409 (476)
Q Consensus 359 ~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~ 409 (476)
... ..+...+.++.++|.+||+.+|++||++.+|++| |||
T Consensus 217 --~~~-----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~----~~~ 256 (256)
T cd08218 217 --SYP-----PVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK----NFI 256 (256)
T ss_pred --CCC-----CCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC----cCC
Confidence 000 0112235688999999999999999999999997 775
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=328.24 Aligned_cols=259 Identities=26% Similarity=0.436 Sum_probs=202.2
Q ss_pred cCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccC-HHHHHHHHHHHhCCCCCceeeEEEEEEeC
Q 011851 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQG-HKEWLAEVNYLGGLIHPNLVKLIGCCIED 199 (476)
Q Consensus 121 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~-~~~~~~E~~~l~~l~hpnIv~l~~~~~~~ 199 (476)
++|+..+.||+|+||.||+|.+..++.. ....||+|.+....... ..++.+|+.+++.++||||+++++++...
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~ 81 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGET-----VKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP 81 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCc-----ceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC
Confidence 4688889999999999999987643321 12358999887553322 33678899999999999999999998754
Q ss_pred CeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCcC
Q 011851 200 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAK 279 (476)
Q Consensus 200 ~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~ 279 (476)
..++|+||+++|+|.+++......+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 82 -~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~ 157 (303)
T cd05110 82 -TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLAR 157 (303)
T ss_pred -CceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEccccccc
Confidence 578999999999999999776667899999999999999999999988 9999999999999999999999999998
Q ss_pred CCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhhcccccc
Q 011851 280 DGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPQLGERRRF 358 (476)
Q Consensus 280 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 358 (476)
...............++..|+|||++.+..++.++|||||||++|||++ |..||........ ..+.. ....+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~---~~~~~----~~~~~ 230 (303)
T cd05110 158 LLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREI---PDLLE----KGERL 230 (303)
T ss_pred cccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH---HHHHH----CCCCC
Confidence 7543322211222345778999999998999999999999999999997 8999965432111 11111 00000
Q ss_pred ccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 011851 359 YRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKP 405 (476)
Q Consensus 359 ~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~ 405 (476)
+ .....+..+.+++.+||..+|++||++.++++.|..
T Consensus 231 -----~-----~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~ 267 (303)
T cd05110 231 -----P-----QPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSR 267 (303)
T ss_pred -----C-----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 0 011124578899999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=322.04 Aligned_cols=261 Identities=28% Similarity=0.396 Sum_probs=202.2
Q ss_pred cCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCc-cCHHHHHHHHHH-HhCCCCCceeeEEEEEEe
Q 011851 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL-QGHKEWLAEVNY-LGGLIHPNLVKLIGCCIE 198 (476)
Q Consensus 121 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~-~~~~~~~~E~~~-l~~l~hpnIv~l~~~~~~ 198 (476)
++|++.+.||+|+||.||+|.+. .+|+.||||.++.... ....++..|+.+ ++.++||||+++++++..
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~ 71 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHV---------PTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFR 71 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEc---------CCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEec
Confidence 36889999999999999998654 4788899999876532 223456666665 667789999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeEecCCCCCCeeecCCCceEEee
Q 011851 199 DDQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALDAAKGLAFLHEE-AEKPVIYRDFKTSNILLDGEYNAKLSD 274 (476)
Q Consensus 199 ~~~~~lV~E~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~al~~lH~~-~~~~ivHrDlKp~NILl~~~~~vkl~D 274 (476)
++..|+||||++ ++|.+++.. ....+++..++.++.||+.||.|||++ + ++||||||+|||++.++.+||+|
T Consensus 72 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~d 147 (283)
T cd06617 72 EGDVWICMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCD 147 (283)
T ss_pred CCcEEEEhhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEee
Confidence 999999999996 688777754 345689999999999999999999986 6 99999999999999999999999
Q ss_pred cCCcCCCCCCCccceeeeeecCCCCCCcchhhc----CCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhh
Q 011851 275 FGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT----GHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP 350 (476)
Q Consensus 275 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~ 350 (476)
||++....... ..+...|+..|+|||++.+ ..++.++|+|||||++|+|++|+.||....... ..+.....
T Consensus 148 fg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-~~~~~~~~- 222 (283)
T cd06617 148 FGISGYLVDSV---AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPF-QQLKQVVE- 222 (283)
T ss_pred ccccccccccc---ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCH-HHHHHHHh-
Confidence 99998653321 1223568899999998865 457889999999999999999999996432110 11110000
Q ss_pred hhccccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCcccccCcc
Q 011851 351 QLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDMASSS 416 (476)
Q Consensus 351 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~~~~~~ 416 (476)
. ..+.. .....+.++.++|.+||..+|++||++.+++++ ||++....+.
T Consensus 223 ---~-------~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~----~~~~~~~~~~ 271 (283)
T cd06617 223 ---E-------PSPQL---PAEKFSPEFQDFVNKCLKKNYKERPNYPELLQH----PFFELHLSKN 271 (283)
T ss_pred ---c-------CCCCC---CccccCHHHHHHHHHHccCChhhCcCHHHHhcC----chhhhccccc
Confidence 0 00000 011235789999999999999999999999997 9998765543
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=320.26 Aligned_cols=258 Identities=27% Similarity=0.407 Sum_probs=207.1
Q ss_pred CCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCc-cCHHHHHHHHHHHhCCC---CCceeeEEEEEE
Q 011851 122 SFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL-QGHKEWLAEVNYLGGLI---HPNLVKLIGCCI 197 (476)
Q Consensus 122 ~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~-~~~~~~~~E~~~l~~l~---hpnIv~l~~~~~ 197 (476)
.|++.+.||+|+||.||+|.+. .+++.||+|.++.... ....++.+|+.+++++. ||||+++++++.
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~---------~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~ 72 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHV---------PTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYL 72 (277)
T ss_pred hhhhhhheeccCCceEEEEEEc---------CCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeee
Confidence 4788899999999999998754 4678899999875432 33456888999999886 999999999999
Q ss_pred eCCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCC
Q 011851 198 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGL 277 (476)
Q Consensus 198 ~~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~ 277 (476)
.+...|+||||+++++|.+++.. ..+++..+..++.|++.||.|||+.+ |+|+||+|+||+++.++.++|+|||+
T Consensus 73 ~~~~~~lv~e~~~~~~L~~~~~~--~~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~ 147 (277)
T cd06917 73 KGPRLWIIMEYAEGGSVRTLMKA--GPIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGV 147 (277)
T ss_pred eCCEEEEEEecCCCCcHHHHHHc--cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCc
Confidence 99999999999999999998854 37899999999999999999999988 99999999999999999999999999
Q ss_pred cCCCCCCCccceeeeeecCCCCCCcchhhcC-CCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhcccc
Q 011851 278 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERR 356 (476)
Q Consensus 278 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~ 356 (476)
+........ ......|+..|+|||.+.++ .++.++|+|||||++|+|++|..||.............
T Consensus 148 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~---------- 215 (277)
T cd06917 148 AALLNQNSS--KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIP---------- 215 (277)
T ss_pred eeecCCCcc--ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccc----------
Confidence 987544321 12335789999999988754 57899999999999999999999997543321111000
Q ss_pred ccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCcccccCc
Q 011851 357 RFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDMASS 415 (476)
Q Consensus 357 ~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~~~~~ 415 (476)
....+.+.. ...+.++.+++.+||+.||++||++.+++++ +|++.....
T Consensus 216 ---~~~~~~~~~---~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~----~~~~~~~~~ 264 (277)
T cd06917 216 ---KSKPPRLED---NGYSKLLREFVAACLDEEPKERLSAEELLKS----KWIKAHSKT 264 (277)
T ss_pred ---cCCCCCCCc---ccCCHHHHHHHHHHcCCCcccCcCHHHHhhC----hHhhccccC
Confidence 000011111 0135688999999999999999999999986 999876543
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=320.89 Aligned_cols=260 Identities=25% Similarity=0.372 Sum_probs=205.9
Q ss_pred cCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCcc-CHHHHHHHHHHHhCCCCCceeeEEEEEEeC
Q 011851 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQ-GHKEWLAEVNYLGGLIHPNLVKLIGCCIED 199 (476)
Q Consensus 121 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~ 199 (476)
.+|++.+.||+|+||.||+|+..... ...+.+.|++|.+...... ..+.+.+|++++++++|+||+++++++.+.
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~----~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 80 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIE----EEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREA 80 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCC----cCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCC
Confidence 46889999999999999999876432 1245677999998765433 346788999999999999999999999999
Q ss_pred CeeEEEEEecCCCCHHHHHhhcC--------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceE
Q 011851 200 DQRLLVYEFMPRGSLENHLFRRS--------LPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAK 271 (476)
Q Consensus 200 ~~~~lV~E~~~~g~L~~~l~~~~--------~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vk 271 (476)
+..|+||||+++++|.+++.... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.++
T Consensus 81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~ 157 (275)
T cd05046 81 EPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVK 157 (275)
T ss_pred CcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEE
Confidence 99999999999999999986433 16899999999999999999999988 99999999999999999999
Q ss_pred EeecCCcCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhh
Q 011851 272 LSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARP 350 (476)
Q Consensus 272 l~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~ellt-G~~pf~~~~~~~~~~~~~~~~~ 350 (476)
|+|||++......... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||....... .+.....
T Consensus 158 l~~~~~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~---~~~~~~~ 233 (275)
T cd05046 158 VSLLSLSKDVYNSEYY-KLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE---VLNRLQA 233 (275)
T ss_pred EcccccccccCccccc-ccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHH---HHHHHHc
Confidence 9999998754322211 1223456778999999988889999999999999999999 788986443211 1111100
Q ss_pred hhccccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 011851 351 QLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALK 404 (476)
Q Consensus 351 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~ 404 (476)
.. +........+..+.+++.+||+.||++||++.+++..|.
T Consensus 234 -----~~--------~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 234 -----GK--------LELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred -----CC--------cCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 00 000011123568999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=317.05 Aligned_cols=252 Identities=29% Similarity=0.439 Sum_probs=204.0
Q ss_pred CCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCc-----cCHHHHHHHHHHHhCCCCCceeeEEEEE
Q 011851 122 SFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL-----QGHKEWLAEVNYLGGLIHPNLVKLIGCC 196 (476)
Q Consensus 122 ~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~-----~~~~~~~~E~~~l~~l~hpnIv~l~~~~ 196 (476)
+|+..+.||+|+||.||+|... .++..|++|.+..... +..+.+.+|+.+++.++|+||+++++++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~---------~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~ 71 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNL---------DDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTE 71 (258)
T ss_pred CccccceeeecCCceEEEEEEc---------CCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeE
Confidence 4788899999999999998654 3577899999865432 2345688999999999999999999999
Q ss_pred EeCCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecC
Q 011851 197 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFG 276 (476)
Q Consensus 197 ~~~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG 276 (476)
..+..+|+||||+++++|.+++.+. ..+++..+..++.||+.||.|||+.+ |+|+||+|+||+++.++.+||+|||
T Consensus 72 ~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~ 147 (258)
T cd06632 72 REEDNLYIFLELVPGGSLAKLLKKY-GSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFG 147 (258)
T ss_pred ecCCeEEEEEEecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCc
Confidence 9999999999999999999998544 46899999999999999999999988 9999999999999999999999999
Q ss_pred CcCCCCCCCccceeeeeecCCCCCCcchhhcCC-CCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhccc
Q 011851 277 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGH-LTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGER 355 (476)
Q Consensus 277 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~ 355 (476)
++....... ......|+..|+|||.+.... ++.++|+|||||++|+|++|+.||....... ....+.. ....
T Consensus 148 ~~~~~~~~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~--~~~~~~~--~~~~ 220 (258)
T cd06632 148 MAKQVVEFS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVA--AVFKIGR--SKEL 220 (258)
T ss_pred cceeccccc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHH--HHHHHHh--cccC
Confidence 987654322 123456899999999988776 8999999999999999999999997543211 1111100 0000
Q ss_pred cccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCc
Q 011851 356 RRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYL 409 (476)
Q Consensus 356 ~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~ 409 (476)
..++...+..+.+++.+||+.+|++||++.+++.+ ||+
T Consensus 221 ------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~----~~~ 258 (258)
T cd06632 221 ------------PPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEH----PFV 258 (258)
T ss_pred ------------CCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcC----CCC
Confidence 01112235778899999999999999999999987 664
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-41 Score=326.72 Aligned_cols=270 Identities=27% Similarity=0.332 Sum_probs=202.8
Q ss_pred cCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCcc--CHHHHHHHHHHHhCCCCCceeeEEEEEEe
Q 011851 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQ--GHKEWLAEVNYLGGLIHPNLVKLIGCCIE 198 (476)
Q Consensus 121 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~l~~~~~~ 198 (476)
++|++.+.||+|+||.||+|.+. .+++.||+|++...... ..+.+.+|+++++.++||||+++++++..
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~---------~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 71 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHK---------ETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRR 71 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEEC---------CCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhccc
Confidence 36889999999999999998654 36778999998654332 24567889999999999999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCc
Q 011851 199 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLA 278 (476)
Q Consensus 199 ~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a 278 (476)
++..|+||||++++.|.+++. ....+++..++.++.||+.||.|||+.+ |+|+||+|+||+++.++.++|+|||++
T Consensus 72 ~~~~~lv~e~~~~~~l~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~ 147 (286)
T cd07846 72 KKRLYLVFEFVDHTVLDDLEK-YPNGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFA 147 (286)
T ss_pred CCeEEEEEecCCccHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeee
Confidence 999999999999988887664 3445899999999999999999999988 999999999999999999999999998
Q ss_pred CCCCCCCccceeeeeecCCCCCCcchhhcC-CCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhccc--
Q 011851 279 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGER-- 355 (476)
Q Consensus 279 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~-- 355 (476)
........ ......++..|+|||++.+. .++.++|||||||++|||++|+.||...........+..........
T Consensus 148 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (286)
T cd07846 148 RTLAAPGE--VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQ 225 (286)
T ss_pred eeccCCcc--ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhH
Confidence 76543221 12335688999999998764 57889999999999999999999996543211100000000000000
Q ss_pred ------cccccccCcccCCC-----CChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCc
Q 011851 356 ------RRFYRLIDPCLEGC-----FSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYL 409 (476)
Q Consensus 356 ------~~~~~~~d~~l~~~-----~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~ 409 (476)
..+.....+..... .....+..+.+|+.+||+.||++||++.+++++ +||
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~----~~~ 286 (286)
T cd07846 226 EIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH----EFF 286 (286)
T ss_pred HHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC----CCC
Confidence 00000000000000 001225679999999999999999999999997 775
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=317.73 Aligned_cols=259 Identities=27% Similarity=0.413 Sum_probs=212.7
Q ss_pred cCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCc-cCHHHHHHHHHHHhCCCCCceeeEEEEEEeC
Q 011851 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL-QGHKEWLAEVNYLGGLIHPNLVKLIGCCIED 199 (476)
Q Consensus 121 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~ 199 (476)
++|++.+.||+|++|.||+|.+. .+++.|++|++..... .....+.+|+.++.+++|+||+++++++...
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~---------~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 71 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHK---------PTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKE 71 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEc---------CCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccC
Confidence 36889999999999999998654 4678899999876654 3356788999999999999999999999999
Q ss_pred CeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCCeeecCCCceEEeecCCc
Q 011851 200 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHE-EAEKPVIYRDFKTSNILLDGEYNAKLSDFGLA 278 (476)
Q Consensus 200 ~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~-~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a 278 (476)
+.+++||||+++++|.+++... ..+++..+..++.|++.||.|||+ .+ ++||||+|+||+++.++.++|+|||++
T Consensus 72 ~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~ 147 (264)
T cd06623 72 GEISIVLEYMDGGSLADLLKKV-GKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGIS 147 (264)
T ss_pred CeEEEEEEecCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccc
Confidence 9999999999999999999654 679999999999999999999999 88 999999999999999999999999999
Q ss_pred CCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhcccccc
Q 011851 279 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRRF 358 (476)
Q Consensus 279 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 358 (476)
......... .....++..|+|||.+.+..++.++||||||+++|+|++|+.||..................
T Consensus 148 ~~~~~~~~~--~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~------- 218 (264)
T cd06623 148 KVLENTLDQ--CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDG------- 218 (264)
T ss_pred eecccCCCc--ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcC-------
Confidence 875432221 12456899999999999989999999999999999999999999765432211221111100
Q ss_pred ccccCcccCCCCChH-HHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCcccc
Q 011851 359 YRLIDPCLEGCFSIK-GAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDM 412 (476)
Q Consensus 359 ~~~~d~~l~~~~~~~-~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~~ 412 (476)
..+ ..+.. .+..+.++|.+||..+|++||++.+++++ ||++..
T Consensus 219 ---~~~----~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~----~~~~~~ 262 (264)
T cd06623 219 ---PPP----SLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH----PFIKKA 262 (264)
T ss_pred ---CCC----CCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC----HHHHhc
Confidence 000 01112 36789999999999999999999999997 887654
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=320.36 Aligned_cols=255 Identities=31% Similarity=0.481 Sum_probs=199.5
Q ss_pred ccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCc-cCHHHHHHHHHHHhCCCCCceeeEEEEEEeCCeeEEE
Q 011851 127 CLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL-QGHKEWLAEVNYLGGLIHPNLVKLIGCCIEDDQRLLV 205 (476)
Q Consensus 127 ~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV 205 (476)
+.||+|+||.||+|.+..... ....++.+|||.+..... .....+.+|+.+++.++||||+++++++...+..++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~---~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 77 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILG---PGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYII 77 (269)
T ss_pred CccccccceeEEeeeeccccc---CcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEE
Confidence 368999999999998754221 122456799998865432 3356788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhc------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCC-----ceEEee
Q 011851 206 YEFMPRGSLENHLFRR------SLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEY-----NAKLSD 274 (476)
Q Consensus 206 ~E~~~~g~L~~~l~~~------~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~-----~vkl~D 274 (476)
|||+++++|.+++.+. ...+++..++.++.||+.||.|||+.+ ++|+||||+|||++.++ .++|+|
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~d 154 (269)
T cd05044 78 MELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGD 154 (269)
T ss_pred EeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECC
Confidence 9999999999999642 234788999999999999999999987 99999999999999877 899999
Q ss_pred cCCcCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhhc
Q 011851 275 FGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPQLG 353 (476)
Q Consensus 275 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~ 353 (476)
||++................++..|+|||++.+..++.++|||||||++|||++ |+.||...... .......
T Consensus 155 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~---~~~~~~~---- 227 (269)
T cd05044 155 FGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQ---EVLQHVT---- 227 (269)
T ss_pred cccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHH---HHHHHHh----
Confidence 999976543322222222346788999999999999999999999999999998 99999644321 1111100
Q ss_pred cccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 011851 354 ERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALK 404 (476)
Q Consensus 354 ~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~ 404 (476)
....+ ..+...+..+.+++.+||..+|++||++.++++.|+
T Consensus 228 ~~~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 228 AGGRL----------QKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred cCCcc----------CCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 00000 011223678899999999999999999999999875
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-40 Score=324.62 Aligned_cols=262 Identities=28% Similarity=0.403 Sum_probs=207.8
Q ss_pred ccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCcc---CHHHHHHHHHHHhCCCCCceeeEEEEE
Q 011851 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQ---GHKEWLAEVNYLGGLIHPNLVKLIGCC 196 (476)
Q Consensus 120 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~---~~~~~~~E~~~l~~l~hpnIv~l~~~~ 196 (476)
...|.+.+.||+|+||.||+|.+. .+++.||+|++...... ..+++.+|+++++.++||||+++++++
T Consensus 14 ~~~y~~~~~lg~g~~g~vy~~~~~---------~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~ 84 (307)
T cd06607 14 EKLFTDLREIGHGSFGAVYFARDV---------RTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCY 84 (307)
T ss_pred chhhhhheeecCCCCeEEEEEEEc---------CCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 346899999999999999998654 36778999998654332 234688999999999999999999999
Q ss_pred EeCCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecC
Q 011851 197 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFG 276 (476)
Q Consensus 197 ~~~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG 276 (476)
.+++..|+||||+. |+|.+.+......+++..+..++.||+.||.|||+.+ |+||||+|+||+++.++.++|+|||
T Consensus 85 ~~~~~~~lv~e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg 160 (307)
T cd06607 85 LREHTAWLVMEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFG 160 (307)
T ss_pred EeCCeEEEEHHhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecC
Confidence 99999999999996 5787777665667999999999999999999999988 9999999999999999999999999
Q ss_pred CcCCCCCCCccceeeeeecCCCCCCcchhh---cCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhc
Q 011851 277 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVM---TGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLG 353 (476)
Q Consensus 277 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~ 353 (476)
++...... ....|++.|+|||++. ...++.++||||||+++|||++|+.||.............. .
T Consensus 161 ~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~-----~ 229 (307)
T cd06607 161 SASLVSPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ-----N 229 (307)
T ss_pred cceecCCC------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhc-----C
Confidence 98764322 2356888999999874 35688999999999999999999999965432111000000 0
Q ss_pred cccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCcccccCcchHHH
Q 011851 354 ERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDMASSSSYVQ 420 (476)
Q Consensus 354 ~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~~~~~~~~~~ 420 (476)
.. +.+ .....+..+.+++.+||+.||++||++.+|+.+ +|+..........+
T Consensus 230 ~~--------~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~----~~~~~~~~~~~~~~ 281 (307)
T cd06607 230 DS--------PTL---SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH----RFVLRERPPTVIID 281 (307)
T ss_pred CC--------CCC---CchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC----hhhcccCCcHHHHH
Confidence 00 000 011235689999999999999999999999987 88887655443333
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=321.14 Aligned_cols=257 Identities=30% Similarity=0.423 Sum_probs=203.4
Q ss_pred hccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCC-CCCceeeEEEEEE
Q 011851 119 ATKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGL-IHPNLVKLIGCCI 197 (476)
Q Consensus 119 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~ 197 (476)
.+++|++.+.||+|+||.||+|.+. .+++.|++|++..... ....+.+|+.+++++ .|+||+++++++.
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~---------~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~ 73 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHK---------KTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFI 73 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEEC---------CCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEE
Confidence 4678999999999999999998754 3577899999876543 346788999999999 6999999999997
Q ss_pred eCC------eeEEEEEecCCCCHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCC
Q 011851 198 EDD------QRLLVYEFMPRGSLENHLFRR---SLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEY 268 (476)
Q Consensus 198 ~~~------~~~lV~E~~~~g~L~~~l~~~---~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~ 268 (476)
+.. .+|+||||+++++|.+++... +..+++..+..++.|++.||.|||+.+ |+|+||+|+||+++.++
T Consensus 74 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~ 150 (275)
T cd06608 74 KKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNA 150 (275)
T ss_pred ecCCCCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCC
Confidence 644 489999999999999988642 467999999999999999999999988 99999999999999999
Q ss_pred ceEEeecCCcCCCCCCCccceeeeeecCCCCCCcchhhc-----CCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcch
Q 011851 269 NAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-----GHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHN 343 (476)
Q Consensus 269 ~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~ 343 (476)
.++|+|||++........ ......|+..|+|||++.. ..++.++|||||||++|+|++|+.||....... .
T Consensus 151 ~~~l~d~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--~ 226 (275)
T cd06608 151 EVKLVDFGVSAQLDSTLG--RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMR--A 226 (275)
T ss_pred eEEECCCccceecccchh--hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHH--H
Confidence 999999999876433211 1233568999999998864 347789999999999999999999996432211 1
Q ss_pred hHHhhhhhhccccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCc
Q 011851 344 LVEWARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYL 409 (476)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~ 409 (476)
...... . ..+.+. .+...+..+.+||.+||..||++|||+.+++++ ||+
T Consensus 227 ~~~~~~------~-----~~~~~~--~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~----~~~ 275 (275)
T cd06608 227 LFKIPR------N-----PPPTLK--SPENWSKKFNDFISECLIKNYEQRPFMEELLEH----PFI 275 (275)
T ss_pred HHHhhc------c-----CCCCCC--chhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC----CCC
Confidence 111000 0 000000 111235688999999999999999999999997 774
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=320.40 Aligned_cols=253 Identities=25% Similarity=0.345 Sum_probs=207.2
Q ss_pred CCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCc---cCHHHHHHHHHHHhCCCCCceeeEEEEEEe
Q 011851 122 SFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL---QGHKEWLAEVNYLGGLIHPNLVKLIGCCIE 198 (476)
Q Consensus 122 ~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~ 198 (476)
+|.+.+.||.|+||.||+|.+. .+++.||+|++..... ...+.+.+|++++++++||||+++++++.+
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~---------~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 71 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKR---------DTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQD 71 (258)
T ss_pred CceEEEEeccCCCceEEEEEEc---------cCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcC
Confidence 4888999999999999998654 4678899999976443 234678899999999999999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCc
Q 011851 199 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLA 278 (476)
Q Consensus 199 ~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a 278 (476)
+...|+||||+.+++|.+++... .++++..+..++.||++||.|||+++ |+|+||+|+||+++.++.++|+|||++
T Consensus 72 ~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~ 147 (258)
T cd05578 72 EENMYLVVDLLLGGDLRYHLSQK-VKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIA 147 (258)
T ss_pred CCeEEEEEeCCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccc
Confidence 99999999999999999998654 57999999999999999999999988 999999999999999999999999999
Q ss_pred CCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhcccccc
Q 011851 279 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRRF 358 (476)
Q Consensus 279 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 358 (476)
....... ......|+..|+|||++.+..++.++|+||||+++|+|++|..||..........+......
T Consensus 148 ~~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-------- 216 (258)
T cd05578 148 TKVTPDT---LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQET-------- 216 (258)
T ss_pred cccCCCc---cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhcc--------
Confidence 8754432 12335688999999999988899999999999999999999999986554311111111000
Q ss_pred ccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCH--HHHHHHhcCCCCc
Q 011851 359 YRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRM--SEVVEALKPLPYL 409 (476)
Q Consensus 359 ~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~--~ell~~L~~~~~~ 409 (476)
....++...+..+.++|.+||+.||.+||++ ++++++ |||
T Consensus 217 -------~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~~----~~~ 258 (258)
T cd05578 217 -------ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKNH----PYF 258 (258)
T ss_pred -------ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhcC----CCC
Confidence 0011222235789999999999999999999 666654 876
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=318.70 Aligned_cols=255 Identities=28% Similarity=0.382 Sum_probs=190.4
Q ss_pred ccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCcc-CHHHHHHHHHHHhCCCCCceeeEEEEEEeCCeeEEE
Q 011851 127 CLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQ-GHKEWLAEVNYLGGLIHPNLVKLIGCCIEDDQRLLV 205 (476)
Q Consensus 127 ~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV 205 (476)
+.||+|+||.||+|..... .....+|+|.+...... ....+.+|+.+++.++|+||+++++++.+....|||
T Consensus 1 ~~lg~G~fg~v~~~~~~~~-------~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv 73 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRG-------MSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLV 73 (269)
T ss_pred CcCCccCCceEEEEEEecC-------CCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEE
Confidence 3599999999999965321 24456899987654322 234678899999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhcC----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCcCCC
Q 011851 206 YEFMPRGSLENHLFRRS----LPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDG 281 (476)
Q Consensus 206 ~E~~~~g~L~~~l~~~~----~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~ 281 (476)
|||+++|+|.+++.... ...++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++...
T Consensus 74 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~ 150 (269)
T cd05042 74 LEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQ 150 (269)
T ss_pred EEeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEecccccccc
Confidence 99999999999996542 23467888999999999999999988 999999999999999999999999998754
Q ss_pred CCCCccceeeeeecCCCCCCcchhhc-------CCCCccchhhhhHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhhc
Q 011851 282 PEGDKTHVSTRVMGTYGYAAPEYVMT-------GHLTAKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPQLG 353 (476)
Q Consensus 282 ~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwslGv~l~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~ 353 (476)
.............++..|+|||++.. ..++.++|||||||++|||++ |..||....... ..... ..
T Consensus 151 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~---~~~~~---~~ 224 (269)
T cd05042 151 YPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQ---VLKQV---VR 224 (269)
T ss_pred ccchheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHH---HHHHH---hh
Confidence 33221111222346778999998753 356889999999999999999 788886543211 11000 00
Q ss_pred cccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 011851 354 ERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALK 404 (476)
Q Consensus 354 ~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~ 404 (476)
. ....+..+.+ +...+..+.+++..|| .||++|||+.+|++.|.
T Consensus 225 ~--~~~~~~~~~~----~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 225 E--QDIKLPKPQL----DLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred c--cCccCCCCcc----cccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 0 0011111211 2223567788999998 59999999999999763
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-40 Score=315.33 Aligned_cols=252 Identities=26% Similarity=0.373 Sum_probs=204.5
Q ss_pred CCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCc--cCHHHHHHHHHHHhCCCCCceeeEEEEEEeC
Q 011851 122 SFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL--QGHKEWLAEVNYLGGLIHPNLVKLIGCCIED 199 (476)
Q Consensus 122 ~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~ 199 (476)
+|++.+.||+|+||.||+|.+. .+++.+|+|.+..... ...+.+.+|+++|+.++||||+++++.+..+
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~---------~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~ 71 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRK---------ADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLED 71 (256)
T ss_pred CceEEEEecccCceEEEEEEEc---------CCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecC
Confidence 4888999999999999998654 3678899999876533 2345788999999999999999999999999
Q ss_pred CeeEEEEEecCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCC-CceEEeecCC
Q 011851 200 DQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGE-YNAKLSDFGL 277 (476)
Q Consensus 200 ~~~~lV~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~-~~vkl~DFG~ 277 (476)
+..++||||+++++|.+++... ...+++..+..++.|++.+|.|||+++ |+|+||||+||+++.+ +.+||+|||+
T Consensus 72 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~ 148 (256)
T cd08220 72 KALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGI 148 (256)
T ss_pred CEEEEEEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCC
Confidence 9999999999999999999764 345899999999999999999999988 9999999999999855 4689999999
Q ss_pred cCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhccccc
Q 011851 278 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRR 357 (476)
Q Consensus 278 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 357 (476)
+........ .....|+..|+|||.+.+..++.++||||||+++|+|++|+.||........ ..... . ..
T Consensus 149 ~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~---~~~~~---~--~~ 217 (256)
T cd08220 149 SKILSSKSK---AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPAL---VLKIM---S--GT 217 (256)
T ss_pred ceecCCCcc---ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHH---HHHHH---h--cC
Confidence 987543221 2235689999999999988899999999999999999999999975433211 11000 0 00
Q ss_pred cccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCc
Q 011851 358 FYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYL 409 (476)
Q Consensus 358 ~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~ 409 (476)
..+ .....+.++.+++.+||..||++|||+.+++++ ||+
T Consensus 218 ----~~~-----~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~----p~~ 256 (256)
T cd08220 218 ----FAP-----ISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ----PIC 256 (256)
T ss_pred ----CCC-----CCCCcCHHHHHHHHHHccCChhhCCCHHHHhhC----CCC
Confidence 000 111235688999999999999999999999997 664
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=320.18 Aligned_cols=257 Identities=26% Similarity=0.396 Sum_probs=203.2
Q ss_pred cCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCC-ccCHHHHHHHHHHHhCCCCCceeeEEEEEEeC
Q 011851 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDG-LQGHKEWLAEVNYLGGLIHPNLVKLIGCCIED 199 (476)
Q Consensus 121 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~ 199 (476)
.+|.+.++||+|+||.||+|.+.... .+...||||...... ....+.+.+|+.++++++||||+++++++.+
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~------~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~- 78 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPE------NEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE- 78 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCC------CCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-
Confidence 45888999999999999999865321 234569999987654 2334578899999999999999999998865
Q ss_pred CeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCcC
Q 011851 200 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAK 279 (476)
Q Consensus 200 ~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~ 279 (476)
+..|+||||+++++|.+++......+++..++.++.|++.||+|||+.+ ++||||||+|||++.++.++|+|||+++
T Consensus 79 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~ 155 (270)
T cd05056 79 NPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSR 155 (270)
T ss_pred CCcEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceee
Confidence 5678999999999999999765557899999999999999999999988 9999999999999999999999999998
Q ss_pred CCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhhcccccc
Q 011851 280 DGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPQLGERRRF 358 (476)
Q Consensus 280 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 358 (476)
....... ...+...++..|+|||.+....++.++|||||||++|||++ |..||...........+. .....
T Consensus 156 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~-------~~~~~ 227 (270)
T cd05056 156 YLEDESY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIE-------NGERL 227 (270)
T ss_pred ecccccc-eecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH-------cCCcC
Confidence 6543321 11122334568999999988889999999999999999996 999997554321111110 00000
Q ss_pred ccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 011851 359 YRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKP 405 (476)
Q Consensus 359 ~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~ 405 (476)
+ .+...+..+.+++.+||..+|++|||+.++++.|+.
T Consensus 228 -----~-----~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~ 264 (270)
T cd05056 228 -----P-----MPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSD 264 (270)
T ss_pred -----C-----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 0 111225689999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=322.84 Aligned_cols=270 Identities=26% Similarity=0.367 Sum_probs=204.9
Q ss_pred cCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccC--HHHHHHHHHHHhCCCCCceeeEEEEEEe
Q 011851 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQG--HKEWLAEVNYLGGLIHPNLVKLIGCCIE 198 (476)
Q Consensus 121 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~--~~~~~~E~~~l~~l~hpnIv~l~~~~~~ 198 (476)
++|++.+.||.|+||.||+|.+. .+++.||+|.++...... ...+.+|+.++++++||||+++++++..
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~---------~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~ 75 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDK---------KTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVG 75 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEEC---------CCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEe
Confidence 46889999999999999998764 367789999997543322 2356789999999999999999999988
Q ss_pred C--CeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecC
Q 011851 199 D--DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFG 276 (476)
Q Consensus 199 ~--~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG 276 (476)
. +..||||||++ ++|.+++......+++..++.++.||+.||.|||+.+ |+|+||||+|||++.++.+||+|||
T Consensus 76 ~~~~~~~lv~e~~~-~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g 151 (293)
T cd07843 76 SNLDKIYMVMEYVE-HDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFG 151 (293)
T ss_pred cCCCcEEEEehhcC-cCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecC
Confidence 7 89999999996 5999988766667999999999999999999999988 9999999999999999999999999
Q ss_pred CcCCCCCCCccceeeeeecCCCCCCcchhhcC-CCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhH-Hhhh-----
Q 011851 277 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV-EWAR----- 349 (476)
Q Consensus 277 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~-~~~~----- 349 (476)
++........ ......+++.|+|||++.+. .++.++||||||+++|+|++|..||...........+ ....
T Consensus 152 ~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~ 229 (293)
T cd07843 152 LAREYGSPLK--PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEK 229 (293)
T ss_pred ceeeccCCcc--ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchH
Confidence 9987544321 12234678899999988765 4689999999999999999999999754332111100 0000
Q ss_pred --h---hhc--cccccccccCcccCCCCChH-HHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCc
Q 011851 350 --P---QLG--ERRRFYRLIDPCLEGCFSIK-GAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYL 409 (476)
Q Consensus 350 --~---~~~--~~~~~~~~~d~~l~~~~~~~-~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~ 409 (476)
+ .+. ............+...++.. .++.+.+||.+||+.||++|||+.|++++ +||
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~----~~f 293 (293)
T cd07843 230 IWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH----PYF 293 (293)
T ss_pred HHHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC----CCC
Confidence 0 000 00000000011111222222 36778999999999999999999999997 775
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-40 Score=322.88 Aligned_cols=258 Identities=26% Similarity=0.362 Sum_probs=210.1
Q ss_pred cCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCCCCCceeeEEEEEEeCC
Q 011851 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHPNLVKLIGCCIEDD 200 (476)
Q Consensus 121 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 200 (476)
.+|.+.+.||+|+||.||++... .++..||+|.+........+.+.+|+.+++.++||||+++++++...+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~---------~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~ 89 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDV---------ATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGD 89 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEc---------CCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCC
Confidence 57999999999999999998653 357789999987655555567889999999999999999999999999
Q ss_pred eeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCcCC
Q 011851 201 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKD 280 (476)
Q Consensus 201 ~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~ 280 (476)
..|+|+||+++++|.+++.+. .+++..+..++.|++.||.|||+++ ++||||||+||+++.++.++|+|||++..
T Consensus 90 ~~~lv~e~~~~~~L~~~~~~~--~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~ 164 (293)
T cd06647 90 ELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQ 164 (293)
T ss_pred cEEEEEecCCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceec
Confidence 999999999999999998543 4789999999999999999999988 99999999999999999999999999876
Q ss_pred CCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhcccccccc
Q 011851 281 GPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRRFYR 360 (476)
Q Consensus 281 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 360 (476)
...... ......|++.|+|||++....++.++|||||||++|+|++|+.||............. .
T Consensus 165 ~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~--~----------- 229 (293)
T cd06647 165 ITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA--T----------- 229 (293)
T ss_pred cccccc--ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehh--c-----------
Confidence 543222 1223568899999999988889999999999999999999999997654322111100 0
Q ss_pred ccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCccccc
Q 011851 361 LIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDMA 413 (476)
Q Consensus 361 ~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~~~ 413 (476)
............+..+.++|.+||..+|++||++.+++.| +||+...
T Consensus 230 --~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h----~~~~~~~ 276 (293)
T cd06647 230 --NGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH----PFLKIAK 276 (293)
T ss_pred --CCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC----HHHhcCc
Confidence 0000000111235678899999999999999999999997 8988655
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=314.00 Aligned_cols=281 Identities=22% Similarity=0.312 Sum_probs=207.0
Q ss_pred ccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCcc--CHHHHHHHHHHHhCCCCCceeeEEEEEE
Q 011851 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQ--GHKEWLAEVNYLGGLIHPNLVKLIGCCI 197 (476)
Q Consensus 120 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~l~~~~~ 197 (476)
...|+.+..||+|+||.||+|.....+. ...+.+|||.++.+... -.....+|+.+++.|+||||+.|..+|.
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~-----kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl 97 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTND-----KRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFL 97 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCc-----ccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHh
Confidence 3469999999999999999995432211 11347999999765322 1245678999999999999999999988
Q ss_pred e-CCeeEEEEEecCCCCHHHHHhh----cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCC----C
Q 011851 198 E-DDQRLLVYEFMPRGSLENHLFR----RSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGE----Y 268 (476)
Q Consensus 198 ~-~~~~~lV~E~~~~g~L~~~l~~----~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~----~ 268 (476)
. +..++|++||.+. +|...|.- ....++...+..|++||+.|+.|||++- |+||||||.|||+..+ |
T Consensus 98 ~~d~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG 173 (438)
T KOG0666|consen 98 SHDKKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERG 173 (438)
T ss_pred ccCceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccC
Confidence 7 8899999999976 88888852 2346899999999999999999999999 9999999999999888 8
Q ss_pred ceEEeecCCcCCCCCCCccc-eeeeeecCCCCCCcchhhcC-CCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcch---
Q 011851 269 NAKLSDFGLAKDGPEGDKTH-VSTRVMGTYGYAAPEYVMTG-HLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHN--- 343 (476)
Q Consensus 269 ~vkl~DFG~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~--- 343 (476)
.|||+|||+++.+.+.-... ....++-|.+|+|||++.+. .|+.+.||||+|||+.||+|-.+.|.+........
T Consensus 174 ~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pf 253 (438)
T KOG0666|consen 174 RVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPF 253 (438)
T ss_pred eeEeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCc
Confidence 99999999999875543322 23347789999999999986 79999999999999999999999887543321111
Q ss_pred ---hHHhh-----hhhhccccc---cccc-----------cCcc-cCCCCChH--HHHHHHHHHHHhcccCCCCCCCHHH
Q 011851 344 ---LVEWA-----RPQLGERRR---FYRL-----------IDPC-LEGCFSIK--GAEKTIQLAASCLNRDQKARPRMSE 398 (476)
Q Consensus 344 ---~~~~~-----~~~~~~~~~---~~~~-----------~d~~-l~~~~~~~--~~~~~~~li~~cL~~dP~~RPt~~e 398 (476)
.+... .+....+.. +.+. .+.+ |..++... .++...+|+.++|..||.+|.|+++
T Consensus 254 q~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~q 333 (438)
T KOG0666|consen 254 QHDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQ 333 (438)
T ss_pred hHHHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHH
Confidence 11100 011001100 0000 0110 10000000 1334889999999999999999999
Q ss_pred HHHHhcCCCCccccc
Q 011851 399 VVEALKPLPYLKDMA 413 (476)
Q Consensus 399 ll~~L~~~~~~~~~~ 413 (476)
.+++ +||....
T Consensus 334 Aleh----~yF~~d~ 344 (438)
T KOG0666|consen 334 ALEH----PYFTEDP 344 (438)
T ss_pred Hhcc----cccccCC
Confidence 9998 7777654
|
|
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=316.63 Aligned_cols=253 Identities=25% Similarity=0.344 Sum_probs=204.1
Q ss_pred CCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCcc--CHHHHHHHHHHHhCCCCCceeeEEEEEEe-
Q 011851 122 SFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQ--GHKEWLAEVNYLGGLIHPNLVKLIGCCIE- 198 (476)
Q Consensus 122 ~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~l~~~~~~- 198 (476)
+|++.+.||.|+||.||+|.+. .+++.||+|++...... ..+++..|++++++++|+||+++++++..
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~---------~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 71 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRK---------SDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDR 71 (265)
T ss_pred CceeeeeeccCCCeEEEEeeec---------CCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecC
Confidence 4788899999999999998654 46778999998754432 23567889999999999999999998764
Q ss_pred -CCeeEEEEEecCCCCHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHHH-----hcCCCCeEecCCCCCCeeecCCCc
Q 011851 199 -DDQRLLVYEFMPRGSLENHLFRR---SLPLPWSIRMKIALDAAKGLAFLH-----EEAEKPVIYRDFKTSNILLDGEYN 269 (476)
Q Consensus 199 -~~~~~lV~E~~~~g~L~~~l~~~---~~~l~~~~~~~i~~qi~~al~~lH-----~~~~~~ivHrDlKp~NILl~~~~~ 269 (476)
+...|++|||+++++|.+++... ...+++..++.++.||+.||.||| +.+ |+|+||||+||+++.++.
T Consensus 72 ~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~---i~h~dl~p~nili~~~~~ 148 (265)
T cd08217 72 SNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNT---VLHRDLKPANIFLDANNN 148 (265)
T ss_pred CCCEEEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCc---ceecCCCHHHEEEecCCC
Confidence 45689999999999999998653 567999999999999999999999 655 999999999999999999
Q ss_pred eEEeecCCcCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhh
Q 011851 270 AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR 349 (476)
Q Consensus 270 vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~ 349 (476)
+||+|||++........ ......|++.|+|||++.+..++.++|+||||+++|+|++|+.||...... .+.....
T Consensus 149 ~kl~d~g~~~~~~~~~~--~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~~~~~ 223 (265)
T cd08217 149 VKLGDFGLAKILGHDSS--FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQL---QLASKIK 223 (265)
T ss_pred EEEecccccccccCCcc--cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHH---HHHHHHh
Confidence 99999999987644322 122357899999999999888999999999999999999999999764311 1111100
Q ss_pred hhhccccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCc
Q 011851 350 PQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYL 409 (476)
Q Consensus 350 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~ 409 (476)
. . ....++...+.++.+++.+||+.+|++||++.+|+++ ||+
T Consensus 224 ----~-~---------~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~----~~~ 265 (265)
T cd08217 224 ----E-G---------KFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL----PLI 265 (265)
T ss_pred ----c-C---------CCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC----CCC
Confidence 0 0 0011222336789999999999999999999999997 764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=320.88 Aligned_cols=250 Identities=26% Similarity=0.369 Sum_probs=195.0
Q ss_pred cccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccC---HHHHHHHHH---HHhCCCCCceeeEEEEEEeCCe
Q 011851 128 LLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQG---HKEWLAEVN---YLGGLIHPNLVKLIGCCIEDDQ 201 (476)
Q Consensus 128 ~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~---~~~~~~E~~---~l~~l~hpnIv~l~~~~~~~~~ 201 (476)
+||+|+||.||++.+. .+++.||+|.+....... ...+.+|.. ++...+||||+.+++++..++.
T Consensus 1 ~lg~G~~g~Vy~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 71 (279)
T cd05633 1 IIGRGGFGEVYGCRKA---------DTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDK 71 (279)
T ss_pred CcccCCCeEEEEEEEC---------CCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCe
Confidence 4899999999998654 467889999987643321 122344443 3444579999999999999999
Q ss_pred eEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCcCCC
Q 011851 202 RLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDG 281 (476)
Q Consensus 202 ~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~ 281 (476)
.++||||+++++|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.++|+|||++...
T Consensus 72 ~~lv~e~~~~~~L~~~i~~~-~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~ 147 (279)
T cd05633 72 LCFILDLMNGGDLHYHLSQH-GVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDF 147 (279)
T ss_pred EEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceec
Confidence 99999999999999988544 56999999999999999999999988 999999999999999999999999998754
Q ss_pred CCCCccceeeeeecCCCCCCcchhhc-CCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhcccccccc
Q 011851 282 PEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRRFYR 360 (476)
Q Consensus 282 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 360 (476)
.... .....||..|+|||.+.+ ..++.++|||||||++|+|++|..||..........+... ...
T Consensus 148 ~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~---~~~------- 213 (279)
T cd05633 148 SKKK----PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM---TLT------- 213 (279)
T ss_pred cccC----ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHH---hhc-------
Confidence 3321 123468999999998874 5689999999999999999999999976543221111110 000
Q ss_pred ccCcccCCCCChHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHhcCCCCccccc
Q 011851 361 LIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARP-----RMSEVVEALKPLPYLKDMA 413 (476)
Q Consensus 361 ~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RP-----t~~ell~~L~~~~~~~~~~ 413 (476)
... .++...+.++.++|.+||+.||++|| ++.++++| |||++..
T Consensus 214 -~~~----~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h----~~~~~~~ 262 (279)
T cd05633 214 -VNV----ELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH----VFFKGID 262 (279)
T ss_pred -CCc----CCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC----ccccCCC
Confidence 000 11222367889999999999999999 59988887 9999865
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-40 Score=314.20 Aligned_cols=255 Identities=34% Similarity=0.505 Sum_probs=203.7
Q ss_pred CCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCcc-CHHHHHHHHHHHhCCCCCceeeEEEEEEeCCe
Q 011851 123 FRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQ-GHKEWLAEVNYLGGLIHPNLVKLIGCCIEDDQ 201 (476)
Q Consensus 123 y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~ 201 (476)
+.+.+.||.|+||.||+|.+...+. .++..||+|++...... ..+.+..|+.+++.++|+||+++++++.+.+.
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 75 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSG-----EKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEP 75 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCC-----CCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCe
Confidence 3567889999999999998764321 24588999999766543 45678899999999999999999999999999
Q ss_pred eEEEEEecCCCCHHHHHhhcCCC-CCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCcCC
Q 011851 202 RLLVYEFMPRGSLENHLFRRSLP-LPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKD 280 (476)
Q Consensus 202 ~~lV~E~~~~g~L~~~l~~~~~~-l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~ 280 (476)
.|++|||+++++|.+++...... +++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++..
T Consensus 76 ~~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~ 152 (258)
T smart00219 76 LMIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRD 152 (258)
T ss_pred eEEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCcee
Confidence 99999999999999999654433 899999999999999999999988 99999999999999999999999999987
Q ss_pred CCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhhccccccc
Q 011851 281 GPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPQLGERRRFY 359 (476)
Q Consensus 281 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 359 (476)
......... ....+++.|+|||.+.+..++.++|||||||++|+|++ |..||...... ....... ....
T Consensus 153 ~~~~~~~~~-~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~---~~~~~~~----~~~~-- 222 (258)
T smart00219 153 LYDDDYYKK-KGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNE---EVLEYLK----KGYR-- 222 (258)
T ss_pred ccccccccc-ccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHHh----cCCC--
Confidence 654322211 12336789999999988889999999999999999998 78888653221 1111100 0000
Q ss_pred cccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011851 360 RLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEAL 403 (476)
Q Consensus 360 ~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L 403 (476)
. ......+.++.+++.+||..||++|||+.++++.|
T Consensus 223 -~-------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 223 -L-------PKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred -C-------CCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 0 01111367899999999999999999999999864
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-40 Score=318.52 Aligned_cols=260 Identities=26% Similarity=0.404 Sum_probs=208.6
Q ss_pred CCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCc-cCHHHHHHHHHHHhCCCCCceeeEEEEEEeCC
Q 011851 122 SFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL-QGHKEWLAEVNYLGGLIHPNLVKLIGCCIEDD 200 (476)
Q Consensus 122 ~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 200 (476)
-|++.+.||+|+||.||+|.+. .+++.||||++..... ...+.+.+|+.++++++||||+++++++..++
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 75 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDN---------RTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDT 75 (277)
T ss_pred hhhhheeEeecCCeEEEEEEEC---------CCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCC
Confidence 3778899999999999998654 3577899999865433 23456888999999999999999999999999
Q ss_pred eeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCcCC
Q 011851 201 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKD 280 (476)
Q Consensus 201 ~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~ 280 (476)
..|+||||+++++|.+++.. ..+++..+..++.|++.+|.|||+.+ ++|+||||+||+++.++.++|+|||++..
T Consensus 76 ~~~lv~e~~~~~~l~~~i~~--~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~ 150 (277)
T cd06641 76 KLWIIMEYLGGGSALDLLEP--GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQ 150 (277)
T ss_pred eEEEEEEeCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeeccccee
Confidence 99999999999999998853 36899999999999999999999988 99999999999999999999999999876
Q ss_pred CCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhcccccccc
Q 011851 281 GPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRRFYR 360 (476)
Q Consensus 281 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 360 (476)
...... ......|+..|+|||.+.+..++.++|+|||||++|+|++|..||........ ... +....
T Consensus 151 ~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~---~~~----~~~~~---- 217 (277)
T cd06641 151 LTDTQI--KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKV---LFL----IPKNN---- 217 (277)
T ss_pred cccchh--hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHH---HHH----HhcCC----
Confidence 543221 12235688999999999888899999999999999999999999965432111 110 00000
Q ss_pred ccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCcccccCcchH
Q 011851 361 LIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDMASSSSY 418 (476)
Q Consensus 361 ~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~~~~~~~~ 418 (476)
.+ .+....+.++.+++.+||+.+|++||++.++++| ||+........+
T Consensus 218 --~~----~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~----~~~~~~~~~~~~ 265 (277)
T cd06641 218 --PP----TLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH----KFIVRFAKKTSY 265 (277)
T ss_pred --CC----CCCcccCHHHHHHHHHHccCChhhCcCHHHHHhC----HHHhhhhhccch
Confidence 00 0112235678899999999999999999999997 888876554433
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-40 Score=321.27 Aligned_cols=257 Identities=26% Similarity=0.382 Sum_probs=207.7
Q ss_pred CCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCCCCCceeeEEEEEEeCCee
Q 011851 123 FRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHPNLVKLIGCCIEDDQR 202 (476)
Q Consensus 123 y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~ 202 (476)
|...+.||+|+||.||++.+. .+++.+++|.+........+.+.+|+.+++.++||||+++++++...+..
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~---------~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~ 91 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDK---------STGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDEL 91 (285)
T ss_pred hhcceEeccCCCeEEEEEEEC---------CCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeE
Confidence 555678999999999998654 36778999998765555556788999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCcCCCC
Q 011851 203 LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGP 282 (476)
Q Consensus 203 ~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~ 282 (476)
++|+||+++++|.+++.. ..+++..+..++.|++.||.|||+++ |+||||+|+||+++.++.++|+|||++....
T Consensus 92 ~~v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~ 166 (285)
T cd06648 92 WVVMEFLEGGALTDIVTH--TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVS 166 (285)
T ss_pred EEEEeccCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhc
Confidence 999999999999999865 46899999999999999999999988 9999999999999999999999999887543
Q ss_pred CCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhcccccccccc
Q 011851 283 EGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRRFYRLI 362 (476)
Q Consensus 283 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 362 (476)
.... ......|++.|+|||++.+..++.++|||||||++|+|++|+.||....+.... ...... .
T Consensus 167 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~---~~~~~~----------~ 231 (285)
T cd06648 167 KEVP--RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAM---KRIRDN----------L 231 (285)
T ss_pred cCCc--ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHH---HHHHhc----------C
Confidence 3211 122356899999999999889999999999999999999999999754321111 100000 0
Q ss_pred CcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCcccccC
Q 011851 363 DPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDMAS 414 (476)
Q Consensus 363 d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~~~~ 414 (476)
.+.+.. ....+..+.+++.+||+.+|++||++.+++++ +|++....
T Consensus 232 ~~~~~~--~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~----~~~~~~~~ 277 (285)
T cd06648 232 PPKLKN--LHKVSPRLRSFLDRMLVRDPAQRATAAELLNH----PFLAKAGP 277 (285)
T ss_pred CCCCcc--cccCCHHHHHHHHHHcccChhhCcCHHHHccC----cccccCCC
Confidence 000100 11135689999999999999999999999987 99887654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-40 Score=318.29 Aligned_cols=250 Identities=27% Similarity=0.433 Sum_probs=193.7
Q ss_pred ccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCc-cCHHHHHHHHHHHhCC-CCCceeeEEEEEEeCCeeEE
Q 011851 127 CLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL-QGHKEWLAEVNYLGGL-IHPNLVKLIGCCIEDDQRLL 204 (476)
Q Consensus 127 ~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~-~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~l 204 (476)
+.||+|+||.||+|.+..++ ....+|+|.+..... ...+.+.+|++++.++ +||||+++++++...+..|+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~-------~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~l 73 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDG-------LRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 73 (270)
T ss_pred CcCCCCCCceEEEEEEcCCC-------CeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceE
Confidence 36899999999999775322 123578898875332 2345688899999999 79999999999999999999
Q ss_pred EEEecCCCCHHHHHhhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCc
Q 011851 205 VYEFMPRGSLENHLFRRS---------------LPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYN 269 (476)
Q Consensus 205 V~E~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~ 269 (476)
||||+++++|.+++.... ..+++..+..++.|++.||+|||+.+ ++||||||+|||++.++.
T Consensus 74 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~ 150 (270)
T cd05047 74 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYV 150 (270)
T ss_pred EEEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCe
Confidence 999999999999986432 24789999999999999999999988 999999999999999999
Q ss_pred eEEeecCCcCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHh-CCCCCCCCCCCCcchhHHhh
Q 011851 270 AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWA 348 (476)
Q Consensus 270 vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~ellt-G~~pf~~~~~~~~~~~~~~~ 348 (476)
+||+|||++....... .......+..|+|||++....++.++|||||||++|||++ |..||....... .....
T Consensus 151 ~kl~dfgl~~~~~~~~---~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~---~~~~~ 224 (270)
T cd05047 151 AKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE---LYEKL 224 (270)
T ss_pred EEECCCCCccccchhh---hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHH---HHHHH
Confidence 9999999986422111 1111233567999999988899999999999999999997 999996543211 11110
Q ss_pred hhhhccccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011851 349 RPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPL 406 (476)
Q Consensus 349 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~ 406 (476)
...... ......+.++.+|+.+||+.||.+|||+.++++.|..+
T Consensus 225 ----~~~~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~ 268 (270)
T cd05047 225 ----PQGYRL----------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 268 (270)
T ss_pred ----hCCCCC----------CCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHh
Confidence 000000 01112256788999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=325.90 Aligned_cols=274 Identities=27% Similarity=0.332 Sum_probs=205.1
Q ss_pred ccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccC--HHHHHHHHHHHhCCCCCceeeEEEEEE
Q 011851 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQG--HKEWLAEVNYLGGLIHPNLVKLIGCCI 197 (476)
Q Consensus 120 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~--~~~~~~E~~~l~~l~hpnIv~l~~~~~ 197 (476)
.++|++.+.||+|+||.||+|.+. .+|+.||+|.++...... ...+.+|+.++++++|+||+++++++.
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 76 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDT---------TSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVV 76 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEEC---------CCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEe
Confidence 457999999999999999998654 468889999987543222 234668999999999999999999987
Q ss_pred eC--CeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeec
Q 011851 198 ED--DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDF 275 (476)
Q Consensus 198 ~~--~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DF 275 (476)
+. +.+++||||+. ++|.+++......+++..++.++.||+.||.|||+.+ |+||||||+||+++.++.+||+||
T Consensus 77 ~~~~~~~~lv~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~df 152 (309)
T cd07845 77 GKHLDSIFLVMEYCE-QDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADF 152 (309)
T ss_pred cCCCCeEEEEEecCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcc
Confidence 65 56899999996 5898888765677999999999999999999999988 999999999999999999999999
Q ss_pred CCcCCCCCCCccceeeeeecCCCCCCcchhhc-CCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhh-hhhhc
Q 011851 276 GLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA-RPQLG 353 (476)
Q Consensus 276 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~-~~~~~ 353 (476)
|++......... .....+++.|+|||++.+ ..++.++|||||||++|||++|+.||...........+... .....
T Consensus 153 g~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~ 230 (309)
T cd07845 153 GLARTYGLPAKP--MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNE 230 (309)
T ss_pred ceeeecCCccCC--CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence 999875432211 122346888999999876 46899999999999999999999999765432221111100 00000
Q ss_pred ccc-ccc-----ccc--CcccCCCCC---hHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCcccc
Q 011851 354 ERR-RFY-----RLI--DPCLEGCFS---IKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDM 412 (476)
Q Consensus 354 ~~~-~~~-----~~~--d~~l~~~~~---~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~~ 412 (476)
... .+. ..+ .......+. ...+.++.+||.+||+.||++|||+.++++| |||++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h----~~f~~~ 296 (309)
T cd07845 231 SIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES----SYFKEK 296 (309)
T ss_pred hhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC----hhhccC
Confidence 000 000 000 000000000 0125678899999999999999999999987 998754
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-40 Score=324.53 Aligned_cols=273 Identities=24% Similarity=0.341 Sum_probs=202.7
Q ss_pred CCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCC---ccCHHHHHHHHHHHhCCCCCceeeEEEEEEe
Q 011851 122 SFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDG---LQGHKEWLAEVNYLGGLIHPNLVKLIGCCIE 198 (476)
Q Consensus 122 ~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~ 198 (476)
+|++.+.||+|+||.||+|.+... .+++.||+|.+.... ....+.+.+|+.++++++||||+++++++.+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~-------~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 73 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNG-------KDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLE 73 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCC-------CCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeC
Confidence 488889999999999999976531 267889999998743 2334567889999999999999999999998
Q ss_pred C--CeeEEEEEecCCCCHHHHHhhc----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecC----CC
Q 011851 199 D--DQRLLVYEFMPRGSLENHLFRR----SLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDG----EY 268 (476)
Q Consensus 199 ~--~~~~lV~E~~~~g~L~~~l~~~----~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~----~~ 268 (476)
. ..+||||||+++ +|.+.+... ...+++..++.++.||+.||.|||+.+ |+||||||+|||++. ++
T Consensus 74 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~ 149 (316)
T cd07842 74 HADKSVYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERG 149 (316)
T ss_pred CCCceEEEEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccc
Confidence 8 889999999964 777766432 236899999999999999999999988 999999999999999 89
Q ss_pred ceEEeecCCcCCCCCCCc-cceeeeeecCCCCCCcchhhcC-CCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcc----
Q 011851 269 NAKLSDFGLAKDGPEGDK-THVSTRVMGTYGYAAPEYVMTG-HLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEH---- 342 (476)
Q Consensus 269 ~vkl~DFG~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~---- 342 (476)
.+||+|||++........ ........++..|+|||++.+. .++.++|||||||++|+|++|+.||.........
T Consensus 150 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~ 229 (316)
T cd07842 150 VVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPF 229 (316)
T ss_pred eEEECCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchh
Confidence 999999999986543222 1112235789999999988764 6889999999999999999999999765443210
Q ss_pred ---hhHHhhh----------hhhccccccccccC---------cccCCCCCh--HHHHHHHHHHHHhcccCCCCCCCHHH
Q 011851 343 ---NLVEWAR----------PQLGERRRFYRLID---------PCLEGCFSI--KGAEKTIQLAASCLNRDQKARPRMSE 398 (476)
Q Consensus 343 ---~~~~~~~----------~~~~~~~~~~~~~d---------~~l~~~~~~--~~~~~~~~li~~cL~~dP~~RPt~~e 398 (476)
.+..... ........+....+ ..+...+.. ..+.++.+++.+||+.||++|||+.+
T Consensus 230 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~e 309 (316)
T cd07842 230 QRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEE 309 (316)
T ss_pred HHHHHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHH
Confidence 0000000 00000000000000 000000000 23467899999999999999999999
Q ss_pred HHHHhcCCCCc
Q 011851 399 VVEALKPLPYL 409 (476)
Q Consensus 399 ll~~L~~~~~~ 409 (476)
+++| |||
T Consensus 310 il~~----~~f 316 (316)
T cd07842 310 ALEH----PYF 316 (316)
T ss_pred HhcC----CCC
Confidence 9997 886
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-40 Score=314.01 Aligned_cols=248 Identities=25% Similarity=0.448 Sum_probs=194.8
Q ss_pred ccccccCCccEEEEEEccCCce-eeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCCCCCceeeEEEEEEeCCeeEEE
Q 011851 127 CLLGEGGFGCVYKGWINMNGTA-TVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHPNLVKLIGCCIEDDQRLLV 205 (476)
Q Consensus 127 ~~LG~G~fg~Vy~a~~~~~~~~-~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV 205 (476)
+.||+|+||.||+|.+...... .........+++|++...... ...+.+|+.+|++++||||+++++++.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 4699999999999988643311 001122346888887655433 5778899999999999999999999988 788999
Q ss_pred EEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCC-------ceEEeecCCc
Q 011851 206 YEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEY-------NAKLSDFGLA 278 (476)
Q Consensus 206 ~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~-------~vkl~DFG~a 278 (476)
|||+++++|.+++......+++..+..++.||+.||.|||+++ |+||||||+|||++.++ .+||+|||++
T Consensus 79 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a 155 (259)
T cd05037 79 EEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP 155 (259)
T ss_pred EEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCCCcc
Confidence 9999999999999766557999999999999999999999988 99999999999999887 7999999999
Q ss_pred CCCCCCCccceeeeeecCCCCCCcchhhcC--CCCccchhhhhHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhhccc
Q 011851 279 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTG--HLTAKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPQLGER 355 (476)
Q Consensus 279 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslGv~l~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~ 355 (476)
..... .....++..|+|||++.+. .++.++|||||||++|||++ |..||............. ..
T Consensus 156 ~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~-------~~ 222 (259)
T cd05037 156 ITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQ-------DQ 222 (259)
T ss_pred ccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHh-------cC
Confidence 86533 1124567789999999876 78999999999999999999 577776543221111100 00
Q ss_pred cccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 011851 356 RRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALK 404 (476)
Q Consensus 356 ~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~ 404 (476)
. . .+......+.+++.+||..+|.+|||+.++++.|.
T Consensus 223 ~---~---------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 223 H---R---------LPMPDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred C---C---------CCCCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 0 0 00111268889999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-40 Score=315.37 Aligned_cols=253 Identities=29% Similarity=0.430 Sum_probs=201.5
Q ss_pred ccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCCCCCceeeEEEEEEeC
Q 011851 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHPNLVKLIGCCIED 199 (476)
Q Consensus 120 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~ 199 (476)
..+|++.+.||+|+||.||+|.+. .+..+|+|.+.... .....+.+|+.++++++|+||+++++++.+
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~----------~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~- 72 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYN----------KHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK- 72 (260)
T ss_pred ccceeEEeEecCccceEEEEEEec----------CCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-
Confidence 357999999999999999998654 34459999887543 234578899999999999999999999887
Q ss_pred CeeEEEEEecCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCc
Q 011851 200 DQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLA 278 (476)
Q Consensus 200 ~~~~lV~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a 278 (476)
...++||||+++++|.+++.+. ...+++..++.++.||+.||.|||+.+ ++||||||+||+++.++.+||+|||++
T Consensus 73 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~ 149 (260)
T cd05073 73 EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLA 149 (260)
T ss_pred CCeEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcce
Confidence 7889999999999999999653 456788999999999999999999988 999999999999999999999999999
Q ss_pred CCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhhccccc
Q 011851 279 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPQLGERRR 357 (476)
Q Consensus 279 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 357 (476)
......... ......++..|+|||++....++.++|||||||++|+|++ |+.||....... ...... ....
T Consensus 150 ~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~---~~~~~~----~~~~ 221 (260)
T cd05073 150 RVIEDNEYT-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE---VIRALE----RGYR 221 (260)
T ss_pred eeccCCCcc-cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHH---HHHHHh----CCCC
Confidence 765432221 1122345677999999998889999999999999999999 999997543211 111110 0000
Q ss_pred cccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 011851 358 FYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKP 405 (476)
Q Consensus 358 ~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~ 405 (476)
.+ .....+.++.+++.+||+.||++||++.++++.|+.
T Consensus 222 -----~~-----~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 222 -----MP-----RPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred -----CC-----CcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 00 011225689999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-40 Score=321.12 Aligned_cols=266 Identities=29% Similarity=0.390 Sum_probs=204.6
Q ss_pred CCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCcc-CHHHHHHHHHHHhCCC-CCceeeEEEEEEeC
Q 011851 122 SFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQ-GHKEWLAEVNYLGGLI-HPNLVKLIGCCIED 199 (476)
Q Consensus 122 ~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~-~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~ 199 (476)
+|...+.||+|+||.||++.+. .+++.||+|.+...... ....+.+|+.++.++. |+||+++++++..+
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~ 75 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHK---------PSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFRE 75 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEEC---------CCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecC
Confidence 4666788999999999998654 46788999998754332 3456788999999996 99999999999999
Q ss_pred CeeEEEEEecCCCCHHHHHh---h-cCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeEecCCCCCCeeecCCCceEEee
Q 011851 200 DQRLLVYEFMPRGSLENHLF---R-RSLPLPWSIRMKIALDAAKGLAFLHEE-AEKPVIYRDFKTSNILLDGEYNAKLSD 274 (476)
Q Consensus 200 ~~~~lV~E~~~~g~L~~~l~---~-~~~~l~~~~~~~i~~qi~~al~~lH~~-~~~~ivHrDlKp~NILl~~~~~vkl~D 274 (476)
+..+++|||+. ++|.++.. . ....+++..+..++.|++.||+|||+. + |+||||||+|||++.++.+||+|
T Consensus 76 ~~~~~~~e~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~d 151 (288)
T cd06616 76 GDCWICMELMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCD 151 (288)
T ss_pred CcEEEEEeccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEEee
Confidence 99999999985 46555432 2 246799999999999999999999974 6 99999999999999999999999
Q ss_pred cCCcCCCCCCCccceeeeeecCCCCCCcchhhcC---CCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhh
Q 011851 275 FGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG---HLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQ 351 (476)
Q Consensus 275 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~ 351 (476)
||++........ .....|+..|+|||++.+. .++.++|||||||++|+|++|+.||..... ........
T Consensus 152 fg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-----~~~~~~~~ 223 (288)
T cd06616 152 FGISGQLVDSIA---KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS-----VFDQLTQV 223 (288)
T ss_pred cchhHHhccCCc---cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch-----HHHHHhhh
Confidence 999976433221 1234689999999998876 689999999999999999999999975431 11110000
Q ss_pred hccccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCcccccCcchHH
Q 011851 352 LGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDMASSSSYV 419 (476)
Q Consensus 352 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~~~~~~~~~ 419 (476)
.. ...+.+........+.++.+|+.+||+.||++|||+.+|+++ ||++.........
T Consensus 224 ~~-------~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~----~~~~~~~~~~~~~ 280 (288)
T cd06616 224 VK-------GDPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH----PFIKDYEERNVDV 280 (288)
T ss_pred cC-------CCCCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC----hhhhchhhcchhH
Confidence 00 001111111112346789999999999999999999999998 9998766555443
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=331.37 Aligned_cols=269 Identities=24% Similarity=0.306 Sum_probs=202.9
Q ss_pred hccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCC--ccCHHHHHHHHHHHhCCCCCceeeEEEEE
Q 011851 119 ATKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDG--LQGHKEWLAEVNYLGGLIHPNLVKLIGCC 196 (476)
Q Consensus 119 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~ 196 (476)
..++|++.+.||+|+||.||+|.+. .+|+.||||.+.... ......+.+|+.++++++|+||++++++|
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 84 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDT---------VTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVF 84 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEEC---------CCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeee
Confidence 3568999999999999999998654 467889999986532 22345677899999999999999999998
Q ss_pred EeC------CeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCce
Q 011851 197 IED------DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNA 270 (476)
Q Consensus 197 ~~~------~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~v 270 (476)
... ...|+||||+. ++|.+.+... +++..+..++.|++.||+|||+++ |+||||||+|||++.++.+
T Consensus 85 ~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~---l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~ 157 (353)
T cd07850 85 TPQKSLEEFQDVYLVMELMD-ANLCQVIQMD---LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTL 157 (353)
T ss_pred ccCCCccccCcEEEEEeccC-CCHHHHHhhc---CCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCE
Confidence 644 35799999995 5888877433 889999999999999999999988 9999999999999999999
Q ss_pred EEeecCCcCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhH-H---
Q 011851 271 KLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV-E--- 346 (476)
Q Consensus 271 kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~-~--- 346 (476)
||+|||+++....... .....|+..|+|||++.+..++.++|||||||++|+|++|+.||...+.......+ .
T Consensus 158 kL~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~ 234 (353)
T cd07850 158 KILDFGLARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLG 234 (353)
T ss_pred EEccCccceeCCCCCC---CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcC
Confidence 9999999986543221 22356899999999999999999999999999999999999999754321110000 0
Q ss_pred --------hh----hhhhccc-----cccccccCcccC----CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 011851 347 --------WA----RPQLGER-----RRFYRLIDPCLE----GCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKP 405 (476)
Q Consensus 347 --------~~----~~~~~~~-----~~~~~~~d~~l~----~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~ 405 (476)
.. ....... ..+..++...+. .......+.++.++|.+||+.||++|||+.++|++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~--- 311 (353)
T cd07850 235 TPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH--- 311 (353)
T ss_pred CCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC---
Confidence 00 0000000 000111111100 00011235678999999999999999999999997
Q ss_pred CCCcc
Q 011851 406 LPYLK 410 (476)
Q Consensus 406 ~~~~~ 410 (476)
||++
T Consensus 312 -~~~~ 315 (353)
T cd07850 312 -PYIN 315 (353)
T ss_pred -hhHh
Confidence 8876
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-40 Score=317.62 Aligned_cols=263 Identities=25% Similarity=0.336 Sum_probs=198.8
Q ss_pred CCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCcc-CHHHHHHHHHHHhCCC-CCceeeEEEEEEeC-
Q 011851 123 FRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQ-GHKEWLAEVNYLGGLI-HPNLVKLIGCCIED- 199 (476)
Q Consensus 123 y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~-~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~- 199 (476)
|++.+.||+|+||.||+|.+. .++..||+|+++..... ......+|+.++.++. |+||+++++++.++
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~---------~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 71 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSR---------KTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRK 71 (282)
T ss_pred CceEeeccccccceEEEEEEc---------CCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCC
Confidence 678899999999999998754 36778999998764322 2234457899999885 99999999999987
Q ss_pred -CeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCc
Q 011851 200 -DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLA 278 (476)
Q Consensus 200 -~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a 278 (476)
+.+++||||++ ++|.+.+......+++..++.++.||+.||.|||+.+ |+||||||+||+++. +.+||+|||++
T Consensus 72 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~ 146 (282)
T cd07831 72 TGRLALVFELMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSC 146 (282)
T ss_pred CCcEEEEEecCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccc
Confidence 89999999996 5888888665567999999999999999999999988 999999999999999 99999999999
Q ss_pred CCCCCCCccceeeeeecCCCCCCcchhhc-CCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhcc---
Q 011851 279 KDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGE--- 354 (476)
Q Consensus 279 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~--- 354 (476)
+....... .....++..|+|||++.. ..++.++|||||||++|||++|..||...+.... +.........
T Consensus 147 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~---~~~~~~~~~~~~~ 220 (282)
T cd07831 147 RGIYSKPP---YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQ---IAKIHDVLGTPDA 220 (282)
T ss_pred cccccCCC---cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHH---HHHHHHHcCCCCH
Confidence 86543221 123568899999997754 4678899999999999999999999976543211 1111000000
Q ss_pred ----cccc---ccccCcccCC----CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCc
Q 011851 355 ----RRRF---YRLIDPCLEG----CFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYL 409 (476)
Q Consensus 355 ----~~~~---~~~~d~~l~~----~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~ 409 (476)
.... .....+.... ......+..+.+||.+||+.||++||++.+++++ |||
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~----~~~ 282 (282)
T cd07831 221 EVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH----PYF 282 (282)
T ss_pred HHHHhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC----CCC
Confidence 0000 0000000000 0011236789999999999999999999999998 775
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-40 Score=322.50 Aligned_cols=270 Identities=23% Similarity=0.312 Sum_probs=201.3
Q ss_pred ccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCcc--CHHHHHHHHHHHhCCCCCceeeEEEEEE
Q 011851 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQ--GHKEWLAEVNYLGGLIHPNLVKLIGCCI 197 (476)
Q Consensus 120 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~l~~~~~ 197 (476)
.++|++.+.||+|+||.||+|.+. .+++.||||.+...... ....+.+|+.++++++||||+++++++.
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~---------~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 81 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHK---------KTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICR 81 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEEC---------CCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEe
Confidence 356999999999999999998654 46788999998654322 2335678999999999999999999987
Q ss_pred eCC--------eeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCc
Q 011851 198 EDD--------QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYN 269 (476)
Q Consensus 198 ~~~--------~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~ 269 (476)
..+ ..++||||+. ++|.+.+......+++..++.++.||+.||.|||+++ |+|+||||+||+++.++.
T Consensus 82 ~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~ 157 (310)
T cd07865 82 TKATPYNRYKGSFYLVFEFCE-HDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGI 157 (310)
T ss_pred cccccccCCCceEEEEEcCCC-cCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCc
Confidence 654 4599999995 5888888766667999999999999999999999988 999999999999999999
Q ss_pred eEEeecCCcCCCCCCCcc--ceeeeeecCCCCCCcchhhcC-CCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHH
Q 011851 270 AKLSDFGLAKDGPEGDKT--HVSTRVMGTYGYAAPEYVMTG-HLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVE 346 (476)
Q Consensus 270 vkl~DFG~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~ 346 (476)
+||+|||++......... .......++..|+|||++.+. .++.++||||||+++|||++|..||...........+.
T Consensus 158 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~ 237 (310)
T cd07865 158 LKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLIS 237 (310)
T ss_pred EEECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 999999999765332211 111234678899999988765 47889999999999999999999997654322221111
Q ss_pred hhhhhhcc-----cc--ccc----------cccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCc
Q 011851 347 WARPQLGE-----RR--RFY----------RLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYL 409 (476)
Q Consensus 347 ~~~~~~~~-----~~--~~~----------~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~ 409 (476)
........ .. ... ..+...+.. ...+..+.+||.+||..||.+|||+.++++| |||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~---~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h----~~f 310 (310)
T cd07865 238 QLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKP---YVKDPHALDLIDKLLVLDPAKRIDADTALNH----DFF 310 (310)
T ss_pred HHhCCCChhhcccccchhhhhhccCCCccchhhHHhccc---ccCCHHHHHHHHHHhcCChhhccCHHHHhcC----CCC
Confidence 11100000 00 000 000000000 0113567899999999999999999999987 876
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-40 Score=314.93 Aligned_cols=251 Identities=24% Similarity=0.330 Sum_probs=202.9
Q ss_pred ccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCcc---CHHHHHHHHHHHhCCCCCceeeEEEEEEeCCeeEEE
Q 011851 129 LGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQ---GHKEWLAEVNYLGGLIHPNLVKLIGCCIEDDQRLLV 205 (476)
Q Consensus 129 LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~---~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV 205 (476)
||.|+||.||+|.+. .+++.||+|++...... ..+.+.+|+.+++.++||||+++++++.++...|+|
T Consensus 1 lg~g~~~~v~~~~~~---------~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 71 (262)
T cd05572 1 LGVGGFGRVELVKVK---------SKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYML 71 (262)
T ss_pred CCCCCceEEEEEEEC---------CCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEE
Confidence 799999999998764 36788999999764332 345688999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCcCCCCCCC
Q 011851 206 YEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGD 285 (476)
Q Consensus 206 ~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~ 285 (476)
|||+++++|.+++.+. ..+++..+..++.||+.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 72 ~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~ 147 (262)
T cd05572 72 MEYCLGGELWTILRDR-GLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ 147 (262)
T ss_pred EecCCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc
Confidence 9999999999999554 46899999999999999999999988 9999999999999999999999999998765432
Q ss_pred ccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhccccccccccCcc
Q 011851 286 KTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRRFYRLIDPC 365 (476)
Q Consensus 286 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 365 (476)
......|++.|++||.+.+..++.++|+||||+++|+|++|..||....... ..... .. .+..
T Consensus 148 ---~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~~---~~----------~~~~ 210 (262)
T cd05572 148 ---KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDP-MEIYN---DI----------LKGN 210 (262)
T ss_pred ---ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCH-HHHHH---HH----------hccC
Confidence 1223578999999999988889999999999999999999999997654211 11111 00 0000
Q ss_pred cCCCCChHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHHhcCCCCccccc
Q 011851 366 LEGCFSIKGAEKTIQLAASCLNRDQKARPR-----MSEVVEALKPLPYLKDMA 413 (476)
Q Consensus 366 l~~~~~~~~~~~~~~li~~cL~~dP~~RPt-----~~ell~~L~~~~~~~~~~ 413 (476)
....++...+.++.++|.+||+.||++||+ +.|+++| |||++..
T Consensus 211 ~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~----~~~~~~~ 259 (262)
T cd05572 211 GKLEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKH----KWFNGFD 259 (262)
T ss_pred CCCCCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcC----hhhhCCC
Confidence 011122223678999999999999999999 7777765 9998754
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-40 Score=316.31 Aligned_cols=258 Identities=26% Similarity=0.446 Sum_probs=200.4
Q ss_pred CCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCc--cCHHHHHHHHHHHhCCCCCceeeEEEEEEeCC
Q 011851 123 FRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL--QGHKEWLAEVNYLGGLIHPNLVKLIGCCIEDD 200 (476)
Q Consensus 123 y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 200 (476)
|++.+.||+|+||.||+|.+..+ ..+++.||||++..... ...+++.+|+++|++++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~------~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 74 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSE------DGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSR 74 (273)
T ss_pred CcchhcccCCCCCCEEeeEeecc------CCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCC
Confidence 67788999999999999976532 24688999999875432 23456889999999999999999999886542
Q ss_pred ------eeEEEEEecCCCCHHHHHhhc-----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCc
Q 011851 201 ------QRLLVYEFMPRGSLENHLFRR-----SLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYN 269 (476)
Q Consensus 201 ------~~~lV~E~~~~g~L~~~l~~~-----~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~ 269 (476)
..++++||+.+++|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.
T Consensus 75 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~ 151 (273)
T cd05074 75 AKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMT 151 (273)
T ss_pred CCCcccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCC
Confidence 247899999999998887432 235788999999999999999999988 999999999999999999
Q ss_pred eEEeecCCcCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHh-CCCCCCCCCCCCcchhHHhh
Q 011851 270 AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWA 348 (476)
Q Consensus 270 vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~ellt-G~~pf~~~~~~~~~~~~~~~ 348 (476)
+||+|||+++...............+++.|++||.+....++.++|||||||++|||++ |+.||...... ....+.
T Consensus 152 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~---~~~~~~ 228 (273)
T cd05074 152 VCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENS---EIYNYL 228 (273)
T ss_pred EEECcccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHH---HHHHHH
Confidence 99999999986543322212223445678999999999999999999999999999999 88888654321 111110
Q ss_pred hhhhccccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011851 349 RPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPL 406 (476)
Q Consensus 349 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~ 406 (476)
. .... +. .+...+..+.+++.+||+.+|++||++.++++.|+.+
T Consensus 229 ~----~~~~--------~~--~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 229 I----KGNR--------LK--QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred H----cCCc--------CC--CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0 0000 00 0112256899999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=313.98 Aligned_cols=254 Identities=23% Similarity=0.340 Sum_probs=190.7
Q ss_pred cccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCc-cCHHHHHHHHHHHhCCCCCceeeEEEEEEeCCeeEEEE
Q 011851 128 LLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL-QGHKEWLAEVNYLGGLIHPNLVKLIGCCIEDDQRLLVY 206 (476)
Q Consensus 128 ~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~ 206 (476)
.||+|+||.||+|..... .....+++|.+..... ...+.+.+|+.+++.++||||+++++++.+....|+||
T Consensus 2 ~lg~G~~g~v~~~~~~~~-------~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~ 74 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTD-------TGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVF 74 (268)
T ss_pred cCCCCcCceEEEEEEEcC-------CCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEE
Confidence 599999999999865422 2334577887765432 33567899999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCcCCCCC
Q 011851 207 EFMPRGSLENHLFRR---SLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPE 283 (476)
Q Consensus 207 E~~~~g~L~~~l~~~---~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~ 283 (476)
||+++++|.+++.+. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.++|+|||++.....
T Consensus 75 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~ 151 (268)
T cd05086 75 EYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYK 151 (268)
T ss_pred ecCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCc
Confidence 999999999999653 234677788899999999999999988 99999999999999999999999999864322
Q ss_pred CCccceeeeeecCCCCCCcchhhc-------CCCCccchhhhhHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhhccc
Q 011851 284 GDKTHVSTRVMGTYGYAAPEYVMT-------GHLTAKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPQLGER 355 (476)
Q Consensus 284 ~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwslGv~l~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~ 355 (476)
...........|+..|+|||++.. ..++.++|||||||++|||++ |..||....... ..... ..
T Consensus 152 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~---~~~~~---~~-- 223 (268)
T cd05086 152 EDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDRE---VLNHV---IK-- 223 (268)
T ss_pred chhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHH---Hh--
Confidence 221112234578899999998753 245789999999999999997 466775433211 11110 00
Q ss_pred cccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 011851 356 RRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALK 404 (476)
Q Consensus 356 ~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~ 404 (476)
.......++.+... .+..+.+++..|| .+|++||++++|++.|.
T Consensus 224 ~~~~~~~~~~~~~~----~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 224 DQQVKLFKPQLELP----YSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred hcccccCCCccCCC----CcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 01112223333222 3567888999999 68999999999998764
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=316.24 Aligned_cols=250 Identities=27% Similarity=0.396 Sum_probs=196.3
Q ss_pred cccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccC---HHHHHHH---HHHHhCCCCCceeeEEEEEEeCCe
Q 011851 128 LLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQG---HKEWLAE---VNYLGGLIHPNLVKLIGCCIEDDQ 201 (476)
Q Consensus 128 ~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~---~~~~~~E---~~~l~~l~hpnIv~l~~~~~~~~~ 201 (476)
+||+|+||.||+|.+. .+++.||+|++....... ...+..| +.+++...||||+.+++++...+.
T Consensus 1 ~ig~g~~g~Vy~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 71 (278)
T cd05606 1 IIGRGGFGEVYGCRKA---------DTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDK 71 (278)
T ss_pred CcccCCCeEEEEEEEe---------cCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCE
Confidence 4899999999998654 467889999987643321 1123333 345556689999999999999999
Q ss_pred eEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCcCCC
Q 011851 202 RLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDG 281 (476)
Q Consensus 202 ~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~ 281 (476)
.|+||||++|++|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++...
T Consensus 72 ~~~v~e~~~g~~L~~~l~~-~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~ 147 (278)
T cd05606 72 LSFILDLMNGGDLHYHLSQ-HGVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDF 147 (278)
T ss_pred EEEEEecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCcccc
Confidence 9999999999999988854 457999999999999999999999988 999999999999999999999999998765
Q ss_pred CCCCccceeeeeecCCCCCCcchhhcC-CCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhcccccccc
Q 011851 282 PEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRRFYR 360 (476)
Q Consensus 282 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 360 (476)
.... .....|+..|+|||++.++ .++.++|||||||++|||++|+.||.............. ...
T Consensus 148 ~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~---~~~------- 213 (278)
T cd05606 148 SKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM---TLT------- 213 (278)
T ss_pred CccC----CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHH---hhc-------
Confidence 3321 1235799999999998754 689999999999999999999999976533222111100 000
Q ss_pred ccCcccCCCCChHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHhcCCCCccccc
Q 011851 361 LIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARP-----RMSEVVEALKPLPYLKDMA 413 (476)
Q Consensus 361 ~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RP-----t~~ell~~L~~~~~~~~~~ 413 (476)
.... ++...+.++.+++.+||..||.+|| ++.+++++ ||+++..
T Consensus 214 -~~~~----~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~----~~~~~~~ 262 (278)
T cd05606 214 -MAVE----LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH----PFFRSLD 262 (278)
T ss_pred -cCCC----CCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC----ccccCCC
Confidence 0011 1112267899999999999999999 99999886 9998865
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=308.56 Aligned_cols=251 Identities=27% Similarity=0.431 Sum_probs=207.4
Q ss_pred CCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCCCCCceeeEEEEEEeCCe
Q 011851 122 SFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHPNLVKLIGCCIEDDQ 201 (476)
Q Consensus 122 ~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~ 201 (476)
+|.+.+.||+|+||.||++.+. .+++.|++|++........+.+.+|++++++++|+||+++++++..+..
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~---------~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 71 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHK---------RTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDE 71 (253)
T ss_pred CceeeeeeccCCceEEEEEEEC---------CCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCe
Confidence 4788899999999999998764 3577899999987655556788999999999999999999999999999
Q ss_pred eEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCcCCC
Q 011851 202 RLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDG 281 (476)
Q Consensus 202 ~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~ 281 (476)
.++++||+++++|.+++......+++..+..++.|++.||.|||+.+ ++||||+|+||+++.++.++|+|||.+...
T Consensus 72 ~~l~~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~ 148 (253)
T cd05122 72 LWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQL 148 (253)
T ss_pred EEEEEecCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeeccccccc
Confidence 99999999999999998766567999999999999999999999987 999999999999999999999999999876
Q ss_pred CCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhccccccccc
Q 011851 282 PEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRRFYRL 361 (476)
Q Consensus 282 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 361 (476)
..... .....|+..|+|||++....++.++||||||+++|+|++|+.||............. . ......
T Consensus 149 ~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~---~-----~~~~~~ 217 (253)
T cd05122 149 SDTKA---RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIA---T-----NGPPGL 217 (253)
T ss_pred ccccc---ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHH---h-----cCCCCc
Confidence 54332 234678999999999998889999999999999999999999997543211111100 0 000000
Q ss_pred cCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011851 362 IDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEA 402 (476)
Q Consensus 362 ~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~ 402 (476)
.. ....+..+.++|.+||+.||++|||+.++++|
T Consensus 218 ~~-------~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 218 RN-------PEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred Cc-------ccccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 00 11125679999999999999999999999987
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=317.82 Aligned_cols=264 Identities=26% Similarity=0.388 Sum_probs=213.2
Q ss_pred hccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCCCCCceeeEEEEEEe
Q 011851 119 ATKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHPNLVKLIGCCIE 198 (476)
Q Consensus 119 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~ 198 (476)
.++.|...+.||+|+||.||+|.+. .++..|++|++..... ..+.+.+|+++++.++|+||+++++++..
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~---------~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 86 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDR---------ATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLV 86 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEc---------cCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEE
Confidence 4567889999999999999998765 3577899999976544 45678899999999999999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCc
Q 011851 199 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLA 278 (476)
Q Consensus 199 ~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a 278 (476)
.+..|+|+||+++++|.+++......+++..+..++.|++.||.|||+.+ |+|+||+|+||+++.++.++|+|||++
T Consensus 87 ~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~ 163 (286)
T cd06614 87 GDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFA 163 (286)
T ss_pred CCEEEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchh
Confidence 99999999999999999999765557999999999999999999999988 999999999999999999999999998
Q ss_pred CCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhcccccc
Q 011851 279 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRRF 358 (476)
Q Consensus 279 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 358 (476)
........ ......++..|++||++.+..++.++|||||||++|+|++|+.||....+.... ...... ..
T Consensus 164 ~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~--~~~~~~------~~ 233 (286)
T cd06614 164 AQLTKEKS--KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRAL--FLITTK------GI 233 (286)
T ss_pred hhhccchh--hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHH--HHHHhc------CC
Confidence 75433211 112346888999999998888999999999999999999999999654322111 110000 00
Q ss_pred ccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCcccccCcc
Q 011851 359 YRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDMASSS 416 (476)
Q Consensus 359 ~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~~~~~~ 416 (476)
.. .. .....+..+.++|.+||+.+|.+||++.+++++ +|++.....+
T Consensus 234 ~~-----~~--~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~----~~~~~~~~~~ 280 (286)
T cd06614 234 PP-----LK--NPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQH----PFLKKACPKE 280 (286)
T ss_pred CC-----Cc--chhhCCHHHHHHHHHHhccChhhCcCHHHHhhC----hHhhccCchH
Confidence 00 00 011135678999999999999999999999997 8888755443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-40 Score=319.16 Aligned_cols=268 Identities=25% Similarity=0.347 Sum_probs=201.3
Q ss_pred CCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCcc--CHHHHHHHHHHHhCCCCCceeeEEEEEEeC
Q 011851 122 SFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQ--GHKEWLAEVNYLGGLIHPNLVKLIGCCIED 199 (476)
Q Consensus 122 ~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~ 199 (476)
+|++.+.||.|+||.||+|.+. .+|+.||||.+...... ....+.+|++++++++||||+++++++.++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~---------~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 71 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNK---------LTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTE 71 (284)
T ss_pred CceeeeeecCCCceEEEEEEEC---------CCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccC
Confidence 4888999999999999998654 46788999998754322 235688899999999999999999999999
Q ss_pred CeeEEEEEecCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCc
Q 011851 200 DQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLA 278 (476)
Q Consensus 200 ~~~~lV~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a 278 (476)
+..++||||+. ++|.+++... ...+++..+..++.||+.||+|||+.+ ++||||+|+||+++.++.+||+|||++
T Consensus 72 ~~~~~v~e~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~ 147 (284)
T cd07860 72 NKLYLVFEFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLA 147 (284)
T ss_pred CcEEEEeeccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccch
Confidence 99999999995 6898888653 456899999999999999999999988 999999999999999999999999998
Q ss_pred CCCCCCCccceeeeeecCCCCCCcchhhcC-CCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcc-hhHHhhhhhh----
Q 011851 279 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEH-NLVEWARPQL---- 352 (476)
Q Consensus 279 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~-~~~~~~~~~~---- 352 (476)
........ ......+++.|+|||++.+. .++.++|||||||++|+|+||+.||......... ..........
T Consensus 148 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (284)
T cd07860 148 RAFGVPVR--TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVW 225 (284)
T ss_pred hhcccCcc--ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhh
Confidence 76433211 12234578899999988765 4688999999999999999999999754321110 0000000000
Q ss_pred ------c-cccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCc
Q 011851 353 ------G-ERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYL 409 (476)
Q Consensus 353 ------~-~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~ 409 (476)
. ....+..+....+... ....+.++.++|.+||+.||++|||+.++++| |||
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~----~~f 284 (284)
T cd07860 226 PGVTSLPDYKPSFPKWARQDFSKV-VPPLDEDGRDLLSQMLHYDPNKRISAKAALAH----PFF 284 (284)
T ss_pred hhhhHHHHHHhhcccccccCHHHH-cccCCHHHHHHHHHhcCCCcccCCCHHHHhcC----CCC
Confidence 0 0000000000000000 01124678899999999999999999999987 886
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=312.80 Aligned_cols=257 Identities=30% Similarity=0.441 Sum_probs=205.3
Q ss_pred CCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCcc--CHHHHHHHHHHHhCCCCCceeeEEEEEEeC
Q 011851 122 SFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQ--GHKEWLAEVNYLGGLIHPNLVKLIGCCIED 199 (476)
Q Consensus 122 ~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~ 199 (476)
+|.+.+.||+|+||.||+|.+. .+++.||+|.+...... ..+.+..|+.++++++|+||+++++++...
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~---------~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~ 71 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNL---------DTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHR 71 (264)
T ss_pred CceeeeEeecCCCcEEEEEEEC---------CCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecC
Confidence 5888999999999999998654 35778999999766543 456788999999999999999999999999
Q ss_pred CeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCcC
Q 011851 200 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAK 279 (476)
Q Consensus 200 ~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~ 279 (476)
+.+++|+||+++++|.+++... ..+++..++.++.|++.||.|||+.+ |+|+||+|+||+++.++.+||+|||++.
T Consensus 72 ~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~ 147 (264)
T cd06626 72 EKVYIFMEYCSGGTLEELLEHG-RILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAV 147 (264)
T ss_pred CEEEEEEecCCCCcHHHHHhhc-CCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccccccc
Confidence 9999999999999999998553 45889999999999999999999988 9999999999999999999999999998
Q ss_pred CCCCCCccce--eeeeecCCCCCCcchhhcCC---CCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhcc
Q 011851 280 DGPEGDKTHV--STRVMGTYGYAAPEYVMTGH---LTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGE 354 (476)
Q Consensus 280 ~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~---~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~ 354 (476)
.......... .....++..|+|||++.+.. ++.++||||||+++|+|++|+.||........ ..+.... ..
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~---~~~~~~~-~~ 223 (264)
T cd06626 148 KLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQ---IMFHVGA-GH 223 (264)
T ss_pred ccCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHH---HHHHHhc-CC
Confidence 7544322111 11256788999999998766 88999999999999999999999975432111 0000000 00
Q ss_pred ccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCc
Q 011851 355 RRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYL 409 (476)
Q Consensus 355 ~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~ 409 (476)
.+.+.. ....+..+.++|.+||+.+|++||++.+++.+ ||+
T Consensus 224 --------~~~~~~--~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~----~~~ 264 (264)
T cd06626 224 --------KPPIPD--SLQLSPEGKDFLDRCLESDPKKRPTASELLQH----PFV 264 (264)
T ss_pred --------CCCCCc--ccccCHHHHHHHHHHccCCcccCCCHHHHhcC----CCC
Confidence 000100 01125678899999999999999999999987 774
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=316.49 Aligned_cols=268 Identities=24% Similarity=0.351 Sum_probs=203.2
Q ss_pred CCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCcc-CHHHHHHHHHHHhCCCCCceeeEEEEEEeCC
Q 011851 122 SFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQ-GHKEWLAEVNYLGGLIHPNLVKLIGCCIEDD 200 (476)
Q Consensus 122 ~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 200 (476)
+|++.+.||.|++|.||+|.+. .+|+.||||+++..... ....+.+|+.++++++|+||+++++++.+.+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~---------~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 71 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNR---------TTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTEN 71 (284)
T ss_pred CceEeeeeccCCceEEEEEEEC---------CCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCC
Confidence 4888999999999999998764 36788999999765433 3456778999999999999999999999999
Q ss_pred eeEEEEEecCCCCHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCc
Q 011851 201 QRLLVYEFMPRGSLENHLFRRS--LPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLA 278 (476)
Q Consensus 201 ~~~lV~E~~~~g~L~~~l~~~~--~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a 278 (476)
..+|||||+++ +|.+++.... ..+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.++|+|||++
T Consensus 72 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~ 147 (284)
T cd07836 72 KLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLA 147 (284)
T ss_pred cEEEEEecCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchh
Confidence 99999999975 8888886543 56899999999999999999999988 999999999999999999999999999
Q ss_pred CCCCCCCccceeeeeecCCCCCCcchhhcC-CCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcch-hHHhhhhh-----
Q 011851 279 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHN-LVEWARPQ----- 351 (476)
Q Consensus 279 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~-~~~~~~~~----- 351 (476)
........ ......++..|++||++.+. .++.++|||||||++|+|++|+.||.......... ........
T Consensus 148 ~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (284)
T cd07836 148 RAFGIPVN--TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTW 225 (284)
T ss_pred hhhcCCcc--ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhH
Confidence 75432211 12234578899999988764 57889999999999999999999997654321111 00000000
Q ss_pred --hcccccccc----ccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCc
Q 011851 352 --LGERRRFYR----LIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYL 409 (476)
Q Consensus 352 --~~~~~~~~~----~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~ 409 (476)
+.....+.. ..+... ..+....+..+.+++.+||+.||.+||++.+++++ |||
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~----~~f 284 (284)
T cd07836 226 PGISQLPEYKPTFPRYPPQDL-QQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH----PWF 284 (284)
T ss_pred HHHhcCchhcccccCCChHHH-HHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC----CCC
Confidence 000000000 000000 00111235678899999999999999999999987 876
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=312.78 Aligned_cols=246 Identities=30% Similarity=0.479 Sum_probs=197.5
Q ss_pred cCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCCCCCceeeEEEEEEeCC
Q 011851 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHPNLVKLIGCCIEDD 200 (476)
Q Consensus 121 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 200 (476)
++|++.+.||+|+||.||++.. +++.||+|.++... ....+.+|+.++++++||||+++++++..+
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-----------~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~- 71 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-----------TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN- 71 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-----------CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-
Confidence 3588999999999999998742 56779999986542 245788999999999999999999998765
Q ss_pred eeEEEEEecCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCcC
Q 011851 201 QRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAK 279 (476)
Q Consensus 201 ~~~lV~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~ 279 (476)
..++||||+++++|.+++... ...+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||++.
T Consensus 72 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~ 148 (254)
T cd05083 72 GLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLAR 148 (254)
T ss_pred CcEEEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccce
Confidence 579999999999999999654 345899999999999999999999988 9999999999999999999999999987
Q ss_pred CCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhhcccccc
Q 011851 280 DGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPQLGERRRF 358 (476)
Q Consensus 280 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 358 (476)
...... .....+..|+|||.+.+..++.++|||||||++|||++ |+.||........... ......
T Consensus 149 ~~~~~~-----~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~-------~~~~~~- 215 (254)
T cd05083 149 VGSMGV-----DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKEC-------VEKGYR- 215 (254)
T ss_pred eccccC-----CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHH-------HhCCCC-
Confidence 643221 11234567999999998899999999999999999998 9999975433211111 000000
Q ss_pred ccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 011851 359 YRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKP 405 (476)
Q Consensus 359 ~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~ 405 (476)
.+ .....+..+.+++.+||+.+|++||++.++++.|+.
T Consensus 216 ---~~------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 216 ---ME------PPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred ---CC------CCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 00 111235788999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=311.69 Aligned_cols=255 Identities=23% Similarity=0.267 Sum_probs=198.7
Q ss_pred hHHHHhccCCCccccc--cccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhC-CCCCcee
Q 011851 114 NELKSATKSFRPECLL--GEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGG-LIHPNLV 190 (476)
Q Consensus 114 ~~~~~~~~~y~~~~~L--G~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~-l~hpnIv 190 (476)
.+.....+.|.+.+.+ |+|+||.||++... .++..+|+|++........ |+..... .+|+||+
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~---------~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv 72 (267)
T PHA03390 7 SELVQFLKNCEIVKKLKLIDGKFGKVSVLKHK---------PTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFI 72 (267)
T ss_pred HHHHHHHHhhccccceeecCCCceEEEEEEEc---------CCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEE
Confidence 3444455677887776 99999999997544 5678899999876433221 2222221 2699999
Q ss_pred eEEEEEEeCCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCC-c
Q 011851 191 KLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEY-N 269 (476)
Q Consensus 191 ~l~~~~~~~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~-~ 269 (476)
++++++...+..|+||||+++++|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+||+++.++ .
T Consensus 73 ~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~ 148 (267)
T PHA03390 73 KLYYSVTTLKGHVLIMDYIKDGDLFDLLKKE-GKLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDR 148 (267)
T ss_pred EEEEEEecCCeeEEEEEcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCe
Confidence 9999999999999999999999999999654 48999999999999999999999988 99999999999999998 9
Q ss_pred eEEeecCCcCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhh
Q 011851 270 AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR 349 (476)
Q Consensus 270 vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~ 349 (476)
++|+|||++...... ....|+..|+|||++.+..++.++|||||||++|+|++|+.||....... .....+..
T Consensus 149 ~~l~dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~-~~~~~~~~ 221 (267)
T PHA03390 149 IYLCDYGLCKIIGTP------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE-LDLESLLK 221 (267)
T ss_pred EEEecCccceecCCC------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch-hhHHHHHH
Confidence 999999998764321 12468999999999999899999999999999999999999997443221 11111111
Q ss_pred hhhccccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCC-HHHHHHHhcCCCCcc
Q 011851 350 PQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPR-MSEVVEALKPLPYLK 410 (476)
Q Consensus 350 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt-~~ell~~L~~~~~~~ 410 (476)
.. .... + .....+..+.++|.+||+.||.+||+ ++++++| |||+
T Consensus 222 ~~-~~~~-------~-----~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h----~~~~ 266 (267)
T PHA03390 222 RQ-QKKL-------P-----FIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKH----PFLK 266 (267)
T ss_pred hh-cccC-------C-----cccccCHHHHHHHHHHhccChhhCCchHHHHhcC----Cccc
Confidence 11 0000 0 11123678999999999999999996 6999987 9986
|
|
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=315.86 Aligned_cols=256 Identities=29% Similarity=0.414 Sum_probs=199.3
Q ss_pred ccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCcc---CHHHHHHHHHHHhCCCCCceeeEEEEEEeCCeeEEE
Q 011851 129 LGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQ---GHKEWLAEVNYLGGLIHPNLVKLIGCCIEDDQRLLV 205 (476)
Q Consensus 129 LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~---~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV 205 (476)
||+|+||+||+|.+. .+|+.||+|++...... ....+..|+++|++++||||+++++++...+..|+|
T Consensus 1 lg~g~~g~vy~~~~~---------~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 71 (277)
T cd05577 1 LGKGGFGEVCACQVK---------ATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLV 71 (277)
T ss_pred CCCCCceeEEEEEEc---------CCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEE
Confidence 699999999998654 46778999998754322 234567899999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCcCCCCCC
Q 011851 206 YEFMPRGSLENHLFRRS-LPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEG 284 (476)
Q Consensus 206 ~E~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~ 284 (476)
|||+++++|.+++.... ..+++..+..++.|++.||.|||+.+ |+||||+|+||+++.++.++|+|||++......
T Consensus 72 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~ 148 (277)
T cd05577 72 MTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGG 148 (277)
T ss_pred EecCCCCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhccC
Confidence 99999999999986543 36899999999999999999999988 999999999999999999999999998765431
Q ss_pred CccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhccccccccccCc
Q 011851 285 DKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRRFYRLIDP 364 (476)
Q Consensus 285 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 364 (476)
.. .....++..|+|||++.+..++.++|||||||++|+|++|+.||...........+. ......
T Consensus 149 ~~---~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~--~~~~~~---------- 213 (277)
T cd05577 149 KK---IKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELK--RRTLEM---------- 213 (277)
T ss_pred Cc---cccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHH--hccccc----------
Confidence 11 223467889999999988889999999999999999999999997654321111110 000000
Q ss_pred ccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHH-HHHHhcCCCCccccc
Q 011851 365 CLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSE-VVEALKPLPYLKDMA 413 (476)
Q Consensus 365 ~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~e-ll~~L~~~~~~~~~~ 413 (476)
...++...+..+.++|.+||+.||.+||++.+ ....|..+|||.++.
T Consensus 214 --~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h~~~~~~~ 261 (277)
T cd05577 214 --AVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKDLN 261 (277)
T ss_pred --cccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhChhhhcCC
Confidence 00011223678899999999999999994444 333333459997654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-41 Score=337.96 Aligned_cols=252 Identities=24% Similarity=0.407 Sum_probs=197.3
Q ss_pred CccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecC----CCccCHHHHHHHHHHHhCCCCCceeeEEEEEEeC
Q 011851 124 RPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNH----DGLQGHKEWLAEVNYLGGLIHPNLVKLIGCCIED 199 (476)
Q Consensus 124 ~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~----~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~ 199 (476)
+...+||+|+|-+||+|.+.. +|..||=-.++. ......++|..|+.+|+.|+|||||++|++|.+.
T Consensus 43 k~~evLGrGafKtVYka~De~---------~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~ 113 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEE---------EGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDT 113 (632)
T ss_pred ehhhhcccccceeeeeccccc---------cchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecC
Confidence 455679999999999998753 566666322221 1122346789999999999999999999999987
Q ss_pred Ce--eEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCC-CceEEeecC
Q 011851 200 DQ--RLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGE-YNAKLSDFG 276 (476)
Q Consensus 200 ~~--~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~-~~vkl~DFG 276 (476)
.+ +.+|+|++..|+|..|+.+ .+.+....++.|++||++||.|||++. .+|||||||-+||+|+++ |.|||+|+|
T Consensus 114 ~n~~in~iTEL~TSGtLr~Y~kk-~~~vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLG 191 (632)
T KOG0584|consen 114 DNKTINFITELFTSGTLREYRKK-HRRVNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLG 191 (632)
T ss_pred CCceeeeeeecccCCcHHHHHHH-hccCCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchh
Confidence 66 7789999999999999954 457899999999999999999999987 789999999999999765 899999999
Q ss_pred CcCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhcccc
Q 011851 277 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERR 356 (476)
Q Consensus 277 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~ 356 (476)
||....... ...++|||.|||||+.. ..|+..+||||||++++||+|+..||..-..... +-+....
T Consensus 192 LAtl~r~s~----aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQ-----IYKKV~S--- 258 (632)
T KOG0584|consen 192 LATLLRKSH----AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQ-----IYKKVTS--- 258 (632)
T ss_pred HHHHhhccc----cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHH-----HHHHHHc---
Confidence 998754322 23389999999999776 8899999999999999999999999975332211 1110000
Q ss_pred ccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCccc
Q 011851 357 RFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKD 411 (476)
Q Consensus 357 ~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~ 411 (476)
-.....|..-...++.+||.+||.. ..+|+|+.|+|++ |||..
T Consensus 259 -------GiKP~sl~kV~dPevr~fIekCl~~-~~~R~sa~eLL~d----~Ff~~ 301 (632)
T KOG0584|consen 259 -------GIKPAALSKVKDPEVREFIEKCLAT-KSERLSAKELLKD----PFFDE 301 (632)
T ss_pred -------CCCHHHhhccCCHHHHHHHHHHhcC-chhccCHHHHhhC----hhhcc
Confidence 0000111111146888999999999 9999999999998 77765
|
|
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=312.76 Aligned_cols=253 Identities=26% Similarity=0.422 Sum_probs=200.6
Q ss_pred CCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCc----------cCHHHHHHHHHHHhC-CCCCcee
Q 011851 122 SFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL----------QGHKEWLAEVNYLGG-LIHPNLV 190 (476)
Q Consensus 122 ~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~----------~~~~~~~~E~~~l~~-l~hpnIv 190 (476)
.|.+.+.||+|+||.||+|.+.. .+++.+|+|.+..... ....++..|+.++.+ ++||||+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~--------~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~ 72 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKN--------NGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIV 72 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcC--------CCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCee
Confidence 47888999999999999997653 1467899998864321 123456778888875 7999999
Q ss_pred eEEEEEEeCCeeEEEEEecCCCCHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCCeeecC
Q 011851 191 KLIGCCIEDDQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALDAAKGLAFLHE-EAEKPVIYRDFKTSNILLDG 266 (476)
Q Consensus 191 ~l~~~~~~~~~~~lV~E~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~al~~lH~-~~~~~ivHrDlKp~NILl~~ 266 (476)
++++++.+++..++||||+++++|.+++.. ....+++..++.++.|++.||.|||+ .+ |+|+||+|+|||++.
T Consensus 73 ~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~dl~~~nil~~~ 149 (269)
T cd08528 73 RYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR---IVHRDLTPNNIMLGE 149 (269)
T ss_pred eEEeeEccCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc---eeecCCCHHHEEECC
Confidence 999999999999999999999999988743 34568999999999999999999996 45 999999999999999
Q ss_pred CCceEEeecCCcCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHH
Q 011851 267 EYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVE 346 (476)
Q Consensus 267 ~~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~ 346 (476)
++.++|+|||++....... ......|+..|+|||++.+..++.++||||||+++|+|++|+.||........ ..
T Consensus 150 ~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~---~~ 223 (269)
T cd08528 150 DDKVTITDFGLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSL---AT 223 (269)
T ss_pred CCcEEEecccceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHH---HH
Confidence 9999999999998754432 22345789999999999988899999999999999999999999964422111 00
Q ss_pred hhhhhhccccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 011851 347 WARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALK 404 (476)
Q Consensus 347 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~ 404 (476)
..... ...+.... ..+..+.++|.+||+.||++||++.++.++|+
T Consensus 224 ---~~~~~------~~~~~~~~----~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 224 ---KIVEA------VYEPLPEG----MYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred ---HHhhc------cCCcCCcc----cCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 00000 00111111 12568899999999999999999999999865
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=316.20 Aligned_cols=274 Identities=23% Similarity=0.311 Sum_probs=212.1
Q ss_pred HHhccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCCCC--C----cee
Q 011851 117 KSATKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIH--P----NLV 190 (476)
Q Consensus 117 ~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~h--p----nIv 190 (476)
...+++|.+...||+|+||.|..+++. .++..||||+++.-. ...+..+-|+++|.++.+ | -+|
T Consensus 85 D~l~~Ry~i~~~lGeGtFGkV~ec~D~---------~~~~~vAlKIik~V~-kYreAa~iEi~vLqki~~~DP~g~~rcv 154 (415)
T KOG0671|consen 85 DILTNRYEIVDLLGEGTFGKVVECWDR---------ETKEHVALKIIKNVD-KYREAALIEIEVLQKINESDPNGKFRCV 154 (415)
T ss_pred cccccceehhhhhcCCcccceEEEeec---------CCCceehHHHHHHHH-HHhhHHHHHHHHHHHHHhcCCCCceEEE
Confidence 344789999999999999999997765 457889999997543 223455679999999942 3 378
Q ss_pred eEEEEEEeCCeeEEEEEecCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecC---
Q 011851 191 KLIGCCIEDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDG--- 266 (476)
Q Consensus 191 ~l~~~~~~~~~~~lV~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~--- 266 (476)
.+.+||...++.|||+|.+ |-+++++|..+ ..+++...++.+++|++++++|||+.+ ++|.||||+|||+..
T Consensus 155 ~m~~wFdyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~ 230 (415)
T KOG0671|consen 155 QMRDWFDYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEY 230 (415)
T ss_pred eeehhhhccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccce
Confidence 9999999999999999999 77999999663 567899999999999999999999988 999999999999831
Q ss_pred -----------------CCceEEeecCCcCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhC
Q 011851 267 -----------------EYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTG 329 (476)
Q Consensus 267 -----------------~~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG 329 (476)
+..|+|+|||.|....+.. +.++.|..|+|||++++-+++..+||||+||||+||+||
T Consensus 231 ~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h-----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG 305 (415)
T KOG0671|consen 231 FKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH-----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTG 305 (415)
T ss_pred EEEeccCCccceeccCCCcceEEEecCCcceeccCc-----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeecc
Confidence 3358999999998754432 347889999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCcchhHHhhhhhhcccccc------------------------ccccCcccC--C--CCChHHHHHHHHH
Q 011851 330 RRSMDKNRPNGEHNLVEWARPQLGERRRF------------------------YRLIDPCLE--G--CFSIKGAEKTIQL 381 (476)
Q Consensus 330 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~------------------------~~~~d~~l~--~--~~~~~~~~~~~~l 381 (476)
...|+.....+...+++.....++...-. ....++|.. . .-......++.||
T Consensus 306 ~~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDL 385 (415)
T KOG0671|consen 306 ETLFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDL 385 (415)
T ss_pred ceecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHH
Confidence 99999877544443333322222111000 000011100 0 0011234579999
Q ss_pred HHHhcccCCCCCCCHHHHHHHhcCCCCccccc
Q 011851 382 AASCLNRDQKARPRMSEVVEALKPLPYLKDMA 413 (476)
Q Consensus 382 i~~cL~~dP~~RPt~~ell~~L~~~~~~~~~~ 413 (476)
+++||..||.+|+|+.|+|.| |||+...
T Consensus 386 l~~mL~fDP~~RiTl~EAL~H----pFF~~~~ 413 (415)
T KOG0671|consen 386 LRRMLEFDPARRITLREALSH----PFFARLT 413 (415)
T ss_pred HHHHHccCccccccHHHHhcC----HHhhcCC
Confidence 999999999999999999998 9998653
|
|
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=319.02 Aligned_cols=270 Identities=23% Similarity=0.304 Sum_probs=199.8
Q ss_pred cCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCcc--CHHHHHHHHHHHhCCC-CCceeeEEEEEE
Q 011851 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQ--GHKEWLAEVNYLGGLI-HPNLVKLIGCCI 197 (476)
Q Consensus 121 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~--~~~~~~~E~~~l~~l~-hpnIv~l~~~~~ 197 (476)
++|++.+.||+|+||.||+|.+. .+++.||||.++..... ....+.+|+.+++.+. |+||+++++++.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~---------~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~ 71 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDK---------NTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEH 71 (295)
T ss_pred CCceEeeEecccCCeEEEEEEEC---------CCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEe
Confidence 36889999999999999998764 46778999998654322 2356788999999995 699999999998
Q ss_pred eCCe-----eEEEEEecCCCCHHHHHhhc----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecC-C
Q 011851 198 EDDQ-----RLLVYEFMPRGSLENHLFRR----SLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDG-E 267 (476)
Q Consensus 198 ~~~~-----~~lV~E~~~~g~L~~~l~~~----~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~-~ 267 (476)
..+. .|+||||+++ +|.+++... ...+++..++.++.||+.||.|||+.+ |+||||||+||+++. +
T Consensus 72 ~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~ 147 (295)
T cd07837 72 VEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQK 147 (295)
T ss_pred ecCCCCCceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCC
Confidence 7766 8999999975 898888643 245899999999999999999999988 999999999999998 8
Q ss_pred CceEEeecCCcCCCCCCCccceeeeeecCCCCCCcchhhc-CCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcch-hH
Q 011851 268 YNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHN-LV 345 (476)
Q Consensus 268 ~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~-~~ 345 (476)
+.+||+|||++........ ......+++.|+|||++.+ ..++.++|||||||++|+|++|..||.......... +.
T Consensus 148 ~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~ 225 (295)
T cd07837 148 GLLKIADLGLGRAFSIPVK--SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIF 225 (295)
T ss_pred CeEEEeecccceecCCCcc--ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Confidence 8999999999876432111 1122357889999998875 467899999999999999999999997543221110 00
Q ss_pred Hhhh-hh------hccccc---cccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCcc
Q 011851 346 EWAR-PQ------LGERRR---FYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLK 410 (476)
Q Consensus 346 ~~~~-~~------~~~~~~---~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~ 410 (476)
.... +. ...... +.......+. ......+.++.++|.+||..||.+||++.+++.| ||++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~----~~~~ 295 (295)
T cd07837 226 KLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLS-RAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH----PYFD 295 (295)
T ss_pred HHhCCCChhhCcchhhccchhhcCcccchhHH-HhccccCHHHHHHHHHHccCChhhcCCHHHHhcC----CCcC
Confidence 0000 00 000000 0000000000 0001235678999999999999999999999998 8874
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=308.67 Aligned_cols=256 Identities=29% Similarity=0.447 Sum_probs=208.3
Q ss_pred CCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCc--cCHHHHHHHHHHHhCCCCCceeeEEEEEEeC
Q 011851 122 SFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL--QGHKEWLAEVNYLGGLIHPNLVKLIGCCIED 199 (476)
Q Consensus 122 ~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~ 199 (476)
+|++.+.||+|++|.||+|.+. .++..|++|++..... ...+.+.+|+.++++++|+||+++++.+.+.
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~---------~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 71 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDK---------DTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDE 71 (260)
T ss_pred CceeeeEeeecCceEEEEEEEC---------CCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecC
Confidence 4788899999999999998664 3677899999876543 3356788999999999999999999999988
Q ss_pred --CeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCC
Q 011851 200 --DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGL 277 (476)
Q Consensus 200 --~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~ 277 (476)
..+++||||+++++|.+++.... .+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||.
T Consensus 72 ~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~ 147 (260)
T cd06606 72 EKNTLNIFLEYVSGGSLSSLLKKFG-KLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGC 147 (260)
T ss_pred CCCeEEEEEEecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccccc
Confidence 89999999999999999986554 8999999999999999999999988 99999999999999999999999999
Q ss_pred cCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhccccc
Q 011851 278 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRR 357 (476)
Q Consensus 278 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 357 (476)
+................++..|+|||.+.+..++.++||||||+++|+|++|..||...... .... +. ..
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--~~~~-~~---~~---- 217 (260)
T cd06606 148 AKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNP--MAAL-YK---IG---- 217 (260)
T ss_pred EEecccccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch--HHHH-Hh---cc----
Confidence 98765433211123356889999999998888999999999999999999999999765411 0000 00 00
Q ss_pred cccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCc
Q 011851 358 FYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYL 409 (476)
Q Consensus 358 ~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~ 409 (476)
........+...+..+.++|.+||+.||++||++.+++.+ |||
T Consensus 218 -----~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~----~~~ 260 (260)
T cd06606 218 -----SSGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQH----PFL 260 (260)
T ss_pred -----ccCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhC----CCC
Confidence 0000011122236789999999999999999999999998 775
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=318.98 Aligned_cols=262 Identities=26% Similarity=0.360 Sum_probs=207.9
Q ss_pred ccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCCCCCceeeEEEEEEeCCeeEE
Q 011851 125 PECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHPNLVKLIGCCIEDDQRLL 204 (476)
Q Consensus 125 ~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 204 (476)
...+||+|+||.||++... .+++.||||.+..........+.+|+.+++.++|+||+++++++..++..|+
T Consensus 24 ~~~~lg~g~~g~v~~~~~~---------~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 94 (292)
T cd06657 24 NFIKIGEGSTGIVCIATVK---------SSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWV 94 (292)
T ss_pred hHHHcCCCCCeEEEEEEEc---------CCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEE
Confidence 3467999999999998654 4678899999865544455678899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCcCCCCCC
Q 011851 205 VYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEG 284 (476)
Q Consensus 205 V~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~ 284 (476)
||||+++++|.+++.. ..+++..+..++.|++.||+|||+.+ |+|+||+|+||+++.++.++|+|||++......
T Consensus 95 v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~ 169 (292)
T cd06657 95 VMEFLEGGALTDIVTH--TRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE 169 (292)
T ss_pred EEecCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceecccc
Confidence 9999999999987743 35899999999999999999999988 999999999999999999999999998754332
Q ss_pred CccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhccccccccccCc
Q 011851 285 DKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRRFYRLIDP 364 (476)
Q Consensus 285 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 364 (476)
.. ......|++.|+|||++.+..++.++|+||||+++|+|++|..||........ ........ ..
T Consensus 170 ~~--~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~---~~~~~~~~----------~~ 234 (292)
T cd06657 170 VP--RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKA---MKMIRDNL----------PP 234 (292)
T ss_pred cc--cccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHhhC----------Cc
Confidence 21 12235689999999999888899999999999999999999999975432211 11111000 00
Q ss_pred ccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCcccccCcchHHHH
Q 011851 365 CLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDMASSSSYVQA 421 (476)
Q Consensus 365 ~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~~~~~~~~~~~ 421 (476)
.+.. ....+..+.+++.+||+.||.+||++.+++++ +||.....+....+.
T Consensus 235 ~~~~--~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~----~~~~~~~~~~~~~~~ 285 (292)
T cd06657 235 KLKN--LHKVSPSLKGFLDRLLVRDPAQRATAAELLKH----PFLAKAGPPSCIVPL 285 (292)
T ss_pred ccCC--cccCCHHHHHHHHHHHhCCcccCcCHHHHhcC----hHHhccCCCcccccH
Confidence 0000 01125578899999999999999999999997 998876655444333
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=322.43 Aligned_cols=261 Identities=26% Similarity=0.390 Sum_probs=211.8
Q ss_pred cCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCH---HHHHHHHHHHhCC-CCCceeeEEEEE
Q 011851 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGH---KEWLAEVNYLGGL-IHPNLVKLIGCC 196 (476)
Q Consensus 121 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~---~~~~~E~~~l~~l-~hpnIv~l~~~~ 196 (476)
.+|..+.+||+|+||.|.+|.. ++|.+.||||+++++..... +--+.|-++|... +-|.+++++.+|
T Consensus 349 tDFnFl~VlGKGSFGKVlLaer---------kgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScF 419 (683)
T KOG0696|consen 349 TDFNFLMVLGKGSFGKVLLAER---------KGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCF 419 (683)
T ss_pred cccceEEEeccCccceeeeecc---------cCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHh
Confidence 4688999999999999999854 36778899999988754322 2234577777765 468899999999
Q ss_pred EeCCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecC
Q 011851 197 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFG 276 (476)
Q Consensus 197 ~~~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG 276 (476)
+.-+.+|+||||+.||+|.-+|++ -+.+.+..+..++.+|+-||-|||+++ ||+||||.+|||||.+|+|||+|||
T Consensus 420 QTmDRLyFVMEyvnGGDLMyhiQQ-~GkFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFG 495 (683)
T KOG0696|consen 420 QTMDRLYFVMEYVNGGDLMYHIQQ-VGKFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFG 495 (683)
T ss_pred hhhhheeeEEEEecCchhhhHHHH-hcccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeecc
Confidence 999999999999999999988854 457889999999999999999999988 9999999999999999999999999
Q ss_pred CcCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhcccc
Q 011851 277 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERR 356 (476)
Q Consensus 277 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~ 356 (476)
+++...-...+ +.++||||.|+|||++..++|+.++|+||+||+|||||.|++||++.+..+....+
T Consensus 496 mcKEni~~~~T--TkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI----------- 562 (683)
T KOG0696|consen 496 MCKENIFDGVT--TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAI----------- 562 (683)
T ss_pred cccccccCCcc--eeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH-----------
Confidence 99875443333 45699999999999999999999999999999999999999999987553322111
Q ss_pred ccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHH-HHHHHhcCCCCcccccC
Q 011851 357 RFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMS-EVVEALKPLPYLKDMAS 414 (476)
Q Consensus 357 ~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~-ell~~L~~~~~~~~~~~ 414 (476)
++. .-.|+-..+.++.++++..|..+|.+|.... +-.+.++.+|||+.+..
T Consensus 563 -----~eh--nvsyPKslSkEAv~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~iDW 614 (683)
T KOG0696|consen 563 -----MEH--NVSYPKSLSKEAVAICKGLLTKHPGKRLGCGPEGERDIREHPFFRRIDW 614 (683)
T ss_pred -----HHc--cCcCcccccHHHHHHHHHHhhcCCccccCCCCccccchhhCcchhhccH
Confidence 111 1124445588999999999999999995432 22345666799997753
|
|
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-40 Score=314.40 Aligned_cols=251 Identities=25% Similarity=0.401 Sum_probs=200.9
Q ss_pred ccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCc---cCHHHHHHHHHHHhCCCCCceeeEEEEEEeCCeeEEE
Q 011851 129 LGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL---QGHKEWLAEVNYLGGLIHPNLVKLIGCCIEDDQRLLV 205 (476)
Q Consensus 129 LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV 205 (476)
||.|+||.||++++. .+|+.|++|++..... ...+.+.+|++++++++||||+++++.+..+...|+|
T Consensus 1 lg~g~~~~vy~~~~~---------~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 71 (265)
T cd05579 1 ISKGAYGRVFLAKKK---------STGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLV 71 (265)
T ss_pred CCCCCceEEEEEEEC---------CCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEE
Confidence 689999999998754 4678899999976544 2345688899999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCcCCCCCCC
Q 011851 206 YEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGD 285 (476)
Q Consensus 206 ~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~ 285 (476)
|||+++++|.+++.+.. .+++..+..++.||+.||.|||+.+ |+|+||+|+||+++.++.++|+|||++.......
T Consensus 72 ~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~ 147 (265)
T cd05579 72 MEYLPGGDLASLLENVG-SLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRR 147 (265)
T ss_pred EecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCc
Confidence 99999999999986544 7899999999999999999999988 9999999999999999999999999987643321
Q ss_pred c------cceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhccccccc
Q 011851 286 K------THVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRRFY 359 (476)
Q Consensus 286 ~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 359 (476)
. ........++..|+|||.+....++.++||||||+++|+|++|..||............. .....
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~------~~~~~-- 219 (265)
T cd05579 148 QINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNIL------NGKIE-- 219 (265)
T ss_pred ccccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh------cCCcC--
Confidence 1 112233568899999999988889999999999999999999999997554221111100 00000
Q ss_pred cccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCH---HHHHHHhcCCCCcccc
Q 011851 360 RLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRM---SEVVEALKPLPYLKDM 412 (476)
Q Consensus 360 ~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~---~ell~~L~~~~~~~~~ 412 (476)
. .. ....+..+.+++.+||+.+|++|||+ .+++++ |||+++
T Consensus 220 -~-----~~--~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~----~~~~~~ 263 (265)
T cd05579 220 -W-----PE--DVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNH----PFFKGI 263 (265)
T ss_pred -C-----Cc--cccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcC----ccccCC
Confidence 0 00 00125788999999999999999999 666665 998865
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=326.43 Aligned_cols=272 Identities=24% Similarity=0.328 Sum_probs=201.9
Q ss_pred ccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCc-cCHHHHHHHHHHHhCCCCCceeeEEEEEEe
Q 011851 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL-QGHKEWLAEVNYLGGLIHPNLVKLIGCCIE 198 (476)
Q Consensus 120 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~ 198 (476)
.++|.+.+.||+|+||.||+|.+. .+|+.||||++..... .....+.+|+.++++++|+||+++++++..
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 74 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHK---------PTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRP 74 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEc---------CCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeec
Confidence 467999999999999999998654 4678899999864322 234567889999999999999999998765
Q ss_pred CC-----eeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEe
Q 011851 199 DD-----QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLS 273 (476)
Q Consensus 199 ~~-----~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~ 273 (476)
.. ..|+||||+. ++|.+++.. ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+
T Consensus 75 ~~~~~~~~~~lv~e~~~-~~l~~~~~~--~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~ 148 (336)
T cd07849 75 PSFESFNDVYIVQELME-TDLYKLIKT--QHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKIC 148 (336)
T ss_pred ccccccceEEEEehhcc-cCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEC
Confidence 43 5799999995 588877743 46899999999999999999999988 9999999999999999999999
Q ss_pred ecCCcCCCCCCCc-cceeeeeecCCCCCCcchhhc-CCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhh
Q 011851 274 DFGLAKDGPEGDK-THVSTRVMGTYGYAAPEYVMT-GHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQ 351 (476)
Q Consensus 274 DFG~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~ 351 (476)
|||++........ ........||+.|+|||.+.+ ..++.++|||||||++|+|++|+.||...........+ ...
T Consensus 149 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~---~~~ 225 (336)
T cd07849 149 DFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLI---LGV 225 (336)
T ss_pred cccceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---HHH
Confidence 9999876533221 111223578999999998765 46899999999999999999999999654321110000 000
Q ss_pred hcc--ccccccccCc-----------ccCCC---CChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCccccc
Q 011851 352 LGE--RRRFYRLIDP-----------CLEGC---FSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDMA 413 (476)
Q Consensus 352 ~~~--~~~~~~~~d~-----------~l~~~---~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~~~ 413 (476)
... ...+..+.+. ..... .....+.++.++|.+||+.||++|||+.++++| ||++...
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h----p~~~~~~ 299 (336)
T cd07849 226 LGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH----PYLEQYH 299 (336)
T ss_pred cCCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC----ccccccC
Confidence 000 0000000000 00000 001125678999999999999999999999998 8988553
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-39 Score=316.75 Aligned_cols=257 Identities=28% Similarity=0.408 Sum_probs=205.1
Q ss_pred CCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCcc---CHHHHHHHHHHHhCCCCCceeeEEEEEEeC
Q 011851 123 FRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQ---GHKEWLAEVNYLGGLIHPNLVKLIGCCIED 199 (476)
Q Consensus 123 y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~---~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~ 199 (476)
|...+.||+|+||.||+|.+. .+|+.|++|++...... ....+.+|+++++.++||||+++++++.+.
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~---------~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 93 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNS---------HTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKE 93 (313)
T ss_pred hhcceeeccCCCeEEEEEEEC---------CCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeC
Confidence 667788999999999998654 46788999998754332 234678899999999999999999999999
Q ss_pred CeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCcC
Q 011851 200 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAK 279 (476)
Q Consensus 200 ~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~ 279 (476)
...|+||||+. ++|.+++.....++++..+..++.||+.||.|||+.+ |+|+||+|+||+++.++.+||+|||++.
T Consensus 94 ~~~~lv~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~ 169 (313)
T cd06633 94 HTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSAS 169 (313)
T ss_pred CEEEEEEecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCc
Confidence 99999999995 5888888766678999999999999999999999988 9999999999999999999999999986
Q ss_pred CCCCCCccceeeeeecCCCCCCcchhh---cCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhcccc
Q 011851 280 DGPEGDKTHVSTRVMGTYGYAAPEYVM---TGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERR 356 (476)
Q Consensus 280 ~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~ 356 (476)
.... .....|+..|+|||++. ...++.++|||||||++|+|++|..||.............. ..
T Consensus 170 ~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~-----~~-- 236 (313)
T cd06633 170 KSSP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ-----ND-- 236 (313)
T ss_pred ccCC------CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHh-----cC--
Confidence 5322 12357899999999984 35688899999999999999999999876432211111000 00
Q ss_pred ccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCcccccCcchH
Q 011851 357 RFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDMASSSSY 418 (476)
Q Consensus 357 ~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~~~~~~~~ 418 (476)
.... .....+..+.+|+.+||+.+|.+||++.+++.+ ||++........
T Consensus 237 -~~~~--------~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~----~~~~~~~~~~~~ 285 (313)
T cd06633 237 -SPTL--------QSNEWTDSFRGFVDYCLQKIPQERPASAELLRH----DFVRRDRPARVL 285 (313)
T ss_pred -CCCC--------CccccCHHHHHHHHHHccCChhhCcCHHHHhcC----cccCCCchhHHH
Confidence 0000 011124568899999999999999999999987 999876544433
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=308.29 Aligned_cols=253 Identities=25% Similarity=0.407 Sum_probs=208.8
Q ss_pred CCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCc--cCHHHHHHHHHHHhCCCCCceeeEEEEEEeC
Q 011851 122 SFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL--QGHKEWLAEVNYLGGLIHPNLVKLIGCCIED 199 (476)
Q Consensus 122 ~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~ 199 (476)
+|++.+.||+|+||.||++.+. .++..||+|++..... ...+.+.+|+++++.++|+|++++++.+...
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~---------~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~ 71 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRK---------SDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEK 71 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEc---------CCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecC
Confidence 4888999999999999998764 3677899999976544 3456788999999999999999999999999
Q ss_pred CeeEEEEEecCCCCHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecC
Q 011851 200 DQRLLVYEFMPRGSLENHLFRR---SLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFG 276 (476)
Q Consensus 200 ~~~~lV~E~~~~g~L~~~l~~~---~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG 276 (476)
+..++||||+++++|.+++... ...+++..+..++.+++.||.|||+.+ ++|+||+|+||+++.++.++|+|||
T Consensus 72 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~ 148 (258)
T cd08215 72 GKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFG 148 (258)
T ss_pred CEEEEEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCcc
Confidence 9999999999999999999764 377999999999999999999999988 9999999999999999999999999
Q ss_pred CcCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhcccc
Q 011851 277 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERR 356 (476)
Q Consensus 277 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~ 356 (476)
++....... .......|++.|+|||.+....++.++|+||||+++|+|++|..||....... ... ....
T Consensus 149 ~~~~~~~~~--~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~---~~~---~~~~--- 217 (258)
T cd08215 149 ISKVLSSTV--DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLE---LAL---KILK--- 217 (258)
T ss_pred ceeecccCc--ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHH---HHH---HHhc---
Confidence 998754432 12233578999999999998899999999999999999999999996543211 111 0000
Q ss_pred ccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCc
Q 011851 357 RFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYL 409 (476)
Q Consensus 357 ~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~ 409 (476)
....+ .+...+.++.+++.+||..+|++|||+.+++++ |||
T Consensus 218 ---~~~~~-----~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~----~~~ 258 (258)
T cd08215 218 ---GQYPP-----IPSQYSSELRNLVSSLLQKDPEERPSIAQILQS----PFI 258 (258)
T ss_pred ---CCCCC-----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC----CCC
Confidence 00111 111235788999999999999999999999997 775
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=318.12 Aligned_cols=273 Identities=23% Similarity=0.314 Sum_probs=202.5
Q ss_pred cCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCcc--CHHHHHHHHHHHhCCCCCceeeEEEEEEe
Q 011851 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQ--GHKEWLAEVNYLGGLIHPNLVKLIGCCIE 198 (476)
Q Consensus 121 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~l~~~~~~ 198 (476)
++|++.+.||+|+||.||+|.+. .+|+.||+|.+...... ....+.+|++++++++||||+++++++.+
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~---------~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 72 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDR---------VTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHS 72 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEec---------CCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEec
Confidence 46899999999999999998654 46788999998654332 23567889999999999999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecC-CCceEEeecC
Q 011851 199 DDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDG-EYNAKLSDFG 276 (476)
Q Consensus 199 ~~~~~lV~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~-~~~vkl~DFG 276 (476)
+...|+||||++ ++|.+++... ...+++..+..++.||+.||+|||+++ |+||||+|+||+++. ++.+||+|||
T Consensus 73 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg 148 (294)
T PLN00009 73 EKRLYLVFEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFG 148 (294)
T ss_pred CCeEEEEEeccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccc
Confidence 999999999995 5888877543 333678888999999999999999988 999999999999985 5679999999
Q ss_pred CcCCCCCCCccceeeeeecCCCCCCcchhhcC-CCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcch-hHHhhhhhhcc
Q 011851 277 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHN-LVEWARPQLGE 354 (476)
Q Consensus 277 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~-~~~~~~~~~~~ 354 (476)
++....... .......+++.|+|||++.+. .++.++|||||||++|+|++|+.||.......... ...........
T Consensus 149 ~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 226 (294)
T PLN00009 149 LARAFGIPV--RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEE 226 (294)
T ss_pred cccccCCCc--cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence 997643211 112234678899999988764 67899999999999999999999997643321111 00000000000
Q ss_pred cc-----------ccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCccccc
Q 011851 355 RR-----------RFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDMA 413 (476)
Q Consensus 355 ~~-----------~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~~~ 413 (476)
.. .+..+....+. ......+.++.+++.+||+.||++||++.+++++ |||.+..
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~----~~~~~~~ 291 (294)
T PLN00009 227 TWPGVTSLPDYKSAFPKWPPKDLA-TVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH----EYFKDLG 291 (294)
T ss_pred hccccccchhhhhhcccCCCCCHH-HhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC----chHhHHh
Confidence 00 00000000000 0011235678999999999999999999999997 8988653
|
|
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=316.70 Aligned_cols=246 Identities=29% Similarity=0.426 Sum_probs=198.2
Q ss_pred CCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCcc---CHHHHHHHHHHHhCCCCCceeeEEEEEEe
Q 011851 122 SFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQ---GHKEWLAEVNYLGGLIHPNLVKLIGCCIE 198 (476)
Q Consensus 122 ~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~---~~~~~~~E~~~l~~l~hpnIv~l~~~~~~ 198 (476)
.|...+.||+|+||.||+|.+. .++..||+|++...... ....+.+|++++++++|+||+++++++.+
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~---------~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 96 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDV---------RTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLR 96 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEc---------CCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEee
Confidence 3778889999999999998754 36778999998754332 23468889999999999999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCc
Q 011851 199 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLA 278 (476)
Q Consensus 199 ~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a 278 (476)
++..||||||+. |+|.+.+.....++++..+..++.||+.||.|||+.+ |+||||+|+||+++.++.++|+|||++
T Consensus 97 ~~~~~lv~e~~~-g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~ 172 (317)
T cd06635 97 EHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSA 172 (317)
T ss_pred CCeEEEEEeCCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCc
Confidence 999999999996 4888888666677999999999999999999999988 999999999999999999999999998
Q ss_pred CCCCCCCccceeeeeecCCCCCCcchhh---cCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhccc
Q 011851 279 KDGPEGDKTHVSTRVMGTYGYAAPEYVM---TGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGER 355 (476)
Q Consensus 279 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~ 355 (476)
...... ....|++.|+|||++. .+.++.++|||||||++|||++|+.||.......... .+... ..
T Consensus 173 ~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~--~~~~~---~~ 241 (317)
T cd06635 173 SIASPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY--HIAQN---ES 241 (317)
T ss_pred cccCCc------ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHH--HHHhc---cC
Confidence 754321 2356889999999874 4568899999999999999999999986542211110 00000 00
Q ss_pred cccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011851 356 RRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEA 402 (476)
Q Consensus 356 ~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~ 402 (476)
+. ......+..+.+|+.+||+.+|.+||++.+++++
T Consensus 242 --------~~---~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 277 (317)
T cd06635 242 --------PT---LQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKH 277 (317)
T ss_pred --------CC---CCCccccHHHHHHHHHHccCCcccCcCHHHHHhC
Confidence 00 0011235678999999999999999999999998
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=311.12 Aligned_cols=253 Identities=23% Similarity=0.379 Sum_probs=203.7
Q ss_pred CCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCc--cCHHHHHHHHHHHhCCCCCceeeEEEEEEeC
Q 011851 122 SFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL--QGHKEWLAEVNYLGGLIHPNLVKLIGCCIED 199 (476)
Q Consensus 122 ~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~ 199 (476)
+|.+.+.||+|+||.||+|.+. .+|..||+|.+..... ...+.+.+|+.+++.++|+||+++++++.++
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~---------~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~ 71 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAK---------SDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQEN 71 (257)
T ss_pred CceEEEEecCCCcceEEEEEEc---------CCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccC
Confidence 4788899999999999998765 3567799999875432 2345678999999999999999999999999
Q ss_pred CeeEEEEEecCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCc-eEEeecCC
Q 011851 200 DQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYN-AKLSDFGL 277 (476)
Q Consensus 200 ~~~~lV~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~-vkl~DFG~ 277 (476)
+..|+||||+++++|.+++.+. ...+++..+..++.|++.||.|||+.+ |+|+||||+||++++++. +||+|||.
T Consensus 72 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~ 148 (257)
T cd08225 72 GRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGI 148 (257)
T ss_pred CeEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEeccccc
Confidence 9999999999999999998654 335899999999999999999999988 999999999999988864 69999999
Q ss_pred cCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhccccc
Q 011851 278 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRR 357 (476)
Q Consensus 278 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 357 (476)
+........ ......|++.|+|||++.+..++.++|+|||||++|||++|..||....... ........
T Consensus 149 ~~~~~~~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~------~~~~~~~~--- 217 (257)
T cd08225 149 ARQLNDSME--LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQ------LVLKICQG--- 217 (257)
T ss_pred chhccCCcc--cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHH------HHHHHhcc---
Confidence 976543221 1223468999999999988889999999999999999999999996543211 11110000
Q ss_pred cccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCc
Q 011851 358 FYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYL 409 (476)
Q Consensus 358 ~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~ 409 (476)
.+.+ .....+.++.+++.+||..+|++|||+.+++++ |||
T Consensus 218 ---~~~~-----~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~----~~~ 257 (257)
T cd08225 218 ---YFAP-----ISPNFSRDLRSLISQLFKVSPRDRPSITSILKR----PFL 257 (257)
T ss_pred ---cCCC-----CCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC----CCC
Confidence 0000 111225689999999999999999999999997 775
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-39 Score=309.89 Aligned_cols=252 Identities=25% Similarity=0.344 Sum_probs=199.9
Q ss_pred cCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCC-----ccCHHHHHHHHHHHhCCCCCceeeEEEE
Q 011851 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDG-----LQGHKEWLAEVNYLGGLIHPNLVKLIGC 195 (476)
Q Consensus 121 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~-----~~~~~~~~~E~~~l~~l~hpnIv~l~~~ 195 (476)
.+|++.+.||+|+||.||+|.+. .++..||+|.+.... ......+.+|++++++++|+||++++++
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~---------~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~ 72 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDA---------DTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGC 72 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEc---------CCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEE
Confidence 46899999999999999998654 467889999875321 1223467889999999999999999999
Q ss_pred EEeC--CeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEe
Q 011851 196 CIED--DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLS 273 (476)
Q Consensus 196 ~~~~--~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~ 273 (476)
+.+. ..+++||||+++++|.+++... ..+++..+..++.||+.||.|||+.+ |+|+||||+||+++.++.++|+
T Consensus 73 ~~~~~~~~~~~v~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~ 148 (264)
T cd06653 73 LRDPEEKKLSIFVEYMPGGSIKDQLKAY-GALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLG 148 (264)
T ss_pred EEcCCCCEEEEEEEeCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEC
Confidence 8764 4688999999999999998543 45889999999999999999999988 9999999999999999999999
Q ss_pred ecCCcCCCCCCCc-cceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhh
Q 011851 274 DFGLAKDGPEGDK-THVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQL 352 (476)
Q Consensus 274 DFG~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~ 352 (476)
|||+++....... ........|+..|+|||++.+..++.++|||||||++|+|++|+.||....... ......
T Consensus 149 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~~~~~---- 222 (264)
T cd06653 149 DFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMA--AIFKIA---- 222 (264)
T ss_pred ccccccccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHH--HHHHHH----
Confidence 9999986432111 011123568999999999998889999999999999999999999997532211 111100
Q ss_pred ccccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011851 353 GERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEA 402 (476)
Q Consensus 353 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~ 402 (476)
.......++...++++.+++.+||. +|..||++.+++.|
T Consensus 223 ----------~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~ 261 (264)
T cd06653 223 ----------TQPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRH 261 (264)
T ss_pred ----------cCCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcC
Confidence 0001112233446789999999999 57999999999887
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=326.33 Aligned_cols=276 Identities=22% Similarity=0.316 Sum_probs=205.6
Q ss_pred cCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCc--cCHHHHHHHHHHHhCCCCCceeeEEEEEEe
Q 011851 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL--QGHKEWLAEVNYLGGLIHPNLVKLIGCCIE 198 (476)
Q Consensus 121 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~ 198 (476)
.+|.+.+.||+|+||.||+|.+. .+|+.||+|++..... ...+.+.+|+.+|++++||||+++++++..
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~---------~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 75 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDT---------RSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRP 75 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEc---------CCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccc
Confidence 57999999999999999998654 4688899999875432 334567889999999999999999998763
Q ss_pred ----CCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEee
Q 011851 199 ----DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSD 274 (476)
Q Consensus 199 ----~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~D 274 (476)
...+|+||||+. ++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|
T Consensus 76 ~~~~~~~~~lv~e~~~-~~l~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~d 150 (334)
T cd07855 76 PGADFKDVYVVMDLME-SDLHHIIHS-DQPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGD 150 (334)
T ss_pred cCCCCceEEEEEehhh-hhHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEecc
Confidence 356899999995 689888844 456999999999999999999999988 99999999999999999999999
Q ss_pred cCCcCCCCCCCcc--ceeeeeecCCCCCCcchhhc-CCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhh
Q 011851 275 FGLAKDGPEGDKT--HVSTRVMGTYGYAAPEYVMT-GHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQ 351 (476)
Q Consensus 275 FG~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~ 351 (476)
||++......... .......|+..|+|||++.+ ..++.++|||||||++|||++|+.||...........+......
T Consensus 151 fg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~ 230 (334)
T cd07855 151 FGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGS 230 (334)
T ss_pred cccceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCC
Confidence 9999764332211 11233578999999998866 46899999999999999999999999764332111110000000
Q ss_pred hc-------cccccccccC---cccC---CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCcccccC
Q 011851 352 LG-------ERRRFYRLID---PCLE---GCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDMAS 414 (476)
Q Consensus 352 ~~-------~~~~~~~~~d---~~l~---~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~~~~ 414 (476)
.. ....+.+.++ .... .......+.++.++|.+||+.||++||++.+++.+ ||+++...
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~----~~~~~~~~ 302 (334)
T cd07855 231 PSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH----PFLAQYHD 302 (334)
T ss_pred ChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC----hhhhhccC
Confidence 00 0000000000 0000 00011236789999999999999999999999997 99876543
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=323.50 Aligned_cols=276 Identities=26% Similarity=0.346 Sum_probs=204.4
Q ss_pred hccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCC--CccCHHHHHHHHHHHhCC-CCCceeeEEEE
Q 011851 119 ATKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHD--GLQGHKEWLAEVNYLGGL-IHPNLVKLIGC 195 (476)
Q Consensus 119 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~--~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~ 195 (476)
..++|.+.+.||+|+||.||+|.+. .+|+.||+|.+... .......+.+|+.+++++ +||||++++++
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~---------~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~ 75 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDR---------RTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNV 75 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEc---------CCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeee
Confidence 3467999999999999999998754 36778999988543 222344577899999999 99999999999
Q ss_pred EEeC--CeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEe
Q 011851 196 CIED--DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLS 273 (476)
Q Consensus 196 ~~~~--~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~ 273 (476)
+... ...|+||||++ ++|.+++... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+
T Consensus 76 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~ 149 (337)
T cd07852 76 IKAENDKDIYLVFEYME-TDLHAVIRAN--ILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLA 149 (337)
T ss_pred eccCCCceEEEEecccc-cCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEe
Confidence 8654 36899999996 5998888543 6889999999999999999999988 9999999999999999999999
Q ss_pred ecCCcCCCCCCCcc---ceeeeeecCCCCCCcchhhc-CCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhh
Q 011851 274 DFGLAKDGPEGDKT---HVSTRVMGTYGYAAPEYVMT-GHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR 349 (476)
Q Consensus 274 DFG~a~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~ 349 (476)
|||++......... .......||..|+|||++.+ ..++.++|||||||++|+|++|+.||...........+....
T Consensus 150 d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~ 229 (337)
T cd07852 150 DFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVI 229 (337)
T ss_pred eccchhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Confidence 99999865433221 12234678999999998765 467899999999999999999999996543321111000000
Q ss_pred hhh----------ccccccccccC----cccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCcccccC
Q 011851 350 PQL----------GERRRFYRLID----PCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDMAS 414 (476)
Q Consensus 350 ~~~----------~~~~~~~~~~d----~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~~~~ 414 (476)
... .....+...+. ..+.... ...+.++.++|.+||+.||++|||+.+++++ +|++++..
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~l~~li~~~l~~~P~~Rps~~~il~~----~~~~~~~~ 303 (337)
T cd07852 230 GPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELL-PKASDDALDLLKKLLVFNPNKRLTAEEALEH----PYVAQFHN 303 (337)
T ss_pred CCCCHHHHHHHHhhhHHHhhhhcccccccchhhhc-cCCCHHHHHHHHHhccCCcccccCHHHHhhC----hhhhhhcc
Confidence 000 00000000000 0000000 1135788999999999999999999999997 88877543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=315.10 Aligned_cols=267 Identities=25% Similarity=0.339 Sum_probs=200.7
Q ss_pred CCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCcc--CHHHHHHHHHHHhCCCCCceeeEEEEEEeCC
Q 011851 123 FRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQ--GHKEWLAEVNYLGGLIHPNLVKLIGCCIEDD 200 (476)
Q Consensus 123 y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 200 (476)
|++.+.||.|++|.||+|.+. .+|..||+|++...... ....+.+|+++++.++||||+++++++.+++
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~---------~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~ 71 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDK---------LTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSEN 71 (283)
T ss_pred CchheEecCCCCeEEEEEEEc---------CCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCC
Confidence 677889999999999998764 36778999998754322 2356788999999999999999999999999
Q ss_pred eeEEEEEecCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCcC
Q 011851 201 QRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAK 279 (476)
Q Consensus 201 ~~~lV~E~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~ 279 (476)
..|+||||++ ++|.+++.... ..+++..++.++.||+.||+|||+.+ ++||||+|+||+++.++.++|+|||++.
T Consensus 72 ~~~iv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~ 147 (283)
T cd07835 72 KLYLVFEFLD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLAR 147 (283)
T ss_pred eEEEEEeccC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeeccccc
Confidence 9999999994 68999886543 46899999999999999999999987 9999999999999999999999999997
Q ss_pred CCCCCCccceeeeeecCCCCCCcchhhcC-CCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcch-hHHhhhhhh-----
Q 011851 280 DGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHN-LVEWARPQL----- 352 (476)
Q Consensus 280 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~-~~~~~~~~~----- 352 (476)
........ .....++..|+|||++.+. .++.++|||||||++|+|++|+.||.......... .........
T Consensus 148 ~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (283)
T cd07835 148 AFGVPVRT--YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWP 225 (283)
T ss_pred ccCCCccc--cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhh
Confidence 64322111 1223568899999988764 57899999999999999999999997543311110 000000000
Q ss_pred --cc----ccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCc
Q 011851 353 --GE----RRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYL 409 (476)
Q Consensus 353 --~~----~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~ 409 (476)
.. ...+.......... .....+..+.++|.+||+.||++|||+.+++++ +||
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~----~~~ 283 (283)
T cd07835 226 GVTSLPDYKPTFPKWARQDLSK-VVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH----PYF 283 (283)
T ss_pred hhhhchhhhhhcccccccchhh-hcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC----CCC
Confidence 00 00000000000000 011224688999999999999999999999987 775
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=315.13 Aligned_cols=269 Identities=24% Similarity=0.317 Sum_probs=203.8
Q ss_pred CCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCC--ccCHHHHHHHHHHHhCCCCCceeeEEEEEEeC-
Q 011851 123 FRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDG--LQGHKEWLAEVNYLGGLIHPNLVKLIGCCIED- 199 (476)
Q Consensus 123 y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~- 199 (476)
|.+.+.||+|+||.||+|.+. .+++.||+|.+.... ......+.+|++++++++|+||+++++++...
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~---------~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 71 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNK---------KTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKG 71 (287)
T ss_pred CeeeEEeccCCCeEEEEEEEC---------CCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCC
Confidence 677889999999999998765 357789999998763 22345678899999999999999999999988
Q ss_pred -CeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCc
Q 011851 200 -DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLA 278 (476)
Q Consensus 200 -~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a 278 (476)
+..++||||+++ +|.+++......+++..++.++.||+.||+|||+.+ ++|+||||+|||+++++.+||+|||++
T Consensus 72 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~ 147 (287)
T cd07840 72 KGSIYMVFEYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLA 147 (287)
T ss_pred CCcEEEEeccccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccce
Confidence 899999999964 898888666567999999999999999999999988 999999999999999999999999999
Q ss_pred CCCCCCCccceeeeeecCCCCCCcchhhc-CCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhh-h-hhhccc
Q 011851 279 KDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA-R-PQLGER 355 (476)
Q Consensus 279 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~-~-~~~~~~ 355 (476)
......... ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||...........+... . +.....
T Consensus 148 ~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (287)
T cd07840 148 RPYTKRNSA-DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENW 226 (287)
T ss_pred eeccCCCcc-cccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhc
Confidence 876443211 1223457888999998765 46889999999999999999999999765432211111000 0 000000
Q ss_pred ccccc-----------ccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCc
Q 011851 356 RRFYR-----------LIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYL 409 (476)
Q Consensus 356 ~~~~~-----------~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~ 409 (476)
..+.. .....+...+....+..+.+++.+||+.||.+||++.+++++ +||
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~----~~~ 287 (287)
T cd07840 227 PGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH----EYF 287 (287)
T ss_pred cccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC----cCC
Confidence 00000 000000111111126688999999999999999999999987 775
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=324.81 Aligned_cols=272 Identities=24% Similarity=0.324 Sum_probs=203.8
Q ss_pred ccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCC--ccCHHHHHHHHHHHhCCCCCceeeEEEEEE
Q 011851 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDG--LQGHKEWLAEVNYLGGLIHPNLVKLIGCCI 197 (476)
Q Consensus 120 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~ 197 (476)
.++|.+.+.||+|+||+||+|.+. .+++.||||.+.... ......+.+|+.+++.++|+||+++++++.
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~ 74 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNS---------ETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMP 74 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEec---------CCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHhee
Confidence 457999999999999999998654 478889999987532 223456778999999999999999999876
Q ss_pred eC-----CeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEE
Q 011851 198 ED-----DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKL 272 (476)
Q Consensus 198 ~~-----~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl 272 (476)
.. ...||||||+. ++|.+++.. ...+++..+..++.||+.||.|||+.+ ++||||||+|||++.++.+||
T Consensus 75 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL 149 (337)
T cd07858 75 PPHREAFNDVYIVYELMD-TDLHQIIRS-SQTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKI 149 (337)
T ss_pred cccccccCcEEEEEeCCC-CCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEE
Confidence 54 35899999995 689888854 457999999999999999999999988 999999999999999999999
Q ss_pred eecCCcCCCCCCCccceeeeeecCCCCCCcchhhc-CCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHH-hhhh
Q 011851 273 SDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVE-WARP 350 (476)
Q Consensus 273 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~-~~~~ 350 (476)
+|||+++...... .......++..|+|||++.. ..++.++|||||||++|+|++|+.||...........+. ....
T Consensus 150 ~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 227 (337)
T cd07858 150 CDFGLARTTSEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGS 227 (337)
T ss_pred CcCccccccCCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCC
Confidence 9999998754322 11233568899999998875 468999999999999999999999997543211110000 0000
Q ss_pred hhcc------ccccccc-------cCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCcccc
Q 011851 351 QLGE------RRRFYRL-------IDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDM 412 (476)
Q Consensus 351 ~~~~------~~~~~~~-------~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~~ 412 (476)
.... .....+. .+...... ....+.++.+||.+||+.||++|||+.++++| ||+..+
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h----~~~~~~ 297 (337)
T cd07858 228 PSEEDLGFIRNEKARRYIRSLPYTPRQSFARL-FPHANPLAIDLLEKMLVFDPSKRITVEEALAH----PYLASL 297 (337)
T ss_pred CChHHhhhcCchhhhHHHHhcCcccccCHHHH-cccCCHHHHHHHHHHhcCChhhccCHHHHHcC----cchhhh
Confidence 0000 0000000 00000000 11235778999999999999999999999998 888754
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=322.03 Aligned_cols=258 Identities=29% Similarity=0.466 Sum_probs=214.6
Q ss_pred CCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCC-ccCHHHHHHHHHHHhCCCCCceeeEEEEEEeCC
Q 011851 122 SFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDG-LQGHKEWLAEVNYLGGLIHPNLVKLIGCCIEDD 200 (476)
Q Consensus 122 ~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 200 (476)
...+.++||.|-||.||+|.+... +++...-||||..+.+. ....+.|+.|..+|++++|||||+|+|++.+.
T Consensus 390 ~Itl~r~iG~GqFGdVy~gvYt~~-----~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~- 463 (974)
T KOG4257|consen 390 LITLKRLIGEGQFGDVYKGVYTDP-----EKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ- 463 (974)
T ss_pred hccHHHhhcCCcccceeeeEeccc-----ccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-
Confidence 345667899999999999987643 23455669999998743 44566799999999999999999999998765
Q ss_pred eeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCcCC
Q 011851 201 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKD 280 (476)
Q Consensus 201 ~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~ 280 (476)
..|||||+++-|.|..+|..+...++......++.||+.||.|||+.. +|||||...|||+.....|||+|||+++.
T Consensus 464 P~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGLSR~ 540 (974)
T KOG4257|consen 464 PMWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGLSRY 540 (974)
T ss_pred ceeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccchhhh
Confidence 789999999999999999888888999999999999999999999977 99999999999999999999999999999
Q ss_pred CCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhhccccccc
Q 011851 281 GPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPQLGERRRFY 359 (476)
Q Consensus 281 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 359 (476)
..+...+..+ +..-...|||||-+.-..++.++|||-|||++||++. |..||.+....+....++ +..+
T Consensus 541 ~ed~~yYkaS-~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iE-------nGeR-- 610 (974)
T KOG4257|consen 541 LEDDAYYKAS-RGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIE-------NGER-- 610 (974)
T ss_pred ccccchhhcc-ccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEec-------CCCC--
Confidence 8776655443 3445678999999999999999999999999999886 899998766554332222 1111
Q ss_pred cccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011851 360 RLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPL 406 (476)
Q Consensus 360 ~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~ 406 (476)
-|+.. .++..+..|+.+||..+|.+||++.+|...|..+
T Consensus 611 ---lP~P~-----nCPp~LYslmskcWayeP~kRPrftei~~~lsdv 649 (974)
T KOG4257|consen 611 ---LPCPP-----NCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDV 649 (974)
T ss_pred ---CCCCC-----CCChHHHHHHHHHhccCcccCCcHHHHHHHHHHH
Confidence 12223 3477888999999999999999999999987654
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=319.43 Aligned_cols=272 Identities=28% Similarity=0.347 Sum_probs=201.2
Q ss_pred ccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccC--HHHHHHHHHHHhCCCCCceeeEEEEEE
Q 011851 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQG--HKEWLAEVNYLGGLIHPNLVKLIGCCI 197 (476)
Q Consensus 120 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~--~~~~~~E~~~l~~l~hpnIv~l~~~~~ 197 (476)
.++|++.++||+|+||.||+|.+. .+++.||||++....... ...+.+|+++++.++||||+++++++.
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~---------~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 77 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQI---------KTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAV 77 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEEC---------CCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhhee
Confidence 467999999999999999998654 467789999986543322 345678999999999999999999875
Q ss_pred eCC--------eeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCc
Q 011851 198 EDD--------QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYN 269 (476)
Q Consensus 198 ~~~--------~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~ 269 (476)
+.. .+|+||||+. ++|...+......+++..+..++.||++||.|||+.+ |+||||||+|||++.++.
T Consensus 78 ~~~~~~~~~~~~~~lv~~~~~-~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~ 153 (311)
T cd07866 78 ERPDKSKRKRGSVYMVTPYMD-HDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGI 153 (311)
T ss_pred cccccccccCceEEEEEecCC-cCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCC
Confidence 543 4699999995 4788777666667999999999999999999999988 999999999999999999
Q ss_pred eEEeecCCcCCCCCCCcc---------ceeeeeecCCCCCCcchhhcC-CCCccchhhhhHHHHHHHHhCCCCCCCCCCC
Q 011851 270 AKLSDFGLAKDGPEGDKT---------HVSTRVMGTYGYAAPEYVMTG-HLTAKSDVYSFGVVLLEMLTGRRSMDKNRPN 339 (476)
Q Consensus 270 vkl~DFG~a~~~~~~~~~---------~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGv~l~elltG~~pf~~~~~~ 339 (476)
++|+|||+++........ ...+...|++.|+|||++.+. .++.++|||||||++|||++|++||......
T Consensus 154 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~ 233 (311)
T cd07866 154 LKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDI 233 (311)
T ss_pred EEECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHH
Confidence 999999999764332211 111235678999999988764 5889999999999999999999999764432
Q ss_pred CcchhHHhhhhh-----hccccccccc--------cCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011851 340 GEHNLVEWARPQ-----LGERRRFYRL--------IDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPL 406 (476)
Q Consensus 340 ~~~~~~~~~~~~-----~~~~~~~~~~--------~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~ 406 (476)
.....+...... ......+... ..+.+...+ ......+.++|.+||+.||++|||+.+++.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~---- 308 (311)
T cd07866 234 DQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERF-GKLGPEGLDLLSKLLSLDPYKRLTASDALEH---- 308 (311)
T ss_pred HHHHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHc-ccCChhHHHHHHHHcccCcccCcCHHHHhcC----
Confidence 211111000000 0000000000 000010000 0113578899999999999999999999987
Q ss_pred CCc
Q 011851 407 PYL 409 (476)
Q Consensus 407 ~~~ 409 (476)
|||
T Consensus 309 ~~f 311 (311)
T cd07866 309 PYF 311 (311)
T ss_pred CCC
Confidence 775
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-39 Score=309.03 Aligned_cols=250 Identities=26% Similarity=0.345 Sum_probs=193.9
Q ss_pred ccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccC---HHHHHHHHHH-HhCCCCCceeeEEEEEEeCCee
Q 011851 127 CLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQG---HKEWLAEVNY-LGGLIHPNLVKLIGCCIEDDQR 202 (476)
Q Consensus 127 ~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~---~~~~~~E~~~-l~~l~hpnIv~l~~~~~~~~~~ 202 (476)
+.||+|+||.||+|.+. .+|+.||+|+++...... ...+..|..+ ...++|+||+++++++..++.+
T Consensus 2 ~~l~~g~~~~v~~a~~~---------~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~ 72 (260)
T cd05611 2 KPISKGAFGSVYLAKKR---------STGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYL 72 (260)
T ss_pred ccCCcCCCeeEEEEEec---------CCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeE
Confidence 56999999999998654 367789999997654322 2234445444 4456899999999999999999
Q ss_pred EEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCcCCCC
Q 011851 203 LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGP 282 (476)
Q Consensus 203 ~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~ 282 (476)
|+||||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||+|+||+++.++.++|+|||++....
T Consensus 73 ~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 148 (260)
T cd05611 73 YLVMEYLNGGDCASLIKT-LGGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGL 148 (260)
T ss_pred EEEEeccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceecc
Confidence 999999999999998854 356899999999999999999999988 9999999999999999999999999987643
Q ss_pred CCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhcccccccccc
Q 011851 283 EGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRRFYRLI 362 (476)
Q Consensus 283 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 362 (476)
. .....|+..|+|||.+.+..++.++||||||+++|+|++|..||....... ..... ......
T Consensus 149 ~------~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~---~~~~~---~~~~~~----- 211 (260)
T cd05611 149 E------NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDA---VFDNI---LSRRIN----- 211 (260)
T ss_pred c------cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHH---HHHHH---HhcccC-----
Confidence 2 123568899999999988889999999999999999999999997543211 11100 000000
Q ss_pred CcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHH---HHHHHhcCCCCccccc
Q 011851 363 DPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMS---EVVEALKPLPYLKDMA 413 (476)
Q Consensus 363 d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~---ell~~L~~~~~~~~~~ 413 (476)
.........+.++.+++.+||+.||++||++. |++.| ||+++..
T Consensus 212 ---~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~----~~~~~~~ 258 (260)
T cd05611 212 ---WPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSH----PFFKSIN 258 (260)
T ss_pred ---CCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcC----hHhhcCC
Confidence 00001112357889999999999999999664 55554 8987654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-39 Score=315.14 Aligned_cols=272 Identities=25% Similarity=0.311 Sum_probs=203.1
Q ss_pred hccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCc--cCHHHHHHHHHHHhCCCCCceeeEEEEE
Q 011851 119 ATKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL--QGHKEWLAEVNYLGGLIHPNLVKLIGCC 196 (476)
Q Consensus 119 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~ 196 (476)
..++|++.+.||+|+||.||+|.+. .+|+.||+|+++.... .....+.+|++++++++||||+++++++
T Consensus 5 ~~~~~~~~~~lg~g~~g~v~~~~~~---------~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~ 75 (302)
T cd07864 5 CVDKFDIIGQIGEGTYGQVYKARDK---------DTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIV 75 (302)
T ss_pred hhhhhheeeeecccCCEEEEEEEEC---------CCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeehee
Confidence 4567999999999999999998764 3677899999975432 2234577899999999999999999998
Q ss_pred EeCC----------eeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecC
Q 011851 197 IEDD----------QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDG 266 (476)
Q Consensus 197 ~~~~----------~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~ 266 (476)
.+.. .+||||||+++ +|.+.+......+++..+..++.||+.||.|||+.+ |+||||||+||+++.
T Consensus 76 ~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~ 151 (302)
T cd07864 76 TDKQDALDFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNN 151 (302)
T ss_pred cCcchhhhccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECC
Confidence 7655 79999999975 787777665567999999999999999999999988 999999999999999
Q ss_pred CCceEEeecCCcCCCCCCCccceeeeeecCCCCCCcchhhcC-CCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhH
Q 011851 267 EYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV 345 (476)
Q Consensus 267 ~~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~ 345 (476)
++.+||+|||++......... ......++..|+|||++.+. .++.++|||||||++|||++|+.||...........+
T Consensus 152 ~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~ 230 (302)
T cd07864 152 KGQIKLADFGLARLYNSEESR-PYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELI 230 (302)
T ss_pred CCcEEeCcccccccccCCccc-ccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence 999999999999865443221 11223567889999988654 5789999999999999999999999754332211111
Q ss_pred Hhhh-hhhc-ccccc-----ccccC------cccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCc
Q 011851 346 EWAR-PQLG-ERRRF-----YRLID------PCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYL 409 (476)
Q Consensus 346 ~~~~-~~~~-~~~~~-----~~~~d------~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~ 409 (476)
.... .... ....+ ....+ ..+...+. ..+..+.+++.+||+.||.+||++.+++.+ ||+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~~l~~~P~~Rp~~~~il~~----~~~ 302 (302)
T cd07864 231 SRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFS-FIPTPALDLLDHMLTLDPSKRCTAEEALNS----PWL 302 (302)
T ss_pred HHHhCCCChhhcccccccccccccccccccccchhhhcC-CCCHHHHHHHHHHccCChhhCCCHHHHhcC----CCC
Confidence 1100 0000 00000 00000 00000010 125688999999999999999999999987 775
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=313.20 Aligned_cols=267 Identities=27% Similarity=0.352 Sum_probs=205.2
Q ss_pred CCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCcc--CHHHHHHHHHHHhCCCCCceeeEEEEEEeCC
Q 011851 123 FRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQ--GHKEWLAEVNYLGGLIHPNLVKLIGCCIEDD 200 (476)
Q Consensus 123 y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 200 (476)
|++.+.||+|++|.||+|.+. .+++.+++|.+...... ....+..|+.+|++++|+||+++++++..++
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~---------~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 71 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDK---------LTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKG 71 (283)
T ss_pred CccceeeecCCCceEEEEEcC---------CCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCC
Confidence 667789999999999998654 46788999998765433 3456788999999999999999999999999
Q ss_pred eeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCcCC
Q 011851 201 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKD 280 (476)
Q Consensus 201 ~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~ 280 (476)
..++||||+++ +|.+++......+++..+..++.||+.||.|||+.+ |+|+||||+||+++.++.++|+|||.+..
T Consensus 72 ~~~~v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~ 147 (283)
T cd05118 72 DLYLVFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARS 147 (283)
T ss_pred CEEEEEeccCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEe
Confidence 99999999965 898888776678999999999999999999999988 99999999999999999999999999977
Q ss_pred CCCCCccceeeeeecCCCCCCcchhhcC-CCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHH-hh-hhhhccccc
Q 011851 281 GPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVE-WA-RPQLGERRR 357 (476)
Q Consensus 281 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~-~~-~~~~~~~~~ 357 (476)
...... ......++..|+|||.+.+. .++.++||||||+++|+|++|+.||...........+. .. .+.......
T Consensus 148 ~~~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (283)
T cd05118 148 FGSPVR--PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPK 225 (283)
T ss_pred cCCCcc--cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhccc
Confidence 644321 12234688899999998877 78999999999999999999999997554321111100 00 000000000
Q ss_pred ccc--------c---cCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCc
Q 011851 358 FYR--------L---IDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYL 409 (476)
Q Consensus 358 ~~~--------~---~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~ 409 (476)
+.. . .+... .......+.++.++|.+||+.||.+||++.+++.+ ||+
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~----~~~ 283 (283)
T cd05118 226 FTSLARNYKFSFPKKAGMPL-PKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH----PYF 283 (283)
T ss_pred chhhhhhhhhhhccccccCH-HHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC----CCC
Confidence 000 0 00000 00111236789999999999999999999999997 775
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=320.71 Aligned_cols=269 Identities=21% Similarity=0.264 Sum_probs=197.7
Q ss_pred cccccc--CCccEEEEEEccCCceeeeCCCCceEEEEEecCCCcc--CHHHHHHHHHHHhCCCCCceeeEEEEEEeCCee
Q 011851 127 CLLGEG--GFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQ--GHKEWLAEVNYLGGLIHPNLVKLIGCCIEDDQR 202 (476)
Q Consensus 127 ~~LG~G--~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~ 202 (476)
..||+| +||+||+|.+. .+|+.||+|++...... ..+.+.+|+.+++.++||||++++++|..++..
T Consensus 4 ~~ig~g~~~~~~v~~a~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~ 74 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHT---------PTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWL 74 (328)
T ss_pred HHhCCcccCceeEEEEEEc---------CCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCce
Confidence 457776 99999998654 46888999998754332 235678899999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCcCCC
Q 011851 203 LLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDG 281 (476)
Q Consensus 203 ~lV~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~ 281 (476)
|+||||+.+++|.+++.+. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.++++||+.+...
T Consensus 75 ~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~ 151 (328)
T cd08226 75 WVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSL 151 (328)
T ss_pred EEEEecccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhh
Confidence 9999999999999988653 345899999999999999999999988 999999999999999999999999865432
Q ss_pred CCCCccc-----eeeeeecCCCCCCcchhhcC--CCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhh--
Q 011851 282 PEGDKTH-----VSTRVMGTYGYAAPEYVMTG--HLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQL-- 352 (476)
Q Consensus 282 ~~~~~~~-----~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~-- 352 (476)
....... ......++..|+|||++.+. .++.++|||||||++|||++|+.||........ .........
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~--~~~~~~~~~~~ 229 (328)
T cd08226 152 VRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQM--LLQKLKGPPYS 229 (328)
T ss_pred hccCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHH--HHHHhcCCCCC
Confidence 2111000 00112356679999999764 478999999999999999999999975432111 000000000
Q ss_pred -------c--------ccccc--------------ccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011851 353 -------G--------ERRRF--------------YRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEAL 403 (476)
Q Consensus 353 -------~--------~~~~~--------------~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L 403 (476)
. ....+ ....+..+........+..+.+|+.+||+.||++|||+.++++|
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~- 308 (328)
T cd08226 230 PLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSH- 308 (328)
T ss_pred CccccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhC-
Confidence 0 00000 00000111111122346789999999999999999999999998
Q ss_pred cCCCCccccc
Q 011851 404 KPLPYLKDMA 413 (476)
Q Consensus 404 ~~~~~~~~~~ 413 (476)
+||+...
T Consensus 309 ---~~~~~~~ 315 (328)
T cd08226 309 ---AFFKQVK 315 (328)
T ss_pred ---HHHHHHH
Confidence 8887543
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=304.89 Aligned_cols=252 Identities=30% Similarity=0.480 Sum_probs=206.9
Q ss_pred CCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCc--cCHHHHHHHHHHHhCCCCCceeeEEEEEEeC
Q 011851 122 SFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL--QGHKEWLAEVNYLGGLIHPNLVKLIGCCIED 199 (476)
Q Consensus 122 ~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~ 199 (476)
+|++.+.||+|+||.||+|.+. .+++.||+|.+..... .....+.+|++++++++|+||+++++++.++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~---------~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 71 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNL---------ETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETS 71 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEc---------CCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeC
Confidence 4888999999999999998654 4677899999987654 3446788999999999999999999999999
Q ss_pred CeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCcC
Q 011851 200 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAK 279 (476)
Q Consensus 200 ~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~ 279 (476)
+..++||||+++++|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++.
T Consensus 72 ~~~~~v~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~ 147 (254)
T cd06627 72 DSLYIILEYAENGSLRQIIKKF-GPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVAT 147 (254)
T ss_pred CEEEEEEecCCCCcHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccce
Confidence 9999999999999999998554 67999999999999999999999988 9999999999999999999999999998
Q ss_pred CCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhccccccc
Q 011851 280 DGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRRFY 359 (476)
Q Consensus 280 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 359 (476)
........ .....++..|+|||.+.+..++.++||||||+++|+|++|..||....... ..... ... ..
T Consensus 148 ~~~~~~~~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~--~~~~~---~~~---~~- 216 (254)
T cd06627 148 KLNDVSKD--DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMA--ALFRI---VQD---DH- 216 (254)
T ss_pred ecCCCccc--ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHH--HHHHH---hcc---CC-
Confidence 76543321 223568999999999988888999999999999999999999997543211 01110 000 00
Q ss_pred cccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCc
Q 011851 360 RLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYL 409 (476)
Q Consensus 360 ~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~ 409 (476)
..++...+..+.+++.+||..+|++||++.+++.+ +||
T Consensus 217 --------~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~----~~~ 254 (254)
T cd06627 217 --------PPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKH----PWI 254 (254)
T ss_pred --------CCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcC----CCC
Confidence 01112235788999999999999999999999986 765
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-39 Score=315.23 Aligned_cols=269 Identities=29% Similarity=0.437 Sum_probs=206.3
Q ss_pred ccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCcc-CHHHHHHHHHHHhCCC-CCceeeEEEEEE
Q 011851 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQ-GHKEWLAEVNYLGGLI-HPNLVKLIGCCI 197 (476)
Q Consensus 120 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~-~~~~~~~E~~~l~~l~-hpnIv~l~~~~~ 197 (476)
.++|++.+.||+|+||.||+|.+. .+++.||||.++..... ...++..|+.++.++. |+||+++++++.
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~---------~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~ 84 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFK---------KTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFI 84 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEEC---------CCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeee
Confidence 356889999999999999998764 35788999999764332 3345677887776665 999999999999
Q ss_pred eCCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCCeeecCCCceEEeecC
Q 011851 198 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHE-EAEKPVIYRDFKTSNILLDGEYNAKLSDFG 276 (476)
Q Consensus 198 ~~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~-~~~~~ivHrDlKp~NILl~~~~~vkl~DFG 276 (476)
++...|+||||+. ++|.+++......+++..+..++.||+.||.|||+ .+ |+||||+|+||+++.++.+||+|||
T Consensus 85 ~~~~~~~v~e~~~-~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL~dfg 160 (296)
T cd06618 85 TDSDVFICMELMS-TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDFG 160 (296)
T ss_pred cCCeEEEEeeccC-cCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEECccc
Confidence 9999999999994 57877776656689999999999999999999997 46 9999999999999999999999999
Q ss_pred CcCCCCCCCccceeeeeecCCCCCCcchhhcCC----CCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhh
Q 011851 277 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGH----LTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQL 352 (476)
Q Consensus 277 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~ 352 (476)
++........ .....++..|+|||++.+.. ++.++||||||+++|+|++|+.||...... ...... ..
T Consensus 161 ~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--~~~~~~---~~ 232 (296)
T cd06618 161 ISGRLVDSKA---KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE--FEVLTK---IL 232 (296)
T ss_pred cchhccCCCc---ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH--HHHHHH---Hh
Confidence 9876533221 12245788999999987553 888999999999999999999999653221 111110 00
Q ss_pred ccccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCcccccCcchHHHHH
Q 011851 353 GERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDMASSSSYVQAM 422 (476)
Q Consensus 353 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~~~~~~~~~~~~ 422 (476)
.... +.+.. ....+.++.+|+.+||+.||++||++.+++++ +|+..........+..
T Consensus 233 ~~~~-------~~~~~--~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~----~~~~~~~~~~~~~~~~ 289 (296)
T cd06618 233 QEEP-------PSLPP--NEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH----PFIRRYETAEVDVAGW 289 (296)
T ss_pred cCCC-------CCCCC--CCCCCHHHHHHHHHHccCChhhCCCHHHHhcC----hhhhccchhHHHHHHH
Confidence 0000 00000 01125678999999999999999999999987 9988766655544333
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=311.53 Aligned_cols=263 Identities=19% Similarity=0.227 Sum_probs=189.0
Q ss_pred ccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCH-----------HHHHHHHHHHhCCCCCc
Q 011851 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGH-----------KEWLAEVNYLGGLIHPN 188 (476)
Q Consensus 120 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~-----------~~~~~E~~~l~~l~hpn 188 (476)
.++|++.++||+|+||.||+|.+..++. .+..+|+|+......... .....+...+..+.|+|
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~------~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~ 84 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHC------INNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLG 84 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcc------cccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCC
Confidence 3579999999999999999997653311 145577776543322111 11223445567789999
Q ss_pred eeeEEEEEEeCC----eeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeee
Q 011851 189 LVKLIGCCIEDD----QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILL 264 (476)
Q Consensus 189 Iv~l~~~~~~~~----~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl 264 (476)
|+++++++.... ..+++||++ ..++.+.+.. ....++..+..++.|++.||.|||+.+ |+||||||+|||+
T Consensus 85 i~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill 159 (294)
T PHA02882 85 IPKYYGCGSFKRCRMYYRFILLEKL-VENTKEIFKR-IKCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMV 159 (294)
T ss_pred CCcEEEeeeEecCCceEEEEEEehh-ccCHHHHHHh-hccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEE
Confidence 999999876543 347888887 4467666633 334678889999999999999999988 9999999999999
Q ss_pred cCCCceEEeecCCcCCCCCCCcc-----ceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCC
Q 011851 265 DGEYNAKLSDFGLAKDGPEGDKT-----HVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPN 339 (476)
Q Consensus 265 ~~~~~vkl~DFG~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~ 339 (476)
+.++.++|+|||+|+........ .......||+.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus 160 ~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~ 239 (294)
T PHA02882 160 DGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHN 239 (294)
T ss_pred cCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccc
Confidence 99999999999999865322111 1112256999999999999999999999999999999999999999865332
Q ss_pred CcchhHHhhhhhhccccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011851 340 GEHNLVEWARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEAL 403 (476)
Q Consensus 340 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L 403 (476)
... +......... .+..... .....+.++.+++..||..+|++||++.++++.|
T Consensus 240 ~~~--~~~~~~~~~~-----~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 240 GNL--IHAAKCDFIK-----RLHEGKI---KIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred hHH--HHHhHHHHHH-----Hhhhhhh---ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 221 1110000000 0000000 0011257899999999999999999999999865
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=312.05 Aligned_cols=263 Identities=26% Similarity=0.358 Sum_probs=204.8
Q ss_pred CCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCc----cCHHHHHHHHHHHhCC-CCCceeeEEEEE
Q 011851 122 SFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL----QGHKEWLAEVNYLGGL-IHPNLVKLIGCC 196 (476)
Q Consensus 122 ~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~----~~~~~~~~E~~~l~~l-~hpnIv~l~~~~ 196 (476)
+|++.+.||.|+||.||+|.... ...+|..||+|++..... ...+.+.+|+.+|.++ +|+||+.+++++
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~------~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~ 74 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVS------GHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF 74 (290)
T ss_pred CceeeeeeccCCcceEEEEEecc------CCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEe
Confidence 47888999999999999987642 124688899999975432 2235677899999999 599999999999
Q ss_pred EeCCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecC
Q 011851 197 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFG 276 (476)
Q Consensus 197 ~~~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG 276 (476)
..+...|+||||+++++|.+++... ..+++..+..++.||+.||.|||+.+ ++||||+|+|||++.++.+||+|||
T Consensus 75 ~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg 150 (290)
T cd05613 75 QTDTKLHLILDYINGGELFTHLSQR-ERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFG 150 (290)
T ss_pred ecCCeEEEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCc
Confidence 9999999999999999999998654 56889999999999999999999988 9999999999999999999999999
Q ss_pred CcCCCCCCCccceeeeeecCCCCCCcchhhcC--CCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhcc
Q 011851 277 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG--HLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGE 354 (476)
Q Consensus 277 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~ 354 (476)
++........ .......|+..|+|||.+... .++.++||||||+++|+|++|..||......... ..+.......
T Consensus 151 ~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~--~~~~~~~~~~ 227 (290)
T cd05613 151 LSKEFHEDEV-ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQ--AEISRRILKS 227 (290)
T ss_pred cceecccccc-cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccH--HHHHHHhhcc
Confidence 9986543221 112235789999999998753 5788999999999999999999999643222111 1111111000
Q ss_pred ccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHhcCCCCccccc
Q 011851 355 RRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARP-----RMSEVVEALKPLPYLKDMA 413 (476)
Q Consensus 355 ~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RP-----t~~ell~~L~~~~~~~~~~ 413 (476)
. + .++...+..+.+++.+||+.||++|| ++.+++.+ |||+...
T Consensus 228 ~--------~----~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~----~~~~~~~ 275 (290)
T cd05613 228 E--------P----PYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH----PFFQKIN 275 (290)
T ss_pred C--------C----CCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC----cccccCC
Confidence 0 0 01122356788999999999999997 66777665 9988764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=314.33 Aligned_cols=254 Identities=25% Similarity=0.334 Sum_probs=206.1
Q ss_pred cCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCc---cCHHHHHHHHHHHhCCC-CCceeeEEEEE
Q 011851 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL---QGHKEWLAEVNYLGGLI-HPNLVKLIGCC 196 (476)
Q Consensus 121 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~---~~~~~~~~E~~~l~~l~-hpnIv~l~~~~ 196 (476)
++|.+.+.||+|+||.||+|.+. .+|+.||+|++..... ...+.+.+|+++++++. |+||+++++++
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~---------~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~ 71 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEK---------ETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTF 71 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEc---------CCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHh
Confidence 46899999999999999998654 3678899999976432 22356788999999998 99999999999
Q ss_pred EeCCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecC
Q 011851 197 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFG 276 (476)
Q Consensus 197 ~~~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG 276 (476)
..++..++||||+++++|.+++.+. ..+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||
T Consensus 72 ~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~ 147 (280)
T cd05581 72 QDEENLYFVLEYAPNGELLQYIRKY-GSLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFG 147 (280)
T ss_pred cCCceEEEEEcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCc
Confidence 9999999999999999999999654 47999999999999999999999988 9999999999999999999999999
Q ss_pred CcCCCCCCCcc------------------ceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCC
Q 011851 277 LAKDGPEGDKT------------------HVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRP 338 (476)
Q Consensus 277 ~a~~~~~~~~~------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~ 338 (476)
++......... .......|+..|+|||++....++.++||||||+++++|++|..||.....
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~ 227 (280)
T cd05581 148 TAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNE 227 (280)
T ss_pred cccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccH
Confidence 98865432211 112235688999999999888899999999999999999999999976542
Q ss_pred CCcchhHHhhhhhhccccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCH----HHHHHHhcCCCCc
Q 011851 339 NGEHNLVEWARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRM----SEVVEALKPLPYL 409 (476)
Q Consensus 339 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~----~ell~~L~~~~~~ 409 (476)
... ..... .. ...++...++.+.+++.+||+.||++||++ .++++| |||
T Consensus 228 ~~~---~~~~~---~~------------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~----~~~ 280 (280)
T cd05581 228 YLT---FQKIL---KL------------EYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAH----PFF 280 (280)
T ss_pred HHH---HHHHH---hc------------CCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcC----CCC
Confidence 111 11000 00 001122236788999999999999999999 777776 775
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=329.41 Aligned_cols=253 Identities=28% Similarity=0.443 Sum_probs=207.6
Q ss_pred CCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCcc-CHHHHHHHHHHHhCCCCCceeeEEEEEEeCCe
Q 011851 123 FRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQ-GHKEWLAEVNYLGGLIHPNLVKLIGCCIEDDQ 201 (476)
Q Consensus 123 y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~ 201 (476)
.++.++||+|.||.|++|.|..... +-..||||+++..... ....|++|+.+|.+|+|+|+++|||+..+ ..
T Consensus 112 i~l~e~LG~GsFgvV~rg~Wt~psg------k~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp 184 (1039)
T KOG0199|consen 112 IKLYELLGEGSFGVVKRGTWTQPSG------KHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QP 184 (1039)
T ss_pred HHHHHHhcCcceeeEeeccccCCCC------cEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-ch
Confidence 4566889999999999999875432 3456999999877655 56789999999999999999999999887 67
Q ss_pred eEEEEEecCCCCHHHHHhh-cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCcCC
Q 011851 202 RLLVYEFMPRGSLENHLFR-RSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKD 280 (476)
Q Consensus 202 ~~lV~E~~~~g~L~~~l~~-~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~ 280 (476)
..||||+++.|+|.+.|++ ....|.....-.++.||+.|+.||..++ +|||||...|+||-..-.|||||||+.+.
T Consensus 185 ~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRa 261 (1039)
T KOG0199|consen 185 AMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRA 261 (1039)
T ss_pred hhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceec
Confidence 8899999999999999987 4567888888999999999999999987 99999999999998888999999999998
Q ss_pred CCCCCccceee-eeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhhcccccc
Q 011851 281 GPEGDKTHVST-RVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPQLGERRRF 358 (476)
Q Consensus 281 ~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 358 (476)
+...+...... ...-...|+|||.+....++.++|||+|||+||||+| |..||.+.........++ ++.++
T Consensus 262 Lg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD-------~~erL 334 (1039)
T KOG0199|consen 262 LGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNID-------AGERL 334 (1039)
T ss_pred cCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhcc-------ccccC
Confidence 76655443222 1223557999999999999999999999999999998 678998765543332222 11111
Q ss_pred ccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011851 359 YRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEA 402 (476)
Q Consensus 359 ~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~ 402 (476)
++ +..+++.++++++.||..+|++|||+.+|.+.
T Consensus 335 -----pR-----Pk~csedIY~imk~cWah~paDRptFsair~~ 368 (1039)
T KOG0199|consen 335 -----PR-----PKYCSEDIYQIMKNCWAHNPADRPTFSAIRED 368 (1039)
T ss_pred -----CC-----CCCChHHHHHHHHHhccCCccccccHHHHHHh
Confidence 11 22348999999999999999999999999643
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=313.39 Aligned_cols=256 Identities=28% Similarity=0.398 Sum_probs=203.3
Q ss_pred cCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCc---cCHHHHHHHHHHHhCCCCCceeeEEEEEE
Q 011851 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL---QGHKEWLAEVNYLGGLIHPNLVKLIGCCI 197 (476)
Q Consensus 121 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~l~~~~~ 197 (476)
+.|...+.||+|+||.||+|.+. .+++.||+|.+..... ....++.+|+++++.++|+||+++++++.
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~---------~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 85 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDV---------RNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYL 85 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEc---------CCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEE
Confidence 34777889999999999998764 3577899999865322 22346778999999999999999999999
Q ss_pred eCCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCC
Q 011851 198 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGL 277 (476)
Q Consensus 198 ~~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~ 277 (476)
.....|+||||+. ++|.+.+.....++++..+..++.|++.||.|||+.+ ++||||||+|||++.++.++|+|||+
T Consensus 86 ~~~~~~lv~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~ 161 (308)
T cd06634 86 REHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGS 161 (308)
T ss_pred cCCeeEEEEEccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCccc
Confidence 9999999999996 5888887666667899999999999999999999988 99999999999999999999999999
Q ss_pred cCCCCCCCccceeeeeecCCCCCCcchhh---cCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhcc
Q 011851 278 AKDGPEGDKTHVSTRVMGTYGYAAPEYVM---TGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGE 354 (476)
Q Consensus 278 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~ 354 (476)
+...... ....|++.|+|||++. ...++.++|||||||++|+|++|..||......... ..+..
T Consensus 162 ~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~--~~~~~----- 228 (308)
T cd06634 162 ASIMAPA------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL--YHIAQ----- 228 (308)
T ss_pred ceeecCc------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHH--HHHhh-----
Confidence 8764321 2356889999999985 346788999999999999999999998653221111 00000
Q ss_pred ccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCcccccCc
Q 011851 355 RRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDMASS 415 (476)
Q Consensus 355 ~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~~~~~ 415 (476)
.. .+.. .....+..+.+||.+||+.+|++||++.+++++ +|+......
T Consensus 229 ~~------~~~~---~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~----~~~~~~~~~ 276 (308)
T cd06634 229 NE------SPAL---QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH----RFVLRERPP 276 (308)
T ss_pred cC------CCCc---CcccccHHHHHHHHHHhhCCcccCCCHHHHhhC----ccccccCCh
Confidence 00 0000 011235678999999999999999999999998 887765443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=327.52 Aligned_cols=245 Identities=26% Similarity=0.295 Sum_probs=200.9
Q ss_pred hccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCC-CCCceeeEEEEEE
Q 011851 119 ATKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGL-IHPNLVKLIGCCI 197 (476)
Q Consensus 119 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~ 197 (476)
.+..|.+...+|.|+|+.|-.+ ....+++.+++|++.+.... ..+|+.++... +||||+++.+.+.
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~---------~~~~t~~~~~vkii~~~~~~----~~~e~~~~~~~~~h~niv~~~~v~~ 386 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYC---------ESSPTDQEPAVKIISKRADD----NQDEIPISLLVRDHPNIVKSHDVYE 386 (612)
T ss_pred cchhhccccccCCCCccceeee---------eccccccchhheeccccccc----cccccchhhhhcCCCcceeecceec
Confidence 3567888889999999999875 45568899999999876222 23566655554 6999999999999
Q ss_pred eCCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeee-cCCCceEEeecC
Q 011851 198 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILL-DGEYNAKLSDFG 276 (476)
Q Consensus 198 ~~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl-~~~~~vkl~DFG 276 (476)
++.+.|+|||++.|+.|.+.+.... .....+..|+.+|+.|+.|||+++ ||||||||+|||+ +..++++|+|||
T Consensus 387 ~~~~~~~v~e~l~g~ell~ri~~~~--~~~~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG 461 (612)
T KOG0603|consen 387 DGKEIYLVMELLDGGELLRRIRSKP--EFCSEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFG 461 (612)
T ss_pred CCceeeeeehhccccHHHHHHHhcc--hhHHHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEec
Confidence 9999999999999999988886543 233778889999999999999988 9999999999999 588999999999
Q ss_pred CcCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhcccc
Q 011851 277 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERR 356 (476)
Q Consensus 277 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~ 356 (476)
.++..... ....+-|..|.|||++....|+.++||||||++||+||+|+.||...... .++..
T Consensus 462 ~a~~~~~~-----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~--~ei~~---------- 524 (612)
T KOG0603|consen 462 FWSELERS-----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG--IEIHT---------- 524 (612)
T ss_pred hhhhCchh-----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch--HHHHH----------
Confidence 99876543 22356788999999999999999999999999999999999999865443 11111
Q ss_pred ccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCc
Q 011851 357 RFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYL 409 (476)
Q Consensus 357 ~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~ 409 (476)
....+.++...+.++++||.+||+.||.+|+++.+++.| +|+
T Consensus 525 -------~i~~~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h----~w~ 566 (612)
T KOG0603|consen 525 -------RIQMPKFSECVSDEAKDLLQQLLQVDPALRLGADEIGAH----PWF 566 (612)
T ss_pred -------hhcCCccccccCHHHHHHHHHhccCChhhCcChhhhccC----cch
Confidence 111122334458899999999999999999999999987 888
|
|
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-39 Score=319.49 Aligned_cols=275 Identities=25% Similarity=0.316 Sum_probs=202.8
Q ss_pred ccCCCc-cccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccC--------------HHHHHHHHHHHhCC
Q 011851 120 TKSFRP-ECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQG--------------HKEWLAEVNYLGGL 184 (476)
Q Consensus 120 ~~~y~~-~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~--------------~~~~~~E~~~l~~l 184 (476)
.++|.. .+.||.|+||+||+|.+. .+++.||||++....... ...+.+|+++++.+
T Consensus 7 ~~ry~~~~~~ig~G~~g~vy~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 77 (335)
T PTZ00024 7 SERYIQKGAHLGEGTYGKVEKAYDT---------LTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEI 77 (335)
T ss_pred ccchhhhhhcccCCCceeEEEEEEC---------CCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhC
Confidence 345654 577999999999998754 467889999986543221 12467899999999
Q ss_pred CCCceeeEEEEEEeCCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeee
Q 011851 185 IHPNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILL 264 (476)
Q Consensus 185 ~hpnIv~l~~~~~~~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl 264 (476)
+|+||+++++++..++..|+||||+. ++|.+++.. ...+++.....++.||+.||.|||+.+ |+|+||+|+||++
T Consensus 78 ~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~-~~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill 152 (335)
T PTZ00024 78 KHENIMGLVDVYVEGDFINLVMDIMA-SDLKKVVDR-KIRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFI 152 (335)
T ss_pred CCcceeeeeEEEecCCcEEEEEeccc-cCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEE
Confidence 99999999999999999999999996 689988844 456899999999999999999999988 9999999999999
Q ss_pred cCCCceEEeecCCcCCCCCCC------------ccceeeeeecCCCCCCcchhhcC-CCCccchhhhhHHHHHHHHhCCC
Q 011851 265 DGEYNAKLSDFGLAKDGPEGD------------KTHVSTRVMGTYGYAAPEYVMTG-HLTAKSDVYSFGVVLLEMLTGRR 331 (476)
Q Consensus 265 ~~~~~vkl~DFG~a~~~~~~~------------~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGv~l~elltG~~ 331 (476)
+.++.++|+|||++....... .........+++.|+|||++.+. .++.++|||||||++|+|++|+.
T Consensus 153 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~ 232 (335)
T PTZ00024 153 NSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKP 232 (335)
T ss_pred CCCCCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCC
Confidence 999999999999987654110 00111224578899999998764 47899999999999999999999
Q ss_pred CCCCCCCCCcchhH-Hhhhhhhcc----cc------ccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 011851 332 SMDKNRPNGEHNLV-EWARPQLGE----RR------RFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVV 400 (476)
Q Consensus 332 pf~~~~~~~~~~~~-~~~~~~~~~----~~------~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell 400 (476)
||...........+ ......... .. .+.....+..... ....+.++.++|.+||+.+|++||++.+++
T Consensus 233 p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~R~s~~~~l 311 (335)
T PTZ00024 233 LFPGENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTI-FPNASDDAIDLLQSLLKLNPLERISAKEAL 311 (335)
T ss_pred CCCCCCHHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHh-CcCCChHHHHHHHHHcCCCchhccCHHHHh
Confidence 99765432211100 000000000 00 0000000000000 011256789999999999999999999999
Q ss_pred HHhcCCCCccccc
Q 011851 401 EALKPLPYLKDMA 413 (476)
Q Consensus 401 ~~L~~~~~~~~~~ 413 (476)
.+ +||+...
T Consensus 312 ~~----~~~~~~~ 320 (335)
T PTZ00024 312 KH----EYFKSDP 320 (335)
T ss_pred cC----cccCCCC
Confidence 87 9988653
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-41 Score=326.42 Aligned_cols=258 Identities=22% Similarity=0.297 Sum_probs=214.3
Q ss_pred cCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCH---HHHHHHHHHHhCCCCCceeeEEEEEE
Q 011851 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGH---KEWLAEVNYLGGLIHPNLVKLIGCCI 197 (476)
Q Consensus 121 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~---~~~~~E~~~l~~l~hpnIv~l~~~~~ 197 (476)
.++..+.-||-|+||.|=+...+.. ...+|+|++++...-+. +-+..|-+||..++.|.||++|-.|.
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~---------~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfr 490 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQ---------KATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFR 490 (732)
T ss_pred hhhhhhhhcccCccceEEEEEeccc---------chHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhc
Confidence 3466677899999999988755422 22489999987654433 34678999999999999999999999
Q ss_pred eCCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCC
Q 011851 198 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGL 277 (476)
Q Consensus 198 ~~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~ 277 (476)
++.++||+||-|-||.|+..|.++ +.++...++.++..+++|++|||+++ ||+|||||+|+||+.+|.+||.|||+
T Consensus 491 d~kyvYmLmEaClGGElWTiLrdR-g~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGF 566 (732)
T KOG0614|consen 491 DSKYVYMLMEACLGGELWTILRDR-GSFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGF 566 (732)
T ss_pred cchhhhhhHHhhcCchhhhhhhhc-CCcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhh
Confidence 999999999999999999999554 57999999999999999999999988 99999999999999999999999999
Q ss_pred cCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhccccc
Q 011851 278 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRR 357 (476)
Q Consensus 278 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 357 (476)
|+....+.+ +.++||||.|.|||++.+...+.++|.||||+++||||+|.+||.+.++-...+++......+
T Consensus 567 AKki~~g~K---TwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i----- 638 (732)
T KOG0614|consen 567 AKKIGSGRK---TWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKI----- 638 (732)
T ss_pred HHHhccCCc---eeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhh-----
Confidence 998766554 566999999999999999999999999999999999999999999877655444433222111
Q ss_pred cccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHHhcCCCCcccccC
Q 011851 358 FYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPR-----MSEVVEALKPLPYLKDMAS 414 (476)
Q Consensus 358 ~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt-----~~ell~~L~~~~~~~~~~~ 414 (476)
.++......+.+||++++..+|.+|.. +.+|-+ +.||.++..
T Consensus 639 -----------~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkk----H~Wf~gfdw 685 (732)
T KOG0614|consen 639 -----------EFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKK----HRWFEGFDW 685 (732)
T ss_pred -----------hcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHh----hhhhhcCCh
Confidence 123334678889999999999999975 455555 489988754
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-39 Score=320.68 Aligned_cols=270 Identities=23% Similarity=0.350 Sum_probs=200.6
Q ss_pred ccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCc--cCHHHHHHHHHHHhCCCCCceeeEEEEEE
Q 011851 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL--QGHKEWLAEVNYLGGLIHPNLVKLIGCCI 197 (476)
Q Consensus 120 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~ 197 (476)
.++|.+.+.||+|+||.||+|.+. .+|+.||||++..... .....+.+|+.+++.++||||+++++++.
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~ 84 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDK---------RTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFT 84 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeC---------CCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheec
Confidence 468999999999999999998654 4688899999875322 22346788999999999999999999987
Q ss_pred eCC------eeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceE
Q 011851 198 EDD------QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAK 271 (476)
Q Consensus 198 ~~~------~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vk 271 (476)
... .+|+||||+. .+|.+++ ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+|
T Consensus 85 ~~~~~~~~~~~~lv~e~~~-~~l~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~k 157 (342)
T cd07879 85 SAVSGDEFQDFYLVMPYMQ-TDLQKIM---GHPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELK 157 (342)
T ss_pred ccccCCCCceEEEEecccc-cCHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEE
Confidence 543 4699999995 4776655 235899999999999999999999988 99999999999999999999
Q ss_pred EeecCCcCCCCCCCccceeeeeecCCCCCCcchhhc-CCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhh
Q 011851 272 LSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP 350 (476)
Q Consensus 272 l~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~ 350 (476)
|+|||+++..... .....++..|+|||++.+ ..++.++|||||||++|||++|+.||...........+.....
T Consensus 158 L~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~ 232 (342)
T cd07879 158 ILDFGLARHADAE-----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTG 232 (342)
T ss_pred EeeCCCCcCCCCC-----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC
Confidence 9999999764321 123567889999999876 4689999999999999999999999976432111110000000
Q ss_pred ----hh----cc--ccccccccCcccCCCCC---hHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCcccccC
Q 011851 351 ----QL----GE--RRRFYRLIDPCLEGCFS---IKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDMAS 414 (476)
Q Consensus 351 ----~~----~~--~~~~~~~~d~~l~~~~~---~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~~~~ 414 (476)
.. .. ...+...........+. ...+.++.+||.+||+.||++||++.+++.| |||+....
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h----~~f~~~~~ 305 (342)
T cd07879 233 VPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEH----PYFDSFRD 305 (342)
T ss_pred CCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcC----cchhhccc
Confidence 00 00 00000000000000000 0124678899999999999999999999997 99887643
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-41 Score=357.13 Aligned_cols=254 Identities=29% Similarity=0.377 Sum_probs=205.4
Q ss_pred ccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCc--cCHHHHHHHHHHHhCCCCCceeeEEEEEE
Q 011851 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL--QGHKEWLAEVNYLGGLIHPNLVKLIGCCI 197 (476)
Q Consensus 120 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~ 197 (476)
+-+|.-...||.|.||.||-|.+ ..||+..|+|.++.... ...+.+.+|+.+|..|+|||+|++|++-.
T Consensus 1234 ~~rWqrg~~Ig~G~fG~VYtavN---------~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEv 1304 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVN---------LDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEV 1304 (1509)
T ss_pred eeeeccccccCCcceeeeEEeec---------CCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceee
Confidence 44677778899999999998754 45788899998865433 33456889999999999999999999999
Q ss_pred eCCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCC
Q 011851 198 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGL 277 (476)
Q Consensus 198 ~~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~ 277 (476)
+.+..+|.||||++|+|.+.+ +.++-.++.....+..|++.|+.|||++| ||||||||+||||+.+|.+|++|||.
T Consensus 1305 HRekv~IFMEyC~~GsLa~ll-~~gri~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGs 1380 (1509)
T KOG4645|consen 1305 HREKVYIFMEYCEGGSLASLL-EHGRIEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGS 1380 (1509)
T ss_pred cHHHHHHHHHHhccCcHHHHH-HhcchhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccc
Confidence 999999999999999999988 55556888888899999999999999999 99999999999999999999999999
Q ss_pred cCCCCCCCccc--eeeeeecCCCCCCcchhhcC---CCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhh
Q 011851 278 AKDGPEGDKTH--VSTRVMGTYGYAAPEYVMTG---HLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQL 352 (476)
Q Consensus 278 a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~ 352 (476)
|........+. .....+||+.|||||++.+. +...+.|||||||++.||+||+.||...+.+ ..-+-.-..
T Consensus 1381 a~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne----~aIMy~V~~ 1456 (1509)
T KOG4645|consen 1381 AVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNE----WAIMYHVAA 1456 (1509)
T ss_pred eeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccch----hHHHhHHhc
Confidence 98765432111 11246899999999999864 5678999999999999999999999754321 000001111
Q ss_pred ccccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011851 353 GERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEA 402 (476)
Q Consensus 353 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~ 402 (476)
+... .++...+.+-.++|.+||..||++|.++.||+++
T Consensus 1457 gh~P------------q~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1457 GHKP------------QIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred cCCC------------CCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 1111 1233457888999999999999999999999997
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=314.04 Aligned_cols=251 Identities=25% Similarity=0.335 Sum_probs=189.8
Q ss_pred CCceEEEEEecCCC--ccCHHHHHHHHHHHhCCCCCceeeEEEEEEeCCeeEEEEEecCCCCHHHHHhhc-CCCCCHHHH
Q 011851 154 TGLPVAVKTLNHDG--LQGHKEWLAEVNYLGGLIHPNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIR 230 (476)
Q Consensus 154 ~g~~vAiK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~g~L~~~l~~~-~~~l~~~~~ 230 (476)
+++.||||++.... ....+.+.+|+++++.++|+||+++++++.+++..|++|||+++++|.+++... ...+++..+
T Consensus 24 ~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~ 103 (314)
T cd08216 24 TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAI 103 (314)
T ss_pred CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHHHHhcccCCCHHHH
Confidence 68889999997652 234467889999999999999999999999999999999999999999999653 456899999
Q ss_pred HHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCcCCCCCCCc-----cceeeeeecCCCCCCcchh
Q 011851 231 MKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDK-----THVSTRVMGTYGYAAPEYV 305 (476)
Q Consensus 231 ~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~~-----~~~~~~~~gt~~y~aPE~~ 305 (476)
..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||.+........ ........++..|+|||++
T Consensus 104 ~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 180 (314)
T cd08216 104 AFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVL 180 (314)
T ss_pred HHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeeccccccccccccccccccccccccCHHHh
Confidence 999999999999999988 99999999999999999999999998875432211 1111234578889999998
Q ss_pred hcC--CCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhc---ccc-------cccc----ccCc----c
Q 011851 306 MTG--HLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLG---ERR-------RFYR----LIDP----C 365 (476)
Q Consensus 306 ~~~--~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~---~~~-------~~~~----~~d~----~ 365 (476)
... .++.++|||||||++|||++|+.||....... ...+....... ... .... ..++ .
T Consensus 181 ~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (314)
T cd08216 181 QQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQ--MLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDS 258 (314)
T ss_pred cCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHhccCccccccCchhhhcCCcCcccccccccchhhh
Confidence 763 58899999999999999999999997543221 11110000000 000 0000 0000 0
Q ss_pred cCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCccccc
Q 011851 366 LEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDMA 413 (476)
Q Consensus 366 l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~~~ 413 (476)
.........+.++.+|+.+||+.||++|||+.++++| |||+.+.
T Consensus 259 ~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~----p~~~~~~ 302 (314)
T cd08216 259 VDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH----SFFKQCK 302 (314)
T ss_pred hhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC----chHhhhc
Confidence 1111222335688999999999999999999999997 9988664
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=321.31 Aligned_cols=274 Identities=25% Similarity=0.322 Sum_probs=207.6
Q ss_pred CCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCC--ccCHHHHHHHHHHHhCCCCCceeeEEEEEEeC
Q 011851 122 SFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDG--LQGHKEWLAEVNYLGGLIHPNLVKLIGCCIED 199 (476)
Q Consensus 122 ~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~ 199 (476)
+|++.+.||.|+||.||+|.+. .+++.||||.+.... ....+.+.+|+.+++.++|+||+++++++...
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~---------~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 71 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDK---------RTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPP 71 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeC---------CCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhccc
Confidence 5889999999999999998654 457889999987643 33446788999999999999999999998877
Q ss_pred C-----eeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEee
Q 011851 200 D-----QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSD 274 (476)
Q Consensus 200 ~-----~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~D 274 (476)
+ .+|+||||++ ++|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.++|+|
T Consensus 72 ~~~~~~~~~lv~e~~~-~~l~~~l~~-~~~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~d 146 (330)
T cd07834 72 SPEDFNDVYIVTELME-TDLHKVIKS-PQPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICD 146 (330)
T ss_pred CcccccceEEEecchh-hhHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcc
Confidence 5 7899999996 588888854 348999999999999999999999988 99999999999999999999999
Q ss_pred cCCcCCCCCCCcc-ceeeeeecCCCCCCcchhhcC-CCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhh-
Q 011851 275 FGLAKDGPEGDKT-HVSTRVMGTYGYAAPEYVMTG-HLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQ- 351 (476)
Q Consensus 275 FG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~- 351 (476)
||++......... .......++..|+|||++.+. .++.++|||||||++|+|++|+.||...........+......
T Consensus 147 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~ 226 (330)
T cd07834 147 FGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTP 226 (330)
T ss_pred cCceEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCC
Confidence 9999875443210 112335689999999999888 8999999999999999999999999765432111110000000
Q ss_pred hc------cccccccccC---cccC---CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCccccc
Q 011851 352 LG------ERRRFYRLID---PCLE---GCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDMA 413 (476)
Q Consensus 352 ~~------~~~~~~~~~d---~~l~---~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~~~ 413 (476)
.. ........+. .... .......+.++.++|.+||+.||++||++.+++.+ |||++..
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~----~~~~~~~ 296 (330)
T cd07834 227 SEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH----PYLAQLH 296 (330)
T ss_pred ChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhC----ccHHhhc
Confidence 00 0000000000 0000 00011135678999999999999999999999987 9988654
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=323.54 Aligned_cols=264 Identities=25% Similarity=0.351 Sum_probs=208.0
Q ss_pred CCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHH---HHHHHHHHhCCCCCceeeEEEEEEeC
Q 011851 123 FRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKE---WLAEVNYLGGLIHPNLVKLIGCCIED 199 (476)
Q Consensus 123 y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~---~~~E~~~l~~l~hpnIv~l~~~~~~~ 199 (476)
|..++.||-|+||.|.++.. ..|...||+|.+++.+.-...+ +..|.+||..-+.+.||+||..|.++
T Consensus 631 Fvkik~iGvGAFGeV~Lv~K---------vDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDk 701 (1034)
T KOG0608|consen 631 FVKIKTIGVGAFGEVCLVRK---------VDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDK 701 (1034)
T ss_pred eEEEeeecccccceeEEEee---------cchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccC
Confidence 66778899999999998753 3467789999998766543333 56799999999999999999999999
Q ss_pred CeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCcC
Q 011851 200 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAK 279 (476)
Q Consensus 200 ~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~ 279 (476)
+++|+||+|++||++..+|.+.+ -|++..++.++.++..|++++|..| +|||||||+|||||.+|+|||+||||+.
T Consensus 702 dnLYFVMdYIPGGDmMSLLIrmg-IFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCT 777 (1034)
T KOG0608|consen 702 DNLYFVMDYIPGGDMMSLLIRMG-IFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCT 777 (1034)
T ss_pred CceEEEEeccCCccHHHHHHHhc-cCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeeccccc
Confidence 99999999999999999997664 6899999999999999999999999 9999999999999999999999999975
Q ss_pred CC---------CCCCccc-------------------------------eeeeeecCCCCCCcchhhcCCCCccchhhhh
Q 011851 280 DG---------PEGDKTH-------------------------------VSTRVMGTYGYAAPEYVMTGHLTAKSDVYSF 319 (476)
Q Consensus 280 ~~---------~~~~~~~-------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 319 (476)
-+ .+++... .....+||+.|+|||++....|+..+|+||.
T Consensus 778 GfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~ 857 (1034)
T KOG0608|consen 778 GFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSV 857 (1034)
T ss_pred cceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHh
Confidence 21 1111000 0112689999999999999999999999999
Q ss_pred HHHHHHHHhCCCCCCCCCCCCcc-hhHHhhhhhhccccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHH
Q 011851 320 GVVLLEMLTGRRSMDKNRPNGEH-NLVEWARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSE 398 (476)
Q Consensus 320 Gv~l~elltG~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~e 398 (476)
|||||||+.|+.||....+.+.. .++.|.. +.. -.+..+.+.++.+||.+++ .+++.|..- .
T Consensus 858 gvil~em~~g~~pf~~~tp~~tq~kv~nw~~--------~l~-------~~~~~~ls~e~~~li~kLc-~sad~RLGk-n 920 (1034)
T KOG0608|consen 858 GVILYEMLVGQPPFLADTPGETQYKVINWRN--------FLH-------IPYQGNLSKEALDLIQKLC-CSADSRLGK-N 920 (1034)
T ss_pred hHHHHHHhhCCCCccCCCCCcceeeeeehhh--------ccc-------cccccccCHHHHHHHHHHh-cChhhhhcc-c
Confidence 99999999999999887776543 2333322 111 1123344788889988754 366777531 1
Q ss_pred HHHHhcCCCCcccccCcc
Q 011851 399 VVEALKPLPYLKDMASSS 416 (476)
Q Consensus 399 ll~~L~~~~~~~~~~~~~ 416 (476)
..+.++.+|||+++..++
T Consensus 921 g~d~vKaHpfFkgIDfss 938 (1034)
T KOG0608|consen 921 GADQVKAHPFFKGIDFSS 938 (1034)
T ss_pred chhhhhcCccccccchHh
Confidence 222466679999987654
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=328.06 Aligned_cols=255 Identities=31% Similarity=0.432 Sum_probs=195.1
Q ss_pred CCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCC-ccCHHHHHHHHHHHhCCCCCceeeEEEEEEeCC-
Q 011851 123 FRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDG-LQGHKEWLAEVNYLGGLIHPNLVKLIGCCIEDD- 200 (476)
Q Consensus 123 y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~- 200 (476)
|...+.||+|+||.||+|+++ .||+.||||.++... ....+.+.+|+++|++|+|+|||+++++-++..
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnk---------etG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~ 85 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNK---------ETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFL 85 (732)
T ss_pred eeehhhhcCCccceeeeeccc---------ccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCcccc
Confidence 455678999999999999765 589999999998754 334567889999999999999999999865543
Q ss_pred -----eeEEEEEecCCCCHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeec--CCC--c
Q 011851 201 -----QRLLVYEFMPRGSLENHLFRR--SLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLD--GEY--N 269 (476)
Q Consensus 201 -----~~~lV~E~~~~g~L~~~l~~~--~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~--~~~--~ 269 (476)
...+|||||.||+|+..|.+. ...|++.+.+.++.+++.||.|||+++ ||||||||.||++- .+| .
T Consensus 86 ~~~~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~I 162 (732)
T KOG4250|consen 86 GLVTRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSI 162 (732)
T ss_pred CcccccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceE
Confidence 467999999999999999753 456999999999999999999999988 99999999999982 223 4
Q ss_pred eEEeecCCcCCCCCCCccceeeeeecCCCCCCcchhhc-CCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhh
Q 011851 270 AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA 348 (476)
Q Consensus 270 vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~ 348 (476)
.||+|||.|+...++. ..+.++||..|++||++.. +.|+..+|.|||||++|+++||..||..........-+.|.
T Consensus 163 yKLtDfG~Arel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~ 239 (732)
T KOG4250|consen 163 YKLTDFGAARELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWH 239 (732)
T ss_pred EeeecccccccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhh
Confidence 6999999999987654 4567999999999999984 88999999999999999999999999765443221111111
Q ss_pred h---hhhc--------cc--cccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCC
Q 011851 349 R---PQLG--------ER--RRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARP 394 (476)
Q Consensus 349 ~---~~~~--------~~--~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RP 394 (476)
. .... +. ..+...+ |. ...........+-..+..+|..||++|-
T Consensus 240 ~~tkkp~~v~i~~~~~eNgpv~~s~~l-P~-p~~Ls~~l~~~~~kwLa~~L~~~~~~~~ 296 (732)
T KOG4250|consen 240 IITKKPSGVAIGAQEEENGPVEWSSTL-PQ-PNHLSRGLATRLTKWLASMLEWNPRKRG 296 (732)
T ss_pred hhccCCCceeEeeecccCCceeeeccC-CC-cccccHHHHhhhhHHHHHHHhhhHHHhC
Confidence 0 0000 00 0000000 00 1112223345677888899999999998
|
|
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=304.39 Aligned_cols=248 Identities=25% Similarity=0.372 Sum_probs=203.5
Q ss_pred CCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCc--cCHHHHHHHHHHHhCCCCCceeeEEEEEEeC
Q 011851 122 SFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL--QGHKEWLAEVNYLGGLIHPNLVKLIGCCIED 199 (476)
Q Consensus 122 ~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~ 199 (476)
+|++.+.||+|+||.||++.+. .+++.+|+|.+..... ....++.+|+++++.++|+||+++++++.+.
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~---------~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 71 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRL---------SDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDG 71 (256)
T ss_pred CceEeeeecCCCceeEEEEEEC---------CCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccC
Confidence 4888999999999999998654 4678899999875432 2244678899999999999999999999999
Q ss_pred CeeEEEEEecCCCCHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecC
Q 011851 200 DQRLLVYEFMPRGSLENHLFRR---SLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFG 276 (476)
Q Consensus 200 ~~~~lV~E~~~~g~L~~~l~~~---~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG 276 (476)
...|+||||+++++|.+++.+. ...+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||
T Consensus 72 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g 148 (256)
T cd08530 72 NKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLG 148 (256)
T ss_pred CEEEEEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeecc
Confidence 9999999999999999988652 356899999999999999999999988 9999999999999999999999999
Q ss_pred CcCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhcccc
Q 011851 277 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERR 356 (476)
Q Consensus 277 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~ 356 (476)
++...... ......|++.|++||.+.+..++.++|+||||+++|+|++|+.||....... +... .. ..
T Consensus 149 ~~~~~~~~----~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~---~~~~----~~-~~ 216 (256)
T cd08530 149 ISKVLKKN----MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQD---LRYK----VQ-RG 216 (256)
T ss_pred chhhhccC----CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHH----Hh-cC
Confidence 99876443 1222468899999999999899999999999999999999999997543211 1000 00 00
Q ss_pred ccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011851 357 RFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEA 402 (476)
Q Consensus 357 ~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~ 402 (476)
.+ ...+...+.++.+++.+||+.+|++||++.+++++
T Consensus 217 ~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 217 KY---------PPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred CC---------CCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 00 01112346789999999999999999999999987
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-39 Score=321.11 Aligned_cols=274 Identities=22% Similarity=0.281 Sum_probs=202.3
Q ss_pred ccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCCCCCceeeEEEEEEeC
Q 011851 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHPNLVKLIGCCIED 199 (476)
Q Consensus 120 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~ 199 (476)
..+|++.+.||.|+||.||+|.+. .+|+.||+|.+........+.+.+|++++++++||||+++++++...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~---------~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~ 74 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDS---------DCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPS 74 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEEC---------CCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccc
Confidence 357999999999999999998654 47888999999776666667788999999999999999999876544
Q ss_pred --------------CeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeec
Q 011851 200 --------------DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLD 265 (476)
Q Consensus 200 --------------~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~ 265 (476)
...|+||||++ ++|.+++.. ..+++..++.++.||+.||.|||+.+ |+||||||+||+++
T Consensus 75 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~ 148 (342)
T cd07854 75 GSDLTEDVGSLTELNSVYIVQEYME-TDLANVLEQ--GPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFIN 148 (342)
T ss_pred ccccccccccccccceEEEEeeccc-ccHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEc
Confidence 35799999996 589887743 35899999999999999999999988 99999999999997
Q ss_pred C-CCceEEeecCCcCCCCCCCcc-ceeeeeecCCCCCCcchhhc-CCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcc
Q 011851 266 G-EYNAKLSDFGLAKDGPEGDKT-HVSTRVMGTYGYAAPEYVMT-GHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEH 342 (476)
Q Consensus 266 ~-~~~vkl~DFG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~ 342 (476)
. ++.+||+|||++......... .......|+..|+|||++.. ..++.++|||||||++|+|++|+.||....+....
T Consensus 149 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~ 228 (342)
T cd07854 149 TEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQM 228 (342)
T ss_pred CCCceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 4 567899999999764321111 11122467889999998765 46888999999999999999999999765432221
Q ss_pred hhHHhhhhhhc--cccccccccCc-----ccCCC-----CChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCcc
Q 011851 343 NLVEWARPQLG--ERRRFYRLIDP-----CLEGC-----FSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLK 410 (476)
Q Consensus 343 ~~~~~~~~~~~--~~~~~~~~~d~-----~l~~~-----~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~ 410 (476)
.......+... ....+...... ..... +....+.++.+||.+||+.||++|||+.+++.| |||+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h----~~~~ 304 (342)
T cd07854 229 QLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH----PYMS 304 (342)
T ss_pred HHHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC----Cccc
Confidence 11110000000 00000000000 00000 001125678899999999999999999999997 9987
Q ss_pred cc
Q 011851 411 DM 412 (476)
Q Consensus 411 ~~ 412 (476)
..
T Consensus 305 ~~ 306 (342)
T cd07854 305 CY 306 (342)
T ss_pred cc
Confidence 54
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=306.14 Aligned_cols=266 Identities=26% Similarity=0.354 Sum_probs=198.6
Q ss_pred CCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccC--HHHHHHHHHHHhCC---CCCceeeEEEEEE
Q 011851 123 FRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQG--HKEWLAEVNYLGGL---IHPNLVKLIGCCI 197 (476)
Q Consensus 123 y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~--~~~~~~E~~~l~~l---~hpnIv~l~~~~~ 197 (476)
|++.+.||+|+||.||+|.+. .+++.||+|+++...... ...+.+|+.+++++ +|+||+++++++.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~ 71 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDL---------NTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCH 71 (287)
T ss_pred CeEEEEecccCceEEEEEEEC---------CCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEe
Confidence 677889999999999998765 357789999997543322 23456677776655 6999999999999
Q ss_pred eCCe-----eEEEEEecCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceE
Q 011851 198 EDDQ-----RLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAK 271 (476)
Q Consensus 198 ~~~~-----~~lV~E~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vk 271 (476)
..+. ++++|||+. ++|.+++.... ..+++..++.++.||+.||.|||+.+ ++|+||+|+||+++.++.+|
T Consensus 72 ~~~~~~~~~~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~ 147 (287)
T cd07838 72 GPRTDRELKLTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVK 147 (287)
T ss_pred eccCCCCceeEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEE
Confidence 8877 999999996 48988886543 36899999999999999999999988 99999999999999999999
Q ss_pred EeecCCcCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchh-HHhhhh
Q 011851 272 LSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNL-VEWARP 350 (476)
Q Consensus 272 l~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~-~~~~~~ 350 (476)
|+|||++........ .....++..|+|||++.+..++.++|||||||++|+|++|..||........... ......
T Consensus 148 l~dfg~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (287)
T cd07838 148 IADFGLARIYSFEMA---LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGL 224 (287)
T ss_pred EeccCcceeccCCcc---cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCC
Confidence 999999977543221 1234578899999999999999999999999999999999999976443211110 000000
Q ss_pred h-hcc--------ccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCc
Q 011851 351 Q-LGE--------RRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYL 409 (476)
Q Consensus 351 ~-~~~--------~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~ 409 (476)
. ... ...+........ .......+..+.++|.+||+.||++||++.+++.| |||
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~----~~~ 287 (287)
T cd07838 225 PSEEEWPRNVSLPRSSFPSYTPRSF-KSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH----PYF 287 (287)
T ss_pred CChHhcCCCcccchhhcccccccch-hhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC----cCC
Confidence 0 000 000000000000 00111335778899999999999999999999987 775
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=318.48 Aligned_cols=280 Identities=23% Similarity=0.332 Sum_probs=207.9
Q ss_pred cChhHHHHhccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCc--cCHHHHHHHHHHHhCCCCCc
Q 011851 111 FSFNELKSATKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL--QGHKEWLAEVNYLGGLIHPN 188 (476)
Q Consensus 111 ~~~~~~~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~--~~~~~~~~E~~~l~~l~hpn 188 (476)
....++....++|.+.+.||+|+||.||+|.+. .+++.||+|++..... ...+.+.+|++++++++|||
T Consensus 7 ~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~ 77 (345)
T cd07877 7 ELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDT---------KTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHEN 77 (345)
T ss_pred hHHHHHhhccCceEEEEEeeecCCeEEEEEEEc---------CCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCc
Confidence 344556667889999999999999999998654 4678899999875422 22356778999999999999
Q ss_pred eeeEEEEEEeC------CeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCe
Q 011851 189 LVKLIGCCIED------DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNI 262 (476)
Q Consensus 189 Iv~l~~~~~~~------~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NI 262 (476)
|+++++++... ...|++++++ +++|.+++.. ..+++..++.++.||+.||.|||+.+ |+||||||+||
T Consensus 78 iv~~~~~~~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NI 151 (345)
T cd07877 78 VIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNL 151 (345)
T ss_pred ccceeeeeeecccccccccEEEEehhc-ccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHE
Confidence 99999988643 3478899987 7899887743 35899999999999999999999988 99999999999
Q ss_pred eecCCCceEEeecCCcCCCCCCCccceeeeeecCCCCCCcchhhc-CCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCc
Q 011851 263 LLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGE 341 (476)
Q Consensus 263 Ll~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~ 341 (476)
+++.++.+||+|||++...... .....|+..|+|||++.+ ..++.++|||||||++|+|++|+.||........
T Consensus 152 ll~~~~~~kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~ 226 (345)
T cd07877 152 AVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ 226 (345)
T ss_pred EEcCCCCEEEeccccccccccc-----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 9999999999999998764321 123568999999998876 5788999999999999999999999965433211
Q ss_pred chhH-Hhhh-------hhhccc--cccccccCcccCCCC---ChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCC
Q 011851 342 HNLV-EWAR-------PQLGER--RRFYRLIDPCLEGCF---SIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPY 408 (476)
Q Consensus 342 ~~~~-~~~~-------~~~~~~--~~~~~~~d~~l~~~~---~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~ 408 (476)
...+ .... ..+... ..+...+.......+ ....+.++.+||.+||+.||.+||++.++++| ||
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h----~~ 302 (345)
T cd07877 227 LKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH----AY 302 (345)
T ss_pred HHHHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC----hh
Confidence 1110 0000 000000 000000000000000 00125678999999999999999999999998 89
Q ss_pred cccccC
Q 011851 409 LKDMAS 414 (476)
Q Consensus 409 ~~~~~~ 414 (476)
|+++..
T Consensus 303 f~~~~~ 308 (345)
T cd07877 303 FAQYHD 308 (345)
T ss_pred hhhcCC
Confidence 886543
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=307.55 Aligned_cols=266 Identities=26% Similarity=0.353 Sum_probs=205.4
Q ss_pred CCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCc----cCHHHHHHHHHHHhCC-CCCceeeEEEEE
Q 011851 122 SFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL----QGHKEWLAEVNYLGGL-IHPNLVKLIGCC 196 (476)
Q Consensus 122 ~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~----~~~~~~~~E~~~l~~l-~hpnIv~l~~~~ 196 (476)
+|++.+.||+|+||.||++.... ...++..||||+++.... ...+.+..|+.++.++ +||||+++++.+
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~------~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ 74 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVG------GHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAF 74 (288)
T ss_pred CceEEEEeccCCCceEEEEEEec------cccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheee
Confidence 47888999999999999987542 223678899999875432 2234577899999999 599999999999
Q ss_pred EeCCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecC
Q 011851 197 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFG 276 (476)
Q Consensus 197 ~~~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG 276 (476)
..+...|+||||+++++|.+++... ..+++..+..++.|++.+|.|||+.+ ++||||||+||+++.++.++|+|||
T Consensus 75 ~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg 150 (288)
T cd05583 75 QTDTKLHLILDYVNGGELFTHLYQR-EHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFG 150 (288)
T ss_pred ecCCEEEEEEecCCCCcHHHHHhhc-CCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECc
Confidence 9999999999999999999998554 46899999999999999999999987 9999999999999999999999999
Q ss_pred CcCCCCCCCccceeeeeecCCCCCCcchhhcCC--CCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhcc
Q 011851 277 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGH--LTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGE 354 (476)
Q Consensus 277 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~ 354 (476)
+++........ ......|+..|+|||.+.+.. ++.++||||||+++|||++|..||......... ..........
T Consensus 151 ~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~--~~~~~~~~~~ 227 (288)
T cd05583 151 LSKEFLAEEEE-RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQ--SEISRRILKS 227 (288)
T ss_pred ccccccccccc-ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchH--HHHHHHHHcc
Confidence 98765432221 122356899999999987664 788999999999999999999999643221111 1111111100
Q ss_pred ccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCccccc
Q 011851 355 RRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDMA 413 (476)
Q Consensus 355 ~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~~~ 413 (476)
.+. .+...+..+.+++.+||+.||++|||+.++.+.| .+||++...
T Consensus 228 --------~~~----~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l-~~~~~~~~~ 273 (288)
T cd05583 228 --------KPP----FPKTMSAEARDFIQKLLEKDPKKRLGANGADEIK-NHPFFQGID 273 (288)
T ss_pred --------CCC----CCcccCHHHHHHHHHHhcCCHhhccCcchHHHHh-cCcccccCC
Confidence 000 1112246788999999999999999987766633 348887653
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=315.41 Aligned_cols=275 Identities=23% Similarity=0.264 Sum_probs=198.7
Q ss_pred CCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCc--cCHHHHHHHHHHHhCC-CCCceeeEEEEEEe
Q 011851 122 SFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL--QGHKEWLAEVNYLGGL-IHPNLVKLIGCCIE 198 (476)
Q Consensus 122 ~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~--~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~ 198 (476)
+|++.+.||+|+||.||++.+... ..+..||+|.+..... ...+.+.+|+.+++++ +||||+++++.+..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~-------~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 73 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAET-------SEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIV 73 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCC-------CcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeee
Confidence 478889999999999999876521 1267899999865322 2245678899999999 59999999987543
Q ss_pred C----CeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEee
Q 011851 199 D----DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSD 274 (476)
Q Consensus 199 ~----~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~D 274 (476)
. ...|++|||+. ++|.+++. ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|
T Consensus 74 ~~~~~~~~~~~~e~~~-~~L~~~l~-~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~D 148 (332)
T cd07857 74 FPGNFNELYLYEELME-ADLHQIIR-SGQPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICD 148 (332)
T ss_pred ccccCCcEEEEEeccc-CCHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCc
Confidence 2 45789999995 68988884 4457899999999999999999999988 99999999999999999999999
Q ss_pred cCCcCCCCCCCcc--ceeeeeecCCCCCCcchhhc-CCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhh--
Q 011851 275 FGLAKDGPEGDKT--HVSTRVMGTYGYAAPEYVMT-GHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR-- 349 (476)
Q Consensus 275 FG~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~-- 349 (476)
||+++........ .......||..|+|||++.+ ..++.++|||||||++|+|++|..||...........+....
T Consensus 149 fg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 228 (332)
T cd07857 149 FGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGT 228 (332)
T ss_pred CCCceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCC
Confidence 9999865432211 11223578999999998766 468999999999999999999999997643211110000000
Q ss_pred -------h-hhccccccccccCcccCCC---CChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCcccc
Q 011851 350 -------P-QLGERRRFYRLIDPCLEGC---FSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDM 412 (476)
Q Consensus 350 -------~-~~~~~~~~~~~~d~~l~~~---~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~~ 412 (476)
. .......+........... .....+..+.+|+.+||+.||++|||+.+++.+ ||++..
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~----~~~~~~ 298 (332)
T cd07857 229 PDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH----PYLAIW 298 (332)
T ss_pred CCHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC----hhhhhh
Confidence 0 0000000000000000000 001125678999999999999999999999887 887543
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=307.83 Aligned_cols=267 Identities=28% Similarity=0.394 Sum_probs=204.1
Q ss_pred CCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCC--ccCHHHHHHHHHHHhCCCCCceeeEEEEEEeCC
Q 011851 123 FRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDG--LQGHKEWLAEVNYLGGLIHPNLVKLIGCCIEDD 200 (476)
Q Consensus 123 y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 200 (476)
|++.+.||+|.||.||+|... .+++.||+|++.... ....+.+..|+.++++++|+||+++++++.+.+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~---------~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~ 71 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDK---------KTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTER 71 (282)
T ss_pred CeeehcccccCcceEEEeeec---------CCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCC
Confidence 567788999999999998654 467889999998653 223456788999999999999999999999999
Q ss_pred eeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCcCC
Q 011851 201 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKD 280 (476)
Q Consensus 201 ~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~ 280 (476)
..++||||++ ++|.+++.+....+++..+..++.|++.||.|||+++ |+||||+|+||+++.++.++|+|||++..
T Consensus 72 ~~~~v~e~~~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~ 147 (282)
T cd07829 72 KLYLVFEYCD-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARA 147 (282)
T ss_pred ceEEEecCcC-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccc
Confidence 9999999997 5999999766567999999999999999999999988 99999999999999999999999999986
Q ss_pred CCCCCccceeeeeecCCCCCCcchhhcC-CCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchh-HHhhh-------hh
Q 011851 281 GPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNL-VEWAR-------PQ 351 (476)
Q Consensus 281 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~-~~~~~-------~~ 351 (476)
...... ......++..|+|||++.+. .++.++|||||||++|||++|..||........... ..... ..
T Consensus 148 ~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (282)
T cd07829 148 FGIPLR--TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPG 225 (282)
T ss_pred cCCCcc--ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHh
Confidence 543221 12224567889999998876 889999999999999999999999976442211110 00000 00
Q ss_pred hccc----cccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCc
Q 011851 352 LGER----RRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYL 409 (476)
Q Consensus 352 ~~~~----~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~ 409 (476)
.... ..+...........++ ..+..+.++|.+||..||++||++.+++.+ |||
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~----p~~ 282 (282)
T cd07829 226 VTKLPDYKPTFPKFPPKDLEKVLP-RLDPEGIDLLSKMLQYNPAKRISAKEALKH----PYF 282 (282)
T ss_pred hcccccccccccccCccchHHhcc-cccHHHHHHHHHhhccCcccCCCHHHHhhC----cCC
Confidence 0000 0000000000001111 125689999999999999999999999998 886
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-39 Score=275.48 Aligned_cols=273 Identities=23% Similarity=0.282 Sum_probs=209.6
Q ss_pred CCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccC--HHHHHHHHHHHhCCCCCceeeEEEEEEeC
Q 011851 122 SFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQG--HKEWLAEVNYLGGLIHPNLVKLIGCCIED 199 (476)
Q Consensus 122 ~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~--~~~~~~E~~~l~~l~hpnIv~l~~~~~~~ 199 (476)
.|.-.++||+|.||+||+|+.. .|++.||+|.++.++..+ ....++|+.+|+.|+|.|||++++....+
T Consensus 3 ~ydkmekigegtygtvfkarn~---------~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsd 73 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNR---------ETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSD 73 (292)
T ss_pred chHHHHhhcCCcceeeEecccC---------CccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccC
Confidence 3556688999999999998765 478889999998654332 35678999999999999999999999999
Q ss_pred CeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCcC
Q 011851 200 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAK 279 (476)
Q Consensus 200 ~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~ 279 (476)
..+.||+||| ..+|..+...-++.++.+.++.++.|+++||.|||+++ +.||||||.|+||+.+|.+||+|||+++
T Consensus 74 kkltlvfe~c-dqdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglar 149 (292)
T KOG0662|consen 74 KKLTLVFEFC-DQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLAR 149 (292)
T ss_pred ceeEEeHHHh-hHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhh
Confidence 9999999999 45899998888889999999999999999999999998 9999999999999999999999999998
Q ss_pred CCCCCCccceeeeeecCCCCCCcchhhcC-CCCccchhhhhHHHHHHHHhCC-CCCCCCCCCCcchhHHhhh--hhhccc
Q 011851 280 DGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTAKSDVYSFGVVLLEMLTGR-RSMDKNRPNGEHNLVEWAR--PQLGER 355 (476)
Q Consensus 280 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGv~l~elltG~-~pf~~~~~~~~~~~~~~~~--~~~~~~ 355 (476)
.+.-.- .-....+-|..|.+|.++.+. -|+...|+||.|||+.|+.... +.|.+.+.......+-+.. +....+
T Consensus 150 afgipv--rcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~w 227 (292)
T KOG0662|consen 150 AFGIPV--RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQW 227 (292)
T ss_pred hcCCce--EeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccC
Confidence 754321 112234568999999999886 5899999999999999999754 4455554333322221211 111122
Q ss_pred cccccccCcccCCCCCh---------HHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCccccc
Q 011851 356 RRFYRLIDPCLEGCFSI---------KGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDMA 413 (476)
Q Consensus 356 ~~~~~~~d~~l~~~~~~---------~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~~~ 413 (476)
..+..+.|-.+-..|+. .....-.+|++++|.-+|.+|.++++.+++ |||.+..
T Consensus 228 ps~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh----pyf~d~s 290 (292)
T KOG0662|consen 228 PSMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH----PYFSDFS 290 (292)
T ss_pred CccccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC----ccccccC
Confidence 22222222212122221 112345799999999999999999999998 9987653
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=341.90 Aligned_cols=146 Identities=27% Similarity=0.353 Sum_probs=130.6
Q ss_pred cCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccC---HHHHHHHHHHHhCCCCCceeeEEEEEE
Q 011851 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQG---HKEWLAEVNYLGGLIHPNLVKLIGCCI 197 (476)
Q Consensus 121 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~---~~~~~~E~~~l~~l~hpnIv~l~~~~~ 197 (476)
++|.+.++||+|+||.||+|++. .+++.||||+++...... ...+..|+.++..++||||+++++++.
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~---------~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~ 74 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKK---------NNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQ 74 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEEC---------CCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEE
Confidence 57999999999999999998765 367889999997654332 356788999999999999999999999
Q ss_pred eCCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCC
Q 011851 198 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGL 277 (476)
Q Consensus 198 ~~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~ 277 (476)
..+++||||||+.+++|.+++... ..+++..++.|+.||+.||.|||..+ ||||||||+||||+.++.+||+|||+
T Consensus 75 ~~~~~~lVmEy~~g~~L~~li~~~-~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGl 150 (669)
T cd05610 75 SANNVYLVMEYLIGGDVKSLLHIY-GYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGL 150 (669)
T ss_pred ECCEEEEEEeCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCC
Confidence 999999999999999999998543 46899999999999999999999987 99999999999999999999999998
Q ss_pred cC
Q 011851 278 AK 279 (476)
Q Consensus 278 a~ 279 (476)
++
T Consensus 151 s~ 152 (669)
T cd05610 151 SK 152 (669)
T ss_pred Cc
Confidence 75
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=306.72 Aligned_cols=266 Identities=29% Similarity=0.445 Sum_probs=200.3
Q ss_pred CCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCcc-CHHHHHHHHHHHhCCC-CCceeeEEEEEEeCC
Q 011851 123 FRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQ-GHKEWLAEVNYLGGLI-HPNLVKLIGCCIEDD 200 (476)
Q Consensus 123 y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~-~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~ 200 (476)
|.+.+.||+|+||.||+|... .+++.||||.+...... ......+|+..+++++ |+||+++++++.+++
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~---------~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~ 71 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNK---------ETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFREND 71 (283)
T ss_pred CeeheeeccCCceEEEEEEEC---------CCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCC
Confidence 677889999999999998764 35778999998654322 2234567999999999 999999999999999
Q ss_pred eeEEEEEecCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCcC
Q 011851 201 QRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAK 279 (476)
Q Consensus 201 ~~~lV~E~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~ 279 (476)
..|+||||+ +++|.+++.... ..+++..+..++.|++.+|.|||+++ |+|+||+|+||+++.++.++|+|||++.
T Consensus 72 ~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~ 147 (283)
T cd07830 72 ELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAR 147 (283)
T ss_pred cEEEEEecC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccce
Confidence 999999999 789999886653 57899999999999999999999988 9999999999999999999999999997
Q ss_pred CCCCCCccceeeeeecCCCCCCcchhhc-CCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhH-H---------hh
Q 011851 280 DGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV-E---------WA 348 (476)
Q Consensus 280 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~-~---------~~ 348 (476)
....... .....++..|+|||++.. ..++.++|+||||+++|||++|+.||............ . |.
T Consensus 148 ~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (283)
T cd07830 148 EIRSRPP---YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWP 224 (283)
T ss_pred eccCCCC---cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhh
Confidence 6543221 123568889999998754 46789999999999999999999999765432211100 0 00
Q ss_pred hhh-hccc--cccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCc
Q 011851 349 RPQ-LGER--RRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYL 409 (476)
Q Consensus 349 ~~~-~~~~--~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~ 409 (476)
... .... ..+.......+...++ ..+..+.++|.+||+.||++|||+.|++.+ |||
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~----~~~ 283 (283)
T cd07830 225 EGYKLASKLGFRFPQFAPTSLHQLIP-NASPEAIDLIKDMLRWDPKKRPTASQALQH----PYF 283 (283)
T ss_pred hHhhhhccccccccccccccHHHHcc-cCCHHHHHHHHHhcccCcccCCCHHHHhhC----CCC
Confidence 000 0000 0000000000111111 114679999999999999999999999987 775
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=313.42 Aligned_cols=273 Identities=24% Similarity=0.321 Sum_probs=204.2
Q ss_pred HHhccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCc--cCHHHHHHHHHHHhCCCCCceeeEEE
Q 011851 117 KSATKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL--QGHKEWLAEVNYLGGLIHPNLVKLIG 194 (476)
Q Consensus 117 ~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~ 194 (476)
...+++|.+.+.||.|+||.||+|.+. .+++.||+|.+..... ...+.+.+|++++++++||||+++++
T Consensus 6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 76 (328)
T cd07856 6 FEITNRYVDLQPVGMGAFGLVCSARDQ---------LTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSD 76 (328)
T ss_pred eccccceEEEEeecccCCeEEEEEEEC---------CCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEee
Confidence 345778999999999999999998654 4678899998865322 23456788999999999999999999
Q ss_pred EEEe-CCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEe
Q 011851 195 CCIE-DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLS 273 (476)
Q Consensus 195 ~~~~-~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~ 273 (476)
+|.. ....|+||||+ +++|.+++.. .++++..+..++.||+.||.|||+.+ |+||||+|+|||++.++.++|+
T Consensus 77 ~~~~~~~~~~lv~e~~-~~~L~~~~~~--~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~ 150 (328)
T cd07856 77 IFISPLEDIYFVTELL-GTDLHRLLTS--RPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKIC 150 (328)
T ss_pred eEecCCCcEEEEeehh-ccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeC
Confidence 9876 56789999999 6689887743 35888889999999999999999988 9999999999999999999999
Q ss_pred ecCCcCCCCCCCccceeeeeecCCCCCCcchhhc-CCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhH-Hhhhh-
Q 011851 274 DFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV-EWARP- 350 (476)
Q Consensus 274 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~-~~~~~- 350 (476)
|||++...... .....++..|+|||++.+ ..++.++|||||||++|+|++|+.||...........+ +....
T Consensus 151 dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~ 225 (328)
T cd07856 151 DFGLARIQDPQ-----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTP 225 (328)
T ss_pred ccccccccCCC-----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 99998754321 122467889999998766 57899999999999999999999999754321111100 00000
Q ss_pred ------hhccccccccccCc-ccCCCCC-----hHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCcccccC
Q 011851 351 ------QLGERRRFYRLIDP-CLEGCFS-----IKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDMAS 414 (476)
Q Consensus 351 ------~~~~~~~~~~~~d~-~l~~~~~-----~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~~~~ 414 (476)
....... .+++.. ......+ ...+..+.++|.+||+.+|++||++.+++.+ +|+.....
T Consensus 226 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~----~~~~~~~~ 296 (328)
T cd07856 226 PDDVINTICSENT-LRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH----PYLAPYHD 296 (328)
T ss_pred CHHHHHhccchhh-HHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC----CccccccC
Confidence 0000000 000000 0000011 1125789999999999999999999999997 88875543
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=352.61 Aligned_cols=260 Identities=32% Similarity=0.504 Sum_probs=205.7
Q ss_pred cCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCCCCCceeeEEEEEEeCC
Q 011851 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHPNLVKLIGCCIEDD 200 (476)
Q Consensus 121 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 200 (476)
..|...++||+|+||.||+|.+. .++..||||.+...... ...|+++|++++|||||++++++.+++
T Consensus 690 ~~~~~~~~ig~G~~g~Vy~~~~~---------~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~ 756 (968)
T PLN00113 690 SSLKEENVISRGKKGASYKGKSI---------KNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEK 756 (968)
T ss_pred hhCCcccEEccCCCeeEEEEEEC---------CCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCC
Confidence 45778889999999999998764 35778999998654322 135688999999999999999999999
Q ss_pred eeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCcCC
Q 011851 201 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKD 280 (476)
Q Consensus 201 ~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~ 280 (476)
..|+||||+++|+|.+++. .++|..+..++.||+.||+|||.....+|+||||||+||+++.++..++. ||....
T Consensus 757 ~~~lv~Ey~~~g~L~~~l~----~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~ 831 (968)
T PLN00113 757 GAYLIHEYIEGKNLSEVLR----NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGL 831 (968)
T ss_pred CCEEEEeCCCCCcHHHHHh----cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccc
Confidence 9999999999999999994 38899999999999999999996544559999999999999999888875 666544
Q ss_pred CCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhcccccccc
Q 011851 281 GPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRRFYR 360 (476)
Q Consensus 281 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 360 (476)
... .....||+.|+|||++.+..++.++|||||||++|||+||+.||+.... ....++.|....... .....
T Consensus 832 ~~~------~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~-~~~~~~~~~~~~~~~-~~~~~ 903 (968)
T PLN00113 832 LCT------DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFG-VHGSIVEWARYCYSD-CHLDM 903 (968)
T ss_pred ccc------CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccC-CCCcHHHHHHHhcCc-cchhh
Confidence 221 1123688999999999999999999999999999999999999964322 223445554433221 22334
Q ss_pred ccCcccCCC--CChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011851 361 LIDPCLEGC--FSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPL 406 (476)
Q Consensus 361 ~~d~~l~~~--~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~ 406 (476)
++|+.+... .+.....++.+++.+||+.||++||||.++++.|+.+
T Consensus 904 ~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~ 951 (968)
T PLN00113 904 WIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESA 951 (968)
T ss_pred eeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHh
Confidence 556555432 2334556788999999999999999999999997643
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=315.36 Aligned_cols=269 Identities=24% Similarity=0.342 Sum_probs=201.9
Q ss_pred hccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCcc--CHHHHHHHHHHHhCCCCCceeeEEEEE
Q 011851 119 ATKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQ--GHKEWLAEVNYLGGLIHPNLVKLIGCC 196 (476)
Q Consensus 119 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~l~~~~ 196 (476)
..++|.+.+.||+|+||.||+|.+. .+|..||||++...... ....+.+|+++|++++||||+++++++
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 83 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDR---------RTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVF 83 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEEC---------CCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeee
Confidence 4568999999999999999998654 46788999998653222 234678899999999999999999998
Q ss_pred EeCC------eeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCce
Q 011851 197 IEDD------QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNA 270 (476)
Q Consensus 197 ~~~~------~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~v 270 (476)
..+. .+++||||+ +++|.+++.. ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+
T Consensus 84 ~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~--~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~ 157 (343)
T cd07880 84 TPDLSLDRFHDFYLVMPFM-GTDLGKLMKH--EKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCEL 157 (343)
T ss_pred cCCccccccceEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCE
Confidence 7654 358999999 7799888743 46899999999999999999999988 9999999999999999999
Q ss_pred EEeecCCcCCCCCCCccceeeeeecCCCCCCcchhhc-CCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcch-hHHhh
Q 011851 271 KLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHN-LVEWA 348 (476)
Q Consensus 271 kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~-~~~~~ 348 (476)
+|+|||++...... .....+++.|+|||++.+ ..++.++|+|||||++|+|++|+.||.......... .....
T Consensus 158 kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~ 232 (343)
T cd07880 158 KILDFGLARQTDSE-----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVT 232 (343)
T ss_pred EEeecccccccccC-----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Confidence 99999999865332 123467899999999876 458899999999999999999999997543211100 00000
Q ss_pred hh-------hhc-c-ccc----cccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCcccc
Q 011851 349 RP-------QLG-E-RRR----FYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDM 412 (476)
Q Consensus 349 ~~-------~~~-~-~~~----~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~~ 412 (476)
.. .+. . ... +.......+. ......+..+.++|.+||+.||++|||+.+++++ |||+..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~----~~~~~~ 304 (343)
T cd07880 233 GTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFR-SLLPNANPLAVNVLEKMLVLDAESRITAAEALAH----PYFEEF 304 (343)
T ss_pred CCCCHHHHHhhcchhHHHHHHhccccCcchHH-HhccCCChHHHHHHHHHcCCChhhCCCHHHHhcC----ccHhhh
Confidence 00 000 0 000 0000000000 0001224578899999999999999999999987 998865
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-39 Score=318.46 Aligned_cols=253 Identities=28% Similarity=0.402 Sum_probs=206.6
Q ss_pred CCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCCCCCceeeEEEEEEeCCe
Q 011851 122 SFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHPNLVKLIGCCIEDDQ 201 (476)
Q Consensus 122 ~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~ 201 (476)
+.....+||-|.||.||.|.|+... ..||||.++.+.. ..++|+.|..+|+.++|||+|+|+++|..+..
T Consensus 268 dItMkhKLGGGQYGeVYeGvWKkys---------lTvAVKtLKEDtM-eveEFLkEAAvMKeikHpNLVqLLGVCT~EpP 337 (1157)
T KOG4278|consen 268 DITMKHKLGGGQYGEVYEGVWKKYS---------LTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPP 337 (1157)
T ss_pred heeeeeccCCCcccceeeeeeeccc---------eeeehhhhhhcch-hHHHHHHHHHHHHhhcCccHHHHhhhhccCCC
Confidence 4566789999999999999987543 3499999987654 46789999999999999999999999999999
Q ss_pred eEEEEEecCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCcCC
Q 011851 202 RLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKD 280 (476)
Q Consensus 202 ~~lV~E~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~ 280 (476)
.|||.|||..|+|.+||++.+ ..++....++++.||..|++||...+ +|||||...|+|+.++..|||+|||+++.
T Consensus 338 FYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLsRl 414 (1157)
T KOG4278|consen 338 FYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLSRL 414 (1157)
T ss_pred eEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchhhh
Confidence 999999999999999998754 44677788899999999999999977 99999999999999999999999999998
Q ss_pred CCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhhccccccc
Q 011851 281 GPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPQLGERRRFY 359 (476)
Q Consensus 281 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 359 (476)
.....++ ......-...|.|||-+....++.++|||+|||+|||+.| |..||.+.+-.....+.+
T Consensus 415 MtgDTYT-AHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLE------------- 480 (1157)
T KOG4278|consen 415 MTGDTYT-AHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLE------------- 480 (1157)
T ss_pred hcCCcee-cccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHh-------------
Confidence 7553332 2222223567999999999999999999999999999998 667886654322222211
Q ss_pred cccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 011851 360 RLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKP 405 (476)
Q Consensus 360 ~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~ 405 (476)
.-..-.-+..+++.+++|+..||+++|.+||++.|+-+.++.
T Consensus 481 ----kgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEt 522 (1157)
T KOG4278|consen 481 ----KGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFET 522 (1157)
T ss_pred ----ccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHH
Confidence 111111223347899999999999999999999999888664
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=299.95 Aligned_cols=244 Identities=30% Similarity=0.404 Sum_probs=197.6
Q ss_pred ccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCcc---CHHHHHHHHHHHhCCCCCceeeEEEEEEeCCeeEEE
Q 011851 129 LGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQ---GHKEWLAEVNYLGGLIHPNLVKLIGCCIEDDQRLLV 205 (476)
Q Consensus 129 LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~---~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV 205 (476)
||.|+||.||++.+. .+++.||+|+++..... ....+..|++++++++|+||+++++.+..++..|+|
T Consensus 1 lg~G~~~~v~~~~~~---------~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 71 (250)
T cd05123 1 LGKGSFGKVLLVRKK---------DTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLV 71 (250)
T ss_pred CCCCCceEEEEEEEC---------CCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEE
Confidence 699999999998654 35778999998765433 234678899999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCcCCCCCCC
Q 011851 206 YEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGD 285 (476)
Q Consensus 206 ~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~ 285 (476)
|||+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 72 ~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~ 147 (250)
T cd05123 72 LEYAPGGELFSHLSKE-GRFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEG 147 (250)
T ss_pred EecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCC
Confidence 9999999999999554 46899999999999999999999988 9999999999999999999999999998754322
Q ss_pred ccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhccccccccccCcc
Q 011851 286 KTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRRFYRLIDPC 365 (476)
Q Consensus 286 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 365 (476)
. ......++..|++||.+.+..++.++|+||||+++|+|++|..||...... ....... ....
T Consensus 148 ~--~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~---~~~~~~~---~~~~--------- 210 (250)
T cd05123 148 S--RTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRK---EIYEKIL---KDPL--------- 210 (250)
T ss_pred C--cccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH---HHHHHHh---cCCC---------
Confidence 1 123356889999999998888999999999999999999999999654321 1111100 0000
Q ss_pred cCCCCChHHHHHHHHHHHHhcccCCCCCCCH---HHHHHHhcCCCCc
Q 011851 366 LEGCFSIKGAEKTIQLAASCLNRDQKARPRM---SEVVEALKPLPYL 409 (476)
Q Consensus 366 l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~---~ell~~L~~~~~~ 409 (476)
.++...+..+.+++.+||..||++||++ .++++| |||
T Consensus 211 ---~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~----~~f 250 (250)
T cd05123 211 ---RFPEFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAH----PFF 250 (250)
T ss_pred ---CCCCCCCHHHHHHHHHHhcCCHhhCCCcccHHHHHhC----CCC
Confidence 1122226788999999999999999999 555554 886
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=328.98 Aligned_cols=259 Identities=25% Similarity=0.450 Sum_probs=216.0
Q ss_pred CCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCcc-CHHHHHHHHHHHhCCCCCceeeEEEEEEeCC
Q 011851 122 SFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQ-GHKEWLAEVNYLGGLIHPNLVKLIGCCIEDD 200 (476)
Q Consensus 122 ~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 200 (476)
...+.++||.|.||.|++|+++..++. -..||||.++....+ .+.+|+.|..||.+++||||++|.|+.....
T Consensus 630 ~i~Ie~VIGaGEFGEVc~GrLk~pgkr------e~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~ 703 (996)
T KOG0196|consen 630 CVKIEKVIGAGEFGEVCSGRLKLPGKR------EITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSK 703 (996)
T ss_pred heEEEEEEecccccceecccccCCCCc------ceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCc
Confidence 456889999999999999999876643 456999999865443 3457999999999999999999999999999
Q ss_pred eeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCcCC
Q 011851 201 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKD 280 (476)
Q Consensus 201 ~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~ 280 (476)
...||.|||++|+|+.+|+++.+.+++.+..-+++.|+.|++||-+.+ +|||||...|||++.+..+||+|||+++.
T Consensus 704 PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSRv 780 (996)
T KOG0196|consen 704 PVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSRV 780 (996)
T ss_pred eeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccceee
Confidence 999999999999999999998888999999999999999999999988 99999999999999999999999999997
Q ss_pred CCCCCccceeee-eecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhhcccccc
Q 011851 281 GPEGDKTHVSTR-VMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPQLGERRRF 358 (476)
Q Consensus 281 ~~~~~~~~~~~~-~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 358 (476)
..+......++. -.-...|.|||.+....++.++|||||||+|||.++ |..||-.....+....++ +..++
T Consensus 781 ledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe-------~gyRL 853 (996)
T KOG0196|consen 781 LEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIE-------QGYRL 853 (996)
T ss_pred cccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHHH-------hccCC
Confidence 765442222221 112368999999999999999999999999999776 889987665543333222 11221
Q ss_pred ccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011851 359 YRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPL 406 (476)
Q Consensus 359 ~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~ 406 (476)
. .+.+++..+.+|+..||++|-.+||.+.+|+.+|.++
T Consensus 854 P----------pPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDkl 891 (996)
T KOG0196|consen 854 P----------PPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKL 891 (996)
T ss_pred C----------CCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHH
Confidence 1 2345588999999999999999999999999987643
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=295.33 Aligned_cols=267 Identities=25% Similarity=0.370 Sum_probs=208.4
Q ss_pred ccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCcc---CHHHHHHHHHHHhCC-CCCceeeEEEE
Q 011851 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQ---GHKEWLAEVNYLGGL-IHPNLVKLIGC 195 (476)
Q Consensus 120 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~---~~~~~~~E~~~l~~l-~hpnIv~l~~~ 195 (476)
.++|+++++||+|+|++|.++++. +|.+.||+|+++++-.. +......|-.+..+- +||.+|-|..+
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~---------~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhsc 319 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLK---------KTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSC 319 (593)
T ss_pred cccceeeeeecCcchhhhhheehc---------ccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhh
Confidence 467999999999999999987654 58889999999875433 333455566666554 69999999999
Q ss_pred EEeCCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeec
Q 011851 196 CIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDF 275 (476)
Q Consensus 196 ~~~~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DF 275 (476)
|..+..+++|.||++||+|.-++.+ ...++++.++.+...|+.||.|||++| ||+||||.+|||||..|++||.|+
T Consensus 320 fqtesrlffvieyv~ggdlmfhmqr-qrklpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdy 395 (593)
T KOG0695|consen 320 FQTESRLFFVIEYVNGGDLMFHMQR-QRKLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDY 395 (593)
T ss_pred hcccceEEEEEEEecCcceeeehhh-hhcCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeeccc
Confidence 9999999999999999999888844 457999999999999999999999998 999999999999999999999999
Q ss_pred CCcCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCC-CCCcchhHHhhhhhhcc
Q 011851 276 GLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNR-PNGEHNLVEWARPQLGE 354 (476)
Q Consensus 276 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~-~~~~~~~~~~~~~~~~~ 354 (476)
|+++...... ..+.++||||.|+|||++.+..|+..+|+|+|||+++||+.|+.||+-.. .+...+...+....+.+
T Consensus 396 gmcke~l~~g--d~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvile 473 (593)
T KOG0695|consen 396 GMCKEGLGPG--DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILE 473 (593)
T ss_pred chhhcCCCCC--cccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhh
Confidence 9998754322 23456999999999999999999999999999999999999999997432 12222222222211111
Q ss_pred c-cccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHH--HHHHHhcCCCCccccc
Q 011851 355 R-RRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMS--EVVEALKPLPYLKDMA 413 (476)
Q Consensus 355 ~-~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~--ell~~L~~~~~~~~~~ 413 (476)
+ .+ .+...+-.+..+++..|+.||.+|.... -=+..++.++||+.+.
T Consensus 474 kqir------------iprslsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~id 523 (593)
T KOG0695|consen 474 KQIR------------IPRSLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSID 523 (593)
T ss_pred hccc------------ccceeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCC
Confidence 1 11 1112245677899999999999995321 1234466679988654
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=301.98 Aligned_cols=252 Identities=23% Similarity=0.321 Sum_probs=198.1
Q ss_pred CCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCc-----cCHHHHHHHHHHHhCCCCCceeeEEEEE
Q 011851 122 SFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL-----QGHKEWLAEVNYLGGLIHPNLVKLIGCC 196 (476)
Q Consensus 122 ~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~-----~~~~~~~~E~~~l~~l~hpnIv~l~~~~ 196 (476)
+|.+.+.||+|+||.||++.+.. ++..+++|+++.... ....++..|+.+++.++||||+++++++
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 71 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKK---------AVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASF 71 (260)
T ss_pred CceeeeeecCCCCceEEEEEecC---------CCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHH
Confidence 58899999999999999987652 344466666543221 2233566799999999999999999999
Q ss_pred EeCCeeEEEEEecCCCCHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEe
Q 011851 197 IEDDQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLS 273 (476)
Q Consensus 197 ~~~~~~~lV~E~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~ 273 (476)
.+....++||||+++++|.+++.. ....+++..++.++.|++.||.|||+.+ ++|+||||+||+++. +.++|+
T Consensus 72 ~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~ 147 (260)
T cd08222 72 LERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIG 147 (260)
T ss_pred hcCCceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeec
Confidence 999999999999999999988854 3457899999999999999999999988 999999999999975 569999
Q ss_pred ecCCcCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhc
Q 011851 274 DFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLG 353 (476)
Q Consensus 274 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~ 353 (476)
|||++........ ......|++.|+|||.+.+..++.++|+||||+++|+|++|..||...... .... ....
T Consensus 148 d~g~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~---~~~~---~~~~ 219 (260)
T cd08222 148 DFGVSRLLMGSCD--LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFL---SVVL---RIVE 219 (260)
T ss_pred ccCceeecCCCcc--cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHH---HHHH---HHHc
Confidence 9999876543221 122356889999999998888999999999999999999999999643211 1111 0000
Q ss_pred cccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCc
Q 011851 354 ERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYL 409 (476)
Q Consensus 354 ~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~ 409 (476)
. ..+ ..+...+.++.++|.+||..||++||++.+++++ ||+
T Consensus 220 --~-----~~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~----~~~ 260 (260)
T cd08222 220 --G-----PTP----SLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN----PFI 260 (260)
T ss_pred --C-----CCC----CCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC----CCC
Confidence 0 001 1122346789999999999999999999999998 775
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=317.33 Aligned_cols=271 Identities=24% Similarity=0.330 Sum_probs=204.3
Q ss_pred hccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCC--ccCHHHHHHHHHHHhCCCCCceeeEEEEE
Q 011851 119 ATKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDG--LQGHKEWLAEVNYLGGLIHPNLVKLIGCC 196 (476)
Q Consensus 119 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~ 196 (476)
..++|.+.+.||+|+||.||+|.+. .+++.||||++.... ....+.+.+|+.+++++.|+||+++++++
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 83 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDT---------KTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVF 83 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEEC---------CCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHh
Confidence 4567999999999999999998765 367789999986532 22335677899999999999999999988
Q ss_pred EeCCe------eEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCce
Q 011851 197 IEDDQ------RLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNA 270 (476)
Q Consensus 197 ~~~~~------~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~v 270 (476)
...+. .|+|+||+ +++|.+++.. ..+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+
T Consensus 84 ~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~ 157 (343)
T cd07851 84 TPASSLEDFQDVYLVTHLM-GADLNNIVKC--QKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCEL 157 (343)
T ss_pred hccccccccccEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCE
Confidence 76654 89999999 6799988854 46899999999999999999999988 9999999999999999999
Q ss_pred EEeecCCcCCCCCCCccceeeeeecCCCCCCcchhhcC-CCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhH-Hhh
Q 011851 271 KLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV-EWA 348 (476)
Q Consensus 271 kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~-~~~ 348 (476)
+|+|||++...... .....++..|+|||.+.+. .++.++|||||||++|+|++|+.||...........+ ...
T Consensus 158 kL~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~ 232 (343)
T cd07851 158 KILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLV 232 (343)
T ss_pred EEcccccccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhc
Confidence 99999999865432 2235688899999988764 6789999999999999999999999754332111100 000
Q ss_pred h---hhhcccc---ccccccC---cccCCCCC---hHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCccccc
Q 011851 349 R---PQLGERR---RFYRLID---PCLEGCFS---IKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDMA 413 (476)
Q Consensus 349 ~---~~~~~~~---~~~~~~d---~~l~~~~~---~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~~~ 413 (476)
. +...... ....++. ......+. ...+.++.++|.+||+.||++|||+.+|++| ||++...
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h----~~~~~~~ 305 (343)
T cd07851 233 GTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH----PYLAEYH 305 (343)
T ss_pred CCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC----CCccccC
Confidence 0 0000000 0000000 00000000 1125789999999999999999999999987 9998653
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-40 Score=295.10 Aligned_cols=287 Identities=23% Similarity=0.335 Sum_probs=214.8
Q ss_pred CCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCc-c-CHHHHHHHHHHHhCCCCCceeeEEEEEEe-
Q 011851 122 SFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL-Q-GHKEWLAEVNYLGGLIHPNLVKLIGCCIE- 198 (476)
Q Consensus 122 ~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~-~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~~- 198 (476)
.|.-..+||+|.||.||+|+.. .+|+.||+|++-.++. + -....++|+++|..|.|+|++.+++.|..
T Consensus 18 ~yek~~kigqGtfgeVFkAr~~---------n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk 88 (376)
T KOG0669|consen 18 KYEKLAKIGQGTFGEVFKARSK---------NTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTK 88 (376)
T ss_pred HHHHHHhcCCchHHHHHHHhhc---------CccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhc
Confidence 4666788999999999998654 5788899986543221 1 23456899999999999999999887753
Q ss_pred -------CCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceE
Q 011851 199 -------DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAK 271 (476)
Q Consensus 199 -------~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vk 271 (476)
...+||||.+|+. +|.-+|......++..++.+++.++..||.|+|... |+|||+|++|+||+.+|.+|
T Consensus 89 ~Tp~~r~r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilk 164 (376)
T KOG0669|consen 89 ATPTNRDRATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILK 164 (376)
T ss_pred cCCcccccceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEE
Confidence 2358999999966 899888777778999999999999999999999988 99999999999999999999
Q ss_pred EeecCCcCCCCCCCcc--ceeeeeecCCCCCCcchhhcC-CCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhh
Q 011851 272 LSDFGLAKDGPEGDKT--HVSTRVMGTYGYAAPEYVMTG-HLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA 348 (476)
Q Consensus 272 l~DFG~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~ 348 (476)
|+|||+++.+...... ...++.+-|..|++||.+.+. .|+.+.|||+.||++.||+||.+.|.++.......++...
T Consensus 165 lADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~L 244 (376)
T KOG0669|consen 165 LADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQL 244 (376)
T ss_pred eeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHH
Confidence 9999999765432221 113345669999999999876 7999999999999999999999999987765554444322
Q ss_pred hhhhcc-------cccccccc--CcccCCCCC--------hHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCccc
Q 011851 349 RPQLGE-------RRRFYRLI--DPCLEGCFS--------IKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKD 411 (476)
Q Consensus 349 ~~~~~~-------~~~~~~~~--d~~l~~~~~--------~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~ 411 (476)
...+.. ...++..+ .|...+.+. ....++.++|+.++|..||.+|+++++++.| .||..
T Consensus 245 cGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh----~~F~k 320 (376)
T KOG0669|consen 245 CGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNH----DFFWK 320 (376)
T ss_pred hccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhch----hhhhc
Confidence 111100 00111111 111111111 1113578899999999999999999999998 78877
Q ss_pred ccCcchHHHHHHHH
Q 011851 412 MASSSSYVQAMQAE 425 (476)
Q Consensus 412 ~~~~~~~~~~~~~~ 425 (476)
-+.....++.+...
T Consensus 321 dp~pqanl~~ml~t 334 (376)
T KOG0669|consen 321 DPMPQANLQDMLST 334 (376)
T ss_pred CCcchhhHHHHHHH
Confidence 66554555544433
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-40 Score=297.02 Aligned_cols=262 Identities=26% Similarity=0.388 Sum_probs=202.6
Q ss_pred ccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCc-cCHHHHHHHHHHHh-CCCCCceeeEEEEEEeCCee
Q 011851 125 PECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL-QGHKEWLAEVNYLG-GLIHPNLVKLIGCCIEDDQR 202 (476)
Q Consensus 125 ~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~-~~~~~~~~E~~~l~-~l~hpnIv~l~~~~~~~~~~ 202 (476)
-+..||.|+||+|++ ..++.+|+..|||.++.... ...++++.|.+... .-++||||++||+...++..
T Consensus 68 dlg~iG~G~fG~V~K---------M~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdc 138 (361)
T KOG1006|consen 68 DLGEIGNGAFGTVNK---------MLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDC 138 (361)
T ss_pred HHHHhcCCcchhhhh---------hhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCce
Confidence 346799999999998 45667899999999987665 44567888888654 44799999999999999999
Q ss_pred EEEEEecCCCCHHHHHhh----cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCc
Q 011851 203 LLVYEFMPRGSLENHLFR----RSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLA 278 (476)
Q Consensus 203 ~lV~E~~~~g~L~~~l~~----~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a 278 (476)
||.||+| ..+|..+... ....+++...-.|...++.||.||.... .|||||+||+||||+..|.|||||||++
T Consensus 139 WiCMELM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIc 215 (361)
T KOG1006|consen 139 WICMELM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGIC 215 (361)
T ss_pred eeeHHHH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccch
Confidence 9999999 5577655421 3567999999999999999999998854 3999999999999999999999999998
Q ss_pred CCCCCCCccceeeeeecCCCCCCcchhhc--CCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhcccc
Q 011851 279 KDGPEGDKTHVSTRVMGTYGYAAPEYVMT--GHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERR 356 (476)
Q Consensus 279 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~ 356 (476)
-.+.+ ....+.-.|-..|||||.+.. ..|+.++||||||++|||+.||+.||...... .+.+. .-..++..
T Consensus 216 GqLv~---SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~sv--feql~--~Vv~gdpp 288 (361)
T KOG1006|consen 216 GQLVD---SIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSV--FEQLC--QVVIGDPP 288 (361)
T ss_pred HhHHH---HHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHH--HHHHH--HHHcCCCC
Confidence 76533 222344678889999999864 36999999999999999999999999876431 11111 11111110
Q ss_pred ccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCcccccCcc
Q 011851 357 RFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDMASSS 416 (476)
Q Consensus 357 ~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~~~~~~ 416 (476)
++. ...-....+..+..+|.-||..|-.+||.+.+++++ ||.+......
T Consensus 289 ----~l~---~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~----~fyr~y~~~~ 337 (361)
T KOG1006|consen 289 ----ILL---FDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF----PFYRMYAVEG 337 (361)
T ss_pred ----eec---CcccccccCHHHHHHHHHHhhcccccCcchhhhhcC----chhhhhhhcC
Confidence 111 111123347789999999999999999999998876 8888765443
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=335.43 Aligned_cols=257 Identities=28% Similarity=0.411 Sum_probs=191.1
Q ss_pred HhccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCC-ccCHHHHHHHHHHHhCCCCCceeeEEEEE
Q 011851 118 SATKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDG-LQGHKEWLAEVNYLGGLIHPNLVKLIGCC 196 (476)
Q Consensus 118 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~ 196 (476)
+-.++|+.+++||+||||.||+++++. +|+.||||.|.... ......+.+|+..|.+|+|||||++|..|
T Consensus 476 RY~~DFEEL~lLGkGGFG~VvkVRNKl---------DGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAW 546 (1351)
T KOG1035|consen 476 RYLNDFEELELLGKGGFGSVVKVRNKL---------DGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAW 546 (1351)
T ss_pred hHhhhhHHHHHhcCCCCceEEEEeecc---------cchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhh
Confidence 455678888999999999999988775 57789999998664 22234688999999999999999987654
Q ss_pred EeC-----------------------------------------------------------------------------
Q 011851 197 IED----------------------------------------------------------------------------- 199 (476)
Q Consensus 197 ~~~----------------------------------------------------------------------------- 199 (476)
.+.
T Consensus 547 VEs~~~~~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~ded 626 (1351)
T KOG1035|consen 547 VESTAELTVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDED 626 (1351)
T ss_pred hccCCccccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccc
Confidence 210
Q ss_pred ------------------------------------------CeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHH
Q 011851 200 ------------------------------------------DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDA 237 (476)
Q Consensus 200 ------------------------------------------~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi 237 (476)
-.+||-||||+...|.+++.++...-.....++++++|
T Consensus 627 g~~~S~tS~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreI 706 (1351)
T KOG1035|consen 627 GRNLSNTSDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREI 706 (1351)
T ss_pred ccccccccccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHH
Confidence 11488999998877776664443222577889999999
Q ss_pred HHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCcCCCC------C----------CCccceeeeeecCCCCCC
Q 011851 238 AKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGP------E----------GDKTHVSTRVMGTYGYAA 301 (476)
Q Consensus 238 ~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~------~----------~~~~~~~~~~~gt~~y~a 301 (476)
++||.|+|+++ ||||||||.||+|+.++.|||+|||+|.... + +......+..+||.-|+|
T Consensus 707 lEGLaYIH~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvA 783 (1351)
T KOG1035|consen 707 LEGLAYIHDQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVA 783 (1351)
T ss_pred HHHHHHHHhCc---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeec
Confidence 99999999998 9999999999999999999999999998621 0 111112456799999999
Q ss_pred cchhhcC---CCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhccccccccccCcccCCCCChHHHHHH
Q 011851 302 PEYVMTG---HLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRRFYRLIDPCLEGCFSIKGAEKT 378 (476)
Q Consensus 302 PE~~~~~---~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~ 378 (476)
||++.+. .|+.|+|+||||||++||+. ||...... ..++...+ ...+ |.. ..|.......-
T Consensus 784 PEll~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMER--a~iL~~LR-----~g~i-----P~~-~~f~~~~~~~e 847 (1351)
T KOG1035|consen 784 PELLSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSMER--ASILTNLR-----KGSI-----PEP-ADFFDPEHPEE 847 (1351)
T ss_pred HHHhcccccccccchhhhHHHHHHHHHHhc---cCCchHHH--HHHHHhcc-----cCCC-----CCC-cccccccchHH
Confidence 9999865 49999999999999999995 45432111 11111000 0000 001 12233334566
Q ss_pred HHHHHHhcccCCCCCCCHHHHHHH
Q 011851 379 IQLAASCLNRDQKARPRMSEVVEA 402 (476)
Q Consensus 379 ~~li~~cL~~dP~~RPt~~ell~~ 402 (476)
..+|.+||+.||.+|||+.|+|+.
T Consensus 848 ~slI~~Ll~hdP~kRPtA~eLL~s 871 (1351)
T KOG1035|consen 848 ASLIRWLLSHDPSKRPTATELLNS 871 (1351)
T ss_pred HHHHHHHhcCCCccCCCHHHHhhc
Confidence 789999999999999999999986
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=294.64 Aligned_cols=233 Identities=23% Similarity=0.252 Sum_probs=182.5
Q ss_pred cCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCCCCCceeeEEEEEEeCCeeEEEEEecCC
Q 011851 132 GGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHPNLVKLIGCCIEDDQRLLVYEFMPR 211 (476)
Q Consensus 132 G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~ 211 (476)
|.||.||++++. .+++.||+|.++... .+..|...+....||||+++++++.+.+..|+||||+++
T Consensus 4 g~~~~v~~~~~~---------~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 69 (237)
T cd05576 4 GVIDKVLLVMDT---------RTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEG 69 (237)
T ss_pred cccceEEEEEEc---------cCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCC
Confidence 899999998654 578889999997653 223445555566799999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCcCCCCCCCccceee
Q 011851 212 GSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVST 291 (476)
Q Consensus 212 g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~ 291 (476)
++|.+++.+. ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++...... ..
T Consensus 70 ~~L~~~l~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~-----~~ 140 (237)
T cd05576 70 GKLWSHISKF-LNIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS-----CD 140 (237)
T ss_pred CCHHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhccccc-----cc
Confidence 9999998654 46899999999999999999999988 999999999999999999999999988654332 12
Q ss_pred eeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhccccccccccCcccCCCCC
Q 011851 292 RVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRRFYRLIDPCLEGCFS 371 (476)
Q Consensus 292 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 371 (476)
...++..|+|||.+.+..++.++|||||||++|||++|+.|+........ ... .. ..+
T Consensus 141 ~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~~------------~~~------~~----~~~ 198 (237)
T cd05576 141 GEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGIN------------THT------TL----NIP 198 (237)
T ss_pred cCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhcc------------ccc------cc----CCc
Confidence 24567789999999888899999999999999999999988754321100 000 00 011
Q ss_pred hHHHHHHHHHHHHhcccCCCCCCCHHH-HHHHhcCCCCc
Q 011851 372 IKGAEKTIQLAASCLNRDQKARPRMSE-VVEALKPLPYL 409 (476)
Q Consensus 372 ~~~~~~~~~li~~cL~~dP~~RPt~~e-ll~~L~~~~~~ 409 (476)
...+..+.++|.+||+.||++||++.+ .++.+..+|||
T Consensus 199 ~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h~~~ 237 (237)
T cd05576 199 EWVSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSHPFF 237 (237)
T ss_pred ccCCHHHHHHHHHHccCCHHHhcCCCccchHHHHcCCCC
Confidence 122567889999999999999999722 13333344885
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=317.52 Aligned_cols=261 Identities=28% Similarity=0.383 Sum_probs=211.7
Q ss_pred HhccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCC-CCCceeeEEEEE
Q 011851 118 SATKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGL-IHPNLVKLIGCC 196 (476)
Q Consensus 118 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~ 196 (476)
..+..|++.+.||.|.+|.||++... .+++..|+|++...... .+++..|.+||+.+ +|||++.+|++|
T Consensus 16 dp~d~~ei~evig~Gtygkv~k~k~~---------~~~~~aa~kI~~~~~d~-deEiE~eynil~~~~~hpnv~~fyg~~ 85 (953)
T KOG0587|consen 16 DPADIFEIIEVIGNGTYGKVYKGRHV---------KTGQLAAIKIMDPTEDE-EEEIELEYNMLKKYSHHPNVATFYGAF 85 (953)
T ss_pred CCCCccEEEEEEeeccceeEEEEeee---------ecCceeeeEeecCCccc-cHHHHHHHHHHHhccCCCCcceEEEEE
Confidence 34556899999999999999998654 46777899988765433 45677899999977 699999999998
Q ss_pred Ee-----CCeeEEEEEecCCCCHHHHHhh-cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCce
Q 011851 197 IE-----DDQRLLVYEFMPRGSLENHLFR-RSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNA 270 (476)
Q Consensus 197 ~~-----~~~~~lV~E~~~~g~L~~~l~~-~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~v 270 (476)
.. ++.+|||||||.||+.-|++.. .+..+.|..+.+|++.++.||.+||.+. ++|||||-.|||++.++.|
T Consensus 86 ~k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~V 162 (953)
T KOG0587|consen 86 IKKDPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEV 162 (953)
T ss_pred EEecCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcE
Confidence 74 5789999999999999999854 3677999999999999999999999988 9999999999999999999
Q ss_pred EEeecCCcCCCCCCCccceeeeeecCCCCCCcchhhcC-----CCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhH
Q 011851 271 KLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-----HLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV 345 (476)
Q Consensus 271 kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~ 345 (476)
||+|||++......- ......+|||.|||||++... .|+..+|+||||++..||.-|.+|+-...+.-.+..
T Consensus 163 KLvDFGvSaQldsT~--grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~- 239 (953)
T KOG0587|consen 163 KLVDFGVSAQLDSTV--GRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFL- 239 (953)
T ss_pred EEeeeeeeeeeeccc--ccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhcc-
Confidence 999999998764322 223457899999999999754 478899999999999999999999976544211111
Q ss_pred HhhhhhhccccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCcccc
Q 011851 346 EWARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDM 412 (476)
Q Consensus 346 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~~ 412 (476)
..-+|.+.-.-+.+-++++.++|..||..|-.+||++.++|+| ||+...
T Consensus 240 --------------IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h----pFi~e~ 288 (953)
T KOG0587|consen 240 --------------IPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH----PFITEQ 288 (953)
T ss_pred --------------CCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccC----Cccccc
Confidence 0111222222234558899999999999999999999999997 888743
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-38 Score=302.54 Aligned_cols=262 Identities=27% Similarity=0.380 Sum_probs=202.5
Q ss_pred ccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCcc-------CHHHHHHHHHHHhCCCCCceeeE
Q 011851 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQ-------GHKEWLAEVNYLGGLIHPNLVKL 192 (476)
Q Consensus 120 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~-------~~~~~~~E~~~l~~l~hpnIv~l 192 (476)
.++|-++.+||+|+|+.||+|.+.. ..+.||+|+-...... ..+-..+|.+|.+.|+||.||++
T Consensus 462 n~RYLlLhLLGrGGFSEVyKAFDl~---------EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKl 532 (775)
T KOG1151|consen 462 NDRYLLLHLLGRGGFSEVYKAFDLT---------EQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKL 532 (775)
T ss_pred HHHHHHHHHhccccHHHHHHhcccc---------hhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeee
Confidence 3468889999999999999997653 4567999986432211 12346789999999999999999
Q ss_pred EEEEEeC-CeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeec---CCC
Q 011851 193 IGCCIED-DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLD---GEY 268 (476)
Q Consensus 193 ~~~~~~~-~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~---~~~ 268 (476)
|++|.-+ +..|-|+|||+|.+|.-+| +....+++.+++.|+.||+.||.||.+.. .+|||-||||.||||. .-|
T Consensus 533 YDyfslDtdsFCTVLEYceGNDLDFYL-KQhklmSEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPgNILLv~GtacG 610 (775)
T KOG1151|consen 533 YDYFSLDTDSFCTVLEYCEGNDLDFYL-KQHKLMSEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPGNILLVNGTACG 610 (775)
T ss_pred eeeeeeccccceeeeeecCCCchhHHH-HhhhhhhHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCccEEEecCcccc
Confidence 9998754 5688999999999998888 55567999999999999999999999876 7799999999999994 347
Q ss_pred ceEEeecCCcCCCCCCCcc-----ceeeeeecCCCCCCcchhhcC----CCCccchhhhhHHHHHHHHhCCCCCCCCCCC
Q 011851 269 NAKLSDFGLAKDGPEGDKT-----HVSTRVMGTYGYAAPEYVMTG----HLTAKSDVYSFGVVLLEMLTGRRSMDKNRPN 339 (476)
Q Consensus 269 ~vkl~DFG~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~----~~~~~~DiwslGv~l~elltG~~pf~~~~~~ 339 (476)
.+||.|||+++........ ..+....||.+|++||.+.-+ .++.++||||+|||+|..+.|+.||..+...
T Consensus 611 eIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQ 690 (775)
T KOG1151|consen 611 EIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQ 690 (775)
T ss_pred eeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhH
Confidence 8999999999986554332 234457899999999988644 4788999999999999999999999754322
Q ss_pred CcchhHHhhhhhhccccccccccCcccCCCCC--hHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCcc
Q 011851 340 GEHNLVEWARPQLGERRRFYRLIDPCLEGCFS--IKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLK 410 (476)
Q Consensus 340 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~--~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~ 410 (476)
.++.+... ++.. .+-.|+ +..+.++.++|.+||+..-++|....++..+ |+|.
T Consensus 691 --QdILqeNT-----------IlkA-tEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~d----pyll 745 (775)
T KOG1151|consen 691 --QDILQENT-----------ILKA-TEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACD----PYLL 745 (775)
T ss_pred --HHHHhhhc-----------hhcc-eeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccC----cccc
Confidence 11211100 1110 011121 2236789999999999999999998887765 6654
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=318.74 Aligned_cols=272 Identities=22% Similarity=0.297 Sum_probs=178.3
Q ss_pred hccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCCCCCceeeEEEE---
Q 011851 119 ATKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHPNLVKLIGC--- 195 (476)
Q Consensus 119 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~--- 195 (476)
..++|.+.++||+|+||.||+|++..+.. ..+..||+|.+...... +.+..| .++...+.+++.++..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~-----~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~ 200 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQS-----KKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLE 200 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCcc-----ccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhc
Confidence 45689999999999999999998764311 13778999988643221 111111 1222222333222221
Q ss_pred ---EEeCCeeEEEEEecCCCCHHHHHhhcCCCC-------------------CHHHHHHHHHHHHHHHHHHHhcCCCCeE
Q 011851 196 ---CIEDDQRLLVYEFMPRGSLENHLFRRSLPL-------------------PWSIRMKIALDAAKGLAFLHEEAEKPVI 253 (476)
Q Consensus 196 ---~~~~~~~~lV~E~~~~g~L~~~l~~~~~~l-------------------~~~~~~~i~~qi~~al~~lH~~~~~~iv 253 (476)
...+..++|||||+.+++|.+++.....+. ....+..++.||+.||.|||+++ |+
T Consensus 201 ~~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---Ii 277 (566)
T PLN03225 201 PVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IV 277 (566)
T ss_pred ccccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EE
Confidence 245668999999999999999986543211 23345679999999999999988 99
Q ss_pred ecCCCCCCeeecC-CCceEEeecCCcCCCCCCCccceeeeeecCCCCCCcchhhcC----------------------CC
Q 011851 254 YRDFKTSNILLDG-EYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG----------------------HL 310 (476)
Q Consensus 254 HrDlKp~NILl~~-~~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~ 310 (476)
||||||+||||+. ++.+||+|||+|+....... .....++||+.|+|||.+... .+
T Consensus 278 HRDLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~-~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~ 356 (566)
T PLN03225 278 HRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGIN-YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNL 356 (566)
T ss_pred eCcCCHHHEEEeCCCCcEEEEeCCCccccccccc-cCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccC
Confidence 9999999999985 57999999999986543222 223457899999999976432 23
Q ss_pred CccchhhhhHHHHHHHHhCCCCCCCCCCC-------CcchhHHhhhhhhccccccccccCcccCCCCC--hHHHHHHHHH
Q 011851 311 TAKSDVYSFGVVLLEMLTGRRSMDKNRPN-------GEHNLVEWARPQLGERRRFYRLIDPCLEGCFS--IKGAEKTIQL 381 (476)
Q Consensus 311 ~~~~DiwslGv~l~elltG~~pf~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~--~~~~~~~~~l 381 (476)
+.++|||||||+||||+++..+++..... .......|...... ...+.+...+. .......++|
T Consensus 357 ~~k~DVwSlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~d~~~~~~~dL 429 (566)
T PLN03225 357 PDRFDIYSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEP-------RASPDLRRGFEVLDLDGGAGWEL 429 (566)
T ss_pred CCCcccHHHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhcc-------ccchhhhhhhhhccccchHHHHH
Confidence 45679999999999999987665321000 00001111110000 00000000000 0012346689
Q ss_pred HHHhcccCCCCCCCHHHHHHHhcCCCCcccccC
Q 011851 382 AASCLNRDQKARPRMSEVVEALKPLPYLKDMAS 414 (476)
Q Consensus 382 i~~cL~~dP~~RPt~~ell~~L~~~~~~~~~~~ 414 (476)
|.+||+.||++|||+.++++| |||++...
T Consensus 430 i~~mL~~dP~kR~ta~e~L~H----pff~~~~~ 458 (566)
T PLN03225 430 LKSMMRFKGRQRISAKAALAH----PYFDREGL 458 (566)
T ss_pred HHHHccCCcccCCCHHHHhCC----cCcCCCCc
Confidence 999999999999999999997 99986543
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=289.44 Aligned_cols=273 Identities=22% Similarity=0.297 Sum_probs=199.2
Q ss_pred cCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCCC-----C---CceeeE
Q 011851 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLI-----H---PNLVKL 192 (476)
Q Consensus 121 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~-----h---pnIv~l 192 (476)
.+|.+.++||.|.|++||+|++.. +.+.||+|+.+... ...+..+.||++|++++ | ..||+|
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq---------~~r~VAlKVvKSAq-hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~L 147 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQ---------NKRYVALKVVKSAQ-HYTEAALDEIKLLQQVREGDPNDPGKKCVVQL 147 (590)
T ss_pred ceEEEEEeccccccceeEEEeecc---------CCeEEEEEEEehhh-HHHHHHHHHHHHHHHHHhcCCCCCCCceeeee
Confidence 689999999999999999998764 56679999996542 23355678999999873 3 369999
Q ss_pred EEEEEe----CCeeEEEEEecCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCC
Q 011851 193 IGCCIE----DDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGE 267 (476)
Q Consensus 193 ~~~~~~----~~~~~lV~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~ 267 (476)
+++|.. +.++|||+|++ |.+|..+|... ...++...++.|++||+.||.|||...+ |||.||||+||||..+
T Consensus 148 lD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecg--IIHTDlKPENvLl~~~ 224 (590)
T KOG1290|consen 148 LDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECG--IIHTDLKPENVLLCST 224 (590)
T ss_pred eccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcC--ccccCCCcceeeeecc
Confidence 999986 45899999999 77999998764 4569999999999999999999999754 9999999999998210
Q ss_pred -----------C--------------------------------------------------------------------
Q 011851 268 -----------Y-------------------------------------------------------------------- 268 (476)
Q Consensus 268 -----------~-------------------------------------------------------------------- 268 (476)
+
T Consensus 225 e~~~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n 304 (590)
T KOG1290|consen 225 EIDPAKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYN 304 (590)
T ss_pred ccchhhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccc
Confidence 0
Q ss_pred --------------------------------------------------------------------------------
Q 011851 269 -------------------------------------------------------------------------------- 268 (476)
Q Consensus 269 -------------------------------------------------------------------------------- 268 (476)
T Consensus 305 ~~~~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~ 384 (590)
T KOG1290|consen 305 NEPRINGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDI 384 (590)
T ss_pred cccCCCccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCC
Confidence
Q ss_pred -------ceEEeecCCcCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCc
Q 011851 269 -------NAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGE 341 (476)
Q Consensus 269 -------~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~ 341 (476)
.+||+|||.|+.... ..+.-+.|..|+|||++.+..|+..+||||++|++|||+||...|+.......
T Consensus 385 ~~~~~di~vKIaDlGNACW~~k-----hFT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y 459 (590)
T KOG1290|consen 385 PLPECDIRVKIADLGNACWVHK-----HFTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENY 459 (590)
T ss_pred CCCccceeEEEeeccchhhhhh-----hhchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCC
Confidence 023333333332111 11223568899999999999999999999999999999999999975443321
Q ss_pred c---hhHHhhhhhhc--------cccccccccCc-----------------ccCC--CCChHHHHHHHHHHHHhcccCCC
Q 011851 342 H---NLVEWARPQLG--------ERRRFYRLIDP-----------------CLEG--CFSIKGAEKTIQLAASCLNRDQK 391 (476)
Q Consensus 342 ~---~~~~~~~~~~~--------~~~~~~~~~d~-----------------~l~~--~~~~~~~~~~~~li~~cL~~dP~ 391 (476)
. +.+......++ ....-.++++. .|.+ .++...+.++.+++.-||+++|+
T Consensus 460 ~rDEDHiA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~Pe 539 (590)
T KOG1290|consen 460 SRDEDHIALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPE 539 (590)
T ss_pred CccHHHHHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCcc
Confidence 1 11111100000 00000111111 1111 24455678999999999999999
Q ss_pred CCCCHHHHHHHhcCCCCcccccCc
Q 011851 392 ARPRMSEVVEALKPLPYLKDMASS 415 (476)
Q Consensus 392 ~RPt~~ell~~L~~~~~~~~~~~~ 415 (476)
+|||+.++|+| ||+.....+
T Consensus 540 KR~tA~~cl~h----PwLn~~~~~ 559 (590)
T KOG1290|consen 540 KRPTAAQCLKH----PWLNPVAGP 559 (590)
T ss_pred ccccHHHHhcC----ccccCCCCC
Confidence 99999999998 999876553
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=304.16 Aligned_cols=274 Identities=19% Similarity=0.267 Sum_probs=190.0
Q ss_pred hccCCCccccccccCCccEEEEEEccCCce-------eeeCCCCceEEEEEecCCCccCHHHH--------------HHH
Q 011851 119 ATKSFRPECLLGEGGFGCVYKGWINMNGTA-------TVKPGTGLPVAVKTLNHDGLQGHKEW--------------LAE 177 (476)
Q Consensus 119 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~-------~~~~~~g~~vAiK~~~~~~~~~~~~~--------------~~E 177 (476)
..++|++.++||+|+||.||+|.+...+.. ......++.||||.+........++| ..|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 356899999999999999999976432211 12334567899999875433222222 346
Q ss_pred HHHHhCCCCCce-----eeEEEEEEe--------CCeeEEEEEecCCCCHHHHHhhcC----------------------
Q 011851 178 VNYLGGLIHPNL-----VKLIGCCIE--------DDQRLLVYEFMPRGSLENHLFRRS---------------------- 222 (476)
Q Consensus 178 ~~~l~~l~hpnI-----v~l~~~~~~--------~~~~~lV~E~~~~g~L~~~l~~~~---------------------- 222 (476)
+.++.+++|.++ ++++++|.. .+..||||||+++++|.+++....
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 667777766554 677777653 356899999999999999886421
Q ss_pred -CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCcCCCCCCCccceeeeeecCCCCCC
Q 011851 223 -LPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAA 301 (476)
Q Consensus 223 -~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~a 301 (476)
..+++..++.++.|++.+|.|||+.+ |+||||||+|||++.++.+||+|||++......... ......+|+.|+|
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~-~~~~g~~tp~Y~a 378 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINF-NPLYGMLDPRYSP 378 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCcc-CccccCCCcceeC
Confidence 12456778899999999999999988 999999999999999999999999999765332211 1112345889999
Q ss_pred cchhhcCC--------------------CC--ccchhhhhHHHHHHHHhCCC-CCCCCCCCC------cchhHHhhhhhh
Q 011851 302 PEYVMTGH--------------------LT--AKSDVYSFGVVLLEMLTGRR-SMDKNRPNG------EHNLVEWARPQL 352 (476)
Q Consensus 302 PE~~~~~~--------------------~~--~~~DiwslGv~l~elltG~~-pf~~~~~~~------~~~~~~~~~~~~ 352 (476)
||++.... |+ .+.||||+||++|+|++|.. ||....... ......|... .
T Consensus 379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~-~ 457 (507)
T PLN03224 379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMY-K 457 (507)
T ss_pred hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhh-c
Confidence 99886432 12 24799999999999999986 664321110 0011111110 0
Q ss_pred ccccccccccCcccCCCCChHHHHHHHHHHHHhcccCC---CCCCCHHHHHHHhcCCCCccc
Q 011851 353 GERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQ---KARPRMSEVVEALKPLPYLKD 411 (476)
Q Consensus 353 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP---~~RPt~~ell~~L~~~~~~~~ 411 (476)
.. ...-......++..++|+.+||..+| .+|+|+.|+|+| |||..
T Consensus 458 ~~----------~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H----p~f~~ 505 (507)
T PLN03224 458 GQ----------KYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH----RFFLP 505 (507)
T ss_pred cc----------CCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC----CCcCC
Confidence 00 00000111236789999999999866 689999999998 99853
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=291.36 Aligned_cols=263 Identities=29% Similarity=0.441 Sum_probs=194.8
Q ss_pred CCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHh--CCCCCceeeEEEEEEeC
Q 011851 122 SFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLG--GLIHPNLVKLIGCCIED 199 (476)
Q Consensus 122 ~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~--~l~hpnIv~l~~~~~~~ 199 (476)
...+.++||+|.||+||+|.+. ++.||||++... ..+.|..|-+|.. .+.|+||++++++-...
T Consensus 211 pl~l~eli~~Grfg~V~KaqL~-----------~~~VAVKifp~~---~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~ 276 (534)
T KOG3653|consen 211 PLQLLELIGRGRFGCVWKAQLD-----------NRLVAVKIFPEQ---EKQSFQNEKNIYSLPGMKHENILQFIGAEKRG 276 (534)
T ss_pred chhhHHHhhcCccceeehhhcc-----------CceeEEEecCHH---HHHHHHhHHHHHhccCccchhHHHhhchhccC
Confidence 3556688999999999999764 578999999754 3456777877776 45799999999987665
Q ss_pred C----eeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcC------CCCeEecCCCCCCeeecCCCc
Q 011851 200 D----QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEA------EKPVIYRDFKTSNILLDGEYN 269 (476)
Q Consensus 200 ~----~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~------~~~ivHrDlKp~NILl~~~~~ 269 (476)
+ .++||+||.+.|+|.++|... .++|....+++.-+++||+|||+.- +.+|+|||||..||||..|++
T Consensus 277 t~~~~eywLVt~fh~kGsL~dyL~~n--tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlT 354 (534)
T KOG3653|consen 277 TADRMEYWLVTEFHPKGSLCDYLKAN--TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLT 354 (534)
T ss_pred CccccceeEEeeeccCCcHHHHHHhc--cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCc
Confidence 5 899999999999999999544 5999999999999999999999863 356999999999999999999
Q ss_pred eEEeecCCcCCCCCCCccceeeeeecCCCCCCcchhhcC-CCC-----ccchhhhhHHHHHHHHhCCCCCCC-CCCCCcc
Q 011851 270 AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLT-----AKSDVYSFGVVLLEMLTGRRSMDK-NRPNGEH 342 (476)
Q Consensus 270 vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~-----~~~DiwslGv~l~elltG~~pf~~-~~~~~~~ 342 (476)
..|+|||+|..+..+.........+||..|||||++.+. .+. .+.||||+|.+||||++.-.-++. ..+....
T Consensus 355 ccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yql 434 (534)
T KOG3653|consen 355 CCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQL 434 (534)
T ss_pred EEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccC
Confidence 999999999987655444334457899999999998764 222 258999999999999997655432 1111111
Q ss_pred hh----------HHhhhhhhccccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 011851 343 NL----------VEWARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKP 405 (476)
Q Consensus 343 ~~----------~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~ 405 (476)
-+ -+.......++ .+..+.. .+.......-+.+.++.||..|++.|.|+.=+.+.+..
T Consensus 435 pfe~evG~hPt~e~mq~~VV~kK--~RP~~p~---~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~ 502 (534)
T KOG3653|consen 435 PFEAEVGNHPTLEEMQELVVRKK--QRPKIPD---AWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAE 502 (534)
T ss_pred chhHHhcCCCCHHHHHHHHHhhc--cCCCChh---hhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHH
Confidence 00 00000000000 0011111 11112335678999999999999999999877776443
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=313.69 Aligned_cols=262 Identities=31% Similarity=0.481 Sum_probs=206.5
Q ss_pred CCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCcc-CHHHHHHHHHHHhCC-CCCceeeEEEEEEeC
Q 011851 122 SFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQ-GHKEWLAEVNYLGGL-IHPNLVKLIGCCIED 199 (476)
Q Consensus 122 ~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~-~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~ 199 (476)
+..+.+.||+|+||.|++|......... ......||||.++..... +.+.+..|+++|+.+ .|+||+.+++++..+
T Consensus 297 ~l~~~~~lg~g~fG~v~~~~~~~~~~~~--~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~ 374 (609)
T KOG0200|consen 297 NLKLGKYLGEGAFGQVVKALLFGLSKAL--LSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQD 374 (609)
T ss_pred hccccceeecccccceEeEEEeeccccc--ccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccC
Confidence 3456679999999999999865322110 112567999999765443 456789999999999 599999999999999
Q ss_pred CeeEEEEEecCCCCHHHHHhhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeee
Q 011851 200 DQRLLVYEFMPRGSLENHLFRRS---------------LPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILL 264 (476)
Q Consensus 200 ~~~~lV~E~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl 264 (476)
+.+++|+||+..|+|.+++.... ..++......+++||+.|++||++.. +|||||-..|||+
T Consensus 375 ~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAaRNVLi 451 (609)
T KOG0200|consen 375 GPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAARNVLI 451 (609)
T ss_pred CceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhhhhEEe
Confidence 99999999999999999997665 34889999999999999999999977 9999999999999
Q ss_pred cCCCceEEeecCCcCCCCCCCccceeeeeec--CCCCCCcchhhcCCCCccchhhhhHHHHHHHHh-CCCCCCCCCCCCc
Q 011851 265 DGEYNAKLSDFGLAKDGPEGDKTHVSTRVMG--TYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLT-GRRSMDKNRPNGE 341 (476)
Q Consensus 265 ~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~~DiwslGv~l~ellt-G~~pf~~~~~~~~ 341 (476)
..+..+||+|||+|+.....+..... .-.| ...|||||.+....|+.++|||||||+||||+| |..||.+....
T Consensus 452 ~~~~~~kIaDFGlar~~~~~~~y~~~-~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~-- 528 (609)
T KOG0200|consen 452 TKNKVIKIADFGLARDHYNKDYYRTK-SSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPT-- 528 (609)
T ss_pred cCCCEEEEccccceeccCCCCceEec-CCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcH--
Confidence 99999999999999976554443221 1122 335999999999999999999999999999999 67788653211
Q ss_pred chhHHhhhhhhccccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 011851 342 HNLVEWARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKP 405 (476)
Q Consensus 342 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~ 405 (476)
.++.++.+ ...+ + ..+..++.++.++++.||+.+|++||++.++.+.|+.
T Consensus 529 ~~l~~~l~----~G~r---~-------~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~ 578 (609)
T KOG0200|consen 529 EELLEFLK----EGNR---M-------EQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEK 578 (609)
T ss_pred HHHHHHHh----cCCC---C-------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHH
Confidence 12222111 1111 0 1122337899999999999999999999999998776
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-35 Score=274.56 Aligned_cols=243 Identities=30% Similarity=0.423 Sum_probs=196.3
Q ss_pred CCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccC-HHHHHHHHHHHhCCCCCceeeEEEEEEeCCeeEEEEEecCC
Q 011851 133 GFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQG-HKEWLAEVNYLGGLIHPNLVKLIGCCIEDDQRLLVYEFMPR 211 (476)
Q Consensus 133 ~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~-~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~ 211 (476)
+||.||+|.+. .+|+.+|+|++....... .+.+.+|++.+++++|+||+++++++..+...+++|||+++
T Consensus 1 ~~g~v~~~~~~---------~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~ 71 (244)
T smart00220 1 SFGKVYLARDK---------KTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDG 71 (244)
T ss_pred CceEEEEEEEC---------CCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCC
Confidence 58999998764 367889999998765554 67889999999999999999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCcCCCCCCCccceee
Q 011851 212 GSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVST 291 (476)
Q Consensus 212 g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~ 291 (476)
++|.+++.... .+++..+..++.+++.+|.|||+.+ |+|+||+|.||+++.++.++|+|||.+....... ...
T Consensus 72 ~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~ 144 (244)
T smart00220 72 GDLFDLLKKRG-RLSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLT 144 (244)
T ss_pred CCHHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc---ccc
Confidence 99999986543 3899999999999999999999988 9999999999999999999999999998765432 123
Q ss_pred eeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhccccccccccCcccCCCCC
Q 011851 292 RVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRRFYRLIDPCLEGCFS 371 (476)
Q Consensus 292 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 371 (476)
...++..|++||.+....++.++||||||+++|+|++|..||...... ............ ... . ..
T Consensus 145 ~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~--~~~~~~~~~~~~------~~~---~---~~ 210 (244)
T smart00220 145 TFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQL--LELFKKIGKPKP------PFP---P---PE 210 (244)
T ss_pred cccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH--HHHHHHHhccCC------CCc---c---cc
Confidence 356889999999999888999999999999999999999999753111 111111110000 000 0 00
Q ss_pred hHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCc
Q 011851 372 IKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYL 409 (476)
Q Consensus 372 ~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~ 409 (476)
...+.++.+++.+||..+|++||++.+++++ |||
T Consensus 211 ~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~~----~~~ 244 (244)
T smart00220 211 WKISPEAKDLIRKLLVKDPEKRLTAEEALQH----PFF 244 (244)
T ss_pred ccCCHHHHHHHHHHccCCchhccCHHHHhhC----CCC
Confidence 0035688999999999999999999999986 764
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-36 Score=305.66 Aligned_cols=256 Identities=28% Similarity=0.417 Sum_probs=211.6
Q ss_pred CCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCC-ccCHHHHHHHHHHHhCCCCCceeeEEEEEEeCCe
Q 011851 123 FRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDG-LQGHKEWLAEVNYLGGLIHPNLVKLIGCCIEDDQ 201 (476)
Q Consensus 123 y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~ 201 (476)
.+..++||+|+||+||+|.+--.+.. -..+||||++.... .+...+++.|+-+|.+|+|||+++|++++....
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~-----vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~- 771 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGEN-----VKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST- 771 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCce-----ecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-
Confidence 45567899999999999998755443 34579999986543 344678999999999999999999999998776
Q ss_pred eEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCcCCC
Q 011851 202 RLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDG 281 (476)
Q Consensus 202 ~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~ 281 (476)
+-||++|++.|+|.|+++....++-....+.|..||++||.|||++. +|||||-..|||+..-..+||.|||+++..
T Consensus 772 ~qlvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll 848 (1177)
T KOG1025|consen 772 LQLVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLL 848 (1177)
T ss_pred HHHHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhcc
Confidence 88999999999999999888888999999999999999999999988 999999999999999999999999999987
Q ss_pred CCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhhcccccccc
Q 011851 282 PEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPQLGERRRFYR 360 (476)
Q Consensus 282 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 360 (476)
.............-.+.|||=|.+....|+.++|||||||++||++| |..|+++....+..++.+....
T Consensus 849 ~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geR---------- 918 (1177)
T KOG1025|consen 849 APDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGER---------- 918 (1177)
T ss_pred CcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhcccc----------
Confidence 65444332222333567999999999999999999999999999998 8889988766554444332111
Q ss_pred ccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 011851 361 LIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALK 404 (476)
Q Consensus 361 ~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~ 404 (476)
+ .-+...+.+++.++.+||..|++.||+++++...+.
T Consensus 919 L-------sqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs 955 (1177)
T KOG1025|consen 919 L-------SQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFS 955 (1177)
T ss_pred C-------CCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHH
Confidence 1 112334778999999999999999999999988654
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-36 Score=266.09 Aligned_cols=266 Identities=20% Similarity=0.303 Sum_probs=202.2
Q ss_pred ccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCCC-CCceeeEEEEEEe
Q 011851 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLI-HPNLVKLIGCCIE 198 (476)
Q Consensus 120 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~ 198 (476)
.++|++.+++|+|.++.||.|... .+++.++||+++.-. .+.+.+|+.||..|. ||||++|+++..+
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~---------~~~eK~ViKiLKPVk---kkKIkREikIL~nL~gg~NIi~L~DiV~D 104 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINI---------TNNEKCVIKILKPVK---KKKIKREIKILQNLRGGPNIIKLLDIVKD 104 (338)
T ss_pred cchHHHHHHHcCccHhhHhccccc---------CCCceEEEeeechHH---HHHHHHHHHHHHhccCCCCeeehhhhhcC
Confidence 467999999999999999998644 356779999997543 356889999999997 9999999999876
Q ss_pred C--CeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCC-CceEEeec
Q 011851 199 D--DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGE-YNAKLSDF 275 (476)
Q Consensus 199 ~--~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~-~~vkl~DF 275 (476)
. ....||+||+.+.+...+. ..++...++.++.+++.||.|||+.| |+|||+||.|++||.. -.++|+|+
T Consensus 105 p~SktpaLiFE~v~n~Dfk~ly----~tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDW 177 (338)
T KOG0668|consen 105 PESKTPSLIFEYVNNTDFKQLY----PTLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDW 177 (338)
T ss_pred ccccCchhHhhhhccccHHHHh----hhhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeec
Confidence 4 4567999999887665544 34777889999999999999999999 9999999999999865 46999999
Q ss_pred CCcCCCCCCCccceeeeeecCCCCCCcchhhc-CCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhh-----
Q 011851 276 GLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR----- 349 (476)
Q Consensus 276 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~----- 349 (476)
|+|.....+..... .+.+..|.-||++.. ..|+.+-|+|||||+|..|+..+.||.....+..+ ++..+.
T Consensus 178 GLAEFYHp~~eYnV---RVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQ-LVkIakVLGt~ 253 (338)
T KOG0668|consen 178 GLAEFYHPGKEYNV---RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQ-LVKIAKVLGTD 253 (338)
T ss_pred chHhhcCCCceeee---eeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHH-HHHHHHHhChH
Confidence 99998766554332 457888999998875 57899999999999999999999999765544332 222111
Q ss_pred --------hhhccccccccccCcccC----CCCC---h-HHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCcccc
Q 011851 350 --------PQLGERRRFYRLIDPCLE----GCFS---I-KGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDM 412 (476)
Q Consensus 350 --------~~~~~~~~~~~~~d~~l~----~~~~---~-~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~~ 412 (476)
..+....++..++..... ...+ . -.++++.||+.++|..|-.+|+|+.|.+.| |||...
T Consensus 254 el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~H----pyF~~~ 328 (338)
T KOG0668|consen 254 ELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAH----PYFAPV 328 (338)
T ss_pred HHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcC----chHHHH
Confidence 111111112221111110 0000 0 114789999999999999999999999998 888743
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=279.94 Aligned_cols=265 Identities=23% Similarity=0.368 Sum_probs=200.8
Q ss_pred CCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCC--CccCHHHHHHHHHHHhCCCCCceeeEEEEEEeC-
Q 011851 123 FRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHD--GLQGHKEWLAEVNYLGGLIHPNLVKLIGCCIED- 199 (476)
Q Consensus 123 y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~- 199 (476)
.+..+.||.|+||+||. +++..+|+.||+|.+... .....+++.+|+.+|.-++|.|++..+++..-.
T Consensus 55 i~PDRPIGYGAFGVVWs---------VTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph 125 (449)
T KOG0664|consen 55 IQPDRPIGYGAFGVVWS---------VTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPAN 125 (449)
T ss_pred CCCCCcccccceeEEEe---------ccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCC
Confidence 45668899999999997 456678999999988643 233457788999999999999999998876533
Q ss_pred ----CeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeec
Q 011851 200 ----DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDF 275 (476)
Q Consensus 200 ----~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DF 275 (476)
.++|++.|+| ..+|...| -...+++...+.-+++||++||+|||+.+ |+||||||.|+|++.+..+|||||
T Consensus 126 ~dfFqEiYV~TELm-QSDLHKII-VSPQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDF 200 (449)
T KOG0664|consen 126 PSFFQELYVLTELM-QSDLHKII-VSPQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDF 200 (449)
T ss_pred chHHHHHHHHHHHH-Hhhhhhee-ccCCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEeccc
Confidence 3578899999 45787766 45568999999999999999999999988 999999999999999999999999
Q ss_pred CCcCCCCCCCccceeeeeecCCCCCCcchhhcC-CCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhh--hhh
Q 011851 276 GLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR--PQL 352 (476)
Q Consensus 276 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~--~~~ 352 (476)
|+|+.-...+.. ..+..+-|.+|+|||++++. .|+.++||||+|||+.||+..+..|....+....+++.-.. +.+
T Consensus 201 GLARvee~d~~~-hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~ 279 (449)
T KOG0664|consen 201 GLARTWDQRDRL-NMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQ 279 (449)
T ss_pred ccccccchhhhh-hhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcH
Confidence 999975443333 34445678999999999986 79999999999999999999999998877765554432110 000
Q ss_pred c------cccccc--c--ccCcccCCCCC----hHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011851 353 G------ERRRFY--R--LIDPCLEGCFS----IKGAEKTIQLAASCLNRDQKARPRMSEVVEA 402 (476)
Q Consensus 353 ~------~~~~~~--~--~~d~~l~~~~~----~~~~~~~~~li~~cL~~dP~~RPt~~ell~~ 402 (476)
. +..+.+ + .-.|.+.-.|. .....+..+++.++|..||++|.+..+.+.+
T Consensus 280 EaMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~ 343 (449)
T KOG0664|consen 280 EAMKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQH 343 (449)
T ss_pred HHHHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccc
Confidence 0 000000 0 00011111111 1223567889999999999999999999887
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=293.64 Aligned_cols=271 Identities=22% Similarity=0.271 Sum_probs=208.6
Q ss_pred hccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCCC------CCceeeE
Q 011851 119 ATKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLI------HPNLVKL 192 (476)
Q Consensus 119 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~------hpnIv~l 192 (476)
.-.+|.+....|+|-|++|.+|.+. ..|+.||||+|+..... .+.=+.|++||++|+ --++++|
T Consensus 430 LD~RY~V~~~~GkGvFs~Vvra~D~---------~r~~~vAiKIIRnNE~M-~KtGl~EleiLkKL~~AD~Edk~Hclrl 499 (752)
T KOG0670|consen 430 LDSRYEVQGYTGKGVFSTVVRARDQ---------ARGQEVAIKIIRNNEVM-HKTGLKELEILKKLNDADPEDKFHCLRL 499 (752)
T ss_pred hcceeEEEeccccceeeeeeecccc---------CCCCeeEEEEeecchHH-hhhhhHHHHHHHHhhccCchhhhHHHHH
Confidence 4568999999999999999998765 35668999999876543 345578999999995 3478999
Q ss_pred EEEEEeCCeeEEEEEecCCCCHHHHHhh--cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCC-Cc
Q 011851 193 IGCCIEDDQRLLVYEFMPRGSLENHLFR--RSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGE-YN 269 (476)
Q Consensus 193 ~~~~~~~~~~~lV~E~~~~g~L~~~l~~--~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~-~~ 269 (476)
+-.|...+++|||+|-+ ..+|.+.|.+ .+..|....+..++.|++-||..|-..+ |+|.||||+|||+++. ..
T Consensus 500 ~r~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k~i 575 (752)
T KOG0670|consen 500 FRHFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESKNI 575 (752)
T ss_pred HHHhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCcce
Confidence 99999999999999998 6799999965 3456888899999999999999999988 9999999999999865 46
Q ss_pred eEEeecCCcCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhh
Q 011851 270 AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR 349 (476)
Q Consensus 270 vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~ 349 (476)
+||||||.|....+.+.+. +.-+..|.|||++.+-+|++..|+||+||+||||+||+..|.+...+....+..-..
T Consensus 576 LKLCDfGSA~~~~eneitP----YLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~K 651 (752)
T KOG0670|consen 576 LKLCDFGSASFASENEITP----YLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELK 651 (752)
T ss_pred eeeccCccccccccccccH----HHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhc
Confidence 8999999998876544322 223456999999999999999999999999999999999998876654443221111
Q ss_pred hhhccc----cc---------------------------cccccCc------ccCCC--CC---hHHHHHHHHHHHHhcc
Q 011851 350 PQLGER----RR---------------------------FYRLIDP------CLEGC--FS---IKGAEKTIQLAASCLN 387 (476)
Q Consensus 350 ~~~~~~----~~---------------------------~~~~~d~------~l~~~--~~---~~~~~~~~~li~~cL~ 387 (476)
..++.. .. +...+.| .+.++ ++ ...-.++.+|+.+||.
T Consensus 652 Gk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~ 731 (752)
T KOG0670|consen 652 GKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLI 731 (752)
T ss_pred CCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhc
Confidence 111100 00 0000111 11111 11 2234678999999999
Q ss_pred cCCCCCCCHHHHHHHhcCCCCccc
Q 011851 388 RDQKARPRMSEVVEALKPLPYLKD 411 (476)
Q Consensus 388 ~dP~~RPt~~ell~~L~~~~~~~~ 411 (476)
+||++|.|..++|+| ||+..
T Consensus 732 LdP~KRit~nqAL~H----pFi~~ 751 (752)
T KOG0670|consen 732 LDPEKRITVNQALKH----PFITE 751 (752)
T ss_pred cChhhcCCHHHHhcC----CcccC
Confidence 999999999999998 88753
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-35 Score=282.11 Aligned_cols=265 Identities=26% Similarity=0.369 Sum_probs=198.6
Q ss_pred ccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhC--CCCCceeeEEEEEE
Q 011851 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGG--LIHPNLVKLIGCCI 197 (476)
Q Consensus 120 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~--l~hpnIv~l~~~~~ 197 (476)
.++..+.+.||+|.||.||+|.+. |+.||||++...+ ...+.+|.+|.+. |+|+||+.+++.-.
T Consensus 210 arqI~L~e~IGkGRyGEVwrG~wr-----------Ge~VAVKiF~srd---E~SWfrEtEIYqTvmLRHENILgFIaaD~ 275 (513)
T KOG2052|consen 210 ARQIVLQEIIGKGRFGEVWRGRWR-----------GEDVAVKIFSSRD---ERSWFRETEIYQTVMLRHENILGFIAADN 275 (513)
T ss_pred hheeEEEEEecCccccceeecccc-----------CCceEEEEecccc---hhhhhhHHHHHHHHHhccchhhhhhhccc
Confidence 456788899999999999999885 7789999997543 3567788888774 58999999998865
Q ss_pred eCC----eeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhc-----CCCCeEecCCCCCCeeecCCC
Q 011851 198 EDD----QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEE-----AEKPVIYRDFKTSNILLDGEY 268 (476)
Q Consensus 198 ~~~----~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~-----~~~~ivHrDlKp~NILl~~~~ 268 (476)
.+. ++|||.+|.+.|+|+|+|.+ ..++....++++.-++.||++||.. |+..|.|||||..|||+..++
T Consensus 276 ~~~gs~TQLwLvTdYHe~GSL~DyL~r--~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~ 353 (513)
T KOG2052|consen 276 KDNGSWTQLWLVTDYHEHGSLYDYLNR--NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG 353 (513)
T ss_pred cCCCceEEEEEeeecccCCcHHHHHhh--ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCC
Confidence 443 68999999999999999966 4689999999999999999999975 445699999999999999999
Q ss_pred ceEEeecCCcCCCCCCCcc--ceeeeeecCCCCCCcchhhcCC----C-C-ccchhhhhHHHHHHHHhC----------C
Q 011851 269 NAKLSDFGLAKDGPEGDKT--HVSTRVMGTYGYAAPEYVMTGH----L-T-AKSDVYSFGVVLLEMLTG----------R 330 (476)
Q Consensus 269 ~vkl~DFG~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~----~-~-~~~DiwslGv~l~elltG----------~ 330 (476)
..-|+|+|+|......... ...+..+||..|||||++...- + + ..+||||||.++||++.. +
T Consensus 354 ~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~ 433 (513)
T KOG2052|consen 354 TCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQ 433 (513)
T ss_pred cEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhc
Confidence 9999999999876543221 1223468999999999987531 1 2 258999999999999874 4
Q ss_pred CCCCCCCCCCcchhHHhhhhhhccccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011851 331 RSMDKNRPNGEHNLVEWARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPL 406 (476)
Q Consensus 331 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~ 406 (476)
.||...-+.+... .++....- ..++...++ ..+.+...-..+.+|++.||..||..|-|+-.|-+.|.++
T Consensus 434 ~Pyyd~Vp~DPs~-eeMrkVVC--v~~~RP~ip---nrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l 503 (513)
T KOG2052|consen 434 LPYYDVVPSDPSF-EEMRKVVC--VQKLRPNIP---NRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKL 503 (513)
T ss_pred CCcccCCCCCCCH-HHHhccee--ecccCCCCC---cccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHH
Confidence 6776554433211 11100000 011111111 1223334566888999999999999999998888876544
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-35 Score=300.34 Aligned_cols=260 Identities=27% Similarity=0.396 Sum_probs=198.0
Q ss_pred CCccccccccCCcc-EEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCC-CCCceeeEEEEEEeCC
Q 011851 123 FRPECLLGEGGFGC-VYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGL-IHPNLVKLIGCCIEDD 200 (476)
Q Consensus 123 y~~~~~LG~G~fg~-Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~ 200 (476)
|...+.+|.|+-|+ ||+|... |+.||||.+-... .....+|+..|+.- .|||||++|+.-.++.
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~ye-----------~R~VAVKrll~e~---~~~A~rEi~lL~eSD~H~NviRyyc~E~d~q 576 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVYE-----------GREVAVKRLLEEF---FDFAQREIQLLQESDEHPNVIRYYCSEQDRQ 576 (903)
T ss_pred eccHHHcccCCCCcEEEEEeeC-----------CceehHHHHhhHh---HHHHHHHHHHHHhccCCCceEEEEeeccCCc
Confidence 45557799999876 7898764 7789999885432 23567899999988 4999999999988999
Q ss_pred eeEEEEEecCCCCHHHHHhhc--CCCC-CHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecC---C--CceEE
Q 011851 201 QRLLVYEFMPRGSLENHLFRR--SLPL-PWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDG---E--YNAKL 272 (476)
Q Consensus 201 ~~~lV~E~~~~g~L~~~l~~~--~~~l-~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~---~--~~vkl 272 (476)
..||+.|+| ..+|.+++... .... .....+.++.|++.||++||+.+ ||||||||.||||+. + ..++|
T Consensus 577 F~YIalELC-~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~i 652 (903)
T KOG1027|consen 577 FLYIALELC-ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKI 652 (903)
T ss_pred eEEEEehHh-hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEe
Confidence 999999999 55999999663 1111 11345778899999999999988 999999999999965 3 47899
Q ss_pred eecCCcCCCCCCCcc-ceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhC-CCCCCCCCCCCcchhHHhhhh
Q 011851 273 SDFGLAKDGPEGDKT-HVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTG-RRSMDKNRPNGEHNLVEWARP 350 (476)
Q Consensus 273 ~DFG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG-~~pf~~~~~~~~~~~~~~~~~ 350 (476)
+|||+++....+... .......||-+|+|||++....-+.++|||||||++|+.++| ..||...-.... +++.
T Consensus 653 SDfglsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~-NIl~---- 727 (903)
T KOG1027|consen 653 SDFGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQA-NILT---- 727 (903)
T ss_pred cccccccccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhh-hhhc----
Confidence 999999987654332 123347899999999999999888899999999999999997 889975432211 1100
Q ss_pred hhccccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCcccccCcchHHHH
Q 011851 351 QLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDMASSSSYVQA 421 (476)
Q Consensus 351 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~~~~~~~~~~~ 421 (476)
.... +. .+... ...++.+||.+|++.+|..||++.+||.| |+|.+.+....+++.
T Consensus 728 ---~~~~---L~--~L~~~----~d~eA~dLI~~ml~~dP~~RPsa~~VL~H----PlFW~~ekrL~Fl~d 782 (903)
T KOG1027|consen 728 ---GNYT---LV--HLEPL----PDCEAKDLISRMLNPDPQLRPSATDVLNH----PLFWDSEKRLSFLRD 782 (903)
T ss_pred ---Cccc---ee--eeccC----chHHHHHHHHHhcCCCcccCCCHHHHhCC----CccCChHHHHHHHHh
Confidence 0000 00 01100 01278899999999999999999999998 999987766666544
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=252.70 Aligned_cols=201 Identities=28% Similarity=0.360 Sum_probs=165.8
Q ss_pred CCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCC-ccCHHHHHHHHHHHhCC-CCCceeeEEEEEEeC
Q 011851 122 SFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDG-LQGHKEWLAEVNYLGGL-IHPNLVKLIGCCIED 199 (476)
Q Consensus 122 ~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~ 199 (476)
....+..||+|++|.|-+-+ +..+|...|+|.++..- .+..+++++|+++..+. .+|.+|.+|+.+...
T Consensus 47 ~L~~i~elGrGayG~vekmr---------h~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~re 117 (282)
T KOG0984|consen 47 DLVGIEELGRGAYGVVEKMR---------HIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFRE 117 (282)
T ss_pred hhhhhhhhcCCccchhhhee---------eccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhcc
Confidence 34456779999999997644 44678889999997543 23456788999976655 699999999999999
Q ss_pred CeeEEEEEecCCCCHHHHHh---hcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecC
Q 011851 200 DQRLLVYEFMPRGSLENHLF---RRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFG 276 (476)
Q Consensus 200 ~~~~lV~E~~~~g~L~~~l~---~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG 276 (476)
...|+.||.| ..+|..+.. +.+..+++...-+|+..|++||.|||++- .|||||+||+||||+.+|+||+||||
T Consensus 118 gdvwIcME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFG 194 (282)
T KOG0984|consen 118 GDVWICMELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFG 194 (282)
T ss_pred ccEEEeHHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccc
Confidence 9999999999 557776653 46788999999999999999999999965 39999999999999999999999999
Q ss_pred CcCCCCCCCccceeeeeecCCCCCCcchhhc----CCCCccchhhhhHHHHHHHHhCCCCCCCCC
Q 011851 277 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT----GHLTAKSDVYSFGVVLLEMLTGRRSMDKNR 337 (476)
Q Consensus 277 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslGv~l~elltG~~pf~~~~ 337 (476)
++-.+.+.- ..+--.|-..|||||.+.. ..|+.++||||||++++||.+++.||+...
T Consensus 195 IsG~L~dSi---Akt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~ 256 (282)
T KOG0984|consen 195 ISGYLVDSI---AKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWG 256 (282)
T ss_pred cceeehhhh---HHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccC
Confidence 997654322 1222457788999998864 379999999999999999999999997643
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=283.43 Aligned_cols=197 Identities=23% Similarity=0.309 Sum_probs=169.2
Q ss_pred cCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCH--------HHHHHHHHHHhCCC---CCce
Q 011851 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGH--------KEWLAEVNYLGGLI---HPNL 189 (476)
Q Consensus 121 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~--------~~~~~E~~~l~~l~---hpnI 189 (476)
.+|...+.||+|+||.|++|.++. +...|+||.+.++..-.. -.+-.|+.||..|+ |+||
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~---------n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NI 631 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKE---------NNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENI 631 (772)
T ss_pred ccceeeeeccccccceEEEeeecc---------cceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccch
Confidence 458999999999999999986654 456799999987543211 11346999999997 9999
Q ss_pred eeEEEEEEeCCeeEEEEEec-CCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCC
Q 011851 190 VKLIGCCIEDDQRLLVYEFM-PRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEY 268 (476)
Q Consensus 190 v~l~~~~~~~~~~~lV~E~~-~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~ 268 (476)
++++++|++++++||+||-. +|.+|+++|.. ...+++.++..|++||+.|+++||+++ |||||||-+||.++.+|
T Consensus 632 lKlLdfFEddd~yyl~te~hg~gIDLFd~IE~-kp~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g 707 (772)
T KOG1152|consen 632 LKLLDFFEDDDYYYLETEVHGEGIDLFDFIEF-KPRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNG 707 (772)
T ss_pred hhhhheeecCCeeEEEecCCCCCcchhhhhhc-cCccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCC
Confidence 99999999999999999976 45699999944 456999999999999999999999999 99999999999999999
Q ss_pred ceEEeecCCcCCCCCCCccceeeeeecCCCCCCcchhhcCCC-CccchhhhhHHHHHHHHhCCCCCC
Q 011851 269 NAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHL-TAKSDVYSFGVVLLEMLTGRRSMD 334 (476)
Q Consensus 269 ~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslGv~l~elltG~~pf~ 334 (476)
-+||+|||.|.....+. ...++||..|.|||++.+..| +..-|||+||++||.++....||.
T Consensus 708 ~~klidfgsaa~~ksgp----fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 708 FVKLIDFGSAAYTKSGP----FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred eEEEeeccchhhhcCCC----cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 99999999997755433 334899999999999999877 456899999999999999998885
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=264.21 Aligned_cols=266 Identities=24% Similarity=0.323 Sum_probs=199.2
Q ss_pred cCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCC--CccCHHHHHHHHHHHhCCCCCceeeEEEEEEe
Q 011851 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHD--GLQGHKEWLAEVNYLGGLIHPNLVKLIGCCIE 198 (476)
Q Consensus 121 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~ 198 (476)
.+|.-++.+|.|+- .|..|.+. -+++.||+|.+... .....++..+|+.++..+.|+||++++.+|.-
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~---------v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP 86 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQ---------VLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTP 86 (369)
T ss_pred eeeeeecccCCCCc-eEEecchh---------hccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCc
Confidence 46777888999988 66655443 46788999987543 22345677899999999999999999999874
Q ss_pred C------CeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEE
Q 011851 199 D------DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKL 272 (476)
Q Consensus 199 ~------~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl 272 (476)
. ...|+||||| ..+|...+. ..++.....+|++|++.|++|||+.+ |+||||||+||++..++.+||
T Consensus 87 ~~~l~~~~e~y~v~e~m-~~nl~~vi~---~elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi 159 (369)
T KOG0665|consen 87 QKTLEEFQEVYLVMELM-DANLCQVIL---MELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKI 159 (369)
T ss_pred cccHHHHHhHHHHHHhh-hhHHHHHHH---HhcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheee
Confidence 4 3579999999 569988886 34778899999999999999999998 999999999999999999999
Q ss_pred eecCCcCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcch---------
Q 011851 273 SDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHN--------- 343 (476)
Q Consensus 273 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~--------- 343 (476)
.|||+|+..... ...+-.+.|..|.|||++.+-.|...+||||+||++.||++|+.-|.+...-..-.
T Consensus 160 ~dfg~ar~e~~~---~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtp 236 (369)
T KOG0665|consen 160 LDFGLARTEDTD---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTP 236 (369)
T ss_pred ccchhhcccCcc---cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCC
Confidence 999999874322 23455788999999999999889999999999999999999999887543211110
Q ss_pred -------hHHhhhhhhccc-----cccccccCcc-cCCC--CChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCC
Q 011851 344 -------LVEWARPQLGER-----RRFYRLIDPC-LEGC--FSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPY 408 (476)
Q Consensus 344 -------~~~~~~~~~~~~-----~~~~~~~d~~-l~~~--~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~ 408 (476)
+...++-..... ..+.+.+... .... .+......+.+|+.+||..||++|.+++++|+| ||
T Consensus 237 d~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H----PY 312 (369)
T KOG0665|consen 237 DPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH----PY 312 (369)
T ss_pred CHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC----Ce
Confidence 000000000000 1111111111 0000 011124578899999999999999999999998 88
Q ss_pred cc
Q 011851 409 LK 410 (476)
Q Consensus 409 ~~ 410 (476)
++
T Consensus 313 ~~ 314 (369)
T KOG0665|consen 313 IK 314 (369)
T ss_pred ee
Confidence 86
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=288.67 Aligned_cols=259 Identities=24% Similarity=0.360 Sum_probs=209.9
Q ss_pred ccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCCCCCceeeEEEEEEeC
Q 011851 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHPNLVKLIGCCIED 199 (476)
Q Consensus 120 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~ 199 (476)
..+|.+...+|+|++|.||+|++. .+++..|+|+++.+.-.+..-+..|+-+++.++|||||.+++.+...
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~---------~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~ 84 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDK---------RSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRR 84 (829)
T ss_pred ccchhheeeecCCcccchhhhccc---------ccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhh
Confidence 357999999999999999998765 47788999999987766777778899999999999999999999999
Q ss_pred CeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCcC
Q 011851 200 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAK 279 (476)
Q Consensus 200 ~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~ 279 (476)
+.+|++||||.||+|.+.. .-.+++++.++.++++..++||+|||+.+ =+|||||-.|||+++.|.+|++|||.+.
T Consensus 85 dklwicMEycgggslQdiy-~~TgplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsa 160 (829)
T KOG0576|consen 85 DKLWICMEYCGGGSLQDIY-HVTGPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSA 160 (829)
T ss_pred cCcEEEEEecCCCccccee-eecccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchh
Confidence 9999999999999999866 44568999999999999999999999988 7999999999999999999999999986
Q ss_pred CCCCCCccceeeeeecCCCCCCcchhh---cCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhcccc
Q 011851 280 DGPEGDKTHVSTRVMGTYGYAAPEYVM---TGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERR 356 (476)
Q Consensus 280 ~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~ 356 (476)
..... ......+.||++|||||+.. .+.|...+|||++|+...|+---++|.....+.....+... .
T Consensus 161 qitat--i~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTk--------S 230 (829)
T KOG0576|consen 161 QITAT--IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTK--------S 230 (829)
T ss_pred hhhhh--hhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhc--------c
Confidence 54321 12234589999999999764 56899999999999999999988888654433222111111 1
Q ss_pred ccccccC-cccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCccc
Q 011851 357 RFYRLID-PCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKD 411 (476)
Q Consensus 357 ~~~~~~d-~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~ 411 (476)
.++ +.+++ ...-++.+-+|++.||..+|++||+++.+|.| ||+..
T Consensus 231 ----~~qpp~lkD--k~kws~~fh~fvK~altknpKkRptaeklL~h----~fvs~ 276 (829)
T KOG0576|consen 231 ----GFQPPTLKD--KTKWSEFFHNFVKGALTKNPKKRPTAEKLLQH----PFVSQ 276 (829)
T ss_pred ----CCCCCcccC--CccchHHHHHHHHHHhcCCCccCCChhhheec----eeecc
Confidence 111 11111 12236788899999999999999999998876 66543
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2e-32 Score=260.99 Aligned_cols=269 Identities=27% Similarity=0.390 Sum_probs=214.2
Q ss_pred hhHHHHhccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCcc-CHHHHHHHHHHHhCCCCCceee
Q 011851 113 FNELKSATKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQ-GHKEWLAEVNYLGGLIHPNLVK 191 (476)
Q Consensus 113 ~~~~~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~ 191 (476)
..++.....++++..++-+|.||.||+|.+.+..+- .+.+.|-+|.++....+ ....++.|-..|..+.|||+..
T Consensus 276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~----n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~ 351 (563)
T KOG1024|consen 276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTY----NDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLS 351 (563)
T ss_pred HHhhhhhhhheechhhhhcCchhheeeeeecccCCc----chHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccc
Confidence 334445556789999999999999999988754332 23456777877544322 3456888999999999999999
Q ss_pred EEEEEEeC-CeeEEEEEecCCCCHHHHHhh-----c--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCee
Q 011851 192 LIGCCIED-DQRLLVYEFMPRGSLENHLFR-----R--SLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNIL 263 (476)
Q Consensus 192 l~~~~~~~-~~~~lV~E~~~~g~L~~~l~~-----~--~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NIL 263 (476)
+.+++.++ +..++++.++.-|+|..+|.. . .+.++..+...++.|++.|++|||+++ |||.||...|++
T Consensus 352 V~~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCv 428 (563)
T KOG1024|consen 352 VLGVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCV 428 (563)
T ss_pred eeEEEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcce
Confidence 99997765 467888999988999999972 1 234667778889999999999999998 999999999999
Q ss_pred ecCCCceEEeecCCcCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHh-CCCCCCCCCCCCcc
Q 011851 264 LDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEH 342 (476)
Q Consensus 264 l~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~ellt-G~~pf~~~~~~~~~ 342 (476)
||+..++||+|=.+++..-..+......+......||+||.+.+..|+.++|+|||||+||||+| |+.|+...++.+..
T Consensus 429 Idd~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~ 508 (563)
T KOG1024|consen 429 IDDQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEME 508 (563)
T ss_pred ehhheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHH
Confidence 99999999999999999887777666555556778999999999999999999999999999998 88898766554322
Q ss_pred hhHHhhhhhhccccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 011851 343 NLVEWARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKP 405 (476)
Q Consensus 343 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~ 405 (476)
..+ .+.. ++- -+.++++++..++.-||..+|++||+++++..-|.+
T Consensus 509 ~yl-------kdGy---Rla-------QP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLse 554 (563)
T KOG1024|consen 509 HYL-------KDGY---RLA-------QPFNCPDELFTVMACCWALLPEERPSFSQLVICLSE 554 (563)
T ss_pred HHH-------hccc---eec-------CCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHH
Confidence 211 1111 111 234558999999999999999999999999987653
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.2e-31 Score=243.22 Aligned_cols=212 Identities=37% Similarity=0.567 Sum_probs=183.6
Q ss_pred ccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCcc-CHHHHHHHHHHHhCCCCCceeeEEEEEEeCCeeEEEEE
Q 011851 129 LGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQ-GHKEWLAEVNYLGGLIHPNLVKLIGCCIEDDQRLLVYE 207 (476)
Q Consensus 129 LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E 207 (476)
||+|.+|.||++... .+++.+++|++...... ....+.+|++.++.+.|++|+++++++......+++||
T Consensus 1 l~~g~~~~v~~~~~~---------~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e 71 (215)
T cd00180 1 LGEGGFGTVYLARDK---------KTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVME 71 (215)
T ss_pred CCcCCceEEEEEEec---------CCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEe
Confidence 689999999998764 35788999999766443 34678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecC-CCceEEeecCCcCCCCCCCc
Q 011851 208 FMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDG-EYNAKLSDFGLAKDGPEGDK 286 (476)
Q Consensus 208 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~-~~~vkl~DFG~a~~~~~~~~ 286 (476)
|+++++|.+++......+++..+..++.+++.+|.+||+.+ ++|+||+|.||+++. ++.++|+|||.+........
T Consensus 72 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~ 148 (215)
T cd00180 72 YCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS 148 (215)
T ss_pred cCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc
Confidence 99989999998665456899999999999999999999988 999999999999999 89999999999986544321
Q ss_pred cceeeeeecCCCCCCcchhhcC-CCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhccccccccccCcc
Q 011851 287 THVSTRVMGTYGYAAPEYVMTG-HLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRRFYRLIDPC 365 (476)
Q Consensus 287 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 365 (476)
......+...|++||.+... .++.+.|+|+||+++++|
T Consensus 149 --~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l--------------------------------------- 187 (215)
T cd00180 149 --LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL--------------------------------------- 187 (215)
T ss_pred --hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH---------------------------------------
Confidence 12235678889999998887 888999999999999999
Q ss_pred cCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011851 366 LEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEAL 403 (476)
Q Consensus 366 l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L 403 (476)
..+.+++.+||+.||++||++.+++++|
T Consensus 188 ----------~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 ----------PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred ----------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 2455899999999999999999998763
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.7e-32 Score=261.22 Aligned_cols=281 Identities=24% Similarity=0.342 Sum_probs=206.1
Q ss_pred HhccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCCC-CCceeeEEEEE
Q 011851 118 SATKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLI-HPNLVKLIGCC 196 (476)
Q Consensus 118 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~ 196 (476)
...+.|+.+++||+|.|++||+|.+... ....+.||+|.+..... ..++..|+++|..+. +.||+++.+++
T Consensus 33 ~~~~~~~~v~kigeGsFssv~~a~~~~~------~~~~~~valk~i~~ts~--p~ri~~El~~L~~~gG~~ni~~~~~~~ 104 (418)
T KOG1167|consen 33 FISNAYKVVNKIGEGSFSSVYKATDIEQ------DTKRRYVALKAIYRTSS--PSRILNELEMLYRLGGSDNIIKLNGCF 104 (418)
T ss_pred hhhhhhhhhccccccchhhhhhhhHhhh------ccccceEeeeecccccC--chHHHHHHHHHHHhccchhhhcchhhh
Confidence 3456799999999999999999987642 23578899999876543 356889999999995 89999999999
Q ss_pred EeCCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCC-CceEEeec
Q 011851 197 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGE-YNAKLSDF 275 (476)
Q Consensus 197 ~~~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~-~~vkl~DF 275 (476)
..++...+||||++.....+++. .++...+..+++.++.||.++|.+| ||||||||.|+|.+.. +.-.|+||
T Consensus 105 rnnd~v~ivlp~~~H~~f~~l~~----~l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDF 177 (418)
T KOG1167|consen 105 RNNDQVAIVLPYFEHDRFRDLYR----SLSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDF 177 (418)
T ss_pred ccCCeeEEEecccCccCHHHHHh----cCCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEec
Confidence 99999999999999998888773 3668899999999999999999988 9999999999999754 56799999
Q ss_pred CCcCCCCC-------------------CC---------------cc--------ceeeeeecCCCCCCcchhhcC-CCCc
Q 011851 276 GLAKDGPE-------------------GD---------------KT--------HVSTRVMGTYGYAAPEYVMTG-HLTA 312 (476)
Q Consensus 276 G~a~~~~~-------------------~~---------------~~--------~~~~~~~gt~~y~aPE~~~~~-~~~~ 312 (476)
|+|..... +. .. .......||++|.|||++..- ..+.
T Consensus 178 gLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qtt 257 (418)
T KOG1167|consen 178 GLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTT 257 (418)
T ss_pred hhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCC
Confidence 99861100 00 00 001125799999999998764 6788
Q ss_pred cchhhhhHHHHHHHHhCCCCCCCCCCCCcc--hhHHhh-hhh-------hcc---------------ccccccc-cCccc
Q 011851 313 KSDVYSFGVVLLEMLTGRRSMDKNRPNGEH--NLVEWA-RPQ-------LGE---------------RRRFYRL-IDPCL 366 (476)
Q Consensus 313 ~~DiwslGv~l~elltG~~pf~~~~~~~~~--~~~~~~-~~~-------~~~---------------~~~~~~~-~d~~l 366 (476)
++||||.|||+..+++++.||......... .++... ... .+. ...+... +..+.
T Consensus 258 aiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~ 337 (418)
T KOG1167|consen 258 AIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIY 337 (418)
T ss_pred ccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcc
Confidence 999999999999999999999754332211 111100 000 000 0001111 01111
Q ss_pred CC--------CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCcccccCcch
Q 011851 367 EG--------CFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDMASSSS 417 (476)
Q Consensus 367 ~~--------~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~~~~~~~ 417 (476)
.. ......+..+.+|+.+||..||.+|.|+++.|+| |||........
T Consensus 338 ~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkH----pFF~~~~~~~~ 392 (418)
T KOG1167|consen 338 KSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKH----PFFDEADRTER 392 (418)
T ss_pred cccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcC----cCCcchhhhhh
Confidence 10 0111124478999999999999999999999998 99996544333
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.6e-32 Score=246.58 Aligned_cols=253 Identities=23% Similarity=0.334 Sum_probs=188.6
Q ss_pred ccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCC-CCCceeeEEEE-EE
Q 011851 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGL-IHPNLVKLIGC-CI 197 (476)
Q Consensus 120 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~-~~ 197 (476)
.+.|.+.+.||+|.||.+.+++++ ++...+++|-+.... ...++|.+|...--.| .|.||+.-|+. |+
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr---------~s~t~ivlKavp~p~-tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFq 92 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHR---------QSKTRIVLKAVPRPQ-TTQADFVREFHYSFFLSPHQHIIDTYEVAFQ 92 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeecc---------CCceEEEeeccCcch-hhHHHHHHHhccceeeccchhhhHHHHHHhh
Confidence 346999999999999999997655 567789999987653 3467888998865555 48999998876 67
Q ss_pred eCCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeee-c-CCCceEEeec
Q 011851 198 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILL-D-GEYNAKLSDF 275 (476)
Q Consensus 198 ~~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl-~-~~~~vkl~DF 275 (476)
..+.++++|||++.|+|..-+... .+-+.....++.|++.||.|+|+.+ +||||||.+|||| + +..+||||||
T Consensus 93 t~d~YvF~qE~aP~gdL~snv~~~--GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDF 167 (378)
T KOG1345|consen 93 TSDAYVFVQEFAPRGDLRSNVEAA--GIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDF 167 (378)
T ss_pred cCceEEEeeccCccchhhhhcCcc--cccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeec
Confidence 778889999999999998877443 4788899999999999999999988 9999999999999 3 3458999999
Q ss_pred CCcCCCCCCCccceeeeeecCCCCCCcchhhcC-----CCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhh
Q 011851 276 GLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-----HLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP 350 (476)
Q Consensus 276 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~ 350 (476)
|+.+.....- ....-+..|.+||++... ...+.+|||.||+++|.+|||..||+.... .....++|...
T Consensus 168 G~t~k~g~tV-----~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~-~d~~Y~~~~~w 241 (378)
T KOG1345|consen 168 GLTRKVGTTV-----KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASI-MDKPYWEWEQW 241 (378)
T ss_pred ccccccCcee-----hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhc-cCchHHHHHHH
Confidence 9997643211 113345679999987643 346789999999999999999999984322 22222333222
Q ss_pred hhccccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011851 351 QLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEA 402 (476)
Q Consensus 351 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~ 402 (476)
.-.....+.+. |. ..++.+..+.++-|..++++|--..++.+.
T Consensus 242 ~~rk~~~~P~~--------F~-~fs~~a~r~Fkk~lt~~~~drcki~~~kk~ 284 (378)
T KOG1345|consen 242 LKRKNPALPKK--------FN-PFSEKALRLFKKSLTPRFKDRCKIWTAKKM 284 (378)
T ss_pred hcccCccCchh--------hc-ccCHHHHHHHHHhcCCcccccchhHHHHHH
Confidence 22111121222 11 125678889999999999999555555543
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-30 Score=239.90 Aligned_cols=200 Identities=34% Similarity=0.435 Sum_probs=173.3
Q ss_pred CCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCcc-CHHHHHHHHHHHhCCCCCceeeEEEEEEeCCe
Q 011851 123 FRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQ-GHKEWLAEVNYLGGLIHPNLVKLIGCCIEDDQ 201 (476)
Q Consensus 123 y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~ 201 (476)
|++.+.||.|++|.||++... .+++.+|+|.+...... ..+.+.+|++.+++++|+||+++++++.....
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~---------~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~ 71 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDK---------GTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEP 71 (225)
T ss_pred CceeeEeecCCCeEEEEEEEc---------CCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCc
Confidence 567789999999999998765 35778999999876554 56778899999999999999999999999999
Q ss_pred eEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCcCCC
Q 011851 202 RLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDG 281 (476)
Q Consensus 202 ~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~ 281 (476)
.++++||+++++|.+++......+++..+..++.+++.+|.+||+.+ ++|+||+|.||+++.++.++|+|||++...
T Consensus 72 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~ 148 (225)
T smart00221 72 LYLVMEYCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFI 148 (225)
T ss_pred eEEEEeccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEe
Confidence 99999999999999998654433899999999999999999999987 999999999999999999999999999876
Q ss_pred CCCCccceeeeeecCCCCCCcchh-hcCCCCccchhhhhHHHHHHHHhCCCCCCC
Q 011851 282 PEGDKTHVSTRVMGTYGYAAPEYV-MTGHLTAKSDVYSFGVVLLEMLTGRRSMDK 335 (476)
Q Consensus 282 ~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslGv~l~elltG~~pf~~ 335 (476)
...... ......++..|++||.+ ....++.++|||+||+++|+|++|+.||..
T Consensus 149 ~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 149 HRDLAA-LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred cCcccc-cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 543210 12335788899999998 666788899999999999999999999965
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-30 Score=289.45 Aligned_cols=202 Identities=18% Similarity=0.256 Sum_probs=146.3
Q ss_pred CCCC-CceeeEEEEE-------EeCCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEe
Q 011851 183 GLIH-PNLVKLIGCC-------IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIY 254 (476)
Q Consensus 183 ~l~h-pnIv~l~~~~-------~~~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivH 254 (476)
.+.| +||++++++| .+.+.++++|||+ +++|.++|......+++..++.++.||+.||.|||+++ |+|
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~g---IvH 103 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQG---IVV 103 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCC---eee
Confidence 3445 5788888877 3345678889988 66999999766667999999999999999999999988 999
Q ss_pred cCCCCCCeeecCC-------------------CceEEeecCCcCCCCCCCc--------------cceeeeeecCCCCCC
Q 011851 255 RDFKTSNILLDGE-------------------YNAKLSDFGLAKDGPEGDK--------------THVSTRVMGTYGYAA 301 (476)
Q Consensus 255 rDlKp~NILl~~~-------------------~~vkl~DFG~a~~~~~~~~--------------~~~~~~~~gt~~y~a 301 (476)
|||||+||||+.. +.+||+|||+++....... .......+||+.|||
T Consensus 104 rDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~A 183 (793)
T PLN00181 104 HNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTS 183 (793)
T ss_pred ccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEC
Confidence 9999999999654 4455666666653211000 000112468999999
Q ss_pred cchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhccccccccccCcccCCCCChHHHHHHHHH
Q 011851 302 PEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQL 381 (476)
Q Consensus 302 PE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l 381 (476)
||++.+..|+.++|||||||+||||++|..|+..... ....... ..+.+.. .....+..++
T Consensus 184 PE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~----~~~~~~~----------~~~~~~~-----~~~~~~~~~~ 244 (793)
T PLN00181 184 PEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR----TMSSLRH----------RVLPPQI-----LLNWPKEASF 244 (793)
T ss_pred hhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH----HHHHHHH----------hhcChhh-----hhcCHHHHHH
Confidence 9999999999999999999999999999888653210 0000000 0011100 0112345688
Q ss_pred HHHhcccCCCCCCCHHHHHHHhcCCCCccc
Q 011851 382 AASCLNRDQKARPRMSEVVEALKPLPYLKD 411 (476)
Q Consensus 382 i~~cL~~dP~~RPt~~ell~~L~~~~~~~~ 411 (476)
+.+||+.||.+||++.++++| ||+..
T Consensus 245 ~~~~L~~~P~~Rps~~eil~h----~~~~~ 270 (793)
T PLN00181 245 CLWLLHPEPSCRPSMSELLQS----EFINE 270 (793)
T ss_pred HHHhCCCChhhCcChHHHhhc----hhhhh
Confidence 999999999999999999997 88865
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-27 Score=216.22 Aligned_cols=164 Identities=23% Similarity=0.224 Sum_probs=125.3
Q ss_pred CCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCcCCCCCCCccceee
Q 011851 212 GSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVST 291 (476)
Q Consensus 212 g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~ 291 (476)
|+|.+++......+++..++.++.||+.||.|||+++ ||+|||++.++.+|+ ||+++......
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~~------ 63 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPEQ------ 63 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeecccc------
Confidence 6899999776778999999999999999999999854 999999999999999 99987653311
Q ss_pred eeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhccccccccccCcccCCCCC
Q 011851 292 RVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRRFYRLIDPCLEGCFS 371 (476)
Q Consensus 292 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 371 (476)
..||+.|||||++.+..|+.++|||||||++|||++|+.||........ ............ ++. .....
T Consensus 64 -~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~--~~~~~~~~~~~~-------~~~-~~~~~ 132 (176)
T smart00750 64 -SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSA--ILEILLNGMPAD-------DPR-DRSNL 132 (176)
T ss_pred -CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcH--HHHHHHHHhccC-------Ccc-ccccH
Confidence 2689999999999999999999999999999999999999965432111 111111000000 000 00011
Q ss_pred hHHHH--HHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011851 372 IKGAE--KTIQLAASCLNRDQKARPRMSEVVEAL 403 (476)
Q Consensus 372 ~~~~~--~~~~li~~cL~~dP~~RPt~~ell~~L 403 (476)
..... ++.+++.+||..||++||++.++++++
T Consensus 133 ~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~ 166 (176)
T smart00750 133 ESVSAARSFADFMRVCASRLPQRREAANHYLAHC 166 (176)
T ss_pred HHHHhhhhHHHHHHHHHhcccccccCHHHHHHHH
Confidence 12233 689999999999999999999999984
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-27 Score=214.58 Aligned_cols=260 Identities=20% Similarity=0.216 Sum_probs=205.8
Q ss_pred ccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCCCC-CceeeEEEEEEe
Q 011851 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIH-PNLVKLIGCCIE 198 (476)
Q Consensus 120 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~h-pnIv~l~~~~~~ 198 (476)
...|+++++||+|+||.+|+|... .+|+.||||+..... ...++..|..+.+.|++ ..|..+..++.+
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~~i---------~~ge~VAiK~Es~~a--~hpqL~yEskvY~iL~~g~GiP~i~~y~~e 82 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGISI---------TSGEEVAIKLESSKA--KHPQLLYESKVYRILQGGVGIPHIRHYGTE 82 (341)
T ss_pred ccceEEEEeecCCchhheeeeeec---------cCCceEEEEeecccC--CCcchhHHHHHHHHhccCCCCchhhhhccc
Confidence 457999999999999999998654 478899999986543 34567788999888875 788888989999
Q ss_pred CCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCC---CceEEeec
Q 011851 199 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGE---YNAKLSDF 275 (476)
Q Consensus 199 ~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~---~~vkl~DF 275 (476)
..+-.|||+++ |.+|++++.-....++..+++-++-|++.-|+|+|.++ +|||||||+|+|..-+ ..+.|+||
T Consensus 83 ~~ynvlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDF 158 (341)
T KOG1163|consen 83 KDYNVLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDF 158 (341)
T ss_pred cccceeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEec
Confidence 99999999999 88999998777778999999999999999999999988 9999999999998533 46899999
Q ss_pred CCcCCCCCCCc-----cceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhh
Q 011851 276 GLAKDGPEGDK-----THVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP 350 (476)
Q Consensus 276 G~a~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~ 350 (476)
|+|+...+... ........||..|.+-....+...+.+.|+=|+|.+|.++.-|..||++..+.......+....
T Consensus 159 GLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~E 238 (341)
T KOG1163|consen 159 GLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISE 238 (341)
T ss_pred cchhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHH
Confidence 99987654322 1123347899999998877777888999999999999999999999998776554433222111
Q ss_pred hhccccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 011851 351 QLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALK 404 (476)
Q Consensus 351 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~ 404 (476)
.++...+. .++...+.++.-.+.-|-..-.++-|+..-+-+.+.
T Consensus 239 -----kK~s~~ie-----~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFr 282 (341)
T KOG1163|consen 239 -----KKMSTPIE-----VLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFR 282 (341)
T ss_pred -----hhcCCCHH-----HHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHH
Confidence 11111111 112223678899999999999999999888777644
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.5e-27 Score=220.60 Aligned_cols=257 Identities=19% Similarity=0.235 Sum_probs=202.7
Q ss_pred CCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCCC-CCceeeEEEEEEeCC
Q 011851 122 SFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLI-HPNLVKLIGCCIEDD 200 (476)
Q Consensus 122 ~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~ 200 (476)
.|++.++||+|+||..++|... -+++.||||...... ...++..|.+..+.|. .++|...|.+..++-
T Consensus 29 hyrVGkKIGeGsFG~lf~G~Nl---------~nne~VAIKfEPrkS--~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~ 97 (449)
T KOG1165|consen 29 HYRVGKKIGEGSFGVLFLGKNL---------YNNEPVAIKFEPRKS--EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGK 97 (449)
T ss_pred cceeccccccCcceeeeccccc---------ccCceEEEEeccccC--CcchHHHHHHHHHHHcCCCCCCceeeeccccc
Confidence 5999999999999999999765 367889999875443 2356777888887774 699999999999999
Q ss_pred eeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCC-----CceEEeec
Q 011851 201 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGE-----YNAKLSDF 275 (476)
Q Consensus 201 ~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~-----~~vkl~DF 275 (476)
+-.||||++ |.+|+|+..-.+..++.+.+..++.|++.-++|+|++. +|+|||||+|+||..- ..|.|+||
T Consensus 98 ~NiLVidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDF 173 (449)
T KOG1165|consen 98 YNILVIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDF 173 (449)
T ss_pred hhhhhhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEec
Confidence 999999999 88999999888889999999999999999999999988 9999999999999543 35899999
Q ss_pred CCcCCCCCCCcc-----ceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhh
Q 011851 276 GLAKDGPEGDKT-----HVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP 350 (476)
Q Consensus 276 G~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~ 350 (476)
|+|+...+.... .......||..||+-...++...+.+.|+=|||-+++++|-|..||++..........+
T Consensus 174 GmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYe---- 249 (449)
T KOG1165|consen 174 GMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYE---- 249 (449)
T ss_pred cchhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHH----
Confidence 999987553321 11224679999999999999999999999999999999999999999865543322211
Q ss_pred hhccccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011851 351 QLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEAL 403 (476)
Q Consensus 351 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L 403 (476)
.+++..+.-.+- .+....++++...+.-.-.++..+-|..+-+...+
T Consensus 250 KIGe~Kr~T~i~------~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf 296 (449)
T KOG1165|consen 250 KIGETKRSTPIE------VLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLF 296 (449)
T ss_pred HhccccccCCHH------HHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHH
Confidence 122222111111 11222377888888888899999999987766543
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.1e-26 Score=228.84 Aligned_cols=258 Identities=22% Similarity=0.233 Sum_probs=196.4
Q ss_pred CCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCCCC----CceeeEEEEE-
Q 011851 122 SFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIH----PNLVKLIGCC- 196 (476)
Q Consensus 122 ~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~h----pnIv~l~~~~- 196 (476)
+|.+.++||+|+||.||++.+.... ...+|+|+...........+..|+.+|..+.. .++..+++.+
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~--------~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~ 90 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEK--------NKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGR 90 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCC--------CeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEecc
Confidence 7999999999999999998765321 35799999876544433367788888888862 6899999999
Q ss_pred EeCCeeEEEEEecCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCC-----Cce
Q 011851 197 IEDDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGE-----YNA 270 (476)
Q Consensus 197 ~~~~~~~lV~E~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~-----~~v 270 (476)
..+...||||+.+ |.+|.++..... ..++..++..|+.|++.+|++||+.| ++||||||+|+++... -.+
T Consensus 91 ~~~~~~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~ 166 (322)
T KOG1164|consen 91 STEDFNFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTL 166 (322)
T ss_pred CCCceeEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceE
Confidence 5778899999999 889999875443 78999999999999999999999988 9999999999999755 369
Q ss_pred EEeecCCcC--CCCCCCc----cc-e-eeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcc
Q 011851 271 KLSDFGLAK--DGPEGDK----TH-V-STRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEH 342 (476)
Q Consensus 271 kl~DFG~a~--~~~~~~~----~~-~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~ 342 (476)
.|.|||+++ ....... .. . ...+.||..|+++....+...+.+.|+||++.++.||+.|..||.........
T Consensus 167 ~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~ 246 (322)
T KOG1164|consen 167 YLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLK 246 (322)
T ss_pred EEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchH
Confidence 999999998 3221111 11 1 12356999999999999999999999999999999999999999765433221
Q ss_pred hhHHhhhhhhccccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 011851 343 NLVEWARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALK 404 (476)
Q Consensus 343 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~ 404 (476)
......... ..... +....+.++.++...+-..+..++|....+...|+
T Consensus 247 ~~~~~~~~~--------~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~ 295 (322)
T KOG1164|consen 247 SKFEKDPRK--------LLTDR-----FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLK 295 (322)
T ss_pred HHHHHHhhh--------hcccc-----ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHH
Confidence 111100000 00000 11122567777888888899999999999888743
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.6e-26 Score=230.10 Aligned_cols=176 Identities=18% Similarity=0.145 Sum_probs=132.9
Q ss_pred hccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCC-----ccCHHHHHHHHHHHhCCCCCceee-E
Q 011851 119 ATKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDG-----LQGHKEWLAEVNYLGGLIHPNLVK-L 192 (476)
Q Consensus 119 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~-----~~~~~~~~~E~~~l~~l~hpnIv~-l 192 (476)
...+|.+.+.||+|+||+||+|++.. .+++.||||++.... ......+.+|+++|++++|+||+. +
T Consensus 16 ~~~~Y~~~~~IG~G~fg~Vy~a~~~~--------~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l 87 (365)
T PRK09188 16 LSARFVETAVLKRDVFSTVERGYFAG--------DPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQL 87 (365)
T ss_pred ccCCceEccEEeecCcEEEEEEEEcC--------CCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEE
Confidence 34579999999999999999997642 246678999875331 112346889999999999999985 4
Q ss_pred EEEEEeCCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCC-CCCCeeecCCCceE
Q 011851 193 IGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDF-KTSNILLDGEYNAK 271 (476)
Q Consensus 193 ~~~~~~~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDl-Kp~NILl~~~~~vk 271 (476)
++ .+..|||||||+|++|.. + .. .. ...++.|++.+|.|||+.+ |+|||| ||+|||++.++.+|
T Consensus 88 ~~----~~~~~LVmE~~~G~~L~~-~-~~---~~---~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ik 152 (365)
T PRK09188 88 LA----TGKDGLVRGWTEGVPLHL-A-RP---HG---DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAA 152 (365)
T ss_pred EE----cCCcEEEEEccCCCCHHH-h-Cc---cc---hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEE
Confidence 43 256899999999999963 2 11 11 1467889999999999988 999999 99999999999999
Q ss_pred EeecCCcCCCCCCCccce------eeeeecCCCCCCcchhhcCC------CCccchhh
Q 011851 272 LSDFGLAKDGPEGDKTHV------STRVMGTYGYAAPEYVMTGH------LTAKSDVY 317 (476)
Q Consensus 272 l~DFG~a~~~~~~~~~~~------~~~~~gt~~y~aPE~~~~~~------~~~~~Diw 317 (476)
|+|||+|+.......... .+...+++.|+|||.+.-.. .+...|-|
T Consensus 153 LiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW 210 (365)
T PRK09188 153 VIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW 210 (365)
T ss_pred EEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence 999999986644321111 13467899999999886432 23346666
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1e-27 Score=253.50 Aligned_cols=263 Identities=19% Similarity=0.220 Sum_probs=194.4
Q ss_pred CccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecC---CCccC---HHHHHHHHHHHhCCCCCceeeEEEEEE
Q 011851 124 RPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNH---DGLQG---HKEWLAEVNYLGGLIHPNLVKLIGCCI 197 (476)
Q Consensus 124 ~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~---~~~~~---~~~~~~E~~~l~~l~hpnIv~l~~~~~ 197 (476)
....++|.|++|.|+.+..... ...++.|..+. ..... ...+..|+.+-..|.|+|++..+..+.
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~---------~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~ 391 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSD---------LKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQ 391 (601)
T ss_pred CccceeeecccCceEEEEecCC---------CccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHh
Confidence 4567899999998877654422 22233333221 11111 122566888888999999988887777
Q ss_pred eCCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCC
Q 011851 198 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGL 277 (476)
Q Consensus 198 ~~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~ 277 (476)
+....+-+||||++ +|+.++... ..+....+-.++.|++.||+|||+.| |.|||||++|++++.+|.+||+|||.
T Consensus 392 ~~~~~~~~mE~~~~-Dlf~~~~~~-~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~ 466 (601)
T KOG0590|consen 392 EIDGILQSMEYCPY-DLFSLVMSN-GKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGA 466 (601)
T ss_pred hcccchhhhhcccH-HHHHHHhcc-cccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCc
Confidence 76666666999999 999988543 56888999999999999999999999 99999999999999999999999999
Q ss_pred cCCCCCCCcc--ceeeeeecCCCCCCcchhhcCCCCcc-chhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhcc
Q 011851 278 AKDGPEGDKT--HVSTRVMGTYGYAAPEYVMTGHLTAK-SDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGE 354 (476)
Q Consensus 278 a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~ 354 (476)
+..+...... .....++|+..|+|||++.+..|++. .||||.|++++.|++|+.||............. . . ..
T Consensus 467 ~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~-~--~-~~ 542 (601)
T KOG0590|consen 467 ASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTN-N--Y-SD 542 (601)
T ss_pred ceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhh-c--c-cc
Confidence 9766544443 45567899999999999999999875 899999999999999999998655443321000 0 0 00
Q ss_pred ccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCccccc
Q 011851 355 RRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDMA 413 (476)
Q Consensus 355 ~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~~~ 413 (476)
.+... .-........+.+...+|.+||+.||.+|.|+++|++. +|++...
T Consensus 543 --~~~~~---~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d----~W~~~i~ 592 (601)
T KOG0590|consen 543 --QRNIF---EGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILND----EWIRSIE 592 (601)
T ss_pred --ccccc---cChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhC----hHhhhcc
Confidence 00000 00000112236788999999999999999999999997 8988653
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.6e-25 Score=215.36 Aligned_cols=259 Identities=31% Similarity=0.400 Sum_probs=198.0
Q ss_pred CCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccC---HHHHHHHHHHHhCCCCC-ceeeEEEEEEe
Q 011851 123 FRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQG---HKEWLAEVNYLGGLIHP-NLVKLIGCCIE 198 (476)
Q Consensus 123 y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~---~~~~~~E~~~l~~l~hp-nIv~l~~~~~~ 198 (476)
|.+.+.||.|+||.||++.+. ..+++|.+....... ...+.+|+.++..+.|+ +|+++++++..
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~------------~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~ 69 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR------------KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQD 69 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec------------cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEec
Confidence 677889999999999998765 458999987655443 56788999999999988 79999999988
Q ss_pred CCeeEEEEEecCCCCHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCC-ceEEeec
Q 011851 199 DDQRLLVYEFMPRGSLENHLFRRS--LPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEY-NAKLSDF 275 (476)
Q Consensus 199 ~~~~~lV~E~~~~g~L~~~l~~~~--~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~-~vkl~DF 275 (476)
....+++++|+.+++|.+++.... ..+.......++.|++.++.|+|..+ ++||||||+||+++..+ .++++||
T Consensus 70 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~df 146 (384)
T COG0515 70 EGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDF 146 (384)
T ss_pred CCEEEEEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEecc
Confidence 778899999999999997664443 26899999999999999999999988 99999999999999988 7999999
Q ss_pred CCcCCCCCCCccc----eeeeeecCCCCCCcchhhc---CCCCccchhhhhHHHHHHHHhCCCCCCCCCCC-CcchhHHh
Q 011851 276 GLAKDGPEGDKTH----VSTRVMGTYGYAAPEYVMT---GHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPN-GEHNLVEW 347 (476)
Q Consensus 276 G~a~~~~~~~~~~----~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslGv~l~elltG~~pf~~~~~~-~~~~~~~~ 347 (476)
|++.......... ......||..|+|||.+.+ ..+....|+|++|++++++++|..||...... ........
T Consensus 147 g~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~ 226 (384)
T COG0515 147 GLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKI 226 (384)
T ss_pred CcceecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHH
Confidence 9998554433221 2345789999999999987 57889999999999999999999997655431 00111111
Q ss_pred hhhhhccccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011851 348 ARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEA 402 (476)
Q Consensus 348 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~ 402 (476)
....... .+.. .............+.+++..|+..+|..|.+..+....
T Consensus 227 ~~~~~~~--~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 227 ILELPTP--SLAS----PLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred HHhcCCc--cccc----ccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 1100000 0000 00000001223578899999999999999999887764
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.3e-26 Score=232.97 Aligned_cols=247 Identities=26% Similarity=0.334 Sum_probs=195.8
Q ss_pred cccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCH--HHHHHHHHHHhCCC-CCceeeEEEEEEeCCeeEE
Q 011851 128 LLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGH--KEWLAEVNYLGGLI-HPNLVKLIGCCIEDDQRLL 204 (476)
Q Consensus 128 ~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~--~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~~l 204 (476)
.+|.|+||.|++++- +.-...|.-+|+|++++...... .....|..++..++ ||.+|++...|+.+..+++
T Consensus 1 vlg~g~~gkvfLvrk------~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l 74 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRK------AGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYL 74 (612)
T ss_pred CCCcCCCcchHHHHH------hccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhH
Confidence 379999999998642 23345678899999876543321 13345888888887 9999999999999999999
Q ss_pred EEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCcCCCCCC
Q 011851 205 VYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEG 284 (476)
Q Consensus 205 V~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~ 284 (476)
+++|..||.|+..+.+. ..+.+.....+...++-+++++|+.+ |+|||+|++||+++.+|++++.|||+++.....
T Consensus 75 ~ld~~rgg~lft~l~~~-~~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~ 150 (612)
T KOG0603|consen 75 ILDFLRGGDLFTRLSKE-VMFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKE 150 (612)
T ss_pred hhhhcccchhhhccccC-CchHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhh
Confidence 99999999998888443 45777888888889999999999998 999999999999999999999999999876543
Q ss_pred CccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhccccccccccCc
Q 011851 285 DKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRRFYRLIDP 364 (476)
Q Consensus 285 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 364 (476)
.. .|||..|||||++. ....++|+||||++++||+||..||.. .....+ +.
T Consensus 151 ~~------~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~I----------------l~- 201 (612)
T KOG0603|consen 151 KI------ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRI----------------LK- 201 (612)
T ss_pred hh------cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHH----------------hh-
Confidence 32 28999999999998 678899999999999999999999976 111111 00
Q ss_pred ccCCCCChHHHHHHHHHHHHhcccCCCCCCCHH-HHHHHhcCCCCcccccC
Q 011851 365 CLEGCFSIKGAEKTIQLAASCLNRDQKARPRMS-EVVEALKPLPYLKDMAS 414 (476)
Q Consensus 365 ~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~-ell~~L~~~~~~~~~~~ 414 (476)
..-.++...+..+.+++..++..+|..|.-.. +.+..++.+++++....
T Consensus 202 -~~~~~p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h~f~~~i~~ 251 (612)
T KOG0603|consen 202 -AELEMPRELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQHEFFQSIDW 251 (612)
T ss_pred -hccCCchhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhccchheeeeH
Confidence 01123445577889999999999999997653 45555666788876643
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.4e-24 Score=201.60 Aligned_cols=171 Identities=9% Similarity=0.053 Sum_probs=134.8
Q ss_pred hccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHH---------HHHHHHHHhCCCCCce
Q 011851 119 ATKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKE---------WLAEVNYLGGLIHPNL 189 (476)
Q Consensus 119 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~---------~~~E~~~l~~l~hpnI 189 (476)
..++|++.++||.|+||.||++.. ++..+|||+++......... +.+|+..+.++.|++|
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~-----------~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI 97 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDT-----------DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGL 97 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEec-----------CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCC
Confidence 467899999999999999998533 24569999997654433222 5789999999999999
Q ss_pred eeEEEEEEeC--------CeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCC
Q 011851 190 VKLIGCCIED--------DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSN 261 (476)
Q Consensus 190 v~l~~~~~~~--------~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~N 261 (476)
..+.+++... +..+|||||++|.+|.++. .+++ ....+|+.+|..||+.+ |+||||||+|
T Consensus 98 ~~~~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~-----~~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~N 165 (232)
T PRK10359 98 ASLNDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMP-----EISE----DVKAKIKASIESLHQHG---MVSGDPHKGN 165 (232)
T ss_pred CcceEeeeecccccccccCCeEEEEEEECCccHHHhh-----hccH----HHHHHHHHHHHHHHHcC---CccCCCChHH
Confidence 9999987644 3578999999999998764 1332 34569999999999988 9999999999
Q ss_pred eeecCCCceEEeecCCcCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHH
Q 011851 262 ILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEML 327 (476)
Q Consensus 262 ILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~ell 327 (476)
|+++.+| ++|+|||........... ..+++...|+.++|+|+||+++..+.
T Consensus 166 ili~~~g-i~liDfg~~~~~~e~~a~--------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 166 FIVSKNG-LRIIDLSGKRCTAQRKAK--------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred EEEeCCC-EEEEECCCcccccchhhH--------------HHHHHHhHhcccccccceeEeehHHH
Confidence 9999988 999999998765321110 11456667888999999999987665
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.6e-23 Score=190.42 Aligned_cols=139 Identities=17% Similarity=0.169 Sum_probs=107.4
Q ss_pred cccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCcc--C-------H-----------------HHHHHHHH
Q 011851 126 ECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQ--G-------H-----------------KEWLAEVN 179 (476)
Q Consensus 126 ~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~--~-------~-----------------~~~~~E~~ 179 (476)
...||+|+||.||+|.+. +|+.||||+++..... . . .....|++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~----------~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 71 (190)
T cd05147 2 NGCISTGKEANVYHATTA----------NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMR 71 (190)
T ss_pred CCccccccceEEEEEECC----------CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHH
Confidence 467999999999998643 6888999999754221 1 0 11234999
Q ss_pred HHhCCCCCceeeEEEEEEeCCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHH-HhcCCCCeEecCCC
Q 011851 180 YLGGLIHPNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFL-HEEAEKPVIYRDFK 258 (476)
Q Consensus 180 ~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~l-H~~~~~~ivHrDlK 258 (476)
+|.++.+++|.....+.. ...+|||||++|++|...+.. ...+++..+..++.|++.+|.|| |+.+ |+|||||
T Consensus 72 ~l~~l~~~~v~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~-~~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlk 145 (190)
T cd05147 72 NLKRLVTAGIPCPEPILL--KSHVLVMEFIGDDGWAAPRLK-DAPLSESKARELYLQVIQIMRILYQDCR---LVHADLS 145 (190)
T ss_pred HHHHHHHCCCCCCcEEEe--cCCEEEEEEeCCCCCcchhhh-cCCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCC
Confidence 999998877644333222 223899999998877655433 35789999999999999999999 6877 9999999
Q ss_pred CCCeeecCCCceEEeecCCcCCC
Q 011851 259 TSNILLDGEYNAKLSDFGLAKDG 281 (476)
Q Consensus 259 p~NILl~~~~~vkl~DFG~a~~~ 281 (476)
|+|||++ ++.++|+|||+|...
T Consensus 146 P~NIli~-~~~v~LiDFG~a~~~ 167 (190)
T cd05147 146 EYNLLYH-DGKLYIIDVSQSVEH 167 (190)
T ss_pred HHHEEEE-CCcEEEEEccccccC
Confidence 9999998 578999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.7e-24 Score=227.98 Aligned_cols=249 Identities=23% Similarity=0.276 Sum_probs=180.8
Q ss_pred CCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCc----cCHHHHHHHHHHHhCCCCCceeeEEEEEE
Q 011851 122 SFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL----QGHKEWLAEVNYLGGLIHPNLVKLIGCCI 197 (476)
Q Consensus 122 ~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~----~~~~~~~~E~~~l~~l~hpnIv~l~~~~~ 197 (476)
+|...+.||++.|=+|.+|.+. .|. |+||++-+... ...++.+.|++ ...++|||++.+.-+-.
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~----------eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~ 91 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDR----------EGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLV 91 (1431)
T ss_pred ceeeecccCchhhhhhhhccCC----------Cce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHH
Confidence 5778899999999999998765 455 88999865442 22344555666 56678999999988877
Q ss_pred eCCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCC
Q 011851 198 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGL 277 (476)
Q Consensus 198 ~~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~ 277 (476)
.+...|||-+|+.+ +|+|.|..+ .-+...+.+.|+.|++.||..||..+ |+|+|||.+||||+...-+.|+||..
T Consensus 92 t~kAAylvRqyvkh-nLyDRlSTR-PFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAs 166 (1431)
T KOG1240|consen 92 TDKAAYLVRQYVKH-NLYDRLSTR-PFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFAS 166 (1431)
T ss_pred hhHHHHHHHHHHhh-hhhhhhccc-hHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccc
Confidence 88889999999955 999999544 34777888999999999999999988 99999999999999999999999998
Q ss_pred cCCC--CCCCcccee---eeeecCCCCCCcchhhcC----------C-CCccchhhhhHHHHHHHHhC-CCCCCCCCCCC
Q 011851 278 AKDG--PEGDKTHVS---TRVMGTYGYAAPEYVMTG----------H-LTAKSDVYSFGVVLLEMLTG-RRSMDKNRPNG 340 (476)
Q Consensus 278 a~~~--~~~~~~~~~---~~~~gt~~y~aPE~~~~~----------~-~~~~~DiwslGv~l~elltG-~~pf~~~~~~~ 340 (476)
-+.. .+.+..... .+-..-.+|+|||.+... . .+++-||||+||+++||++- +++|...
T Consensus 167 FKPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS---- 242 (1431)
T KOG1240|consen 167 FKPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS---- 242 (1431)
T ss_pred cCCccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH----
Confidence 7643 222221111 111223479999988641 2 57789999999999999985 6677421
Q ss_pred cchhHHhhhhhhccccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 011851 341 EHNLVEWARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALK 404 (476)
Q Consensus 341 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~ 404 (476)
.+..+............+.+. ...+++||..|+++||.+|.++++.|+.-.
T Consensus 243 --QL~aYr~~~~~~~e~~Le~Ie-----------d~~~Rnlil~Mi~rdPs~RlSAedyL~~yr 293 (1431)
T KOG1240|consen 243 --QLLAYRSGNADDPEQLLEKIE-----------DVSLRNLILSMIQRDPSKRLSAEDYLQKYR 293 (1431)
T ss_pred --HHHhHhccCccCHHHHHHhCc-----------CccHHHHHHHHHccCchhccCHHHHHHhhh
Confidence 122221111001111111111 236779999999999999999999999744
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.9e-22 Score=183.04 Aligned_cols=141 Identities=17% Similarity=0.162 Sum_probs=110.5
Q ss_pred cccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCcc---------------------C-----HHHHHHHHH
Q 011851 126 ECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQ---------------------G-----HKEWLAEVN 179 (476)
Q Consensus 126 ~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~---------------------~-----~~~~~~E~~ 179 (476)
.+.||+|+||.||+|.+. +|+.||||+++..... . ...+..|.+
T Consensus 2 ~~~ig~G~~~~Vy~a~~~----------~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 71 (190)
T cd05145 2 NGCISTGKEANVYHARTG----------DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFR 71 (190)
T ss_pred CceeecCCCcEEEEEEcC----------CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHH
Confidence 568999999999998643 6788999999865211 0 112357899
Q ss_pred HHhCCCCCceeeEEEEEEeCCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCC
Q 011851 180 YLGGLIHPNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHE-EAEKPVIYRDFK 258 (476)
Q Consensus 180 ~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~-~~~~~ivHrDlK 258 (476)
.+.++.|++|.....+... ..||||||++|+++...+.. ...++......++.|++.+|.+||+ .+ |+|||||
T Consensus 72 ~l~~l~~~~i~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~-~~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlk 145 (190)
T cd05145 72 NLKRLYEAGVPVPEPILLK--KNVLVMEFIGDDGSPAPRLK-DVPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLS 145 (190)
T ss_pred HHHHHHhCCCCCceEEEec--CCEEEEEEecCCCchhhhhh-hccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCC
Confidence 9999999987554444333 34899999988765443322 3467888999999999999999999 88 9999999
Q ss_pred CCCeeecCCCceEEeecCCcCCCCC
Q 011851 259 TSNILLDGEYNAKLSDFGLAKDGPE 283 (476)
Q Consensus 259 p~NILl~~~~~vkl~DFG~a~~~~~ 283 (476)
|+|||++ ++.++|+|||++.....
T Consensus 146 P~NIll~-~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 146 EYNILYH-DGKPYIIDVSQAVELDH 169 (190)
T ss_pred hhhEEEE-CCCEEEEEcccceecCC
Confidence 9999999 88999999999987543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=6.4e-22 Score=180.20 Aligned_cols=188 Identities=17% Similarity=0.071 Sum_probs=140.1
Q ss_pred CccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccC----HHHHHHHHHHHhCCC-CCceeeEEEEEEe
Q 011851 124 RPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQG----HKEWLAEVNYLGGLI-HPNLVKLIGCCIE 198 (476)
Q Consensus 124 ~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~----~~~~~~E~~~l~~l~-hpnIv~l~~~~~~ 198 (476)
-+...|++|+||+||++.. .+.+++.+.+....... ...+.+|+++|++|. |++|++++++
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-----------~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~--- 70 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-----------GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW--- 70 (218)
T ss_pred ccceeecCCCcceEEEeec-----------CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE---
Confidence 3557899999999997532 45667777776543311 124678999999995 5889999886
Q ss_pred CCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCC-CCCCeeecCCCceEEeecCC
Q 011851 199 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDF-KTSNILLDGEYNAKLSDFGL 277 (476)
Q Consensus 199 ~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDl-Kp~NILl~~~~~vkl~DFG~ 277 (476)
+..|++|||+.|.+|.+.+.. ....++.|++.+|.+||+++ |+|||| ||+|||++.++.++|+|||+
T Consensus 71 -~~~~lvmeyI~G~~L~~~~~~--------~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~ 138 (218)
T PRK12274 71 -DGRHLDRSYLAGAAMYQRPPR--------GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQL 138 (218)
T ss_pred -cCEEEEEeeecCccHHhhhhh--------hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCC
Confidence 456999999999998654311 11357789999999999998 999999 79999999999999999999
Q ss_pred cCCCCCCCcc----c-------eeeeeecCCCCCCcchhhcC-CCC-ccchhhhhHHHHHHHHhCCCCCCCCC
Q 011851 278 AKDGPEGDKT----H-------VSTRVMGTYGYAAPEYVMTG-HLT-AKSDVYSFGVVLLEMLTGRRSMDKNR 337 (476)
Q Consensus 278 a~~~~~~~~~----~-------~~~~~~gt~~y~aPE~~~~~-~~~-~~~DiwslGv~l~elltG~~pf~~~~ 337 (476)
|......... . .......++.|++|+...-. ..+ .+.++++.|+-+|.++|+..++....
T Consensus 139 A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~ 211 (218)
T PRK12274 139 AVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN 211 (218)
T ss_pred ceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence 9865432210 0 00112368889999855432 233 56899999999999999999875443
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.88 E-value=7e-23 Score=217.20 Aligned_cols=230 Identities=24% Similarity=0.332 Sum_probs=161.3
Q ss_pred ccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCCCCCceeeEEEEEEeC
Q 011851 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHPNLVKLIGCCIED 199 (476)
Q Consensus 120 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~ 199 (476)
..+|..+++|..|++|.||+.+++ .|.+++|+| ++++... ++- ||.....|.+|
T Consensus 82 e~df~~IklisngAygavylvrh~---------~trqrfa~k-iNkq~li-----lRn--ilt~a~npfvv--------- 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHK---------ETRQRFAMK-INKQNLI-----LRN--ILTFAGNPFVV--------- 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeecc---------ccccchhhc-ccccchh-----hhc--cccccCCccee---------
Confidence 346889999999999999996544 578889994 4333211 111 33333344444
Q ss_pred CeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCcC
Q 011851 200 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAK 279 (476)
Q Consensus 200 ~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~ 279 (476)
|+-...+ +.-++++... +.+++|||+.+ |+|||+||+|.||+.-|++|+.|||+++
T Consensus 136 ------------gDc~tll-k~~g~lPvdm--------vla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk 191 (1205)
T KOG0606|consen 136 ------------GDCATLL-KNIGPLPVDM--------VLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSK 191 (1205)
T ss_pred ------------chhhhhc-ccCCCCcchh--------hHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhh
Confidence 3333334 3334455443 67999999988 9999999999999999999999999987
Q ss_pred CCCCCCcc-------------ceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHH
Q 011851 280 DGPEGDKT-------------HVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVE 346 (476)
Q Consensus 280 ~~~~~~~~-------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~ 346 (476)
.......+ .....+||||.|+|||++....|+..+|||++|+|+||.+-|..||.+..+.+....+-
T Consensus 192 ~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~vi 271 (1205)
T KOG0606|consen 192 KGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVI 271 (1205)
T ss_pred hhhhhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhh
Confidence 53221111 11224799999999999999999999999999999999999999999886654433221
Q ss_pred hhhhhhccccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCcccccCc
Q 011851 347 WARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDMASS 415 (476)
Q Consensus 347 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~~~~~ 415 (476)
....... +- ......+++++|.++|+.+|.+|--....++ ++.+.||+.+...
T Consensus 272 sd~i~wp------E~---------dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~e-vk~h~ff~~LDw~ 324 (1205)
T KOG0606|consen 272 SDDIEWP------EE---------DEALPPEAQDLIEQLLRQNPLCRLGTGGALE-VKQHGFFQLLDWK 324 (1205)
T ss_pred hhhcccc------cc---------CcCCCHHHHHHHHHHHHhChHhhcccchhhh-hhhccceeecccc
Confidence 1111000 00 1122578999999999999999964444333 5667888877655
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.3e-22 Score=189.90 Aligned_cols=231 Identities=20% Similarity=0.270 Sum_probs=148.3
Q ss_pred CCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCcc---CHHHHHHHHHHHhCCCC----------Cce
Q 011851 123 FRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQ---GHKEWLAEVNYLGGLIH----------PNL 189 (476)
Q Consensus 123 y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~---~~~~~~~E~~~l~~l~h----------pnI 189 (476)
+...+.||.|+|+.||.+.+ ..||+.+|+|+....... ..+++.+|.-....+.+ -.+
T Consensus 14 l~~~~~i~~g~~~~v~~v~d---------~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~ 84 (288)
T PF14531_consen 14 LVRGRIIGKGGFSIVFEVTD---------VETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRF 84 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEE---------TTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B
T ss_pred EEEccccccCCceEEEEEEE---------ccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceE
Confidence 45667899999999999754 468999999997544322 24456666555444322 122
Q ss_pred eeEEEEEE---------eC---C-----eeEEEEEecCCCCHHHHHh---hcC---CCCCHHHHHHHHHHHHHHHHHHHh
Q 011851 190 VKLIGCCI---------ED---D-----QRLLVYEFMPRGSLENHLF---RRS---LPLPWSIRMKIALDAAKGLAFLHE 246 (476)
Q Consensus 190 v~l~~~~~---------~~---~-----~~~lV~E~~~~g~L~~~l~---~~~---~~l~~~~~~~i~~qi~~al~~lH~ 246 (476)
+-.++... .. . +.+++|+-+ .++|.+++. ... ..+....++.+..|+++.+++||.
T Consensus 85 l~P~d~~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~ 163 (288)
T PF14531_consen 85 LVPLDLLRIPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHS 163 (288)
T ss_dssp ---SEEEEETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EeeeEEEEEcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhh
Confidence 22222221 11 1 346788887 568887753 222 124455566777999999999999
Q ss_pred cCCCCeEecCCCCCCeeecCCCceEEeecCCcCCCCCCCccceeeeeecCCCCCCcchhhcC--------CCCccchhhh
Q 011851 247 EAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG--------HLTAKSDVYS 318 (476)
Q Consensus 247 ~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--------~~~~~~Diws 318 (476)
.| |||+||+|+|+|++.+|.++|+||+....... . ... ...+..|.+||..... .++.+.|.|+
T Consensus 164 ~G---lVHgdi~~~nfll~~~G~v~Lg~F~~~~r~g~--~--~~~-~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~ 235 (288)
T PF14531_consen 164 YG---LVHGDIKPENFLLDQDGGVFLGDFSSLVRAGT--R--YRC-SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQ 235 (288)
T ss_dssp TT---EEEST-SGGGEEE-TTS-EEE--GGGEEETTE--E--EEG-GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHH
T ss_pred cc---eEecccceeeEEEcCCCCEEEcChHHHeecCc--e--eec-cCCCcccCChhhhhhhcccCcccceeeeccCHHH
Confidence 99 99999999999999999999999998776422 1 111 2345779999977542 4788999999
Q ss_pred hHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhccccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCC
Q 011851 319 FGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKAR 393 (476)
Q Consensus 319 lGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~R 393 (476)
||+++|.|++|..||....+...... ....|- +.++.+.+||..+|+.||.+|
T Consensus 236 LG~~ly~lWC~~lPf~~~~~~~~~~~--------------------~f~~C~--~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 236 LGITLYSLWCGRLPFGLSSPEADPEW--------------------DFSRCR--DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHHHHHHHHHSS-STCCCGGGSTSGG--------------------GGTTSS-----HHHHHHHHHHT-SSGGGS
T ss_pred HHHHHHHHHHccCCCCCCCccccccc--------------------cchhcC--CcCHHHHHHHHHHccCCcccC
Confidence 99999999999999986533222111 122232 458899999999999999988
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=4.6e-23 Score=188.77 Aligned_cols=245 Identities=22% Similarity=0.338 Sum_probs=187.7
Q ss_pred CccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccC--HHHHHHHHHHHhCCCCCceeeEEEEEEeCCe
Q 011851 124 RPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQG--HKEWLAEVNYLGGLIHPNLVKLIGCCIEDDQ 201 (476)
Q Consensus 124 ~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~--~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~ 201 (476)
.+..+|.+...|..|+|++..+ .++.|++....... ..+|..|.-.|+-+.||||+.+++.|....+
T Consensus 193 nl~tkl~e~hsgelwrgrwqgn-----------divakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppn 261 (448)
T KOG0195|consen 193 NLITKLAESHSGELWRGRWQGN-----------DIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPN 261 (448)
T ss_pred hhhhhhccCCCcccccccccCc-----------chhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCC
Confidence 4556788999999999998744 36678776544332 3568889999999999999999999999999
Q ss_pred eEEEEEecCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEe--ecCCc
Q 011851 202 RLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLS--DFGLA 278 (476)
Q Consensus 202 ~~lV~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~--DFG~a 278 (476)
+.++..||+-|+|+..|+.. +...+..++.+++.+|++|+.|||+... -|..--|....|+||++.+.+|. |--++
T Consensus 262 lv~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep-~ipr~~lns~hvmidedltarismad~kfs 340 (448)
T KOG0195|consen 262 LVIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEP-MIPRFYLNSKHVMIDEDLTARISMADTKFS 340 (448)
T ss_pred ceEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcch-hhhhhhcccceEEecchhhhheecccceee
Confidence 99999999999999999765 4456788999999999999999999763 24445689999999999887774 22221
Q ss_pred CCCCCCCccceeeeeecCCCCCCcchhhcCCCC---ccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhccc
Q 011851 279 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLT---AKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGER 355 (476)
Q Consensus 279 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~---~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~ 355 (476)
.. . ....-.|.||+||.+...+-+ .++|+|||.++||||.|...||....+-+.--.+
T Consensus 341 fq----e-----~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmki---------- 401 (448)
T KOG0195|consen 341 FQ----E-----VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKI---------- 401 (448)
T ss_pred ee----c-----cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhh----------
Confidence 11 1 112347889999999876543 4789999999999999999999876553321111
Q ss_pred cccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 011851 356 RRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKP 405 (476)
Q Consensus 356 ~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~ 405 (476)
.-.-+.-..++..+..+..|+.-|++.||.+||.++.|+-.|+.
T Consensus 402 ------aleglrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilek 445 (448)
T KOG0195|consen 402 ------ALEGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEK 445 (448)
T ss_pred ------hhccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHH
Confidence 11122233444557889999999999999999999998877654
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.87 E-value=8e-22 Score=213.04 Aligned_cols=196 Identities=21% Similarity=0.213 Sum_probs=158.0
Q ss_pred ccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCCC---CCceeeEEEEE
Q 011851 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLI---HPNLVKLIGCC 196 (476)
Q Consensus 120 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~---hpnIv~l~~~~ 196 (476)
...|.|.+.||+|+||.||+|... .|+.||||+-+........-. .+++.+|+ -+.|+.+..++
T Consensus 697 ~~~~~I~~e~G~g~y~~vy~a~~~----------~~~~~alK~e~P~~~WEfYI~---~q~~~RLk~~~~~~~~~~~~a~ 763 (974)
T KOG1166|consen 697 GEKFCISKEIGEGSYGSVYVATHS----------NGKLVALKVEKPPNPWEFYIC---LQVMERLKPQMLPSIMHISSAH 763 (974)
T ss_pred ceeEEEEeeeccccceEEEEeecC----------CCcEEEEEeecCCCceeeeeh---HHHHHhhchhhhcchHHHHHHH
Confidence 346888899999999999998654 378899999877654432111 12222332 34566666667
Q ss_pred EeCCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeec-------CCCc
Q 011851 197 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLD-------GEYN 269 (476)
Q Consensus 197 ~~~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~-------~~~~ 269 (476)
...+.-+||+||.+.|+|.+++. ....++|..++.++.|++..|+.||..+ |||+||||+|+||. +...
T Consensus 764 ~~~~~S~lv~ey~~~Gtlld~~N-~~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~ 839 (974)
T KOG1166|consen 764 VFQNASVLVSEYSPYGTLLDLIN-TNKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKG 839 (974)
T ss_pred ccCCcceeeeeccccccHHHhhc-cCCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccc
Confidence 77788899999999999999996 5667999999999999999999999999 99999999999993 2346
Q ss_pred eEEeecCCcCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCC
Q 011851 270 AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRS 332 (476)
Q Consensus 270 vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~p 332 (476)
++|+|||.+.+...-........+++|-.+-.+|+..|.+|++.+|.|.|+.+++-||.|+.-
T Consensus 840 l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~ 902 (974)
T KOG1166|consen 840 LYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM 902 (974)
T ss_pred eEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence 999999999765433333345567899999999999999999999999999999999999743
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.6e-21 Score=178.12 Aligned_cols=136 Identities=20% Similarity=0.214 Sum_probs=107.0
Q ss_pred ccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCC-----CCCceeeEEEEEEeC
Q 011851 125 PECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGL-----IHPNLVKLIGCCIED 199 (476)
Q Consensus 125 ~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l-----~hpnIv~l~~~~~~~ 199 (476)
-.++||+|+||.||. +. .++.. +||++........+.+.+|+.+++.+ +||||++++++++++
T Consensus 6 ~~~~LG~G~~~~Vy~--hp---------~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~ 73 (210)
T PRK10345 6 EQSPLGTGRHRKCYA--HP---------EDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETD 73 (210)
T ss_pred CcceecCCCceEEEE--CC---------CCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeC
Confidence 457899999999995 22 24444 69998766555567789999999999 579999999999987
Q ss_pred C---eeE-EEEEe--cCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHH-HHHHhcCCCCeEecCCCCCCeeecC----CC
Q 011851 200 D---QRL-LVYEF--MPRGSLENHLFRRSLPLPWSIRMKIALDAAKGL-AFLHEEAEKPVIYRDFKTSNILLDG----EY 268 (476)
Q Consensus 200 ~---~~~-lV~E~--~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al-~~lH~~~~~~ivHrDlKp~NILl~~----~~ 268 (476)
. .++ +|||| +.+++|.+++.+. .+++. ..++.|++.++ +|||+++ |+||||||+|||++. ++
T Consensus 74 ~g~g~v~~~I~e~~G~~~~tL~~~l~~~--~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~ 146 (210)
T PRK10345 74 CGTGYVYDVIADFDGKPSITLTEFAEQC--RYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEV 146 (210)
T ss_pred CCCeEEEEEEecCCCCcchhHHHHHHcc--cccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCC
Confidence 4 434 78999 5579999999543 36555 35678888787 9999988 999999999999974 34
Q ss_pred ceEEeecCCcC
Q 011851 269 NAKLSDFGLAK 279 (476)
Q Consensus 269 ~vkl~DFG~a~ 279 (476)
.++|+||+.+.
T Consensus 147 ~~~LiDg~G~~ 157 (210)
T PRK10345 147 IPVVCDNIGES 157 (210)
T ss_pred cEEEEECCCCc
Confidence 79999955443
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=2.9e-21 Score=185.45 Aligned_cols=197 Identities=23% Similarity=0.293 Sum_probs=139.0
Q ss_pred CCCceeeEEEEEEeC---------------------------CeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHH
Q 011851 185 IHPNLVKLIGCCIED---------------------------DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDA 237 (476)
Q Consensus 185 ~hpnIv~l~~~~~~~---------------------------~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi 237 (476)
.|||||+++++|.+. ..+||||.-.+. +|..++..+. .+.....-++.|+
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~--~s~r~~~~~laQl 350 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRH--RSYRTGRVILAQL 350 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCC--CchHHHHHHHHHH
Confidence 599999999887532 247999998854 9999986543 5667778889999
Q ss_pred HHHHHHHHhcCCCCeEecCCCCCCeee--cCCC--ceEEeecCCcCCCCCCCc----cceeeeeecCCCCCCcchhhcCC
Q 011851 238 AKGLAFLHEEAEKPVIYRDFKTSNILL--DGEY--NAKLSDFGLAKDGPEGDK----THVSTRVMGTYGYAAPEYVMTGH 309 (476)
Q Consensus 238 ~~al~~lH~~~~~~ivHrDlKp~NILl--~~~~--~vkl~DFG~a~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~ 309 (476)
++|+.|||.++ |.|||||.+|||| |+|+ .+.|+|||++--.....- .......-|.-.-||||+...-+
T Consensus 351 LEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~P 427 (598)
T KOG4158|consen 351 LEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVP 427 (598)
T ss_pred HHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCC
Confidence 99999999999 9999999999998 4443 578999998754322110 00011235778899999886532
Q ss_pred ------CCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhccccccccccCcccCCCCChHHHHHHHHHHH
Q 011851 310 ------LTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAA 383 (476)
Q Consensus 310 ------~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~ 383 (476)
--.++|.|+.|.+.||+++...||..... ...+.-.+...++ |.+ +...+..+.+|+.
T Consensus 428 Gp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGe-m~L~~r~Yqe~qL-----------Pal----p~~vpp~~rqlV~ 491 (598)
T KOG4158|consen 428 GPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGE-MLLDTRTYQESQL-----------PAL----PSRVPPVARQLVF 491 (598)
T ss_pred CCceeeccchhhhhhhhhhHHHHhccCCcccccch-heechhhhhhhhC-----------CCC----cccCChHHHHHHH
Confidence 13479999999999999999999986321 1111111111111 111 1223567889999
Q ss_pred HhcccCCCCCCCHHHHHHHh
Q 011851 384 SCLNRDQKARPRMSEVVEAL 403 (476)
Q Consensus 384 ~cL~~dP~~RPt~~ell~~L 403 (476)
.+|+.||.+|++..-....|
T Consensus 492 ~lL~r~pskRvsp~iAANvl 511 (598)
T KOG4158|consen 492 DLLKRDPSKRVSPNIAANVL 511 (598)
T ss_pred HHhcCCccccCCccHHHhHH
Confidence 99999999999876555443
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=6.6e-21 Score=193.44 Aligned_cols=215 Identities=27% Similarity=0.435 Sum_probs=164.7
Q ss_pred HhCCCCCceeeEEEEEEeCCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCe-EecCCCC
Q 011851 181 LGGLIHPNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPV-IYRDFKT 259 (476)
Q Consensus 181 l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i-vHrDlKp 259 (476)
|+.+.|.|+.++++.+.++...++|.+||..|+|.|.+......+++.....++++|+.||.|||... | .|+.|+.
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~---i~~hg~l~s 77 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSP---IGYHGALKS 77 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCc---ceeeeeecc
Confidence 46789999999999999999999999999999999999887888999999999999999999999865 4 9999999
Q ss_pred CCeeecCCCceEEeecCCcCCCCCCCccceeeeeecCCCCCCcchhhcCC-------CCccchhhhhHHHHHHHHhCCCC
Q 011851 260 SNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGH-------LTAKSDVYSFGVVLLEMLTGRRS 332 (476)
Q Consensus 260 ~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-------~~~~~DiwslGv~l~elltG~~p 332 (476)
.|+++|..+.+||+|||+.................-..-|.|||++.... .+.+.||||||++++|+++.+.|
T Consensus 78 ~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~ 157 (484)
T KOG1023|consen 78 SNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGP 157 (484)
T ss_pred ccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCc
Confidence 99999999999999999987764211111111122345699999988641 46679999999999999999999
Q ss_pred CCCCCCCCcc-hhHHhhhhhhccccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011851 333 MDKNRPNGEH-NLVEWARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPL 406 (476)
Q Consensus 333 f~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~ 406 (476)
|......... .++..... .. ...+.|.+.... ...+++..++.+||..+|.+||++.++-..++.+
T Consensus 158 ~~~~~~~~~~~eii~~~~~--~~----~~~~rP~i~~~~--e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~ 224 (484)
T KOG1023|consen 158 FDLRNLVEDPDEIILRVKK--GG----SNPFRPSIELLN--ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTI 224 (484)
T ss_pred cccccccCChHHHHHHHHh--cC----CCCcCcchhhhh--hcchHHHHHHHHhcccChhhCccHHHHHhhhhhh
Confidence 9864443332 23332211 01 111112111110 2244789999999999999999999999887654
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.4e-19 Score=171.37 Aligned_cols=145 Identities=19% Similarity=0.160 Sum_probs=110.9
Q ss_pred cCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCcc-------------------C-----HHHHHH
Q 011851 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQ-------------------G-----HKEWLA 176 (476)
Q Consensus 121 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~-------------------~-----~~~~~~ 176 (476)
.-|.+.+.||+|+||.||+|.+. ..+|+.||||+++..... . ...+..
T Consensus 28 ~~~~i~~~Lg~G~~g~Vy~a~~~--------~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 99 (237)
T smart00090 28 ILSAIGGCISTGKEANVYHALDF--------DGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEK 99 (237)
T ss_pred chHHhCCeeccCcceeEEEEEec--------CCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHH
Confidence 35889999999999999998621 236889999998754311 0 122467
Q ss_pred HHHHHhCCCCCc--eeeEEEEEEeCCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEe
Q 011851 177 EVNYLGGLIHPN--LVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIY 254 (476)
Q Consensus 177 E~~~l~~l~hpn--Iv~l~~~~~~~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivH 254 (476)
|+.++.++.+.+ +.+++++ ...+|||||++|.+|...+.. ...+.......++.||+.+|.+||+.+. |+|
T Consensus 100 E~~~L~~L~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~g~--iiH 172 (237)
T smart00090 100 EFRNLQRLYEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLK-DVEPEEEEEFELYDDILEEMRKLYKEGE--LVH 172 (237)
T ss_pred HHHHHHHHHhcCCCCCeeeEe----cCceEEEEEecCCcccccccc-cCCcchHHHHHHHHHHHHHHHHHHhcCC--EEe
Confidence 999999997533 3444432 235899999999888765433 2346666778999999999999998652 999
Q ss_pred cCCCCCCeeecCCCceEEeecCCcCCC
Q 011851 255 RDFKTSNILLDGEYNAKLSDFGLAKDG 281 (476)
Q Consensus 255 rDlKp~NILl~~~~~vkl~DFG~a~~~ 281 (476)
|||||+||+++ ++.++|+|||.+...
T Consensus 173 ~Dikp~NIli~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 173 GDLSEYNILVH-DGKVVIIDVSQSVEL 198 (237)
T ss_pred CCCChhhEEEE-CCCEEEEEChhhhcc
Confidence 99999999999 889999999998754
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=4.2e-19 Score=165.47 Aligned_cols=134 Identities=18% Similarity=0.241 Sum_probs=112.2
Q ss_pred ccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccC--------HHHHHHHHHHHhCCCCCceeeEEEEEEe
Q 011851 127 CLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQG--------HKEWLAEVNYLGGLIHPNLVKLIGCCIE 198 (476)
Q Consensus 127 ~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~--------~~~~~~E~~~l~~l~hpnIv~l~~~~~~ 198 (476)
+.||+|++|.||+|.+ .|..+++|+........ ...+.+|+.++..+.|++|.....++..
T Consensus 2 ~~l~~G~~~~vy~~~~-----------~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~ 70 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-----------LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVD 70 (211)
T ss_pred cccccCceEEEEEEee-----------CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEe
Confidence 5799999999999865 35569999865433211 1346789999999999998887777777
Q ss_pred CCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCc
Q 011851 199 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLA 278 (476)
Q Consensus 199 ~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a 278 (476)
.+..++||||++|++|.+++.... . .+..++.+++.+|.++|+.+ ++|+|++|.|||++ ++.++|+|||++
T Consensus 71 ~~~~~lv~e~~~G~~L~~~~~~~~----~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a 141 (211)
T PRK14879 71 PENFIIVMEYIEGEPLKDLINSNG----M-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLA 141 (211)
T ss_pred CCCCEEEEEEeCCcCHHHHHHhcc----H-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcc
Confidence 888999999999999999885432 2 78899999999999999988 99999999999999 788999999998
Q ss_pred CC
Q 011851 279 KD 280 (476)
Q Consensus 279 ~~ 280 (476)
..
T Consensus 142 ~~ 143 (211)
T PRK14879 142 EF 143 (211)
T ss_pred cC
Confidence 65
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.80 E-value=9.5e-21 Score=188.94 Aligned_cols=174 Identities=24% Similarity=0.378 Sum_probs=129.0
Q ss_pred CeeEEEEEecCCCCHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCC
Q 011851 200 DQRLLVYEFMPRGSLENHLFRR--SLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGL 277 (476)
Q Consensus 200 ~~~~lV~E~~~~g~L~~~l~~~--~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~ 277 (476)
.++||.|++|...+|.++|.++ ....++.....++.|++.|++| ++ .+|||+||.||++..+..+||.|||+
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFgl 402 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFGL 402 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhhh
Confidence 3578999999999999999643 4456788899999999999999 55 99999999999999999999999999
Q ss_pred cCCCCCCC----ccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhh
Q 011851 278 AKDGPEGD----KTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPQL 352 (476)
Q Consensus 278 a~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~ellt-G~~pf~~~~~~~~~~~~~~~~~~~ 352 (476)
........ .....+...||..||+||.+.+..|+.++||||||+||+||+. =...|+.... ...+
T Consensus 403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~~t----------~~d~ 472 (516)
T KOG1033|consen 403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERIAT----------LTDI 472 (516)
T ss_pred eeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHHHh----------hhhh
Confidence 87655433 1223445789999999999999999999999999999999997 2222221100 0000
Q ss_pred ccccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHH
Q 011851 353 GERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEV 399 (476)
Q Consensus 353 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~el 399 (476)
.+ .++++.... ..++-..|+.++|...|.+||++.+.
T Consensus 473 r~-----g~ip~~~~~-----d~p~e~~ll~~lls~~p~~RP~~~~~ 509 (516)
T KOG1033|consen 473 RD-----GIIPPEFLQ-----DYPEEYTLLQQLLSPSPEERPSAIEV 509 (516)
T ss_pred hc-----CCCChHHhh-----cCcHHHHHHHHhcCCCcccCchHHHH
Confidence 00 011110000 02344589999999999999955443
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.80 E-value=3.7e-19 Score=164.29 Aligned_cols=131 Identities=20% Similarity=0.299 Sum_probs=106.2
Q ss_pred cccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccC--------HHHHHHHHHHHhCCCCCceeeEEEEEEeC
Q 011851 128 LLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQG--------HKEWLAEVNYLGGLIHPNLVKLIGCCIED 199 (476)
Q Consensus 128 ~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~--------~~~~~~E~~~l~~l~hpnIv~l~~~~~~~ 199 (476)
.||+|+||.||+|.+ +|..|++|+........ ..++.+|++++..+.|+++.....++...
T Consensus 1 ~ig~G~~~~vy~~~~-----------~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~ 69 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-----------LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDP 69 (199)
T ss_pred CCCCCceEEEEEeec-----------CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEC
Confidence 489999999999963 45679999865432211 24567899999999988766555556677
Q ss_pred CeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCcC
Q 011851 200 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAK 279 (476)
Q Consensus 200 ~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~ 279 (476)
+..+|||||++|++|.+.+..... .++.+++.+|.+||+.+ ++|+|++|+|||++ ++.++|+|||++.
T Consensus 70 ~~~~lv~e~~~g~~l~~~~~~~~~--------~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~ 137 (199)
T TIGR03724 70 DNKTIVMEYIEGKPLKDVIEEGND--------ELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGK 137 (199)
T ss_pred CCCEEEEEEECCccHHHHHhhcHH--------HHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCc
Confidence 778999999999999988744211 78899999999999988 99999999999999 8899999999987
Q ss_pred CC
Q 011851 280 DG 281 (476)
Q Consensus 280 ~~ 281 (476)
..
T Consensus 138 ~~ 139 (199)
T TIGR03724 138 YS 139 (199)
T ss_pred CC
Confidence 64
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.79 E-value=6.7e-19 Score=162.63 Aligned_cols=146 Identities=17% Similarity=0.101 Sum_probs=111.7
Q ss_pred hHHHHhccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCcc----------------------CH
Q 011851 114 NELKSATKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQ----------------------GH 171 (476)
Q Consensus 114 ~~~~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~----------------------~~ 171 (476)
.++......|.+.+.||+|+||.||+|... +|+.||||+++..... ..
T Consensus 8 ~~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~----------~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 77 (198)
T cd05144 8 HTLVKRGVVESLGNQIGVGKESDVYLALDP----------DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSR 77 (198)
T ss_pred HHHHHcCchhhcCCccccCcceEEEEEEcC----------CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhH
Confidence 344444445889999999999999998542 6788999987653210 01
Q ss_pred HHHHHHHHHHhCCCCCc--eeeEEEEEEeCCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCC
Q 011851 172 KEWLAEVNYLGGLIHPN--LVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAE 249 (476)
Q Consensus 172 ~~~~~E~~~l~~l~hpn--Iv~l~~~~~~~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~ 249 (476)
.....|+.++..+.|++ +...++ ....++||||++|++|.+.... .....++.+++.++.++|+.+
T Consensus 78 ~~~~~E~~~l~~l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~-------~~~~~~~~~i~~~l~~lh~~g- 145 (198)
T cd05144 78 LAAQKEFAALKALYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRVL-------EDPEEVLDEILEEIVKAYKHG- 145 (198)
T ss_pred HHHHHHHHHHHHHHHcCCCCCceee----cCCceEEEEEeCCcchhhcccc-------ccHHHHHHHHHHHHHHHHHCC-
Confidence 12567888999888774 444443 2456899999999998765421 335678899999999999988
Q ss_pred CCeEecCCCCCCeeecCCCceEEeecCCcCCCCC
Q 011851 250 KPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPE 283 (476)
Q Consensus 250 ~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~ 283 (476)
|+||||||+||+++.++.++|+|||++.....
T Consensus 146 --i~H~Dl~p~Nill~~~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 146 --IIHGDLSEFNILVDDDEKIYIIDWPQMVSTDH 177 (198)
T ss_pred --CCcCCCCcccEEEcCCCcEEEEECCccccCCC
Confidence 99999999999999999999999999976543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.2e-18 Score=184.83 Aligned_cols=139 Identities=20% Similarity=0.249 Sum_probs=111.8
Q ss_pred hccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCc--------cCHHHHHHHHHHHhCCCCCcee
Q 011851 119 ATKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL--------QGHKEWLAEVNYLGGLIHPNLV 190 (476)
Q Consensus 119 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~--------~~~~~~~~E~~~l~~l~hpnIv 190 (476)
....|...++||+|+||.||+|.+... .+++|+...... ...+++.+|+++++.++|++|+
T Consensus 331 ~~~~~~~~~~iG~G~~g~Vy~~~~~~~-----------~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~ 399 (535)
T PRK09605 331 VKRRKIPDHLIGKGAEADIKKGEYLGR-----------DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVP 399 (535)
T ss_pred cccccCccceeccCCcEEEEEEeecCc-----------cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCC
Confidence 344567789999999999999876422 234443211110 1124578899999999999999
Q ss_pred eEEEEEEeCCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCce
Q 011851 191 KLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNA 270 (476)
Q Consensus 191 ~l~~~~~~~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~v 270 (476)
..+.++.+....+|||||++|++|.+++. ....++.+++.+|.|||+.+ |+||||||+|||+ .++.+
T Consensus 400 ~p~~~~~~~~~~~lv~E~~~g~~L~~~l~---------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~ 466 (535)
T PRK09605 400 TPVIYDVDPEEKTIVMEYIGGKDLKDVLE---------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRL 466 (535)
T ss_pred eeEEEEEeCCCCEEEEEecCCCcHHHHHH---------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcE
Confidence 88888877778899999999999999884 35678999999999999988 9999999999999 57799
Q ss_pred EEeecCCcCCC
Q 011851 271 KLSDFGLAKDG 281 (476)
Q Consensus 271 kl~DFG~a~~~ 281 (476)
+|+|||+++..
T Consensus 467 ~liDFGla~~~ 477 (535)
T PRK09605 467 YLIDFGLGKYS 477 (535)
T ss_pred EEEeCcccccC
Confidence 99999999763
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.77 E-value=3.9e-20 Score=196.03 Aligned_cols=262 Identities=23% Similarity=0.250 Sum_probs=196.3
Q ss_pred CCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCC--ccCHHHHHHHHHHHhCCC-CCceeeEEEEEEe
Q 011851 122 SFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDG--LQGHKEWLAEVNYLGGLI-HPNLVKLIGCCIE 198 (476)
Q Consensus 122 ~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~--~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~ 198 (476)
.|.+.+.||+|+|+.|-+.....+ +...+|+|.+.... .........|..+-..+. |.|++.+++...+
T Consensus 21 ~~~~~~~ig~gs~~~~~~~~~~~~--------~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~ 92 (601)
T KOG0590|consen 21 QYKLSRSIGKGSFSSSALASNSRD--------PESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSS 92 (601)
T ss_pred cccccccccccccchhhhhhhcCC--------CcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCC
Confidence 366777899999999988765433 33457777765543 112233445777777777 9999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHH-hhcCCCCCHHHHHHHHHHHHHHHHHHH-hcCCCCeEecCCCCCCeeecCCC-ceEEeec
Q 011851 199 DDQRLLVYEFMPRGSLENHL-FRRSLPLPWSIRMKIALDAAKGLAFLH-EEAEKPVIYRDFKTSNILLDGEY-NAKLSDF 275 (476)
Q Consensus 199 ~~~~~lV~E~~~~g~L~~~l-~~~~~~l~~~~~~~i~~qi~~al~~lH-~~~~~~ivHrDlKp~NILl~~~~-~vkl~DF 275 (476)
.+..++++||..|+++++.+ .......+...+..++.|+..++.|+| ..+ +.||||||+|.+++..+ .+++.||
T Consensus 93 ~~~~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df 169 (601)
T KOG0590|consen 93 PRSYLLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADF 169 (601)
T ss_pred CcccccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCc
Confidence 99999999999999999988 433336777788899999999999999 777 99999999999999999 9999999
Q ss_pred CCcCCCCC-CCccceeeeeec-CCCCCCcchhhcC-CCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhh
Q 011851 276 GLAKDGPE-GDKTHVSTRVMG-TYGYAAPEYVMTG-HLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQL 352 (476)
Q Consensus 276 G~a~~~~~-~~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~ 352 (476)
|+|..... ..........+| ++.|+|||...+. ......|+||.|+++.-+++|..|+.......... ..|.....
T Consensus 170 ~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~-~~~~~~~~ 248 (601)
T KOG0590|consen 170 GLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRY-SSWKSNKG 248 (601)
T ss_pred hhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccc-eeeccccc
Confidence 99987766 344444445788 9999999998885 55678999999999999999999997654433111 11111000
Q ss_pred ccccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCccc
Q 011851 353 GERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKD 411 (476)
Q Consensus 353 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~ 411 (476)
..... .-........+++.+++..+|..|.+.+++... +|+..
T Consensus 249 ~~~~~------------~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d----~~~~~ 291 (601)
T KOG0590|consen 249 RFTQL------------PWNSISDQAHDLLHKILKENPSNRLSIEELKLD----NWLSS 291 (601)
T ss_pred ccccC------------ccccCChhhhhcccccccCCchhcccccccccc----ccccc
Confidence 00000 001124567789999999999999998886554 88766
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.72 E-value=3.5e-17 Score=149.54 Aligned_cols=137 Identities=21% Similarity=0.180 Sum_probs=96.9
Q ss_pred cccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccC--HHH----------------------HHHHHHHH
Q 011851 126 ECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQG--HKE----------------------WLAEVNYL 181 (476)
Q Consensus 126 ~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~--~~~----------------------~~~E~~~l 181 (476)
.+.||+|+||.||+|.+. +|+.||||+++...... ... ...|...+
T Consensus 2 ~~~lg~G~~g~Vy~a~~~----------~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l 71 (187)
T cd05119 2 GGPIGTGKEADVYLALDG----------DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNL 71 (187)
T ss_pred CcccccccceeEEEEECC----------CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHH
Confidence 467999999999998643 57789999987542211 111 13466666
Q ss_pred hCCCCCc--eeeEEEEEEeCCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCC
Q 011851 182 GGLIHPN--LVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHE-EAEKPVIYRDFK 258 (476)
Q Consensus 182 ~~l~hpn--Iv~l~~~~~~~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~-~~~~~ivHrDlK 258 (476)
.++.+.. +.+.+++ ...+|||||++++.+........ ... .....++.+++.++.++|. .+ |+|||||
T Consensus 72 ~~l~~~~~~~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~-~~~-~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~ 142 (187)
T cd05119 72 KRLYEAGVPVPKPIDL----NRHVLVMEFIGGDGIPAPRLKDV-RLL-EDPEELYDQILELMRKLYREAG---LVHGDLS 142 (187)
T ss_pred HHHHHcCCCCCceEec----CCCEEEEEEeCCCCccChhhhhh-hhc-ccHHHHHHHHHHHHHHHhhccC---cCcCCCC
Confidence 6664432 4445443 34699999999854322111111 011 5678899999999999999 77 9999999
Q ss_pred CCCeeecCCCceEEeecCCcCCCC
Q 011851 259 TSNILLDGEYNAKLSDFGLAKDGP 282 (476)
Q Consensus 259 p~NILl~~~~~vkl~DFG~a~~~~ 282 (476)
|+||+++ ++.++|+|||.+....
T Consensus 143 p~Nili~-~~~~~liDfg~a~~~~ 165 (187)
T cd05119 143 EYNILVD-DGKVYIIDVPQAVEID 165 (187)
T ss_pred hhhEEEE-CCcEEEEECccccccc
Confidence 9999999 8899999999997643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.2e-16 Score=139.43 Aligned_cols=136 Identities=22% Similarity=0.130 Sum_probs=113.0
Q ss_pred ccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCCCC--CceeeEEEEEEeCCee
Q 011851 125 PECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIH--PNLVKLIGCCIEDDQR 202 (476)
Q Consensus 125 ~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~h--pnIv~l~~~~~~~~~~ 202 (476)
+.+.||+|.++.||++... +..+++|....... ...+..|+.++..+.| .++++++.++...+..
T Consensus 2 ~~~~i~~g~~~~v~~~~~~-----------~~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~ 68 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTK-----------DEDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWS 68 (155)
T ss_pred cceecccccccceEEEEec-----------CCeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCcc
Confidence 4577999999999998653 25699999866543 4568889999999976 5899999988888889
Q ss_pred EEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCcCCC
Q 011851 203 LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDG 281 (476)
Q Consensus 203 ~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~ 281 (476)
+++|||++++.+..+ +......++.+++.+|.++|.....+++|+||+|+|||++..+.++++|||.+...
T Consensus 69 ~~v~e~~~g~~~~~~--------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~ 139 (155)
T cd05120 69 YLLMEWIEGETLDEV--------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYG 139 (155)
T ss_pred EEEEEecCCeecccC--------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCC
Confidence 999999988777543 55667788999999999999864345999999999999999899999999998753
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.69 E-value=2.7e-16 Score=149.21 Aligned_cols=135 Identities=21% Similarity=0.221 Sum_probs=102.0
Q ss_pred cccc-ccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCc-------------cCHHHHHHHHHHHhCCCCCce--e
Q 011851 127 CLLG-EGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL-------------QGHKEWLAEVNYLGGLIHPNL--V 190 (476)
Q Consensus 127 ~~LG-~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~-------------~~~~~~~~E~~~l~~l~hpnI--v 190 (476)
..|| .|+.|+||++.. .+..++||.+..... ....++.+|++++.+|.|++| +
T Consensus 37 ~~lg~~~g~gtv~~v~~-----------~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP 105 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQT-----------PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVP 105 (239)
T ss_pred ceeecCCCCccEEEEEe-----------CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCc
Confidence 4577 788888887644 255688887753211 123457889999999998775 6
Q ss_pred eEEEEEEeCCe----eEEEEEecCC-CCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeec
Q 011851 191 KLIGCCIEDDQ----RLLVYEFMPR-GSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLD 265 (476)
Q Consensus 191 ~l~~~~~~~~~----~~lV~E~~~~-g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~ 265 (476)
..+++...... .+|||||++| .+|.+++.. .+++.. .+.+|+.+|.+||+.+ |+||||||+|||++
T Consensus 106 ~pl~~~~~~~~~~~~~~lV~e~l~G~~~L~~~l~~--~~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~ 176 (239)
T PRK01723 106 RPIAARVVRHGLFYRADILIERIEGARDLVALLQE--APLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLD 176 (239)
T ss_pred eeEeeeeeecCcceeeeEEEEecCCCCCHHHHHhc--CCCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEc
Confidence 77776544322 2599999997 689888743 245544 3568999999999988 99999999999999
Q ss_pred CCCceEEeecCCcCCC
Q 011851 266 GEYNAKLSDFGLAKDG 281 (476)
Q Consensus 266 ~~~~vkl~DFG~a~~~ 281 (476)
.++.++|+|||.+...
T Consensus 177 ~~~~v~LIDfg~~~~~ 192 (239)
T PRK01723 177 PDGKFWLIDFDRGELR 192 (239)
T ss_pred CCCCEEEEECCCcccC
Confidence 9899999999998763
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.62 E-value=3.2e-15 Score=152.27 Aligned_cols=252 Identities=23% Similarity=0.279 Sum_probs=188.3
Q ss_pred CCCccccccc--cCCccEEEEEEccCCceeeeCCCCceEEEEEecC--CCccCHHHHHHHHHHHhCCC-CCceeeEEEEE
Q 011851 122 SFRPECLLGE--GGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNH--DGLQGHKEWLAEVNYLGGLI-HPNLVKLIGCC 196 (476)
Q Consensus 122 ~y~~~~~LG~--G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~--~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~ 196 (476)
.|-+.+.+|. |.+|.||.+.. ....++..+|+|.-+. ........-.+|+...+.++ |+|.++.+..+
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~-------~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~ 187 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRC-------TNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAW 187 (524)
T ss_pred hcccccccccCCCCCceeecccC-------CcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCccc
Confidence 4777888999 99999999864 2246788899998433 22233333456777777774 99999999999
Q ss_pred EeCCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHH----HHHHHHhcCCCCeEecCCCCCCeeecCC-CceE
Q 011851 197 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAK----GLAFLHEEAEKPVIYRDFKTSNILLDGE-YNAK 271 (476)
Q Consensus 197 ~~~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~----al~~lH~~~~~~ivHrDlKp~NILl~~~-~~vk 271 (476)
+..+.+|+-+|+| +.+|..+.......++....+.+..+... ||.++|..+ ++|-|+||+||++..+ ...+
T Consensus 188 e~~~~lfiqtE~~-~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~ 263 (524)
T KOG0601|consen 188 EGSGILFIQTELC-GESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCK 263 (524)
T ss_pred ccCCcceeeeccc-cchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceee
Confidence 9999999999999 57888888776666889999999999999 999999988 9999999999999988 8899
Q ss_pred EeecCCcCCCCCCCccce---eeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhh
Q 011851 272 LSDFGLAKDGPEGDKTHV---STRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA 348 (476)
Q Consensus 272 l~DFG~a~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~ 348 (476)
++|||+......+.-... ..+..|...|++|| +.++-++.+.|||+||.++.+..++.......... .|.
T Consensus 264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke-~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~------~W~ 336 (524)
T KOG0601|consen 264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKE-LLNGLATFASDIFSLGEVILEAILGSHLPSVGKNS------SWS 336 (524)
T ss_pred cCCcceeEEccCCccccceeeeecCCCCceEeChh-hhccccchHhhhcchhhhhHhhHhhcccccCCCCC------Ccc
Confidence 999999987765542211 12235778899999 45567899999999999999999987665432110 011
Q ss_pred hhhhccccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011851 349 RPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEA 402 (476)
Q Consensus 349 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~ 402 (476)
. +..+. +...|....+..+...+..+++.+|..|++.+.+..+
T Consensus 337 ~--------~r~~~---ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l 379 (524)
T KOG0601|consen 337 Q--------LRQGY---IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTAL 379 (524)
T ss_pred c--------ccccc---CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhcc
Confidence 0 00000 1111222224455569999999999999999888775
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.56 E-value=1.3e-14 Score=149.42 Aligned_cols=140 Identities=20% Similarity=0.174 Sum_probs=96.5
Q ss_pred cccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCH------------------------------H---
Q 011851 126 ECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGH------------------------------K--- 172 (476)
Q Consensus 126 ~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~------------------------------~--- 172 (476)
.+.||.|++|.||+|++. +|+.||||+.+....... +
T Consensus 122 ~~plasaSigQVh~A~l~----------~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~ 191 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLV----------DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFE 191 (437)
T ss_pred CcceeeeehhheEEEEec----------CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHH
Confidence 367999999999999764 678899999865321100 0
Q ss_pred -------HHHHHHHHHhCC----C-CCceeeEEEEE-EeCCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHH
Q 011851 173 -------EWLAEVNYLGGL----I-HPNLVKLIGCC-IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAK 239 (476)
Q Consensus 173 -------~~~~E~~~l~~l----~-hpnIv~l~~~~-~~~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~ 239 (476)
++.+|...+.++ . +++| .+-.++ ...+..+|||||++|++|.+.........+ ...++.+++.
T Consensus 192 ~~l~~Eldf~~Ea~n~~~~~~~~~~~~~v-~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~ 267 (437)
T TIGR01982 192 KTLRRELDLRREAANASELGENFKNDPGV-YVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLAR 267 (437)
T ss_pred HHHHHHHCHHHHHHHHHHHHHhcCCCCCE-EeCCEehhhcCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHH
Confidence 133444444444 2 3333 222222 234457999999999999887643221222 3455666655
Q ss_pred -HHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCcCCCC
Q 011851 240 -GLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGP 282 (476)
Q Consensus 240 -al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~ 282 (476)
.+..+|..+ ++|+|+||.||+++.++.++|+|||++....
T Consensus 268 ~~l~ql~~~g---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 268 SFLNQVLRDG---FFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred HHHHHHHhCC---ceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 467889888 9999999999999999999999999997754
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.49 E-value=2.8e-14 Score=134.78 Aligned_cols=205 Identities=21% Similarity=0.283 Sum_probs=141.7
Q ss_pred HHHHHhCCCCCceeeEEEEEEeCC-----eeEEEEEecCCCCHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHHhcC
Q 011851 177 EVNYLGGLIHPNLVKLIGCCIEDD-----QRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALDAAKGLAFLHEEA 248 (476)
Q Consensus 177 E~~~l~~l~hpnIv~l~~~~~~~~-----~~~lV~E~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~al~~lH~~~ 248 (476)
-..-|-++.|-|||+++.|+.+.. ...++.||+..|+|..+|.+ ....+....-.+|+.||+.||.|||+..
T Consensus 117 vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~ 196 (458)
T KOG1266|consen 117 VFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCD 196 (458)
T ss_pred HHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccC
Confidence 345556677999999999887543 47889999999999999964 3456788888899999999999999987
Q ss_pred CCCeEecCCCCCCeeecCCCceEEeecCCcCCCC--CCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHH
Q 011851 249 EKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGP--EGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEM 326 (476)
Q Consensus 249 ~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~--~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~el 326 (476)
.+|+|+++..+-|++..+|-|||.----..... ............+-++|.+||.=.....+.++|||+||....||
T Consensus 197 -PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlem 275 (458)
T KOG1266|consen 197 -PPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEM 275 (458)
T ss_pred -CccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHH
Confidence 779999999999999999988874211100000 00000011123567889999976666778899999999999999
Q ss_pred HhCCCCCCCCCCCCcchhHHhhhhhhccccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011851 327 LTGRRSMDKNRPNGEHNLVEWARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEA 402 (476)
Q Consensus 327 ltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~ 402 (476)
.-+..--...... ...-.......+... ...-++++.+||+..|..||+|.+++.|
T Consensus 276 ailEiq~tnseS~-~~~ee~ia~~i~~le-------------------n~lqr~~i~kcl~~eP~~rp~ar~llfH 331 (458)
T KOG1266|consen 276 AILEIQSTNSESK-VEVEENIANVIIGLE-------------------NGLQRGSITKCLEGEPNGRPDARLLLFH 331 (458)
T ss_pred HHheeccCCCcce-eehhhhhhhheeecc-------------------CccccCcCcccccCCCCCCcchhhhhcC
Confidence 9876432111111 000001111111100 0112368899999999999999999987
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.49 E-value=5.5e-15 Score=157.83 Aligned_cols=264 Identities=21% Similarity=0.217 Sum_probs=187.8
Q ss_pred CCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCcc---CHHHHHHHHHHHhCCCCCceeeEEEEEEe
Q 011851 122 SFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQ---GHKEWLAEVNYLGGLIHPNLVKLIGCCIE 198 (476)
Q Consensus 122 ~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~---~~~~~~~E~~~l~~l~hpnIv~l~~~~~~ 198 (476)
.+.+.+-+-+|.|+.++.+. ...+|..+++|+....... +.+....+-.++-...||-++...--+..
T Consensus 805 ~~~i~~p~qS~sp~ss~p~~---------pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~ 875 (1205)
T KOG0606|consen 805 GFEITKPSQSGSPSSSFPAS---------PAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPC 875 (1205)
T ss_pred cceecccccCCCCcccccCC---------ccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCC
Confidence 45666778899999998753 3345666777766543322 12233444455444556877776655667
Q ss_pred CCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCc
Q 011851 199 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLA 278 (476)
Q Consensus 199 ~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a 278 (476)
....+|||+|+.+++|...|+... ..+.+.++..+..+..+++|||... ++|||++|.|+|+..++..++.|||..
T Consensus 876 rsP~~L~~~~~~~~~~~Skl~~~~-~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t~ 951 (1205)
T KOG0606|consen 876 RSPLPLVGHYLNGGDLPSKLHNSG-CLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGTL 951 (1205)
T ss_pred CCCcchhhHHhccCCchhhhhcCC-CcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCccccc
Confidence 788999999999999999886543 5677777788889999999999977 899999999999999999999999843
Q ss_pred CCCCCC-----------------------------CccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhC
Q 011851 279 KDGPEG-----------------------------DKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTG 329 (476)
Q Consensus 279 ~~~~~~-----------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG 329 (476)
...... +.........||+.|.+||.+.+......+|+|++|++++|.++|
T Consensus 952 ~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g 1031 (1205)
T KOG0606|consen 952 SKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTG 1031 (1205)
T ss_pred cccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcC
Confidence 211100 000112236799999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCcchhHHhhhhhhccccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCc
Q 011851 330 RRSMDKNRPNGEHNLVEWARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYL 409 (476)
Q Consensus 330 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~ 409 (476)
..||....+.....-+. .+ +..+ ..-+...+.++.+++...|..+|.+|-.+.-..+ .+.+++|
T Consensus 1032 ~pp~na~tpq~~f~ni~-------~~-------~~~~-p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e-~k~~~~~ 1095 (1205)
T KOG0606|consen 1032 IPPFNAETPQQIFENIL-------NR-------DIPW-PEGPEEGSYEAQDLINRLLTEEPTQRLGAKGAAE-VKGHPFF 1095 (1205)
T ss_pred CCCCCCcchhhhhhccc-------cC-------CCCC-CCCccccChhhhhhhhhhhccCchhccCcccccc-cccCCcc
Confidence 99998766543321110 00 0000 0112233678889999999999999988773222 4555888
Q ss_pred ccccC
Q 011851 410 KDMAS 414 (476)
Q Consensus 410 ~~~~~ 414 (476)
++...
T Consensus 1096 ~~~~~ 1100 (1205)
T KOG0606|consen 1096 QDVDW 1100 (1205)
T ss_pred CCCCc
Confidence 76554
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.46 E-value=2.9e-13 Score=121.37 Aligned_cols=131 Identities=18% Similarity=0.039 Sum_probs=95.3
Q ss_pred cccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCCCCCcee-eEEEEEEeCCeeEE
Q 011851 126 ECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHPNLV-KLIGCCIEDDQRLL 204 (476)
Q Consensus 126 ~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv-~l~~~~~~~~~~~l 204 (476)
.+.|+.|.++.||++.. .+..|++|+...... ....+..|+.+++.+.+.+++ +++.+. .+..++
T Consensus 3 ~~~l~~G~~~~vy~~~~-----------~~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~l 68 (170)
T cd05151 3 ISPLKGGMTNKNYRVEV-----------ANKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVL 68 (170)
T ss_pred eeecCCcccCceEEEEE-----------CCeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeE
Confidence 35689999999999754 256799999765432 122456788888888655543 455443 334689
Q ss_pred EEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcC--CCCeEecCCCCCCeeecCCCceEEeecCCcCC
Q 011851 205 VYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEA--EKPVIYRDFKTSNILLDGEYNAKLSDFGLAKD 280 (476)
Q Consensus 205 V~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~--~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~ 280 (476)
||||++|.++.+.. .....++.+++++|..||..+ ...++|+|++|.||+++ ++.++|+|||.+..
T Consensus 69 v~e~i~G~~l~~~~---------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 69 ITEFIEGSELLTED---------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred EEEecCCCcccccc---------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 99999998875420 112345679999999999976 12259999999999999 66899999999864
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.46 E-value=5.5e-14 Score=146.61 Aligned_cols=143 Identities=16% Similarity=0.103 Sum_probs=92.9
Q ss_pred cCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccC------------------------------
Q 011851 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQG------------------------------ 170 (476)
Q Consensus 121 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~------------------------------ 170 (476)
..|.. +.||+|++|+||+|++. .+|+.||||+++..-.+.
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~---------~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~ 189 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLK---------DNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREV 189 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEEC---------CCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHH
Confidence 34666 78999999999999765 258889999997542100
Q ss_pred ----HHH------HHHHHHHHhCCC----CCceeeEEEEEEe-CCeeEEEEEecCCCCHHHHH--hhcCC---CCCHHHH
Q 011851 171 ----HKE------WLAEVNYLGGLI----HPNLVKLIGCCIE-DDQRLLVYEFMPRGSLENHL--FRRSL---PLPWSIR 230 (476)
Q Consensus 171 ----~~~------~~~E~~~l~~l~----hpnIv~l~~~~~~-~~~~~lV~E~~~~g~L~~~l--~~~~~---~l~~~~~ 230 (476)
.+. +.+|...+.++. +.+.+.+-.++.+ ....+|||||++|+.|.+.. ...+. .+.+..+
T Consensus 190 v~e~~~~l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v 269 (537)
T PRK04750 190 VAEFEKTLHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGV 269 (537)
T ss_pred HHHHHHHHHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHH
Confidence 011 233443333332 3333333333322 44568999999999998743 22221 2333334
Q ss_pred HHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCC----ceEEeecCCcCCCCC
Q 011851 231 MKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEY----NAKLSDFGLAKDGPE 283 (476)
Q Consensus 231 ~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~----~vkl~DFG~a~~~~~ 283 (476)
..++.||+ ..| ++|+|+||.||+++.++ .++++|||++.....
T Consensus 270 ~~~~~Qif-------~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 270 EVFFTQVF-------RDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred HHHHHHHH-------hCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 44444543 455 99999999999999888 999999999877644
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.41 E-value=3.4e-12 Score=131.62 Aligned_cols=229 Identities=17% Similarity=0.200 Sum_probs=151.9
Q ss_pred CCCCceEEEEEecCCCccCHHHHHHHHHHHhCCCCCceeeEEEEEEeCCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHH
Q 011851 152 PGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHPNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRM 231 (476)
Q Consensus 152 ~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~ 231 (476)
+.++.+|.|+..+...........+-++.|+.|+||||+++++.++.++.+|||+|-+. .|..++.+. ......
T Consensus 34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l----~~~~v~ 107 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKEL----GKEEVC 107 (690)
T ss_pred eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHh----HHHHHH
Confidence 35778888988876655334456778899999999999999999999999999999983 566667443 356677
Q ss_pred HHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCcCCCCCCCccceeeeeecCCCCCCcchhhcCCCC
Q 011851 232 KIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLT 311 (476)
Q Consensus 232 ~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 311 (476)
.-++||+.||.|||+.+ +++|++|.-..|+++..|..||++|-++......... .....--..|..|+.+....
T Consensus 108 ~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~--~~~~~~~~s~~~P~~~~~s~-- 181 (690)
T KOG1243|consen 108 LGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAP--AKSLYLIESFDDPEEIDPSE-- 181 (690)
T ss_pred HHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcc--cccchhhhcccChhhcCccc--
Confidence 78899999999999754 3999999999999999999999999988654332210 00111222366666443222
Q ss_pred ccchhhhhHHHHHHHHhCCCCCCCCCCC--Ccc-hhHHhhhhhhccccccccccCcccCCCCChHHHHHHHHHHHHhccc
Q 011851 312 AKSDVYSFGVVLLEMLTGRRSMDKNRPN--GEH-NLVEWARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNR 388 (476)
Q Consensus 312 ~~~DiwslGv~l~elltG~~pf~~~~~~--~~~-~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~ 388 (476)
-..|.|-|||+++|++.|..+-...... ..- ..+......+.... + ..+. ...++..|+..
T Consensus 182 ~s~D~~~Lg~li~el~ng~~~~~~~~~~~~~ipk~~~~~~~k~~~~~~---------~------~r~n-~~~~~~~~~~~ 245 (690)
T KOG1243|consen 182 WSIDSWGLGCLIEELFNGSLLTKTDLSNTGKIPKALIELYCKKLGATE---------L------KRPN-KLRFILECRLL 245 (690)
T ss_pred cchhhhhHHHHHHHHhCcccCcchhhhccCccchhHHHHHHHHhcccc---------c------cccc-hhhHHHHHHhc
Confidence 4579999999999999993221111000 000 01111100110000 0 0011 45677777777
Q ss_pred CCCCCCCHHHHHHHhcCCCC
Q 011851 389 DQKARPRMSEVVEALKPLPY 408 (476)
Q Consensus 389 dP~~RPt~~ell~~L~~~~~ 408 (476)
..--|=.+-+++..|+.+..
T Consensus 246 ~gff~n~fvd~~~fLeel~l 265 (690)
T KOG1243|consen 246 GGFFRNDFVDTLLFLEELRL 265 (690)
T ss_pred cccccchHHHHHHHHHhccc
Confidence 77777777777777776643
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.38 E-value=7.6e-12 Score=114.06 Aligned_cols=145 Identities=13% Similarity=0.067 Sum_probs=100.4
Q ss_pred cccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCc---------------------cC-HHHH----HHHHH
Q 011851 126 ECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL---------------------QG-HKEW----LAEVN 179 (476)
Q Consensus 126 ~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~---------------------~~-~~~~----~~E~~ 179 (476)
...||.|--+.||.|....+.. ....+..+|||+.+.... .. .+.+ .+|++
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~---~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r 78 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNET---EQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMH 78 (197)
T ss_pred CCccccCcceEEEEEecCcccc---cccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHH
Confidence 3568999999999996532100 112356899999763210 01 1112 37999
Q ss_pred HHhCCCC--CceeeEEEEEEeCCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHH-HhcCCCCeEecC
Q 011851 180 YLGGLIH--PNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFL-HEEAEKPVIYRD 256 (476)
Q Consensus 180 ~l~~l~h--pnIv~l~~~~~~~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~l-H~~~~~~ivHrD 256 (476)
.|.++.. -++..++++ ...+|||||+.+..+.....+ ...++......+..+++.+|..| |..+ |||+|
T Consensus 79 ~L~rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lk-d~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHGD 150 (197)
T cd05146 79 NLKRMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLK-DAKLNDEEMKNAYYQVLSMMKQLYKECN---LVHAD 150 (197)
T ss_pred HHHHHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhh-ccccCHHHHHHHHHHHHHHHHHHHHhCC---eecCC
Confidence 9998853 456666654 456899999976544222212 22355566777889999999999 8877 99999
Q ss_pred CCCCCeeecCCCceEEeecCCcCCCC
Q 011851 257 FKTSNILLDGEYNAKLSDFGLAKDGP 282 (476)
Q Consensus 257 lKp~NILl~~~~~vkl~DFG~a~~~~ 282 (476)
|++.|||++ ++.+.|+|||.+....
T Consensus 151 Ls~~NIL~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 151 LSEYNMLWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred CCHHHEEEE-CCcEEEEECCCceeCC
Confidence 999999997 4689999999987653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.34 E-value=1e-12 Score=134.09 Aligned_cols=245 Identities=21% Similarity=0.161 Sum_probs=174.2
Q ss_pred ccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHH--HHHHHHHHhCC-CCCceeeEEEEE
Q 011851 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKE--WLAEVNYLGGL-IHPNLVKLIGCC 196 (476)
Q Consensus 120 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~--~~~E~~~l~~l-~hpnIv~l~~~~ 196 (476)
..+|..+..||.|.|+.|+..... ..++..|++|.+.+.-.....+ -+.|+-+...+ .|.+++.++..|
T Consensus 264 ~~df~~v~~i~~~~~~~~~~~~~r--------~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W 335 (524)
T KOG0601|consen 264 LTDFGLVSKISDGNFSSVFKVSKR--------PEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSW 335 (524)
T ss_pred cCCcceeEEccCCccccceeeeec--------CCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCc
Confidence 456888899999999999986432 2356679999876544333222 24566665555 488999999999
Q ss_pred EeCCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCC-CceEEeec
Q 011851 197 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGE-YNAKLSDF 275 (476)
Q Consensus 197 ~~~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~-~~vkl~DF 275 (476)
....+.|+-.|||+++++...+ .-...+.+..++.+..|++.++.++|+.. ++|+|+||+||++..+ +..++.||
T Consensus 336 ~~~r~~~ip~e~~~~~s~~l~~-~~~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~~ 411 (524)
T KOG0601|consen 336 SQLRQGYIPLEFCEGGSSSLRS-VTSQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGDF 411 (524)
T ss_pred cccccccCchhhhcCcchhhhh-HHHHhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhcccc
Confidence 9888999999999999887766 33345788889999999999999999877 9999999999999876 78899999
Q ss_pred CCcCCCCCCCccceeeeeecCCCCC--CcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhc
Q 011851 276 GLAKDGPEGDKTHVSTRVMGTYGYA--APEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLG 353 (476)
Q Consensus 276 G~a~~~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~ 353 (476)
|++..+.... ....++-.++ +++......+..+.|++|||..+++.+++..--.... .|..
T Consensus 412 ~~~t~~~~~~-----~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~--------~~~~---- 474 (524)
T KOG0601|consen 412 GCWTRLAFSS-----GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGV--------QSLT---- 474 (524)
T ss_pred ccccccceec-----ccccccccccccchhhccccccccccccccccccccccccCcccCcccc--------ccee----
Confidence 9986422111 1122333344 4444455678899999999999999999864322111 0100
Q ss_pred cccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011851 354 ERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEA 402 (476)
Q Consensus 354 ~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~ 402 (476)
+....+.. .+ ....++..+.+.++..++..||.+.++..+
T Consensus 475 -------i~~~~~p~-~~-~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~ 514 (524)
T KOG0601|consen 475 -------IRSGDTPN-LP-GLKLQLQVLLKVMINPDRKRRPSAVELSLH 514 (524)
T ss_pred -------eecccccC-CC-chHHhhhhhhhhhcCCccccchhhhhhccc
Confidence 00000000 01 113677889999999999999999887765
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.30 E-value=3.5e-11 Score=106.31 Aligned_cols=131 Identities=24% Similarity=0.299 Sum_probs=97.9
Q ss_pred ccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCcc--------CHHHHHHHHHHHhCCCCCceeeEEEEEEe
Q 011851 127 CLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQ--------GHKEWLAEVNYLGGLIHPNLVKLIGCCIE 198 (476)
Q Consensus 127 ~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~--------~~~~~~~E~~~l~~l~hpnIv~l~~~~~~ 198 (476)
..+++|+-+.+|++.+. |..+++|.--..... ...+..+|..+|.++.--.|..-+=++.+
T Consensus 2 ~~i~~GAEa~i~~~~~~-----------g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD 70 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-----------GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVD 70 (204)
T ss_pred chhhCCcceeEEeeecc-----------CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEc
Confidence 45789999999987543 334566643221111 12345679999998876566555555667
Q ss_pred CCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCc
Q 011851 199 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLA 278 (476)
Q Consensus 199 ~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a 278 (476)
.+...|+|||++|..|.+.+... ...++..|-.-+.-||..+ |||+||.++||++..+. +.++|||++
T Consensus 71 ~~~~~I~me~I~G~~lkd~l~~~--------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg 138 (204)
T COG3642 71 PDNGLIVMEYIEGELLKDALEEA--------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLG 138 (204)
T ss_pred CCCCEEEEEEeCChhHHHHHHhc--------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCcc
Confidence 77889999999999998888544 2566777888888999998 99999999999998664 999999999
Q ss_pred CC
Q 011851 279 KD 280 (476)
Q Consensus 279 ~~ 280 (476)
..
T Consensus 139 ~~ 140 (204)
T COG3642 139 EF 140 (204)
T ss_pred cc
Confidence 75
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.27 E-value=3.7e-11 Score=112.32 Aligned_cols=143 Identities=21% Similarity=0.224 Sum_probs=108.1
Q ss_pred ccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCc-cCHHHHHHHHHHHhCCCC--CceeeEEEEEEeC---C
Q 011851 127 CLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL-QGHKEWLAEVNYLGGLIH--PNLVKLIGCCIED---D 200 (476)
Q Consensus 127 ~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~-~~~~~~~~E~~~l~~l~h--pnIv~l~~~~~~~---~ 200 (476)
+.|+.|.++.||++... .|..+++|+...... .....+..|+.+++.+.+ .++.+++.+.... +
T Consensus 4 ~~l~~G~~n~~~~v~~~----------~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~ 73 (223)
T cd05154 4 RQLSGGQSNLTYLLTAG----------GGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLG 73 (223)
T ss_pred eecCCCccceEEEEEec----------CCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccC
Confidence 56899999999997542 256799999865432 134567889999999875 4467777776654 3
Q ss_pred eeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcC--------------------------------
Q 011851 201 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEA-------------------------------- 248 (476)
Q Consensus 201 ~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~-------------------------------- 248 (476)
..++||||++|.+|.+.+.. ..++......++.+++++|.+||+..
T Consensus 74 ~~~~v~e~i~G~~l~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 151 (223)
T cd05154 74 TPFYVMERVDGRVLRDRLLR--PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRT 151 (223)
T ss_pred CceEEEEEeCCEecCCCCCC--CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcc
Confidence 67899999999888765532 35677777888888888888888531
Q ss_pred ---------------------CCCeEecCCCCCCeeecC--CCceEEeecCCcCCC
Q 011851 249 ---------------------EKPVIYRDFKTSNILLDG--EYNAKLSDFGLAKDG 281 (476)
Q Consensus 249 ---------------------~~~ivHrDlKp~NILl~~--~~~vkl~DFG~a~~~ 281 (476)
...++|+|+.+.|||++. ++.+.|+||+.+...
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~g 207 (223)
T cd05154 152 DEPPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATLG 207 (223)
T ss_pred cccHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccccC
Confidence 134799999999999998 667899999988653
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.24 E-value=8.3e-11 Score=103.47 Aligned_cols=142 Identities=20% Similarity=0.197 Sum_probs=104.8
Q ss_pred ccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCC-----Ccc---CHHHHHHHHHHHhCCCCCceeeEEEEE
Q 011851 125 PECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHD-----GLQ---GHKEWLAEVNYLGGLIHPNLVKLIGCC 196 (476)
Q Consensus 125 ~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~-----~~~---~~~~~~~E~~~l~~l~hpnIv~l~~~~ 196 (476)
...+|-+|+-+.|+++.+ .|+.+.||.-... ... ..++..+|.++|.++.--.|.--.-+|
T Consensus 11 ~l~likQGAEArv~~~~~-----------~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~ 79 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF-----------SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIF 79 (229)
T ss_pred cceeeeccceeeEeeecc-----------CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEE
Confidence 567789999999999865 4666777753221 111 234677899999988755555445556
Q ss_pred EeCCeeEEEEEecCC-CCHHHHHhhcCCCCCHHH-HHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCC---ceE
Q 011851 197 IEDDQRLLVYEFMPR-GSLENHLFRRSLPLPWSI-RMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEY---NAK 271 (476)
Q Consensus 197 ~~~~~~~lV~E~~~~-g~L~~~l~~~~~~l~~~~-~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~---~vk 271 (476)
.+...-.|+|||++| .++.+++......-.+.. ...++..|-+.|.-||..+ |||+||..+||+|..++ .+.
T Consensus 80 ~D~~~~~i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~ 156 (229)
T KOG3087|consen 80 IDTYGGQIYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPI 156 (229)
T ss_pred EecCCCeEEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceE
Confidence 777778899999976 478888865433333333 3788999999999999988 99999999999996554 358
Q ss_pred EeecCCcCC
Q 011851 272 LSDFGLAKD 280 (476)
Q Consensus 272 l~DFG~a~~ 280 (476)
|+|||++..
T Consensus 157 lIdfgls~~ 165 (229)
T KOG3087|consen 157 LIDFGLSSV 165 (229)
T ss_pred EEeecchhc
Confidence 999999864
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.20 E-value=4.6e-10 Score=112.70 Aligned_cols=215 Identities=17% Similarity=0.237 Sum_probs=155.2
Q ss_pred ccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCCCCCceeeEEEEEEe----CCeeEEEEEecC
Q 011851 135 GCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHPNLVKLIGCCIE----DDQRLLVYEFMP 210 (476)
Q Consensus 135 g~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~----~~~~~lV~E~~~ 210 (476)
.+.|+++.. .+|..|++|+++....+.......-+++++++.|.|||.+.++|.. +..++||++|.+
T Consensus 290 ~Ttyk~~s~---------~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP 360 (655)
T KOG3741|consen 290 ITTYKATSN---------VDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYP 360 (655)
T ss_pred ceeEeeeec---------cCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCC
Confidence 567777655 3677799999965544444344567899999999999999998873 457899999988
Q ss_pred C-CCHHHHHhh--------------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeec
Q 011851 211 R-GSLENHLFR--------------RSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDF 275 (476)
Q Consensus 211 ~-g~L~~~l~~--------------~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DF 275 (476)
+ ++|.++... .+...++...|.++.|+..||.++|+.| +.-+-|.+.+||++++.+++|...
T Consensus 361 ~s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C 437 (655)
T KOG3741|consen 361 SSPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGC 437 (655)
T ss_pred CCchHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecc
Confidence 6 578777642 2344788999999999999999999999 888999999999999999999988
Q ss_pred CCcCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhccc
Q 011851 276 GLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGER 355 (476)
Q Consensus 276 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~ 355 (476)
|+........ + |-+.. -.+-|.=.||.+++.|.||..--..... ..+.....
T Consensus 438 ~i~Dvl~~d~---------~-------~~le~---~Qq~D~~~lG~ll~aLAt~~~ns~~~d~-----~~~s~~~~---- 489 (655)
T KOG3741|consen 438 GIMDVLQEDP---------T-------EPLES---QQQNDLRDLGLLLLALATGTENSNRTDS-----TQSSHLTR---- 489 (655)
T ss_pred cceeeecCCC---------C-------cchhH---HhhhhHHHHHHHHHHHhhcccccccccc-----hHHHHHHH----
Confidence 8765543321 0 11111 2356888999999999999644211100 00000000
Q ss_pred cccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 011851 356 RRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALK 404 (476)
Q Consensus 356 ~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~ 404 (476)
.....+.++.++|.-+...++++ -++.+++.++-
T Consensus 490 --------------I~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~~~ 523 (655)
T KOG3741|consen 490 --------------ITTTYSTDLRNVVEYLESLNFRE-KSIQDLLPMIG 523 (655)
T ss_pred --------------hhhhhhHHHHHHHHHHHhcCccc-ccHHHHHHHHH
Confidence 11234678889999999999987 68888888743
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.00 E-value=8.4e-09 Score=99.21 Aligned_cols=124 Identities=15% Similarity=0.046 Sum_probs=90.0
Q ss_pred CCceEEEEEecCCCcc-----------CHHHHHHHHHHHhCCCCCc--eeeEEEEEEe-----CCeeEEEEEecCCC-CH
Q 011851 154 TGLPVAVKTLNHDGLQ-----------GHKEWLAEVNYLGGLIHPN--LVKLIGCCIE-----DDQRLLVYEFMPRG-SL 214 (476)
Q Consensus 154 ~g~~vAiK~~~~~~~~-----------~~~~~~~E~~~l~~l~hpn--Iv~l~~~~~~-----~~~~~lV~E~~~~g-~L 214 (476)
.|+.|.||........ ....+.+|...+.+|..-+ +..++.+++. ....+||||++++. +|
T Consensus 44 ~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte~l~~~~sL 123 (268)
T PRK15123 44 AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITEDLAPTISL 123 (268)
T ss_pred CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEeeCCCCccH
Confidence 3567889976433211 0113678888887774333 3444555543 23578999999886 79
Q ss_pred HHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecC-------CCceEEeecCCcCC
Q 011851 215 ENHLFRR-SLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDG-------EYNAKLSDFGLAKD 280 (476)
Q Consensus 215 ~~~l~~~-~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~-------~~~vkl~DFG~a~~ 280 (476)
.+++... ..+.+......++.+++..+.-||..| |+|+||++.|||++. ++.+.|+||+.+..
T Consensus 124 ~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~~ 194 (268)
T PRK15123 124 EDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQI 194 (268)
T ss_pred HHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCCceEEEEECCcccc
Confidence 8887431 344567778899999999999999999 999999999999975 46899999998854
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.98 E-value=3.8e-09 Score=96.00 Aligned_cols=98 Identities=20% Similarity=0.230 Sum_probs=65.0
Q ss_pred HHHHHHHHhCCCCC--ceeeEEEEEEeCCeeEEEEEecC--CCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHH-HHhcC
Q 011851 174 WLAEVNYLGGLIHP--NLVKLIGCCIEDDQRLLVYEFMP--RGSLENHLFRRSLPLPWSIRMKIALDAAKGLAF-LHEEA 248 (476)
Q Consensus 174 ~~~E~~~l~~l~hp--nIv~l~~~~~~~~~~~lV~E~~~--~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~-lH~~~ 248 (476)
..+|.+.|.++..- ++.+++++. ..+|||||++ |..+..+. ... ++......++.+++..+.. +|..+
T Consensus 55 ~~~E~~~L~~l~~~Gv~vP~p~~~~----~~~ivME~I~~~G~~~~~l~-~~~--~~~~~~~~~~~~il~~~~~~~~~~g 127 (188)
T PF01163_consen 55 AKKEFRNLKRLYEAGVPVPKPYDYN----RNVIVMEYIGEDGVPLPRLK-DVD--LSPEEPKELLEEILEEIIKMLHKAG 127 (188)
T ss_dssp HHHHHHHHHHCCCTT-SS--EEEEE----TTEEEEE--EETTEEGGCHH-HCG--GGGSTHHHHHHHHHHHHHHHHHCTT
T ss_pred HHHHHHHHHHHHHCCccCCcEEEEe----CCEEEEEecCCCccchhhHH-hcc--ccchhHHHHHHHHHHHHHHHHHhcC
Confidence 56799999999765 466666542 4479999998 55554433 221 1134456677788885555 56777
Q ss_pred CCCeEecCCCCCCeeecCCCceEEeecCCcCCCC
Q 011851 249 EKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGP 282 (476)
Q Consensus 249 ~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~ 282 (476)
|+|+||.+.|||++++ .+.|+|||.+....
T Consensus 128 ---ivHGDLs~~NIlv~~~-~~~iIDf~qav~~~ 157 (188)
T PF01163_consen 128 ---IVHGDLSEYNILVDDG-KVYIIDFGQAVDSS 157 (188)
T ss_dssp ---EEESS-STTSEEEETT-CEEE--GTTEEETT
T ss_pred ---ceecCCChhhEEeecc-eEEEEecCcceecC
Confidence 9999999999999877 89999999987653
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.97 E-value=3.6e-08 Score=96.97 Aligned_cols=257 Identities=16% Similarity=0.142 Sum_probs=153.8
Q ss_pred CccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCC-CCCceeeEEEEE------
Q 011851 124 RPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGL-IHPNLVKLIGCC------ 196 (476)
Q Consensus 124 ~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~------ 196 (476)
...+.||+|+-+.+|---- -...+-|+..........+. +..|... .||-+-.-+.|=
T Consensus 14 ~~gr~LgqGgea~ly~l~e------------~~d~VAKIYh~Pppa~~aqk---~a~la~~p~~p~~~~rvaWPqa~L~G 78 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGE------------VRDQVAKIYHAPPPAAQAQK---VAELAATPDAPLLNYRVAWPQATLHG 78 (637)
T ss_pred CCCccccCCccceeeecch------------hhchhheeecCCCchHHHHH---HHHhccCCCCcchhhhhcccHHHhhC
Confidence 3457799999999995311 11134577766544332222 2223333 466443311110
Q ss_pred -EeCCeeEEEEEecCCCCH-HHHHh-----hcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCc
Q 011851 197 -IEDDQRLLVYEFMPRGSL-ENHLF-----RRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYN 269 (476)
Q Consensus 197 -~~~~~~~lV~E~~~~g~L-~~~l~-----~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~ 269 (476)
.....+-++|..++|..- ..++. +......|...+++++.++.+...||+.| .+-+|+.++|+|+.+++.
T Consensus 79 ~~~~~~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~ 155 (637)
T COG4248 79 GRRGKVIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSK 155 (637)
T ss_pred CCccceeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCce
Confidence 112236678888877532 22221 12334789999999999999999999999 888999999999999999
Q ss_pred eEEeecCCcCCCCCCCccceeeeeecCCCCCCcchhhcC-----CCCccchhhhhHHHHHHHHhC-CCCCCCCCCCCcc-
Q 011851 270 AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-----HLTAKSDVYSFGVVLLEMLTG-RRSMDKNRPNGEH- 342 (476)
Q Consensus 270 vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DiwslGv~l~elltG-~~pf~~~~~~~~~- 342 (476)
|.|.|=..-....+ .....-.+|...|.+||...-+ .-+...|.|.||+++++||.| +.||.+.......
T Consensus 156 V~LVdsDsfqi~~n---g~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap 232 (637)
T COG4248 156 VVLVDSDSFQINAN---GTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAP 232 (637)
T ss_pred EEEEcccceeeccC---CceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCC
Confidence 99998554433322 1223346799999999976522 345678999999999999998 8899764321111
Q ss_pred ---h-hHHhhhhhhccccccccccCcccCCCCChHHHHHHHHHHHHhccc--CCCCCCCHHHHHHHh
Q 011851 343 ---N-LVEWARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNR--DQKARPRMSEVVEAL 403 (476)
Q Consensus 343 ---~-~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~--dP~~RPt~~ell~~L 403 (476)
+ -+...........+ .-..+......-.-.+..+..|..+|+.. ++.-|||++.-+..|
T Consensus 233 ~p~E~~Ia~g~f~ya~~~~--~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl 297 (637)
T COG4248 233 NPLETDIAHGRFAYASDQR--RGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAAL 297 (637)
T ss_pred Ccchhhhhcceeeechhcc--CCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Confidence 0 11100000000000 00011111111111245677788888864 467899988766654
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.92 E-value=5.4e-10 Score=115.98 Aligned_cols=156 Identities=22% Similarity=0.345 Sum_probs=108.6
Q ss_pred HHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCcCCCCCCCccc-------eeeeeecCCCCCCcchhhcC
Q 011851 236 DAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTH-------VSTRVMGTYGYAAPEYVMTG 308 (476)
Q Consensus 236 qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~ 308 (476)
+++.|+.|+|...+ +||+.|.|++|.++.++..||+.|+++.......... ...-..-...|.|||++...
T Consensus 107 ~v~dgl~flh~sAk--~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~ 184 (700)
T KOG2137|consen 107 NVADGLAFLHRSAK--VVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGT 184 (700)
T ss_pred cccchhhhhccCcc--eeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccc
Confidence 45589999999654 9999999999999999999999999887654322110 00112345689999999998
Q ss_pred CCCccchhhhhHHHHHHHH-hCCCCCCCCCCCCcchhHHhhhhhhccccccccccCcccCCCCChHHHHHHHHHHHHhcc
Q 011851 309 HLTAKSDVYSFGVVLLEML-TGRRSMDKNRPNGEHNLVEWARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLN 387 (476)
Q Consensus 309 ~~~~~~DiwslGv~l~ell-tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~ 387 (476)
..+.++|+|||||++|.+. .|+.-+............ ...+..-...+....+.++.+=+.+++.
T Consensus 185 ~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~--------------~~~~~~~~~~~s~~~p~el~~~l~k~l~ 250 (700)
T KOG2137|consen 185 TNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFS--------------RNLLNAGAFGYSNNLPSELRESLKKLLN 250 (700)
T ss_pred cccccccceeeeeEEEEEecCCcchhhccCCcchhhhh--------------hcccccccccccccCcHHHHHHHHHHhc
Confidence 8899999999999999999 555555433221111110 0011111112234457899999999999
Q ss_pred cCCCCCCCHHHHHHHhcCCCCccc
Q 011851 388 RDQKARPRMSEVVEALKPLPYLKD 411 (476)
Q Consensus 388 ~dP~~RPt~~ell~~L~~~~~~~~ 411 (476)
.++.-||++..++.. +||.+
T Consensus 251 ~~~~~rp~~~~l~~~----~ff~D 270 (700)
T KOG2137|consen 251 GDSAVRPTLDLLLSI----PFFSD 270 (700)
T ss_pred CCcccCcchhhhhcc----cccCC
Confidence 999999987776653 56554
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.83 E-value=1.7e-08 Score=94.57 Aligned_cols=136 Identities=18% Similarity=0.074 Sum_probs=97.7
Q ss_pred CCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCc----------------------cCHHHHHHHHHH
Q 011851 123 FRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL----------------------QGHKEWLAEVNY 180 (476)
Q Consensus 123 y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~----------------------~~~~~~~~E~~~ 180 (476)
+.+...||-|.-+.||.|.+. .|.++|||.=+.... .......+|.++
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~----------~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~ 162 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDP----------KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEA 162 (304)
T ss_pred HhhccccccCccceEEEEECC----------CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHH
Confidence 567789999999999998654 678899997432100 011235679999
Q ss_pred HhCCCCC--ceeeEEEEEEeCCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCC
Q 011851 181 LGGLIHP--NLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFK 258 (476)
Q Consensus 181 l~~l~hp--nIv~l~~~~~~~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlK 258 (476)
|.+|.-. .|.+.+++ +...+||||++|-.|...- ++......++..|++-+.-+-..| |||+|+.
T Consensus 163 L~~L~~~G~~VP~P~~~----nRHaVvMe~ieG~eL~~~r------~~~en~~~il~~il~~~~~~~~~G---iVHGDlS 229 (304)
T COG0478 163 LQRLYPEGVKVPKPIAW----NRHAVVMEYIEGVELYRLR------LDVENPDEILDKILEEVRKAYRRG---IVHGDLS 229 (304)
T ss_pred HHHhhhcCCCCCCcccc----ccceeeeehcccceeeccc------CcccCHHHHHHHHHHHHHHHHHcC---ccccCCc
Confidence 9999654 67777655 4668999999887664322 123334445555555555555666 9999999
Q ss_pred CCCeeecCCCceEEeecCCcCCC
Q 011851 259 TSNILLDGEYNAKLSDFGLAKDG 281 (476)
Q Consensus 259 p~NILl~~~~~vkl~DFG~a~~~ 281 (476)
+-|||++++|.+.++||-.+...
T Consensus 230 efNIlV~~dg~~~vIDwPQ~v~~ 252 (304)
T COG0478 230 EFNILVTEDGDIVVIDWPQAVPI 252 (304)
T ss_pred hheEEEecCCCEEEEeCcccccC
Confidence 99999999999999999877654
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.74 E-value=7.8e-08 Score=89.24 Aligned_cols=106 Identities=22% Similarity=0.170 Sum_probs=83.1
Q ss_pred HHHHHHHHHHhCCCC--CceeeEEEEEEeCC----eeEEEEEecCCC-CHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHH
Q 011851 172 KEWLAEVNYLGGLIH--PNLVKLIGCCIEDD----QRLLVYEFMPRG-SLENHLFRRSLPLPWSIRMKIALDAAKGLAFL 244 (476)
Q Consensus 172 ~~~~~E~~~l~~l~h--pnIv~l~~~~~~~~----~~~lV~E~~~~g-~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~l 244 (476)
....+|...+..|.. -.+.+.+.+.+... ..+||+|++++. +|.+++..... .+......++.+++..+.-|
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~-~~~~~~~~ll~~l~~~i~~l 134 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ-LDPSQRRELLRALARLIAKL 134 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc-cchhhHHHHHHHHHHHHHHH
Confidence 456778887777743 23456666655532 458999999884 78888855322 66777889999999999999
Q ss_pred HhcCCCCeEecCCCCCCeeecCCC---ceEEeecCCcCCC
Q 011851 245 HEEAEKPVIYRDFKTSNILLDGEY---NAKLSDFGLAKDG 281 (476)
Q Consensus 245 H~~~~~~ivHrDlKp~NILl~~~~---~vkl~DFG~a~~~ 281 (476)
|..+ |+|+|+++.|||++.++ .+.|+||+-++..
T Consensus 135 H~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 135 HDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 9999 99999999999998887 8999999988753
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.72 E-value=1.3e-09 Score=111.97 Aligned_cols=190 Identities=19% Similarity=0.122 Sum_probs=138.1
Q ss_pred hccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCCCCCc-eeeEEEEEE
Q 011851 119 ATKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHPN-LVKLIGCCI 197 (476)
Q Consensus 119 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~hpn-Iv~l~~~~~ 197 (476)
.+..|...+-+++|+++.+++.+... +.. ...+++.. .....-++++|.+++||| .+..++-++
T Consensus 240 k~kws~~fh~fvK~altknpKkRpta---------ekl-L~h~fvs~-----~l~~rl~~eLLdK~n~P~~~v~~~~d~~ 304 (829)
T KOG0576|consen 240 KTKWSEFFHNFVKGALTKNPKKRPTA---------EKL-LQHPFVSQ-----TLSRRLAIELLDKVNNPNPVVRYLEDYD 304 (829)
T ss_pred CccchHHHHHHHHHHhcCCCccCCCh---------hhh-eeceeecc-----chhhHHHHHHHHHccCCCCcccccccCC
Confidence 34455566678999999999865431 111 12343322 244566899999999999 777777777
Q ss_pred eCCeeEEEEEecCCC-CHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecC
Q 011851 198 EDDQRLLVYEFMPRG-SLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFG 276 (476)
Q Consensus 198 ~~~~~~lV~E~~~~g-~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG 276 (476)
.++..+++|+++.++ +-...+......+...+...+.+.-+++++++|+.. =+||| ||+..+ +..+..||+
T Consensus 305 ~E~~~~i~~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~ 376 (829)
T KOG0576|consen 305 GEDYLWIPMRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFA 376 (829)
T ss_pred cccccchhhhhhcCCccccccCChhhHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-ccccccccc
Confidence 788899999999877 222222122223444455566777788999999854 48999 887765 679999999
Q ss_pred CcCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCC
Q 011851 277 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMD 334 (476)
Q Consensus 277 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~ 334 (476)
....+.... ..+...+|+.++|||+...+.+....|.|++|+-..+|.-|-+|-.
T Consensus 377 v~~~L~~~~---~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~ 431 (829)
T KOG0576|consen 377 VPPQLTRTM---KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS 431 (829)
T ss_pred CCcccCccc---ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence 998775543 2345789999999999999999999999999998888888877654
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.71 E-value=4.1e-08 Score=102.18 Aligned_cols=142 Identities=17% Similarity=0.139 Sum_probs=92.0
Q ss_pred ccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccC--------------------------H--------H
Q 011851 127 CLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQG--------------------------H--------K 172 (476)
Q Consensus 127 ~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~--------------------------~--------~ 172 (476)
+.|+.++-|.||+|++. +|+.||||+.+..-.+. . +
T Consensus 131 ~PiAsASIaQVH~A~L~----------sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~ 200 (517)
T COG0661 131 EPIASASIAQVHRAVLK----------SGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEK 200 (517)
T ss_pred CchhhhhHhhheeEEec----------CCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHH
Confidence 67999999999999876 68999999987531110 0 0
Q ss_pred ------HHHHHHHHHhCCC-----CCceeeEEEEEEeCCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHH
Q 011851 173 ------EWLAEVNYLGGLI-----HPNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGL 241 (476)
Q Consensus 173 ------~~~~E~~~l~~l~-----hpnIv~l~~~~~~~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al 241 (476)
++.+|...+.++. .++|.--.=|++-.+.-.|+|||++|-.+.+........++.+.+.....++. +
T Consensus 201 ~l~~ElDy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~f--~ 278 (517)
T COG0661 201 RLREELDYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRAF--L 278 (517)
T ss_pred HHHHHhCHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHHH--H
Confidence 1233444444442 34433222223345567899999999988887533334455333333322222 1
Q ss_pred HHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCcCCCCC
Q 011851 242 AFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPE 283 (476)
Q Consensus 242 ~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~ 283 (476)
..+-..| ++|.|..|.||+++.+|.+.+.|||+......
T Consensus 279 ~q~~~dg---ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 279 RQLLRDG---FFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred HHHHhcC---ccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 2222234 99999999999999999999999999876654
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.63 E-value=6.4e-07 Score=84.28 Aligned_cols=138 Identities=18% Similarity=0.167 Sum_probs=84.7
Q ss_pred ccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCCCCCc--eeeEEEEEEeCCeeEE
Q 011851 127 CLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHPN--LVKLIGCCIEDDQRLL 204 (476)
Q Consensus 127 ~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~hpn--Iv~l~~~~~~~~~~~l 204 (476)
..||.|..+.||+. .|..+++|+..... ....+.+|.++++.+..-+ +.+.+++....+...+
T Consensus 7 ~~i~~G~t~~~y~~-------------~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~gl 71 (226)
T TIGR02172 7 TQTGEGGNGESYTH-------------KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGL 71 (226)
T ss_pred eeecCCCCcceeEe-------------cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeee
Confidence 46899999999973 23357888876532 3355788999998885433 4677777777788899
Q ss_pred EEEecCCCC-HHHHH--------------hh-----cCC---CCCHHHHH-HHHH----------HHHH-HHHHHHhc-C
Q 011851 205 VYEFMPRGS-LENHL--------------FR-----RSL---PLPWSIRM-KIAL----------DAAK-GLAFLHEE-A 248 (476)
Q Consensus 205 V~E~~~~g~-L~~~l--------------~~-----~~~---~l~~~~~~-~i~~----------qi~~-al~~lH~~-~ 248 (476)
|||+++|.. +...+ .+ ... ........ .+.. .+.. ...+|... .
T Consensus 72 v~e~i~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~ 151 (226)
T TIGR02172 72 IYELIVGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPD 151 (226)
T ss_pred eeeecCCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCC
Confidence 999998863 21111 00 000 01111100 0000 0111 12222211 1
Q ss_pred CCCeEecCCCCCCeeecCCCceEEeecCCcCC
Q 011851 249 EKPVIYRDFKTSNILLDGEYNAKLSDFGLAKD 280 (476)
Q Consensus 249 ~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~ 280 (476)
...++|+|+.|.||++++++ +.|+||+.+..
T Consensus 152 ~~~~~HgD~~~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 152 TSTCLHGDFQIGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred CCceEecCCCCCcEEEcCCC-cEEEechhcCc
Confidence 23478999999999999888 99999998864
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.59 E-value=6.5e-07 Score=82.11 Aligned_cols=137 Identities=19% Similarity=0.131 Sum_probs=98.5
Q ss_pred ccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCC---C---ccCHHHHHHHHHHHhCCCCC--ceeeEEEEEE-e-
Q 011851 129 LGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHD---G---LQGHKEWLAEVNYLGGLIHP--NLVKLIGCCI-E- 198 (476)
Q Consensus 129 LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~---~---~~~~~~~~~E~~~l~~l~hp--nIv~l~~~~~-~- 198 (476)
-|+||.+-|++-... |+.+-+|..... . .-....|.+|+..|.+|..- .+.++. ++. .
T Consensus 26 ~~rgG~SgV~r~~~~-----------g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k 93 (216)
T PRK09902 26 YRRNGMSGVQCVERN-----------GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVK 93 (216)
T ss_pred cCCCCcceEEEEEeC-----------CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeec
Confidence 467999999985443 334667765311 0 12456788999999888532 244444 322 1
Q ss_pred ---CCeeEEEEEecCC-CCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCc--eE
Q 011851 199 ---DDQRLLVYEFMPR-GSLENHLFRR-SLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYN--AK 271 (476)
Q Consensus 199 ---~~~~~lV~E~~~~-g~L~~~l~~~-~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~--vk 271 (476)
.-..+||+|-++| -+|.+++... -.+.+......++.+|+..|.-||+.+ +.|+|+-+.|||++.++. ++
T Consensus 94 ~~~~~rA~LVTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~ 170 (216)
T PRK09902 94 IEGEWRALLVTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAG 170 (216)
T ss_pred cCCceEEEEEEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEE
Confidence 1236899998854 4888887543 235677888899999999999999998 999999999999986667 99
Q ss_pred EeecCCcCC
Q 011851 272 LSDFGLAKD 280 (476)
Q Consensus 272 l~DFG~a~~ 280 (476)
++||--++.
T Consensus 171 lIDlEk~r~ 179 (216)
T PRK09902 171 FLDLEKSRR 179 (216)
T ss_pred EEEhhccch
Confidence 999977654
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.52 E-value=1.2e-06 Score=80.64 Aligned_cols=138 Identities=11% Similarity=0.055 Sum_probs=88.9
Q ss_pred hccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHH---------HHHHHHHhCCC---C
Q 011851 119 ATKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEW---------LAEVNYLGGLI---H 186 (476)
Q Consensus 119 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~---------~~E~~~l~~l~---h 186 (476)
..++|.+.+++-......|.+-.. .|..+++|..+.......+.| .+++..+.++. -
T Consensus 29 ~~~~~~~~kv~k~~~r~~ValIei-----------~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~ 97 (229)
T PF06176_consen 29 LDNNYKIIKVFKNTKRNYVALIEI-----------DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGF 97 (229)
T ss_pred HhCCceEEEeecCCCccEEEEEEE-----------CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCc
Confidence 346788888887777666665332 467799999876543322222 23333333332 2
Q ss_pred CceeeEEEEEE-----eCCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCC
Q 011851 187 PNLVKLIGCCI-----EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSN 261 (476)
Q Consensus 187 pnIv~l~~~~~-----~~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~N 261 (476)
-.++.++-+.+ .....+|||||++|..|.+... +++ .+...|.+++.-||..| ++|+|+.|.|
T Consensus 98 ~~~~~~yl~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~-----i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgN 165 (229)
T PF06176_consen 98 TEPADPYLAAEKKIFRYTSSYVLLMEYIEGVELNDIED-----IDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGN 165 (229)
T ss_pred cccccceeeeeeeeccceeEEEEEEEEecCeecccchh-----cCH----HHHHHHHHHHHHHHHcC---CccCCCCcCc
Confidence 22223222222 2234568999999988866441 222 24456778899999999 9999999999
Q ss_pred eeecCCCceEEeecCCcCC
Q 011851 262 ILLDGEYNAKLSDFGLAKD 280 (476)
Q Consensus 262 ILl~~~~~vkl~DFG~a~~ 280 (476)
+++++++ ++++||+..+.
T Consensus 166 Flv~~~~-i~iID~~~k~~ 183 (229)
T PF06176_consen 166 FLVSNNG-IRIIDTQGKRM 183 (229)
T ss_pred EEEECCc-EEEEECccccc
Confidence 9998654 99999987654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.45 E-value=1.3e-06 Score=81.41 Aligned_cols=152 Identities=20% Similarity=0.167 Sum_probs=101.1
Q ss_pred cChhHHHHhccCCCcccc---ccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCcc------------------
Q 011851 111 FSFNELKSATKSFRPECL---LGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQ------------------ 169 (476)
Q Consensus 111 ~~~~~~~~~~~~y~~~~~---LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~------------------ 169 (476)
.+...+....++..+... |.+|.-+.||+|.. ..+..+|+|+.+.....
T Consensus 35 ~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~----------~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~ 104 (268)
T COG1718 35 RTLETLRRLLSRGVITELVGCISTGKEANVYLAET----------GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSR 104 (268)
T ss_pred HHHHHHHHHhcCCceeeeEeeecCCcceEEEeecc----------CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCC
Confidence 345555556666666555 55677778999854 35778999998743221
Q ss_pred -CHH-----HHHHHHHHHhCCC--CCceeeEEEEEEeCCeeEEEEEecCCCCHH-HHHhhcCCCCCHHHHHHHHHHHHHH
Q 011851 170 -GHK-----EWLAEVNYLGGLI--HPNLVKLIGCCIEDDQRLLVYEFMPRGSLE-NHLFRRSLPLPWSIRMKIALDAAKG 240 (476)
Q Consensus 170 -~~~-----~~~~E~~~l~~l~--hpnIv~l~~~~~~~~~~~lV~E~~~~g~L~-~~l~~~~~~l~~~~~~~i~~qi~~a 240 (476)
..+ ....|+..|+++. +-.+.+-+.+. +..|||||+....+- -.| ...++...+...+..++++.
T Consensus 105 ~~rr~lv~~W~~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~L--kDv~~e~~e~~~~~~~~v~~ 178 (268)
T COG1718 105 SNRRKLVFAWARKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRL--KDVPLELEEAEGLYEDVVEY 178 (268)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCc--ccCCcCchhHHHHHHHHHHH
Confidence 111 1245888888774 44455556543 347999999543110 011 12233444677778888888
Q ss_pred HHHHHh-cCCCCeEecCCCCCCeeecCCCceEEeecCCcCCCC
Q 011851 241 LAFLHE-EAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGP 282 (476)
Q Consensus 241 l~~lH~-~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~ 282 (476)
+.-|-. .+ +||+||..-|||+. ++.+.|+|||.|....
T Consensus 179 ~~~l~~~a~---LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~ 217 (268)
T COG1718 179 MRRLYKEAG---LVHGDLSEYNILVH-DGEPYIIDVSQAVTID 217 (268)
T ss_pred HHHHHHhcC---cccccchhhheEEE-CCeEEEEECccccccC
Confidence 888877 55 99999999999999 8899999999997654
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.42 E-value=3.4e-06 Score=80.32 Aligned_cols=138 Identities=19% Similarity=0.083 Sum_probs=81.8
Q ss_pred ccccCC-ccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCCC-CCceeeEEEEEEeCCeeEEEE
Q 011851 129 LGEGGF-GCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLI-HPNLVKLIGCCIEDDQRLLVY 206 (476)
Q Consensus 129 LG~G~f-g~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~~lV~ 206 (476)
|-.|.. ..||+... .+..+.+|+..... ...+.+|+++++.+. +--+.+++++...++..++||
T Consensus 6 ~~~g~~~~~v~~~~~-----------~~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~ 71 (244)
T cd05150 6 VTEGQSGATVYRLDG-----------KNPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLT 71 (244)
T ss_pred cCCCCCcCeEEEEcC-----------CCCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEE
Confidence 444555 78898532 23468888876543 234567888888773 344667788777767789999
Q ss_pred EecCCCCHHHHHh-------------------hc---CCCCCHH--HHHHHHH--------------------HHHHHHH
Q 011851 207 EFMPRGSLENHLF-------------------RR---SLPLPWS--IRMKIAL--------------------DAAKGLA 242 (476)
Q Consensus 207 E~~~~g~L~~~l~-------------------~~---~~~l~~~--~~~~i~~--------------------qi~~al~ 242 (476)
|+++|.+|..... .- ..++... ....... .+...+.
T Consensus 72 e~i~G~~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 151 (244)
T cd05150 72 SAVPGVPAAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYA 151 (244)
T ss_pred EeeCCccHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHH
Confidence 9999987764320 00 0011100 0000000 0111112
Q ss_pred HHHhc----CCCCeEecCCCCCCeeecCCCceEEeecCCcCC
Q 011851 243 FLHEE----AEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKD 280 (476)
Q Consensus 243 ~lH~~----~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~ 280 (476)
.|-.. ....++|+|+.|.|||+++++.+.|+||+.+..
T Consensus 152 ~l~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~ 193 (244)
T cd05150 152 ELEATRPAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV 193 (244)
T ss_pred HHHhhCCCcCceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence 22110 123389999999999999887788999998754
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.37 E-value=2.2e-06 Score=89.16 Aligned_cols=140 Identities=16% Similarity=0.092 Sum_probs=87.8
Q ss_pred ccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccC-------------------------------HHH--
Q 011851 127 CLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQG-------------------------------HKE-- 173 (476)
Q Consensus 127 ~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~-------------------------------~~~-- 173 (476)
+.||.-+.|.||+|+.+ .|+.||||+.+..-... .+.
T Consensus 167 ~piaaASlaQVhrA~L~----------~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~ 236 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLK----------NGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLP 236 (538)
T ss_pred chhhhcchhheEEEEec----------CCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhH
Confidence 67999999999999876 48889999976421110 011
Q ss_pred ----HHHHHHHHh----CCCCCc------eeeEEEEEEeCCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHH
Q 011851 174 ----WLAEVNYLG----GLIHPN------LVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAK 239 (476)
Q Consensus 174 ----~~~E~~~l~----~l~hpn------Iv~l~~~~~~~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~ 239 (476)
|..|.+... .+.|-+ |.++|- .-.....|+||||+|..+.|.-.-....++...+...+.+...
T Consensus 237 ~ELDF~~EA~Nae~~~~~f~~~~~~~~V~VP~Vy~--~~st~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~~~l~~~~~ 314 (538)
T KOG1235|consen 237 QELDFTKEAKNAERFRENFKDFSLLTYVLVPKVYW--DLSTKRVLTMEYVDGIKINDLDAIDKRGISPHDILNKLVEAYL 314 (538)
T ss_pred hhcchHHHHHhHHHHHHHHHhcccccceeCCeehh--hcCcceEEEEEecCCccCCCHHHHHHcCCCHHHHHHHHHHHHH
Confidence 223333222 223444 334432 2234678999999998776654333334555544433333332
Q ss_pred HHHHHHhcCCCCeEecCCCCCCeeec----CCCceEEeecCCcCCCCC
Q 011851 240 GLAFLHEEAEKPVIYRDFKTSNILLD----GEYNAKLSDFGLAKDGPE 283 (476)
Q Consensus 240 al~~lH~~~~~~ivHrDlKp~NILl~----~~~~vkl~DFG~a~~~~~ 283 (476)
-+-+.| | ++|.|-.|.||+++ .++.+.+-|||+......
T Consensus 315 ~qIf~~--G---ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 315 EQIFKT--G---FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred HHHHhc--C---CccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 222233 3 99999999999998 367899999999887654
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.36 E-value=2.3e-06 Score=80.28 Aligned_cols=142 Identities=18% Similarity=0.116 Sum_probs=81.7
Q ss_pred cccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCCCCC--ceeeEEEEEEe---CC
Q 011851 126 ECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHP--NLVKLIGCCIE---DD 200 (476)
Q Consensus 126 ~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~hp--nIv~l~~~~~~---~~ 200 (476)
++.|+.|..+.||+.... + ..+++|+.... .....+..|..+++.|... .+.+++.+... ..
T Consensus 2 i~~l~~G~~n~~~~v~~~----------~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~ 68 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTD----------D-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNG 68 (239)
T ss_dssp EEEEEESSSSEEEEEEET----------T-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETS
T ss_pred CccCCCCCeeeEEEEEEC----------C-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccc
Confidence 357899999999986543 2 47999997654 3345677888888877432 35566664432 33
Q ss_pred eeEEEEEecCCCCHHH----------------HHh---hc---CCCCCHHHH---------HHH------------HHHH
Q 011851 201 QRLLVYEFMPRGSLEN----------------HLF---RR---SLPLPWSIR---------MKI------------ALDA 237 (476)
Q Consensus 201 ~~~lV~E~~~~g~L~~----------------~l~---~~---~~~l~~~~~---------~~i------------~~qi 237 (476)
..+++|++++|..+.. .+. .. ..++..... ... ...+
T Consensus 69 ~~~~~~~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 148 (239)
T PF01636_consen 69 FPYLLMEYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEEL 148 (239)
T ss_dssp EEEEEEEEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHH
T ss_pred cceEEEEEeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHH
Confidence 5789999999988877 110 11 111111110 000 1112
Q ss_pred HH-HHHHHHhc----CCCCeEecCCCCCCeeec-CCCceEEeecCCcCC
Q 011851 238 AK-GLAFLHEE----AEKPVIYRDFKTSNILLD-GEYNAKLSDFGLAKD 280 (476)
Q Consensus 238 ~~-al~~lH~~----~~~~ivHrDlKp~NILl~-~~~~vkl~DFG~a~~ 280 (476)
.. .+..++.. ....++|+|+.|.|||++ .++.+-|+||+.+..
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 149 EERLLQELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp HHHHHHHHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred HHHHHHHHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence 22 33444432 234499999999999999 666678999987743
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.29 E-value=5.4e-06 Score=73.18 Aligned_cols=130 Identities=18% Similarity=0.122 Sum_probs=89.0
Q ss_pred CCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCCCCCcee-eEEEEEEeCCe
Q 011851 123 FRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHPNLV-KLIGCCIEDDQ 201 (476)
Q Consensus 123 y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv-~l~~~~~~~~~ 201 (476)
-+..+.|++|.+|.||++.+. |..+|+|+-+.+.. ...+..|.++|..+.--++- ++|.|..
T Consensus 24 ~~v~~~L~KG~~s~Vyl~~~~-----------~~~~a~Kvrr~ds~--r~~l~kEakiLeil~g~~~~p~vy~yg~---- 86 (201)
T COG2112 24 LRVEKELAKGTTSVVYLGEWR-----------GGEVALKVRRRDSP--RRNLEKEAKILEILAGEGVTPEVYFYGE---- 86 (201)
T ss_pred hhhhhhhhcccccEEEEeecc-----------CceEEEEEecCCcc--hhhHHHHHHHHHHhhhcCCCceEEEech----
Confidence 345678999999999999774 55799999877643 46788899999988766653 5555533
Q ss_pred eEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCC-CCCeeecCCCceEEeecCCcCC
Q 011851 202 RLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFK-TSNILLDGEYNAKLSDFGLAKD 280 (476)
Q Consensus 202 ~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlK-p~NILl~~~~~vkl~DFG~a~~ 280 (476)
.++.|||+.|-.|.+.-... +-. -+..+++.---|-..| |-|..|. |..++|..++.+.|+||..|..
T Consensus 87 ~~i~me~i~G~~L~~~~~~~----~rk----~l~~vlE~a~~LD~~G---I~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 87 DFIRMEYIDGRPLGKLEIGG----DRK----HLLRVLEKAYKLDRLG---IEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred hhhhhhhhcCcchhhhhhcc----cHH----HHHHHHHHHHHHHHhc---cchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 34669999988887655321 122 2234444433344445 8888886 4444444455899999999874
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.23 E-value=2.1e-05 Score=71.70 Aligned_cols=125 Identities=27% Similarity=0.360 Sum_probs=89.1
Q ss_pred cCCCccccccccCC-ccEEEEEEccCCceeeeCCCCceEEEEEecCC---C-------cc-----------CHHHHHHHH
Q 011851 121 KSFRPECLLGEGGF-GCVYKGWINMNGTATVKPGTGLPVAVKTLNHD---G-------LQ-----------GHKEWLAEV 178 (476)
Q Consensus 121 ~~y~~~~~LG~G~f-g~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~---~-------~~-----------~~~~~~~E~ 178 (476)
.+++.++.||.|.- |.||++.. .|+.||+|+++.- . .. ...-|..|.
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I-----------~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~EC 105 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEI-----------DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCEC 105 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEE-----------CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHH
Confidence 57888999999999 99999876 4678999994321 0 00 012366788
Q ss_pred HHHhCCC---CCce--eeEEEEEEeCC------------------eeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHH
Q 011851 179 NYLGGLI---HPNL--VKLIGCCIEDD------------------QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 235 (476)
Q Consensus 179 ~~l~~l~---hpnI--v~l~~~~~~~~------------------~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~ 235 (476)
+...+|+ +.++ |+++||..-.. ...||.||++... .+ ...-+.
T Consensus 106 RAfgRLke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~----------~~----~~~~~~ 171 (207)
T PF13095_consen 106 RAFGRLKEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP----------PL----QIRDIP 171 (207)
T ss_pred HhhHHHHhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc----------cc----chhHHH
Confidence 8777774 4556 99999974321 1357888876543 12 223455
Q ss_pred HHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCc
Q 011851 236 DAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLA 278 (476)
Q Consensus 236 qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a 278 (476)
+|.+-|..+|..+ |+-+|+++.|.. +| ||+|||.+
T Consensus 172 ~~~~dl~~~~k~g---I~~~Dv~~~ny~---~G--~lvDfs~~ 206 (207)
T PF13095_consen 172 QMLRDLKILHKLG---IVPRDVKPRNYR---GG--KLVDFSSS 206 (207)
T ss_pred HHHHHHHHHHHCC---eeeccCcccccc---CC--EEEecccC
Confidence 7778888999988 999999999986 33 89999965
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.16 E-value=2.8e-05 Score=87.04 Aligned_cols=149 Identities=15% Similarity=0.170 Sum_probs=90.3
Q ss_pred cccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCc-cCHHHHHHHHHHHhCCC-CCce--eeEEEEEEeC--
Q 011851 126 ECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL-QGHKEWLAEVNYLGGLI-HPNL--VKLIGCCIED-- 199 (476)
Q Consensus 126 ~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~-~~~~~~~~E~~~l~~l~-hpnI--v~l~~~~~~~-- 199 (476)
.+.|+.|.+..+|+......+ ....+++|+...... .....+.+|+++|+.|. |.+| .+++.++.+.
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~-------~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v 115 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGG-------SVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASV 115 (822)
T ss_pred EEEeCCCCcCceEEEEECCCC-------cceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCc
Confidence 467899999999986543210 113577887654322 23356789999999995 6665 7778777654
Q ss_pred -CeeEEEEEecCCCCHHH--------------------HH---hhcC----------CCCC--HHHHHHHHH--------
Q 011851 200 -DQRLLVYEFMPRGSLEN--------------------HL---FRRS----------LPLP--WSIRMKIAL-------- 235 (476)
Q Consensus 200 -~~~~lV~E~~~~g~L~~--------------------~l---~~~~----------~~l~--~~~~~~i~~-------- 235 (476)
+..|+||||++|..+.+ .| +.-. .+.. ..++..+..
T Consensus 116 ~G~~flVME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~ 195 (822)
T PLN02876 116 IGTAFYIMEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGE 195 (822)
T ss_pred CCCceEEEEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcc
Confidence 46799999998864321 11 1100 0001 111211111
Q ss_pred -------HHHHHHHHHHhcCC--------CCeEecCCCCCCeeecCC-Cc-eEEeecCCcCCC
Q 011851 236 -------DAAKGLAFLHEEAE--------KPVIYRDFKTSNILLDGE-YN-AKLSDFGLAKDG 281 (476)
Q Consensus 236 -------qi~~al~~lH~~~~--------~~ivHrDlKp~NILl~~~-~~-vkl~DFG~a~~~ 281 (476)
.+...+.+|..+-. ..+||+|+++.|||++.+ +. +-|.||.++...
T Consensus 196 ~~~~~~~~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~G 258 (822)
T PLN02876 196 GKPPRNPKMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTLG 258 (822)
T ss_pred cCCCCChhHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeeccccC
Confidence 12334566644322 239999999999999753 33 579999987653
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.15 E-value=4e-05 Score=70.26 Aligned_cols=128 Identities=20% Similarity=0.223 Sum_probs=88.7
Q ss_pred cccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCC----------------ccCHHHHHHHHHHHhCCC----
Q 011851 126 ECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDG----------------LQGHKEWLAEVNYLGGLI---- 185 (476)
Q Consensus 126 ~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~----------------~~~~~~~~~E~~~l~~l~---- 185 (476)
...||+|+.-.||.- + ......||++.... ....++..+|+.....+.
T Consensus 6 ~~~i~~G~~R~cy~H-----------P-~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~ 73 (199)
T PF10707_consen 6 SDLIAQGGERDCYQH-----------P-DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRG 73 (199)
T ss_pred CcccccCCCceEEEC-----------C-CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccC
Confidence 357999999999962 1 22336688887665 122345566666555554
Q ss_pred --CCceeeEEEEEEeCCeeEEEEEecCC------CCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCC
Q 011851 186 --HPNLVKLIGCCIEDDQRLLVYEFMPR------GSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDF 257 (476)
Q Consensus 186 --hpnIv~l~~~~~~~~~~~lV~E~~~~------g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDl 257 (476)
+.+|.+++|+.+++-..-+|+|.+.+ .+|.+++... .++. ... ..+-+-..||-+++ |+.+||
T Consensus 74 ~~~~~i~r~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~--~~~~-~~~---~~L~~f~~~l~~~~---Iv~~dl 144 (199)
T PF10707_consen 74 VDWSHIPRFYGFVETNLGLGLVVELIRDADGNISPTLEDYLKEG--GLTE-ELR---QALDEFKRYLLDHH---IVIRDL 144 (199)
T ss_pred CcccccccEeEEEecCCceEEEEEEEECCCCCcCccHHHHHHcC--CccH-HHH---HHHHHHHHHHHHcC---CeecCC
Confidence 78899999999999999999998643 2788888433 3555 333 33344556677766 999999
Q ss_pred CCCCeeecCC--C--ceEEee
Q 011851 258 KTSNILLDGE--Y--NAKLSD 274 (476)
Q Consensus 258 Kp~NILl~~~--~--~vkl~D 274 (476)
+|.||++... + .+.|+|
T Consensus 145 ~~~NIv~~~~~~~~~~lvlID 165 (199)
T PF10707_consen 145 NPHNIVVQRRDSGEFRLVLID 165 (199)
T ss_pred CcccEEEEecCCCceEEEEEe
Confidence 9999999432 2 577887
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=98.13 E-value=1.8e-05 Score=75.02 Aligned_cols=73 Identities=15% Similarity=0.153 Sum_probs=44.8
Q ss_pred ccccccCCc-cEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCCCCC---ceeeEEEEEEeC---
Q 011851 127 CLLGEGGFG-CVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHP---NLVKLIGCCIED--- 199 (476)
Q Consensus 127 ~~LG~G~fg-~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~hp---nIv~l~~~~~~~--- 199 (476)
+.|+.|+.. .||+. +..+++|+.+... ....+.+|.++|..|... -+.++++.....
T Consensus 3 ~~~~~gG~~n~vy~~--------------~~~~VlR~~~~~~--~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~ 66 (235)
T cd05155 3 EPVDSGGTDNATFRL--------------GDDMSVRLPSAAG--YAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGY 66 (235)
T ss_pred eeccCCCcccceEEc--------------CCceEEEcCCccc--hHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCC
Confidence 457777776 48873 1237788765422 234678899988877521 234444433322
Q ss_pred CeeEEEEEecCCCCHH
Q 011851 200 DQRLLVYEFMPRGSLE 215 (476)
Q Consensus 200 ~~~~lV~E~~~~g~L~ 215 (476)
...|+|||+++|.++.
T Consensus 67 ~~~~~l~~~i~G~~l~ 82 (235)
T cd05155 67 PWPWSVYRWLEGETAT 82 (235)
T ss_pred CcceEEEEeecCCCCC
Confidence 2358999999997664
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.12 E-value=7.5e-06 Score=90.15 Aligned_cols=194 Identities=21% Similarity=0.257 Sum_probs=138.9
Q ss_pred HHHHHHHhCCCCCceeeEEEEEEeCCe----eEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCC
Q 011851 175 LAEVNYLGGLIHPNLVKLIGCCIEDDQ----RLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEK 250 (476)
Q Consensus 175 ~~E~~~l~~l~hpnIv~l~~~~~~~~~----~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~ 250 (476)
..|++.+.++.|+|++.++.|-.+... ..+..|+|..-++...+. .-..++....+.+..++.+||.|+|+..
T Consensus 230 E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q-~v~~i~~~~~r~~~~~~~~GL~~~h~~~-- 306 (1351)
T KOG1035|consen 230 EIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQ-SVGSIPLETLRILHQKLLEGLAYLHSLS-- 306 (1351)
T ss_pred HHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHh-hccccCHHHHHHHHHHHhhhHHHHHHhc--
Confidence 457778889999999999998766433 234567888888888774 4457888999999999999999999976
Q ss_pred CeEecCCCCC---CeeecCCCceEEe--ecCCcCCCCCCCccceeeeeecCCCCCCcchhhcCCCCcc--chhhhhHHHH
Q 011851 251 PVIYRDFKTS---NILLDGEYNAKLS--DFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAK--SDVYSFGVVL 323 (476)
Q Consensus 251 ~ivHrDlKp~---NILl~~~~~vkl~--DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~--~DiwslGv~l 323 (476)
..|.-|... +...+.++.+.++ ||+..+......... ...-+..+.++|......+..+ .|+|.+|.++
T Consensus 307 -l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~---~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~ 382 (1351)
T KOG1035|consen 307 -LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSF---SDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLL 382 (1351)
T ss_pred -cceeEEecccccccccCccceeecchhhhcccccCCCcccch---hhcCccccccccccccccchhhhhhHHHHHHHHH
Confidence 555555444 4455667777777 999988765543321 1234556788887777666554 7999999999
Q ss_pred HHHHhCCCCCCCCCCCCcchhHHhhhhhhccccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011851 324 LEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEA 402 (476)
Q Consensus 324 ~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~ 402 (476)
..+..|..+-...... ..+++ ........++..+|+..++++|+++.+++.+
T Consensus 383 ~~~~~~~~i~~~~~~~-------------------~~~l~--------~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~ 434 (1351)
T KOG1035|consen 383 LQLSQGEDISEKSAVP-------------------VSLLD--------VLSTSELLDALPKCLDEDSEERLSALELLTH 434 (1351)
T ss_pred hhhhhcCcccccccch-------------------hhhhc--------cccchhhhhhhhhhcchhhhhccchhhhhhc
Confidence 9999887553221110 00000 0001156688999999999999999999997
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.07 E-value=1.7e-05 Score=72.39 Aligned_cols=101 Identities=28% Similarity=0.281 Sum_probs=80.4
Q ss_pred HHHHHHhCCCC-CceeeEEEEEEeCCeeEEEEEecCCCCHHHHH--hhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCe
Q 011851 176 AEVNYLGGLIH-PNLVKLIGCCIEDDQRLLVYEFMPRGSLENHL--FRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPV 252 (476)
Q Consensus 176 ~E~~~l~~l~h-pnIv~l~~~~~~~~~~~lV~E~~~~g~L~~~l--~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i 252 (476)
.|.-+|+.+.+ +++.+++|+|- .++|.||...+++.... ...-...+|..+.+|+.++++.++++++.-...+
T Consensus 8 ~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~ 83 (188)
T PF12260_consen 8 NEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGFF 83 (188)
T ss_pred cHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCcE
Confidence 47888888876 69999999982 36789999877664210 0112246899999999999999999998554448
Q ss_pred EecCCCCCCeeecCCCceEEeecCCcCC
Q 011851 253 IYRDFKTSNILLDGEYNAKLSDFGLAKD 280 (476)
Q Consensus 253 vHrDlKp~NILl~~~~~vkl~DFG~a~~ 280 (476)
.-.|++++|+-+++++++|++|...+..
T Consensus 84 ~lcDv~~~nfgv~~~~~lk~iDld~v~~ 111 (188)
T PF12260_consen 84 YLCDVSPDNFGVNDDGRLKLIDLDDVFV 111 (188)
T ss_pred EEeecchHHeEEeCCCcEEEEechhcch
Confidence 8899999999999999999999987654
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.91 E-value=0.00018 Score=70.74 Aligned_cols=76 Identities=12% Similarity=0.030 Sum_probs=52.9
Q ss_pred cccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCCCC---CceeeEEEEEEe---C
Q 011851 126 ECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIH---PNLVKLIGCCIE---D 199 (476)
Q Consensus 126 ~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~h---pnIv~l~~~~~~---~ 199 (476)
.+.||.|..+.||+.... .+ .+.+|..+.. .....+..|.+.|+.|.- -.+.++++++.. .
T Consensus 19 ~~~i~~G~~~~vy~~~~~----------~~-~~~~k~~~~~--~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~ 85 (297)
T PRK10593 19 VECISEQPYAALWALYDS----------QG-NPMPLMARSF--STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSP 85 (297)
T ss_pred eeecCCccceeEEEEEcC----------CC-CEEEEEeccc--ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcC
Confidence 456999999999985321 23 4677875431 122467789988887742 357788877654 3
Q ss_pred CeeEEEEEecCCCCH
Q 011851 200 DQRLLVYEFMPRGSL 214 (476)
Q Consensus 200 ~~~~lV~E~~~~g~L 214 (476)
+..+||||+++|.++
T Consensus 86 g~~~LVmE~i~G~~~ 100 (297)
T PRK10593 86 GPDVLLLERLRGVSV 100 (297)
T ss_pred CCeEEEEeccCCEec
Confidence 668999999998765
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.90 E-value=7e-05 Score=73.41 Aligned_cols=141 Identities=18% Similarity=0.109 Sum_probs=82.4
Q ss_pred cccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCCCCCc--eeeEEE------EEE
Q 011851 126 ECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHPN--LVKLIG------CCI 197 (476)
Q Consensus 126 ~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~hpn--Iv~l~~------~~~ 197 (476)
.+.|..|....+|+... .+..+++|+... .....+..|++++..|.+.+ +.+++. +..
T Consensus 19 i~~i~~G~~n~~y~v~~-----------~~~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~ 84 (296)
T cd05153 19 FEGISAGIENTNYFVTT-----------DSGRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSE 84 (296)
T ss_pred eecccCccccceEEEEe-----------CCCcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeee
Confidence 45677788889998532 233588998764 22345667777777774322 444433 123
Q ss_pred eCCeeEEEEEecCCCCHHH----HH----------hh--cC--------CCCCHHHHH----------HHHHHHHHHHHH
Q 011851 198 EDDQRLLVYEFMPRGSLEN----HL----------FR--RS--------LPLPWSIRM----------KIALDAAKGLAF 243 (476)
Q Consensus 198 ~~~~~~lV~E~~~~g~L~~----~l----------~~--~~--------~~l~~~~~~----------~i~~qi~~al~~ 243 (476)
.++..++|++|++|..+.. .+ +. .. ....|.... .....+..++.+
T Consensus 85 ~~~~~~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 164 (296)
T cd05153 85 LAGKPAALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELAR 164 (296)
T ss_pred eCCceEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHH
Confidence 3456789999999876532 11 11 00 001111110 011122334445
Q ss_pred HHhc----CCCCeEecCCCCCCeeecCCCceEEeecCCcCC
Q 011851 244 LHEE----AEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKD 280 (476)
Q Consensus 244 lH~~----~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~ 280 (476)
+... ....++|+|+.|.|||+++++.+.|+||+.+..
T Consensus 165 l~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 165 QDAFDPSDLPRGVIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred HHhhhhhcCCCcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 4431 123499999999999999887778999998754
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.89 E-value=0.00014 Score=68.74 Aligned_cols=75 Identities=19% Similarity=0.080 Sum_probs=45.0
Q ss_pred ccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCCCCCc-eeeEEEEEEeCCeeEEE
Q 011851 127 CLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHPN-LVKLIGCCIEDDQRLLV 205 (476)
Q Consensus 127 ~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~hpn-Iv~l~~~~~~~~~~~lV 205 (476)
+.|..|-...+|+..... ..+..|++|+....... .-...+|+.+++.+...+ ..+++..+. + .+|
T Consensus 4 ~~l~gG~tN~~~~v~~~~--------~~~~~~vlR~~~~~~~~-~~d~~~E~~~~~~l~~~gl~P~v~~~~~-~---~~l 70 (235)
T cd05157 4 KRFTGGITNKLVKVSNKE--------DNQDAVLVRVYGNKTEL-IIDRERELRIHKLLSKHGLAPKLYATFQ-N---GLI 70 (235)
T ss_pred EEcCCcccceEEEEEcCC--------CCCCeEEEEEccCCccc-eecHHHHHHHHHHHHhCCCCCeEEEEeC-C---cEE
Confidence 457778888999864221 02456889977543221 112346888888774333 344544332 2 489
Q ss_pred EEecCCCCH
Q 011851 206 YEFMPRGSL 214 (476)
Q Consensus 206 ~E~~~~g~L 214 (476)
|||++|.++
T Consensus 71 ~e~i~G~~l 79 (235)
T cd05157 71 YEFIPGRTL 79 (235)
T ss_pred EEeeCCCcC
Confidence 999998765
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.81 E-value=0.00014 Score=69.78 Aligned_cols=136 Identities=16% Similarity=0.110 Sum_probs=75.7
Q ss_pred ccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCCCCCce-eeEEEEEEeCCeeEEEEE
Q 011851 129 LGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHPNL-VKLIGCCIEDDQRLLVYE 207 (476)
Q Consensus 129 LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~hpnI-v~l~~~~~~~~~~~lV~E 207 (476)
+..|-...+|+.. .++..+++|+.......-.-...+|..+++.+..-.+ .+++... . -++|||
T Consensus 4 ~~~G~tn~~y~~~-----------~~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~--~--~~~v~e 68 (256)
T TIGR02721 4 LSGGLTNRSWRIE-----------HPGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN--E--HWLLVE 68 (256)
T ss_pred CCCcCcCCeEEEE-----------eCCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe--C--CEEEEE
Confidence 4567788899753 2455688887654322210124578888888754333 3344332 2 378999
Q ss_pred ecCCCCHHHH----------H-------hhc---CCCCCHHH-HHHHHHHH---------HHHHHHHHhc-----CCCCe
Q 011851 208 FMPRGSLENH----------L-------FRR---SLPLPWSI-RMKIALDA---------AKGLAFLHEE-----AEKPV 252 (476)
Q Consensus 208 ~~~~g~L~~~----------l-------~~~---~~~l~~~~-~~~i~~qi---------~~al~~lH~~-----~~~~i 252 (476)
|++|..+... + +.. ..+++... ...+..++ ...+..+-.. ....+
T Consensus 69 ~i~G~~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 148 (256)
T TIGR02721 69 WLEGEVITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAP 148 (256)
T ss_pred eccCcccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCee
Confidence 9998765321 1 111 11122211 11111111 1112222211 01238
Q ss_pred EecCCCCCCeeecCCCceEEeecCCcCC
Q 011851 253 IYRDFKTSNILLDGEYNAKLSDFGLAKD 280 (476)
Q Consensus 253 vHrDlKp~NILl~~~~~vkl~DFG~a~~ 280 (476)
+|+|+.|.|||+++++ +.|+||..+..
T Consensus 149 ~H~Dl~~~Nil~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 149 LHMDVHAYNLVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred ecCCCCcCcEEEeCCC-CEEEeccccCc
Confidence 9999999999999877 78999998865
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.71 E-value=4.6e-06 Score=93.58 Aligned_cols=174 Identities=14% Similarity=0.020 Sum_probs=125.1
Q ss_pred EEEEEecCCCccCHHH-----HHHHHHHHhCCCCCceeeEEEEEE--eCCeeEEEEEecCCCCHHHHHhhc---CCCCCH
Q 011851 158 VAVKTLNHDGLQGHKE-----WLAEVNYLGGLIHPNLVKLIGCCI--EDDQRLLVYEFMPRGSLENHLFRR---SLPLPW 227 (476)
Q Consensus 158 vAiK~~~~~~~~~~~~-----~~~E~~~l~~l~hpnIv~l~~~~~--~~~~~~lV~E~~~~g~L~~~l~~~---~~~l~~ 227 (476)
+-+|+.+..+.+..-+ .+.|.+.++...|+++...+.-.. +....|.+++|+.+|.+++.|.+. ..++..
T Consensus 1255 Fk~~I~ke~d~e~LsePlkemll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~ 1334 (2724)
T KOG1826|consen 1255 FKFSIYKEYDFENLSEPLKEMLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDR 1334 (2724)
T ss_pred eEEEeehhhhHHHHhhHHHHhhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchh
Confidence 4456655444433222 334555666678999887765543 344678999999999999999763 334444
Q ss_pred HHHHHHHHHHHHHHHHHHhcCC--CCeEecCCCCCCeeecCCCceEEeecCCcCCCCCCCccceeeeeecCCCCCCcchh
Q 011851 228 SIRMKIALDAAKGLAFLHEEAE--KPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYV 305 (476)
Q Consensus 228 ~~~~~i~~qi~~al~~lH~~~~--~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~ 305 (476)
..+.....+.+.+..-+|...+ .-.+|++||+-|.+|..+..+|++++|+.+.... .........+++.|++|++.
T Consensus 1335 ~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp--~~sf~Gl~l~sp~~v~qli~ 1412 (2724)
T KOG1826|consen 1335 SPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNP--VLSFFGLELCSPIYVLQLIK 1412 (2724)
T ss_pred chHHHHHHHHHhccchhhhcccCCccchhhhhhhhccceecCCcccccccccccccCc--hHhhhhhhhCCHHHHHHHHH
Confidence 4444444454777777777643 2379999999999999999999999999984322 11122335688899999988
Q ss_pred hcCCCCccchhhhhHHHHHHHHhCCCCC
Q 011851 306 MTGHLTAKSDVYSFGVVLLEMLTGRRSM 333 (476)
Q Consensus 306 ~~~~~~~~~DiwslGv~l~elltG~~pf 333 (476)
..-.++.++|+|..|+.+|++.-|..+|
T Consensus 1413 N~ik~t~rsdilr~s~~ly~rs~~n~~f 1440 (2724)
T KOG1826|consen 1413 NEIKFTKRSDILRRSLSLYLRSDGNAYF 1440 (2724)
T ss_pred HHHhhhhHHHHHHHHHHHHHHhcccHHH
Confidence 8888898999999999999999888776
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.70 E-value=0.00062 Score=69.15 Aligned_cols=75 Identities=16% Similarity=0.075 Sum_probs=51.5
Q ss_pred ccccccCCccEEEEEEccCCceeeeCCCC-ceEEEEEecCC------C-ccCHHHHHHHHHHHhCCC---CCceeeEEEE
Q 011851 127 CLLGEGGFGCVYKGWINMNGTATVKPGTG-LPVAVKTLNHD------G-LQGHKEWLAEVNYLGGLI---HPNLVKLIGC 195 (476)
Q Consensus 127 ~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g-~~vAiK~~~~~------~-~~~~~~~~~E~~~l~~l~---hpnIv~l~~~ 195 (476)
+.||.|.+..||+..+. .| +.|+||.-... . .....+...|.+.|..+. -.++.+++.+
T Consensus 32 ~elggGn~N~VyrV~~~----------~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~ 101 (401)
T PRK09550 32 REIGDGNLNLVFRVSDT----------EGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY 101 (401)
T ss_pred eEcCCCceEEEEEEEeC----------CCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE
Confidence 56899999999997653 23 46889975311 1 123456677888888763 3457777766
Q ss_pred EEeCCeeEEEEEecCCCC
Q 011851 196 CIEDDQRLLVYEFMPRGS 213 (476)
Q Consensus 196 ~~~~~~~~lV~E~~~~g~ 213 (476)
+.+..++||||+++..
T Consensus 102 --D~~~~~lVME~L~~~~ 117 (401)
T PRK09550 102 --DEELAVTVMEDLSDHK 117 (401)
T ss_pred --CCCCCEEEEecCCCcc
Confidence 4466789999998743
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.64 E-value=0.0018 Score=64.21 Aligned_cols=31 Identities=29% Similarity=0.444 Sum_probs=26.5
Q ss_pred CCeEecCCCCCCeeecCCCceEEeecCCcCC
Q 011851 250 KPVIYRDFKTSNILLDGEYNAKLSDFGLAKD 280 (476)
Q Consensus 250 ~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~ 280 (476)
.++||+|+.+.|||++++...-|+||+.+..
T Consensus 187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 187 RGVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred cccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 4599999999999999765568999998864
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.62 E-value=0.00041 Score=68.24 Aligned_cols=146 Identities=24% Similarity=0.246 Sum_probs=81.5
Q ss_pred ccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCCCCCce-eeEEEEEEeCCeeEEE
Q 011851 127 CLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHPNL-VKLIGCCIEDDQRLLV 205 (476)
Q Consensus 127 ~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~hpnI-v~l~~~~~~~~~~~lV 205 (476)
+.|..|--..||+....... ..+.+++.|++|+..... .......+|.+++..+...++ .+++.++. + .+|
T Consensus 4 ~~l~gGltN~~y~v~~~~~~---~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~-~---~~v 75 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDED---ALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFP-N---GRI 75 (302)
T ss_pred EEecCcccceeEEEEcCCcc---cccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeC-C---Cch
Confidence 34556666788886532210 022346789999976543 222344578877777753333 35555443 2 368
Q ss_pred EEecCCCCHHHHH-----------------hhcCCC--------CC--HHHHHH--------------------------
Q 011851 206 YEFMPRGSLENHL-----------------FRRSLP--------LP--WSIRMK-------------------------- 232 (476)
Q Consensus 206 ~E~~~~g~L~~~l-----------------~~~~~~--------l~--~~~~~~-------------------------- 232 (476)
+||++|..+.... +..... .+ +.....
T Consensus 76 ~e~i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (302)
T cd05156 76 EEFIPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSL 155 (302)
T ss_pred hheeCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHH
Confidence 9999887664310 111100 00 111111
Q ss_pred HHHHHHHHHHHHHh------cCCCCeEecCCCCCCeeecCC----CceEEeecCCcCC
Q 011851 233 IALDAAKGLAFLHE------EAEKPVIYRDFKTSNILLDGE----YNAKLSDFGLAKD 280 (476)
Q Consensus 233 i~~qi~~al~~lH~------~~~~~ivHrDlKp~NILl~~~----~~vkl~DFG~a~~ 280 (476)
+...+...+.+|-. .....++|+|+.+.|||++++ +.+.|+||..|..
T Consensus 156 ~~~~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~ 213 (302)
T cd05156 156 FLEDEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASY 213 (302)
T ss_pred HHHHHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCC
Confidence 11122223334432 123458999999999999875 8899999998854
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.58 E-value=0.00072 Score=66.73 Aligned_cols=142 Identities=18% Similarity=0.181 Sum_probs=80.3
Q ss_pred cccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCCCCC--ceeeEEEE------EE
Q 011851 126 ECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHP--NLVKLIGC------CI 197 (476)
Q Consensus 126 ~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~hp--nIv~l~~~------~~ 197 (476)
.+.++.|....+|+... .+| .+++|+.+... ...++..|++++..|... .+.+++.. ..
T Consensus 27 i~~~~~G~~n~~y~v~t----------~~~-~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~ 93 (307)
T TIGR00938 27 LKGIAEGVENSNYLLTT----------DVG-RYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLST 93 (307)
T ss_pred ccccCCccccceEEEEe----------CCC-cEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehh
Confidence 45677887789998532 123 47789875421 234455677777666422 23344331 12
Q ss_pred eCCeeEEEEEecCCCCHH----HH----------HhhcCCCC-----------CHHHHH------------HHHHHHHHH
Q 011851 198 EDDQRLLVYEFMPRGSLE----NH----------LFRRSLPL-----------PWSIRM------------KIALDAAKG 240 (476)
Q Consensus 198 ~~~~~~lV~E~~~~g~L~----~~----------l~~~~~~l-----------~~~~~~------------~i~~qi~~a 240 (476)
.++..++||||++|..+. +. ++.....+ .|.... .....+...
T Consensus 94 ~~g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~ 173 (307)
T TIGR00938 94 LAGKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKE 173 (307)
T ss_pred cCCeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHH
Confidence 345678999999885432 11 11100000 011000 011123334
Q ss_pred HHHHHh----cCCCCeEecCCCCCCeeecCCCceEEeecCCcCC
Q 011851 241 LAFLHE----EAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKD 280 (476)
Q Consensus 241 l~~lH~----~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~ 280 (476)
++++.. .....++|+|+.+.||+++.++.+.|+||+.+..
T Consensus 174 ~~~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~ 217 (307)
T TIGR00938 174 LDYLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFACT 217 (307)
T ss_pred HHHHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeecccccC
Confidence 555543 1234599999999999999887778999998754
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.18 E-value=0.0034 Score=63.03 Aligned_cols=144 Identities=16% Similarity=0.137 Sum_probs=79.9
Q ss_pred ccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCCCCCce-eeEEEEEEeCCeeEEE
Q 011851 127 CLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHPNL-VKLIGCCIEDDQRLLV 205 (476)
Q Consensus 127 ~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~hpnI-v~l~~~~~~~~~~~lV 205 (476)
..|-.|-.-.+|+....... ..+++.|++|+.......... ...|..+++.+..-++ .++++.+.. + .|
T Consensus 42 ~~l~gGlTN~~y~v~~~~~~-----~~~~~~~v~Ri~g~~t~~~id-R~~E~~~~~~l~~~gl~P~~~~~~~~-g---~v 111 (344)
T PLN02236 42 IPLKGAMTNEVFQIKWPTKE-----GNLGRKVLVRIYGEGVELFFD-RDDEIRTFECMSRHGQGPRLLGRFPN-G---RV 111 (344)
T ss_pred EEcCCcccceeEEEEeCCCC-----CCCCCeEEEEEccCCCCeeec-hHHHHHHHHHHHHcCCCCceEEEECC-c---eE
Confidence 34545778889986543211 123467999988654322222 2568888887754333 355555532 2 58
Q ss_pred EEecCCCCHHHH----------H-------hhcCC-----CCCHHHHHHHHHHH-----------------HHHHHHH--
Q 011851 206 YEFMPRGSLENH----------L-------FRRSL-----PLPWSIRMKIALDA-----------------AKGLAFL-- 244 (476)
Q Consensus 206 ~E~~~~g~L~~~----------l-------~~~~~-----~l~~~~~~~i~~qi-----------------~~al~~l-- 244 (476)
+||+++.+|... + +.... ...+.....+..++ ...+..|
T Consensus 112 ~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~ 191 (344)
T PLN02236 112 EEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEK 191 (344)
T ss_pred EEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHH
Confidence 999987766421 0 11110 11123333332221 1112222
Q ss_pred --Hh-cCCCCeEecCCCCCCeeecC-CCceEEeecCCcCC
Q 011851 245 --HE-EAEKPVIYRDFKTSNILLDG-EYNAKLSDFGLAKD 280 (476)
Q Consensus 245 --H~-~~~~~ivHrDlKp~NILl~~-~~~vkl~DFG~a~~ 280 (476)
.. .....++|+|+++.|||+++ ++.+.|+||..+..
T Consensus 192 ~~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 192 ELSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred HhcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 11 11234899999999999976 46899999988754
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.12 E-value=0.0028 Score=62.55 Aligned_cols=141 Identities=16% Similarity=0.115 Sum_probs=90.3
Q ss_pred ccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCc--------------------c-C-HH----HHHHHH
Q 011851 125 PECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL--------------------Q-G-HK----EWLAEV 178 (476)
Q Consensus 125 ~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~--------------------~-~-~~----~~~~E~ 178 (476)
+...|..|.-+.||.|... .|..+|||+.+..-. . . ++ ....|+
T Consensus 148 inGCiSTGKEANVYHat~~----------dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~ 217 (520)
T KOG2270|consen 148 INGCISTGKEANVYHATEE----------DGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEM 217 (520)
T ss_pred cccccccCccceeEeeecC----------CCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHH
Confidence 4456788999999987543 677899999763211 0 0 01 123588
Q ss_pred HHHhCCCCCceeeEEEEEEeCCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCC
Q 011851 179 NYLGGLIHPNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFK 258 (476)
Q Consensus 179 ~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlK 258 (476)
+-|.+|+...|.-.--+.. ....|||+|+.. +=+-.=.-....++...+..+-.|++.-+.-|.+... +||.||.
T Consensus 218 RNLkRl~~aGIP~PePIlL--k~hVLVM~FlGr-dgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~--LVHADLS 292 (520)
T KOG2270|consen 218 RNLKRLNNAGIPCPEPILL--KNHVLVMEFLGR-DGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCR--LVHADLS 292 (520)
T ss_pred HHHHHHHhcCCCCCCceee--ecceEeeeeccC-CCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhc--eeccchh
Confidence 8888876444321111111 134789999953 2221111133457777777777777777777766442 9999999
Q ss_pred CCCeeecCCCceEEeecCCcCCC
Q 011851 259 TSNILLDGEYNAKLSDFGLAKDG 281 (476)
Q Consensus 259 p~NILl~~~~~vkl~DFG~a~~~ 281 (476)
--|+|+- +|.+.|+|-+.+...
T Consensus 293 EfN~Lyh-dG~lyiIDVSQSVE~ 314 (520)
T KOG2270|consen 293 EFNLLYH-DGKLYIIDVSQSVEH 314 (520)
T ss_pred hhhheEE-CCEEEEEEccccccC
Confidence 9999986 678999999887654
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.10 E-value=0.00045 Score=66.91 Aligned_cols=135 Identities=16% Similarity=0.105 Sum_probs=90.9
Q ss_pred CCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCC-----------------ccC-----HHHHHHHHHH
Q 011851 123 FRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDG-----------------LQG-----HKEWLAEVNY 180 (476)
Q Consensus 123 y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~-----------------~~~-----~~~~~~E~~~ 180 (476)
+.+...||-|.-+.||.+-+. .|.+.++|+-+... ... +-...+|+..
T Consensus 94 ~svGnqIGVGKESDIY~v~d~----------~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfaf 163 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVADE----------EGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAF 163 (465)
T ss_pred hhhccccccccccceEEEecC----------CCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHH
Confidence 677889999999999987654 57778888633210 000 1123568888
Q ss_pred HhCCC-CC-ceeeEEEEEEeCCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCC
Q 011851 181 LGGLI-HP-NLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFK 258 (476)
Q Consensus 181 l~~l~-hp-nIv~l~~~~~~~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlK 258 (476)
|+.|. |- -|.+.+++ +..++|||++.|-.|...-.-. +. ..+...+..-+--|-.+| +||+|..
T Consensus 164 mkaL~e~gfpVPkpiD~----~RH~Vvmelv~g~Pl~~v~~v~----d~---~~ly~~lm~~Iv~la~~G---lIHgDFN 229 (465)
T KOG2268|consen 164 MKALYERGFPVPKPIDH----NRHCVVMELVDGYPLRQVRHVE----DP---PTLYDDLMGLIVRLANHG---LIHGDFN 229 (465)
T ss_pred HHHHHHcCCCCCCcccc----cceeeHHHhhcccceeeeeecC----Ch---HHHHHHHHHHHHHHHHcC---ceecccc
Confidence 88874 22 24444443 4668999999887775433111 22 233344444555666777 9999999
Q ss_pred CCCeeecCCCceEEeecCCcCCC
Q 011851 259 TSNILLDGEYNAKLSDFGLAKDG 281 (476)
Q Consensus 259 p~NILl~~~~~vkl~DFG~a~~~ 281 (476)
-=||++++++.++++||-.....
T Consensus 230 EFNimv~dd~~i~vIDFPQmvS~ 252 (465)
T KOG2268|consen 230 EFNIMVKDDDKIVVIDFPQMVST 252 (465)
T ss_pred hheeEEecCCCEEEeechHhhcc
Confidence 99999999999999999865543
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.02 E-value=0.0065 Score=59.00 Aligned_cols=31 Identities=29% Similarity=0.429 Sum_probs=26.0
Q ss_pred CeEecCCCCCCeeecCCCc-eEEeecCCcCCC
Q 011851 251 PVIYRDFKTSNILLDGEYN-AKLSDFGLAKDG 281 (476)
Q Consensus 251 ~ivHrDlKp~NILl~~~~~-vkl~DFG~a~~~ 281 (476)
.++|+|+.+.|||+++++. .-|+||+.+...
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~iG 217 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKVG 217 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhcccC
Confidence 3899999999999997565 469999998653
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.96 E-value=0.0081 Score=59.06 Aligned_cols=127 Identities=17% Similarity=0.221 Sum_probs=72.1
Q ss_pred CceEEEEEecC--CCccCHHHHHHHHHHHhCCCC--CceeeEEEEEEeCC--eeEEEEEecCCCCHHHHHhhc-------
Q 011851 155 GLPVAVKTLNH--DGLQGHKEWLAEVNYLGGLIH--PNLVKLIGCCIEDD--QRLLVYEFMPRGSLENHLFRR------- 221 (476)
Q Consensus 155 g~~vAiK~~~~--~~~~~~~~~~~E~~~l~~l~h--pnIv~l~~~~~~~~--~~~lV~E~~~~g~L~~~l~~~------- 221 (476)
++.++++ ... ..........+|+.+|+.+.- --+...+++|.++. ..|.||+|++|..+.+.+...
T Consensus 48 ~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~~~~~~~~~~~~~~ 126 (321)
T COG3173 48 GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVWSALPPESLGRQFA 126 (321)
T ss_pred CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceeccCcCCcccchHHHH
Confidence 6778888 331 222233455678888887643 22344556665554 669999999884322211000
Q ss_pred -----------------CCC-------CCHHHHHHHHH--------------HHHHHHHHHHhcC-----CCCeEecCCC
Q 011851 222 -----------------SLP-------LPWSIRMKIAL--------------DAAKGLAFLHEEA-----EKPVIYRDFK 258 (476)
Q Consensus 222 -----------------~~~-------l~~~~~~~i~~--------------qi~~al~~lH~~~-----~~~ivHrDlK 258 (476)
+.+ ....+...+.. ....-..+|+.+. ...++|+|+.
T Consensus 127 ~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~~p~~~~~~~lvHGD~~ 206 (321)
T COG3173 127 LDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEANRPPWAGPPVLVHGDYR 206 (321)
T ss_pred HHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhcCCCcCCCceeeeCCcc
Confidence 000 00001111111 1122344444432 2348999999
Q ss_pred CCCeeecCCCceEEeecCCcCCCC
Q 011851 259 TSNILLDGEYNAKLSDFGLAKDGP 282 (476)
Q Consensus 259 p~NILl~~~~~vkl~DFG~a~~~~ 282 (476)
+.||+|+.++-+=|.||+++....
T Consensus 207 ~gNlii~~~~~~gVlDwe~~~lGD 230 (321)
T COG3173 207 PGNLIIDPGRPTGVLDWELATLGD 230 (321)
T ss_pred cCCEEEeCCCeeEEEeccccccCC
Confidence 999999999889999999997653
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.80 E-value=0.0091 Score=58.18 Aligned_cols=73 Identities=23% Similarity=0.222 Sum_probs=44.7
Q ss_pred cccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCC---CCCceeeEEEEEEeCCee
Q 011851 126 ECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGL---IHPNLVKLIGCCIEDDQR 202 (476)
Q Consensus 126 ~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l---~hpnIv~l~~~~~~~~~~ 202 (476)
.+.|+-|....+|+.. .+++.+.||+-... ....+..|.+-|+.| .--.+.+++.+...++..
T Consensus 22 ~~~v~GG~i~~a~~~~-----------~~~~~~FvK~~~~~---~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~ 87 (288)
T PF03881_consen 22 IEPVSGGDINEAYRLD-----------TDGGSYFVKVNSES---GRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDA 87 (288)
T ss_dssp EEEE--SSSSEEEEEE-----------TTS-EEEEEEEEGG---GCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCC
T ss_pred eEecCCCChhheEEEE-----------CCCccEEEEecChh---hHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCc
Confidence 3568889999999753 35677999987632 223466777777766 345577889988888888
Q ss_pred EEEEEecCCC
Q 011851 203 LLVYEFMPRG 212 (476)
Q Consensus 203 ~lV~E~~~~g 212 (476)
||||||++.+
T Consensus 88 fLlle~l~~~ 97 (288)
T PF03881_consen 88 FLLLEFLEMG 97 (288)
T ss_dssp EEEEE-----
T ss_pred eEEEEeecCC
Confidence 9999999766
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.77 E-value=0.0012 Score=67.60 Aligned_cols=167 Identities=24% Similarity=0.294 Sum_probs=92.5
Q ss_pred HHHHHHHHHHHhCCCCCceeeEEEEEEeC-CeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCC
Q 011851 171 HKEWLAEVNYLGGLIHPNLVKLIGCCIED-DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAE 249 (476)
Q Consensus 171 ~~~~~~E~~~l~~l~hpnIv~l~~~~~~~-~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~ 249 (476)
..+++....+++.+.|+|....+++.... ....+|||++ +.+|++.+..+. +-.. ++. -|.
T Consensus 26 s~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~--l~~~-------s~~-----~~~--- 87 (725)
T KOG1093|consen 26 SIQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGN--LKDE-------SLL-----AHG--- 87 (725)
T ss_pred HHHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhcc--cchh-------hhc-----ccc---
Confidence 35667788899999999999999886643 3578899999 779999885543 1111 111 111
Q ss_pred CCeEecCCCCCCeeecCCCceEEeecCCcCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhC
Q 011851 250 KPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTG 329 (476)
Q Consensus 250 ~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG 329 (476)
+.|- |+ ++++| -++. + | | .+..+++|||++|.++.|+.-|
T Consensus 88 --~~~~-----~~-------~~~td-~~~t------~------------~--~-----~~~~pKsdVwsl~~i~~el~L~ 127 (725)
T KOG1093|consen 88 --VLHL-----NI-------IYITD-HFLT------K------------Y--P-----SPIGPKSDVWSLGFIILELYLG 127 (725)
T ss_pred --ccee-----hh-------hhccc-cccc------c------------C--C-----CCCCcchhhhhHHHHHHHHHHh
Confidence 3222 22 23333 0100 0 0 0 0111499999999999999998
Q ss_pred CCCCCCCCCCCcchhHHhhhhhhccccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 011851 330 RRSMDKNRPNGEHNLVEWARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVE 401 (476)
Q Consensus 330 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~ 401 (476)
..-+...........+............+ .....+.....+.+.++.++|+-..|..||...++.+
T Consensus 128 ~~l~~~~~~s~~l~~i~k~~~~d~~~~~~------a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k 193 (725)
T KOG1093|consen 128 ISLEAELTESEYLEILLKYYTDDQELLST------AMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELSK 193 (725)
T ss_pred hHHHHHHHHHHHHHHHHHhccCchhHHHH------HHHHHHHHhhhHhHHHHhccCCccccccccchhHHhc
Confidence 76654322211111110000000000000 0000111233567889999999999999987655544
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.77 E-value=0.018 Score=57.49 Aligned_cols=74 Identities=14% Similarity=0.065 Sum_probs=46.4
Q ss_pred cccccCCccEEEEEEccCCceeeeCCCCceEEEEEecC-------CCccCHHHHHHHHHHHhCCC--CC-ceeeEEEEEE
Q 011851 128 LLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNH-------DGLQGHKEWLAEVNYLGGLI--HP-NLVKLIGCCI 197 (476)
Q Consensus 128 ~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~-------~~~~~~~~~~~E~~~l~~l~--hp-nIv~l~~~~~ 197 (476)
.||.|....||++.+.. .+..|+||.-.. .-.-...+..-|.+.|+... .| .+.++|. .
T Consensus 2 EigdGnlN~VfrV~~~~---------g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~--~ 70 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQE---------GDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFH--F 70 (370)
T ss_pred cCCCCceEEEEEEEcCC---------CCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEE--E
Confidence 47999999999986431 224588886421 11223455667778877653 34 4555553 3
Q ss_pred eCCeeEEEEEecCCC
Q 011851 198 EDDQRLLVYEFMPRG 212 (476)
Q Consensus 198 ~~~~~~lV~E~~~~g 212 (476)
+.+...+|||+++..
T Consensus 71 D~e~~~~vMEdL~~~ 85 (370)
T TIGR01767 71 DTEMAVTVMEDLSHH 85 (370)
T ss_pred ccccceehHhhCccc
Confidence 555667999999653
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.72 E-value=0.0044 Score=61.98 Aligned_cols=60 Identities=18% Similarity=0.153 Sum_probs=42.5
Q ss_pred eEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeec
Q 011851 202 RLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLD 265 (476)
Q Consensus 202 ~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~ 265 (476)
..||-+|..|.++..++.... .+++...+++.--+.||.-+--.. +++|.|+.|.||++-
T Consensus 320 ~vl~E~~~~Gl~v~~~v~~~~--~pe~l~kkva~lg~~AllkMl~vD--NFvHaDlHPGNVlir 379 (565)
T KOG1236|consen 320 LVLVETYERGLSVLRFVKWKS--QPEALVKKVAKLGVNALLKMLIVD--NFVHADLHPGNVLIR 379 (565)
T ss_pred ceeeeeccccccHHhhhhccc--ChHHHHHHHHHHHHHHHHHHHHhh--cceecccCCCcEEEE
Confidence 456777888989988886554 455666666666566665443322 299999999999994
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.63 E-value=0.011 Score=58.28 Aligned_cols=75 Identities=20% Similarity=0.164 Sum_probs=57.0
Q ss_pred CCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCc
Q 011851 199 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLA 278 (476)
Q Consensus 199 ~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a 278 (476)
..+.|++|++- |+.|.- + ....++++..++++-+..+.-+... .+.-|||+.-.||||+ +|+|.|+||-++
T Consensus 298 ~~y~yl~~kdh-gt~is~-i----k~~~~~e~lsff~s~~sil~~lekk--f~fehrnlt~~niLId-~GnvtLIDfkls 368 (488)
T COG5072 298 TLYLYLHFKDH-GTPISI-I----KADRSEEELSFFWSCISILDILEKK--FPFEHRNLTLDNILID-EGNVTLIDFKLS 368 (488)
T ss_pred ceEEEEEEecC-Cceeee-e----ecccHHHHHHHHHHHHHHHhhhhhc--CCcccccccccceeee-cCceEEEEeeee
Confidence 34567888886 556532 2 1245788888888877777666653 4589999999999999 999999999999
Q ss_pred CCCC
Q 011851 279 KDGP 282 (476)
Q Consensus 279 ~~~~ 282 (476)
+...
T Consensus 369 Rl~~ 372 (488)
T COG5072 369 RLSY 372 (488)
T ss_pred eccc
Confidence 8543
|
|
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=96.59 E-value=0.074 Score=49.48 Aligned_cols=57 Identities=28% Similarity=0.353 Sum_probs=39.7
Q ss_pred ceEEEEEecCCCccCHHHHHHHHHHHhCC---CCCceeeEEEEEEeCCeeEEEEEecCCCCHH
Q 011851 156 LPVAVKTLNHDGLQGHKEWLAEVNYLGGL---IHPNLVKLIGCCIEDDQRLLVYEFMPRGSLE 215 (476)
Q Consensus 156 ~~vAiK~~~~~~~~~~~~~~~E~~~l~~l---~hpnIv~l~~~~~~~~~~~lV~E~~~~g~L~ 215 (476)
..|-+|+-.... ..-|..|+.-|..| +--+|.+++.+..+.++.||||||++-+.+.
T Consensus 40 ~~~FvK~n~~~~---~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~~~d 99 (286)
T COG3001 40 DPFFVKCNQREQ---LSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTGPLD 99 (286)
T ss_pred cceEEEecchhh---HHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCCCCC
Confidence 457788654322 23455666655554 4456788899989999999999999886554
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.57 E-value=0.044 Score=53.91 Aligned_cols=30 Identities=23% Similarity=0.326 Sum_probs=25.8
Q ss_pred CCeEecCCCCCCeeecCCCceEEeecCCcCC
Q 011851 250 KPVIYRDFKTSNILLDGEYNAKLSDFGLAKD 280 (476)
Q Consensus 250 ~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~ 280 (476)
..++|+|+.+.|||++. +.+.|+||+.+..
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~~ 216 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCTI 216 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECccccc
Confidence 44899999999999987 6789999997654
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.47 E-value=0.041 Score=55.97 Aligned_cols=80 Identities=13% Similarity=-0.007 Sum_probs=50.5
Q ss_pred cccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCc-------cCHHHHHHHHHHHhCCC---CCceeeEEEE
Q 011851 126 ECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL-------QGHKEWLAEVNYLGGLI---HPNLVKLIGC 195 (476)
Q Consensus 126 ~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~-------~~~~~~~~E~~~l~~l~---hpnIv~l~~~ 195 (476)
.+.||.|....||+.... +..|+||.-..... ....+...|.+.|+.+. ..++.++|.+
T Consensus 37 ~~eiggGn~N~VyrV~~~-----------~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ 105 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVSS-----------SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHF 105 (418)
T ss_pred EEEcCCCceeeEEEEEcC-----------CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEE
Confidence 457899999999985431 23488887541110 12344455677776553 3477888877
Q ss_pred EEeCCeeEEEEEecCC--CCHHHHH
Q 011851 196 CIEDDQRLLVYEFMPR--GSLENHL 218 (476)
Q Consensus 196 ~~~~~~~~lV~E~~~~--g~L~~~l 218 (476)
+. +..++||||+++ ..+.+.+
T Consensus 106 de--d~~vlvME~L~~~~~ilr~~L 128 (418)
T PLN02756 106 DR--TMALIGMRYLEPPHIILRKGL 128 (418)
T ss_pred CC--CCCEEEEeecCCcceehhhhh
Confidence 66 456889999977 3444443
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=96.41 E-value=0.0043 Score=57.60 Aligned_cols=29 Identities=31% Similarity=0.407 Sum_probs=20.6
Q ss_pred eEecCCCCCCeee-cCCCceEEeecCCcCC
Q 011851 252 VIYRDFKTSNILL-DGEYNAKLSDFGLAKD 280 (476)
Q Consensus 252 ivHrDlKp~NILl-~~~~~vkl~DFG~a~~ 280 (476)
++|.||.+.|||+ +.++.++|+||-.|..
T Consensus 145 ~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 145 FCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred EeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 7899999999999 8889999999988753
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.21 E-value=0.069 Score=52.71 Aligned_cols=31 Identities=16% Similarity=0.163 Sum_probs=28.1
Q ss_pred CCeEecCCCCCCeeecCCCceEEeecCCcCC
Q 011851 250 KPVIYRDFKTSNILLDGEYNAKLSDFGLAKD 280 (476)
Q Consensus 250 ~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~ 280 (476)
..++|+|+.++|||+++++.+.|+||..+..
T Consensus 196 ~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 196 TVLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred eeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 3499999999999999999999999998865
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.19 E-value=0.033 Score=55.61 Aligned_cols=142 Identities=17% Similarity=0.194 Sum_probs=76.0
Q ss_pred cccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCCCCCce-eeEEEEEEeCCeeEEEE
Q 011851 128 LLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHPNL-VKLIGCCIEDDQRLLVY 206 (476)
Q Consensus 128 ~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~hpnI-v~l~~~~~~~~~~~lV~ 206 (476)
.|..|--..+|+...... ..++..|.+|+........ -.-.+|..+++.+..-++ .++++++. .+ +|.
T Consensus 21 ~l~gGlTN~~~~v~~~~~------~~~~~~~v~Ri~g~~t~~~-IdR~~E~~il~~l~~~gl~P~~l~~~~-~G---~i~ 89 (330)
T PLN02421 21 RISGGITNLLLKVSVKEE------NGNEVSVTVRLFGPNTDYV-IDRERELQAIKYLSAAGFGAKLLGVFG-NG---MIQ 89 (330)
T ss_pred EeCCcccceEEEEEecCC------CCCCceEEEEEecCCcCeE-echHHHHHHHHHHHhcCCCCceeEEeC-Cc---Eee
Confidence 344476777887653211 0123468899876543211 122467888887765444 35565552 22 589
Q ss_pred EecCCCCHHHH-------H----------hhcCC-----CCCHHHHHHHHHHH----------------------HHHHH
Q 011851 207 EFMPRGSLENH-------L----------FRRSL-----PLPWSIRMKIALDA----------------------AKGLA 242 (476)
Q Consensus 207 E~~~~g~L~~~-------l----------~~~~~-----~l~~~~~~~i~~qi----------------------~~al~ 242 (476)
+|+++..|... + +.... +..+..+..+..++ ..-+.
T Consensus 90 ~fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 169 (330)
T PLN02421 90 SFINARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIV 169 (330)
T ss_pred hhhcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHH
Confidence 99987655221 1 11110 11123322222221 11122
Q ss_pred HHHh----cC-CCCeEecCCCCCCeeecC-CCceEEeecCCcCC
Q 011851 243 FLHE----EA-EKPVIYRDFKTSNILLDG-EYNAKLSDFGLAKD 280 (476)
Q Consensus 243 ~lH~----~~-~~~ivHrDlKp~NILl~~-~~~vkl~DFG~a~~ 280 (476)
.+.. .+ ..-++|.||.+.|||+++ ++.++++||..|..
T Consensus 170 ~l~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 170 ELKEITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred HHHHHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 1111 11 123789999999999974 57899999998854
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=95.93 E-value=0.15 Score=58.50 Aligned_cols=31 Identities=39% Similarity=0.454 Sum_probs=26.3
Q ss_pred CCeEecCCCCCCeeecCCC--ceE-EeecCCcCC
Q 011851 250 KPVIYRDFKTSNILLDGEY--NAK-LSDFGLAKD 280 (476)
Q Consensus 250 ~~ivHrDlKp~NILl~~~~--~vk-l~DFG~a~~ 280 (476)
..+||.|+.+.|||++.++ .+. |+|||-+..
T Consensus 203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 203 AQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred cceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 4499999999999998875 565 999998865
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=95.90 E-value=0.025 Score=52.16 Aligned_cols=102 Identities=14% Similarity=0.072 Sum_probs=67.8
Q ss_pred EEEEEecCCCcc-CHHHHHHHHHHHhCCCCCceeeEEEEEEeCCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHH
Q 011851 158 VAVKTLNHDGLQ-GHKEWLAEVNYLGGLIHPNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALD 236 (476)
Q Consensus 158 vAiK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~q 236 (476)
..+|.++..... ...-+..+.+++.+++ .|+++..- ..-.+-+++|+|-.... . ...++..
T Consensus 88 L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i----------~----~~N~i~a 149 (308)
T PF07387_consen 88 LFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKI----------N----FSNFITA 149 (308)
T ss_pred hhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCccc----------c----hhHHHHH
Confidence 345665544444 3455677889888875 58888721 23345688999843211 0 1122222
Q ss_pred HHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCc
Q 011851 237 AAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLA 278 (476)
Q Consensus 237 i~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a 278 (476)
=+.+|.-.|+.. .+.+|+|-.|+||+-|..|.+||.|=+..
T Consensus 150 gi~~L~~fH~~~-~~~lHGD~np~NiM~D~~G~lKlVDP~~L 190 (308)
T PF07387_consen 150 GIKDLMDFHSEN-QHCLHGDCNPDNIMCDKFGYLKLVDPVCL 190 (308)
T ss_pred hHHHHHHhhccC-CCeecCCCChhheeecCCCCEEecChhhh
Confidence 246788889655 45999999999999999999999996654
|
The function of this family is unknown. |
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.80 E-value=0.088 Score=52.32 Aligned_cols=135 Identities=20% Similarity=0.241 Sum_probs=77.9
Q ss_pred CCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCCCCCce------eeEEEE--EEeCC--ee
Q 011851 133 GFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHPNL------VKLIGC--CIEDD--QR 202 (476)
Q Consensus 133 ~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~hpnI------v~l~~~--~~~~~--~~ 202 (476)
.-..||+... ..|. +++|+.+.. ....++..|+..|..|.-.+| ..+=|- ..-.+ +.
T Consensus 37 ~eN~~f~~~~----------~~g~-~iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~ 103 (331)
T COG2334 37 EENSNFRVQT----------EDGR-YILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRP 103 (331)
T ss_pred ccCceEEEEe----------cCCC-eEEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCcee
Confidence 4456776433 2344 489998765 345667778888887742221 111111 11123 67
Q ss_pred EEEEEecCCCCHHH-H--------------Hhh--cCC---------CCCHHH-------------HHHHHHHHHHHHHH
Q 011851 203 LLVYEFMPRGSLEN-H--------------LFR--RSL---------PLPWSI-------------RMKIALDAAKGLAF 243 (476)
Q Consensus 203 ~lV~E~~~~g~L~~-~--------------l~~--~~~---------~l~~~~-------------~~~i~~qi~~al~~ 243 (476)
+-|++|++|..+.. . |+. ++. ...|.. ......++...+..
T Consensus 104 a~lf~~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~ 183 (331)
T COG2334 104 AALFEYLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDR 183 (331)
T ss_pred EEEEEecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHH
Confidence 78999999987772 1 110 111 122321 01133344455555
Q ss_pred HHhcC----CCC---eEecCCCCCCeeecCCCc-eEEeecCCcCC
Q 011851 244 LHEEA----EKP---VIYRDFKTSNILLDGEYN-AKLSDFGLAKD 280 (476)
Q Consensus 244 lH~~~----~~~---ivHrDlKp~NILl~~~~~-vkl~DFG~a~~ 280 (476)
+.+.- ... +||+|+.|.|||++.+.. +.++|||-+..
T Consensus 184 ~~~~~~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~~ 228 (331)
T COG2334 184 LLARLPAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAGY 228 (331)
T ss_pred HHhhchhhCCcccceeeecCCCccceeEcCCCCeeeEEEcccccc
Confidence 54432 112 899999999999998874 89999998864
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=95.34 E-value=0.058 Score=54.64 Aligned_cols=75 Identities=17% Similarity=0.165 Sum_probs=48.0
Q ss_pred cccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecC------CCccCHHHHHHHHHHHhCCC--CC-ceeeEEEEE
Q 011851 126 ECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNH------DGLQGHKEWLAEVNYLGGLI--HP-NLVKLIGCC 196 (476)
Q Consensus 126 ~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~------~~~~~~~~~~~E~~~l~~l~--hp-nIv~l~~~~ 196 (476)
.+.||.|.-.-||++.+.. .+..|+||.-.. +-.-...+..-|.++|+.+. .| .+.++|.
T Consensus 34 ~~eigdGnlN~VfrV~~~~---------~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~-- 102 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQ---------KNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYL-- 102 (409)
T ss_pred eeEcCCCceEEEEEEeeCC---------CCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEE--
Confidence 4578999999999987531 134577876321 11223456677888888653 34 4556664
Q ss_pred EeCCeeEEEEEecCC
Q 011851 197 IEDDQRLLVYEFMPR 211 (476)
Q Consensus 197 ~~~~~~~lV~E~~~~ 211 (476)
.+.+...+|||+++.
T Consensus 103 ~D~e~~~~vMEdL~~ 117 (409)
T PRK12396 103 FDSVMNCCVMEDLSD 117 (409)
T ss_pred ECcHHhhHHHHhCcc
Confidence 355567789999864
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.33 E-value=0.35 Score=48.07 Aligned_cols=29 Identities=21% Similarity=0.219 Sum_probs=24.4
Q ss_pred CCeEecCCCCCCeeecCCCceEEeecCCcCC
Q 011851 250 KPVIYRDFKTSNILLDGEYNAKLSDFGLAKD 280 (476)
Q Consensus 250 ~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~ 280 (476)
..+||+|+.+.|||++ + .+.|+||+-+..
T Consensus 196 ~~liHgD~h~~NvL~~-d-~~~iIDFDd~~~ 224 (325)
T PRK11768 196 LLRLHGDCHPGNILWR-D-GPHFVDLDDARM 224 (325)
T ss_pred ccceecCCCchhcccc-C-CcEEEeCCCCCC
Confidence 3489999999999995 4 578999998864
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.27 E-value=0.35 Score=49.22 Aligned_cols=81 Identities=15% Similarity=0.035 Sum_probs=43.6
Q ss_pred ccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCCCCCce-eeEEEEEEeCCeeEEE
Q 011851 127 CLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHPNL-VKLIGCCIEDDQRLLV 205 (476)
Q Consensus 127 ~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~hpnI-v~l~~~~~~~~~~~lV 205 (476)
+.|..|--..+|++....... ..-..+.|.+++........ -.-.+|+++++.|...++ .++++.+. -++|
T Consensus 56 ~~l~gGLTN~l~~v~~~~~~~---~~~~~k~Vl~R~~g~~~~l~-IdR~~E~~i~~~Ls~~glgP~l~~~f~----~g~l 127 (383)
T PTZ00384 56 KKMNNGITNQVYQATLVDGDK---DRYPIKSVCIKKSSTYNSLV-IDNDLQYNIAKLLGDNNFGPKIIGRFG----DFTI 127 (383)
T ss_pred EEeCCcccceEEEEEecCCCC---CccccceEEEEeccCCCceE-eccHHHHHHHHHHHhCCCCCeEEEecC----CEEE
Confidence 455558888899876432110 00001124444432211111 122468888888865555 45565553 2699
Q ss_pred EEecCCCCHH
Q 011851 206 YEFMPRGSLE 215 (476)
Q Consensus 206 ~E~~~~g~L~ 215 (476)
.||++|..|.
T Consensus 128 ~efIeGr~l~ 137 (383)
T PTZ00384 128 QEWVEGNTMG 137 (383)
T ss_pred EEEeccccCC
Confidence 9999987664
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 476 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 3e-52 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 1e-51 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 1e-46 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 9e-46 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-43 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 6e-43 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 2e-42 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 6e-40 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 3e-23 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 9e-23 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 3e-22 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 3e-22 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 8e-22 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 1e-21 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 1e-21 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 2e-21 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-21 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-21 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 2e-21 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 2e-21 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 2e-21 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-21 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 2e-21 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 3e-21 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 3e-21 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 3e-21 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 4e-21 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 4e-21 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 8e-21 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 9e-21 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 1e-20 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 2e-20 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 2e-20 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 3e-20 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 4e-20 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 4e-20 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 4e-20 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 5e-20 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 5e-20 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 5e-20 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 5e-20 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 5e-20 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 5e-20 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 5e-20 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 5e-20 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 6e-20 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 6e-20 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 6e-20 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 7e-20 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 7e-20 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 7e-20 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 7e-20 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 8e-20 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 8e-20 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 8e-20 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 8e-20 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 8e-20 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 9e-20 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 9e-20 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 9e-20 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-19 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 1e-19 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-19 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-19 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-19 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-19 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 3e-19 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-19 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 4e-19 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 6e-19 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 6e-19 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 7e-19 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 8e-19 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 9e-19 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 9e-19 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 2e-18 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 2e-18 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 3e-18 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 3e-18 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 4e-18 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 5e-18 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 5e-18 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 5e-18 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 5e-18 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 7e-18 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 7e-18 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 7e-18 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 7e-18 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 7e-18 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 7e-18 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 8e-18 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 8e-18 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 8e-18 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 9e-18 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 9e-18 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 9e-18 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-17 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 1e-17 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 1e-17 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 1e-17 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 1e-17 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 1e-17 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-17 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-17 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 1e-17 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 1e-17 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 1e-17 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 1e-17 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 1e-17 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 2e-17 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 2e-17 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 2e-17 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-17 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-17 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 2e-17 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 2e-17 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-17 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 2e-17 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 3e-17 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 3e-17 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 3e-17 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 3e-17 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 3e-17 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-17 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 3e-17 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 4e-17 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 4e-17 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 4e-17 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 4e-17 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 4e-17 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 4e-17 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 4e-17 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 4e-17 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 4e-17 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 5e-17 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 5e-17 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-17 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 5e-17 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 5e-17 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 5e-17 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 5e-17 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 5e-17 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 5e-17 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 5e-17 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 6e-17 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 6e-17 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 6e-17 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 6e-17 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 6e-17 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 6e-17 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 6e-17 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 8e-17 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 8e-17 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 8e-17 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 9e-17 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 9e-17 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 9e-17 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 9e-17 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 9e-17 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 9e-17 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-16 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 1e-16 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 1e-16 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 1e-16 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 1e-16 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 1e-16 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 1e-16 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 1e-16 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 1e-16 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 1e-16 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 1e-16 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 1e-16 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 1e-16 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 1e-16 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 1e-16 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 1e-16 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 2e-16 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 2e-16 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 2e-16 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 2e-16 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-16 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 2e-16 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 2e-16 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-16 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 2e-16 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-16 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 3e-16 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 3e-16 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 3e-16 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 3e-16 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-16 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 3e-16 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 3e-16 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 3e-16 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 4e-16 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 4e-16 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 4e-16 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 4e-16 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 4e-16 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 4e-16 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-16 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 5e-16 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 5e-16 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 5e-16 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 5e-16 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 6e-16 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 6e-16 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 7e-16 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 7e-16 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 7e-16 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 7e-16 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 8e-16 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 8e-16 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 8e-16 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 9e-16 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 9e-16 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 9e-16 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 9e-16 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 9e-16 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 9e-16 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 1e-15 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 1e-15 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 1e-15 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 1e-15 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 1e-15 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 1e-15 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-15 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 2e-15 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 2e-15 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 2e-15 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-15 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-15 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-15 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 2e-15 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-15 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 2e-15 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-15 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 2e-15 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 3e-15 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 3e-15 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 3e-15 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 3e-15 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-15 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-15 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-15 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 3e-15 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 3e-15 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 3e-15 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 3e-15 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 3e-15 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 3e-15 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 3e-15 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 3e-15 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 3e-15 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-15 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-15 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 3e-15 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 4e-15 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 4e-15 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 4e-15 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 4e-15 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 4e-15 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 4e-15 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 4e-15 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 4e-15 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 4e-15 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 4e-15 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 4e-15 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 4e-15 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 4e-15 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 4e-15 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 4e-15 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 4e-15 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 4e-15 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 5e-15 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 5e-15 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 5e-15 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 6e-15 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 6e-15 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 6e-15 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 7e-15 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 7e-15 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 7e-15 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 7e-15 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 8e-15 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 8e-15 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 8e-15 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 8e-15 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 9e-15 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 9e-15 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-15 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 9e-15 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 9e-15 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 9e-15 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 9e-15 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 9e-15 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 9e-15 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-14 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 1e-14 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 1e-14 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 1e-14 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 1e-14 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 1e-14 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 1e-14 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 1e-14 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 1e-14 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 1e-14 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-14 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 1e-14 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-14 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 1e-14 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-14 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 1e-14 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 1e-14 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-14 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 1e-14 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-14 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 2e-14 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-14 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 2e-14 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 2e-14 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 2e-14 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 2e-14 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 2e-14 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 2e-14 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-14 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 2e-14 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 2e-14 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 2e-14 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 2e-14 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-14 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 2e-14 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 2e-14 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 2e-14 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 2e-14 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 2e-14 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-14 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 2e-14 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 2e-14 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 2e-14 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 2e-14 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 2e-14 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 3e-14 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 3e-14 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-14 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-14 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 3e-14 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-14 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 3e-14 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 3e-14 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 3e-14 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-14 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 3e-14 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-14 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 3e-14 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 3e-14 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 3e-14 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-14 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 3e-14 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 3e-14 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 3e-14 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 3e-14 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 3e-14 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 3e-14 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 3e-14 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-14 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 4e-14 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 4e-14 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-14 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 4e-14 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 4e-14 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 5e-14 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 6e-14 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 6e-14 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 6e-14 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 7e-14 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 7e-14 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 7e-14 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 7e-14 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 7e-14 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 8e-14 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 8e-14 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 8e-14 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 9e-14 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 9e-14 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-13 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 1e-13 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 1e-13 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-13 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 1e-13 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 1e-13 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-13 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 2e-13 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 2e-13 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 2e-13 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-13 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 2e-13 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 2e-13 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 2e-13 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-13 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 2e-13 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-13 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 2e-13 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 2e-13 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 2e-13 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 2e-13 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 2e-13 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-13 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 3e-13 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 3e-13 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 3e-13 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-13 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-13 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 4e-13 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 5e-13 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 6e-13 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 6e-13 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 6e-13 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 6e-13 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-13 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 7e-13 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-13 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 8e-13 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-13 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 9e-13 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-12 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 1e-12 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-12 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 1e-12 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 1e-12 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 1e-12 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 1e-12 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-12 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-12 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 2e-12 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-12 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 2e-12 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 2e-12 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 2e-12 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 2e-12 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 2e-12 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 2e-12 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 2e-12 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 2e-12 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 2e-12 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 2e-12 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 2e-12 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-12 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-12 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 3e-12 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-12 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 4e-12 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 6e-12 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 6e-12 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 6e-12 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 7e-12 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 7e-12 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 7e-12 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 7e-12 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 8e-12 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 8e-12 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 9e-12 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 9e-12 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 9e-12 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 9e-12 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 9e-12 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 9e-12 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 9e-12 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 1e-11 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 1e-11 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 1e-11 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 1e-11 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 1e-11 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 1e-11 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 1e-11 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 1e-11 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-11 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 1e-11 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 1e-11 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 1e-11 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 1e-11 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 2e-11 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-11 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-11 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-11 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 2e-11 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-11 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-11 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 2e-11 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 2e-11 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-11 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 2e-11 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 2e-11 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-11 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 2e-11 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 2e-11 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 2e-11 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 3e-11 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 3e-11 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 3e-11 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 3e-11 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 3e-11 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 3e-11 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 3e-11 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 3e-11 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 3e-11 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 4e-11 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 4e-11 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 4e-11 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 4e-11 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 5e-11 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-11 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 5e-11 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 5e-11 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-11 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 5e-11 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 5e-11 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 5e-11 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 5e-11 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 6e-11 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 6e-11 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 6e-11 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 7e-11 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 8e-11 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 8e-11 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 8e-11 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 8e-11 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 8e-11 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 8e-11 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 8e-11 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 8e-11 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 9e-11 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 9e-11 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 9e-11 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 1e-10 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 1e-10 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 1e-10 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 1e-10 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-10 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-10 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 1e-10 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 1e-10 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-10 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-10 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 1e-10 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 1e-10 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-10 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 1e-10 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 1e-10 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-10 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-10 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-10 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-10 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 2e-10 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-10 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 2e-10 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 2e-10 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 2e-10 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-10 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 2e-10 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 2e-10 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-10 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-10 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-10 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-10 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-10 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-10 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 2e-10 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-10 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-10 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 2e-10 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 2e-10 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-10 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 2e-10 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-10 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 2e-10 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 2e-10 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-10 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 2e-10 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-10 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-10 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-10 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-10 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 3e-10 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-10 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 3e-10 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 3e-10 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 3e-10 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 3e-10 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-10 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 3e-10 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 3e-10 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 3e-10 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 3e-10 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 3e-10 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 3e-10 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 3e-10 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 3e-10 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 3e-10 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 3e-10 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 3e-10 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-10 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 3e-10 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 3e-10 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 3e-10 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 3e-10 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 4e-10 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 4e-10 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 4e-10 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 4e-10 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-10 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 4e-10 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 5e-10 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 5e-10 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 5e-10 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 6e-10 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 6e-10 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 8e-10 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 8e-10 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 9e-10 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 1e-09 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 1e-09 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 1e-09 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 1e-09 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 1e-09 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 2e-09 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 2e-09 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 2e-09 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-09 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 2e-09 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 2e-09 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-09 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 2e-09 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 3e-09 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 3e-09 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-09 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 3e-09 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 3e-09 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-09 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-09 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 3e-09 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 4e-09 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 4e-09 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 4e-09 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-09 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-09 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 5e-09 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 5e-09 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 6e-09 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 6e-09 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 6e-09 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 7e-09 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 8e-09 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 8e-09 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 8e-09 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 8e-09 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 8e-09 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 9e-09 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 9e-09 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 9e-09 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 9e-09 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 9e-09 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 9e-09 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 1e-08 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 1e-08 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 1e-08 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 1e-08 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 1e-08 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 1e-08 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 1e-08 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 1e-08 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 1e-08 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 1e-08 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 1e-08 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 1e-08 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 1e-08 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 1e-08 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 1e-08 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 1e-08 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 1e-08 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 1e-08 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 1e-08 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 1e-08 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 1e-08 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 1e-08 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 1e-08 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 1e-08 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 1e-08 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 1e-08 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 1e-08 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 1e-08 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 1e-08 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 1e-08 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 1e-08 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 1e-08 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 1e-08 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-08 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 2e-08 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 2e-08 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 2e-08 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-08 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-08 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 2e-08 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 3e-08 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-08 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-08 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-08 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-08 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 4e-08 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 4e-08 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-08 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 4e-08 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 5e-08 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 5e-08 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 5e-08 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 5e-08 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 5e-08 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 5e-08 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 5e-08 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 5e-08 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 5e-08 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 6e-08 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 6e-08 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 6e-08 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 6e-08 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 6e-08 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 6e-08 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 6e-08 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 6e-08 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 7e-08 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 7e-08 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 7e-08 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 7e-08 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 8e-08 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 8e-08 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 8e-08 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 8e-08 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 8e-08 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 8e-08 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 9e-08 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 9e-08 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 9e-08 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 9e-08 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 9e-08 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 9e-08 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 9e-08 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 9e-08 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 9e-08 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 1e-07 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 1e-07 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 1e-07 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-07 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 1e-07 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 1e-07 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 1e-07 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 1e-07 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 1e-07 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-07 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-07 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 1e-07 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 1e-07 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-07 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-07 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 1e-07 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 1e-07 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-07 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 1e-07 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 1e-07 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-07 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-07 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 1e-07 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 2e-07 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 2e-07 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 2e-07 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 2e-07 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-07 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-07 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 2e-07 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 2e-07 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-07 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 2e-07 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-07 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 2e-07 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-07 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 2e-07 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 2e-07 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 2e-07 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-07 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-07 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-07 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 2e-07 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-07 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 2e-07 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 2e-07 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 2e-07 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 2e-07 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 2e-07 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-07 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 3e-07 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 3e-07 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 3e-07 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 3e-07 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 3e-07 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 3e-07 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 3e-07 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 3e-07 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 3e-07 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 3e-07 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 4e-07 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 4e-07 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 4e-07 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 4e-07 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 4e-07 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 4e-07 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 4e-07 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 4e-07 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 5e-07 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 5e-07 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 5e-07 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 5e-07 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 5e-07 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 5e-07 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 5e-07 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 5e-07 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 6e-07 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 6e-07 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 6e-07 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 6e-07 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 6e-07 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 7e-07 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 7e-07 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 7e-07 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 8e-07 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 8e-07 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 8e-07 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 8e-07 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 8e-07 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 9e-07 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 9e-07 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 1e-06 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 1e-06 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 1e-06 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 1e-06 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 1e-06 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 1e-06 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 1e-06 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 1e-06 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 1e-06 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 1e-06 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 1e-06 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 1e-06 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 1e-06 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-06 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 1e-06 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 2e-06 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 2e-06 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 2e-06 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 2e-06 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 2e-06 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 2e-06 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 2e-06 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 2e-06 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 2e-06 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 2e-06 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 2e-06 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 2e-06 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 2e-06 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 3e-06 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-06 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 3e-06 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 3e-06 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-06 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 3e-06 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 3e-06 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 3e-06 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 3e-06 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 4e-06 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 5e-06 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 6e-06 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 6e-06 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 6e-06 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 7e-06 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 7e-06 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 8e-06 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 1e-05 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 1e-05 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 1e-05 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 1e-05 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 1e-05 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 1e-05 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 1e-05 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 1e-05 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 1e-05 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 2e-05 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 2e-05 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 2e-05 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 2e-05 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-05 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 2e-05 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 2e-05 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 2e-05 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 2e-05 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 2e-05 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 2e-05 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 2e-05 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 2e-05 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-05 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 2e-05 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 2e-05 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-05 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 2e-05 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 2e-05 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 2e-05 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-05 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-05 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-05 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-05 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 2e-05 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-05 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 2e-05 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 3e-05 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-05 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 3e-05 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 3e-05 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 3e-05 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-05 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 3e-05 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-05 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 3e-05 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 3e-05 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 3e-05 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-05 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 4e-05 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 4e-05 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 4e-05 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 4e-05 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 4e-05 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 4e-05 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 4e-05 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 4e-05 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 4e-05 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 5e-05 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 6e-05 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 6e-05 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 7e-05 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 7e-05 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 8e-05 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 9e-05 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 9e-05 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 1e-04 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 1e-04 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 1e-04 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 1e-04 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 1e-04 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 1e-04 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 1e-04 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 1e-04 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 1e-04 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 1e-04 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 1e-04 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 1e-04 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 1e-04 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 1e-04 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 1e-04 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 1e-04 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 1e-04 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 1e-04 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 1e-04 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 2e-04 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 2e-04 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 2e-04 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 2e-04 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 2e-04 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 2e-04 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 2e-04 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 2e-04 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 2e-04 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 2e-04 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 2e-04 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 2e-04 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 2e-04 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 2e-04 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 2e-04 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 2e-04 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 2e-04 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 3e-04 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 3e-04 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 3e-04 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 3e-04 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 3e-04 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 4e-04 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 4e-04 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 5e-04 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 6e-04 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 6e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 536 bits (1384), Expect = 0.0
Identities = 111/321 (34%), Positives = 170/321 (52%), Gaps = 31/321 (9%)
Query: 99 GEELKI-SPQLRKFSFNELKSATKSFRPEC------LLGEGGFGCVYKGWINMNGTATVK 151
+ L++ + FSF ELK+ T +F +GEGGFG VYKG++N
Sbjct: 2 NKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN-------- 53
Query: 152 PGTGLPVAVKTL----NHDGLQGHKEWLAEVNYLGGLIHPNLVKLIGCCIEDDQRLLVYE 207
VAVK L + + +++ E+ + H NLV+L+G + D LVY
Sbjct: 54 ---NTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYV 110
Query: 208 FMPRGSLENHLFRR--SLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLD 265
+MP GSL + L + PL W +R KIA AA G+ FLHE I+RD K++NILLD
Sbjct: 111 YMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLD 167
Query: 266 GEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLE 325
+ AK+SDFGLA+ + +T +++R++GT Y APE + G +T KSD+YSFGVVLLE
Sbjct: 168 EAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLE 226
Query: 326 MLTGRRSMDKNRPNGEHNLVEWARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASC 385
++TG ++D++R L++ E + ID + E +A+ C
Sbjct: 227 IITGLPAVDEHRE--PQLLLDIKEEIEDEEKTIEDYIDKKMND-ADSTSVEAMYSVASQC 283
Query: 386 LNRDQKARPRMSEVVEALKPL 406
L+ + RP + +V + L+ +
Sbjct: 284 LHEKKNKRPDIKKVQQLLQEM 304
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 515 bits (1328), Expect = 0.0
Identities = 113/332 (34%), Positives = 178/332 (53%), Gaps = 17/332 (5%)
Query: 85 TSNAESTTPSTPKIGEELKISPQLRKFSFNELKSATKSFRPECLLGEGGFGCVYKGWINM 144
+ +++T + + + + +L+ AT +F + L+G G FG VYKG +
Sbjct: 3 SKYSKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLR- 61
Query: 145 NGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHPNLVKLIGCCIEDDQRLL 204
+G VA+K + QG +E+ E+ L HP+LV LIG C E ++ +L
Sbjct: 62 DGA---------KVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMIL 112
Query: 205 VYEFMPRGSLENHLFRR---SLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSN 261
+Y++M G+L+ HL+ ++ + W R++I + AA+GL +LH +I+RD K+ N
Sbjct: 113 IYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSIN 169
Query: 262 ILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGV 321
ILLD + K++DFG++K G E D+TH+ST V GT GY PEY + G LT KSDVYSFGV
Sbjct: 170 ILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGV 229
Query: 322 VLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQL 381
VL E+L R ++ ++ P NL EWA + +++DP L + K
Sbjct: 230 VLFEVLCARSAIVQSLPREMVNLAEWAVESH-NNGQLEQIVDPNLADKIRPESLRKFGDT 288
Query: 382 AASCLNRDQKARPRMSEVVEALKPLPYLKDMA 413
A CL + RP M +V+ L+ L++
Sbjct: 289 AVKCLALSSEDRPSMGDVLWKLEYALRLQESV 320
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 458 bits (1181), Expect = e-161
Identities = 123/304 (40%), Positives = 183/304 (60%), Gaps = 18/304 (5%)
Query: 107 QLRKFSFNELKSATKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHD 166
QL++FS EL+ A+ +F + +LG GGFG VYKG + +GT VAVK L +
Sbjct: 16 QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLA-DGT---------LVAVKRLKEE 65
Query: 167 GLQGHK-EWLAEVNYLGGLIHPNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRR---S 222
QG + ++ EV + +H NL++L G C+ +RLLVY +M GS+ + L R
Sbjct: 66 RTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQ 125
Query: 223 LPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGP 282
PL W R +IAL +A+GLA+LH+ + +I+RD K +NILLD E+ A + DFGLAK
Sbjct: 126 PPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 185
Query: 283 EGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEH 342
D THV+T V GT G+ APEY+ TG + K+DV+ +GV+LLE++TG+R+ D R +
Sbjct: 186 YKD-THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDD 244
Query: 343 --NLVEWARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVV 400
L++W + L + ++ L+D L+G + + E+ IQ+A C RP+MSEVV
Sbjct: 245 DVMLLDWVKG-LLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVV 303
Query: 401 EALK 404
L+
Sbjct: 304 RMLE 307
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 267 bits (685), Expect = 1e-86
Identities = 78/325 (24%), Positives = 125/325 (38%), Gaps = 39/325 (12%)
Query: 111 FSFNELKSATKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQG 170
L + + + G FGCV+K + VAVK +Q
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQLL-----------NEYVAVKIFP---IQD 59
Query: 171 HKEWLAE--VNYLGGLIHPNLVKLIGCCIEDD----QRLLVYEFMPRGSLENHLFRRSLP 224
+ W E V L G+ H N+++ IG L+ F +GSL + L
Sbjct: 60 KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN--V 117
Query: 225 LPWSIRMKIALDAAKGLAFLHEE------AEKP-VIYRDFKTSNILLDGEYNAKLSDFGL 277
+ W+ IA A+GLA+LHE+ KP + +RD K+ N+LL A ++DFGL
Sbjct: 118 VSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGL 177
Query: 278 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHL-----TAKSDVYSFGVVLLEMLTGRRS 332
A G + +GT Y APE + + D+Y+ G+VL E+ + +
Sbjct: 178 ALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTA 237
Query: 333 MDKNRPNGEHNLVE--WARPQLGERRRF--YRLIDPCL-EGCFSIKGAEKTIQLAASCLN 387
D E P L + + ++ P L + G + C +
Sbjct: 238 ADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWD 297
Query: 388 RDQKARPRMSEVVEALKPLPYLKDM 412
D +AR V E + + L ++
Sbjct: 298 HDAEARLSAGCVGERITQMQRLTNI 322
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 214 bits (546), Expect = 9e-66
Identities = 68/332 (20%), Positives = 126/332 (37%), Gaps = 54/332 (16%)
Query: 111 FSFNELKSATKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQG 170
+ +E + + L+G G +G VYKG ++ PVAVK +
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGS--LDER---------PVAVKVFS---FAN 48
Query: 171 HKEWLAEVN--YLGGLIHPNLVKLIGCCIEDD-----QRLLVYEFMPRGSLENHLFRRSL 223
+ ++ E N + + H N+ + I + LLV E+ P GSL +L +
Sbjct: 49 RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTS 108
Query: 224 PLPWSIRMKIALDAAKGLAFLHEEAEK------PVIYRDFKTSNILLDGEYNAKLSDFGL 277
W ++A +GLA+LH E + + +RD + N+L+ + +SDFGL
Sbjct: 109 D--WVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGL 166
Query: 278 AK------DGPEGDKTHVSTRVMGTYGYAAPEYVM-------TGHLTAKSDVYSFGVVLL 324
+ G++ + + +GT Y APE + + D+Y+ G++
Sbjct: 167 SMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYW 226
Query: 325 EMLTGRRSMDKNRPNGEHNL----VEWARPQLGERRRF-----YRLIDPCLEGCFSIKGA 375
E+ + E+ + P + + R P E A
Sbjct: 227 EIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFP--EAWKENSLA 284
Query: 376 EKTI-QLAASCLNRDQKARPRMSEVVEALKPL 406
+++ + C ++D +AR E + L
Sbjct: 285 VRSLKETIEDCWDQDAEARLTAQXAEERMAEL 316
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 210 bits (536), Expect = 1e-64
Identities = 74/281 (26%), Positives = 114/281 (40%), Gaps = 38/281 (13%)
Query: 129 LGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHPN 188
+G G FG V K VA+K + + + K ++ E+ L + HPN
Sbjct: 16 VGRGAFGVVCKAKWR-----------AKDVAIKQIESESER--KAFIVELRQLSRVNHPN 62
Query: 189 LVKLIGCCIEDDQRLLVYEFMPRGSLEN--HLFRRSLPLPWSIRMKIALDAAKGLAFLHE 246
+VKL G C+ LV E+ GSL N H + M L ++G+A+LH
Sbjct: 63 IVKLYGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHS 120
Query: 247 EAEKPVIYRDFKTSNILLDGEYN-AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYV 305
K +I+RD K N+LL K+ DFG A D T G+ + APE
Sbjct: 121 MQPKALIHRDLKPPNLLLVAGGTVLKICDFGTAC-----DIQTHMTNNKGSAAWMAPEVF 175
Query: 306 MTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRRFYRLIDPC 365
+ + K DV+S+G++L E++T R +P E + R
Sbjct: 176 EGSNYSEKCDVFSWGIILWEVITRR------KPFDEIGGPAFRIMWAVHNG--TRPPLI- 226
Query: 366 LEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPL 406
+ + L C ++D RP M E+V+ + L
Sbjct: 227 -KNL-----PKPIESLMTRCWSKDPSQRPSMEEIVKIMTHL 261
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 209 bits (535), Expect = 2e-64
Identities = 75/302 (24%), Positives = 120/302 (39%), Gaps = 46/302 (15%)
Query: 123 FRPECL-----LGEGGFGCVYKG-WINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLA 176
FRP L LG+G FG K TG + +K L + + +L
Sbjct: 7 FRPSDLIHGEVLGKGCFGQAIKVTHR----------ETGEVMVMKELIRFDEETQRTFLK 56
Query: 177 EVNYLGGLIHPNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALD 236
EV + L HPN++K IG +D + + E++ G+L + PWS R+ A D
Sbjct: 57 EVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKD 116
Query: 237 AAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAK------------DGPEG 284
A G+A+LH +I+RD + N L+ N ++DFGLA+ +
Sbjct: 117 IASGMAYLH---SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKK 173
Query: 285 DKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNL 344
V+G + APE + K DV+SFG+VL E++ + P+
Sbjct: 174 PDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNA----DPDYLPRT 229
Query: 345 VEWARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALK 404
+++ R F C C + C + D + RP ++ L+
Sbjct: 230 MDFGLNV----RGFLDR--YCPPNC-----PPSFFPITVRCCDLDPEKRPSFVKLEHWLE 278
Query: 405 PL 406
L
Sbjct: 279 TL 280
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 208 bits (531), Expect = 3e-64
Identities = 81/293 (27%), Positives = 137/293 (46%), Gaps = 47/293 (16%)
Query: 129 LGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGH-------KEWLAEVNYL 181
+G+GGFG V+KG + + + VA+K+L +G +E+ EV +
Sbjct: 27 IGKGGFGLVHKGRLVKDKS---------VVAIKSLILGDSEGETEMIEKFQEFQREVFIM 77
Query: 182 GGLIHPNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGL 241
L HPN+VKL G +V EF+P G L + L ++ P+ WS+++++ LD A G+
Sbjct: 78 SNLNHPNIVKLYGLMHN--PPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGI 135
Query: 242 AFLHEEAEKPVIYRDFKTSNILLD-----GEYNAKLSDFGLAKDGPEGDKTHVSTRVMGT 296
++ + P+++RD ++ NI L AK++DFGL++ H + ++G
Sbjct: 136 EYMQNQNP-PIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ-----QSVHSVSGLLGN 189
Query: 297 YGYAAPEYVMTG---HLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLG 353
+ + APE + T K+D YSF ++L +LTG P E++ + +
Sbjct: 190 FQWMAPE-TIGAEEESYTEKADTYSFAMILYTILTGE------GPFDEYSYGK-IKFINM 241
Query: 354 ERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPL 406
R R P E C + + C + D K RP S +V+ L L
Sbjct: 242 IREEGLRPTIP--EDC-----PPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 206 bits (526), Expect = 2e-63
Identities = 85/291 (29%), Positives = 130/291 (44%), Gaps = 47/291 (16%)
Query: 129 LGEGGFGCVYKG-WINMNGTATVKPGTGLPVAVKTLNHDGLQGH----KEWLAEVNYLGG 183
+G GGFG VY+ W G VAVK HD + + E
Sbjct: 15 IGIGGFGKVYRAFW---IGD---------EVAVKAARHDPDEDISQTIENVRQEAKLFAM 62
Query: 184 LIHPNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAF 243
L HPN++ L G C+++ LV EF G L L + +P I + A+ A+G+ +
Sbjct: 63 LKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGK--RIPPDILVNWAVQIARGMNY 120
Query: 244 LHEEAEKPVIYRDFKTSNILLDGEY--------NAKLSDFGLAKDGPEGDKTHVSTRVMG 295
LH+EA P+I+RD K+SNIL+ + K++DFGLA+ E +T + G
Sbjct: 121 LHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR---EWHRTTKMSAA-G 176
Query: 296 TYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGER 355
Y + APE + + SDV+S+GV+L E+LTG P + + A +
Sbjct: 177 AYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGE------VPFRGIDGLAVAY-GVAMN 229
Query: 356 RRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPL 406
+ L P C E +L C N D +RP + +++ L +
Sbjct: 230 K--LAL--PIPSTC-----PEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 206 bits (527), Expect = 3e-63
Identities = 85/330 (25%), Positives = 136/330 (41%), Gaps = 48/330 (14%)
Query: 81 SSSTTSNAESTTPSTPKIGEELKISPQLRKFSFNELKSATKSFRPECLLGEGGFGCVYKG 140
S E+ G+++ I + +L K +G G FG V++
Sbjct: 11 SDYDIPTTENLYFQGAMDGDDMDIP-------WCDLNIKEK-------IGAGSFGTVHRA 56
Query: 141 WINMNGTATVKPGTGLPVAVKTLNHDGLQGH--KEWLAEVNYLGGLIHPNLVKLIGCCIE 198
+ G VAVK L E+L EV + L HPN+V +G +
Sbjct: 57 EWH-----------GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQ 105
Query: 199 DDQRLLVYEFMPRGSLENHLFRRS--LPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRD 256
+V E++ RGSL L + L R+ +A D AKG+ +LH P+++R+
Sbjct: 106 PPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRN 164
Query: 257 FKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDV 316
K+ N+L+D +Y K+ DFGL++ + S GT + APE + KSDV
Sbjct: 165 LKSPNLLVDKKYTVKVCDFGLSRLKASTFLS--SKSAAGTPEWMAPEVLRDEPSNEKSDV 222
Query: 317 YSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRRFYRLIDPCLEGCFSIKGAE 376
YSFGV+L E+ T + +P G N + + RL P
Sbjct: 223 YSFGVILWELATLQ------QPWGNLNPAQVV---AAVGFKCKRLEIP--RNL-----NP 266
Query: 377 KTIQLAASCLNRDQKARPRMSEVVEALKPL 406
+ + C + RP + +++ L+PL
Sbjct: 267 QVAAIIEGCWTNEPWKRPSFATIMDLLRPL 296
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 197 bits (504), Expect = 2e-60
Identities = 65/288 (22%), Positives = 112/288 (38%), Gaps = 47/288 (16%)
Query: 129 LGEGGFGCVYKG-WINMNGTATVKPGTGLPVAVKTLNHDGLQGH--KEWLAEVNYLGGLI 185
L E G ++KG W G + VK L +++ E L
Sbjct: 18 LNENHSGELWKGRW---QGN---------DIVVKVLKVRDWSTRKSRDFNEECPRLRIFS 65
Query: 186 HPNLVKLIGCCIE--DDQRLLVYEFMPRGSLENHLFR-RSLPLPWSIRMKIALDAAKGLA 242
HPN++ ++G C L+ +MP GSL N L + + S +K ALD A+G+A
Sbjct: 66 HPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMA 125
Query: 243 FLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAP 302
FLH E + + ++++D + A++S + + S M + AP
Sbjct: 126 FLHTL-EPLIPRHALNSRSVMIDEDMTARISMADVK-------FSFQSPGRMYAPAWVAP 177
Query: 303 EYVMTG----HLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRRF 358
E + +D++SF V+L E++T P + + +E +
Sbjct: 178 E-ALQKKPEDTNRRSADMWSFAVLLWELVTRE------VPFADLSNMEIG---MKVALEG 227
Query: 359 YRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPL 406
R P G + +L C+N D RP+ +V L+ +
Sbjct: 228 LRPTIP--PGI-----SPHVSKLMKICMNEDPAKRPKFDMIVPILEKM 268
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 197 bits (504), Expect = 4e-60
Identities = 75/285 (26%), Positives = 122/285 (42%), Gaps = 35/285 (12%)
Query: 129 LGEGGFGCVYKG-WINMNGTATVKPGTGLPVAVKTLNHDGLQGH--KEWLAEVNYLGGLI 185
+G G FG VYKG W +G VAVK LN + + EV L
Sbjct: 32 IGSGSFGTVYKGKW---HGD----------VAVKMLNVTAPTPQQLQAFKNEVGVLRKTR 78
Query: 186 HPNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLH 245
H N++ +G Q +V ++ SL +HL + IA A+G+ +LH
Sbjct: 79 HVNILLFMGYSTAP-QLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH 137
Query: 246 EEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPE-- 303
K +I+RD K++NI L + K+ DFGLA + +H ++ G+ + APE
Sbjct: 138 A---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVI 194
Query: 304 -YVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRRFYRLI 362
+ + +SDVY+FG+VL E++TG+ P N + +G +
Sbjct: 195 RMQDSNPYSFQSDVYAFGIVLYELMTGQ------LPYSNINNRDQIIEMVGRGSLSPD-L 247
Query: 363 DPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLP 407
C ++ +L A CL + + RP ++ ++ L
Sbjct: 248 SKVRSNC-----PKRMKRLMAECLKKKRDERPSFPRILAEIEELA 287
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 194 bits (494), Expect = 3e-58
Identities = 58/314 (18%), Positives = 113/314 (35%), Gaps = 72/314 (22%)
Query: 129 LGEGGFGCVYKG-WINMNGTATVKPGTGLPVAVKTLNHDGLQGH--KEWLAEVNYLGGLI 185
+G+G FG VY G W +G VA++ ++ + K + EV
Sbjct: 41 IGKGRFGQVYHGRW---HGE----------VAIRLIDIERDNEDQLKAFKREVMAYRQTR 87
Query: 186 HPNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLH 245
H N+V +G C+ ++ +L + + + L + +IA + KG+ +LH
Sbjct: 88 HENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLH 147
Query: 246 EEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAK---DGPEGDKTHVSTRVMGTYGYAAP 302
K ++++D K+ N+ D ++DFGL G + G + AP
Sbjct: 148 ---AKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAP 203
Query: 303 EYVMTG---------HLTAKSDVYSFGVVLLEMLTGR---RSMDKNRPNGEHNLVEWA-- 348
E + + SDV++ G + E+ ++ + W
Sbjct: 204 EIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEA-------IIWQMG 256
Query: 349 ---RPQLGER---RRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEA 402
+P L + + ++ C +Q+ RP +++++
Sbjct: 257 TGMKPNLSQIGMGKEISDIL--------------------LFCWAFEQEERPTFTKLMDM 296
Query: 403 LKPLPYLKDMASSS 416
L+ LP K S
Sbjct: 297 LEKLP--KRNRRLS 308
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 194 bits (494), Expect = 5e-58
Identities = 73/306 (23%), Positives = 121/306 (39%), Gaps = 47/306 (15%)
Query: 128 LLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAE--VNYLGGLI 185
+G+G FG V++G G VAVK + + + W E + L
Sbjct: 49 SIGKGRFGEVWRG--KWRGE---------EVAVKIFS---SREERSWFREAEIYQTVMLR 94
Query: 186 HPNLVKLIGCCIEDD----QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGL 241
H N++ I +D+ Q LV ++ GSL ++L + +K+AL A GL
Sbjct: 95 HENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL--NRYTVTVEGMIKLALSTASGL 152
Query: 242 AFLHEEAE----KPVI-YRDFKTSNILLDGEYNAKLSDFGLA--KDGPEGDKTHVSTRVM 294
A LH E KP I +RD K+ NIL+ ++D GLA D +
Sbjct: 153 AHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRV 212
Query: 295 GTYGYAAPEYVMTGHL-------TAKSDVYSFGVVLLEMLTGRRSMDKNRP-NGEHNLVE 346
GT Y APE V+ + ++D+Y+ G+V E+ + + +
Sbjct: 213 GTKRYMAPE-VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV 271
Query: 347 WARPQLGERRRF-----YRL-IDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVV 400
+ P + E R+ R I + C +++ K ++ C + AR +
Sbjct: 272 PSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMR---ECWYANGAARLTALRIK 328
Query: 401 EALKPL 406
+ L L
Sbjct: 329 KTLSQL 334
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 192 bits (490), Expect = 6e-58
Identities = 66/308 (21%), Positives = 113/308 (36%), Gaps = 51/308 (16%)
Query: 128 LLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAE--VNYLGGLI 185
+G+G +G V++G + G VAVK + + K W E + L
Sbjct: 15 CVGKGRYGEVWRG--SWQGE---------NVAVKIFSS---RDEKSWFRETELYNTVMLR 60
Query: 186 HPNLVKLIGCCIEDD----QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGL 241
H N++ I + Q L+ + GSL ++L + L ++I L A GL
Sbjct: 61 HENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYL--QLTTLDTVSCLRIVLSIASGL 118
Query: 242 AFLHEEAEK-----PVIYRDFKTSNILLDGEYNAKLSDFGLA--KDGPEGDKTHVSTRVM 294
A LH E + +RD K+ NIL+ ++D GLA + +
Sbjct: 119 AHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRV 178
Query: 295 GTYGYAAPEYVMTGHL-------TAKSDVYSFGVVLLEMLTGRRSMDKNRP--------N 339
GT Y APE V+ + + D+++FG+VL E+ S
Sbjct: 179 GTKRYMAPE-VLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVV 237
Query: 340 GEHNLVEWARPQLGERRRFYRL-IDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSE 398
E R + ++ R I ++ K ++ C ++ AR
Sbjct: 238 PNDPSFEDMRKVVCVDQQ--RPNIPNRWFSDPTLTSLAKLMK---ECWYQNPSARLTALR 292
Query: 399 VVEALKPL 406
+ + L +
Sbjct: 293 IKKTLTKI 300
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 191 bits (487), Expect = 5e-57
Identities = 64/308 (20%), Positives = 106/308 (34%), Gaps = 51/308 (16%)
Query: 128 LLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWL--AEVNYLGGLI 185
+G+G +G V+ G G VAVK W E+ +
Sbjct: 44 QIGKGRYGEVWMG--KWRGE---------KVAVKVFFT---TEEASWFRETEIYQTVLMR 89
Query: 186 HPNLVKLIGCCIEDD----QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGL 241
H N++ I I+ Q L+ ++ GSL ++L +S L +K+A + GL
Sbjct: 90 HENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYL--KSTTLDAKSMLKLAYSSVSGL 147
Query: 242 AFLHEEAEK-----PVIYRDFKTSNILLDGEYNAKLSDFGLA--KDGPEGDKTHVSTRVM 294
LH E + +RD K+ NIL+ ++D GLA + +
Sbjct: 148 CHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRV 207
Query: 295 GTYGYAAPEYVMTGHLTA-------KSDVYSFGVVLLEMLTGRRSMDKNRP--------N 339
GT Y PE V+ L +D+YSFG++L E+ S
Sbjct: 208 GTKRYMPPE-VLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLV 266
Query: 340 GEHNLVEWARPQLGERRRFYRL-IDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSE 398
E R + ++ R ++ K + C + +R
Sbjct: 267 PSDPSYEDMREIVCIKKL--RPSFPNRWSSDECLRQMGKLMT---ECWAHNPASRLTALR 321
Query: 399 VVEALKPL 406
V + L +
Sbjct: 322 VKKTLAKM 329
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 8e-48
Identities = 72/279 (25%), Positives = 117/279 (41%), Gaps = 29/279 (10%)
Query: 129 LGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHD-GLQGHKEWLAEVNYLGGLIHP 187
+G G FG V+ G + + T VAVK+ ++L E L HP
Sbjct: 122 IGRGNFGEVFSGRLRADNT---------LVAVKSCRETLPPDLKAKFLQEARILKQYSHP 172
Query: 188 NLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEE 247
N+V+LIG C + +V E + G L L +++ DAA G+ +L
Sbjct: 173 NIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLE-- 230
Query: 248 AEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT 307
K I+RD N L+ + K+SDFG++++ +G + APE +
Sbjct: 231 -SKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNY 289
Query: 308 GHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRRFYRLIDPCLE 367
G +++SDV+SFG++L E + S N N + R + + RL PC E
Sbjct: 290 GRYSSESDVWSFGILLWETFSLGASPYPNLSNQQ------TREFV---EKGGRL--PCPE 338
Query: 368 GCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPL 406
C + +L C + RP S + + L+ +
Sbjct: 339 LC-----PDAVFRLMEQCWAYEPGQRPSFSTIYQELQSI 372
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 2e-47
Identities = 86/291 (29%), Positives = 121/291 (41%), Gaps = 38/291 (13%)
Query: 129 LGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHD-GLQGHKEWLAEVNYLGGLIHP 187
LGEG FG V + GTG VAVK L D G Q W E++ L L H
Sbjct: 39 LGEGHFGKVSLYCYDPTN-----DGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHE 93
Query: 188 NLVKLIGCCIEDDQR--LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLH 245
+++K GCC + LV E++P GSL ++L R S+ L + A +G+A+LH
Sbjct: 94 HIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLF--AQQICEGMAYLH 151
Query: 246 EEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVST-------RVMGTYG 298
+ I+RD N+LLD + K+ DFGLAK PEG + +
Sbjct: 152 A---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY---- 204
Query: 299 YAAPEYVMTGHLTAKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPQLGERRR 357
APE + SDV+SFGV L E+LT S E + + +
Sbjct: 205 --APECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTE 262
Query: 358 F----YRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALK 404
RL P + C + L +C + RP ++ LK
Sbjct: 263 LLERGERL--PRPDKC-----PAEVYHLMKNCWETEASFRPTFENLIPILK 306
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 162 bits (413), Expect = 2e-46
Identities = 80/304 (26%), Positives = 117/304 (38%), Gaps = 41/304 (13%)
Query: 129 LGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHPN 188
LG+G FG V + G TG VAVK L H G +++ E+ L L
Sbjct: 31 LGKGNFGSVELCRYDPLG-----DNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDF 85
Query: 189 LVKLIGCCIEDDQR--LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHE 246
+VK G ++ LV E++P G L + L R L S + + KG+ +L
Sbjct: 86 IVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLG- 144
Query: 247 EAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVST-------RVMGTYGY 299
+ ++RD NIL++ E + K++DFGLAK P +V
Sbjct: 145 --SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWY----- 197
Query: 300 AAPEYVMTGHLTAKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPQLGERRRF 358
APE + + +SDV+SFGVVL E+ T +S + E P L
Sbjct: 198 -APESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLEL 256
Query: 359 ----YRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDMAS 414
RL P C + +L C + RP S + L + S
Sbjct: 257 LEEGQRL--PAPPAC-----PAEVHELMKLCWAPSPQDRPSFSALGP------QLDMLWS 303
Query: 415 SSSY 418
S
Sbjct: 304 GSRG 307
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 160 bits (408), Expect = 5e-46
Identities = 74/294 (25%), Positives = 117/294 (39%), Gaps = 38/294 (12%)
Query: 129 LGEGGFGCVYKG-WINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHP 187
LG+G FG V + + TG VAVK L H + +++ E+ L L H
Sbjct: 18 LGKGNFGSVEMCRYDPLQD------NTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHD 71
Query: 188 NLVKLIGCCIEDDQR--LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLH 245
N+VK G C +R L+ E++P GSL ++L + + ++ KG+ +L
Sbjct: 72 NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG 131
Query: 246 EEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVST-------RVMGTYG 298
K I+RD T NIL++ E K+ DFGL K P+ +
Sbjct: 132 ---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWY---- 184
Query: 299 YAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERR-- 356
APE + + SDV+SFGVVL E+ T + + Q+
Sbjct: 185 --APESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI 242
Query: 357 ----RFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPL 406
RL P +GC ++ + C N + RP ++ + +
Sbjct: 243 ELLKNNGRL--PRPDGC-----PDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 289
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 1e-45
Identities = 74/294 (25%), Positives = 118/294 (40%), Gaps = 38/294 (12%)
Query: 129 LGEGGFGCVYKG-WINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHP 187
LG+G FG V + + TG VAVK L H + +++ E+ L L H
Sbjct: 49 LGKGNFGSVEMCRYDPLQD------NTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHD 102
Query: 188 NLVKLIGCCIEDDQR--LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLH 245
N+VK G C +R L+ E++P GSL ++L + + ++ KG+ +L
Sbjct: 103 NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL- 161
Query: 246 EEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVST-------RVMGTYG 298
K I+RD T NIL++ E K+ DFGL K P+ + +
Sbjct: 162 --GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWY---- 215
Query: 299 YAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERR-- 356
APE + + SDV+SFGVVL E+ T + + Q+
Sbjct: 216 --APESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI 273
Query: 357 ----RFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPL 406
RL P +GC ++ + C N + RP ++ + +
Sbjct: 274 ELLKNNGRL--PRPDGC-----PDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 320
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 4e-45
Identities = 78/293 (26%), Positives = 117/293 (39%), Gaps = 36/293 (12%)
Query: 129 LGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHD-GLQGHKEWLAEVNYLGGLIHP 187
LGEG FG V + G TG VAVK+L + G + E+ L L H
Sbjct: 29 LGEGHFGKVELCRYDPEG-----DNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHE 83
Query: 188 NLVKLIGCCIEDDQR--LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLH 245
N+VK G C ED L+ EF+P GSL+ +L + + ++K A+ KG+ +L
Sbjct: 84 NIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYL- 142
Query: 246 EEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVST-------RVMGTYG 298
+ ++RD N+L++ E+ K+ DFGL K + +
Sbjct: 143 --GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWY---- 196
Query: 299 YAAPEYVMTGHLTAKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLV---EWARPQLGE 354
APE +M SDV+SFGV L E+LT + + +L
Sbjct: 197 --APECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVN 254
Query: 355 R-RRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPL 406
+ RL PC C ++ QL C R ++E + L
Sbjct: 255 TLKEGKRL--PCPPNC-----PDEVYQLMRKCWEFQPSNRTSFQNLIEGFEAL 300
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 5e-44
Identities = 69/282 (24%), Positives = 124/282 (43%), Gaps = 38/282 (13%)
Query: 129 LGEGGFGCVYKG-WINMNGTATVKPGTGLPVAVKTLNHD-GLQGHKEWLAEVNYLGGLIH 186
LG G FG VYKG WI + PVA+K L + +KE L E + + +
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKI------PVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 187 PNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHE 246
P++ +L+G C+ L+ + MP G L +++ + + + AKG+ +L
Sbjct: 77 PHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL-- 133
Query: 247 EAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM 306
++ +++RD N+L+ + K++DFGLAK +K + + + A E ++
Sbjct: 134 -EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 192
Query: 307 TGHLTAKSDVYSFGVVLLEMLT-GRR---SMDKNRPNGE-HNLVEWARPQLGERRRFYRL 361
T +SDV+S+GV + E++T G + + P E +++E + RL
Sbjct: 193 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGI----PASEISSILE----------KGERL 238
Query: 362 IDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEAL 403
P C + C D +RP+ E++
Sbjct: 239 --PQPPIC-----TIDVYMIMRKCWMIDADSRPKFRELIIEF 273
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 154 bits (390), Expect = 1e-42
Identities = 87/373 (23%), Positives = 148/373 (39%), Gaps = 59/373 (15%)
Query: 47 SPKTDGANSGTSTQYAESKSTNDTSRGQPVVPIGSSSTTSNAESTTPSTPKIGEELKISP 106
P+ G + S S + + + G+++ + + P + + + I P
Sbjct: 27 VPRGSPGLDGICSIEELSTSLYKKAGSENLYFQGANTVHIDLSALNPELVQAVQHVVIGP 86
Query: 107 QLRKFSFNELKSATKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHD 166
FNE+ +G G FGCVY G T G + AVK+LN
Sbjct: 87 SSLIVHFNEV------------IGRGHFGCVYHG------TLLDNDGKKIHCAVKSLNRI 128
Query: 167 -GLQGHKEWLAEVNYLGGLIHPNLVKLIGCCIEDD-QRLLVYEFMPRGSLENHLFRRSLP 224
+ ++L E + HPN++ L+G C+ + L+V +M G L N + +
Sbjct: 129 TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN 188
Query: 225 LPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEG 284
+ L AKG+ FL A K ++RD N +LD ++ K++DFGLA+D +
Sbjct: 189 PTVKDLIGFGLQVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 245
Query: 285 DKTHVSTRVMG------TYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLT-GRR---SMD 334
+ V + A E + T T KSDV+SFGV+L E++T G ++
Sbjct: 246 EFDSVHNKTGAKLPVKWM----ALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN 301
Query: 335 KNRPNGE-HNLVEWARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKAR 393
+ + + RL E C + ++ C + + R
Sbjct: 302 ----TFDITVYLL----------QGRRL--LQPEYC-----PDPLYEVMLKCWHPKAEMR 340
Query: 394 PRMSEVVEALKPL 406
P SE+V + +
Sbjct: 341 PSFSELVSRISAI 353
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 2e-42
Identities = 65/303 (21%), Positives = 114/303 (37%), Gaps = 47/303 (15%)
Query: 129 LGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHPN 188
LG+G F ++KG G T V +K L+ + + + + L H +
Sbjct: 16 LGQGTFTKIFKGVRREVGDYGQLHET--EVLLKVLDKAHRNYSESFFEAASMMSKLSHKH 73
Query: 189 LVKLIGCCIEDDQRLLVYEFMPRGSLENHL--FRRSLPLPWSIRMKIALDAAKGLAFLHE 246
LV G C+ D+ +LV EF+ GSL+ +L + + + W + + A A + FL
Sbjct: 74 LVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEV--AKQLAAAMHFL-- 129
Query: 247 EAEKPVIYRDFKTSNILLDGEYN--------AKLSDFGLAKDGPEGDKTHVSTRVMGTYG 298
E +I+ + NILL E + KLSD G++ D +
Sbjct: 130 -EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPWV---- 184
Query: 299 YAAPEYVMTG-HLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGE-HNLVEWARPQLGERR 356
PE + +L +D +SFG L E+ +G + E
Sbjct: 185 --PPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYE---------- 232
Query: 357 RFYRLIDPCLEGCFSIKGAEKTI-QLAASCLNRDQKARPRMSEVVEALKPLPYLKDMASS 415
++L P + + L +C++ + RP ++ L L + D+
Sbjct: 233 DRHQL--PAPKAA--------ELANLINNCMDYEPDHRPSFRAIIRDLNSL-FTPDLVPR 281
Query: 416 SSY 418
S+
Sbjct: 282 GSH 284
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 4e-42
Identities = 78/347 (22%), Positives = 134/347 (38%), Gaps = 49/347 (14%)
Query: 116 LKSATKSFRPECL-----LGEGGFGCVYKG-WINMNGTATVKPGTGLPVAVKTLNHD-GL 168
+K + F+ L LG G FG V+KG WI + + PV +K + G
Sbjct: 3 MKVLARIFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKI------PVCIKVIEDKSGR 56
Query: 169 QGHKEWLAEVNYLGGLIHPNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWS 228
Q + + +G L H ++V+L+G C LV +++P GSL +H+ + L
Sbjct: 57 QSFQAVTDHMLAIGSLDHAHIVRLLGLCPGS-SLQLVTQYLPLGSLLDHVRQHRGALGPQ 115
Query: 229 IRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTH 288
+ + + AKG+ +L E +++R+ N+LL +++DFG+A P DK
Sbjct: 116 LLLNWGVQIAKGMYYL---EEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQL 172
Query: 289 VSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLT-GRR---SMDKNRPNGE-HN 343
+ + + A E + G T +SDV+S+GV + E++T G + E +
Sbjct: 173 LYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGL----RLAEVPD 228
Query: 344 LVEWARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEAL 403
L+E + RL + C + C D+ RP E+
Sbjct: 229 LLE----------KGERL--AQPQIC-----TIDVYMVMVKCWMIDENIRPTFKELAN-- 269
Query: 404 KPLPYLKDMASSSSYVQAMQAERVRLNLNAKHGSRVPRKGQPTRSLS 450
MA ++ E + K L
Sbjct: 270 ----EFTRMARDPPRYLVIKRESGPGIAPGPEPHGLTNKKLEEVELE 312
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 5e-42
Identities = 78/302 (25%), Positives = 132/302 (43%), Gaps = 39/302 (12%)
Query: 129 LGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHPN 188
LG G +G VY+G L VAVKTL D ++ +E+L E + + HPN
Sbjct: 228 LGGGQYGEVYEGVWK---------KYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPN 277
Query: 189 LVKLIGCCIEDDQRLLVYEFMPRGSLENHL-FRRSLPLPWSIRMKIALDAAKGLAFLHEE 247
LV+L+G C + ++ EFM G+L ++L + + + +A + + +L
Sbjct: 278 LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL--- 334
Query: 248 AEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT 307
+K I+R+ N L+ + K++DFGL++ GD + APE +
Sbjct: 335 EKKNFIHRNLAARNCLVGENHLVKVADFGLSRL-MTGDTYTAHAGAKFPIKWTAPESLAY 393
Query: 308 GHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGE-HNLVEWARPQLGERRRFYRLIDPCL 366
+ KSDV++FGV+L E+ T S + + L+E + YR+
Sbjct: 394 NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE----------KDYRM--ERP 441
Query: 367 EGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDMASSSSYVQAMQAER 426
EGC EK +L +C + RP +E+ + + M SS ++ E
Sbjct: 442 EGC-----PEKVYELMRACWQWNPSDRPSFAEIHQ------AFETMFQESSISDEVEKEL 490
Query: 427 VR 428
+
Sbjct: 491 GK 492
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 6e-42
Identities = 63/218 (28%), Positives = 105/218 (48%), Gaps = 33/218 (15%)
Query: 129 LGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDG--LQGHKEWLAEVNYLGGLIH 186
LGEG FG V +G + GT L VAVKT+ D + +E+L+E + H
Sbjct: 42 LGEGEFGSVMEG------NLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSH 95
Query: 187 PNLVKLIGCCIEDDQR-----LLVYEFMPRGSLENHL-FRRSLPLPWSIRMK----IALD 236
PN+++L+G CIE + +++ FM G L +L + R P I ++ +D
Sbjct: 96 PNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVD 155
Query: 237 AAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGD--KTHVSTRV- 293
A G+ +L + + ++RD N +L + ++DFGL+K GD + ++
Sbjct: 156 IALGMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMP 212
Query: 294 ---MGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLT 328
+ A E + T+KSDV++FGV + E+ T
Sbjct: 213 VKWI------AIESLADRVYTSKSDVWAFGVTMWEIAT 244
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 7e-42
Identities = 73/310 (23%), Positives = 131/310 (42%), Gaps = 43/310 (13%)
Query: 129 LGEGGFGCVYKG-WINMNGTATVKPGTGLPVAVKTLNHD-GLQGHKEWLAEVNYLGGLIH 186
LG G FG VYKG WI + PVA+K L + +KE L E + + +
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKI------PVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 187 PNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHE 246
P++ +L+G C+ L+ + MP G L +++ + + + AKG+ +L
Sbjct: 77 PHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL-- 133
Query: 247 EAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM 306
++ +++RD N+L+ + K++DFGLAK +K + + + A E ++
Sbjct: 134 -EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 192
Query: 307 TGHLTAKSDVYSFGVVLLEMLT-GRR---SMDKNRPNGE-HNLVEWARPQLGERRRFYRL 361
T +SDV+S+GV + E++T G + + P E +++E + RL
Sbjct: 193 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGI----PASEISSILE----------KGERL 238
Query: 362 IDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDMASSSSYVQA 421
P C + C D +RP+ E++ + Y+
Sbjct: 239 --PQPPIC-----TIDVYMIMVKCWMIDADSRPKFRELIIEFSKM-----ARDPQRYLVI 286
Query: 422 MQAERVRLNL 431
ER+ L
Sbjct: 287 QGDERMHLPS 296
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 7e-42
Identities = 75/311 (24%), Positives = 128/311 (41%), Gaps = 55/311 (17%)
Query: 129 LGEGGFGCVYKG-WINMNGTATVKPGTGLPVAVKTLNHD-GLQGHKEWLAEVNYLGGLIH 186
LG+G FG VY+G + VK VA+KT+N ++ E+L E + +
Sbjct: 33 LGQGSFGMVYEGVAKGV-----VKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNC 87
Query: 187 PNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRS---------LPLPWSIRMKIALDA 237
++V+L+G + L++ E M RG L+++L P S +++A +
Sbjct: 88 HHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEI 147
Query: 238 AKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRV---- 293
A G+A+L ++RD N ++ ++ K+ DFG+ +D E D +
Sbjct: 148 ADGMAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV 204
Query: 294 --MGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLT-GRRSMDKNRP-NGEHNLVEWAR 349
M +PE + G T SDV+SFGVVL E+ T +P G N
Sbjct: 205 RWM------SPESLKDGVFTTYSDVWSFGVVLWEIATLAE------QPYQGLSN------ 246
Query: 350 PQLGER-RRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPY 408
Q+ L + C + +L C + K RP E++ ++K
Sbjct: 247 EQVLRFVMEGGLL--DKPDNC-----PDMLFELMRMCWQYNPKMRPSFLEIISSIKEE-- 297
Query: 409 LKDMASSSSYV 419
++ S+
Sbjct: 298 MEPGFREVSFY 308
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 1e-41
Identities = 77/321 (23%), Positives = 131/321 (40%), Gaps = 56/321 (17%)
Query: 104 ISPQLRKFSFNELKSATKSFRPECL-----LGEGGFGCVYKGWINMNGTATVKPGTGLPV 158
++P+L ++ + +G G FGCVY G T G +
Sbjct: 7 LNPEL----VQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHG------TLLDNDGKKIHC 56
Query: 159 AVKTLNHD-GLQGHKEWLAEVNYLGGLIHPNLVKLIGCCIEDD-QRLLVYEFMPRGSLEN 216
AVK+LN + ++L E + HPN++ L+G C+ + L+V +M G L N
Sbjct: 57 AVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRN 116
Query: 217 HLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFG 276
+ + + L AKG+ +L A K ++RD N +LD ++ K++DFG
Sbjct: 117 FIRNETHNPTVKDLIGFGLQVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFG 173
Query: 277 LAKDGPEGDKTHVSTRVMG------TYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLT-G 329
LA+D + + V + A E + T T KSDV+SFGV+L E++T G
Sbjct: 174 LARDMYDKEYYSVHNKTGAKLPVKWM----ALESLQTQKFTTKSDVWSFGVLLWELMTRG 229
Query: 330 RR---SMDKNRPNGE-HNLVEWARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASC 385
++ + + + RL E C + ++ C
Sbjct: 230 APPYPDVN----TFDITVYLL----------QGRRL--LQPEYC-----PDPLYEVMLKC 268
Query: 386 LNRDQKARPRMSEVVEALKPL 406
+ + RP SE+V + +
Sbjct: 269 WHPKAEMRPSFSELVSRISAI 289
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 1e-41
Identities = 77/362 (21%), Positives = 128/362 (35%), Gaps = 70/362 (19%)
Query: 80 GSSSTTSNAESTTPSTPKIGEELKISPQLRKFSFNELKSATKSFRPECL-----LGEGGF 134
G+ + S+ T + + +PQ + + + LGEG F
Sbjct: 1 GAMGSGSSLSPTEGKGSGLQGHIIENPQYFSDAC------VHHIKRRDIVLKWELGEGAF 54
Query: 135 GCVYKG-WINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHPNLVKLI 193
G V+ N+ + + VAVK L +++ E L L H ++V+
Sbjct: 55 GKVFLAECHNL-----LPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFF 109
Query: 194 GCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIR--------------MKIALDAAK 239
G C E L+V+E+M G L L + +A A
Sbjct: 110 GVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAA 169
Query: 240 GLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRV------ 293
G+ +L A ++RD T N L+ K+ DFG+++D D V R
Sbjct: 170 GMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRW 226
Query: 294 MGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLT-GRR---SMDKNRPNGEHNLVEWAR 349
M PE ++ T +SDV+SFGVVL E+ T G++ + N E ++
Sbjct: 227 M------PPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQL----SNTE--AIDCI- 273
Query: 350 PQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYL 409
+ L C + + C R+ + R + +V L+ L
Sbjct: 274 ------TQGREL--ERPRAC-----PPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA 320
Query: 410 KD 411
Sbjct: 321 PP 322
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 5e-41
Identities = 81/299 (27%), Positives = 132/299 (44%), Gaps = 41/299 (13%)
Query: 129 LGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHK-EWLAEVNYLGGLIHP 187
+G G G V G + + G V PVA+K L + + ++L+E + +G HP
Sbjct: 57 IGSGDSGEVCYGRLRVPGQRDV------PVAIKALKAGYTERQRRDFLSEASIMGQFDHP 110
Query: 188 NLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEE 247
N+++L G ++V E+M GSL+ L + + G+ +L
Sbjct: 111 NIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYL--- 167
Query: 248 AEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKD-GPEGDKTHVSTRVMGTYGYAAPEYVM 306
++ ++RD N+L+D K+SDFGL++ + D + +T + APE +
Sbjct: 168 SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIA 227
Query: 307 TGHLTAKSDVYSFGVVLLEMLT-GRR---SMDKNRPNGE-HNLVEWARPQLGERRRFYRL 361
++ SDV+SFGVV+ E+L G R +M N + + VE YRL
Sbjct: 228 FRTFSSASDVWSFGVVMWEVLAYGERPYWNMT----NRDVISSVE----------EGYRL 273
Query: 362 IDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPL----PYLKDMASSS 416
P GC QL C ++D+ RPR S++V L L L+ A+ S
Sbjct: 274 --PAPMGC-----PHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPESLRATATVS 325
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 6e-41
Identities = 54/219 (24%), Positives = 100/219 (45%), Gaps = 34/219 (15%)
Query: 129 LGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL--QGHKEWLAEVNYLGGLIH 186
LG+G FG V + + G+ + VAVK L D + +E+L E + H
Sbjct: 31 LGKGEFGSVREA------QLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDH 84
Query: 187 PNLVKLIGCCIEDDQR------LLVYEFMPRGSLENHL-FRRSLPLPWSIRMK----IAL 235
P++ KL+G + + +++ FM G L L R P+++ ++ +
Sbjct: 85 PHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMV 144
Query: 236 DAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGD--KTHVSTRV 293
D A G+ +L + + I+RD N +L + ++DFGL++ GD + ++++
Sbjct: 145 DIACGMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKL 201
Query: 294 ----MGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLT 328
+ A E + T SDV++FGV + E++T
Sbjct: 202 PVKWL------ALESLADNLYTVHSDVWAFGVTMWEIMT 234
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 7e-41
Identities = 75/293 (25%), Positives = 125/293 (42%), Gaps = 51/293 (17%)
Query: 129 LGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHD-GLQGHKEWLAEVNYLGGLIHP 187
+G+G FG VY G + + A+K+L+ +Q + +L E + GL HP
Sbjct: 29 IGKGHFGVVYHG------EYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHP 82
Query: 188 NLVKLIGCCIEDD-QRLLVYEFMPRGSLENHL--FRRSLPLPWSIRMKIALDAAKGLAFL 244
N++ LIG + + ++ +M G L + +R+ + I L A+G+ +L
Sbjct: 83 NVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISF--GLQVARGMEYL 140
Query: 245 HEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMG------TYG 298
AE+ ++RD N +LD + K++DFGLA+D + + V T
Sbjct: 141 ---AEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWT-- 195
Query: 299 YAAPEYVMTGHLTAKSDVYSFGVVLLEMLT-GRR---SMDKNRPNGE-HNLVEWARPQLG 353
A E + T T KSDV+SFGV+L E+LT G +D + + +
Sbjct: 196 --ALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHID----PFDLTHFLA------- 242
Query: 354 ERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPL 406
+ RL P E C + Q+ C D RP +V ++ +
Sbjct: 243 ---QGRRL--PQPEYC-----PDSLYQVMQQCWEADPAVRPTFRVLVGEVEQI 285
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 9e-41
Identities = 79/306 (25%), Positives = 126/306 (41%), Gaps = 55/306 (17%)
Query: 129 LGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL--QGHKEWLAEVNYLGGLIH 186
LG G FG V KG+ M VAVK L ++ E LAE N + L +
Sbjct: 25 LGSGNFGTVKKGYYQMKKVVK-------TVAVKILKNEANDPALKDELLAEANVMQQLDN 77
Query: 187 PNLVKLIGCCIEDDQRLLVYEFMPRGSLENHL-FRRSLPLPWSIRMKIALDAAKGLAFLH 245
P +V++IG C E + +LV E G L +L R + I + + G+ +L
Sbjct: 78 PYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIEL--VHQVSMGMKYL- 133
Query: 246 EEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYG------Y 299
E ++RD N+LL ++ AK+SDFGL+K + + + +
Sbjct: 134 --EESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT-----HGKWPVKW 186
Query: 300 AAPEYVMTGHLTAKSDVYSFGVVLLEMLT-GRR---SMDKNRPNGE-HNLVEWARPQLGE 354
APE + ++KSDV+SFGV++ E + G++ M E ++E
Sbjct: 187 YAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM----KGSEVTAMLE-------- 234
Query: 355 RRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDMAS 414
+ R+ C GC + L C D + RP + V L+ Y D+ +
Sbjct: 235 --KGERM--GCPAGC-----PREMYDLMNLCWTYDVENRPGFAAVELRLR--NYYYDVVN 283
Query: 415 SSSYVQ 420
+
Sbjct: 284 EGHHHH 289
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 1e-40
Identities = 71/284 (25%), Positives = 118/284 (41%), Gaps = 43/284 (15%)
Query: 129 LGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHPN 188
LG G FG V G G VAVK + +G E+ E + L HP
Sbjct: 16 LGSGQFGVVKLG--KWKGQ--------YDVAVKMIK-EGSMSEDEFFQEAQTMMKLSHPK 64
Query: 189 LVKLIGCCIEDDQRLLVYEFMPRGSLENHL--FRRSLPLPWSIRMKIALDAAKGLAFLHE 246
LVK G C ++ +V E++ G L N+L + L + M D +G+AFL
Sbjct: 65 LVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEM--CYDVCEGMAFL-- 120
Query: 247 EAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGT---YGYAAPE 303
I+RD N L+D + K+SDFG+ + + +GT ++APE
Sbjct: 121 -ESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ----YVSSVGTKFPVKWSAPE 175
Query: 304 YVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGE-HNLVEWARPQLGERRRFYRLI 362
++KSDV++FG+++ E+ + + N E V + +RL
Sbjct: 176 VFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVS----------QGHRL- 224
Query: 363 DPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPL 406
++ Q+ SC + + RP +++ +++PL
Sbjct: 225 -YRPHLA-----SDTIYQIMYSCWHELPEKRPTFQQLLSSIEPL 262
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 1e-40
Identities = 79/292 (27%), Positives = 121/292 (41%), Gaps = 39/292 (13%)
Query: 129 LGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHPN 188
LG+G FG V+ G N VA+KTL G + +L E + L H
Sbjct: 192 LGQGCFGEVWMGTWNGTT----------RVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEK 240
Query: 189 LVKLIGCCIEDDQRLLVYEFMPRGSLENHL-FRRSLPLPWSIRMKIALDAAKGLAFLHEE 247
LV+L E+ +V E+M +GSL + L L + +A A G+A++
Sbjct: 241 LVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV--- 296
Query: 248 AEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT 307
++RD + +NIL+ K++DFGLA+ E ++ + APE +
Sbjct: 297 ERMNYVHRDLRAANILVGENLVCKVADFGLARL-IEDNEYTARQGAKFPIKWTAPEAALY 355
Query: 308 GHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGE-HNLVEWARPQLGERRRFYRLIDPCL 366
G T KSDV+SFG++L E+ T R N E + VE R YR+ PC
Sbjct: 356 GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE----------RGYRM--PCP 403
Query: 367 EGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDMASSSSY 418
C E L C ++ + RP + L+ ++ Y
Sbjct: 404 PEC-----PESLHDLMCQCWRKEPEERPTFEYLQAFLEDY----FTSTEPQY 446
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 1e-40
Identities = 78/306 (25%), Positives = 122/306 (39%), Gaps = 50/306 (16%)
Query: 129 LGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHK---EWLAEVNYLGGLI 185
LG+G FG V +G + TV VAVK L D L + +++ EVN + L
Sbjct: 26 LGDGSFGVVRRGEWDAPSGKTV------SVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD 79
Query: 186 HPNLVKLIGCCIEDDQRLLVYEFMPRGSLENHL--FRRSLPLPWSIRMKIALDAAKGLAF 243
H NL++L G + +V E P GSL + L + L R A+ A+G+ +
Sbjct: 80 HRNLIRLYGVVLTP-PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRY--AVQVAEGMGY 136
Query: 244 LHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGT---YGYA 300
L K I+RD N+LL K+ DFGL + P+ D +V + +
Sbjct: 137 L---ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQE--HRKVPFAWC 191
Query: 301 APEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGE-HNLVEWARPQLGERRRFY 359
APE + T + SD + FGV L EM T + + + ++ +
Sbjct: 192 APESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKID---------KEGE 242
Query: 360 RLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDMASSSSYV 419
RL P E C + + C + RP + + +L + +
Sbjct: 243 RL--PRPEDC-----PQDIYNVMVQCWAHKPEDRPTFVALRD------FLLEAQPTD--- 286
Query: 420 QAMQAE 425
M+AE
Sbjct: 287 --MRAE 290
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 2e-40
Identities = 76/317 (23%), Positives = 132/317 (41%), Gaps = 56/317 (17%)
Query: 129 LGEGGFGCVYKG-WINMNGTATVKPGTGLPVAVKTLNHDG-LQGHKEWLAEVNYLGGLIH 186
+G G FG VYKG +G V PVA+KTL + ++L E +G H
Sbjct: 52 IGAGEFGEVYKGMLKTSSGKKEV------PVAIKTLKAGYTEKQRVDFLGEAGIMGQFSH 105
Query: 187 PNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHE 246
N+++L G + +++ E+M G+L+ L + + + A G+ +L
Sbjct: 106 HNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYL-- 163
Query: 247 EAEKPVIYRDFKTSNILLDGEYNAKLSDFGLA---KDGPEGDKTHVSTRV----MGTYGY 299
A ++RD NIL++ K+SDFGL+ +D PE T ++
Sbjct: 164 -ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWT----- 217
Query: 300 AAPEYVMTGHLTAKSDVYSFGVVLLEMLT-GRR---SMDKNRPNGE-HNLVEWARPQLGE 354
APE + T+ SDV+SFG+V+ E++T G R + N E +
Sbjct: 218 -APEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWEL----SNHEVMKAIN-------- 264
Query: 355 RRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDMAS 414
+RL P C QL C +++ RP+ +++V L +
Sbjct: 265 --DGFRL--PTPMDC-----PSAIYQLMMQCWQQERARRPKFADIVS------ILDKLIR 309
Query: 415 SSSYVQAMQAERVRLNL 431
+ ++ + R+++
Sbjct: 310 APDSLKTLADFDPRVSI 326
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 3e-40
Identities = 71/310 (22%), Positives = 119/310 (38%), Gaps = 49/310 (15%)
Query: 126 ECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHD-GLQGHKEWLAEVNYLGGL 184
+ LG G FG V +G M VA+K L +E + E + L
Sbjct: 15 DIELGCGNFGSVRQGVYRMRKKQI-------DVAIKVLKQGTEKADTEEMMREAQIMHQL 67
Query: 185 IHPNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFL 244
+P +V+LIG C + + +LV E G L L + +P S ++ + G+ +L
Sbjct: 68 DNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYL 126
Query: 245 HEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYG------ 298
EK ++RD N+LL + AK+SDFGL+K D + +
Sbjct: 127 ---EEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARS-----AGKWPLK 178
Query: 299 YAAPEYVMTGHLTAKSDVYSFGVVLLEMLT-GRR---SMDKNRPNGE-HNLVEWARPQLG 353
+ APE + +++SDV+S+GV + E L+ G++ M E +E
Sbjct: 179 WYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM----KGPEVMAFIE------- 227
Query: 354 ERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDMA 413
+ R+ C C + L + C + RP V + ++ Y
Sbjct: 228 ---QGKRM--ECPPEC-----PPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASK 277
Query: 414 SSSSYVQAMQ 423
+
Sbjct: 278 VEGHHHHHHH 287
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 3e-40
Identities = 76/304 (25%), Positives = 120/304 (39%), Gaps = 60/304 (19%)
Query: 129 LGEGGFGCVYKG-WINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHP 187
LGEG FG V+ N++ T + VAVK L L K++ E L L H
Sbjct: 23 LGEGAFGKVFLAECYNLSPTKDK-----MLVAVKALKDPTLAARKDFQREAELLTNLQHE 77
Query: 188 NLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIR---------------MK 232
++VK G C + D ++V+E+M G L L + +
Sbjct: 78 HIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLH 137
Query: 233 IALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTR 292
IA A G+ +L A + ++RD T N L+ K+ DFG+++D D V
Sbjct: 138 IASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGH 194
Query: 293 V------MGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLT-GRR---SMDKNRPNGEH 342
M PE +M T +SDV+SFGV+L E+ T G++ + N E
Sbjct: 195 TMLPIRWM------PPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQL----SNTE- 243
Query: 343 NLVEWARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEA 402
++E + L C ++ + C R+ + R + E+ +
Sbjct: 244 -VIECI-------TQGRVL--ERPRVC-----PKEVYDVMLGCWQREPQQRLNIKEIYKI 288
Query: 403 LKPL 406
L L
Sbjct: 289 LHAL 292
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 4e-40
Identities = 79/292 (27%), Positives = 127/292 (43%), Gaps = 54/292 (18%)
Query: 129 LGEGGFGCVYKG-WINMNGTATVKPGTGLPVAVKTLNHDGLQGHK-EWLAEVNYLGGLIH 186
LGEG FG VY+G + N G VAVKT D +K ++++E + L H
Sbjct: 20 LGEGFFGEVYEGVYTNHKGEKI-------NVAVKTCKKDCTLDNKEKFMSEAVIMKNLDH 72
Query: 187 PNLVKLIGCCIEDDQRLLVYEFMPRGSLENHL--FRRSLPLPWSIRMKIALDAAKGLAFL 244
P++VKLIG E+ ++ E P G L ++L + SL + + +L K +A+L
Sbjct: 73 PHIVKLIGIIEEE-PTWIIMELYPYGELGHYLERNKNSLKVLTLVLY--SLQICKAMAYL 129
Query: 245 HEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVST-----RVMGTYGY 299
++RD NIL+ KL DFGL++ + D S + M
Sbjct: 130 ---ESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWM----- 181
Query: 300 AAPEYVMTGHLTAKSDVYSFGVVLLEMLT-GRR---SMDKNRPNGE-HNLVEWARPQLGE 354
+PE + T SDV+ F V + E+L+ G++ ++ N + ++E
Sbjct: 182 -SPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLE----NKDVIGVLE-------- 228
Query: 355 RRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPL 406
+ RL P + C L C + D RPR +E+V +L +
Sbjct: 229 --KGDRL--PKPDLC-----PPVLYTLMTRCWDYDPSDRPRFTELVCSLSDV 271
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 6e-40
Identities = 74/287 (25%), Positives = 120/287 (41%), Gaps = 49/287 (17%)
Query: 129 LGEGGFGCVYKG-WINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHP 187
+G G FG V+ G W+N + VA+KT+ +G ++++ E + L HP
Sbjct: 16 IGSGQFGLVHLGYWLNKD-----------KVAIKTI-REGAMSEEDFIEEAEVMMKLSHP 63
Query: 188 NLVKLIGCCIEDDQRLLVYEFMPRGSLENHL--FRRSLPLPWSIRMKIALDAAKGLAFLH 245
LV+L G C+E LV EFM G L ++L R + M LD +G+A+L
Sbjct: 64 KLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGM--CLDVCEGMAYL- 120
Query: 246 EEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGD-KTHVSTRV----MGTYGYA 300
E VI+RD N L+ K+SDFG+ + + + T+
Sbjct: 121 --EEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWA------ 172
Query: 301 APEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGE-HNLVEWARPQLGERRRFY 359
+PE ++KSDV+SFGV++ E+ + + +NR N E + +
Sbjct: 173 SPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS----------TGF 222
Query: 360 RLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPL 406
RL + Q+ C + RP S ++ L +
Sbjct: 223 RL--YKPRLA-----STHVYQIMNHCWRERPEDRPAFSRLLRQLAEI 262
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 7e-40
Identities = 75/322 (23%), Positives = 133/322 (41%), Gaps = 55/322 (17%)
Query: 129 LGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDG-LQGHKEWLAEVNYLGGLIHP 187
+G G FG V G + + + VA+KTL + +++L E + +G HP
Sbjct: 53 VGAGEFGEVCSGRLKLPSKKEI------SVAIKTLKVGYTEKQRRDFLGEASIMGQFDHP 106
Query: 188 NLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEE 247
N+++L G + ++V E+M GSL++ L + + + A G+ +L
Sbjct: 107 NIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYL--- 163
Query: 248 AEKPVIYRDFKTSNILLDGEYNAKLSDFGLA---KDGPEGDKTHVSTRV----MGTYGYA 300
++ ++RD NIL++ K+SDFGL +D PE T ++
Sbjct: 164 SDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWT------ 217
Query: 301 APEYVMTGHLTAKSDVYSFGVVLLEMLT-GRR---SMDKNRPNGE-HNLVEWARPQLGER 355
+PE + T+ SDV+S+G+VL E+++ G R M N + V+
Sbjct: 218 SPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMS----NQDVIKAVD--------- 264
Query: 356 RRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDMASS 415
YRL P C QL C +D+ RP+ ++V L + +
Sbjct: 265 -EGYRL--PPPMDC-----PAALYQLMLDCWQKDRNNRPKFEQIVS------ILDKLIRN 310
Query: 416 SSYVQAMQAERVRLNLNAKHGS 437
++ + + R + S
Sbjct: 311 PGSLKIITSAAARPSNLLLDQS 332
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 7e-40
Identities = 77/307 (25%), Positives = 129/307 (42%), Gaps = 49/307 (15%)
Query: 129 LGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHPN 188
LG G +G VY+G L VAVKTL + +E+L E + + HPN
Sbjct: 21 LGGGQYGEVYEGVWK---------KYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPN 70
Query: 189 LVKLIGCCIEDDQRLLVYEFMPRGSLENHL-FRRSLPLPWSIRMKIALDAAKGLAFLHEE 247
LV+L+G C + ++ EFM G+L ++L + + + +A + + +L
Sbjct: 71 LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL--- 127
Query: 248 AEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGD-KTHVSTRV----MGTYGYAAP 302
+K I+RD N L+ + K++DFGL++ H + AP
Sbjct: 128 EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT------AP 181
Query: 303 EYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGE-HNLVEWARPQLGERRRFYRL 361
E + + KSDV++FGV+L E+ T S + + L+E + YR+
Sbjct: 182 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE----------KDYRM 231
Query: 362 IDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDMASSSSYVQA 421
EGC EK +L +C + RP +E+ + + M SS
Sbjct: 232 --ERPEGC-----PEKVYELMRACWQWNPSDRPSFAEIHQ------AFETMFQESSISDE 278
Query: 422 MQAERVR 428
++ E +
Sbjct: 279 VEKELGK 285
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 2e-39
Identities = 66/308 (21%), Positives = 120/308 (38%), Gaps = 43/308 (13%)
Query: 105 SPQLRKFSFNELKSATKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLN 164
+P + + K LG G FG V G G VA+K +
Sbjct: 8 APSTAGLGYGSWEIDPKDLTFLKELGTGQFGVVKYG--KWRGQ--------YDVAIKMIK 57
Query: 165 HDGLQGHKEWLAEVNYLGGLIHPNLVKLIGCCIEDDQRLLVYEFMPRGSLENHL--FRRS 222
+G E++ E + L H LV+L G C + ++ E+M G L N+L R
Sbjct: 58 -EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHR 116
Query: 223 LPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGP 282
+ M D + + +L K ++RD N L++ + K+SDFGL++
Sbjct: 117 FQTQQLLEM--CKDVCEAMEYL---ESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVL 171
Query: 283 EGDKTHVSTRVMGT---YGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPN 339
+ + T +G+ ++ PE +M ++KSD+++FGV++ E+ + + + N
Sbjct: 172 DDE----YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN 227
Query: 340 GE-HNLVEWARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSE 398
E + + RL +EK + SC + RP
Sbjct: 228 SETAEHIA----------QGLRL--YRPHLA-----SEKVYTIMYSCWHEKADERPTFKI 270
Query: 399 VVEALKPL 406
++ + +
Sbjct: 271 LLSNILDV 278
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 3e-39
Identities = 75/281 (26%), Positives = 127/281 (45%), Gaps = 41/281 (14%)
Query: 129 LGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHPN 188
+G+G FG V G G VAVK + +D + +LAE + + L H N
Sbjct: 201 IGKGEFGDVMLGDYR-----------GNKVAVKCIKNDATA--QAFLAEASVMTQLRHSN 247
Query: 189 LVKLIGCCIEDDQRL-LVYEFMPRGSLENHL-FRRSLPLPWSIRMKIALDAAKGLAFLHE 246
LV+L+G +E+ L +V E+M +GSL ++L R L +K +LD + + +L
Sbjct: 248 LVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL-- 305
Query: 247 EAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM 306
++RD N+L+ + AK+SDFGL K+ T + ++ + APE +
Sbjct: 306 -EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA---SSTQDTGKL--PVKWTAPEALR 359
Query: 307 TGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGE-HNLVEWARPQLGERRRFYRLIDPC 365
+ KSDV+SFG++L E+ + R P + VE + Y++
Sbjct: 360 EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE----------KGYKM--DA 407
Query: 366 LEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPL 406
+GC + +C + D RP ++ E L+ +
Sbjct: 408 PDGC-----PPAVYDVMKNCWHLDAATRPTFLQLREQLEHI 443
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 6e-39
Identities = 74/291 (25%), Positives = 112/291 (38%), Gaps = 52/291 (17%)
Query: 129 LGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHK-EWLAEVNYLGGLIHP 187
+GEG FG V++G L VA+KT + + ++L E + HP
Sbjct: 23 IGEGQFGDVHQG------IYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHP 76
Query: 188 NLVKLIGCCIEDDQRLLVYEFMPRGSLENHL--FRRSLPLPWSIRMKIALDAAKGLAFLH 245
++VKLIG E+ ++ E G L + L + SL L I A + LA+L
Sbjct: 77 HIVKLIGVITEN-PVWIIMELCTLGELRSFLQVRKYSLDLASLILY--AYQLSTALAYL- 132
Query: 246 EEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVST-----RVMGTYGYA 300
K ++RD N+L+ KL DFGL++ + S + M
Sbjct: 133 --ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM------ 184
Query: 301 APEYVMTGHLTAKSDVYSFGVVLLEMLT-GRR---SMDKNRPNGE-HNLVEWARPQLGER 355
APE + T+ SDV+ FGV + E+L G + + N + +E
Sbjct: 185 APESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV----KNNDVIGRIE--------- 231
Query: 356 RRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPL 406
RL P C L C D RPR +E+ L +
Sbjct: 232 -NGERL--PMPPNC-----PPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 274
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 148 bits (374), Expect = 7e-39
Identities = 77/342 (22%), Positives = 131/342 (38%), Gaps = 38/342 (11%)
Query: 69 DTSRGQPVVPIGSSSTTSNAESTTPSTPKIGEELKISPQLRKFSFNELKSATKSFRPECL 128
DT P + T+ + P + E P+ K LK +
Sbjct: 285 DTLNSDGYTPEPARITSPDKPRPMPMDTSVFESPFSDPEELKDKKLFLKRDNLLIA-DIE 343
Query: 129 LGEGGFGCVYKG-WINMNGTATVKPGTGLPVAVKTLNHD-GLQGHKEWLAEVNYLGGLIH 186
LG G FG V +G + + VA+K L +E + E + L +
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQ--------IDVAIKVLKQGTEKADTEEMMREAQIMHQLDN 395
Query: 187 PNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHE 246
P +V+LIG C + + +LV E G L L + +P S ++ + G+ +L
Sbjct: 396 PYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYL-- 452
Query: 247 EAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGT---YGYAAPE 303
EK ++R+ N+LL + AK+SDFGL+K D + + + APE
Sbjct: 453 -EEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARS--AGKWPLKWYAPE 509
Query: 304 YVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGE-HNLVEWARPQLGERRRFYRLI 362
+ +++SDV+S+GV + E L+ + K E +E + R+
Sbjct: 510 CINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE----------QGKRM- 558
Query: 363 DPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALK 404
C C + L + C + RP V + ++
Sbjct: 559 -ECPPEC-----PPELYALMSDCWIYKWEDRPDFLTVEQRMR 594
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 8e-39
Identities = 79/292 (27%), Positives = 121/292 (41%), Gaps = 39/292 (13%)
Query: 129 LGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHPN 188
LG+G FG V+ G N VA+KTL G + +L E + L H
Sbjct: 275 LGQGCFGEVWMGTWNGTT----------RVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEK 323
Query: 189 LVKLIGCCIEDDQRLLVYEFMPRGSLENHL-FRRSLPLPWSIRMKIALDAAKGLAFLHEE 247
LV+L E+ +V E+M +GSL + L L + +A A G+A++
Sbjct: 324 LVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV--- 379
Query: 248 AEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT 307
++RD + +NIL+ K++DFGLA+ E ++ + APE +
Sbjct: 380 ERMNYVHRDLRAANILVGENLVCKVADFGLARL-IEDNEYTARQGAKFPIKWTAPEAALY 438
Query: 308 GHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGE-HNLVEWARPQLGERRRFYRLIDPCL 366
G T KSDV+SFG++L E+ T R N E + VE R YR+ PC
Sbjct: 439 GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE----------RGYRM--PCP 486
Query: 367 EGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDMASSSSY 418
C E L C ++ + RP + L+ ++ Y
Sbjct: 487 PEC-----PESLHDLMCQCWRKEPEERPTFEYLQAFLEDY----FTSTEPQY 529
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 9e-39
Identities = 72/304 (23%), Positives = 114/304 (37%), Gaps = 63/304 (20%)
Query: 129 LGEGGFGCVYKG-WINMNGTATVKPGTGLPVAVKTLNHD-GLQGHKEWLAEVNYLGGLIH 186
LGE FG VYKG VA+KTL +E+ E L H
Sbjct: 17 LGEDRFGKVYKGHLFGP-----APGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQH 71
Query: 187 PNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIR---------------M 231
PN+V L+G +D +++ + G L L RS +
Sbjct: 72 PNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFV 131
Query: 232 KIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGD--KTHV 289
+ A G+ +L + V+++D T N+L+ + N K+SD GL ++ D K
Sbjct: 132 HLVAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLG 188
Query: 290 STRV----MGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLT-GRR---SMDKNRPNGE 341
++ + M APE +M G + SD++S+GVVL E+ + G + N +
Sbjct: 189 NSLLPIRWM------APEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGY----SNQD 238
Query: 342 -HNLVEWARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVV 400
++ L PC + C L C N RPR ++
Sbjct: 239 VVEMIR----------NRQVL--PCPDDC-----PAWVYALMIECWNEFPSRRPRFKDIH 281
Query: 401 EALK 404
L+
Sbjct: 282 SRLR 285
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 2e-38
Identities = 76/363 (20%), Positives = 129/363 (35%), Gaps = 50/363 (13%)
Query: 59 TQYAESKSTNDTSRGQPVVPIGSSSTTSNAESTTPSTPKIGEELKISPQLRKFSFNEL-K 117
+S G+ +P + + T + E + + + +
Sbjct: 322 NGATQSFIIRPQKEGERALPSIPKLANNEKQGVRSHTVSVSETDDYAEIIDEEDTYTMPS 381
Query: 118 SATKSFRPECL-----LGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHD-GLQGH 171
+ + E + +GEG FG V++G + VA+KT +
Sbjct: 382 TRDYEIQRERIELGRCIGEGQFGDVHQG------IYMSPENPAMAVAIKTCKNCTSDSVR 435
Query: 172 KEWLAEVNYLGGLIHPNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRM 231
+++L E + HP++VKLIG E+ ++ E G L + L R L + +
Sbjct: 436 EKFLQEALTMRQFDHPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQVRKFSLDLASLI 494
Query: 232 KIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVST 291
A + LA+L K ++RD N+L+ KL DFGL++ + S
Sbjct: 495 LYAYQLSTALAYL---ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASK 551
Query: 292 R---VMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLT-GRR---SMDKNRPNGE-HN 343
+ APE + T+ SDV+ FGV + E+L G + + N +
Sbjct: 552 GKLPIKWM----APESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV----KNNDVIG 603
Query: 344 LVEWARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEAL 403
+E RL P C L C D RPR +E+ L
Sbjct: 604 RIE----------NGERL--PMPPNC-----PPTLYSLMTKCWAYDPSRRPRFTELKAQL 646
Query: 404 KPL 406
+
Sbjct: 647 STI 649
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 2e-38
Identities = 81/318 (25%), Positives = 129/318 (40%), Gaps = 69/318 (21%)
Query: 128 LLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHD-GLQGHKEWLAEVNYLGGLI- 185
++GEG FG V K I K G + A+K + H+++ E+ L L
Sbjct: 32 VIGEGNFGQVLKARIK-------KDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 84
Query: 186 HPNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIR--------------- 230
HPN++ L+G C L E+ P G+L + L R+S L
Sbjct: 85 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFL-RKSRVLETDPAFAIANSTASTLSSQQ 143
Query: 231 -MKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHV 289
+ A D A+G+ +L ++K I+RD NIL+ Y AK++DFGL++ K
Sbjct: 144 LLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKT- 199
Query: 290 STRV----MGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLT-GRR---SMDKNRPNGE 341
R+ M A E + T SDV+S+GV+L E+++ G M E
Sbjct: 200 MGRLPVRWM------AIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM----TCAE 249
Query: 342 HNLVEWARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVE 401
L E +L + YRL C ++ L C RP ++++
Sbjct: 250 --LYE----KLPQG---YRL--EKPLNC-----DDEVYDLMRQCWREKPYERPSFAQILV 293
Query: 402 ALKPLPYLKDMASSSSYV 419
+L + + +YV
Sbjct: 294 SLNRM-----LEERKTYV 306
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 2e-38
Identities = 77/295 (26%), Positives = 115/295 (38%), Gaps = 47/295 (15%)
Query: 129 LGEGGFGCVYKG-WINMNGTATVKPGTGLPVAVKTLNHD-GLQGHKEWLAEVNYLGGLIH 186
LG G FG VY+G M + L VAVKTL Q ++L E + H
Sbjct: 38 LGHGAFGEVYEGQVSGMPNDPSP-----LQVAVKTLPEVCSEQDELDFLMEALIISKFNH 92
Query: 187 PNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLP-------LPWSIRMKIALDAAK 239
N+V+ IG ++ R ++ E M G L++ L R + P L + +A D A
Sbjct: 93 QNIVRCIGVSLQSLPRFILMELMAGGDLKSFL-RETRPRPSQPSSLAMLDLLHVARDIAC 151
Query: 240 GLAFLHEEAEKPVIYRDFKTSNILLDGE---YNAKLSDFGLAKDGPEGDKTHVSTRVMGT 296
G +L E I+RD N LL AK+ DFG+A+D M
Sbjct: 152 GCQYL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLP 208
Query: 297 YGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLT-GRR---SMDKNRPNGE-HNLVEWARPQ 351
+ PE M G T+K+D +SFGV+L E+ + G S N E V
Sbjct: 209 VKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSK----SNQEVLEFV------ 258
Query: 352 LGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPL 406
R+ + C ++ C + RP + ++E ++
Sbjct: 259 ----TSGGRM--DPPKNC-----PGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 302
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 2e-38
Identities = 78/281 (27%), Positives = 124/281 (44%), Gaps = 37/281 (13%)
Query: 129 LGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHPN 188
LG G FG V+ G+ N + VAVK+L G +LAE N + L H
Sbjct: 21 LGAGQFGEVWMGYYNGHT----------KVAVKSLK-QGSMSPDAFLAEANLMKQLQHQR 69
Query: 189 LVKLIGCCIEDDQRLLVYEFMPRGSLENHL-FRRSLPLPWSIRMKIALDAAKGLAFLHEE 247
LV+L ++ ++ E+M GSL + L + L + + +A A+G+AF+
Sbjct: 70 LVRLYAVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI--- 125
Query: 248 AEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGD-KTHVSTRVMGTYGYAAPEYVM 306
E+ I+RD + +NIL+ + K++DFGLA+ + + + + APE +
Sbjct: 126 EERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFP--IKWTAPEAIN 183
Query: 307 TGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGE-HNLVEWARPQLGERRRFYRLIDPC 365
G T KSDV+SFG++L E++T R N E +E R YR+
Sbjct: 184 YGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE----------RGYRM--VR 231
Query: 366 LEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPL 406
+ C E+ QL C + RP + L+
Sbjct: 232 PDNC-----PEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 2e-38
Identities = 73/303 (24%), Positives = 123/303 (40%), Gaps = 54/303 (17%)
Query: 129 LGEGGFGCVYKG-WINMNGTATVKPGTGLPVAVKTLNHD-GLQGHKEWLAEVNYLGGLI- 185
LGEG FG V + ++ KP + VAVK L D + + ++E+ + +
Sbjct: 89 LGEGCFGQVVMAEAVGIDKD---KPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 145
Query: 186 HPNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIR--------------- 230
H N++ L+G C +D ++ E+ +G+L +L R P
Sbjct: 146 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 205
Query: 231 MKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGD--KTH 288
+ A+G+ +L A + I+RD N+L+ K++DFGLA+D D K
Sbjct: 206 VSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKT 262
Query: 289 VSTRV----MGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGE-HN 343
+ R+ M APE + T +SDV+SFGV++ E+ T S P E
Sbjct: 263 TNGRLPVKWM------APEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK 316
Query: 344 LVEWARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEAL 403
L+ + +R+ C + + C + RP ++VE L
Sbjct: 317 LL----------KEGHRM--DKPANC-----TNELYMMMRDCWHAVPSQRPTFKQLVEDL 359
Query: 404 KPL 406
+
Sbjct: 360 DRI 362
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 3e-38
Identities = 76/289 (26%), Positives = 129/289 (44%), Gaps = 57/289 (19%)
Query: 129 LGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHPN 188
+G+G FG V G G VAVK + +D + +LAE + + L H N
Sbjct: 29 IGKGEFGDVMLGDYR-----------GNKVAVKCIKNDATA--QAFLAEASVMTQLRHSN 75
Query: 189 LVKLIGCCIEDDQRL-LVYEFMPRGSLENHL-FRRSLPLPWSIRMKIALDAAKGLAFLHE 246
LV+L+G +E+ L +V E+M +GSL ++L R L +K +LD + + +L
Sbjct: 76 LVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL-- 133
Query: 247 EAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRV----MGTYGYAAP 302
++RD N+L+ + AK+SDFGL K+ T + ++ AP
Sbjct: 134 -EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA---SSTQDTGKLPVKWT------AP 183
Query: 303 EYVMTGHLTAKSDVYSFGVVLLEMLT-GRR---SMDKNRPNGE-HNLVEWARPQLGERRR 357
E + + KSDV+SFG++L E+ + GR + P + VE +
Sbjct: 184 EALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI----PLKDVVPRVE----------K 229
Query: 358 FYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPL 406
Y++ +GC ++ +C + D RP ++ E L+ +
Sbjct: 230 GYKM--DAPDGC-----PPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 271
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 3e-38
Identities = 62/223 (27%), Positives = 99/223 (44%), Gaps = 34/223 (15%)
Query: 129 LGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHD-GLQGHKEWLAEVNYLGGLI-H 186
LGEG FG V G KP + VAVK L D + + ++E+ + + H
Sbjct: 43 LGEGAFGQVVMA--EAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 187 PNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIR---------------M 231
N++ L+G C +D ++ E+ +G+L +L R P +
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 232 KIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGD--KTHV 289
A+G+ +L A + I+RD N+L+ K++DFGLA+D D K
Sbjct: 161 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 217
Query: 290 STRV----MGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLT 328
+ R+ M APE + T +SDV+SFGV++ E+ T
Sbjct: 218 NGRLPVKWM------APEALFDRVYTHQSDVWSFGVLMWEIFT 254
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 3e-38
Identities = 73/343 (21%), Positives = 109/343 (31%), Gaps = 46/343 (13%)
Query: 74 QPVVPIGSSSTTSNAESTTPSTPKIGEELKISPQLRKFSFNELKSAT---KSFRPECLLG 130
+ ++ + S L+ ++ + + +SF+ LG
Sbjct: 7 HSSGVDLGTENLYFQSMHQLQPRRVSFRGEASETLQSPGYDPSRPESFFQQSFQRLSRLG 66
Query: 131 EGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHD--GLQGHKEWLAEVNYLGGLI-HP 187
G +G V+K G AVK G + LAEV + HP
Sbjct: 67 HGSYGEVFKV---------RSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHP 117
Query: 188 NLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEE 247
V+L E L E SL+ H LP + D LA LH
Sbjct: 118 CCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHS- 175
Query: 248 AEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT 307
+ +++ D K +NI L KL DFGL + V G Y APE +
Sbjct: 176 --QGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEV---QEGDPRYMAPELLQG 230
Query: 308 GHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRRFYRLIDPCLE 367
+ +DV+S G+ +LE+ H W QL + + P
Sbjct: 231 SY-GTAADVFSLGLTILEVACNMELP--------HGGEGW--QQLRQGY-----LPPEFT 274
Query: 368 GCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLK 410
S + + L D K R L LP L+
Sbjct: 275 AGLS----SELRSVLVMMLEPDPKLRATAEA----LLALPVLR 309
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 4e-38
Identities = 63/238 (26%), Positives = 99/238 (41%), Gaps = 35/238 (14%)
Query: 100 EELKISPQLRKFSFNELKSATKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVA 159
+ + +S R F+ +G G F VYKG ++ T + VA
Sbjct: 17 KAVGMSNDGRFLKFDIE------------IGRGSFKTVYKG---LDTE------TTVEVA 55
Query: 160 VKTLNHDGL--QGHKEWLAEVNYLGGLIHPNLVKLIGCCI---EDDQRLLVY-EFMPRGS 213
L L + + E L GL HPN+V+ + + +++ E M G+
Sbjct: 56 WCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGT 115
Query: 214 LENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEY-NAKL 272
L+ +L +R + + KGL FLH P+I+RD K NI + G + K+
Sbjct: 116 LKTYL-KRFKVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKI 173
Query: 273 SDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGR 330
D GLA + + V+GT + APE + DVY+FG+ +LEM T
Sbjct: 174 GDLGLATLK----RASFAKAVIGTPEFMAPEMYEEKY-DESVDVYAFGMCMLEMATSE 226
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 5e-38
Identities = 65/223 (29%), Positives = 101/223 (45%), Gaps = 34/223 (15%)
Query: 129 LGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHD-GLQGHKEWLAEVNYLGGLI-H 186
LGEG FG V G KP VAVK L D + + ++E+ + + H
Sbjct: 77 LGEGAFGQVVLA--EAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 134
Query: 187 PNLVKLIGCCIEDDQRLLVYEFMPRGSLENHL-----------FRRSLPLPWSIRMK--- 232
N++ L+G C +D ++ E+ +G+L +L + S + K
Sbjct: 135 KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 194
Query: 233 -IALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGD--KTHV 289
A A+G+ +L A K I+RD N+L+ + K++DFGLA+D D K
Sbjct: 195 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 251
Query: 290 STRV----MGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLT 328
+ R+ M APE + T +SDV+SFGV+L E+ T
Sbjct: 252 NGRLPVKWM------APEALFDRIYTHQSDVWSFGVLLWEIFT 288
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 7e-38
Identities = 72/327 (22%), Positives = 122/327 (37%), Gaps = 74/327 (22%)
Query: 129 LGEGGFGCVYKG-WINMNGTATVKPGTGLPVAVKTLNHD-GLQGHKEWLAEVNYLGGLIH 186
+GEG FG V++ + + VAVK L + ++ E + +
Sbjct: 55 IGEGAFGRVFQARAPGL-----LPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDN 109
Query: 187 PNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIR---------------- 230
PN+VKL+G C L++E+M G L L S S+
Sbjct: 110 PNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPP 169
Query: 231 -------MKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPE 283
+ IA A G+A+L +E+ ++RD T N L+ K++DFGL+++
Sbjct: 170 PLSCAEQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYS 226
Query: 284 GD--KTHVSTRV----MGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLT-GRR---SM 333
D K + + M PE + T +SDV+++GVVL E+ + G + M
Sbjct: 227 ADYYKADGNDAIPIRWM------PPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGM 280
Query: 334 DKNRPNGEHNLVEWARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKAR 393
+ E ++ + R L C E C + L C ++ R
Sbjct: 281 ----AHEE--VIYYVRDG-------NIL--ACPENC-----PLELYNLMRLCWSKLPADR 320
Query: 394 PRMSEVVEALKPLPYLKDMASSSSYVQ 420
P + L+ + + V
Sbjct: 321 PSFCSIHRILQRM-----CERAEGTVG 342
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 1e-37
Identities = 76/295 (25%), Positives = 116/295 (39%), Gaps = 47/295 (15%)
Query: 129 LGEGGFGCVYKG-WINMNGTATVKPGTGLPVAVKTLNHD-GLQGHKEWLAEVNYLGGLIH 186
LG G FG VY+G M + L VAVKTL Q ++L E + H
Sbjct: 79 LGHGAFGEVYEGQVSGMPNDPSP-----LQVAVKTLPEVCSEQDELDFLMEALIISKFNH 133
Query: 187 PNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPL-----PWSIR--MKIALDAAK 239
N+V+ IG ++ R ++ E M G L++ L R + P ++ + +A D A
Sbjct: 134 QNIVRCIGVSLQSLPRFILLELMAGGDLKSFL-RETRPRPSQPSSLAMLDLLHVARDIAC 192
Query: 240 GLAFLHEEAEKPVIYRDFKTSNILLDGE---YNAKLSDFGLAKDGPEGDKTHVSTRVMGT 296
G +L E I+RD N LL AK+ DFG+A+D M
Sbjct: 193 GCQYL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLP 249
Query: 297 YGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLT-GRR---SMDKNRPNGE-HNLVEWARPQ 351
+ PE M G T+K+D +SFGV+L E+ + G S N E V
Sbjct: 250 VKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSK----SNQEVLEFV------ 299
Query: 352 LGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPL 406
R+ + C ++ C + RP + ++E ++
Sbjct: 300 ----TSGGRM--DPPKNC-----PGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 343
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 1e-37
Identities = 81/294 (27%), Positives = 125/294 (42%), Gaps = 39/294 (13%)
Query: 129 LGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHPN 188
LG G FG V+ N + VAVKT+ G + +LAE N + L H
Sbjct: 196 LGAGQFGEVWMATYNKHT----------KVAVKTM-KPGSMSVEAFLAEANVMKTLQHDK 244
Query: 189 LVKLIGCCIEDDQRLLVYEFMPRGSLENHLF-RRSLPLPWSIRMKIALDAAKGLAFLHEE 247
LVKL ++ ++ EFM +GSL + L P + + A+G+AF+
Sbjct: 245 LVKLHAVVTKE-PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFI--- 300
Query: 248 AEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT 307
++ I+RD + +NIL+ K++DFGLA+ E ++ + APE +
Sbjct: 301 EQRNYIHRDLRAANILVSASLVCKIADFGLARV-IEDNEYTAREGAKFPIKWTAPEAINF 359
Query: 308 GHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGE-HNLVEWARPQLGERRRFYRLIDPCL 366
G T KSDV+SFG++L+E++T R N E +E R YR+ P
Sbjct: 360 GSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALE----------RGYRM--PRP 407
Query: 367 EGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDMASSSSYVQ 420
E C E+ + C + RP + L A+ S Y +
Sbjct: 408 ENC-----PEELYNIMMRCWKNRPEERPTFEYIQSVLDDF----YTATESQYEE 452
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 2e-37
Identities = 75/322 (23%), Positives = 124/322 (38%), Gaps = 70/322 (21%)
Query: 129 LGEGGFGCVYKG-WINMNGTATVKPGTGLPVAVKTLNHD-GLQGHKEWLAEVNYLGGLI- 185
LG G FG V + + +K + VAVK L L + ++E+ L L
Sbjct: 31 LGAGAFGKVVEATAYGL-----IKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGN 85
Query: 186 HPNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIR--------------- 230
H N+V L+G C L++ E+ G L N L R+ S
Sbjct: 86 HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLE 145
Query: 231 --MKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTH 288
+ + AKG+AFL A K I+RD NILL K+ DFGLA+D
Sbjct: 146 DLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYV 202
Query: 289 VST------RVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLT-GRR---SMDKNRP 338
V + M APE + T +SDV+S+G+ L E+ + G M +
Sbjct: 203 VKGNARLPVKWM------APESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS- 255
Query: 339 NGEHNLVEWARPQLGER-RRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMS 397
+ + + +R+ E + + +C + D RP
Sbjct: 256 ------------KFYKMIKEGFRM--LSPEHA-----PAEMYDIMKTCWDADPLKRPTFK 296
Query: 398 EVVEALKPLPYLKDMASSSSYV 419
++V+ ++ ++ S++++
Sbjct: 297 QIVQLIEKQ-----ISESTNHI 313
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 2e-37
Identities = 69/232 (29%), Positives = 102/232 (43%), Gaps = 47/232 (20%)
Query: 129 LGEGGFGCVYKG-WINMNGTATVKPGTGLPVAVKTLNHD-GLQGHKEWLAEVNYLGGLIH 186
LGEG FG V K ++ G A VAVK L + ++ L+E N L + H
Sbjct: 31 LGEGEFGKVVKATAFHLKGRAGY-----TTVAVKMLKENASPSELRDLLSEFNVLKQVNH 85
Query: 187 PNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIR---------------- 230
P+++KL G C +D LL+ E+ GSL L R S +
Sbjct: 86 PHVIKLYGACSQDGPLLLIVEYAKYGSLRGFL-RESRKVGPGYLGSGGSRNSSSLDHPDE 144
Query: 231 --------MKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGP 282
+ A ++G+ +L AE +++RD NIL+ K+SDFGL++D
Sbjct: 145 RALTMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVY 201
Query: 283 EGD--KTHVSTRV----MGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLT 328
E D R+ M A E + T +SDV+SFGV+L E++T
Sbjct: 202 EEDSYVKRSQGRIPVKWM------AIESLFDHIYTTQSDVWSFGVLLWEIVT 247
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 2e-37
Identities = 77/309 (24%), Positives = 121/309 (39%), Gaps = 66/309 (21%)
Query: 129 LGEGGFGCVYKG-WINMNGTATVKPGTGLPVAVKTLNHD-GLQGHKEWLAEVNYLGGLI- 185
LG G FG V + ++ TAT + VAVK L H+ ++E+ L +
Sbjct: 35 LGRGAFGQVIEADAFGIDKTATCRT-----VAVKMLKEGATHSEHRALMSELKILIHIGH 89
Query: 186 HPNLVKLIGCCIEDDQ-RLLVYEFMPRGSLENHLFRRSLPLPWSIR-------------- 230
H N+V L+G C + +++ EF G+L +L R +
Sbjct: 90 HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL-RSKRNEFVPYKVAPEDLYKDFLTLE 148
Query: 231 --MKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGD--K 286
+ + AKG+ FL A + I+RD NILL + K+ DFGLA+D +
Sbjct: 149 HLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV 205
Query: 287 THVSTRV----MGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLT-GRR---SMDKNRP 338
R+ M APE + T +SDV+SFGV+L E+ + G + +
Sbjct: 206 RKGDARLPLKWM------APETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE- 258
Query: 339 NGEHNLVEWARPQLGER-RRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMS 397
+ R + R+ + + Q C + + RP S
Sbjct: 259 ------------EFCRRLKEGTRM--RAPDYT-----TPEMYQTMLDCWHGEPSQRPTFS 299
Query: 398 EVVEALKPL 406
E+VE L L
Sbjct: 300 ELVEHLGNL 308
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 9e-36
Identities = 74/348 (21%), Positives = 115/348 (33%), Gaps = 74/348 (21%)
Query: 79 IGSSSTTSNAESTTPSTPKIGEELKISPQLRKFSFNELKSATKSFRPECLLGEGGFGCVY 138
+GSS + S + G + I K + LGEGGF V
Sbjct: 1 MGSSHHHHHHSSGRENLYFQGHMVIID--------------NKHYLFIQKLGEGGFSYVD 46
Query: 139 KGWINMNGTATVKP-GTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHPNLVKLIGCCI 197
V+ G A+K + Q +E E + HPN+++L+ C+
Sbjct: 47 L----------VEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCL 96
Query: 198 EDDQR----LLVYEFMPRGSLENHLFRRSL---PLPWSIRMKIALDAAKGLAFLHEEAEK 250
+ L+ F RG+L N + R L + + L +GL +H K
Sbjct: 97 RERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA---K 153
Query: 251 PVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVM-------GTYGYAAPE 303
+RD K +NILL E L D G + + T Y APE
Sbjct: 154 GYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPE 213
Query: 304 ------YVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRR 357
+ + ++DV+S G VL M+ G D G+
Sbjct: 214 LFSVQSHCVIDE---RTDVWSLGCVLYAMMFGEGPYDMVFQKGDS--------------- 255
Query: 358 FYRLIDPCLEGCFSIKGA----EKTIQLAASCLNRDQKARPRMSEVVE 401
L ++ SI + QL S + D RP + ++
Sbjct: 256 -VALA---VQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLS 299
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 1e-35
Identities = 64/222 (28%), Positives = 95/222 (42%), Gaps = 36/222 (16%)
Query: 129 LGEGGFGCVYKG-WINMNGTATVKPGTGLPVAVKTLNHD-GLQGHKEWLAEVNYLGGLI- 185
LG G FG V + + V L VAVK L + ++E+ + L
Sbjct: 54 LGAGAFGKVVEATAFGLGKEDAV-----LKVAVKMLKSTAHADEKEALMSELKIMSHLGQ 108
Query: 186 HPNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIR-------------MK 232
H N+V L+G C L++ E+ G L N L R+S L +
Sbjct: 109 HENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLH 168
Query: 233 IALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVST- 291
+ A+G+AFL A K I+RD N+LL + AK+ DFGLA+D V
Sbjct: 169 FSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGN 225
Query: 292 -----RVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLT 328
+ M APE + T +SDV+S+G++L E+ +
Sbjct: 226 ARLPVKWM------APESIFDCVYTVQSDVWSYGILLWEIFS 261
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 4e-35
Identities = 68/314 (21%), Positives = 111/314 (35%), Gaps = 70/314 (22%)
Query: 129 LGEGGFGCVYKG-WINMNGTATVKPGTGLPVAVKTLNHD-GLQGHKEWLAEVNYLGGLI- 185
LG G FG V ++ K G + VAVK L + ++E+ + L
Sbjct: 53 LGSGAFGKVMNATAYGIS-----KTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGS 107
Query: 186 HPNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIR--------------- 230
H N+V L+G C L++E+ G L N+L +
Sbjct: 108 HENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLN 167
Query: 231 -------MKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPE 283
+ A AKG+ FL K ++RD N+L+ K+ DFGLA+D
Sbjct: 168 VLTFEDLLCFAYQVAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMS 224
Query: 284 GD--KTHVSTRV----MGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLT-GRR---SM 333
+ R+ M APE + G T KSDV+S+G++L E+ + G +
Sbjct: 225 DSNYVVRGNARLPVKWM------APESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI 278
Query: 334 DKNRPNGEHNLVEWARPQLGER-RRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKA 392
+ + + +++ E+ + SC D +
Sbjct: 279 PVDA-------------NFYKLIQNGFKM--DQPFYA-----TEEIYIIMQSCWAFDSRK 318
Query: 393 RPRMSEVVEALKPL 406
RP + L
Sbjct: 319 RPSFPNLTSFLGCQ 332
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 5e-35
Identities = 62/267 (23%), Positives = 102/267 (38%), Gaps = 24/267 (8%)
Query: 70 TSRGQPVVPIGSSSTTSNAESTTPSTPKIGEELKISPQLRKFSFNELKSATKSFRPECLL 129
+ + + + + ++ +A+ E + + K E + + +
Sbjct: 7 SGQAHSLASLAKTWSSGSAKLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWMTHQPRV 66
Query: 130 GEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHPNL 189
G G FG V++ + TG AVK + L+ + E+ GL P +
Sbjct: 67 GRGSFGEVHRM---KDKQ------TGFQCAVKKVR---LEVFRV--EELVACAGLSSPRI 112
Query: 190 VKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAE 249
V L G E + E + GSL L ++ LP + A +GL +LH
Sbjct: 113 VPLYGAVREGPWVNIFMELLEGGSL-GQLIKQMGCLPEDRALYYLGQALEGLEYLHTRR- 170
Query: 250 KPVIYRDFKTSNILLDGE-YNAKLSDFGLAK---DGPEGDKTHVSTRVMGTYGYAAPEYV 305
+++ D K N+LL + A L DFG A G + GT + APE V
Sbjct: 171 --ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVV 228
Query: 306 M-TGHLTAKSDVYSFGVVLLEMLTGRR 331
M AK D++S ++L ML G
Sbjct: 229 MGKPC-DAKVDIWSSCCMMLHMLNGCH 254
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 7e-35
Identities = 64/301 (21%), Positives = 110/301 (36%), Gaps = 61/301 (20%)
Query: 128 LLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHP 187
+LG+G FG V K A+K + H + L+EV L L H
Sbjct: 13 VLGQGAFGQVVKA---------RNALDSRYYAIKKIRHTEEK-LSTILSEVMLLASLNHQ 62
Query: 188 NLVKLIGCCIEDDQRL-------------LVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 234
+V+ +E + + E+ G+L + + +L ++
Sbjct: 63 YVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLF 122
Query: 235 LDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAK-------------DG 281
+ L+++H + +I+RD K NI +D N K+ DFGLAK
Sbjct: 123 RQILEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQN 179
Query: 282 PEGDKTHVSTRVMGTYGYAAPEYVM--TGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPN 339
G ++++ + GT Y A E V+ TGH K D+YS G++ EM+ +
Sbjct: 180 LPGSSDNLTSAI-GTAMYVATE-VLDGTGHYNEKIDMYSLGIIFFEMIYP--------FS 229
Query: 340 GEHNLVE-WARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSE 398
V + + P + K +K I+ ++ D RP
Sbjct: 230 TGMERVNILKKLRSVSIE-----FPPDFDDNKM-KVEKKIIR---LLIDHDPNKRPGART 280
Query: 399 V 399
+
Sbjct: 281 L 281
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 1e-34
Identities = 63/353 (17%), Positives = 116/353 (32%), Gaps = 47/353 (13%)
Query: 128 LLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEW---LAEVNYLGGL 184
+GEG FG G +K +N + KE EV L +
Sbjct: 31 KIGEGSFGKAILV---------KSTEDGRQYVIKEINISRMS-SKEREESRREVAVLANM 80
Query: 185 IHPNLVKLIGCCIEDDQRLLVYEFMPRGSLENHL-FRRSLPLPWSIRMKIALDAAKGLAF 243
HPN+V+ E+ +V ++ G L + ++ + + + L
Sbjct: 81 KHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKH 140
Query: 244 LHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPE 303
+H+ + +++RD K+ NI L + +L DFG+A+ + GT Y +PE
Sbjct: 141 VHD---RKILHRDIKSQNIFLTKDGTVQLGDFGIARVL-NSTVELARACI-GTPYYLSPE 195
Query: 304 YVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRRFYRLID 363
KSD+++ G VL E+ T + + + +
Sbjct: 196 ICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSF------------- 242
Query: 364 PCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDMASSSSYVQAMQ 423
P + +S L + R+ + RP ++ ++E ++ Q +
Sbjct: 243 PPVSLHYS----YDLRSLVSQLFKRNPRDRPSVNSILE----KGFIAKRIEKFLSPQLIA 294
Query: 424 AERVRLNLNAKHGSRVPRKGQPTRSLSIPNAPHVSPYHLNNPHYSPKPNVSQP 476
E + +P K + SI P P P
Sbjct: 295 EEFCLKTFSKFGSQPIPAKRPASGQNSISVMP-------AQKITKPAAKYGIP 340
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 135 bits (340), Expect = 3e-34
Identities = 72/293 (24%), Positives = 108/293 (36%), Gaps = 41/293 (13%)
Query: 129 LGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKE-WLAEVNYLGGLIHP 187
LG GGFG V + WI+ + TG VA+K + ++E W E+ + L HP
Sbjct: 22 LGTGGFGYVLR-WIHQD--------TGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHP 72
Query: 188 NLVKLIGCCIEDDQRL-------LVYEFMPRGSLENHLFR--RSLPLPWSIRMKIALDAA 238
N+V + Q+L L E+ G L +L + L + D +
Sbjct: 73 NVVSAR-EVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDIS 131
Query: 239 KGLAFLHEEAEKPVIYRDFKTSNILLDGEYNA---KLSDFGLAKDGPEGDKTHVSTRVMG 295
L +LHE +I+RD K NI+L K+ D G AK+ +G+ V G
Sbjct: 132 SALRYLHE---NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCT--EFV-G 185
Query: 296 TYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRR---------SMDKNRPNGEHNLVE 346
T Y APE + T D +SFG + E +TG R + +
Sbjct: 186 TLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIV 245
Query: 347 WARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEV 399
G + L P E+ +Q L Q+ R +
Sbjct: 246 VYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCM---LMWHQRQRGTDPQN 295
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 2e-33
Identities = 63/297 (21%), Positives = 102/297 (34%), Gaps = 49/297 (16%)
Query: 128 LLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKE-WLAEVNYLGGLIH 186
+LG+G V++G TG A+K N+ + + E L L H
Sbjct: 16 ILGQGATANVFRG---------RHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNH 66
Query: 187 PNLVKLIGCCIEDDQRLLVY---EFMPRGSLENHLFR--RSLPLPWSIRMKIALDAAKGL 241
N+VKL E+ EF P GSL L + LP S + + D G+
Sbjct: 67 KNIVKLFAI-EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGM 125
Query: 242 AFLHEEAEKPVIYRDFKTSNILL----DGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTY 297
L E +++R+ K NI+ DG+ KL+DFG A++ + ++ + GT
Sbjct: 126 NHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFV--SLY-GTE 179
Query: 298 GYAAPEYVMTGHL--------TAKSDVYSFGVVLLEMLTGRR-------------SMDKN 336
Y P+ L A D++S GV TG M K
Sbjct: 180 EYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKI 239
Query: 337 RPNGEHNLVEWARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKAR 393
+ + + + ++ + A+ L DQ+
Sbjct: 240 ITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQ--VLLTPVLANILEADQEKC 294
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 3e-33
Identities = 54/211 (25%), Positives = 95/211 (45%), Gaps = 23/211 (10%)
Query: 128 LLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHP 187
+LG+G +G VY G + + + +A+K + + + E+ L H
Sbjct: 29 VLGKGTYGIVYAG---RDLS------NQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHK 79
Query: 188 NLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWS---IRMKIALDAAKGLAFL 244
N+V+ +G E+ + E +P GSL L + PL + I +GL +L
Sbjct: 80 NIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIG-FYTKQILEGLKYL 138
Query: 245 HEEAEKPVIYRDFKTSNILLDGEY-NAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPE 303
H+ +++RD K N+L++ K+SDFG +K + + GT Y APE
Sbjct: 139 HDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET--FTGTLQYMAPE 193
Query: 304 YV---MTGHLTAKSDVYSFGVVLLEMLTGRR 331
+ G+ +D++S G ++EM TG+
Sbjct: 194 IIDKGPRGY-GKAADIWSLGCTIIEMATGKP 223
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 3e-33
Identities = 71/309 (22%), Positives = 113/309 (36%), Gaps = 62/309 (20%)
Query: 123 FRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLG 182
F+ L+G GGFG V+K A + G +K + ++ + +E V L
Sbjct: 13 FKEIELIGSGGFGQVFK--------AKHRI-DGKTYVIKRVKYNNEKAERE----VKALA 59
Query: 183 GLIHPNLVKLIGCCIEDDQRL----------------LVYEFMPRGSLENHL-FRRSLPL 225
L H N+V GC D + EF +G+LE + RR L
Sbjct: 60 KLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKL 119
Query: 226 PWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGD 285
+ +++ KG+ ++H K +I RD K SNI L K+ DFGL
Sbjct: 120 DKVLALELFEQITKGVDYIHS---KKLINRDLKPSNIFLVDTKQVKIGDFGLVT---SLK 173
Query: 286 KTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV 345
TR GT Y +PE + + + D+Y+ G++L E+L
Sbjct: 174 NDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCD-----TAFETSKF- 227
Query: 346 EWARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKP 405
F L D + F +K L L++ + RP SE++
Sbjct: 228 ------------FTDLRDGIISDIFD----KKEKTLLQKLLSKKPEDRPNTSEILR---- 267
Query: 406 LPYLKDMAS 414
+ +
Sbjct: 268 TLTVWKKSP 276
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 3e-33
Identities = 75/322 (23%), Positives = 128/322 (39%), Gaps = 41/322 (12%)
Query: 84 TTSNAESTTPSTPKIGEELKISPQLRKFSFNELKSATKSFRPECLLGEGGFGCVYKGWIN 143
+ P P+ + + P + + +FR E +G G F VY+
Sbjct: 2 DEQSQGMQGPPVPQFQPQKALRP-------DMGYNTLANFRIEKKIGRGQFSEVYRA--- 51
Query: 144 MNGTATVKPGTGLPVAVKTLNHDGLQGHKE---WLAEVNYLGGLIHPNLVKLIGCCIEDD 200
G+PVA+K + L K + E++ L L HPN++K IED+
Sbjct: 52 ------ACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDN 105
Query: 201 QRLLVYEFMPRGSLENHL---FRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDF 257
+ +V E G L + ++ +P K + L +H + V++RD
Sbjct: 106 ELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHS---RRVMHRDI 162
Query: 258 KTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVY 317
K +N+ + KL D GL + T + V GT Y +PE + KSD++
Sbjct: 163 KPANVFITATGVVKLGDLGLGRF-FSSKTTAAHSLV-GTPYYMSPERIHENGYNFKSDIW 220
Query: 318 SFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRRFYRLIDPCLEGCFSIKGAEK 377
S G +L EM + ++ N ++L + E+ + P +S E+
Sbjct: 221 SLGCLLYEMAALQSPFYGDKMN-LYSLC-----KKIEQCDY----PPLPSDHYS----EE 266
Query: 378 TIQLAASCLNRDQKARPRMSEV 399
QL C+N D + RP ++ V
Sbjct: 267 LRQLVNMCINPDPEKRPDVTYV 288
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 8e-33
Identities = 62/314 (19%), Positives = 105/314 (33%), Gaps = 49/314 (15%)
Query: 128 LLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKE-WLAEVNYLGGLIH 186
+LG+G V++ + TG A+K N+ + + E L L H
Sbjct: 16 ILGQGATANVFR-GRHKK--------TGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNH 66
Query: 187 PNLVKLIGCCIEDDQRLLVY---EFMPRGSLENHLFR--RSLPLPWSIRMKIALDAAKGL 241
N+VKL E+ EF P GSL L + LP S + + D G+
Sbjct: 67 KNIVKLF-AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGM 125
Query: 242 AFLHEEAEKPVIYRDFKTSNILL----DGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTY 297
L E +++R+ K NI+ DG+ KL+DFG A++ + ++ + GT
Sbjct: 126 NHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFV--SLY-GTE 179
Query: 298 GYAAPEYVMTGHL--------TAKSDVYSFGVVLLEMLTGRR-------------SMDKN 336
Y P+ L A D++S GV TG M K
Sbjct: 180 EYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKI 239
Query: 337 RPNGEHNLVEWARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRM 396
+ + + + ++ + A+ L DQ+
Sbjct: 240 ITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQ--VLLTPVLANILEADQEKCWGF 297
Query: 397 SEVVEALKPLPYLK 410
+ + +
Sbjct: 298 DQFFAETSDILHRM 311
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 9e-33
Identities = 60/208 (28%), Positives = 88/208 (42%), Gaps = 19/208 (9%)
Query: 128 LLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLA----EVNYLGG 183
LG GG VY + VA+K + + +E L EV+
Sbjct: 18 KLGGGGMSTVYLAEDTILNI---------KVAIKAI-FIPPREKEETLKRFEREVHNSSQ 67
Query: 184 LIHPNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAF 243
L H N+V +I EDD LV E++ +L ++ PL + G+
Sbjct: 68 LSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHG-PLSVDTAINFTNQILDGIKH 126
Query: 244 LHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPE 303
H+ +++RD K NIL+D K+ DFG+AK E T + V+GT Y +PE
Sbjct: 127 AHD---MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNH-VLGTVQYFSPE 182
Query: 304 YVMTGHLTAKSDVYSFGVVLLEMLTGRR 331
+D+YS G+VL EML G
Sbjct: 183 QAKGEATDECTDIYSIGIVLYEMLVGEP 210
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 1e-32
Identities = 67/319 (21%), Positives = 114/319 (35%), Gaps = 68/319 (21%)
Query: 123 FRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKE-WLAEVNYL 181
F P LG GGFG V++ A K A+K + + +E + EV L
Sbjct: 7 FEPIQCLGRGGFGVVFE--------AKNKV-DDCNYAIKRIRLPNRELAREKVMREVKAL 57
Query: 182 GGLIHPNLVKLIGCCIEDD---------QRLLVY---EFMPRGSLENHLFRR--SLPLPW 227
L HP +V+ +E + ++ +Y + + +L++ + R
Sbjct: 58 AKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERER 117
Query: 228 SIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAK-------- 279
S+ + I L A+ + FLH K +++RD K SNI + K+ DFGL
Sbjct: 118 SVCLHIFLQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEE 174
Query: 280 --DGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNR 337
T +GT Y +PE + + K D++S G++L E+L
Sbjct: 175 QTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY--------P 226
Query: 338 PNGEHNLVEWARPQLGERRRFYRLID----PCLEGCFSIKGAEKTIQLAASCLNRDQKAR 393
+ + ER R + P L + L+ R
Sbjct: 227 FSTQM-----------ERVRTLTDVRNLKFPPLFTQKY----PCEYVMVQDMLSPSPMER 271
Query: 394 PRMSEVVEALKPLPYLKDM 412
P ++E +D+
Sbjct: 272 PEAINIIE----NAVFEDL 286
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 2e-32
Identities = 58/211 (27%), Positives = 82/211 (38%), Gaps = 25/211 (11%)
Query: 128 LLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLA----EVNYLGG 183
L+G GG G VY+ VA+K + + L + E G
Sbjct: 41 LVGRGGMGDVYEA---------EDTVRERIVALKLM-SETLSSDPVFRTRMQREARTAGR 90
Query: 184 LIHPNLVKL--IGCCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKG 240
L P++V + G E D +L + + L L RR PL + I
Sbjct: 91 LQEPHVVPIHDFG---EIDGQLYVDMRLINGVDLAAML-RRQGPLAPPRAVAIVRQIGSA 146
Query: 241 LAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYA 300
L H +RD K NIL+ + A L DFG+A + T + +GT Y
Sbjct: 147 LDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGN-TVGTLYYM 202
Query: 301 APEYVMTGHLTAKSDVYSFGVVLLEMLTGRR 331
APE H T ++D+Y+ VL E LTG
Sbjct: 203 APERFSESHATYRADIYALTCVLYECLTGSP 233
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 126 bits (317), Expect = 2e-32
Identities = 50/290 (17%), Positives = 84/290 (28%), Gaps = 27/290 (9%)
Query: 59 TQYAESKSTNDTSRGQPVVPIGSSSTTSNAESTTP---STPKIGEELKISPQLRKFSFNE 115
+ S T D P + S P E P ++ + E
Sbjct: 2 SPQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKT--E 59
Query: 116 LKSATKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWL 175
+ +K LLGEG F VY+ A +K
Sbjct: 60 FQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAK----NKQKFVLKVQKPANPWEFYIGT 115
Query: 176 AEVNYLGGLIHPNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSL----PLPWSIRM 231
+ L + +K + + +LV E G+L N + +P + +
Sbjct: 116 QLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVI 175
Query: 232 KIALDAAKGLAFLHEEAEKPVIYRDFKTSNILL-----------DGEYNAKLSDFGLAKD 280
A+ + +H+ +I+ D K N +L D L D G + D
Sbjct: 176 SFAMRMLYMIEQVHD---CEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSID 232
Query: 281 GPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGR 330
K + T T G+ E + + D + + ML G
Sbjct: 233 MKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGT 282
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 7e-32
Identities = 67/394 (17%), Positives = 134/394 (34%), Gaps = 64/394 (16%)
Query: 60 QYAESKSTNDTSRGQPVVPIGSSSTTSNAESTTPSTPKIGEELKISPQLRKFSFNELKSA 119
+ S+ RG + +++ +P ++ S S
Sbjct: 1 HHHHHHSSGLVPRGSGMKE-TAAAKFERQHMDSPDLGTDDDDKASSSANECISVKG---- 55
Query: 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL--QGHKEWLAE 177
+ + +G GG V++ +N A+K +N + Q + E
Sbjct: 56 -RIYSILKQIGSGGSSKVFQV-LNEKKQI---------YAIKYVNLEEADNQTLDSYRNE 104
Query: 178 VNYLGGLIHPNL--VKLIGCCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 234
+ YL L + ++L DQ + +V E L + L ++ + R
Sbjct: 105 IAYLNKLQQHSDKIIRLYDY-EITDQYIYMVMEC-GNIDLNSWLKKKK-SIDPWERKSYW 161
Query: 235 LDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVM 294
+ + + +H+ +++ D K +N L+ + KL DFG+A + V +
Sbjct: 162 KNMLEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQV 217
Query: 295 GTYGYAAPEYVM-----------TGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRP-NGEH 342
G Y PE + ++ KSDV+S G +L M G+ P
Sbjct: 218 GAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK------TPFQQII 271
Query: 343 NLVE--WARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVV 400
N + A F + + + ++ CL RD K R + E++
Sbjct: 272 NQISKLHAIIDPNHEIEFPDIPEK---------DLQDVLK---CCLKRDPKQRISIPELL 319
Query: 401 E----ALKPLPYLKDMASSSSYVQAMQAERVRLN 430
++ P + ++ ++ + + V LN
Sbjct: 320 AHPYVQIQTHPVNQMAKGTTEEMKYVLGQLVGLN 353
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 2e-31
Identities = 69/307 (22%), Positives = 120/307 (39%), Gaps = 45/307 (14%)
Query: 116 LKSATKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL--QGHKE 173
+ S + + +G G +G K + G + K L++ + +
Sbjct: 1 MPSRAEDYEVLYTIGTGSYGRCQKI---------RRKSDGKILVWKELDYGSMTEAEKQM 51
Query: 174 WLAEVNYLGGLIHPNLVKLIGCCIEDDQRLL--VYEFMPRGSLENHL---FRRSLPLPWS 228
++EVN L L HPN+V+ I+ L V E+ G L + + + L
Sbjct: 52 LVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEE 111
Query: 229 IRMKIALDAAKGLAFLHE--EAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDK 286
+++ L H + V++RD K +N+ LDG+ N KL DFGLA+ D
Sbjct: 112 FVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL-NHDT 170
Query: 287 THVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVE 346
+ T V GT Y +PE + KSD++S G +L E+ P +
Sbjct: 171 SFAKTFV-GTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALM------PPFTAFSQ-- 221
Query: 347 WARPQLGER--RRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALK 404
+L + +R I +S ++ ++ LN RP + E++E
Sbjct: 222 ---KELAGKIREGKFRRIPY----RYS----DELNEIITRMLNLKDYHRPSVEEILE--- 267
Query: 405 PLPYLKD 411
P + +
Sbjct: 268 -NPLILE 273
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 6e-31
Identities = 58/207 (28%), Positives = 88/207 (42%), Gaps = 22/207 (10%)
Query: 128 LLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHK---EWLAEVNYLGGL 184
LG+G FG VY A K + +A+K L L+ + EV L
Sbjct: 16 PLGKGKFGNVYL--------AREKQ-SKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 185 IHPNLVKLIGCCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAF 243
HPN+++L G D R+ L+ E+ P G++ L ++ + A L++
Sbjct: 67 RHPNILRLYGY-FHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSY 124
Query: 244 LHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPE 303
H K VI+RD K N+LL K++DFG + P + GT Y PE
Sbjct: 125 CHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-SSRRTDLC---GTLDYLPPE 177
Query: 304 YVMTGHLTAKSDVYSFGVVLLEMLTGR 330
+ K D++S GV+ E L G+
Sbjct: 178 MIEGRMHDEKVDLWSLGVLCYEFLVGK 204
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 6e-31
Identities = 60/209 (28%), Positives = 91/209 (43%), Gaps = 23/209 (11%)
Query: 128 LLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHK---EWLAEVNYLGGL 184
LLG+G F VY+ A TGL VA+K ++ + EV L
Sbjct: 18 LLGKGSFAGVYR--------AESIH-TGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQL 68
Query: 185 IHPNLVKLIGCCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAF 243
HP++++L ED + LV E G + +L R P + G+ +
Sbjct: 69 KHPSILELYNY-FEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLY 127
Query: 244 LHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLA-KDGPEGDKTHVSTRVMGTYGYAAP 302
LH +++RD SN+LL N K++DFGLA + +K + GT Y +P
Sbjct: 128 LHS---HGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLC---GTPNYISP 181
Query: 303 EYVM-TGHLTAKSDVYSFGVVLLEMLTGR 330
E + H +SDV+S G + +L GR
Sbjct: 182 EIATRSAH-GLESDVWSLGCMFYTLLIGR 209
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 1e-30
Identities = 64/314 (20%), Positives = 107/314 (34%), Gaps = 45/314 (14%)
Query: 98 IGEELKISPQLRKFSFNELKSATKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLP 157
+G + + + SF P+ +LG G G + +
Sbjct: 1 MGSSPSLEQDDGDEETSVVIVGKISFCPKDVLGHGAEGTIVYRGMF----------DNRD 50
Query: 158 VAVKTLNHDGLQGHKEWLAEVNYLGGL-IHPNLVKLIGCCIEDDQRL-LVYEFMPRGSLE 215
VAVK + + EV L HPN+++ C +D Q + E +L+
Sbjct: 51 VAVKRILPECFSFADR---EVQLLRESDEHPNVIRYF-CTEKDRQFQYIAIELCA-ATLQ 105
Query: 216 NHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILL-----DGEYNA 270
++ ++ + + GLA LH +++RD K NIL+ G+ A
Sbjct: 106 EYVEQKDFAHLGLEPITLLQQTTSGLAHLHS---LNIVHRDLKPHNILISMPNAHGKIKA 162
Query: 271 KLSDFGLAK--DGPEGDKTHVSTRVMGTYGYAAPEYV---MTGHLTAKSDVYSFGVVLLE 325
+SDFGL K + S GT G+ APE + + T D++S G V
Sbjct: 163 MISDFGLCKKLAVGRHSFSRRSGVP-GTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYY 221
Query: 326 MLTGRRSMDKNRPNGEHNLVEWARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASC 385
+++ P G+ + Q L E +L
Sbjct: 222 VISEGS-----HPFGKSL-----QRQANILLGACSLDCLHPEKHED----VIARELIEKM 267
Query: 386 LNRDQKARPRMSEV 399
+ D + RP V
Sbjct: 268 IAMDPQKRPSAKHV 281
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 1e-30
Identities = 61/326 (18%), Positives = 117/326 (35%), Gaps = 58/326 (17%)
Query: 128 LLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGH--KEWLAEVNYLGGLI 185
+G GG V++ +N A+K +N + + E+ YL L
Sbjct: 16 QIGSGGSSKVFQV-LNEKKQI---------YAIKYVNLEEADNQTLDSYRNEIAYLNKLQ 65
Query: 186 HPNL--VKLIGCCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLA 242
+ ++L DQ + +V E L + L ++ + R + + +
Sbjct: 66 QHSDKIIRLYDY-EITDQYIYMVMEC-GNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVH 122
Query: 243 FLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAP 302
+H+ +++ D K +N L+ + KL DFG+A + V +GT Y P
Sbjct: 123 TIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPP 178
Query: 303 EYVM-----------TGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRP-NGEHNLVE--WA 348
E + ++ KSDV+S G +L M G+ P N + A
Sbjct: 179 EAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK------TPFQQIINQISKLHA 232
Query: 349 RPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVE----ALK 404
F + + + ++ CL RD K R + E++ ++
Sbjct: 233 IIDPNHEIEFPDIPEK---------DLQDVLK---CCLKRDPKQRISIPELLAHPYVQIQ 280
Query: 405 PLPYLKDMASSSSYVQAMQAERVRLN 430
P + ++ ++ + + V LN
Sbjct: 281 THPVNQMAKGTTEEMKYVLGQLVGLN 306
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 2e-30
Identities = 46/231 (19%), Positives = 82/231 (35%), Gaps = 49/231 (21%)
Query: 129 LGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLA------------ 176
L +G F + K A+K L+ +++
Sbjct: 39 LNQGKFNKIILC---------EK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKY 87
Query: 177 -----EVNYLGGLIHPNLVKLIGCCIEDDQRL-LVYEFMPRGSLENHL-------FRRSL 223
E+ + + + + G I + + ++YE+M S+ +
Sbjct: 88 DDFKNELQIITDIKNEYCLTCEGI-ITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTC 146
Query: 224 PLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPE 283
+P + I +++H EK + +RD K SNIL+D KLSDFG ++ +
Sbjct: 147 FIPIQVIKCIIKSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVD 204
Query: 284 GD-KTHVSTRVMGTYGYAAPEYVMTGHLT---AKSDVYSFGVVLLEMLTGR 330
K GTY + PE + + AK D++S G+ L M
Sbjct: 205 KKIKG-----SRGTYEFMPPE-FFSNESSYNGAKVDIWSLGICLYVMFYNV 249
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 3e-30
Identities = 55/207 (26%), Positives = 85/207 (41%), Gaps = 22/207 (10%)
Query: 128 LLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHK--EWLA-EVNYLGGL 184
LG+G FG VY + +A+K L L+ L E+ L
Sbjct: 21 PLGKGKFGNVYLA---------REKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHL 71
Query: 185 IHPNLVKLIGCCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAF 243
HPN++++ D +R+ L+ EF PRG L L ++ + A L +
Sbjct: 72 RHPNILRMYNY-FHDRKRIYLMLEFAPRGELYKEL-QKHGRFDEQRSATFMEELADALHY 129
Query: 244 LHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPE 303
HE + VI+RD K N+L+ + K++DFG + P + GT Y PE
Sbjct: 130 CHE---RKVIHRDIKPENLLMGYKGELKIADFGWSVHAP-SLRRRTMC---GTLDYLPPE 182
Query: 304 YVMTGHLTAKSDVYSFGVVLLEMLTGR 330
+ K D++ GV+ E L G
Sbjct: 183 MIEGKTHDEKVDLWCAGVLCYEFLVGM 209
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 123 bits (309), Expect = 3e-30
Identities = 67/357 (18%), Positives = 126/357 (35%), Gaps = 57/357 (15%)
Query: 128 LLGEGGFGCVYKGW-INMNGTATVKPGTGLPVAVKTLNHDGLQGHKE-WLAEVNYLGGLI 185
+ GG G +Y N+NG PV +K L H G + +AE +L ++
Sbjct: 87 CIAHGGLGWIYLALDRNVNGR---------PVVLKGLVHSGDAEAQAMAMAERQFLAEVV 137
Query: 186 HPNLVKLIGCCIEDDQRL-----LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKG 240
HP++V++ D+ +V E++ SL+ + LP+ +I L+
Sbjct: 138 HPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSK-GQKLPVAEAIA--YLLEILPA 194
Query: 241 LAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYA 300
L++LH ++Y D K NI+L E KL D G + GT G+
Sbjct: 195 LSYLHS---IGLVYNDLKPENIMLTEE-QLKLIDLGAVSR-----INSFGY-LYGTPGFQ 244
Query: 301 APEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRRFYR 360
APE ++ T +D+Y+ G L + + + +G P L + R
Sbjct: 245 APE-IVRTGPTVATDIYTVGRTLAALTLDLPTRNGRYVDGLPEDD----PVLKTYDSYGR 299
Query: 361 LIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPR-MSEVVEALKPLPYLKDMASSSSYV 419
L+ ++ D + R E+ L + L+++ + + V
Sbjct: 300 LL--------------------RRAIDPDPRQRFTTAEEMSAQLTGV--LREVVAQDTGV 337
Query: 420 QAMQAERVRLNLNAKHGSRVPRKGQPTRSLSIPNAPHVSPYHLNNPHYSPKPNVSQP 476
+ + G + +A ++ + P + +
Sbjct: 338 PRPGLSTIFSPSRSTFGVDLLVAHTDVYLDGQVHAEKLTANEIVTALSVPLVDPTDV 394
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 4e-30
Identities = 63/242 (26%), Positives = 112/242 (46%), Gaps = 20/242 (8%)
Query: 93 PSTPKIGEELKISPQLRKFSFNELKSATKS---FRPECLLGEGGFGCVYKGWINMNGTAT 149
++ + + +L F + K F LG G G V+K +
Sbjct: 2 KKLEELELDEQQRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFK--------VS 53
Query: 150 VKPGTGLPVAVKTLNHDG-LQGHKEWLAEVNYLGGLIHPNLVKLIGCCIEDDQRLLVYEF 208
KP +GL +A K ++ + + + E+ L P +V G D + + E
Sbjct: 54 HKP-SGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 112
Query: 209 MPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEY 268
M GSL+ + +++ +P I K+++ KGL +L E+ +++RD K SNIL++
Sbjct: 113 MDGGSLDQ-VLKKAGRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRG 169
Query: 269 NAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLT 328
KL DFG++ + + ++ V GT Y +PE + H + +SD++S G+ L+EM
Sbjct: 170 EIKLCDFGVSG---QLIDSMANSFV-GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAV 225
Query: 329 GR 330
GR
Sbjct: 226 GR 227
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 5e-30
Identities = 57/291 (19%), Positives = 103/291 (35%), Gaps = 54/291 (18%)
Query: 128 LLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGH--KEWLAEVNYLGGLI 185
+G GG V++ +N A+K +N + + E+ YL L
Sbjct: 35 QIGSGGSSKVFQV-LNEKKQI---------YAIKYVNLEEADNQTLDSYRNEIAYLNKLQ 84
Query: 186 HPNL--VKLIGCCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLA 242
+ ++L DQ + +V E L + L ++ + R + + +
Sbjct: 85 QHSDKIIRLYDY-EITDQYIYMVMECG-NIDLNSWLKKKK-SIDPWERKSYWKNMLEAVH 141
Query: 243 FLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAP 302
+H+ +++ D K +N L+ + KL DFG+A + V +GT Y P
Sbjct: 142 TIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPP 197
Query: 303 EYVM-----------TGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRP-NGEHNLVE--WA 348
E + ++ KSDV+S G +L M G+ P N + A
Sbjct: 198 EAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK------TPFQQIINQISKLHA 251
Query: 349 RPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEV 399
F + + + ++ CL RD K R + E+
Sbjct: 252 IIDPNHEIEFPDIPEK---------DLQDVLK---CCLKRDPKQRISIPEL 290
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 1e-29
Identities = 64/263 (24%), Positives = 97/263 (36%), Gaps = 36/263 (13%)
Query: 74 QPVVPIGSSSTTSNAESTTPSTPKIGEELKISPQLRKFSFNELKSATKSFRPECLLGEGG 133
P A + P +I E L R++ LG+GG
Sbjct: 6 DPGKAGVPGVAAPGAPAAAPPAKEIPEVLVDPRSRRRYVRGRF------------LGKGG 53
Query: 134 FGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHK---EWLAEVNYLGGLIHPNLV 190
F ++ T A K + L + E++ L H ++V
Sbjct: 54 FAKCFEI---------SDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVV 104
Query: 191 KLIGCCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAE 249
G ED+ + +V E R SL RR R G +LH
Sbjct: 105 GFHGF-FEDNDFVFVVLELCRRRSLLELHKRRKALTEPEAR-YYLRQIVLGCQYLHR--- 159
Query: 250 KPVIYRDFKTSNILLDGEYNAKLSDFGLA-KDGPEGDKTHVSTRVMGTYGYAAPEYVM-T 307
VI+RD K N+ L+ + K+ DFGLA K +G++ V GT Y APE +
Sbjct: 160 NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC---GTPNYIAPEVLSKK 216
Query: 308 GHLTAKSDVYSFGVVLLEMLTGR 330
GH + + DV+S G ++ +L G+
Sbjct: 217 GH-SFEVDVWSIGCIMYTLLVGK 238
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 118 bits (296), Expect = 1e-29
Identities = 40/323 (12%), Positives = 73/323 (22%), Gaps = 62/323 (19%)
Query: 115 ELKSATKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEW 174
L + + L G V+ A+K E
Sbjct: 56 LLSQGERKLKLVEPLRVGDRSVVFLV---------RDVERLEDFALKVFTMGAENSRSEL 106
Query: 175 ---LAEVNYLGGLIHPNLVKLIGCC-----------------------IEDDQRLLVYEF 208
L+ + + +D
Sbjct: 107 ERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLL 166
Query: 209 MPR--------GSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTS 260
MP S + ++ + + A L K +++ F
Sbjct: 167 MPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQS---KGLVHGHFTPD 223
Query: 261 NILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHL--TAKSDVYS 318
N+ + + L D G + S+ YA E++ T + +
Sbjct: 224 NLFIMPDGRLMLGDVSALW--KVGTRGPASS---VPVTYAPREFLNASTATFTHALNAWQ 278
Query: 319 FGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRRFYRLIDPCLEGCFSIKGAEKT 378
G+ + + P + W RP L C +K
Sbjct: 279 LGLSIYRVWCLFLPFGLVTPGIKG---SWKRPSLRVPGTDSLAFGSCTPLPDFVK----- 330
Query: 379 IQLAASCLNRDQKARPRMSEVVE 401
L LN D++ R E +E
Sbjct: 331 -TLIGRFLNFDRRRRLLPLEAME 352
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 2e-29
Identities = 58/210 (27%), Positives = 90/210 (42%), Gaps = 26/210 (12%)
Query: 128 LLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHK---EWLAEVNYLGGL 184
LG+GGF ++ T A K + L + E++ L
Sbjct: 22 FLGKGGFAKCFEI---------SDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSL 72
Query: 185 IHPNLVKLIGCCIEDDQRL-LVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALDAAKGLA 242
H ++V G ED+ + +V E R SL RR +L P + + G
Sbjct: 73 AHQHVVGFHGF-FEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQI--VLGCQ 129
Query: 243 FLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLA-KDGPEGDKTHVSTRVMGTYGYAA 301
+LH VI+RD K N+ L+ + K+ DFGLA K +G++ V GT Y A
Sbjct: 130 YLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC---GTPNYIA 183
Query: 302 PEYVM-TGHLTAKSDVYSFGVVLLEMLTGR 330
PE + GH + + DV+S G ++ +L G+
Sbjct: 184 PEVLSKKGH-SFEVDVWSIGCIMYTLLVGK 212
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 5e-29
Identities = 58/213 (27%), Positives = 91/213 (42%), Gaps = 23/213 (10%)
Query: 128 LLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLA----EVNYLGG 183
+LG GG V+ + VAVK L L + E
Sbjct: 19 ILGFGGMSEVHLARDLRDHR---------DVAVKVL-RADLARDPSFYLRFRREAQNAAA 68
Query: 184 LIHPNLVKL--IGCCIEDDQRL--LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAK 239
L HP +V + G L +V E++ +L + + P+ +++ DA +
Sbjct: 69 LNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIADACQ 127
Query: 240 GLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVST-RVMGTYG 298
L F H+ +I+RD K +NI++ K+ DFG+A+ + + T V+GT
Sbjct: 128 ALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 184
Query: 299 YAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRR 331
Y +PE + A+SDVYS G VL E+LTG
Sbjct: 185 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGEP 217
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 6e-29
Identities = 58/302 (19%), Positives = 100/302 (33%), Gaps = 66/302 (21%)
Query: 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVK--TLNHDGLQGHKEWLAE 177
T F +G G FG V+K VK G A+K G + L E
Sbjct: 10 TTEFHELEKIGSGEFGSVFKC---------VKRLDGCIYAIKRSKKPLAGSVDEQNALRE 60
Query: 178 VNYLGGLI-HPNLVKLIGCCIEDDQRLLVYEFMPRGSLENHL---FRRSLPLPWSIRMKI 233
V L H ++V+ EDD L+ E+ GSL + + +R + +
Sbjct: 61 VYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDL 120
Query: 234 ALDAAKGLAFLHEEAEKPVIYRDFKTSNILLD-------------------GEYNAKLSD 274
L +GL ++H + +++ D K SNI + + K+ D
Sbjct: 121 LLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGD 177
Query: 275 FGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM--TGHLTAKSDVYSFGVVLLEMLTGRRS 332
G V G + A E + HL K+D+++ + ++
Sbjct: 178 LGHVT---RISSPQVEE---GDSRFLANEVLQENYTHLP-KADIFALALTVVCAAGAEPL 230
Query: 333 MDKNRPNGEHNLVEWARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKA 392
P +W + G P + S ++ +L ++ D +
Sbjct: 231 -----PRNGD---QWHEIRQGRL--------PRIPQVLS----QEFTELLKVMIHPDPER 270
Query: 393 RP 394
RP
Sbjct: 271 RP 272
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 3e-28
Identities = 75/243 (30%), Positives = 100/243 (41%), Gaps = 25/243 (10%)
Query: 97 KIGEELKISPQLRKF---SFNELKSATKS-FRPECLLGEGGFGCVYKGWINMNGTATVKP 152
+ S +F + E + TK+ FR +LG+GGFG V A
Sbjct: 156 APFADYLDSIYFNRFLQWKWLERQPVTKNTFRQYRVLGKGGFGEVC---------ACQVR 206
Query: 153 GTGLPVAVKTLNHDGLQGHKEW---LAEVNYLGGLIHPNLVKLIGCCIEDDQRL-LVYEF 208
TG A K L ++ K L E L + +V L E L LV
Sbjct: 207 ATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLA-YAYETKDALCLVLTL 265
Query: 209 MPRGSLENHLFRRSLPLPWSIRMKI-ALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGE 267
M G L+ H++ R A + GL LH E ++YRD K NILLD
Sbjct: 266 MNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDH 322
Query: 268 YNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEML 327
+ ++SD GLA PEG RV GT GY APE V T D ++ G +L EM+
Sbjct: 323 GHIRISDLGLAVHVPEGQTIK--GRV-GTVGYMAPEVVKNERYTFSPDWWALGCLLYEMI 379
Query: 328 TGR 330
G+
Sbjct: 380 AGQ 382
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 5e-28
Identities = 42/370 (11%), Positives = 96/370 (25%), Gaps = 88/370 (23%)
Query: 79 IGSSSTTSNAESTTPSTPKIGEELKISPQLRKFSFNELKSATKSFRPECLLGEGGFGCVY 138
I ++ + +E + + + +EL ++ +LG+
Sbjct: 31 IPQANVRTTSEYMQSAADSLVSTSLWNTGQPFRVESELGERPRTLVRGTVLGQEDPYAYL 90
Query: 139 KGWINMNGTATVKPGTGLPVAVKTLNHDGL----------------------------QG 170
+ TG V +
Sbjct: 91 EA---------TDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKV 141
Query: 171 HKEWLAEVNYLGGLIHPNLVKLIGCC--IEDDQRLLVYEFMP-----RGSLENHLFRRSL 223
H ++ + + ++++ + R +Y M G +
Sbjct: 142 HLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHK 201
Query: 224 PLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPE 283
L R+++ L + LA LH +++ + +I+LD L+ F +
Sbjct: 202 SLVHHARLQLTLQVIRLLASLHH---YGLVHTYLRPVDIVLDQRGGVFLTGFEHLV--RD 256
Query: 284 GDKTHVSTRVMGTYGYAAPEYVMT-----------GHLTAKSDVYSFGVVLLEMLTGRRS 332
G + + G+ PE +T D ++ G+V+ +
Sbjct: 257 GAR----VVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD-- 310
Query: 333 MDKNRPNGEHNLVEWARPQLGERRRFYRLIDPCLEGCFSI-KGAEKTIQLAASCLNRDQK 391
P + + I C +I + L L ++
Sbjct: 311 ----LPITKDAALGG-----------SEWI---FRSCKNIPQPVR---ALLEGFLRYPKE 349
Query: 392 ARPRMSEVVE 401
R + +E
Sbjct: 350 DRLLPLQAME 359
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 1e-27
Identities = 65/238 (27%), Positives = 94/238 (39%), Gaps = 35/238 (14%)
Query: 107 QLRKFSFNELKSATKS-FRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNH 165
+ ++ + E + + F +LG GGFG V+ A TG A K LN
Sbjct: 170 RFLQWKWLEAQPMGEDWFLDFRVLGRGGFGEVF---------ACQMKATGKLYACKKLNK 220
Query: 166 DGLQGHKEW---LAEVNYLGGLIHPNLVKLIGCCIEDDQRL-LVYEFMPRGSLENHLFRR 221
L+ K + + E L + +V L E L LV M G + H++
Sbjct: 221 KRLKKRKGYQGAMVEKKILAKVHSRFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNV 279
Query: 222 SLPLPWSIRMKIALDAAK--------GLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLS 273
A GL LH+ +IYRD K N+LLD + N ++S
Sbjct: 280 D-----EDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRIS 331
Query: 274 DFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKS-DVYSFGVVLLEMLTGR 330
D GLA + G GT G+ APE ++ G S D ++ GV L EM+ R
Sbjct: 332 DLGLAVELKAGQTK-TKGYA-GTPGFMAPE-LLLGEEYDFSVDYFALGVTLYEMIAAR 386
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 2e-27
Identities = 51/227 (22%), Positives = 92/227 (40%), Gaps = 35/227 (15%)
Query: 128 LLGEGGFGCVYKGWINMNGTATVKP-GTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLI- 185
+L EGGF VY+ + G+G A+K L + + ++ + EV ++ L
Sbjct: 35 VLAEGGFAFVYE----------AQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSG 84
Query: 186 HPNLVKLIGCCIEDDQR-------LLVYEFMPRGSLENHLFRRSL--PLPWSIRMKIALD 236
HPN+V+ + L+ + +G L L + PL +KI
Sbjct: 85 HPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQ 144
Query: 237 AAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLA---KDGPEGDKTHVSTRV 293
+ + +H + P+I+RD K N+LL + KL DFG A P+ + +
Sbjct: 145 TCRAVQHMHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRAL 203
Query: 294 M-------GTYGYAAPEYV-MTGHL--TAKSDVYSFGVVLLEMLTGR 330
+ T Y PE + + + K D+++ G +L + +
Sbjct: 204 VEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQ 250
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 3e-27
Identities = 55/217 (25%), Positives = 87/217 (40%), Gaps = 24/217 (11%)
Query: 123 FRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDG-LQGHKEWLAEVN-Y 180
P LG G +G V K P +G +AVK + Q K L +++
Sbjct: 9 LEPIMELGRGAYGVVEK--------MRHVP-SGQIMAVKRIRATVNSQEQKRLLMDLDIS 59
Query: 181 LGGLIHPNLVKLIGCCIEDDQRLLVYEFMPRGSLEN---HLFRRSLPLPWSIRMKIALDA 237
+ + P V G + + E M SL+ + + +P I KIA+
Sbjct: 60 MRTVDCPFTVTFYGALFREGDVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSI 118
Query: 238 AKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTY 297
K L LH + VI+RD K SN+L++ K+ DFG++ G
Sbjct: 119 VKALEHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISG---YLVDDVAKDIDAGCK 173
Query: 298 GYAAPEYVMTGHL----TAKSDVYSFGVVLLEMLTGR 330
Y APE + + KSD++S G+ ++E+ R
Sbjct: 174 PYMAPERINPELNQKGYSVKSDIWSLGITMIELAILR 210
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 1e-26
Identities = 78/332 (23%), Positives = 130/332 (39%), Gaps = 76/332 (22%)
Query: 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWL-AEV 178
+ F +G+G FG V+KG N T VA+K ++ + + E + E+
Sbjct: 21 EELFTKLEKIGKGSFGEVFKGIDN---------RTQKVVAIKIIDLEEAEDEIEDIQQEI 71
Query: 179 NYLGGLIHPNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL--- 235
L P + K G ++D + ++ E++ GS + L L IA
Sbjct: 72 TVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQ-----IATILR 126
Query: 236 DAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTR--- 292
+ KGL +LH E I+RD K +N+LL KL+DFG+A G T +
Sbjct: 127 EILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVA-----GQLTDTQIKRNT 178
Query: 293 VMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGR---------RSM---DKNRPNG 340
+GT + APE + +K+D++S G+ +E+ G + + KN P
Sbjct: 179 FVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNP-- 236
Query: 341 EHNLVEWARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSE-- 398
P LEG +S + + +CLN++ RP E
Sbjct: 237 -----------------------PTLEGNYS----KPLKEFVEACLNKEPSFRPTAKELL 269
Query: 399 ----VVEALKPLPYLKDMASSSSYVQAMQAER 426
++ K YL ++ +A Q+
Sbjct: 270 KHKFILRNAKKTSYLTELIDRYKRWKAEQSHD 301
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 2e-26
Identities = 63/213 (29%), Positives = 91/213 (42%), Gaps = 30/213 (14%)
Query: 128 LLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEW---LAEVNYL--- 181
++G GGFG VY K TG A+K L+ ++ + L E L
Sbjct: 196 IIGRGGFGEVY---------GCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLV 246
Query: 182 GGLIHPNLVKLIGCCIEDDQRL-LVYEFMPRGSLENHLFR-RSLPLPWSIRMKI-ALDAA 238
P +V + +L + + M G L HL + M+ A +
Sbjct: 247 STGDCPFIVCMS-YAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEA---DMRFYAAEII 302
Query: 239 KGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYG 298
GL +H V+YRD K +NILLD + ++SD GLA D + K H V GT+G
Sbjct: 303 LGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSK-KKPH--ASV-GTHG 355
Query: 299 YAAPEYVMTGHLTAKS-DVYSFGVVLLEMLTGR 330
Y APE + G S D +S G +L ++L G
Sbjct: 356 YMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGH 388
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 3e-26
Identities = 68/281 (24%), Positives = 106/281 (37%), Gaps = 40/281 (14%)
Query: 123 FRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDG-LQGHKEWLAEVNYL 181
+G G G V+K TG +AVK + G + +K L +++ +
Sbjct: 27 LENLGEMGSGTCGQVWKMRFR---------KTGHVIAVKQMRRSGNKEENKRILMDLDVV 77
Query: 182 GGLI-HPNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKG 240
P +V+ G I + + E M E R P+P I K+ + K
Sbjct: 78 LKSHDCPYIVQCFGTFITNTDVFIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKA 136
Query: 241 LAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYA 300
L +L E+ VI+RD K SNILLD KL DFG++ R G Y
Sbjct: 137 LYYLKEK--HGVIHRDVKPSNILLDERGQIKLCDFGISG---RLVDDKAKDRSAGCAAYM 191
Query: 301 APEYVMTGHL-----TAKSDVYSFGVVLLEMLTGRRSMDKNRPNGE--HNLVEWARPQLG 353
APE + ++DV+S G+ L+E+ TG+ + + E +++ P L
Sbjct: 192 APERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLP 251
Query: 354 ERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARP 394
F + CL +D + RP
Sbjct: 252 GHMGF----------------SGDFQSFVKDCLTKDHRKRP 276
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 4e-26
Identities = 59/211 (27%), Positives = 96/211 (45%), Gaps = 18/211 (8%)
Query: 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVN 179
K + +G+G G VY TG VA++ +N + + E+
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDV---------ATGQEVAIRQMNLQQQPKKELIINEIL 69
Query: 180 YLGGLIHPNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAK 239
+ +PN+V + + D+ +V E++ GSL + + + I + + +
Sbjct: 70 VMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQ-I-AAVCRECLQ 127
Query: 240 GLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGL-AKDGPEGDKTHVSTRVMGTYG 298
L FLH VI+RD K+ NILL + + KL+DFG A+ PE K T V GT
Sbjct: 128 ALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS--TMV-GTPY 181
Query: 299 YAAPEYVMTGHLTAKSDVYSFGVVLLEMLTG 329
+ APE V K D++S G++ +EM+ G
Sbjct: 182 WMAPEVVTRKAYGPKVDIWSLGIMAIEMIEG 212
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 6e-26
Identities = 59/250 (23%), Positives = 103/250 (41%), Gaps = 21/250 (8%)
Query: 81 SSSTTSNAESTTPSTPKIGEELKISPQLRKFSFNELKSATKSFRPECLLGEGGFGCVYKG 140
SS E+ + + E + LR +GEG G V
Sbjct: 8 SSGVDLGTENLYFQSGVVTHE-QFKAALRMVVDQG--DPRLLLDSYVKIGEGSTGIVCLA 64
Query: 141 WINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHPNLVKLIGCCIEDD 200
+G VAVK ++ Q + EV + H N+V++ + +
Sbjct: 65 REK---------HSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGE 115
Query: 201 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTS 260
+ ++ EF+ G+L + + + L + + LA+LH + VI+RD K+
Sbjct: 116 ELWVLMEFLQGGALTDIV--SQVRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSD 170
Query: 261 NILLDGEYNAKLSDFGL-AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSF 319
+ILL + KLSDFG A+ + K + V GT + APE + + D++S
Sbjct: 171 SILLTLDGRVKLSDFGFCAQISKDVPKRK--SLV-GTPYWMAPEVISRSLYATEVDIWSL 227
Query: 320 GVVLLEMLTG 329
G++++EM+ G
Sbjct: 228 GIMVIEMVDG 237
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 9e-26
Identities = 36/248 (14%), Positives = 71/248 (28%), Gaps = 63/248 (25%)
Query: 128 LLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHD--------------------- 166
+LG+ + TG V
Sbjct: 85 VLGQEDPYAYLEA---------TDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLL 135
Query: 167 -GLQGHKEWLAEVNYLGG---LIHPNLVKLIGCCIEDDQRLLVYEF--MPRGSLENHLFR 220
G++ K+ + ++ + P K+I +++ ++ F PR F
Sbjct: 136 RGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFG 195
Query: 221 RSL--------PLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKL 272
L L R+++ L + LA LH +++ + +I+LD L
Sbjct: 196 EVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH---YGLVHTYLRPVDIVLDQRGGVFL 252
Query: 273 SDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM----------TGHLTAKSDVYSFGVV 322
+ F +G S G+A PE +T D ++ G+
Sbjct: 253 TGFEHLV--RDGA----SAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLA 306
Query: 323 LLEMLTGR 330
+ +
Sbjct: 307 IYWIWCAD 314
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 2e-25
Identities = 61/253 (24%), Positives = 102/253 (40%), Gaps = 34/253 (13%)
Query: 86 SNAESTTPSTPKIGEELKISPQLRKFSFNELKSATKSFRPECLLGEGGFGCVYKGWINMN 145
A P + + + PQ RK F+ +LGEG F V
Sbjct: 3 GTAAEPRPGAGSL-QHAQPPPQPRKKRPE-------DFKFGKILGEGSFSTVV------- 47
Query: 146 GTATVKPGTGLPVAVKTLNHDGLQGHKEW---LAEVNYLGGLIHPNLVKLIGCCIEDDQR 202
A T A+K L + + E + + L HP VKL +DD++
Sbjct: 48 -LAREL-ATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTF-QDDEK 104
Query: 203 L-LVYEFMPRGSLENHLFR-RSLPLPWSIRMKIA--LDAAKGLAFLHEEAEKPVIYRDFK 258
L + G L ++ + S + R A + A L +LH K +I+RD K
Sbjct: 105 LYFGLSYAKNGELLKYIRKIGSFDETCT-RFYTAEIVSA---LEYLHG---KGIIHRDLK 157
Query: 259 TSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTAKSDVY 317
NILL+ + + +++DFG AK K + +GT Y +PE + + SD++
Sbjct: 158 PENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKS-SDLW 216
Query: 318 SFGVVLLEMLTGR 330
+ G ++ +++ G
Sbjct: 217 ALGCIIYQLVAGL 229
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-25
Identities = 80/383 (20%), Positives = 127/383 (33%), Gaps = 73/383 (19%)
Query: 117 KSATKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLA 176
+S E +LG G G V G+ G PVAVK + + L
Sbjct: 11 QSLKNLVVSEKILGYGSSGTVVFQ-----GSFQ-----GRPVAVKRML---IDFCDIALM 57
Query: 177 EVNYLGGLI-HPNLVKLIGCCIEDDQRL-LVYEFMPRGSL-----ENHLFRRSLPLPWSI 229
E+ L HPN+++ C D+ L + E +L ++ +L L
Sbjct: 58 EIKLLTESDDHPNVIRYY-CSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEY 115
Query: 230 RMKIAL-DAAKGLAFLHEEAEKPVIYRDFKTSNILLD-------------GEYNAKLSDF 275
L A G+A LH +I+RD K NIL+ +SDF
Sbjct: 116 NPISLLRQIASGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDF 172
Query: 276 GLAK---DGPEGDKTHVSTRVMGTYGYAAPE-------YVMTGHLTAKSDVYSFGVVLLE 325
GL K G +T+++ GT G+ APE LT D++S G V
Sbjct: 173 GLCKKLDSGQSSFRTNLNNPS-GTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYY 231
Query: 326 MLTGRRSMDKNRPNGEHNLVEWARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASC 385
+L+ G+H + + R + L + S+ + L +
Sbjct: 232 ILSK----------GKHPFGDKYSRESNIIRGIFSLDEMKCLHDRSL--IAEATDLISQM 279
Query: 386 LNRDQKARPRMSEV------VEALKPLPYLKDMASSSSYVQAMQAERVRLNLNA--KHGS 437
++ D RP +V K L +L + S ++ + L
Sbjct: 280 IDHDPLKRPTAMKVLRHPLFWPKSKKLEFLLKV---SDRLEIENRDPPSALLMKFDAGSD 336
Query: 438 RVPRKGQPTRSLSIPNAPHVSPY 460
V G T ++ Y
Sbjct: 337 FVIPSGDWTVKFDKTFMDNLERY 359
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 2e-25
Identities = 63/233 (27%), Positives = 104/233 (44%), Gaps = 21/233 (9%)
Query: 101 ELKISPQLRKFSFNELKSA---TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLP 157
+L+ P+ + +E + F LGEG +G VYK TG
Sbjct: 6 QLRNPPRRQLKKLDEDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHK---------ETGQI 56
Query: 158 VAVKTLNHDGLQGHKEWLAEVNYLGGLIHPNLVKLIGCCIEDDQRLLVYEFMPRGSLENH 217
VA+K + + +E + E++ + P++VK G ++ +V E+ GS+ +
Sbjct: 57 VAIKQVPVE--SDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDI 114
Query: 218 LFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGL 277
+ R+ L I KGL +LH I+RD K NILL+ E +AKL+DFG+
Sbjct: 115 IRLRNKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGV 171
Query: 278 -AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTG 329
+ K + V+GT + APE + +D++S G+ +EM G
Sbjct: 172 AGQLTDTMAKRNT---VIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEG 221
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 3e-25
Identities = 55/218 (25%), Positives = 95/218 (43%), Gaps = 25/218 (11%)
Query: 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVN 179
+ + LG+G FG VYK TG A K + + ++++ E+
Sbjct: 18 NEVWEIVGELGDGAFGKVYKA---------KNKETGALAAAKVIETKSEEELEDYIVEIE 68
Query: 180 YLGGLIHPNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAK 239
L HP +VKL+G D + ++ EF P G+++ + L + +
Sbjct: 69 ILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLE 128
Query: 240 GLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTR---VMGT 296
L FLH + +I+RD K N+L+ E + +L+DFG++ + +GT
Sbjct: 129 ALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVS-----AKNLKTLQKRDSFIGT 180
Query: 297 YGYAAPEYVMTGHLT-----AKSDVYSFGVVLLEMLTG 329
+ APE VM + K+D++S G+ L+EM
Sbjct: 181 PYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQI 218
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 4e-25
Identities = 60/219 (27%), Positives = 90/219 (41%), Gaps = 40/219 (18%)
Query: 128 LLGEGGFGCVYKGWINMNGTATV-KPGTGLPVAVKTLNHDGLQGHKEW---LAEVNYLGG 183
+G+G FG V V K T A+K +N E E+ + G
Sbjct: 22 AIGKGSFGKVCI----------VQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQG 71
Query: 184 LIHPNLVKLIGCCIEDDQRL-LVYEFMPRGSLENHLFR-RSLPLPWSIRMK-----IALD 236
L HP LV L +D++ + +V + + G L HL + +K + +
Sbjct: 72 LEHPFLVNLW-YSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEE---TVKLFICELVM- 126
Query: 237 AAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGT 296
L +L + +I+RD K NILLD + ++DF +A P + T + GT
Sbjct: 127 ---ALDYLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQI---TTMAGT 177
Query: 297 YGYAAPEYVM----TGHLTAKSDVYSFGVVLLEMLTGRR 331
Y APE G+ A D +S GV E+L GRR
Sbjct: 178 KPYMAPEMFSSRKGAGYSFA-VDWWSLGVTAYELLRGRR 215
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 4e-25
Identities = 79/308 (25%), Positives = 116/308 (37%), Gaps = 44/308 (14%)
Query: 36 KFRFIGGCLSSSPKTDGANSGTSTQYAES-KSTNDTSRGQPVVPIGSSSTTSNAESTTPS 94
FI CL T + E+ + + + V G +
Sbjct: 70 PNTFIIRCL------QWTTVIERTFHVETPEEREEWTTAIQTVADGLKKQAAAEMDFRSG 123
Query: 95 TPKIGE-----ELKISPQLRKFSFNELKSATKSFRPECLLGEGGFGCVYKGWINMNGTAT 149
+P E+ ++ + + NE F LLG+G FG V
Sbjct: 124 SPSDNSGAEEMEVSLAKPKHRVTMNE-------FEYLKLLGKGTFGKVI---------LV 167
Query: 150 VKPGTGLPVAVKTLNHDGLQGHKEW---LAEVNYLGGLIHPNLVKLIGCCIEDDQRL-LV 205
+ TG A+K L + + E L E L HP L L + RL V
Sbjct: 168 KEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK-YSFQTHDRLCFV 226
Query: 206 YEFMPRGSLENHLFR-RSLPLPWSIRMKI-ALDAAKGLAFLHEEAEKPVIYRDFKTSNIL 263
E+ G L HL R R R + + L +LH +EK V+YRD K N++
Sbjct: 227 MEYANGGELFFHLSRERVFSED---RARFYGAEIVSALDYLH--SEKNVVYRDLKLENLM 281
Query: 264 LDGEYNAKLSDFGLAKDGPEGDKTHVSTRVM-GTYGYAAPEYVMTGHLTAKSDVYSFGVV 322
LD + + K++DFGL K+G + T + GT Y APE + D + GVV
Sbjct: 282 LDKDGHIKITDFGLCKEGIKDGAT---MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVV 338
Query: 323 LLEMLTGR 330
+ EM+ GR
Sbjct: 339 MYEMMCGR 346
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 4e-25
Identities = 72/318 (22%), Positives = 123/318 (38%), Gaps = 57/318 (17%)
Query: 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLA-EVN 179
+ + ++G G V A P VA+K +N + Q + L E+
Sbjct: 15 DDYELQEVIGSGATAVVQA--------AYCAP-KKEKVAIKRINLEKCQTSMDELLKEIQ 65
Query: 180 YLGGLIHPNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK-----IA 234
+ HPN+V + D+ LV + + GS+ + + + IA
Sbjct: 66 AMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSV-LDIIKHIVAKGEHKSGVLDESTIA 124
Query: 235 L---DAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGL-AKDGPEGDKTHVS 290
+ +GL +LH+ I+RD K NILL + + +++DFG+ A GD T
Sbjct: 125 TILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNK 181
Query: 291 TR--VMGTYGYAAPEYVMTGHL-TAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEW 347
R +GT + APE + K+D++SFG+ +E+ TG K P
Sbjct: 182 VRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPM-------- 233
Query: 348 ARPQLGERRRFYRLI----DPCLEGCFSIKGAEKT-----IQLAASCLNRDQKARPRMSE 398
+ L P LE K K ++ + CL +D + RP +E
Sbjct: 234 ---------KVLMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAE 284
Query: 399 V-----VEALKPLPYLKD 411
+ + K +L++
Sbjct: 285 LLRHKFFQKAKNKEFLQE 302
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 6e-25
Identities = 61/218 (27%), Positives = 90/218 (41%), Gaps = 25/218 (11%)
Query: 123 FRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDG-LQGHKEWLAEVN-Y 180
+ +G G +G V K KP +G +AVK + + K+ L +++
Sbjct: 24 LKDLGEIGRGAYGSVNK--------MVHKP-SGQIMAVKRIRSTVDEKEQKQLLMDLDVV 74
Query: 181 LGGLIHPNLVKLIGCCIEDDQRLLVYEFMPRGSLENHL----FRRSLPLPWSIRMKIALD 236
+ P +V+ G + + E M S + +P I KI L
Sbjct: 75 MRSSDCPYIVQFYGALFREGDCWICMELMS-TSFDKFYKYVYSVLDDVIPEEILGKITLA 133
Query: 237 AAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGT 296
K L L E +I+RD K SNILLD N KL DFG++ + + TR G
Sbjct: 134 TVKALNHLKEN--LKIIHRDIKPSNILLDRSGNIKLCDFGISG---QLVDSIAKTRDAGC 188
Query: 297 YGYAAPEYVMTGHL----TAKSDVYSFGVVLLEMLTGR 330
Y APE + +SDV+S G+ L E+ TGR
Sbjct: 189 RPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGR 226
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 7e-25
Identities = 65/310 (20%), Positives = 109/310 (35%), Gaps = 53/310 (17%)
Query: 46 SSPKTDGANSGTSTQYAESKSTNDTSRGQPVVPIGSSSTTSNAESTTPSTPKIGEELKIS 105
+ + ++ + R P + P + +
Sbjct: 19 RRRARREIRHLPNLNREQRRAFIRSLRDDPSQSANLLAEAKKLNDAQPKGTENLYFQSMG 78
Query: 106 PQLRKFSFNELKSATKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNH 165
P+ + K + + P+ ++G G V + V TG AVK +
Sbjct: 79 PEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRC---------VHRATGHEFAVKIMEV 129
Query: 166 DGLQGHKEWLA--------EVNYLGGLI-HPNLVKLIGCCIEDDQRL-LVYEFMPRGSLE 215
+ E L E + L + HP+++ LI E + LV++ M +G E
Sbjct: 130 TAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSY-ESSSFMFLVFDLMRKG--E 186
Query: 216 NHLFRRSLPLPWSIRMKIAL---DAAK-------GLAFLHEEAEKPVIYRDFKTSNILLD 265
LF + K+AL + ++FLH +++RD K NILLD
Sbjct: 187 --LFDY-------LTEKVALSEKETRSIMRSLLEAVSFLHA---NNIVHRDLKPENILLD 234
Query: 266 GEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPE------YVMTGHLTAKSDVYSF 319
+LSDFG + G+K GT GY APE + D+++
Sbjct: 235 DNMQIRLSDFGFSCHLEPGEKL--RELC-GTPGYLAPEILKCSMDETHPGYGKEVDLWAC 291
Query: 320 GVVLLEMLTG 329
GV+L +L G
Sbjct: 292 GVILFTLLAG 301
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 74/251 (29%), Positives = 103/251 (41%), Gaps = 45/251 (17%)
Query: 94 STPKIGEELKISPQLRKFS---FNELKSATKSFRPECLLGEGGFGCVYKGWINMNGTATV 150
S +I + K F LK +LG+G FG V
Sbjct: 4 SIKEIAITHHVKEGHEKADPSQFELLK----------VLGQGSFGKV------FLVKKIS 47
Query: 151 KPGTGLPVAVKTLNHDGLQGHKEW--LAEVNYLGGLIHPNLVKLIGCCIEDDQRL-LVYE 207
A+K L L+ E + L + HP +VKL + + +L L+ +
Sbjct: 48 GSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLH-YAFQTEGKLYLILD 106
Query: 208 FMPRGSLENHLFR-RSLPLPWSIRMK-----IALDAAKGLAFLHEEAEKPVIYRDFKTSN 261
F+ G L L + +K +AL L LH +IYRD K N
Sbjct: 107 FLRGGDLFTRLSKEVMFTEE---DVKFYLAELAL----ALDHLHS---LGIIYRDLKPEN 156
Query: 262 ILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVM-GTYGYAAPEYVM-TGHLTAKSDVYSF 319
ILLD E + KL+DFGL+K+ + +K GT Y APE V GH T +D +SF
Sbjct: 157 ILLDEEGHIKLTDFGLSKESIDHEKK---AYSFCGTVEYMAPEVVNRRGH-TQSADWWSF 212
Query: 320 GVVLLEMLTGR 330
GV++ EMLTG
Sbjct: 213 GVLMFEMLTGT 223
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 1e-24
Identities = 51/226 (22%), Positives = 83/226 (36%), Gaps = 30/226 (13%)
Query: 120 TKSFRPECLLGEG--GFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQ--GHKEWL 175
+ ++G+G V A KP TG V V+ +N +
Sbjct: 24 GGCYELLTVIGKGFEDLMTVNL--------ARYKP-TGEYVTVRRINLEACSNEMVTFLQ 74
Query: 176 AEVNYLGGLIHPNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 235
E++ HPN+V I D++ +V FM GS + L + + IA
Sbjct: 75 GELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAK-DLICTHFMDGMN-ELAIAY 132
Query: 236 ---DAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFG-LAKDGPEGDKTHV-- 289
K L ++H ++R K S+IL+ + LS G + V
Sbjct: 133 ILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVH 189
Query: 290 --STRVMGTYGYAAPEYVMTGHL---TAKSDVYSFGVVLLEMLTGR 330
+ + +PE V+ +L AKSD+YS G+ E+ G
Sbjct: 190 DFPKYSVKVLPWLSPE-VLQQNLQGYDAKSDIYSVGITACELANGH 234
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 1e-24
Identities = 63/251 (25%), Positives = 104/251 (41%), Gaps = 30/251 (11%)
Query: 89 ESTTPSTPKIGEELKISPQLRKFSFNELKSATKSFRPECLLGEGGFGCVYKGWINMNGTA 148
S+ +L+ +P + F ++ ++ ++ LG G +G V
Sbjct: 7 HSSGRENLYFQGDLQATPGM--FITSKKGHLSEMYQRVKKLGSGAYGEVLL--------C 56
Query: 149 TVKPGTGLPVAVKTLNHDGLQG--HKEWLAEVNYLGGLIHPNLVKLIGCCIEDDQRL-LV 205
K T + A+K + + + + L EV L L HPN++KL ED + LV
Sbjct: 57 RDK-VTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFF-EDKRNYYLV 114
Query: 206 YEFMPRGSLENHLFRRSLPLPWSIRM--KIALDAAKGLAFLHEEAEKPVIYRDFKTSNIL 263
E G L + + R ++ I G+ +LH + +++RD K N+L
Sbjct: 115 MECYKGGELFDEIIHRM---KFNEVDAAVIIKQVLSGVTYLH---KHNIVHRDLKPENLL 168
Query: 264 L---DGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFG 320
L + + K+ DFGL+ K +GT Y APE V+ K DV+S G
Sbjct: 169 LESKEKDALIKIVDFGLSAVFENQKKMK---ERLGTAYYIAPE-VLRKKYDEKCDVWSIG 224
Query: 321 VVLLEMLTGRR 331
V+L +L G
Sbjct: 225 VILFILLAGYP 235
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 69/264 (26%), Positives = 108/264 (40%), Gaps = 33/264 (12%)
Query: 74 QPVVPIGSSSTTSNAESTTPSTPKIGEELKISPQLRKFSFNELKSATKSFRPECLLGEGG 133
+P + A P+ + G P + + F + K F +G G
Sbjct: 11 DYDIPTTENLYFQGAMDPMPAGGRAGSLKD--PDVAELFFKD--DPEKLFSDLREIGHGS 66
Query: 134 FGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEW---LAEVNYLGGLIHPNLV 190
FG VY VA+K +++ G Q +++W + EV +L L HPN +
Sbjct: 67 FGAVYFARDV---------RNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTI 117
Query: 191 KLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEK 250
+ GC + + LV E+ GS + L PL + A +GLA+LH
Sbjct: 118 QYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN-- 174
Query: 251 PVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTR--VMGTYGYAAPEYVMT- 307
+I+RD K NILL KL DFG A + ++ +GT + APE ++
Sbjct: 175 -MIHRDVKAGNILLSEPGLVKLGDFGSA--------SIMAPANSFVGTPYWMAPEVILAM 225
Query: 308 --GHLTAKSDVYSFGVVLLEMLTG 329
G K DV+S G+ +E+
Sbjct: 226 DEGQYDGKVDVWSLGITCIELAER 249
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 68/236 (28%), Positives = 99/236 (41%), Gaps = 42/236 (17%)
Query: 103 KISPQLRKFSFNELKSATKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKT 162
K++ F+ LK LLG+G FG V + TG A+K
Sbjct: 1 KVTMN----DFDYLK----------LLGKGTFGKVIL---------VREKATGRYYAMKI 37
Query: 163 LNHDGLQGHKEW---LAEVNYLGGLIHPNLVKLIGCCIEDDQRL-LVYEFMPRGSLENHL 218
L + + E + E L HP L L + RL V E+ G L HL
Sbjct: 38 LRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK-YAFQTHDRLCFVMEYANGGELFFHL 96
Query: 219 FR-RSLPLPWSIRMKI-ALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFG 276
R R R + + L +LH + V+YRD K N++LD + + K++DFG
Sbjct: 97 SRERVFTEE---RARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFG 150
Query: 277 LAKDGPEGDKTHVSTRVM-GTYGYAAPEYVMTGHLTAKS-DVYSFGVVLLEMLTGR 330
L K+G T + GT Y APE V+ + ++ D + GVV+ EM+ GR
Sbjct: 151 LCKEGISDGAT---MKTFCGTPEYLAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGR 202
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 4e-24
Identities = 50/255 (19%), Positives = 90/255 (35%), Gaps = 34/255 (13%)
Query: 94 STPKIGEELKISPQLRKFSFNELKSATKSFRPEC-----LLGEGGFGCVYKGWINMNGTA 148
++ ++ ++ L+ ++ + + ++G G F V
Sbjct: 29 GASELAQDKYVADFLQWAEPIVVRLKEVRLQRDDFEILKVIGRGAFSEVAV--------- 79
Query: 149 TVKPGTGLPVAVKTLNHDGLQGHKE---WLAEVNYLGGLIHPNLVKLIGCCIEDDQRL-L 204
TG A+K +N + E + E + L + +L +D+ L L
Sbjct: 80 VKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLH-FAFQDENYLYL 138
Query: 205 VYEFMPRGSLENHLFR--RSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNI 262
V E+ G L L + +P + R +A + + +H ++RD K NI
Sbjct: 139 VMEYYVGGDLLTLLSKFGERIPAEMA-RFYLA-EIVMAIDSVHR---LGYVHRDIKPDNI 193
Query: 263 LLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVY----- 317
LLD + +L+DFG V GT Y +PE + + Y
Sbjct: 194 LLDRCGHIRLADFGSCLKLRADGTVRSLVAV-GTPDYLSPEILQAVGGGPGTGSYGPECD 252
Query: 318 --SFGVVLLEMLTGR 330
+ GV EM G+
Sbjct: 253 WWALGVFAYEMFYGQ 267
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 4e-24
Identities = 65/302 (21%), Positives = 111/302 (36%), Gaps = 41/302 (13%)
Query: 45 SSSPKTDGANSGTSTQYAESKSTNDTSRGQPVVPIGSSSTTSNAESTTPSTPKIGEELKI 104
S D Q ++ D+ G S+ S + I
Sbjct: 7 HHSSGVDLGTENLYFQSMKNSGDQDSRSGHNEAKEVWSNADLTERMPVKSKRTSALAVDI 66
Query: 105 SPQLRKFSFNELKSATKSFR------PECLLGEGGFGCVYKGWINMNGTATVKPGTGLPV 158
F + + + +LG G FG V+K TGL +
Sbjct: 67 PAPPAPFDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHK--------CEET-ATGLKL 117
Query: 159 AVKTLNHDGLQGHKEWLAEVNYLGGLIHPNLVKLIGCCIEDDQRL-LVYEFMPRGSL--- 214
A K + G++ +E E++ + L H NL++L E + LV E++ G L
Sbjct: 118 AAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYD-AFESKNDIVLVMEYVDGGELFDR 176
Query: 215 ---ENHLF--RRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILL--DGE 267
E++ ++ MK + G+ +H + +++ D K NIL
Sbjct: 177 IIDESYNLTELDTILF-----MKQICE---GIRHMH---QMYILHLDLKPENILCVNRDA 225
Query: 268 YNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEML 327
K+ DFGLA+ +K V GT + APE V ++ +D++S GV+ +L
Sbjct: 226 KQIKIIDFGLARRYKPREKLKV---NFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLL 282
Query: 328 TG 329
+G
Sbjct: 283 SG 284
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 7e-24
Identities = 72/256 (28%), Positives = 101/256 (39%), Gaps = 42/256 (16%)
Query: 93 PSTPKIGEELKISPQLRKFSFNELKSATKSFRPEC-----LLGEGGFGCVYKGWINMNGT 147
P P++ P N S+ +P ++G+G FG V
Sbjct: 5 PQEPELMNANPAPPPAPSQQINLGPSSNPHAKPSDFHFLKVIGKGSFGKVLL-------- 56
Query: 148 ATVKPGTGLPVAVKTLNHDGLQGHKEW---LAEVNYLGGLI-HPNLVKLIGCCIEDDQRL 203
+ AVK L + KE ++E N L + HP LV L + +L
Sbjct: 57 -ARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH-FSFQTADKL 114
Query: 204 -LVYEFMPRGSLENHLFR-RSLPLPWSIRMK-----IALDAAKGLAFLHEEAEKPVIYRD 256
V +++ G L HL R R P R + IA L +LH ++YRD
Sbjct: 115 YFVLDYINGGELFYHLQRERCFLEP---RARFYAAEIAS----ALGYLHS---LNIVYRD 164
Query: 257 FKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVM-GTYGYAAPEYVM-TGHLTAKS 314
K NILLD + + L+DFGL K+ E + T T GT Y APE + +
Sbjct: 165 LKPENILLDSQGHIVLTDFGLCKENIEHNST---TSTFCGTPEYLAPEVLHKQPY-DRTV 220
Query: 315 DVYSFGVVLLEMLTGR 330
D + G VL EML G
Sbjct: 221 DWWCLGAVLYEMLYGL 236
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 1e-23
Identities = 63/269 (23%), Positives = 105/269 (39%), Gaps = 51/269 (18%)
Query: 87 NAESTTPSTPKIGEELKISPQLRKFSFNELKSATKSFRPECLLGEGGFGCVYKGWINMNG 146
+ ++ + + I+P + + + +S+ LG G +G V
Sbjct: 4 HHHHSSGRENLYFQGIAINPGM--YVRKKEGKIGESYFKVRKLGSGAYGEVLLC------ 55
Query: 147 TATVKPGTGLPVAVKTLN------------HDGLQGHKEWLA-EVNYLGGLIHPNLVKLI 193
+ A+K + + ++ E + E++ L L HPN++KL
Sbjct: 56 ---KEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLF 112
Query: 194 GCCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAK-------GLAFLH 245
ED + LV EF G L + R + DAA G+ +LH
Sbjct: 113 DVF-EDKKYFYLVTEFYEGGELFEQIINRH---KFDEC-----DAANIMKQILSGICYLH 163
Query: 246 EEAEKPVIYRDFKTSNILL---DGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAP 302
+ +++RD K NILL + N K+ DFGL+ + K +GT Y AP
Sbjct: 164 ---KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLR---DRLGTAYYIAP 217
Query: 303 EYVMTGHLTAKSDVYSFGVVLLEMLTGRR 331
E V+ K DV+S GV++ +L G
Sbjct: 218 E-VLKKKYNEKCDVWSCGVIMYILLCGYP 245
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 1e-23
Identities = 68/287 (23%), Positives = 105/287 (36%), Gaps = 47/287 (16%)
Query: 62 AESKSTNDTSRGQPVVPIGSSSTTSNAESTTPSTPKIGEELKISPQLRKFS---FNELKS 118
A ++ G G+S+ + + ++ K F LK
Sbjct: 2 AHHHHHHEEEGGSSGGAAGTSADGGDGGEQLLTVKHELRTANLTGHAEKVGIENFELLK- 60
Query: 119 ATKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEW---- 174
+LG G +G V TG A+K L + +
Sbjct: 61 ---------VLGTGAYGKV------FLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHT 105
Query: 175 LAEVNYLGGLIH-PNLVKLIGCCIEDDQRL-LVYEFMPRGSLENHLFR-RSLPLPWSIRM 231
E L + P LV L + + +L L+ +++ G L HL + +
Sbjct: 106 RTERQVLEHIRQSPFLVTLH-YAFQTETKLHLILDYINGGELFTHLSQRERFTEH---EV 161
Query: 232 K-----IALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDK 286
+ I L L LH+ +IYRD K NILLD + L+DFGL+K+ +
Sbjct: 162 QIYVGEIVL----ALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADET 214
Query: 287 THVSTRVMGTYGYAAPEYVM---TGHLTAKSDVYSFGVVLLEMLTGR 330
GT Y AP+ V +GH A D +S GV++ E+LTG
Sbjct: 215 ERAYDFC-GTIEYMAPDIVRGGDSGHDKA-VDWWSLGVLMYELLTGA 259
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 99 bits (250), Expect = 1e-23
Identities = 65/221 (29%), Positives = 94/221 (42%), Gaps = 34/221 (15%)
Query: 123 FRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHK---EW-LAEV 178
F +LG+GG+G V TG A+K L + + AE
Sbjct: 19 FELLRVLGKGGYGKV------FQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAER 72
Query: 179 NYLGGLIHPNLVKLIGCCIEDDQRL-LVYEFMPRGSLENHLFR-RSLPLPWSIRMK---- 232
N L + HP +V LI + +L L+ E++ G L L R
Sbjct: 73 NILEEVKHPFIVDLI-YAFQTGGKLYLILEYLSGGELFMQLEREGIFMED---TACFYLA 128
Query: 233 -IALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVST 291
I++ L LH+ K +IYRD K NI+L+ + + KL+DFGL K+ T
Sbjct: 129 EISM----ALGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTV---T 178
Query: 292 RVM-GTYGYAAPEYVM-TGHLTAKSDVYSFGVVLLEMLTGR 330
GT Y APE +M +GH D +S G ++ +MLTG
Sbjct: 179 HTFCGTIEYMAPEILMRSGH-NRAVDWWSLGALMYDMLTGA 218
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 98.8 bits (247), Expect = 2e-23
Identities = 61/214 (28%), Positives = 88/214 (41%), Gaps = 33/214 (15%)
Query: 128 LLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLA-EVNYLGGLIH 186
LGEG +G V +N T VAVK ++ E + E+ L H
Sbjct: 14 TLGEGAYGEVQLA-VNRV--------TEEAVAVKIVDMKRAVDCPENIKKEICINKMLNH 64
Query: 187 PNLVKLIGCCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAK------ 239
N+VK G + L E+ G L + + I M DA +
Sbjct: 65 ENVVKFYGH-RREGNIQYLFLEYCSGGELFDRIEPD-------IGMPEP-DAQRFFHQLM 115
Query: 240 -GLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYG 298
G+ +LH + +RD K N+LLD N K+SDFGLA ++ + ++ GT
Sbjct: 116 AGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLP 172
Query: 299 YAAPEYVMTGHL--TAKSDVYSFGVVLLEMLTGR 330
Y APE ++ DV+S G+VL ML G
Sbjct: 173 YVAPE-LLKRREFHAEPVDVWSCGIVLTAMLAGE 205
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-23
Identities = 73/316 (23%), Positives = 110/316 (34%), Gaps = 74/316 (23%)
Query: 49 KTDGANSGTSTQYAESKSTNDTSRGQPVVPIGSSSTTSNAESTTPSTPKIGEELKISPQL 108
+ + Y E S N T +V G +N E+ +S
Sbjct: 64 FREVGPKNSYIAYIEDHSGNGTFVNTELVGKGKRRPLNN-----------NSEIALSLSR 112
Query: 109 RK-FSFNELKSATKSFRPECL---------LGEGGFGCVYKGWINMNGTATVKPGTGLPV 158
K F F +L +S P+ L LG G G V + T V
Sbjct: 113 NKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLA---------FERKTCKKV 163
Query: 159 AVKTLNHDGLQGHKEWLA--------EVNYLGGLIHPNLVKLIGCCIEDDQRLLVYEFMP 210
A++ ++ A E+ L L HP ++K+ + + +V E M
Sbjct: 164 AIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKN-FFDAEDYYIVLELME 222
Query: 211 RGSLENHLFRRSLPLPWSIRMKIAL---DAAK-------GLAFLHEEAEKPVIYRDFKTS 260
G E LF + + L + +LH E +I+RD K
Sbjct: 223 GG--E--LFDK-------VVGNKRLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPE 268
Query: 261 NILL---DGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTA----K 313
N+LL + + K++DFG +K E T GT Y APE V+ TA
Sbjct: 269 NVLLSSQEEDCLIKITDFGHSKILGETSLM--RTLC-GTPTYLAPE-VLVSVGTAGYNRA 324
Query: 314 SDVYSFGVVLLEMLTG 329
D +S GV+L L+G
Sbjct: 325 VDCWSLGVILFICLSG 340
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 2e-23
Identities = 65/240 (27%), Positives = 104/240 (43%), Gaps = 31/240 (12%)
Query: 100 EELKISPQLRKFSFNELKSATKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVA 159
+ L +P + F + + ++ + +LG+G FG V TG A
Sbjct: 7 DHLHATPGM--FVQHSTAIFSDRYKGQRVLGKGSFGEVILC---------KDKITGQECA 55
Query: 160 VKTLNHDGLQGHKEW---LAEVNYLGGLIHPNLVKLIGCCIEDDQRL-LVYEFMPRGSLE 215
VK ++ ++ + L EV L L HPN++KL ED LV E G L
Sbjct: 56 VKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFF-EDKGYFYLVGEVYTGGELF 114
Query: 216 NHLFRRSLPLPWSIRM--KIALDAAKGLAFLHEEAEKPVIYRDFKTSNILL---DGEYNA 270
+ + R +S +I G+ ++H + +++RD K N+LL + N
Sbjct: 115 DEIISRK---RFSEVDAARIIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANI 168
Query: 271 KLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGR 330
++ DFGL+ K +GT Y APE V+ G K DV+S GV+L +L+G
Sbjct: 169 RIIDFGLSTHFEASKKMK---DKIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSGC 224
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 6e-23
Identities = 61/214 (28%), Positives = 88/214 (41%), Gaps = 33/214 (15%)
Query: 128 LLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLA-EVNYLGGLIH 186
LGEG +G V +N T VAVK ++ E + E+ L H
Sbjct: 14 TLGEGAYGEVQLA-VNRV--------TEEAVAVKIVDMKRAVDCPENIKKEICINKMLNH 64
Query: 187 PNLVKLIGCCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAK------ 239
N+VK G + L E+ G L + + I M DA +
Sbjct: 65 ENVVKFYGH-RREGNIQYLFLEYCSGGELFDRIEPD-------IGMPEP-DAQRFFHQLM 115
Query: 240 -GLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYG 298
G+ +LH + +RD K N+LLD N K+SDFGLA ++ + ++ GT
Sbjct: 116 AGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLP 172
Query: 299 YAAPEYVMTGHL--TAKSDVYSFGVVLLEMLTGR 330
Y APE ++ DV+S G+VL ML G
Sbjct: 173 YVAPE-LLKRREFHAEPVDVWSCGIVLTAMLAGE 205
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 98.4 bits (245), Expect = 7e-23
Identities = 47/316 (14%), Positives = 104/316 (32%), Gaps = 42/316 (13%)
Query: 112 SFNELKSATKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGH 171
+ + + L G + W+ + + + ++ +
Sbjct: 44 RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPS 103
Query: 172 KEWLA--EVNYLGGLIHPNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRR--SLPLPW 227
++ + N V + + + + +L++ + RR
Sbjct: 104 PMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREH 163
Query: 228 SIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKD------- 280
+ + I + A+ + FLH K +++RD K SNI + K+ DFGL
Sbjct: 164 GVCLHIFIQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEE 220
Query: 281 ---GPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNR 337
T +GT Y +PE + + + K D++S G++L E+L +
Sbjct: 221 QTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQM--- 277
Query: 338 PNGEHNLVEWARPQLGERRRFYRLI-DPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRM 396
ER R + + F+ K ++ + L+ RP
Sbjct: 278 ----------------ERVRIITDVRNLKFPLLFTQKYPQEH-MMVQDMLSPSPTERPEA 320
Query: 397 SEVVEALKPLPYLKDM 412
++++E +++
Sbjct: 321 TDIIE----NAIFENL 332
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 41.8 bits (98), Expect = 3e-04
Identities = 21/80 (26%), Positives = 32/80 (40%), Gaps = 10/80 (12%)
Query: 123 FRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKE-WLAEVNYL 181
F P +G GGFG V++ A K A+K + + +E + EV L
Sbjct: 8 FEPIQCMGRGGFGVVFE--------AKNKV-DDCNYAIKRIRLPNRELAREKVMREVKAL 58
Query: 182 GGLIHPNLVKLIGCCIEDDQ 201
L HP +V+ +E
Sbjct: 59 AKLEHPGIVRYFNAWLETPP 78
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 97.6 bits (244), Expect = 8e-23
Identities = 60/212 (28%), Positives = 89/212 (41%), Gaps = 32/212 (15%)
Query: 129 LGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEW-----LAEVNYLGG 183
+GEG +G V+K N + TG VA+K L E+ L
Sbjct: 11 IGEGSYGVVFKC-RNRD--------TGQIVAIKKFL---ESEDDPVIKKIALREIRMLKQ 58
Query: 184 LIHPNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAF 243
L HPNLV L+ + LV+E+ ++ + L R +P + I + + F
Sbjct: 59 LKHPNLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQTLQAVNF 117
Query: 244 LHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKD--GPEGDKTH-VSTRVMGTYGYA 300
H+ I+RD K NIL+ KL DFG A+ GP V+TR Y
Sbjct: 118 CHK---HNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATR-----WYR 169
Query: 301 APEYVMTG--HLTAKSDVYSFGVVLLEMLTGR 330
+PE ++ G DV++ G V E+L+G
Sbjct: 170 SPE-LLVGDTQYGPPVDVWAIGCVFAELLSGV 200
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 8e-23
Identities = 64/250 (25%), Positives = 100/250 (40%), Gaps = 29/250 (11%)
Query: 94 STPKIGEELKISPQLRKFSFNELKSATKSFRPEC-----LLGEGGFGCVYKGWINMNGTA 148
P + + I L ++ K + E ++G G FG V
Sbjct: 37 DFPALRKNKNIDNFLSRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQL--------- 87
Query: 149 TVKPGTGLPVAVKTLNHDGLQGHKE---WLAEVNYLGGLIHPNLVKLIGCCIEDDQRL-L 204
T A+K L+ + + + E + + P +V+L +DD+ L +
Sbjct: 88 VRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF-YAFQDDRYLYM 146
Query: 205 VYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILL 264
V E+MP G L N + +P W+ R A + L +H I+RD K N+LL
Sbjct: 147 VMEYMPGGDLVNLMSNYDVPEKWA-RFYTA-EVVLALDAIHS---MGFIHRDVKPDNMLL 201
Query: 265 DGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT----GHLTAKSDVYSFG 320
D + KL+DFG + T V GT Y +PE + + G+ + D +S G
Sbjct: 202 DKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVG 260
Query: 321 VVLLEMLTGR 330
V L EML G
Sbjct: 261 VFLYEMLVGD 270
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 2e-22
Identities = 56/224 (25%), Positives = 89/224 (39%), Gaps = 46/224 (20%)
Query: 128 LLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLA----EVNYLGG 183
LLGEG +G V + + T AVK L L+ A E+ L
Sbjct: 12 LLGEGSYGKVKEVL-DSE--------TLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRR 62
Query: 184 LIHPNLVKLIG-CCIEDDQRL-LVYEFMPRGSLE--NHLFRRSLPLPWSIRMKIALDAAK 239
L H N+++L+ E+ Q++ +V E+ G E + + + P+ A
Sbjct: 63 LRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVC---------QAHG 113
Query: 240 -------GLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLA---KDGPEGDKTHV 289
GL +LH + ++++D K N+LL K+S G+A D
Sbjct: 114 YFCQLIDGLEYLHS---QGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRT 170
Query: 290 STRVMGTYGYAAPEYVMTGHLT---AKSDVYSFGVVLLEMLTGR 330
S G+ + PE + G T K D++S GV L + TG
Sbjct: 171 SQ---GSPAFQPPE-IANGLDTFSGFKVDIWSAGVTLYNITTGL 210
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 2e-22
Identities = 71/247 (28%), Positives = 104/247 (42%), Gaps = 40/247 (16%)
Query: 95 TPKIGEELKISPQLRKFS---FNELKSATKSFRPECLLGEGGFGCVYKGWINMNGTATVK 151
T + + + FN L +LG+G FG V + +
Sbjct: 1 TTNTVSKFDNNGNRDRMKLTDFNFLM----------VLGKGSFGKVML---------SER 41
Query: 152 PGTGLPVAVKTLNHDGLQGHKEW---LAEVNYLGGLI-HPNLVKLIGCCIEDDQRL-LVY 206
GT AVK L D + + + E L P L +L C + RL V
Sbjct: 42 KGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH-SCFQTMDRLYFVM 100
Query: 207 EFMPRGSLENHLFR-RSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLD 265
E++ G L H+ + P + A + A GL FL K +IYRD K N++LD
Sbjct: 101 EYVNGGDLMYHIQQVGRFKEPHA-VFYAA-EIAIGLFFLQS---KGIIYRDLKLDNVMLD 155
Query: 266 GEYNAKLSDFGLAKDGPEGDKTHVSTRVM-GTYGYAAPEYVMTGHLTAKS-DVYSFGVVL 323
E + K++DFG+ K+ T T+ GT Y APE ++ KS D ++FGV+L
Sbjct: 156 SEGHIKIADFGMCKENIWDGVT---TKTFCGTPDYIAPE-IIAYQPYGKSVDWWAFGVLL 211
Query: 324 LEMLTGR 330
EML G+
Sbjct: 212 YEMLAGQ 218
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 99.7 bits (248), Expect = 2e-22
Identities = 75/297 (25%), Positives = 110/297 (37%), Gaps = 29/297 (9%)
Query: 43 CLSSSPKTDGANSGTSTQYAESKSTNDTSRGQPVVPIGSSSTTSNAESTTPSTPKIGEEL 102
+S K E + N + T E+
Sbjct: 263 GISELQKAGVDGWFKLLSQEEGEYFNVPVPPEGSEGNEELRQKFERAKIGQGTKAPEEKT 322
Query: 103 KISPQLRKFSFNELKSATKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKT 162
+ + N + F +LG+G FG V + GT AVK
Sbjct: 323 ANTISKFDNNGNRDRMKLTDFNFLMVLGKGSFGKVMLS---------ERKGTDELYAVKI 373
Query: 163 LNHDGLQGHKEW---LAEVNYLGGLI-HPNLVKLIGCCIEDDQRL-LVYEFMPRGSLENH 217
L D + + + E L P L +L C + RL V E++ G L H
Sbjct: 374 LKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYH 432
Query: 218 LFR-RSLPLPWSIRMKI-ALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDF 275
+ + P A + A GL FL K +IYRD K N++LD E + K++DF
Sbjct: 433 IQQVGRFKEP---HAVFYAAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADF 486
Query: 276 GLAKDGPEGDKTHVSTRVM-GTYGYAAPEYVMTGHLTAKS-DVYSFGVVLLEMLTGR 330
G+ K+ T T+ GT Y APE ++ KS D ++FGV+L EML G+
Sbjct: 487 GMCKENIWDGVT---TKTFCGTPDYIAPE-IIAYQPYGKSVDWWAFGVLLYEMLAGQ 539
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 2e-22
Identities = 62/214 (28%), Positives = 93/214 (43%), Gaps = 34/214 (15%)
Query: 129 LGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQG--HKEWLAEVNYLGGLIH 186
LG+G FG V K + T AVK +N + L EV L L H
Sbjct: 30 LGKGSFGEVLK--------CKDR-ITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 187 PNLVKLIGCCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIR-----MKIALDAAKG 240
PN++KL ED +V E G L + + +R +S +K
Sbjct: 81 PNIMKLFEIL-EDSSSFYIVGELYTGGELFDEIIKRK---RFSEHDAARIIKQVFSG--- 133
Query: 241 LAFLHEEAEKPVIYRDFKTSNILL---DGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTY 297
+ ++H + +++RD K NILL + + + K+ DFGL+ + K +GT
Sbjct: 134 ITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMK---DRIGTA 187
Query: 298 GYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRR 331
Y APE V+ G K DV+S GV+L +L+G
Sbjct: 188 YYIAPE-VLRGTYDEKCDVWSAGVILYILLSGTP 220
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 97.1 bits (242), Expect = 2e-22
Identities = 67/246 (27%), Positives = 99/246 (40%), Gaps = 44/246 (17%)
Query: 105 SPQLRKFSFNELKSATKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLN 164
+ L + + L+ F L+G G +G VYKG ++ TG A+K ++
Sbjct: 8 ARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKG-RHVK--------TGQLAAIKVMD 58
Query: 165 HDGLQGHKEWLAEVNYLGGLI-HPNLVKLIGC------CIEDDQRLLVYEFMPRGSLE-- 215
G +E E+N L H N+ G DDQ LV EF GS+
Sbjct: 59 VTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDL 117
Query: 216 -NHLFRRSLPLPWSIRMKIAL---DAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAK 271
+ +L W IA + +GL+ LH+ VI+RD K N+LL K
Sbjct: 118 IKNTKGNTLKEEW-----IAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVK 169
Query: 272 LSDFGLAKDGPEGDKTHVSTR---VMGTYGYAAPEYVMTGHLT-----AKSDVYSFGVVL 323
L DFG++ R +GT + APE + KSD++S G+
Sbjct: 170 LVDFGVS-----AQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITA 224
Query: 324 LEMLTG 329
+EM G
Sbjct: 225 IEMAEG 230
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 2e-22
Identities = 70/246 (28%), Positives = 103/246 (41%), Gaps = 41/246 (16%)
Query: 93 PSTPKIGEELKISPQLRKFSFNELKSATKSFRPECLLGEGGFGCVYKGWINMNGTATVKP 152
+ + ++K+ + F K +LG+G FG V+ A K
Sbjct: 3 LNKERPSLQIKLKIE----DFILHK----------MLGKGSFGKVFL--------AEFK- 39
Query: 153 GTGLPVAVKTLNHDGLQGHKEW---LAEVNYLGGLI-HPNLVKLIGCCIEDDQRL-LVYE 207
T A+K L D + + + E L HP L + C + + L V E
Sbjct: 40 KTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMF-CTFQTKENLFFVME 98
Query: 208 FMPRGSLENHLFR-RSLPLPWSIRMKI-ALDAAKGLAFLHEEAEKPVIYRDFKTSNILLD 265
++ G L H+ L R A + GL FLH K ++YRD K NILLD
Sbjct: 99 YLNGGDLMYHIQSCHKFDLS---RATFYAAEIILGLQFLHS---KGIVYRDLKLDNILLD 152
Query: 266 GEYNAKLSDFGLAKDGPEGDKTHVSTRVM-GTYGYAAPEYVMTGHLTAKSDVYSFGVVLL 324
+ + K++DFG+ K+ GD T GT Y APE ++ D +SFGV+L
Sbjct: 153 KDGHIKIADFGMCKENMLGDAK---TNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLY 209
Query: 325 EMLTGR 330
EML G+
Sbjct: 210 EMLIGQ 215
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 2e-22
Identities = 62/256 (24%), Positives = 104/256 (40%), Gaps = 34/256 (13%)
Query: 87 NAESTTPSTPKIGEELKISPQLRKFSFNELKSATKSFRPECL-----LGEGGFGCVYKGW 141
NA + + + + ++ F + + + + LG G FG V
Sbjct: 2 NAAAAKKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVML-- 59
Query: 142 INMNGTATVKPGTGLPVAVKTLNHDGLQGHKEW---LAEVNYLGGLIHPNLVKLIGCCIE 198
+G A+K L+ + K+ L E L + P LVKL +
Sbjct: 60 -------VKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSF-K 111
Query: 199 DDQRL-LVYEFMPRGSLENHLFR-RSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRD 256
D+ L +V E++ G + +HL R P + R A +LH +IYRD
Sbjct: 112 DNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHA-RFYAA-QIVLTFEYLHS---LDLIYRD 166
Query: 257 FKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTAKS- 314
K N+L+D + +++DFG AK T + GT APE +++ G+ K+
Sbjct: 167 LKPENLLIDQQGYIQVTDFGFAKRVKGRTWT-----LCGTPEALAPEIILSKGY--NKAV 219
Query: 315 DVYSFGVVLLEMLTGR 330
D ++ GV++ EM G
Sbjct: 220 DWWALGVLIYEMAAGY 235
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 97.9 bits (244), Expect = 3e-22
Identities = 59/253 (23%), Positives = 87/253 (34%), Gaps = 32/253 (12%)
Query: 94 STPKIGEELKISPQLRKFSFNELKSATKSFRPEC-----LLGEGGFGCVYKGWINMNGTA 148
+ + E I L K E ++G G FG V
Sbjct: 42 NNSPLRREKNILEYLEWAKPFTSKVKQMRLHREDFEILKVIGRGAFGEVAV--------- 92
Query: 149 TVKPGTGLPVAVKTLNHDGLQGHKE---WLAEVNYLGGLIHPNLVKLIGCCIEDDQRL-L 204
A+K LN + E + E + L + L +DD L L
Sbjct: 93 VKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLH-YAFQDDNNLYL 151
Query: 205 VYEFMPRGSLENHL--FRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNI 262
V ++ G L L F LP + R +A + + +H+ ++RD K NI
Sbjct: 152 VMDYYVGGDLLTLLSKFEDRLPEEMA-RFYLA-EMVIAIDSVHQ---LHYVHRDIKPDNI 206
Query: 263 LLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKS-----DVY 317
L+D + +L+DFG E S V GT Y +PE + D +
Sbjct: 207 LMDMNGHIRLADFGSCLKLMEDGTVQSSVAV-GTPDYISPEILQAMEGGKGRYGPECDWW 265
Query: 318 SFGVVLLEMLTGR 330
S GV + EML G
Sbjct: 266 SLGVCMYEMLYGE 278
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 3e-22
Identities = 61/216 (28%), Positives = 95/216 (43%), Gaps = 41/216 (18%)
Query: 129 LGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLA----EVNYLGGL 184
+G+G F V TG VA+K ++ L L EV + L
Sbjct: 23 IGKGNFAKVKLA---------RHILTGREVAIKIIDKTQLN--PTSLQKLFREVRIMKIL 71
Query: 185 IHPNLVKLIGCCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAK---- 239
HPN+VKL IE ++ L L+ E+ G + ++L RMK +A
Sbjct: 72 NHPNIVKLFEV-IETEKTLYLIMEYASGGEVFDYLVAHG-------RMKEK-EARSKFRQ 122
Query: 240 ---GLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGT 296
+ + H+ K +++RD K N+LLD + N K++DFG + + G K G
Sbjct: 123 IVSAVQYCHQ---KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFC---GA 176
Query: 297 YGYAAPEYVMTGHL--TAKSDVYSFGVVLLEMLTGR 330
YAAPE + G + DV+S GV+L +++G
Sbjct: 177 PPYAAPE-LFQGKKYDGPEVDVWSLGVILYTLVSGS 211
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 95.7 bits (239), Expect = 5e-22
Identities = 66/236 (27%), Positives = 103/236 (43%), Gaps = 47/236 (19%)
Query: 106 PQLRKFSFNELKSATKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNH 165
P+ F L+ LG G FG V+ G A+K L
Sbjct: 1 PKYSLQDFQILR----------TLGTGSFGRVHL---------IRSRHNGRYYAMKVLKK 41
Query: 166 DGLQGHKEW---LAEVNYLGGLIHPNLVKLIGCCIEDDQRL-LVYEFMPRGSLENHLFR- 220
+ + K+ E L + HP ++++ G +D Q++ ++ +++ G L + L +
Sbjct: 42 EIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTF-QDAQQIFMIMDYIEGGELFSLLRKS 100
Query: 221 RSLPLPWSIRMK-----IALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDF 275
+ P P K + L L +LH K +IYRD K NILLD + K++DF
Sbjct: 101 QRFPNP---VAKFYAAEVCL----ALEYLHS---KDIIYRDLKPENILLDKNGHIKITDF 150
Query: 276 GLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTAKSDVYSFGVVLLEMLTGR 330
G AK P+ T + GT Y APE V T + + D +SFG+++ EML G
Sbjct: 151 GFAKYVPDVTYT-----LCGTPDYIAPEVVSTKPYNKS-IDWWSFGILIYEMLAGY 200
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 7e-22
Identities = 64/220 (29%), Positives = 91/220 (41%), Gaps = 47/220 (21%)
Query: 129 LGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLA-EVNYLGGLIHP 187
LG G FG V+ + +GL +KT+N D Q E + E+ L L HP
Sbjct: 30 LGSGAFGDVHL--------VEER-SSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHP 80
Query: 188 NLVKLIGCCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL-------DAAK 239
N++K+ ED + +V E G E L R I A A+
Sbjct: 81 NIIKIFE-VFEDYHNMYIVMETCEGG--E--LLER-------IVSAQARGKALSEGYVAE 128
Query: 240 -------GLAFLHEEAEKPVIYRDFKTSNILL---DGEYNAKLSDFGLAKDGPEGDKTHV 289
LA+ H + V+++D K NIL K+ DFGLA+ +
Sbjct: 129 LMKQMMNALAYFH---SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEH--S 183
Query: 290 STRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTG 329
+ GT Y APE V +T K D++S GVV+ +LTG
Sbjct: 184 TNAA-GTALYMAPE-VFKRDVTFKCDIWSAGVVMYFLLTG 221
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 9e-22
Identities = 57/226 (25%), Positives = 84/226 (37%), Gaps = 53/226 (23%)
Query: 129 LGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLA--------EVNY 180
LG G G V + T VA+K ++ A E+
Sbjct: 18 LGSGACGEVKLA---------FERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEI 68
Query: 181 LGGLIHPNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL---DA 237
L L HP ++K+ + + +V E M G E LF + + L
Sbjct: 69 LKKLNHPCIIKIKN-FFDAEDYYIVLELMEGG--E--LFDK-------VVGNKRLKEATC 116
Query: 238 AK-------GLAFLHEEAEKPVIYRDFKTSNILL---DGEYNAKLSDFGLAKDGPEGDKT 287
+ +LH E +I+RD K N+LL + + K++DFG +K E
Sbjct: 117 KLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLM 173
Query: 288 HVSTRVMGTYGYAAPEYVMTGHLTA----KSDVYSFGVVLLEMLTG 329
T GT Y APE V+ TA D +S GV+L L+G
Sbjct: 174 --RTLC-GTPTYLAPE-VLVSVGTAGYNRAVDCWSLGVILFICLSG 215
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 1e-21
Identities = 63/211 (29%), Positives = 97/211 (45%), Gaps = 27/211 (12%)
Query: 128 LLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEW---LAEVNYLGGL 184
++G G + V T A+K + + + ++ E +
Sbjct: 16 VIGRGSYAKVLL---------VRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQA 66
Query: 185 I-HPNLVKLIGCCIEDDQRL-LVYEFMPRGSLENHLFR-RSLPLPWSIRMKIALDAAKGL 241
HP LV L C + + RL V E++ G L H+ R R LP + R A + + L
Sbjct: 67 SNHPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHA-RFYSA-EISLAL 123
Query: 242 AFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVM-GTYGYA 300
+LHE + +IYRD K N+LLD E + KL+D+G+ K+G T T GT Y
Sbjct: 124 NYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT---TSTFCGTPNYI 177
Query: 301 APEYVMTGHLTAKS-DVYSFGVVLLEMLTGR 330
APE ++ G S D ++ GV++ EM+ GR
Sbjct: 178 APE-ILRGEDYGFSVDWWALGVLMFEMMAGR 207
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 1e-21
Identities = 70/279 (25%), Positives = 114/279 (40%), Gaps = 47/279 (16%)
Query: 60 QYAESKSTNDTSRGQPVVPIGSSSTTSNAESTTPSTPKIGEELKISPQLRKFSFNELKSA 119
Y + N +G I N + ++ +G + F+ L+
Sbjct: 11 DYDIPTTENLYFQGAMGSGIEEEKEAMNTRESGKASSSLGLQ----------DFDLLR-- 58
Query: 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEW---LA 176
++G G + V T A++ + + + ++
Sbjct: 59 --------VIGRGSYAKVLL---------VRLKKTDRIYAMRVVKKELVNDDEDIDWVQT 101
Query: 177 EVNYLGGLI-HPNLVKLIGCCIEDDQRL-LVYEFMPRGSLENHLFR-RSLPLPWSIRMKI 233
E + HP LV L C + + RL V E++ G L H+ R R LP + R
Sbjct: 102 EKHVFEQASNHPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHA-RFYS 159
Query: 234 ALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRV 293
A + + L +LHE + +IYRD K N+LLD E + KL+D+G+ K+G T T
Sbjct: 160 A-EISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT---TST 212
Query: 294 M-GTYGYAAPEYVMTGHLTAKS-DVYSFGVVLLEMLTGR 330
GT Y APE ++ G S D ++ GV++ EM+ GR
Sbjct: 213 FCGTPNYIAPE-ILRGEDYGFSVDWWALGVLMFEMMAGR 250
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 1e-21
Identities = 58/211 (27%), Positives = 87/211 (41%), Gaps = 30/211 (14%)
Query: 129 LGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEW-----LAEVNYLGG 183
+GEG +G V K N + TG VA+K + + E+ L
Sbjct: 33 VGEGSYGMVMKC-RNKD--------TGRIVAIKKFL---ESDDDKMVKKIAMREIKLLKQ 80
Query: 184 LIHPNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAF 243
L H NLV L+ C + + LV+EF+ ++ + L L + + K G+ F
Sbjct: 81 LRHENLVNLLEVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQIINGIGF 139
Query: 244 LHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKD--GPEGDKTH-VSTRVMGTYGYA 300
H +I+RD K NIL+ KL DFG A+ P V+TR Y
Sbjct: 140 CHS---HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATR-----WYR 191
Query: 301 APEYVM-TGHLTAKSDVYSFGVVLLEMLTGR 330
APE ++ DV++ G ++ EM G
Sbjct: 192 APELLVGDVKYGKAVDVWAIGCLVTEMFMGE 222
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 93.4 bits (233), Expect = 1e-21
Identities = 62/216 (28%), Positives = 98/216 (45%), Gaps = 38/216 (17%)
Query: 128 LLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLA---EVNYLGGL 184
LG G FG V G + TG VAVK LN ++ E+ L
Sbjct: 18 TLGVGTFGKVKIG-EHQL--------TGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLF 68
Query: 185 IHPNLVKLIGCCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAK---- 239
HP+++KL I +V E++ G L +++ + R++ +A +
Sbjct: 69 RHPHIIKLYQV-ISTPTDFFMVMEYVSGGELFDYICKHG-------RVEEM-EARRLFQQ 119
Query: 240 ---GLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGT 296
+ + H V++RD K N+LLD NAK++DFGL+ +G+ S G+
Sbjct: 120 ILSAVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC---GS 173
Query: 297 YGYAAPEYVMTGHL--TAKSDVYSFGVVLLEMLTGR 330
YAAPE V++G L + D++S GV+L +L G
Sbjct: 174 PNYAAPE-VISGRLYAGPEVDIWSCGVILYALLCGT 208
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 96.8 bits (241), Expect = 1e-21
Identities = 59/286 (20%), Positives = 100/286 (34%), Gaps = 29/286 (10%)
Query: 54 NSGTSTQYAESKSTNDTSRGQPVVPIGSSSTTSNAESTTPSTPKIGEELKISPQLRKFSF 113
N ++ E + + G T + + +++
Sbjct: 86 NKHGQSKPCEPTAPVLIPGDERKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYP 145
Query: 114 NELKSATKSFRP----ECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQ 169
++ LG G FG V++ T + TG A K +
Sbjct: 146 QPVEIKHDHVLDHYDIHEELGTGAFGVVHR--------VTER-ATGNNFAAKFVMTPHES 196
Query: 170 GHKEWLAEVNYLGGLIHPNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSI 229
+ E+ + L HP LV L +D++ +++YEFM G E LF + +
Sbjct: 197 DKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGG--E--LFEKVADEHNKM 252
Query: 230 RMKIALDAAK----GLAFLHEEAEKPVIYRDFKTSNILL--DGEYNAKLSDFGLAKDGPE 283
A++ + GL +H E ++ D K NI+ KL DFGL
Sbjct: 253 SEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP 309
Query: 284 GDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTG 329
V GT +AAPE + +D++S GV+ +L+G
Sbjct: 310 KQSVKV---TTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSG 352
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 1e-21
Identities = 73/259 (28%), Positives = 107/259 (41%), Gaps = 46/259 (17%)
Query: 80 GSSSTTSNAESTTPSTPKIGEELKISPQLRKFSFNELKSATKSFRPECLLGEGGFGCVYK 139
G ++ ++ ++ +F ++ +LG+G FG V
Sbjct: 1 GPKESSKEGNGIGVNSSN-----RLGID----NFEFIR----------VLGKGSFGKVML 41
Query: 140 GWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEW---LAEVNYLGGLI-HPNLVKLIGC 195
TG AVK L D + + + E L HP L +L C
Sbjct: 42 ---------ARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLF-C 91
Query: 196 CIEDDQRL-LVYEFMPRGSLENHLFR-RSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVI 253
C + RL V EF+ G L H+ + R + R A + L FLH+ K +I
Sbjct: 92 CFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARA-RFYAA-EIISALMFLHD---KGII 146
Query: 254 YRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVM-GTYGYAAPEYVMTGHLTA 312
YRD K N+LLD E + KL+DFG+ K+G T T GT Y APE ++ L
Sbjct: 147 YRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVT---TATFCGTPDYIAPE-ILQEMLYG 202
Query: 313 KS-DVYSFGVVLLEMLTGR 330
+ D ++ GV+L EML G
Sbjct: 203 PAVDWWAMGVLLYEMLCGH 221
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 2e-21
Identities = 67/217 (30%), Positives = 95/217 (43%), Gaps = 44/217 (20%)
Query: 129 LGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQG--HKEWLAEVNYLGGLIH 186
LG+G FG V K + T AVK +N + L EV L L H
Sbjct: 30 LGKGSFGEVLK--------CKDR-ITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 187 PNLVKLIGCCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL---DAAK--- 239
PN++KL ED +V E G E LF I + DAA+
Sbjct: 81 PNIMKLFEIL-EDSSSFYIVGELYTGG--E--LFDE-------IIKRKRFSEHDAARIIK 128
Query: 240 ----GLAFLHEEAEKPVIYRDFKTSNILL---DGEYNAKLSDFGLAKDGPEGDKTHVSTR 292
G+ ++H + +++RD K NILL + + + K+ DFGL+ + K R
Sbjct: 129 QVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM--KDR 183
Query: 293 VMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTG 329
+ GT Y APE V+ G K DV+S GV+L +L+G
Sbjct: 184 I-GTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSG 218
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 95.2 bits (237), Expect = 2e-21
Identities = 52/219 (23%), Positives = 95/219 (43%), Gaps = 31/219 (14%)
Query: 129 LGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHPN 188
+G G +G VYK A+K + G+ E+ L L HPN
Sbjct: 29 VGRGTYGHVYKAK-------RKDGKDDKDYALKQIEGTGI--SMSACREIALLRELKHPN 79
Query: 189 LVKLIGCCIED-DQRL-LVYEFMP---RGSLENH----LFRRSLPLPWSIRMKIALDAAK 239
++ L + D+++ L++++ ++ H ++ + LP + +
Sbjct: 80 VISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILD 139
Query: 240 GLAFLHEEAEKPVIYRDFKTSNILLDGEYNA----KLSDFGLAK--DGPEGDKTHVSTRV 293
G+ +LH V++RD K +NIL+ GE K++D G A+ + P + V
Sbjct: 140 GIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVV 196
Query: 294 MGTYGYAAPEYVMTG--HLTAKSDVYSFGVVLLEMLTGR 330
+ T+ Y APE ++ G H T D+++ G + E+LT
Sbjct: 197 V-TFWYRAPE-LLLGARHYTKAIDIWAIGCIFAELLTSE 233
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 93.3 bits (233), Expect = 2e-21
Identities = 58/211 (27%), Positives = 95/211 (45%), Gaps = 31/211 (14%)
Query: 129 LGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKE-----WLAEVNYLGG 183
+GEG +G VYK + G A+K + L+ E + E++ L
Sbjct: 10 IGEGTYGVVYKA----------QNNYGETFALKKIR---LEKEDEGIPSTTIREISILKE 56
Query: 184 LIHPNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAF 243
L H N+VKL + +LV+E + + L+ L L L G+A+
Sbjct: 57 LKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAY 115
Query: 244 LHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKD--GPEGDKTHVSTRVMGTYGYAA 301
H+ + V++RD K N+L++ E K++DFGLA+ P TH ++ T Y A
Sbjct: 116 CHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH---EIV-TLWYRA 168
Query: 302 PEYVMTG--HLTAKSDVYSFGVVLLEMLTGR 330
P+ V+ G + D++S G + EM+ G
Sbjct: 169 PD-VLMGSKKYSTTIDIWSVGCIFAEMVNGT 198
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 94.1 bits (234), Expect = 2e-21
Identities = 56/255 (21%), Positives = 90/255 (35%), Gaps = 68/255 (26%)
Query: 129 LGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLA-----EVNYLGG 183
+G+G +G V ++ T A+K +N + ++ EV +
Sbjct: 34 IGQGSYGVVRVA---------IENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKK 84
Query: 184 LIHPNLVKLIGCCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL------- 235
L HPN+ +L ED+Q + LV E G L + L M +
Sbjct: 85 LHHPNIARLYEV-YEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCP 143
Query: 236 -------------------------DAAK-------GLAFLHEEAEKPVIYRDFKTSNIL 263
+ L +LH + + +RD K N L
Sbjct: 144 ECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHN---QGICHRDIKPENFL 200
Query: 264 L--DGEYNAKLSDFGLAK---DGPEGDKTHVSTRVMGTYGYAAPEYVMTGHL---TAKSD 315
+ + KL DFGL+K G+ ++T+ GT + APE V+ K D
Sbjct: 201 FSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKA-GTPYFVAPE-VLNTTNESYGPKCD 258
Query: 316 VYSFGVVLLEMLTGR 330
+S GV+L +L G
Sbjct: 259 AWSAGVLLHLLLMGA 273
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 2e-21
Identities = 59/215 (27%), Positives = 91/215 (42%), Gaps = 42/215 (19%)
Query: 129 LGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHPN 188
+G G +G V V+ GT + A K + ++ + E+ + L HPN
Sbjct: 17 IGRGSWGEVKIA---------VQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPN 67
Query: 189 LVKLIGCCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL---DAAK----- 239
+++L ED+ + LV E G E LF R + K DAA+
Sbjct: 68 IIRLYE-TFEDNTDIYLVMELCTGG--E--LFER-------VVHKRVFRESDAARIMKDV 115
Query: 240 --GLAFLHEEAEKPVIYRDFKTSNILL---DGEYNAKLSDFGLAKDGPEGDKTHVSTRVM 294
+A+ H + V +RD K N L + KL DFGLA G + T+V
Sbjct: 116 LSAVAYCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKM--MRTKV- 169
Query: 295 GTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTG 329
GT Y +P+ V+ G + D +S GV++ +L G
Sbjct: 170 GTPYYVSPQ-VLEGLYGPECDEWSAGVMMYVLLCG 203
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 94.4 bits (235), Expect = 4e-21
Identities = 63/264 (23%), Positives = 106/264 (40%), Gaps = 35/264 (13%)
Query: 80 GSSSTTSNAESTTPSTPKIGEELKISPQLRKFSFNELKSATKSFRPECLLGEGGFGCVYK 139
+ + + + K++ + + S+ ++G G FG VY+
Sbjct: 13 SCKPVQQPSAFGSMKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQ 72
Query: 140 GWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHPNLVKLIGCCIED 199
A + +G VA+K + LQ + E+ + L H N+V+L
Sbjct: 73 --------AKLCD-SGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIVRLRYFFYSS 119
Query: 200 DQRL------LVYEFMPR--GSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKP 251
++ LV +++P + H R LP + LA++H
Sbjct: 120 GEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG--- 176
Query: 252 VIYRDFKTSNILLDGEYNA-KLSDFGLAKDGPEGDK-TH-VSTRVMGTYGYAAPEYVMTG 308
+ +RD K N+LLD + KL DFG AK G+ + +R Y Y APE ++ G
Sbjct: 177 ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR----Y-YRAPE-LIFG 230
Query: 309 --HLTAKSDVYSFGVVLLEMLTGR 330
T+ DV+S G VL E+L G+
Sbjct: 231 ATDYTSSIDVWSAGCVLAELLLGQ 254
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 92.6 bits (231), Expect = 4e-21
Identities = 64/211 (30%), Positives = 97/211 (45%), Gaps = 31/211 (14%)
Query: 129 LGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKE-----WLAEVNYLGG 183
+GEG +G VYK K G VA+K + L E + E++ L
Sbjct: 29 VGEGTYGVVYKA----------KDSQGRIVALKRIR---LDAEDEGIPSTAIREISLLKE 75
Query: 184 LIHPNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAF 243
L HPN+V LI + LV+EFM + L+ L L S +G+A
Sbjct: 76 LHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAH 134
Query: 244 LHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKD--GPEGDKTHVSTRVMGTYGYAA 301
H+ +++RD K N+L++ + KL+DFGLA+ P TH V+ T Y A
Sbjct: 135 CHQ---HRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTH---EVV-TLWYRA 187
Query: 302 PEYVMTG--HLTAKSDVYSFGVVLLEMLTGR 330
P+ V+ G + D++S G + EM+TG+
Sbjct: 188 PD-VLMGSKKYSTSVDIWSIGCIFAEMITGK 217
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 92.2 bits (230), Expect = 4e-21
Identities = 57/212 (26%), Positives = 89/212 (41%), Gaps = 30/212 (14%)
Query: 129 LGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKE-----WLAEVNYLGG 183
+GEG +G V+K T VA+K + L E L E+ L
Sbjct: 10 IGEGTYGTVFKAKNRE---------THEIVALKRVR---LDDDDEGVPSSALREICLLKE 57
Query: 184 LIHPNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAF 243
L H N+V+L D + LV+EF + L+ + + L I KGL F
Sbjct: 58 LKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGF 116
Query: 244 LHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKD--GPEGDKTHVSTRVMGTYGYAA 301
H + V++RD K N+L++ KL++FGLA+ P + V+ T Y
Sbjct: 117 CHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSA---EVV-TLWYRP 169
Query: 302 PEYVMTG--HLTAKSDVYSFGVVLLEMLTGRR 331
P+ V+ G + D++S G + E+ R
Sbjct: 170 PD-VLFGAKLYSTSIDMWSAGCIFAELANAGR 200
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 4e-21
Identities = 76/322 (23%), Positives = 113/322 (35%), Gaps = 66/322 (20%)
Query: 128 LLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLI-H 186
+LGEG V + T AVK + EV L H
Sbjct: 20 VLGEGAHARVQTC---------INLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGH 70
Query: 187 PNLVKLIGCCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMK----------IAL 235
N+++LI E++ R LV+E M GS + I + +
Sbjct: 71 RNVLELIE-FFEEEDRFYLVFEKMRGGS----ILSH-------IHKRRHFNELEASVVVQ 118
Query: 236 DAAKGLAFLHEEAEKPVIYRDFKTSNILL---DGEYNAKLSDFGLAKD-GPEGDKTHVST 291
D A L FLH K + +RD K NIL + K+ DF L GD + +ST
Sbjct: 119 DVASALDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPIST 175
Query: 292 RVM----GTYGYAAPEYVMTGHLTAKS-----DVYSFGVVLLEMLTGRRSMDKNRP-NGE 341
+ G+ Y APE V A D++S GV+L +L+G P G
Sbjct: 176 PELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGY------PPFVGR 229
Query: 342 HNLVEWARPQLGERRRFYRLIDPCLEGCFSIKGAE-KTIQLAA-----SCLNRDQKARPR 395
L + EG + + I AA L RD K R
Sbjct: 230 CGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLS 289
Query: 396 MSEVVEALKPLPYLKDMASSSS 417
++V++ P+++ A ++
Sbjct: 290 AAQVLQH----PWVQGCAPENT 307
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 7e-21
Identities = 66/281 (23%), Positives = 99/281 (35%), Gaps = 54/281 (19%)
Query: 66 STNDTSRGQPVVPIGSSSTTSNAESTTPSTPKIGEELKISPQLRKFSFNELKSATKSFRP 125
S + +VP GS N T P +E S ++
Sbjct: 4 SHHHHHHSSGLVPRGSHMAPCNDLHATKLAPGKEKEPLESQ----------------YQV 47
Query: 126 ECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLA------EVN 179
LLG GGFG VY G ++ LPVA+K + D + E EV
Sbjct: 48 GPLLGSGGFGSVYSG---------IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV 98
Query: 180 YLGGLIH--PNLVKLIGCCIEDDQRL-LVYEF-MPRGSLENHLFRRSLPLPWSIRMKIAL 235
L + +++L+ E L+ E P L + + R L +
Sbjct: 99 LLKKVSSGFSGVIRLLDW-FERPDSFVLILERPEPVQDLFDFITERG-ALQEELARSFFW 156
Query: 236 DAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEY-NAKLSDFGLA---KDGPEGDKTHVST 291
+ + H V++RD K NIL+D KL DFG KD
Sbjct: 157 QVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY--TDFD-- 209
Query: 292 RVMGTYGYAAPEYVMTGHL--TAKSDVYSFGVVLLEMLTGR 330
GT Y+ PE++ H + V+S G++L +M+ G
Sbjct: 210 ---GTRVYSPPEWIR-YHRYHGRSAAVWSLGILLYDMVCGD 246
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 7e-21
Identities = 58/228 (25%), Positives = 92/228 (40%), Gaps = 54/228 (23%)
Query: 129 LGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLN--------HDGLQGHKEWLA-EVN 179
LG G V + + T AVK ++ + +Q +E EV+
Sbjct: 25 LGRGVSSVVRRC---------IHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVD 75
Query: 180 YLGGL-IHPNLVKLIGCCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL-- 235
L + HPN+++L E + LV++ M +G E LF + K+ L
Sbjct: 76 ILRKVSGHPNIIQLKDTY-ETNTFFFLVFDLMKKG--E--LFDY-------LTEKVTLSE 123
Query: 236 -DAAK-------GLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKT 287
+ K + LH+ +++RD K NILLD + N KL+DFG + G+K
Sbjct: 124 KETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL 180
Query: 288 HVSTRVMGTYGYAAPE------YVMTGHLTAKSDVYSFGVVLLEMLTG 329
GT Y APE + D++S GV++ +L G
Sbjct: 181 --REVC-GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 225
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 7e-21
Identities = 58/211 (27%), Positives = 94/211 (44%), Gaps = 31/211 (14%)
Query: 129 LGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKE-----WLAEVNYLGG 183
LGEG + VYKG + T VA+K + + H+E + EV+ L
Sbjct: 10 LGEGTYATVYKGKSKL---------TDNLVALKEIRLE----HEEGAPCTAIREVSLLKD 56
Query: 184 LIHPNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAF 243
L H N+V L + LV+E++ + L+ +L + +GLA+
Sbjct: 57 LKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAY 115
Query: 244 LHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLA--KDGPEGDKTHVSTRVMGTYGYAA 301
H + V++RD K N+L++ KL+DFGLA K P + V+ T Y
Sbjct: 116 CHR---QKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDN---EVV-TLWYRP 168
Query: 302 PEYVMTG--HLTAKSDVYSFGVVLLEMLTGR 330
P+ ++ G + + D++ G + EM TGR
Sbjct: 169 PD-ILLGSTDYSTQIDMWGVGCIFYEMATGR 198
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 7e-21
Identities = 53/216 (24%), Positives = 82/216 (37%), Gaps = 42/216 (19%)
Query: 128 LLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHP 187
+LG G F V+ + TG A+K + E+ L + H
Sbjct: 16 VLGSGAFSEVFLV---------KQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHE 66
Query: 188 NLVKLIGCCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL---DAAK---- 239
N+V L E LV + + G E LF R I + DA+
Sbjct: 67 NIVTLED-IYESTTHYYLVMQLVSGG--E--LFDR-------ILERGVYTEKDASLVIQQ 114
Query: 240 ---GLAFLHEEAEKPVIYRDFKTSNILL---DGEYNAKLSDFGLAKDGPEGDKTHVSTRV 293
+ +LH E +++RD K N+L + ++DFGL+K G + +
Sbjct: 115 VLSAVKYLH---ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG----IMSTA 167
Query: 294 MGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTG 329
GT GY APE + + D +S GV+ +L G
Sbjct: 168 CGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCG 203
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 92.9 bits (231), Expect = 9e-21
Identities = 55/260 (21%), Positives = 97/260 (37%), Gaps = 26/260 (10%)
Query: 80 GSSSTTSNAESTTPSTPK---IGEELKISPQLRKFSFNELKSATKSFRP----ECLLGEG 132
GS + + +K+ ++ S LG G
Sbjct: 3 GSHHHHHHGSKVRGKYDGPKINDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSG 62
Query: 133 GFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHPNLVKL 192
FG V++ V+ TG K +N E++ + L HP L+ L
Sbjct: 63 AFGVVHRC---------VEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINL 113
Query: 193 IGCCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKP 251
ED + L+ EF+ G L + + + + + A +GL +H E
Sbjct: 114 HD-AFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH---EHS 169
Query: 252 VIYRDFKTSNILLDGEYNA--KLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGH 309
+++ D K NI+ + + + K+ DFGLA + V T +AAPE V
Sbjct: 170 IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKV---TTATAEFAAPEIVDREP 226
Query: 310 LTAKSDVYSFGVVLLEMLTG 329
+ +D+++ GV+ +L+G
Sbjct: 227 VGFYTDMWAIGVLGYVLLSG 246
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 1e-20
Identities = 52/221 (23%), Positives = 83/221 (37%), Gaps = 44/221 (19%)
Query: 129 LGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLA--------EVNY 180
LG G FG V+ V V VK + + + E+
Sbjct: 32 LGSGAFGFVWTA---------VDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAI 82
Query: 181 LGGLIHPNLVKLIGCCIEDDQRL-LVYEFMPRGS-LENHLFRRSLPLPWSIRMKIALDAA 238
L + H N++K++ E+ LV E G L + R R+ L A+
Sbjct: 83 LSRVEHANIIKVLDI-FENQGFFQLVMEKHGSGLDLFAFIDRHP-------RLDEPL-AS 133
Query: 239 K-------GLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVST 291
+ +L K +I+RD K NI++ ++ KL DFG A G +
Sbjct: 134 YIFRQLVSAVGYLRL---KDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFC 190
Query: 292 RVMGTYGYAAPEYVMTGHL--TAKSDVYSFGVVLLEMLTGR 330
GT Y APE V+ G+ + +++S GV L ++
Sbjct: 191 ---GTIEYCAPE-VLMGNPYRGPELEMWSLGVTLYTLVFEE 227
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 1e-20
Identities = 71/226 (31%), Positives = 101/226 (44%), Gaps = 29/226 (12%)
Query: 115 ELKSATKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKE- 173
++KS K + LGEG F VYK + N T VA+K + K+
Sbjct: 4 DVKSRAKRYEKLDFLGEGQFATVYKA-RDKN--------TNQIVAIKKIKLGHRSEAKDG 54
Query: 174 ----WLAEVNYLGGLIHPNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSI 229
L E+ L L HPN++ L+ LV++FM LE + SL L S
Sbjct: 55 INRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSH 113
Query: 230 RMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAK--DGPEGDKT 287
L +GL +LH+ +++RD K +N+LLD KL+DFGLAK P T
Sbjct: 114 IKAYMLMTLQGLEYLHQ---HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYT 170
Query: 288 H-VSTRVMGTYGYAAPEYVMTG--HLTAKSDVYSFGVVLLEMLTGR 330
H V TR Y APE ++ G D+++ G +L E+L
Sbjct: 171 HQVVTR-----WYRAPE-LLFGARMYGVGVDMWAVGCILAELLLRV 210
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 1e-20
Identities = 64/242 (26%), Positives = 100/242 (41%), Gaps = 31/242 (12%)
Query: 103 KISPQLRKFSFNELKSATKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKT 162
+S + + F+ E + G+G FG V K TG+ VA+K
Sbjct: 5 MMSLNAAAAADERSRKEMDRFQVERMAGQGTFGTVQL--------GKEKS-TGMSVAIKK 55
Query: 163 LNHDGLQGHKEWLAEVNYLGGLIHPNLVKLI------GCCIEDDQRL-LVYEFMPR--GS 213
+ D ++E L + L L HPN+V+L G D L +V E++P
Sbjct: 56 VIQDPRFRNRE-LQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHR 114
Query: 214 LENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNA-KL 272
+ +RR + P + + + LH + V +RD K N+L++ KL
Sbjct: 115 CCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN-VCHRDIKPHNVLVNEADGTLKL 173
Query: 273 SDFGLAKD-GPEGDKTH-VSTRVMGTYGYAAPEYVMTG--HLTAKSDVYSFGVVLLEMLT 328
DFG AK P + +R Y Y APE ++ G H T D++S G + EM+
Sbjct: 174 CDFGSAKKLSPSEPNVAYICSR----Y-YRAPE-LIFGNQHYTTAVDIWSVGCIFAEMML 227
Query: 329 GR 330
G
Sbjct: 228 GE 229
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 90.3 bits (225), Expect = 2e-20
Identities = 58/218 (26%), Positives = 93/218 (42%), Gaps = 45/218 (20%)
Query: 129 LGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQG--HKEWLAEVNYLGGLIH 186
LG+G F V + V TGL A K +N L ++ E L H
Sbjct: 14 LGKGAFSVVRRC---------VHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 187 PNLVKLIGCCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL---DAAK--- 239
PN+V+L I+++ LV++ + G E LF I + DA+
Sbjct: 65 PNIVRLHD-SIQEESFHYLVFDLVTGG--E--LFED-------IVAREFYSEADASHCIQ 112
Query: 240 ----GLAFLHEEAEKPVIYRDFKTSNILLDGEYNA---KLSDFGLAKDGPEGDKTHVSTR 292
+A+ H +++R+ K N+LL + KL+DFGLA + + + H
Sbjct: 113 QILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWH--GF 167
Query: 293 VMGTYGYAAPEYVMTGHL-TAKSDVYSFGVVLLEMLTG 329
GT GY +PE V+ + D+++ GV+L +L G
Sbjct: 168 A-GTPGYLSPE-VLKKDPYSKPVDIWACGVILYILLVG 203
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 3e-20
Identities = 58/222 (26%), Positives = 93/222 (41%), Gaps = 48/222 (21%)
Query: 129 LGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLA------EVNYLG 182
LG G F V K + TGL A K + + + + EV+ L
Sbjct: 20 LGSGQFAIVKKC---------REKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILR 70
Query: 183 GLIHPNLVKLIGCCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL---DAA 238
++HPN++ L E+ + L+ E + G E LF + K +L +A
Sbjct: 71 QVLHPNIITLHDV-YENRTDVVLILELVSGG--E--LFDF-------LAQKESLSEEEAT 118
Query: 239 K-------GLAFLHEEAEKPVIYRDFKTSNILL----DGEYNAKLSDFGLAKDGPEGDKT 287
G+ +LH K + + D K NI+L + KL DFGLA + +G +
Sbjct: 119 SFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF 175
Query: 288 HVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTG 329
+ GT + APE V L ++D++S GV+ +L+G
Sbjct: 176 KN---IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 91.8 bits (228), Expect = 4e-20
Identities = 62/216 (28%), Positives = 99/216 (45%), Gaps = 38/216 (17%)
Query: 128 LLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLA---EVNYLGGL 184
LG G FG V G + TG VAVK LN ++ E+ L
Sbjct: 23 TLGVGTFGKVKVG-KHEL--------TGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLF 73
Query: 185 IHPNLVKLIGCCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAK---- 239
HP+++KL I + +V E++ G L +++ + R+ ++ +
Sbjct: 74 RHPHIIKLYQV-ISTPSDIFMVMEYVSGGELFDYICKNG-------RLDEK-ESRRLFQQ 124
Query: 240 ---GLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGT 296
G+ + H V++RD K N+LLD NAK++DFGL+ +G+ S G+
Sbjct: 125 ILSGVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC---GS 178
Query: 297 YGYAAPEYVMTGHL--TAKSDVYSFGVVLLEMLTGR 330
YAAPE V++G L + D++S GV+L +L G
Sbjct: 179 PNYAAPE-VISGRLYAGPEVDIWSSGVILYALLCGT 213
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 4e-20
Identities = 60/215 (27%), Positives = 99/215 (46%), Gaps = 34/215 (15%)
Query: 129 LGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKE-----WLAEVNYLGG 183
LG G + VYKG TG+ VA+K + D +E + E++ +
Sbjct: 13 LGNGTYATVYKGLNKT---------TGVYVALKEVKLD----SEEGTPSTAIREISLMKE 59
Query: 184 LIHPNLVKLIGCCIEDDQRLLVYEFMP---RGSLENHLFRRS-LPLPWSIRMKIALDAAK 239
L H N+V+L +++ LV+EFM + +++ + L ++ +
Sbjct: 60 LKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQ 119
Query: 240 GLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLA--KDGPEGDKTHVSTRVMGTY 297
GLAF HE +++RD K N+L++ KL DFGLA P + V+ T
Sbjct: 120 GLAFCHE---NKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSS---EVV-TL 172
Query: 298 GYAAPEYVMTG--HLTAKSDVYSFGVVLLEMLTGR 330
Y AP+ V+ G + D++S G +L EM+TG+
Sbjct: 173 WYRAPD-VLMGSRTYSTSIDIWSCGCILAEMITGK 206
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 5e-20
Identities = 57/222 (25%), Positives = 93/222 (41%), Gaps = 48/222 (21%)
Query: 129 LGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLA------EVNYLG 182
LG G F V K + TGL A K + + + ++ EV+ L
Sbjct: 20 LGSGQFAIVKKC---------REKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70
Query: 183 GLIHPNLVKLIGCCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL---DAA 238
++H N++ L E+ + L+ E + G E LF + K +L +A
Sbjct: 71 QVLHHNVITLHDV-YENRTDVVLILELVSGG--E--LFDF-------LAQKESLSEEEAT 118
Query: 239 K-------GLAFLHEEAEKPVIYRDFKTSNILL----DGEYNAKLSDFGLAKDGPEGDKT 287
G+ +LH K + + D K NI+L + KL DFGLA + +G +
Sbjct: 119 SFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF 175
Query: 288 HVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTG 329
+ GT + APE V L ++D++S GV+ +L+G
Sbjct: 176 KN---IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 7e-20
Identities = 56/218 (25%), Positives = 86/218 (39%), Gaps = 33/218 (15%)
Query: 129 LGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEW-----LAEVNYLGG 183
+G+G F V + + TG AVK ++ E +
Sbjct: 32 IGKGPFSVVRRC---------INRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHM 82
Query: 184 LIHPNLVKLIGCCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPW------SIRMKIALD 236
L HP++V+L+ D L +V+EFM L + +R+ S M+ L+
Sbjct: 83 LKHPHIVELLETY-SSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILE 141
Query: 237 AAKGLAFLHEEAEKPVIYRDFKTSNILL---DGEYNAKLSDFGLAKDGPEGDKTHVSTRV 293
A L + H + +I+RD K +LL + KL FG+A E RV
Sbjct: 142 A---LRYCH---DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLV-AGGRV 194
Query: 294 MGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRR 331
GT + APE V DV+ GV+L +L+G
Sbjct: 195 -GTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCL 231
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 1e-19
Identities = 61/262 (23%), Positives = 105/262 (40%), Gaps = 37/262 (14%)
Query: 82 SSTTSNAESTTPSTPKIGEELKISPQLRKFSFNELKSATKSFRPECLLGEGGFGCVYKGW 141
S T SNA + + K+ L + ++ ++G G FG V++
Sbjct: 2 SFTMSNAPLNGVKLNPLDDPNKVIKVLASDGKT-GEQREIAYTNCKVIGNGSFGVVFQAK 60
Query: 142 INMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHPNLVKLIGCCIEDDQ 201
+ + VA+K + LQ + E+ + + HPN+V L +
Sbjct: 61 LVESD----------EVAIKKV----LQDKRFKNRELQIMRIVKHPNVVDLKAFFYSNGD 106
Query: 202 RL------LVYEFMPR--GSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVI 253
+ LV E++P H + +P + + LA++H +
Sbjct: 107 KKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---IC 163
Query: 254 YRDFKTSNILLDGEYNA-KLSDFGLAKDGPEGDK-TH-VSTRVMGTYGYAAPEYVMTG-- 308
+RD K N+LLD KL DFG AK G+ + +R Y Y APE ++ G
Sbjct: 164 HRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSR----Y-YRAPE-LIFGAT 217
Query: 309 HLTAKSDVYSFGVVLLEMLTGR 330
+ T D++S G V+ E++ G+
Sbjct: 218 NYTTNIDIWSTGCVMAELMQGQ 239
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 1e-19
Identities = 57/217 (26%), Positives = 92/217 (42%), Gaps = 43/217 (19%)
Query: 129 LGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQG--HKEWLAEVNYLGGLIH 186
LG+G F V + V TGL A K +N L ++ E L H
Sbjct: 37 LGKGAFSVVRRC---------VHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 87
Query: 187 PNLVKLIGCCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL---DAAK--- 239
PN+V+L I+++ LV++ + G E LF I + DA+
Sbjct: 88 PNIVRLHD-SIQEESFHYLVFDLVTGG--E--LFED-------IVAREFYSEADASHCIQ 135
Query: 240 ----GLAFLHEEAEKPVIYRDFKTSNILLDGEYNA---KLSDFGLAKDGPEGDKTHVSTR 292
+A+ H +++R+ K N+LL + KL+DFGLA + + + H
Sbjct: 136 QILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWH--GF 190
Query: 293 VMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTG 329
GT GY +PE + + D+++ GV+L +L G
Sbjct: 191 A-GTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 226
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 2e-19
Identities = 54/226 (23%), Positives = 84/226 (37%), Gaps = 50/226 (22%)
Query: 128 LLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLN------HDGLQGHKEWLAEVNYL 181
LLG+GGFG V+ G + L VA+K + L EV L
Sbjct: 38 LLGKGGFGTVFAG---------HRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALL 88
Query: 182 ----GGLIHPNLVKLIGCCIEDDQRL-LVYEF-MPRGSLENHLFRRSLPLPWSIRM---- 231
G HP +++L+ E + LV E +P L +++ + +
Sbjct: 89 WKVGAGGGHPGVIRLLDW-FETQEGFMLVLERPLPAQDLFDYITEKG-------PLGEGP 140
Query: 232 --KIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNA-KLSDFGLA---KDGPEGD 285
+ H + V++RD K NIL+D KL DFG D P
Sbjct: 141 SRCFFGQVVAAIQHCHS---RGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPY-- 195
Query: 286 KTHVSTRVMGTYGYAAPEYVMTGHLT-AKSDVYSFGVVLLEMLTGR 330
GT Y+ PE++ + V+S G++L +M+ G
Sbjct: 196 TDFD-----GTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGD 236
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 2e-19
Identities = 62/216 (28%), Positives = 98/216 (45%), Gaps = 39/216 (18%)
Query: 128 LLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLA---EVNYLGGL 184
LGEG FG V + T VA+K ++ L+ + E++YL L
Sbjct: 16 TLGEGSFGKVKLA-THYK--------TQQKVALKFISRQLLKKSDMHMRVEREISYLKLL 66
Query: 185 IHPNLVKLIGCCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAK---- 239
HP+++KL I + +V E+ G L +++ + RM + +
Sbjct: 67 RHPHIIKLYDV-ITTPTDIVMVIEYAG-GELFDYIVEKK-------RMTED-EGRRFFQQ 116
Query: 240 ---GLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGT 296
+ + H +++RD K N+LLD N K++DFGL+ +G+ S G+
Sbjct: 117 IICAIEYCHR---HKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSC---GS 170
Query: 297 YGYAAPEYVMTGHL--TAKSDVYSFGVVLLEMLTGR 330
YAAPE V+ G L + DV+S G+VL ML GR
Sbjct: 171 PNYAAPE-VINGKLYAGPEVDVWSCGIVLYVMLVGR 205
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 3e-19
Identities = 60/257 (23%), Positives = 101/257 (39%), Gaps = 40/257 (15%)
Query: 90 STTPSTPKIGEELKISPQLRKFSFNELKSATKSFRPECL--LGEGGFGCVYKGWINMNGT 147
E P S + SAT R + LGEG +G VYK +
Sbjct: 3 HHHHHHMGTLEAQTQGP--GSMSVSAAPSATSIDRYRRITKLGEGTYGEVYKAIDTV--- 57
Query: 148 ATVKPGTGLPVAVKTLNHDGLQGHKE-----WLAEVNYLGGLIHPNLVKLIGCCIEDDQR 202
T VA+K + L+ +E + EV+ L L H N+++L + +
Sbjct: 58 ------TNETVAIKRIR---LEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRL 108
Query: 203 LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNI 262
L++E+ L+ ++ ++ + + G+ F H + ++RD K N+
Sbjct: 109 HLIFEYAEN-DLKKYM-DKNPDVSMRVIKSFLYQLINGVNFCH---SRRCLHRDLKPQNL 163
Query: 263 LLDGEYNA-----KLSDFGLAKD--GPEGDKTHVSTRVMGTYGYAAPEYVMTG--HLTAK 313
LL + K+ DFGLA+ P TH ++ T Y PE ++ G H +
Sbjct: 164 LLSVSDASETPVLKIGDFGLARAFGIPIRQFTH---EII-TLWYRPPE-ILLGSRHYSTS 218
Query: 314 SDVYSFGVVLLEMLTGR 330
D++S + EML
Sbjct: 219 VDIWSIACIWAEMLMKT 235
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 3e-19
Identities = 55/235 (23%), Positives = 94/235 (40%), Gaps = 49/235 (20%)
Query: 128 LLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLA----------- 176
+G+G +G V N N A+K L+ L +
Sbjct: 20 EIGKGSYGVVKLA-YNEN--------DNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAP 70
Query: 177 ---------------EVNYLGGLIHPNLVKLIGCCIEDDQRL---LVYEFMPRGSLENHL 218
E+ L L HPN+VKL+ ++D +V+E + +G +
Sbjct: 71 GGCIQPRGPIEQVYQEIAILKKLDHPNVVKLV-EVLDDPNEDHLYMVFELVNQGPVMEVP 129
Query: 219 FRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLA 278
+ PL D KG+ +LH + +I+RD K SN+L+ + + K++DFG++
Sbjct: 130 TLK--PLSEDQARFYFQDLIKGIEYLHY---QKIIHRDIKPSNLLVGEDGHIKIADFGVS 184
Query: 279 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLT---AKSDVYSFGVVLLEMLTGR 330
+ +G +S V GT + APE + DV++ GV L + G+
Sbjct: 185 NE-FKGSDALLSNTV-GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 5e-19
Identities = 59/222 (26%), Positives = 93/222 (41%), Gaps = 48/222 (21%)
Query: 129 LGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLA------EVNYLG 182
LG G F V K + GTG A K + L + ++ EVN L
Sbjct: 13 LGSGQFAIVRKC---------RQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 63
Query: 183 GLIHPNLVKLIGCCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL---DAA 238
+ HPN++ L E+ + L+ E + G E LF + K +L +A
Sbjct: 64 EIRHPNIITLHDIF-ENKTDVVLILELVSGG--E--LFDF-------LAEKESLTEDEAT 111
Query: 239 K-------GLAFLHEEAEKPVIYRDFKTSNILL---DGEYNA-KLSDFGLAKDGPEGDKT 287
+ G+ +LH K + + D K NI+L + KL DFG+A G++
Sbjct: 112 QFLKQILDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF 168
Query: 288 HVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTG 329
+ GT + APE V L ++D++S GV+ +L+G
Sbjct: 169 KN---IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 207
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 8e-19
Identities = 76/338 (22%), Positives = 121/338 (35%), Gaps = 77/338 (22%)
Query: 129 LGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGL-IHP 187
LGEG F K V + AVK ++ ++ E+ L HP
Sbjct: 19 LGEGSFSICRKC---------VHKKSNQAFAVKIISKRMEANTQK---EITALKLCEGHP 66
Query: 188 NLVKLIGCCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL---DAAK---- 239
N+VKL D LV E + G LF R I+ K +A+
Sbjct: 67 NIVKLHEVF-HDQLHTFLVMELLNGGE----LFER-------IKKKKHFSETEASYIMRK 114
Query: 240 ---GLAFLHEEAEKPVIYRDFKTSNILL---DGEYNAKLSDFGLAKDGPEGDKTHVSTRV 293
++ +H + V++RD K N+L + K+ DFG A+ P ++ + T
Sbjct: 115 LVSAVSHMH---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQP-LKTPC 170
Query: 294 MGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLG 353
T YAAPE + D++S GV+L ML+G+ P + +
Sbjct: 171 -FTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQ------VPF-------QSHDRSL 216
Query: 354 ERRRFYRLIDPCLEGCFSIKGAE-KTIQLAA-----SCLNRDQKARPRMSEVVE------ 401
++ +G FS +G K + A L D R +MS +
Sbjct: 217 TCTSAVEIMKKIKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQD 276
Query: 402 ----ALKPLPYLKDMASSSSYVQAMQAERVRLNLNAKH 435
+ PL + SS + V V+ +A +
Sbjct: 277 GSQLSSNPLMTPDILGSSGAAVHT----CVKATFHAFN 310
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 9e-19
Identities = 55/216 (25%), Positives = 78/216 (36%), Gaps = 40/216 (18%)
Query: 128 LLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLA-EVNYLGGLIH 186
+G G FG T VAVK + E + E+ L H
Sbjct: 27 DIGSGNFGVARLM---------RDKLTKELVAVKYIERGAAI--DENVQREIINHRSLRH 75
Query: 187 PNLVKLIGCCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAK------ 239
PN+V+ I L ++ E+ G L + R +A
Sbjct: 76 PNIVRFKEV-ILTPTHLAIIMEYASGGELYERICNAG-------RFSED-EARFFFQQLL 126
Query: 240 -GLAFLHEEAEKPVIYRDFKTSNILLDGEY--NAKLSDFGLAKDGPEGDKTHVSTRVMGT 296
G+++ H + +RD K N LLDG K+ DFG +K + + V GT
Sbjct: 127 SGVSYCHS---MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK--STV-GT 180
Query: 297 YGYAAPEYVMTGHL--TAKSDVYSFGVVLLEMLTGR 330
Y APE V+ +DV+S GV L ML G
Sbjct: 181 PAYIAPE-VLLRQEYDGKIADVWSCGVTLYVMLVGA 215
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 2e-18
Identities = 40/211 (18%), Positives = 77/211 (36%), Gaps = 34/211 (16%)
Query: 129 LGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHPN 188
LG G FG V++ + K + G E++ L H N
Sbjct: 13 LGRGEFGIVHR--------CVET-SSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRN 62
Query: 189 LVKLIGCCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAK-------G 240
++ L E + L +++EF+ + + + L +
Sbjct: 63 ILHLHESF-ESMEELVMIFEFISGLDIFERINTSAFELN-------EREIVSYVHQVCEA 114
Query: 241 LAFLHEEAEKPVIYRDFKTSNILLDGEYNA--KLSDFGLAKDGPEGDKTHVSTRVMGTYG 298
L FLH + + D + NI+ ++ K+ +FG A+ GD + +
Sbjct: 115 LQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL---LFTAPE 168
Query: 299 YAAPEYVMTGHLTAKSDVYSFGVVLLEMLTG 329
Y APE ++ +D++S G ++ +L+G
Sbjct: 169 YYAPEVHQHDVVSTATDMWSLGTLVYVLLSG 199
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 2e-18
Identities = 56/222 (25%), Positives = 92/222 (41%), Gaps = 48/222 (21%)
Query: 129 LGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLA------EVNYLG 182
LG G F V K + TGL A K + + + ++ EV+ L
Sbjct: 19 LGSGQFAVVKKC---------REKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 183 GLIHPNLVKLIGCCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL---DAA 238
+ HPN++ L E+ + L+ E + G E LF + K +L +A
Sbjct: 70 EIQHPNVITLHEV-YENKTDVILILELVAGG--E--LFDF-------LAEKESLTEEEAT 117
Query: 239 K-------GLAFLHEEAEKPVIYRDFKTSNILL----DGEYNAKLSDFGLAKDGPEGDKT 287
+ G+ +LH + + D K NI+L + K+ DFGLA G++
Sbjct: 118 EFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF 174
Query: 288 HVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTG 329
+ GT + APE V L ++D++S GV+ +L+G
Sbjct: 175 KN---IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 3e-18
Identities = 51/217 (23%), Positives = 84/217 (38%), Gaps = 46/217 (21%)
Query: 129 LGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLI-HP 187
+G G + + + T + AVK ++ E E+ L HP
Sbjct: 30 IGVGSYSVCKRC---------IHKATNMEFAVKIIDKSKRDP-TE---EIEILLRYGQHP 76
Query: 188 NLVKLIGCCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL---DAAK---- 239
N++ L +D + + +V E M G L + I + +A+
Sbjct: 77 NIITLKDVY-DDGKYVYVVTELMKGGE----LLDK-------ILRQKFFSEREASAVLFT 124
Query: 240 ---GLAFLHEEAEKPVIYRDFKTSNILL----DGEYNAKLSDFGLAKDGPEGDKTHVSTR 292
+ +LH + V++RD K SNIL + ++ DFG AK + + T
Sbjct: 125 ITKTVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGL-LMTP 180
Query: 293 VMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTG 329
T + APE + A D++S GV+L MLTG
Sbjct: 181 C-YTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTG 216
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 4e-18
Identities = 49/220 (22%), Positives = 84/220 (38%), Gaps = 46/220 (20%)
Query: 129 LGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQG--HKEWLAEVNYLGGLIH 186
LG G F V + + TG A K L E L E+ L
Sbjct: 37 LGRGKFAVVRQC---------ISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKS 87
Query: 187 -PNLVKLIGCCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIA-----LDAAK 239
P ++ L E+ + L+ E+ G E +F ++A D +
Sbjct: 88 CPRVINLHEV-YENTSEIILILEYAAGG--E--IFSL-------CLPELAEMVSENDVIR 135
Query: 240 -------GLAFLHEEAEKPVIYRDFKTSNILL---DGEYNAKLSDFGLAKDGPEGDKTHV 289
G+ +LH+ +++ D K NILL + K+ DFG+++ +
Sbjct: 136 LIKQILEGVYYLHQ---NNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELRE 192
Query: 290 STRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTG 329
+MGT Y APE + +T +D+++ G++ +LT
Sbjct: 193 ---IMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTH 229
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 5e-18
Identities = 54/236 (22%), Positives = 94/236 (39%), Gaps = 39/236 (16%)
Query: 105 SPQLRKFSFNELKSATKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLN 164
P+ +K++ + +K +LG G G V + TG A+K L
Sbjct: 18 GPEPKKYAVTDDYQLSKQ-----VLGLGVNGKVLEC---------FHRRTGQKCALKLLY 63
Query: 165 HDGLQGHKEWLAEVNYLGGLI-HPNLVKLIGCCIEDDQR-----LLVYEFMPRGSLENHL 218
+ EV++ P++V ++ E+ L++ E M G L + +
Sbjct: 64 D-----SPKARQEVDHHWQASGGPHIVCILDVY-ENMHHGKRCLLIIMECMEGGELFSRI 117
Query: 219 FRRSLPLPWSIRM--KIALDAAKGLAFLHEEAEKPVIYRDFKTSNILL---DGEYNAKLS 273
R ++ R +I D + FLH + +RD K N+L + + KL+
Sbjct: 118 QERG-DQAFTEREAAEIMRDIGTAIQFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLT 173
Query: 274 DFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTG 329
DFG AK+ + + T T Y APE + D++S GV++ +L G
Sbjct: 174 DFGFAKETTQNA---LQTPC-YTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 225
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 8e-18
Identities = 57/218 (26%), Positives = 90/218 (41%), Gaps = 44/218 (20%)
Query: 129 LGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQG--HKEWLAEVNYLGGLIH 186
LG+G F V + VK G A +N L H++ E L H
Sbjct: 19 LGKGAFSVVRRC---------VKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKH 69
Query: 187 PNLVKLIGCCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL---DAAK--- 239
PN+V+L I ++ L+++ + G E LF I + DA+
Sbjct: 70 PNIVRLHD-SISEEGHHYLIFDLVTGG--E--LFED-------IVAREYYSEADASHCIQ 117
Query: 240 ----GLAFLHEEAEKPVIYRDFKTSNILLDGEYNA---KLSDFGLAKDGPEGDKTHVSTR 292
+ H + V++R+ K N+LL + KL+DFGLA + EG++
Sbjct: 118 QILEAVLHCH---QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIE-VEGEQQAWFGF 173
Query: 293 VMGTYGYAAPEYVMTGHL-TAKSDVYSFGVVLLEMLTG 329
GT GY +PE V+ D+++ GV+L +L G
Sbjct: 174 A-GTPGYLSPE-VLRKDPYGKPVDLWACGVILYILLVG 209
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 1e-17
Identities = 70/279 (25%), Positives = 103/279 (36%), Gaps = 50/279 (17%)
Query: 65 KSTNDTSRGQPVVPIGSSSTTSNAESTTPSTPKIGEELKISPQLRKFSFNELKSATKSFR 124
+ + + S +S S P T + + I + + + F
Sbjct: 4 HHHHSSGVDLGTENLYFQSMSSVTASAAPGTASLVPDYWIDG-------SNRDALSDFFE 56
Query: 125 PECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGL 184
E LG G VY+ K GT P A+K L K E+ L L
Sbjct: 57 VESELGRGATSIVYR--------CKQK-GTQKPYALKVLKKT--VDKKIVRTEIGVLLRL 105
Query: 185 IHPNLVKLIGCCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL---DAAK- 239
HPN++KL E + LV E + G L F R I K DAA
Sbjct: 106 SHPNIIKLKEIF-ETPTEISLVLELVTGGEL----FDR-------IVEKGYYSERDAADA 153
Query: 240 ------GLAFLHEEAEKPVIYRDFKTSNILL---DGEYNAKLSDFGLAKDGPEGDKTHVS 290
+A+LHE +++RD K N+L + K++DFGL+K
Sbjct: 154 VKQILEAVAYLHE---NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLM--- 207
Query: 291 TRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTG 329
V GT GY APE + + D++S G++ +L G
Sbjct: 208 KTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCG 246
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 82.9 bits (205), Expect = 2e-17
Identities = 56/284 (19%), Positives = 99/284 (34%), Gaps = 38/284 (13%)
Query: 57 TSTQYAESKSTNDTSRGQPVVPIGSSSTTSNAESTTPSTPKIGEELKISPQLRKFSFNEL 116
+++Q P P + P +K Q++K + +
Sbjct: 3 SNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDD 62
Query: 117 KSATKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLA 176
T +LG G G V + T A+K L +
Sbjct: 63 YKVTSQ-----VLGLGINGKVLQI---------FNKRTQEKFALKMLQD-----CPKARR 103
Query: 177 EVNYLGGLI-HPNLVKLIGCCIEDDQR-----LLVYEFMPRGSLENHLFRRSLPLPWSIR 230
EV P++V+++ E+ L+V E + G L + + R ++ R
Sbjct: 104 EVELHWRASQCPHIVRIVDVY-ENLYAGRKCLLIVMECLDGGELFSRIQDRG-DQAFTER 161
Query: 231 M--KIALDAAKGLAFLHEEAEKPVIYRDFKTSNILL---DGEYNAKLSDFGLAKDGPEGD 285
+I + + +LH + +RD K N+L KL+DFG AK+ +
Sbjct: 162 EASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN 218
Query: 286 KTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTG 329
++T T Y APE + D++S GV++ +L G
Sbjct: 219 S--LTTPC-YTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 259
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 4e-17
Identities = 57/222 (25%), Positives = 91/222 (40%), Gaps = 40/222 (18%)
Query: 129 LGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKE-----WLAEVNYLGG 183
+G+G FG V+K + TG VA+K + ++ KE L E+ L
Sbjct: 25 IGQGTFGEVFKA-RHRK--------TGQKVALKKVL---MENEKEGFPITALREIKILQL 72
Query: 184 LIHPNLVKLIGCCIEDDQRL--------LVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 235
L H N+V LI C LV++F L L + S ++
Sbjct: 73 LKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQ 131
Query: 236 DAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLA------KDGPEGDKTHV 289
GL ++H +++RD K +N+L+ + KL+DFGLA K+ T+
Sbjct: 132 MLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTN- 187
Query: 290 STRVMGTYGYAAPEYVM-TGHLTAKSDVYSFGVVLLEMLTGR 330
RV+ T Y PE ++ D++ G ++ EM T
Sbjct: 188 --RVV-TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRS 226
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 4e-17
Identities = 59/219 (26%), Positives = 91/219 (41%), Gaps = 38/219 (17%)
Query: 129 LGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKE-----WLAEVNYLGG 183
+GEG +G V+K A G VA+K + +Q +E + EV L
Sbjct: 19 IGEGAYGKVFK--------ARDLKNGGRFVALKRVR---VQTGEEGMPLSTIREVAVLRH 67
Query: 184 L---IHPNLVKLI----GCCIEDDQRL-LVYEFMP---RGSLENHLFRRSLPLPWSIRMK 232
L HPN+V+L + + +L LV+E + L+ +P
Sbjct: 68 LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKV---PEPGVPTETIKD 124
Query: 233 IALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKD-GPEGDKTHVST 291
+ +GL FLH V++RD K NIL+ KL+DFGLA+ + T
Sbjct: 125 MMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTS--- 178
Query: 292 RVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGR 330
V+ T Y APE ++ D++S G + EM +
Sbjct: 179 VVV-TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 5e-17
Identities = 57/222 (25%), Positives = 88/222 (39%), Gaps = 42/222 (18%)
Query: 129 LGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLA--------EVNY 180
+G G +G VYK + + +G VA+K++ + EV
Sbjct: 17 IGVGAYGTVYKA-RDPH--------SGHFVALKSVR---VPNGGGGGGGLPISTVREVAL 64
Query: 181 LGGL---IHPNLVKLIGCCIEDDQRL-----LVYEFMP---RGSLENHLFRRSLPLPWSI 229
L L HPN+V+L+ C LV+E + R L+ LP
Sbjct: 65 LRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKA---PPPGLPAET 121
Query: 230 RMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKD-GPEGDKTH 288
+ +GL FLH +++RD K NIL+ KL+DFGLA+ + T
Sbjct: 122 IKDLMRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTP 178
Query: 289 VSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGR 330
V+ T Y APE ++ D++S G + EM +
Sbjct: 179 ---VVV-TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 2e-16
Identities = 27/212 (12%), Positives = 56/212 (26%), Gaps = 47/212 (22%)
Query: 123 FRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL---QGHKEWLAEVN 179
+R G ++ VA+ ++ G+ +E L+
Sbjct: 33 YRLLIFHGGVPPLQFWQALDTA---------LDRQVALTFVDPQGVLPDDVLQETLSRTL 83
Query: 180 YLGGLIHPNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAK 239
L + P + +++ L+V E++ GSL+ + P P ++ A
Sbjct: 84 RLSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVA--DTSPSPVGA-IRAMQSLAA 140
Query: 240 GLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGY 299
H V S + + + + L+
Sbjct: 141 AADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPA----------------------T 175
Query: 300 AAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRR 331
+ D+ G L +L R
Sbjct: 176 MPDA-------NPQDDIRGIGASLYALLVNRW 200
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 6e-16
Identities = 52/258 (20%), Positives = 93/258 (36%), Gaps = 71/258 (27%)
Query: 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVK-TLNHDGLQGHKEWLAEV 178
+K + LG G FG V + +G A+K L + E+
Sbjct: 6 SKKYSLGKTLGTGSFGIVCE--------VFDIE-SGKRFALKKVLQDP-----RYKNREL 51
Query: 179 NYLGGLIHPNLVKLIGC-------------------------------------CIEDDQ 201
+ + L H N++KL+ ++
Sbjct: 52 DIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNK 111
Query: 202 RL-LVYEFMPR--GSLENHLFRRSLPLPWSIRMKIAL-DAAKGLAFLHEEAEKPVIYRDF 257
L ++ E++P + R +P + I + + + F+H + +RD
Sbjct: 112 YLNVIMEYVPDTLHKVLKSFIRSGRSIP-MNLISIYIYQLFRAVGFIHSLG---ICHRDI 167
Query: 258 KTSNILLDGEYNA-KLSDFGLAKDGPEGDK-TH-VSTRVMGTYGYAAPEYVMTG--HLTA 312
K N+L++ + N KL DFG AK + + +R + Y APE +M G T
Sbjct: 168 KPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSR----F-YRAPE-LMLGATEYTP 221
Query: 313 KSDVYSFGVVLLEMLTGR 330
D++S G V E++ G+
Sbjct: 222 SIDLWSIGCVFGELILGK 239
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 77.7 bits (191), Expect = 8e-16
Identities = 35/114 (30%), Positives = 51/114 (44%), Gaps = 3/114 (2%)
Query: 215 ENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSD 274
E L + + AKG+ FL A + I+RD NILL + K+ D
Sbjct: 180 EAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICD 236
Query: 275 FGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLT 328
FGLA+D + + APE + T +SDV+SFGV+L E+ +
Sbjct: 237 FGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 66.1 bits (161), Expect = 5e-12
Identities = 29/97 (29%), Positives = 44/97 (45%), Gaps = 9/97 (9%)
Query: 129 LGEGGFGCVYKG-WINMNGTATVKPGTGLPVAVKTLNHD-GLQGHKEWLAEVNYLGGL-I 185
LG G FG V + ++ K T VAVK L H+ ++E+ L +
Sbjct: 30 LGRGAFGQVIEADAFGID-----KTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGH 84
Query: 186 HPNLVKLIGCCIEDDQRLLV-YEFMPRGSLENHLFRR 221
H N+V L+G C + L+V EF G+L +L +
Sbjct: 85 HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSK 121
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 1e-15
Identities = 48/213 (22%), Positives = 82/213 (38%), Gaps = 37/213 (17%)
Query: 129 LGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLI-HP 187
LG G + V++ N V VK L K+ E+ L L P
Sbjct: 44 LGRGKYSEVFEAINITNNE---------KVVVKILK---PVKKKKIKREIKILENLRGGP 91
Query: 188 NLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPL--PWSIR--MKIALDAAKGLAF 243
N++ L + R F + N F++ + IR M L K L +
Sbjct: 92 NIITLADIVKDPVSRTPALVFEH---VNNTDFKQLYQTLTDYDIRFYMYEIL---KALDY 145
Query: 244 LHEEAEKPVIYRDFKTSNILLDGEYNA-KLSDFGLAKDG-PEGDKTH-VSTRVMGTYGYA 300
H +++RD K N+++D E+ +L D+GLA+ P + V++R +
Sbjct: 146 CHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRY-----FK 197
Query: 301 APEYVMTG--HLTAKSDVYSFGVVLLEMLTGRR 331
PE ++ D++S G +L M+ +
Sbjct: 198 GPE-LLVDYQMYDYSLDMWSLGCMLASMIFRKE 229
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 74.1 bits (182), Expect = 2e-14
Identities = 53/222 (23%), Positives = 87/222 (39%), Gaps = 33/222 (14%)
Query: 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNH--DGLQGHKEWLAE 177
K ++ +G G G V A VA+K L+ K E
Sbjct: 61 LKRYQNLKPIGSGAQGIVCA--------AYDAV-LDRNVAIKKLSRPFQNQTHAKRAYRE 111
Query: 178 VNYLGGLIHPNLVKLI-----GCCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRM 231
+ + + H N++ L+ +E+ Q + LV E M + + + L RM
Sbjct: 112 LVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM--DANLCQVIQMEL---DHERM 166
Query: 232 KIAL-DAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKT--H 288
L G+ LH +I+RD K SNI++ + K+ DFGLA+ +
Sbjct: 167 SYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY 223
Query: 289 VSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGR 330
V TR Y APE ++ D++S G ++ EM+ +
Sbjct: 224 VVTRY-----YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 3e-14
Identities = 57/229 (24%), Positives = 98/229 (42%), Gaps = 48/229 (20%)
Query: 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNH--DGLQGHKEWLAE 177
K++ +G G +G V A K +G VA+K L+ K E
Sbjct: 23 PKTYVSPTHVGSGAYGSVCS--------AIDKR-SGEKVAIKKLSRPFQSEIFAKRAYRE 73
Query: 178 VNYLGGLIHPNLVKLI-----GCCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRM 231
+ L + H N++ L+ + + LV FM + L + + +
Sbjct: 74 LLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFM-----QTDLQK-------IMGL 121
Query: 232 KIALD--------AAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPE 283
K + + KGL ++H A V++RD K N+ ++ + K+ DFGLA+ +
Sbjct: 122 KFSEEKIQYLVYQMLKGLKYIHS-AG--VVHRDLKPGNLAVNEDCELKILDFGLAR-HAD 177
Query: 284 GDKTH-VSTRVMGTYGYAAPEYVMT-GHLTAKSDVYSFGVVLLEMLTGR 330
+ T V TR + Y APE +++ H D++S G ++ EMLTG+
Sbjct: 178 AEMTGYVVTR----W-YRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 1e-13
Identities = 56/231 (24%), Positives = 89/231 (38%), Gaps = 40/231 (17%)
Query: 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEW----- 174
+ + + G +G V G+PVA+K + + G
Sbjct: 21 QSPYTVQRFISSGSYGAVCA----------GVDSEGIPVAIKRVFNTVSDGRTVNILSDS 70
Query: 175 ------LAEVNYLGGLIHPNLVKLIGCCIEDDQRL-----LVYEFMPRGSLENHLFRRSL 223
L E+ L HPN++ L + ++ LV E M L + + +
Sbjct: 71 FLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRI 129
Query: 224 PLPWSIRMK-IALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLA-KDG 281
+ ++ GL LHE A V++RD NILL + + DF LA +D
Sbjct: 130 VIS-PQHIQYFMYHILLGLHVLHE-AG--VVHRDLHPGNILLADNNDITICDFNLAREDT 185
Query: 282 PEGDKT-HVSTRVMGTYGYAAPEYVMT-GHLTAKSDVYSFGVVLLEMLTGR 330
+ +KT +V+ R Y APE VM T D++S G V+ EM +
Sbjct: 186 ADANKTHYVTHRW-----YRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 2e-13
Identities = 57/222 (25%), Positives = 90/222 (40%), Gaps = 33/222 (14%)
Query: 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNH--DGLQGHKEWLAE 177
K ++ +G G G V A VA+K L+ K E
Sbjct: 24 LKRYQNLKPIGSGAQGIVCA--------AYDAI-LERNVAIKKLSRPFQNQTHAKRAYRE 74
Query: 178 VNYLGGLIHPNLVKLI-----GCCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRM 231
+ + + H N++ L+ +E+ Q + +V E M +L + + L RM
Sbjct: 75 LVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD-ANL-CQVIQMEL---DHERM 129
Query: 232 KIAL-DAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLA-KDGPEGDKT-H 288
L G+ LH A +I+RD K SNI++ + K+ DFGLA G T +
Sbjct: 130 SYLLYQMLCGIKHLHS-AG--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY 186
Query: 289 VSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGR 330
V TR Y APE ++ D++S G ++ EM+ G
Sbjct: 187 VVTRY-----YRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 5e-13
Identities = 57/223 (25%), Positives = 97/223 (43%), Gaps = 35/223 (15%)
Query: 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNH--DGLQGHKEWLAE 177
+ ++ +G G +G V + TGL VAVK L+ + K E
Sbjct: 28 PERYQNLSPVGSGAYGSVCAAFDT---------KTGLRVAVKKLSRPFQSIIHAKRTYRE 78
Query: 178 VNYLGGLIHPNLVKLI-----GCCIEDDQRL-LVYEFMPRGSLENHLFR--RSLPLPWSI 229
+ L + H N++ L+ +E+ + LV M L + L
Sbjct: 79 LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-----GADLNNIVKCQKLTDDH 133
Query: 230 RMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKT-H 288
+ +GL ++H A+ +I+RD K SN+ ++ + K+ DFGLA+ + T +
Sbjct: 134 VQFLIYQILRGLKYIHS-AD--IIHRDLKPSNLAVNEDCELKILDFGLAR-HTADEMTGY 189
Query: 289 VSTRVMGTYGYAAPEYVMT-GHLTAKSDVYSFGVVLLEMLTGR 330
V+TR Y APE ++ H D++S G ++ E+LTGR
Sbjct: 190 VATRW-----YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 7e-13
Identities = 55/231 (23%), Positives = 90/231 (38%), Gaps = 38/231 (16%)
Query: 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVN 179
+ LG GG G V+ A VA+K + Q K L E+
Sbjct: 10 GSRYMDLKPLGCGGNGLVFS--------AVDND-CDKRVAIKKIVLTDPQSVKHALREIK 60
Query: 180 YLGGLIHPNLVKLIGCCIEDDQRL--------------LVYEFMPRGSLENHLFR--RSL 223
+ L H N+VK+ +L +V E+M E L
Sbjct: 61 IIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYM-----ETDLANVLEQG 115
Query: 224 PLPWSIRMK-IALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGE-YNAKLSDFGLAK-D 280
PL + +GL ++H A V++RD K +N+ ++ E K+ DFGLA+
Sbjct: 116 PLL-EEHARLFMYQLLRGLKYIHS-AN--VLHRDLKPANLFINTEDLVLKIGDFGLARIM 171
Query: 281 GPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTAKSDVYSFGVVLLEMLTGR 330
P + + T Y +P +++ + T D+++ G + EMLTG+
Sbjct: 172 DPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 1e-12
Identities = 57/223 (25%), Positives = 91/223 (40%), Gaps = 35/223 (15%)
Query: 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNH--DGLQGHKEWLAE 177
+R +G G +G V A TG VA+K L K E
Sbjct: 24 RAVYRDLQPVGSGAYGAVCS--------AVDGR-TGAKVAIKKLYRPFQSELFAKRAYRE 74
Query: 178 VNYLGGLIHPNLVKLIGCCIEDDQRL------LVYEFMPRGSLENHLFR--RSLPLPWSI 229
+ L + H N++ L+ D+ LV FM L + + L
Sbjct: 75 LRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-----GTDLGKLMKHEKLGEDR 129
Query: 230 RMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKT-H 288
+ KGL ++H A +I+RD K N+ ++ + K+ DFGLA+ + + T +
Sbjct: 130 IQFLVYQMLKGLRYIHA-AG--IIHRDLKPGNLAVNEDCELKILDFGLAR-QADSEMTGY 185
Query: 289 VSTRVMGTYGYAAPEYVMT-GHLTAKSDVYSFGVVLLEMLTGR 330
V TR Y APE ++ T D++S G ++ EM+TG+
Sbjct: 186 VVTRW-----YRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 67.1 bits (164), Expect = 3e-12
Identities = 42/240 (17%), Positives = 76/240 (31%), Gaps = 46/240 (19%)
Query: 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDG----------LQG 170
+ ++ + G +Y+ + ++K DG
Sbjct: 42 RQWKLKSFQTRDNQGILYEA-APTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAA 100
Query: 171 HKEWLAEVNYLGGLIHPNLVKLIGC-CIEDDQRLLVYEFMPR--GSLENHLFRRSLPLPW 227
+ + L + +G +D R LV +P SL+ S
Sbjct: 101 KPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLV---LPSLGRSLQ-SALDVSPKHVL 156
Query: 228 SIRM--KIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAK--LSDFGLAK---D 280
S R ++A L FLH E ++ + NI +D E ++ L+ +G A
Sbjct: 157 SERSVLQVACRLLDALEFLH---ENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCP 213
Query: 281 GPEGDKTHVSTR------VMGTYGYAAPEYVMTGHL----TAKSDVYSFGVVLLEMLTGR 330
HV+ G + + M H + +SD+ S G +L+ L G
Sbjct: 214 ----SGKHVAYVEGSRSPHEGDLEFIS----MDLHKGCGPSRRSDLQSLGYCMLKWLYGF 265
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 67.5 bits (165), Expect = 3e-12
Identities = 52/307 (16%), Positives = 97/307 (31%), Gaps = 53/307 (17%)
Query: 70 TSRGQPVVPIGSSSTTSNAESTTPSTPKIGEELKISPQLRKFSFNELKSATKSFRPECLL 129
+S +S T + + + P + + L+
Sbjct: 2 SSHEAAAAQQHNSGTQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQIPDRYEIRHLI 61
Query: 130 GEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLA-----EVNYLGGL 184
G G +G V + A K VA+K + E+ L L
Sbjct: 62 GTGSYGHVCE--------AYDKL-EKRVVAIKKILRVF---EDLIDCKRILREIAILNRL 109
Query: 185 IHPNLVKLIGCCI----EDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAK 239
H ++VK++ I E L +V E LFR + L + +
Sbjct: 110 NHDHVVKVLDIVIPKDVEKFDELYVVLEIADS-DF-KKLFRTPVYLTELHIKTLLYNLLV 167
Query: 240 GLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGY 299
G+ ++H A +++RD K +N L++ + + K+ DFGLA+ + + +
Sbjct: 168 GVKYVHS-AG--ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDD 224
Query: 300 AAP--------------EYVMT------------GHLTAKSDVYSFGVVLLEMLTGRRSM 333
+V+T + T DV+S G + E+L +
Sbjct: 225 MNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKEN 284
Query: 334 DKNRPNG 340
+
Sbjct: 285 VAYHADR 291
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 3e-12
Identities = 56/228 (24%), Positives = 97/228 (42%), Gaps = 41/228 (17%)
Query: 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLN-HDGLQGHKEWLAEV 178
+ +GEG +G V A + VA+K ++ + + L E+
Sbjct: 26 GPRYTNLSYIGEGAYGMVCS--------AYDNL-NKVRVAIKKISPFEHQTYCQRTLREI 76
Query: 179 NYLGGLIHPNLVKLIGC----CIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKI 233
L H N++ + IE + + +V + M E L++ ++ +
Sbjct: 77 KILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM-----ETDLYK-------LLKTQH 124
Query: 234 ALDA---------AKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAK-DGPE 283
+ +GL ++H A V++RD K SN+LL+ + K+ DFGLA+ P+
Sbjct: 125 LSNDHICYFLYQILRGLKYIHS-AN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPD 181
Query: 284 GDKTHVSTRVMGTYGYAAPEYVMT-GHLTAKSDVYSFGVVLLEMLTGR 330
D T T + T Y APE ++ T D++S G +L EML+ R
Sbjct: 182 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 3e-12
Identities = 59/235 (25%), Positives = 95/235 (40%), Gaps = 48/235 (20%)
Query: 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLN-HDGLQGHKEWLAEV 178
+ F+ + LLGEG +G V AT KP TG VA+K + D L E+
Sbjct: 10 SSDFQLKSLLGEGAYGVVCS--------ATHKP-TGEIVAIKKIEPFDKPLFALRTLREI 60
Query: 179 NYLGGLIHPNLVKLIGC----CIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKI 233
L H N++ + E+ + ++ E M + L R I ++
Sbjct: 61 KILKHFKHENIITIFNIQRPDSFENFNEVYIIQELM-----QTDLHR-------VISTQM 108
Query: 234 ALDA---------AKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLA----KD 280
D + + LH + VI+RD K SN+L++ + K+ DFGLA +
Sbjct: 109 LSDDHIQYFIYQTLRAVKVLHG-SN--VIHRDLKPSNLLINSNCDLKVCDFGLARIIDES 165
Query: 281 GPEGDKTHVSTRVMGTY----GYAAPEYVMTGHL-TAKSDVYSFGVVLLEMLTGR 330
+ + M + Y APE ++T + DV+S G +L E+ R
Sbjct: 166 AADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 64.4 bits (157), Expect = 2e-11
Identities = 56/258 (21%), Positives = 95/258 (36%), Gaps = 62/258 (24%)
Query: 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNH--DGLQGHKEWLAE 177
++ + L+G G +G VY A K T VA+K +N + L K L E
Sbjct: 25 PDNYIIKHLIGRGSYGYVYL--------AYDKN-TEKNVAIKKVNRMFEDLIDCKRILRE 75
Query: 178 VNYLGGLIHPNLVKLIGCCIEDDQRL-----LVYEFMPRGSLENHLFRRSLPLPWSIRMK 232
+ L L +++L I DD +V E ++ L + +
Sbjct: 76 ITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIA-----DSDLKK-------LFKTP 123
Query: 233 IALDAA----------KGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGP 282
I L G F+HE + +I+RD K +N LL+ + + K+ DFGLA+
Sbjct: 124 IFLTEEHIKTILYNLLLGENFIHE-SG--IIHRDLKPANCLLNQDCSVKVCDFGLARTIN 180
Query: 283 EGDKTHVSTRVMGTYGYAAP---------EYVMT------------GHLTAKSDVYSFGV 321
T++ + +V+T + T D++S G
Sbjct: 181 SEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGC 240
Query: 322 VLLEMLTGRRSMDKNRPN 339
+ E+L +S + N
Sbjct: 241 IFAELLNMLQSHINDPTN 258
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 1e-10
Identities = 51/229 (22%), Positives = 85/229 (37%), Gaps = 46/229 (20%)
Query: 123 FRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKT--LNHDGLQGHKEWLAEVNY 180
++ +GEG FG +++G N+ VA+K D Q E+
Sbjct: 12 YKVGRRIGEGSFGVIFEG-TNLL--------NNQQVAIKFEPRRSDAPQLRDEYRTYKLL 62
Query: 181 LGGLIHPNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALDA 237
G + + E +LV + + SLE L R + ++ M A
Sbjct: 63 AGC---TGIPNVYYFGQEGLHNVLVIDLLGP-SLE-DLLDLCGRKFSVK-TVAM-AAKQM 115
Query: 238 AKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAK-----LSDFGLAK---DGPEGDKTHV 289
+ +H EK ++YRD K N L+ + + DFG+ K D K H+
Sbjct: 116 LARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDP--VTKQHI 170
Query: 290 STR----VMGTYGYAAPEYVMTGHL----TAKSDVYSFGVVLLEMLTGR 330
R + GT Y + + HL + + D+ + G V + L G
Sbjct: 171 PYREKKNLSGTARYMS----INTHLGREQSRRDDLEALGHVFMYFLRGS 215
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 2e-10
Identities = 56/225 (24%), Positives = 88/225 (39%), Gaps = 40/225 (17%)
Query: 123 FRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKT--LNHDGLQGHKEWLAEVNY 180
+R +G G FG +Y G ++ G VA+K + Q H E
Sbjct: 11 YRLGRKIGSGSFGDIYLG-TDIA--------AGEEVAIKLECVKTKHPQLHIESKI-YKM 60
Query: 181 LGGLIHPNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALDA 237
+ G + + + C E D ++V E + SLE LF R L ++ + +A
Sbjct: 61 MQGGVG--IPTIRWCGAEGDYNVMVMELLGP-SLE-DLFNFCSRKFSLK-TVLL-LADQM 114
Query: 238 AKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAK---LSDFGLAKD-GPEGDKTHVSTR- 292
+ ++H K I+RD K N L+ + DFGLAK H+ R
Sbjct: 115 ISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRE 171
Query: 293 ---VMGTYGYAAPEYVMTGHL----TAKSDVYSFGVVLLEMLTGR 330
+ GT YA+ + HL + + D+ S G VL+ G
Sbjct: 172 NKNLTGTARYAS----INTHLGIEQSRRDDLESLGYVLMYFNLGS 212
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 2e-10
Identities = 46/246 (18%), Positives = 85/246 (34%), Gaps = 53/246 (21%)
Query: 128 LLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHP 187
LG G F V+ +N T VA+K + D + E+ L +
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTH---------VAMKIVRGDK-VYTEAAEDEIKLLQRVNDA 75
Query: 188 NLVKLIG----CCIEDDQRLLVYEFMPRGSLENHLF------RRSL----------PLPW 227
+ K + +LL + F +G H+ +L +P
Sbjct: 76 DNTKEDSMGANHIL----KLLDH-FNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPL 130
Query: 228 SIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLD------GEYNAKLSDFGLAKDG 281
+I+ GL ++H +I+ D K N+L++ K++D G A
Sbjct: 131 IYVKQISKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWY 188
Query: 282 PEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGR-----RSMDKN 336
E + TR Y +PE ++ +D++S ++ E++TG
Sbjct: 189 DEHYTNSIQTRE-----YRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSY 243
Query: 337 RPNGEH 342
+ +H
Sbjct: 244 TKDDDH 249
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 2e-10
Identities = 56/245 (22%), Positives = 95/245 (38%), Gaps = 58/245 (23%)
Query: 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNH--DGLQGHKEWLAE 177
+ + LG+G +G V+K + + TG VAVK + + E
Sbjct: 8 LRKYELVKKLGKGAYGIVWK--------SIDRR-TGEVVAVKKIFDAFQNSTDAQRTFRE 58
Query: 178 VNYLGGL-IHPNLVKLIGCCI-EDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 234
+ L L H N+V L+ ++D+ + LV+++M E L IR I
Sbjct: 59 IMILTELSGHENIVNLLNVLRADNDRDVYLVFDYM-----ETDLHA-------VIRANIL 106
Query: 235 LDA---------AKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGD 285
K + +LH +++RD K SNILL+ E + K++DFGL++
Sbjct: 107 EPVHKQYVVYQLIKVIKYLHS-GG--LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIR 163
Query: 286 KTHVSTRVMGTYGYAAP--------EYVMT------------GHLTAKSDVYSFGVVLLE 325
+ + + +YV T T D++S G +L E
Sbjct: 164 RVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGE 223
Query: 326 MLTGR 330
+L G+
Sbjct: 224 ILCGK 228
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 5e-10
Identities = 54/228 (23%), Positives = 83/228 (36%), Gaps = 44/228 (19%)
Query: 123 FRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEV-NYL 181
FR +G G FG + G N+ T VA+K L
Sbjct: 11 FRVGKKIGCGNFGELRLG-KNLY--------TNEYVAIKLEPMKSRAPQLHLEYRFYKQL 61
Query: 182 GGLIHPNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALDAA 238
G + ++ +V E + SLE LF R+ L ++ M IA+
Sbjct: 62 GS--GDGIPQVYYFGPCGKYNAMVLELLGP-SLE-DLFDLCDRTFSLK-TVLM-IAIQLI 115
Query: 239 KGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAK-----LSDFGLAK---DGPEGDKTHVS 290
+ ++H K +IYRD K N L+ N + DF LAK D K H+
Sbjct: 116 SRMEYVHS---KNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDP--ETKKHIP 170
Query: 291 TR----VMGTYGYAAPEYVMTGHL----TAKSDVYSFGVVLLEMLTGR 330
R + GT Y + + HL + + D+ + G + + L G
Sbjct: 171 YREHKSLTGTARYMS----INTHLGKEQSRRDDLEALGHMFMYFLRGS 214
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 59.9 bits (144), Expect = 5e-10
Identities = 38/218 (17%), Positives = 58/218 (26%), Gaps = 49/218 (22%)
Query: 102 LKISPQLRKFSFNELKSATKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVK 161
+ Q F+ K R E +GEG FG V++ I + +K + +
Sbjct: 2 MGECSQKGPVPFSHCLPTEKLQRCE-KIGEGVFGEVFQT-IADHTPVAIKI---IAIEGP 56
Query: 162 TLNHDGLQGH-KEWLAEVNYLGGLI---------HPNLVKLIGCCI-------------- 197
L + Q +E L E+ L + L
Sbjct: 57 DLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWD 116
Query: 198 ----------------EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGL 241
+DDQ +V EF G + + + I L
Sbjct: 117 HYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTK--LSSLATAKSILHQLTASL 174
Query: 242 AFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAK 279
A +RD N+LL KL K
Sbjct: 175 AVAEASLR--FEHRDLHWGNVLLKKTSLKKLHYTLNGK 210
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 5e-10
Identities = 46/223 (20%), Positives = 74/223 (33%), Gaps = 76/223 (34%)
Query: 129 LGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLI-HP 187
LG G G V + T A+K L + EV P
Sbjct: 26 LGLGINGKVLQI---------FNKRTQEKFALKMLQD-----CPKARREVELHWRASQCP 71
Query: 188 NLVKLIGCCIEDDQR-----LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL-----DA 237
++V+++ E+ L+V E + G E LF R I+ + +A
Sbjct: 72 HIVRIVDVY-ENLYAGRKCLLIVMECLDGG--E--LFSR-------IQDRGDQAFTEREA 119
Query: 238 A-------KGLAFLHEEAEKPVIYRDFKTSNILL---DGEYNAKLSDFGLAKDGPEGDKT 287
+ + + +LH + +RD K N+L KL+DFG A E
Sbjct: 120 SEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFA---KE---- 169
Query: 288 HVSTRVMGT-YGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTG 329
G Y + D++S GV++ +L G
Sbjct: 170 -----TTGEKYDKSC-------------DMWSLGVIMYILLCG 194
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 59.4 bits (144), Expect = 7e-10
Identities = 49/241 (20%), Positives = 91/241 (37%), Gaps = 48/241 (19%)
Query: 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEW-----L 175
+++ +G+GGFGC+Y +N + G+ P VK D E
Sbjct: 35 AAWKVGLPIGQGGFGCIYLADMNSSE----SVGSDAPCVVKVEPSDNGPLFTELKFYQRA 90
Query: 176 AEVNYLGGLIHPNLVKLIG----------CCIEDDQRLLVYEFMPR-G-SLENHLFR--- 220
A+ + I +K +G R ++ M R G L+ ++
Sbjct: 91 AKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMI---MDRFGSDLQ-KIYEANA 146
Query: 221 RSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAK--LSDFGLA 278
+ ++ ++L L ++H E ++ D K SN+LL+ + + L D+GLA
Sbjct: 147 KRFSRK-TVLQ-LSLRILDILEYIH---EHEYVHGDIKASNLLLNYKNPDQVYLVDYGLA 201
Query: 279 KD-GPEGDKTHVSTR----VMGTYGYAAPEYVMTGHL----TAKSDVYSFGVVLLEMLTG 329
PEG + GT + + + H + + D+ G +++ LTG
Sbjct: 202 YRYCPEGVHKAYAADPKRCHDGTIEFTS----IDAHNGVAPSRRGDLEILGYCMIQWLTG 257
Query: 330 R 330
Sbjct: 258 H 258
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 58.1 bits (140), Expect = 3e-09
Identities = 61/225 (27%), Positives = 89/225 (39%), Gaps = 40/225 (17%)
Query: 123 FRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKT--LNHDGLQGHKEWLAEVNY 180
FR +G G FG +Y G N+ T VA+K + Q E
Sbjct: 9 FRLGRKIGSGSFGEIYLG-TNIQ--------TNEEVAIKLENVKTKHPQLLYES-KIYRI 58
Query: 181 LGGLIHPNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALDA 237
L G + + +E D +LV + + SLE LF R L L ++ M +A
Sbjct: 59 LQG--GTGIPNVRWFGVEGDYNVLVMDLLGP-SLE-DLFNFCSRKLSLK-TVLM-LADQM 112
Query: 238 AKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAK---LSDFGLAKD-GPEGDKTHVSTR- 292
+ F+H K ++RD K N L+ A + DFGLAK H+ R
Sbjct: 113 INRVEFVH---SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRE 169
Query: 293 ---VMGTYGYAAPEYVMTGHL----TAKSDVYSFGVVLLEMLTGR 330
+ GT YA+ + HL + + D+ S G VL+ L G
Sbjct: 170 NKNLTGTARYAS----VNTHLGIEQSRRDDLESLGYVLMYFLRGS 210
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 4e-09
Identities = 55/224 (24%), Positives = 90/224 (40%), Gaps = 52/224 (23%)
Query: 128 LLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTL-NHDGLQGHKEWLAEVNYLGGLIH 186
++G+G FG V K + VA+K + N H++ E+ L L
Sbjct: 104 VIGKGSFGQVVKAY---------DHKVHQHVALKMVRNEKRF--HRQAAEEIRILEHLRK 152
Query: 187 ------PNLVKLIGC-------CI--EDDQRLL---VYEFMPRGSLENHLFRRSLPLPWS 228
N++ ++ C+ E LL +YE + + + LP
Sbjct: 153 QDKDNTMNVIHMLENFTFRNHICMTFE----LLSMNLYELIKKNKF------QGFSLP-L 201
Query: 229 IRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILL--DGEYNAKLSDFGLAKDGPEGDK 286
+R K A + L LH+ +I+ D K NILL G K+ DFG + +
Sbjct: 202 VR-KFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVY 257
Query: 287 THVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGR 330
T++ +R Y APE ++ D++S G +L E+LTG
Sbjct: 258 TYIQSRF-----YRAPEVILGARYGMPIDMWSLGCILAELLTGY 296
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 56.7 bits (137), Expect = 6e-09
Identities = 43/238 (18%), Positives = 81/238 (34%), Gaps = 45/238 (18%)
Query: 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEW-----L 175
+ +G GGFG +Y N VK + E +
Sbjct: 37 NQWVLGKKIGSGGFGLIYLA-FPTNKPEKDA-----RHVVKVEYQENGPLFSELKFYQRV 90
Query: 176 AEVNYLGGLIHPNLVKLIG----------CCIEDDQRLLVYEFMPR--GSLENHLFRRSL 223
A+ + + I + +G R +V M R L+ + ++
Sbjct: 91 AKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMV---MERLGIDLQ-KISGQNG 146
Query: 224 PLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAK--LSDFGLAKD- 280
S +++ + L ++H E ++ D K +N+LL + + L+D+GL+
Sbjct: 147 TFKKSTVLQLGIRMLDVLEYIH---ENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRY 203
Query: 281 GPEGDKTHVSTRV----MGTYGYAAPEYVMTGHL----TAKSDVYSFGVVLLEMLTGR 330
P G+ GT + + + H + +SDV G +L L G+
Sbjct: 204 CPNGNHKQYQENPRKGHNGTIEFTS----LDAHKGVALSRRSDVEILGYCMLRWLCGK 257
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 7e-09
Identities = 55/225 (24%), Positives = 85/225 (37%), Gaps = 52/225 (23%)
Query: 128 LLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTL-NHDGLQGHKEWLAEVNYLGGLIH 186
L+G+G FG V K + VA+K + N + EV L +
Sbjct: 61 LIGKGSFGQVVKAY---------DRVEQEWVAIKIIKNKKAF--LNQAQIEVRLLELMNK 109
Query: 187 P------NLVKLIGC-------CI--EDDQRLL---VYEFMPRGSLENHLFRRSLPLPWS 228
+V L C+ E +L +Y+ L N FR + +
Sbjct: 110 HDTEMKYYIVHLKRHFMFRNHLCLVFE----MLSYNLYDL-----LRNTNFR---GVSLN 157
Query: 229 IRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNA--KLSDFGLAKDGPEGDK 286
+ K A L FL E +I+ D K NILL + K+ DFG + +
Sbjct: 158 LTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIY 216
Query: 287 THVSTRVMGTYGYAAPEYVMTGHL-TAKSDVYSFGVVLLEMLTGR 330
++ +R Y +PE V+ G D++S G +L+EM TG
Sbjct: 217 QYIQSRF-----YRSPE-VLLGMPYDLAIDMWSLGCILVEMHTGE 255
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 55.2 bits (132), Expect = 3e-08
Identities = 44/342 (12%), Positives = 85/342 (24%), Gaps = 140/342 (40%)
Query: 109 RKFSFNELKSATKSFRPE---CLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNH 165
R + +L+ A RP + G G G K W VA+
Sbjct: 133 RLQPYLKLRQALLELRPAKNVLIDGVLGSG---KTW----------------VALDVCLS 173
Query: 166 DGLQGHKE----WLAEVNYLGGLIHPNLVKLIGCCIEDDQRL-----LVYEFMPRG-SLE 215
+Q + WL + C + L L+Y+ P S
Sbjct: 174 YKVQCKMDFKIFWLN----------------LKNCNSPETVLEMLQKLLYQIDPNWTSRS 217
Query: 216 NHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAK-LSD 274
+H L + + E + + + ++ ++L NAK +
Sbjct: 218 DHSSNIKLRIHS----------------IQAELRRLLKSKPYENCLLVLLNVQNAKAWNA 261
Query: 275 FGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMD 334
F L K ++TR
Sbjct: 262 FNL------SCKILLTTR-----------------------------------------F 274
Query: 335 KNRPNGEHNLVEWARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARP 394
K + L + +D + ++ L L+ + P
Sbjct: 275 KQVTD-----------FLSAATTTHISLDHHSMT-LT---PDEVKSLLLKYLDCRPQDLP 319
Query: 395 RMSEVVEALKPLPY--------LKDMASSSSYVQAMQAERVR 428
R E L P ++D ++ + + +++
Sbjct: 320 R-----EVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLT 356
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 53.8 bits (129), Expect = 6e-08
Identities = 31/190 (16%), Positives = 56/190 (29%), Gaps = 58/190 (30%)
Query: 204 LVYEFMPRGSLENHLFR-RSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNI 262
+V+E + L + + LP KI +GL +LH + +I+ D K NI
Sbjct: 122 MVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCR--IIHTDIKPENI 178
Query: 263 LL-------------------------------------------------DGEYNAKLS 273
LL + K++
Sbjct: 179 LLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIA 238
Query: 274 DFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSM 333
D G A + + TR Y + E ++ +D++S + E+ TG
Sbjct: 239 DLGNACWVHKHFTEDIQTRQ-----YRSLEVLIGSGYNTPADIWSTACMAFELATGDYLF 293
Query: 334 DKNRPNGEHN 343
+ +
Sbjct: 294 EPHSGEEYTR 303
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 8e-07
Identities = 58/241 (24%), Positives = 82/241 (34%), Gaps = 70/241 (29%)
Query: 128 LLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTL-NHDGLQGHKEWLAEVNYLGGLIH 186
LGEG FG V + + VA+K + N + E+N L +
Sbjct: 26 NLGEGTFGKVVECLDHAR--------GKSQVALKIIRNVGKY--REAARLEINVLKKIKE 75
Query: 187 P------NLVKLIGC-------CI--EDDQRLL---VYEFMPRGSLENHLFRRSLPLPWS 228
V + CI E LL +EF L+ + F+ P P
Sbjct: 76 KDKENKFLCVLMSDWFNFHGHMCIAFE----LLGKNTFEF-----LKENNFQ---PYPLP 123
Query: 229 IRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILL-DGEYNA----------------- 270
+A L FLHE + + D K NIL + E+
Sbjct: 124 HVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTS 180
Query: 271 -KLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHL-TAKSDVYSFGVVLLEMLT 328
+++DFG A E T V+TR Y PE V+ DV+S G +L E
Sbjct: 181 IRVADFGSATFDHEHHTTIVATRH-----YRPPE-VILELGWAQPCDVWSIGCILFEYYR 234
Query: 329 G 329
G
Sbjct: 235 G 235
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 48.0 bits (115), Expect = 3e-06
Identities = 62/241 (25%), Positives = 86/241 (35%), Gaps = 70/241 (29%)
Query: 128 LLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTL-NHDGLQGHKEWLAEVNYLGGLIH 186
LGEG FG V + + G V AVK + N D + +E+ L L
Sbjct: 21 TLGEGAFGKVVECIDHKAGGRHV--------AVKIVKNVDRY--CEAARSEIQVLEHLNT 70
Query: 187 P------NLVKLIGC-------CI--EDDQRLL---VYEFMPRGSLENHLFRRSLPLPWS 228
V+++ CI E LL Y+F ++ + F P
Sbjct: 71 TDPNSTFRCVQMLEWFEHHGHICIVFE----LLGLSTYDF-----IKENGFL---PFRLD 118
Query: 229 IRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILL-DGEYNA----------------- 270
K+A K + FLH + + D K NIL +Y
Sbjct: 119 HIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPD 175
Query: 271 -KLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHL-TAKSDVYSFGVVLLEMLT 328
K+ DFG A E T VSTR Y APE V+ + DV+S G +L+E
Sbjct: 176 IKVVDFGSATYDDEHHSTLVSTRH-----YRAPE-VILALGWSQPCDVWSIGCILIEYYL 229
Query: 329 G 329
G
Sbjct: 230 G 230
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 6e-06
Identities = 54/246 (21%), Positives = 83/246 (33%), Gaps = 76/246 (30%)
Query: 128 LLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTL-NHDGLQGHKEWLAEVNYLGGLIH 186
+G+G FG V N AVK + N + E + L + +
Sbjct: 42 KMGDGTFGRVLLCQHIDNKKY---------YAVKVVRNIKKY--TRSAKIEADILKKIQN 90
Query: 187 -----PNLVKLIGC-------CI--EDDQRLL---VYEFMPRGSLENHLFRRSLPLPWSI 229
N+VK G C+ E L +YE + + +
Sbjct: 91 DDINNNNIVKYHGKFMYYDHMCLIFE----PLGPSLYEI-----ITRNNYN---GFHIED 138
Query: 230 RMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILL-DGEYNA------------------ 270
++ K L +L + + + + D K NILL D +
Sbjct: 139 IKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYR 195
Query: 271 ------KLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHL-TAKSDVYSFGVVL 323
KL DFG A + + ++TR Y APE V+ SD++SFG VL
Sbjct: 196 TKSTGIKLIDFGCATFKSDYHGSIINTRQ-----YRAPE-VILNLGWDVSSDMWSFGCVL 249
Query: 324 LEMLTG 329
E+ TG
Sbjct: 250 AELYTG 255
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 476 | |||
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 100.0 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.96 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.92 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.85 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.74 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.48 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.29 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.19 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.12 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.76 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.57 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.54 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.53 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.46 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.38 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.32 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.21 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.85 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.81 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.63 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.61 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.48 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.41 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.34 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.32 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.16 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.12 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.87 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.84 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.8 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.01 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 94.53 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 89.8 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 87.97 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 80.69 |
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-62 Score=479.81 Aligned_cols=263 Identities=22% Similarity=0.287 Sum_probs=220.7
Q ss_pred cCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCC---ccCHHHHHHHHHHHhCCCCCceeeEEEEEE
Q 011851 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDG---LQGHKEWLAEVNYLGGLIHPNLVKLIGCCI 197 (476)
Q Consensus 121 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~ 197 (476)
++|++.++||+|+||+||+|++. .+|+.||||++.+.. ....+.+.+|+++|++|+|||||+++++|+
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~---------~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~ 102 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLAREL---------ATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQ 102 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEET---------TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEEC---------CCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence 35999999999999999998654 578899999997542 234567899999999999999999999999
Q ss_pred eCCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCC
Q 011851 198 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGL 277 (476)
Q Consensus 198 ~~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~ 277 (476)
+++++|||||||+||+|.++|.+. +.+++..++.++.||+.||+|||+++ ||||||||+||||+.++.+||+|||+
T Consensus 103 ~~~~~yivmEy~~gG~L~~~i~~~-~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGl 178 (311)
T 4aw0_A 103 DDEKLYFGLSYAKNGELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGT 178 (311)
T ss_dssp CSSEEEEEECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTT
T ss_pred eCCEEEEEEecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCC
Confidence 999999999999999999999654 57999999999999999999999988 99999999999999999999999999
Q ss_pred cCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhccccc
Q 011851 278 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRR 357 (476)
Q Consensus 278 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 357 (476)
|+.............++||+.|||||++.+..|+.++|||||||++|||+||+.||...+... +.... ......
T Consensus 179 a~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~---~~~~i---~~~~~~ 252 (311)
T 4aw0_A 179 AKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGL---IFAKI---IKLEYD 252 (311)
T ss_dssp CEECCTTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHH---HHTCCC
T ss_pred ceecCCCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHH---HcCCCC
Confidence 997654444444556899999999999999999999999999999999999999997643221 11110 100011
Q ss_pred cccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--hcCCCCcccccC
Q 011851 358 FYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEA--LKPLPYLKDMAS 414 (476)
Q Consensus 358 ~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~--L~~~~~~~~~~~ 414 (476)
++...++++.+||.+||+.||++|||++|++.+ |..+|||+++..
T Consensus 253 ------------~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~idw 299 (311)
T 4aw0_A 253 ------------FPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTW 299 (311)
T ss_dssp ------------CCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCC
T ss_pred ------------CCcccCHHHHHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCCCH
Confidence 122236789999999999999999999997543 677899998764
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-61 Score=482.15 Aligned_cols=257 Identities=21% Similarity=0.341 Sum_probs=208.9
Q ss_pred cCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCcc--CHHHHHHHHHHHhCCCCCceeeEEEEEEe
Q 011851 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQ--GHKEWLAEVNYLGGLIHPNLVKLIGCCIE 198 (476)
Q Consensus 121 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~l~~~~~~ 198 (476)
++|++++.||+|+||+||+|++. .+|+.||||+++..... ..+.+.+|+++|++|+|||||+++++|++
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~---------~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~ 94 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKST---------EDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEE 94 (350)
T ss_dssp CCEEEEEEC------CEEEEEET---------TTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEEC---------CCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEE
Confidence 57999999999999999998654 57889999999865433 24568899999999999999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCC
Q 011851 199 DDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGL 277 (476)
Q Consensus 199 ~~~~~lV~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~ 277 (476)
++.+|||||||+||+|.++|... ...+++..++.|+.||+.||+|||+++ ||||||||+||||+.+|.+||+|||+
T Consensus 95 ~~~~yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGl 171 (350)
T 4b9d_A 95 NGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGI 171 (350)
T ss_dssp TTEEEEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTE
T ss_pred CCEEEEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEccccc
Confidence 99999999999999999999754 456899999999999999999999988 99999999999999999999999999
Q ss_pred cCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhccccc
Q 011851 278 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRR 357 (476)
Q Consensus 278 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 357 (476)
|+..... ....+..+||+.|||||++.+..|+.++|||||||+||||+||+.||...+... +... .... .
T Consensus 172 a~~~~~~--~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~---~~~~---i~~~--~ 241 (350)
T 4b9d_A 172 ARVLNST--VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKN---LVLK---IISG--S 241 (350)
T ss_dssp ESCCCHH--HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHH---HHHT--C
T ss_pred ceeecCC--cccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH---HHHH---HHcC--C
Confidence 9876432 122344789999999999999999999999999999999999999997653221 1111 0000 0
Q ss_pred cccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCcccc
Q 011851 358 FYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDM 412 (476)
Q Consensus 358 ~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~~ 412 (476)
+.+ .+...+.++.+||.+||+.||++|||+.|+++| ||++..
T Consensus 242 ----~~~-----~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h----p~~~~~ 283 (350)
T 4b9d_A 242 ----FPP-----VSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEK----GFIAKR 283 (350)
T ss_dssp ----CCC-----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS----HHHHTT
T ss_pred ----CCC-----CCccCCHHHHHHHHHHccCChhHCcCHHHHhcC----HHhhcC
Confidence 001 112236789999999999999999999999987 888653
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-61 Score=480.19 Aligned_cols=260 Identities=24% Similarity=0.348 Sum_probs=218.7
Q ss_pred cCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCCCCCceeeEEEEEEeCC
Q 011851 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHPNLVKLIGCCIEDD 200 (476)
Q Consensus 121 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 200 (476)
..|++.+.||+|+||+||+|++. .||+.||||+++.......+.+.+|+++|++|+|||||+++++|.+++
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~---------~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~ 144 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVR---------SSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGD 144 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEET---------TTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred HhcEEeEEeecCcCeEEEEEEEC---------CCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence 46999999999999999998654 578899999998766666677899999999999999999999999999
Q ss_pred eeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCcCC
Q 011851 201 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKD 280 (476)
Q Consensus 201 ~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~ 280 (476)
.+|||||||+||+|.+++.+ ..+++..+..|+.||+.||+|||+++ ||||||||+||||+.+|.+||+|||+|+.
T Consensus 145 ~~~ivmEy~~gg~L~~~l~~--~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~ 219 (346)
T 4fih_A 145 ELWVVMEFLEGGALTDIVTH--TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQ 219 (346)
T ss_dssp EEEEEECCCTTEEHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEEEeCCCCCcHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCcee
Confidence 99999999999999999865 35999999999999999999999988 99999999999999999999999999987
Q ss_pred CCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhcccccccc
Q 011851 281 GPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRRFYR 360 (476)
Q Consensus 281 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 360 (476)
...... .....+||+.|||||++.+..|+.++|||||||++|||++|+.||....... ........
T Consensus 220 ~~~~~~--~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~---~~~~i~~~--------- 285 (346)
T 4fih_A 220 VSKEVP--RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK---AMKMIRDN--------- 285 (346)
T ss_dssp CCSSSC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH---HHHHHHHS---------
T ss_pred cCCCCC--cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH---HHHHHHcC---------
Confidence 644322 2345799999999999999999999999999999999999999997643321 11111110
Q ss_pred ccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCcccccCc
Q 011851 361 LIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDMASS 415 (476)
Q Consensus 361 ~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~~~~~ 415 (476)
..+.+. .....+.++.+||.+||+.||++|||+.|+++| |||+.....
T Consensus 286 -~~~~~~--~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~H----p~~~~~~~p 333 (346)
T 4fih_A 286 -LPPRLK--NLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH----PFLAKAGPP 333 (346)
T ss_dssp -SCCCCS--CGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC----GGGGGCCCG
T ss_pred -CCCCCC--ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC----HhhcCCCCC
Confidence 001111 112336789999999999999999999999987 999876543
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-60 Score=485.28 Aligned_cols=261 Identities=24% Similarity=0.356 Sum_probs=219.6
Q ss_pred cCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCCCCCceeeEEEEEEeCC
Q 011851 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHPNLVKLIGCCIEDD 200 (476)
Q Consensus 121 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 200 (476)
+.|++.+.||+|+||+||+|++. .+|+.||||++........+.+.+|+.+|++|+|||||+++++|.+++
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~---------~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~ 221 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVR---------SSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGD 221 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEET---------TTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred HhcEeeeEeccCcCcEEEEEEEC---------CCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECC
Confidence 56999999999999999998654 578899999998777666778999999999999999999999999999
Q ss_pred eeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCcCC
Q 011851 201 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKD 280 (476)
Q Consensus 201 ~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~ 280 (476)
.+|||||||+||+|.+++... .+++..+..|+.||+.||+|||+++ ||||||||+||||+.+|.+||+|||+|+.
T Consensus 222 ~~~iVmEy~~gG~L~~~i~~~--~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~ 296 (423)
T 4fie_A 222 ELWVVMEFLEGGALTDIVTHT--RMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQ 296 (423)
T ss_dssp EEEEEEECCTTEEHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEE
T ss_pred EEEEEEeCCCCCcHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceE
Confidence 999999999999999998543 5999999999999999999999988 99999999999999999999999999987
Q ss_pred CCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhcccccccc
Q 011851 281 GPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRRFYR 360 (476)
Q Consensus 281 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 360 (476)
...... ....++||+.|||||++.+..|+.++|||||||++|||++|+.||........ .......
T Consensus 297 ~~~~~~--~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~---~~~i~~~--------- 362 (423)
T 4fie_A 297 VSKEVP--RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKA---MKMIRDN--------- 362 (423)
T ss_dssp CCSSCC--CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH---HHHHHHS---------
T ss_pred CCCCCc--cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH---HHHHHcC---------
Confidence 644322 23457999999999999999999999999999999999999999976433211 1111110
Q ss_pred ccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCcccccCcc
Q 011851 361 LIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDMASSS 416 (476)
Q Consensus 361 ~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~~~~~~ 416 (476)
..+.+.. ....+.++.+||.+||+.||++|||+.|+|+| |||+......
T Consensus 363 -~~~~~~~--~~~~s~~~~dli~~~L~~dP~~R~ta~ell~H----p~~~~~~~p~ 411 (423)
T 4fie_A 363 -LPPRLKN--LHKVSPSLKGFLDRLLVRDPAQRATAAELLKH----PFLAKAGPPA 411 (423)
T ss_dssp -CCCCCSC--TTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTC----GGGGGCCCGG
T ss_pred -CCCCCcc--cccCCHHHHHHHHHHcCCChhHCcCHHHHhcC----HHhcCCCCCc
Confidence 0111111 11236789999999999999999999999987 9998765433
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-59 Score=465.17 Aligned_cols=261 Identities=24% Similarity=0.256 Sum_probs=212.3
Q ss_pred ccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCCCCCceeeEEEEEEeC
Q 011851 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHPNLVKLIGCCIED 199 (476)
Q Consensus 120 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~ 199 (476)
.+.|++.++||+|+||+||+|++. .+|+.||||+++..... .+|+.+|++|+|||||+++++|.++
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~---------~~g~~vAiK~i~~~~~~-----~~E~~il~~l~HpnIV~l~~~~~~~ 122 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDK---------QTGFQCAVKKVRLEVFR-----VEELVACAGLSSPRIVPLYGAVREG 122 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEET---------TTCCEEEEEEEETTTCC-----THHHHTTTTCCCTTBCCEEEEEEET
T ss_pred hhheEeCcEeccCCCeEEEEEEEC---------CCCCEEEEEEECHHHhH-----HHHHHHHHhCCCCCCCcEEEEEEEC
Confidence 356888999999999999998654 57889999999865432 4699999999999999999999999
Q ss_pred CeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCC-ceEEeecCCc
Q 011851 200 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEY-NAKLSDFGLA 278 (476)
Q Consensus 200 ~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~-~vkl~DFG~a 278 (476)
+.+|||||||+||+|.++|.+. ..+++..+..|+.||+.||+|||+++ ||||||||+||||+.+| .+||+|||+|
T Consensus 123 ~~~~ivmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla 198 (336)
T 4g3f_A 123 PWVNIFMELLEGGSLGQLIKQM-GCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHA 198 (336)
T ss_dssp TEEEEEECCCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTC
T ss_pred CEEEEEEeccCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCC
Confidence 9999999999999999999654 57999999999999999999999988 99999999999999987 6999999999
Q ss_pred CCCCCCCcc---ceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhccc
Q 011851 279 KDGPEGDKT---HVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGER 355 (476)
Q Consensus 279 ~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~ 355 (476)
+........ .....++||+.|||||++.+..|+.++|||||||++|||+||+.||...........+....+
T Consensus 199 ~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~----- 273 (336)
T 4g3f_A 199 LCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPP----- 273 (336)
T ss_dssp EEC------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCC-----
T ss_pred eEccCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCC-----
Confidence 876432211 112346899999999999999999999999999999999999999987655433222211110
Q ss_pred cccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc---------CCCCccccc
Q 011851 356 RRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALK---------PLPYLKDMA 413 (476)
Q Consensus 356 ~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~---------~~~~~~~~~ 413 (476)
.+. .++...+.++.+||.+||+.||++|||+.||+++|. .+||+....
T Consensus 274 -~~~---------~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~~ 330 (336)
T 4g3f_A 274 -PIR---------EIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEYK 330 (336)
T ss_dssp -GGG---------GSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSCC
T ss_pred -Cch---------hcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCCC
Confidence 000 012233678999999999999999999999998863 467766543
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-59 Score=451.71 Aligned_cols=252 Identities=25% Similarity=0.353 Sum_probs=197.5
Q ss_pred cCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCc---cCHHHHHHHHHHHhCCCCCceeeEEEEEE
Q 011851 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL---QGHKEWLAEVNYLGGLIHPNLVKLIGCCI 197 (476)
Q Consensus 121 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~l~~~~~ 197 (476)
++|++.+.||+|+||+||+|++. .+|+.||||++++... ...+.+.+|+++|++++|||||++++++.
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~---------~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~ 83 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHT---------TTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIK 83 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECT---------TTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEEC---------CCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEE
Confidence 57999999999999999998644 5788999999976543 23457899999999999999999999999
Q ss_pred eCCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCC
Q 011851 198 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGL 277 (476)
Q Consensus 198 ~~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~ 277 (476)
+++.+||||||| +|+|.+++.+. ..+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+
T Consensus 84 ~~~~~~ivmEy~-~g~L~~~l~~~-~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGl 158 (275)
T 3hyh_A 84 SKDEIIMVIEYA-GNELFDYIVQR-DKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGL 158 (275)
T ss_dssp CSSEEEEEEECC-CEEHHHHHHHS-CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSC
T ss_pred ECCEEEEEEeCC-CCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCC
Confidence 999999999999 67999999654 57999999999999999999999988 99999999999999999999999999
Q ss_pred cCCCCCCCccceeeeeecCCCCCCcchhhcCCC-CccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhcccc
Q 011851 278 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHL-TAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERR 356 (476)
Q Consensus 278 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~ 356 (476)
|+...... .....+||+.|||||++.+..| +.++|||||||++|||+||+.||...... .+..... ....
T Consensus 159 a~~~~~~~---~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~---~~~~~i~---~~~~ 229 (275)
T 3hyh_A 159 SNIMTDGN---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIP---VLFKNIS---NGVY 229 (275)
T ss_dssp C------------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHH---HTCC
T ss_pred CeecCCCC---ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHH---HHHHHHH---cCCC
Confidence 98754422 2345789999999999998876 57999999999999999999999754321 1111110 0001
Q ss_pred ccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCccc
Q 011851 357 RFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKD 411 (476)
Q Consensus 357 ~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~ 411 (476)
. ++...++++.+||.+||+.||++|||+.|+++| |||+.
T Consensus 230 ~------------~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~h----pw~k~ 268 (275)
T 3hyh_A 230 T------------LPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQD----DWFKV 268 (275)
T ss_dssp C------------CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHC----HHHHT
T ss_pred C------------CCCCCCHHHHHHHHHHccCChhHCcCHHHHHcC----ccccc
Confidence 1 112236789999999999999999999999997 99874
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-60 Score=461.99 Aligned_cols=261 Identities=28% Similarity=0.421 Sum_probs=213.1
Q ss_pred cCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCCCCCceeeEEEEEEeCC
Q 011851 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHPNLVKLIGCCIEDD 200 (476)
Q Consensus 121 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 200 (476)
++|.+.+.||+|+||+||+|.+... ....+++.||||+++.......++|.+|+++|++|+|||||++++++.+++
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~----~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~ 88 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNL----CPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGD 88 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSC----C----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCc----ccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCC
Confidence 4688999999999999999987532 223478899999998766666678999999999999999999999999999
Q ss_pred eeEEEEEecCCCCHHHHHhhc------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCC
Q 011851 201 QRLLVYEFMPRGSLENHLFRR------------SLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEY 268 (476)
Q Consensus 201 ~~~lV~E~~~~g~L~~~l~~~------------~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~ 268 (476)
.+|||||||++|+|.++|.+. ...+++..+..|+.||+.||.|||+++ ||||||||+||||+.++
T Consensus 89 ~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~ 165 (299)
T 4asz_A 89 PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENL 165 (299)
T ss_dssp SEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGG
T ss_pred EEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCC
Confidence 999999999999999999653 246999999999999999999999988 99999999999999999
Q ss_pred ceEEeecCCcCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHh-CCCCCCCCCCCCcchhHHh
Q 011851 269 NAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEW 347 (476)
Q Consensus 269 ~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~ellt-G~~pf~~~~~~~~~~~~~~ 347 (476)
.+||+|||+|+.....+........+||+.|||||++.+..|+.++|||||||+||||+| |+.||....... +...
T Consensus 166 ~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~---~~~~ 242 (299)
T 4asz_A 166 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE---VIEC 242 (299)
T ss_dssp CEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH---HHHH
T ss_pred cEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHH
Confidence 999999999986544333333344679999999999999999999999999999999998 899997654321 1111
Q ss_pred hhhhhccccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 011851 348 ARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKP 405 (476)
Q Consensus 348 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~ 405 (476)
... ... .+ .+...++++.+|+.+||+.||++|||+++|++.|+.
T Consensus 243 i~~----~~~-----~~-----~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~ 286 (299)
T 4asz_A 243 ITQ----GRV-----LQ-----RPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQN 286 (299)
T ss_dssp HHH----TCC-----CC-----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHc----CCC-----CC-----CCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 110 000 00 122336789999999999999999999999887653
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-59 Score=463.79 Aligned_cols=261 Identities=26% Similarity=0.422 Sum_probs=206.9
Q ss_pred cCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCCCCCceeeEEEEEEeCC
Q 011851 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHPNLVKLIGCCIEDD 200 (476)
Q Consensus 121 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 200 (476)
++|.+.++||+|+||+||+|.+.. .....+++.||||+++.......++|.+|+++|++|+|||||+++++|.+++
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~----~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~ 116 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHN----LLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGR 116 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESS----SCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred HHeEEEEEEccCCCcEEEEEEECC----cccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence 357788999999999999998753 1233578899999998776666678999999999999999999999999999
Q ss_pred eeEEEEEecCCCCHHHHHhhc--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecC
Q 011851 201 QRLLVYEFMPRGSLENHLFRR--------------SLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDG 266 (476)
Q Consensus 201 ~~~lV~E~~~~g~L~~~l~~~--------------~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~ 266 (476)
.+|||||||++|+|.++|.+. ..++++..++.|+.||+.||.|||+++ ||||||||+||||+.
T Consensus 117 ~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~ 193 (329)
T 4aoj_A 117 PLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQ 193 (329)
T ss_dssp SEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEET
T ss_pred EEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECC
Confidence 999999999999999999653 246999999999999999999999988 999999999999999
Q ss_pred CCceEEeecCCcCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHh-CCCCCCCCCCCCcchhH
Q 011851 267 EYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLV 345 (476)
Q Consensus 267 ~~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~ellt-G~~pf~~~~~~~~~~~~ 345 (476)
++.+||+|||+|+.....+........+||+.|||||++.+..|+.++|||||||+||||+| |+.||....... ++
T Consensus 194 ~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~---~~ 270 (329)
T 4aoj_A 194 GLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTE---AI 270 (329)
T ss_dssp TTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHH---HH
T ss_pred CCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHH---HH
Confidence 99999999999997655444444556789999999999999999999999999999999999 899997654321 11
Q ss_pred HhhhhhhccccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 011851 346 EWARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKP 405 (476)
Q Consensus 346 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~ 405 (476)
.... ...+ . ..+...++++.+|+.+||+.||++|||+.||+++|+.
T Consensus 271 ~~i~----~g~~---~-------~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~ 316 (329)
T 4aoj_A 271 DCIT----QGRE---L-------ERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQA 316 (329)
T ss_dssp HHHH----HTCC---C-------CCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHH
T ss_pred HHHH----cCCC---C-------CCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHH
Confidence 1111 0000 0 0122236789999999999999999999999998764
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-59 Score=453.78 Aligned_cols=254 Identities=26% Similarity=0.441 Sum_probs=203.8
Q ss_pred CCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCcc--CHHHHHHHHHHHhCCCCCceeeEEEEEEe--
Q 011851 123 FRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQ--GHKEWLAEVNYLGGLIHPNLVKLIGCCIE-- 198 (476)
Q Consensus 123 y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~l~~~~~~-- 198 (476)
|++.++||+|+||+||+|.+. .+++.||+|++...... ..+.+.+|+++|++|+|||||+++++|.+
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~~---------~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~ 98 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLDT---------ETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV 98 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEET---------TTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEEC---------CCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeecc
Confidence 467788999999999998764 57888999999754332 34568999999999999999999999875
Q ss_pred --CCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecC-CCceEEeec
Q 011851 199 --DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDG-EYNAKLSDF 275 (476)
Q Consensus 199 --~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~-~~~vkl~DF 275 (476)
++.+|||||||+||+|.+++.+. ..+++..+..|+.||+.||+|||+++ .+||||||||+||||+. ++.+||+||
T Consensus 99 ~~~~~~~lvmEy~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DF 176 (290)
T 3fpq_A 99 KGKKCIVLVTELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDL 176 (290)
T ss_dssp TTEEEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCT
T ss_pred CCCcEEEEEEeCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeC
Confidence 35689999999999999999654 57999999999999999999999876 45999999999999974 799999999
Q ss_pred CCcCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhccc
Q 011851 276 GLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGER 355 (476)
Q Consensus 276 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~ 355 (476)
|+|+..... .....+||+.|||||++.+ .|+.++|||||||+||||+||+.||....... .+...... .
T Consensus 177 Gla~~~~~~----~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~--~~~~~i~~----~ 245 (290)
T 3fpq_A 177 GLATLKRAS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA--QIYRRVTS----G 245 (290)
T ss_dssp TGGGGCCTT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH--HHHHHHTT----T
T ss_pred cCCEeCCCC----ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHH--HHHHHHHc----C
Confidence 999864321 2345799999999998865 69999999999999999999999997543211 11111100 0
Q ss_pred cccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCccc
Q 011851 356 RRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKD 411 (476)
Q Consensus 356 ~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~ 411 (476)
. .+ ..++...++++.+||.+||+.||++|||+.|+++| |||++
T Consensus 246 ~------~~---~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~H----p~~~~ 288 (290)
T 3fpq_A 246 V------KP---ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH----AFFQE 288 (290)
T ss_dssp C------CC---GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS----GGGC-
T ss_pred C------CC---CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC----ccccC
Confidence 0 00 00111225678999999999999999999999997 99975
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-60 Score=462.23 Aligned_cols=259 Identities=27% Similarity=0.346 Sum_probs=207.1
Q ss_pred cCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCcc--CHHHHHHHHHHHhCCCCCceeeEEEEEEe
Q 011851 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQ--GHKEWLAEVNYLGGLIHPNLVKLIGCCIE 198 (476)
Q Consensus 121 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~l~~~~~~ 198 (476)
++|++++.||+|+||+||+|++.. ...+++.||||++++.... ...++.+|+++|++|+|||||+++++|.+
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~------~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~ 97 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKIS------GSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQT 97 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECS------STTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEcc------CCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE
Confidence 469999999999999999997642 2347889999999764322 23467889999999999999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCc
Q 011851 199 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLA 278 (476)
Q Consensus 199 ~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a 278 (476)
++.+|||||||+||+|.++|.+. ..+++..+..++.||+.||+|||+++ ||||||||+|||++.+|.+||+|||+|
T Consensus 98 ~~~~~ivmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla 173 (304)
T 3ubd_A 98 EGKLYLILDFLRGGDLFTRLSKE-VMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLS 173 (304)
T ss_dssp TTEEEEEECCCTTCEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEE
T ss_pred CCEEEEEEEcCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccc
Confidence 99999999999999999999654 57999999999999999999999988 999999999999999999999999999
Q ss_pred CCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhcccccc
Q 011851 279 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRRF 358 (476)
Q Consensus 279 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 358 (476)
+....... .....+||+.|||||++.+..|+.++|||||||++|||+||+.||.+.+.......+ ......
T Consensus 174 ~~~~~~~~--~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i------~~~~~~- 244 (304)
T 3ubd_A 174 KESIDHEK--KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMI------LKAKLG- 244 (304)
T ss_dssp EC-----C--CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH------HHCCCC-
T ss_pred eeccCCCc--cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHH------HcCCCC-
Confidence 86543222 234578999999999999999999999999999999999999999765332111111 000000
Q ss_pred ccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCH-----HHHHHHhcCCCCccccc
Q 011851 359 YRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRM-----SEVVEALKPLPYLKDMA 413 (476)
Q Consensus 359 ~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~-----~ell~~L~~~~~~~~~~ 413 (476)
++...+.++.+||.+||+.||++|||+ +|+++| |||+++.
T Consensus 245 -----------~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~H----p~f~~id 289 (304)
T 3ubd_A 245 -----------MPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRH----SFFSTID 289 (304)
T ss_dssp -----------CCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTS----GGGTTCC
T ss_pred -----------CCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcC----ccccCCC
Confidence 122236789999999999999999985 566655 9999864
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-58 Score=452.79 Aligned_cols=257 Identities=26% Similarity=0.400 Sum_probs=202.5
Q ss_pred ccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCc--cCHHHHHHHHHHHhCCCCCceeeEEEEEE
Q 011851 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL--QGHKEWLAEVNYLGGLIHPNLVKLIGCCI 197 (476)
Q Consensus 120 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~ 197 (476)
.++|++.++||+|+||+||+|.+. ..||||+++.... +..++|.+|+.+|++++|||||++++++.
T Consensus 35 ~~~l~l~~~iG~G~fG~Vy~~~~~------------~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~ 102 (307)
T 3omv_A 35 ASEVMLSTRIGSGSFGTVYKGKWH------------GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMT 102 (307)
T ss_dssp TTSCCEEEECCCCSSSEEEEEESS------------SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred HHHeEEeeEEeeCCCcEEEEEEEC------------CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence 346888999999999999999653 2499999975432 23467899999999999999999999875
Q ss_pred eCCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCC
Q 011851 198 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGL 277 (476)
Q Consensus 198 ~~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~ 277 (476)
++.+|||||||++|+|.++|......+++..+..|+.||+.||+|||+++ ||||||||+||||+.++.+||+|||+
T Consensus 103 -~~~~~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGl 178 (307)
T 3omv_A 103 -KDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGL 178 (307)
T ss_dssp -SSSCEEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSS
T ss_pred -CCeEEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccC
Confidence 46789999999999999999877778999999999999999999999988 99999999999999999999999999
Q ss_pred cCCCCCCCccceeeeeecCCCCCCcchhhc---CCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhcc
Q 011851 278 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMT---GHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGE 354 (476)
Q Consensus 278 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~ 354 (476)
|+..............+||+.|||||++.+ +.|+.++|||||||+||||+||+.||......... ..... .
T Consensus 179 a~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~--~~~~~----~ 252 (307)
T 3omv_A 179 ATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQI--IFMVG----R 252 (307)
T ss_dssp CBC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHH--HHHHH----T
T ss_pred ceecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHH--HHHHh----c
Confidence 987654443334455789999999999974 36999999999999999999999999765432111 11110 0
Q ss_pred ccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 011851 355 RRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALK 404 (476)
Q Consensus 355 ~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~ 404 (476)
. ...+.+. ..+...+.++.+||.+||+.||++|||+.+|+++|+
T Consensus 253 ~-----~~~p~~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le 296 (307)
T 3omv_A 253 G-----YASPDLS-KLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIE 296 (307)
T ss_dssp T-----CCCCCST-TSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHH
T ss_pred C-----CCCCCcc-cccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHH
Confidence 0 0111111 112233678999999999999999999999999875
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-58 Score=453.20 Aligned_cols=261 Identities=28% Similarity=0.419 Sum_probs=212.1
Q ss_pred CCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCc-cCHHHHHHHHHHHhCCCCCceeeEEEEEEeCC
Q 011851 122 SFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL-QGHKEWLAEVNYLGGLIHPNLVKLIGCCIEDD 200 (476)
Q Consensus 122 ~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 200 (476)
++++.+.||+|+||+||+|.+... .+..+++.||||+++.... ...++|.+|+.+|++|+|||||++++++.+++
T Consensus 27 ~~~~~~~lG~G~fG~Vykg~~~~~----~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~ 102 (308)
T 4gt4_A 27 AVRFMEELGEDRFGKVYKGHLFGP----APGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQ 102 (308)
T ss_dssp GEEEEEEEEECSSCEEEEEEEC-----------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HCeEeeEeccCCCcEEEEEEEcCC----ccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECC
Confidence 467789999999999999987531 2234678999999975433 34578999999999999999999999999999
Q ss_pred eeEEEEEecCCCCHHHHHhhc---------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeec
Q 011851 201 QRLLVYEFMPRGSLENHLFRR---------------SLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLD 265 (476)
Q Consensus 201 ~~~lV~E~~~~g~L~~~l~~~---------------~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~ 265 (476)
.+|||||||++|+|.++|..+ ...+++..+..|+.||+.||+|||+++ ||||||||+||||+
T Consensus 103 ~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~ 179 (308)
T 4gt4_A 103 PLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVY 179 (308)
T ss_dssp SCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEC
T ss_pred EEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEEC
Confidence 999999999999999999643 245899999999999999999999988 99999999999999
Q ss_pred CCCceEEeecCCcCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHh-CCCCCCCCCCCCcchh
Q 011851 266 GEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNL 344 (476)
Q Consensus 266 ~~~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~ellt-G~~pf~~~~~~~~~~~ 344 (476)
+++.+||+|||+|+.....+........+||+.|||||++.++.|+.++|||||||+||||+| |..||.+.... .+
T Consensus 180 ~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~---~~ 256 (308)
T 4gt4_A 180 DKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ---DV 256 (308)
T ss_dssp GGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHH---HH
T ss_pred CCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHH---HH
Confidence 999999999999987644433333455789999999999999999999999999999999998 89999765432 22
Q ss_pred HHhhhhhhccccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011851 345 VEWARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPL 406 (476)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~ 406 (476)
..... .... .+. +...+.++.+|+.+||+.||++|||+.||+++|+..
T Consensus 257 ~~~i~----~~~~-----~~~-----p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 257 VEMIR----NRQV-----LPC-----PDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp HHHHH----TTCC-----CCC-----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred HHHHH----cCCC-----CCC-----cccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 22111 1110 111 223367899999999999999999999999999853
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-57 Score=450.57 Aligned_cols=265 Identities=28% Similarity=0.366 Sum_probs=215.6
Q ss_pred HhccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCcc-CHHHHHHHHHHHhCCCC-CceeeEEEE
Q 011851 118 SATKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQ-GHKEWLAEVNYLGGLIH-PNLVKLIGC 195 (476)
Q Consensus 118 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~-~~~~~~~E~~~l~~l~h-pnIv~l~~~ 195 (476)
...++|++.+.||+|+||+||+|.+...+ +..+++.||||++...... ..+++.+|+++|.++.| ||||+++++
T Consensus 61 i~~~~~~l~~~LG~G~fG~Vy~a~~~~~~----~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~ 136 (353)
T 4ase_A 61 FPRDRLKLGKPLGRGAFGQVIEADAFGID----KTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA 136 (353)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEETSS----STTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ecHHHeEEeeEEecCCCeEEEEEEEcCCC----cccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEE
Confidence 34567999999999999999999876432 2245678999999765443 34578999999999965 899999999
Q ss_pred EEeC-CeeEEEEEecCCCCHHHHHhhc---------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCC
Q 011851 196 CIED-DQRLLVYEFMPRGSLENHLFRR---------------SLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKT 259 (476)
Q Consensus 196 ~~~~-~~~~lV~E~~~~g~L~~~l~~~---------------~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp 259 (476)
|.+. +.+|||||||++|+|.++|... ...+++..+..++.||+.||+|||+++ ||||||||
T Consensus 137 ~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHRDLK~ 213 (353)
T 4ase_A 137 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAA 213 (353)
T ss_dssp ECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSG
T ss_pred EEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecCccCc
Confidence 8764 5689999999999999999653 235899999999999999999999988 99999999
Q ss_pred CCeeecCCCceEEeecCCcCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHh-CCCCCCCCCC
Q 011851 260 SNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLT-GRRSMDKNRP 338 (476)
Q Consensus 260 ~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~ellt-G~~pf~~~~~ 338 (476)
+||||+.++.+||+|||+|+..............+||+.|||||++.+..|+.++|||||||+||||+| |+.||.....
T Consensus 214 ~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~ 293 (353)
T 4ase_A 214 RNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 293 (353)
T ss_dssp GGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred cceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999999997755444444556789999999999999999999999999999999998 9999976543
Q ss_pred CCcchhHHhhhhhhccccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 011851 339 NGEHNLVEWARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKP 405 (476)
Q Consensus 339 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~ 405 (476)
... +..... ...++ ..+...++++.+||.+||+.||++|||+.+|+++|+.
T Consensus 294 ~~~--~~~~i~----~g~~~----------~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~ 344 (353)
T 4ase_A 294 DEE--FCRRLK----EGTRM----------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 344 (353)
T ss_dssp SHH--HHHHHH----HTCCC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHH--HHHHHH----cCCCC----------CCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHH
Confidence 321 111111 10000 0112236789999999999999999999999999764
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-56 Score=436.89 Aligned_cols=259 Identities=23% Similarity=0.372 Sum_probs=194.3
Q ss_pred cCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCcc-CHHHHHHHHHHHhCCCCCceeeEEEEEEeC
Q 011851 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQ-GHKEWLAEVNYLGGLIHPNLVKLIGCCIED 199 (476)
Q Consensus 121 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~ 199 (476)
++|++++.||+|+||+||+|++. .+|+.||||+++....+ ..+.+.+|+++|++|+|||||+++++|.+.
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~---------~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~ 75 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNK---------VDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEK 75 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEET---------TTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEE
T ss_pred hhCEEeeEEecCCCeEEEEEEEC---------CCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEec
Confidence 45999999999999999998654 47888999999765433 345688999999999999999999999865
Q ss_pred C------------eeEEEEEecCCCCHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeec
Q 011851 200 D------------QRLLVYEFMPRGSLENHLFRRS--LPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLD 265 (476)
Q Consensus 200 ~------------~~~lV~E~~~~g~L~~~l~~~~--~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~ 265 (476)
+ ++|||||||++|+|.+++.... ...++..++.|+.||+.||+|||+++ ||||||||+||||+
T Consensus 76 ~~~~~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~ 152 (299)
T 4g31_A 76 NTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFT 152 (299)
T ss_dssp C----------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEC
T ss_pred CccccccccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEEC
Confidence 4 3799999999999999996543 23566778999999999999999988 99999999999999
Q ss_pred CCCceEEeecCCcCCCCCCCcc----------ceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCC
Q 011851 266 GEYNAKLSDFGLAKDGPEGDKT----------HVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDK 335 (476)
Q Consensus 266 ~~~~vkl~DFG~a~~~~~~~~~----------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~ 335 (476)
.++.+||+|||+|+........ ...+..+||+.|||||++.+..|+.++|||||||++|||++ ||..
T Consensus 153 ~~~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~ 229 (299)
T 4g31_A 153 MDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFST 229 (299)
T ss_dssp TTCCEEECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSS
T ss_pred CCCcEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCC
Confidence 9999999999999876443211 11234689999999999999999999999999999999996 7743
Q ss_pred CCCCCcchhHHhhhhhhccccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCcccccC
Q 011851 336 NRPNGEHNLVEWARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDMAS 414 (476)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~~~~ 414 (476)
.. ........ .. ...+.. .....++.+.+||.+||+.||++|||+.|+++| |||+++..
T Consensus 230 ~~-----~~~~~~~~-~~-~~~~p~---------~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h----~~~~~~~~ 288 (299)
T 4g31_A 230 QM-----ERVRTLTD-VR-NLKFPP---------LFTQKYPCEYVMVQDMLSPSPMERPEAINIIEN----AVFEDLDF 288 (299)
T ss_dssp HH-----HHHHHHHH-HH-TTCCCH---------HHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTS----GGGCCC--
T ss_pred cc-----HHHHHHHH-Hh-cCCCCC---------CCcccCHHHHHHHHHHcCCChhHCcCHHHHhcC----HhhCCCCC
Confidence 11 11100000 00 000000 001223567899999999999999999999987 99988754
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-55 Score=465.84 Aligned_cols=261 Identities=23% Similarity=0.296 Sum_probs=219.1
Q ss_pred ccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCCCCCceeeEEEEEEeC
Q 011851 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHPNLVKLIGCCIED 199 (476)
Q Consensus 120 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~ 199 (476)
.++|++.+.||+|+||+||+|.+. .+|+.||||++........+.+.+|+++|+.|+|||||+++++|.++
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~---------~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 226 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTER---------ATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDD 226 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEET---------TTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECS
T ss_pred ccccEEEEEEeeccCeEEEEEEEC---------CCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEEC
Confidence 367999999999999999998654 57889999999876665667789999999999999999999999999
Q ss_pred CeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCC--CceEEeecCC
Q 011851 200 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGE--YNAKLSDFGL 277 (476)
Q Consensus 200 ~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~--~~vkl~DFG~ 277 (476)
+.+|||||||+||+|.++|......+++..+..++.||+.||.|||+++ |+||||||+||||+.+ +.+||+|||+
T Consensus 227 ~~~~iv~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~ 303 (573)
T 3uto_A 227 NEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGL 303 (573)
T ss_dssp SEEEEEEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSS
T ss_pred CEEEEEEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccc
Confidence 9999999999999999999777778999999999999999999999988 9999999999999754 8999999999
Q ss_pred cCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhccccc
Q 011851 278 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRR 357 (476)
Q Consensus 278 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 357 (476)
|+...... .....+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.........+.. ...
T Consensus 304 a~~~~~~~---~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~------~~~- 373 (573)
T 3uto_A 304 TAHLDPKQ---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKS------CDW- 373 (573)
T ss_dssp CEECCTTS---EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHT------TCC-
T ss_pred eeEccCCC---ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHh------CCC-
Confidence 99865432 23457899999999999999999999999999999999999999976543221111110 000
Q ss_pred cccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCccccc
Q 011851 358 FYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDMA 413 (476)
Q Consensus 358 ~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~~~ 413 (476)
.+.++.. ...+.++.+||.+||+.||.+|||+.|+|+| |||+...
T Consensus 374 --~~~~~~~-----~~~s~~~~dli~~~L~~dp~~R~t~~e~l~H----pw~~~~~ 418 (573)
T 3uto_A 374 --NMDDSAF-----SGISEDGKDFIRKLLLADPNTRMTIHQALEH----PWLTPGN 418 (573)
T ss_dssp --CCCSGGG-----TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS----TTTSCCC
T ss_pred --CCCcccc-----cCCCHHHHHHHHHHccCChhHCcCHHHHhcC----cCcCCCC
Confidence 0111111 1236789999999999999999999999998 9998643
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-55 Score=446.00 Aligned_cols=276 Identities=22% Similarity=0.277 Sum_probs=210.0
Q ss_pred ccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCcc--CHHHHHHHHHHHhCCCCCceeeEEEEEE
Q 011851 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQ--GHKEWLAEVNYLGGLIHPNLVKLIGCCI 197 (476)
Q Consensus 120 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~l~~~~~ 197 (476)
.++|++++.||+|+||+||+|++. .||+.||||+++..... ..+.+.+|+++|++|+|||||++++++.
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~---------~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~ 123 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRR---------LTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILR 123 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEET---------TTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECC
T ss_pred CCCeEEEEEEecccCeEEEEEEEC---------CCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeee
Confidence 357999999999999999998654 57889999999765332 2456889999999999999999999976
Q ss_pred e------CCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceE
Q 011851 198 E------DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAK 271 (476)
Q Consensus 198 ~------~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vk 271 (476)
. .+.+|||||||+ |+|.+++.+ ...+++..+..|+.||+.||.|||+++ ||||||||+|||++.++.+|
T Consensus 124 ~~~~~~~~~~~~ivmE~~~-g~L~~~i~~-~~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~K 198 (398)
T 4b99_A 124 PTVPYGEFKSVYVVLDLME-SDLHQIIHS-SQPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELK 198 (398)
T ss_dssp CSSCTTTCCCEEEEEECCS-EEHHHHHTS-SSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEE
T ss_pred cccccccCCEEEEEEeCCC-CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEE
Confidence 4 367899999995 689999854 567999999999999999999999988 99999999999999999999
Q ss_pred EeecCCcCCCCCCC--ccceeeeeecCCCCCCcchhhcC-CCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhh
Q 011851 272 LSDFGLAKDGPEGD--KTHVSTRVMGTYGYAAPEYVMTG-HLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA 348 (476)
Q Consensus 272 l~DFG~a~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~ 348 (476)
|+|||+|+...... ........+||+.|||||++.+. .|+.++|||||||++|||++|+.||.+.+.......+...
T Consensus 199 i~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~ 278 (398)
T 4b99_A 199 IGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMV 278 (398)
T ss_dssp ECCCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHH
T ss_pred EeecceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHh
Confidence 99999998754321 12223457999999999998875 5799999999999999999999999865433222211111
Q ss_pred hhhhcc--c-----ccccc---ccCcccCCC---CChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCccccc
Q 011851 349 RPQLGE--R-----RRFYR---LIDPCLEGC---FSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDMA 413 (476)
Q Consensus 349 ~~~~~~--~-----~~~~~---~~d~~l~~~---~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~~~ 413 (476)
...... . ..... .+.+..... .....+.++.+||.+||..||++|||+.|+|+| |||++..
T Consensus 279 ~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H----p~f~~~~ 352 (398)
T 4b99_A 279 LGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH----PFLAKYH 352 (398)
T ss_dssp HCCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS----GGGTTTC
T ss_pred cCCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC----HhhCcCC
Confidence 000000 0 00000 000000000 001225688999999999999999999999997 9998653
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-55 Score=437.35 Aligned_cols=276 Identities=23% Similarity=0.308 Sum_probs=208.5
Q ss_pred HhccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCC-CCCceeeEEEEE
Q 011851 118 SATKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGL-IHPNLVKLIGCC 196 (476)
Q Consensus 118 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~ 196 (476)
...++|++.++||+|+||+||+|+++. +..+++.||||++.... ...++.+|+++|+.+ +|||||+++++|
T Consensus 18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~------~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~ 89 (361)
T 4f9c_A 18 QLSNVFKIEDKIGEGTFSSVYLATAQL------QVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCF 89 (361)
T ss_dssp GGGGTCEEEEEEEECSSEEEEEEEEEB------TTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEE
T ss_pred CccCcEEEEEEEecccCcEEEEEEEcc------cCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEE
Confidence 456789999999999999999997652 23467889999986543 346788999999988 699999999999
Q ss_pred EeCCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCC-CceEEeec
Q 011851 197 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGE-YNAKLSDF 275 (476)
Q Consensus 197 ~~~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~-~~vkl~DF 275 (476)
.+++++|||||||+||+|.+++. .+++..++.++.||+.||+|||+++ ||||||||+||||+.+ +.+||+||
T Consensus 90 ~~~~~~~lvmE~~~g~~L~~~~~----~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DF 162 (361)
T 4f9c_A 90 RKNDHVVIAMPYLEHESFLDILN----SLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDF 162 (361)
T ss_dssp EETTEEEEEEECCCCCCHHHHHT----TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCC
T ss_pred EECCEEEEEEeCCCcccHHHHHc----CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcC
Confidence 99999999999999999999982 4899999999999999999999988 9999999999999877 79999999
Q ss_pred CCcCCCCCCCc--------------------------cceeeeeecCCCCCCcchhhcC-CCCccchhhhhHHHHHHHHh
Q 011851 276 GLAKDGPEGDK--------------------------THVSTRVMGTYGYAAPEYVMTG-HLTAKSDVYSFGVVLLEMLT 328 (476)
Q Consensus 276 G~a~~~~~~~~--------------------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGv~l~ellt 328 (476)
|+|+....... ....+..+||+.|||||++.+. .|+.++||||+||++|||++
T Consensus 163 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~ 242 (361)
T 4f9c_A 163 GLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLS 242 (361)
T ss_dssp TTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHH
T ss_pred CCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHH
Confidence 99975433211 0112346899999999999876 58999999999999999999
Q ss_pred CCCCCCCCCCCCcchhHHhhh----hh-------hcc-----------------------ccccccccCccc----CCCC
Q 011851 329 GRRSMDKNRPNGEHNLVEWAR----PQ-------LGE-----------------------RRRFYRLIDPCL----EGCF 370 (476)
Q Consensus 329 G~~pf~~~~~~~~~~~~~~~~----~~-------~~~-----------------------~~~~~~~~d~~l----~~~~ 370 (476)
|+.||......... +..... +. ... ............ ....
T Consensus 243 G~~Pf~~~~~~~~~-l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~ 321 (361)
T 4f9c_A 243 GRYPFYKASDDLTA-LAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEG 321 (361)
T ss_dssp TCSSSSCCSSHHHH-HHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------
T ss_pred CCCCCCCCCCHHHH-HHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccc
Confidence 99999654321110 000000 00 000 000000000000 0000
Q ss_pred ChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCccccc
Q 011851 371 SIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDMA 413 (476)
Q Consensus 371 ~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~~~ 413 (476)
....++++.|||.+||+.||++|+|++|+|+| |||+++.
T Consensus 322 ~~~is~~a~DLl~~lL~~dP~~R~ta~eaL~H----p~f~~i~ 360 (361)
T 4f9c_A 322 WNEVPDEAYDLLDKLLDLNPASRITAEEALLH----PFFKDMS 360 (361)
T ss_dssp CTTCCHHHHHHHHHHTCSCTTTSCCHHHHHTS----GGGTTC-
T ss_pred cccCCHHHHHHHHHHCcCChhHCcCHHHHhcC----cccCCCC
Confidence 01225688999999999999999999999998 9998763
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-55 Score=430.06 Aligned_cols=263 Identities=25% Similarity=0.342 Sum_probs=197.4
Q ss_pred cCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHH--HHHHHHHhCCCCCceeeEEEEEEe
Q 011851 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEW--LAEVNYLGGLIHPNLVKLIGCCIE 198 (476)
Q Consensus 121 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~--~~E~~~l~~l~hpnIv~l~~~~~~ 198 (476)
++|.+.++||+|+||+||+|.+ +|+.||||+++... .+.+ ..|+..+.+++|||||++++++.+
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~-----------~g~~VAvK~l~~~~---~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~ 68 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW-----------RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNK 68 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE-----------TTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-----------CCEEEEEEEECccc---hhhHHHHHHHHHHhcCCCCCCCcEEEEEEe
Confidence 4578889999999999999975 46789999997543 2333 346666678999999999999987
Q ss_pred CC----eeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcC-----CCCeEecCCCCCCeeecCCCc
Q 011851 199 DD----QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEA-----EKPVIYRDFKTSNILLDGEYN 269 (476)
Q Consensus 199 ~~----~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~-----~~~ivHrDlKp~NILl~~~~~ 269 (476)
++ .+|||||||++|+|.++|... .+++..+..++.|++.||.|||++. ..+||||||||+||||+.++.
T Consensus 69 ~~~~~~~~~lV~Ey~~~gsL~~~l~~~--~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~ 146 (303)
T 3hmm_A 69 DNGTWTQLWLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT 146 (303)
T ss_dssp ECSSSEEEEEEEECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSC
T ss_pred cCCCceEEEEEecCCCCCcHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCC
Confidence 64 579999999999999999654 5899999999999999999999861 124999999999999999999
Q ss_pred eEEeecCCcCCCCCCCcc--ceeeeeecCCCCCCcchhhcC------CCCccchhhhhHHHHHHHHhCCCCCCCCCCCCc
Q 011851 270 AKLSDFGLAKDGPEGDKT--HVSTRVMGTYGYAAPEYVMTG------HLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGE 341 (476)
Q Consensus 270 vkl~DFG~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~------~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~ 341 (476)
+||+|||+|+........ ......+||+.|||||++.+. .|+.++|||||||+||||+||..||........
T Consensus 147 ~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~ 226 (303)
T 3hmm_A 147 CCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQL 226 (303)
T ss_dssp EEECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCC
T ss_pred EEEEeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccc
Confidence 999999999865433221 122346899999999999764 367899999999999999999888754332111
Q ss_pred c---------hhHHhhhhhhccccccccccCcccCC-CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 011851 342 H---------NLVEWARPQLGERRRFYRLIDPCLEG-CFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKP 405 (476)
Q Consensus 342 ~---------~~~~~~~~~~~~~~~~~~~~d~~l~~-~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~ 405 (476)
. ........ .. ...+++.+.. ..+......+.+|+.+||+.||++|||+.+|++.|+.
T Consensus 227 p~~~~~~~~~~~~~~~~~-~~-----~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~ 294 (303)
T 3hmm_A 227 PYYDLVPSDPSVEEMRKV-VC-----EQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 294 (303)
T ss_dssp TTTTTSCSSCCHHHHHHH-HT-----TSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHH
T ss_pred cchhcccccchHHHHHHH-Hh-----cccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHH
Confidence 0 00011000 00 0111222211 1223456789999999999999999999999998764
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-54 Score=456.11 Aligned_cols=257 Identities=26% Similarity=0.373 Sum_probs=209.3
Q ss_pred cCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCc---cCHHHH---HHHHHHHhCCCCCceeeEEE
Q 011851 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL---QGHKEW---LAEVNYLGGLIHPNLVKLIG 194 (476)
Q Consensus 121 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~---~~~~~~---~~E~~~l~~l~hpnIv~l~~ 194 (476)
++|+++++||+|+||+||+|++. .||+.||||++++... .....+ ..++.+++.++|||||++++
T Consensus 189 ddf~i~k~LG~G~fG~V~la~~~---------~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~ 259 (689)
T 3v5w_A 189 NDFSVHRIIGRGGFGEVYGCRKA---------DTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSY 259 (689)
T ss_dssp GGEEEEEEEEECSSEEEEEEEET---------TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEE
T ss_pred HHeEEEEEEecccCeEEEEEEEC---------CCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEE
Confidence 67999999999999999998654 5889999999975322 122223 34577888999999999999
Q ss_pred EEEeCCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEee
Q 011851 195 CCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSD 274 (476)
Q Consensus 195 ~~~~~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~D 274 (476)
+|.+.+++|||||||+||+|.++|.+. ..+++..++.|+.||+.||+|||+++ ||||||||+||||+.+|.+||+|
T Consensus 260 ~f~~~~~lylVmEy~~GGdL~~~l~~~-~~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~D 335 (689)
T 3v5w_A 260 AFHTPDKLSFILDLMNGGDLHYHLSQH-GVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISD 335 (689)
T ss_dssp EEECSSEEEEEECCCCSCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECC
T ss_pred EEEECCEEEEEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecc
Confidence 999999999999999999999999654 57999999999999999999999988 99999999999999999999999
Q ss_pred cCCcCCCCCCCccceeeeeecCCCCCCcchhhc-CCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhc
Q 011851 275 FGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLG 353 (476)
Q Consensus 275 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~ 353 (476)
||+|+...... ....+||+.|||||++.. ..|+.++|||||||+||||++|+.||..........+.... ..
T Consensus 336 FGlA~~~~~~~----~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i---~~ 408 (689)
T 3v5w_A 336 LGLACDFSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT---LT 408 (689)
T ss_dssp CTTCEECSSCC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHH---HH
T ss_pred cceeeecCCCC----CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhh---cC
Confidence 99998764432 234799999999999975 58999999999999999999999999765433222221111 11
Q ss_pred cccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHHhcCCCCccccc
Q 011851 354 ERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPR-----MSEVVEALKPLPYLKDMA 413 (476)
Q Consensus 354 ~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt-----~~ell~~L~~~~~~~~~~ 413 (476)
... .++...+.++.+||.+||+.||.+|++ ++||++| |||+++.
T Consensus 409 ~~~------------~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~H----pfF~~id 457 (689)
T 3v5w_A 409 MAV------------ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES----PFFRSLD 457 (689)
T ss_dssp CCC------------CCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTS----GGGTTCC
T ss_pred CCC------------CCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcC----ccccCCC
Confidence 111 122233678999999999999999998 5776665 9999875
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-50 Score=397.96 Aligned_cols=281 Identities=40% Similarity=0.687 Sum_probs=237.6
Q ss_pred cChhHHHHhccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCCCCCcee
Q 011851 111 FSFNELKSATKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHPNLV 190 (476)
Q Consensus 111 ~~~~~~~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv 190 (476)
+.+.++...+++|++.+.||+|+||.||+|.+. +|+.||||++........+.+.+|+.+|+.++||||+
T Consensus 29 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~----------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 98 (321)
T 2qkw_B 29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLR----------DGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLV 98 (321)
T ss_dssp -CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECT----------TCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBC
T ss_pred ecHHHHHHHHhccCccceeecCCCeeEEEEEEC----------CCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEe
Confidence 344455567889999999999999999998643 5778999999877666667899999999999999999
Q ss_pred eEEEEEEeCCeeEEEEEecCCCCHHHHHhhcC---CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCC
Q 011851 191 KLIGCCIEDDQRLLVYEFMPRGSLENHLFRRS---LPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGE 267 (476)
Q Consensus 191 ~l~~~~~~~~~~~lV~E~~~~g~L~~~l~~~~---~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~ 267 (476)
++++++.+.+..|+||||+++++|.+++.... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.+
T Consensus 99 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~ 175 (321)
T 2qkw_B 99 SLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDEN 175 (321)
T ss_dssp CEEEECCCTTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTT
T ss_pred eEEEEEcCCCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCC
Confidence 99999999999999999999999999986542 35899999999999999999999988 9999999999999999
Q ss_pred CceEEeecCCcCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHh
Q 011851 268 YNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEW 347 (476)
Q Consensus 268 ~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~ 347 (476)
+.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++|+.||....+........|
T Consensus 176 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~ 255 (321)
T 2qkw_B 176 FVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEW 255 (321)
T ss_dssp CCEEECCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHH
T ss_pred CCEEEeecccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHH
Confidence 99999999999865443333333446799999999999999999999999999999999999999987766665555555
Q ss_pred hhhhhccccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 011851 348 ARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKP 405 (476)
Q Consensus 348 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~ 405 (476)
..... ....+..++++.+........+..+.+++.+||+.||++|||+.+++++|+.
T Consensus 256 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~ 312 (321)
T 2qkw_B 256 AVESH-NNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEY 312 (321)
T ss_dssp THHHH-TTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred hhhcc-ccccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHH
Confidence 43322 2233455666666666777888999999999999999999999999999764
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-49 Score=390.16 Aligned_cols=264 Identities=25% Similarity=0.343 Sum_probs=219.0
Q ss_pred ccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCCCCCceeeEEEEEEeC
Q 011851 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHPNLVKLIGCCIED 199 (476)
Q Consensus 120 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~ 199 (476)
.++|++.+.||+|+||+||+|.+. .+|+.||||++........+.+.+|+.++++++||||+++++++...
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 89 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDV---------ATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVG 89 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBT---------TTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred hhceeeeeeeccCCCeEEEEEEEC---------CCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEEC
Confidence 467999999999999999998654 47888999999876666677889999999999999999999999999
Q ss_pred CeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCcC
Q 011851 200 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAK 279 (476)
Q Consensus 200 ~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~ 279 (476)
+.+|+||||+++++|.+++... .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.
T Consensus 90 ~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~ 164 (297)
T 3fxz_A 90 DELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCA 164 (297)
T ss_dssp TEEEEEEECCTTCBHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCE
T ss_pred CEEEEEEECCCCCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCce
Confidence 9999999999999999999654 5899999999999999999999988 9999999999999999999999999998
Q ss_pred CCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhccccccc
Q 011851 280 DGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRRFY 359 (476)
Q Consensus 280 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 359 (476)
....... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||...........+ .... .
T Consensus 165 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~--~~~~---~---- 233 (297)
T 3fxz_A 165 QITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLI--ATNG---T---- 233 (297)
T ss_dssp ECCSTTC--CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH--HHHC---S----
T ss_pred ecCCccc--ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--HhCC---C----
Confidence 7544322 233468999999999999999999999999999999999999999754322111110 0000 0
Q ss_pred cccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCcccccCcchH
Q 011851 360 RLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDMASSSSY 418 (476)
Q Consensus 360 ~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~~~~~~~~ 418 (476)
.....+...+..+.+||.+||+.||++|||+.++++| |||+........
T Consensus 234 ------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h----~~~~~~~~~~~~ 282 (297)
T 3fxz_A 234 ------PELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH----QFLKIAKPLSSL 282 (297)
T ss_dssp ------CCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC----GGGGGCCCGGGG
T ss_pred ------CCCCCccccCHHHHHHHHHHccCChhHCcCHHHHhhC----hhhcccCccccc
Confidence 0001122336788999999999999999999999987 999876554433
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-49 Score=390.07 Aligned_cols=292 Identities=41% Similarity=0.707 Sum_probs=237.6
Q ss_pred cccccChhHHHHhccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCcc-CHHHHHHHHHHHhCCC
Q 011851 107 QLRKFSFNELKSATKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQ-GHKEWLAEVNYLGGLI 185 (476)
Q Consensus 107 ~~~~~~~~~~~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~-~~~~~~~E~~~l~~l~ 185 (476)
....+++.++....++|++.+.||+|+||.||+|.+. +|+.||||++...... ....+.+|+.+++.++
T Consensus 16 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~----------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~ 85 (326)
T 3uim_A 16 QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLA----------DGTLVAVKRLKEERTQGGELQFQTEVEMISMAV 85 (326)
T ss_dssp CCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCS----------SSCCEEEEECCC-----CCCHHHHHHHGGGTCC
T ss_pred ccceecHHHHHHHhhccccceeEecCCCcEEEEEEec----------CCCEEEEEEeccccCchHHHHHHHHHHHHHhcc
Confidence 3467889999999999999999999999999998532 5778999999765432 2336889999999999
Q ss_pred CCceeeEEEEEEeCCeeEEEEEecCCCCHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCe
Q 011851 186 HPNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRR---SLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNI 262 (476)
Q Consensus 186 hpnIv~l~~~~~~~~~~~lV~E~~~~g~L~~~l~~~---~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NI 262 (476)
||||+++++++.+.+..++||||+++++|.+++... ...+++..+..++.||+.||.|||+....+|+||||||+||
T Consensus 86 h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Ni 165 (326)
T 3uim_A 86 HRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANI 165 (326)
T ss_dssp CTTBCCCCEEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGE
T ss_pred CCCccceEEEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhE
Confidence 999999999999999999999999999999999653 33599999999999999999999998111299999999999
Q ss_pred eecCCCceEEeecCCcCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCC--CCC
Q 011851 263 LLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNR--PNG 340 (476)
Q Consensus 263 Ll~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~--~~~ 340 (476)
|++.++.+||+|||+++....... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.... ...
T Consensus 166 l~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~ 244 (326)
T 3uim_A 166 LLDEEFEAVVGDFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDD 244 (326)
T ss_dssp EECTTCCEEECCCSSCEECCSSSS-CEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTS
T ss_pred EECCCCCEEeccCccccccCcccc-cccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCccccccccccc
Confidence 999999999999999987643322 22344679999999999999999999999999999999999999996321 112
Q ss_pred cchhHHhhhhhhccccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCcc
Q 011851 341 EHNLVEWARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLK 410 (476)
Q Consensus 341 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~ 410 (476)
......|..... ....+..+.+..+...+....+..+.+|+.+||+.||.+|||+.+|+++|+.....+
T Consensus 245 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~~~ 313 (326)
T 3uim_A 245 DVMLLDWVKGLL-KEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGLAE 313 (326)
T ss_dssp CSBHHHHHTTTT-SSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSSCSS
T ss_pred chhHHHHHHHHh-hchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcchhh
Confidence 222333333222 223445566667777778888899999999999999999999999999998754443
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-49 Score=394.65 Aligned_cols=256 Identities=29% Similarity=0.359 Sum_probs=213.0
Q ss_pred cCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCC---ccCHHHHHHHHHHHhCCCCCceeeEEEEEE
Q 011851 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDG---LQGHKEWLAEVNYLGGLIHPNLVKLIGCCI 197 (476)
Q Consensus 121 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~ 197 (476)
++|++.+.||+|+||.||+|++. .+|+.||||++++.. ......+.+|+.+|+.++||||+++++++.
T Consensus 5 ~~y~~~~~lG~G~fg~V~~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~ 75 (337)
T 1o6l_A 5 NDFDYLKLLGKGTFGKVILVREK---------ATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQ 75 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEET---------TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEE
T ss_pred HHeEEEEEEecCCCeEEEEEEEC---------CCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEE
Confidence 57999999999999999998654 578889999997542 234567889999999999999999999999
Q ss_pred eCCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCC
Q 011851 198 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGL 277 (476)
Q Consensus 198 ~~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~ 277 (476)
+.+.+||||||++||+|.+++.+. ..+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+
T Consensus 76 ~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~ 151 (337)
T 1o6l_A 76 THDRLCFVMEYANGGELFFHLSRE-RVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGL 151 (337)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTT
T ss_pred eCCEEEEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccc
Confidence 999999999999999999998654 46999999999999999999999988 99999999999999999999999999
Q ss_pred cCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhccccc
Q 011851 278 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRR 357 (476)
Q Consensus 278 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 357 (476)
++....... .....+||+.|+|||++.+..|+.++|||||||++|||++|+.||...... .+... ......
T Consensus 152 a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~---~~~~~---i~~~~~- 222 (337)
T 1o6l_A 152 CKEGISDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---RLFEL---ILMEEI- 222 (337)
T ss_dssp CBCSCCTTC--CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHH---HHHCCC-
T ss_pred hhhcccCCC--cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHH---HHHHH---HHcCCC-
Confidence 986433221 234578999999999999999999999999999999999999999754321 11111 010100
Q ss_pred cccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHhcCCCCccccc
Q 011851 358 FYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARP-----RMSEVVEALKPLPYLKDMA 413 (476)
Q Consensus 358 ~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RP-----t~~ell~~L~~~~~~~~~~ 413 (476)
.++...+.++.+||.+||+.||++|| ++.++++| |||++..
T Consensus 223 -----------~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h----~~f~~~~ 268 (337)
T 1o6l_A 223 -----------RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH----RFFLSIN 268 (337)
T ss_dssp -----------CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS----GGGTTCC
T ss_pred -----------CCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC----CCcCCCC
Confidence 01223367899999999999999999 89998887 9998764
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-49 Score=395.45 Aligned_cols=255 Identities=22% Similarity=0.325 Sum_probs=211.7
Q ss_pred ccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCc--cCHHHHHHHHHHHhCCCCCceeeEEEEEE
Q 011851 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL--QGHKEWLAEVNYLGGLIHPNLVKLIGCCI 197 (476)
Q Consensus 120 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~ 197 (476)
.++|++.+.||+|+||.||+|.+. .+|+.||||++..... ...+.+.+|+++|+.++||||+++++++.
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~ 84 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHI---------LTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIE 84 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEET---------TTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEEC---------CCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence 457999999999999999998654 4788899999976533 23456889999999999999999999999
Q ss_pred eCCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCC
Q 011851 198 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGL 277 (476)
Q Consensus 198 ~~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~ 277 (476)
+.+.+|+||||+++++|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 85 ~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~ 160 (328)
T 3fe3_A 85 TEKTLYLIMEYASGGEVFDYLVAH-GRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGF 160 (328)
T ss_dssp CSSEEEEEECCCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTC
T ss_pred ECCEEEEEEECCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccC
Confidence 999999999999999999999654 46999999999999999999999988 99999999999999999999999999
Q ss_pred cCCCCCCCccceeeeeecCCCCCCcchhhcCCCC-ccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhcccc
Q 011851 278 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLT-AKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERR 356 (476)
Q Consensus 278 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~ 356 (476)
+........ ....+||+.|+|||++.+..+. .++|||||||++|+|++|+.||........... ......
T Consensus 161 a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~------i~~~~~ 231 (328)
T 3fe3_A 161 SNEFTVGGK---LDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRER------VLRGKY 231 (328)
T ss_dssp CGGGSSSCG---GGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH------HHHCCC
T ss_pred ceecCCCCc---cccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHH------HHhCCC
Confidence 986544322 2346899999999999988775 789999999999999999999976432111111 110000
Q ss_pred ccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCcccc
Q 011851 357 RFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDM 412 (476)
Q Consensus 357 ~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~~ 412 (476)
.++...+.++.+|+.+||+.||.+|||+.++++| ||++..
T Consensus 232 ------------~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h----~~~~~~ 271 (328)
T 3fe3_A 232 ------------RIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD----RWINAG 271 (328)
T ss_dssp ------------CCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC----TTTTTT
T ss_pred ------------CCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC----HhhcCC
Confidence 0112236788999999999999999999999987 888753
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-48 Score=393.29 Aligned_cols=260 Identities=24% Similarity=0.342 Sum_probs=213.4
Q ss_pred ccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCcc------CHHHHHHHHHHHhCCCCCceeeEE
Q 011851 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQ------GHKEWLAEVNYLGGLIHPNLVKLI 193 (476)
Q Consensus 120 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~------~~~~~~~E~~~l~~l~hpnIv~l~ 193 (476)
.++|++.+.||+|+||.||+|.+. .+|+.||+|++...... ..+.+.+|+.+|++++||||++++
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~---------~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~ 81 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREK---------STGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLH 81 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEET---------TTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEEC---------CCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEE
Confidence 457999999999999999998654 57889999999765432 346789999999999999999999
Q ss_pred EEEEeCCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCC----c
Q 011851 194 GCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEY----N 269 (476)
Q Consensus 194 ~~~~~~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~----~ 269 (476)
+++.+.+.+||||||++||+|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++ .
T Consensus 82 ~~~~~~~~~~lv~e~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~ 157 (361)
T 2yab_A 82 DVYENRTDVVLILELVSGGELFDFLAQ-KESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPH 157 (361)
T ss_dssp EEEECSSEEEEEEECCCSCBHHHHHTT-CSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCC
T ss_pred EEEEeCCEEEEEEEcCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccC
Confidence 999999999999999999999999954 457999999999999999999999988 99999999999998777 7
Q ss_pred eEEeecCCcCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhh
Q 011851 270 AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR 349 (476)
Q Consensus 270 vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~ 349 (476)
+||+|||+++....... ....+||+.|+|||++.+..|+.++|||||||++|+|++|..||...........+. .
T Consensus 158 vkl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~--~ 232 (361)
T 2yab_A 158 IKLIDFGLAHEIEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANIT--A 232 (361)
T ss_dssp EEECCCSSCEECCTTCC---CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHH--T
T ss_pred EEEEecCCceEcCCCCc---cccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH--h
Confidence 99999999987654322 234689999999999999999999999999999999999999997643221111100 0
Q ss_pred hhhccccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCccccc
Q 011851 350 PQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDMA 413 (476)
Q Consensus 350 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~~~ 413 (476)
....+ ++. +....+.++.+||.+||..||++|||+.++++| |||+...
T Consensus 233 ----~~~~~----~~~----~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h----p~~~~~~ 280 (361)
T 2yab_A 233 ----VSYDF----DEE----FFSQTSELAKDFIRKLLVKETRKRLTIQEALRH----PWITPVD 280 (361)
T ss_dssp ----TCCCC----CHH----HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS----TTTSCSS
T ss_pred ----cCCCC----Cch----hccCCCHHHHHHHHHHCCCChhHCcCHHHHhcC----cCcCCCc
Confidence 00000 000 001125688999999999999999999999997 9998653
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-49 Score=399.00 Aligned_cols=257 Identities=27% Similarity=0.409 Sum_probs=208.2
Q ss_pred ccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCC---ccCHHHHHHHHHHHhCC-CCCceeeEEEE
Q 011851 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDG---LQGHKEWLAEVNYLGGL-IHPNLVKLIGC 195 (476)
Q Consensus 120 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~---~~~~~~~~~E~~~l~~l-~hpnIv~l~~~ 195 (476)
.++|++.++||+|+||+||+|++. .+|+.||||++++.. ....+.+.+|..+|..+ +||||++++++
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~---------~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~ 92 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVK---------ETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCC 92 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEET---------TTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEE
T ss_pred hhheEEEEEEeeCCCEEEEEEEEc---------CCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEE
Confidence 457999999999999999998654 478889999997542 23345678899999988 79999999999
Q ss_pred EEeCCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeec
Q 011851 196 CIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDF 275 (476)
Q Consensus 196 ~~~~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DF 275 (476)
+.+.+.+|||||||+||+|.+++.+. ..+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+||
T Consensus 93 ~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DF 168 (353)
T 3txo_A 93 FQTPDRLFFVMEFVNGGDLMFHIQKS-RRFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADF 168 (353)
T ss_dssp EECSSEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCC
T ss_pred EEeCCEEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEccc
Confidence 99999999999999999999999654 56999999999999999999999988 999999999999999999999999
Q ss_pred CCcCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhccc
Q 011851 276 GLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGER 355 (476)
Q Consensus 276 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~ 355 (476)
|+++...... ......+||+.|+|||++.+..|+.++|||||||++|||++|+.||...........+ ....
T Consensus 169 G~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i------~~~~ 240 (353)
T 3txo_A 169 GMCKEGICNG--VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAI------LNDE 240 (353)
T ss_dssp TTCBCSCC-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH------HHCC
T ss_pred cceeecccCC--ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHH------HcCC
Confidence 9998643322 2234578999999999999999999999999999999999999999765332111111 1110
Q ss_pred cccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCH------HHHHHHhcCCCCccccc
Q 011851 356 RRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRM------SEVVEALKPLPYLKDMA 413 (476)
Q Consensus 356 ~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~------~ell~~L~~~~~~~~~~ 413 (476)
. .++...+..+.+||.+||+.||++||++ .++++| |||+++.
T Consensus 241 ~------------~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~h----p~f~~~~ 288 (353)
T 3txo_A 241 V------------VYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRH----PFFKEID 288 (353)
T ss_dssp C------------CCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTS----GGGTTCC
T ss_pred C------------CCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhC----CcccCCC
Confidence 0 1122236788999999999999999998 777776 9999864
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-48 Score=384.97 Aligned_cols=275 Identities=25% Similarity=0.334 Sum_probs=210.9
Q ss_pred ccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccC--HHHHHHHHHHHhCCCCCceeeEEEEEE
Q 011851 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQG--HKEWLAEVNYLGGLIHPNLVKLIGCCI 197 (476)
Q Consensus 120 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~--~~~~~~E~~~l~~l~hpnIv~l~~~~~ 197 (476)
.++|++.+.||+|+||+||+|.+. +|+.||+|++....... ...+.+|+++|++++||||+++++++.
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~----------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 89 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDS----------QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIH 89 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEET----------TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred HhhhHhhhhccCCCCeEEEEEEEC----------CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEc
Confidence 467999999999999999998763 47789999997543322 356889999999999999999999999
Q ss_pred eCCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCC
Q 011851 198 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGL 277 (476)
Q Consensus 198 ~~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~ 277 (476)
+++.+||||||++ ++|.+++......+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 90 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~ 165 (311)
T 3niz_A 90 SERCLTLVFEFME-KDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGL 165 (311)
T ss_dssp CSSCEEEEEECCS-EEHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTT
T ss_pred cCCEEEEEEcCCC-CCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcC
Confidence 9999999999997 4898888777777999999999999999999999988 99999999999999999999999999
Q ss_pred cCCCCCCCccceeeeeecCCCCCCcchhhc-CCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhh-hhhc-c
Q 011851 278 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR-PQLG-E 354 (476)
Q Consensus 278 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~-~~~~-~ 354 (476)
++....... .....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...........+.... .... .
T Consensus 166 a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 243 (311)
T 3niz_A 166 ARAFGIPVR--SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPRE 243 (311)
T ss_dssp CEETTSCCC-----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTT
T ss_pred ceecCCCcc--cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHH
Confidence 987543221 2234578999999999886 568999999999999999999999998765443322111100 0000 0
Q ss_pred ccc---c-------ccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCcccccC
Q 011851 355 RRR---F-------YRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDMAS 414 (476)
Q Consensus 355 ~~~---~-------~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~~~~ 414 (476)
... + ...++...........+.++.+||.+||+.||++|||+.|+++| |||+++..
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h----p~f~~~~~ 309 (311)
T 3niz_A 244 WPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNH----PYFKDLDP 309 (311)
T ss_dssp SGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTS----GGGTTSCT
T ss_pred hhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcC----cccccCCc
Confidence 000 0 00000000000011124688999999999999999999999997 99998653
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-48 Score=395.47 Aligned_cols=262 Identities=25% Similarity=0.392 Sum_probs=210.5
Q ss_pred cCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCcc---CHHHHHHHHHHHhCC-CCCceeeEEEEE
Q 011851 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQ---GHKEWLAEVNYLGGL-IHPNLVKLIGCC 196 (476)
Q Consensus 121 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~---~~~~~~~E~~~l~~l-~hpnIv~l~~~~ 196 (476)
++|++.++||+|+||+||+|++. .+++.||||++++.... ....+..|..+|.++ +||||++++++|
T Consensus 52 ~~y~~~~~LG~G~fG~V~~~~~~---------~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~ 122 (396)
T 4dc2_A 52 QDFDLLRVIGRGSYAKVLLVRLK---------KTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCF 122 (396)
T ss_dssp GGEEEEEEEEECSSEEEEEEEET---------TTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred hHcEEEEEEeeCCCeEEEEEEEC---------CCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEE
Confidence 46999999999999999998654 47888999999765332 234577899999876 899999999999
Q ss_pred EeCCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecC
Q 011851 197 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFG 276 (476)
Q Consensus 197 ~~~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG 276 (476)
.+.+.+|||||||++|+|.+++.+. ..+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||
T Consensus 123 ~~~~~~~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFG 198 (396)
T 4dc2_A 123 QTESRLFFVIEYVNGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYG 198 (396)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCT
T ss_pred EECCEEEEEEEcCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecc
Confidence 9999999999999999999999654 46999999999999999999999988 9999999999999999999999999
Q ss_pred CcCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcc--hhHHhhhh-hhc
Q 011851 277 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEH--NLVEWARP-QLG 353 (476)
Q Consensus 277 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~--~~~~~~~~-~~~ 353 (476)
+++....... .....+||+.|+|||++.+..|+.++|||||||++|||++|+.||......... ........ ...
T Consensus 199 la~~~~~~~~--~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~ 276 (396)
T 4dc2_A 199 MCKEGLRPGD--TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE 276 (396)
T ss_dssp TCBCCCCTTC--CBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHH
T ss_pred eeeecccCCC--ccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhc
Confidence 9986432222 234578999999999999999999999999999999999999999754322111 00110000 001
Q ss_pred cccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCH------HHHHHHhcCCCCccccc
Q 011851 354 ERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRM------SEVVEALKPLPYLKDMA 413 (476)
Q Consensus 354 ~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~------~ell~~L~~~~~~~~~~ 413 (476)
... .++...+.++.+||.+||+.||++||++ .+|++| |||+++.
T Consensus 277 ~~~------------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~H----pff~~i~ 326 (396)
T 4dc2_A 277 KQI------------RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH----PFFRNVD 326 (396)
T ss_dssp CCC------------CCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHS----TTTTTCC
T ss_pred ccc------------CCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcC----ccccCCC
Confidence 100 1222336789999999999999999996 677776 9998864
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-48 Score=385.85 Aligned_cols=253 Identities=28% Similarity=0.394 Sum_probs=211.6
Q ss_pred cCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCC---ccCHHHHHHHHHHHhCCCCCceeeEEEEEE
Q 011851 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDG---LQGHKEWLAEVNYLGGLIHPNLVKLIGCCI 197 (476)
Q Consensus 121 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~ 197 (476)
++|++.+.||+|+||.||+|++. .+|+.||||++++.. ....+.+.+|+.+|+.++||||+++++++.
T Consensus 6 ~~y~~~~~lG~G~~g~V~~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~ 76 (318)
T 1fot_A 6 QDFQILRTLGTGSFGRVHLIRSR---------HNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQ 76 (318)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET---------TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEE
T ss_pred HHcEEEEEEeeCCCEEEEEEEEC---------CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEE
Confidence 56999999999999999998654 478889999997542 234566788999999999999999999999
Q ss_pred eCCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCC
Q 011851 198 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGL 277 (476)
Q Consensus 198 ~~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~ 277 (476)
+.+.+||||||++||+|.+++.+ ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 77 ~~~~~~lv~e~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~ 152 (318)
T 1fot_A 77 DAQQIFMIMDYIEGGELFSLLRK-SQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGF 152 (318)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHH-TSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSS
T ss_pred eCCEEEEEEeCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCc
Confidence 99999999999999999999965 457999999999999999999999988 99999999999999999999999999
Q ss_pred cCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhccccc
Q 011851 278 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRR 357 (476)
Q Consensus 278 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 357 (476)
++..... ....+||+.|+|||++.+..++.++|||||||++|||++|+.||....... ... .......
T Consensus 153 a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~---~~~---~i~~~~~- 220 (318)
T 1fot_A 153 AKYVPDV-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK---TYE---KILNAEL- 220 (318)
T ss_dssp CEECSSC-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH---HHH---HHHHCCC-
T ss_pred ceecCCc-----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH---HHH---HHHhCCC-
Confidence 9875432 234689999999999999999999999999999999999999997543211 111 0111100
Q ss_pred cccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHhcCCCCccccc
Q 011851 358 FYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARP-----RMSEVVEALKPLPYLKDMA 413 (476)
Q Consensus 358 ~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RP-----t~~ell~~L~~~~~~~~~~ 413 (476)
.++...+.++.+||.+||..||++|| +++++++| |||++..
T Consensus 221 -----------~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~h----p~f~~~~ 266 (318)
T 1fot_A 221 -----------RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH----PWFKEVV 266 (318)
T ss_dssp -----------CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS----GGGSSCC
T ss_pred -----------CCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcC----ccccCCC
Confidence 01222367899999999999999999 88888887 9998764
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-48 Score=377.37 Aligned_cols=272 Identities=23% Similarity=0.284 Sum_probs=210.7
Q ss_pred cCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccC--HHHHHHHHHHHhCCCCCceeeEEEEEEe
Q 011851 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQG--HKEWLAEVNYLGGLIHPNLVKLIGCCIE 198 (476)
Q Consensus 121 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~--~~~~~~E~~~l~~l~hpnIv~l~~~~~~ 198 (476)
++|++.+.||+|+||+||+|.+. .+|+.||||++....... ...+.+|+.+|++++||||+++++++.+
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 72 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNR---------ETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS 72 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEET---------TTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEEC---------CCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEe
Confidence 47999999999999999998764 467889999997654332 3568899999999999999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCc
Q 011851 199 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLA 278 (476)
Q Consensus 199 ~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a 278 (476)
++.+||||||+++ +|.+.+......+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 73 ~~~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~ 148 (292)
T 3o0g_A 73 DKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLA 148 (292)
T ss_dssp TTEEEEEEECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred CCEEEEEEecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccc
Confidence 9999999999965 777777676778999999999999999999999988 999999999999999999999999999
Q ss_pred CCCCCCCccceeeeeecCCCCCCcchhhcCC-CCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhh-----
Q 011851 279 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGH-LTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQL----- 352 (476)
Q Consensus 279 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~----- 352 (476)
+....... ......||+.|+|||++.+.. ++.++|||||||++|+|++|..||....... ..........
T Consensus 149 ~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~--~~~~~i~~~~~~~~~ 224 (292)
T 3o0g_A 149 RAFGIPVR--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD--DQLKRIFRLLGTPTE 224 (292)
T ss_dssp EECCSCCS--CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHH--HHHHHHHHHHCCCCT
T ss_pred eecCCccc--cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHH--HHHHHHHHHhCCCCh
Confidence 86543221 223467899999999998765 8999999999999999999988865432211 1111100000
Q ss_pred ccccccccccC---------cccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCccccc
Q 011851 353 GERRRFYRLID---------PCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDMA 413 (476)
Q Consensus 353 ~~~~~~~~~~d---------~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~~~ 413 (476)
.....+....+ ...........+.++.+||.+||+.||++|||+.|+++| |||++..
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h----p~f~~~~ 290 (292)
T 3o0g_A 225 EQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH----PYFSDFC 290 (292)
T ss_dssp TTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS----GGGTTC-
T ss_pred hhhhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC----cccccCC
Confidence 00000000000 000001112346788999999999999999999999997 9998764
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-48 Score=380.91 Aligned_cols=273 Identities=24% Similarity=0.343 Sum_probs=222.3
Q ss_pred ccChhHHHHhccC----------CCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHH
Q 011851 110 KFSFNELKSATKS----------FRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVN 179 (476)
Q Consensus 110 ~~~~~~~~~~~~~----------y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~ 179 (476)
.+++++++.+++. |...+.||+|+||.||+|.+. .+|+.||||++........+.+.+|+.
T Consensus 24 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~---------~~g~~vavK~~~~~~~~~~~~~~~E~~ 94 (321)
T 2c30_A 24 VVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREK---------HSGRQVAVKMMDLRKQQRRELLFNEVV 94 (321)
T ss_dssp -CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEET---------TTCCEEEEEEEETTTCCSHHHHHHHHH
T ss_pred cCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEEC---------CCCcEEEEEEEeccchhHHHHHHHHHH
Confidence 3566666666543 777789999999999998764 467889999998776667778999999
Q ss_pred HHhCCCCCceeeEEEEEEeCCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCC
Q 011851 180 YLGGLIHPNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKT 259 (476)
Q Consensus 180 ~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp 259 (476)
+|++++||||+++++++...+..||||||+++++|.+++.. ..+++..+..++.||+.||.|||+.+ |+||||||
T Consensus 95 ~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp 169 (321)
T 2c30_A 95 IMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ--VRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKS 169 (321)
T ss_dssp HHTTCCCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSG
T ss_pred HHHhCCCCCcceEEEEEEECCEEEEEEecCCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCH
Confidence 99999999999999999999999999999999999998854 36999999999999999999999988 99999999
Q ss_pred CCeeecCCCceEEeecCCcCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCC
Q 011851 260 SNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPN 339 (476)
Q Consensus 260 ~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~ 339 (476)
+|||++.++.+||+|||++........ ......||+.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus 170 ~NIll~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~ 247 (321)
T 2c30_A 170 DSILLTLDGRVKLSDFGFCAQISKDVP--KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPV 247 (321)
T ss_dssp GGEEECTTCCEEECCCTTCEECCSSSC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH
T ss_pred HHEEECCCCcEEEeeeeeeeecccCcc--ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 999999999999999999986543221 123468999999999999999999999999999999999999999754321
Q ss_pred CcchhHHhhhhhhccccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCcccccCcch
Q 011851 340 GEHNLVEWARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDMASSSS 417 (476)
Q Consensus 340 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~~~~~~~ 417 (476)
........ ...+.+. .....+..+.+||.+||+.||++|||+.+++++ |||........
T Consensus 248 ---~~~~~~~~----------~~~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h----p~~~~~~~~~~ 306 (321)
T 2c30_A 248 ---QAMKRLRD----------SPPPKLK--NSHKVSPVLRDFLERMLVRDPQERATAQELLDH----PFLLQTGLPEC 306 (321)
T ss_dssp ---HHHHHHHH----------SSCCCCT--TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS----GGGGGCCCGGG
T ss_pred ---HHHHHHhc----------CCCCCcC--ccccCCHHHHHHHHHHccCChhhCcCHHHHhcC----hhhccCCCccc
Confidence 11111100 0001111 111235788999999999999999999999997 99987654443
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-48 Score=380.71 Aligned_cols=259 Identities=26% Similarity=0.391 Sum_probs=212.4
Q ss_pred cCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCCCCCceeeEEEEEEeCC
Q 011851 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHPNLVKLIGCCIEDD 200 (476)
Q Consensus 121 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 200 (476)
++|++.++||+|+||+||+|.+. .+++.||+|++........+.+.+|+++|++++||||+++++++.+++
T Consensus 10 ~~~~~~~~lG~G~~g~V~~~~~~---------~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 80 (310)
T 3s95_A 10 SDLIHGEVLGKGCFGQAIKVTHR---------ETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDK 80 (310)
T ss_dssp GGEEEEEEEECCSSEEEEEEEET---------TTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETT
T ss_pred hHeeccceecCCCCEEEEEEEEC---------CCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCC
Confidence 46899999999999999998765 467889999997665556678999999999999999999999999999
Q ss_pred eeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCcCC
Q 011851 201 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKD 280 (476)
Q Consensus 201 ~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~ 280 (476)
..++||||+++++|.+++......+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 157 (310)
T 3s95_A 81 RLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARL 157 (310)
T ss_dssp EEEEEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEE
T ss_pred eeEEEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeeccccee
Confidence 999999999999999999876778999999999999999999999988 99999999999999999999999999986
Q ss_pred CCCCCccc------------eeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhh
Q 011851 281 GPEGDKTH------------VSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA 348 (476)
Q Consensus 281 ~~~~~~~~------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~ 348 (476)
........ .....+||+.|+|||++.+..++.++|||||||++|||++|..||...............
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~ 237 (310)
T 3s95_A 158 MVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVR 237 (310)
T ss_dssp CC--------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHH
T ss_pred cccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhh
Confidence 54322111 111467999999999999999999999999999999999999998764433221110000
Q ss_pred hhhhccccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011851 349 RPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPL 406 (476)
Q Consensus 349 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~ 406 (476)
. ..+.. .+...+..+.+|+.+||+.||++|||+.++++.|+.+
T Consensus 238 ~-----------~~~~~----~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l 280 (310)
T 3s95_A 238 G-----------FLDRY----CPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETL 280 (310)
T ss_dssp H-----------HHHHT----CCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred c-----------ccccc----CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 0 00000 1112245788999999999999999999999987754
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-49 Score=393.36 Aligned_cols=258 Identities=26% Similarity=0.396 Sum_probs=211.8
Q ss_pred hccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCC---ccCHHHHHHHHHHHhCC-CCCceeeEEE
Q 011851 119 ATKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDG---LQGHKEWLAEVNYLGGL-IHPNLVKLIG 194 (476)
Q Consensus 119 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~---~~~~~~~~~E~~~l~~l-~hpnIv~l~~ 194 (476)
..++|++.+.||+|+||.||+|++. .+|+.||||++++.. ......+..|..+|..+ +||||+++++
T Consensus 15 ~~~~y~~~~~lG~G~fg~V~~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~ 85 (345)
T 1xjd_A 15 KIEDFILHKMLGKGSFGKVFLAEFK---------KTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFC 85 (345)
T ss_dssp -CTTEEEEEEEEECSSSEEEEEEET---------TTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEE
T ss_pred ChHHeEEEEEEeeCCCeEEEEEEEC---------CCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEE
Confidence 4568999999999999999998654 478889999997642 23345678899999876 8999999999
Q ss_pred EEEeCCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEee
Q 011851 195 CCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSD 274 (476)
Q Consensus 195 ~~~~~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~D 274 (476)
++.+.+.+||||||++||+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|
T Consensus 86 ~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~D 161 (345)
T 1xjd_A 86 TFQTKENLFFVMEYLNGGDLMYHIQSC-HKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIAD 161 (345)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECC
T ss_pred EEEeCCEEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeE
Confidence 999999999999999999999999654 46999999999999999999999988 99999999999999999999999
Q ss_pred cCCcCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhcc
Q 011851 275 FGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGE 354 (476)
Q Consensus 275 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~ 354 (476)
||+++....... .....+||+.|+|||++.+..|+.++|||||||++|||++|+.||....... +..... ..
T Consensus 162 FG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~---~~~~i~---~~ 233 (345)
T 1xjd_A 162 FGMCKENMLGDA--KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE---LFHSIR---MD 233 (345)
T ss_dssp CTTCBCCCCTTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHH---HC
T ss_pred ChhhhhcccCCC--cccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHH---HHHHHH---hC
Confidence 999986433222 2345789999999999999999999999999999999999999997543221 111110 00
Q ss_pred ccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHH-HHHHHhcCCCCccccc
Q 011851 355 RRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMS-EVVEALKPLPYLKDMA 413 (476)
Q Consensus 355 ~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~-ell~~L~~~~~~~~~~ 413 (476)
.. .++...+.++.+||.+||+.||++||++. +|++| |||+++.
T Consensus 234 ~~------------~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~h----p~f~~~~ 277 (345)
T 1xjd_A 234 NP------------FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQH----PLFREIN 277 (345)
T ss_dssp CC------------CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGS----GGGTTCC
T ss_pred CC------------CCCcccCHHHHHHHHHHhcCCHhHcCCChHHHHcC----ccccCCC
Confidence 00 11122367899999999999999999997 76665 9998764
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-48 Score=392.59 Aligned_cols=259 Identities=25% Similarity=0.365 Sum_probs=213.1
Q ss_pred cCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCC---ccCHHHHHHHHHHHhCCCCCceeeEEEEEE
Q 011851 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDG---LQGHKEWLAEVNYLGGLIHPNLVKLIGCCI 197 (476)
Q Consensus 121 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~ 197 (476)
++|++.+.||+|+||.||+|.+. .+++.||||++.... ....+.+.+|+.+|+.++||||++++++|.
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~~---------~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~ 85 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQKN---------DTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQ 85 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEET---------TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEEC---------CCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence 46999999999999999998654 578889999996532 234567889999999999999999999999
Q ss_pred eCCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCC
Q 011851 198 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGL 277 (476)
Q Consensus 198 ~~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~ 277 (476)
+.+.+|+||||+.||+|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+
T Consensus 86 ~~~~~~lv~e~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~ 161 (384)
T 4fr4_A 86 DEEDMFMVVDLLLGGDLRYHLQQ-NVHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNI 161 (384)
T ss_dssp CSSEEEEEECCCTTEEHHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTT
T ss_pred eCCEEEEEEecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccce
Confidence 99999999999999999999854 457999999999999999999999988 99999999999999999999999999
Q ss_pred cCCCCCCCccceeeeeecCCCCCCcchhhc---CCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhcc
Q 011851 278 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMT---GHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGE 354 (476)
Q Consensus 278 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~ 354 (476)
++....... ....+||+.|+|||++.. ..|+.++|||||||++|||++|+.||..........+........
T Consensus 162 a~~~~~~~~---~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~-- 236 (384)
T 4fr4_A 162 AAMLPRETQ---ITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTV-- 236 (384)
T ss_dssp CEECCTTCC---BCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCC--
T ss_pred eeeccCCCc---eeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcc--
Confidence 987644322 344789999999999874 468999999999999999999999997654433322222111110
Q ss_pred ccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCC-HHHHHHHhcCCCCcccccC
Q 011851 355 RRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPR-MSEVVEALKPLPYLKDMAS 414 (476)
Q Consensus 355 ~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt-~~ell~~L~~~~~~~~~~~ 414 (476)
. .++...+.++.+||.+||+.||++||+ ++++++| |||+++..
T Consensus 237 -~------------~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~h----p~f~~~~w 280 (384)
T 4fr4_A 237 -V------------TYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNF----PYMNDINW 280 (384)
T ss_dssp -C------------CCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTS----GGGTTCCH
T ss_pred -c------------CCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcC----hhhhcCCH
Confidence 0 112223678999999999999999998 6776665 99987643
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-49 Score=404.78 Aligned_cols=272 Identities=20% Similarity=0.242 Sum_probs=217.9
Q ss_pred hHHHHhccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCc---cCHHHHHHHHHHHhCCCCCcee
Q 011851 114 NELKSATKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL---QGHKEWLAEVNYLGGLIHPNLV 190 (476)
Q Consensus 114 ~~~~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv 190 (476)
.++....++|++.++||+|+||+||+|++. .+++.||||++++... .....+.+|+.+|..++||||+
T Consensus 67 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~---------~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv 137 (437)
T 4aw2_A 67 KQMRLHREDFEILKVIGRGAFGEVAVVKLK---------NADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWIT 137 (437)
T ss_dssp HHHSCCGGGEEEEEEEEECSSEEEEEEEET---------TTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBC
T ss_pred hcccCChhheEEEEEEEeCCCEEEEEEEEc---------CCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEE
Confidence 334445678999999999999999998765 4678899999975321 1223478899999999999999
Q ss_pred eEEEEEEeCCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCce
Q 011851 191 KLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNA 270 (476)
Q Consensus 191 ~l~~~~~~~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~v 270 (476)
+++++|.+++.+|||||||+||+|.+++.+....+++..++.++.||+.||.|||+.+ ||||||||+||||+.++.+
T Consensus 138 ~l~~~~~~~~~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~v 214 (437)
T 4aw2_A 138 TLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHI 214 (437)
T ss_dssp CEEEEEECSSEEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCE
T ss_pred EEEEEEeeCCEEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCE
Confidence 9999999999999999999999999999776678999999999999999999999988 9999999999999999999
Q ss_pred EEeecCCcCCCCCCCccceeeeeecCCCCCCcchhh-----cCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhH
Q 011851 271 KLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV 345 (476)
Q Consensus 271 kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~ 345 (476)
||+|||+++....... ......+||+.|+|||++. ...|+.++|||||||++|||++|+.||...........+
T Consensus 215 kL~DFGla~~~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i 293 (437)
T 4aw2_A 215 RLADFGSCLKLMEDGT-VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI 293 (437)
T ss_dssp EECCCTTCEECCTTSC-EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH
T ss_pred EEcchhhhhhcccCCC-cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhh
Confidence 9999999976544322 2233468999999999997 457999999999999999999999999764332211111
Q ss_pred HhhhhhhccccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCC--CCCHHHHHHHhcCCCCcccccCc
Q 011851 346 EWARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKA--RPRMSEVVEALKPLPYLKDMASS 415 (476)
Q Consensus 346 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~--RPt~~ell~~L~~~~~~~~~~~~ 415 (476)
..... ...+. ..+ ...+.++.+||.+||..+|++ ||+++|+++| |||+++...
T Consensus 294 ~~~~~----~~~~p----~~~-----~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H----pff~~i~w~ 348 (437)
T 4aw2_A 294 MNHKE----RFQFP----TQV-----TDVSENAKDLIRRLICSREHRLGQNGIEDFKKH----PFFSGIDWD 348 (437)
T ss_dssp HTHHH----HCCCC----SSC-----CCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS----GGGTTCCTT
T ss_pred hhccc----cccCC----ccc-----ccCCHHHHHHHHHHhcccccccCCCCHHHHhCC----CccCCCCHH
Confidence 10000 00000 000 112678999999999998888 9999999987 999987654
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-48 Score=387.82 Aligned_cols=259 Identities=19% Similarity=0.271 Sum_probs=213.7
Q ss_pred ccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCCCCCceeeEEEEEEeC
Q 011851 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHPNLVKLIGCCIED 199 (476)
Q Consensus 120 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~ 199 (476)
.++|++.+.||+|+||.||+|.+. .+++.||+|++.... .....+.+|+.+|+.++||||+++++++.+.
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~---------~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 73 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVET---------SSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESM 73 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEET---------TTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEET
T ss_pred hhceEeeeEEecCCCeEEEEEEEC---------CCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecC
Confidence 467999999999999999998654 578889999997543 3345678999999999999999999999999
Q ss_pred CeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecC--CCceEEeecCC
Q 011851 200 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDG--EYNAKLSDFGL 277 (476)
Q Consensus 200 ~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~--~~~vkl~DFG~ 277 (476)
+.+|||||||++++|.+++......+++..++.++.||+.||.|||+++ |+||||||+|||++. ++.+||+|||+
T Consensus 74 ~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~ 150 (321)
T 1tki_A 74 EELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQ 150 (321)
T ss_dssp TEEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTT
T ss_pred CEEEEEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCC
Confidence 9999999999999999999776668999999999999999999999988 999999999999987 78999999999
Q ss_pred cCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhccccc
Q 011851 278 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRR 357 (476)
Q Consensus 278 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 357 (476)
++....... .....||+.|+|||++.+..++.++|||||||++|+|++|..||....... ...... .....
T Consensus 151 a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---~~~~i~---~~~~~ 221 (321)
T 1tki_A 151 ARQLKPGDN---FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ---IIENIM---NAEYT 221 (321)
T ss_dssp CEECCTTCE---EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH---HHHHHH---HTCCC
T ss_pred CeECCCCCc---cccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHH---HHHHHH---cCCCC
Confidence 987654332 344689999999999999889999999999999999999999997643221 111100 00000
Q ss_pred cccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCcccc
Q 011851 358 FYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDM 412 (476)
Q Consensus 358 ~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~~ 412 (476)
+. ...+ ...+.++.+||.+||..||++|||+.|+++| ||+++.
T Consensus 222 ~~---~~~~-----~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h----p~~~~~ 264 (321)
T 1tki_A 222 FD---EEAF-----KEISIEAMDFVDRLLVKERKSRMTASEALQH----PWLKQK 264 (321)
T ss_dssp CC---HHHH-----TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS----HHHHSC
T ss_pred CC---hhhh-----ccCCHHHHHHHHHHcCCChhHCcCHHHHhcC----hhhccC
Confidence 00 0000 0125789999999999999999999999997 888754
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-48 Score=385.14 Aligned_cols=261 Identities=25% Similarity=0.334 Sum_probs=210.3
Q ss_pred ccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCcc-CHHHHHHHHHHHhCCCCCceeeEEEEEEe
Q 011851 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQ-GHKEWLAEVNYLGGLIHPNLVKLIGCCIE 198 (476)
Q Consensus 120 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~~ 198 (476)
.++|++.+.||+|+||+||+|.+. .+++.||||++...... ..+.+.+|+.+++.++||||+++++++.+
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~---------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~ 76 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNR---------VTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRRE 76 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEET---------TTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred hhhceeeeEEecCCCEEEEEEEEC---------CCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEec
Confidence 457999999999999999998654 46788999999754332 23567899999999999999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCc
Q 011851 199 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLA 278 (476)
Q Consensus 199 ~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a 278 (476)
++..|||||||++++|.+++. ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 77 ~~~~~lv~e~~~~~~L~~~l~-~~~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a 152 (323)
T 3tki_A 77 GNIQYLFLEYCSGGELFDRIE-PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLA 152 (323)
T ss_dssp SSEEEEEEECCTTEEGGGGSB-TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred CCeEEEEEEcCCCCcHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeecc
Confidence 999999999999999999884 4456999999999999999999999988 999999999999999999999999999
Q ss_pred CCCCCCCccceeeeeecCCCCCCcchhhcCCC-CccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhccccc
Q 011851 279 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHL-TAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRR 357 (476)
Q Consensus 279 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 357 (476)
+..............+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||......... ...+.....
T Consensus 153 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~-~~~~~~~~~----- 226 (323)
T 3tki_A 153 TVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-YSDWKEKKT----- 226 (323)
T ss_dssp EECEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHH-HHHHHTTCT-----
T ss_pred ceeccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHH-HHHHhcccc-----
Confidence 86543333333345789999999999988765 77899999999999999999999765432211 111111000
Q ss_pred cccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCcccc
Q 011851 358 FYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDM 412 (476)
Q Consensus 358 ~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~~ 412 (476)
... .....+..+.+||.+||+.||++|||+.|++++ |||+..
T Consensus 227 ---~~~------~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h----~~~~~~ 268 (323)
T 3tki_A 227 ---YLN------PWKKIDSAPLALLHKILVENPSARITIPDIKKD----RWYNKP 268 (323)
T ss_dssp ---TST------TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC----TTTTCC
T ss_pred ---cCC------ccccCCHHHHHHHHHHccCChhhCcCHHHHhhC----hhhccc
Confidence 000 011235788899999999999999999999987 998754
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-48 Score=391.41 Aligned_cols=265 Identities=24% Similarity=0.361 Sum_probs=213.4
Q ss_pred ccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCcc-CHHHHHHHHHHHhCC-CCCceeeEEEEEE
Q 011851 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQ-GHKEWLAEVNYLGGL-IHPNLVKLIGCCI 197 (476)
Q Consensus 120 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~-~~~~~~~E~~~l~~l-~hpnIv~l~~~~~ 197 (476)
.++|++.+.||+|+||.||+|.+..... ....++..||||+++..... ..+.+.+|+.+|+++ +||||+++++++.
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~--~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~ 157 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDK--DKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 157 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCST--TCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEEC
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccC--cCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEc
Confidence 3579999999999999999998753211 12346778999999765332 345688999999999 8999999999999
Q ss_pred eCCeeEEEEEecCCCCHHHHHhhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCe
Q 011851 198 EDDQRLLVYEFMPRGSLENHLFRRS---------------LPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNI 262 (476)
Q Consensus 198 ~~~~~~lV~E~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NI 262 (476)
+++.+||||||+++|+|.+++.... ..+++..++.++.||+.||.|||+++ |+||||||+||
T Consensus 158 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NI 234 (370)
T 2psq_A 158 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNV 234 (370)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGE
T ss_pred cCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhE
Confidence 9999999999999999999997543 34899999999999999999999988 99999999999
Q ss_pred eecCCCceEEeecCCcCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHh-CCCCCCCCCCCCc
Q 011851 263 LLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLT-GRRSMDKNRPNGE 341 (476)
Q Consensus 263 Ll~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~ellt-G~~pf~~~~~~~~ 341 (476)
||+.++.+||+|||+++...............||+.|+|||++.+..|+.++|||||||++|||++ |..||........
T Consensus 235 ll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~ 314 (370)
T 2psq_A 235 LVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL 314 (370)
T ss_dssp EECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH
T ss_pred EECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence 999999999999999986554333222333567889999999999999999999999999999999 9999976543221
Q ss_pred chhHHhhhhhhccccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011851 342 HNLVEWARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPL 406 (476)
Q Consensus 342 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~ 406 (476)
...... .. ....+...+.++.+||.+||+.||++||++.+++++|+.+
T Consensus 315 ---~~~~~~----~~----------~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~i 362 (370)
T 2psq_A 315 ---FKLLKE----GH----------RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 362 (370)
T ss_dssp ---HHHHHT----TC----------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---HHHHhc----CC----------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 111100 00 0011222367899999999999999999999999997643
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-48 Score=388.29 Aligned_cols=253 Identities=24% Similarity=0.299 Sum_probs=211.8
Q ss_pred cCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCC---ccCHHHHHHHHHHHhCCCCCceeeEEEEEE
Q 011851 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDG---LQGHKEWLAEVNYLGGLIHPNLVKLIGCCI 197 (476)
Q Consensus 121 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~ 197 (476)
++|++.+.||+|+||.||+|.+. .+|+.||||++.+.. ....+.+.+|+++|+.++||||+++++++.
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 111 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHK---------ESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK 111 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET---------TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred HHCEEEEEeecCcCcEEEEEEEC---------CCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence 57999999999999999998654 478889999996542 234567889999999999999999999999
Q ss_pred eCCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCC
Q 011851 198 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGL 277 (476)
Q Consensus 198 ~~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~ 277 (476)
+.+.+||||||+++|+|.+++.+. ..+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+
T Consensus 112 ~~~~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~ 187 (350)
T 1rdq_E 112 DNSNLYMVMEYVAGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGF 187 (350)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTT
T ss_pred cCCEEEEEEcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEccccc
Confidence 999999999999999999999654 46999999999999999999999988 99999999999999999999999999
Q ss_pred cCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhccccc
Q 011851 278 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRR 357 (476)
Q Consensus 278 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 357 (476)
++..... ....+||+.|+|||++.+..++.++|||||||++|||++|+.||....... +... ......
T Consensus 188 a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~---~~~~---i~~~~~- 255 (350)
T 1rdq_E 188 AKRVKGR-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ---IYEK---IVSGKV- 255 (350)
T ss_dssp CEECSSC-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHH---HHHCCC-
T ss_pred ceeccCC-----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHH---HHHH---HHcCCC-
Confidence 9875432 234689999999999999999999999999999999999999997543211 1110 000000
Q ss_pred cccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHHhcCCCCccccc
Q 011851 358 FYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPR-----MSEVVEALKPLPYLKDMA 413 (476)
Q Consensus 358 ~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt-----~~ell~~L~~~~~~~~~~ 413 (476)
.++...+.++.+||.+||+.||.+||+ +.+|++| |||++..
T Consensus 256 -----------~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h----~~f~~~~ 301 (350)
T 1rdq_E 256 -----------RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH----KWFATTD 301 (350)
T ss_dssp -----------CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS----GGGTTCC
T ss_pred -----------CCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhC----cCcCCCC
Confidence 012223678999999999999999998 7887776 9998764
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-48 Score=382.17 Aligned_cols=260 Identities=23% Similarity=0.319 Sum_probs=212.6
Q ss_pred ccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCcc------CHHHHHHHHHHHhCCCCCceeeEE
Q 011851 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQ------GHKEWLAEVNYLGGLIHPNLVKLI 193 (476)
Q Consensus 120 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~------~~~~~~~E~~~l~~l~hpnIv~l~ 193 (476)
.++|++.+.||+|+||.||+|.+. .+|+.||+|++...... ..+.+.+|+.+|++++||||++++
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~---------~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~ 80 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREK---------STGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLH 80 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEET---------TTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred ccceEeceEEeeCCCeEEEEEEEC---------CCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEE
Confidence 346999999999999999998654 47888999999765432 356789999999999999999999
Q ss_pred EEEEeCCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCC----c
Q 011851 194 GCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEY----N 269 (476)
Q Consensus 194 ~~~~~~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~----~ 269 (476)
+++.+.+..|+||||+++++|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++ .
T Consensus 81 ~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~ 156 (326)
T 2y0a_A 81 EVYENKTDVILILELVAGGELFDFLAE-KESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPR 156 (326)
T ss_dssp EEEECSSEEEEEEECCCSCBHHHHHTT-SSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCC
T ss_pred EEEEeCCEEEEEEEcCCCCCHHHHHHh-cCCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCC
Confidence 999999999999999999999999954 457999999999999999999999988 99999999999998887 7
Q ss_pred eEEeecCCcCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhh
Q 011851 270 AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR 349 (476)
Q Consensus 270 vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~ 349 (476)
+||+|||+++....... ....+||+.|+|||++.+..++.++|||||||++|+|++|..||...........+. .
T Consensus 157 ~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~--~ 231 (326)
T 2y0a_A 157 IKIIDFGLAHKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVS--A 231 (326)
T ss_dssp EEECCCTTCEECCTTSC---CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHH--H
T ss_pred EEEEECCCCeECCCCCc---cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHH--h
Confidence 99999999987643322 234679999999999999999999999999999999999999997543211111100 0
Q ss_pred hhhccccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCccccc
Q 011851 350 PQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDMA 413 (476)
Q Consensus 350 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~~~ 413 (476)
. ... ..+... ...+..+.+||.+||+.||++|||+.++++| |||+...
T Consensus 232 ~----~~~---~~~~~~-----~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h----p~~~~~~ 279 (326)
T 2y0a_A 232 V----NYE---FEDEYF-----SNTSALAKDFIRRLLVKDPKKRMTIQDSLQH----PWIKPKD 279 (326)
T ss_dssp T----CCC---CCHHHH-----TTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS----TTTSCCS
T ss_pred c----CCC---cCcccc-----ccCCHHHHHHHHHHccCChhhCCCHHHHhcC----CCccCCc
Confidence 0 000 000000 1125678999999999999999999999998 9998654
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-48 Score=389.35 Aligned_cols=257 Identities=25% Similarity=0.362 Sum_probs=210.6
Q ss_pred ccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCC---ccCHHHHHHHHHHHhCC-CCCceeeEEEE
Q 011851 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDG---LQGHKEWLAEVNYLGGL-IHPNLVKLIGC 195 (476)
Q Consensus 120 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~---~~~~~~~~~E~~~l~~l-~hpnIv~l~~~ 195 (476)
.++|++.+.||+|+||.||+|.+. .+|+.||||++++.. ....+.+..|..+|..+ +||||++++++
T Consensus 19 ~~~y~~~~~lG~G~fg~V~~~~~~---------~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~ 89 (353)
T 2i0e_A 19 LTDFNFLMVLGKGSFGKVMLSERK---------GTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSC 89 (353)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEET---------TEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEEC---------CCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEE
Confidence 467999999999999999998654 467889999997542 23456678899999988 79999999999
Q ss_pred EEeCCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeec
Q 011851 196 CIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDF 275 (476)
Q Consensus 196 ~~~~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DF 275 (476)
+.+.+.+||||||++||+|.+++.+. ..+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+||
T Consensus 90 ~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DF 165 (353)
T 2i0e_A 90 FQTMDRLYFVMEYVNGGDLMYHIQQV-GRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADF 165 (353)
T ss_dssp EECSSEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCC
T ss_pred EEcCCEEEEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeC
Confidence 99999999999999999999999654 46999999999999999999999988 999999999999999999999999
Q ss_pred CCcCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhccc
Q 011851 276 GLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGER 355 (476)
Q Consensus 276 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~ 355 (476)
|+++....... .....+||+.|+|||++.+..|+.++|||||||++|||++|+.||....... +... .....
T Consensus 166 G~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~---~~~~---i~~~~ 237 (353)
T 2i0e_A 166 GMCKENIWDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE---LFQS---IMEHN 237 (353)
T ss_dssp TTCBCCCCTTC--CBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHH---HHHCC
T ss_pred CcccccccCCc--ccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHH---HHHH---HHhCC
Confidence 99986432221 2345789999999999999999999999999999999999999997543211 1111 11110
Q ss_pred cccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCH-----HHHHHHhcCCCCccccc
Q 011851 356 RRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRM-----SEVVEALKPLPYLKDMA 413 (476)
Q Consensus 356 ~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~-----~ell~~L~~~~~~~~~~ 413 (476)
. .++...+.++.+||.+||+.||.+||++ .+|++| |||+++.
T Consensus 238 ~------------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h----~~f~~~~ 284 (353)
T 2i0e_A 238 V------------AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH----AFFRYID 284 (353)
T ss_dssp C------------CCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTS----GGGTTCC
T ss_pred C------------CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC----ccccCCC
Confidence 0 1122336789999999999999999964 666655 9998754
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-48 Score=390.37 Aligned_cols=260 Identities=21% Similarity=0.286 Sum_probs=214.8
Q ss_pred ccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCCCCCceeeEEEEEEeC
Q 011851 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHPNLVKLIGCCIED 199 (476)
Q Consensus 120 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~ 199 (476)
.++|++.+.||+|+||.||+|.+. .+|+.||+|++..........+.+|+.+|+.++||||+++++++.+.
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~---------~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~ 120 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEK---------ATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDK 120 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEET---------TTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECS
T ss_pred ccceEEEEEEecCCCEEEEEEEEC---------CCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeC
Confidence 457999999999999999998654 47888999999876555556788999999999999999999999999
Q ss_pred CeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecC--CCceEEeecCC
Q 011851 200 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDG--EYNAKLSDFGL 277 (476)
Q Consensus 200 ~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~--~~~vkl~DFG~ 277 (476)
+.+||||||+++++|.+++......+++..+..++.||+.||.|||+++ |+||||||+|||++. ++.+||+|||+
T Consensus 121 ~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~ 197 (387)
T 1kob_A 121 YEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGL 197 (387)
T ss_dssp SEEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTT
T ss_pred CEEEEEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEeccc
Confidence 9999999999999999999766667999999999999999999999988 999999999999974 57899999999
Q ss_pred cCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhccccc
Q 011851 278 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRR 357 (476)
Q Consensus 278 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 357 (476)
++....... ....+||+.|+|||++.+..++.++|||||||++|||++|..||...... ........ ...
T Consensus 198 a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~---~~~~~i~~---~~~- 267 (387)
T 1kob_A 198 ATKLNPDEI---VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL---ETLQNVKR---CDW- 267 (387)
T ss_dssp CEECCTTSC---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH---HHHHHHHH---CCC-
T ss_pred ceecCCCcc---eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHH---HHHHHHHh---CCC-
Confidence 987644322 33467999999999999999999999999999999999999999764321 11111000 000
Q ss_pred cccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCcccc
Q 011851 358 FYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDM 412 (476)
Q Consensus 358 ~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~~ 412 (476)
.. +. ......+.++.+||.+||+.||++|||+.++++| ||+++.
T Consensus 268 --~~-~~----~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h----p~~~~~ 311 (387)
T 1kob_A 268 --EF-DE----DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH----PWLKGD 311 (387)
T ss_dssp --CC-CS----STTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS----TTTSSC
T ss_pred --CC-Cc----cccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC----ccccCC
Confidence 00 00 0111236789999999999999999999999997 998764
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=384.20 Aligned_cols=263 Identities=25% Similarity=0.389 Sum_probs=209.9
Q ss_pred cCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccC---HHHHHHHHHHHhCC-CCCceeeEEEEE
Q 011851 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQG---HKEWLAEVNYLGGL-IHPNLVKLIGCC 196 (476)
Q Consensus 121 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~---~~~~~~E~~~l~~l-~hpnIv~l~~~~ 196 (476)
++|++.+.||+|+||.||+|++. .+++.||||++.+..... .+.+.+|+.+|.++ +||||+++++++
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~ 79 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLK---------KTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCF 79 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEET---------TTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEEC---------CCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEE
Confidence 46999999999999999998654 478889999998654333 34577899999887 899999999999
Q ss_pred EeCCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecC
Q 011851 197 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFG 276 (476)
Q Consensus 197 ~~~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG 276 (476)
.+.+.+||||||+++|+|.+++.+. ..+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||
T Consensus 80 ~~~~~~~lv~e~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG 155 (345)
T 3a8x_A 80 QTESRLFFVIEYVNGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYG 155 (345)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGG
T ss_pred EeCCEEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEecc
Confidence 9999999999999999999999654 46999999999999999999999988 9999999999999999999999999
Q ss_pred CcCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcc--hhHHhhhhhhcc
Q 011851 277 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEH--NLVEWARPQLGE 354 (476)
Q Consensus 277 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~--~~~~~~~~~~~~ 354 (476)
+++....... .....+||+.|+|||++.+..|+.++|||||||++|||++|+.||......... .........+..
T Consensus 156 ~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~ 233 (345)
T 3a8x_A 156 MCKEGLRPGD--TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE 233 (345)
T ss_dssp GCBCSCCTTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHH
T ss_pred ccccccCCCC--cccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHc
Confidence 9986432221 234578999999999999999999999999999999999999999753221110 000000000000
Q ss_pred ccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCH------HHHHHHhcCCCCccccc
Q 011851 355 RRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRM------SEVVEALKPLPYLKDMA 413 (476)
Q Consensus 355 ~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~------~ell~~L~~~~~~~~~~ 413 (476)
..+ .++...+.++.+||.+||+.||++||++ .++++| |||+++.
T Consensus 234 ---------~~~--~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~h----p~f~~~~ 283 (345)
T 3a8x_A 234 ---------KQI--RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH----PFFRNVD 283 (345)
T ss_dssp ---------CCC--CCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTS----GGGTTCC
T ss_pred ---------CCC--CCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcC----CccCCCC
Confidence 000 1222336789999999999999999996 566655 9998764
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-48 Score=393.19 Aligned_cols=260 Identities=26% Similarity=0.342 Sum_probs=206.4
Q ss_pred cCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCcc---CHHHHHHHHHH-HhCCCCCceeeEEEEE
Q 011851 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQ---GHKEWLAEVNY-LGGLIHPNLVKLIGCC 196 (476)
Q Consensus 121 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~---~~~~~~~E~~~-l~~l~hpnIv~l~~~~ 196 (476)
++|++.+.||+|+||.||+|++. .+++.||||++++.... ....+..|..+ ++.++||||+++++++
T Consensus 38 ~~y~~~~~lG~G~fg~V~~~~~~---------~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~ 108 (373)
T 2r5t_A 38 SDFHFLKVIGKGSFGKVLLARHK---------AEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSF 108 (373)
T ss_dssp GGEEEEEEEECCTTCEEEEEEET---------TTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEEc---------CCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEE
Confidence 46999999999999999998654 46788999999765432 23446677776 5778999999999999
Q ss_pred EeCCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecC
Q 011851 197 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFG 276 (476)
Q Consensus 197 ~~~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG 276 (476)
.+.+.+||||||++||+|.+++.+. ..+++..++.++.||+.||+|||+++ |+||||||+||||+.+|.+||+|||
T Consensus 109 ~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG 184 (373)
T 2r5t_A 109 QTADKLYFVLDYINGGELFYHLQRE-RCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFG 184 (373)
T ss_dssp ECSSEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCC
T ss_pred EeCCEEEEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCc
Confidence 9999999999999999999999654 46899999999999999999999988 9999999999999999999999999
Q ss_pred CcCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhcccc
Q 011851 277 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERR 356 (476)
Q Consensus 277 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~ 356 (476)
+++....... .....+||+.|+|||++.+..|+.++|||||||++|||++|..||....... +.. .......
T Consensus 185 ~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~---~~~---~i~~~~~ 256 (373)
T 2r5t_A 185 LCKENIEHNS--TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE---MYD---NILNKPL 256 (373)
T ss_dssp BCGGGBCCCC--CCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHH---HHH---HHHHSCC
T ss_pred cccccccCCC--ccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHH---HHH---HHHhccc
Confidence 9986332221 2345789999999999999999999999999999999999999997543211 111 0010000
Q ss_pred ccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCccccc
Q 011851 357 RFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDMA 413 (476)
Q Consensus 357 ~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~~~ 413 (476)
.++...+.++.+||.+||+.||.+||++.+.++.+..+|||+++.
T Consensus 257 ------------~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~~ 301 (373)
T 2r5t_A 257 ------------QLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLIN 301 (373)
T ss_dssp ------------CCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTTCC
T ss_pred ------------CCCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCccccCCC
Confidence 011223678999999999999999999987777777889998764
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-48 Score=398.61 Aligned_cols=271 Identities=20% Similarity=0.218 Sum_probs=215.3
Q ss_pred hHHHHhccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCc---cCHHHHHHHHHHHhCCCCCcee
Q 011851 114 NELKSATKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL---QGHKEWLAEVNYLGGLIHPNLV 190 (476)
Q Consensus 114 ~~~~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv 190 (476)
.+.....++|++.++||+|+||.||+|++. .+|+.||||++++... .....+.+|+.+|..++||||+
T Consensus 54 ~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~---------~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv 124 (412)
T 2vd5_A 54 KEVRLQRDDFEILKVIGRGAFSEVAVVKMK---------QTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWIT 124 (412)
T ss_dssp HHHSCCGGGEEEEEEEEECSSCEEEEEEET---------TTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBC
T ss_pred hhccCChhhEEEEEEEeeCCCeEEEEEEEC---------CCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCee
Confidence 344445678999999999999999998654 4788999999975322 1223477899999999999999
Q ss_pred eEEEEEEeCCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCce
Q 011851 191 KLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNA 270 (476)
Q Consensus 191 ~l~~~~~~~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~v 270 (476)
+++++|.+.+.+||||||++||+|.+++.+....+++..++.++.||+.||+|||+++ |+||||||+||||+.++.+
T Consensus 125 ~l~~~~~~~~~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~v 201 (412)
T 2vd5_A 125 QLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHI 201 (412)
T ss_dssp CEEEEEECSSEEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCE
T ss_pred eEEEEEeeCCEEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCE
Confidence 9999999999999999999999999999776667999999999999999999999988 9999999999999999999
Q ss_pred EEeecCCcCCCCCCCccceeeeeecCCCCCCcchhh-------cCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcch
Q 011851 271 KLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-------TGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHN 343 (476)
Q Consensus 271 kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~ 343 (476)
||+|||+++....... ......+||+.|+|||++. ...|+.++|||||||++|||++|+.||..........
T Consensus 202 kL~DFGla~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~ 280 (412)
T 2vd5_A 202 RLADFGSCLKLRADGT-VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYG 280 (412)
T ss_dssp EECCCTTCEECCTTSC-EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH
T ss_pred EEeechhheeccCCCc-cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHH
Confidence 9999999987644222 1223468999999999997 3578999999999999999999999997643321111
Q ss_pred hHHhhhhhhccccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCC---CCHHHHHHHhcCCCCcccccCc
Q 011851 344 LVEWARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKAR---PRMSEVVEALKPLPYLKDMASS 415 (476)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~R---Pt~~ell~~L~~~~~~~~~~~~ 415 (476)
.+...... .. -+.. ....+.++.+||.+||. +|.+| |+++++++| |||+++...
T Consensus 281 ~i~~~~~~----~~-----~p~~----~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H----pff~~i~w~ 337 (412)
T 2vd5_A 281 KIVHYKEH----LS-----LPLV----DEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH----PFFFGLDWD 337 (412)
T ss_dssp HHHTHHHH----CC-----CC--------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS----GGGTTCCST
T ss_pred HHHhcccC----cC-----CCcc----ccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC----CCcCCCCHH
Confidence 11100000 00 0100 11226789999999999 99998 589998887 999877543
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-48 Score=396.65 Aligned_cols=266 Identities=23% Similarity=0.280 Sum_probs=213.9
Q ss_pred HHhccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCc---cCHHHHHHHHHHHhCCCCCceeeEE
Q 011851 117 KSATKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL---QGHKEWLAEVNYLGGLIHPNLVKLI 193 (476)
Q Consensus 117 ~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~l~ 193 (476)
....++|++.++||+|+||+||+|++. .+++.||+|++.+... .....+.+|+.+|+.++||||++++
T Consensus 65 ~~~~~~y~~~~~LG~G~fG~V~~~~~~---------~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~ 135 (410)
T 3v8s_A 65 RMKAEDYEVVKVIGRGAFGEVQLVRHK---------STRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 135 (410)
T ss_dssp SCCGGGEEEEEEEEECSSEEEEEEEET---------TTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEE
T ss_pred ccCccccEEEEEEEcCCCEEEEEEEEC---------CCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEE
Confidence 344578999999999999999998654 4788899999965221 2234577899999999999999999
Q ss_pred EEEEeCCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEe
Q 011851 194 GCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLS 273 (476)
Q Consensus 194 ~~~~~~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~ 273 (476)
++|.+++.+|||||||+||+|.+++... .+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+
T Consensus 136 ~~~~~~~~~~lV~E~~~gg~L~~~l~~~--~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~ 210 (410)
T 3v8s_A 136 YAFQDDRYLYMVMEYMPGGDLVNLMSNY--DVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLA 210 (410)
T ss_dssp EEEECSSEEEEEECCCTTEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEEC
T ss_pred EEEEECCEEEEEEeCCCCCcHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEe
Confidence 9999999999999999999999998653 5899999999999999999999988 9999999999999999999999
Q ss_pred ecCCcCCCCCCCccceeeeeecCCCCCCcchhhcCC----CCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhh
Q 011851 274 DFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGH----LTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR 349 (476)
Q Consensus 274 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~ 349 (476)
|||+++...... .......+||+.|+|||++.+.. |+.++|||||||++|||++|+.||...........+....
T Consensus 211 DFG~a~~~~~~~-~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~ 289 (410)
T 3v8s_A 211 DFGTCMKMNKEG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHK 289 (410)
T ss_dssp CCTTCEECCTTS-EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHH
T ss_pred ccceeEeeccCC-cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhcc
Confidence 999998754432 12233578999999999998765 8899999999999999999999997643321111111000
Q ss_pred hhhccccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCC--CCCHHHHHHHhcCCCCcccccCc
Q 011851 350 PQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKA--RPRMSEVVEALKPLPYLKDMASS 415 (476)
Q Consensus 350 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~--RPt~~ell~~L~~~~~~~~~~~~ 415 (476)
... .+ +. ....+.++.+||.+||..+|.+ ||++.||++| |||++....
T Consensus 290 ~~~----~~-----p~-----~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H----p~f~~~~w~ 339 (410)
T 3v8s_A 290 NSL----TF-----PD-----DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH----LFFKNDQWA 339 (410)
T ss_dssp HHC----CC-----CT-----TCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS----GGGCCSSCC
T ss_pred ccc----cC-----CC-----cccccHHHHHHHHHHccChhhhCCCCCHHHHhcC----ccccCCCHH
Confidence 000 00 00 0122678999999999999988 9999999987 999987543
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=395.99 Aligned_cols=260 Identities=22% Similarity=0.309 Sum_probs=211.1
Q ss_pred hccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCcc--CHHHHHHHHHHHhCCCCCceeeEEEEE
Q 011851 119 ATKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQ--GHKEWLAEVNYLGGLIHPNLVKLIGCC 196 (476)
Q Consensus 119 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~l~~~~ 196 (476)
..++|++.+.||+|+||.||+|.+. .+|+.||+|++...... ..+.+.+|+.+|+.++||||+++++++
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~~~---------~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~ 79 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCVKV---------LAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSI 79 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEEET---------TTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEE
T ss_pred ccCCeEEEEEeccCCCeEEEEEEEC---------CCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEE
Confidence 3567999999999999999997654 57888999999765433 245688999999999999999999999
Q ss_pred EeCCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeec---CCCceEEe
Q 011851 197 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLD---GEYNAKLS 273 (476)
Q Consensus 197 ~~~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~---~~~~vkl~ 273 (476)
.+++..|||||||+||+|.+.+... ..+++..+..++.||+.||.|||+++ |+||||||+|||++ .++.+||+
T Consensus 80 ~~~~~~~lv~E~~~gg~L~~~i~~~-~~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~ 155 (444)
T 3soa_A 80 SEEGHHYLIFDLVTGGELFEDIVAR-EYYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLA 155 (444)
T ss_dssp ECSSEEEEEECCCBCCBHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEEC
T ss_pred EECCEEEEEEEeCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEc
Confidence 9999999999999999999999654 56999999999999999999999988 99999999999998 56789999
Q ss_pred ecCCcCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhc
Q 011851 274 DFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLG 353 (476)
Q Consensus 274 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~ 353 (476)
|||++........ .....+||+.|+|||++.+..|+.++|||||||++|+|++|..||....... +......
T Consensus 156 DFG~a~~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~---~~~~i~~--- 227 (444)
T 3soa_A 156 DFGLAIEVEGEQQ--AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHR---LYQQIKA--- 227 (444)
T ss_dssp CCSSCBCCCTTCC--BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHH---
T ss_pred cCceeEEecCCCc--eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHH---HHHHHHh---
Confidence 9999987654322 2234689999999999999999999999999999999999999997543211 1111100
Q ss_pred cccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCccc
Q 011851 354 ERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKD 411 (476)
Q Consensus 354 ~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~ 411 (476)
.. .....+.+. ..+.++.+||.+||+.||++|||+.++++| ||++.
T Consensus 228 ~~---~~~~~~~~~-----~~s~~~~~li~~~L~~dP~~Rpta~e~L~h----p~~~~ 273 (444)
T 3soa_A 228 GA---YDFPSPEWD-----TVTPEAKDLINKMLTINPSKRITAAEALKH----PWISH 273 (444)
T ss_dssp TC---CCCCTTTTT-----TSCHHHHHHHHHHSCSSTTTSCCHHHHHHS----CTTHH
T ss_pred CC---CCCCccccc-----cCCHHHHHHHHHHcCCChhHCCCHHHHhcC----ccccC
Confidence 00 011111111 226789999999999999999999999998 99974
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-48 Score=386.85 Aligned_cols=253 Identities=25% Similarity=0.335 Sum_probs=209.1
Q ss_pred ccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCC---ccCHHHHHHHHHHHhCCCCCceeeEEEEE
Q 011851 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDG---LQGHKEWLAEVNYLGGLIHPNLVKLIGCC 196 (476)
Q Consensus 120 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~ 196 (476)
.++|++.+.||+|+||.||+|.+. .+++.||||++.... ......+.+|+.+|+.++||||+++++++
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~ 78 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHY---------KTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVI 78 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEET---------TTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEEC---------CCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 457999999999999999998654 478889999986532 12235788999999999999999999999
Q ss_pred EeCCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecC
Q 011851 197 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFG 276 (476)
Q Consensus 197 ~~~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG 276 (476)
.+.+..||||||+ +|+|.+++... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 79 ~~~~~~~lv~E~~-~g~l~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG 153 (336)
T 3h4j_B 79 TTPTDIVMVIEYA-GGELFDYIVEK-KRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFG 153 (336)
T ss_dssp ECSSEEEEEECCC-CEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSS
T ss_pred EeCCEEEEEEECC-CCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEec
Confidence 9999999999999 78999988654 46999999999999999999999998 9999999999999999999999999
Q ss_pred CcCCCCCCCccceeeeeecCCCCCCcchhhcCCC-CccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhccc
Q 011851 277 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHL-TAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGER 355 (476)
Q Consensus 277 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~ 355 (476)
++........ ....+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||...........+
T Consensus 154 ~s~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i---------- 220 (336)
T 3h4j_B 154 LSNIMTDGNF---LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKV---------- 220 (336)
T ss_dssp CTBTTTTSBT---TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCC----------
T ss_pred cceeccCCcc---cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHH----------
Confidence 9987644322 234689999999999988876 78999999999999999999999764332211110
Q ss_pred cccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCccc
Q 011851 356 RRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKD 411 (476)
Q Consensus 356 ~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~ 411 (476)
... ...++...+.++.+||.+||+.||.+|||+.|+++| |||+.
T Consensus 221 -------~~~-~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h----p~~~~ 264 (336)
T 3h4j_B 221 -------NSC-VYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRD----PWFNV 264 (336)
T ss_dssp -------CSS-CCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTC----HHHHT
T ss_pred -------HcC-CCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhC----hhhcc
Confidence 000 001122236788999999999999999999999987 88764
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-48 Score=374.89 Aligned_cols=272 Identities=24% Similarity=0.314 Sum_probs=206.3
Q ss_pred cCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCcc--CHHHHHHHHHHHhCCCCCceeeEEEEEEe
Q 011851 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQ--GHKEWLAEVNYLGGLIHPNLVKLIGCCIE 198 (476)
Q Consensus 121 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~l~~~~~~ 198 (476)
++|++.+.||+|+||.||+|.+. +|+.||+|++...... ....+.+|+.+|++++||||+++++++.+
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~----------~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 71 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNN----------YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHT 71 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET----------TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcC----------CCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEcc
Confidence 47999999999999999998653 5778999999754322 23678899999999999999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCc
Q 011851 199 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLA 278 (476)
Q Consensus 199 ~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a 278 (476)
.+..|+||||+++ +|.+++......+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 72 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 147 (288)
T 1ob3_A 72 KKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLA 147 (288)
T ss_dssp SSCEEEEEECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHH
T ss_pred CCeEEEEEEecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccc
Confidence 9999999999965 999999776678999999999999999999999988 999999999999999999999999999
Q ss_pred CCCCCCCccceeeeeecCCCCCCcchhhcC-CCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhH-Hhhhh-hhccc
Q 011851 279 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV-EWARP-QLGER 355 (476)
Q Consensus 279 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~-~~~~~-~~~~~ 355 (476)
+...... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||...........+ ..... .....
T Consensus 148 ~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 225 (288)
T 1ob3_A 148 RAFGIPV--RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNW 225 (288)
T ss_dssp HHHCC-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred cccCccc--cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhc
Confidence 7643211 112335789999999999764 6899999999999999999999999764322111100 00000 00000
Q ss_pred ccccc--ccCccc-------CCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCcccc
Q 011851 356 RRFYR--LIDPCL-------EGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDM 412 (476)
Q Consensus 356 ~~~~~--~~d~~l-------~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~~ 412 (476)
..... ..++.. ...+....+.++.+||.+||+.||++|||+.++++| |||++.
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h----p~f~~~ 287 (288)
T 1ob3_A 226 PNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH----AYFKEN 287 (288)
T ss_dssp TTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS----GGGGC-
T ss_pred hhhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC----cchhhc
Confidence 00000 000000 001111236788999999999999999999999997 998753
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=388.20 Aligned_cols=255 Identities=25% Similarity=0.342 Sum_probs=206.2
Q ss_pred cccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCCCCCceeeEEEEEEeCCeeEEE
Q 011851 126 ECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHPNLVKLIGCCIEDDQRLLV 205 (476)
Q Consensus 126 ~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV 205 (476)
.+.||+|+||.||+|.+. .+|+.||+|+++.......+.+.+|+++|++++||||+++++++.+.+.+|||
T Consensus 94 ~~~lG~G~~g~Vy~a~~~---------~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 164 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEET---------ATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLV 164 (373)
T ss_dssp EEECC-----CEEEEEET---------TTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ceEEecCcCEEEEEEEEc---------CCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence 578999999999998654 46888999999877655667889999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeee--cCCCceEEeecCCcCCCCC
Q 011851 206 YEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILL--DGEYNAKLSDFGLAKDGPE 283 (476)
Q Consensus 206 ~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl--~~~~~vkl~DFG~a~~~~~ 283 (476)
|||+++++|.+++......+++..++.++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||+++....
T Consensus 165 ~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~ 241 (373)
T 2x4f_A 165 MEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKP 241 (373)
T ss_dssp EECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCT
T ss_pred EeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCC
Confidence 9999999999999776667999999999999999999999988 9999999999999 6678999999999987654
Q ss_pred CCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhccccccccccC
Q 011851 284 GDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRRFYRLID 363 (476)
Q Consensus 284 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 363 (476)
... ....+||+.|+|||++.+..++.++|||||||++|||++|+.||......... ..+... .. .+..
T Consensus 242 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~--~~i~~~----~~---~~~~ 309 (373)
T 2x4f_A 242 REK---LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETL--NNILAC----RW---DLED 309 (373)
T ss_dssp TCB---CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH--HHHHHT----CC---CSCS
T ss_pred ccc---cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHH--HHHHhc----cC---CCCh
Confidence 332 22357999999999999999999999999999999999999999764322111 111100 00 0001
Q ss_pred cccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCccccc
Q 011851 364 PCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDMA 413 (476)
Q Consensus 364 ~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~~~ 413 (476)
... ...+.++.+||.+||+.||.+|||+.++++| |||++..
T Consensus 310 ~~~-----~~~~~~~~~li~~~L~~dp~~Rps~~e~l~h----p~~~~~~ 350 (373)
T 2x4f_A 310 EEF-----QDISEEAKEFISKLLIKEKSWRISASEALKH----PWLSDHK 350 (373)
T ss_dssp GGG-----TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS----HHHHCHH
T ss_pred hhh-----ccCCHHHHHHHHHHcCCChhhCCCHHHHhcC----cCcCCCc
Confidence 111 1225789999999999999999999999998 9988653
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-48 Score=382.39 Aligned_cols=259 Identities=26% Similarity=0.378 Sum_probs=203.7
Q ss_pred cCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCc----cCHHHHHHHHHHHhCCCCCceeeEEEEE
Q 011851 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL----QGHKEWLAEVNYLGGLIHPNLVKLIGCC 196 (476)
Q Consensus 121 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~----~~~~~~~~E~~~l~~l~hpnIv~l~~~~ 196 (476)
++|++.+.||+|+||.||+|++.. ...+|+.||||+++.... .....+.+|+.+|+.++||||+++++++
T Consensus 17 ~~y~~~~~lG~G~~g~V~~~~~~~------~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 90 (327)
T 3a62_A 17 ECFELLRVLGKGGYGKVFQVRKVT------GANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAF 90 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECS------STTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEE
T ss_pred HHeEEEEEEEeCCCEEEEEEEEec------cCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEE
Confidence 469999999999999999997642 235788999999976532 2334577899999999999999999999
Q ss_pred EeCCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecC
Q 011851 197 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFG 276 (476)
Q Consensus 197 ~~~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG 276 (476)
.+++.+||||||+++++|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||
T Consensus 91 ~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg 166 (327)
T 3a62_A 91 QTGGKLYLILEYLSGGELFMQLERE-GIFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFG 166 (327)
T ss_dssp ECSSCEEEEEECCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCS
T ss_pred EcCCEEEEEEeCCCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCC
Confidence 9999999999999999999999654 46899999999999999999999988 9999999999999999999999999
Q ss_pred CcCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhcccc
Q 011851 277 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERR 356 (476)
Q Consensus 277 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~ 356 (476)
+++....... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||....... .... ......
T Consensus 167 ~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~~~~---i~~~~~ 238 (327)
T 3a62_A 167 LCKESIHDGT--VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKK---TIDK---ILKCKL 238 (327)
T ss_dssp CC------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHH---HHHTCC
T ss_pred cccccccCCc--cccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHH---HHHH---HHhCCC
Confidence 9976432211 2234689999999999999999999999999999999999999997543211 1110 000000
Q ss_pred ccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHhcCCCCccccc
Q 011851 357 RFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARP-----RMSEVVEALKPLPYLKDMA 413 (476)
Q Consensus 357 ~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RP-----t~~ell~~L~~~~~~~~~~ 413 (476)
.++...+.++.+||.+||+.||++|| ++.++++| |||++..
T Consensus 239 ------------~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~h----p~f~~~~ 284 (327)
T 3a62_A 239 ------------NLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAH----PFFRHIN 284 (327)
T ss_dssp ------------CCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHS----GGGSSCC
T ss_pred ------------CCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcC----CcccCCC
Confidence 01122367899999999999999999 78899887 9998754
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=398.02 Aligned_cols=275 Identities=22% Similarity=0.316 Sum_probs=192.7
Q ss_pred ccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCc--cCHHHHHHHHHHHhCCCCCceeeEEEEEE
Q 011851 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL--QGHKEWLAEVNYLGGLIHPNLVKLIGCCI 197 (476)
Q Consensus 120 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~ 197 (476)
.++|++.++||+|+||+||+|.+. .+|+.||||++..... ...+++.+|+.+|++++||||+++++++.
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~---------~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 122 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDK---------LEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVI 122 (458)
T ss_dssp CTTEEECCC-------CEEEEEEC---------C--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECC
T ss_pred CCCeEEeeEeeecCCeEEEEEEEC---------CCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEe
Confidence 357999999999999999998654 4688899999965432 23467889999999999999999999985
Q ss_pred eC-----CeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEE
Q 011851 198 ED-----DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKL 272 (476)
Q Consensus 198 ~~-----~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl 272 (476)
.. ..+||||||+ +++|.+++. ....+++..++.++.||+.||.|||+.+ ||||||||+||||+.++.+||
T Consensus 123 ~~~~~~~~~~~lv~e~~-~~~L~~~~~-~~~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl 197 (458)
T 3rp9_A 123 PKDVEKFDELYVVLEIA-DSDFKKLFR-TPVYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKV 197 (458)
T ss_dssp CSCTTTCCCEEEEECCC-SEEHHHHHH-SSCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEE
T ss_pred cCCcccCceEEEEEecc-ccchhhhcc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEee
Confidence 43 5789999998 579998884 4467999999999999999999999988 999999999999999999999
Q ss_pred eecCCcCCCCCCCcc-------------------------ceeeeeecCCCCCCcchhh-cCCCCccchhhhhHHHHHHH
Q 011851 273 SDFGLAKDGPEGDKT-------------------------HVSTRVMGTYGYAAPEYVM-TGHLTAKSDVYSFGVVLLEM 326 (476)
Q Consensus 273 ~DFG~a~~~~~~~~~-------------------------~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslGv~l~el 326 (476)
+|||+++........ ...+..+||+.|+|||++. +..|+.++|||||||+||||
T Consensus 198 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~el 277 (458)
T 3rp9_A 198 CDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAEL 277 (458)
T ss_dssp CCCTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHH
T ss_pred cccccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHH
Confidence 999999875422110 1234468999999999864 56799999999999999999
Q ss_pred Hh-----------CCCCCCCCCCCCc-----------------chhHHhhhhhhcc-------------ccccccccC--
Q 011851 327 LT-----------GRRSMDKNRPNGE-----------------HNLVEWARPQLGE-------------RRRFYRLID-- 363 (476)
Q Consensus 327 lt-----------G~~pf~~~~~~~~-----------------~~~~~~~~~~~~~-------------~~~~~~~~d-- 363 (476)
++ |+++|.+...... .+........++. ...+...+.
T Consensus 278 ltg~~~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~ 357 (458)
T 3rp9_A 278 LNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKR 357 (458)
T ss_dssp HTTSTTTCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCC
T ss_pred HHhccccccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCC
Confidence 99 5666654321100 0000000000000 000000000
Q ss_pred --cccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCccccc
Q 011851 364 --PCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDMA 413 (476)
Q Consensus 364 --~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~~~ 413 (476)
..+...+ ...+.++.+||.+||..||++|||+.|+|+| |||++..
T Consensus 358 ~~~~~~~~~-~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~H----p~f~~~~ 404 (458)
T 3rp9_A 358 EGTDLAERF-PASSADAIHLLKRMLVFNPNKRITINECLAH----PFFKEVR 404 (458)
T ss_dssp CCCCGGGGS-TTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS----GGGTTTC
T ss_pred CCCCHHHHC-CCCCHHHHHHHHHHhccCccccCCHHHHhcC----HhhhhcC
Confidence 0001111 1226789999999999999999999999998 9998764
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-47 Score=377.42 Aligned_cols=276 Identities=24% Similarity=0.345 Sum_probs=198.1
Q ss_pred ccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCcc-CHHHHHHHHHHHhCCCCCceeeEEEEEEe
Q 011851 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQ-GHKEWLAEVNYLGGLIHPNLVKLIGCCIE 198 (476)
Q Consensus 120 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~~ 198 (476)
.++|++.+.||+|+||.||+|.+. .+|+.||||+++..... ....+.+|+.+|++++||||+++++++.+
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 74 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNK---------TTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHT 74 (317)
T ss_dssp ---------------CEEEEEECS---------SSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECC
T ss_pred ccceeEeeEECCCCCEEEEEEEEC---------CCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEE
Confidence 457999999999999999998654 47888999999765432 34678899999999999999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHHhhc-----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEe
Q 011851 199 DDQRLLVYEFMPRGSLENHLFRR-----SLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLS 273 (476)
Q Consensus 199 ~~~~~lV~E~~~~g~L~~~l~~~-----~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~ 273 (476)
++.+||||||++ ++|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+
T Consensus 75 ~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~ 150 (317)
T 2pmi_A 75 ENKLTLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLG 150 (317)
T ss_dssp TTEEEEEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEEC
T ss_pred CCeEEEEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEEC
Confidence 999999999997 5999988643 245899999999999999999999988 9999999999999999999999
Q ss_pred ecCCcCCCCCCCccceeeeeecCCCCCCcchhhcC-CCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhh-
Q 011851 274 DFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQ- 351 (476)
Q Consensus 274 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~- 351 (476)
|||+++....... .....+||+.|+|||++.+. .++.++|||||||++|||++|+.||...........+......
T Consensus 151 Dfg~~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~ 228 (317)
T 2pmi_A 151 DFGLARAFGIPVN--TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTP 228 (317)
T ss_dssp CCSSCEETTSCCC--CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSC
T ss_pred cCccceecCCCcc--cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence 9999986543221 12345799999999999864 6899999999999999999999999765432211111000000
Q ss_pred -------hccccccccccCc--------ccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCcccccC
Q 011851 352 -------LGERRRFYRLIDP--------CLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDMAS 414 (476)
Q Consensus 352 -------~~~~~~~~~~~d~--------~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~~~~ 414 (476)
......+...+.. .+........+.++.+||.+||+.||++|||+.++++| |||++...
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h----p~f~~~~~ 302 (317)
T 2pmi_A 229 NESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH----PWFAEYYH 302 (317)
T ss_dssp CTTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTS----GGGGGGCC
T ss_pred ChhHhhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCC----hhhhcccc
Confidence 0000000000000 00000011225689999999999999999999999987 99987654
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=380.78 Aligned_cols=260 Identities=25% Similarity=0.417 Sum_probs=209.4
Q ss_pred ccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCc-cCHHHHHHHHHHHhCCCCCceeeEEEEEEe
Q 011851 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL-QGHKEWLAEVNYLGGLIHPNLVKLIGCCIE 198 (476)
Q Consensus 120 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~ 198 (476)
.++|++.+.||+|+||.||+|.+...+ ..+..||||+++.... ...+.+.+|+.+|++++||||+++++++.+
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 121 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPG------QRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTR 121 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTT------SCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECG
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCC------CCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEe
Confidence 356999999999999999999876332 2456699999976533 234578899999999999999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCc
Q 011851 199 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLA 278 (476)
Q Consensus 199 ~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a 278 (476)
.+..||||||+++++|.+++......+++..++.++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||++
T Consensus 122 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a 198 (325)
T 3kul_A 122 GRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLS 198 (325)
T ss_dssp GGCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSC
T ss_pred CCccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCcc
Confidence 99999999999999999999777678999999999999999999999988 999999999999999999999999999
Q ss_pred CCCCCCCcc-ceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhhcccc
Q 011851 279 KDGPEGDKT-HVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPQLGERR 356 (476)
Q Consensus 279 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~ 356 (476)
+........ .......+|+.|+|||++.+..++.++|||||||++|||++ |..||....... ....... ..
T Consensus 199 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~---~~~~~~~----~~ 271 (325)
T 3kul_A 199 RVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRD---VISSVEE----GY 271 (325)
T ss_dssp EECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH---HHHHHHT----TC
T ss_pred cccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHH---HHHHHHc----CC
Confidence 876443221 11223456788999999999999999999999999999999 999997543221 1111100 00
Q ss_pred ccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 011851 357 RFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKP 405 (476)
Q Consensus 357 ~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~ 405 (476)
....+...+..+.+||.+||..||++|||+.+|++.|+.
T Consensus 272 ----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~ 310 (325)
T 3kul_A 272 ----------RLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDA 310 (325)
T ss_dssp ----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ----------CCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 001122336789999999999999999999999998764
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-48 Score=386.70 Aligned_cols=259 Identities=24% Similarity=0.320 Sum_probs=209.1
Q ss_pred cCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCC-----ccCHHHHHHHHHHHhCCCCCceeeEEEE
Q 011851 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDG-----LQGHKEWLAEVNYLGGLIHPNLVKLIGC 195 (476)
Q Consensus 121 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~-----~~~~~~~~~E~~~l~~l~hpnIv~l~~~ 195 (476)
++|++.+.||+|+||+||+|.+. .+|+.||||++.... ....+.+.+|+.+|+.++||||++++++
T Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~---------~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~ 94 (351)
T 3c0i_A 24 DVYELCEVIGKGPFSVVRRCINR---------ETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLET 94 (351)
T ss_dssp HHEEEEEEEEECSSEEEEEEEET---------TTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cceEEeeEEeeCCCEEEEEEEEC---------CCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEE
Confidence 46999999999999999998654 478889999986422 2245678999999999999999999999
Q ss_pred EEeCCeeEEEEEecCCCCHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCc---
Q 011851 196 CIEDDQRLLVYEFMPRGSLENHLFRR---SLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYN--- 269 (476)
Q Consensus 196 ~~~~~~~~lV~E~~~~g~L~~~l~~~---~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~--- 269 (476)
+.+++.+|||||||++++|.+++... ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.
T Consensus 95 ~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~ 171 (351)
T 3c0i_A 95 YSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAP 171 (351)
T ss_dssp EEETTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCC
T ss_pred EEeCCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCc
Confidence 99999999999999999999888643 346899999999999999999999988 999999999999976654
Q ss_pred eEEeecCCcCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhh
Q 011851 270 AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR 349 (476)
Q Consensus 270 vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~ 349 (476)
+||+|||+++....... .....+||+.|+|||++.+..|+.++|||||||++|+|++|+.||..... .+....
T Consensus 172 vkl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~----~~~~~i- 244 (351)
T 3c0i_A 172 VKLGGFGVAIQLGESGL--VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE----RLFEGI- 244 (351)
T ss_dssp EEECCCTTCEECCTTSC--BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH----HHHHHH-
T ss_pred EEEecCcceeEecCCCe--eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH----HHHHHH-
Confidence 99999999987654322 23346899999999999999999999999999999999999999975321 111100
Q ss_pred hhhccccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCcccc
Q 011851 350 PQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDM 412 (476)
Q Consensus 350 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~~ 412 (476)
...... .....+ ...+.++.+||.+||+.||++|||+.++++| ||++..
T Consensus 245 --~~~~~~---~~~~~~-----~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h----p~~~~~ 293 (351)
T 3c0i_A 245 --IKGKYK---MNPRQW-----SHISESAKDLVRRMLMLDPAERITVYEALNH----PWLKER 293 (351)
T ss_dssp --HHTCCC---CCHHHH-----TTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS----HHHHTH
T ss_pred --HcCCCC---CCcccc-----ccCCHHHHHHHHHHCCCChhHCcCHHHHhcC----hhhcCC
Confidence 000000 000000 0125788999999999999999999999997 888753
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-48 Score=376.39 Aligned_cols=255 Identities=24% Similarity=0.345 Sum_probs=201.1
Q ss_pred ccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCcc--------------------------CHHH
Q 011851 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQ--------------------------GHKE 173 (476)
Q Consensus 120 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~--------------------------~~~~ 173 (476)
.++|++.+.||+|+||.||+|++. .+++.||||++...... ..+.
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~---------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNE---------NDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQ 82 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEET---------TTTEEEEEEEEECC-------------------------------CH
T ss_pred ecceEEEeEEeecCCEEEEEEEEC---------CCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHH
Confidence 357999999999999999998654 46788999999764321 1246
Q ss_pred HHHHHHHHhCCCCCceeeEEEEEEe--CCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC
Q 011851 174 WLAEVNYLGGLIHPNLVKLIGCCIE--DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKP 251 (476)
Q Consensus 174 ~~~E~~~l~~l~hpnIv~l~~~~~~--~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ 251 (476)
+.+|+++|++++||||+++++++.+ .+.+||||||+++++|.+++. ...+++..++.++.||+.||.|||+++
T Consensus 83 ~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~--- 157 (298)
T 2zv2_A 83 VYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT--LKPLSEDQARFYFQDLIKGIEYLHYQK--- 157 (298)
T ss_dssp HHHHHHHHHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC--SSCCCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHHHHHHHHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---
Confidence 8899999999999999999999987 568999999999999987653 347999999999999999999999988
Q ss_pred eEecCCCCCCeeecCCCceEEeecCCcCCCCCCCccceeeeeecCCCCCCcchhhcCC---CCccchhhhhHHHHHHHHh
Q 011851 252 VIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGH---LTAKSDVYSFGVVLLEMLT 328 (476)
Q Consensus 252 ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DiwslGv~l~ellt 328 (476)
|+||||||+|||++.++.+||+|||+++....... ......||+.|+|||++.+.. ++.++|||||||++|+|++
T Consensus 158 ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~ 235 (298)
T 2zv2_A 158 IIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDA--LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVF 235 (298)
T ss_dssp EECCCCCGGGEEECTTSCEEECCCTTCEECSSSSC--EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHH
T ss_pred eeccCCCHHHEEECCCCCEEEecCCCccccccccc--cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHH
Confidence 99999999999999999999999999987544322 233468999999999998765 4788999999999999999
Q ss_pred CCCCCCCCCCCCcchhHHhhhhhhccccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCC
Q 011851 329 GRRSMDKNRPNGEHNLVEWARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPY 408 (476)
Q Consensus 329 G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~ 408 (476)
|+.||...... .+.... ...... . + .....+.++.+||.+||+.||++|||+.++++| ||
T Consensus 236 g~~pf~~~~~~---~~~~~~---~~~~~~---~--~-----~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~h----p~ 295 (298)
T 2zv2_A 236 GQCPFMDERIM---CLHSKI---KSQALE---F--P-----DQPDIAEDLKDLITRMLDKNPESRIVVPEIKLH----PW 295 (298)
T ss_dssp SSCSSCCSSHH---HHHHHH---HHCCCC---C--C-----SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTC----HH
T ss_pred CCCCCCCccHH---HHHHHH---hcccCC---C--C-----CccccCHHHHHHHHHHhhcChhhCCCHHHHhcC----cc
Confidence 99999754211 111100 000000 0 0 011225789999999999999999999999887 87
Q ss_pred cc
Q 011851 409 LK 410 (476)
Q Consensus 409 ~~ 410 (476)
|.
T Consensus 296 ~~ 297 (298)
T 2zv2_A 296 VT 297 (298)
T ss_dssp HH
T ss_pred cc
Confidence 64
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-47 Score=386.95 Aligned_cols=258 Identities=23% Similarity=0.357 Sum_probs=210.3
Q ss_pred ccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCcc--CHHHHHHHHHHHhCCCCCceeeEEEEEE
Q 011851 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQ--GHKEWLAEVNYLGGLIHPNLVKLIGCCI 197 (476)
Q Consensus 120 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~l~~~~~ 197 (476)
.++|++.+.||+|+||.||+|.+. .+|+.||+|++...... ..+.+.+|+.+|++++||||+++++++.
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~---------~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~ 98 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHK---------TTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQ 98 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEET---------TTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred ccCeEEeeEEecCCCeEEEEEEEC---------CCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence 457999999999999999998654 47888999999765432 3456889999999999999999999999
Q ss_pred eCCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCC---CceEEee
Q 011851 198 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGE---YNAKLSD 274 (476)
Q Consensus 198 ~~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~---~~vkl~D 274 (476)
+++..||||||+++++|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.+ +.+||+|
T Consensus 99 ~~~~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~D 174 (362)
T 2bdw_A 99 EESFHYLVFDLVTGGELFEDIVAR-EFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLAD 174 (362)
T ss_dssp CSSEEEEEECCCCSCBHHHHHTTC-SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECC
T ss_pred eCCEEEEEEecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEee
Confidence 999999999999999999998544 57999999999999999999999988 9999999999999765 4599999
Q ss_pred cCCcCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhcc
Q 011851 275 FGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGE 354 (476)
Q Consensus 275 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~ 354 (476)
||++........ ....+||+.|+|||++.+..|+.++|||||||++|+|++|..||...... .+.......
T Consensus 175 fG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~---~~~~~i~~~--- 245 (362)
T 2bdw_A 175 FGLAIEVNDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH---RLYAQIKAG--- 245 (362)
T ss_dssp CTTCBCCTTCCS---CCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHT---
T ss_pred cCcceEecCCcc---cccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH---HHHHHHHhC---
Confidence 999987654322 23468999999999999999999999999999999999999999754321 111111000
Q ss_pred ccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCccc
Q 011851 355 RRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKD 411 (476)
Q Consensus 355 ~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~ 411 (476)
. .....+.+ ...+.++.+||.+||+.||++|||+.++++| ||+..
T Consensus 246 ~---~~~~~~~~-----~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h----p~~~~ 290 (362)
T 2bdw_A 246 A---YDYPSPEW-----DTVTPEAKSLIDSMLTVNPKKRITADQALKV----PWICN 290 (362)
T ss_dssp C---CCCCTTGG-----GGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS----HHHHT
T ss_pred C---CCCCcccc-----cCCCHHHHHHHHHHcCCChhhCcCHHHHhcC----cccCC
Confidence 0 00001111 1225788999999999999999999999987 88864
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-48 Score=382.18 Aligned_cols=270 Identities=27% Similarity=0.355 Sum_probs=206.5
Q ss_pred ccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCCCCCceeeEEEEEEeC
Q 011851 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHPNLVKLIGCCIED 199 (476)
Q Consensus 120 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~ 199 (476)
.++|++.++||+|+||+||+|.+. ++.||||++..... .......|+.+|++++||||+++++++.+.
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~-----------~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 90 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLL-----------NEYVAVKIFPIQDK-QSWQNEYEVYSLPGMKHENILQFIGAEKRG 90 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEET-----------TEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEE
T ss_pred hhhchhhheecccCceEEEEEEEC-----------CCEEEEEEeecCch-HHHHHHHHHHHHhcCCCCCchhhcceeccC
Confidence 457999999999999999999653 57899999975432 233456689999999999999999999885
Q ss_pred C----eeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhc----------CCCCeEecCCCCCCeeec
Q 011851 200 D----QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEE----------AEKPVIYRDFKTSNILLD 265 (476)
Q Consensus 200 ~----~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~----------~~~~ivHrDlKp~NILl~ 265 (476)
. .+||||||+++|+|.+++... .+++..++.++.||+.||.|||+. + |+||||||+|||++
T Consensus 91 ~~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~---ivH~Dlkp~Nill~ 165 (322)
T 3soc_A 91 TSVDVDLWLITAFHEKGSLSDFLKAN--VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA---ISHRDIKSKNVLLK 165 (322)
T ss_dssp CSSSEEEEEEEECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE---EECSCCSGGGEEEC
T ss_pred CCCCceEEEEEecCCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC---EEeCCCChHhEEEC
Confidence 4 479999999999999999654 499999999999999999999997 6 99999999999999
Q ss_pred CCCceEEeecCCcCCCCCCCccceeeeeecCCCCCCcchhhcC-----CCCccchhhhhHHHHHHHHhCCCCCCCCCCCC
Q 011851 266 GEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-----HLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNG 340 (476)
Q Consensus 266 ~~~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DiwslGv~l~elltG~~pf~~~~~~~ 340 (476)
.++.+||+|||+++..............+||+.|+|||++.+. .++.++|||||||++|||++|+.||.......
T Consensus 166 ~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~ 245 (322)
T 3soc_A 166 NNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEY 245 (322)
T ss_dssp TTCCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCC
T ss_pred CCCeEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchh
Confidence 9999999999999765443332223346799999999999873 45678999999999999999999998654433
Q ss_pred cchhHHhhhh--hhcc--ccccccccCcccCCC-CChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011851 341 EHNLVEWARP--QLGE--RRRFYRLIDPCLEGC-FSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPL 406 (476)
Q Consensus 341 ~~~~~~~~~~--~~~~--~~~~~~~~d~~l~~~-~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~ 406 (476)
.......... .... .........+.+... .....+.++.+||.+||+.||++|||+.+|++.|+.+
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l 316 (322)
T 3soc_A 246 MLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQM 316 (322)
T ss_dssp CCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ccchhhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 2222111000 0000 000001111111111 1224467799999999999999999999999997654
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-48 Score=399.56 Aligned_cols=257 Identities=28% Similarity=0.368 Sum_probs=203.7
Q ss_pred ccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCC---CccCHHHHHHHHHHHhCCCCCceeeEEEEE
Q 011851 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHD---GLQGHKEWLAEVNYLGGLIHPNLVKLIGCC 196 (476)
Q Consensus 120 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~ 196 (476)
.++|++.++||+|+||.||+|.+. .+|+.||||++... .......+.+|+.+|+.++||||+++++++
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~ 217 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEK---------ATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSF 217 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET---------TTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEc---------CCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEE
Confidence 356999999999999999998654 57888999999753 223345677899999999999999999999
Q ss_pred EeCCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCCeeecCCCceEEeec
Q 011851 197 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHE-EAEKPVIYRDFKTSNILLDGEYNAKLSDF 275 (476)
Q Consensus 197 ~~~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~-~~~~~ivHrDlKp~NILl~~~~~vkl~DF 275 (476)
.+.+.+||||||+++++|.+++... ..+++..+..++.||+.||+|||+ .+ |+||||||+||||+.++.+||+||
T Consensus 218 ~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DF 293 (446)
T 4ejn_A 218 QTHDRLCFVMEYANGGELFFHLSRE-RVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDF 293 (446)
T ss_dssp EETTEEEEEECCCSSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCC
T ss_pred eeCCEEEEEEeeCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccC
Confidence 9999999999999999999998654 479999999999999999999998 77 999999999999999999999999
Q ss_pred CCcCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhccc
Q 011851 276 GLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGER 355 (476)
Q Consensus 276 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~ 355 (476)
|+++....... .....+||+.|+|||++.+..|+.++|||||||++|||++|+.||...........+ ....
T Consensus 294 G~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i------~~~~ 365 (446)
T 4ejn_A 294 GLCKEGIKDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI------LMEE 365 (446)
T ss_dssp CCCCTTCC-------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH------HHCC
T ss_pred CCceeccCCCc--ccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHH------HhCC
Confidence 99986433222 233478999999999999999999999999999999999999999754322111111 1111
Q ss_pred cccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHhcCCCCccccc
Q 011851 356 RRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARP-----RMSEVVEALKPLPYLKDMA 413 (476)
Q Consensus 356 ~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RP-----t~~ell~~L~~~~~~~~~~ 413 (476)
.. ++...+.++.+||.+||+.||++|| ++.++++| |||+++.
T Consensus 366 ~~------------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~h----p~f~~~~ 412 (446)
T 4ejn_A 366 IR------------FPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQH----RFFAGIV 412 (446)
T ss_dssp CC------------CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS----GGGTTCC
T ss_pred CC------------CCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhC----ccccCCC
Confidence 11 1222357899999999999999999 99999987 9999864
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-47 Score=383.80 Aligned_cols=259 Identities=21% Similarity=0.273 Sum_probs=199.8
Q ss_pred ccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCCCCCceeeEEEEEEeC
Q 011851 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHPNLVKLIGCCIED 199 (476)
Q Consensus 120 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~ 199 (476)
.++|++.+.||+|+||+||+|.+. .+++.||||++...... .+.+.+|+.+++.++||||+++++++.+.
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~---------~~~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 88 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDK---------LTKELVAVKYIERGAAI-DENVQREIINHRSLRHPNIVRFKEVILTP 88 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEET---------TTCCEEEEEEEESSTTS-CHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred CCcEEEEEEeccCCCEEEEEEEEC---------CCCcEEEEEEEecCccc-cHHHHHHHHHHHhCCCCCCCcEEEEEeeC
Confidence 457999999999999999998654 47888999999765433 36688999999999999999999999999
Q ss_pred CeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCc--eEEeecCC
Q 011851 200 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYN--AKLSDFGL 277 (476)
Q Consensus 200 ~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~--vkl~DFG~ 277 (476)
+.+||||||+++|+|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+||||+.++. +||+|||+
T Consensus 89 ~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~ 164 (361)
T 3uc3_A 89 THLAIIMEYASGGELYERICNA-GRFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGY 164 (361)
T ss_dssp SEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCC
T ss_pred CEEEEEEEeCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCc
Confidence 9999999999999999998554 46999999999999999999999988 999999999999987765 99999999
Q ss_pred cCCCCCCCccceeeeeecCCCCCCcchhhcCCCCcc-chhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhcccc
Q 011851 278 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAK-SDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERR 356 (476)
Q Consensus 278 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~ 356 (476)
++...... .....+||+.|+|||++.+..++.+ +|||||||++|+|++|+.||............ .........
T Consensus 165 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~--~~~~~~~~~ 239 (361)
T 3uc3_A 165 SKSSVLHS---QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKT--IQRILSVKY 239 (361)
T ss_dssp C------------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHH--HHHHHTTCC
T ss_pred cccccccC---CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHH--HHHHhcCCC
Confidence 97533221 1234679999999999998888766 89999999999999999999765443222111 111110000
Q ss_pred ccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCccc
Q 011851 357 RFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKD 411 (476)
Q Consensus 357 ~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~ 411 (476)
.+. .....+.++.+||.+||+.||++|||+.++++| |||..
T Consensus 240 ~~~----------~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h----p~f~~ 280 (361)
T 3uc3_A 240 SIP----------DDIRISPECCHLISRIFVADPATRISIPEIKTH----SWFLK 280 (361)
T ss_dssp CCC----------TTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS----HHHHT
T ss_pred CCC----------CcCCCCHHHHHHHHHHccCChhHCcCHHHHHhC----cchhc
Confidence 000 011125788999999999999999999999998 88754
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-47 Score=376.58 Aligned_cols=256 Identities=29% Similarity=0.441 Sum_probs=199.7
Q ss_pred ccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCcc--CHHHHHHHHHHHhCCCCCceeeEEEEEE
Q 011851 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQ--GHKEWLAEVNYLGGLIHPNLVKLIGCCI 197 (476)
Q Consensus 120 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~l~~~~~ 197 (476)
.++|++.+.||+|+||+||+|.+ +|..||||++...... ..+++.+|+++|++++||||+++++++.
T Consensus 36 ~~~y~i~~~lG~G~~g~V~~~~~-----------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 104 (309)
T 3p86_A 36 WCDLNIKEKIGAGSFGTVHRAEW-----------HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVT 104 (309)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEE-----------TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred hhHceeeeEeecCCCeEEEEEEE-----------CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence 45799999999999999999864 4677999999765433 2356889999999999999999999999
Q ss_pred eCCeeEEEEEecCCCCHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeec
Q 011851 198 EDDQRLLVYEFMPRGSLENHLFRRS--LPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDF 275 (476)
Q Consensus 198 ~~~~~~lV~E~~~~g~L~~~l~~~~--~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DF 275 (476)
+.+..++||||+++++|.+++.+.. ..+++..++.++.||+.||.|||+.+ .+|+||||||+|||++.++.+||+||
T Consensus 105 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Df 183 (309)
T 3p86_A 105 QPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDF 183 (309)
T ss_dssp STTCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCC
T ss_pred ECCceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCC
Confidence 9999999999999999999996543 23899999999999999999999865 44999999999999999999999999
Q ss_pred CCcCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhccc
Q 011851 276 GLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGER 355 (476)
Q Consensus 276 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~ 355 (476)
|+++...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...........+. .. ..
T Consensus 184 g~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~---~~-~~- 256 (309)
T 3p86_A 184 GLSRLKASTF--LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVG---FK-CK- 256 (309)
T ss_dssp C-------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHH---HS-CC-
T ss_pred CCCccccccc--cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH---hc-CC-
Confidence 9997643321 12234679999999999999999999999999999999999999997543221111110 00 00
Q ss_pred cccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 011851 356 RRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKP 405 (476)
Q Consensus 356 ~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~ 405 (476)
...++...+.++.+||.+||+.||++|||+.++++.|+.
T Consensus 257 -----------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~ 295 (309)
T 3p86_A 257 -----------RLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRP 295 (309)
T ss_dssp -----------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred -----------CCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 001122336789999999999999999999999998763
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-46 Score=367.64 Aligned_cols=280 Identities=38% Similarity=0.600 Sum_probs=225.8
Q ss_pred ccccChhHHHHhccCCCcc------ccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCC----ccCHHHHHHH
Q 011851 108 LRKFSFNELKSATKSFRPE------CLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDG----LQGHKEWLAE 177 (476)
Q Consensus 108 ~~~~~~~~~~~~~~~y~~~------~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~----~~~~~~~~~E 177 (476)
...+++.++...+++|... +.||+|+||.||+|.+ +++.||||++.... ....+.+.+|
T Consensus 12 ~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-----------~~~~vavK~~~~~~~~~~~~~~~~~~~E 80 (307)
T 2nru_A 12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-----------NNTTVAVKKLAAMVDITTEELKQQFDQE 80 (307)
T ss_dssp CEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-----------SSCEEEEEEECCCTTSCTTTHHHHHHHH
T ss_pred CCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-----------CCceEEEEEEecccCcchHHHHHHHHHH
Confidence 4568899999999888777 8999999999999864 46679999987532 1224578899
Q ss_pred HHHHhCCCCCceeeEEEEEEeCCeeEEEEEecCCCCHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEec
Q 011851 178 VNYLGGLIHPNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRR--SLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYR 255 (476)
Q Consensus 178 ~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~g~L~~~l~~~--~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHr 255 (476)
+.++++++||||+++++++.+.+..++||||+++++|.+++... ..++++..++.++.||+.||.|||+.+ |+||
T Consensus 81 ~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~ 157 (307)
T 2nru_A 81 IKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHR 157 (307)
T ss_dssp HHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECS
T ss_pred HHHHHhcCCCCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecC
Confidence 99999999999999999999999999999999999999998642 456999999999999999999999988 9999
Q ss_pred CCCCCCeeecCCCceEEeecCCcCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCC
Q 011851 256 DFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDK 335 (476)
Q Consensus 256 DlKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~ 335 (476)
||||+|||++.++.+||+|||++................||+.|+|||++.+ .++.++|||||||++|+|++|..||..
T Consensus 158 dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~ 236 (307)
T 2nru_A 158 DIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDE 236 (307)
T ss_dssp CCCGGGEEECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCT
T ss_pred CCCHHHEEEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCccc
Confidence 9999999999999999999999987654333333344679999999998765 588999999999999999999999987
Q ss_pred CCCCCcchhHHhhhhhhccccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 011851 336 NRPNGEHNLVEWARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKP 405 (476)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~ 405 (476)
......... +..........+...+++.+. ..+...+..+.+++.+||+.||.+|||+.+++++|+.
T Consensus 237 ~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~ 303 (307)
T 2nru_A 237 HREPQLLLD--IKEEIEDEEKTIEDYIDKKMN-DADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQE 303 (307)
T ss_dssp TBSSSBTTH--HHHHHHTTSCCHHHHSCSSCS-CCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred CcchHHHHH--HHHHhhhhhhhhhhhcccccc-ccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHH
Confidence 554332221 111111112223333444332 2345667899999999999999999999999999764
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-47 Score=384.49 Aligned_cols=269 Identities=27% Similarity=0.351 Sum_probs=214.8
Q ss_pred hHHHHhccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCcc-CHHHHHHHHHHHhCC-CCCceee
Q 011851 114 NELKSATKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQ-GHKEWLAEVNYLGGL-IHPNLVK 191 (476)
Q Consensus 114 ~~~~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~-~~~~~~~E~~~l~~l-~hpnIv~ 191 (476)
.++....++|++.+.||+|+||.||+|.+... .+..+++.||||+++..... ..+.+.+|+++|.++ +||||++
T Consensus 15 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~----~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~ 90 (359)
T 3vhe_A 15 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGI----DKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN 90 (359)
T ss_dssp HHHBCCGGGEEEEEEEEECSSEEEEEEEEESS----SSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred ccccccccceeeceeecCCCCceEEEEEeccc----cccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceee
Confidence 33444567899999999999999999986532 13457889999999765432 245688999999999 7999999
Q ss_pred EEEEEEeCCe-eEEEEEecCCCCHHHHHhhcCC-----------------------------------------------
Q 011851 192 LIGCCIEDDQ-RLLVYEFMPRGSLENHLFRRSL----------------------------------------------- 223 (476)
Q Consensus 192 l~~~~~~~~~-~~lV~E~~~~g~L~~~l~~~~~----------------------------------------------- 223 (476)
+++++.+.+. +++|||||++|+|.+++.....
T Consensus 91 ~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (359)
T 3vhe_A 91 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEE 170 (359)
T ss_dssp EEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------
T ss_pred eeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccc
Confidence 9999987654 8999999999999999965432
Q ss_pred ------------------CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCcCCCCCCC
Q 011851 224 ------------------PLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGD 285 (476)
Q Consensus 224 ------------------~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~ 285 (476)
.+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++......
T Consensus 171 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 247 (359)
T 3vhe_A 171 KSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 247 (359)
T ss_dssp -------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCT
T ss_pred cccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeecccc
Confidence 2899999999999999999999988 9999999999999999999999999998765444
Q ss_pred ccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhhccccccccccCc
Q 011851 286 KTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPQLGERRRFYRLIDP 364 (476)
Q Consensus 286 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 364 (476)
.........||+.|+|||++.+..++.++|||||||++|||++ |..||......... ....... ...
T Consensus 248 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~--~~~~~~~--~~~-------- 315 (359)
T 3vhe_A 248 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF--CRRLKEG--TRM-------- 315 (359)
T ss_dssp TCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHH--HHHHHHT--CCC--------
T ss_pred cchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHH--HHHHHcC--CCC--------
Confidence 3334445779999999999999999999999999999999998 99999765432211 1111000 000
Q ss_pred ccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 011851 365 CLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKP 405 (476)
Q Consensus 365 ~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~ 405 (476)
..+...+.++.+|+.+||+.||++|||+.+++++|+.
T Consensus 316 ----~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~ 352 (359)
T 3vhe_A 316 ----RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 352 (359)
T ss_dssp ----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ----CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHH
Confidence 0111225789999999999999999999999999764
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-46 Score=370.04 Aligned_cols=270 Identities=24% Similarity=0.278 Sum_probs=211.7
Q ss_pred ccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCc-cCHHHHHHHHHHHhCCCCCceeeEEEEEEe
Q 011851 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL-QGHKEWLAEVNYLGGLIHPNLVKLIGCCIE 198 (476)
Q Consensus 120 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~ 198 (476)
.++|++.++||+|+||+||+|.+. .+|+.||||++..... ...+.+.+|+++|++++||||+++++++..
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 78 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHK---------KTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEE 78 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEET---------TTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred CCCEEEEEEecCCCCeEEEEEEEC---------CCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeec
Confidence 457999999999999999998765 4678899999976443 345678899999999999999999999987
Q ss_pred CC--eeEEEEEecCCCCHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeee----cCCCce
Q 011851 199 DD--QRLLVYEFMPRGSLENHLFRRS--LPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILL----DGEYNA 270 (476)
Q Consensus 199 ~~--~~~lV~E~~~~g~L~~~l~~~~--~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl----~~~~~v 270 (476)
.+ ..||||||+++++|.+++.... ..+++..++.++.||+.||.|||+.+ |+||||||+|||| +.++.+
T Consensus 79 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~ 155 (319)
T 4euu_A 79 TTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVY 155 (319)
T ss_dssp TTTCCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEE
T ss_pred CCCceEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceE
Confidence 65 7899999999999999996542 34999999999999999999999988 9999999999999 788889
Q ss_pred EEeecCCcCCCCCCCccceeeeeecCCCCCCcchhh--------cCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcc
Q 011851 271 KLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM--------TGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEH 342 (476)
Q Consensus 271 kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~ 342 (476)
||+|||+++....... .....||+.|+|||++. +..++.++|||||||++|||++|+.||.........
T Consensus 156 kL~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~ 232 (319)
T 4euu_A 156 KLTDFGAARELEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN 232 (319)
T ss_dssp EECCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGC
T ss_pred EEccCCCceecCCCCc---eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchh
Confidence 9999999987654332 23467999999999987 568899999999999999999999999754432222
Q ss_pred h-hHHhhhhhhc-cc-cccc-------ccc-CcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 011851 343 N-LVEWARPQLG-ER-RRFY-------RLI-DPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALK 404 (476)
Q Consensus 343 ~-~~~~~~~~~~-~~-~~~~-------~~~-d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~ 404 (476)
. .......... .. ..+. .+. +-.....+....+..+.+||.+||+.||++|||+.|++++..
T Consensus 233 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~ 305 (319)
T 4euu_A 233 KEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS 305 (319)
T ss_dssp HHHHHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHH
T ss_pred HHHHHHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccH
Confidence 1 1111111000 00 0000 000 001122345567889999999999999999999999999954
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-47 Score=376.89 Aligned_cols=258 Identities=22% Similarity=0.389 Sum_probs=202.5
Q ss_pred ccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCcc-CHHHHHHHHHHHhCCCCCceeeEEEEEEe
Q 011851 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQ-GHKEWLAEVNYLGGLIHPNLVKLIGCCIE 198 (476)
Q Consensus 120 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~~ 198 (476)
.++|++.+.||+|+||.||+|.+. .+|+.||||+++..... ..+.+.+|+.+|++++||||++++++|.+
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~---------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 75 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNK---------VDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLE 75 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEET---------TTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEE
T ss_pred hhcCceeeEecCCCCeEEEEEEEc---------CCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEE
Confidence 456999999999999999998764 46788999999765433 34678999999999999999999999876
Q ss_pred CC---------------------------------------------------------eeEEEEEecCCCCHHHHHhhc
Q 011851 199 DD---------------------------------------------------------QRLLVYEFMPRGSLENHLFRR 221 (476)
Q Consensus 199 ~~---------------------------------------------------------~~~lV~E~~~~g~L~~~l~~~ 221 (476)
.. ..|+|||||++++|.+++...
T Consensus 76 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~ 155 (332)
T 3qd2_B 76 TPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRR 155 (332)
T ss_dssp CCSCHHHHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTC
T ss_pred eccchhhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcc
Confidence 54 389999999999999999654
Q ss_pred C--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCcCCCCCCCcc----------ce
Q 011851 222 S--LPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKT----------HV 289 (476)
Q Consensus 222 ~--~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~~~----------~~ 289 (476)
. ...++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++........ ..
T Consensus 156 ~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~ 232 (332)
T 3qd2_B 156 CSLEDREHGVCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYAT 232 (332)
T ss_dssp CSGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------C
T ss_pred cCccchhhHHHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhcccccccccccc
Confidence 2 23567778999999999999999988 999999999999999999999999999876543211 11
Q ss_pred eeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhccccccccccCcccCCC
Q 011851 290 STRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRRFYRLIDPCLEGC 369 (476)
Q Consensus 290 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 369 (476)
....+||+.|+|||++.+..++.++|||||||++|||++|..|+... ........ . ..+. .
T Consensus 233 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~-----~~~~~~~~----~-~~~~---------~ 293 (332)
T 3qd2_B 233 HTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMER-----VRIITDVR----N-LKFP---------L 293 (332)
T ss_dssp CCSCC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHH-----HHHHHHHH----T-TCCC---------H
T ss_pred ccccCCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHH-----HHHHHHhh----c-cCCC---------c
Confidence 23357999999999999999999999999999999999987664210 00000000 0 0000 0
Q ss_pred CChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCcccc
Q 011851 370 FSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDM 412 (476)
Q Consensus 370 ~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~~ 412 (476)
.....+.++.+||.+||+.||++|||+.++++| |||+++
T Consensus 294 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~----~~f~~~ 332 (332)
T 3qd2_B 294 LFTQKYPQEHMMVQDMLSPSPTERPEATDIIEN----AIFENL 332 (332)
T ss_dssp HHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHHS----TTCCCC
T ss_pred ccccCChhHHHHHHHHccCCCCcCCCHHHHhhc----hhhhcC
Confidence 011234677899999999999999999999998 999864
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-47 Score=369.23 Aligned_cols=260 Identities=24% Similarity=0.348 Sum_probs=205.3
Q ss_pred ccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccC---HHHHHHHHHHHhCCCCCceeeEEEEE
Q 011851 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQG---HKEWLAEVNYLGGLIHPNLVKLIGCC 196 (476)
Q Consensus 120 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~---~~~~~~E~~~l~~l~hpnIv~l~~~~ 196 (476)
.++|++.+.||+|+||.||+|.+. .+++.||+|++....... .+.+.+|+.++++++||||+++++++
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~ 80 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDT---------ILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVD 80 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEET---------TTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEEC---------CCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEee
Confidence 467999999999999999998654 467889999986544333 35688999999999999999999999
Q ss_pred EeCCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecC
Q 011851 197 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFG 276 (476)
Q Consensus 197 ~~~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG 276 (476)
.+++.+|+||||+++++|.+++... .++++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||
T Consensus 81 ~~~~~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg 156 (294)
T 4eqm_A 81 EEDDCYYLVMEYIEGPTLSEYIESH-GPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFG 156 (294)
T ss_dssp ECSSEEEEEEECCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCS
T ss_pred eeCCeEEEEEeCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCC
Confidence 9999999999999999999999654 47999999999999999999999988 9999999999999999999999999
Q ss_pred CcCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhcccc
Q 011851 277 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERR 356 (476)
Q Consensus 277 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~ 356 (476)
+++....... ......+||+.|+|||++.+..++.++|||||||++|+|++|+.||........ ... .....
T Consensus 157 ~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~--~~~----~~~~~- 228 (294)
T 4eqm_A 157 IAKALSETSL-TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSI--AIK----HIQDS- 228 (294)
T ss_dssp SSTTC--------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHH--HHH----HHSSC-
T ss_pred Cccccccccc-cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH--HHH----Hhhcc-
Confidence 9987644222 223346799999999999999999999999999999999999999976432110 000 00000
Q ss_pred ccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHhcCC
Q 011851 357 RFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARP-RMSEVVEALKPL 406 (476)
Q Consensus 357 ~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RP-t~~ell~~L~~~ 406 (476)
. +.+........+..+.++|.+||+.||++|| +++++++.|+.+
T Consensus 229 -~-----~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~ 273 (294)
T 4eqm_A 229 -V-----PNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSV 273 (294)
T ss_dssp -C-----CCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTS
T ss_pred -C-----CCcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHH
Confidence 0 0000001112357899999999999999998 888898887754
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-47 Score=372.05 Aligned_cols=271 Identities=25% Similarity=0.287 Sum_probs=205.0
Q ss_pred ccCCCcc-ccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCC-CCCceeeEEEEEE
Q 011851 120 TKSFRPE-CLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGL-IHPNLVKLIGCCI 197 (476)
Q Consensus 120 ~~~y~~~-~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~ 197 (476)
.+.|++. +.||+|+||.||+|.+. .+++.||||++..........+.+|+.+|.++ +||||+++++++.
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~---------~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~ 81 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINL---------ITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFE 81 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECS---------SSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred ceeEEecCceecCCceEEEEEEEEc---------CCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence 3468884 78999999999998654 46888999999877666677899999999885 7999999999999
Q ss_pred eCCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCc---eEEee
Q 011851 198 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYN---AKLSD 274 (476)
Q Consensus 198 ~~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~---vkl~D 274 (476)
+++.+||||||+++++|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++. +||+|
T Consensus 82 ~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~D 157 (316)
T 2ac3_A 82 EEDRFYLVFEKMRGGSILSHIHKR-RHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICD 157 (316)
T ss_dssp ETTEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECC
T ss_pred eCCEEEEEEEcCCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEE
Confidence 999999999999999999999654 46999999999999999999999988 999999999999988776 99999
Q ss_pred cCCcCCCCCCCc-----cceeeeeecCCCCCCcchhhc-----CCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchh
Q 011851 275 FGLAKDGPEGDK-----THVSTRVMGTYGYAAPEYVMT-----GHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNL 344 (476)
Q Consensus 275 FG~a~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~ 344 (476)
||++........ .......+||+.|+|||++.+ ..++.++|||||||++|||++|+.||...........
T Consensus 158 fg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~ 237 (316)
T 2ac3_A 158 FDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWD 237 (316)
T ss_dssp TTCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC-
T ss_pred ccCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCccccccccccc
Confidence 999976532111 111223569999999999975 5689999999999999999999999986544321100
Q ss_pred H--------HhhhhhhccccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCcccccC
Q 011851 345 V--------EWARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDMAS 414 (476)
Q Consensus 345 ~--------~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~~~~ 414 (476)
. ......+... . ..+..... ...+.++.+||.+||+.||++|||+.++++| |||++...
T Consensus 238 ~~~~~~~~~~~~~~~i~~~-~-~~~~~~~~-----~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h----p~~~~~~~ 304 (316)
T 2ac3_A 238 RGEACPACQNMLFESIQEG-K-YEFPDKDW-----AHISCAAKDLISKLLVRDAKQRLSAAQVLQH----PWVQGCAP 304 (316)
T ss_dssp ---CCHHHHHHHHHHHHHC-C-CCCCHHHH-----TTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS----TTCC----
T ss_pred ccccchhHHHHHHHHHhcc-C-cccCchhc-----ccCCHHHHHHHHHHhhCChhhCCCHHHHhcC----hhhcCCCC
Confidence 0 0000000000 0 00000000 0125689999999999999999999999998 99987543
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-47 Score=387.46 Aligned_cols=258 Identities=22% Similarity=0.292 Sum_probs=198.8
Q ss_pred ccCCCcc-ccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHH-hCCCCCceeeEEEEEE
Q 011851 120 TKSFRPE-CLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYL-GGLIHPNLVKLIGCCI 197 (476)
Q Consensus 120 ~~~y~~~-~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l-~~l~hpnIv~l~~~~~ 197 (476)
.++|.+. ++||+|+||+||+|.+. .+|+.||||++... ..+.+|++++ +.++||||++++++|.
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~---------~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~ 125 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNK---------RTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYE 125 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEET---------TTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEE
T ss_pred cccceeccceeeeccCeEEEEEEEC---------CCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEe
Confidence 3457776 78999999999998654 47888999999632 4567888887 4558999999999987
Q ss_pred e----CCeeEEEEEecCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecC---CCc
Q 011851 198 E----DDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDG---EYN 269 (476)
Q Consensus 198 ~----~~~~~lV~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~---~~~ 269 (476)
. .+.+|||||||+||+|.+++... ...+++..+..++.||+.||.|||+++ |+||||||+||||+. ++.
T Consensus 126 ~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~ 202 (400)
T 1nxk_A 126 NLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAI 202 (400)
T ss_dssp EEETTEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCC
T ss_pred ecccCCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCcc
Confidence 6 56799999999999999999764 346999999999999999999999988 999999999999987 789
Q ss_pred eEEeecCCcCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcch-hHHhh
Q 011851 270 AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHN-LVEWA 348 (476)
Q Consensus 270 vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~-~~~~~ 348 (476)
+||+|||+++...... .....+||+.|+|||++.+..|+.++|||||||++|||++|+.||.......... .....
T Consensus 203 ~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i 279 (400)
T 1nxk_A 203 LKLTDFGFAKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRI 279 (400)
T ss_dssp EEECCCTTCEECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHH
T ss_pred EEEEecccccccCCCC---ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHH
Confidence 9999999998654322 1234789999999999999999999999999999999999999998654432211 11110
Q ss_pred hhhhccccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCcccc
Q 011851 349 RPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDM 412 (476)
Q Consensus 349 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~~ 412 (476)
.. . . ..+..+.+ ...+.++.+||.+||+.||++|||+.++++| |||.+.
T Consensus 280 ~~--~-~---~~~~~~~~-----~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h----p~~~~~ 328 (400)
T 1nxk_A 280 RM--G-Q---YEFPNPEW-----SEVSEEVKMLIRNLLKTEPTQRMTITEFMNH----PWIMQS 328 (400)
T ss_dssp HH--T-C---CCCCTTTT-----TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS----HHHHTT
T ss_pred Hc--C-c---ccCCCccc-----ccCCHHHHHHHHHHCCCChhHCcCHHHHhcC----ccccCC
Confidence 00 0 0 00111111 1236789999999999999999999999998 887643
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-47 Score=380.95 Aligned_cols=261 Identities=25% Similarity=0.330 Sum_probs=197.8
Q ss_pred hccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCCCCCceeeEEEEEEe
Q 011851 119 ATKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHPNLVKLIGCCIE 198 (476)
Q Consensus 119 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~ 198 (476)
..++|++.+.||+|+||.||+|.+. .+++.||||++.... ..+.+.+|+.+|++++||||+++++++.+
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~---------~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 119 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQK---------GTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFET 119 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEET---------TTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEEC
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEEC---------CCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEec
Confidence 3567999999999999999998764 467889999997653 33567889999999999999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecC---CCceEEeec
Q 011851 199 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDG---EYNAKLSDF 275 (476)
Q Consensus 199 ~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~---~~~vkl~DF 275 (476)
.+..+|||||+++++|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++. ++.+||+||
T Consensus 120 ~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Df 195 (349)
T 2w4o_A 120 PTEISLVLELVTGGELFDRIVE-KGYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADF 195 (349)
T ss_dssp SSEEEEEECCCCSCBHHHHHTT-CSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCC
T ss_pred CCeEEEEEEeCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccC
Confidence 9999999999999999999954 456999999999999999999999988 999999999999975 889999999
Q ss_pred CCcCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhccc
Q 011851 276 GLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGER 355 (476)
Q Consensus 276 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~ 355 (476)
|+++...... .....+||+.|+|||++.+..++.++|||||||++|||++|..||....... ...... ....
T Consensus 196 g~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~--~~~~~i---~~~~ 267 (349)
T 2w4o_A 196 GLSKIVEHQV---LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQ--FMFRRI---LNCE 267 (349)
T ss_dssp C-------------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHH--HHHHHH---HTTC
T ss_pred ccccccCccc---ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccH--HHHHHH---HhCC
Confidence 9998654322 2234679999999999999999999999999999999999999997543221 011100 0000
Q ss_pred cccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCcccccC
Q 011851 356 RRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDMAS 414 (476)
Q Consensus 356 ~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~~~~ 414 (476)
.....+. ....+.++.+||.+||+.||++|||+.++++| |||.+...
T Consensus 268 ---~~~~~~~-----~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h----p~~~~~~~ 314 (349)
T 2w4o_A 268 ---YYFISPW-----WDEVSLNAKDLVRKLIVLDPKKRLTTFQALQH----PWVTGKAA 314 (349)
T ss_dssp ---CCCCTTT-----TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS----TTTTSTTC
T ss_pred ---CccCCch-----hhhCCHHHHHHHHHHccCChhhCcCHHHHhcC----cccCCCcc
Confidence 0011111 11236789999999999999999999999997 99986544
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-46 Score=368.81 Aligned_cols=259 Identities=17% Similarity=0.161 Sum_probs=209.4
Q ss_pred ccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCC-CCCceeeEEEEEEe
Q 011851 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGL-IHPNLVKLIGCCIE 198 (476)
Q Consensus 120 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~ 198 (476)
.++|++.+.||+|+||.||+|.+. .+|+.||||++..... .+.+.+|+.+|++| +||||+++++++.+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 76 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNL---------YTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPC 76 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEET---------TTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEEC---------CCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEec
Confidence 457999999999999999998654 4788899999976533 24578999999999 89999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCc-----eEEe
Q 011851 199 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYN-----AKLS 273 (476)
Q Consensus 199 ~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~-----vkl~ 273 (476)
++..||||||+ +++|.+++......+++..++.++.||+.||.|||+.+ |+||||||+|||++.++. +||+
T Consensus 77 ~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~ 152 (330)
T 2izr_A 77 GKYNAMVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHII 152 (330)
T ss_dssp TTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEEC
T ss_pred CCccEEEEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEE
Confidence 99999999999 99999999776678999999999999999999999988 999999999999998887 9999
Q ss_pred ecCCcCCCCCCCccc-----eeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhh
Q 011851 274 DFGLAKDGPEGDKTH-----VSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA 348 (476)
Q Consensus 274 DFG~a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~ 348 (476)
|||+++......... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||...............
T Consensus 153 DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i 232 (330)
T 2izr_A 153 DFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKI 232 (330)
T ss_dssp CCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHH
T ss_pred EcccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHH
Confidence 999998654322211 123478999999999999999999999999999999999999999876544332222211
Q ss_pred hhhhccccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 011851 349 RPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALK 404 (476)
Q Consensus 349 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~ 404 (476)
...... . ....+.. ..+ ++.+|+..||+.||.+||++.+|++.|+
T Consensus 233 ~~~~~~-~-----~~~~~~~----~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~ 277 (330)
T 2izr_A 233 GDTKRA-T-----PIEVLCE----NFP-EMATYLRYVRRLDFFEKPDYDYLRKLFT 277 (330)
T ss_dssp HHHHHH-S-----CHHHHTT----TCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHH
T ss_pred Hhhhcc-C-----CHHHHhc----cCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHH
Confidence 110000 0 0000000 114 8999999999999999999999999865
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-47 Score=367.76 Aligned_cols=253 Identities=28% Similarity=0.438 Sum_probs=209.1
Q ss_pred cCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCCCCCceeeEEEEEEeCC
Q 011851 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHPNLVKLIGCCIEDD 200 (476)
Q Consensus 121 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 200 (476)
++|++.+.||+|+||.||+|.+. +++.||+|++.... ...+++.+|++++++++||||+++++++.+++
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~----------~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 78 (269)
T 4hcu_A 10 SELTFVQEIGSGQFGLVHLGYWL----------NKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQA 78 (269)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET----------TTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred hhceeeheecCCCccEEEEEEec----------CCCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence 56999999999999999999764 45679999997654 34567899999999999999999999999999
Q ss_pred eeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCcCC
Q 011851 201 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKD 280 (476)
Q Consensus 201 ~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~ 280 (476)
..|+||||+++++|.+++......+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 79 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 155 (269)
T 4hcu_A 79 PICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRF 155 (269)
T ss_dssp SEEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGG
T ss_pred ceEEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEecccccccc
Confidence 999999999999999999777778999999999999999999999988 99999999999999999999999999986
Q ss_pred CCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhhccccccc
Q 011851 281 GPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPQLGERRRFY 359 (476)
Q Consensus 281 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 359 (476)
..... ........||+.|+|||++.+..++.++|||||||++|+|++ |+.||....... ....... . .
T Consensus 156 ~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~---~~~~~~~----~---~ 224 (269)
T 4hcu_A 156 VLDDQ-YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE---VVEDIST----G---F 224 (269)
T ss_dssp BCCHH-HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HHHHHHT----T---C
T ss_pred ccccc-cccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHH---HHHHHhc----C---c
Confidence 53321 111223457788999999999999999999999999999999 999997543221 1111100 0 0
Q ss_pred cccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 011851 360 RLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKP 405 (476)
Q Consensus 360 ~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~ 405 (476)
.. ..+...+..+.+|+.+||+.||++|||+.+++++|+.
T Consensus 225 ~~-------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~ 263 (269)
T 4hcu_A 225 RL-------YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAE 263 (269)
T ss_dssp CC-------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred cC-------CCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHH
Confidence 00 0111225789999999999999999999999999764
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-48 Score=377.93 Aligned_cols=268 Identities=26% Similarity=0.361 Sum_probs=208.2
Q ss_pred ccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCCCCCceeeEEEEEEeC
Q 011851 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHPNLVKLIGCCIED 199 (476)
Q Consensus 120 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~ 199 (476)
.++|++.+.||+|+||.||+|++.. .+..+++.||||++........+.+.+|+++|++++||||+++++++...
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~-----~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 83 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDP-----LQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA 83 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECT-----TCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHH
T ss_pred HHHhhhhheeeccCCEEEEEEEEec-----ccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence 3579999999999999999997542 23457899999999876655567789999999999999999999998653
Q ss_pred --CeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCC
Q 011851 200 --DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGL 277 (476)
Q Consensus 200 --~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~ 277 (476)
..+++||||+++++|.+++......+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 84 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~ 160 (295)
T 3ugc_A 84 GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGL 160 (295)
T ss_dssp HHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCS
T ss_pred CCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCcc
Confidence 5689999999999999999776667999999999999999999999988 99999999999999999999999999
Q ss_pred cCCCCCCCcc-ceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCC---------CcchhHHh
Q 011851 278 AKDGPEGDKT-HVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPN---------GEHNLVEW 347 (476)
Q Consensus 278 a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~---------~~~~~~~~ 347 (476)
++........ .......|+..|+|||++.+..++.++|||||||++|||++|..||...... ........
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (295)
T 3ugc_A 161 TKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 240 (295)
T ss_dssp CC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHH
T ss_pred cccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHH
Confidence 9875433221 1122345778899999999999999999999999999999999998642110 00000000
Q ss_pred hhhhhccccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 011851 348 ARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKP 405 (476)
Q Consensus 348 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~ 405 (476)
..... ........+...+.++.+||.+||+.||++|||+.++++.|+.
T Consensus 241 ~~~~~----------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~ 288 (295)
T 3ugc_A 241 LIELL----------KNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQ 288 (295)
T ss_dssp HHHHH----------HTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHH----------hccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHH
Confidence 00000 0000111122336789999999999999999999999998764
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-47 Score=366.06 Aligned_cols=255 Identities=27% Similarity=0.406 Sum_probs=210.5
Q ss_pred ccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCCCCCceeeEEEEEEeC
Q 011851 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHPNLVKLIGCCIED 199 (476)
Q Consensus 120 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~ 199 (476)
.++|++.+.||+|+||.||+|.+. ++..||+|++..... ..+++.+|+.++++++||||+++++++.++
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~----------~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 75 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWK----------GQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKE 75 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET----------TTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hhheeeeeeeccCCCceEEEEEec----------CceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccC
Confidence 457999999999999999998654 456799999976543 456789999999999999999999999999
Q ss_pred CeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCcC
Q 011851 200 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAK 279 (476)
Q Consensus 200 ~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~ 279 (476)
+..|+||||+++++|.+++......+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.
T Consensus 76 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~ 152 (268)
T 3sxs_A 76 YPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTR 152 (268)
T ss_dssp SSEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEE
T ss_pred CceEEEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccce
Confidence 9999999999999999999776667999999999999999999999988 9999999999999999999999999998
Q ss_pred CCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhhcccccc
Q 011851 280 DGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPQLGERRRF 358 (476)
Q Consensus 280 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 358 (476)
....... .......+|+.|+|||++.+..++.++||||||+++|+|++ |+.||...........+ ....
T Consensus 153 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~-------~~~~-- 222 (268)
T 3sxs_A 153 YVLDDQY-VSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKV-------SQGH-- 222 (268)
T ss_dssp ECCTTCE-EECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH-------HTTC--
T ss_pred ecchhhh-hcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHH-------HcCC--
Confidence 7544322 12223456778999999999999999999999999999999 99999754322111100 0000
Q ss_pred ccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011851 359 YRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPL 406 (476)
Q Consensus 359 ~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~ 406 (476)
... .+...+..+.+|+.+||+.||++|||+.+++++|+.+
T Consensus 223 -~~~-------~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l 262 (268)
T 3sxs_A 223 -RLY-------RPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPL 262 (268)
T ss_dssp -CCC-------CCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGG
T ss_pred -CCC-------CCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHh
Confidence 000 1111256899999999999999999999999998765
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-47 Score=393.81 Aligned_cols=254 Identities=26% Similarity=0.343 Sum_probs=209.7
Q ss_pred ccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCc---cCHHHHHHHHHHHhCCCCCceeeEEEEE
Q 011851 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL---QGHKEWLAEVNYLGGLIHPNLVKLIGCC 196 (476)
Q Consensus 120 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~l~~~~ 196 (476)
.++|.+.+.||+|+||.||+|.+. .+|+.||||++..... .....+.+|+.+|+.++||||+++++++
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~---------~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~ 85 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHE---------LTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVI 85 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEET---------TTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred ecCEEEEEEEeeCCCeEEEEEEEC---------CCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence 357999999999999999998654 4788999999975422 2345788999999999999999999999
Q ss_pred EeCCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecC
Q 011851 197 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFG 276 (476)
Q Consensus 197 ~~~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG 276 (476)
.+.+.+||||||+++++|.+++.+ ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||
T Consensus 86 ~~~~~~~lv~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG 161 (476)
T 2y94_A 86 STPSDIFMVMEYVSGGELFDYICK-NGRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFG 161 (476)
T ss_dssp ECSSEEEEEEECCSSEEHHHHTTS-SSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCS
T ss_pred EECCEEEEEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEecc
Confidence 999999999999999999999954 457999999999999999999999988 9999999999999999999999999
Q ss_pred CcCCCCCCCccceeeeeecCCCCCCcchhhcCCC-CccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhccc
Q 011851 277 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHL-TAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGER 355 (476)
Q Consensus 277 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~ 355 (476)
+++....... ....+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||....... +..... ...
T Consensus 162 ~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~---~~~~i~---~~~ 232 (476)
T 2y94_A 162 LSNMMSDGEF---LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPT---LFKKIC---DGI 232 (476)
T ss_dssp SCEECCTTCC---BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHH---HHHHHH---TTC
T ss_pred chhhcccccc---ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHH---HHHHHh---cCC
Confidence 9987654322 234689999999999998765 689999999999999999999997543221 111100 000
Q ss_pred cccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCccc
Q 011851 356 RRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKD 411 (476)
Q Consensus 356 ~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~ 411 (476)
. ..+...+.++.+||.+||+.||++|||+.++++| |||+.
T Consensus 233 ~------------~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~h----p~~~~ 272 (476)
T 2y94_A 233 F------------YTPQYLNPSVISLLKHMLQVDPMKRATIKDIREH----EWFKQ 272 (476)
T ss_dssp C------------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTC----HHHHT
T ss_pred c------------CCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhC----HHhhh
Confidence 0 0111225688999999999999999999999987 66653
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-47 Score=376.79 Aligned_cols=251 Identities=25% Similarity=0.279 Sum_probs=199.4
Q ss_pred cCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccC--HHHHHHHHHHHhCC-CCCceeeEEEEEE
Q 011851 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQG--HKEWLAEVNYLGGL-IHPNLVKLIGCCI 197 (476)
Q Consensus 121 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~--~~~~~~E~~~l~~l-~hpnIv~l~~~~~ 197 (476)
++|++.++||+|+||+||+|.+. .+|+.||||++....... ..++..|+..+.++ .||||+++++++.
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~---------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~ 127 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSK---------EDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWE 127 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEET---------TTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEEC---------CCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEE
Confidence 56999999999999999998765 467889999986543322 23445565555544 8999999999999
Q ss_pred eCCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCC
Q 011851 198 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGL 277 (476)
Q Consensus 198 ~~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~ 277 (476)
+++.+||||||+ +++|.+++......+++..++.++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+
T Consensus 128 ~~~~~~lv~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~ 203 (311)
T 3p1a_A 128 EGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGL 203 (311)
T ss_dssp ETTEEEEEEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTT
T ss_pred eCCEEEEEEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEcccee
Confidence 999999999999 77999999877778999999999999999999999988 99999999999999999999999999
Q ss_pred cCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhccccc
Q 011851 278 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRR 357 (476)
Q Consensus 278 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 357 (476)
+....... ......||+.|+|||++.+ .++.++|||||||++|||++|..++.... ....... .
T Consensus 204 a~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~-----~~~~~~~-----~-- 267 (311)
T 3p1a_A 204 LVELGTAG---AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGE-----GWQQLRQ-----G-- 267 (311)
T ss_dssp CEECC---------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHH-----HHHHHTT-----T--
T ss_pred eeecccCC---CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcc-----HHHHHhc-----c--
Confidence 98754322 2234579999999998876 79999999999999999999977664321 0000000 0
Q ss_pred cccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCccc
Q 011851 358 FYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKD 411 (476)
Q Consensus 358 ~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~ 411 (476)
...+ .+....+.++.+||.+||+.||++|||+.+++++ |||++
T Consensus 268 ---~~~~----~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h----p~~~~ 310 (311)
T 3p1a_A 268 ---YLPP----EFTAGLSSELRSVLVMMLEPDPKLRATAEALLAL----PVLRQ 310 (311)
T ss_dssp ---CCCH----HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS----GGGSC
T ss_pred ---CCCc----ccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhC----ccccC
Confidence 0000 0111225789999999999999999999999997 99875
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-47 Score=380.66 Aligned_cols=258 Identities=23% Similarity=0.328 Sum_probs=201.6
Q ss_pred ccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCcc--CHHHHHHHHHHHhCCCC--CceeeEEEE
Q 011851 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQ--GHKEWLAEVNYLGGLIH--PNLVKLIGC 195 (476)
Q Consensus 120 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~--~~~~~~~E~~~l~~l~h--pnIv~l~~~ 195 (476)
.++|++.+.||+|+||.||+|.+. +++.||||++...... ..+.+.+|+.+|++++| +||++++++
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~----------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~ 77 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNE----------KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDY 77 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECT----------TSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeC----------CCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeee
Confidence 457999999999999999998653 5778999999765432 23568899999999976 999999999
Q ss_pred EEeCCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeec
Q 011851 196 CIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDF 275 (476)
Q Consensus 196 ~~~~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DF 275 (476)
+.+++.+|||||+ .+++|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+||||+ ++.+||+||
T Consensus 78 ~~~~~~~~lv~e~-~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DF 151 (343)
T 3dbq_A 78 EITDQYIYMVMEC-GNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDF 151 (343)
T ss_dssp EECSSEEEEEECC-CSEEHHHHHHHS-CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCC
T ss_pred EeeCCEEEEEEeC-CCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeec
Confidence 9999999999995 588999999654 57999999999999999999999988 99999999999997 678999999
Q ss_pred CCcCCCCCCCccceeeeeecCCCCCCcchhhc-----------CCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchh
Q 011851 276 GLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-----------GHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNL 344 (476)
Q Consensus 276 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~ 344 (476)
|+++..............+||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... .
T Consensus 152 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~----~ 227 (343)
T 3dbq_A 152 GIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ----I 227 (343)
T ss_dssp SSSCCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSH----H
T ss_pred ccccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhH----H
Confidence 99987654433333445789999999999875 67899999999999999999999999643221 0
Q ss_pred HHhhhhhhccccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCcccc
Q 011851 345 VEWARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDM 412 (476)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~~ 412 (476)
... ..++++.....++...+.++.+||.+||+.||++|||+.++++| ||++..
T Consensus 228 -~~~----------~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h----p~~~~~ 280 (343)
T 3dbq_A 228 -SKL----------HAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH----PYVQIQ 280 (343)
T ss_dssp -HHH----------HHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS----HHHHSC
T ss_pred -HHH----------HHHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhC----cccccc
Confidence 000 11111111222222235688999999999999999999999997 888754
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-47 Score=387.45 Aligned_cols=276 Identities=22% Similarity=0.315 Sum_probs=198.6
Q ss_pred HhccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCc--cCHHHHHHHHHHHhCCC-CCceeeEEE
Q 011851 118 SATKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL--QGHKEWLAEVNYLGGLI-HPNLVKLIG 194 (476)
Q Consensus 118 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~--~~~~~~~~E~~~l~~l~-hpnIv~l~~ 194 (476)
...++|++.+.||+|+||.||+|.+. .+|+.||||++..... ...+++.+|+.+|+++. ||||+++++
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~~~---------~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~ 76 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSIDR---------RTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLN 76 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEEET---------TTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEE
T ss_pred cccCceEEEEEeeeCCCeEEEEEEEC---------CCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeee
Confidence 34578999999999999999998654 5788899999865422 23456789999999997 999999999
Q ss_pred EEEeCC--eeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEE
Q 011851 195 CCIEDD--QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKL 272 (476)
Q Consensus 195 ~~~~~~--~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl 272 (476)
++...+ .+|||||||+ ++|.+++.. ..+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||
T Consensus 77 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl 150 (388)
T 3oz6_A 77 VLRADNDRDVYLVFDYME-TDLHAVIRA--NILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKV 150 (388)
T ss_dssp EEECTTSSCEEEEEECCS-EEHHHHHHH--TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEE
T ss_pred EEecCCCCEEEEEecccC-cCHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEe
Confidence 998654 7899999996 589988865 36899999999999999999999988 999999999999999999999
Q ss_pred eecCCcCCCCCCC-------------------ccceeeeeecCCCCCCcchhhc-CCCCccchhhhhHHHHHHHHhCCCC
Q 011851 273 SDFGLAKDGPEGD-------------------KTHVSTRVMGTYGYAAPEYVMT-GHLTAKSDVYSFGVVLLEMLTGRRS 332 (476)
Q Consensus 273 ~DFG~a~~~~~~~-------------------~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGv~l~elltG~~p 332 (476)
+|||+++...... .....+..+||+.|+|||++.+ ..|+.++|||||||++|||++|+.|
T Consensus 151 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~p 230 (388)
T 3oz6_A 151 ADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPI 230 (388)
T ss_dssp CCCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred cCCcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCC
Confidence 9999997643211 1112334689999999999987 6799999999999999999999999
Q ss_pred CCCCCCCCcchhHHhhhhhhccccccccc------------------cCcccCCCC------------ChHHHHHHHHHH
Q 011851 333 MDKNRPNGEHNLVEWARPQLGERRRFYRL------------------IDPCLEGCF------------SIKGAEKTIQLA 382 (476)
Q Consensus 333 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------------~d~~l~~~~------------~~~~~~~~~~li 382 (476)
|.+.........+.... .......+..+ ........+ ....+.++.+||
T Consensus 231 f~~~~~~~~~~~i~~~~-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll 309 (388)
T 3oz6_A 231 FPGSSTMNQLERIIGVI-DFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLL 309 (388)
T ss_dssp CCCSSHHHHHHHHHHHH-CCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHH
T ss_pred CCCCCHHHHHHHHHHhc-CCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHH
Confidence 97654322111110000 00000000000 000000000 002256899999
Q ss_pred HHhcccCCCCCCCHHHHHHHhcCCCCccccc
Q 011851 383 ASCLNRDQKARPRMSEVVEALKPLPYLKDMA 413 (476)
Q Consensus 383 ~~cL~~dP~~RPt~~ell~~L~~~~~~~~~~ 413 (476)
.+||+.||++|||+.|+++| |||+...
T Consensus 310 ~~~L~~dP~~R~t~~e~l~H----p~~~~~~ 336 (388)
T 3oz6_A 310 DKLLQFNPNKRISANDALKH----PFVSIFH 336 (388)
T ss_dssp HHHCCSSGGGSCCHHHHTTS----TTTTTTC
T ss_pred HHhhccCcccCCCHHHHhCC----HHHHHhc
Confidence 99999999999999999987 9987643
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-47 Score=376.93 Aligned_cols=259 Identities=25% Similarity=0.395 Sum_probs=204.1
Q ss_pred cCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCC-ccCHHHHHHHHHHHhCCCCCceeeEEEEEEeC
Q 011851 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDG-LQGHKEWLAEVNYLGGLIHPNLVKLIGCCIED 199 (476)
Q Consensus 121 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~ 199 (476)
++|++.++||+|+||+||+|.+..++.. ....||+|.++... ....+++.+|+.+|++++||||+++++++.+.
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 89 (327)
T 3poz_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEK-----VKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS 89 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECC---------CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS
T ss_pred HHcccceEEeeCCCeEEEEEEEcCCCce-----EEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC
Confidence 4699999999999999999987643322 23357899886543 24457789999999999999999999999875
Q ss_pred CeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCcC
Q 011851 200 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAK 279 (476)
Q Consensus 200 ~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~ 279 (476)
..++||||+.+|+|.+++......+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 90 -~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~ 165 (327)
T 3poz_A 90 -TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAK 165 (327)
T ss_dssp -SEEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHH
T ss_pred -CeEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCccee
Confidence 478999999999999999887778999999999999999999999988 9999999999999999999999999998
Q ss_pred CCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhhcccccc
Q 011851 280 DGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPQLGERRRF 358 (476)
Q Consensus 280 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 358 (476)
...............||+.|+|||++.+..++.++|||||||++|||++ |+.||...........+.. . .
T Consensus 166 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~---~----~-- 236 (327)
T 3poz_A 166 LLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK---G----E-- 236 (327)
T ss_dssp HHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHT---T----C--
T ss_pred EccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHc---C----C--
Confidence 6544333333334567889999999999999999999999999999999 9999976543322111110 0 0
Q ss_pred ccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 011851 359 YRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKP 405 (476)
Q Consensus 359 ~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~ 405 (476)
....+...+.++.+|+.+||+.||++||++.+++++|+.
T Consensus 237 --------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~ 275 (327)
T 3poz_A 237 --------RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSK 275 (327)
T ss_dssp --------CCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHH
T ss_pred --------CCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHH
Confidence 001112235689999999999999999999999998764
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-47 Score=376.81 Aligned_cols=260 Identities=26% Similarity=0.416 Sum_probs=206.6
Q ss_pred cCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCC-ccCHHHHHHHHHHHhCCCCCceeeEEEEEEeC
Q 011851 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDG-LQGHKEWLAEVNYLGGLIHPNLVKLIGCCIED 199 (476)
Q Consensus 121 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~ 199 (476)
++|++.++||+|+||.||+|.+..++.. ....||+|.+.... ......+.+|+.++++++||||+++++++. +
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~-----~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~ 86 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGES-----IKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-G 86 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCS-----CCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-B
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCce-----EEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-C
Confidence 4799999999999999999987643321 22348888875443 223356778999999999999999999886 5
Q ss_pred CeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCcC
Q 011851 200 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAK 279 (476)
Q Consensus 200 ~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~ 279 (476)
+..++||||+++|+|.+++......+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 87 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~ 163 (325)
T 3kex_A 87 SSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVAD 163 (325)
T ss_dssp SSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGG
T ss_pred CccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCccc
Confidence 6789999999999999999776667999999999999999999999988 9999999999999999999999999998
Q ss_pred CCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhhcccccc
Q 011851 280 DGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPQLGERRRF 358 (476)
Q Consensus 280 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 358 (476)
...............||+.|+|||++.+..++.++|||||||++|+|++ |..||...........+... ....
T Consensus 164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~-----~~~~- 237 (325)
T 3kex_A 164 LLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKG-----ERLA- 237 (325)
T ss_dssp GSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTT-----CBCC-
T ss_pred ccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcC-----CCCC-
Confidence 7655444434455678899999999999999999999999999999999 99999865443222221110 0000
Q ss_pred ccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011851 359 YRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPL 406 (476)
Q Consensus 359 ~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~ 406 (476)
.+...+.++.+||.+||+.||.+||++.+++++|+.+
T Consensus 238 -----------~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~ 274 (325)
T 3kex_A 238 -----------QPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRM 274 (325)
T ss_dssp -----------CCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHH
T ss_pred -----------CCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 0111244677899999999999999999999997644
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-47 Score=371.02 Aligned_cols=276 Identities=24% Similarity=0.319 Sum_probs=206.8
Q ss_pred cCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccC--HHHHHHHHHHHhCCCCCceeeEEEEEEe
Q 011851 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQG--HKEWLAEVNYLGGLIHPNLVKLIGCCIE 198 (476)
Q Consensus 121 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~--~~~~~~E~~~l~~l~hpnIv~l~~~~~~ 198 (476)
++|++.+.||+|+||+||+|.+. .+|+.||||++....... .+.+.+|+.++++++||||+++++++.+
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 73 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNR---------DTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRR 73 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEET---------TTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeC---------CCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeec
Confidence 57999999999999999998764 468889999986654322 3567889999999999999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCc
Q 011851 199 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLA 278 (476)
Q Consensus 199 ~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a 278 (476)
.+..++||||+++++|.+++. ....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 74 ~~~~~lv~e~~~~~~l~~~~~-~~~~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~ 149 (311)
T 4agu_A 74 KRRLHLVFEYCDHTVLHELDR-YQRGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFA 149 (311)
T ss_dssp TTEEEEEEECCSEEHHHHHHH-TSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred CCeEEEEEEeCCCchHHHHHh-hhcCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCc
Confidence 999999999999988888774 4457999999999999999999999988 999999999999999999999999999
Q ss_pred CCCCCCCccceeeeeecCCCCCCcchhhc-CCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhh-----
Q 011851 279 KDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQL----- 352 (476)
Q Consensus 279 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~----- 352 (476)
........ .....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...........+.......
T Consensus 150 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (311)
T 4agu_A 150 RLLTGPSD--YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQ 227 (311)
T ss_dssp EECC--------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred hhccCccc--ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccc
Confidence 87543222 2234679999999999986 578999999999999999999999997654322221111100000
Q ss_pred ---ccccccccccCcccCCCCC-----hHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCcccccCc
Q 011851 353 ---GERRRFYRLIDPCLEGCFS-----IKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDMASS 415 (476)
Q Consensus 353 ---~~~~~~~~~~d~~l~~~~~-----~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~~~~~ 415 (476)
.....+.....+....... ...+.++.+||.+||+.||++|||+.++++| |||++....
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h----p~f~~~~~~ 294 (311)
T 4agu_A 228 QVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH----PYFENIREI 294 (311)
T ss_dssp HHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS----GGGTTCC--
T ss_pred cccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC----hHHHhccCH
Confidence 0000000000000000000 1225678999999999999999999999997 999987544
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-47 Score=375.64 Aligned_cols=257 Identities=24% Similarity=0.296 Sum_probs=185.4
Q ss_pred cccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCCC-CCceeeEEEEEEeCCeeEE
Q 011851 126 ECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLI-HPNLVKLIGCCIEDDQRLL 204 (476)
Q Consensus 126 ~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~~l 204 (476)
.+.||+|+||.||+|.+. .+|+.||||++... ....+.+|+.+|+.+. ||||+++++++.+++..||
T Consensus 16 ~~~lG~G~~g~V~~~~~~---------~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~l 83 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHK---------KSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFL 83 (325)
T ss_dssp SCCSEEETTEEEEEEEET---------TTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred CCccccCCCeEEEEEEEC---------CCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEE
Confidence 378999999999998654 47888999999653 3456788999999997 9999999999999999999
Q ss_pred EEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCC---ceEEeecCCcCCC
Q 011851 205 VYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEY---NAKLSDFGLAKDG 281 (476)
Q Consensus 205 V~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~---~vkl~DFG~a~~~ 281 (476)
||||+++++|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++ .+||+|||+++..
T Consensus 84 v~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~ 159 (325)
T 3kn6_A 84 VMELLNGGELFERIKKK-KHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLK 159 (325)
T ss_dssp EECCCCSCBHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEEC
T ss_pred EEEccCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccceec
Confidence 99999999999999654 57999999999999999999999988 99999999999997765 8999999999865
Q ss_pred CCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcch-hHHhhhhhhcccccccc
Q 011851 282 PEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHN-LVEWARPQLGERRRFYR 360 (476)
Q Consensus 282 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 360 (476)
..... .....+||+.|+|||++.+..|+.++|||||||++|+|++|+.||.......... ..+.......... .
T Consensus 160 ~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~---~ 234 (325)
T 3kn6_A 160 PPDNQ--PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDF---S 234 (325)
T ss_dssp CC------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCC---C
T ss_pred CCCCC--cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCC---C
Confidence 43222 2234678999999999999999999999999999999999999997654321111 1111110000000 0
Q ss_pred ccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCcccc
Q 011851 361 LIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDM 412 (476)
Q Consensus 361 ~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~~ 412 (476)
..... ....+.++.+||.+||+.||++|||+.++++| ||+++.
T Consensus 235 ~~~~~-----~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h----~w~~~~ 277 (325)
T 3kn6_A 235 FEGEA-----WKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYN----EWLQDG 277 (325)
T ss_dssp CCSHH-----HHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTC----GGGCTT
T ss_pred CCccc-----ccCCCHHHHHHHHHHCCCChhHCCCHHHHhcC----hhhccC
Confidence 00000 01226789999999999999999999999887 999864
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-47 Score=365.62 Aligned_cols=258 Identities=26% Similarity=0.378 Sum_probs=190.9
Q ss_pred ccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCC---ccCHHHHHHHHHHHhCCCCCceeeEEEEE
Q 011851 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDG---LQGHKEWLAEVNYLGGLIHPNLVKLIGCC 196 (476)
Q Consensus 120 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~ 196 (476)
.++|++.+.||+|+||.||+|.+. .+|+.||||++.... ....+.+.+|+.++++++||||+++++++
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~---------~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 80 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESI---------HTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYF 80 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET---------TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEc---------cCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEE
Confidence 356999999999999999998654 467889999996532 12346788999999999999999999999
Q ss_pred EeCCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecC
Q 011851 197 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFG 276 (476)
Q Consensus 197 ~~~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG 276 (476)
.+.+..|+||||+++++|.+++......+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||
T Consensus 81 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg 157 (278)
T 3cok_A 81 EDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFG 157 (278)
T ss_dssp ECSSEEEEEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCT
T ss_pred ccCCeEEEEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeec
Confidence 9999999999999999999999776678999999999999999999999988 9999999999999999999999999
Q ss_pred CcCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhcccc
Q 011851 277 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERR 356 (476)
Q Consensus 277 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~ 356 (476)
++........ ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+ ..
T Consensus 158 ~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~------~~--- 226 (278)
T 3cok_A 158 LATQLKMPHE--KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKV------VL--- 226 (278)
T ss_dssp TCEECC------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----C------CS---
T ss_pred ceeeccCCCC--cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHH------hh---
Confidence 9987543221 122367999999999999999999999999999999999999999765432211100 00
Q ss_pred ccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCccccc
Q 011851 357 RFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDMA 413 (476)
Q Consensus 357 ~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~~~ 413 (476)
.+. ..+...+.++.+||.+||+.||++|||+.++++| |||.+..
T Consensus 227 -----~~~----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h----~~~~~~~ 270 (278)
T 3cok_A 227 -----ADY----EMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDH----PFMSRNS 270 (278)
T ss_dssp -----SCC----CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS----TTTC---
T ss_pred -----ccc----CCccccCHHHHHHHHHHcccCHhhCCCHHHHhcC----ccccCCC
Confidence 000 0111235688999999999999999999999987 9988654
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=370.44 Aligned_cols=275 Identities=26% Similarity=0.309 Sum_probs=203.7
Q ss_pred hccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCc-----cCHHHHHHHHHHHhCCC---CCcee
Q 011851 119 ATKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL-----QGHKEWLAEVNYLGGLI---HPNLV 190 (476)
Q Consensus 119 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~-----~~~~~~~~E~~~l~~l~---hpnIv 190 (476)
..++|++.+.||+|+||+||+|.+. .+|+.||||++..... .....+.+|+.+++.+. ||||+
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv 77 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDP---------HSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVV 77 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECT---------TTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBC
T ss_pred cccceEEEEEEecCCCeEEEEEEEC---------CCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeE
Confidence 3568999999999999999998654 4788899999874321 12345667777777664 99999
Q ss_pred eEEEEEEeCC-----eeEEEEEecCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeee
Q 011851 191 KLIGCCIEDD-----QRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILL 264 (476)
Q Consensus 191 ~l~~~~~~~~-----~~~lV~E~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl 264 (476)
++++++.... .+++||||+. ++|.+++.... ..+++..++.++.||+.||.|||+++ |+||||||+|||+
T Consensus 78 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~ 153 (308)
T 3g33_A 78 RLMDVCATSRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILV 153 (308)
T ss_dssp CEEEEEEECCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEE
T ss_pred EeeeeeeccCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEE
Confidence 9999998765 5899999996 59999996643 34999999999999999999999988 9999999999999
Q ss_pred cCCCceEEeecCCcCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchh
Q 011851 265 DGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNL 344 (476)
Q Consensus 265 ~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~ 344 (476)
+.++.+||+|||+++....... ....+||+.|+|||++.+..++.++|||||||++|+|++|+.||...........
T Consensus 154 ~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~ 230 (308)
T 3g33_A 154 TSGGTVKLADFGLARIYSYQMA---LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGK 230 (308)
T ss_dssp CTTSCEEECSCSCTTTSTTCCC---SGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHH
T ss_pred cCCCCEEEeeCccccccCCCcc---cCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 9999999999999987543222 2346899999999999999999999999999999999999999976543221111
Q ss_pred HHhhhhhhcc--ccccccc----cCcc---cCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCccccc
Q 011851 345 VEWARPQLGE--RRRFYRL----IDPC---LEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDMA 413 (476)
Q Consensus 345 ~~~~~~~~~~--~~~~~~~----~d~~---l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~~~ 413 (476)
+......... ......+ +.+. .........++.+.+||.+||+.||++|||+.++++| |||++..
T Consensus 231 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h----~~~~~~~ 304 (308)
T 3g33_A 231 IFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH----SYLHKDE 304 (308)
T ss_dssp HHHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS----TTC----
T ss_pred HHHHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC----ccccCCC
Confidence 1000000000 0000000 0000 0000011235788999999999999999999999997 9998653
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-47 Score=384.03 Aligned_cols=277 Identities=18% Similarity=0.216 Sum_probs=210.5
Q ss_pred ccCCCcccccccc--CCccEEEEEEccCCceeeeCCCCceEEEEEecCCCcc--CHHHHHHHHHHHhCCCCCceeeEEEE
Q 011851 120 TKSFRPECLLGEG--GFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQ--GHKEWLAEVNYLGGLIHPNLVKLIGC 195 (476)
Q Consensus 120 ~~~y~~~~~LG~G--~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~l~~~ 195 (476)
.++|++.++||+| +||.||+|.+. .+|+.||||++...... ..+.+.+|+.+|+.++||||++++++
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~---------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~ 94 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYK---------PTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRAT 94 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEET---------TTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEc---------CCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEE
Confidence 4579999999999 99999998764 47888999999765432 23567889999999999999999999
Q ss_pred EEeCCeeEEEEEecCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEee
Q 011851 196 CIEDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSD 274 (476)
Q Consensus 196 ~~~~~~~~lV~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~D 274 (476)
+.+++.+|||||||++++|.+++... ...+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|
T Consensus 95 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~d 171 (389)
T 3gni_B 95 FIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSG 171 (389)
T ss_dssp EEETTEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECC
T ss_pred EEECCEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcc
Confidence 99999999999999999999999664 356999999999999999999999988 99999999999999999999999
Q ss_pred cCCcCCCCCCCc-----cceeeeeecCCCCCCcchhhc--CCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHh
Q 011851 275 FGLAKDGPEGDK-----THVSTRVMGTYGYAAPEYVMT--GHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEW 347 (476)
Q Consensus 275 FG~a~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~ 347 (476)
||++........ .......+||+.|+|||++.+ ..|+.++|||||||++|||++|+.||.......... ..
T Consensus 172 fg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~--~~ 249 (389)
T 3gni_B 172 LRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLL--EK 249 (389)
T ss_dssp GGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHH--HC
T ss_pred cccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHH--HH
Confidence 998864322111 011122478999999999987 579999999999999999999999997654432211 10
Q ss_pred hhhhhcc---c-----c-------------cccccc---------CcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHH
Q 011851 348 ARPQLGE---R-----R-------------RFYRLI---------DPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMS 397 (476)
Q Consensus 348 ~~~~~~~---~-----~-------------~~~~~~---------d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ 397 (476)
....... . . .+...+ .......+....+.++.+||.+||+.||++|||+.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ 329 (389)
T 3gni_B 250 LNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSAS 329 (389)
T ss_dssp --------------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHH
T ss_pred hcCCCCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHH
Confidence 0000000 0 0 000000 00000011222356799999999999999999999
Q ss_pred HHHHHhcCCCCcccccC
Q 011851 398 EVVEALKPLPYLKDMAS 414 (476)
Q Consensus 398 ell~~L~~~~~~~~~~~ 414 (476)
++++| |||+....
T Consensus 330 ell~h----p~f~~~~~ 342 (389)
T 3gni_B 330 TLLNH----SFFKQIKR 342 (389)
T ss_dssp HHTTS----GGGGGC--
T ss_pred HHhcC----HHHHHHhh
Confidence 99987 99987654
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-47 Score=398.46 Aligned_cols=260 Identities=30% Similarity=0.413 Sum_probs=214.0
Q ss_pred ccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCC---ccCHHHHHHHHHHHhCCCCCceeeEEEEE
Q 011851 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDG---LQGHKEWLAEVNYLGGLIHPNLVKLIGCC 196 (476)
Q Consensus 120 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~ 196 (476)
.++|++.++||+|+||.||+|.+. .+|+.||||++.+.. ......+.+|+++|+.++||||+++++++
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~---------~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~ 253 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVR---------ATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAY 253 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET---------TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccceEEEEEEeeCCCEEEEEEEEC---------CCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEE
Confidence 467999999999999999998654 478899999996532 22345678999999999999999999999
Q ss_pred EeCCeeEEEEEecCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeec
Q 011851 197 IEDDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDF 275 (476)
Q Consensus 197 ~~~~~~~lV~E~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DF 275 (476)
.+.+.+||||||++||+|.+++.... ..+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+||
T Consensus 254 ~~~~~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DF 330 (576)
T 2acx_A 254 ETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDL 330 (576)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCC
T ss_pred eeCCEEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEec
Confidence 99999999999999999999996543 35999999999999999999999988 999999999999999999999999
Q ss_pred CCcCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhccc
Q 011851 276 GLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGER 355 (476)
Q Consensus 276 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~ 355 (476)
|+++....... ....+||+.|+|||++.+..|+.++|||||||++|||++|+.||...........+... .....
T Consensus 331 Gla~~~~~~~~---~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~--i~~~~ 405 (576)
T 2acx_A 331 GLAVHVPEGQT---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERL--VKEVP 405 (576)
T ss_dssp TTCEECCTTCC---EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHH--HHHCC
T ss_pred ccceecccCcc---ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHH--hhccc
Confidence 99987654322 23468999999999999999999999999999999999999999865433221111110 00000
Q ss_pred cccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHhcCCCCcccc
Q 011851 356 RRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARP-----RMSEVVEALKPLPYLKDM 412 (476)
Q Consensus 356 ~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RP-----t~~ell~~L~~~~~~~~~ 412 (476)
..++...+.++.+||.+||+.||.+|| ++.||++| |||+++
T Consensus 406 ------------~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H----pfF~~i 451 (576)
T 2acx_A 406 ------------EEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEH----PLFKKL 451 (576)
T ss_dssp ------------CCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS----GGGTTC
T ss_pred ------------ccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC----hhhccC
Confidence 012223367899999999999999999 78888887 888864
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-47 Score=376.87 Aligned_cols=275 Identities=21% Similarity=0.288 Sum_probs=201.1
Q ss_pred ccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccC--HHHHHHHHHHHhCCCCCceeeEEEEEE
Q 011851 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQG--HKEWLAEVNYLGGLIHPNLVKLIGCCI 197 (476)
Q Consensus 120 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~--~~~~~~E~~~l~~l~hpnIv~l~~~~~ 197 (476)
.++|++.+.||+|+||+||+|.+. .+++.||||+++...... .+.+.+|+.+|++++||||+++++++.
T Consensus 33 ~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 103 (329)
T 3gbz_A 33 IDRYRRITKLGEGTYGEVYKAIDT---------VTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIH 103 (329)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEET---------TTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEE
T ss_pred hhhEEEEEEEEecCCeEEEEEEEC---------CCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEe
Confidence 457999999999999999998654 478889999997654322 345778999999999999999999999
Q ss_pred eCCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeee-----cCCCceEE
Q 011851 198 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILL-----DGEYNAKL 272 (476)
Q Consensus 198 ~~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl-----~~~~~vkl 272 (476)
+++.+||||||++ ++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||| +.++.+||
T Consensus 104 ~~~~~~lv~e~~~-~~L~~~~~~~-~~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl 178 (329)
T 3gbz_A 104 HNHRLHLIFEYAE-NDLKKYMDKN-PDVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKI 178 (329)
T ss_dssp ETTEEEEEEECCS-EEHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEE
T ss_pred cCCEEEEEEecCC-CCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEE
Confidence 9999999999997 5999998554 46999999999999999999999988 9999999999999 45556999
Q ss_pred eecCCcCCCCCCCccceeeeeecCCCCCCcchhhcC-CCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhh--
Q 011851 273 SDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR-- 349 (476)
Q Consensus 273 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~-- 349 (476)
+|||+++....... .....+||+.|+|||++.+. .++.++|||||||++|||++|+.||...........+....
T Consensus 179 ~Dfg~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~ 256 (329)
T 3gbz_A 179 GDFGLARAFGIPIR--QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGL 256 (329)
T ss_dssp CCTTHHHHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCC
T ss_pred CcCCCccccCCccc--ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCC
Confidence 99999976432211 22346789999999999875 58999999999999999999999997643321111110000
Q ss_pred hhhccc----------cccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCcccccC
Q 011851 350 PQLGER----------RRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDMAS 414 (476)
Q Consensus 350 ~~~~~~----------~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~~~~ 414 (476)
+..... ..+.......+...+....+.++.+||.+||+.||++|||+.|+++| |||++...
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h----p~f~~~~~ 327 (329)
T 3gbz_A 257 PDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEH----PYFSHNDF 327 (329)
T ss_dssp CCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS----GGGSSSCS
T ss_pred CchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCC----cccCCCCC
Confidence 000000 00000000000000111135788999999999999999999999997 99987653
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-47 Score=381.52 Aligned_cols=279 Identities=23% Similarity=0.258 Sum_probs=213.7
Q ss_pred cccChhHHHHhccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCCC---
Q 011851 109 RKFSFNELKSATKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLI--- 185 (476)
Q Consensus 109 ~~~~~~~~~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~--- 185 (476)
..+++.+.....++|++.++||+|+||+||+|.+. .+++.||||++.... .....+..|+.+|+.+.
T Consensus 23 ~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~---------~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~~~ 92 (360)
T 3llt_A 23 VHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHI---------DNKKYYAVKVVRNIK-KYTRSAKIEADILKKIQNDD 92 (360)
T ss_dssp GSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEET---------TTCCEEEEEEECSCH-HHHHHHHHHHHHHHHTCCCS
T ss_pred eeeeeecceEecCEEEEEEEEcccCCeEEEEEEEC---------CCCeEEEEEEeccch-hhhhhhHHHHHHHHHhcccC
Confidence 34555555666789999999999999999998764 467889999997432 23455678999999886
Q ss_pred --CCceeeEEEEEEeCCeeEEEEEecCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCe
Q 011851 186 --HPNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNI 262 (476)
Q Consensus 186 --hpnIv~l~~~~~~~~~~~lV~E~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NI 262 (476)
||||+++++++...+..||||||+ +++|.+++.... ..+++..++.++.||+.||.|||+++ |+||||||+||
T Consensus 93 ~~h~~iv~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NI 168 (360)
T 3llt_A 93 INNNNIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENI 168 (360)
T ss_dssp TTGGGBCCEEEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGE
T ss_pred CCCCCeecccceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccE
Confidence 999999999999999999999999 899999997653 45999999999999999999999988 99999999999
Q ss_pred eecC-------------------------CCceEEeecCCcCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhh
Q 011851 263 LLDG-------------------------EYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVY 317 (476)
Q Consensus 263 Ll~~-------------------------~~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diw 317 (476)
||+. ++.+||+|||+++..... ....+||+.|+|||++.+..++.++|||
T Consensus 169 ll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Diw 243 (360)
T 3llt_A 169 LLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY-----HGSIINTRQYRAPEVILNLGWDVSSDMW 243 (360)
T ss_dssp EESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC-----CCSCCSCGGGCCHHHHTTCCCCTTHHHH
T ss_pred EEccccccccccchhcccccccccccccCCCCEEEEeccCceecCCC-----CcCccCcccccCcHHHcCCCCCCccchH
Confidence 9975 789999999999864332 2246799999999999999999999999
Q ss_pred hhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhccc-------cccccccCc-----ccCCC-------------CC-
Q 011851 318 SFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGER-------RRFYRLIDP-----CLEGC-------------FS- 371 (476)
Q Consensus 318 slGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~d~-----~l~~~-------------~~- 371 (476)
||||++|+|++|+.||...........+.......... ......++. .+... .+
T Consensus 244 slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~ 323 (360)
T 3llt_A 244 SFGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPL 323 (360)
T ss_dssp HHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCH
T ss_pred HHHHHHHHHHHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccc
Confidence 99999999999999997654322211111110000000 000000000 00000 00
Q ss_pred --hHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCcc
Q 011851 372 --IKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLK 410 (476)
Q Consensus 372 --~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~ 410 (476)
...++.+.+||.+||+.||++|||+.|+|+| |||+
T Consensus 324 ~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~h----p~f~ 360 (360)
T 3llt_A 324 YKIIKHELFCDFLYSILQIDPTLRPSPAELLKH----KFLE 360 (360)
T ss_dssp HHHCCCHHHHHHHHHHCCSSGGGSCCHHHHTTS----GGGC
T ss_pred cccchHHHHHHHHHHHhcCChhhCCCHHHHhcC----cccC
Confidence 0012678899999999999999999999987 8875
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=386.87 Aligned_cols=261 Identities=27% Similarity=0.375 Sum_probs=206.9
Q ss_pred cCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCc-cCHHHHHHHHHHHhCCCCCceeeEEEEEEeC
Q 011851 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL-QGHKEWLAEVNYLGGLIHPNLVKLIGCCIED 199 (476)
Q Consensus 121 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~ 199 (476)
++|++.+.||+|+||+||+|.+... .+..+++.||||+++.... .....+.+|+.+|++++||||+++++++.+.
T Consensus 71 ~~~~~~~~LG~G~fg~Vy~~~~~~~----~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 146 (367)
T 3l9p_A 71 KNITLIRGLGHGAFGEVYEGQVSGM----PNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQS 146 (367)
T ss_dssp GGEEEEEECCCCSSSCEEEEEECC---------CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hHeEEeeEeeeCCCEEEEEEEEccC----CCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecC
Confidence 5699999999999999999986532 1234788999999975432 2345688999999999999999999999999
Q ss_pred CeeEEEEEecCCCCHHHHHhhcC------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCC---ce
Q 011851 200 DQRLLVYEFMPRGSLENHLFRRS------LPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEY---NA 270 (476)
Q Consensus 200 ~~~~lV~E~~~~g~L~~~l~~~~------~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~---~v 270 (476)
+..|||||||++|+|.+++.... ..+++..++.++.||+.||.|||+++ |+||||||+||||+.++ .+
T Consensus 147 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~ 223 (367)
T 3l9p_A 147 LPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVA 223 (367)
T ss_dssp SSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCE
T ss_pred CCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceE
Confidence 99999999999999999997543 45899999999999999999999988 99999999999998555 59
Q ss_pred EEeecCCcCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHh-CCCCCCCCCCCCcchhHHhhh
Q 011851 271 KLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWAR 349 (476)
Q Consensus 271 kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~ellt-G~~pf~~~~~~~~~~~~~~~~ 349 (476)
||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++ |..||....... +.....
T Consensus 224 kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~---~~~~i~ 300 (367)
T 3l9p_A 224 KIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE---VLEFVT 300 (367)
T ss_dssp EECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH---HHHHHH
T ss_pred EECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHH
Confidence 9999999974322122222233568999999999999999999999999999999998 999997643221 111111
Q ss_pred hhhccccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 011851 350 PQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKP 405 (476)
Q Consensus 350 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~ 405 (476)
. .. ....+...+..+.+||.+||+.||++|||+.+|+++|+.
T Consensus 301 ~----~~----------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~ 342 (367)
T 3l9p_A 301 S----GG----------RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEY 342 (367)
T ss_dssp T----TC----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred c----CC----------CCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 0 00 000112235688999999999999999999999999653
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=388.59 Aligned_cols=257 Identities=25% Similarity=0.419 Sum_probs=208.4
Q ss_pred ccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCcc-CHHHHHHHHHHHhCCCCCceeeEEEEEEe
Q 011851 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQ-GHKEWLAEVNYLGGLIHPNLVKLIGCCIE 198 (476)
Q Consensus 120 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~~ 198 (476)
.++|.+.+.||+|+||.||+|.+. .+++.||||+++..... ...++.+|+++|++++||||+++++++.+
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~---------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 183 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLR---------ADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQ 183 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET---------TTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECS
T ss_pred hHHeEEeeEeccCCCCeEEEEEEe---------cCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEec
Confidence 457899999999999999998765 36778999999754322 23457889999999999999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCc
Q 011851 199 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLA 278 (476)
Q Consensus 199 ~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a 278 (476)
++..||||||+++|+|.+++......+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 184 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s 260 (377)
T 3cbl_A 184 KQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMS 260 (377)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGC
T ss_pred CCCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCc
Confidence 99999999999999999999776667999999999999999999999988 999999999999999999999999999
Q ss_pred CCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhhccccc
Q 011851 279 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPQLGERRR 357 (476)
Q Consensus 279 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 357 (476)
+...............+++.|+|||++.+..++.++|||||||++|||++ |..||....... ...... ....
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~---~~~~~~----~~~~ 333 (377)
T 3cbl_A 261 REEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQ---TREFVE----KGGR 333 (377)
T ss_dssp EECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHH---HHHHHH----TTCC
T ss_pred eecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHH----cCCC
Confidence 86443221111112346778999999999999999999999999999998 999997643221 111110 0000
Q ss_pred cccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 011851 358 FYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKP 405 (476)
Q Consensus 358 ~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~ 405 (476)
. + .+...+.++.+||.+||+.||++|||+.+|++.|+.
T Consensus 334 ---~--~-----~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~ 371 (377)
T 3cbl_A 334 ---L--P-----CPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQS 371 (377)
T ss_dssp ---C--C-----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ---C--C-----CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHH
Confidence 0 0 111235789999999999999999999999998764
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-47 Score=376.58 Aligned_cols=263 Identities=25% Similarity=0.377 Sum_probs=211.8
Q ss_pred ccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCc-cCHHHHHHHHHHHhCC-CCCceeeEEEEEE
Q 011851 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL-QGHKEWLAEVNYLGGL-IHPNLVKLIGCCI 197 (476)
Q Consensus 120 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~-~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~ 197 (476)
.++|++.+.||+|+||.||+|.+... .+..+++.||||++..... ...+.+.+|+.+|+++ .||||+++++++.
T Consensus 44 ~~~y~~~~~lG~G~~g~V~~~~~~~~----~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 119 (344)
T 1rjb_A 44 RENLEFGKVLGSGAFGKVMNATAYGI----SKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACT 119 (344)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESC----SSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred HHHceeeeeecCCCCceeEEeeeecc----ccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence 46799999999999999999986421 1234677899999975432 2346788999999999 8999999999999
Q ss_pred eCCeeEEEEEecCCCCHHHHHhhcCC----------------------CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEec
Q 011851 198 EDDQRLLVYEFMPRGSLENHLFRRSL----------------------PLPWSIRMKIALDAAKGLAFLHEEAEKPVIYR 255 (476)
Q Consensus 198 ~~~~~~lV~E~~~~g~L~~~l~~~~~----------------------~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHr 255 (476)
..+..||||||+++|+|.+++..... .+++..++.++.||+.||.|||+++ |+||
T Consensus 120 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~ 196 (344)
T 1rjb_A 120 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHR 196 (344)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEET
T ss_pred eCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cccC
Confidence 99999999999999999999976432 3789999999999999999999988 9999
Q ss_pred CCCCCCeeecCCCceEEeecCCcCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHh-CCCCCC
Q 011851 256 DFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLT-GRRSMD 334 (476)
Q Consensus 256 DlKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~ellt-G~~pf~ 334 (476)
||||+||||+.++.+||+|||++................||+.|+|||++.+..++.++|||||||++|+|+| |..||.
T Consensus 197 Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~ 276 (344)
T 1rjb_A 197 DLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP 276 (344)
T ss_dssp TCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred CCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcc
Confidence 9999999999999999999999987644333333344678999999999999999999999999999999998 999997
Q ss_pred CCCCCCcchhHHhhhhhhccccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 011851 335 KNRPNGEHNLVEWARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKP 405 (476)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~ 405 (476)
....... ........ .....+...+.++.+||.+||+.||.+|||+.+++++|+.
T Consensus 277 ~~~~~~~--~~~~~~~~--------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~ 331 (344)
T 1rjb_A 277 GIPVDAN--FYKLIQNG--------------FKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGC 331 (344)
T ss_dssp TCCCSHH--HHHHHHTT--------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred cCCcHHH--HHHHHhcC--------------CCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHH
Confidence 6543221 11111100 0001112236789999999999999999999999999764
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-47 Score=364.85 Aligned_cols=259 Identities=21% Similarity=0.267 Sum_probs=211.7
Q ss_pred ccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCCCCCceeeEEEEEEeC
Q 011851 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHPNLVKLIGCCIED 199 (476)
Q Consensus 120 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~ 199 (476)
.++|++.+.||+|+||.||+|.+. .++..||+|++........+.+.+|+++|++++||||+++++++.+.
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 78 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQK---------GTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDN 78 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEET---------TTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred hhhEEeeeEEeecCCEEEEEEEeC---------CCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence 457999999999999999998654 46778999999876666778899999999999999999999999999
Q ss_pred CeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeee---cCCCceEEeecC
Q 011851 200 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILL---DGEYNAKLSDFG 276 (476)
Q Consensus 200 ~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl---~~~~~vkl~DFG 276 (476)
+..|+||||+++++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||+ +.++.+||+|||
T Consensus 79 ~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg 154 (277)
T 3f3z_A 79 TDIYLVMELCTGGELFERVVHK-RVFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFG 154 (277)
T ss_dssp SEEEEEEECCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCT
T ss_pred CeEEEEEeccCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecc
Confidence 9999999999999999988654 46999999999999999999999988 9999999999999 788999999999
Q ss_pred CcCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhcccc
Q 011851 277 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERR 356 (476)
Q Consensus 277 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~ 356 (476)
++........ .....||+.|+|||++.+. ++.++|||||||++|+|++|+.||........... ... ...
T Consensus 155 ~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~--~~~----~~~ 224 (277)
T 3f3z_A 155 LAARFKPGKM---MRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLK--IRE----GTF 224 (277)
T ss_dssp TCEECCTTSC---BCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH--HHH----CCC
T ss_pred cceeccCccc---hhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHH--HHh----CCC
Confidence 9987544322 2346799999999987654 89999999999999999999999976432111110 000 000
Q ss_pred ccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCccccc
Q 011851 357 RFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDMA 413 (476)
Q Consensus 357 ~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~~~ 413 (476)
. ...... ...+..+.+||.+||+.||++|||+.++++| |||++..
T Consensus 225 ~---~~~~~~-----~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h----~~~~~~~ 269 (277)
T 3f3z_A 225 T---FPEKDW-----LNVSPQAESLIRRLLTKSPKQRITSLQALEH----EWFEKQL 269 (277)
T ss_dssp C---CCHHHH-----TTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS----HHHHHHH
T ss_pred C---CCchhh-----hcCCHHHHHHHHHHccCChhhCcCHHHHhcC----HHHhccc
Confidence 0 000000 0125688999999999999999999999987 8887643
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-47 Score=377.93 Aligned_cols=258 Identities=22% Similarity=0.331 Sum_probs=206.1
Q ss_pred ccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCC-CCCceeeEEEEEEe
Q 011851 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGL-IHPNLVKLIGCCIE 198 (476)
Q Consensus 120 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~ 198 (476)
.++|++.+.||+|+||.||+|.+. .+|+.||||++...... ..+|+++|.++ +||||+++++++.+
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~---------~~~~~~avK~~~~~~~~----~~~E~~~l~~~~~hp~iv~~~~~~~~ 87 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHK---------ATNMEFAVKIIDKSKRD----PTEEIEILLRYGQHPNIITLKDVYDD 87 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEET---------TTTEEEEEEEEETTTCC----CHHHHHHHHHHTTSTTBCCEEEEEEC
T ss_pred cccEEEEEEEeeCCCEEEEEEEEC---------CCCCEEEEEEEEcccCC----hHHHHHHHHHhcCCCCcCeEEEEEEc
Confidence 456999999999999999998654 57888999999765433 34688888877 79999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCC----CceEEee
Q 011851 199 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGE----YNAKLSD 274 (476)
Q Consensus 199 ~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~----~~vkl~D 274 (476)
++.+|||||||+||+|.+++.+. ..+++..+..++.||+.||.|||+++ |+||||||+|||+..+ +.+||+|
T Consensus 88 ~~~~~lv~E~~~gg~L~~~i~~~-~~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~D 163 (342)
T 2qr7_A 88 GKYVYVVTELMKGGELLDKILRQ-KFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICD 163 (342)
T ss_dssp SSEEEEEECCCCSCBHHHHHHTC-TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECC
T ss_pred CCEEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEE
Confidence 99999999999999999999554 57999999999999999999999988 9999999999998433 3599999
Q ss_pred cCCcCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhcc
Q 011851 275 FGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGE 354 (476)
Q Consensus 275 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~ 354 (476)
||+++....... .....+||+.|+|||++.+..|+.++|||||||++|||++|..||..........+.......
T Consensus 164 fg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~--- 238 (342)
T 2qr7_A 164 FGFAKQLRAENG--LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSG--- 238 (342)
T ss_dssp CTTCEECBCTTC--CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHC---
T ss_pred CCCcccCcCCCC--ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccC---
Confidence 999986543222 223468999999999999888999999999999999999999999764332222222111100
Q ss_pred ccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCccc
Q 011851 355 RRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKD 411 (476)
Q Consensus 355 ~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~ 411 (476)
.. . +...+....+.++.+||.+||..||++|||+.++++| ||+.+
T Consensus 239 ~~---~-----~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~h----p~~~~ 283 (342)
T 2qr7_A 239 KF---S-----LSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRH----PWIVH 283 (342)
T ss_dssp CC---C-----CCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS----HHHHT
T ss_pred Cc---c-----cCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC----CeecC
Confidence 00 0 0111112236789999999999999999999999987 88754
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=371.49 Aligned_cols=261 Identities=23% Similarity=0.316 Sum_probs=213.1
Q ss_pred ccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCcc------CHHHHHHHHHHHhCCCCCceeeEE
Q 011851 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQ------GHKEWLAEVNYLGGLIHPNLVKLI 193 (476)
Q Consensus 120 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~------~~~~~~~E~~~l~~l~hpnIv~l~ 193 (476)
.++|++.+.||+|+||.||+|.+. .+|+.||+|++...... ..+.+.+|+.+|++++||||++++
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 81 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREK---------STGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLH 81 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEET---------TTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred hccEEEeeEeeecCCEEEEEEEEC---------CCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEE
Confidence 456999999999999999998654 47888999999764332 356789999999999999999999
Q ss_pred EEEEeCCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCC----c
Q 011851 194 GCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEY----N 269 (476)
Q Consensus 194 ~~~~~~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~----~ 269 (476)
+++.+.+..|+||||+++++|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++ .
T Consensus 82 ~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~ 157 (321)
T 2a2a_A 82 DVYENRTDVVLILELVSGGELFDFLAQ-KESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPH 157 (321)
T ss_dssp EEEECSSEEEEEECCCCSCBHHHHHHT-CSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCC
T ss_pred EEEecCCEEEEEEEcCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCC
Confidence 999999999999999999999999954 457999999999999999999999988 99999999999999888 7
Q ss_pred eEEeecCCcCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhh
Q 011851 270 AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR 349 (476)
Q Consensus 270 vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~ 349 (476)
+||+|||++........ .....||+.|+|||++.+..++.++|||||||++|+|++|..||....... ......
T Consensus 158 ~kl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~~~i~ 231 (321)
T 2a2a_A 158 IKLIDFGLAHEIEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE---TLANIT 231 (321)
T ss_dssp EEECCCTTCEECCTTCC---CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH---HHHHHH
T ss_pred EEEccCccceecCcccc---ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHH---HHHHHH
Confidence 99999999987654322 234679999999999999999999999999999999999999997543211 111000
Q ss_pred hhhccccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCcccccC
Q 011851 350 PQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDMAS 414 (476)
Q Consensus 350 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~~~~ 414 (476)
..... .++.. ....+..+.+||.+||+.||++|||+.++++| ||+.....
T Consensus 232 ---~~~~~----~~~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~h----p~~~~~~~ 281 (321)
T 2a2a_A 232 ---SVSYD----FDEEF----FSHTSELAKDFIRKLLVKETRKRLTIQEALRH----PWITPVDN 281 (321)
T ss_dssp ---TTCCC----CCHHH----HTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHS----TTTSCSSH
T ss_pred ---hcccc----cChhh----hcccCHHHHHHHHHHcCCChhhCcCHHHHhcC----ccccCCCc
Confidence 00000 00000 01125678999999999999999999999998 99986543
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=365.75 Aligned_cols=256 Identities=26% Similarity=0.356 Sum_probs=203.8
Q ss_pred cCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCc-cCHHHHHHHHHHHhCCCCCceeeEEEEEEeC
Q 011851 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL-QGHKEWLAEVNYLGGLIHPNLVKLIGCCIED 199 (476)
Q Consensus 121 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~ 199 (476)
++|++.+.||+|+||.||+|.+. .+++.||+|++..... ...+.+.+|+++|++++||||+++++++.+.
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 92 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEER---------SSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDY 92 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEET---------TTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred hheeecceeccCCCeEEEEEEEc---------cCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecC
Confidence 46999999999999999998654 4678899999876543 3457789999999999999999999999999
Q ss_pred CeeEEEEEecCCCCHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeee---cCCCceEEe
Q 011851 200 DQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILL---DGEYNAKLS 273 (476)
Q Consensus 200 ~~~~lV~E~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl---~~~~~vkl~ 273 (476)
+..|+||||+++++|.+++.. ....+++..++.++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+
T Consensus 93 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~ 169 (285)
T 3is5_A 93 HNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKII 169 (285)
T ss_dssp SEEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEEC
T ss_pred CeEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEE
Confidence 999999999999999999854 2467999999999999999999999988 9999999999999 556789999
Q ss_pred ecCCcCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhc
Q 011851 274 DFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLG 353 (476)
Q Consensus 274 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~ 353 (476)
|||++........ .....||+.|+|||++. ..++.++|||||||++|+|++|+.||..............
T Consensus 170 Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~------ 239 (285)
T 3is5_A 170 DFGLAELFKSDEH---STNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATY------ 239 (285)
T ss_dssp CCCCCCC-------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH------
T ss_pred eeecceecCCccc---CcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhcc------
Confidence 9999986543221 23467999999999875 5789999999999999999999999976432111111100
Q ss_pred cccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCccc
Q 011851 354 ERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKD 411 (476)
Q Consensus 354 ~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~ 411 (476)
....+ ... ....+.++.+||.+||+.||++|||+.|+++| |||++
T Consensus 240 ~~~~~----~~~-----~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h----p~f~~ 284 (285)
T 3is5_A 240 KEPNY----AVE-----CRPLTPQAVDLLKQMLTKDPERRPSAAQVLHH----EWFKQ 284 (285)
T ss_dssp CCCCC----CC-------CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTS----GGGGC
T ss_pred CCccc----ccc-----cCcCCHHHHHHHHHHccCChhhCcCHHHHhcC----HHhhc
Confidence 00000 000 00125688899999999999999999999997 99875
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=390.18 Aligned_cols=270 Identities=23% Similarity=0.269 Sum_probs=201.5
Q ss_pred ccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCC--ccCHHHHHHHHHHHhCCCCCceeeEEEEEE
Q 011851 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDG--LQGHKEWLAEVNYLGGLIHPNLVKLIGCCI 197 (476)
Q Consensus 120 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~ 197 (476)
.++|++.+.||+|+||+||+|++. .+|+.||||++.... ....+++.+|+.+|+.++||||+++++++.
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~---------~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~ 131 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDA---------VLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFT 131 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEET---------TTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEC
T ss_pred cCCeEEEEEeecCCCeEEEEEEEC---------CCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEc
Confidence 568999999999999999998654 478889999997642 223456889999999999999999999997
Q ss_pred eC------CeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceE
Q 011851 198 ED------DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAK 271 (476)
Q Consensus 198 ~~------~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vk 271 (476)
.. ..+||||||+++ +|.+.+.. .+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+|
T Consensus 132 ~~~~~~~~~~~~lv~E~~~~-~l~~~~~~---~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~k 204 (464)
T 3ttj_A 132 PQKTLEEFQDVYLVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLK 204 (464)
T ss_dssp SCCSTTTCCEEEEEEECCSE-EHHHHHTS---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEE
T ss_pred cCCccccCCeEEEEEeCCCC-CHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEE
Confidence 55 357999999965 57776633 4899999999999999999999988 99999999999999999999
Q ss_pred EeecCCcCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhH-Hhhh-
Q 011851 272 LSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV-EWAR- 349 (476)
Q Consensus 272 l~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~-~~~~- 349 (476)
|+|||+++...... ..+..+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.........+ ....
T Consensus 205 l~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~ 281 (464)
T 3ttj_A 205 ILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGT 281 (464)
T ss_dssp ECCCCCC-----CC---CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCS
T ss_pred EEEEEeeeecCCCc---ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence 99999998754322 234478999999999999999999999999999999999999999765422111110 0000
Q ss_pred --------------hhhccc-----cccccccCcccCCC---CChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCC
Q 011851 350 --------------PQLGER-----RRFYRLIDPCLEGC---FSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLP 407 (476)
Q Consensus 350 --------------~~~~~~-----~~~~~~~d~~l~~~---~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~ 407 (476)
...... ..+...+...+... .....+.++.+||.+||+.||++|||+.|+++| |
T Consensus 282 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H----p 357 (464)
T 3ttj_A 282 PCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH----P 357 (464)
T ss_dssp CCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS----T
T ss_pred CCHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC----h
Confidence 000000 00000000000000 011125689999999999999999999999998 9
Q ss_pred Ccccc
Q 011851 408 YLKDM 412 (476)
Q Consensus 408 ~~~~~ 412 (476)
||+..
T Consensus 358 ~~~~~ 362 (464)
T 3ttj_A 358 YINVW 362 (464)
T ss_dssp TTGGG
T ss_pred hhhhc
Confidence 99753
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-47 Score=381.45 Aligned_cols=261 Identities=25% Similarity=0.436 Sum_probs=199.8
Q ss_pred ccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCc-cCHHHHHHHHHHHhCCCCCceeeEEEEEEe
Q 011851 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL-QGHKEWLAEVNYLGGLIHPNLVKLIGCCIE 198 (476)
Q Consensus 120 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~ 198 (476)
..+|.+.+.||+|+||.||+|++... ..++..||||+++.... ...+++.+|+.+|++++||||+++++++.+
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~------~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 117 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLP------SKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTK 117 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCT------TSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecC------CCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee
Confidence 34799999999999999999976522 23577899999976532 234578999999999999999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCc
Q 011851 199 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLA 278 (476)
Q Consensus 199 ~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a 278 (476)
.+..||||||+++++|.+++.+....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 118 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a 194 (373)
T 2qol_A 118 SKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLG 194 (373)
T ss_dssp SSSCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC---
T ss_pred CCceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCccc
Confidence 99999999999999999999777778999999999999999999999988 999999999999999999999999999
Q ss_pred CCCCCCCccc-eeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhhcccc
Q 011851 279 KDGPEGDKTH-VSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPQLGERR 356 (476)
Q Consensus 279 ~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~ 356 (476)
+......... ......+|+.|+|||++.+..++.++|||||||++|||++ |+.||...... .+..... ...
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~---~~~~~i~----~~~ 267 (373)
T 2qol_A 195 RVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ---DVIKAVD----EGY 267 (373)
T ss_dssp -------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHH---HHHHHHH----TTE
T ss_pred cccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHHH----cCC
Confidence 8764422211 1122346788999999999999999999999999999998 99999754321 1111111 000
Q ss_pred ccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011851 357 RFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPL 406 (476)
Q Consensus 357 ~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~ 406 (476)
. ...+...+..+.+||.+||+.||++||++.+|++.|+.+
T Consensus 268 ~----------~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~ 307 (373)
T 2qol_A 268 R----------LPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307 (373)
T ss_dssp E----------CCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred C----------CCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHH
Confidence 0 001122357899999999999999999999999987643
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-46 Score=372.41 Aligned_cols=252 Identities=21% Similarity=0.293 Sum_probs=209.6
Q ss_pred hccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCcc--------CHHHHHHHHHHHhCCCCCcee
Q 011851 119 ATKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQ--------GHKEWLAEVNYLGGLIHPNLV 190 (476)
Q Consensus 119 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~--------~~~~~~~E~~~l~~l~hpnIv 190 (476)
..++|++.+.||+|+||.||+|.+. .+++.||||++...... ....+.+|+.+|++++||||+
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~---------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv 92 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDK---------EKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANII 92 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEET---------TTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBC
T ss_pred cccceEEEeEEEecCCEEEEEEEEC---------CCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEe
Confidence 3567999999999999999998654 46788999999765422 223567899999999999999
Q ss_pred eEEEEEEeCCeeEEEEEecCCC-CHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCc
Q 011851 191 KLIGCCIEDDQRLLVYEFMPRG-SLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYN 269 (476)
Q Consensus 191 ~l~~~~~~~~~~~lV~E~~~~g-~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~ 269 (476)
++++++.+.+..++||||+.+| +|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.
T Consensus 93 ~~~~~~~~~~~~~lv~e~~~~g~~l~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~ 168 (335)
T 3dls_A 93 KVLDIFENQGFFQLVMEKHGSGLDLFAFIDR-HPRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFT 168 (335)
T ss_dssp CEEEEEECSSEEEEEEECCTTSCBHHHHHHT-CCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSC
T ss_pred eEEEEEeeCCEEEEEEEeCCCCccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCc
Confidence 9999999999999999999776 99998854 457999999999999999999999988 999999999999999999
Q ss_pred eEEeecCCcCCCCCCCccceeeeeecCCCCCCcchhhcCCC-CccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhh
Q 011851 270 AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHL-TAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA 348 (476)
Q Consensus 270 vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~ 348 (476)
+||+|||+++....... ....+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||......
T Consensus 169 ~kL~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--------- 236 (335)
T 3dls_A 169 IKLIDFGSAAYLERGKL---FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET--------- 236 (335)
T ss_dssp EEECCCTTCEECCTTCC---BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG---------
T ss_pred EEEeecccceECCCCCc---eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH---------
Confidence 99999999987654322 234679999999999998876 88999999999999999999999642110
Q ss_pred hhhhccccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCcccccC
Q 011851 349 RPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDMAS 414 (476)
Q Consensus 349 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~~~~ 414 (476)
.. .... .+...+.++.+||.+||+.||++|||+.+++++ |||++...
T Consensus 237 ---~~------~~~~------~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h----p~~~~~~~ 283 (335)
T 3dls_A 237 ---VE------AAIH------PPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD----PWVTQPVN 283 (335)
T ss_dssp ---TT------TCCC------CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC----TTTTCCCC
T ss_pred ---Hh------hccC------CCcccCHHHHHHHHHHccCChhhCcCHHHHhcC----ccccCCcc
Confidence 00 0000 011125789999999999999999999999998 99986543
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-46 Score=362.59 Aligned_cols=255 Identities=30% Similarity=0.523 Sum_probs=205.8
Q ss_pred cCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccC-------HHHHHHHHHHHhCCCCCceeeEE
Q 011851 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQG-------HKEWLAEVNYLGGLIHPNLVKLI 193 (476)
Q Consensus 121 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~-------~~~~~~E~~~l~~l~hpnIv~l~ 193 (476)
++|++.+.||+|+||.||+|.+. .+++.||||++....... .+.+.+|+.++++++||||++++
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~ 89 (287)
T 4f0f_A 19 NEIEYEKQIGKGGFGLVHKGRLV---------KDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLY 89 (287)
T ss_dssp TTEEEEEECCCCSSSCEEEEEET---------TTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEE
T ss_pred ccceehhccccCCceeEEEEEEc---------CCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhh
Confidence 57999999999999999998764 467889999987544322 15688999999999999999999
Q ss_pred EEEEeCCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCc----
Q 011851 194 GCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYN---- 269 (476)
Q Consensus 194 ~~~~~~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~---- 269 (476)
+++.+.. ++||||+++++|.+++......+++..++.++.||+.||.|||+++ .+|+||||||+|||++.++.
T Consensus 90 ~~~~~~~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~ 166 (287)
T 4f0f_A 90 GLMHNPP--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPV 166 (287)
T ss_dssp EEETTTT--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSC
T ss_pred eeecCCC--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCce
Confidence 9986554 7999999999999999877778999999999999999999999865 44999999999999988776
Q ss_pred -eEEeecCCcCCCCCCCccceeeeeecCCCCCCcchhh--cCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHH
Q 011851 270 -AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM--TGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVE 346 (476)
Q Consensus 270 -vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~ 346 (476)
+||+|||+++.... ......||+.|+|||++. ...++.++|||||||++|+|++|+.||.............
T Consensus 167 ~~kl~Dfg~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~ 241 (287)
T 4f0f_A 167 CAKVADFGLSQQSVH-----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINM 241 (287)
T ss_dssp CEEECCCTTCBCCSS-----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHH
T ss_pred eEEeCCCCccccccc-----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHH
Confidence 99999999985432 133467999999999984 4567899999999999999999999997654332211111
Q ss_pred hhhhhhccccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011851 347 WARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPL 406 (476)
Q Consensus 347 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~ 406 (476)
.... .....++...+.++.+||.+||+.||++|||+.++++.|+.+
T Consensus 242 ~~~~--------------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 242 IREE--------------GLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp HHHS--------------CCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred Hhcc--------------CCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 1000 001111223367899999999999999999999999998753
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-47 Score=366.22 Aligned_cols=255 Identities=26% Similarity=0.390 Sum_probs=207.9
Q ss_pred ccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCc---cCHHHHHHHHHHHhCCCCCceeeEEEEE
Q 011851 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL---QGHKEWLAEVNYLGGLIHPNLVKLIGCC 196 (476)
Q Consensus 120 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~l~~~~ 196 (476)
.++|++.+.||+|+||.||+|.+. .+++.||+|++..... .....+.+|+.++++++||||+++++++
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 78 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREK---------QSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYF 78 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET---------TTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEc---------cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheE
Confidence 457999999999999999998665 4677899999865322 2345688999999999999999999999
Q ss_pred EeCCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecC
Q 011851 197 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFG 276 (476)
Q Consensus 197 ~~~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG 276 (476)
.+.+..++||||+++++|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 79 ~~~~~~~lv~e~~~~~~l~~~l~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg 154 (279)
T 3fdn_A 79 HDATRVYLILEYAPLGTVYRELQKL-SKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFG 154 (279)
T ss_dssp ECSSEEEEEECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCC
T ss_pred ecCCEEEEEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEecc
Confidence 9999999999999999999998654 46999999999999999999999988 9999999999999999999999999
Q ss_pred CcCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhcccc
Q 011851 277 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERR 356 (476)
Q Consensus 277 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~ 356 (476)
++....... .....||+.|+|||++.+..++.++||||||+++|+|++|..||...........+. ...
T Consensus 155 ~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~------~~~- 223 (279)
T 3fdn_A 155 WSVHAPSSR----RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS------RVE- 223 (279)
T ss_dssp EESCC------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH------HTC-
T ss_pred ccccCCccc----ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHH------hCC-
Confidence 987643322 234679999999999999999999999999999999999999997543211111100 000
Q ss_pred ccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCccccc
Q 011851 357 RFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDMA 413 (476)
Q Consensus 357 ~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~~~ 413 (476)
..++...+..+.+||.+||+.||++|||+.++++| ||++...
T Consensus 224 -----------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h----~~~~~~~ 265 (279)
T 3fdn_A 224 -----------FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH----PWITANS 265 (279)
T ss_dssp -----------CCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC----HHHHHHC
T ss_pred -----------CCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhC----ccccCCc
Confidence 01112235788999999999999999999999998 8887643
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-46 Score=394.09 Aligned_cols=262 Identities=26% Similarity=0.391 Sum_probs=213.9
Q ss_pred ccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCc---cCHHHHHHHHHHHhCCCCCceeeEEEEE
Q 011851 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL---QGHKEWLAEVNYLGGLIHPNLVKLIGCC 196 (476)
Q Consensus 120 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~l~~~~ 196 (476)
.++|++.++||+|+||.||+|++. .+|+.||||++.+... .....+.+|+.+|++++||||+++++++
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~---------~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~ 254 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMK---------ATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAF 254 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEET---------TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEC---------CCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence 367999999999999999998654 4788999999975432 3346788999999999999999999999
Q ss_pred EeCCeeEEEEEecCCCCHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEe
Q 011851 197 IEDDQRLLVYEFMPRGSLENHLFRR---SLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLS 273 (476)
Q Consensus 197 ~~~~~~~lV~E~~~~g~L~~~l~~~---~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~ 273 (476)
.+.+.+||||||++||+|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+||||+.+|.+||+
T Consensus 255 ~~~~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~ 331 (543)
T 3c4z_A 255 ETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRIS 331 (543)
T ss_dssp ECSSEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEEC
T ss_pred eeCCEEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEe
Confidence 9999999999999999999998653 346999999999999999999999988 9999999999999999999999
Q ss_pred ecCCcCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhc
Q 011851 274 DFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLG 353 (476)
Q Consensus 274 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~ 353 (476)
|||+++....... .....+||+.|+|||++.+..|+.++|||||||++|||++|+.||.......... ........
T Consensus 332 DFGla~~~~~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~--~~~~~i~~ 407 (543)
T 3c4z_A 332 DLGLAVELKAGQT--KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENK--ELKQRVLE 407 (543)
T ss_dssp CCTTCEECCTTCC--CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHH--HHHHHHHH
T ss_pred ecceeeeccCCCc--ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHH--HHHHHHhh
Confidence 9999987644322 1234689999999999999999999999999999999999999998654322111 11111111
Q ss_pred cccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCH-----HHHHHHhcCCCCccccc
Q 011851 354 ERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRM-----SEVVEALKPLPYLKDMA 413 (476)
Q Consensus 354 ~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~-----~ell~~L~~~~~~~~~~ 413 (476)
... .++...+.++.+||.+||+.||++||++ .+|++| |||+++.
T Consensus 408 ~~~------------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~H----pff~~i~ 456 (543)
T 3c4z_A 408 QAV------------TYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTH----PLFRDIS 456 (543)
T ss_dssp CCC------------CCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTS----GGGTTCC
T ss_pred ccc------------CCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcC----ccccCCC
Confidence 100 1222336789999999999999999976 556554 9999864
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=381.27 Aligned_cols=265 Identities=26% Similarity=0.361 Sum_probs=214.1
Q ss_pred ccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCcc-CHHHHHHHHHHHhCC-CCCceeeEEEEEE
Q 011851 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQ-GHKEWLAEVNYLGGL-IHPNLVKLIGCCI 197 (476)
Q Consensus 120 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~-~~~~~~~E~~~l~~l-~hpnIv~l~~~~~ 197 (476)
.++|++.+.||+|+||.||+|.+...+. ....++..||||++...... ...++.+|+++++++ +||||+++++++.
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~--~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~ 145 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDK--DKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT 145 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSST--TCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccc--cccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeec
Confidence 3579999999999999999998753221 12235578999999765332 235688999999999 8999999999999
Q ss_pred eCCeeEEEEEecCCCCHHHHHhhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCe
Q 011851 198 EDDQRLLVYEFMPRGSLENHLFRRS---------------LPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNI 262 (476)
Q Consensus 198 ~~~~~~lV~E~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NI 262 (476)
+++..||||||+++++|.+++.... ..+++..++.++.||+.||.|||+.+ |+||||||+||
T Consensus 146 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NI 222 (382)
T 3tt0_A 146 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNV 222 (382)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGE
T ss_pred cCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcceE
Confidence 9999999999999999999997643 35999999999999999999999988 99999999999
Q ss_pred eecCCCceEEeecCCcCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHh-CCCCCCCCCCCCc
Q 011851 263 LLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLT-GRRSMDKNRPNGE 341 (476)
Q Consensus 263 Ll~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~ellt-G~~pf~~~~~~~~ 341 (476)
||+.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|+|++ |..||.......
T Consensus 223 ll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~- 301 (382)
T 3tt0_A 223 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE- 301 (382)
T ss_dssp EECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH-
T ss_pred EEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH-
Confidence 999999999999999987654433333344568899999999999999999999999999999999 999997543221
Q ss_pred chhHHhhhhhhccccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011851 342 HNLVEWARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPL 406 (476)
Q Consensus 342 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~ 406 (476)
+....... . ....+...+.++.+||.+||+.||++|||+.+|+++|+.+
T Consensus 302 --~~~~~~~~----~----------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 350 (382)
T 3tt0_A 302 --LFKLLKEG----H----------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 350 (382)
T ss_dssp --HHHHHHTT----C----------CCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --HHHHHHcC----C----------CCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 11111100 0 0001122367899999999999999999999999997654
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-47 Score=368.32 Aligned_cols=258 Identities=23% Similarity=0.342 Sum_probs=207.1
Q ss_pred ccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCCCCCceeeEEEEEEeC
Q 011851 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHPNLVKLIGCCIED 199 (476)
Q Consensus 120 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~ 199 (476)
.++|++.+.||+|+||.||+|.+...+... ...+..||+|++........+.+.+|+.+|++++||||+++++++.++
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~--~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 84 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYG--QLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCG 84 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGG--CEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCT
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccc--cccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeC
Confidence 357999999999999999999876432110 001356999999876666677899999999999999999999999999
Q ss_pred CeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCc--------eE
Q 011851 200 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYN--------AK 271 (476)
Q Consensus 200 ~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~--------vk 271 (476)
+..|+||||+++++|.+++......+++..++.++.||+.||.|||+++ |+||||||+|||++.++. +|
T Consensus 85 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~k 161 (289)
T 4fvq_A 85 DENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIK 161 (289)
T ss_dssp TCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCEEE
T ss_pred CCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCcccccccceee
Confidence 9999999999999999999776666999999999999999999999988 999999999999988887 99
Q ss_pred EeecCCcCCCCCCCccceeeeeecCCCCCCcchhhc-CCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhh
Q 011851 272 LSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP 350 (476)
Q Consensus 272 l~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~ 350 (476)
|+|||++..... .....||+.|+|||++.+ ..++.++|||||||++|||++|..|+....... ......
T Consensus 162 l~Dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~--~~~~~~-- 231 (289)
T 4fvq_A 162 LSDPGISITVLP------KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQ--RKLQFY-- 231 (289)
T ss_dssp ECCCCSCTTTSC------HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH--HHHHHH--
T ss_pred eccCcccccccC------ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchH--HHHHHh--
Confidence 999999976432 123568999999999987 679999999999999999999655543322111 111100
Q ss_pred hhccccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011851 351 QLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPL 406 (476)
Q Consensus 351 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~ 406 (476)
.....+ +...+.++.+|+.+||+.||++|||+.+++++|+.+
T Consensus 232 --~~~~~~------------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l 273 (289)
T 4fvq_A 232 --EDRHQL------------PAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSL 273 (289)
T ss_dssp --HTTCCC------------CCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTC
T ss_pred --hccCCC------------CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 000000 111145678999999999999999999999998865
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=369.81 Aligned_cols=262 Identities=28% Similarity=0.385 Sum_probs=212.9
Q ss_pred ccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCc-cCHHHHHHHHHHHhCCCCCceeeEEEEEEe
Q 011851 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL-QGHKEWLAEVNYLGGLIHPNLVKLIGCCIE 198 (476)
Q Consensus 120 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~ 198 (476)
.++|++.+.||+|+||.||+|.+.... ...+++.||||++..... ...+.+.+|+++|++++||||+++++++.+
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 97 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHLK----GRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQ 97 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETGG----GCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred hhheeeeeeecccCCeeEEEEEEeccC----cccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEec
Confidence 457999999999999999999874321 124668899999976432 234568899999999999999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHHhhcC-----------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEec
Q 011851 199 DDQRLLVYEFMPRGSLENHLFRRS-----------------------LPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYR 255 (476)
Q Consensus 199 ~~~~~lV~E~~~~g~L~~~l~~~~-----------------------~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHr 255 (476)
++..|+||||+++++|.+++.... ..+++..++.++.||+.||.|||+++ |+||
T Consensus 98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~ 174 (314)
T 2ivs_A 98 DGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHR 174 (314)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EECC
T ss_pred CCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---Cccc
Confidence 999999999999999999997542 24899999999999999999999988 9999
Q ss_pred CCCCCCeeecCCCceEEeecCCcCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHh-CCCCCC
Q 011851 256 DFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLT-GRRSMD 334 (476)
Q Consensus 256 DlKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~ellt-G~~pf~ 334 (476)
||||+|||++.++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||++ |..||.
T Consensus 175 dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~ 254 (314)
T 2ivs_A 175 DLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYP 254 (314)
T ss_dssp CCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred ccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 9999999999999999999999987654333322334567889999999999999999999999999999999 999997
Q ss_pred CCCCCCcchhHHhhhhhhccccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 011851 335 KNRPNGEHNLVEWARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKP 405 (476)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~ 405 (476)
..........+. .. . ....+...+.++.+||.+||+.||++||++.+++++|+.
T Consensus 255 ~~~~~~~~~~~~---~~----~----------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~ 308 (314)
T 2ivs_A 255 GIPPERLFNLLK---TG----H----------RMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEK 308 (314)
T ss_dssp TCCGGGHHHHHH---TT----C----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCHHHHHHHhh---cC----C----------cCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 654322111111 00 0 001112236789999999999999999999999999764
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=364.30 Aligned_cols=258 Identities=25% Similarity=0.366 Sum_probs=198.5
Q ss_pred ccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCcc-CHHHHHHHHHHHhCCCCCceeeEEEEEEe
Q 011851 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQ-GHKEWLAEVNYLGGLIHPNLVKLIGCCIE 198 (476)
Q Consensus 120 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~~ 198 (476)
.++|++.+.||+|+||.||+|.+...+ ..+..||+|++...... ..+.+.+|+.++++++||||+++++++ .
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~------~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~ 86 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPE------NPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-T 86 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--------CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-C
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCC------CCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEE-c
Confidence 357999999999999999999875322 24677999998764332 345688999999999999999999997 4
Q ss_pred CCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCc
Q 011851 199 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLA 278 (476)
Q Consensus 199 ~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a 278 (476)
++..|+||||+++++|.+++......+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 87 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 163 (281)
T 1mp8_A 87 ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLS 163 (281)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC----
T ss_pred cCccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECccccc
Confidence 56789999999999999999777668999999999999999999999988 999999999999999999999999999
Q ss_pred CCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhhccccc
Q 011851 279 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPQLGERRR 357 (476)
Q Consensus 279 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 357 (476)
+........ ......+|+.|+|||++.+..++.++|||||||++|||++ |..||...........+. ....
T Consensus 164 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~-------~~~~ 235 (281)
T 1mp8_A 164 RYMEDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE-------NGER 235 (281)
T ss_dssp ----------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH-------TTCC
T ss_pred cccCccccc-ccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHH-------cCCC
Confidence 876442221 1223467889999999999999999999999999999997 999997654322111110 0000
Q ss_pred cccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 011851 358 FYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKP 405 (476)
Q Consensus 358 ~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~ 405 (476)
..++...+..+.+|+.+||+.||++|||+.+++++|+.
T Consensus 236 ----------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~ 273 (281)
T 1mp8_A 236 ----------LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLST 273 (281)
T ss_dssp ----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ----------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 00112236789999999999999999999999998764
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=370.28 Aligned_cols=263 Identities=25% Similarity=0.382 Sum_probs=214.6
Q ss_pred ccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCc-cCHHHHHHHHHHHhCC-CCCceeeEEEEEE
Q 011851 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL-QGHKEWLAEVNYLGGL-IHPNLVKLIGCCI 197 (476)
Q Consensus 120 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~-~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~ 197 (476)
.++|++.+.||+|+||.||+|.+.. ..+..+++.||||+++.... ...+.+.+|+.+|+++ +||||+++++++.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~----~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 97 (313)
T 1t46_A 22 RNRLSFGKTLGAGAFGKVVEATAYG----LIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACT 97 (313)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEES----SSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred hhhhhHHHhhCccCCcceEEEEEee----ccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEe
Confidence 4579999999999999999997642 12345788999999976543 2346688999999999 8999999999999
Q ss_pred eCCeeEEEEEecCCCCHHHHHhhcCC-----------------CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCC
Q 011851 198 EDDQRLLVYEFMPRGSLENHLFRRSL-----------------PLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTS 260 (476)
Q Consensus 198 ~~~~~~lV~E~~~~g~L~~~l~~~~~-----------------~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~ 260 (476)
+++..++||||+++++|.+++..... .+++..++.++.||+.||.|||+++ |+||||||+
T Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~ 174 (313)
T 1t46_A 98 IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAAR 174 (313)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGG
T ss_pred cCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccc
Confidence 99999999999999999999976432 4899999999999999999999988 999999999
Q ss_pred CeeecCCCceEEeecCCcCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHh-CCCCCCCCCCC
Q 011851 261 NILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLT-GRRSMDKNRPN 339 (476)
Q Consensus 261 NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~ellt-G~~pf~~~~~~ 339 (476)
|||++.++.+||+|||++................||+.|+|||++.+..++.++|||||||++|+|++ |..||......
T Consensus 175 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~ 254 (313)
T 1t46_A 175 NILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD 254 (313)
T ss_dssp GEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS
T ss_pred eEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccch
Confidence 99999999999999999987655443333344668899999999999999999999999999999999 99999765432
Q ss_pred CcchhHHhhhhhhccccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 011851 340 GEHNLVEWARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKP 405 (476)
Q Consensus 340 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~ 405 (476)
.. ........ .....+...+.++.+||.+||+.||.+|||+.+++++|+.
T Consensus 255 ~~--~~~~~~~~--------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~ 304 (313)
T 1t46_A 255 SK--FYKMIKEG--------------FRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK 304 (313)
T ss_dssp HH--HHHHHHHT--------------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred hH--HHHHhccC--------------CCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHH
Confidence 21 11111100 0000112236789999999999999999999999998763
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-47 Score=376.58 Aligned_cols=274 Identities=22% Similarity=0.312 Sum_probs=204.1
Q ss_pred cCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCH-HHHHHHHHHHhCCCCCceeeEEEEEEeC
Q 011851 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGH-KEWLAEVNYLGGLIHPNLVKLIGCCIED 199 (476)
Q Consensus 121 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~-~~~~~E~~~l~~l~hpnIv~l~~~~~~~ 199 (476)
++|++.+.||+|+||.||+|.+. .+++.||||++........ ..+.+|+.+|++++||||+++++++.++
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~---------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 72 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSK---------LTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTE 72 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEET---------TTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECS
T ss_pred CceEEEEEEcCCCCEEEEEEEEC---------CCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeC
Confidence 47999999999999999998764 4678899999975433221 2345799999999999999999999999
Q ss_pred CeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCcC
Q 011851 200 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAK 279 (476)
Q Consensus 200 ~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~ 279 (476)
+..||||||++ ++|.+++......+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 73 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~ 148 (324)
T 3mtl_A 73 KSLTLVFEYLD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLAR 148 (324)
T ss_dssp SCEEEEEECCS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEE
T ss_pred CEEEEEecccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccc
Confidence 99999999996 5999999877778999999999999999999999988 9999999999999999999999999998
Q ss_pred CCCCCCccceeeeeecCCCCCCcchhhc-CCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhcccccc
Q 011851 280 DGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRRF 358 (476)
Q Consensus 280 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 358 (476)
....... .....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...........+....... ....+
T Consensus 149 ~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~-~~~~~ 225 (324)
T 3mtl_A 149 AKSIPTK--TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTP-TEETW 225 (324)
T ss_dssp CC--------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC-CTTTS
T ss_pred cccCCcc--ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC-ChHhc
Confidence 6543221 2234578999999999887 578999999999999999999999997654322111111000000 00000
Q ss_pred cccc---------CcccCC----CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCcccccC
Q 011851 359 YRLI---------DPCLEG----CFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDMAS 414 (476)
Q Consensus 359 ~~~~---------d~~l~~----~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~~~~ 414 (476)
.... .+.... ......+.++.+||.+||+.||++|||+.|+++| |||.+...
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h----p~f~~~~~ 290 (324)
T 3mtl_A 226 PGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKH----PFFLSLGE 290 (324)
T ss_dssp TTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS----GGGGGGCS
T ss_pred hhhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcC----hhhhhccc
Confidence 0000 000000 0001125678999999999999999999999997 99987643
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-47 Score=376.98 Aligned_cols=264 Identities=24% Similarity=0.375 Sum_probs=212.1
Q ss_pred hccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCcc-CHHHHHHHHHHHhCCCCCceeeEEEEEE
Q 011851 119 ATKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQ-GHKEWLAEVNYLGGLIHPNLVKLIGCCI 197 (476)
Q Consensus 119 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~ 197 (476)
..++|++.+.||+|+||.||+|.+.... ...+++.||||+++..... ..+.+.+|+.+|++++||||+++++++.
T Consensus 45 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 120 (343)
T 1luf_A 45 PRNNIEYVRDIGEGAFGRVFQARAPGLL----PYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA 120 (343)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSS----TTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred cHHHCeeeeeeeecCCeeEEEEEecCcC----CCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence 4568999999999999999999875321 1135688999999765432 2456889999999999999999999999
Q ss_pred eCCeeEEEEEecCCCCHHHHHhhcC-----------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEe
Q 011851 198 EDDQRLLVYEFMPRGSLENHLFRRS-----------------------LPLPWSIRMKIALDAAKGLAFLHEEAEKPVIY 254 (476)
Q Consensus 198 ~~~~~~lV~E~~~~g~L~~~l~~~~-----------------------~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivH 254 (476)
+++..||||||+++++|.+++.... ..+++..++.++.||+.||.|||+++ |+|
T Consensus 121 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---ivH 197 (343)
T 1luf_A 121 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVH 197 (343)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCC
T ss_pred cCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eec
Confidence 9999999999999999999997532 57999999999999999999999988 999
Q ss_pred cCCCCCCeeecCCCceEEeecCCcCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHh-CCCCC
Q 011851 255 RDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLT-GRRSM 333 (476)
Q Consensus 255 rDlKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~ellt-G~~pf 333 (476)
|||||+|||++.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++ |..||
T Consensus 198 ~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~ 277 (343)
T 1luf_A 198 RDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY 277 (343)
T ss_dssp SCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred CCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcC
Confidence 99999999999999999999999976433222222334678999999999999999999999999999999999 99999
Q ss_pred CCCCCCCcchhHHhhhhhhccccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011851 334 DKNRPNGEHNLVEWARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPL 406 (476)
Q Consensus 334 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~ 406 (476)
...... .+..... .. ... ..+...+.++.+||.+||+.||++||++.+++++|+.+
T Consensus 278 ~~~~~~---~~~~~~~----~~-~~~---------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~ 333 (343)
T 1luf_A 278 YGMAHE---EVIYYVR----DG-NIL---------ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRM 333 (343)
T ss_dssp TTSCHH---HHHHHHH----TT-CCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred CCCChH---HHHHHHh----CC-CcC---------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHH
Confidence 754321 1111100 00 000 01122357899999999999999999999999998765
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-46 Score=385.29 Aligned_cols=263 Identities=24% Similarity=0.330 Sum_probs=200.8
Q ss_pred HhccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCc--------cCHHHHHHHHHHHhCCCCCce
Q 011851 118 SATKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL--------QGHKEWLAEVNYLGGLIHPNL 189 (476)
Q Consensus 118 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~--------~~~~~~~~E~~~l~~l~hpnI 189 (476)
...++|++.+.||+|+||.||+|.+. .+++.||||++..... .....+.+|+.+|++++||||
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~---------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpni 202 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFER---------KTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 202 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEET---------TTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTB
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEEC---------CCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCE
Confidence 44678999999999999999998654 5788899999875421 112347899999999999999
Q ss_pred eeEEEEEEeCCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCC-
Q 011851 190 VKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEY- 268 (476)
Q Consensus 190 v~l~~~~~~~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~- 268 (476)
+++++++. .+..||||||+++++|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++
T Consensus 203 v~l~~~~~-~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~ 277 (419)
T 3i6u_A 203 IKIKNFFD-AEDYYIVLELMEGGELFDKVVG-NKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEE 277 (419)
T ss_dssp CCCCEEEE-SSEEEEEEECCTTCBGGGGTSS-SCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSS
T ss_pred eeEEEEEe-cCceEEEEEcCCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCC
Confidence 99999975 5568999999999999998854 457999999999999999999999988 99999999999996544
Q ss_pred --ceEEeecCCcCCCCCCCccceeeeeecCCCCCCcchhhc---CCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcch
Q 011851 269 --NAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT---GHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHN 343 (476)
Q Consensus 269 --~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~ 343 (476)
.+||+|||+++...... .....+||+.|+|||++.+ ..|+.++|||||||++|+|++|+.||.........
T Consensus 278 ~~~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~- 353 (419)
T 3i6u_A 278 DCLIKITDFGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL- 353 (419)
T ss_dssp SCCEEECCSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCH-
T ss_pred cceEEEeecccceecCCCc---cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHH-
Confidence 59999999998764322 2344789999999999864 57889999999999999999999999764332221
Q ss_pred hHHhhhhhhccccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCcccccC
Q 011851 344 LVEWARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDMAS 414 (476)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~~~~ 414 (476)
........ .......+ ...+..+.+||.+||+.||++|||+.++++| |||++...
T Consensus 354 -~~~i~~~~------~~~~~~~~-----~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h----p~~~~~~~ 408 (419)
T 3i6u_A 354 -KDQITSGK------YNFIPEVW-----AEVSEKALDLVKKLLVVDPKARFTTEEALRH----PWLQDEDM 408 (419)
T ss_dssp -HHHHHTTC------CCCCHHHH-----TTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS----GGGCCHHH
T ss_pred -HHHHhcCC------CCCCchhh-----cccCHHHHHHHHHHccCChhHCcCHHHHhCC----cccCChhH
Confidence 11110000 00000000 0125789999999999999999999999998 99986543
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=407.05 Aligned_cols=258 Identities=25% Similarity=0.359 Sum_probs=212.0
Q ss_pred hccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCC---ccCHHHHHHHHHHHhCC-CCCceeeEEE
Q 011851 119 ATKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDG---LQGHKEWLAEVNYLGGL-IHPNLVKLIG 194 (476)
Q Consensus 119 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~---~~~~~~~~~E~~~l~~l-~hpnIv~l~~ 194 (476)
..++|+++++||+|+||.||+|.+. .+++.||||++++.. ....+.+..|..+|..+ +||||+.+++
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~---------~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~ 409 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERK---------GTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHS 409 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEES---------SSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEEC---------CCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEE
Confidence 3567999999999999999998754 478889999997532 23345678899999988 7999999999
Q ss_pred EEEeCCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEee
Q 011851 195 CCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSD 274 (476)
Q Consensus 195 ~~~~~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~D 274 (476)
++.+.+.+||||||++||+|.+++... ..+++..++.|+.||+.||+|||+++ ||||||||+||||+.++.+||+|
T Consensus 410 ~~~~~~~~~lV~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~D 485 (674)
T 3pfq_A 410 CFQTMDRLYFVMEYVNGGDLMYHIQQV-GRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIAD 485 (674)
T ss_dssp ECBCSSEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECC
T ss_pred EEEeCCEEEEEEeCcCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEee
Confidence 999999999999999999999999654 46999999999999999999999988 99999999999999999999999
Q ss_pred cCCcCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhcc
Q 011851 275 FGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGE 354 (476)
Q Consensus 275 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~ 354 (476)
||+++....... .....+||+.|+|||++.+..|+.++|||||||+||||++|+.||....... +... ....
T Consensus 486 FGla~~~~~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~---~~~~---i~~~ 557 (674)
T 3pfq_A 486 FGMCKENIWDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE---LFQS---IMEH 557 (674)
T ss_dssp CTTCEECCCTTC--CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHH---HHSS
T ss_pred cceeeccccCCc--ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHH---HHHH---HHhC
Confidence 999986433222 2345789999999999999999999999999999999999999997643221 1111 1111
Q ss_pred ccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCH-----HHHHHHhcCCCCccccc
Q 011851 355 RRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRM-----SEVVEALKPLPYLKDMA 413 (476)
Q Consensus 355 ~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~-----~ell~~L~~~~~~~~~~ 413 (476)
.. .++...+.++.+||.+||+.||++||++ .+|++ +|||+++.
T Consensus 558 ~~------------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~----h~ff~~i~ 605 (674)
T 3pfq_A 558 NV------------AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE----HAFFRYID 605 (674)
T ss_dssp CC------------CCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS----SGGGSSCC
T ss_pred CC------------CCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc----CccccCCC
Confidence 00 1222346789999999999999999998 55555 49998764
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-46 Score=376.78 Aligned_cols=271 Identities=19% Similarity=0.269 Sum_probs=209.9
Q ss_pred ccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccC-----------HHHHHHHHHHHhCCCCCc
Q 011851 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQG-----------HKEWLAEVNYLGGLIHPN 188 (476)
Q Consensus 120 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~-----------~~~~~~E~~~l~~l~hpn 188 (476)
.++|++.++||+|+||.||+|.+..... ...++.||||++....... ...+..|+..++.++|||
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~----~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~ 109 (364)
T 3op5_A 34 AAAWKVGLPIGQGGFGCIYLADMNSSES----VGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLG 109 (364)
T ss_dssp CCEEEEEEECCCC-CCEEEEEEECCSSC----CCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCC
T ss_pred CCeEEEEEEEecCCCeEEEEeeecCccc----cccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCC
Confidence 4579999999999999999998764322 1357889999987654211 122445677888999999
Q ss_pred eeeEEEEEEeC----CeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeee
Q 011851 189 LVKLIGCCIED----DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILL 264 (476)
Q Consensus 189 Iv~l~~~~~~~----~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl 264 (476)
|+++++++... ...||||||+ +++|.+++......+++..++.++.||+.||.|||+++ |+||||||+||||
T Consensus 110 iv~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill 185 (364)
T 3op5_A 110 VPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLL 185 (364)
T ss_dssp SCCEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEE
T ss_pred CCeEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEE
Confidence 99999998875 4589999999 99999999877678999999999999999999999988 9999999999999
Q ss_pred c--CCCceEEeecCCcCCCCCCCcc-----ceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCC
Q 011851 265 D--GEYNAKLSDFGLAKDGPEGDKT-----HVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNR 337 (476)
Q Consensus 265 ~--~~~~vkl~DFG~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~ 337 (476)
+ .++.+||+|||+++........ ......+||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 186 ~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~ 265 (364)
T 3op5_A 186 NYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNL 265 (364)
T ss_dssp ESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred ecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccc
Confidence 8 8899999999999765332111 11123569999999999999999999999999999999999999998543
Q ss_pred CCCcchhHHhhhhhhccccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 011851 338 PNGEHNLVEWARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKP 405 (476)
Q Consensus 338 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~ 405 (476)
.... ........ ....+..++++++.. ...+.++.+|+..||+.||++||++.+|++.|+.
T Consensus 266 ~~~~--~~~~~~~~--~~~~~~~~~~~~~~~---~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~ 326 (364)
T 3op5_A 266 KDPK--YVRDSKIR--YRENIASLMDKCFPA---ANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQ 326 (364)
T ss_dssp TCHH--HHHHHHHH--HHHCHHHHHHHHSCT---TCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHH
T ss_pred cCHH--HHHHHHHH--hhhhHHHHHHHhccc---ccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHH
Confidence 2211 11111111 111223344444421 1226789999999999999999999999998764
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=360.51 Aligned_cols=261 Identities=17% Similarity=0.164 Sum_probs=210.7
Q ss_pred ccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCC-CCCceeeEEEEEEe
Q 011851 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGL-IHPNLVKLIGCCIE 198 (476)
Q Consensus 120 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~ 198 (476)
.++|++.+.||+|+||.||+|.+. .+|+.||||++..... .+.+.+|+.+++.+ +|+||+++++++.+
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vavK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~ 77 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNL---------LNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQE 77 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEET---------TTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEEC---------CCCcEEEEEEeccCCc--cHHHHHHHHHHHHHhcCCCCCeEEeecCC
Confidence 457999999999999999998654 4688899999875432 34577899999999 79999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCc-----eEEe
Q 011851 199 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYN-----AKLS 273 (476)
Q Consensus 199 ~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~-----vkl~ 273 (476)
....|+||||+ +++|.+++......+++..+..++.||+.||.|||+++ |+||||||+|||++.++. +||+
T Consensus 78 ~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~ 153 (298)
T 1csn_A 78 GLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVV 153 (298)
T ss_dssp TTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEEC
T ss_pred CceeEEEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEE
Confidence 99999999999 99999999877677999999999999999999999988 999999999999987776 9999
Q ss_pred ecCCcCCCCCCCcc-----ceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhh
Q 011851 274 DFGLAKDGPEGDKT-----HVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA 348 (476)
Q Consensus 274 DFG~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~ 348 (476)
|||+++........ .......||+.|+|||++.+..++.++|||||||++|||++|+.||...............
T Consensus 154 Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~ 233 (298)
T 1csn_A 154 DFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERI 233 (298)
T ss_dssp CCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHH
T ss_pred ECccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHH
Confidence 99999865433221 1123467999999999999999999999999999999999999999875543332222211
Q ss_pred hhhhccccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 011851 349 RPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKP 405 (476)
Q Consensus 349 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~ 405 (476)
...... ...... ....+.++.+|+.+||+.||++||++.+|++.|+.
T Consensus 234 ~~~~~~-~~~~~~---------~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~ 280 (298)
T 1csn_A 234 GEKKQS-TPLREL---------CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSK 280 (298)
T ss_dssp HHHHHH-SCHHHH---------TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHH
T ss_pred HhhccC-ccHHHH---------HhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHH
Confidence 111000 000000 01125789999999999999999999999998764
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-46 Score=383.66 Aligned_cols=277 Identities=24% Similarity=0.311 Sum_probs=202.8
Q ss_pred ccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCc--cCHHHHHHHHHHHhCCCCCceeeEEEEEE
Q 011851 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL--QGHKEWLAEVNYLGGLIHPNLVKLIGCCI 197 (476)
Q Consensus 120 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~ 197 (476)
.++|++.+.||+|+||.||+|.+. .+|+.||||++..... ...+++.+|+.+|++++||||+++++++.
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~---------~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~ 95 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDK---------NTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLII 95 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEET---------TTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECC
T ss_pred cCCEEEEEEEeecCCEEEEEEEEC---------CCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEe
Confidence 457999999999999999998654 4788899999975432 23467889999999999999999999998
Q ss_pred eC-----CeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEE
Q 011851 198 ED-----DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKL 272 (476)
Q Consensus 198 ~~-----~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl 272 (476)
.. +.+||||||++ ++|.+++. ....+++..++.++.||+.||.|||+.+ |+||||||+||||+.++.+||
T Consensus 96 ~~~~~~~~~~~lv~e~~~-~~L~~~~~-~~~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL 170 (432)
T 3n9x_A 96 PDDLLKFDELYIVLEIAD-SDLKKLFK-TPIFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKV 170 (432)
T ss_dssp CSCTTTCCCEEEEEECCS-EEHHHHHH-SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEE
T ss_pred cCCCCcCCeEEEEEecCC-cCHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEE
Confidence 76 57999999995 59999884 4567999999999999999999999988 999999999999999999999
Q ss_pred eecCCcCCCCCCCcc--------------------ceeeeeecCCCCCCcchhh-cCCCCccchhhhhHHHHHHHHhCCC
Q 011851 273 SDFGLAKDGPEGDKT--------------------HVSTRVMGTYGYAAPEYVM-TGHLTAKSDVYSFGVVLLEMLTGRR 331 (476)
Q Consensus 273 ~DFG~a~~~~~~~~~--------------------~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslGv~l~elltG~~ 331 (476)
+|||+++........ ...+..+||+.|+|||++. ...|+.++|||||||++|||++|..
T Consensus 171 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~ 250 (432)
T 3n9x_A 171 CDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQ 250 (432)
T ss_dssp CCCTTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCT
T ss_pred ccCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccc
Confidence 999999875432211 1234578999999999864 5679999999999999999998655
Q ss_pred CCCC-----------CCCCCc--------------chhHHhhhhhhcc----------ccccccc---cCcccCCC---C
Q 011851 332 SMDK-----------NRPNGE--------------HNLVEWARPQLGE----------RRRFYRL---IDPCLEGC---F 370 (476)
Q Consensus 332 pf~~-----------~~~~~~--------------~~~~~~~~~~~~~----------~~~~~~~---~d~~l~~~---~ 370 (476)
||.. ...... ..........++. ....... +....... .
T Consensus 251 p~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 330 (432)
T 3n9x_A 251 SHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQK 330 (432)
T ss_dssp TTCSSGGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHH
T ss_pred ccccccccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHH
Confidence 5432 211000 0000000000000 0000000 00000000 0
Q ss_pred ChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCcccccC
Q 011851 371 SIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDMAS 414 (476)
Q Consensus 371 ~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~~~~ 414 (476)
....+.++.+||.+||+.||++|||+.|+|+| |||++...
T Consensus 331 ~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H----p~f~~~~~ 370 (432)
T 3n9x_A 331 YPSISDDGINLLESMLKFNPNKRITIDQALDH----PYLKDVRK 370 (432)
T ss_dssp STTSCHHHHHHHHHHSCSSTTTSCCHHHHHTC----GGGTTTCC
T ss_pred CCCCCHHHHHHHHHHhcCCcccCCCHHHHhcC----hhhhhccC
Confidence 01236789999999999999999999999997 99887643
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-46 Score=383.42 Aligned_cols=258 Identities=22% Similarity=0.326 Sum_probs=201.8
Q ss_pred cCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCcc--CHHHHHHHHHHHhCCC--CCceeeEEEEE
Q 011851 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQ--GHKEWLAEVNYLGGLI--HPNLVKLIGCC 196 (476)
Q Consensus 121 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~--~~~~~~~E~~~l~~l~--hpnIv~l~~~~ 196 (476)
.+|++.+.||+|+||.||+|.+. +++.||||++...... ..+.+.+|+.+|+++. ||||+++++++
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~----------~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~ 125 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNE----------KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE 125 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECT----------TCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcC----------CCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEE
Confidence 45999999999999999998643 4778999999765432 3456889999999996 59999999999
Q ss_pred EeCCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecC
Q 011851 197 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFG 276 (476)
Q Consensus 197 ~~~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG 276 (476)
..++.+||||| +.+++|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+||||+ ++.+||+|||
T Consensus 126 ~~~~~~~lv~E-~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG 199 (390)
T 2zmd_A 126 ITDQYIYMVME-CGNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFG 199 (390)
T ss_dssp ECSSEEEEEEE-CCSEEHHHHHHHC-SSCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCS
T ss_pred ecCCEEEEEEe-cCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecC
Confidence 99999999999 5588999999654 47899999999999999999999988 99999999999996 5899999999
Q ss_pred CcCCCCCCCccceeeeeecCCCCCCcchhhc-----------CCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhH
Q 011851 277 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-----------GHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV 345 (476)
Q Consensus 277 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~ 345 (476)
+++..............+||+.|+|||++.+ ..|+.++|||||||++|||++|+.||...... .
T Consensus 200 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~-----~ 274 (390)
T 2zmd_A 200 IANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-----I 274 (390)
T ss_dssp SSCCC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCH-----H
T ss_pred ccccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHH-----H
Confidence 9987654333323345689999999999875 36899999999999999999999999753221 0
Q ss_pred HhhhhhhccccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCccccc
Q 011851 346 EWARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDMA 413 (476)
Q Consensus 346 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~~~ 413 (476)
... ..++++.....++...+.++.+||.+||+.||++|||+.++++| ||++...
T Consensus 275 ~~~----------~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h----p~~~~~~ 328 (390)
T 2zmd_A 275 SKL----------HAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH----PYVQIQT 328 (390)
T ss_dssp HHH----------HHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS----HHHHSCC
T ss_pred HHH----------HHHhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhC----cCccccC
Confidence 000 01111111111122225688999999999999999999999997 8887543
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-46 Score=359.78 Aligned_cols=262 Identities=24% Similarity=0.336 Sum_probs=212.1
Q ss_pred ccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCc-cCHHHHHHHHHHHhCCCCCceeeEEEEEEe
Q 011851 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL-QGHKEWLAEVNYLGGLIHPNLVKLIGCCIE 198 (476)
Q Consensus 120 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~ 198 (476)
.++|++.+.||+|+||.||+|.+. .+++.||||++..... ...+.+.+|+.+++.++||||+++++++.+
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 76 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNR---------VTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRRE 76 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEET---------TTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEEC---------CCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEc
Confidence 457999999999999999998654 4678899999975433 234678899999999999999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCc
Q 011851 199 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLA 278 (476)
Q Consensus 199 ~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a 278 (476)
++..|+||||+++++|.+++. ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 77 ~~~~~lv~e~~~~~~L~~~l~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~ 152 (276)
T 2yex_A 77 GNIQYLFLEYCSGGELFDRIE-PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLA 152 (276)
T ss_dssp TTEEEEEEECCTTEEGGGGSB-TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred CCEEEEEEEecCCCcHHHHHh-hccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCc
Confidence 999999999999999999884 3456999999999999999999999988 999999999999999999999999999
Q ss_pred CCCCCCCccceeeeeecCCCCCCcchhhcCCC-CccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhccccc
Q 011851 279 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHL-TAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRR 357 (476)
Q Consensus 279 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 357 (476)
................||+.|+|||++.+..+ +.++|||||||++|+|++|+.||........ ....+.... .
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~~~~----~- 226 (276)
T 2yex_A 153 TVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EYSDWKEKK----T- 226 (276)
T ss_dssp EECEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSH-HHHHHHTTC----T-
T ss_pred cccCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH-HHHHhhhcc----c-
Confidence 76543322222344679999999999987765 7789999999999999999999976543221 111111100 0
Q ss_pred cccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCccccc
Q 011851 358 FYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDMA 413 (476)
Q Consensus 358 ~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~~~ 413 (476)
... .....+..+.+||.+||+.||++|||+.++++| |||++..
T Consensus 227 ---~~~------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~----~~~~~~~ 269 (276)
T 2yex_A 227 ---YLN------PWKKIDSAPLALLHKILVENPSARITIPDIKKD----RWYNKPL 269 (276)
T ss_dssp ---TST------TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC----TTTTCCC
T ss_pred ---ccC------chhhcCHHHHHHHHHHCCCCchhCCCHHHHhcC----ccccChh
Confidence 000 011235688899999999999999999999987 9988654
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=376.11 Aligned_cols=260 Identities=28% Similarity=0.407 Sum_probs=211.0
Q ss_pred cCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccC---HHHHHHHHHHHhCCCCCceeeEEEEEE
Q 011851 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQG---HKEWLAEVNYLGGLIHPNLVKLIGCCI 197 (476)
Q Consensus 121 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~---~~~~~~E~~~l~~l~hpnIv~l~~~~~ 197 (476)
+.|++.+.||+|+||.||+|.+. .+|+.||||++....... .+.+.+|+++|++++||||+++++++.
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 124 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDV---------RNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYL 124 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEET---------TTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEc---------cCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence 45899999999999999998754 467889999997654322 346889999999999999999999999
Q ss_pred eCCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCC
Q 011851 198 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGL 277 (476)
Q Consensus 198 ~~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~ 277 (476)
+++..||||||+. |+|.+++......+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+
T Consensus 125 ~~~~~~lv~e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~ 200 (348)
T 1u5q_A 125 REHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGS 200 (348)
T ss_dssp ETTEEEEEEECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTT
T ss_pred ECCeEEEEEecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccC
Confidence 9999999999996 6888888766678999999999999999999999988 99999999999999999999999999
Q ss_pred cCCCCCCCccceeeeeecCCCCCCcchhh---cCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhcc
Q 011851 278 AKDGPEGDKTHVSTRVMGTYGYAAPEYVM---TGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGE 354 (476)
Q Consensus 278 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~ 354 (476)
+...... ...+||+.|+|||++. ...++.++|||||||++|||++|+.||........ +...... .
T Consensus 201 a~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~--~~~~~~~---~ 269 (348)
T 1u5q_A 201 ASIMAPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA--LYHIAQN---E 269 (348)
T ss_dssp CBSSSSB------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH--HHHHHHS---C
T ss_pred ceecCCC------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH--HHHHHhc---C
Confidence 9875431 2367999999999985 46789999999999999999999999975432111 1110000 0
Q ss_pred ccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCcccccCcchHH
Q 011851 355 RRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDMASSSSYV 419 (476)
Q Consensus 355 ~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~~~~~~~~~ 419 (476)
.+.+ .....+..+.+||.+||+.||++|||+.+++++ ||+..........
T Consensus 270 --------~~~~---~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h----~~~~~~~~~~~~~ 319 (348)
T 1u5q_A 270 --------SPAL---QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH----RFVLRERPPTVIM 319 (348)
T ss_dssp --------CCCC---CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC----HHHHSCCCTTHHH
T ss_pred --------CCCC---CCCCCCHHHHHHHHHHcccChhhCcCHHHHhhC----hhhhccCCcchhh
Confidence 0000 011225778999999999999999999999987 8887665544443
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=365.51 Aligned_cols=254 Identities=22% Similarity=0.378 Sum_probs=205.8
Q ss_pred ccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCCCCCceeeEEEEEEeC
Q 011851 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHPNLVKLIGCCIED 199 (476)
Q Consensus 120 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~ 199 (476)
.++|++.+.||+|+||.||+|.+. ++..||||++..... ..+++.+|+++|++++||||+++++++.+.
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~----------~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 91 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKWR----------GQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQ 91 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEET----------TTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred HHHHHhHhhcCCCCCceEEEEEEc----------CCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEecC
Confidence 346999999999999999998664 466799999976543 357789999999999999999999999999
Q ss_pred CeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCcC
Q 011851 200 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAK 279 (476)
Q Consensus 200 ~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~ 279 (476)
+..|+||||+++++|.+++......+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 92 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~ 168 (283)
T 3gen_A 92 RPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSR 168 (283)
T ss_dssp SSEEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGG
T ss_pred CCeEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEccccccc
Confidence 9999999999999999999775667999999999999999999999988 9999999999999999999999999998
Q ss_pred CCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhhcccccc
Q 011851 280 DGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPQLGERRRF 358 (476)
Q Consensus 280 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 358 (476)
....... .......+|+.|+|||++.+..++.++|||||||++|+|++ |+.||...........+ . ..
T Consensus 169 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~---~----~~--- 237 (283)
T 3gen_A 169 YVLDDEY-TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI---A----QG--- 237 (283)
T ss_dssp GBCCHHH-HSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH---H----TT---
T ss_pred ccccccc-ccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHH---h----cc---
Confidence 6533211 11222456788999999999999999999999999999998 99999764322111110 0 00
Q ss_pred ccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 011851 359 YRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKP 405 (476)
Q Consensus 359 ~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~ 405 (476)
.....+...++.+.+|+.+||+.||++|||+.+++++|+.
T Consensus 238 -------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~ 277 (283)
T 3gen_A 238 -------LRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILD 277 (283)
T ss_dssp -------CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred -------cCCCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHH
Confidence 0001111225789999999999999999999999999764
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-47 Score=376.67 Aligned_cols=268 Identities=24% Similarity=0.290 Sum_probs=207.6
Q ss_pred HHHhccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCC-----ccCHHHHHHHHHHHhCCCCCcee
Q 011851 116 LKSATKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDG-----LQGHKEWLAEVNYLGGLIHPNLV 190 (476)
Q Consensus 116 ~~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~-----~~~~~~~~~E~~~l~~l~hpnIv 190 (476)
+....++|++.+.||+|+||.||+|.+. .+++.||+|++.... ....+.+.+|+.+|++++||||+
T Consensus 21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv 91 (345)
T 3hko_A 21 LLELQKKYHLKGAIGQGSYGVVRVAIEN---------QTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIA 91 (345)
T ss_dssp HHHHHHHEEEEEEEEECSSCEEEEEEET---------TTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBC
T ss_pred hhhhhhheeecceeeecCCeEEEEEEEC---------CCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcc
Confidence 3455678999999999999999998654 467889999986532 23356788999999999999999
Q ss_pred eEEEEEEeCCeeEEEEEecCCCCHHHHHhhc---------------------------------------CCCCCHHHHH
Q 011851 191 KLIGCCIEDDQRLLVYEFMPRGSLENHLFRR---------------------------------------SLPLPWSIRM 231 (476)
Q Consensus 191 ~l~~~~~~~~~~~lV~E~~~~g~L~~~l~~~---------------------------------------~~~l~~~~~~ 231 (476)
++++++.+.+..|||||||++|+|.+++... ...+++..++
T Consensus 92 ~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (345)
T 3hko_A 92 RLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLIS 171 (345)
T ss_dssp CEEEEEECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHH
T ss_pred eeehhhccCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHH
Confidence 9999999999999999999999999988420 1123677888
Q ss_pred HHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCC--ceEEeecCCcCCCCCCC--ccceeeeeecCCCCCCcchhhc
Q 011851 232 KIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEY--NAKLSDFGLAKDGPEGD--KTHVSTRVMGTYGYAAPEYVMT 307 (476)
Q Consensus 232 ~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~--~vkl~DFG~a~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~ 307 (476)
.++.||+.||.|||+.+ |+||||||+||||+.++ .+||+|||+++...... .........||+.|+|||++.+
T Consensus 172 ~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 248 (345)
T 3hko_A 172 NIMRQIFSALHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNT 248 (345)
T ss_dssp HHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTC
T ss_pred HHHHHHHHHHHHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhcc
Confidence 99999999999999988 99999999999998776 89999999997543211 1112334679999999999975
Q ss_pred --CCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhccccccccccCcccCCCCChHHHHHHHHHHHHh
Q 011851 308 --GHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASC 385 (476)
Q Consensus 308 --~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~c 385 (476)
..++.++|||||||++|||++|+.||.......... .. ..... ....+.. ...+.++.+||.+|
T Consensus 249 ~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~--~~----~~~~~---~~~~~~~-----~~~~~~~~~li~~~ 314 (345)
T 3hko_A 249 TNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTIS--QV----LNKKL---CFENPNY-----NVLSPLARDLLSNL 314 (345)
T ss_dssp SSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH--HH----HHCCC---CTTSGGG-----GGSCHHHHHHHHHH
T ss_pred CCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCChHHHHH--HH----Hhccc---ccCCccc-----ccCCHHHHHHHHHH
Confidence 678999999999999999999999997543221111 10 00000 0001111 11257899999999
Q ss_pred cccCCCCCCCHHHHHHHhcCCCCccccc
Q 011851 386 LNRDQKARPRMSEVVEALKPLPYLKDMA 413 (476)
Q Consensus 386 L~~dP~~RPt~~ell~~L~~~~~~~~~~ 413 (476)
|+.||++||++.++++| |||++..
T Consensus 315 l~~~p~~Rps~~~~l~h----p~~~~~~ 338 (345)
T 3hko_A 315 LNRNVDERFDAMRALQH----PWISQFS 338 (345)
T ss_dssp SCSCTTTSCCHHHHHHS----HHHHTTS
T ss_pred cCCChhHCCCHHHHhcC----hhhccCh
Confidence 99999999999999998 8888754
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-46 Score=371.73 Aligned_cols=279 Identities=22% Similarity=0.295 Sum_probs=210.9
Q ss_pred cCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCcc--CHHHHHHHHHHHhCCCCCceeeEEEEEEe
Q 011851 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQ--GHKEWLAEVNYLGGLIHPNLVKLIGCCIE 198 (476)
Q Consensus 121 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~l~~~~~~ 198 (476)
++|++.+.||+|+||.||+|.+. .+|+.||||++...... ....+.+|+.+|+.++||||+++++++..
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 87 (351)
T 3mi9_A 17 SKYEKLAKIGQGTFGEVFKARHR---------KTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRT 87 (351)
T ss_dssp GGEEEEEECSSCSTTSEEEEEET---------TTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred cceeEEEEEecCCCcEEEEEEEC---------CCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeec
Confidence 57999999999999999998764 47888999998654432 24567899999999999999999999987
Q ss_pred --------CCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCce
Q 011851 199 --------DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNA 270 (476)
Q Consensus 199 --------~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~v 270 (476)
.+.+||||||+++ +|.+.+......+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+
T Consensus 88 ~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~ 163 (351)
T 3mi9_A 88 KASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVL 163 (351)
T ss_dssp C--------CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCE
T ss_pred cccccccCCceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCE
Confidence 4568999999965 888888776678999999999999999999999988 9999999999999999999
Q ss_pred EEeecCCcCCCCCCCc--cceeeeeecCCCCCCcchhhc-CCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHh
Q 011851 271 KLSDFGLAKDGPEGDK--THVSTRVMGTYGYAAPEYVMT-GHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEW 347 (476)
Q Consensus 271 kl~DFG~a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~ 347 (476)
||+|||+++....... .......+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...........+..
T Consensus 164 kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~ 243 (351)
T 3mi9_A 164 KLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQ 243 (351)
T ss_dssp EECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred EEccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence 9999999976542211 112234678999999999876 4689999999999999999999999986543222211111
Q ss_pred hhhhhccc-------cccccccCcccCCCCChH-------HHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCccccc
Q 011851 348 ARPQLGER-------RRFYRLIDPCLEGCFSIK-------GAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDMA 413 (476)
Q Consensus 348 ~~~~~~~~-------~~~~~~~d~~l~~~~~~~-------~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~~~ 413 (476)
........ ......+........... .+..+.+||.+||+.||++|||+.|+++| |||+...
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h----p~f~~~~ 319 (351)
T 3mi9_A 244 LCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH----DFFWSDP 319 (351)
T ss_dssp HHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS----GGGGSSS
T ss_pred HhCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC----CCcCCCC
Confidence 10000000 000000000000000000 13568899999999999999999999998 9998765
Q ss_pred Ccc
Q 011851 414 SSS 416 (476)
Q Consensus 414 ~~~ 416 (476)
.+.
T Consensus 320 ~~~ 322 (351)
T 3mi9_A 320 MPS 322 (351)
T ss_dssp CCC
T ss_pred Ccc
Confidence 544
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-46 Score=369.91 Aligned_cols=261 Identities=25% Similarity=0.395 Sum_probs=203.5
Q ss_pred ccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCC-ccCHHHHHHHHHHHhCCCCCceeeEEEEEEe
Q 011851 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDG-LQGHKEWLAEVNYLGGLIHPNLVKLIGCCIE 198 (476)
Q Consensus 120 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~ 198 (476)
.++|++.++||+|+||.||+|.+..++.. ....||+|.+.... ....+.+.+|+.+|++++||||+++++++..
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~-----~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 88 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEK-----VKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT 88 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCS-----CCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEES
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCce-----EEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEec
Confidence 35799999999999999999987644322 12346888876443 3456788999999999999999999999987
Q ss_pred CCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCc
Q 011851 199 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLA 278 (476)
Q Consensus 199 ~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a 278 (476)
+. .++||||+.+|+|.+++......+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 89 ~~-~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a 164 (327)
T 3lzb_A 89 ST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLA 164 (327)
T ss_dssp SS-EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC-
T ss_pred CC-ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcce
Confidence 64 88999999999999999887778999999999999999999999988 999999999999999999999999999
Q ss_pred CCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhhccccc
Q 011851 279 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPQLGERRR 357 (476)
Q Consensus 279 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 357 (476)
+...............||+.|+|||++.+..++.++|||||||++|||++ |..||...........+.. . .
T Consensus 165 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~---~----~- 236 (327)
T 3lzb_A 165 KLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK---G----E- 236 (327)
T ss_dssp ---------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHT---T----C-
T ss_pred eEccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHc---C----C-
Confidence 87644333333334567889999999999999999999999999999999 9999976543322111110 0 0
Q ss_pred cccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011851 358 FYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPL 406 (476)
Q Consensus 358 ~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~ 406 (476)
....+...+.++.+||.+||+.||.+||++.++++.|+.+
T Consensus 237 ---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 276 (327)
T 3lzb_A 237 ---------RLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKM 276 (327)
T ss_dssp ---------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---------CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 0001122356899999999999999999999999987654
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-46 Score=363.64 Aligned_cols=259 Identities=27% Similarity=0.454 Sum_probs=195.1
Q ss_pred ccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCcc--CHHHHHHHHHHHhCCCCCceeeEEEEEE
Q 011851 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQ--GHKEWLAEVNYLGGLIHPNLVKLIGCCI 197 (476)
Q Consensus 120 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~l~~~~~ 197 (476)
.++|++.+.||+|+||.||+|.+. ..||+|+++..... ..+.+.+|+.+|++++||||+++++++
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~------------~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~- 89 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKWH------------GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS- 89 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEESS------------SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-
T ss_pred ccceeeeeEecCCCCeEEEEEEEc------------CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-
Confidence 457999999999999999998643 24999999765432 245688999999999999999999954
Q ss_pred eCCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCC
Q 011851 198 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGL 277 (476)
Q Consensus 198 ~~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~ 277 (476)
..+..++||||+++++|.+++......+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 90 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~ 166 (289)
T 3og7_A 90 TAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGL 166 (289)
T ss_dssp CSSSCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC-
T ss_pred cCCccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEcccee
Confidence 566789999999999999999777778999999999999999999999988 99999999999999999999999999
Q ss_pred cCCCCCCCccceeeeeecCCCCCCcchhh---cCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhcc
Q 011851 278 AKDGPEGDKTHVSTRVMGTYGYAAPEYVM---TGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGE 354 (476)
Q Consensus 278 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~ 354 (476)
+................||+.|+|||++. +..++.++|||||||++|+|++|+.||....... .+.......
T Consensus 167 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~--~~~~~~~~~--- 241 (289)
T 3og7_A 167 ATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD--QIIEMVGRG--- 241 (289)
T ss_dssp -----------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHH--HHHHHHHHT---
T ss_pred ccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHH--HHHHHhccc---
Confidence 98654323222334467999999999987 5678999999999999999999999997643321 111111110
Q ss_pred ccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011851 355 RRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPL 406 (476)
Q Consensus 355 ~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~ 406 (476)
. ..+.+. ......+..+.+||.+||+.||++|||+.++++.|+.+
T Consensus 242 --~----~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l 286 (289)
T 3og7_A 242 --S----LSPDLS-KVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEEL 286 (289)
T ss_dssp --S----CCCCTT-SSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred --c----cCcchh-hccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHH
Confidence 0 001010 01122367899999999999999999999999998754
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=373.47 Aligned_cols=274 Identities=26% Similarity=0.357 Sum_probs=206.4
Q ss_pred cCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccC--HHHHHHHHHHHhCCCCCceeeEEEEEEe
Q 011851 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQG--HKEWLAEVNYLGGLIHPNLVKLIGCCIE 198 (476)
Q Consensus 121 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~--~~~~~~E~~~l~~l~hpnIv~l~~~~~~ 198 (476)
++|++.+.||+|+||.||+|.+. .+|+.||||++....... .+.+.+|+.++++++||||+++++++.+
T Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 95 (331)
T 4aaa_A 25 EKYENLGLVGEGSYGMVMKCRNK---------DTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKK 95 (331)
T ss_dssp GGEEEEEEGGGGTTSSEEEEEET---------TTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred hhheeeeEEeecCCEEEEEEEEC---------CCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeec
Confidence 46999999999999999998764 467889999986554322 3457789999999999999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCc
Q 011851 199 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLA 278 (476)
Q Consensus 199 ~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a 278 (476)
.+..|+||||+++++|.+++ .....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 96 ~~~~~lv~e~~~~~~l~~~~-~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~ 171 (331)
T 4aaa_A 96 KKRWYLVFEFVDHTILDDLE-LFPNGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFA 171 (331)
T ss_dssp TTEEEEEEECCSEEHHHHHH-HSTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred CCEEEEEEecCCcchHHHHH-hhccCCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCc
Confidence 99999999999988888776 44457999999999999999999999988 999999999999999999999999999
Q ss_pred CCCCCCCccceeeeeecCCCCCCcchhhcC-CCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhh------
Q 011851 279 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQ------ 351 (476)
Q Consensus 279 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~------ 351 (476)
+....... ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||...........+......
T Consensus 172 ~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 249 (331)
T 4aaa_A 172 RTLAAPGE--VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQ 249 (331)
T ss_dssp --------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred eeecCCcc--ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhh
Confidence 76543221 22346799999999999876 7899999999999999999999999765432211111000000
Q ss_pred --hccccccccccCcccCCCC-----ChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCccccc
Q 011851 352 --LGERRRFYRLIDPCLEGCF-----SIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDMA 413 (476)
Q Consensus 352 --~~~~~~~~~~~d~~l~~~~-----~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~~~ 413 (476)
......+.....+.+.... ....++.+.+||.+||+.||++|||+.|+++| |||+...
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h----p~f~~~~ 314 (331)
T 4aaa_A 250 ELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH----DFFQMDG 314 (331)
T ss_dssp HHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS----HHHHGGG
T ss_pred hHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC----chhccCC
Confidence 0000000000001111000 11236789999999999999999999999997 9998653
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-46 Score=373.77 Aligned_cols=277 Identities=26% Similarity=0.329 Sum_probs=205.9
Q ss_pred HhccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccC-----HHHHHHHHHHHhCCCCCceeeE
Q 011851 118 SATKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQG-----HKEWLAEVNYLGGLIHPNLVKL 192 (476)
Q Consensus 118 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~-----~~~~~~E~~~l~~l~hpnIv~l 192 (476)
...++|++.+.||+|+||.||+|.+. .+|+.||||++....... .+.+.+|+.+|++++||||+++
T Consensus 7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~---------~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~ 77 (346)
T 1ua2_A 7 SRAKRYEKLDFLGEGQFATVYKARDK---------NTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 77 (346)
T ss_dssp ------CEEEEEEEETTEEEEEEECS---------SCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCE
T ss_pred HHhcccEEEeEEeecCCEEEEEEEEC---------CCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeE
Confidence 34568999999999999999998654 468889999997543221 2467899999999999999999
Q ss_pred EEEEEeCCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEE
Q 011851 193 IGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKL 272 (476)
Q Consensus 193 ~~~~~~~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl 272 (476)
++++.+.+..++||||+++ +|.+++......+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||
T Consensus 78 ~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl 153 (346)
T 1ua2_A 78 LDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKL 153 (346)
T ss_dssp EEEECCTTCCEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEE
T ss_pred EEEEeeCCceEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEE
Confidence 9999999999999999975 899998777777999999999999999999999988 999999999999999999999
Q ss_pred eecCCcCCCCCCCccceeeeeecCCCCCCcchhhcC-CCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhH-Hhh-h
Q 011851 273 SDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV-EWA-R 349 (476)
Q Consensus 273 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~-~~~-~ 349 (476)
+|||+++....... .....+||+.|+|||++.+. .++.++|||||||++|||++|..||...........+ ... .
T Consensus 154 ~Dfg~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~ 231 (346)
T 1ua2_A 154 ADFGLAKSFGSPNR--AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGT 231 (346)
T ss_dssp CCCGGGSTTTSCCC--CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCC
T ss_pred EecccceeccCCcc--cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCC
Confidence 99999987643222 23346799999999999764 5899999999999999999999999765322111110 000 0
Q ss_pred hhhccccccccccCcccCCCC--------ChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCccccc
Q 011851 350 PQLGERRRFYRLIDPCLEGCF--------SIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDMA 413 (476)
Q Consensus 350 ~~~~~~~~~~~~~d~~l~~~~--------~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~~~ 413 (476)
+.......+....+......+ ....+.++.+||.+||+.||++|||+.|+++| |||.+..
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h----~~f~~~~ 299 (346)
T 1ua2_A 232 PTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM----KYFSNRP 299 (346)
T ss_dssp CCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS----GGGTSSS
T ss_pred CChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC----hhhhcCC
Confidence 000000000000000000000 01225789999999999999999999999997 8987643
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-46 Score=365.67 Aligned_cols=270 Identities=24% Similarity=0.405 Sum_probs=213.1
Q ss_pred ccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCCCCCceeeEEEEEEeC
Q 011851 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHPNLVKLIGCCIED 199 (476)
Q Consensus 120 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~ 199 (476)
.++|++.+.||+|+||.||+|.+. .+++.||+|++........+.+.+|+.+|+.++||||+++++++.++
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 88 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNK---------ETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHD 88 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEET---------TTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC
T ss_pred ccceeecceeccCCCeEEEEEEEc---------CCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeC
Confidence 467999999999999999998764 46788999999877666778899999999999999999999999999
Q ss_pred CeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCcC
Q 011851 200 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAK 279 (476)
Q Consensus 200 ~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~ 279 (476)
+..|+||||+++++|.+++......+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.
T Consensus 89 ~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 165 (302)
T 2j7t_A 89 GKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSA 165 (302)
T ss_dssp -CEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHH
T ss_pred CeEEEEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCc
Confidence 9999999999999999998776677999999999999999999999988 9999999999999999999999999875
Q ss_pred CCCCCCccceeeeeecCCCCCCcchhh-----cCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhcc
Q 011851 280 DGPEGDKTHVSTRVMGTYGYAAPEYVM-----TGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGE 354 (476)
Q Consensus 280 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~ 354 (476)
.... .........||+.|+|||++. ...++.++|||||||++|+|++|..||........ ........
T Consensus 166 ~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~~~~~~~~--- 238 (302)
T 2j7t_A 166 KNLK--TLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV--LLKIAKSD--- 238 (302)
T ss_dssp HHHH--HHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH--HHHHHHSC---
T ss_pred cccc--cccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHH--HHHHhccC---
Confidence 3211 011122357999999999984 56789999999999999999999999975432111 11110000
Q ss_pred ccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCcccccCcchHHHHH
Q 011851 355 RRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDMASSSSYVQAM 422 (476)
Q Consensus 355 ~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~~~~~~~~~~~~ 422 (476)
. + ....+...+..+.+||.+||+.||++|||+.++++| ||+++........+.+
T Consensus 239 ~--------~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h----~~~~~~~~~~~~~~~~ 292 (302)
T 2j7t_A 239 P--------P--TLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEH----PFVSSITSNKALRELV 292 (302)
T ss_dssp C--------C--CCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTS----TTTTTCCCCHHHHHHH
T ss_pred C--------c--ccCCccccCHHHHHHHHHHcccChhhCCCHHHHhcC----hHHhhhccchhHHHHH
Confidence 0 0 000112235789999999999999999999999987 9999887665444333
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-47 Score=379.67 Aligned_cols=275 Identities=23% Similarity=0.338 Sum_probs=210.9
Q ss_pred ccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCcc-CHHHHHHHHHHHhCCCCCceeeEEEEEEe
Q 011851 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQ-GHKEWLAEVNYLGGLIHPNLVKLIGCCIE 198 (476)
Q Consensus 120 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~~ 198 (476)
.++|++.+.||+|+||.||+|.+. .+++.||+|++...... ..+.+.+|+.+|++++||||+++++++.+
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 102 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHK---------PSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS 102 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET---------TTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEE
T ss_pred cccceeeeeecCCCCeEEEEEEEC---------CCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEE
Confidence 357999999999999999998764 46788999999765322 24568899999999999999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeEecCCCCCCeeecCCCceEEeecCC
Q 011851 199 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEE-AEKPVIYRDFKTSNILLDGEYNAKLSDFGL 277 (476)
Q Consensus 199 ~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~-~~~~ivHrDlKp~NILl~~~~~vkl~DFG~ 277 (476)
++..||||||+++++|.+++... ..+++..+..++.||+.||.|||+. + |+||||||+|||++.++.+||+|||+
T Consensus 103 ~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~ 178 (360)
T 3eqc_A 103 DGEISICMEHMDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGV 178 (360)
T ss_dssp TTEEEEEECCCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCC
T ss_pred CCEEEEEEECCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCC
Confidence 99999999999999999999654 4699999999999999999999995 7 99999999999999999999999999
Q ss_pred cCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhh-------
Q 011851 278 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP------- 350 (476)
Q Consensus 278 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~------- 350 (476)
+..... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.................
T Consensus 179 ~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 254 (360)
T 3eqc_A 179 SGQLID----SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETP 254 (360)
T ss_dssp CHHHHH----HC----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-----------
T ss_pred Cccccc----ccccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCC
Confidence 865321 112346799999999999999999999999999999999999999975432111100000000
Q ss_pred ---------------hhccccccccc----cCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCccc
Q 011851 351 ---------------QLGERRRFYRL----IDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKD 411 (476)
Q Consensus 351 ---------------~~~~~~~~~~~----~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~ 411 (476)
.........+. .............+.++.+||.+||+.||++|||+.++++| |||++
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h----p~~~~ 330 (360)
T 3eqc_A 255 PRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH----AFIKR 330 (360)
T ss_dssp -------------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS----HHHHH
T ss_pred CCcccCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhC----hHhhc
Confidence 00000000000 00000001111235689999999999999999999999997 99987
Q ss_pred ccCc
Q 011851 412 MASS 415 (476)
Q Consensus 412 ~~~~ 415 (476)
....
T Consensus 331 ~~~~ 334 (360)
T 3eqc_A 331 SDAE 334 (360)
T ss_dssp HHHS
T ss_pred chHh
Confidence 5433
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-47 Score=374.76 Aligned_cols=276 Identities=26% Similarity=0.336 Sum_probs=214.4
Q ss_pred cCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCCCCCceeeEEEEEE--e
Q 011851 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHPNLVKLIGCCI--E 198 (476)
Q Consensus 121 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~--~ 198 (476)
++|++.+.||+|+||.||+|.+.. .+..+++.||||++........+.+.+|+++|++++||||+++++++. +
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 97 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDP-----LGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPG 97 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECT-----TSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred hhhhhhhhccCCCCeEEEEEEecc-----CCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCC
Confidence 569999999999999999997542 233578899999998776555667899999999999999999999987 4
Q ss_pred CCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCc
Q 011851 199 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLA 278 (476)
Q Consensus 199 ~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a 278 (476)
....||||||+++++|.+++......+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~ 174 (327)
T 3lxl_A 98 RQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLA 174 (327)
T ss_dssp SCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGC
T ss_pred CceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEcccccc
Confidence 56789999999999999999775667999999999999999999999988 999999999999999999999999999
Q ss_pred CCCCCCCcc-ceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhccccc
Q 011851 279 KDGPEGDKT-HVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRR 357 (476)
Q Consensus 279 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 357 (476)
......... .......||+.|+|||++.+..++.++|||||||++|+|++|..||........... .. .........
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~-~~-~~~~~~~~~ 252 (327)
T 3lxl_A 175 KLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMM-GC-ERDVPALSR 252 (327)
T ss_dssp EECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHC-C-----CCHHHH
T ss_pred eecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhc-cc-ccccccHHH
Confidence 876443321 122235688899999999999999999999999999999999999864321100000 00 000000000
Q ss_pred cccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011851 358 FYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPL 406 (476)
Q Consensus 358 ~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~ 406 (476)
+...+........+...+..+.+||.+||+.||++|||+.+++++|+.+
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 301 (327)
T 3lxl_A 253 LLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDML 301 (327)
T ss_dssp HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC
T ss_pred HHHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 0011111111112233467899999999999999999999999998755
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-46 Score=369.45 Aligned_cols=260 Identities=25% Similarity=0.397 Sum_probs=191.9
Q ss_pred hccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCc--cCHHHHHHHHHHHhCCCCCceeeEEEEE
Q 011851 119 ATKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL--QGHKEWLAEVNYLGGLIHPNLVKLIGCC 196 (476)
Q Consensus 119 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~ 196 (476)
..++|++.+.||+|+||.||+|.+...+ .+...||||+++.... ...+.+.+|+.++++++||||+++++++
T Consensus 21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 94 (323)
T 3qup_A 21 PEQQFTLGRMLGKGEFGSVREAQLKQED------GSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVS 94 (323)
T ss_dssp C---CEEEEEEEEETTEEEEEEEC-------------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEE
T ss_pred ChhHeEEeceecccCCeEEEEEEEcccC------CcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhcee
Confidence 3567999999999999999999765322 1224799999976532 3356789999999999999999999999
Q ss_pred EeCCee------EEEEEecCCCCHHHHHhhc-----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeec
Q 011851 197 IEDDQR------LLVYEFMPRGSLENHLFRR-----SLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLD 265 (476)
Q Consensus 197 ~~~~~~------~lV~E~~~~g~L~~~l~~~-----~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~ 265 (476)
...... ++||||+++++|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+|||++
T Consensus 95 ~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~ 171 (323)
T 3qup_A 95 LRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLA 171 (323)
T ss_dssp ECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEC
T ss_pred eccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEc
Confidence 887665 9999999999999998643 225899999999999999999999988 99999999999999
Q ss_pred CCCceEEeecCCcCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHh-CCCCCCCCCCCCcchh
Q 011851 266 GEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNL 344 (476)
Q Consensus 266 ~~~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~ellt-G~~pf~~~~~~~~~~~ 344 (476)
.++.+||+|||+++...............+++.|+|||++.+..++.++|||||||++|||++ |..||...........
T Consensus 172 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~ 251 (323)
T 3qup_A 172 EDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNY 251 (323)
T ss_dssp TTSCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHH
T ss_pred CCCCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHH
Confidence 999999999999987654433333334567889999999999999999999999999999999 9999976543221111
Q ss_pred HHhhhhhhccccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 011851 345 VEWARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALK 404 (476)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~ 404 (476)
+. . .. ....+...+.++.+|+.+||+.||++|||+.++++.|+
T Consensus 252 ~~---~----~~----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~ 294 (323)
T 3qup_A 252 LI---G----GN----------RLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELE 294 (323)
T ss_dssp HH---T----TC----------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred Hh---c----CC----------CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 10 0 00 00011223578999999999999999999999988866
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-46 Score=361.38 Aligned_cols=262 Identities=23% Similarity=0.342 Sum_probs=211.7
Q ss_pred hccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCcc--CHHHHHHHHHHHhCCCCCceeeEEEEE
Q 011851 119 ATKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQ--GHKEWLAEVNYLGGLIHPNLVKLIGCC 196 (476)
Q Consensus 119 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~l~~~~ 196 (476)
..++|++.+.||+|+||.||+|.+. .+|+.||+|++...... ..+.+.+|+.++++++||||+++++++
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 74 (284)
T 3kk8_A 4 FSDNYDVKEELGKGAFSVVRRCVHK---------TTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI 74 (284)
T ss_dssp TTTTEEEEEEEEEETTEEEEEEEET---------TTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred hhhhhhhhhhhcCcCCeEEEEEEEc---------CCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEE
Confidence 3568999999999999999998654 46788999999754332 235678999999999999999999999
Q ss_pred EeCCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCc---eEEe
Q 011851 197 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYN---AKLS 273 (476)
Q Consensus 197 ~~~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~---vkl~ 273 (476)
.+++..|+||||+++++|.+.+... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++. +||+
T Consensus 75 ~~~~~~~~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~ 150 (284)
T 3kk8_A 75 QEESFHYLVFDLVTGGELFEDIVAR-EFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLA 150 (284)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEEC
T ss_pred EcCCEEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEe
Confidence 9999999999999999999988654 46999999999999999999999988 999999999999976655 9999
Q ss_pred ecCCcCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhc
Q 011851 274 DFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLG 353 (476)
Q Consensus 274 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~ 353 (476)
|||++........ .....||+.|+|||++.+..++.++||||||+++|+|++|+.||...........+ ..
T Consensus 151 Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~---~~--- 221 (284)
T 3kk8_A 151 DFGLAIEVNDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI---KA--- 221 (284)
T ss_dssp CCTTCEECCSSCB---CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH---HH---
T ss_pred eceeeEEcccCcc---ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHH---Hh---
Confidence 9999976544322 23367999999999999999999999999999999999999999754322111111 00
Q ss_pred cccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCcccccC
Q 011851 354 ERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDMAS 414 (476)
Q Consensus 354 ~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~~~~ 414 (476)
.. .....+.. ...+.++.+||.+||+.||++|||+.++++| ||+++...
T Consensus 222 ~~---~~~~~~~~-----~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h----~~~~~~~~ 270 (284)
T 3kk8_A 222 GA---YDYPSPEW-----DTVTPEAKSLIDSMLTVNPKKRITADQALKV----PWICNRER 270 (284)
T ss_dssp TC---CCCCTTTT-----TTSCHHHHHHHHHHSCSSTTTSCCHHHHTTS----HHHHSCCC
T ss_pred cc---ccCCchhh-----cccCHHHHHHHHHHcccChhhCCCHHHHhcC----ccccCChh
Confidence 00 00111111 1225788999999999999999999999997 88876543
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-46 Score=359.24 Aligned_cols=254 Identities=31% Similarity=0.477 Sum_probs=195.7
Q ss_pred ccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCcc----CHHHHHHHHHHHhCCCCCceeeEEEE
Q 011851 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQ----GHKEWLAEVNYLGGLIHPNLVKLIGC 195 (476)
Q Consensus 120 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~----~~~~~~~E~~~l~~l~hpnIv~l~~~ 195 (476)
.++|++.+.||+|+||.||+|.+ ++..||||+++..... ..+.+.+|+++++.++||||++++++
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~-----------~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 74 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFW-----------IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGV 74 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEE-----------TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred hhheeeeeeeccCCCeEEEEEEE-----------cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEE
Confidence 35799999999999999999875 3667999998764332 24678899999999999999999999
Q ss_pred EEeCCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecC--------C
Q 011851 196 CIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDG--------E 267 (476)
Q Consensus 196 ~~~~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~--------~ 267 (476)
+.+++..|+||||+++++|.+++. ...+++..++.++.||+.||.|||+++..+|+||||||+|||++. +
T Consensus 75 ~~~~~~~~lv~e~~~~~~L~~~~~--~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~ 152 (271)
T 3dtc_A 75 CLKEPNLCLVMEFARGGPLNRVLS--GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSN 152 (271)
T ss_dssp ECCC--CEEEEECCTTEEHHHHHT--SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSS
T ss_pred EecCCceEEEEEcCCCCCHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccC
Confidence 999999999999999999999884 346999999999999999999999977444889999999999986 6
Q ss_pred CceEEeecCCcCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHh
Q 011851 268 YNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEW 347 (476)
Q Consensus 268 ~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~ 347 (476)
+.+||+|||++....... .....||+.|+|||++.+..++.++||||||+++|+|++|+.||...........
T Consensus 153 ~~~kl~Dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~--- 225 (271)
T 3dtc_A 153 KILKITDFGLAREWHRTT----KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYG--- 225 (271)
T ss_dssp CCEEECCCCC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHH---
T ss_pred cceEEccCCccccccccc----ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHh---
Confidence 789999999998654322 2235799999999999999999999999999999999999999975432111000
Q ss_pred hhhhhccccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011851 348 ARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPL 406 (476)
Q Consensus 348 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~ 406 (476)
... .......+...+..+.+|+.+||+.||++|||+.+++++|+.+
T Consensus 226 ---~~~----------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 226 ---VAM----------NKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp ---HHT----------SCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred ---hhc----------CCCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 000 0001111223367899999999999999999999999998753
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-46 Score=363.18 Aligned_cols=261 Identities=25% Similarity=0.327 Sum_probs=200.3
Q ss_pred ccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhC--CCCCceeeEEEEEE
Q 011851 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGG--LIHPNLVKLIGCCI 197 (476)
Q Consensus 120 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~--l~hpnIv~l~~~~~ 197 (476)
.++|++.+.||+|+||+||+|.+ +|+.||||++... ....+..|.+++.. ++||||+++++++.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~-----------~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~ 72 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW-----------QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDM 72 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE-----------TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE-----------CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeec
Confidence 46799999999999999999865 4678999999654 33455666666665 89999999999976
Q ss_pred eC----CeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHH--------hcCCCCeEecCCCCCCeeec
Q 011851 198 ED----DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLH--------EEAEKPVIYRDFKTSNILLD 265 (476)
Q Consensus 198 ~~----~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH--------~~~~~~ivHrDlKp~NILl~ 265 (476)
+. ...|+||||+++|+|.+++.. ..+++..++.++.||+.||.||| +.+ |+||||||+|||++
T Consensus 73 ~~~~~~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~ 147 (301)
T 3q4u_A 73 TSRHSSTQLWLITHYHEMGSLYDYLQL--TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVK 147 (301)
T ss_dssp EEETTEEEEEEEECCCTTCBHHHHHTT--CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEEC
T ss_pred cccCCCceeEEehhhccCCCHHHHHhh--cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEc
Confidence 53 458999999999999999943 46999999999999999999999 766 99999999999999
Q ss_pred CCCceEEeecCCcCCCCCCCccc--eeeeeecCCCCCCcchhhcC------CCCccchhhhhHHHHHHHHhC--------
Q 011851 266 GEYNAKLSDFGLAKDGPEGDKTH--VSTRVMGTYGYAAPEYVMTG------HLTAKSDVYSFGVVLLEMLTG-------- 329 (476)
Q Consensus 266 ~~~~vkl~DFG~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~~DiwslGv~l~elltG-------- 329 (476)
.++.+||+|||+++......... .....+||+.|+|||++.+. .++.++|||||||++|||++|
T Consensus 148 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~ 227 (301)
T 3q4u_A 148 KNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVE 227 (301)
T ss_dssp TTSCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCC
T ss_pred CCCCEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccc
Confidence 99999999999997543322211 12235799999999999876 455789999999999999999
Q ss_pred --CCCCCCCCCCCcchhHHhhhhhhccccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 011851 330 --RRSMDKNRPNGEHNLVEWARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKP 405 (476)
Q Consensus 330 --~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~ 405 (476)
..||............. ....... . .........+....+.++.+|+.+||+.||++|||+.+|++.|+.
T Consensus 228 ~~~~pf~~~~~~~~~~~~~-~~~~~~~-~----~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~ 299 (301)
T 3q4u_A 228 DYKPPFYDVVPNDPSFEDM-RKVVCVD-Q----QRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTK 299 (301)
T ss_dssp CCCCTTTTTSCSSCCHHHH-HHHHTTS-C----CCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHH
T ss_pred cccccccccCCCCcchhhh-hHHHhcc-C----CCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhc
Confidence 78886544333221111 0000000 0 000111122334567899999999999999999999999999764
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=378.46 Aligned_cols=264 Identities=25% Similarity=0.328 Sum_probs=210.3
Q ss_pred cCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCc----cCHHHHHHHHHHHhCC-CCCceeeEEEE
Q 011851 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL----QGHKEWLAEVNYLGGL-IHPNLVKLIGC 195 (476)
Q Consensus 121 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~----~~~~~~~~E~~~l~~l-~hpnIv~l~~~ 195 (476)
++|++.+.||+|+||.||+|++.. ...+|+.||||+++.... ...+.+.+|+++|+++ +||||++++++
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~~~~~~------~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 127 (355)
T 1vzo_A 54 ENFELLKVLGTGAYGKVFLVRKIS------GHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYA 127 (355)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECS------STTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEE
T ss_pred cceEEEEEeccCCCEEEEEEEEcc------cCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEE
Confidence 569999999999999999997642 234788999999875422 2345567899999999 69999999999
Q ss_pred EEeCCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeec
Q 011851 196 CIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDF 275 (476)
Q Consensus 196 ~~~~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DF 275 (476)
+...+.+||||||+++++|.+++... ..+++..++.++.||+.||.|||+.+ |+||||||+||||+.++.+||+||
T Consensus 128 ~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Df 203 (355)
T 1vzo_A 128 FQTETKLHLILDYINGGELFTHLSQR-ERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDF 203 (355)
T ss_dssp EEETTEEEEEECCCCSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCS
T ss_pred EeeCceEEEEeecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeC
Confidence 99999999999999999999999654 46999999999999999999999988 999999999999999999999999
Q ss_pred CCcCCCCCCCccceeeeeecCCCCCCcchhhcC--CCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhc
Q 011851 276 GLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG--HLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLG 353 (476)
Q Consensus 276 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~ 353 (476)
|+++...... .......+||+.|+|||++.+. .++.++|||||||++|||++|+.||........... .......
T Consensus 204 G~a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~--~~~~~~~ 280 (355)
T 1vzo_A 204 GLSKEFVADE-TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAE--ISRRILK 280 (355)
T ss_dssp SEEEECCGGG-GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHH--HHHHHHH
T ss_pred CCCeecccCC-CCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHH--HHHHHhc
Confidence 9998654322 2223346899999999999863 578999999999999999999999975443322211 1111111
Q ss_pred cccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHhcCCCCccccc
Q 011851 354 ERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARP-----RMSEVVEALKPLPYLKDMA 413 (476)
Q Consensus 354 ~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RP-----t~~ell~~L~~~~~~~~~~ 413 (476)
... .++...+..+.+||.+||..||++|| ++.++++| |||++..
T Consensus 281 ~~~------------~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h----~~f~~~~ 329 (355)
T 1vzo_A 281 SEP------------PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH----LFFQKIN 329 (355)
T ss_dssp CCC------------CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS----GGGTTCC
T ss_pred cCC------------CCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcC----cchhcCC
Confidence 000 11222357889999999999999999 99999987 8988653
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-46 Score=367.00 Aligned_cols=267 Identities=27% Similarity=0.361 Sum_probs=209.0
Q ss_pred cCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCc-cCHHHHHHHHHHHhCCCCCceeeEEEEEEeC
Q 011851 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL-QGHKEWLAEVNYLGGLIHPNLVKLIGCCIED 199 (476)
Q Consensus 121 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~ 199 (476)
++|++.+.||+|+||.||+|.+... +..+++.||||++..... ...+.+.+|+.+|++++||||+++++++.+.
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~-----~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 95 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPE-----GDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTED 95 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTT-----SSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-
T ss_pred hhhhhhhccCCCCceEEEEEEEccc-----cCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecC
Confidence 3589999999999999999975422 335789999999975432 3456789999999999999999999999877
Q ss_pred --CeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCC
Q 011851 200 --DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGL 277 (476)
Q Consensus 200 --~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~ 277 (476)
..+++||||+++++|.+++......+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 96 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~ 172 (302)
T 4e5w_A 96 GGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGL 172 (302)
T ss_dssp --CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTT
T ss_pred CCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECcccc
Confidence 6789999999999999999777778999999999999999999999988 99999999999999999999999999
Q ss_pred cCCCCCCCcc-ceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCC--------CCcchhHHhh
Q 011851 278 AKDGPEGDKT-HVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRP--------NGEHNLVEWA 348 (476)
Q Consensus 278 a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~--------~~~~~~~~~~ 348 (476)
+......... .......||..|+|||++.+..++.++|||||||++|+|++|..|+..... ..........
T Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 252 (302)
T 4e5w_A 173 TKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRL 252 (302)
T ss_dssp CEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHH
T ss_pred cccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHH
Confidence 9876543321 222335688899999999999999999999999999999999998643210 0000000000
Q ss_pred hhhhccccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 011851 349 RPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKP 405 (476)
Q Consensus 349 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~ 405 (476)
. ..+........+...+.++.+||.+||+.||.+|||+.++++.|+.
T Consensus 253 ~----------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 299 (302)
T 4e5w_A 253 V----------NTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEA 299 (302)
T ss_dssp H----------HHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred H----------HHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHH
Confidence 0 0000001111222336789999999999999999999999998764
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=366.72 Aligned_cols=267 Identities=21% Similarity=0.283 Sum_probs=207.7
Q ss_pred ccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCCC-CCceeeEEEEEEe
Q 011851 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLI-HPNLVKLIGCCIE 198 (476)
Q Consensus 120 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~ 198 (476)
.++|++.+.||+|+||.||+|.+. .+++.||||++... ..+.+.+|+.+|+++. ||||+++++++.+
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~ 102 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINI---------TNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKD 102 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET---------TTCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEEC
T ss_pred CCceEEEEEecccCCeEEEEEEEC---------CCCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeecc
Confidence 357999999999999999998654 46788999999743 3567889999999997 9999999999998
Q ss_pred --CCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCC-ceEEeec
Q 011851 199 --DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEY-NAKLSDF 275 (476)
Q Consensus 199 --~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~-~vkl~DF 275 (476)
....++||||+++++|.+++. .+++..+..++.||+.||.|||+++ |+||||||+|||++.++ .+||+||
T Consensus 103 ~~~~~~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Df 175 (330)
T 3nsz_A 103 PVSRTPALVFEHVNNTDFKQLYQ----TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDW 175 (330)
T ss_dssp TTTCCEEEEEECCCCCCHHHHGG----GCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCC
T ss_pred CCCCceEEEEeccCchhHHHHHH----hCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeC
Confidence 667899999999999998883 3889999999999999999999988 99999999999999776 8999999
Q ss_pred CCcCCCCCCCccceeeeeecCCCCCCcchhhc-CCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhh----
Q 011851 276 GLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP---- 350 (476)
Q Consensus 276 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~---- 350 (476)
|+++....... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||......... +......
T Consensus 176 g~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~-l~~~~~~~~~~ 251 (330)
T 3nsz_A 176 GLAEFYHPGQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQ-LVRIAKVLGTE 251 (330)
T ss_dssp TTCEECCTTCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHH-HHHHHHHHCHH
T ss_pred CCceEcCCCCc---cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHH-HHHHHHhcCCc
Confidence 99986544332 233579999999999987 67999999999999999999999999644322111 1100000
Q ss_pred hh---------ccccccccc--------cCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCccccc
Q 011851 351 QL---------GERRRFYRL--------IDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDMA 413 (476)
Q Consensus 351 ~~---------~~~~~~~~~--------~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~~~ 413 (476)
.. .....+..+ .............+.++.+||.+||+.||++|||+.++++| |||+++.
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h----p~f~~~~ 327 (330)
T 3nsz_A 252 DLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH----PYFYTVV 327 (330)
T ss_dssp HHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS----GGGTTCC
T ss_pred hhhhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC----ccHhhhc
Confidence 00 000000000 00001111112236789999999999999999999999998 9998764
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-46 Score=368.44 Aligned_cols=256 Identities=23% Similarity=0.318 Sum_probs=197.7
Q ss_pred ccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccC---HHHHHHHHHHHhCCCCCceeeEEEEE
Q 011851 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQG---HKEWLAEVNYLGGLIHPNLVKLIGCC 196 (476)
Q Consensus 120 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~---~~~~~~E~~~l~~l~hpnIv~l~~~~ 196 (476)
.++|++.+.||+|+||.||+|.+. .+++.||||++....... ...+.+|+.++++++||||+++++++
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 81 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDL---------RDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTG 81 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEET---------TTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEEC---------CCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEee
Confidence 457999999999999999998754 467889999998754433 34678999999999999999999998
Q ss_pred EeCCe----eEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEE
Q 011851 197 IEDDQ----RLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKL 272 (476)
Q Consensus 197 ~~~~~----~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl 272 (476)
..... .||||||+++++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||
T Consensus 82 ~~~~~~~~~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl 157 (311)
T 3ork_A 82 EAETPAGPLPYIVMEYVDGVTLRDIVHTE-GPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKV 157 (311)
T ss_dssp EEEETTEEEEEEEEECCCEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEE
T ss_pred eccCCCCcccEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEE
Confidence 87654 49999999999999999654 47999999999999999999999988 999999999999999999999
Q ss_pred eecCCcCCCCCCCcc-ceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhh
Q 011851 273 SDFGLAKDGPEGDKT-HVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQ 351 (476)
Q Consensus 273 ~DFG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~ 351 (476)
+|||+++........ ......+||+.|+|||++.+..++.++|||||||++|||++|+.||......... .. .
T Consensus 158 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~--~~----~ 231 (311)
T 3ork_A 158 MDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVA--YQ----H 231 (311)
T ss_dssp CCCSCC------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH--HH----H
T ss_pred eeccCcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHH--HH----H
Confidence 999999865432221 1223467999999999999999999999999999999999999999764321110 00 0
Q ss_pred hccccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011851 352 LGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEA 402 (476)
Q Consensus 352 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~ 402 (476)
.......... .....+.++.+||.+||+.||++||++.+++.+
T Consensus 232 ~~~~~~~~~~--------~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~ 274 (311)
T 3ork_A 232 VREDPIPPSA--------RHEGLSADLDAVVLKALAKNPENRYQTAAEMRA 274 (311)
T ss_dssp HHCCCCCHHH--------HSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred hcCCCCCccc--------ccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHH
Confidence 0000000000 001125788999999999999999999888876
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-46 Score=372.98 Aligned_cols=256 Identities=23% Similarity=0.294 Sum_probs=210.2
Q ss_pred ccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCcc---CHHHHHHHHHHHhCCCCCceeeEEEEE
Q 011851 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQ---GHKEWLAEVNYLGGLIHPNLVKLIGCC 196 (476)
Q Consensus 120 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~---~~~~~~~E~~~l~~l~hpnIv~l~~~~ 196 (476)
.++|.+.+.||+|+||.||+|.+. .+++.||+|++...... ..+.+.+|+.+++.++||||+++++++
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~---------~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 110 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDA---------DTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFF 110 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEET---------TTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEC---------CCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 457999999999999999998664 46788999999765332 345688899999999999999999999
Q ss_pred EeCCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecC
Q 011851 197 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFG 276 (476)
Q Consensus 197 ~~~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG 276 (476)
.+.+..|+||||+++++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||
T Consensus 111 ~~~~~~~lv~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg 186 (335)
T 2owb_A 111 EDNDFVFVVLELCRRRSLLELHKRR-KALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFG 186 (335)
T ss_dssp ECSSEEEEEECCCTTCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCT
T ss_pred ecCCeEEEEEecCCCCCHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeecc
Confidence 9999999999999999999988554 57999999999999999999999988 9999999999999999999999999
Q ss_pred CcCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhcccc
Q 011851 277 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERR 356 (476)
Q Consensus 277 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~ 356 (476)
++........ ......||+.|+|||++.+..++.++|||||||++|+|++|+.||....... .... ......
T Consensus 187 ~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~~~---~~~~~~ 258 (335)
T 2owb_A 187 LATKVEYDGE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE---TYLR---IKKNEY 258 (335)
T ss_dssp TCEECCSTTC--CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH---HHHH---HHHTCC
T ss_pred CceecccCcc--cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHH---HHHH---HhcCCC
Confidence 9987543222 1234679999999999999999999999999999999999999997543211 1100 000000
Q ss_pred ccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCcccc
Q 011851 357 RFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDM 412 (476)
Q Consensus 357 ~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~~ 412 (476)
. ++...+..+.+||.+||+.||++|||+.+++++ +||...
T Consensus 259 ~------------~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~----~~~~~~ 298 (335)
T 2owb_A 259 S------------IPKHINPVAASLIQKMLQTDPTARPTINELLND----EFFTSG 298 (335)
T ss_dssp C------------CCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS----HHHHTS
T ss_pred C------------CCccCCHHHHHHHHHHccCChhHCcCHHHHhcC----ccccCC
Confidence 0 111225678899999999999999999999987 787643
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-46 Score=389.40 Aligned_cols=256 Identities=26% Similarity=0.384 Sum_probs=212.2
Q ss_pred ccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCCCCCceeeEEEEEEeC
Q 011851 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHPNLVKLIGCCIED 199 (476)
Q Consensus 120 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~ 199 (476)
..+|++.+.||+|+||.||+|.+. .++..||||+++... ...+++.+|+.+|++++||||+++++++.+.
T Consensus 219 ~~~~~~~~~lG~G~fg~Vy~~~~~---------~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~ 288 (495)
T 1opk_A 219 RTDITMKHKLGGGQYGEVYEGVWK---------KYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE 288 (495)
T ss_dssp GGGEEEEEESGGGTTSSEEEEEEG---------GGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHceeeeEecCCCCeEEEEEEEc---------CCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 456899999999999999999765 357789999997654 3467899999999999999999999999999
Q ss_pred CeeEEEEEecCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCc
Q 011851 200 DQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLA 278 (476)
Q Consensus 200 ~~~~lV~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a 278 (476)
+.+||||||+++|+|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||++
T Consensus 289 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a 365 (495)
T 1opk_A 289 PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLS 365 (495)
T ss_dssp SSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCE
T ss_pred CcEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccc
Confidence 9999999999999999999764 456899999999999999999999988 999999999999999999999999999
Q ss_pred CCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhhccccc
Q 011851 279 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPQLGERRR 357 (476)
Q Consensus 279 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 357 (476)
+...... ........+++.|+|||++.+..++.++|||||||++|||++ |..||........ ...... .
T Consensus 366 ~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~---~~~~~~----~-- 435 (495)
T 1opk_A 366 RLMTGDT-YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV---YELLEK----D-- 435 (495)
T ss_dssp ECCTTCC-EECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH---HHHHHT----T--
T ss_pred eeccCCc-eeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHH---HHHHHc----C--
Confidence 8764322 112223456788999999999999999999999999999999 9999976543221 111110 0
Q ss_pred cccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011851 358 FYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPL 406 (476)
Q Consensus 358 ~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~ 406 (476)
.....+...+.++.+||.+||+.||++|||+.+|++.|+.+
T Consensus 436 --------~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~ 476 (495)
T 1opk_A 436 --------YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 476 (495)
T ss_dssp --------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred --------CCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence 00011222367899999999999999999999999998865
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-45 Score=361.81 Aligned_cols=265 Identities=25% Similarity=0.374 Sum_probs=211.4
Q ss_pred hccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCCCCCceeeEEEEEEe
Q 011851 119 ATKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHPNLVKLIGCCIE 198 (476)
Q Consensus 119 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~ 198 (476)
..++|++.+.||+|+||.||+|.+. .+|+.||||++.... ..+.+.+|+.+|++++||||+++++++.+
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~---------~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 95 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHK---------ETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFK 95 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEET---------TTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEEC---------CCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEe
Confidence 3567999999999999999998654 468889999997653 34678899999999999999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCc
Q 011851 199 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLA 278 (476)
Q Consensus 199 ~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a 278 (476)
.+..|+||||+++++|.+++......+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 96 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~ 172 (314)
T 3com_A 96 NTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVA 172 (314)
T ss_dssp TTEEEEEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTC
T ss_pred CCEEEEEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccc
Confidence 99999999999999999999766678999999999999999999999988 999999999999999999999999999
Q ss_pred CCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhcccccc
Q 011851 279 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRRF 358 (476)
Q Consensus 279 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 358 (476)
........ ......||+.|+|||++.+..++.++|||||||++|+|++|+.||........ ....... .
T Consensus 173 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---~~~~~~~--~---- 241 (314)
T 3com_A 173 GQLTDTMA--KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRA---IFMIPTN--P---- 241 (314)
T ss_dssp EECBTTBS--CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHH---HHHHHHS--C----
T ss_pred hhhhhhcc--ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHH---HHHHhcC--C----
Confidence 76543211 12346799999999999999999999999999999999999999975432111 0000000 0
Q ss_pred ccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCcccccCcchH
Q 011851 359 YRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDMASSSSY 418 (476)
Q Consensus 359 ~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~~~~~~~~ 418 (476)
.+.. ..+...+..+.+||.+||..||.+|||+.++++| ||++........
T Consensus 242 ----~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~----~~~~~~~~~~~~ 291 (314)
T 3com_A 242 ----PPTF--RKPELWSDNFTDFVKQCLVKSPEQRATATQLLQH----PFVRSAKGVSIL 291 (314)
T ss_dssp ----CCCC--SSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTS----HHHHTCCCGGGG
T ss_pred ----Cccc--CCcccCCHHHHHHHHHHccCChhhCcCHHHHHhC----HHHhcCCcchHH
Confidence 0000 0111225788999999999999999999999987 999876654433
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-46 Score=369.60 Aligned_cols=265 Identities=26% Similarity=0.410 Sum_probs=212.3
Q ss_pred HhccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCc-cCHHHHHHHHHHHhCCCCCceeeEEEEE
Q 011851 118 SATKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL-QGHKEWLAEVNYLGGLIHPNLVKLIGCC 196 (476)
Q Consensus 118 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~ 196 (476)
...++|++.+.||+|+||.||+|.+.. ..+..+++.||||++..... .....+.+|+.+|++++||||+++++++
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~----~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 97 (322)
T 1p4o_A 22 VAREKITMSRELGQGSFGMVYEGVAKG----VVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV 97 (322)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEEE----EETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEE
T ss_pred chhhheeeeeEeccCCceEEEeeeecC----ccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEE
Confidence 345679999999999999999998652 12223577899999975433 2334688999999999999999999999
Q ss_pred EeCCeeEEEEEecCCCCHHHHHhhcC---------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCC
Q 011851 197 IEDDQRLLVYEFMPRGSLENHLFRRS---------LPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGE 267 (476)
Q Consensus 197 ~~~~~~~lV~E~~~~g~L~~~l~~~~---------~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~ 267 (476)
.+.+..|+||||+++++|.+++.... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.+
T Consensus 98 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli~~~ 174 (322)
T 1p4o_A 98 SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAED 174 (322)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTT
T ss_pred ccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEEEcCC
Confidence 99999999999999999999986421 45799999999999999999999988 9999999999999999
Q ss_pred CceEEeecCCcCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHh-CCCCCCCCCCCCcchhHH
Q 011851 268 YNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVE 346 (476)
Q Consensus 268 ~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~ellt-G~~pf~~~~~~~~~~~~~ 346 (476)
+.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|+|++ |..||....... ...
T Consensus 175 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---~~~ 251 (322)
T 1p4o_A 175 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ---VLR 251 (322)
T ss_dssp CCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHH---HHH
T ss_pred CeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHH---HHH
Confidence 9999999999986543222222233567899999999999999999999999999999999 899997543211 111
Q ss_pred hhhhhhccccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011851 347 WARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPL 406 (476)
Q Consensus 347 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~ 406 (476)
... .. ... ..+...+..+.+||.+||+.||.+|||+.+++++|+.+
T Consensus 252 ~~~----~~-~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~ 297 (322)
T 1p4o_A 252 FVM----EG-GLL---------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE 297 (322)
T ss_dssp HHH----TT-CCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGG
T ss_pred HHH----cC-CcC---------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHh
Confidence 100 00 000 01122357899999999999999999999999998865
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-46 Score=369.56 Aligned_cols=272 Identities=18% Similarity=0.260 Sum_probs=214.1
Q ss_pred hhHHHHhccCCCcc-ccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCC--ccCHHHHHHHHHHHhCCC-CCc
Q 011851 113 FNELKSATKSFRPE-CLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDG--LQGHKEWLAEVNYLGGLI-HPN 188 (476)
Q Consensus 113 ~~~~~~~~~~y~~~-~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~--~~~~~~~~~E~~~l~~l~-hpn 188 (476)
+.......++|.+. +.||+|+||.||+|.+. .+|+.||||++.... ......+.+|+.++..+. |||
T Consensus 20 ~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~---------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~ 90 (327)
T 3lm5_A 20 FQSMENFNNFYILTSKELGRGKFAVVRQCISK---------STGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPR 90 (327)
T ss_dssp SBCHHHHHHHEEEEEEEEEEETTEEEEEEEET---------TTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTT
T ss_pred HHHHHhhhhEEeeccceeCCCCCeEEEEEEEC---------CCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCC
Confidence 34445566778888 89999999999998654 468889999997543 234567899999999994 699
Q ss_pred eeeEEEEEEeCCeeEEEEEecCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecC-
Q 011851 189 LVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDG- 266 (476)
Q Consensus 189 Iv~l~~~~~~~~~~~lV~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~- 266 (476)
|+++++++.+.+..|+||||+++++|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+|||++.
T Consensus 91 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~ 167 (327)
T 3lm5_A 91 VINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSI 167 (327)
T ss_dssp BCCEEEEEECSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCB
T ss_pred EEEEEEEEEeCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecC
Confidence 999999999999999999999999999988543 467999999999999999999999988 999999999999987
Q ss_pred --CCceEEeecCCcCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchh
Q 011851 267 --EYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNL 344 (476)
Q Consensus 267 --~~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~ 344 (476)
++.+||+|||+++....... ....+||+.|+|||++.+..++.++|||||||++|+|++|+.||...........
T Consensus 168 ~~~~~~kL~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~ 244 (327)
T 3lm5_A 168 YPLGDIKIVDFGMSRKIGHACE---LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLN 244 (327)
T ss_dssp TTBCCEEECCGGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred CCCCcEEEeeCccccccCCccc---cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHH
Confidence 78999999999987543221 2346799999999999999999999999999999999999999976432211110
Q ss_pred HHhhhhhhccccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCcccccCcch
Q 011851 345 VEWARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDMASSSS 417 (476)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~~~~~~~ 417 (476)
+. ... . ..... .....+..+.+||.+||+.||++|||+.++++| |||++......
T Consensus 245 i~--~~~----~---~~~~~-----~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h----~~~~~~~~~~~ 299 (327)
T 3lm5_A 245 IS--QVN----V---DYSEE-----TFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH----SWLQQWDFENL 299 (327)
T ss_dssp HH--HTC----C---CCCTT-----TTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC----GGGCCCCTTCC
T ss_pred HH--hcc----c---ccCch-----hhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC----Hhhcccccccc
Confidence 00 000 0 00000 111236789999999999999999999999987 99987755443
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-46 Score=366.07 Aligned_cols=268 Identities=27% Similarity=0.355 Sum_probs=213.8
Q ss_pred HHHHhccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCcc-CHHHHHHHHHHHhCC-CCCceeeE
Q 011851 115 ELKSATKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQ-GHKEWLAEVNYLGGL-IHPNLVKL 192 (476)
Q Consensus 115 ~~~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~-~~~~~~~E~~~l~~l-~hpnIv~l 192 (476)
+.....++|++.+.||+|+||.||+|.+... .+..+++.||||++...... ..+.+.+|+.+|.++ +||||+++
T Consensus 21 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~----~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~ 96 (316)
T 2xir_A 21 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGI----DKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 96 (316)
T ss_dssp HHBCCGGGEEEEEEEEECSSEEEEEEEEESS----SSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ceecchhheeeeeEEcCCCceeEEEEEEecC----CccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeE
Confidence 3334457899999999999999999986431 12357889999999765432 245688999999999 79999999
Q ss_pred EEEEEeCC-eeEEEEEecCCCCHHHHHhhcCC---------------CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecC
Q 011851 193 IGCCIEDD-QRLLVYEFMPRGSLENHLFRRSL---------------PLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRD 256 (476)
Q Consensus 193 ~~~~~~~~-~~~lV~E~~~~g~L~~~l~~~~~---------------~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrD 256 (476)
++++...+ .+++||||+++++|.+++..... .+++..++.++.||+.||.|||+.+ |+|||
T Consensus 97 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~d 173 (316)
T 2xir_A 97 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRD 173 (316)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred EEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---ccccc
Confidence 99988755 58999999999999999965432 2889999999999999999999988 99999
Q ss_pred CCCCCeeecCCCceEEeecCCcCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHh-CCCCCCC
Q 011851 257 FKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLT-GRRSMDK 335 (476)
Q Consensus 257 lKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~ellt-G~~pf~~ 335 (476)
|||+|||++.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|+|++ |..||..
T Consensus 174 ikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~ 253 (316)
T 2xir_A 174 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 253 (316)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred CccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcc
Confidence 999999999999999999999987654433333344678999999999999999999999999999999998 9999976
Q ss_pred CCCCCcchhHHhhhhhhccccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 011851 336 NRPNGEHNLVEWARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKP 405 (476)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~ 405 (476)
...... ........ ... ..+...+.++.+++.+||+.||.+|||+.+++++|+.
T Consensus 254 ~~~~~~--~~~~~~~~--~~~------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~ 307 (316)
T 2xir_A 254 VKIDEE--FCRRLKEG--TRM------------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 307 (316)
T ss_dssp CCCSHH--HHHHHHHT--CCC------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred cchhHH--HHHHhccC--ccC------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 543221 11111000 000 0111225688999999999999999999999999764
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-46 Score=388.42 Aligned_cols=258 Identities=26% Similarity=0.372 Sum_probs=205.0
Q ss_pred ccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCc--cCHHHHHHHHHHHhCCCCCceeeEEEEEE
Q 011851 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL--QGHKEWLAEVNYLGGLIHPNLVKLIGCCI 197 (476)
Q Consensus 120 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~ 197 (476)
.++|++.+.||+|+||+||+|.+. .++..||||++..... .....+.+|+.+|+.++||||+++++++.
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 106 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDK---------VTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFE 106 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEET---------TTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEEC---------CCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence 446999999999999999998654 4788899999976532 23567889999999999999999999999
Q ss_pred eCCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCC---CceEEee
Q 011851 198 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGE---YNAKLSD 274 (476)
Q Consensus 198 ~~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~---~~vkl~D 274 (476)
+.+.+|||||||++|+|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.. +.+||+|
T Consensus 107 ~~~~~~lv~e~~~~g~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~D 182 (494)
T 3lij_A 107 DKRNYYLVMECYKGGELFDEIIHR-MKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVD 182 (494)
T ss_dssp CSSEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECC
T ss_pred eCCEEEEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEE
Confidence 999999999999999999988654 46999999999999999999999988 9999999999999764 5599999
Q ss_pred cCCcCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhcc
Q 011851 275 FGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGE 354 (476)
Q Consensus 275 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~ 354 (476)
||++....... .....+||+.|+|||++. ..|+.++|||||||++|+|++|..||...........+...
T Consensus 183 fG~a~~~~~~~---~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~------ 252 (494)
T 3lij_A 183 FGLSAVFENQK---KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKG------ 252 (494)
T ss_dssp CTTCEECBTTB---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT------
T ss_pred CCCCeECCCCc---cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC------
Confidence 99998764322 233467999999999876 56999999999999999999999999765432111111100
Q ss_pred ccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCcccc
Q 011851 355 RRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDM 412 (476)
Q Consensus 355 ~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~~ 412 (476)
. .....+.+. ..+..+.+||.+||+.||.+|||+.++++| ||++..
T Consensus 253 ~---~~~~~~~~~-----~~s~~~~~li~~~L~~dp~~R~s~~e~l~h----p~~~~~ 298 (494)
T 3lij_A 253 K---YTFDSPEWK-----NVSEGAKDLIKQMLQFDSQRRISAQQALEH----PWIKEM 298 (494)
T ss_dssp C---CCCCSGGGT-----TSCHHHHHHHHHHTCSSTTTSCCHHHHHTC----HHHHHH
T ss_pred C---CCCCchhcc-----cCCHHHHHHHHHHCCCChhhCccHHHHhcC----cccccC
Confidence 0 001111111 125789999999999999999999999987 888753
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-46 Score=361.69 Aligned_cols=252 Identities=24% Similarity=0.337 Sum_probs=208.9
Q ss_pred cCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCC---ccCHHHHHHHHHHHhCCCCCceeeEEEEEE
Q 011851 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDG---LQGHKEWLAEVNYLGGLIHPNLVKLIGCCI 197 (476)
Q Consensus 121 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~ 197 (476)
++|++.+.||+|+||.||+|.+. .+++.||||++.... ......+.+|++++++++||||+++++++.
T Consensus 14 ~~y~~~~~lg~G~~g~Vy~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 84 (284)
T 2vgo_A 14 DDFDIGRPLGKGKFGNVYLAREK---------QNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFH 84 (284)
T ss_dssp GGEEEEEEEEECSSEEEEEEEET---------TTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred hhceeeheecCCCCeEEEEEEEc---------CCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEE
Confidence 56999999999999999998754 467789999986532 223467889999999999999999999999
Q ss_pred eCCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCC
Q 011851 198 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGL 277 (476)
Q Consensus 198 ~~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~ 277 (476)
+.+..|+||||+++++|.+++... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 85 ~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~ 160 (284)
T 2vgo_A 85 DRKRIYLMLEFAPRGELYKELQKH-GRFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGW 160 (284)
T ss_dssp CSSEEEEEECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTT
T ss_pred cCCEEEEEEEeCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccc
Confidence 999999999999999999999654 46999999999999999999999988 99999999999999999999999999
Q ss_pred cCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhccccc
Q 011851 278 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRR 357 (476)
Q Consensus 278 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 357 (476)
+....... .....||+.|+|||++.+..++.++||||||+++|+|++|..||....... ... ......
T Consensus 161 ~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~~---~~~~~~-- 228 (284)
T 2vgo_A 161 SVHAPSLR----RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTE---THR---RIVNVD-- 228 (284)
T ss_dssp CEECSSSC----BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH---HHH---HHHTTC--
T ss_pred cccCcccc----cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhH---HHH---HHhccc--
Confidence 87654322 233679999999999999999999999999999999999999997543211 100 000000
Q ss_pred cccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCccc
Q 011851 358 FYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKD 411 (476)
Q Consensus 358 ~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~ 411 (476)
. .++...+.++.+||.+||+.||.+||++.++++| |||+.
T Consensus 229 ------~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h----~~~~~ 268 (284)
T 2vgo_A 229 ------L----KFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEH----PWVKA 268 (284)
T ss_dssp ------C----CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTC----HHHHH
T ss_pred ------c----CCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhC----HHHHh
Confidence 0 1122235788999999999999999999999987 88764
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-47 Score=383.07 Aligned_cols=248 Identities=17% Similarity=0.198 Sum_probs=196.3
Q ss_pred ccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCC---ccCHHHHHHHH---HHHhCCCCCceeeEE
Q 011851 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDG---LQGHKEWLAEV---NYLGGLIHPNLVKLI 193 (476)
Q Consensus 120 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~---~~~~~~~~~E~---~~l~~l~hpnIv~l~ 193 (476)
.++|++.+.||+|+||.||+|.+. .+|+.||||++.... ....+.+.+|+ ++|++++|||||+++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~---------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~ 142 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQ---------ETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVH 142 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC----------CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHH
T ss_pred CceEEEcceeecCCCEEEEEEEEC---------CCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHH
Confidence 467999999999999999998654 468889999997542 23346788999 556666899999998
Q ss_pred -------EEEEeCCe-----------------eEEEEEecCCCCHHHHHhhcC------CCCCHHHHHHHHHHHHHHHHH
Q 011851 194 -------GCCIEDDQ-----------------RLLVYEFMPRGSLENHLFRRS------LPLPWSIRMKIALDAAKGLAF 243 (476)
Q Consensus 194 -------~~~~~~~~-----------------~~lV~E~~~~g~L~~~l~~~~------~~l~~~~~~~i~~qi~~al~~ 243 (476)
+++.+.+. .||||||+ +|+|.+++.... ..+++..++.|+.||+.||.|
T Consensus 143 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~ 221 (377)
T 3byv_A 143 LRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLAS 221 (377)
T ss_dssp HCBCCCSEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHH
T ss_pred hhhhhhhhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHH
Confidence 77776543 88999999 679999996532 123358888999999999999
Q ss_pred HHhcCCCCeEecCCCCCCeeecCCCceEEeecCCcCCCCCCCccceeeeeecCCCCCCcchhhcC-----------CCCc
Q 011851 244 LHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-----------HLTA 312 (476)
Q Consensus 244 lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~ 312 (476)
||+++ |+||||||+||||+.++.+||+|||+++.... .....+| +.|+|||++.+. .|+.
T Consensus 222 LH~~~---ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~ 292 (377)
T 3byv_A 222 LHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTF 292 (377)
T ss_dssp HHHTT---EECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCH
T ss_pred HHhCC---eecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCCh
Confidence 99988 99999999999999999999999999986322 2344678 999999999987 8999
Q ss_pred cchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhccccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCC
Q 011851 313 KSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKA 392 (476)
Q Consensus 313 ~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~ 392 (476)
++|||||||++|||++|+.||...........+ .. .. ...+.++.+||.+||+.||++
T Consensus 293 ~~DvwSlG~il~elltg~~Pf~~~~~~~~~~~~----------------~~-~~-----~~~~~~~~~li~~~L~~dp~~ 350 (377)
T 3byv_A 293 SFDAWALGLVIYWIWCADLPITKDAALGGSEWI----------------FR-SC-----KNIPQPVRALLEGFLRYPKED 350 (377)
T ss_dssp HHHHHHHHHHHHHHHHSSCCC------CCSGGG----------------GS-SC-----CCCCHHHHHHHHHHTCSSGGG
T ss_pred hhhHHHHHHHHHHHHHCCCCCcccccccchhhh----------------hh-hc-----cCCCHHHHHHHHHHcCCCchh
Confidence 999999999999999999999765432221110 00 00 112578899999999999999
Q ss_pred CCCHHHHHHHhcCCCCcccc
Q 011851 393 RPRMSEVVEALKPLPYLKDM 412 (476)
Q Consensus 393 RPt~~ell~~L~~~~~~~~~ 412 (476)
|||+.++++| |||+++
T Consensus 351 Rpt~~e~l~h----p~f~~~ 366 (377)
T 3byv_A 351 RLLPLQAMET----PEYEQL 366 (377)
T ss_dssp CCCHHHHHTS----HHHHHH
T ss_pred CCCHHHHhhC----hHHHHH
Confidence 9999999997 888764
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-46 Score=375.99 Aligned_cols=271 Identities=21% Similarity=0.305 Sum_probs=204.5
Q ss_pred HhccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCCCCCceeeEEEEEE
Q 011851 118 SATKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHPNLVKLIGCCI 197 (476)
Q Consensus 118 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~ 197 (476)
...++|++.+.||+|+||+||+|.+. .+|+.||||++...... ..+|+.+|+.++||||++++++|.
T Consensus 4 ~~~~~y~~~~~lG~G~fg~V~~a~~~---------~~~~~vAiK~~~~~~~~----~~~E~~il~~l~hpnIv~l~~~~~ 70 (383)
T 3eb0_A 4 TSSKKYSLGKTLGTGSFGIVCEVFDI---------ESGKRFALKKVLQDPRY----KNRELDIMKVLDHVNIIKLVDYFY 70 (383)
T ss_dssp --CTTEEEEEEEECC-CEEEEEEEET---------TTCCEEEEEEEECCTTS----CCHHHHHHTTCCCTTBCCEEEEEE
T ss_pred cccceEEEEEEEEeccCEEEEEEEEC---------CCCCEEEEEEEecCcch----HHHHHHHHHHcCCCCccchhheee
Confidence 44678999999999999999998654 47888999998654322 237999999999999999999985
Q ss_pred e--------------------------------------CCeeEEEEEecCCCCHHHHHh---hcCCCCCHHHHHHHHHH
Q 011851 198 E--------------------------------------DDQRLLVYEFMPRGSLENHLF---RRSLPLPWSIRMKIALD 236 (476)
Q Consensus 198 ~--------------------------------------~~~~~lV~E~~~~g~L~~~l~---~~~~~l~~~~~~~i~~q 236 (476)
. ...++|||||++ ++|.+.+. .....+++..+..++.|
T Consensus 71 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~q 149 (383)
T 3eb0_A 71 TTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQ 149 (383)
T ss_dssp EC-------------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHH
T ss_pred ecCcccccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHH
Confidence 4 334889999997 58877765 34567999999999999
Q ss_pred HHHHHHHHHhcCCCCeEecCCCCCCeeec-CCCceEEeecCCcCCCCCCCccceeeeeecCCCCCCcchhhcC-CCCccc
Q 011851 237 AAKGLAFLHEEAEKPVIYRDFKTSNILLD-GEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTAKS 314 (476)
Q Consensus 237 i~~al~~lH~~~~~~ivHrDlKp~NILl~-~~~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~ 314 (476)
|+.||.|||+.+ |+||||||+|||++ .++.+||+|||+++....... .....||+.|+|||++.+. .++.++
T Consensus 150 i~~aL~~LH~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~ 223 (383)
T 3eb0_A 150 LFRAVGFIHSLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP---SVAYICSRFYRAPELMLGATEYTPSI 223 (383)
T ss_dssp HHHHHHHHHTTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC---CCCCCCCSSCCCHHHHTTCSSCCTHH
T ss_pred HHHHHHHHHHCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC---CcCcccCCCccCHHHhcCCCCCCcch
Confidence 999999999988 99999999999997 688999999999986544332 2346789999999998875 599999
Q ss_pred hhhhhHHHHHHHHhCCCCCCCCCCCCcchhH-Hhhhh-hh-------c--cccccccccCcccCCCCChHHHHHHHHHHH
Q 011851 315 DVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV-EWARP-QL-------G--ERRRFYRLIDPCLEGCFSIKGAEKTIQLAA 383 (476)
Q Consensus 315 DiwslGv~l~elltG~~pf~~~~~~~~~~~~-~~~~~-~~-------~--~~~~~~~~~d~~l~~~~~~~~~~~~~~li~ 383 (476)
|||||||++|||++|+.||...........+ ..... .. . ....+..+....+...++...+.++.+||.
T Consensus 224 DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 303 (383)
T 3eb0_A 224 DLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLE 303 (383)
T ss_dssp HHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHH
T ss_pred hhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHH
Confidence 9999999999999999999865332211111 00000 00 0 000011111111111122334678999999
Q ss_pred HhcccCCCCCCCHHHHHHHhcCCCCcccc
Q 011851 384 SCLNRDQKARPRMSEVVEALKPLPYLKDM 412 (476)
Q Consensus 384 ~cL~~dP~~RPt~~ell~~L~~~~~~~~~ 412 (476)
+||+.||++|||+.|+++| |||+..
T Consensus 304 ~~L~~dP~~R~t~~e~l~h----p~f~~~ 328 (383)
T 3eb0_A 304 QILRYEPDLRINPYEAMAH----PFFDHL 328 (383)
T ss_dssp HHCCSSGGGSCCHHHHHTS----GGGHHH
T ss_pred HHccCChhhCCCHHHHhcC----HHHHHH
Confidence 9999999999999999997 999865
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=362.46 Aligned_cols=259 Identities=23% Similarity=0.327 Sum_probs=209.3
Q ss_pred ccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCCCCCceeeEEEEEEeC
Q 011851 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHPNLVKLIGCCIED 199 (476)
Q Consensus 120 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~ 199 (476)
.++|++.+.||+|+||.||+|.+. .+|+.||+|++........+.+.+|+.+|++++||||+++++++.+.
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 78 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQR---------LTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYEST 78 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEET---------TTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hccceeeeeccCCCCceEEEEEEC---------CCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccC
Confidence 457999999999999999998654 46788999999876554556788999999999999999999999999
Q ss_pred CeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeee---cCCCceEEeecC
Q 011851 200 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILL---DGEYNAKLSDFG 276 (476)
Q Consensus 200 ~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl---~~~~~vkl~DFG 276 (476)
+..|+||||+++++|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||
T Consensus 79 ~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg 154 (304)
T 2jam_A 79 THYYLVMQLVSGGELFDRILER-GVYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFG 154 (304)
T ss_dssp SEEEEEECCCCSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCS
T ss_pred CEEEEEEEcCCCccHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCC
Confidence 9999999999999999998654 46999999999999999999999988 9999999999999 788999999999
Q ss_pred CcCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhcccc
Q 011851 277 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERR 356 (476)
Q Consensus 277 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~ 356 (476)
++....... .....||+.|+|||++.+..++.++|||||||++|+|++|..||...... .+...... ..
T Consensus 155 ~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~~~~i~~---~~- 223 (304)
T 2jam_A 155 LSKMEQNGI----MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETES---KLFEKIKE---GY- 223 (304)
T ss_dssp TTCCCCCBT----THHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHH---HHHHHHHH---CC-
T ss_pred cceecCCCc----cccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH---HHHHHHHc---CC-
Confidence 997643321 22357999999999999999999999999999999999999999754321 11111000 00
Q ss_pred ccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCccccc
Q 011851 357 RFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDMA 413 (476)
Q Consensus 357 ~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~~~ 413 (476)
.....+ +....+.++.+||.+||..||++|||+.++++| |||++..
T Consensus 224 --~~~~~~-----~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h----~~~~~~~ 269 (304)
T 2jam_A 224 --YEFESP-----FWDDISESAKDFICHLLEKDPNERYTCEKALSH----PWIDGNT 269 (304)
T ss_dssp --CCCCTT-----TTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS----HHHHSSC
T ss_pred --CCCCcc-----ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC----ccccCCC
Confidence 001111 111236789999999999999999999999987 8887654
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-46 Score=373.70 Aligned_cols=269 Identities=23% Similarity=0.312 Sum_probs=202.7
Q ss_pred ccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCcc--CHHHHHHHHHHHhCCCCCceeeEEEEEE
Q 011851 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQ--GHKEWLAEVNYLGGLIHPNLVKLIGCCI 197 (476)
Q Consensus 120 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~l~~~~~ 197 (476)
.++|++.+.||+|+||.||+|.+. .+|+.||||++...... ..+++.+|+++|+.++||||+++++++.
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~ 94 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDG---------RTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFT 94 (367)
T ss_dssp BSSEEEEEEC------CEEEEEET---------TTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEEC
T ss_pred cceEEEeEEeeecCCeEEEEEEEC---------CCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEe
Confidence 467999999999999999998654 47888999999654322 2456889999999999999999999998
Q ss_pred eCC------eeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceE
Q 011851 198 EDD------QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAK 271 (476)
Q Consensus 198 ~~~------~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vk 271 (476)
..+ .+||||||+ +++|.+++.. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+|
T Consensus 95 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~k 168 (367)
T 1cm8_A 95 PDETLDDFTDFYLVMPFM-GTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELK 168 (367)
T ss_dssp SCSSTTTCCCCEEEEECC-SEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEE
T ss_pred cCCccccCceEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEE
Confidence 763 469999999 8899998865 46899999999999999999999988 99999999999999999999
Q ss_pred EeecCCcCCCCCCCccceeeeeecCCCCCCcchhhc-CCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhh
Q 011851 272 LSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP 350 (476)
Q Consensus 272 l~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~ 350 (476)
|+|||+++..... ....+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.........+.....
T Consensus 169 l~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g 243 (367)
T 1cm8_A 169 ILDFGLARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTG 243 (367)
T ss_dssp ECCCTTCEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC
T ss_pred EEeeecccccccc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC
Confidence 9999999875432 234679999999999987 6899999999999999999999999976543211111100000
Q ss_pred hhcc----------c----cccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCccccc
Q 011851 351 QLGE----------R----RRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDMA 413 (476)
Q Consensus 351 ~~~~----------~----~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~~~ 413 (476)
.... . ..+.......+.. .....+..+.+||.+||..||++|||+.++++| |||+...
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h----p~f~~~~ 315 (367)
T 1cm8_A 244 TPPAEFVQRLQSDEAKNYMKGLPELEKKDFAS-ILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH----PYFESLH 315 (367)
T ss_dssp CCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGG-TCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS----GGGTTTC
T ss_pred CCCHHHHHHhhhHHHHHHHHhCCCCCCCCHHH-HCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC----hHHHhhc
Confidence 0000 0 0000000001111 111236789999999999999999999999998 9988654
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-46 Score=364.42 Aligned_cols=270 Identities=24% Similarity=0.362 Sum_probs=191.0
Q ss_pred ccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCc-cCHHHHHHHHHHHhCCCCCceeeEEEEEEe
Q 011851 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL-QGHKEWLAEVNYLGGLIHPNLVKLIGCCIE 198 (476)
Q Consensus 120 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~ 198 (476)
.++|++.+.||+|+||.||+|.+. .+++.||||++..... ...+++.+|+.++++++||||+++++++..
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 84 (303)
T 2vwi_A 14 RDDYELQEVIGSGATAVVQAAYCA---------PKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVV 84 (303)
T ss_dssp CCCCEEEEECC---CCCEEEEEC-------------CEEEEECCC----------------CCCCCCCTTBCCEEEEEES
T ss_pred hhhhhhhheeccccceEEEEEEEC---------CCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEee
Confidence 467999999999999999998654 3677899999875432 234568899999999999999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHHhh-------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceE
Q 011851 199 DDQRLLVYEFMPRGSLENHLFR-------RSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAK 271 (476)
Q Consensus 199 ~~~~~lV~E~~~~g~L~~~l~~-------~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vk 271 (476)
.+..|+||||+++++|.+++.. ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+|
T Consensus 85 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~k 161 (303)
T 2vwi_A 85 KDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQ 161 (303)
T ss_dssp SSCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEE
T ss_pred cCCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEE
Confidence 9999999999999999999864 3456999999999999999999999988 99999999999999999999
Q ss_pred EeecCCcCCCCCCCc---cceeeeeecCCCCCCcchhhc-CCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHh
Q 011851 272 LSDFGLAKDGPEGDK---THVSTRVMGTYGYAAPEYVMT-GHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEW 347 (476)
Q Consensus 272 l~DFG~a~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~ 347 (476)
|+|||++........ ........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||........... .
T Consensus 162 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~--~ 239 (303)
T 2vwi_A 162 IADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLML--T 239 (303)
T ss_dssp ECCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHH--H
T ss_pred EEeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHH--H
Confidence 999999876543211 111234679999999999876 5789999999999999999999999976543221110 0
Q ss_pred hhhhhcccccccc-ccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCcccccC
Q 011851 348 ARPQLGERRRFYR-LIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDMAS 414 (476)
Q Consensus 348 ~~~~~~~~~~~~~-~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~~~~ 414 (476)
... ....... ..++. .....+.++.+||.+||+.||.+|||+.++++| |||++...
T Consensus 240 ~~~---~~~~~~~~~~~~~----~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h----~~~~~~~~ 296 (303)
T 2vwi_A 240 LQN---DPPSLETGVQDKE----MLKKYGKSFRKMISLCLQKDPEKRPTAAELLRH----KFFQKAKN 296 (303)
T ss_dssp HTS---SCCCTTC-----C----CCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTS----TTC-----
T ss_pred hcc---CCCccccccccch----hhhhhhHHHHHHHHHHccCChhhCcCHHHHhhC----hhhhcCCC
Confidence 000 0000000 00011 111225688999999999999999999999997 99987543
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-46 Score=359.92 Aligned_cols=256 Identities=27% Similarity=0.395 Sum_probs=212.2
Q ss_pred hccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCCCCCceeeEEEEEEe
Q 011851 119 ATKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHPNLVKLIGCCIE 198 (476)
Q Consensus 119 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~ 198 (476)
..++|++.+.||+|+||.||+|.+. .+++.||+|++.... ...+.+.+|+.++++++||||+++++++.+
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~---------~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 80 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWK---------KYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 80 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEG---------GGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cccceeEEeecCCCCceeEEEeEec---------CCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEcc
Confidence 3567999999999999999998765 357789999997543 335678899999999999999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCC
Q 011851 199 DDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGL 277 (476)
Q Consensus 199 ~~~~~lV~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~ 277 (476)
++..|+||||+++++|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 81 ~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~ 157 (288)
T 3kfa_A 81 EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGL 157 (288)
T ss_dssp SSSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCG
T ss_pred CCCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCcc
Confidence 99999999999999999999763 456999999999999999999999998 99999999999999999999999999
Q ss_pred cCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhhcccc
Q 011851 278 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPQLGERR 356 (476)
Q Consensus 278 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~ 356 (476)
+....... ........+|+.|+|||++.+..++.++||||||+++|+|++ |..||...........+. ..
T Consensus 158 ~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~---~~----- 228 (288)
T 3kfa_A 158 SRLMTGDT-YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE---KD----- 228 (288)
T ss_dssp GGTSCSSS-SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHH---TT-----
T ss_pred ceeccCCc-cccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh---cc-----
Confidence 98765432 222334567889999999999999999999999999999999 999997654322111111 00
Q ss_pred ccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 011851 357 RFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKP 405 (476)
Q Consensus 357 ~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~ 405 (476)
.....+...+..+.+|+.+||+.||.+|||+.++++.|+.
T Consensus 229 ---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~ 268 (288)
T 3kfa_A 229 ---------YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFET 268 (288)
T ss_dssp ---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ---------CCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHH
Confidence 0011112236789999999999999999999999998764
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=365.02 Aligned_cols=261 Identities=25% Similarity=0.339 Sum_probs=204.2
Q ss_pred hccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCc--------cCHHHHHHHHHHHhCCCCCcee
Q 011851 119 ATKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL--------QGHKEWLAEVNYLGGLIHPNLV 190 (476)
Q Consensus 119 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~--------~~~~~~~~E~~~l~~l~hpnIv 190 (476)
..++|++.+.||+|+||.||+|.+. .+++.||||++..... .....+.+|+++|++++||||+
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~ 78 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFER---------KTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCII 78 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEET---------TTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBC
T ss_pred hhhceeEeeEEecCCCEEEEEEEEc---------CCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCc
Confidence 3457999999999999999998654 4678899999975432 1123478899999999999999
Q ss_pred eEEEEEEeCCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCc-
Q 011851 191 KLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYN- 269 (476)
Q Consensus 191 ~l~~~~~~~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~- 269 (476)
++++++..++ .|+||||+++++|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.
T Consensus 79 ~~~~~~~~~~-~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~ 153 (322)
T 2ycf_A 79 KIKNFFDAED-YYIVLELMEGGELFDKVVG-NKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEED 153 (322)
T ss_dssp CEEEEEESSS-EEEEEECCTTEETHHHHST-TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSS
T ss_pred eEeeEEcCCc-eEEEEecCCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCC
Confidence 9999987654 8999999999999998854 457999999999999999999999988 999999999999987654
Q ss_pred --eEEeecCCcCCCCCCCccceeeeeecCCCCCCcchhh---cCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchh
Q 011851 270 --AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM---TGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNL 344 (476)
Q Consensus 270 --vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~ 344 (476)
+||+|||+++...... ......||+.|+|||++. ...++.++|||||||++|+|++|..||.........
T Consensus 154 ~~~kl~Dfg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-- 228 (322)
T 2ycf_A 154 CLIKITDFGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL-- 228 (322)
T ss_dssp CCEEECCCTTCEECCCCH---HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCH--
T ss_pred CeEEEccCccceeccccc---ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHH--
Confidence 9999999998754321 123367999999999975 457899999999999999999999999765433221
Q ss_pred HHhhhhhhccccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCccccc
Q 011851 345 VEWARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDMA 413 (476)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~~~ 413 (476)
....... .. ....... ...+.++.+||.+||+.||++||++.++++| |||++..
T Consensus 229 ~~~~~~~---~~---~~~~~~~-----~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h----~~~~~~~ 282 (322)
T 2ycf_A 229 KDQITSG---KY---NFIPEVW-----AEVSEKALDLVKKLLVVDPKARFTTEEALRH----PWLQDED 282 (322)
T ss_dssp HHHHHHT---CC---CCCHHHH-----TTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS----GGGCCHH
T ss_pred HHHHHhC---cc---ccCchhh-----hhcCHHHHHHHHHHcccCHhhCCCHHHHhhC----cCcCCHH
Confidence 1111000 00 0000000 1125688999999999999999999999997 9998653
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-46 Score=388.49 Aligned_cols=260 Identities=26% Similarity=0.360 Sum_probs=209.2
Q ss_pred ccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCC--ccCHHHHHHHHHHHhCCCCCceeeEEEEEE
Q 011851 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDG--LQGHKEWLAEVNYLGGLIHPNLVKLIGCCI 197 (476)
Q Consensus 120 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~ 197 (476)
.++|++.++||+|+||+||+|.+. .+++.||||++.... ......+.+|+++|++++||||+++++++.
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~---------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 91 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDR---------ITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILE 91 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEET---------TTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred hcceEEeEEEeecCCEEEEEEEEC---------CCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEE
Confidence 456999999999999999998654 478889999986432 234567899999999999999999999999
Q ss_pred eCCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeec---CCCceEEee
Q 011851 198 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLD---GEYNAKLSD 274 (476)
Q Consensus 198 ~~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~---~~~~vkl~D 274 (476)
+.+.+|+|||||.+++|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++ .++.+||+|
T Consensus 92 ~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~D 167 (486)
T 3mwu_A 92 DSSSFYIVGELYTGGELFDEIIKR-KRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIID 167 (486)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECS
T ss_pred cCCEEEEEEEcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEE
Confidence 999999999999999999988654 46999999999999999999999988 99999999999994 456799999
Q ss_pred cCCcCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhcc
Q 011851 275 FGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGE 354 (476)
Q Consensus 275 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~ 354 (476)
||+++....... ....+||+.|+|||++.+ .|+.++|||||||++|+|++|..||...........+.. ..
T Consensus 168 fg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~--~~--- 238 (486)
T 3mwu_A 168 FGLSTCFQQNTK---MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVET--GK--- 238 (486)
T ss_dssp CSCTTTBCCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--TC---
T ss_pred CCcCeECCCCCc---cCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh--CC---
Confidence 999986543221 234679999999998875 599999999999999999999999976433211111110 00
Q ss_pred ccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCcccccC
Q 011851 355 RRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDMAS 414 (476)
Q Consensus 355 ~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~~~~ 414 (476)
. ....+.+ ...+.++.+||.+||+.||.+|||+.++++| ||++....
T Consensus 239 -~---~~~~~~~-----~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h----p~~~~~~~ 285 (486)
T 3mwu_A 239 -Y---AFDLPQW-----RTISDDAKDLIRKMLTFHPSLRITATQCLEH----PWIQKYSS 285 (486)
T ss_dssp -C---CSCSGGG-----GGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC----HHHHHTCC
T ss_pred -C---CCCCccc-----CCCCHHHHHHHHHHcCCChhhCcCHHHHhcC----HhhccCcc
Confidence 0 0000111 1226789999999999999999999999997 99886543
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-46 Score=361.85 Aligned_cols=255 Identities=23% Similarity=0.300 Sum_probs=209.3
Q ss_pred ccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCcc---CHHHHHHHHHHHhCCCCCceeeEEEEE
Q 011851 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQ---GHKEWLAEVNYLGGLIHPNLVKLIGCC 196 (476)
Q Consensus 120 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~---~~~~~~~E~~~l~~l~hpnIv~l~~~~ 196 (476)
.++|++.+.||+|+||.||+|.+. .+++.||+|++...... ..+.+.+|+.+++.++||||+++++++
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~---------~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 84 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDA---------DTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFF 84 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEET---------TTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEEC---------CCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeee
Confidence 457999999999999999998654 46788999998765332 245678899999999999999999999
Q ss_pred EeCCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecC
Q 011851 197 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFG 276 (476)
Q Consensus 197 ~~~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG 276 (476)
.+++..|+||||+++++|.+++... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 85 ~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg 160 (294)
T 2rku_A 85 EDNDFVFVVLELCRRRSLLELHKRR-KALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFG 160 (294)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCT
T ss_pred ccCCEEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEecc
Confidence 9999999999999999999988543 47999999999999999999999988 9999999999999999999999999
Q ss_pred CcCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhcccc
Q 011851 277 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERR 356 (476)
Q Consensus 277 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~ 356 (476)
++........ ......||+.|+|||++.+..++.++||||||+++|+|++|+.||....... .... ......
T Consensus 161 ~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~---~~~~---~~~~~~ 232 (294)
T 2rku_A 161 LATKVEYDGE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE---TYLR---IKKNEY 232 (294)
T ss_dssp TCEECCSTTC--CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH---HHHH---HHTTCC
T ss_pred CceecccCcc--ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHH---HhhccC
Confidence 9986543222 1233679999999999999899999999999999999999999997543211 1000 000000
Q ss_pred ccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCccc
Q 011851 357 RFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKD 411 (476)
Q Consensus 357 ~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~ 411 (476)
.++...+..+.+|+.+||+.||++|||+.+++++ |||..
T Consensus 233 ------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~----~~~~~ 271 (294)
T 2rku_A 233 ------------SIPKHINPVAASLIQKMLQTDPTARPTINELLND----EFFTS 271 (294)
T ss_dssp ------------CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS----HHHHT
T ss_pred ------------CCccccCHHHHHHHHHHcccChhhCcCHHHHhhC----hheec
Confidence 0111225678999999999999999999999987 77754
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-46 Score=368.20 Aligned_cols=263 Identities=25% Similarity=0.362 Sum_probs=211.5
Q ss_pred ccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCcc-CHHHHHHHHHHHhCC-CCCceeeEEEEEE
Q 011851 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQ-GHKEWLAEVNYLGGL-IHPNLVKLIGCCI 197 (476)
Q Consensus 120 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~-~~~~~~~E~~~l~~l-~hpnIv~l~~~~~ 197 (476)
.++|++.+.||+|+||.||+|.+...+. ...+..||+|++...... ..+.+.+|+.+|+++ +||||+++++++.
T Consensus 45 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~----~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 120 (333)
T 2i1m_A 45 RNNLQFGKTLGAGAFGKVVEATAFGLGK----EDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACT 120 (333)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEETTCSS----SCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred HHHceeeeEeccCCCcceEEEEecCCCc----ccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence 4579999999999999999998764322 124567999999765432 345688999999999 8999999999999
Q ss_pred eCCeeEEEEEecCCCCHHHHHhhc-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeee
Q 011851 198 EDDQRLLVYEFMPRGSLENHLFRR-------------SLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILL 264 (476)
Q Consensus 198 ~~~~~~lV~E~~~~g~L~~~l~~~-------------~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl 264 (476)
+.+..||||||+++|+|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+|||+
T Consensus 121 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~ 197 (333)
T 2i1m_A 121 HGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLL 197 (333)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCEE
T ss_pred cCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEEE
Confidence 999999999999999999999643 346899999999999999999999988 9999999999999
Q ss_pred cCCCceEEeecCCcCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHh-CCCCCCCCCCCCcch
Q 011851 265 DGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHN 343 (476)
Q Consensus 265 ~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~ellt-G~~pf~~~~~~~~~~ 343 (476)
+.++.+||+|||++................||+.|+|||++.+..++.++|||||||++|||++ |..||.........
T Consensus 198 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~- 276 (333)
T 2i1m_A 198 TNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKF- 276 (333)
T ss_dssp EGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHH-
T ss_pred CCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHH-
Confidence 9999999999999986544333333334568889999999999999999999999999999998 99999765432211
Q ss_pred hHHhhhhhhccccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 011851 344 LVEWARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKP 405 (476)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~ 405 (476)
........ ....+...+..+.+||.+||+.||.+|||+.+++++|+.
T Consensus 277 -~~~~~~~~--------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~ 323 (333)
T 2i1m_A 277 -YKLVKDGY--------------QMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQE 323 (333)
T ss_dssp -HHHHHHTC--------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred -HHHHhcCC--------------CCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHH
Confidence 11111000 000111225788999999999999999999999998764
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-45 Score=378.64 Aligned_cols=248 Identities=29% Similarity=0.432 Sum_probs=204.8
Q ss_pred ccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCCCCCceeeEEEEEEeC
Q 011851 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHPNLVKLIGCCIED 199 (476)
Q Consensus 120 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~ 199 (476)
.++|++.+.||+|+||.||+|.+. |+.||||+++... ..+.+.+|+.+|++++||||+++++++.+.
T Consensus 192 ~~~~~~~~~lG~G~fg~V~~~~~~-----------~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 258 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVMLGDYR-----------GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEE 258 (450)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET-----------TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECT
T ss_pred hHHeEEEeeecCcCCeeEEEEEec-----------CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcC
Confidence 457899999999999999998653 5679999997654 457899999999999999999999998876
Q ss_pred C-eeEEEEEecCCCCHHHHHhhcCC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCC
Q 011851 200 D-QRLLVYEFMPRGSLENHLFRRSL-PLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGL 277 (476)
Q Consensus 200 ~-~~~lV~E~~~~g~L~~~l~~~~~-~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~ 277 (476)
+ .+||||||+++|+|.+++..... .+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 259 ~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~ 335 (450)
T 1k9a_A 259 KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGL 335 (450)
T ss_dssp TSCEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTT
T ss_pred CCceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCC
Confidence 5 79999999999999999976543 4799999999999999999999988 99999999999999999999999999
Q ss_pred cCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhhcccc
Q 011851 278 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPQLGERR 356 (476)
Q Consensus 278 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~ 356 (476)
++..... .....+++.|+|||++.+..++.++|||||||++|||++ |+.||...........+. ...
T Consensus 336 a~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~-------~~~ 403 (450)
T 1k9a_A 336 TKEASST-----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE-------KGY 403 (450)
T ss_dssp CEECC-----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHH-------TTC
T ss_pred ccccccc-----ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-------cCC
Confidence 9864321 122367889999999999999999999999999999998 999998654432221111 000
Q ss_pred ccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 011851 357 RFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKP 405 (476)
Q Consensus 357 ~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~ 405 (476)
. . ..+...+.++.+||.+||+.||++|||+.+|++.|+.
T Consensus 404 ~---~-------~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~ 442 (450)
T 1k9a_A 404 K---M-------DAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEH 442 (450)
T ss_dssp C---C-------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred C---C-------CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 0 0 0112236789999999999999999999999998764
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=368.56 Aligned_cols=271 Identities=17% Similarity=0.186 Sum_probs=202.5
Q ss_pred ccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCcc-----------CHHHHHHHHHHHhCCCCCc
Q 011851 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQ-----------GHKEWLAEVNYLGGLIHPN 188 (476)
Q Consensus 120 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~-----------~~~~~~~E~~~l~~l~hpn 188 (476)
.++|++.+.||+|+||.||+|.+...+ .++..||||++...... ....+.+|+.+++.+.|||
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~------~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~n 109 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKP------EKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLG 109 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSC------GGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCC
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCC------CccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccC
Confidence 357999999999999999999876421 25678999999765422 1234667889999999999
Q ss_pred eeeEEEEEEe----CCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeee
Q 011851 189 LVKLIGCCIE----DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILL 264 (476)
Q Consensus 189 Iv~l~~~~~~----~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl 264 (476)
|+++++++.. ....||||||+ +++|.+++.... .+++..++.++.||+.||.|||+.+ |+||||||+||||
T Consensus 110 i~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll 184 (345)
T 2v62_A 110 IPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNG-TFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLL 184 (345)
T ss_dssp CCCEEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGG-BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEE
T ss_pred cceeecccccccCCCcEEEEEEecc-CCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEE
Confidence 9999999988 77899999999 999999986544 7999999999999999999999988 9999999999999
Q ss_pred cCCC--ceEEeecCCcCCCCCCCcc-----ceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCC
Q 011851 265 DGEY--NAKLSDFGLAKDGPEGDKT-----HVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNR 337 (476)
Q Consensus 265 ~~~~--~vkl~DFG~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~ 337 (476)
+.++ .+||+|||+++........ .......||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 185 ~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~ 264 (345)
T 2v62_A 185 GYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNL 264 (345)
T ss_dssp ESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGT
T ss_pred ccCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccc
Confidence 8877 9999999999765322111 11134679999999999999999999999999999999999999996432
Q ss_pred CCCcchhHHhhhhhhccccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCC
Q 011851 338 PNGEHNLVEWARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPY 408 (476)
Q Consensus 338 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~ 408 (476)
..... .......... .+...+..... ....+.++.+||.+||+.||++||++.+|++.|+.+.+
T Consensus 265 ~~~~~-~~~~~~~~~~---~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 328 (345)
T 2v62_A 265 KDPVA-VQTAKTNLLD---ELPQSVLKWAP---SGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI 328 (345)
T ss_dssp TCHHH-HHHHHHHHHH---TTTHHHHHHSC---TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred cccHH-HHHHHHhhcc---cccHHHHhhcc---ccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence 22111 1111000000 00010000000 00225689999999999999999999999999987654
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=367.87 Aligned_cols=265 Identities=25% Similarity=0.373 Sum_probs=210.9
Q ss_pred ccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCc-cCHHHHHHHHHHHhCC-CCCceeeEEEEEE
Q 011851 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL-QGHKEWLAEVNYLGGL-IHPNLVKLIGCCI 197 (476)
Q Consensus 120 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~-~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~ 197 (476)
.++|++.+.||+|+||.||+|.+..... ....+++.||||+++.... ...+.+.+|+.+|+++ +||||+++++++.
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~--~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 111 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDK--DKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 111 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCST--TCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccc--cccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEc
Confidence 3579999999999999999998753221 1224678899999976533 2345688999999999 8999999999999
Q ss_pred eCCeeEEEEEecCCCCHHHHHhhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCe
Q 011851 198 EDDQRLLVYEFMPRGSLENHLFRRS---------------LPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNI 262 (476)
Q Consensus 198 ~~~~~~lV~E~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NI 262 (476)
+++..|+||||+++++|.+++.... ..+++..++.++.||+.||.|||+.+ |+||||||+||
T Consensus 112 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NI 188 (334)
T 2pvf_A 112 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNV 188 (334)
T ss_dssp SSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGE
T ss_pred cCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccceE
Confidence 9999999999999999999996543 24899999999999999999999988 99999999999
Q ss_pred eecCCCceEEeecCCcCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHh-CCCCCCCCCCCCc
Q 011851 263 LLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLT-GRRSMDKNRPNGE 341 (476)
Q Consensus 263 Ll~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~ellt-G~~pf~~~~~~~~ 341 (476)
|++.++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||++ |..||.......
T Consensus 189 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~- 267 (334)
T 2pvf_A 189 LVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE- 267 (334)
T ss_dssp EECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH-
T ss_pred EEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHH-
Confidence 999999999999999987654333222334567889999999999999999999999999999999 999997543211
Q ss_pred chhHHhhhhhhccccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011851 342 HNLVEWARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPL 406 (476)
Q Consensus 342 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~ 406 (476)
+...... .. ....+...+.++.+||.+||+.||.+|||+.+++++|+.+
T Consensus 268 --~~~~~~~----~~----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l 316 (334)
T 2pvf_A 268 --LFKLLKE----GH----------RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 316 (334)
T ss_dssp --HHHHHHH----TC----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --HHHHHhc----CC----------CCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 1111100 00 0001122357899999999999999999999999997644
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=358.38 Aligned_cols=259 Identities=28% Similarity=0.398 Sum_probs=206.7
Q ss_pred ccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCc-cCHHHHHHHHHHHhCCCCCceeeEEEEEEe
Q 011851 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL-QGHKEWLAEVNYLGGLIHPNLVKLIGCCIE 198 (476)
Q Consensus 120 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~ 198 (476)
.++|++.+.||+|+||.||+|.+... ..++..||+|++..... ...+.+.+|+.++++++||||+++++++.+
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~------~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 84 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTNH------KGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE 84 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEECT------TCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS
T ss_pred ccceEEEEEEEecCCeeEEEeEEcCC------CCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC
Confidence 45799999999999999999986532 23566799999976532 334678899999999999999999999764
Q ss_pred CCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCc
Q 011851 199 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLA 278 (476)
Q Consensus 199 ~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a 278 (476)
+..|+||||+++++|.+++......+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 85 -~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 160 (281)
T 3cc6_A 85 -EPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLS 160 (281)
T ss_dssp -SSCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGG
T ss_pred -CCCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCC
Confidence 5679999999999999999877777999999999999999999999988 999999999999999999999999999
Q ss_pred CCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhhccccc
Q 011851 279 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPQLGERRR 357 (476)
Q Consensus 279 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 357 (476)
......... ......+|+.|+|||++.+..++.++|||||||++|+|++ |+.||...........+. .. ...
T Consensus 161 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~---~~--~~~- 233 (281)
T 3cc6_A 161 RYIEDEDYY-KASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLE---KG--DRL- 233 (281)
T ss_dssp GCC----------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHH---HT--CCC-
T ss_pred ccccccccc-ccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHh---cC--CCC-
Confidence 875442221 1233567889999999999999999999999999999998 999997543322111111 00 000
Q ss_pred cccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011851 358 FYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPL 406 (476)
Q Consensus 358 ~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~ 406 (476)
+ .+...++.+.+|+.+||+.||++|||+.+++++|+.+
T Consensus 234 ------~-----~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~ 271 (281)
T 3cc6_A 234 ------P-----KPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDV 271 (281)
T ss_dssp ------C-----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ------C-----CCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHH
Confidence 0 1112257799999999999999999999999997643
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=370.79 Aligned_cols=261 Identities=24% Similarity=0.381 Sum_probs=209.8
Q ss_pred HHHhccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccC--------HHHHHHHHHHHhCC-CC
Q 011851 116 LKSATKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQG--------HKEWLAEVNYLGGL-IH 186 (476)
Q Consensus 116 ~~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~--------~~~~~~E~~~l~~l-~h 186 (476)
.....++|++.+.||+|+||.||+|.+. .+|+.||||+++...... .+.+.+|+.+++++ +|
T Consensus 89 ~~~~~~~y~~~~~lg~G~~g~Vy~a~~~---------~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h 159 (365)
T 2y7j_A 89 AKEFYQKYDPKDVIGRGVSSVVRRCVHR---------ATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGH 159 (365)
T ss_dssp HHHHHHHEEEEEEEEECSSEEEEEEEET---------TTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred hhhhhhhcccceEEecCCCEEEEEEEEC---------CCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 3445678999999999999999998764 468889999997653211 34577899999999 79
Q ss_pred CceeeEEEEEEeCCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecC
Q 011851 187 PNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDG 266 (476)
Q Consensus 187 pnIv~l~~~~~~~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~ 266 (476)
|||+++++++...+..||||||+++++|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.
T Consensus 160 p~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~ 235 (365)
T 2y7j_A 160 PHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEK-VALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDD 235 (365)
T ss_dssp TTBCCEEEEEEBSSEEEEEECCCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECT
T ss_pred CCEeEEEEEEeeCCEEEEEEEeCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECC
Confidence 99999999999999999999999999999999654 46999999999999999999999988 999999999999999
Q ss_pred CCceEEeecCCcCCCCCCCccceeeeeecCCCCCCcchhhcC------CCCccchhhhhHHHHHHHHhCCCCCCCCCCCC
Q 011851 267 EYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG------HLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNG 340 (476)
Q Consensus 267 ~~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~DiwslGv~l~elltG~~pf~~~~~~~ 340 (476)
++.+||+|||++........ ....+||+.|+|||++.+. .++.++|||||||++|+|++|..||......
T Consensus 236 ~~~ikl~DfG~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~- 311 (365)
T 2y7j_A 236 NMQIRLSDFGFSCHLEPGEK---LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQI- 311 (365)
T ss_dssp TCCEEECCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-
T ss_pred CCCEEEEecCcccccCCCcc---cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHH-
Confidence 99999999999987654322 2346899999999998743 5889999999999999999999999754321
Q ss_pred cchhHHhhhhhhccccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCcc
Q 011851 341 EHNLVEWARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLK 410 (476)
Q Consensus 341 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~ 410 (476)
........ ... ....+.+. ..+..+.+||.+||+.||++|||+.++++| |||+
T Consensus 312 --~~~~~i~~---~~~---~~~~~~~~-----~~~~~~~~li~~~L~~dP~~Rps~~ell~h----p~f~ 364 (365)
T 2y7j_A 312 --LMLRMIME---GQY---QFSSPEWD-----DRSSTVKDLISRLLQVDPEARLTAEQALQH----PFFE 364 (365)
T ss_dssp --HHHHHHHH---TCC---CCCHHHHS-----SSCHHHHHHHHHHSCSSTTTSCCHHHHHHS----GGGC
T ss_pred --HHHHHHHh---CCC---CCCCcccc-----cCCHHHHHHHHHHcCCChhHCcCHHHHhcC----cccC
Confidence 11111000 000 00001111 114678999999999999999999999998 9986
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-46 Score=359.41 Aligned_cols=258 Identities=24% Similarity=0.349 Sum_probs=207.3
Q ss_pred cCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCcc------CHHHHHHHHHHHhCCCCCceeeEEE
Q 011851 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQ------GHKEWLAEVNYLGGLIHPNLVKLIG 194 (476)
Q Consensus 121 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~------~~~~~~~E~~~l~~l~hpnIv~l~~ 194 (476)
++|++.+.||+|+||.||+|.+. .+|+.||+|++...... ..+.+.+|+.+|++++||||+++++
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~ 75 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQK---------GTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHD 75 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEET---------TTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEc---------CCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhh
Confidence 46999999999999999998654 46788999998764322 3567899999999999999999999
Q ss_pred EEEeCCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCC----ce
Q 011851 195 CCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEY----NA 270 (476)
Q Consensus 195 ~~~~~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~----~v 270 (476)
++.+.+..++||||+++++|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++ .+
T Consensus 76 ~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~ 151 (283)
T 3bhy_A 76 IFENKTDVVLILELVSGGELFDFLAEK-ESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRI 151 (283)
T ss_dssp EEECSSEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCE
T ss_pred eecCCCeEEEEEeecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCce
Confidence 999999999999999999999999553 46999999999999999999999988 99999999999998877 89
Q ss_pred EEeecCCcCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhh
Q 011851 271 KLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP 350 (476)
Q Consensus 271 kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~ 350 (476)
||+|||++........ .....||+.|+|||++.+..++.++||||||+++|+|++|..||...........+ ..
T Consensus 152 kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~--~~- 225 (283)
T 3bhy_A 152 KLIDFGIAHKIEAGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNI--SA- 225 (283)
T ss_dssp EECCCTTCEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH--HT-
T ss_pred EEEecccceeccCCCc---ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHh--Hh-
Confidence 9999999987543222 23457999999999999999999999999999999999999999764321111000 00
Q ss_pred hhccccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCcccc
Q 011851 351 QLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDM 412 (476)
Q Consensus 351 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~~ 412 (476)
.... .... .....+..+.+|+.+||+.||++|||+.++++| |||+.+
T Consensus 226 ---~~~~----~~~~----~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h----~~~~~~ 272 (283)
T 3bhy_A 226 ---VNYD----FDEE----YFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEH----SWIKAI 272 (283)
T ss_dssp ---TCCC----CCHH----HHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHC----HHHHHH
T ss_pred ---cccC----Ccch----hcccCCHHHHHHHHHHccCCHhHCcCHHHHHhC----HHHHHH
Confidence 0000 0000 001125678999999999999999999999997 887754
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=386.51 Aligned_cols=261 Identities=25% Similarity=0.329 Sum_probs=208.4
Q ss_pred hccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCc-------------cCHHHHHHHHHHHhCCC
Q 011851 119 ATKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL-------------QGHKEWLAEVNYLGGLI 185 (476)
Q Consensus 119 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~-------------~~~~~~~~E~~~l~~l~ 185 (476)
..++|++.++||+|+||+||+|.+. .+++.||||++..... ...+.+.+|+.+|++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 104 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEK---------NGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLD 104 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEET---------TTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCC
T ss_pred cccceEEEeEecccCCeEEEEEEEC---------CCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCC
Confidence 3568999999999999999998654 4788899999976432 23467889999999999
Q ss_pred CCceeeEEEEEEeCCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeec
Q 011851 186 HPNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLD 265 (476)
Q Consensus 186 hpnIv~l~~~~~~~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~ 265 (476)
||||+++++++.+.+.+|||||||++|+|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++
T Consensus 105 hpniv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~ 180 (504)
T 3q5i_A 105 HPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINR-HKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLE 180 (504)
T ss_dssp CTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEES
T ss_pred CCCCCeEEEEEEcCCEEEEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEe
Confidence 999999999999999999999999999999998654 46999999999999999999999988 99999999999998
Q ss_pred CCC---ceEEeecCCcCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcc
Q 011851 266 GEY---NAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEH 342 (476)
Q Consensus 266 ~~~---~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~ 342 (476)
.++ .+||+|||++........ ....+||+.|+|||++. +.|+.++|||||||++|+|++|..||.........
T Consensus 181 ~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~ 256 (504)
T 3q5i_A 181 NKNSLLNIKIVDFGLSSFFSKDYK---LRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDII 256 (504)
T ss_dssp STTCCSSEEECCCTTCEECCTTSC---BCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred cCCCCccEEEEECCCCEEcCCCCc---cccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 776 699999999987644322 23467999999999876 56999999999999999999999999765432111
Q ss_pred hhHHhhhhhhccccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCcccccC
Q 011851 343 NLVEWARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDMAS 414 (476)
Q Consensus 343 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~~~~ 414 (476)
..+... ... ...+.+. ..+.++.+||.+||+.||.+|||+.++++| ||++....
T Consensus 257 ~~i~~~------~~~---~~~~~~~-----~~s~~~~~li~~~L~~dp~~R~t~~e~l~h----~~~~~~~~ 310 (504)
T 3q5i_A 257 KKVEKG------KYY---FDFNDWK-----NISDEAKELIKLMLTYDYNKRCTAEEALNS----RWIKKYAN 310 (504)
T ss_dssp HHHHHC------CCC---CCHHHHT-----TSCHHHHHHHHHHTCSSTTTSCCHHHHHTS----HHHHHTCC
T ss_pred HHHHcC------CCC---CCccccC-----CCCHHHHHHHHHHcCCChhHCCCHHHHhcC----Hhhhhchh
Confidence 111100 000 0000000 125789999999999999999999999997 99876543
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-45 Score=359.49 Aligned_cols=265 Identities=26% Similarity=0.402 Sum_probs=216.0
Q ss_pred cCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCc-cCHHHHHHHHHHHhCCCCCceeeEEEEEEeC
Q 011851 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL-QGHKEWLAEVNYLGGLIHPNLVKLIGCCIED 199 (476)
Q Consensus 121 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~ 199 (476)
+.|++.+.||+|+||.||+|.+. .+++.||||++..... ...+.+.+|+.+++.++||||+++++++.++
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 92 (303)
T 3a7i_A 22 ELFTKLEKIGKGSFGEVFKGIDN---------RTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKD 92 (303)
T ss_dssp GTEEEEEEEEECSSSEEEEEEET---------TTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred HHHHHhhhhcccCCeEEEEEEEC---------CCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC
Confidence 46999999999999999998654 4678899999976543 3457789999999999999999999999999
Q ss_pred CeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCcC
Q 011851 200 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAK 279 (476)
Q Consensus 200 ~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~ 279 (476)
+..|+||||+++++|.+++.. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.
T Consensus 93 ~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~ 167 (303)
T 3a7i_A 93 TKLWIIMEYLGGGSALDLLEP--GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAG 167 (303)
T ss_dssp TEEEEEEECCTTEEHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred CeEEEEEEeCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccce
Confidence 999999999999999999854 46999999999999999999999988 9999999999999999999999999997
Q ss_pred CCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhccccccc
Q 011851 280 DGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRRFY 359 (476)
Q Consensus 280 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 359 (476)
....... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||....... ...... ..
T Consensus 168 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~~~~----~~---- 234 (303)
T 3a7i_A 168 QLTDTQI--KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMK---VLFLIP----KN---- 234 (303)
T ss_dssp ECBTTBC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH---HHHHHH----HS----
T ss_pred ecCcccc--ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHH---HHHHhh----cC----
Confidence 6543221 1234679999999999999999999999999999999999999997543211 111100 00
Q ss_pred cccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCcccccCcchHHHHH
Q 011851 360 RLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDMASSSSYVQAM 422 (476)
Q Consensus 360 ~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~~~~~~~~~~~~ 422 (476)
..+.+. ...+..+.+||.+||+.||++|||+.+++++ ||+............+
T Consensus 235 --~~~~~~----~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~----~~~~~~~~~~~~~~~~ 287 (303)
T 3a7i_A 235 --NPPTLE----GNYSKPLKEFVEACLNKEPSFRPTAKELLKH----KFILRNAKKTSYLTEL 287 (303)
T ss_dssp --CCCCCC----SSCCHHHHHHHHHHCCSSGGGSCCHHHHTTC----HHHHHHCCCGGGGHHH
T ss_pred --CCCCCc----cccCHHHHHHHHHHcCCChhhCcCHHHHhhC----hhhhcCCCccHHHHHH
Confidence 001111 1225678999999999999999999999987 8887665555544443
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-46 Score=389.70 Aligned_cols=259 Identities=25% Similarity=0.352 Sum_probs=210.9
Q ss_pred ccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCc---cCHHHHHHHHHHHhCCCCCceeeEEEEE
Q 011851 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL---QGHKEWLAEVNYLGGLIHPNLVKLIGCC 196 (476)
Q Consensus 120 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~l~~~~ 196 (476)
.++|++.++||+|+||.||+|.+. .+|+.||||++..... .....+.+|+.+|++++||||+++++++
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~ 95 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDK---------ITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFF 95 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEET---------TTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEEC---------CCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence 356999999999999999998654 4788899999976532 3456789999999999999999999999
Q ss_pred EeCCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeee---cCCCceEEe
Q 011851 197 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILL---DGEYNAKLS 273 (476)
Q Consensus 197 ~~~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl---~~~~~vkl~ 273 (476)
.+.+..|+|||||.+++|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||+ +.++.+||+
T Consensus 96 ~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~ 171 (484)
T 3nyv_A 96 EDKGYFYLVGEVYTGGELFDEIISR-KRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRII 171 (484)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHHTC-SCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEEC
T ss_pred EeCCEEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEE
Confidence 9999999999999999999998554 57999999999999999999999988 9999999999999 567899999
Q ss_pred ecCCcCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhc
Q 011851 274 DFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLG 353 (476)
Q Consensus 274 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~ 353 (476)
|||+++....... ....+||+.|+|||++.+ .|+.++|||||||++|+|++|..||...........+. ..
T Consensus 172 Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~--~~--- 242 (484)
T 3nyv_A 172 DFGLSTHFEASKK---MKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVE--KG--- 242 (484)
T ss_dssp CTTHHHHBCCCCS---HHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH--HC---
T ss_pred eeeeeEEcccccc---cccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHH--cC---
Confidence 9999986544322 233679999999998876 69999999999999999999999997653321111111 00
Q ss_pred cccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCccccc
Q 011851 354 ERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDMA 413 (476)
Q Consensus 354 ~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~~~ 413 (476)
.. ....+.+ ...+.++.+||.+||+.||.+|||+.++++| ||++...
T Consensus 243 -~~---~~~~~~~-----~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h----~~~~~~~ 289 (484)
T 3nyv_A 243 -KY---TFELPQW-----KKVSESAKDLIRKMLTYVPSMRISARDALDH----EWIQTYT 289 (484)
T ss_dssp -CC---CCCSGGG-----GGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS----HHHHHHT
T ss_pred -CC---CCCCccc-----ccCCHHHHHHHHHHCCCChhHCcCHHHHhhC----hhhcccc
Confidence 00 0000111 1236789999999999999999999999997 8887543
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-46 Score=356.39 Aligned_cols=254 Identities=28% Similarity=0.421 Sum_probs=208.9
Q ss_pred ccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCCCCCceeeEEEEEEeC
Q 011851 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHPNLVKLIGCCIED 199 (476)
Q Consensus 120 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~ 199 (476)
.++|++.+.||+|+||.||+|.+. +++.||+|++..... ..+.+.+|++++++++||||+++++++.++
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~----------~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 75 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWL----------NKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ 75 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET----------TTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred hhheeeeeEecCCCceeEEEEEec----------CCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccC
Confidence 356899999999999999998764 456799999976543 356789999999999999999999999999
Q ss_pred CeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCcC
Q 011851 200 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAK 279 (476)
Q Consensus 200 ~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~ 279 (476)
+..|+||||+++++|.+++......+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.
T Consensus 76 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~ 152 (267)
T 3t9t_A 76 APICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTR 152 (267)
T ss_dssp SSCEEEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGG
T ss_pred CCeEEEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEccccccc
Confidence 9999999999999999999877678999999999999999999999988 9999999999999999999999999998
Q ss_pred CCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhhcccccc
Q 011851 280 DGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPQLGERRRF 358 (476)
Q Consensus 280 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 358 (476)
...... ........||+.|+|||++.+..++.++||||||+++|+|++ |+.||....... ...... ...
T Consensus 153 ~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~~~i~----~~~-- 222 (267)
T 3t9t_A 153 FVLDDQ-YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE---VVEDIS----TGF-- 222 (267)
T ss_dssp GBCCHH-HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HHHHHH----TTC--
T ss_pred cccccc-ccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHH---HHHHHh----cCC--
Confidence 653311 111223457788999999999999999999999999999999 899997543211 111100 000
Q ss_pred ccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 011851 359 YRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKP 405 (476)
Q Consensus 359 ~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~ 405 (476)
.. ..+...+..+.+|+.+||+.||++||++.+++++|+.
T Consensus 223 -~~-------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~ 261 (267)
T 3t9t_A 223 -RL-------YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAE 261 (267)
T ss_dssp -CC-------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred -cC-------CCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 00 0111225788999999999999999999999998764
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=363.35 Aligned_cols=262 Identities=27% Similarity=0.405 Sum_probs=199.2
Q ss_pred HhccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCcc--CHHHHHHHHHHHhCCCCCceeeEEEE
Q 011851 118 SATKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQ--GHKEWLAEVNYLGGLIHPNLVKLIGC 195 (476)
Q Consensus 118 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~l~~~ 195 (476)
...++|.+.+.||+|+||.||+|.+..+ ..+++.||+|++...... ..+.+.+|+.++++++||||++++++
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~------~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 104 (313)
T 3brb_A 31 IDRNLLILGKILGEGEFGSVMEGNLKQE------DGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGV 104 (313)
T ss_dssp CCGGGEEEEEEEEC-CCCCEEEEEEECT------TSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEE
T ss_pred cCHHHeeeccceeecCCeEEEEEEEecc------CCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEE
Confidence 3456799999999999999999976532 236778999999765332 24568899999999999999999999
Q ss_pred EEeCC-----eeEEEEEecCCCCHHHHHhh-----cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeec
Q 011851 196 CIEDD-----QRLLVYEFMPRGSLENHLFR-----RSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLD 265 (476)
Q Consensus 196 ~~~~~-----~~~lV~E~~~~g~L~~~l~~-----~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~ 265 (476)
+.+.+ ..++||||+++++|.+++.. ....+++..++.++.||+.||.|||+++ |+||||||+|||++
T Consensus 105 ~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~ 181 (313)
T 3brb_A 105 CIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLR 181 (313)
T ss_dssp EEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEEC
T ss_pred EeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEc
Confidence 98765 35999999999999999853 3456999999999999999999999988 99999999999999
Q ss_pred CCCceEEeecCCcCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHh-CCCCCCCCCCCCcchh
Q 011851 266 GEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNL 344 (476)
Q Consensus 266 ~~~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~ellt-G~~pf~~~~~~~~~~~ 344 (476)
.++.+||+|||+++...............+++.|+|||++.+..++.++|||||||++|+|++ |..||...........
T Consensus 182 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~ 261 (313)
T 3brb_A 182 DDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDY 261 (313)
T ss_dssp TTSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHH
T ss_pred CCCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHH
Confidence 999999999999987654333222334567889999999999999999999999999999999 8899976543221111
Q ss_pred HHhhhhhhccccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 011851 345 VEWARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKP 405 (476)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~ 405 (476)
.... .. ..++...+.++.+||.+||..||++|||+.+++++|+.
T Consensus 262 ---~~~~--~~------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~ 305 (313)
T 3brb_A 262 ---LLHG--HR------------LKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEK 305 (313)
T ss_dssp ---HHTT--CC------------CCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred ---HHcC--CC------------CCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 1000 00 00112235789999999999999999999999999764
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-45 Score=356.49 Aligned_cols=256 Identities=25% Similarity=0.410 Sum_probs=203.8
Q ss_pred cCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCc--cCHHHHHHHHHHHhCCCCCceeeEEEEEEe
Q 011851 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL--QGHKEWLAEVNYLGGLIHPNLVKLIGCCIE 198 (476)
Q Consensus 121 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~ 198 (476)
+.|++.+.||+|+||.||+|.+. .++..||+|++..... ...+.+.+|+.+|++++||||+++++++..
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~---------~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 96 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDT---------ETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWES 96 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEET---------TTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE
T ss_pred eeEEeeeeccCCCCeEEEEeEec---------CCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecc
Confidence 45888899999999999998654 4678899999875432 234568899999999999999999999876
Q ss_pred ----CCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeec-CCCceEEe
Q 011851 199 ----DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLD-GEYNAKLS 273 (476)
Q Consensus 199 ----~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~-~~~~vkl~ 273 (476)
...+|+||||+++++|.+++... ..+++..++.++.||+.||.|||+.+ .+|+||||||+|||++ .++.+||+
T Consensus 97 ~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~ 174 (290)
T 1t4h_A 97 TVKGKKCIVLVTELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIG 174 (290)
T ss_dssp ESSSCEEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEEC
T ss_pred ccCCCceEEEEEEecCCCCHHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEe
Confidence 35689999999999999999653 56999999999999999999999865 3499999999999997 78999999
Q ss_pred ecCCcCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhc
Q 011851 274 DFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLG 353 (476)
Q Consensus 274 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~ 353 (476)
|||++....... .....||+.|+|||++. +.++.++|||||||++|+|++|+.||....... .........
T Consensus 175 Dfg~~~~~~~~~----~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~--~~~~~~~~~-- 245 (290)
T 1t4h_A 175 DLGLATLKRASF----AKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAA--QIYRRVTSG-- 245 (290)
T ss_dssp CTTGGGGCCTTS----BEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH--HHHHHHTTT--
T ss_pred eCCCcccccccc----cccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHH--HHHHHHhcc--
Confidence 999997643322 23467999999999876 459999999999999999999999997543211 111110000
Q ss_pred cccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCccc
Q 011851 354 ERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKD 411 (476)
Q Consensus 354 ~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~ 411 (476)
. . ...++...+.++.+||.+||+.||++|||+.++++| |||++
T Consensus 246 --~------~---~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h----~~f~~ 288 (290)
T 1t4h_A 246 --V------K---PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH----AFFQE 288 (290)
T ss_dssp --C------C---CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS----GGGC-
T ss_pred --C------C---ccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhC----ccccc
Confidence 0 0 000111124678999999999999999999999997 99875
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-45 Score=356.28 Aligned_cols=259 Identities=22% Similarity=0.339 Sum_probs=205.1
Q ss_pred CCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCCCCCceeeEEEEEEeCCe
Q 011851 122 SFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHPNLVKLIGCCIEDDQ 201 (476)
Q Consensus 122 ~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~ 201 (476)
+|....+||+|+||.||+|.+. .+++.||||++........+.+.+|+.+++.++||||+++++++.+.+.
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 93 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDL---------SNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGF 93 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEET---------TTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTE
T ss_pred CCCCcEEEeecCcEEEEEEEEC---------CCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCc
Confidence 3555668999999999998754 4678899999987766666788999999999999999999999999999
Q ss_pred eEEEEEecCCCCHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecC-CCceEEeecCCc
Q 011851 202 RLLVYEFMPRGSLENHLFRRS--LPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDG-EYNAKLSDFGLA 278 (476)
Q Consensus 202 ~~lV~E~~~~g~L~~~l~~~~--~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~-~~~vkl~DFG~a 278 (476)
.++||||+++++|.+++.... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||++
T Consensus 94 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~ 170 (295)
T 2clq_A 94 IKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTS 170 (295)
T ss_dssp EEEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTC
T ss_pred EEEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccc
Confidence 999999999999999997653 34678999999999999999999988 999999999999987 899999999999
Q ss_pred CCCCCCCccceeeeeecCCCCCCcchhhcCC--CCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhcccc
Q 011851 279 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGH--LTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERR 356 (476)
Q Consensus 279 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~ 356 (476)
........ ......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||........ .. .......
T Consensus 171 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~--~~~~~~~--- 242 (295)
T 2clq_A 171 KRLAGINP--CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQA-AM--FKVGMFK--- 242 (295)
T ss_dssp EESCC-------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHH-HH--HHHHHHC---
T ss_pred cccCCCCC--cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhH-HH--Hhhcccc---
Confidence 86543221 123467999999999998754 89999999999999999999999964322110 00 0000000
Q ss_pred ccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCccccc
Q 011851 357 RFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDMA 413 (476)
Q Consensus 357 ~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~~~ 413 (476)
..+. ++...+.++.+||.+||+.||++||++.+++++ |||+...
T Consensus 243 -----~~~~----~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~----~~~~~~~ 286 (295)
T 2clq_A 243 -----VHPE----IPESMSAEAKAFILKCFEPDPDKRACANDLLVD----EFLKVSS 286 (295)
T ss_dssp -----CCCC----CCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTS----GGGCC--
T ss_pred -----cccc----ccccCCHHHHHHHHHHccCChhhCCCHHHHhcC----hhhhhcc
Confidence 0111 122236788999999999999999999999997 9987543
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=378.86 Aligned_cols=267 Identities=25% Similarity=0.339 Sum_probs=201.8
Q ss_pred cCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCCCCCceeeEEEEEEeC-
Q 011851 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHPNLVKLIGCCIED- 199 (476)
Q Consensus 121 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~- 199 (476)
.+|++.++||+|+||+||+|.+. .+|+.||||++..... ...+|+++|+.++||||++++++|...
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~---------~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~ 120 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLC---------DSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSG 120 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEET---------TTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEEC---------CCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccC
Confidence 46999999999999999998764 4678899999865432 234799999999999999999998642
Q ss_pred -----CeeEEEEEecCCCCHHHHHh---hcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCC-Cce
Q 011851 200 -----DQRLLVYEFMPRGSLENHLF---RRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGE-YNA 270 (476)
Q Consensus 200 -----~~~~lV~E~~~~g~L~~~l~---~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~-~~v 270 (476)
..++|||||+++ +|.+.+. .....+++..++.++.||+.||.|||+++ |+||||||+||||+.+ +.+
T Consensus 121 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~ 196 (420)
T 1j1b_A 121 EKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVL 196 (420)
T ss_dssp TTTTEEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEE
T ss_pred CCCcceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeE
Confidence 236799999975 6666654 34567999999999999999999999988 9999999999999965 578
Q ss_pred EEeecCCcCCCCCCCccceeeeeecCCCCCCcchhhcC-CCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhh
Q 011851 271 KLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR 349 (476)
Q Consensus 271 kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~ 349 (476)
||+|||+++....... ....+||+.|+|||++.+. .|+.++|||||||++|||++|+.||....... .+..+..
T Consensus 197 kl~DFG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~--~l~~i~~ 271 (420)
T 1j1b_A 197 KLCDFGSAKQLVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD--QLVEIIK 271 (420)
T ss_dssp EECCCTTCEECCTTCC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHH
T ss_pred EeccchhhhhcccCCC---ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHH
Confidence 9999999987544322 2346799999999999775 79999999999999999999999998653221 1111111
Q ss_pred h-------hh---c-c--ccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCccccc
Q 011851 350 P-------QL---G-E--RRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDMA 413 (476)
Q Consensus 350 ~-------~~---~-~--~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~~~ 413 (476)
. .+ . . ...+..+....+...+....+.++.+||.+||..||++|||+.|+++| |||+...
T Consensus 272 ~lg~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~h----p~f~~~~ 344 (420)
T 1j1b_A 272 VLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH----SFFDELR 344 (420)
T ss_dssp HHCSCCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS----GGGGGGG
T ss_pred HhCCCCHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCC----Hhhcccc
Confidence 0 00 0 0 000000000011111222346789999999999999999999999987 9987653
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=379.57 Aligned_cols=271 Identities=20% Similarity=0.274 Sum_probs=205.1
Q ss_pred ccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCC------CCCceeeEE
Q 011851 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGL------IHPNLVKLI 193 (476)
Q Consensus 120 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l------~hpnIv~l~ 193 (476)
..+|++.++||+|+||.||+|.+. .+++.||||+++... .....+.+|+.+++.+ .|+||++++
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~---------~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~ 165 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDH---------KVHQHVALKMVRNEK-RFHRQAAEEIRILEHLRKQDKDNTMNVIHML 165 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEET---------TTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEE
T ss_pred cCcEEEEEEcccCccEEEEEEEEC---------CCCcEEEEEEECCcc-chHHHHHHHHHHHHHHhhccccCCcCEEEEE
Confidence 457999999999999999998654 468889999997542 2234566777777765 578999999
Q ss_pred EEEEeCCeeEEEEEecCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCc--e
Q 011851 194 GCCIEDDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYN--A 270 (476)
Q Consensus 194 ~~~~~~~~~~lV~E~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~--v 270 (476)
+++...+.+||||||+. ++|.+++.... ..+++..++.++.||+.||.|||+.+ |+||||||+||||+.++. +
T Consensus 166 ~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~v 241 (429)
T 3kvw_A 166 ENFTFRNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGI 241 (429)
T ss_dssp EEEEETTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCE
T ss_pred eecccCCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcce
Confidence 99999999999999995 69999987653 45999999999999999999999998 999999999999999887 9
Q ss_pred EEeecCCcCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhh
Q 011851 271 KLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP 350 (476)
Q Consensus 271 kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~ 350 (476)
||+|||+++..... ....+||+.|+|||++.+..|+.++|||||||++|||++|..||...........+.....
T Consensus 242 kL~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~ 316 (429)
T 3kvw_A 242 KVIDFGSSCYEHQR-----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLG 316 (429)
T ss_dssp EECCCTTCEETTCC-----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC
T ss_pred EEeecccceecCCc-----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcC
Confidence 99999999764332 2236799999999999999999999999999999999999999976543221111100000
Q ss_pred ----h-hccccccccccC--------------------------------cccC----CCCChHHHHHHHHHHHHhcccC
Q 011851 351 ----Q-LGERRRFYRLID--------------------------------PCLE----GCFSIKGAEKTIQLAASCLNRD 389 (476)
Q Consensus 351 ----~-~~~~~~~~~~~d--------------------------------~~l~----~~~~~~~~~~~~~li~~cL~~d 389 (476)
. .........+++ +... ..+....+..+.+||.+||+.|
T Consensus 317 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~d 396 (429)
T 3kvw_A 317 MPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWD 396 (429)
T ss_dssp CCCHHHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSS
T ss_pred CCCHHHHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCC
Confidence 0 000000000000 0000 0000111467899999999999
Q ss_pred CCCCCCHHHHHHHhcCCCCccccc
Q 011851 390 QKARPRMSEVVEALKPLPYLKDMA 413 (476)
Q Consensus 390 P~~RPt~~ell~~L~~~~~~~~~~ 413 (476)
|++|||+.|+|+| |||++..
T Consensus 397 P~~Rpta~e~L~H----pw~~~~~ 416 (429)
T 3kvw_A 397 PAVRMTPGQALRH----PWLRRRL 416 (429)
T ss_dssp TTTSCCHHHHHTS----TTTC---
T ss_pred hhhCCCHHHHhCC----hhhccCC
Confidence 9999999999998 9998754
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=356.37 Aligned_cols=256 Identities=25% Similarity=0.327 Sum_probs=202.3
Q ss_pred ccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCC---ccCHHHHHHHHHHHhCCCCCceeeEEEEE
Q 011851 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDG---LQGHKEWLAEVNYLGGLIHPNLVKLIGCC 196 (476)
Q Consensus 120 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~ 196 (476)
.++|++.+.||+|+||.||+|.+. .+|+.||||++.... ....+.+.+|+.+++.++||||+++++++
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 80 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQ---------LTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVI 80 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEET---------TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred eccEEEEeeecCCCCeEEEEEEEC---------CCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEE
Confidence 457999999999999999998664 467889999986532 23356788999999999999999999999
Q ss_pred EeCCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecC
Q 011851 197 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFG 276 (476)
Q Consensus 197 ~~~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG 276 (476)
.+.+..|+||||+++++|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 81 ~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg 156 (276)
T 2h6d_A 81 STPTDFFMVMEYVSGGELFDYICKH-GRVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFG 156 (276)
T ss_dssp ECSSEEEEEEECCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCC
T ss_pred ecCCeEEEEEeccCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeecc
Confidence 9999999999999999999999654 46899999999999999999999998 9999999999999999999999999
Q ss_pred CcCCCCCCCccceeeeeecCCCCCCcchhhcCCC-CccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhccc
Q 011851 277 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHL-TAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGER 355 (476)
Q Consensus 277 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~ 355 (476)
++........ .....||+.|+|||++.+..+ +.++||||||+++|+|++|+.||...... ........ ..
T Consensus 157 ~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~~~~~~~~---~~ 227 (276)
T 2h6d_A 157 LSNMMSDGEF---LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVP---TLFKKIRG---GV 227 (276)
T ss_dssp GGGCCCC----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHH---CC
T ss_pred cccccCCCcc---eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHH---HHHHHhhc---Cc
Confidence 9987644321 233579999999999988765 68999999999999999999999753221 11111000 00
Q ss_pred cccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCccccc
Q 011851 356 RRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDMA 413 (476)
Q Consensus 356 ~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~~~ 413 (476)
. .++...+..+.+||.+||+.||++|||+.++++| |||++..
T Consensus 228 ~------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h----~~~~~~~ 269 (276)
T 2h6d_A 228 F------------YIPEYLNRSVATLLMHMLQVDPLKRATIKDIREH----EWFKQDL 269 (276)
T ss_dssp C------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS----HHHHTTC
T ss_pred c------------cCchhcCHHHHHHHHHHccCChhhCCCHHHHHhC----hhhccCc
Confidence 0 0111225678999999999999999999999997 8887543
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=374.82 Aligned_cols=269 Identities=20% Similarity=0.241 Sum_probs=208.0
Q ss_pred ccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCCC--------CCceee
Q 011851 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLI--------HPNLVK 191 (476)
Q Consensus 120 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~--------hpnIv~ 191 (476)
.++|++.++||+|+||+||+|++. .+++.||||++.... ...+.+.+|+.+|+.+. |+||++
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~ 105 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDI---------QGKKFVAMKVVKSAE-HYTETALDEIRLLKSVRNSDPNDPNREMVVQ 105 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEET---------TTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHSCTTCGGGGGBCC
T ss_pred CCeEEEEEEeeecCCeeEEEEEec---------CCCeEEEEEEEecCC-cchHHHHHHHHHHHHHhhcCCCCCCcceeee
Confidence 467999999999999999998654 468889999997542 23456788999999885 788999
Q ss_pred EEEEEE----eCCeeEEEEEecCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeEecCCCCCCeeec
Q 011851 192 LIGCCI----EDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALDAAKGLAFLHEE-AEKPVIYRDFKTSNILLD 265 (476)
Q Consensus 192 l~~~~~----~~~~~~lV~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~al~~lH~~-~~~~ivHrDlKp~NILl~ 265 (476)
+++++. ....+||||||+ +++|.+.+... ...+++..++.++.||+.||.|||++ + |+||||||+||||+
T Consensus 106 ~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~ 181 (397)
T 1wak_A 106 LLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLS 181 (397)
T ss_dssp EEEEEEEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEEC
T ss_pred eecceeecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEe
Confidence 999988 456899999999 66777776554 36799999999999999999999997 7 99999999999998
Q ss_pred CCC-------------------------------------------------ceEEeecCCcCCCCCCCccceeeeeecC
Q 011851 266 GEY-------------------------------------------------NAKLSDFGLAKDGPEGDKTHVSTRVMGT 296 (476)
Q Consensus 266 ~~~-------------------------------------------------~vkl~DFG~a~~~~~~~~~~~~~~~~gt 296 (476)
.++ .+||+|||+++..... ....+||
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt 256 (397)
T 1wak_A 182 VNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQT 256 (397)
T ss_dssp CCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSC
T ss_pred ccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCC
Confidence 775 7999999999875432 2335799
Q ss_pred CCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhh---hhhcc------------------c
Q 011851 297 YGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR---PQLGE------------------R 355 (476)
Q Consensus 297 ~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~---~~~~~------------------~ 355 (476)
+.|+|||++.+..++.++|||||||++|||++|+.||................ ..... .
T Consensus 257 ~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~ 336 (397)
T 1wak_A 257 RQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKK 336 (397)
T ss_dssp GGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTT
T ss_pred CcccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCc
Confidence 99999999999999999999999999999999999998665443221111000 00000 0
Q ss_pred cccccccCccc---------CCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCccc
Q 011851 356 RRFYRLIDPCL---------EGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKD 411 (476)
Q Consensus 356 ~~~~~~~d~~l---------~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~ 411 (476)
..+..+.+... ...++...+..+.+||.+||+.||++|||+.|+++| |||++
T Consensus 337 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h----p~~~~ 397 (397)
T 1wak_A 337 GDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH----PWLNS 397 (397)
T ss_dssp SSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS----GGGGC
T ss_pred cccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC----ccccC
Confidence 00000000000 011345567889999999999999999999999997 99863
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-46 Score=384.27 Aligned_cols=255 Identities=28% Similarity=0.433 Sum_probs=208.1
Q ss_pred hccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCCCCCceeeEEEEEEe
Q 011851 119 ATKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHPNLVKLIGCCIE 198 (476)
Q Consensus 119 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~ 198 (476)
..++|++.+.||+|+||.||+|.+. ++..||||+++... ...+.+.+|+.+|++++||||+++++++.
T Consensus 186 ~~~~~~~~~~lG~G~fg~V~~~~~~----------~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~- 253 (454)
T 1qcf_A 186 PRESLKLEKKLGAGQFGEVWMATYN----------KHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT- 253 (454)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEET----------TTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-
T ss_pred chHHeEEEEEcccCCceEEEEEEEC----------CccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-
Confidence 3567999999999999999999764 35679999997654 45678999999999999999999999986
Q ss_pred CCeeEEEEEecCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCC
Q 011851 199 DDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGL 277 (476)
Q Consensus 199 ~~~~~lV~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~ 277 (476)
++.+||||||+++|+|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+
T Consensus 254 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~ 330 (454)
T 1qcf_A 254 KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGL 330 (454)
T ss_dssp SSSCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTG
T ss_pred CCccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCC
Confidence 66899999999999999999643 236889999999999999999999988 99999999999999999999999999
Q ss_pred cCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhhcccc
Q 011851 278 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPQLGERR 356 (476)
Q Consensus 278 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~ 356 (476)
++...... ........+|+.|+|||++....++.++|||||||++|||++ |+.||....... +..... ...
T Consensus 331 a~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~---~~~~i~----~~~ 402 (454)
T 1qcf_A 331 ARVIEDNE-YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE---VIRALE----RGY 402 (454)
T ss_dssp GGGBCCHH-HHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH---HHHHHH----HTC
T ss_pred ceEcCCCc-eeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHH---HHHHHH----cCC
Confidence 98754321 111222456788999999999999999999999999999999 999997643221 111111 000
Q ss_pred ccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011851 357 RFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPL 406 (476)
Q Consensus 357 ~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~ 406 (476)
. . + .+...+.++.+||.+||+.||++|||+.+|++.|+.+
T Consensus 403 ~---~--~-----~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~ 442 (454)
T 1qcf_A 403 R---M--P-----RPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDF 442 (454)
T ss_dssp C---C--C-----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred C---C--C-----CCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence 0 0 0 1122367899999999999999999999999998865
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-45 Score=365.15 Aligned_cols=261 Identities=24% Similarity=0.414 Sum_probs=203.3
Q ss_pred ccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCcc-CHHHHHHHHHHHhCCCCCceeeEEEEEEe
Q 011851 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQ-GHKEWLAEVNYLGGLIHPNLVKLIGCCIE 198 (476)
Q Consensus 120 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~~ 198 (476)
..+|++.+.||+|+||.||+|.+...+. ..+..||||+++..... ....+.+|+.++++++||||+++++++.+
T Consensus 43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 117 (333)
T 1mqb_A 43 PSCVTRQKVIGAGEFGEVYKGMLKTSSG-----KKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISK 117 (333)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC--------CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred hHHhhcccEEecCCCeEEEEEEEecCCC-----CccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEec
Confidence 3568889999999999999998763321 23557999999765332 24568899999999999999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCc
Q 011851 199 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLA 278 (476)
Q Consensus 199 ~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a 278 (476)
.+..+|||||+++++|.+++......+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 118 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~ 194 (333)
T 1mqb_A 118 YKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLS 194 (333)
T ss_dssp SSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred CCCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcc
Confidence 99999999999999999999877778999999999999999999999988 999999999999999999999999999
Q ss_pred CCCCCCCcc-ceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhhcccc
Q 011851 279 KDGPEGDKT-HVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPQLGERR 356 (476)
Q Consensus 279 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~ 356 (476)
+........ .......+|+.|+|||++.+..++.++|||||||++|||++ |+.||...... .+..... ...
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~---~~~~~~~----~~~ 267 (333)
T 1mqb_A 195 RVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH---EVMKAIN----DGF 267 (333)
T ss_dssp ----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHHHHHH----TTC
T ss_pred hhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHH---HHHHHHH----CCC
Confidence 875432211 11222456888999999999999999999999999999999 99999654321 1111110 000
Q ss_pred ccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 011851 357 RFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKP 405 (476)
Q Consensus 357 ~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~ 405 (476)
. ...+...+..+.+||.+||+.||++||++.+++++|+.
T Consensus 268 ~----------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~ 306 (333)
T 1mqb_A 268 R----------LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDK 306 (333)
T ss_dssp C----------CCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred c----------CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 0 00112236789999999999999999999999998753
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=357.71 Aligned_cols=251 Identities=20% Similarity=0.259 Sum_probs=202.2
Q ss_pred ccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCcc--CHHHHHHHHHHHhCC-CCCceeeEEEEE
Q 011851 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQ--GHKEWLAEVNYLGGL-IHPNLVKLIGCC 196 (476)
Q Consensus 120 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~--~~~~~~~E~~~l~~l-~hpnIv~l~~~~ 196 (476)
.++|++.+.||+|+||.||+|.+. .+++.||||++...... ...++.+|+.++..+ +||||+++++++
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~ 80 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKR---------LDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAW 80 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEET---------TTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEc---------CCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeee
Confidence 467999999999999999998654 46788999999764332 345678899999988 899999999999
Q ss_pred EeCCeeEEEEEecCCCCHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCC------
Q 011851 197 IEDDQRLLVYEFMPRGSLENHLFRR---SLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGE------ 267 (476)
Q Consensus 197 ~~~~~~~lV~E~~~~g~L~~~l~~~---~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~------ 267 (476)
.+++..++||||+++++|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+|||++.+
T Consensus 81 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~ 157 (289)
T 1x8b_A 81 AEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAA 157 (289)
T ss_dssp EETTEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC--------
T ss_pred ecCCeEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCccc
Confidence 9999999999999999999999653 357999999999999999999999988 9999999999999844
Q ss_pred -------------CceEEeecCCcCCCCCCCccceeeeeecCCCCCCcchhhcC-CCCccchhhhhHHHHHHHHhCCCCC
Q 011851 268 -------------YNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTAKSDVYSFGVVLLEMLTGRRSM 333 (476)
Q Consensus 268 -------------~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGv~l~elltG~~pf 333 (476)
..+||+|||++....... ...||+.|+|||++.+. .++.++|||||||++|+|++|..++
T Consensus 158 ~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~ 231 (289)
T 1x8b_A 158 SEEGDEDDWASNKVMFKIGDLGHVTRISSPQ------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLP 231 (289)
T ss_dssp ------------CCCEEECCCTTCEETTCSC------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCC
T ss_pred ccccccccccCCceEEEEcccccccccCCcc------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCC
Confidence 479999999998754322 24599999999999876 6678999999999999999998876
Q ss_pred CCCCCCCcchhHHhhhhhhccccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCcccc
Q 011851 334 DKNRPNGEHNLVEWARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDM 412 (476)
Q Consensus 334 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~~ 412 (476)
.... ........ .. +. ++...+.++.+||.+||+.||++|||+.++++| |||.+.
T Consensus 232 ~~~~-----~~~~~~~~------~~-----~~----~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h----~~~~~~ 286 (289)
T 1x8b_A 232 RNGD-----QWHEIRQG------RL-----PR----IPQVLSQEFTELLKVMIHPDPERRPSAMALVKH----SVLLSA 286 (289)
T ss_dssp SSSH-----HHHHHHTT------CC-----CC----CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTC----TTC---
T ss_pred cchh-----HHHHHHcC------CC-----CC----CCcccCHHHHHHHHHHhCCCcccCCCHHHHhhC----hHhhhh
Confidence 4321 11111000 00 01 111235789999999999999999999999998 998864
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-46 Score=372.66 Aligned_cols=282 Identities=23% Similarity=0.339 Sum_probs=207.7
Q ss_pred ChhHHHHhccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccC-----------HHHHHHHHHH
Q 011851 112 SFNELKSATKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQG-----------HKEWLAEVNY 180 (476)
Q Consensus 112 ~~~~~~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~-----------~~~~~~E~~~ 180 (476)
.+.++....++|++.+.||+|+||.||+|.+. +|+.||||++....... .+.+.+|+++
T Consensus 13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~----------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 82 (362)
T 3pg1_A 13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDS----------EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRL 82 (362)
T ss_dssp HHHHHHHTTCSCEEEEEEEEETTEEEEEEECT----------TSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHH
T ss_pred HHHHHHHhccceEEeEEeccCCCEEEEEEECC----------CCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHH
Confidence 35667788899999999999999999998653 47889999986533221 2678899999
Q ss_pred HhCCCCCceeeEEEEEEeC-----CeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEec
Q 011851 181 LGGLIHPNLVKLIGCCIED-----DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYR 255 (476)
Q Consensus 181 l~~l~hpnIv~l~~~~~~~-----~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHr 255 (476)
|++++||||+++++++... ..+|+||||++ ++|.+++......+++..+..++.||+.||.|||+++ |+||
T Consensus 83 l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~ 158 (362)
T 3pg1_A 83 LNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAG---VVHR 158 (362)
T ss_dssp HHHCCCTTBCCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCC
T ss_pred HHhCCCcCccceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCc---CEec
Confidence 9999999999999998653 36899999996 6899988777778999999999999999999999988 9999
Q ss_pred CCCCCCeeecCCCceEEeecCCcCCCCCCCccceeeeeecCCCCCCcchhhc-CCCCccchhhhhHHHHHHHHhCCCCCC
Q 011851 256 DFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTAKSDVYSFGVVLLEMLTGRRSMD 334 (476)
Q Consensus 256 DlKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGv~l~elltG~~pf~ 334 (476)
||||+|||++.++.+||+|||+++...... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.
T Consensus 159 Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~ 235 (362)
T 3pg1_A 159 DLHPGNILLADNNDITICDFNLAREDTADA---NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFR 235 (362)
T ss_dssp CCCGGGEEECTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred CCChHHEEEcCCCCEEEEecCccccccccc---ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCC
Confidence 999999999999999999999997543322 1234679999999999887 679999999999999999999999997
Q ss_pred CCCCCCcchhH-Hhhhh-hhc-----cccccccccCcccCC-------CCChHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 011851 335 KNRPNGEHNLV-EWARP-QLG-----ERRRFYRLIDPCLEG-------CFSIKGAEKTIQLAASCLNRDQKARPRMSEVV 400 (476)
Q Consensus 335 ~~~~~~~~~~~-~~~~~-~~~-----~~~~~~~~~d~~l~~-------~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell 400 (476)
..........+ ..... ... ........+...+.. ......+..+.+||.+||+.||++|||+.+++
T Consensus 236 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell 315 (362)
T 3pg1_A 236 GSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQAL 315 (362)
T ss_dssp CSSHHHHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred CCCHHHHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHH
Confidence 64322111110 00000 000 000000000000000 01112256789999999999999999999999
Q ss_pred HHhcCCCCcccccC
Q 011851 401 EALKPLPYLKDMAS 414 (476)
Q Consensus 401 ~~L~~~~~~~~~~~ 414 (476)
+| |||+....
T Consensus 316 ~h----p~f~~~~~ 325 (362)
T 3pg1_A 316 RH----PYFESLFD 325 (362)
T ss_dssp TS----GGGTTTCC
T ss_pred cC----chhhhccC
Confidence 97 99987644
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=365.48 Aligned_cols=268 Identities=29% Similarity=0.426 Sum_probs=207.5
Q ss_pred hHHHHhccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCC-CCCceeeE
Q 011851 114 NELKSATKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGL-IHPNLVKL 192 (476)
Q Consensus 114 ~~~~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l 192 (476)
.++....++|++.+.||+|+||.||+|.+. .+|+.||||++.... .....+.+|+.+++++ +||||+++
T Consensus 17 ~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~---------~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~ 86 (326)
T 2x7f_A 17 SALRDPAGIFELVELVGNGTYGQVYKGRHV---------KTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATY 86 (326)
T ss_dssp CCCCCCTTTEEEEEEEEEETTEEEEEEEET---------TTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCE
T ss_pred hhccCCCCcEEEEEEeccCCCEEEEEEEEC---------CCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeee
Confidence 334445678999999999999999998764 467889999997553 3346788999999998 79999999
Q ss_pred EEEEEe------CCeeEEEEEecCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeec
Q 011851 193 IGCCIE------DDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLD 265 (476)
Q Consensus 193 ~~~~~~------~~~~~lV~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~ 265 (476)
++++.. .+.+||||||+++++|.+++... ...+++..++.++.||+.||.|||+.+ |+||||||+|||++
T Consensus 87 ~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~ 163 (326)
T 2x7f_A 87 YGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLT 163 (326)
T ss_dssp EEEEEECC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEC
T ss_pred eeEEeeccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEc
Confidence 999987 56899999999999999999754 357999999999999999999999988 99999999999999
Q ss_pred CCCceEEeecCCcCCCCCCCccceeeeeecCCCCCCcchhh-----cCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCC
Q 011851 266 GEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNG 340 (476)
Q Consensus 266 ~~~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~ 340 (476)
.++.+||+|||++........ ......||+.|+|||++. +..++.++|||||||++|+|++|..||.......
T Consensus 164 ~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~ 241 (326)
T 2x7f_A 164 ENAEVKLVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR 241 (326)
T ss_dssp TTCCEEECCCTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHH
T ss_pred CCCCEEEeeCcCceecCcCcc--ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHH
Confidence 999999999999986543211 123467999999999987 5678999999999999999999999996543211
Q ss_pred cchhHHhhhhhhccccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCcccccCcc
Q 011851 341 EHNLVEWARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDMASSS 416 (476)
Q Consensus 341 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~~~~~~ 416 (476)
.. ..... .. .+.+ .....+..+.+||.+||..||.+||++.++++| |||++.....
T Consensus 242 ~~--~~~~~------~~-----~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h----p~~~~~~~~~ 297 (326)
T 2x7f_A 242 AL--FLIPR------NP-----APRL---KSKKWSKKFQSFIESCLVKNHSQRPATEQLMKH----PFIRDQPNER 297 (326)
T ss_dssp HH--HHHHH------SC-----CCCC---SCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTS----HHHHCCTTHH
T ss_pred HH--HHhhc------Cc-----cccC---CccccCHHHHHHHHHHhccChhhCCCHHHHhhC----hHHhhCcccc
Confidence 10 00000 00 0000 011225789999999999999999999999997 9998765543
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-45 Score=356.71 Aligned_cols=257 Identities=25% Similarity=0.393 Sum_probs=207.1
Q ss_pred cCCCccc-cccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCc-cCHHHHHHHHHHHhCCCCCceeeEEEEEEe
Q 011851 121 KSFRPEC-LLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL-QGHKEWLAEVNYLGGLIHPNLVKLIGCCIE 198 (476)
Q Consensus 121 ~~y~~~~-~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~ 198 (476)
++|.+.+ .||+|+||.||+|.+.. ..+++.||||+++.... ...+.+.+|+++|++++||||+++++++ +
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~-------~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~ 80 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRM-------RKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-Q 80 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC----------CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-E
T ss_pred HHhhhhhccccccCceeEEEeEecc-------CCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-c
Confidence 4566666 99999999999997542 23678899999987533 2346788999999999999999999999 5
Q ss_pred CCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCc
Q 011851 199 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLA 278 (476)
Q Consensus 199 ~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a 278 (476)
.+..++||||+++++|.+++......+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 81 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~ 157 (287)
T 1u59_A 81 AEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLS 157 (287)
T ss_dssp SSSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTC
T ss_pred CCCcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccce
Confidence 66799999999999999999777778999999999999999999999988 999999999999999999999999999
Q ss_pred CCCCCCCcc-ceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhhcccc
Q 011851 279 KDGPEGDKT-HVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPQLGERR 356 (476)
Q Consensus 279 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~ 356 (476)
......... .......||+.|+|||++.+..++.++|||||||++|||++ |+.||....... ....... ..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~---~~~~i~~----~~ 230 (287)
T 1u59_A 158 KALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE---VMAFIEQ----GK 230 (287)
T ss_dssp EECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH---HHHHHHT----TC
T ss_pred eeeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH---HHHHHhc----CC
Confidence 876433221 11222457889999999999999999999999999999998 999997654321 1111100 00
Q ss_pred ccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 011851 357 RFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKP 405 (476)
Q Consensus 357 ~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~ 405 (476)
...++...+.++.+||.+||+.||++||++.+++++|+.
T Consensus 231 ----------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~ 269 (287)
T 1u59_A 231 ----------RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRA 269 (287)
T ss_dssp ----------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred ----------cCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 001122336789999999999999999999999999764
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-45 Score=358.68 Aligned_cols=259 Identities=21% Similarity=0.259 Sum_probs=204.6
Q ss_pred ccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCC----ccCHHHHHHHHHHHhCCCCCceeeEEEE
Q 011851 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDG----LQGHKEWLAEVNYLGGLIHPNLVKLIGC 195 (476)
Q Consensus 120 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~----~~~~~~~~~E~~~l~~l~hpnIv~l~~~ 195 (476)
.++|++.+.||+|+||.||+|.+. .+++.||+|++.... ......+.+|+.++++++||||++++++
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~---------~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~ 74 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDS---------ETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDV 74 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBT---------TTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred ccceeEeeEEecCCCeEEEEEEEC---------CCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEE
Confidence 468999999999999999998654 478889999997542 2234678899999999999999999999
Q ss_pred EE--eCCeeEEEEEecCCCCHHHHHhh-cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEE
Q 011851 196 CI--EDDQRLLVYEFMPRGSLENHLFR-RSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKL 272 (476)
Q Consensus 196 ~~--~~~~~~lV~E~~~~g~L~~~l~~-~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl 272 (476)
+. +.+..|+||||++++ |.+++.. ....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||
T Consensus 75 ~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl 150 (305)
T 2wtk_C 75 LYNEEKQKMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKI 150 (305)
T ss_dssp EECC---CEEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEE
T ss_pred EEcCCCCeEEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEe
Confidence 84 456889999999776 7777754 3457999999999999999999999988 999999999999999999999
Q ss_pred eecCCcCCCCCCCccceeeeeecCCCCCCcchhhcCC--CCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhh
Q 011851 273 SDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGH--LTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP 350 (476)
Q Consensus 273 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~ 350 (476)
+|||++................||+.|+|||++.+.. ++.++|||||||++|+|++|+.||...... .......
T Consensus 151 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~~i~- 226 (305)
T 2wtk_C 151 SALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIY---KLFENIG- 226 (305)
T ss_dssp CCCTTCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHH-
T ss_pred eccccccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHH---HHHHHHh-
Confidence 9999998764433333334467999999999988654 478999999999999999999999754321 1111000
Q ss_pred hhccccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCccccc
Q 011851 351 QLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDMA 413 (476)
Q Consensus 351 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~~~ 413 (476)
.... .++...+..+.+||.+||+.||++|||+.++++| |||++..
T Consensus 227 --~~~~------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~----~~~~~~~ 271 (305)
T 2wtk_C 227 --KGSY------------AIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH----SWFRKKH 271 (305)
T ss_dssp --HCCC------------CCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS----HHHHSCC
T ss_pred --cCCC------------CCCCccCHHHHHHHHHHccCChhhCCCHHHHhcC----cccccCC
Confidence 0000 0111225688899999999999999999999997 8877543
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-45 Score=358.25 Aligned_cols=260 Identities=28% Similarity=0.445 Sum_probs=204.1
Q ss_pred ccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCc-cCHHHHHHHHHHHhCCCCCceeeEEEEEE-
Q 011851 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL-QGHKEWLAEVNYLGGLIHPNLVKLIGCCI- 197 (476)
Q Consensus 120 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~- 197 (476)
..+|++.++||+|+||+||+|.+..++ .++..||+|.+..... ...+.+.+|+.++++++||||+++++++.
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~------~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 97 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDND------GKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLR 97 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----------CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECC
T ss_pred ceehhhcceeeecCCceEEEEEEecCC------CceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEc
Confidence 346899999999999999999865322 2455699999976433 23456889999999999999999999865
Q ss_pred eCCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCC
Q 011851 198 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGL 277 (476)
Q Consensus 198 ~~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~ 277 (476)
.++..|+||||+++++|.+++......+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 98 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~ 174 (298)
T 3f66_A 98 SEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGL 174 (298)
T ss_dssp SSSCCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGG
T ss_pred CCCceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECcccc
Confidence 456889999999999999999777778999999999999999999999988 99999999999999999999999999
Q ss_pred cCCCCCCCcc--ceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhhcc
Q 011851 278 AKDGPEGDKT--HVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPQLGE 354 (476)
Q Consensus 278 a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~ 354 (476)
++........ .......||+.|+|||++.+..++.++|||||||++|+|++ |.+||...........+. ..
T Consensus 175 a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~---~~--- 248 (298)
T 3f66_A 175 ARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL---QG--- 248 (298)
T ss_dssp GCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHH---TT---
T ss_pred cccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHh---cC---
Confidence 9875442211 12233568889999999999999999999999999999999 556665443322111110 00
Q ss_pred ccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 011851 355 RRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKP 405 (476)
Q Consensus 355 ~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~ 405 (476)
. ... .+...+..+.+++.+||+.||++|||+.++++.|+.
T Consensus 249 -~---~~~-------~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~ 288 (298)
T 3f66_A 249 -R---RLL-------QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISA 288 (298)
T ss_dssp -C---CCC-------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred -C---CCC-------CCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 0 000 111225689999999999999999999999998764
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=364.73 Aligned_cols=271 Identities=31% Similarity=0.438 Sum_probs=207.5
Q ss_pred CCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCc-cCHHHHHHHHHHHhCCCCCceeeEEEEEEeC--
Q 011851 123 FRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL-QGHKEWLAEVNYLGGLIHPNLVKLIGCCIED-- 199 (476)
Q Consensus 123 y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~-- 199 (476)
|++.+.||+|+||+||++.+. +.+..+++.||||++..... ...+.+.+|+++|++++||||+++++++.+.
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~-----~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 107 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYD-----PTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGA 107 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEEC-----SCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTT
T ss_pred HhhhheecCCCCeEEEEEEEc-----cCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCC
Confidence 489999999999999998765 23445899999999986543 2345688999999999999999999999984
Q ss_pred CeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCcC
Q 011851 200 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAK 279 (476)
Q Consensus 200 ~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~ 279 (476)
..+++||||+++++|.+++... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.
T Consensus 108 ~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~ 182 (318)
T 3lxp_A 108 ASLQLVMEYVPLGSLRDYLPRH--SIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAK 182 (318)
T ss_dssp TEEEEEECCCTTCBHHHHGGGS--CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCE
T ss_pred ceEEEEEecccCCcHHHHHhhC--CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCccccc
Confidence 6789999999999999999654 4899999999999999999999988 9999999999999999999999999998
Q ss_pred CCCCCCcc-ceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhcccccc
Q 011851 280 DGPEGDKT-HVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRRF 358 (476)
Q Consensus 280 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 358 (476)
........ .......||+.|+|||++.+..++.++|||||||++|+|++|..||....... .....+..... ....+
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~-~~~~~~~~~~~-~~~~~ 260 (318)
T 3lxp_A 183 AVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKF-LELIGIAQGQM-TVLRL 260 (318)
T ss_dssp ECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHH-HHHHCSCCHHH-HHHHH
T ss_pred cccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhh-hhhhcccccch-hHHHH
Confidence 76543321 12234568889999999999999999999999999999999999986431100 00000000000 00000
Q ss_pred ccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 011851 359 YRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKP 405 (476)
Q Consensus 359 ~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~ 405 (476)
...+........+...+.++.+||.+||+.||++|||+.++++.|+.
T Consensus 261 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~ 307 (318)
T 3lxp_A 261 TELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKT 307 (318)
T ss_dssp HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHH
Confidence 11111111111223346789999999999999999999999998764
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-45 Score=368.12 Aligned_cols=255 Identities=18% Similarity=0.176 Sum_probs=203.7
Q ss_pred HhccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCCC---CCceeeEEE
Q 011851 118 SATKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLI---HPNLVKLIG 194 (476)
Q Consensus 118 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~---hpnIv~l~~ 194 (476)
...++|++.++||+|+||+||+|.+... .+..+++.||||++.... ..++..|++++..++ |+||+.+++
T Consensus 62 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~----~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~l~~~~~~~iv~~~~ 134 (365)
T 3e7e_A 62 LGSKLVYVHHLLGEGAFAQVYEATQGDL----NDAKNKQKFVLKVQKPAN---PWEFYIGTQLMERLKPSMQHMFMKFYS 134 (365)
T ss_dssp CSSSEEEEEEEEEECSSEEEEEEEC-----------CCCCEEEEEESSCC---HHHHHHHHHHHHHSCGGGGGGBCCEEE
T ss_pred ECCEEEEEEEEeeccCCEEEEEEEecCC----cccccCcEEEEEEeCCCC---hhHHHHHHHHHHHhhhhhhhhhhhhhe
Confidence 3456799999999999999999964321 133578899999997643 456777788777776 999999999
Q ss_pred EEEeCCeeEEEEEecCCCCHHHHHhh----cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecC----
Q 011851 195 CCIEDDQRLLVYEFMPRGSLENHLFR----RSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDG---- 266 (476)
Q Consensus 195 ~~~~~~~~~lV~E~~~~g~L~~~l~~----~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~---- 266 (476)
++..++..|||||||++|+|.+++.. ....+++..++.++.||+.||+|||+++ ||||||||+||||+.
T Consensus 135 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~ 211 (365)
T 3e7e_A 135 AHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLE 211 (365)
T ss_dssp EEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTC
T ss_pred eeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccC
Confidence 99999999999999999999999964 3567999999999999999999999988 999999999999988
Q ss_pred -------CCceEEeecCCcCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCC
Q 011851 267 -------EYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPN 339 (476)
Q Consensus 267 -------~~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~ 339 (476)
++.+||+|||+++..............+||+.|+|||++.+..|+.++|||||||++|||+||+.||......
T Consensus 212 ~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~ 291 (365)
T 3e7e_A 212 QDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGG 291 (365)
T ss_dssp C------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETT
T ss_pred ccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCC
Confidence 8999999999997543222333345578999999999999999999999999999999999999999643221
Q ss_pred CcchhHHhhhhhhccccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCC-CCHHHHHHHhc
Q 011851 340 GEHNLVEWARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKAR-PRMSEVVEALK 404 (476)
Q Consensus 340 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~R-Pt~~ell~~L~ 404 (476)
.. . +...+... ...+.+.+++..||+.+|.+| |++.++.+.|+
T Consensus 292 ~~---------------~----~~~~~~~~---~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~ 335 (365)
T 3e7e_A 292 EC---------------K----PEGLFRRL---PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLK 335 (365)
T ss_dssp EE---------------E----ECSCCTTC---SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHH
T ss_pred ce---------------e----echhcccc---CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHH
Confidence 00 0 00111111 115678899999999999999 56777777665
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-45 Score=390.94 Aligned_cols=256 Identities=25% Similarity=0.392 Sum_probs=203.3
Q ss_pred CCCccc-cccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCc-cCHHHHHHHHHHHhCCCCCceeeEEEEEEeC
Q 011851 122 SFRPEC-LLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL-QGHKEWLAEVNYLGGLIHPNLVKLIGCCIED 199 (476)
Q Consensus 122 ~y~~~~-~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~ 199 (476)
++.+.+ .||+|+||.||+|.+... .++..||||+++.... ...+++.+|+++|++++|||||++++++..
T Consensus 336 ~~~~~~~~LG~G~fG~Vy~~~~~~~-------~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~- 407 (613)
T 2ozo_A 336 NLLIADIELGCGNFGSVRQGVYRMR-------KKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA- 407 (613)
T ss_dssp SEEEEEEEEEECSSSEEEEEEEECS-------SCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-
T ss_pred ceeEcCcEEecCCCcEEEEEEEecC-------CCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-
Confidence 344444 799999999999976532 3567799999986533 346789999999999999999999999876
Q ss_pred CeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCcC
Q 011851 200 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAK 279 (476)
Q Consensus 200 ~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~ 279 (476)
+.+|||||||++|+|.+++......+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++
T Consensus 408 ~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~ 484 (613)
T 2ozo_A 408 EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSK 484 (613)
T ss_dssp SSEEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTT
T ss_pred CCeEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCcc
Confidence 5799999999999999999777778999999999999999999999988 9999999999999999999999999998
Q ss_pred CCCCCCcc-ceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhhccccc
Q 011851 280 DGPEGDKT-HVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPQLGERRR 357 (476)
Q Consensus 280 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 357 (476)
........ .......+|+.|+|||++.+..++.++|||||||++|||++ |+.||........ ..... ....
T Consensus 485 ~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~---~~~i~----~~~~ 557 (613)
T 2ozo_A 485 ALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEV---MAFIE----QGKR 557 (613)
T ss_dssp TCC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHH---HHHHH----TTCC
T ss_pred cccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHH---HHHHH----cCCC
Confidence 76433221 11122346789999999999999999999999999999998 9999986543221 11111 0000
Q ss_pred cccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 011851 358 FYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKP 405 (476)
Q Consensus 358 ~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~ 405 (476)
..++...+.++.+||.+||+.||++||++.+|++.|+.
T Consensus 558 ----------~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~ 595 (613)
T 2ozo_A 558 ----------MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRA 595 (613)
T ss_dssp ----------CCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHH
T ss_pred ----------CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 01122336789999999999999999999999998764
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=358.34 Aligned_cols=260 Identities=24% Similarity=0.322 Sum_probs=193.7
Q ss_pred ccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccC-H-HHHHHHHHHHhCCCCCceeeEEEEEE
Q 011851 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQG-H-KEWLAEVNYLGGLIHPNLVKLIGCCI 197 (476)
Q Consensus 120 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~-~-~~~~~E~~~l~~l~hpnIv~l~~~~~ 197 (476)
.++|++.+.||+|+||.||+|.+. .+|+.||||++....... . +.+.++...++.++||||+++++++.
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~ 76 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHV---------PSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALF 76 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET---------TTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEec---------CCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeee
Confidence 457999999999999999998754 468889999997653222 2 23445555688899999999999999
Q ss_pred eCCeeEEEEEecCCCCHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeEecCCCCCCeeecCCCceEEe
Q 011851 198 EDDQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALDAAKGLAFLHEE-AEKPVIYRDFKTSNILLDGEYNAKLS 273 (476)
Q Consensus 198 ~~~~~~lV~E~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~al~~lH~~-~~~~ivHrDlKp~NILl~~~~~vkl~ 273 (476)
+++..|+||||++ ++|.+++.. ....+++..++.++.||+.||.|||++ + |+||||||+|||++.++.+||+
T Consensus 77 ~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~ 152 (290)
T 3fme_A 77 REGDVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMC 152 (290)
T ss_dssp CSSSEEEEEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBC
T ss_pred ccCCEEEEEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEe
Confidence 9999999999996 588777653 466899999999999999999999997 8 9999999999999999999999
Q ss_pred ecCCcCCCCCCCccceeeeeecCCCCCCcchh----hcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhh
Q 011851 274 DFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYV----MTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR 349 (476)
Q Consensus 274 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~ 349 (476)
|||++........ .....||+.|+|||++ .+..++.++|||||||++|+|++|+.||........ .+.....
T Consensus 153 Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~~ 228 (290)
T 3fme_A 153 DFGISGYLVDDVA---KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQ-QLKQVVE 228 (290)
T ss_dssp CC------------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHH-HHHHHHH
T ss_pred ecCCccccccccc---ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHH-HHHHHhc
Confidence 9999987543222 2235799999999996 456789999999999999999999999975322111 1111000
Q ss_pred hhhccccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCcccccC
Q 011851 350 PQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDMAS 414 (476)
Q Consensus 350 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~~~~ 414 (476)
. . .........+.++.+||.+||+.||++|||+.++++| |||+....
T Consensus 229 ~---~-----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~h----p~f~~~~~ 275 (290)
T 3fme_A 229 E---P-----------SPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQH----PFFTLHES 275 (290)
T ss_dssp S---C-----------CCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTS----HHHHHHHH
T ss_pred c---C-----------CCCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHhC----cccccCcc
Confidence 0 0 0000111235789999999999999999999999987 99886543
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=352.94 Aligned_cols=262 Identities=19% Similarity=0.205 Sum_probs=203.7
Q ss_pred hccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCCCCCceeeEEEE-EE
Q 011851 119 ATKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHPNLVKLIGC-CI 197 (476)
Q Consensus 119 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~-~~ 197 (476)
..++|++.+.||+|+||.||+|.+. .+++.||||++...... .++.+|+.+++.+.|++++..+.+ +.
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vavK~~~~~~~~--~~~~~e~~~l~~l~~~~~i~~~~~~~~ 75 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDI---------AAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGA 75 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEET---------TTTEEEEEEEEEC---C--CCHHHHHHHHHHHTTSTTCCCEEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEc---------CCCceEEEEeecccccc--hHHHHHHHHHHHhcCCCCCCeeeeecC
Confidence 4568999999999999999998654 46788999987654332 357789999999988776665555 46
Q ss_pred eCCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeee---cCCCceEEee
Q 011851 198 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILL---DGEYNAKLSD 274 (476)
Q Consensus 198 ~~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl---~~~~~vkl~D 274 (476)
+.+..++||||+ +++|.+++......+++..++.++.||+.||.|||+++ |+||||||+|||+ +.++.+||+|
T Consensus 76 ~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~D 151 (296)
T 4hgt_A 76 EGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIID 151 (296)
T ss_dssp ETTEEEEEEECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECC
T ss_pred CCCceEEEEEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEec
Confidence 778889999999 99999999766778999999999999999999999988 9999999999999 7889999999
Q ss_pred cCCcCCCCCCCcc-----ceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhh
Q 011851 275 FGLAKDGPEGDKT-----HVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR 349 (476)
Q Consensus 275 FG~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~ 349 (476)
||+++........ .......||+.|+|||++.+..++.++|||||||++|+|++|+.||................
T Consensus 152 fg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~ 231 (296)
T 4hgt_A 152 FGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERIS 231 (296)
T ss_dssp CTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHH
T ss_pred CccceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhh
Confidence 9999865443221 11234679999999999999999999999999999999999999998765544333222111
Q ss_pred hhhccccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 011851 350 PQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKP 405 (476)
Q Consensus 350 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~ 405 (476)
...... ... .+ ....+.++.+||.+||+.||++|||+.++++.|+.
T Consensus 232 ~~~~~~-----~~~-~~----~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (296)
T 4hgt_A 232 EKKMST-----PIE-VL----CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRN 277 (296)
T ss_dssp HHHHHS-----CHH-HH----TTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHH
T ss_pred cccccc-----hhh-hh----hccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHH
Confidence 110000 000 00 01125689999999999999999999999998764
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=353.50 Aligned_cols=251 Identities=24% Similarity=0.324 Sum_probs=202.6
Q ss_pred cCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCcc--CHHHHHHHHHHHhCCCCCceeeEEEEEEe
Q 011851 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQ--GHKEWLAEVNYLGGLIHPNLVKLIGCCIE 198 (476)
Q Consensus 121 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~l~~~~~~ 198 (476)
++|++.+.||+|+||.||+|.+. +..||||++...... ..+.+.+|+.+|++++||||+++++++.+
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~-----------~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 78 (271)
T 3kmu_A 10 KQLNFLTKLNENHSGELWKGRWQ-----------GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQS 78 (271)
T ss_dssp GGCEEEEEEEEETTEEEEEEEET-----------TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECT
T ss_pred HHhHHHHHhcCCCcceEEEEEEC-----------CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEcc
Confidence 46999999999999999999763 667999999765432 24568899999999999999999999988
Q ss_pred C--CeeEEEEEecCCCCHHHHHhhcCC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeec
Q 011851 199 D--DQRLLVYEFMPRGSLENHLFRRSL-PLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDF 275 (476)
Q Consensus 199 ~--~~~~lV~E~~~~g~L~~~l~~~~~-~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DF 275 (476)
. +..++||||+++++|.+++..... .+++..++.++.||+.||.|||+++ ..|+||||||+|||++.++.++|+||
T Consensus 79 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~ 157 (271)
T 3kmu_A 79 PPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMA 157 (271)
T ss_dssp TTSSSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGG
T ss_pred CCCCCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEec
Confidence 7 788999999999999999976433 5899999999999999999999865 44999999999999999999999999
Q ss_pred CCcCCCCCCCccceeeeeecCCCCCCcchhhcCCCCc---cchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhh
Q 011851 276 GLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTA---KSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQL 352 (476)
Q Consensus 276 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~ 352 (476)
|++..... ....||+.|+|||++.+..++. ++|||||||++|||++|+.||.......... ...
T Consensus 158 ~~~~~~~~-------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~------~~~ 224 (271)
T 3kmu_A 158 DVKFSFQS-------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGM------KVA 224 (271)
T ss_dssp GSCCTTSC-------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHH------HHH
T ss_pred cceeeecc-------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHH------HHH
Confidence 98765322 1246899999999998765544 7999999999999999999997543211100 000
Q ss_pred ccccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011851 353 GERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPL 406 (476)
Q Consensus 353 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~ 406 (476)
.. ......+...+.++.+|+.+||+.||++|||+.++++.|+.+
T Consensus 225 ~~----------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l 268 (271)
T 3kmu_A 225 LE----------GLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKM 268 (271)
T ss_dssp HS----------CCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred hc----------CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHh
Confidence 00 000111222367899999999999999999999999987643
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-46 Score=373.55 Aligned_cols=260 Identities=14% Similarity=0.067 Sum_probs=190.2
Q ss_pred cCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCcc---CHHHHHHH---HHHHhCCCCCceeeEE-
Q 011851 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQ---GHKEWLAE---VNYLGGLIHPNLVKLI- 193 (476)
Q Consensus 121 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~---~~~~~~~E---~~~l~~l~hpnIv~l~- 193 (476)
..|++.+.||+|+||.||+|.+. .+|+.||||++...... ..+.+.+| +.+|+. +||||++++
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~---------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~ 131 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDV---------ERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRR 131 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEET---------TTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------
T ss_pred eeeeeeeeccCCCCEEEEEEEEC---------CCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhce
Confidence 45899999999999999998764 46788999999876542 23456677 556666 799988765
Q ss_pred ------EEEEeCC-----------------eeEEEEEecCCCCHHHHHhhcCCCCCHHHH------HHHHHHHHHHHHHH
Q 011851 194 ------GCCIEDD-----------------QRLLVYEFMPRGSLENHLFRRSLPLPWSIR------MKIALDAAKGLAFL 244 (476)
Q Consensus 194 ------~~~~~~~-----------------~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~------~~i~~qi~~al~~l 244 (476)
+++...+ .+|||||||+ ++|.+++...+..+++..+ ..++.||+.||.||
T Consensus 132 ~~~~p~d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~L 210 (371)
T 3q60_A 132 RLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANL 210 (371)
T ss_dssp CBCCCCEEEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred eEEeeehheecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHH
Confidence 5555433 3899999998 8999999765445566666 78889999999999
Q ss_pred HhcCCCCeEecCCCCCCeeecCCCceEEeecCCcCCCCCCCccceeeeeecCCCCCCcchhhc--CCCCccchhhhhHHH
Q 011851 245 HEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT--GHLTAKSDVYSFGVV 322 (476)
Q Consensus 245 H~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslGv~ 322 (476)
|+++ |+||||||+||||+.++.+||+|||+++..... .....+|+.|+|||++.+ ..|+.++|||||||+
T Consensus 211 H~~~---ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~i 282 (371)
T 3q60_A 211 QSKG---LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR-----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLS 282 (371)
T ss_dssp HHTT---EEETTCSGGGEEECTTSCEEECCGGGEEETTCE-----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHH
T ss_pred HHCC---CccCcCCHHHEEECCCCCEEEEecceeeecCCC-----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHH
Confidence 9988 999999999999999999999999999865321 113567799999999987 689999999999999
Q ss_pred HHHHHhCCCCCCCCCCCCcchhHHhhhhhhccccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011851 323 LLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEA 402 (476)
Q Consensus 323 l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~ 402 (476)
+|||++|+.||............ ..... ......+........+..+.+||.+||+.||++|||+.++++|
T Consensus 283 l~elltg~~Pf~~~~~~~~~~~~---~~~~~------~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 353 (371)
T 3q60_A 283 IYRVWCLFLPFGLVTPGIKGSWK---RPSLR------VPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMET 353 (371)
T ss_dssp HHHHHHSSCSTTBCCTTCTTCCC---BCCTT------SCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTS
T ss_pred HHHHHhCCCCCCCcCcccccchh---hhhhh------hccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 99999999999866433211100 00000 0000000000111236789999999999999999999999987
Q ss_pred hcCCCCcccc
Q 011851 403 LKPLPYLKDM 412 (476)
Q Consensus 403 L~~~~~~~~~ 412 (476)
|||+++
T Consensus 354 ----p~f~~~ 359 (371)
T 3q60_A 354 ----PEFLQL 359 (371)
T ss_dssp ----HHHHHH
T ss_pred ----HHHHHH
Confidence 998865
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-45 Score=371.08 Aligned_cols=272 Identities=23% Similarity=0.276 Sum_probs=211.4
Q ss_pred ccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCc-cCHHHHHHHHHHHhCCCCCceeeEEEEEEe
Q 011851 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL-QGHKEWLAEVNYLGGLIHPNLVKLIGCCIE 198 (476)
Q Consensus 120 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~ 198 (476)
.++|++.++||+|+||+||+|.+. .+|+.||||++..... ...+.+.+|+++|++++||||+++++++.+
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~ 78 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHK---------KTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEE 78 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEET---------TTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred CCceEEEEEEEcCCCeEEEEEEEC---------CCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeecc
Confidence 457999999999999999998765 4688899999976433 345678899999999999999999999987
Q ss_pred CC--eeEEEEEecCCCCHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeee----cCCCce
Q 011851 199 DD--QRLLVYEFMPRGSLENHLFRR--SLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILL----DGEYNA 270 (476)
Q Consensus 199 ~~--~~~lV~E~~~~g~L~~~l~~~--~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl----~~~~~v 270 (476)
.+ ..|||||||++++|.+++... ...+++..++.++.||+.||.|||+.+ |+||||||+|||+ +.++.+
T Consensus 79 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~ 155 (396)
T 4eut_A 79 TTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVY 155 (396)
T ss_dssp TTTCCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEE
T ss_pred CCCCeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeE
Confidence 65 789999999999999999653 234999999999999999999999988 9999999999999 778889
Q ss_pred EEeecCCcCCCCCCCccceeeeeecCCCCCCcchhhc--------CCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcc
Q 011851 271 KLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT--------GHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEH 342 (476)
Q Consensus 271 kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~ 342 (476)
||+|||+++....... ....+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.........
T Consensus 156 kL~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~ 232 (396)
T 4eut_A 156 KLTDFGAARELEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN 232 (396)
T ss_dssp EECCGGGCEECCCGGG---SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTC
T ss_pred EEecCCCceEccCCCc---cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccch
Confidence 9999999987644221 234679999999999875 56788999999999999999999999754332221
Q ss_pred -hhHHhhhhhhcc--ccccc-------ccc-CcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011851 343 -NLVEWARPQLGE--RRRFY-------RLI-DPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPL 406 (476)
Q Consensus 343 -~~~~~~~~~~~~--~~~~~-------~~~-d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~ 406 (476)
..+......... ...+. .+. +......+....+..+.+++.+||+.||++||++.++++.+..+
T Consensus 233 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~i 307 (396)
T 4eut_A 233 KEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307 (396)
T ss_dssp HHHHHHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred HHHHHHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHH
Confidence 111111100000 00000 000 00112234456788999999999999999999999999987643
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=377.64 Aligned_cols=262 Identities=21% Similarity=0.237 Sum_probs=210.0
Q ss_pred ccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCCCC-CceeeEEEEEEe
Q 011851 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIH-PNLVKLIGCCIE 198 (476)
Q Consensus 120 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~h-pnIv~l~~~~~~ 198 (476)
.++|++.++||+|+||.||+|.+. .+++.||||++...... .++.+|+++++.|.| ++|..+..++.+
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~---------~~~~~vAvK~~~~~~~~--~~~~~E~~il~~L~~~~~i~~i~~~~~~ 74 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNI---------QTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRWFGVE 74 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEET---------TTCCEEEEEEEETTCSS--CCHHHHHHHHHHTTTSTTCCCEEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEEC---------CCCcEEEEEEecccccc--HHHHHHHHHHHHhcCCCCCCeEEEEEee
Confidence 467999999999999999998754 46788999998765432 457889999999986 666777777788
Q ss_pred CCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeee---cCCCceEEeec
Q 011851 199 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILL---DGEYNAKLSDF 275 (476)
Q Consensus 199 ~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl---~~~~~vkl~DF 275 (476)
.+..||||||+ +++|.+++......+++..++.|+.||+.||.|||+++ ||||||||+|||| +.++.+||+||
T Consensus 75 ~~~~~lvme~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DF 150 (483)
T 3sv0_A 75 GDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDF 150 (483)
T ss_dssp TTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCC
T ss_pred CCEEEEEEECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeC
Confidence 88999999999 99999999776778999999999999999999999988 9999999999999 68899999999
Q ss_pred CCcCCCCCCCcc-----ceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhh
Q 011851 276 GLAKDGPEGDKT-----HVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP 350 (476)
Q Consensus 276 G~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~ 350 (476)
|+++........ ......+||+.|+|||++.+..++.++|||||||+||||++|+.||...........+.....
T Consensus 151 Gla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~ 230 (483)
T 3sv0_A 151 GLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISE 230 (483)
T ss_dssp TTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHH
T ss_pred CcceeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhh
Confidence 999875443221 112247899999999999999999999999999999999999999987655433332221111
Q ss_pred hhccccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011851 351 QLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPL 406 (476)
Q Consensus 351 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~ 406 (476)
... ...+..... ..+.++.+||.+||+.||++||++.+|++.|+.+
T Consensus 231 ~~~-----~~~~~~l~~-----~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l 276 (483)
T 3sv0_A 231 KKV-----ATSIEALCR-----GYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDL 276 (483)
T ss_dssp HHH-----HSCHHHHHT-----TSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred ccc-----cccHHHHhc-----CCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 100 000111011 1157899999999999999999999999987754
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-45 Score=354.83 Aligned_cols=259 Identities=25% Similarity=0.360 Sum_probs=204.7
Q ss_pred CCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCc-cCHHHHHHHHHHHhCCCCCceeeEEEEEEeCC
Q 011851 122 SFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL-QGHKEWLAEVNYLGGLIHPNLVKLIGCCIEDD 200 (476)
Q Consensus 122 ~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 200 (476)
.|.+.++||+|+||+||+|.+..+. .++..||+|++..... ...+.+.+|+.+|++++||||+++++++.+.+
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~------~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 95 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQA------QNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPE 95 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSS------SCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSS
T ss_pred EEccCceeccCCCceEEEEEEecCC------CceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCC
Confidence 4677799999999999999865332 2455799999976433 23457889999999999999999999998766
Q ss_pred ee-EEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCcC
Q 011851 201 QR-LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAK 279 (476)
Q Consensus 201 ~~-~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~ 279 (476)
.. ++||||+.+++|.+++......+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 96 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~ 172 (298)
T 3pls_A 96 GLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLAR 172 (298)
T ss_dssp SCCEEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSC
T ss_pred CCcEEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCcc
Confidence 65 9999999999999999776778999999999999999999999988 9999999999999999999999999998
Q ss_pred CCCCCCc--cceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhccccc
Q 011851 280 DGPEGDK--THVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRR 357 (476)
Q Consensus 280 ~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 357 (476)
....... ........+|+.|+|||++.+..++.++|||||||++|+|++|..|+...... ...........
T Consensus 173 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~--~~~~~~~~~~~----- 245 (298)
T 3pls_A 173 DILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDP--FDLTHFLAQGR----- 245 (298)
T ss_dssp TTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCG--GGHHHHHHTTC-----
T ss_pred cccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCH--HHHHHHhhcCC-----
Confidence 6543221 11122356889999999999999999999999999999999966554332221 11111111000
Q ss_pred cccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 011851 358 FYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKP 405 (476)
Q Consensus 358 ~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~ 405 (476)
....+...+..+.+|+.+||+.||.+|||+.++++.|+.
T Consensus 246 ---------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~ 284 (298)
T 3pls_A 246 ---------RLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQ 284 (298)
T ss_dssp ---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ---------CCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 000111225789999999999999999999999998764
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=351.31 Aligned_cols=261 Identities=20% Similarity=0.225 Sum_probs=207.2
Q ss_pred ccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCCCCCceeeEEEE-EEe
Q 011851 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHPNLVKLIGC-CIE 198 (476)
Q Consensus 120 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~-~~~ 198 (476)
.++|++.+.||+|+||.||+|.+. .+|+.||||++..... ..++.+|+.+++.+.|++++..+.+ +.+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~ 76 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDI---------AAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAE 76 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEET---------TTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEc---------CCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCC
Confidence 468999999999999999998754 4688899999876543 2468899999999998876655554 466
Q ss_pred CCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeee---cCCCceEEeec
Q 011851 199 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILL---DGEYNAKLSDF 275 (476)
Q Consensus 199 ~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl---~~~~~vkl~DF 275 (476)
.+..++||||+ +++|.+++......+++..++.++.||+.||.|||+++ |+||||||+|||+ +.++.+||+||
T Consensus 77 ~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Df 152 (296)
T 3uzp_A 77 GDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDF 152 (296)
T ss_dssp TTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCC
T ss_pred CCceEEEEEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeC
Confidence 77889999999 99999999766678999999999999999999999988 9999999999999 48889999999
Q ss_pred CCcCCCCCCCcc-----ceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhh
Q 011851 276 GLAKDGPEGDKT-----HVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP 350 (476)
Q Consensus 276 G~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~ 350 (476)
|++......... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.................
T Consensus 153 g~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 232 (296)
T 3uzp_A 153 GLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISE 232 (296)
T ss_dssp TTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHH
T ss_pred CCcccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcc
Confidence 999865443221 112346799999999999999999999999999999999999999987554333322221111
Q ss_pred -hhccccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011851 351 -QLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPL 406 (476)
Q Consensus 351 -~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~ 406 (476)
..... . +.+ ....+.++.+|+.+||+.||++|||+.++++.|+.+
T Consensus 233 ~~~~~~------~-~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~ 278 (296)
T 3uzp_A 233 KKMSTP------I-EVL----CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 278 (296)
T ss_dssp HHHHSC------H-HHH----TTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHH
T ss_pred cccCCc------h-HHH----HhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHH
Confidence 11000 0 000 011257899999999999999999999999987643
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=356.41 Aligned_cols=259 Identities=27% Similarity=0.383 Sum_probs=196.9
Q ss_pred ccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCcc---CHHHHHHHHHHHhCCCCCceeeEEEEE
Q 011851 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQ---GHKEWLAEVNYLGGLIHPNLVKLIGCC 196 (476)
Q Consensus 120 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~---~~~~~~~E~~~l~~l~hpnIv~l~~~~ 196 (476)
..+|++.+.||+|+||.||+|.+. .+|+.||||++...... ....+.+|+.+|++++||||+++++++
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~---------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 101 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACL---------LDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASF 101 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEET---------TTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred ccceEEEEeecCCCCceEEEEEEc---------CCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 346999999999999999998754 46788999999764332 245688999999999999999999999
Q ss_pred EeCCeeEEEEEecCCCCHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEe
Q 011851 197 IEDDQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLS 273 (476)
Q Consensus 197 ~~~~~~~lV~E~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~ 273 (476)
.+++..++||||+++++|.+++.. ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+
T Consensus 102 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~ 178 (310)
T 2wqm_A 102 IEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLG 178 (310)
T ss_dssp EETTEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEEC
T ss_pred EcCCcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEE
Confidence 999999999999999999999864 3567999999999999999999999988 9999999999999999999999
Q ss_pred ecCCcCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhc
Q 011851 274 DFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLG 353 (476)
Q Consensus 274 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~ 353 (476)
|||++........ ......||+.|+|||++.+..++.++|||||||++|+|++|+.||........ .......
T Consensus 179 Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~~---- 251 (310)
T 2wqm_A 179 DLGLGRFFSSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY-SLCKKIE---- 251 (310)
T ss_dssp CC--------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHH-HHHHHHH----
T ss_pred eccceeeecCCCc--cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHH-HHHHHhh----
Confidence 9999986543221 12345799999999999999999999999999999999999999975432211 1111000
Q ss_pred cccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011851 354 ERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPL 406 (476)
Q Consensus 354 ~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~ 406 (476)
. ..+. +.. ....+.++.+||.+||+.||++|||+.+++++|+.+
T Consensus 252 ~-~~~~----~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l 295 (310)
T 2wqm_A 252 Q-CDYP----PLP----SDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRM 295 (310)
T ss_dssp T-TCSC----CCC----TTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred c-ccCC----CCc----ccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 0 0000 000 112257899999999999999999999999987543
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-45 Score=370.87 Aligned_cols=259 Identities=29% Similarity=0.448 Sum_probs=197.4
Q ss_pred cCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCc-cCHHHHHHHHHHHhCCCCCceeeEEEEEEe-
Q 011851 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL-QGHKEWLAEVNYLGGLIHPNLVKLIGCCIE- 198 (476)
Q Consensus 121 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~- 198 (476)
..|++.++||+|+||+||+|.+...+ ..+..||+|.++.... ...+++.+|+.+|++++||||+++++++.+
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~ 162 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDND------GKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS 162 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETT------TEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCC
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCC------CcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcC
Confidence 34778899999999999999875321 2345699999875432 334678999999999999999999998754
Q ss_pred CCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCc
Q 011851 199 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLA 278 (476)
Q Consensus 199 ~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a 278 (476)
++..|+||||+++++|.+++......+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||++
T Consensus 163 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a 239 (373)
T 3c1x_A 163 EGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLA 239 (373)
T ss_dssp SSCCEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC---
T ss_pred CCCeEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeecccc
Confidence 56889999999999999999777777999999999999999999999988 999999999999999999999999999
Q ss_pred CCCCCCCcc--ceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhhccc
Q 011851 279 KDGPEGDKT--HVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPQLGER 355 (476)
Q Consensus 279 ~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~ 355 (476)
+........ .......+|+.|+|||++.+..++.++|||||||++|||++ |.+||...........+. . .
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~---~----~ 312 (373)
T 3c1x_A 240 RDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL---Q----G 312 (373)
T ss_dssp ------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHH---T----T
T ss_pred ccccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHH---c----C
Confidence 865432211 11233567889999999999999999999999999999999 677786554332211111 0 0
Q ss_pred cccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 011851 356 RRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKP 405 (476)
Q Consensus 356 ~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~ 405 (476)
. ... .+...+..+.+++.+||+.||++|||+.+++++|+.
T Consensus 313 ~---~~~-------~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~ 352 (373)
T 3c1x_A 313 R---RLL-------QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISA 352 (373)
T ss_dssp C---CCC-------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred C---CCC-------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 0 000 111225789999999999999999999999998764
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-45 Score=359.91 Aligned_cols=258 Identities=22% Similarity=0.237 Sum_probs=198.4
Q ss_pred ccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccC---HHHHHHHHHHHhCCCCCceeeEEEEE
Q 011851 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQG---HKEWLAEVNYLGGLIHPNLVKLIGCC 196 (476)
Q Consensus 120 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~---~~~~~~E~~~l~~l~hpnIv~l~~~~ 196 (476)
.++|++.+.||+|+||.||+|.+. .+++.||||++....... .+.+.+|+.++++++||||+++++++
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~ 103 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDT---------VRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFG 103 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEET---------TTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEc---------CCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEE
Confidence 467999999999999999998654 467889999997654333 35688999999999999999999999
Q ss_pred EeCCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecC
Q 011851 197 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFG 276 (476)
Q Consensus 197 ~~~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG 276 (476)
.+++..|+||||+++++|.+++... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 104 ~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg 179 (309)
T 2h34_A 104 EIDGQLYVDMRLINGVDLAAMLRRQ-GPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFG 179 (309)
T ss_dssp EETTEEEEEEECCCCEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCC
T ss_pred eeCCeEEEEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCc
Confidence 9999999999999999999999654 46999999999999999999999988 9999999999999999999999999
Q ss_pred CcCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhcccc
Q 011851 277 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERR 356 (476)
Q Consensus 277 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~ 356 (476)
++........ .......||+.|+|||++.+..++.++||||||+++|+|++|+.||...... ..... +....
T Consensus 180 ~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~~~~----~~~~~ 251 (309)
T 2h34_A 180 IASATTDEKL-TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS---VMGAH----INQAI 251 (309)
T ss_dssp C-----------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH---HHHHH----HHSCC
T ss_pred cCcccccccc-ccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH---HHHHH----hccCC
Confidence 9986544221 1223467999999999999999999999999999999999999999754221 11110 00000
Q ss_pred ccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHhcCC
Q 011851 357 RFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARP-RMSEVVEALKPL 406 (476)
Q Consensus 357 ~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RP-t~~ell~~L~~~ 406 (476)
... .......+.++.+||.+||+.||++|| +++++++.|+..
T Consensus 252 ~~~--------~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~ 294 (309)
T 2h34_A 252 PRP--------STVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAA 294 (309)
T ss_dssp CCG--------GGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHT
T ss_pred CCc--------cccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHH
Confidence 000 001122356788999999999999999 999999987643
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-45 Score=356.27 Aligned_cols=257 Identities=28% Similarity=0.399 Sum_probs=204.0
Q ss_pred ccCCCccc-cccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccC--HHHHHHHHHHHhCCCCCceeeEEEEE
Q 011851 120 TKSFRPEC-LLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQG--HKEWLAEVNYLGGLIHPNLVKLIGCC 196 (476)
Q Consensus 120 ~~~y~~~~-~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~--~~~~~~E~~~l~~l~hpnIv~l~~~~ 196 (476)
.++|.+.+ .||+|+||.||+|.+. ...+++.||||+++...... .+++.+|+++++.++||||+++++++
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~-------~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 87 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQ-------MKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC 87 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEE-------CSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred chhhhhccCccccccCeeeEeeeec-------CCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 45688888 9999999999999654 22467889999997654322 46788999999999999999999998
Q ss_pred EeCCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecC
Q 011851 197 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFG 276 (476)
Q Consensus 197 ~~~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG 276 (476)
+.+..|+||||+++++|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 88 -~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg 162 (291)
T 1xbb_A 88 -EAESWMLVMEMAELGPLNKYLQQ-NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFG 162 (291)
T ss_dssp -ESSSEEEEEECCTTEEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCT
T ss_pred -CCCCcEEEEEeCCCCCHHHHHHh-CcCCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCC
Confidence 66789999999999999999965 456999999999999999999999988 9999999999999999999999999
Q ss_pred CcCCCCCCCccc-eeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhhcc
Q 011851 277 LAKDGPEGDKTH-VSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPQLGE 354 (476)
Q Consensus 277 ~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~ 354 (476)
++.......... ......+|+.|+|||++.+..++.++|||||||++|+|++ |+.||....... +...... ..
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~~~~~~--~~ 237 (291)
T 1xbb_A 163 LSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE---VTAMLEK--GE 237 (291)
T ss_dssp TCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH---HHHHHHT--TC
T ss_pred cceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHH---HHHHHHc--CC
Confidence 998764433221 1222456788999999999999999999999999999999 999997643321 1111100 00
Q ss_pred ccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 011851 355 RRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKP 405 (476)
Q Consensus 355 ~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~ 405 (476)
...++...+..+.+||.+||+.||++||++.++++.|+.
T Consensus 238 ------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~ 276 (291)
T 1xbb_A 238 ------------RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN 276 (291)
T ss_dssp ------------CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred ------------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 001122336789999999999999999999999998764
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-45 Score=367.41 Aligned_cols=270 Identities=23% Similarity=0.279 Sum_probs=198.2
Q ss_pred ccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCc--cCHHHHHHHHHHHhCCCCCceeeEEEEEE
Q 011851 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL--QGHKEWLAEVNYLGGLIHPNLVKLIGCCI 197 (476)
Q Consensus 120 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~ 197 (476)
.++|++.+.||+|+||.||+|.+. .+++.||||++..... ...+.+.+|+.+|+.++||||+++++++.
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~---------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 94 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDA---------ILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFT 94 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEET---------TTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred hhheeEeeeeEecCCEEEEEEEEC---------CCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeec
Confidence 468999999999999999998654 4678899999976432 22356789999999999999999999998
Q ss_pred eCC------eeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceE
Q 011851 198 EDD------QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAK 271 (476)
Q Consensus 198 ~~~------~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vk 271 (476)
..+ ..||||||++ ++|.+.+. ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+|
T Consensus 95 ~~~~~~~~~~~~lv~e~~~-~~l~~~~~---~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~k 167 (371)
T 2xrw_A 95 PQKSLEEFQDVYIVMELMD-ANLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLK 167 (371)
T ss_dssp SCCSTTTCCEEEEEEECCS-EEHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEE
T ss_pred cccccccccceEEEEEcCC-CCHHHHHh---hccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEE
Confidence 765 7899999996 47888884 34899999999999999999999988 99999999999999999999
Q ss_pred EeecCCcCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhh---
Q 011851 272 LSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA--- 348 (476)
Q Consensus 272 l~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~--- 348 (476)
|+|||+++...... .....+||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+...
T Consensus 168 l~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~ 244 (371)
T 2xrw_A 168 ILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGT 244 (371)
T ss_dssp ECCCCC-------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCC
T ss_pred EEEeeccccccccc---ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence 99999998654321 223468999999999999999999999999999999999999999765321111000000
Q ss_pred -------------hhhhcccc-----ccccccCcccCC---CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCC
Q 011851 349 -------------RPQLGERR-----RFYRLIDPCLEG---CFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLP 407 (476)
Q Consensus 349 -------------~~~~~~~~-----~~~~~~d~~l~~---~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~ 407 (476)
........ .+...+...... ......+.++.+||.+||+.||++|||+.++++| |
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h----p 320 (371)
T 2xrw_A 245 PCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH----P 320 (371)
T ss_dssp CCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS----H
T ss_pred CCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC----c
Confidence 00000000 000000000000 0011236789999999999999999999999998 8
Q ss_pred Ccccc
Q 011851 408 YLKDM 412 (476)
Q Consensus 408 ~~~~~ 412 (476)
||+..
T Consensus 321 ~~~~~ 325 (371)
T 2xrw_A 321 YINVW 325 (371)
T ss_dssp HHHTT
T ss_pred chhhh
Confidence 88753
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=370.21 Aligned_cols=276 Identities=22% Similarity=0.364 Sum_probs=191.0
Q ss_pred cCCCc-cccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCCCCCceeeEEEEEEe-
Q 011851 121 KSFRP-ECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHPNLVKLIGCCIE- 198 (476)
Q Consensus 121 ~~y~~-~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~- 198 (476)
+.|++ .++||+|+||+||+|.+.. ..+++.||||++..... ...+.+|+.+|++|+||||+++++++..
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~-------~~~~~~vaiK~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 90 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKD-------GKDDKDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSH 90 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESS-------SSCCCCEEEEECSSSSC--CHHHHHHHHHHHHCCCTTBCCCCEEEEET
T ss_pred hhhhhcCcEeeecCCeEEEEEEEcc-------CCCCeEEEEEEECCCCC--CHHHHHHHHHHHhcCCCCeeeEeeEEecC
Confidence 34666 4589999999999997642 23678899999976533 3568899999999999999999999965
Q ss_pred -CCeeEEEEEecCCCCHHHHHhhc--------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeee----c
Q 011851 199 -DDQRLLVYEFMPRGSLENHLFRR--------SLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILL----D 265 (476)
Q Consensus 199 -~~~~~lV~E~~~~g~L~~~l~~~--------~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl----~ 265 (476)
+..+||||||+. ++|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+|||| +
T Consensus 91 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~ 166 (405)
T 3rgf_A 91 ADRKVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGP 166 (405)
T ss_dssp TTTEEEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSST
T ss_pred CCCeEEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCC
Confidence 678999999995 5888877521 235999999999999999999999988 9999999999999 6
Q ss_pred CCCceEEeecCCcCCCCCCCc-cceeeeeecCCCCCCcchhhcC-CCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcc-
Q 011851 266 GEYNAKLSDFGLAKDGPEGDK-THVSTRVMGTYGYAAPEYVMTG-HLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEH- 342 (476)
Q Consensus 266 ~~~~vkl~DFG~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~- 342 (476)
.++.+||+|||+++....... .......+||+.|+|||++.+. .++.++|||||||++|||++|+.||.........
T Consensus 167 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~ 246 (405)
T 3rgf_A 167 ERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTS 246 (405)
T ss_dssp TTTCEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------
T ss_pred CCCcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCcccccccc
Confidence 778999999999987543211 1222346899999999999874 5999999999999999999999999765432100
Q ss_pred -----hhHHhhhhhhc-----cccccccc---------c-CcccCCC--------CChHHHHHHHHHHHHhcccCCCCCC
Q 011851 343 -----NLVEWARPQLG-----ERRRFYRL---------I-DPCLEGC--------FSIKGAEKTIQLAASCLNRDQKARP 394 (476)
Q Consensus 343 -----~~~~~~~~~~~-----~~~~~~~~---------~-d~~l~~~--------~~~~~~~~~~~li~~cL~~dP~~RP 394 (476)
..+......++ ....+..+ + ....... .....+..+.+||.+||+.||.+||
T Consensus 247 ~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ 326 (405)
T 3rgf_A 247 NPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRI 326 (405)
T ss_dssp CCCCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSC
T ss_pred ccchHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCC
Confidence 00000000000 00000000 0 0000000 0001145788999999999999999
Q ss_pred CHHHHHHHhcCCCCccccc
Q 011851 395 RMSEVVEALKPLPYLKDMA 413 (476)
Q Consensus 395 t~~ell~~L~~~~~~~~~~ 413 (476)
|+.|+|+| |||.+..
T Consensus 327 ta~e~L~h----p~f~~~~ 341 (405)
T 3rgf_A 327 TSEQAMQD----PYFLEDP 341 (405)
T ss_dssp CHHHHHTS----GGGTSSS
T ss_pred CHHHHhcC----hhhccCC
Confidence 99999998 9998653
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-45 Score=372.68 Aligned_cols=267 Identities=22% Similarity=0.335 Sum_probs=199.4
Q ss_pred ccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCCCCCceeeEEEEEEeC
Q 011851 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHPNLVKLIGCCIED 199 (476)
Q Consensus 120 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~ 199 (476)
..+|++.++||+|+||+||+|.+.. ++ .||+|.+...... ..+|+++|+.++||||++++++|...
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~---------~~-~~aikk~~~~~~~----~~~E~~il~~l~h~niv~l~~~~~~~ 104 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVE---------SD-EVAIKKVLQDKRF----KNRELQIMRIVKHPNVVDLKAFFYSN 104 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETT---------TE-EEEEEEEECCTTS----CCHHHHHHHTCCCTTBCCEEEEEEEE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECC---------CC-eEEEEEEecCcch----HHHHHHHHHhCCCCCcceEEEEEEec
Confidence 3469999999999999999997652 33 4888887543322 23699999999999999999999765
Q ss_pred Ce------eEEEEEecCCCCHHHHHh---hcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeec-CCCc
Q 011851 200 DQ------RLLVYEFMPRGSLENHLF---RRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLD-GEYN 269 (476)
Q Consensus 200 ~~------~~lV~E~~~~g~L~~~l~---~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~-~~~~ 269 (476)
+. +||||||++++ |.+.+. .....+++..++.++.||+.||.|||+++ |+||||||+||||+ .++.
T Consensus 105 ~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~ 180 (394)
T 4e7w_A 105 GDKKDEVFLNLVLEYVPET-VYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGV 180 (394)
T ss_dssp SSSSSCEEEEEEEECCSEE-HHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTE
T ss_pred CCCCCceEEEEEeeccCcc-HHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCc
Confidence 43 88999999764 444432 23567999999999999999999999988 99999999999998 7999
Q ss_pred eEEeecCCcCCCCCCCccceeeeeecCCCCCCcchhhcC-CCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhh
Q 011851 270 AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA 348 (476)
Q Consensus 270 vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~ 348 (476)
+||+|||+++....... ....+||+.|+|||++.+. .|+.++|||||||++|||++|+.||.+....... ....
T Consensus 181 ~kL~DFG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l--~~i~ 255 (394)
T 4e7w_A 181 LKLIDFGSAKILIAGEP---NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQL--VEII 255 (394)
T ss_dssp EEECCCTTCEECCTTCC---CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH--HHHH
T ss_pred EEEeeCCCcccccCCCC---CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH--HHHH
Confidence 99999999987644332 2346789999999998765 5999999999999999999999999865432111 1111
Q ss_pred hh----------hhc-c--ccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCccccc
Q 011851 349 RP----------QLG-E--RRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDMA 413 (476)
Q Consensus 349 ~~----------~~~-~--~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~~~ 413 (476)
.. ... . ...+..+....+...+....+.++.+||.+||+.||.+|||+.++++| |||+++.
T Consensus 256 ~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h----p~f~~~~ 329 (394)
T 4e7w_A 256 KVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH----PFFDELR 329 (394)
T ss_dssp HHHCCCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS----GGGSTTT
T ss_pred HHhCCCCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC----hhhhhhc
Confidence 00 000 0 000000000011111222236789999999999999999999999987 9988654
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=371.88 Aligned_cols=270 Identities=23% Similarity=0.343 Sum_probs=191.0
Q ss_pred ccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCc--cCHHHHHHHHHHHhCCCCCceeeEEEEEE
Q 011851 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL--QGHKEWLAEVNYLGGLIHPNLVKLIGCCI 197 (476)
Q Consensus 120 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~ 197 (476)
.++|++.+.||+|+||.||+|.+. .+|+.||||++..... ...+.+.+|+.+|+.++||||+++++++.
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~ 98 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDT---------KTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFT 98 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEET---------TTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEC
T ss_pred CCceEEeeEEeecCCeEEEEEEEC---------CCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEe
Confidence 468999999999999999998654 4788899999975432 23456889999999999999999999987
Q ss_pred eC------CeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceE
Q 011851 198 ED------DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAK 271 (476)
Q Consensus 198 ~~------~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vk 271 (476)
.. ..+|+||||+ +++|.+++.. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+|
T Consensus 99 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~k 172 (367)
T 2fst_X 99 PARSLEEFNDVYLVTHLM-GADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELK 172 (367)
T ss_dssp SCSSGGGCCCCEEEEECC-CEECC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEE
T ss_pred cCCccccCCeEEEEeccc-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEE
Confidence 54 5689999999 7899988854 46999999999999999999999988 99999999999999999999
Q ss_pred EeecCCcCCCCCCCccceeeeeecCCCCCCcchhhc-CCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhh
Q 011851 272 LSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP 350 (476)
Q Consensus 272 l~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~ 350 (476)
|+|||+++..... ....+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.........+.....
T Consensus 173 L~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g 247 (367)
T 2fst_X 173 ILDFGLARHTADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVG 247 (367)
T ss_dssp ECC--------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred Eeecccccccccc-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence 9999999865331 234689999999999987 6899999999999999999999999976543211111100000
Q ss_pred h--------hcc--ccccccccCcccCCCC---ChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCccccc
Q 011851 351 Q--------LGE--RRRFYRLIDPCLEGCF---SIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDMA 413 (476)
Q Consensus 351 ~--------~~~--~~~~~~~~d~~l~~~~---~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~~~ 413 (476)
. +.. ...+...+.......+ ....+..+.+||.+||+.||++|||+.++++| |||+...
T Consensus 248 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h----p~~~~~~ 319 (367)
T 2fst_X 248 TPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH----AYFAQYH 319 (367)
T ss_dssp SCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS----GGGTTTC
T ss_pred CCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC----hhhhhcc
Confidence 0 000 0000000000000000 01125678999999999999999999999997 9988654
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-45 Score=365.37 Aligned_cols=274 Identities=23% Similarity=0.303 Sum_probs=207.6
Q ss_pred ccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCcc-CHHHHHHHHHHHhCCCCCceeeEEEEEEe
Q 011851 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQ-GHKEWLAEVNYLGGLIHPNLVKLIGCCIE 198 (476)
Q Consensus 120 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~~ 198 (476)
.++|++.+.||+|+||.||+|.+. .+++.||||++...... ..+.+.+|+++|++++||||+++++++..
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 96 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDN---------LNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRA 96 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEET---------TTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECC
T ss_pred cccEEEEEEeecCCCeEEEEEEEC---------CCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEec
Confidence 467999999999999999998754 46788999999754332 23568899999999999999999999976
Q ss_pred C-----CeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEe
Q 011851 199 D-----DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLS 273 (476)
Q Consensus 199 ~-----~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~ 273 (476)
. ...|+||||+. ++|.+++... .+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+
T Consensus 97 ~~~~~~~~~~iv~e~~~-~~L~~~l~~~--~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~ 170 (364)
T 3qyz_A 97 PTIEQMKDVYIVQDLME-TDLYKLLKTQ--HLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKIC 170 (364)
T ss_dssp SSTTTCCCEEEEEECCS-EEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEEC
T ss_pred CCccccceEEEEEcccC-cCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEE
Confidence 5 36899999996 5999988553 5999999999999999999999988 9999999999999999999999
Q ss_pred ecCCcCCCCCCCcc-ceeeeeecCCCCCCcchhhc-CCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhh
Q 011851 274 DFGLAKDGPEGDKT-HVSTRVMGTYGYAAPEYVMT-GHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQ 351 (476)
Q Consensus 274 DFG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~ 351 (476)
|||+++........ ......+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...........+......
T Consensus 171 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~ 250 (364)
T 3qyz_A 171 DFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGS 250 (364)
T ss_dssp CCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCS
T ss_pred eCcceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCC
Confidence 99999865432211 11234689999999998765 45899999999999999999999999765433322111100000
Q ss_pred h-ccc---------ccc-ccccCcccC--CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCcccc
Q 011851 352 L-GER---------RRF-YRLIDPCLE--GCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDM 412 (476)
Q Consensus 352 ~-~~~---------~~~-~~~~d~~l~--~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~~ 412 (476)
. .+. ..+ .....+... ..+....+.++.+||.+||+.||++|||+.++++| |||++.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h----p~~~~~ 320 (364)
T 3qyz_A 251 PSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH----PYLEQY 320 (364)
T ss_dssp CCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS----GGGTTT
T ss_pred CCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC----cchhhc
Confidence 0 000 000 000000000 00001225678999999999999999999999997 998865
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-45 Score=360.39 Aligned_cols=253 Identities=27% Similarity=0.423 Sum_probs=201.8
Q ss_pred cCCCccccccccCCccEEEEEEccCCceeeeCCCCce--EEEEEecCCC-ccCHHHHHHHHHHHhCC-CCCceeeEEEEE
Q 011851 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLP--VAVKTLNHDG-LQGHKEWLAEVNYLGGL-IHPNLVKLIGCC 196 (476)
Q Consensus 121 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~--vAiK~~~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~ 196 (476)
++|++.+.||+|+||.||+|.+.. ++.. +|+|.+.... ....+.+.+|+++|+++ +||||+++++++
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 95 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKK---------DGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGAC 95 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEE---------TTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEcc---------CCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceee
Confidence 469999999999999999998653 3443 5999987532 23345788999999999 899999999999
Q ss_pred EeCCeeEEEEEecCCCCHHHHHhhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCC
Q 011851 197 IEDDQRLLVYEFMPRGSLENHLFRRS---------------LPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSN 261 (476)
Q Consensus 197 ~~~~~~~lV~E~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~N 261 (476)
.+.+..||||||+++++|.+++.... ..+++..++.++.||+.||.|||+++ |+||||||+|
T Consensus 96 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~N 172 (327)
T 1fvr_A 96 EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARN 172 (327)
T ss_dssp EETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGG
T ss_pred eeCCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccce
Confidence 99999999999999999999996543 47999999999999999999999988 9999999999
Q ss_pred eeecCCCceEEeecCCcCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHh-CCCCCCCCCCCC
Q 011851 262 ILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLT-GRRSMDKNRPNG 340 (476)
Q Consensus 262 ILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~ellt-G~~pf~~~~~~~ 340 (476)
||++.++.+||+|||+++..... .......+++.|+|||++.+..++.++|||||||++|||++ |+.||.......
T Consensus 173 Il~~~~~~~kL~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~ 249 (327)
T 1fvr_A 173 ILVGENYVAKIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE 249 (327)
T ss_dssp EEECGGGCEEECCTTCEESSCEE---CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH
T ss_pred EEEcCCCeEEEcccCcCcccccc---ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHH
Confidence 99999999999999999753221 11223467889999999999999999999999999999998 999997543211
Q ss_pred cchhHHhhhhhhccccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 011851 341 EHNLVEWARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKP 405 (476)
Q Consensus 341 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~ 405 (476)
+... +.... ....+...+.++.+||.+||+.||++|||+.+++++|+.
T Consensus 250 ---~~~~----~~~~~----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~ 297 (327)
T 1fvr_A 250 ---LYEK----LPQGY----------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNR 297 (327)
T ss_dssp ---HHHH----GGGTC----------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ---HHHH----hhcCC----------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 1111 00000 001112235789999999999999999999999998653
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-45 Score=379.98 Aligned_cols=255 Identities=28% Similarity=0.421 Sum_probs=202.9
Q ss_pred hccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCCCCCceeeEEEEEEe
Q 011851 119 ATKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHPNLVKLIGCCIE 198 (476)
Q Consensus 119 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~ 198 (476)
..++|++.+.||+|+||.||+|.+. .+..||||+++... ...+.+.+|+.+|++++||||+++++++.+
T Consensus 182 ~~~~~~~~~~lG~G~fg~Vy~~~~~----------~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 250 (452)
T 1fmk_A 182 PRESLRLEVKLGQGCFGEVWMGTWN----------GTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 250 (452)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEET----------TTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred ChhHceeeeeecCCCCeEEEEEEEC----------CCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC
Confidence 3457899999999999999999765 24569999997654 345789999999999999999999999865
Q ss_pred CCeeEEEEEecCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCC
Q 011851 199 DDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGL 277 (476)
Q Consensus 199 ~~~~~lV~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~ 277 (476)
+..||||||+++|+|.+++... ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 251 -~~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~ 326 (452)
T 1fmk_A 251 -EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGL 326 (452)
T ss_dssp -SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCT
T ss_pred -CceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCcc
Confidence 7799999999999999999653 356899999999999999999999988 99999999999999999999999999
Q ss_pred cCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhhcccc
Q 011851 278 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPQLGERR 356 (476)
Q Consensus 278 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~ 356 (476)
++....... .......+++.|+|||++.+..++.++|||||||++|||++ |+.||....... +..... ...
T Consensus 327 a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~---~~~~i~----~~~ 398 (452)
T 1fmk_A 327 ARLIEDNEY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE---VLDQVE----RGY 398 (452)
T ss_dssp TC---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH---HHHHHH----TTC
T ss_pred ceecCCCce-ecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHH---HHHHHH----cCC
Confidence 987543221 12223457889999999999999999999999999999999 999997543221 111110 000
Q ss_pred ccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011851 357 RFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPL 406 (476)
Q Consensus 357 ~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~ 406 (476)
. . + .+...+..+.+||.+||+.||++|||+.+|++.|+.+
T Consensus 399 ~---~--~-----~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~ 438 (452)
T 1fmk_A 399 R---M--P-----CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 438 (452)
T ss_dssp C---C--C-----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTT
T ss_pred C---C--C-----CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 0 0 0 1122367899999999999999999999999998865
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-45 Score=359.98 Aligned_cols=273 Identities=23% Similarity=0.300 Sum_probs=210.2
Q ss_pred ccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCCCCC------ceeeEE
Q 011851 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHP------NLVKLI 193 (476)
Q Consensus 120 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~hp------nIv~l~ 193 (476)
.++|++.+.||+|+||.||+|.+. ..+++.||||+++... ...+.+.+|+.+++.++|+ +|++++
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~--------~~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~ 83 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDH--------KAGGRHVAVKIVKNVD-RYCEAARSEIQVLEHLNTTDPNSTFRCVQML 83 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEET--------TTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEE
T ss_pred cCceEEEEEEecCCCeEEEEEEec--------CCCCcEEEEEEEecCC-chhHHHHHHHHHHHHhhhcCCCCceeeEeee
Confidence 458999999999999999998753 2367889999997542 2345678899998887655 599999
Q ss_pred EEEEeCCeeEEEEEecCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecC------
Q 011851 194 GCCIEDDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDG------ 266 (476)
Q Consensus 194 ~~~~~~~~~~lV~E~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~------ 266 (476)
+++.+.+..||||||+ +++|.+++.... .++++..+..++.||+.||.|||+++ |+||||||+|||++.
T Consensus 84 ~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~ 159 (339)
T 1z57_A 84 EWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEA 159 (339)
T ss_dssp EEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEE
T ss_pred cccccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccc
Confidence 9999999999999999 889999996653 46899999999999999999999988 999999999999987
Q ss_pred -------------CCceEEeecCCcCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCC
Q 011851 267 -------------EYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSM 333 (476)
Q Consensus 267 -------------~~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf 333 (476)
++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|..||
T Consensus 160 ~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf 234 (339)
T 1z57_A 160 YNPKIKRDERTLINPDIKVVDFGSATYDDEH-----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVF 234 (339)
T ss_dssp EC----CEEEEESCCCEEECCCSSCEETTSC-----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred cCCccccccccccCCCceEeeCcccccCccc-----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCC
Confidence 668999999999864332 22367999999999999999999999999999999999999999
Q ss_pred CCCCCCCcchhHHhhhhhhccc-------ccc------------------ccccCccc-CCCCChHHHHHHHHHHHHhcc
Q 011851 334 DKNRPNGEHNLVEWARPQLGER-------RRF------------------YRLIDPCL-EGCFSIKGAEKTIQLAASCLN 387 (476)
Q Consensus 334 ~~~~~~~~~~~~~~~~~~~~~~-------~~~------------------~~~~d~~l-~~~~~~~~~~~~~~li~~cL~ 387 (476)
...........+.......... ... .....+.. ........++++.+||.+||+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~ 314 (339)
T 1z57_A 235 PTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLE 314 (339)
T ss_dssp CCSCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTC
T ss_pred CCCChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhC
Confidence 7654322111111110000000 000 00000000 001123446789999999999
Q ss_pred cCCCCCCCHHHHHHHhcCCCCcccccC
Q 011851 388 RDQKARPRMSEVVEALKPLPYLKDMAS 414 (476)
Q Consensus 388 ~dP~~RPt~~ell~~L~~~~~~~~~~~ 414 (476)
.||.+|||+.|+++| |||+.+..
T Consensus 315 ~dP~~Rpt~~ell~h----p~f~~~~~ 337 (339)
T 1z57_A 315 YDPAKRITLREALKH----PFFDLLKK 337 (339)
T ss_dssp SSTTTSCCHHHHTTS----GGGGGGGC
T ss_pred cCcccccCHHHHhcC----HHHHHHhc
Confidence 999999999999987 99987654
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-45 Score=355.73 Aligned_cols=260 Identities=25% Similarity=0.352 Sum_probs=209.8
Q ss_pred ccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCc---------cCHHHHHHHHHHHhCCC-CCce
Q 011851 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL---------QGHKEWLAEVNYLGGLI-HPNL 189 (476)
Q Consensus 120 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~---------~~~~~~~~E~~~l~~l~-hpnI 189 (476)
.++|++.+.||+|+||.||+|.+. .+|+.||||++..... ...+.+.+|+++|+++. ||||
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i 86 (298)
T 1phk_A 16 YENYEPKEILGRGVSSVVRRCIHK---------PTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNI 86 (298)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEET---------TTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTB
T ss_pred hhccceeeeecCCCceEEEEEEEc---------CcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCE
Confidence 467999999999999999998654 4788899999976531 11345778999999995 9999
Q ss_pred eeEEEEEEeCCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCc
Q 011851 190 VKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYN 269 (476)
Q Consensus 190 v~l~~~~~~~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~ 269 (476)
+++++++.+++..|+||||+++++|.+++... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.
T Consensus 87 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~ 162 (298)
T 1phk_A 87 IQLKDTYETNTFFFLVFDLMKKGELFDYLTEK-VTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMN 162 (298)
T ss_dssp CCEEEEEECSSEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCC
T ss_pred eeeeeeeccCCeEEEEEeccCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCc
Confidence 99999999999999999999999999999654 56999999999999999999999988 999999999999999999
Q ss_pred eEEeecCCcCCCCCCCccceeeeeecCCCCCCcchhh------cCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcch
Q 011851 270 AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM------TGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHN 343 (476)
Q Consensus 270 vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~ 343 (476)
+||+|||++........ .....||+.|+|||++. ...++.++|||||||++|+|++|..||.......
T Consensus 163 ~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~--- 236 (298)
T 1phk_A 163 IKLTDFGFSCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML--- 236 (298)
T ss_dssp EEECCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---
T ss_pred EEEecccchhhcCCCcc---cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHH---
Confidence 99999999987544322 23467999999999986 4568899999999999999999999997543211
Q ss_pred hHHhhhhhhccccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCccccc
Q 011851 344 LVEWARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDMA 413 (476)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~~~ 413 (476)
..... ..... ....+.. ...+..+.+||.+||+.||++|||+.++++| |||++..
T Consensus 237 ~~~~~---~~~~~---~~~~~~~-----~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h----~~~~~~~ 291 (298)
T 1phk_A 237 MLRMI---MSGNY---QFGSPEW-----DDYSDTVKDLVSRFLVVQPQKRYTAEEALAH----PFFQQYV 291 (298)
T ss_dssp HHHHH---HHTCC---CCCTTTG-----GGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS----GGGCTTC
T ss_pred HHHHH---hcCCc---ccCcccc-----cccCHHHHHHHHHHccCCcccCCCHHHHHhC----hHhhhcc
Confidence 11100 00000 0000111 1236789999999999999999999999987 9998654
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-44 Score=355.56 Aligned_cols=263 Identities=24% Similarity=0.332 Sum_probs=199.6
Q ss_pred HhccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCC--CCCceeeEEEE
Q 011851 118 SATKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGL--IHPNLVKLIGC 195 (476)
Q Consensus 118 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l--~hpnIv~l~~~ 195 (476)
...++|++.+.||+|+||.||+|.+ +++.||||++... ....+..|.+++..+ +||||++++++
T Consensus 34 ~~~~~y~~~~~lg~G~~g~V~~~~~-----------~~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~ 99 (337)
T 3mdy_A 34 TIAKQIQMVKQIGKGRYGEVWMGKW-----------RGEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAA 99 (337)
T ss_dssp THHHHCEEEEEEEEETTEEEEEEEE-----------TTEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEE
T ss_pred ccccceEEEeEeecCCCeEEEEEEE-----------CCceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEE
Confidence 3456799999999999999999865 3678999998643 234455666666655 89999999999
Q ss_pred EEeC----CeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhc--------CCCCeEecCCCCCCee
Q 011851 196 CIED----DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEE--------AEKPVIYRDFKTSNIL 263 (476)
Q Consensus 196 ~~~~----~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~--------~~~~ivHrDlKp~NIL 263 (476)
+.+. ...||||||+++++|.+++... .+++..++.++.||+.||.|||+. + |+||||||+|||
T Consensus 100 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dikp~Nil 174 (337)
T 3mdy_A 100 DIKGTGSWTQLYLITDYHENGSLYDYLKST--TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPA---IAHRDLKSKNIL 174 (337)
T ss_dssp EEESCGGGCEEEEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCC---EECSCCCGGGEE
T ss_pred EccCCCCCCceEEEEeccCCCcHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCC---EEecccchHHEE
Confidence 9987 7899999999999999999554 599999999999999999999987 6 999999999999
Q ss_pred ecCCCceEEeecCCcCCCCCCCccc--eeeeeecCCCCCCcchhhcCCCCcc------chhhhhHHHHHHHHhC------
Q 011851 264 LDGEYNAKLSDFGLAKDGPEGDKTH--VSTRVMGTYGYAAPEYVMTGHLTAK------SDVYSFGVVLLEMLTG------ 329 (476)
Q Consensus 264 l~~~~~vkl~DFG~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~------~DiwslGv~l~elltG------ 329 (476)
++.++.+||+|||+++......... .....+||+.|+|||++.+..++.. +|||||||++|||++|
T Consensus 175 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~ 254 (337)
T 3mdy_A 175 VKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGI 254 (337)
T ss_dssp ECTTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTB
T ss_pred ECCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccc
Confidence 9999999999999997654322211 1123579999999999988776665 9999999999999999
Q ss_pred ----CCCCCCCCCCCcchhHHhhhhhhccccccccccCcccCC-CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 011851 330 ----RRSMDKNRPNGEHNLVEWARPQLGERRRFYRLIDPCLEG-CFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALK 404 (476)
Q Consensus 330 ----~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~-~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~ 404 (476)
..||............ ... ... .....+.+.. ......+.++.+||.+||+.||++|||+.+|+++|+
T Consensus 255 ~~~~~~p~~~~~~~~~~~~~-~~~-~~~-----~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 327 (337)
T 3mdy_A 255 VEEYQLPYHDLVPSDPSYED-MRE-IVC-----IKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLA 327 (337)
T ss_dssp CCCCCCTTTTTSCSSCCHHH-HHH-HHT-----TSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred cccccccHhhhcCCCCchhh-hHH-HHh-----hhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHH
Confidence 5666543332221110 000 000 0001111111 112256788999999999999999999999999976
Q ss_pred CC
Q 011851 405 PL 406 (476)
Q Consensus 405 ~~ 406 (476)
.+
T Consensus 328 ~l 329 (337)
T 3mdy_A 328 KM 329 (337)
T ss_dssp HH
T ss_pred HH
Confidence 43
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-45 Score=353.87 Aligned_cols=254 Identities=28% Similarity=0.422 Sum_probs=205.6
Q ss_pred hccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCCCCCceeeEEEEEEe
Q 011851 119 ATKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHPNLVKLIGCCIE 198 (476)
Q Consensus 119 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~ 198 (476)
..++|++.+.||+|+||.||+|.+. ++..||||++.... ...+.+.+|+++|++++||||+++++++.
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~~----------~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~- 78 (279)
T 1qpc_A 11 PRETLKLVERLGAGQFGEVWMGYYN----------GHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT- 78 (279)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEET----------TTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-
T ss_pred CHHhhhheeeecCCCCeEEEEEEEc----------CCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEc-
Confidence 3467999999999999999999754 45679999997653 34678899999999999999999999876
Q ss_pred CCeeEEEEEecCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCC
Q 011851 199 DDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGL 277 (476)
Q Consensus 199 ~~~~~lV~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~ 277 (476)
++..++||||+++++|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 79 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~ 155 (279)
T 1qpc_A 79 QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGL 155 (279)
T ss_dssp SSSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTT
T ss_pred CCCcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCcc
Confidence 55789999999999999999643 236899999999999999999999988 99999999999999999999999999
Q ss_pred cCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhhcccc
Q 011851 278 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPQLGERR 356 (476)
Q Consensus 278 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~ 356 (476)
+........ .......+++.|+|||++.+..++.++|||||||++|||++ |+.||....... ...... ...
T Consensus 156 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---~~~~~~----~~~ 227 (279)
T 1qpc_A 156 ARLIEDNEY-TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE---VIQNLE----RGY 227 (279)
T ss_dssp CEECSSSCE-ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH---HHHHHH----TTC
T ss_pred cccccCccc-ccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHH---HHHHHh----ccc
Confidence 987644321 11223457889999999999999999999999999999999 999997543211 111110 000
Q ss_pred ccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 011851 357 RFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKP 405 (476)
Q Consensus 357 ~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~ 405 (476)
. ...+...+.++.+|+.+||+.||++|||+.++++.|+.
T Consensus 228 ------~----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~ 266 (279)
T 1qpc_A 228 ------R----MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLED 266 (279)
T ss_dssp ------C----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ------C----CCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHH
Confidence 0 00112235789999999999999999999999998764
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=364.70 Aligned_cols=262 Identities=27% Similarity=0.384 Sum_probs=201.8
Q ss_pred ccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCc-cCHHHHHHHHHHHhCCCCCceeeEEEEEEe
Q 011851 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL-QGHKEWLAEVNYLGGLIHPNLVKLIGCCIE 198 (476)
Q Consensus 120 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~ 198 (476)
.++|++.+.||+|+||.||+|.+... .+..+++.||||++..... ....++.+|+.++++++||||+++++++.+
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~----~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 104 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGM----PNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQ 104 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC------------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCC----CCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcC
Confidence 35699999999999999999975421 1234788999999975432 234568899999999999999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHHhhcC------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecC---CCc
Q 011851 199 DDQRLLVYEFMPRGSLENHLFRRS------LPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDG---EYN 269 (476)
Q Consensus 199 ~~~~~lV~E~~~~g~L~~~l~~~~------~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~---~~~ 269 (476)
.+..||||||+++++|.+++.... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++. +..
T Consensus 105 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~ 181 (327)
T 2yfx_A 105 SLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRV 181 (327)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCC
T ss_pred CCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcce
Confidence 999999999999999999997643 45899999999999999999999988 999999999999984 446
Q ss_pred eEEeecCCcCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHh-CCCCCCCCCCCCcchhHHhh
Q 011851 270 AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWA 348 (476)
Q Consensus 270 vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~ellt-G~~pf~~~~~~~~~~~~~~~ 348 (476)
+||+|||++................||+.|+|||++.+..++.++|||||||++|+|++ |..||...... ......
T Consensus 182 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~---~~~~~~ 258 (327)
T 2yfx_A 182 AKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ---EVLEFV 258 (327)
T ss_dssp EEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---HHHHHH
T ss_pred EEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHH---HHHHHH
Confidence 99999999875433222222233568999999999999999999999999999999998 99999754321 111111
Q ss_pred hhhhccccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 011851 349 RPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKP 405 (476)
Q Consensus 349 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~ 405 (476)
.. ... ...+...+..+.+||.+||+.||.+||++.+++++|+.
T Consensus 259 ~~----~~~----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~ 301 (327)
T 2yfx_A 259 TS----GGR----------MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEY 301 (327)
T ss_dssp HT----TCC----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred hc----CCC----------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHH
Confidence 10 000 00112235788999999999999999999999998653
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=362.61 Aligned_cols=270 Identities=23% Similarity=0.327 Sum_probs=204.0
Q ss_pred ccChhHHHHhccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCcc--CHHHHHHHHHHHhCCC--
Q 011851 110 KFSFNELKSATKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQ--GHKEWLAEVNYLGGLI-- 185 (476)
Q Consensus 110 ~~~~~~~~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~--~~~~~~~E~~~l~~l~-- 185 (476)
.+.+..+....++|++.+.||+|+||.||+|.+. +++.||||++...... ..+.+.+|+.+|+++.
T Consensus 17 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~----------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~ 86 (313)
T 3cek_A 17 NLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNE----------KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQH 86 (313)
T ss_dssp ---CCEEEETTEEEEEEEEEECCSSEEEEEEECT----------TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGG
T ss_pred CCCeeeeeeccceEEEEEEecCCCCEEEEEEEcC----------CCcEEEEEEeccccccccchHHHHHHHHHHHhcccc
Confidence 3444445555678999999999999999998653 4778999999765332 3456889999999997
Q ss_pred CCceeeEEEEEEeCCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeec
Q 011851 186 HPNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLD 265 (476)
Q Consensus 186 hpnIv~l~~~~~~~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~ 265 (476)
|+||+++++++.+++..||||| +.+++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++
T Consensus 87 ~~~iv~~~~~~~~~~~~~lv~e-~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~ 161 (313)
T 3cek_A 87 SDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV 161 (313)
T ss_dssp CTTBCCEEEEEECSSEEEEEEC-CCSEEHHHHHHHC-SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE
T ss_pred CCceEEEEEEeecCCEEEEEEe-cCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEE
Confidence 5999999999999999999999 5588999999654 57899999999999999999999988 99999999999997
Q ss_pred CCCceEEeecCCcCCCCCCCccceeeeeecCCCCCCcchhhc-----------CCCCccchhhhhHHHHHHHHhCCCCCC
Q 011851 266 GEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-----------GHLTAKSDVYSFGVVLLEMLTGRRSMD 334 (476)
Q Consensus 266 ~~~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DiwslGv~l~elltG~~pf~ 334 (476)
++.+||+|||++................||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.
T Consensus 162 -~~~~kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~ 240 (313)
T 3cek_A 162 -DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ 240 (313)
T ss_dssp -TTEEEECCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTT
T ss_pred -CCeEEEeeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchh
Confidence 48999999999987654333222334679999999999875 478899999999999999999999996
Q ss_pred CCCCCCcchhHHhhhhhhccccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCcccccC
Q 011851 335 KNRPNGEHNLVEWARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDMAS 414 (476)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~~~~ 414 (476)
...... .... ..+++.....++...+.++.+||.+||+.||++||++.+++++ |||+....
T Consensus 241 ~~~~~~-~~~~--------------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h----~~~~~~~~ 301 (313)
T 3cek_A 241 QIINQI-SKLH--------------AIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH----PYVQIQTH 301 (313)
T ss_dssp TCCSHH-HHHH--------------HHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS----HHHHCC--
T ss_pred hHHHHH-HHHH--------------HHHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcC----ccccCCCC
Confidence 543210 0000 1111111111222225688999999999999999999999997 88876443
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-45 Score=364.04 Aligned_cols=273 Identities=25% Similarity=0.355 Sum_probs=210.1
Q ss_pred cCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCCCCCceeeEEEEEEeCC
Q 011851 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHPNLVKLIGCCIEDD 200 (476)
Q Consensus 121 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 200 (476)
++|++.+.||+|+||.||+|.+.. .+..+|+.||||++........+.+.+|+++|++++||||+++++++...+
T Consensus 41 ~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 115 (326)
T 2w1i_A 41 RHLKFLQQLGKGNFGSVEMCRYDP-----LQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG 115 (326)
T ss_dssp GGEEEEEEEECCSSEEEEEEEECT-----TSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC--
T ss_pred HHceeeeeeccCCCeEEEEEEecc-----ccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecC
Confidence 468999999999999999997542 233578999999998766555677899999999999999999999987654
Q ss_pred --eeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCc
Q 011851 201 --QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLA 278 (476)
Q Consensus 201 --~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a 278 (476)
.+++||||+++++|.+++......+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 116 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~ 192 (326)
T 2w1i_A 116 RRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLT 192 (326)
T ss_dssp --CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTC
T ss_pred CCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcch
Confidence 789999999999999999877677999999999999999999999988 999999999999999999999999999
Q ss_pred CCCCCCCccc-eeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhc---c
Q 011851 279 KDGPEGDKTH-VSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLG---E 354 (476)
Q Consensus 279 ~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~---~ 354 (476)
.......... ......++..|+|||++.+..++.++|||||||++|||++|..||..... ........... .
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~----~~~~~~~~~~~~~~~ 268 (326)
T 2w1i_A 193 KVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPA----EFMRMIGNDKQGQMI 268 (326)
T ss_dssp EECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHH----HHHHHHCTTCCTHHH
T ss_pred hhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHH----HHHHhhccccchhhh
Confidence 8765432211 12224577889999999999999999999999999999999999863210 00000000000 0
Q ss_pred ccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 011851 355 RRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKP 405 (476)
Q Consensus 355 ~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~ 405 (476)
...+.+.+........+...+.++.+||.+||+.||++|||+.++++.|+.
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~ 319 (326)
T 2w1i_A 269 VFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQ 319 (326)
T ss_dssp HHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 000000000000001122336789999999999999999999999998764
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=356.18 Aligned_cols=250 Identities=31% Similarity=0.494 Sum_probs=194.3
Q ss_pred cCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCCCCCceeeEEEEEEeCC
Q 011851 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHPNLVKLIGCCIEDD 200 (476)
Q Consensus 121 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 200 (476)
++|++.+.||+|+||.||+|.+. ++.||||++... ...+.+.+|+++|++++||||+++++++. +
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~~-----------~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~ 72 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKWR-----------AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACL--N 72 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET-----------TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCT--T
T ss_pred hHeeeeeEeecCCCceEEEEEEC-----------CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--C
Confidence 46899999999999999998653 567999999654 23467889999999999999999999876 4
Q ss_pred eeEEEEEecCCCCHHHHHhhcCC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCc-eEEeecCC
Q 011851 201 QRLLVYEFMPRGSLENHLFRRSL--PLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYN-AKLSDFGL 277 (476)
Q Consensus 201 ~~~lV~E~~~~g~L~~~l~~~~~--~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~-vkl~DFG~ 277 (476)
..||||||+++++|.+++..... .+++..++.++.||+.||.|||+.+..+|+||||||+|||++.++. +||+|||+
T Consensus 73 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~ 152 (307)
T 2eva_A 73 PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGT 152 (307)
T ss_dssp TTEEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC
T ss_pred CcEEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccc
Confidence 58999999999999999965432 4789999999999999999999933233999999999999998886 79999999
Q ss_pred cCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhccccc
Q 011851 278 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRR 357 (476)
Q Consensus 278 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 357 (476)
+...... .....||+.|+|||++.+..++.++|||||||++|||++|+.||......... +.+.... ...
T Consensus 153 ~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~--~~~~~~~-~~~-- 222 (307)
T 2eva_A 153 ACDIQTH-----MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFR--IMWAVHN-GTR-- 222 (307)
T ss_dssp -----------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHH--HHHHHHT-TCC--
T ss_pred ccccccc-----cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHH--HHHHHhc-CCC--
Confidence 9764321 22356999999999999999999999999999999999999999754322111 1111000 000
Q ss_pred cccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 011851 358 FYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKP 405 (476)
Q Consensus 358 ~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~ 405 (476)
+. .....+..+.+|+.+||+.||++|||+.+++++|+.
T Consensus 223 ------~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~ 260 (307)
T 2eva_A 223 ------PP----LIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTH 260 (307)
T ss_dssp ------CC----CBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ------CC----cccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHH
Confidence 00 111225688999999999999999999999998764
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=352.72 Aligned_cols=261 Identities=23% Similarity=0.361 Sum_probs=200.5
Q ss_pred ccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCCCCCceeeEEEEEEe-
Q 011851 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHPNLVKLIGCCIE- 198 (476)
Q Consensus 120 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~- 198 (476)
.++|++.+.||+|+||.||+|.+. .+|+.||||++.... ...+.+.+|+.++++++||||+++++++.+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 74 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNA---------LDSRYYAIKKIRHTE-EKLSTILSEVMLLASLNHQYVVRYYAAWLER 74 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEET---------TTCCEEEEEEEEEEH-HHHHHHHHHHHHHTTCCCTTBCCEEEEEEEC
T ss_pred cccchhhheeccCCcEEEEEEEEc---------CCCeEEEEEEEeccH-HHHHHHHHHHHHHHhcCchHHHHHHHHHHhh
Confidence 457999999999999999998654 467889999996532 334568899999999999999999999865
Q ss_pred ------------CCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecC
Q 011851 199 ------------DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDG 266 (476)
Q Consensus 199 ------------~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~ 266 (476)
.+..|+||||+++++|.+++......+++..++.++.||+.||.|||+++ |+||||||+|||++.
T Consensus 75 ~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~ 151 (303)
T 1zy4_A 75 RNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDE 151 (303)
T ss_dssp CCCCC------CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECT
T ss_pred cchhhhhcccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcC
Confidence 35689999999999999999877667889999999999999999999988 999999999999999
Q ss_pred CCceEEeecCCcCCCCCCCc------------cceeeeeecCCCCCCcchhhcC-CCCccchhhhhHHHHHHHHhCCCCC
Q 011851 267 EYNAKLSDFGLAKDGPEGDK------------THVSTRVMGTYGYAAPEYVMTG-HLTAKSDVYSFGVVLLEMLTGRRSM 333 (476)
Q Consensus 267 ~~~vkl~DFG~a~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGv~l~elltG~~pf 333 (476)
++.+||+|||++........ ........||+.|+|||++.+. .++.++|||||||++|+|++ ||
T Consensus 152 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~ 228 (303)
T 1zy4_A 152 SRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PF 228 (303)
T ss_dssp TSCEEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CC
T ss_pred CCCEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---cc
Confidence 99999999999986543210 1112346799999999999865 78999999999999999998 44
Q ss_pred CCCCCCCcchhHHhhhhhhccccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCccccc
Q 011851 334 DKNRPNGEHNLVEWARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDMA 413 (476)
Q Consensus 334 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~~~ 413 (476)
.... .......... . ....+...++...+..+.+||.+||+.||++|||+.++++| |||+...
T Consensus 229 ~~~~--~~~~~~~~~~---~--------~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h----~~~~~~~ 291 (303)
T 1zy4_A 229 STGM--ERVNILKKLR---S--------VSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS----GWLPVKH 291 (303)
T ss_dssp SSHH--HHHHHHHHHH---S--------TTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS----SCSCCCC
T ss_pred CCch--hHHHHHHhcc---c--------cccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCC----CCcCCCC
Confidence 3210 0001111000 0 00111122333345778999999999999999999999998 9997643
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-45 Score=359.73 Aligned_cols=260 Identities=26% Similarity=0.323 Sum_probs=203.6
Q ss_pred ccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCCCCCceeeEEEEEEe-
Q 011851 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHPNLVKLIGCCIE- 198 (476)
Q Consensus 120 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~- 198 (476)
.++|++.+.||+|+||.||+|.+. .+|+.||||++........+.+.+|+++++.++||||+++++++..
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 98 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGL---------HDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRE 98 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEET---------TTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEec---------CCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEec
Confidence 457999999999999999998654 4678899999976655556778999999999999999999999873
Q ss_pred ---CCeeEEEEEecCCCCHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEE
Q 011851 199 ---DDQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKL 272 (476)
Q Consensus 199 ---~~~~~lV~E~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl 272 (476)
....|+||||+++++|.+++.. ....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||
T Consensus 99 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl 175 (317)
T 2buj_A 99 RGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVL 175 (317)
T ss_dssp ETTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEE
T ss_pred cCCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEE
Confidence 3478999999999999999865 3567999999999999999999999988 999999999999999999999
Q ss_pred eecCCcCCCCCCCccc-------eeeeeecCCCCCCcchhhcCC---CCccchhhhhHHHHHHHHhCCCCCCCCCCCCcc
Q 011851 273 SDFGLAKDGPEGDKTH-------VSTRVMGTYGYAAPEYVMTGH---LTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEH 342 (476)
Q Consensus 273 ~DFG~a~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~---~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~ 342 (476)
+|||++.......... ......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.........
T Consensus 176 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~ 255 (317)
T 2buj_A 176 MDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDS 255 (317)
T ss_dssp CCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSC
T ss_pred EecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccch
Confidence 9999987643211000 011245799999999987654 789999999999999999999999532111111
Q ss_pred hhHHhhhhhhccccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011851 343 NLVEWARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPL 406 (476)
Q Consensus 343 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~ 406 (476)
. ..... .... . + .....+.++.+||.+||+.||.+|||+.+++++|+.+
T Consensus 256 ~-~~~~~----~~~~---~--~-----~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~ 304 (317)
T 2buj_A 256 V-ALAVQ----NQLS---I--P-----QSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEAL 304 (317)
T ss_dssp H-HHHHH----CC-----C--C-----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred h-hHHhh----ccCC---C--C-----ccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhc
Confidence 0 00000 0000 0 0 1112257899999999999999999999999998755
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=361.21 Aligned_cols=278 Identities=24% Similarity=0.344 Sum_probs=197.7
Q ss_pred HHHhccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCCCCCceeeEEEE
Q 011851 116 LKSATKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHPNLVKLIGC 195 (476)
Q Consensus 116 ~~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~ 195 (476)
.....++|++.+.||+|+||.||+|.+. .+|+.||||++..... ....+.+|++.+..++||||++++++
T Consensus 18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vavK~~~~~~~-~~~~~~~~~~~l~~l~h~niv~~~~~ 87 (360)
T 3e3p_A 18 SRKEMDRFQVERMAGQGTFGTVQLGKEK---------STGMSVAIKKVIQDPR-FRNRELQIMQDLAVLHHPNIVQLQSY 87 (360)
T ss_dssp HHHHHTTEEEC----------CEEEEET---------TTCCEEEEEEEECCTT-CCCHHHHHHHHHHHHCCTTBCCEEEE
T ss_pred chhhccceEEEEEEecCCCeEEEEEEEC---------CCCCEEEEEEEecCcc-ccHHHHHHHHHHHhcCCCCcccHHHh
Confidence 3455678999999999999999998754 4678899999865432 23456778888899999999999999
Q ss_pred EEeCCe-------eEEEEEecCCCCHHHHHh---hcCCCCCHHHHHHHHHHHHHHHHHHH--hcCCCCeEecCCCCCCee
Q 011851 196 CIEDDQ-------RLLVYEFMPRGSLENHLF---RRSLPLPWSIRMKIALDAAKGLAFLH--EEAEKPVIYRDFKTSNIL 263 (476)
Q Consensus 196 ~~~~~~-------~~lV~E~~~~g~L~~~l~---~~~~~l~~~~~~~i~~qi~~al~~lH--~~~~~~ivHrDlKp~NIL 263 (476)
+...+. +++||||+++ +|.+.+. .....+++..+..++.||+.||.||| +.+ |+||||||+|||
T Consensus 88 ~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIl 163 (360)
T 3e3p_A 88 FYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVL 163 (360)
T ss_dssp EEEECSSCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEE
T ss_pred hhccccccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEE
Confidence 976443 8899999976 5555443 34567899999999999999999999 777 999999999999
Q ss_pred ecC-CCceEEeecCCcCCCCCCCccceeeeeecCCCCCCcchhhcC-CCCccchhhhhHHHHHHHHhCCCCCCCCCCCCc
Q 011851 264 LDG-EYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGE 341 (476)
Q Consensus 264 l~~-~~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~ 341 (476)
|+. ++.+||+|||+++....... .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||........
T Consensus 164 l~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~ 240 (360)
T 3e3p_A 164 VNEADGTLKLCDFGSAKKLSPSEP---NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQ 240 (360)
T ss_dssp EETTTTEEEECCCTTCBCCCTTSC---CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred EeCCCCcEEEeeCCCceecCCCCC---cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHH
Confidence 996 89999999999987654332 2346789999999998765 489999999999999999999999976543221
Q ss_pred chhHHhhh-h-------hhccccccccccCc------ccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCC
Q 011851 342 HNLVEWAR-P-------QLGERRRFYRLIDP------CLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLP 407 (476)
Q Consensus 342 ~~~~~~~~-~-------~~~~~~~~~~~~d~------~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~ 407 (476)
...+.... . ............+. ..........+.++.+||.+||+.||++|||+.|+++| |
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h----p 316 (360)
T 3e3p_A 241 LHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH----P 316 (360)
T ss_dssp HHHHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS----G
T ss_pred HHHHHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC----c
Confidence 11110000 0 00000000000000 00001112246789999999999999999999999987 9
Q ss_pred CcccccC
Q 011851 408 YLKDMAS 414 (476)
Q Consensus 408 ~~~~~~~ 414 (476)
||++...
T Consensus 317 ~f~~~~~ 323 (360)
T 3e3p_A 317 YFDELHD 323 (360)
T ss_dssp GGGGGGC
T ss_pred cccccCC
Confidence 9987643
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-45 Score=363.75 Aligned_cols=256 Identities=24% Similarity=0.325 Sum_probs=187.5
Q ss_pred ccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCCC-CCceeeEEEEEEe
Q 011851 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLI-HPNLVKLIGCCIE 198 (476)
Q Consensus 120 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~ 198 (476)
..+|++.++||+|+||.||+|.+. .+++.||||++........+.+.+|+.+|.++. ||||+++++++..
T Consensus 27 ~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~ 97 (337)
T 3ll6_A 27 ELRLRVRRVLAEGGFAFVYEAQDV---------GSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASI 97 (337)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEET---------TTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEE
T ss_pred CceEEEEEEEccCCceEEEEEEEC---------CCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccc
Confidence 347999999999999999998754 467889999987665555667889999999996 9999999999953
Q ss_pred --------CCeeEEEEEecCCCCHHHHHhh--cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCC
Q 011851 199 --------DDQRLLVYEFMPRGSLENHLFR--RSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEY 268 (476)
Q Consensus 199 --------~~~~~lV~E~~~~g~L~~~l~~--~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~ 268 (476)
...+++||||+. |+|.+++.. ....+++..++.++.||+.||.|||+.+ .+|+||||||+||||+.++
T Consensus 98 ~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~ 175 (337)
T 3ll6_A 98 GKEESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQG 175 (337)
T ss_dssp CTTTSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTS
T ss_pred cccccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCC
Confidence 345899999995 799998864 4567999999999999999999999865 3499999999999999999
Q ss_pred ceEEeecCCcCCCCCCCccc----------eeeeeecCCCCCCcchh---hcCCCCccchhhhhHHHHHHHHhCCCCCCC
Q 011851 269 NAKLSDFGLAKDGPEGDKTH----------VSTRVMGTYGYAAPEYV---MTGHLTAKSDVYSFGVVLLEMLTGRRSMDK 335 (476)
Q Consensus 269 ~vkl~DFG~a~~~~~~~~~~----------~~~~~~gt~~y~aPE~~---~~~~~~~~~DiwslGv~l~elltG~~pf~~ 335 (476)
.+||+|||+++......... ......||+.|+|||++ .+..++.++|||||||++|+|++|+.||..
T Consensus 176 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~ 255 (337)
T 3ll6_A 176 TIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFED 255 (337)
T ss_dssp CEEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC--
T ss_pred CEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcc
Confidence 99999999998764422211 11135699999999998 566789999999999999999999999975
Q ss_pred CCCCCcchhHHhhhhhhccccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011851 336 NRPNGEHNLVEWARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPL 406 (476)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~ 406 (476)
...... .. .. .........+..+.+||.+||+.||++|||+.+++++|+.+
T Consensus 256 ~~~~~~---~~-------~~----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~ 306 (337)
T 3ll6_A 256 GAKLRI---VN-------GK----------YSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEI 306 (337)
T ss_dssp ------------------------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred hhHHHh---hc-------Cc----------ccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 432110 00 00 00000011134578999999999999999999999997654
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-45 Score=355.91 Aligned_cols=259 Identities=27% Similarity=0.403 Sum_probs=197.9
Q ss_pred cCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCc---cCHHHHHHHHHHHhCCCCCceeeEEEEEE
Q 011851 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL---QGHKEWLAEVNYLGGLIHPNLVKLIGCCI 197 (476)
Q Consensus 121 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~l~~~~~ 197 (476)
++|++.+.||+|+||.||+|.+.... +.+..||||+++.... ...+.+.+|++++++++||||+++++++.
T Consensus 18 ~~y~~~~~lg~G~~g~Vy~~~~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 91 (291)
T 1u46_A 18 KDLRLLEKLGDGSFGVVRRGEWDAPS------GKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVL 91 (291)
T ss_dssp GGEEEEEECC----CCCEEEEEECTT------SCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred hHeeeeeeecCCCceeEEEEEeccCC------CceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEc
Confidence 46999999999999999999764321 2334699999876532 23467889999999999999999999988
Q ss_pred eCCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCC
Q 011851 198 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGL 277 (476)
Q Consensus 198 ~~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~ 277 (476)
+.. .++||||+++++|.+++......+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 92 ~~~-~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~ 167 (291)
T 1u46_A 92 TPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGL 167 (291)
T ss_dssp SSS-CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTT
T ss_pred cCC-ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEccccc
Confidence 764 89999999999999999776667999999999999999999999988 99999999999999999999999999
Q ss_pred cCCCCCCCccc-eeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhhccc
Q 011851 278 AKDGPEGDKTH-VSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPQLGER 355 (476)
Q Consensus 278 a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~ 355 (476)
+.......... ......+|+.|+|||++.+..++.++||||||+++|+|++ |+.||....... ...... ...
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~~~~~---~~~ 241 (291)
T 1u46_A 168 MRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ---ILHKID---KEG 241 (291)
T ss_dssp CEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HHHHHH---TSC
T ss_pred cccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHH---HHHHHH---ccC
Confidence 98764433221 2223567889999999999999999999999999999999 999997653211 111100 000
Q ss_pred cccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 011851 356 RRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKP 405 (476)
Q Consensus 356 ~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~ 405 (476)
.. ...+...+.++.++|.+||..||++|||+.+++++|+.
T Consensus 242 ~~----------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~ 281 (291)
T 1u46_A 242 ER----------LPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLE 281 (291)
T ss_dssp CC----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CC----------CCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHH
Confidence 00 00112236789999999999999999999999998764
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-45 Score=351.52 Aligned_cols=246 Identities=27% Similarity=0.417 Sum_probs=202.9
Q ss_pred hccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCCCCCceeeEEEEEEe
Q 011851 119 ATKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHPNLVKLIGCCIE 198 (476)
Q Consensus 119 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~ 198 (476)
...+|++.+.||+|+||.||+|.+. .+|+.||+|++.... ..+.+|++++++++||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~ 75 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHR---------IDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDG 75 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEET---------TTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred hccccceeeeeccCCceEEEEEEEc---------CCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEec
Confidence 4457999999999999999998764 467889999997653 356789999999999999999999865
Q ss_pred ----------------CCeeEEEEEecCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCC
Q 011851 199 ----------------DDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSN 261 (476)
Q Consensus 199 ----------------~~~~~lV~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~N 261 (476)
...+|+||||+++++|.+++... ...+++..++.++.||+.||.|||+.+ |+||||||+|
T Consensus 76 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~N 152 (284)
T 2a19_B 76 FDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSN 152 (284)
T ss_dssp EEEC---------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGG
T ss_pred cccCcccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHH
Confidence 44589999999999999999654 457999999999999999999999988 9999999999
Q ss_pred eeecCCCceEEeecCCcCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCc
Q 011851 262 ILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGE 341 (476)
Q Consensus 262 ILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~ 341 (476)
||++.++.+||+|||++........ .....||+.|+|||++.+..++.++|||||||++|+|++|..||...
T Consensus 153 il~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~----- 224 (284)
T 2a19_B 153 IFLVDTKQVKIGDFGLVTSLKNDGK---RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET----- 224 (284)
T ss_dssp EEEEETTEEEECCCTTCEESSCCSC---CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH-----
T ss_pred EEEcCCCCEEECcchhheecccccc---ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH-----
Confidence 9999999999999999987644322 23357999999999999999999999999999999999999887421
Q ss_pred chhHHhhhhhhccccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 011851 342 HNLVEWARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKP 405 (476)
Q Consensus 342 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~ 405 (476)
..... . +.+..+.. ..+..+.+||.+||+.||++|||+.+++++|..
T Consensus 225 ~~~~~----~---------~~~~~~~~----~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~ 271 (284)
T 2a19_B 225 SKFFT----D---------LRDGIISD----IFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTV 271 (284)
T ss_dssp HHHHH----H---------HHTTCCCT----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHH----H---------hhcccccc----cCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 00000 0 00111111 225678899999999999999999999999764
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-45 Score=364.95 Aligned_cols=270 Identities=20% Similarity=0.267 Sum_probs=210.6
Q ss_pred ccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccC-----------------HHHHHHHHHHHh
Q 011851 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQG-----------------HKEWLAEVNYLG 182 (476)
Q Consensus 120 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~-----------------~~~~~~E~~~l~ 182 (476)
.++|++.+.||+|+||.||+|.+ +|+.||||++....... .+.+.+|+.+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-----------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 98 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-----------DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIIT 98 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-----------TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHT
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-----------CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHH
Confidence 46899999999999999999864 57789999987532221 177899999999
Q ss_pred CCCCCceeeEEEEEEeCCeeEEEEEecCCCCHHHH------Hhhc-CCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEe
Q 011851 183 GLIHPNLVKLIGCCIEDDQRLLVYEFMPRGSLENH------LFRR-SLPLPWSIRMKIALDAAKGLAFLHE-EAEKPVIY 254 (476)
Q Consensus 183 ~l~hpnIv~l~~~~~~~~~~~lV~E~~~~g~L~~~------l~~~-~~~l~~~~~~~i~~qi~~al~~lH~-~~~~~ivH 254 (476)
+++||||+++++++.+.+..|+||||+++++|.++ +... ...+++..++.++.||+.||.|||+ .+ |+|
T Consensus 99 ~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H 175 (348)
T 2pml_X 99 DIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICH 175 (348)
T ss_dssp TCCCTTBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EEC
T ss_pred hCCCCCcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCC---Eee
Confidence 99999999999999999999999999999999998 5432 5679999999999999999999999 88 999
Q ss_pred cCCCCCCeeecCCCceEEeecCCcCCCCCCCccceeeeeecCCCCCCcchhhcC-CCCc-cchhhhhHHHHHHHHhCCCC
Q 011851 255 RDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTA-KSDVYSFGVVLLEMLTGRRS 332 (476)
Q Consensus 255 rDlKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~~DiwslGv~l~elltG~~p 332 (476)
|||||+|||++.++.+||+|||++...... ......||+.|+|||++.+. .++. ++|||||||++|||++|..|
T Consensus 176 ~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p 251 (348)
T 2pml_X 176 RDVKPSNILMDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVP 251 (348)
T ss_dssp CCCCGGGEEECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCS
T ss_pred cCCChHhEEEcCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCC
Confidence 999999999999999999999999875432 23346799999999999887 6766 99999999999999999999
Q ss_pred CCCCCCCCcchhHHhhhhhhcccc----ccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCC
Q 011851 333 MDKNRPNGEHNLVEWARPQLGERR----RFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPY 408 (476)
Q Consensus 333 f~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~ 408 (476)
|...... ............... .+................+.++.+||.+||+.||.+|||+.++++| ||
T Consensus 252 f~~~~~~--~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~h----p~ 325 (348)
T 2pml_X 252 FSLKISL--VELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKH----EW 325 (348)
T ss_dssp SCCSSCS--HHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTS----GG
T ss_pred CCCCCcH--HHHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcC----cc
Confidence 9865432 111111110000000 0000000000000112236789999999999999999999999997 99
Q ss_pred ccccc
Q 011851 409 LKDMA 413 (476)
Q Consensus 409 ~~~~~ 413 (476)
|++..
T Consensus 326 f~~~~ 330 (348)
T 2pml_X 326 LADTN 330 (348)
T ss_dssp GTTCC
T ss_pred ccCCC
Confidence 98764
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-45 Score=352.16 Aligned_cols=260 Identities=24% Similarity=0.367 Sum_probs=205.2
Q ss_pred ccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCcc--CHHHHHHHHHHHhCCCCCceeeEEEEEE
Q 011851 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQ--GHKEWLAEVNYLGGLIHPNLVKLIGCCI 197 (476)
Q Consensus 120 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~l~~~~~ 197 (476)
.++|++.+.||+|+||.||+|.+. .+|+.||+|++...... ..+.+.+|+.++++++||||+++++++.
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 75 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRK---------SDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRII 75 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEET---------TTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEEC---------CCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEe
Confidence 457999999999999999998654 46788999999765432 3456889999999999999999999886
Q ss_pred e--CCeeEEEEEecCCCCHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHHHhcC--CCCeEecCCCCCCeeecCCCce
Q 011851 198 E--DDQRLLVYEFMPRGSLENHLFRR---SLPLPWSIRMKIALDAAKGLAFLHEEA--EKPVIYRDFKTSNILLDGEYNA 270 (476)
Q Consensus 198 ~--~~~~~lV~E~~~~g~L~~~l~~~---~~~l~~~~~~~i~~qi~~al~~lH~~~--~~~ivHrDlKp~NILl~~~~~v 270 (476)
+ ....|+||||+++++|.+++... ...+++..++.++.||+.||.|||+.+ ..+|+||||||+|||++.++.+
T Consensus 76 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~ 155 (279)
T 2w5a_A 76 DRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNV 155 (279)
T ss_dssp EGGGTEEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCE
T ss_pred cCCCceEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCE
Confidence 4 56899999999999999999653 345999999999999999999999976 2349999999999999999999
Q ss_pred EEeecCCcCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhh
Q 011851 271 KLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP 350 (476)
Q Consensus 271 kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~ 350 (476)
||+|||+++....... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...... .+......
T Consensus 156 kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~~i~~ 230 (279)
T 2w5a_A 156 KLGDFGLARILNHDTS--FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK---ELAGKIRE 230 (279)
T ss_dssp EECCCCHHHHC---CH--HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHH
T ss_pred EEecCchheeeccccc--cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHH---HHHHHHhh
Confidence 9999999986543221 122357999999999999999999999999999999999999999765321 11111100
Q ss_pred hhccccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCccc
Q 011851 351 QLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKD 411 (476)
Q Consensus 351 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~ 411 (476)
. .. + .++...+.++.+||.+||+.||++||++.+|+++ +|+.+
T Consensus 231 ----~-~~-----~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~----~~~~~ 273 (279)
T 2w5a_A 231 ----G-KF-----R----RIPYRYSDELNEIITRMLNLKDYHRPSVEEILEN----PLILE 273 (279)
T ss_dssp ----T-CC-----C----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS----TTCCG
T ss_pred ----c-cc-----c----cCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhC----hhhhh
Confidence 0 00 0 0112236789999999999999999999999998 56554
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=365.66 Aligned_cols=274 Identities=21% Similarity=0.231 Sum_probs=206.0
Q ss_pred HhccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCCC-CC-----ceee
Q 011851 118 SATKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLI-HP-----NLVK 191 (476)
Q Consensus 118 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~-hp-----nIv~ 191 (476)
...++|++.+.||+|+||+||+|.+. .+++.||||+++... ....++..|+.+++.+. |+ +|++
T Consensus 51 ~~~~~y~~~~~lG~G~~g~V~~~~~~---------~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~iv~ 120 (382)
T 2vx3_A 51 KWMDRYEIDSLIGKGSFGQVVKAYDR---------VEQEWVAIKIIKNKK-AFLNQAQIEVRLLELMNKHDTEMKYYIVH 120 (382)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEET---------TTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHCSSGGGGGBCC
T ss_pred EeeeeEEEEEEEeecCCEEEEEEEEc---------CCCcEEEEEEEeccH-HHHHHHHHHHHHHHHHHhcccccceeEEE
Confidence 34678999999999999999998654 467889999997532 22355677888888774 44 4999
Q ss_pred EEEEEEeCCeeEEEEEecCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeec--CCC
Q 011851 192 LIGCCIEDDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLD--GEY 268 (476)
Q Consensus 192 l~~~~~~~~~~~lV~E~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~--~~~ 268 (476)
+++++...+..||||||++ ++|.+++.... ..+++..++.++.||+.||.|||.+. .+|+||||||+||||+ .++
T Consensus 121 ~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~-~~ivHrDlkp~NIll~~~~~~ 198 (382)
T 2vx3_A 121 LKRHFMFRNHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPE-LSIIHCDLKPENILLCNPKRS 198 (382)
T ss_dssp EEEEEEETTEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTT-TCEECCCCSGGGEEESSTTSC
T ss_pred eeeeeccCCceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCC-CCEEcCCCCcccEEEecCCCC
Confidence 9999999999999999995 59999997653 56999999999999999999999532 3399999999999994 578
Q ss_pred ceEEeecCCcCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhh
Q 011851 269 NAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA 348 (476)
Q Consensus 269 ~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~ 348 (476)
.+||+|||+++..... ....+||+.|+|||++.+..++.++|||||||++|||++|+.||...........+...
T Consensus 199 ~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~ 273 (382)
T 2vx3_A 199 AIKIVDFGSSCQLGQR-----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEV 273 (382)
T ss_dssp CEEECCCTTCEETTCC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH
T ss_pred cEEEEeccCceecccc-----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence 8999999999875432 22367999999999999999999999999999999999999999865432211111100
Q ss_pred hhhh-----ccccccccccCccc-----------------------------------------CCCCChHHHHHHHHHH
Q 011851 349 RPQL-----GERRRFYRLIDPCL-----------------------------------------EGCFSIKGAEKTIQLA 382 (476)
Q Consensus 349 ~~~~-----~~~~~~~~~~d~~l-----------------------------------------~~~~~~~~~~~~~~li 382 (476)
.... .........++... ..........++.+||
T Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli 353 (382)
T 2vx3_A 274 LGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLI 353 (382)
T ss_dssp HCSCCHHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHH
T ss_pred hCCCCHHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHH
Confidence 0000 00000000000000 0011223346899999
Q ss_pred HHhcccCCCCCCCHHHHHHHhcCCCCcccc
Q 011851 383 ASCLNRDQKARPRMSEVVEALKPLPYLKDM 412 (476)
Q Consensus 383 ~~cL~~dP~~RPt~~ell~~L~~~~~~~~~ 412 (476)
.+||+.||++|||+.|+|+| |||++.
T Consensus 354 ~~mL~~dP~~Rpta~e~L~h----p~f~~~ 379 (382)
T 2vx3_A 354 LRMLDYDPKTRIQPYYALQH----SFFKKT 379 (382)
T ss_dssp HHHTCSCTTTSCCHHHHTTS----GGGCC-
T ss_pred HHhcCCChhhCCCHHHHhcC----cccccC
Confidence 99999999999999999997 999864
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=349.69 Aligned_cols=248 Identities=28% Similarity=0.428 Sum_probs=196.3
Q ss_pred ccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCCCCCceeeEEEEEEeC
Q 011851 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHPNLVKLIGCCIED 199 (476)
Q Consensus 120 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~ 199 (476)
.++|++.+.||+|+||.||+|.+ +|+.||||+++... ..+.+.+|+.++++++||||+++++++.+.
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~-----------~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 86 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDY-----------RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEE 86 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE-----------TTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC
T ss_pred hhhceEEeEEecCCCceEEEEEE-----------cCCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcC
Confidence 35699999999999999999865 36789999997543 456789999999999999999999997654
Q ss_pred -CeeEEEEEecCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCC
Q 011851 200 -DQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGL 277 (476)
Q Consensus 200 -~~~~lV~E~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~ 277 (476)
+..|+||||+++++|.+++.... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 87 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~ 163 (278)
T 1byg_A 87 KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGL 163 (278)
T ss_dssp --CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC
T ss_pred CCceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeeccc
Confidence 47899999999999999996543 23889999999999999999999988 99999999999999999999999999
Q ss_pred cCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhhcccc
Q 011851 278 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPQLGERR 356 (476)
Q Consensus 278 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~ 356 (476)
+....... ....+++.|+|||++.+..++.++||||||+++|+|++ |+.||....... ...... ..
T Consensus 164 ~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~---~~~~~~----~~- 230 (278)
T 1byg_A 164 TKEASSTQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVPRVE----KG- 230 (278)
T ss_dssp -----------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG---HHHHHT----TT-
T ss_pred cccccccc-----cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHh----cC-
Confidence 97643321 22467899999999999999999999999999999998 999997543221 111100 00
Q ss_pred ccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 011851 357 RFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKP 405 (476)
Q Consensus 357 ~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~ 405 (476)
.....+...+..+.++|.+||+.||++|||+.++++.|+.
T Consensus 231 ---------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~ 270 (278)
T 1byg_A 231 ---------YKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEH 270 (278)
T ss_dssp ---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ---------CCCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHH
Confidence 0001122236789999999999999999999999998764
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=355.91 Aligned_cols=276 Identities=22% Similarity=0.287 Sum_probs=201.7
Q ss_pred ccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCCCCCceeeEEEEEE--
Q 011851 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHPNLVKLIGCCI-- 197 (476)
Q Consensus 120 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~-- 197 (476)
.++|++.+.||+|+||.||+|.+. .+|+.||||++........+.+.+|+.++++++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 80 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDN---------DCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPS 80 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEET---------TTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTT
T ss_pred CCceeEEEEeccCCCeEEEEEEEC---------CCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccc
Confidence 467999999999999999998654 468889999998765555677899999999999999999999873
Q ss_pred ------------eCCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeec
Q 011851 198 ------------EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLD 265 (476)
Q Consensus 198 ------------~~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~ 265 (476)
+....|+||||++ ++|.+++.. .++++..++.++.||+.||.|||+++ |+||||||+|||++
T Consensus 81 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~ 154 (320)
T 2i6l_A 81 GSQLTDDVGSLTELNSVYIVQEYME-TDLANVLEQ--GPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFIN 154 (320)
T ss_dssp SCBCCC----CCSCSEEEEEEECCS-EEHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEE
T ss_pred ccccccccccccccCceeEEeeccC-CCHHHHhhc--CCccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEc
Confidence 4467899999997 699998853 46899999999999999999999988 99999999999997
Q ss_pred -CCCceEEeecCCcCCCCCCCc-cceeeeeecCCCCCCcchhhc-CCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcc
Q 011851 266 -GEYNAKLSDFGLAKDGPEGDK-THVSTRVMGTYGYAAPEYVMT-GHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEH 342 (476)
Q Consensus 266 -~~~~vkl~DFG~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~ 342 (476)
.++.+||+|||+++....... ........||..|+|||++.+ ..++.++|||||||++|||++|+.||.........
T Consensus 155 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~ 234 (320)
T 2i6l_A 155 TEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQM 234 (320)
T ss_dssp TTTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred CCCCeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 567999999999987543211 111223567999999998876 67999999999999999999999999765432111
Q ss_pred hhHHhhhhhhc--cccccccc----cCcccC-C-----CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCcc
Q 011851 343 NLVEWARPQLG--ERRRFYRL----IDPCLE-G-----CFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLK 410 (476)
Q Consensus 343 ~~~~~~~~~~~--~~~~~~~~----~d~~l~-~-----~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~ 410 (476)
..+....+... ....+... +..... . .+....+.++.+||.+||+.||++|||+.++++| |||+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h----p~~~ 310 (320)
T 2i6l_A 235 QLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSH----PYMS 310 (320)
T ss_dssp HHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTS----HHHH
T ss_pred HHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCC----cccc
Confidence 11100000000 00000000 000000 0 0001225789999999999999999999999997 9988
Q ss_pred cccC
Q 011851 411 DMAS 414 (476)
Q Consensus 411 ~~~~ 414 (476)
....
T Consensus 311 ~~~~ 314 (320)
T 2i6l_A 311 IYSF 314 (320)
T ss_dssp TTCC
T ss_pred cccC
Confidence 6544
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-44 Score=354.91 Aligned_cols=276 Identities=25% Similarity=0.329 Sum_probs=207.8
Q ss_pred hccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCcc--CHHHHHHHHHHHhCC---CCCceeeEE
Q 011851 119 ATKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQ--GHKEWLAEVNYLGGL---IHPNLVKLI 193 (476)
Q Consensus 119 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~--~~~~~~~E~~~l~~l---~hpnIv~l~ 193 (476)
..++|++.+.||+|+||.||+|.+.. .+|+.||+|++...... ....+.+|+.+++.+ .||||++++
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~--------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~ 80 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLK--------NGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLF 80 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETT--------TTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEE
T ss_pred chhceeeeeeecccccEEEEEEEecC--------CCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeee
Confidence 45789999999999999999987631 35778999998643221 223456677776655 899999999
Q ss_pred EEEE-----eCCeeEEEEEecCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCC
Q 011851 194 GCCI-----EDDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGE 267 (476)
Q Consensus 194 ~~~~-----~~~~~~lV~E~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~ 267 (476)
+++. .....++||||++ ++|.+++.... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.+
T Consensus 81 ~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~ 156 (326)
T 1blx_A 81 DVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSS 156 (326)
T ss_dssp EEEEEEECSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTT
T ss_pred eeeeecccCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCC
Confidence 9987 5567899999997 69999997643 45999999999999999999999988 9999999999999999
Q ss_pred CceEEeecCCcCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHh
Q 011851 268 YNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEW 347 (476)
Q Consensus 268 ~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~ 347 (476)
+.+||+|||+++...... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+..
T Consensus 157 ~~~kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~ 233 (326)
T 1blx_A 157 GQIKLADFGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILD 233 (326)
T ss_dssp CCEEECSCCSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred CCEEEecCcccccccCCC---CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHH
Confidence 999999999998654321 22346799999999999999999999999999999999999999976543211111100
Q ss_pred h-h-hhhccc--------cccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCcccccC
Q 011851 348 A-R-PQLGER--------RRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDMAS 414 (476)
Q Consensus 348 ~-~-~~~~~~--------~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~~~~ 414 (476)
. . +..... ..+... .......+....+..+.+||.+||+.||++|||+.++++| |||++...
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h----p~~~~~~~ 305 (326)
T 1blx_A 234 VIGLPGEEDWPRDVALPRQAFHSK-SAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH----PYFQDLER 305 (326)
T ss_dssp HHCCCCGGGSCTTCSSCGGGSCCC-CCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS----GGGTTCCC
T ss_pred HcCCCCcccCccccccchhhhccc-CcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcC----ccccccch
Confidence 0 0 000000 000000 0000011112236788999999999999999999999987 99987654
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-45 Score=385.45 Aligned_cols=255 Identities=28% Similarity=0.421 Sum_probs=207.4
Q ss_pred hccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCCCCCceeeEEEEEEe
Q 011851 119 ATKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHPNLVKLIGCCIE 198 (476)
Q Consensus 119 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~ 198 (476)
..++|++.++||+|+||.||+|.+. .+..||||+++... ...+++.+|+++|++|+||||+++++++.+
T Consensus 265 ~~~~~~~~~~lG~G~fg~Vy~~~~~----------~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 333 (535)
T 2h8h_A 265 PRESLRLEVKLGQGCFGEVWMGTWN----------GTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 333 (535)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEET----------TTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred chhhhhhheecccCCCeEEEEEEEC----------CCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee
Confidence 3457899999999999999999765 24569999997654 345789999999999999999999999865
Q ss_pred CCeeEEEEEecCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCC
Q 011851 199 DDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGL 277 (476)
Q Consensus 199 ~~~~~lV~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~ 277 (476)
+.+||||||+++|+|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+
T Consensus 334 -~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~ 409 (535)
T 2h8h_A 334 -EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGL 409 (535)
T ss_dssp -SSCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTS
T ss_pred -ccceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEccccc
Confidence 7799999999999999999653 356899999999999999999999988 99999999999999999999999999
Q ss_pred cCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhhcccc
Q 011851 278 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPQLGERR 356 (476)
Q Consensus 278 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~ 356 (476)
++...... ........++..|+|||++.+..++.++|||||||+||||++ |+.||....... +..... ...
T Consensus 410 a~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~---~~~~i~----~~~ 481 (535)
T 2h8h_A 410 ARLIEDNE-YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE---VLDQVE----RGY 481 (535)
T ss_dssp TTTCCCHH-HHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHH---HHHHHH----TTC
T ss_pred ceecCCCc-eecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHH----cCC
Confidence 98754321 111222456788999999999999999999999999999999 999997543221 111110 000
Q ss_pred ccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011851 357 RFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPL 406 (476)
Q Consensus 357 ~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~ 406 (476)
. + + .+...+..+.+||.+||+.||++|||+.+|++.|+.+
T Consensus 482 ~---~--~-----~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~ 521 (535)
T 2h8h_A 482 R---M--P-----CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 521 (535)
T ss_dssp C---C--C-----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred C---C--C-----CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 0 0 0 1122367899999999999999999999999998865
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-45 Score=363.50 Aligned_cols=274 Identities=26% Similarity=0.301 Sum_probs=205.3
Q ss_pred ccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCcc-CHHHHHHHHHHHhCCCCCceeeEEEEEEe
Q 011851 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQ-GHKEWLAEVNYLGGLIHPNLVKLIGCCIE 198 (476)
Q Consensus 120 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~~ 198 (476)
.++|++.+.||+|+||.||+|.+. .+|+.||||++...... ....+.+|+.+|++++||||+++++++..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 80 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHK---------PTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRP 80 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEET---------TTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCC
T ss_pred ccceEEeeEEcCCCCeEEEEEEEC---------CCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecc
Confidence 467999999999999999998654 46888999999654322 23567899999999999999999999876
Q ss_pred C-----CeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEe
Q 011851 199 D-----DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLS 273 (476)
Q Consensus 199 ~-----~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~ 273 (476)
+ ...|+||||+. ++|.+++.. ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+
T Consensus 81 ~~~~~~~~~~lv~e~~~-~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~ 154 (353)
T 2b9h_A 81 DSFENFNEVYIIQELMQ-TDLHRVIST--QMLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVC 154 (353)
T ss_dssp SCSTTCCCEEEEECCCS-EEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEEC
T ss_pred cccCccceEEEEEeccC-ccHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEE
Confidence 4 67899999996 689998865 36999999999999999999999988 9999999999999999999999
Q ss_pred ecCCcCCCCCCCccc--------eeeeeecCCCCCCcchhhc-CCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchh
Q 011851 274 DFGLAKDGPEGDKTH--------VSTRVMGTYGYAAPEYVMT-GHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNL 344 (476)
Q Consensus 274 DFG~a~~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~ 344 (476)
|||+++......... .....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...........
T Consensus 155 Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~ 234 (353)
T 2b9h_A 155 DFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLL 234 (353)
T ss_dssp CCTTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred ecccccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHH
Confidence 999998654322110 1123578999999998875 6789999999999999999999999976532111110
Q ss_pred HHhhhhhhc--------ccccccccc-------CcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCc
Q 011851 345 VEWARPQLG--------ERRRFYRLI-------DPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYL 409 (476)
Q Consensus 345 ~~~~~~~~~--------~~~~~~~~~-------d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~ 409 (476)
+........ ......+.+ ...+.. .....+.++.+||.+||+.||++|||+.++++| |||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h----p~~ 309 (353)
T 2b9h_A 235 IFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEK-MFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH----PYL 309 (353)
T ss_dssp HHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHH-HSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS----GGG
T ss_pred HHHHhCCCchhccccccccchhhHHhhcccCCCCcchhh-hcccCCHHHHHHHHHhcCcCcccCCCHHHHhcC----ccc
Confidence 000000000 000000000 000000 001235688999999999999999999999997 998
Q ss_pred cccc
Q 011851 410 KDMA 413 (476)
Q Consensus 410 ~~~~ 413 (476)
+...
T Consensus 310 ~~~~ 313 (353)
T 2b9h_A 310 QTYH 313 (353)
T ss_dssp TTTC
T ss_pred cccC
Confidence 8654
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-44 Score=359.99 Aligned_cols=269 Identities=21% Similarity=0.314 Sum_probs=203.1
Q ss_pred ccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCcc--CHHHHHHHHHHHhCCCCCceeeEEEEEE
Q 011851 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQ--GHKEWLAEVNYLGGLIHPNLVKLIGCCI 197 (476)
Q Consensus 120 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~l~~~~~ 197 (476)
.++|++.+.||+|+||.||+|.+. .+|+.||||++...... ..+.+.+|+.+++.++||||+++++++.
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 111 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDK---------RSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFT 111 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEET---------TTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEC
T ss_pred cccEEEEeEEecCCCeEEEEEEEC---------CCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhhee
Confidence 468999999999999999998654 47888999999765332 2456889999999999999999999998
Q ss_pred eCCee------EEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceE
Q 011851 198 EDDQR------LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAK 271 (476)
Q Consensus 198 ~~~~~------~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vk 271 (476)
..+.. |+||||+. ++|.+++. ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+|
T Consensus 112 ~~~~~~~~~~~~lv~e~~~-~~l~~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~k 184 (371)
T 4exu_A 112 PASSLRNFYDFYLVMPFMQ-TDLQKIMG---MEFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELK 184 (371)
T ss_dssp SCSSSTTCCCCEEEEECCC-EEHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEE
T ss_pred ccCCcccceeEEEEEcccc-ccHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEE
Confidence 87765 99999996 68887773 34999999999999999999999988 99999999999999999999
Q ss_pred EeecCCcCCCCCCCccceeeeeecCCCCCCcchhhc-CCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHh-hh
Q 011851 272 LSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEW-AR 349 (476)
Q Consensus 272 l~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~-~~ 349 (476)
|+|||+++..... ....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...........+.. ..
T Consensus 185 L~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~ 259 (371)
T 4exu_A 185 ILDFGLARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTG 259 (371)
T ss_dssp ECSTTCC-------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred EEecCcccccccC-----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Confidence 9999999865332 234678999999999987 6899999999999999999999999976432211111000 00
Q ss_pred hhhcc---------ccccccccCcccCCC---CChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCccccc
Q 011851 350 PQLGE---------RRRFYRLIDPCLEGC---FSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDMA 413 (476)
Q Consensus 350 ~~~~~---------~~~~~~~~d~~l~~~---~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~~~ 413 (476)
....+ ...+...+....... .....+..+.+||.+||+.||++|||+.++++| |||+...
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h----p~f~~~~ 331 (371)
T 4exu_A 260 VPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH----PFFEPFR 331 (371)
T ss_dssp CCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS----GGGTTTC
T ss_pred CCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC----cccccCC
Confidence 00000 000000000000000 001225789999999999999999999999997 9998654
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-44 Score=356.38 Aligned_cols=268 Identities=24% Similarity=0.352 Sum_probs=194.8
Q ss_pred ccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHH--HhCCCCCceeeEEEEEE
Q 011851 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNY--LGGLIHPNLVKLIGCCI 197 (476)
Q Consensus 120 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~--l~~l~hpnIv~l~~~~~ 197 (476)
.++|++.+.||+|+||.||+|.+ +++.||||++.... ...+..|.++ +..++||||+++++++.
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~-----------~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~ 77 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL-----------DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDE 77 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE-----------TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEE
T ss_pred hHHhheeeecccCCCeEEEEEEE-----------CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheeccc
Confidence 35799999999999999999854 46789999997542 3344445544 45689999999998665
Q ss_pred e-----CCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhc---------CCCCeEecCCCCCCee
Q 011851 198 E-----DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEE---------AEKPVIYRDFKTSNIL 263 (476)
Q Consensus 198 ~-----~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~---------~~~~ivHrDlKp~NIL 263 (476)
. ...+||||||+++|+|.+++... ..++..+..++.||+.||.|||+. + |+||||||+|||
T Consensus 78 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~---ivH~Dikp~Nil 152 (336)
T 3g2f_A 78 RVTADGRMEYLLVMEYYPNGSLXKYLSLH--TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA---ISHRDLNSRNVL 152 (336)
T ss_dssp EECTTSCEEEEEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC---EECSSCSGGGEE
T ss_pred ccccCCCceEEEEEecCCCCcHHHHHhhc--ccchhHHHHHHHHHHHHHHHHHhhhccccccccc---eeecccccceEE
Confidence 3 23578999999999999999654 358999999999999999999998 6 999999999999
Q ss_pred ecCCCceEEeecCCcCCCCCCCc------cceeeeeecCCCCCCcchhhc-------CCCCccchhhhhHHHHHHHHhCC
Q 011851 264 LDGEYNAKLSDFGLAKDGPEGDK------THVSTRVMGTYGYAAPEYVMT-------GHLTAKSDVYSFGVVLLEMLTGR 330 (476)
Q Consensus 264 l~~~~~vkl~DFG~a~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwslGv~l~elltG~ 330 (476)
|+.++.+||+|||+++....... .......+||+.|+|||++.+ ..++.++|||||||++|||++|.
T Consensus 153 l~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~ 232 (336)
T 3g2f_A 153 VKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRC 232 (336)
T ss_dssp ECTTSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTB
T ss_pred EcCCCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcC
Confidence 99999999999999986543211 111223579999999999987 45677899999999999999998
Q ss_pred CCCCCCCCCCcc-hhHHhhhhhhcccccc-----ccccCcccCCC--CChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011851 331 RSMDKNRPNGEH-NLVEWARPQLGERRRF-----YRLIDPCLEGC--FSIKGAEKTIQLAASCLNRDQKARPRMSEVVEA 402 (476)
Q Consensus 331 ~pf~~~~~~~~~-~~~~~~~~~~~~~~~~-----~~~~d~~l~~~--~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~ 402 (476)
.||......... ...............+ .....+.+... .....+.++.+||.+||+.||++|||+.++++.
T Consensus 233 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~ 312 (336)
T 3g2f_A 233 TDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEER 312 (336)
T ss_dssp GGGSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred CcCCCccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHH
Confidence 877543332211 1110000000000000 00000111111 122356789999999999999999999999998
Q ss_pred hcCC
Q 011851 403 LKPL 406 (476)
Q Consensus 403 L~~~ 406 (476)
|+.+
T Consensus 313 L~~l 316 (336)
T 3g2f_A 313 MAEL 316 (336)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 7754
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=361.83 Aligned_cols=269 Identities=18% Similarity=0.227 Sum_probs=204.3
Q ss_pred ccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCCCCCceee--------
Q 011851 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHPNLVK-------- 191 (476)
Q Consensus 120 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~-------- 191 (476)
.++|++.+.||+|+||.||+|.+...... .....++.||||++... +.+.+|++++++++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~-~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~ 114 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTC-DSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYST 114 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC------------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTC
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccc-cccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccC
Confidence 35799999999999999999987642111 11114788999999754 45778999999999999987
Q ss_pred -------EEEEEEe-CCeeEEEEEecCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCe
Q 011851 192 -------LIGCCIE-DDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNI 262 (476)
Q Consensus 192 -------l~~~~~~-~~~~~lV~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NI 262 (476)
+++++.. ++..||||||+ +++|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+||
T Consensus 115 ~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NI 190 (352)
T 2jii_A 115 PLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENI 190 (352)
T ss_dssp TTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGGGE
T ss_pred CccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHE
Confidence 6778776 77899999999 99999999764 467999999999999999999999988 99999999999
Q ss_pred eecCCC--ceEEeecCCcCCCCCCCcc-----ceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCC
Q 011851 263 LLDGEY--NAKLSDFGLAKDGPEGDKT-----HVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDK 335 (476)
Q Consensus 263 Ll~~~~--~vkl~DFG~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~ 335 (476)
|++.++ .+||+|||+++........ .......||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 191 l~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 270 (352)
T 2jii_A 191 FVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTN 270 (352)
T ss_dssp EEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred EEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 999998 8999999999765432111 111235799999999999999999999999999999999999999976
Q ss_pred CCCCCcchhHHhhhhhhccccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 011851 336 NRPNGEHNLVEWARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKP 405 (476)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~ 405 (476)
...... .+.......... ...+.+.+... ...+.++.+||.+||+.||++|||+.+|++.|+.
T Consensus 271 ~~~~~~-~~~~~~~~~~~~---~~~~~~~~~~~---~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~ 333 (352)
T 2jii_A 271 CLPNTE-DIMKQKQKFVDK---PGPFVGPCGHW---IRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEA 333 (352)
T ss_dssp GTTCHH-HHHHHHHHHHHS---CCCEECTTSCE---ECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHH
T ss_pred CCcCHH-HHHHHHHhccCC---hhhhhhhcccc---CCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHH
Confidence 542221 111111111111 11111111110 1125789999999999999999999999998764
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-44 Score=354.15 Aligned_cols=264 Identities=25% Similarity=0.372 Sum_probs=205.0
Q ss_pred HHhccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhC--CCCCceeeEEE
Q 011851 117 KSATKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGG--LIHPNLVKLIG 194 (476)
Q Consensus 117 ~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~--l~hpnIv~l~~ 194 (476)
....++|++.+.||+|+||.||+|.+ +|+.||||++... ....+.+|++++.. ++||||+++++
T Consensus 38 ~~~~~~y~~~~~lg~G~~g~Vy~~~~-----------~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~ 103 (342)
T 1b6c_B 38 RTIARTIVLQESIGKGRFGEVWRGKW-----------RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIA 103 (342)
T ss_dssp HHHHHHCEEEEEEEEETTEEEEEEEE-----------TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEE
T ss_pred ccccccEEEEeeecCCCCcEEEEEEE-----------cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEe
Confidence 34456899999999999999999865 3678999999643 34567788888876 78999999999
Q ss_pred EEEeCC----eeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHH--------hcCCCCeEecCCCCCCe
Q 011851 195 CCIEDD----QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLH--------EEAEKPVIYRDFKTSNI 262 (476)
Q Consensus 195 ~~~~~~----~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH--------~~~~~~ivHrDlKp~NI 262 (476)
++.... ..|+||||+++++|.+++.+. .+++..++.++.||+.||.||| +.+ |+||||||+||
T Consensus 104 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NI 178 (342)
T 1b6c_B 104 ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNI 178 (342)
T ss_dssp EEECCCSSCCCEEEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGE
T ss_pred eecccCCccceeEEEEeecCCCcHHHHHhcc--CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHE
Confidence 998876 899999999999999999653 5899999999999999999999 666 99999999999
Q ss_pred eecCCCceEEeecCCcCCCCCCCccc--eeeeeecCCCCCCcchhhcCC------CCccchhhhhHHHHHHHHhC-----
Q 011851 263 LLDGEYNAKLSDFGLAKDGPEGDKTH--VSTRVMGTYGYAAPEYVMTGH------LTAKSDVYSFGVVLLEMLTG----- 329 (476)
Q Consensus 263 Ll~~~~~vkl~DFG~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~------~~~~~DiwslGv~l~elltG----- 329 (476)
||+.++.+||+|||++.......... ......||+.|+|||++.+.. ++.++|||||||++|||++|
T Consensus 179 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~ 258 (342)
T 1b6c_B 179 LVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGG 258 (342)
T ss_dssp EECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTT
T ss_pred EECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCC
Confidence 99999999999999997654332211 123457999999999998762 34689999999999999999
Q ss_pred -----CCCCCCCCCCCcchhHHhhhhhhccccccccccCcccCC-CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011851 330 -----RRSMDKNRPNGEHNLVEWARPQLGERRRFYRLIDPCLEG-CFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEAL 403 (476)
Q Consensus 330 -----~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~-~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L 403 (476)
..||.......... ..+...... ....+.+.. ......+..+.+|+.+||+.||++|||+.+|+++|
T Consensus 259 ~~~~~~~p~~~~~~~~~~~-~~~~~~~~~------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L 331 (342)
T 1b6c_B 259 IHEDYQLPYYDLVPSDPSV-EEMRKVVCE------QKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTL 331 (342)
T ss_dssp BCCCCCCTTTTTSCSSCCH-HHHHHHHTT------SCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHH
T ss_pred cccccccCccccCcCcccH-HHHHHHHHH------HHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHH
Confidence 77886544322111 111111000 001111111 12235577899999999999999999999999997
Q ss_pred cCC
Q 011851 404 KPL 406 (476)
Q Consensus 404 ~~~ 406 (476)
+.+
T Consensus 332 ~~i 334 (342)
T 1b6c_B 332 SQL 334 (342)
T ss_dssp HHH
T ss_pred HHH
Confidence 643
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-44 Score=386.36 Aligned_cols=250 Identities=28% Similarity=0.396 Sum_probs=198.5
Q ss_pred ccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCc--cCHHHHHHHHHHHhCCCCCceeeEEEEEEeCCeeEE
Q 011851 127 CLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL--QGHKEWLAEVNYLGGLIHPNLVKLIGCCIEDDQRLL 204 (476)
Q Consensus 127 ~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 204 (476)
+.||+|+||.||+|.+.. +.+++.||||+++.... ...+++.+|+++|++++|||||++++++. .+..+|
T Consensus 375 ~~LG~G~fG~Vy~~~~~~-------~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~~~~~l 446 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQM-------KKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AESWML 446 (635)
T ss_dssp EEEEECSSEEEEEEEEEC-------SSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSEEE
T ss_pred CEeccCCCEEEEEEEEcC-------CCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCCEEE
Confidence 479999999999997542 34678899999976433 23567999999999999999999999986 456899
Q ss_pred EEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCcCCCCCC
Q 011851 205 VYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEG 284 (476)
Q Consensus 205 V~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~ 284 (476)
|||||++|+|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++.....
T Consensus 447 v~E~~~~g~L~~~l~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~ 522 (635)
T 4fl3_A 447 VMEMAELGPLNKYLQQ-NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRAD 522 (635)
T ss_dssp EEECCTTEEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-
T ss_pred EEEccCCCCHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccC
Confidence 9999999999999954 457999999999999999999999988 999999999999999999999999999865443
Q ss_pred Cc-cceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhhcccccccccc
Q 011851 285 DK-THVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPQLGERRRFYRLI 362 (476)
Q Consensus 285 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 362 (476)
.. ........||+.|+|||++.+..++.++|||||||++|||++ |+.||...........+. . ..
T Consensus 523 ~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~---~----~~------ 589 (635)
T 4fl3_A 523 ENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE---K----GE------ 589 (635)
T ss_dssp ------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH---T----TC------
T ss_pred ccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH---c----CC------
Confidence 22 122233457889999999999999999999999999999998 999997654321111111 0 00
Q ss_pred CcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 011851 363 DPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKP 405 (476)
Q Consensus 363 d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~ 405 (476)
....+...+.++.+||.+||+.||++||++.+|++.|+.
T Consensus 590 ----~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~ 628 (635)
T 4fl3_A 590 ----RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN 628 (635)
T ss_dssp ----CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred ----CCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 001122336789999999999999999999999998764
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-44 Score=362.16 Aligned_cols=271 Identities=21% Similarity=0.277 Sum_probs=205.2
Q ss_pred ccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCCC-----------CCc
Q 011851 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLI-----------HPN 188 (476)
Q Consensus 120 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~-----------hpn 188 (476)
.++|++.+.||+|+||.||+|.+. .+++.||||++.... .....+.+|+.+++++. |||
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~ 87 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDM---------VNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANH 87 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEET---------TTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTT
T ss_pred CCeEEEEEeeeecCCeEEEEEEec---------CCCcEEEEEEecCCc-cchhhhhHHHHHHHHhhcccccchhccccch
Confidence 357999999999999999998654 467889999997542 23456788999998876 899
Q ss_pred eeeEEEEEEeCC----eeEEEEEecCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeEecCCCCCCe
Q 011851 189 LVKLIGCCIEDD----QRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALDAAKGLAFLHEE-AEKPVIYRDFKTSNI 262 (476)
Q Consensus 189 Iv~l~~~~~~~~----~~~lV~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~al~~lH~~-~~~~ivHrDlKp~NI 262 (476)
|+++++++...+ .+++||||+ +++|.+++... ...+++..+..++.||+.||.|||++ + |+||||||+||
T Consensus 88 i~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NI 163 (373)
T 1q8y_A 88 ILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENV 163 (373)
T ss_dssp BCCCCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGE
T ss_pred HHHHHHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHe
Confidence 999999998754 789999999 88999999763 45699999999999999999999997 7 99999999999
Q ss_pred eec------CCCceEEeecCCcCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCC
Q 011851 263 LLD------GEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKN 336 (476)
Q Consensus 263 Ll~------~~~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~ 336 (476)
||+ ..+.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 164 ll~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 238 (373)
T 1q8y_A 164 LMEIVDSPENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPD 238 (373)
T ss_dssp EEEEEETTTTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---
T ss_pred EEeccCCCcCcceEEEcccccccccCCC-----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence 994 4458999999999865432 22357999999999999999999999999999999999999999865
Q ss_pred CCCCcch---hHHhhhhhhcc-----------------ccccccccCc----------ccCCCCChHHHHHHHHHHHHhc
Q 011851 337 RPNGEHN---LVEWARPQLGE-----------------RRRFYRLIDP----------CLEGCFSIKGAEKTIQLAASCL 386 (476)
Q Consensus 337 ~~~~~~~---~~~~~~~~~~~-----------------~~~~~~~~d~----------~l~~~~~~~~~~~~~~li~~cL 386 (476)
....... ........... .......+.. .....++...+.++.+||.+||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 318 (373)
T 1q8y_A 239 EGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPML 318 (373)
T ss_dssp ------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGG
T ss_pred cccccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHh
Confidence 4322110 00000000000 0000000000 0011234566889999999999
Q ss_pred ccCCCCCCCHHHHHHHhcCCCCccccc
Q 011851 387 NRDQKARPRMSEVVEALKPLPYLKDMA 413 (476)
Q Consensus 387 ~~dP~~RPt~~ell~~L~~~~~~~~~~ 413 (476)
+.||++|||+.++++| |||++..
T Consensus 319 ~~dP~~Rpt~~ell~h----p~f~~~~ 341 (373)
T 1q8y_A 319 QLDPRKRADAGGLVNH----PWLKDTL 341 (373)
T ss_dssp CSSTTTCBCHHHHHTC----GGGTTCT
T ss_pred ccCccccCCHHHHhhC----hhhhccc
Confidence 9999999999999997 9998753
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-44 Score=356.32 Aligned_cols=272 Identities=20% Similarity=0.264 Sum_probs=207.5
Q ss_pred ccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCCCCCc------eeeEE
Q 011851 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHPN------LVKLI 193 (476)
Q Consensus 120 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~hpn------Iv~l~ 193 (476)
.++|++.+.||+|+||.||+|.+... .++.||||+++... ...+.+.+|+.+|+++.|++ |+.++
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~ 88 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHAR--------GKSQVALKIIRNVG-KYREAARLEINVLKKIKEKDKENKFLCVLMS 88 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTT--------TTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHHCTTSCSCBCCEE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCC--------CceEEEEEEEcccc-cchhHHHHHHHHHHHHhhcCCCCceeEEEee
Confidence 46899999999999999999876532 23689999997542 23456778999999887655 99999
Q ss_pred EEEEeCCeeEEEEEecCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeee--------
Q 011851 194 GCCIEDDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILL-------- 264 (476)
Q Consensus 194 ~~~~~~~~~~lV~E~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl-------- 264 (476)
+++...+..||||||+ +++|.+++.... ..+++..++.++.||+.||.|||+++ |+||||||+||||
T Consensus 89 ~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~ 164 (355)
T 2eu9_A 89 DWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETL 164 (355)
T ss_dssp EEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEE
T ss_pred eeeeeCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeccccccc
Confidence 9999999999999999 667777776543 57999999999999999999999988 9999999999999
Q ss_pred -----------cCCCceEEeecCCcCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCC
Q 011851 265 -----------DGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSM 333 (476)
Q Consensus 265 -----------~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf 333 (476)
+.++.+||+|||+++..... ....+||+.|+|||++.+..++.++|||||||++|||++|..||
T Consensus 165 ~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf 239 (355)
T 2eu9_A 165 YNEHKSCEEKSVKNTSIRVADFGSATFDHEH-----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLF 239 (355)
T ss_dssp ECCC-CCCEEEESCCCEEECCCTTCEETTSC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred ccccccccccccCCCcEEEeecCcccccccc-----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCC
Confidence 56789999999999864332 23367999999999999999999999999999999999999999
Q ss_pred CCCCCCCcchhHHhhhhhhcc-------cccc------------------ccccCccc-CCCCChHHHHHHHHHHHHhcc
Q 011851 334 DKNRPNGEHNLVEWARPQLGE-------RRRF------------------YRLIDPCL-EGCFSIKGAEKTIQLAASCLN 387 (476)
Q Consensus 334 ~~~~~~~~~~~~~~~~~~~~~-------~~~~------------------~~~~d~~l-~~~~~~~~~~~~~~li~~cL~ 387 (476)
...........+......... ...+ .....+.. ........+.++.+||.+||+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~ 319 (355)
T 2eu9_A 240 QTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLE 319 (355)
T ss_dssp CCSSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTC
T ss_pred CCCCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhc
Confidence 765432211111111000000 0000 00000000 001122346689999999999
Q ss_pred cCCCCCCCHHHHHHHhcCCCCccccc
Q 011851 388 RDQKARPRMSEVVEALKPLPYLKDMA 413 (476)
Q Consensus 388 ~dP~~RPt~~ell~~L~~~~~~~~~~ 413 (476)
.||++|||+.++++| |||+++.
T Consensus 320 ~dP~~Rpt~~e~l~h----p~f~~~~ 341 (355)
T 2eu9_A 320 FDPAQRITLAEALLH----PFFAGLT 341 (355)
T ss_dssp SSTTTSCCHHHHTTS----GGGGGCC
T ss_pred CChhhCcCHHHHhcC----hhhcCCC
Confidence 999999999999987 9999764
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-44 Score=348.09 Aligned_cols=260 Identities=25% Similarity=0.371 Sum_probs=208.2
Q ss_pred hccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCc--cCHHHHHHHHHHHhCCCCCceeeEEEEE
Q 011851 119 ATKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL--QGHKEWLAEVNYLGGLIHPNLVKLIGCC 196 (476)
Q Consensus 119 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~ 196 (476)
..++|++.+.||+|+||.||+|.+. .+++.||||++..... .....+.+|++++++++||||+++++++
T Consensus 20 ~~~~y~i~~~lg~G~~g~V~~~~~~---------~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 90 (287)
T 2wei_A 20 FAERYNIVCMLGKGSFGEVLKCKDR---------ITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEIL 90 (287)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEET---------TTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred HhhcceeeEEEcCCCCEEEEEEEEc---------CCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEE
Confidence 4567999999999999999998654 4678899999865432 3456789999999999999999999999
Q ss_pred EeCCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCC---CceEEe
Q 011851 197 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGE---YNAKLS 273 (476)
Q Consensus 197 ~~~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~---~~vkl~ 273 (476)
.+.+..|+||||+++++|.+++... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.+ +.+||+
T Consensus 91 ~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~ 166 (287)
T 2wei_A 91 EDSSSFYIVGELYTGGELFDEIIKR-KRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKII 166 (287)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred eCCCeEEEEEEccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEe
Confidence 9999999999999999999988654 46999999999999999999999988 9999999999999654 469999
Q ss_pred ecCCcCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhc
Q 011851 274 DFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLG 353 (476)
Q Consensus 274 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~ 353 (476)
|||++........ .....||+.|+|||++.+ .++.++||||||+++|+|++|..||...... ........
T Consensus 167 Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~~~~~~~~--- 236 (287)
T 2wei_A 167 DFGLSTCFQQNTK---MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY---DILKRVET--- 236 (287)
T ss_dssp STTGGGTBCCCSS---CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHH---
T ss_pred ccCcceeecCCCc---cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHH---HHHHHHHc---
Confidence 9999986543221 223568999999998865 4899999999999999999999999764321 11111000
Q ss_pred cccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCccccc
Q 011851 354 ERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDMA 413 (476)
Q Consensus 354 ~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~~~ 413 (476)
... ....+.. ...+.++.+||.+||+.||++|||+.+++++ |||++..
T Consensus 237 ~~~---~~~~~~~-----~~~~~~~~~li~~~l~~dp~~Rps~~ell~h----p~~~~~~ 284 (287)
T 2wei_A 237 GKY---AFDLPQW-----RTISDDAKDLIRKMLTFHPSLRITATQCLEH----PWIQKYS 284 (287)
T ss_dssp CCC---CCCSGGG-----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS----HHHHHHC
T ss_pred CCC---CCCchhh-----hhcCHHHHHHHHHHcccChhhCcCHHHHhcC----HHHhccc
Confidence 000 0000000 1125788999999999999999999999997 8887543
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-44 Score=353.17 Aligned_cols=263 Identities=27% Similarity=0.376 Sum_probs=186.5
Q ss_pred ccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCcc-CHHHHHHHHH-HHhCCCCCceeeEEEEEE
Q 011851 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQ-GHKEWLAEVN-YLGGLIHPNLVKLIGCCI 197 (476)
Q Consensus 120 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~-~~~~~~~E~~-~l~~l~hpnIv~l~~~~~ 197 (476)
.++|++.+.||+|+||.||+|.+. .+|+.||||++...... ...++..|+. +++.++||||+++++++.
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~ 91 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHK---------PSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALF 91 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEET---------TTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEc---------CCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEE
Confidence 357999999999999999998654 46888999999765332 2334556665 778889999999999999
Q ss_pred eCCeeEEEEEecCCCCHHHHHhh----cCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeEecCCCCCCeeecCCCceEE
Q 011851 198 EDDQRLLVYEFMPRGSLENHLFR----RSLPLPWSIRMKIALDAAKGLAFLHEE-AEKPVIYRDFKTSNILLDGEYNAKL 272 (476)
Q Consensus 198 ~~~~~~lV~E~~~~g~L~~~l~~----~~~~l~~~~~~~i~~qi~~al~~lH~~-~~~~ivHrDlKp~NILl~~~~~vkl 272 (476)
+++..|+||||+++ +|.+++.. ....+++..+..++.|++.||.|||+. + |+||||||+|||++.++.+||
T Consensus 92 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl 167 (327)
T 3aln_A 92 REGDCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKL 167 (327)
T ss_dssp CSSEEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEE
T ss_pred eCCceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEE
Confidence 99999999999975 88877753 256799999999999999999999998 8 999999999999999999999
Q ss_pred eecCCcCCCCCCCccceeeeeecCCCCCCcchh----hcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhh
Q 011851 273 SDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYV----MTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA 348 (476)
Q Consensus 273 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~ 348 (476)
+|||+++....... .....||+.|+|||++ .+..++.++|||||||++|+|++|+.||......... +
T Consensus 168 ~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-~---- 239 (327)
T 3aln_A 168 CDFGISGQLVDSIA---KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQ-L---- 239 (327)
T ss_dssp CCCSSSCC---------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC------------
T ss_pred ccCCCceecccccc---cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHH-H----
Confidence 99999987543221 2335799999999998 4567899999999999999999999999754321100 0
Q ss_pred hhhhccccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCcccccC
Q 011851 349 RPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDMAS 414 (476)
Q Consensus 349 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~~~~ 414 (476)
... .....+.+........+..+.+||.+||+.||++|||+.+++++ |||.....
T Consensus 240 ~~~-------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h----p~~~~~~~ 294 (327)
T 3aln_A 240 TQV-------VKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKH----PFILMYEE 294 (327)
T ss_dssp CCC-------CCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS----HHHHHHHH
T ss_pred HHH-------hcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhC----hHHHHhHh
Confidence 000 00000111111112236789999999999999999999999987 99876543
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=355.41 Aligned_cols=258 Identities=21% Similarity=0.346 Sum_probs=200.2
Q ss_pred ccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCc--cCHHHHHHHHHHHhCCCCCceeeEEEEEE
Q 011851 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL--QGHKEWLAEVNYLGGLIHPNLVKLIGCCI 197 (476)
Q Consensus 120 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~ 197 (476)
.++|++.+.||+|+||.||+|.+. ..||+|++..... ...+.+.+|+.++++++||||+++++++.
T Consensus 32 ~~~~~~~~~lg~G~~g~V~~~~~~------------~~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 99 (319)
T 2y4i_B 32 FEQLEIGELIGKGRFGQVYHGRWH------------GEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACM 99 (319)
T ss_dssp CSCEECCCBCCCSSSSEEEEEEES------------SSEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEE
T ss_pred HHHeEEeeEeccCCceEEEEEEEc------------CeEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEe
Confidence 467999999999999999999764 1399999875432 22345778999999999999999999999
Q ss_pred eCCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCC
Q 011851 198 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGL 277 (476)
Q Consensus 198 ~~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~ 277 (476)
+.+..++||||+++++|.+++......+++..++.++.||+.||.|||+++ |+||||||+|||++ ++.+||+|||+
T Consensus 100 ~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~ 175 (319)
T 2y4i_B 100 SPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGL 175 (319)
T ss_dssp CSSCEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSC
T ss_pred cCCceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCC
Confidence 999999999999999999999776667999999999999999999999988 99999999999998 67999999999
Q ss_pred cCCCCCCC---ccceeeeeecCCCCCCcchhhc---------CCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhH
Q 011851 278 AKDGPEGD---KTHVSTRVMGTYGYAAPEYVMT---------GHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV 345 (476)
Q Consensus 278 a~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~---------~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~ 345 (476)
+....... .........||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... ..
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~---~~ 252 (319)
T 2y4i_B 176 FSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEA---II 252 (319)
T ss_dssp CC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHH---HH
T ss_pred ccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HH
Confidence 87543211 1111223569999999999875 357899999999999999999999997543211 11
Q ss_pred HhhhhhhccccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCc
Q 011851 346 EWARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYL 409 (476)
Q Consensus 346 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~ 409 (476)
.. +... ..+.+. ....+.++.+|+.+||..||++|||+.++++.|+.+...
T Consensus 253 ~~----~~~~------~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~ 303 (319)
T 2y4i_B 253 WQ----MGTG------MKPNLS---QIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKR 303 (319)
T ss_dssp HH----HHTT------CCCCCC---CSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC---
T ss_pred HH----hccC------CCCCCC---cCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHh
Confidence 10 0000 001010 011245788999999999999999999999999987543
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-44 Score=354.93 Aligned_cols=259 Identities=22% Similarity=0.282 Sum_probs=178.8
Q ss_pred ccCCCccc-cccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCCCCCceeeEEEEEEe
Q 011851 120 TKSFRPEC-LLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHPNLVKLIGCCIE 198 (476)
Q Consensus 120 ~~~y~~~~-~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~ 198 (476)
.++|.+.+ +||+|+||.||+|.+. .+|+.||||++... .....+....++.+.||||+++++++..
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~---------~~~~~vavK~~~~~----~~~~~e~~~~~~~~~h~~i~~~~~~~~~ 93 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHR---------RTGQKCALKLLYDS----PKARQEVDHHWQASGGPHIVCILDVYEN 93 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEET---------TTCCEEEEEEEESS----HHHHHHHHHHHHHTTSTTBCCEEEEEEE
T ss_pred cceeEecceeeeeCCCeEEEEEEEC---------CCCCEEEEEEecCc----HHHHHHHHHHHHhcCCCChHHHHHHHhh
Confidence 45788854 6999999999998664 46888999999653 1222233344567789999999999986
Q ss_pred ----CCeeEEEEEecCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecC---CCce
Q 011851 199 ----DDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDG---EYNA 270 (476)
Q Consensus 199 ----~~~~~lV~E~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~---~~~v 270 (476)
+..++|||||+++|+|.+++.... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++. ++.+
T Consensus 94 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~ 170 (336)
T 3fhr_A 94 MHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVL 170 (336)
T ss_dssp EETTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCE
T ss_pred ccCCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceE
Confidence 456899999999999999997653 46999999999999999999999988 999999999999976 4559
Q ss_pred EEeecCCcCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhh
Q 011851 271 KLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP 350 (476)
Q Consensus 271 kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~ 350 (476)
||+|||+++...... ....+||+.|+|||++.+..++.++|||||||++|+|++|..||.............. .
T Consensus 171 kl~Dfg~~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~--~ 244 (336)
T 3fhr_A 171 KLTDFGFAKETTQNA----LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKR--R 244 (336)
T ss_dssp EECCCTTCEEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-----------------
T ss_pred EEeccccceeccccc----cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHH--h
Confidence 999999998654321 2346789999999999888999999999999999999999999976543221110000 0
Q ss_pred hhccccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCcccc
Q 011851 351 QLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDM 412 (476)
Q Consensus 351 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~~ 412 (476)
..... .....+.. ...+.++.+||.+||+.||++|||+.++++| |||++.
T Consensus 245 ~~~~~---~~~~~~~~-----~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h----p~~~~~ 294 (336)
T 3fhr_A 245 IRLGQ---YGFPNPEW-----SEVSEDAKQLIRLLLKTDPTERLTITQFMNH----PWINQS 294 (336)
T ss_dssp ---------CCCTTTS-----TTCCHHHHHHHHHHSCSSGGGSCCHHHHHHS----HHHHTG
T ss_pred hhccc---cccCchhh-----ccCCHHHHHHHHHHCCCChhHCcCHHHHhcC----cccccc
Confidence 00000 00000111 1236789999999999999999999999997 888753
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=348.87 Aligned_cols=263 Identities=27% Similarity=0.408 Sum_probs=190.1
Q ss_pred ccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccC-H-HHHHHHHHHHhCCCCCceeeEEEEEE
Q 011851 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQG-H-KEWLAEVNYLGGLIHPNLVKLIGCCI 197 (476)
Q Consensus 120 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~-~-~~~~~E~~~l~~l~hpnIv~l~~~~~ 197 (476)
.++|++.+.||+|+||.||+|.+. .+|+.||||++....... . +.+.++..+++.++||||+++++++.
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~ 94 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFR---------KTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFI 94 (318)
T ss_dssp GGGEEEEEEC------CEEEEEET---------TTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEe---------cCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEe
Confidence 356999999999999999998764 467889999997654322 2 23444556788899999999999999
Q ss_pred eCCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeEecCCCCCCeeecCCCceEEeecC
Q 011851 198 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEE-AEKPVIYRDFKTSNILLDGEYNAKLSDFG 276 (476)
Q Consensus 198 ~~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~-~~~~ivHrDlKp~NILl~~~~~vkl~DFG 276 (476)
+++..||||||+ ++.+..++......+++..++.++.||+.||.|||+. + |+||||||+|||++.++.+||+|||
T Consensus 95 ~~~~~~lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg 170 (318)
T 2dyl_A 95 TNTDVFIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFG 170 (318)
T ss_dssp CSSEEEEEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCT
T ss_pred cCCcEEEEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECC
Confidence 999999999999 6566666655567899999999999999999999995 8 9999999999999999999999999
Q ss_pred CcCCCCCCCccceeeeeecCCCCCCcchhh-----cCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhh
Q 011851 277 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQ 351 (476)
Q Consensus 277 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~ 351 (476)
++........ .....||+.|+|||++. ...++.++|||||||++|+|++|+.||...... ...... .
T Consensus 171 ~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~~---~ 242 (318)
T 2dyl_A 171 ISGRLVDDKA---KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTD--FEVLTK---V 242 (318)
T ss_dssp TC-----------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSH--HHHHHH---H
T ss_pred CchhccCCcc---ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCcc--HHHHHH---H
Confidence 9976543221 23457999999999984 457899999999999999999999999753221 111111 0
Q ss_pred hccccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCcccccCcc
Q 011851 352 LGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDMASSS 416 (476)
Q Consensus 352 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~~~~~~ 416 (476)
..... +.+.. ....+.++.+||.+||+.||.+||++.++++| |||+......
T Consensus 243 ~~~~~-------~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h----~~~~~~~~~~ 294 (318)
T 2dyl_A 243 LQEEP-------PLLPG--HMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEH----SFIKRYETLE 294 (318)
T ss_dssp HHSCC-------CCCCS--SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTS----HHHHHHHHSC
T ss_pred hccCC-------CCCCc--cCCCCHHHHHHHHHHccCChhHCcCHHHHhhC----HHHHhccccc
Confidence 00000 00000 01125789999999999999999999999987 9988764433
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=381.24 Aligned_cols=259 Identities=25% Similarity=0.381 Sum_probs=206.4
Q ss_pred hccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCcc-CHHHHHHHHHHHhCCCCCceeeEEEEEE
Q 011851 119 ATKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQ-GHKEWLAEVNYLGGLIHPNLVKLIGCCI 197 (476)
Q Consensus 119 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~ 197 (476)
..++|++.+.||+|+||.||+|.+...+ ..+..||||.+...... ..+.+.+|+.+|++++||||+++++++.
T Consensus 388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~------~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~ 461 (656)
T 2j0j_A 388 QRERIELGRCIGEGQFGDVHQGIYMSPE------NPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT 461 (656)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEECCSS------SCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccccEEEeeEEeeCCCEEEEEEEEecCC------CccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe
Confidence 3467999999999999999999875332 24677999998764332 2357889999999999999999999984
Q ss_pred eCCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCC
Q 011851 198 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGL 277 (476)
Q Consensus 198 ~~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~ 277 (476)
++..||||||+++|+|.+++......+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 462 -~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG~ 537 (656)
T 2j0j_A 462 -ENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGL 537 (656)
T ss_dssp -SSSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCC
T ss_pred -cCceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecCC
Confidence 56789999999999999999777677999999999999999999999988 99999999999999999999999999
Q ss_pred cCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhhcccc
Q 011851 278 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPQLGERR 356 (476)
Q Consensus 278 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~ 356 (476)
++........ ......+|+.|+|||++.+..++.++|||||||++|||++ |..||....... ....... ....
T Consensus 538 a~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~---~~~~i~~--~~~~ 611 (656)
T 2j0j_A 538 SRYMEDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND---VIGRIEN--GERL 611 (656)
T ss_dssp CCSCCC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HHHHHHH--TCCC
T ss_pred CeecCCCcce-eccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHH---HHHHHHc--CCCC
Confidence 9876443221 2233567889999999999999999999999999999997 999997643221 1111100 0000
Q ss_pred ccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 011851 357 RFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKP 405 (476)
Q Consensus 357 ~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~ 405 (476)
..+...+..+.+||.+||+.||++|||+.+|++.|+.
T Consensus 612 ------------~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~ 648 (656)
T 2j0j_A 612 ------------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLST 648 (656)
T ss_dssp ------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ------------CCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 0112235789999999999999999999999998764
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=354.48 Aligned_cols=268 Identities=22% Similarity=0.319 Sum_probs=202.8
Q ss_pred ccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCcc--CHHHHHHHHHHHhCCCCCceeeEEEEEE
Q 011851 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQ--GHKEWLAEVNYLGGLIHPNLVKLIGCCI 197 (476)
Q Consensus 120 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~l~~~~~ 197 (476)
.++|.+.+.||+|+||.||+|.+. .+|+.||||++...... ..+.+.+|+.+|+.++||||+++++++.
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 93 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDK---------RSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFT 93 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEET---------TTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEC
T ss_pred CceEEEeeeEecCCCeEEEEEEEC---------CCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEe
Confidence 467999999999999999998654 47888999999764332 2356789999999999999999999998
Q ss_pred eCCe------eEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceE
Q 011851 198 EDDQ------RLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAK 271 (476)
Q Consensus 198 ~~~~------~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vk 271 (476)
..+. +|+||||+. ++|.+++. ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+|
T Consensus 94 ~~~~~~~~~~~~lv~e~~~-~~l~~~~~---~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~k 166 (353)
T 3coi_A 94 PASSLRNFYDFYLVMPFMQ-TDLQKIMG---LKFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELK 166 (353)
T ss_dssp SCSSGGGCCCCEEEEECCS-EEGGGTTT---SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEE
T ss_pred cccccccceeEEEEecccc-CCHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEE
Confidence 7654 499999996 58887763 34899999999999999999999988 99999999999999999999
Q ss_pred EeecCCcCCCCCCCccceeeeeecCCCCCCcchhhc-CCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhh
Q 011851 272 LSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP 350 (476)
Q Consensus 272 l~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~ 350 (476)
|+|||+++..... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...........+.....
T Consensus 167 l~Dfg~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~ 241 (353)
T 3coi_A 167 ILDFGLARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTG 241 (353)
T ss_dssp ECSTTCTTC-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHC
T ss_pred EeecccccCCCCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence 9999999864321 234678999999999887 6789999999999999999999999976542211110000000
Q ss_pred h--------hccc------cccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCccccc
Q 011851 351 Q--------LGER------RRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDMA 413 (476)
Q Consensus 351 ~--------~~~~------~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~~~ 413 (476)
. +... ..+.......+. ......+.++.+||.+||+.||++|||+.++++| |||+...
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h----p~f~~~~ 313 (353)
T 3coi_A 242 VPGTEFVQKLNDKAAKSYIQSLPQTPRKDFT-QLFPRASPQAADLLEKMLELDVDKRLTAAQALTH----PFFEPFR 313 (353)
T ss_dssp BCCHHHHTTCSCHHHHHHHHTSCBCSSCCTT-TTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS----GGGTTTC
T ss_pred CCCHHHHHHHhhHHHHHHHHhCcCCCCccHH-HhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC----cchhhcc
Confidence 0 0000 000000000000 0112336789999999999999999999999987 9987653
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-44 Score=353.82 Aligned_cols=252 Identities=25% Similarity=0.394 Sum_probs=207.3
Q ss_pred HhccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCcc------CHHHHHHHHHHHhCCC--CCce
Q 011851 118 SATKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQ------GHKEWLAEVNYLGGLI--HPNL 189 (476)
Q Consensus 118 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~------~~~~~~~E~~~l~~l~--hpnI 189 (476)
...++|++.+.||+|+||.||+|.+. .+++.||||++...... ....+.+|+.+++++. |+||
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~---------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i 110 (320)
T 3a99_A 40 PLESQYQVGPLLGSGGFGSVYSGIRV---------SDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110 (320)
T ss_dssp CCTTTEEEEEECSSSSSCEEEEEEET---------TTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSB
T ss_pred CccCceEEEEEEeeCCCeEEEEEEEC---------CCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCc
Confidence 44568999999999999999998654 46788999999765332 1234667999999986 5999
Q ss_pred eeEEEEEEeCCeeEEEEEecCC-CCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeec-CC
Q 011851 190 VKLIGCCIEDDQRLLVYEFMPR-GSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLD-GE 267 (476)
Q Consensus 190 v~l~~~~~~~~~~~lV~E~~~~-g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~-~~ 267 (476)
+++++++.+.+..++||||+.+ ++|.+++... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++ .+
T Consensus 111 ~~~~~~~~~~~~~~lv~e~~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~ 186 (320)
T 3a99_A 111 IRLLDWFERPDSFVLILERPEPVQDLFDFITER-GALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNR 186 (320)
T ss_dssp CCEEEEEECSSEEEEEEECCSSEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTT
T ss_pred eEEEEEEecCCcEEEEEEcCCCCccHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCC
Confidence 9999999999999999999976 8999998654 57999999999999999999999988 99999999999999 78
Q ss_pred CceEEeecCCcCCCCCCCccceeeeeecCCCCCCcchhhcCCC-CccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHH
Q 011851 268 YNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHL-TAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVE 346 (476)
Q Consensus 268 ~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~ 346 (476)
+.+||+|||+++...... .....||+.|+|||++.+..+ +.++|||||||++|||++|+.||.... ...
T Consensus 187 ~~~kL~Dfg~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~-----~~~- 256 (320)
T 3a99_A 187 GELKLIDFGSGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-----EII- 256 (320)
T ss_dssp TEEEECCCTTCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-----HHH-
T ss_pred CCEEEeeCcccccccccc----ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh-----hhh-
Confidence 999999999998764322 233679999999999987765 688999999999999999999996421 000
Q ss_pred hhhhhhccccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCcccccC
Q 011851 347 WARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDMAS 414 (476)
Q Consensus 347 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~~~~ 414 (476)
. ... . +....+.++.+||.+||+.||++|||+.+|+++ |||++...
T Consensus 257 --~----~~~----~--------~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h----p~~~~~~~ 302 (320)
T 3a99_A 257 --R----GQV----F--------FRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH----PWMQDVLL 302 (320)
T ss_dssp --H----CCC----C--------CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS----GGGSSCCC
T ss_pred --c----ccc----c--------ccccCCHHHHHHHHHHccCChhhCcCHHHHhcC----HhhcCccC
Confidence 0 000 0 111225788999999999999999999999997 99987654
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=365.54 Aligned_cols=258 Identities=24% Similarity=0.332 Sum_probs=195.4
Q ss_pred cCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCC-CCCceeeEEEEEEeC
Q 011851 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGL-IHPNLVKLIGCCIED 199 (476)
Q Consensus 121 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~ 199 (476)
.+|.+.++||+|+||+||.... .+|+.||||++...... .+.+|+.+|+++ +|||||++++++.+.
T Consensus 24 ~~y~~~~~LG~G~~G~V~~~~~----------~~~~~vAvK~~~~~~~~---~~~~E~~~l~~l~~HpnIv~l~~~~~~~ 90 (432)
T 3p23_A 24 ISFCPKDVLGHGAEGTIVYRGM----------FDNRDVAVKRILPECFS---FADREVQLLRESDEHPNVIRYFCTEKDR 90 (432)
T ss_dssp EEEEEEEEEEECGGGCEEEEEE----------SSSSEEEEEEECTTTEE---ECHHHHHHHHHSCCCTTBCCEEEEEEET
T ss_pred EEEecCCeeecCcCEEEEEEEE----------eCCeEEEEEEECHHHHH---HHHHHHHHHHhccCCCCcCeEEEEEecC
Confidence 4588999999999999764321 36788999999765432 346799999998 799999999999999
Q ss_pred CeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecC-----CCceEEee
Q 011851 200 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDG-----EYNAKLSD 274 (476)
Q Consensus 200 ~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~-----~~~vkl~D 274 (476)
+..|||||||. |+|.+++......+.+..+..++.||+.||.|||+++ |+||||||+||||+. ...+||+|
T Consensus 91 ~~~~lv~E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~D 166 (432)
T 3p23_A 91 QFQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISD 166 (432)
T ss_dssp TEEEEEEECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECC
T ss_pred CEEEEEEECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEec
Confidence 99999999995 6999999776666666777899999999999999988 999999999999943 33588999
Q ss_pred cCCcCCCCCCCcc-ceeeeeecCCCCCCcchhh---cCCCCccchhhhhHHHHHHHHh-CCCCCCCCCCCCcchhHHhhh
Q 011851 275 FGLAKDGPEGDKT-HVSTRVMGTYGYAAPEYVM---TGHLTAKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWAR 349 (476)
Q Consensus 275 FG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslGv~l~ellt-G~~pf~~~~~~~~~~~~~~~~ 349 (476)
||+++........ ......+||+.|+|||++. ...++.++|||||||++|||++ |..||....... ....
T Consensus 167 FG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~----~~~~- 241 (432)
T 3p23_A 167 FGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQ----ANIL- 241 (432)
T ss_dssp TTEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHH----HHHH-
T ss_pred ccceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHH----HHHH-
Confidence 9999876433211 2233468999999999998 4567889999999999999999 999995432211 0000
Q ss_pred hhhccccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCcccccC
Q 011851 350 PQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDMAS 414 (476)
Q Consensus 350 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~~~~ 414 (476)
.. ... ...+ ......+..+.+||.+||+.||++|||+.++++| |||+....
T Consensus 242 --~~-~~~-----~~~~--~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~h----p~f~~~~~ 292 (432)
T 3p23_A 242 --LG-ACS-----LDCL--HPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKH----PFFWSLEK 292 (432)
T ss_dssp --TT-CCC-----CTTS--CTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTS----TTTCCHHH
T ss_pred --hc-cCC-----cccc--CccccccHHHHHHHHHHHhCCHhhCCCHHHHHhC----ccccChHH
Confidence 00 000 0000 0112346678899999999999999999999997 99987654
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=349.43 Aligned_cols=251 Identities=26% Similarity=0.407 Sum_probs=197.3
Q ss_pred HhccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccC------HHHHHHHHHHHhCC----CCC
Q 011851 118 SATKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQG------HKEWLAEVNYLGGL----IHP 187 (476)
Q Consensus 118 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~------~~~~~~E~~~l~~l----~hp 187 (476)
...++|++.+.||+|+||.||+|.+. .+++.||||++....... ...+.+|+.++.++ +||
T Consensus 28 ~~~~~y~~~~~lg~G~~g~Vy~~~~~---------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~ 98 (312)
T 2iwi_A 28 AFEAEYRLGPLLGKGGFGTVFAGHRL---------TDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98 (312)
T ss_dssp -----CEEEEEEEEETTEEEEEEECT---------TTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCS
T ss_pred hhhhceEEeeEEEcCCCEEEEEEEEc---------cCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCC
Confidence 34567999999999999999998654 467889999997654321 22355688888888 899
Q ss_pred ceeeEEEEEEeCCeeEEEEEe-cCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeec-
Q 011851 188 NLVKLIGCCIEDDQRLLVYEF-MPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLD- 265 (476)
Q Consensus 188 nIv~l~~~~~~~~~~~lV~E~-~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~- 265 (476)
||+++++++.+.+..++|||| +.+++|.+++... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++
T Consensus 99 ~i~~~~~~~~~~~~~~~v~e~~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~ 174 (312)
T 2iwi_A 99 GVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEK-GPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDL 174 (312)
T ss_dssp SBCCEEEEC-----CEEEEECCSSEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEET
T ss_pred CeeeEEEEEecCCeEEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeC
Confidence 999999999999999999999 7899999999654 46999999999999999999999998 99999999999999
Q ss_pred CCCceEEeecCCcCCCCCCCccceeeeeecCCCCCCcchhhcCCCC-ccchhhhhHHHHHHHHhCCCCCCCCCCCCcchh
Q 011851 266 GEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLT-AKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNL 344 (476)
Q Consensus 266 ~~~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~ 344 (476)
.++.+||+|||++....... .....||+.|+|||++.+..+. .++|||||||++|+|++|+.||.... ..
T Consensus 175 ~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-----~~ 245 (312)
T 2iwi_A 175 RRGCAKLIDFGSGALLHDEP----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ-----EI 245 (312)
T ss_dssp TTTEEEECCCSSCEECCSSC----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-----HH
T ss_pred CCCeEEEEEcchhhhcccCc----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH-----HH
Confidence 88999999999998764432 2346799999999999877664 58999999999999999999996421 10
Q ss_pred HHhhhhhhccccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCccccc
Q 011851 345 VEWARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDMA 413 (476)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~~~ 413 (476)
.. ... .++...+.++.+||.+||+.||++|||+.+++++ |||+...
T Consensus 246 ~~-------~~~------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~----~~~~~~~ 291 (312)
T 2iwi_A 246 LE-------AEL------------HFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLD----PWMQTPA 291 (312)
T ss_dssp HH-------TCC------------CCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHS----TTTCC--
T ss_pred hh-------hcc------------CCcccCCHHHHHHHHHHccCChhhCcCHHHHhcC----hhhcCch
Confidence 00 000 0112235688999999999999999999999998 9988643
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-43 Score=360.04 Aligned_cols=258 Identities=24% Similarity=0.303 Sum_probs=192.3
Q ss_pred cCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCC-CCCceeeEEEEEEeC
Q 011851 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGL-IHPNLVKLIGCCIED 199 (476)
Q Consensus 121 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~ 199 (476)
+.|.+.++||+|+||+||.+.. .+|+.||||++... ..+.+.+|+.+|+++ +||||+++++++.++
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~~----------~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~ 81 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQGS----------FQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTD 81 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEEE----------SSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECS
T ss_pred heeeccCeEeeCCCeEEEEEEE----------ECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecC
Confidence 4566778999999999986432 26889999998653 235678899999876 899999999999999
Q ss_pred CeeEEEEEecCCCCHHHHHhhcCCC------CCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCC------
Q 011851 200 DQRLLVYEFMPRGSLENHLFRRSLP------LPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGE------ 267 (476)
Q Consensus 200 ~~~~lV~E~~~~g~L~~~l~~~~~~------l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~------ 267 (476)
+.+|||||||. |+|.+++...... ..+..++.++.||+.||.|||+++ |+||||||+||||+.+
T Consensus 82 ~~~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~ 157 (434)
T 2rio_A 82 RFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTAD 157 (434)
T ss_dssp SEEEEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSC
T ss_pred CeEEEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccc
Confidence 99999999995 6999999654321 123345789999999999999988 9999999999999654
Q ss_pred -------CceEEeecCCcCCCCCCCccc--eeeeeecCCCCCCcchhhc-------CCCCccchhhhhHHHHHHHHh-CC
Q 011851 268 -------YNAKLSDFGLAKDGPEGDKTH--VSTRVMGTYGYAAPEYVMT-------GHLTAKSDVYSFGVVLLEMLT-GR 330 (476)
Q Consensus 268 -------~~vkl~DFG~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwslGv~l~ellt-G~ 330 (476)
+.+||+|||+++......... .....+||+.|+|||++.+ ..++.++|||||||++|||++ |.
T Consensus 158 ~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~ 237 (434)
T 2rio_A 158 QQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGK 237 (434)
T ss_dssp CTTCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSC
T ss_pred cccCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCC
Confidence 489999999998765432211 1234689999999999976 578999999999999999999 99
Q ss_pred CCCCCCCCCCcchhHHhhhhhhccccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCcc
Q 011851 331 RSMDKNRPNGEHNLVEWARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLK 410 (476)
Q Consensus 331 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~ 410 (476)
.||....... ..+. .. ... .+.+........+.++.+||.+||+.||++|||+.++++| |||+
T Consensus 238 ~Pf~~~~~~~-~~i~---~~----~~~-----~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h----p~f~ 300 (434)
T 2rio_A 238 HPFGDKYSRE-SNII---RG----IFS-----LDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRH----PLFW 300 (434)
T ss_dssp CTTCSTTTHH-HHHH---HT----CCC-----CCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTS----GGGS
T ss_pred CCCCCchhhH-HHHh---cC----CCC-----cccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhC----CccC
Confidence 9996543211 1110 00 000 0111112234557899999999999999999999999987 9997
Q ss_pred cc
Q 011851 411 DM 412 (476)
Q Consensus 411 ~~ 412 (476)
..
T Consensus 301 ~~ 302 (434)
T 2rio_A 301 PK 302 (434)
T ss_dssp CH
T ss_pred Cc
Confidence 54
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=368.92 Aligned_cols=265 Identities=27% Similarity=0.346 Sum_probs=203.0
Q ss_pred cCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCc-cCHHHHHHHHHHHhCCCCCceeeEEEEEEe-
Q 011851 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL-QGHKEWLAEVNYLGGLIHPNLVKLIGCCIE- 198 (476)
Q Consensus 121 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~- 198 (476)
++|++.+.||+|+||.||+|.+ ..+|+.||||+++.... ...+.+.+|+++|++++||||+++++++..
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~---------~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~ 84 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIH---------QDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGL 84 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCC---------TTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTT
T ss_pred CCeEEEEEEeeCCCeEEEEEEE---------CCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeeccc
Confidence 5799999999999999999754 35788899999876432 234568899999999999999999998765
Q ss_pred -----CCeeEEEEEecCCCCHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCc--
Q 011851 199 -----DDQRLLVYEFMPRGSLENHLFRRS--LPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYN-- 269 (476)
Q Consensus 199 -----~~~~~lV~E~~~~g~L~~~l~~~~--~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~-- 269 (476)
++..|||||||++++|.+++.... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.
T Consensus 85 ~~~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~ 161 (676)
T 3qa8_A 85 QKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRL 161 (676)
T ss_dssp CCCCTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSC
T ss_pred ccccCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCce
Confidence 677899999999999999996543 36899999999999999999999988 999999999999987765
Q ss_pred -eEEeecCCcCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhh
Q 011851 270 -AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA 348 (476)
Q Consensus 270 -vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~ 348 (476)
+||+|||++........ .....||+.|+|||++.+..++.++|||||||++|+|++|..||...... ..|.
T Consensus 162 ~vKL~DFG~a~~~~~~~~---~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~-----~~~~ 233 (676)
T 3qa8_A 162 IHKIIDLGYAKELDQGEL---CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQP-----VQWH 233 (676)
T ss_dssp EEEECSCCCCCBTTSCCC---CCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHH-----HHSS
T ss_pred eEEEcccccccccccccc---cccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccch-----hhhh
Confidence 99999999987654322 23468999999999999999999999999999999999999999653210 1110
Q ss_pred hhh-------------hccccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCccc
Q 011851 349 RPQ-------------LGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKD 411 (476)
Q Consensus 349 ~~~-------------~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~ 411 (476)
... ......+... ......+....+..+.+||.+||..||++|||+.++++| |||+.
T Consensus 234 ~~i~~~~~~~~~~~~~l~g~~~~~~~--lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~h----p~F~~ 303 (676)
T 3qa8_A 234 GKVREKSNEHIVVYDDLTGAVKFSSV--LPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNV----GCFQA 303 (676)
T ss_dssp TTCC------CCSCCCCSSSCCCCSS--SCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCC----TTHHH
T ss_pred hhhhcccchhhhhhhhhccccccccc--cCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcC----HHHHH
Confidence 000 0000000000 001122334457899999999999999999999987765 77654
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=354.27 Aligned_cols=248 Identities=18% Similarity=0.207 Sum_probs=188.3
Q ss_pred ccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCcc---CHHHHHHHHHHHhCCCC-Cce------
Q 011851 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQ---GHKEWLAEVNYLGGLIH-PNL------ 189 (476)
Q Consensus 120 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~---~~~~~~~E~~~l~~l~h-pnI------ 189 (476)
...|+..++||+|+||+||+|.+. .+|+.||||++...... ..+.+.+|+.+++.+.| .|+
T Consensus 77 ~~~~~~~~~LG~G~fG~Vy~a~~~---------~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~ 147 (413)
T 3dzo_A 77 PRTLVRGTVLGQEDPYAYLEATDQ---------ETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVH 147 (413)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEET---------TTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHH
T ss_pred ceeEEEecccccCCCEEEEEEEec---------CCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHh
Confidence 345788899999999999998754 46888999999844332 25678899999999987 221
Q ss_pred ---e------------eEEEEEEe-----CCeeEEEEEecCCCCHHHHHh------hcCCCCCHHHHHHHHHHHHHHHHH
Q 011851 190 ---V------------KLIGCCIE-----DDQRLLVYEFMPRGSLENHLF------RRSLPLPWSIRMKIALDAAKGLAF 243 (476)
Q Consensus 190 ---v------------~l~~~~~~-----~~~~~lV~E~~~~g~L~~~l~------~~~~~l~~~~~~~i~~qi~~al~~ 243 (476)
+ .++.++.. ...++++|+++ +++|.+++. .....+++..++.++.||+.||.|
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~ 226 (413)
T 3dzo_A 148 LRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLAS 226 (413)
T ss_dssp TCBCCCCEEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHH
T ss_pred cccccchhhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHH
Confidence 1 11111222 22467788876 679999884 224557888999999999999999
Q ss_pred HHhcCCCCeEecCCCCCCeeecCCCceEEeecCCcCCCCCCCccceeeeeecCCCCCCcchh----------hcCCCCcc
Q 011851 244 LHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYV----------MTGHLTAK 313 (476)
Q Consensus 244 lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~ 313 (476)
||+++ |+||||||+||||+.++.+||+|||+++..... ....+| +.|+|||++ .+..|+.+
T Consensus 227 LH~~~---iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~ 297 (413)
T 3dzo_A 227 LHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFA 297 (413)
T ss_dssp HHHTT---EECSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHH
T ss_pred HHhCC---cccCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCch
Confidence 99988 999999999999999999999999998864321 334678 999999999 44568889
Q ss_pred chhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhccccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCC
Q 011851 314 SDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKAR 393 (476)
Q Consensus 314 ~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~R 393 (476)
+|||||||++|||++|+.||.......... .++.. .. ..++++.+||.+||+.||++|
T Consensus 298 ~DvwSlGvil~elltg~~Pf~~~~~~~~~~----------------~~~~~----~~--~~~~~~~~li~~~l~~dP~~R 355 (413)
T 3dzo_A 298 FDTWTLGLAIYWIWCADLPNTDDAALGGSE----------------WIFRS----CK--NIPQPVRALLEGFLRYPKEDR 355 (413)
T ss_dssp HHHHHHHHHHHHHHHSSCCCCTTGGGSCSG----------------GGGSS----CC--CCCHHHHHHHHHHTCSSGGGS
T ss_pred hhHHHHHHHHHHHHHCCCCCCCcchhhhHH----------------HHHhh----cc--cCCHHHHHHHHHHccCChhhC
Confidence 999999999999999999997543221111 01110 00 125789999999999999999
Q ss_pred CCHHHHHHHhcCCCCcccc
Q 011851 394 PRMSEVVEALKPLPYLKDM 412 (476)
Q Consensus 394 Pt~~ell~~L~~~~~~~~~ 412 (476)
|++.+++++ |||+.+
T Consensus 356 pt~~~~l~~----~~~~~~ 370 (413)
T 3dzo_A 356 LLPLQAMET----PEYEQL 370 (413)
T ss_dssp CCHHHHTTS----HHHHHH
T ss_pred cCHHHHHhC----HHHHHH
Confidence 999999886 887764
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-41 Score=326.03 Aligned_cols=230 Identities=14% Similarity=0.090 Sum_probs=182.7
Q ss_pred ccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccC---HHHHHHHHHHHhCCCCCceeeEEEEE
Q 011851 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQG---HKEWLAEVNYLGGLIHPNLVKLIGCC 196 (476)
Q Consensus 120 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~---~~~~~~E~~~l~~l~hpnIv~l~~~~ 196 (476)
.++|++.+.||+|+||.||+|++. .+|+.||||++....... .+.+.+|+.++.+++||||+++++++
T Consensus 30 ~~~y~i~~~lg~G~~g~Vy~a~~~---------~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~ 100 (286)
T 3uqc_A 30 NGRYRLLIFHGGVPPLQFWQALDT---------ALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVV 100 (286)
T ss_dssp TTTEEEEEEEEBSTTCEEEEEEET---------TTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred cCcEEEEEEEcccCCeEEEEEEec---------CCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEE
Confidence 357999999999999999998764 468889999998664433 35788999999999999999999999
Q ss_pred EeCCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecC
Q 011851 197 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFG 276 (476)
Q Consensus 197 ~~~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG 276 (476)
.+++..||||||++|++|.+++.. + .....+..++.||+.||.|||+++ |+||||||+||||+.++.+||+++|
T Consensus 101 ~~~~~~~lv~e~~~g~~L~~~l~~-~--~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~ 174 (286)
T 3uqc_A 101 HTRAGGLVVAEWIRGGSLQEVADT-S--PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPA 174 (286)
T ss_dssp EETTEEEEEEECCCEEEHHHHHTT-C--CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCC
T ss_pred EECCcEEEEEEecCCCCHHHHHhc-C--CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEecc
Confidence 999999999999999999999843 2 355678889999999999999988 9999999999999999999998543
Q ss_pred CcCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhcccc
Q 011851 277 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERR 356 (476)
Q Consensus 277 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~ 356 (476)
|++ .++.++|||||||++|||++|+.||............. .......
T Consensus 175 ----------------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~---~~~~~~~ 222 (286)
T 3uqc_A 175 ----------------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAE---RDTAGQP 222 (286)
T ss_dssp ----------------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECC---BCTTSCB
T ss_pred ----------------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHH---HHhccCC
Confidence 443 36899999999999999999999998755432110000 0000000
Q ss_pred ccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 011851 357 RFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKP 405 (476)
Q Consensus 357 ~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~ 405 (476)
.... .+....+.++.+||.+||+.||++| |+.++++.|+.
T Consensus 223 ~~~~--------~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~ 262 (286)
T 3uqc_A 223 IEPA--------DIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQ 262 (286)
T ss_dssp CCHH--------HHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHH
T ss_pred CChh--------hcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHH
Confidence 0000 0011225789999999999999999 99999998653
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-41 Score=328.74 Aligned_cols=234 Identities=21% Similarity=0.275 Sum_probs=184.2
Q ss_pred ccCCCcc-ccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHH-hCCCCCceeeEEEEEE
Q 011851 120 TKSFRPE-CLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYL-GGLIHPNLVKLIGCCI 197 (476)
Q Consensus 120 ~~~y~~~-~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l-~~l~hpnIv~l~~~~~ 197 (476)
.++|.+. ++||+|+||.||+|.+. .+++.||||++... ..+.+|+.++ +.++||||+++++++.
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~---------~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~ 81 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNK---------RTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYE 81 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEET---------TTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEE
T ss_pred ccchhhcCcccccCCCeEEEEEEEc---------CCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhh
Confidence 3457776 78999999999998654 46888999999642 4567888887 6668999999999998
Q ss_pred e----CCeeEEEEEecCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecC---CCc
Q 011851 198 E----DDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDG---EYN 269 (476)
Q Consensus 198 ~----~~~~~lV~E~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~---~~~ 269 (476)
. +..+||||||+++++|.+++.... ..+++..++.++.||+.||.|||+++ |+||||||+|||++. ++.
T Consensus 82 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~ 158 (299)
T 3m2w_A 82 NLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAI 158 (299)
T ss_dssp EEETTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCC
T ss_pred hhcCCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCc
Confidence 7 678999999999999999997653 47999999999999999999999988 999999999999988 788
Q ss_pred eEEeecCCcCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhh
Q 011851 270 AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR 349 (476)
Q Consensus 270 vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~ 349 (476)
+||+|||++.... +..++.++|||||||++|||++|+.||............
T Consensus 159 ~kl~Dfg~a~~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~---- 210 (299)
T 3m2w_A 159 LKLTDFGFAKETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM---- 210 (299)
T ss_dssp EEECCCTTCEECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCS----
T ss_pred EEEeccccccccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHH----
Confidence 9999999986432 245678999999999999999999999754332110000
Q ss_pred hhhccccccccccCcccCCCCC----hHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCcccc
Q 011851 350 PQLGERRRFYRLIDPCLEGCFS----IKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDM 412 (476)
Q Consensus 350 ~~~~~~~~~~~~~d~~l~~~~~----~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~~ 412 (476)
... +... ...++ ...+.++.+||.+||+.||++|||+.++++| |||++.
T Consensus 211 ---~~~-----~~~~--~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~h----p~~~~~ 263 (299)
T 3m2w_A 211 ---KTR-----IRMG--QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH----PWIMQS 263 (299)
T ss_dssp ---CCS-----SCTT--CCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS----HHHHTG
T ss_pred ---HHH-----Hhhc--cccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcC----hhhccc
Confidence 000 0000 00011 1125789999999999999999999999997 888654
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-41 Score=365.01 Aligned_cols=237 Identities=26% Similarity=0.392 Sum_probs=191.5
Q ss_pred ccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCc-cCHHHHHHHHHHHhCCCCCceeeEEEEEEe
Q 011851 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL-QGHKEWLAEVNYLGGLIHPNLVKLIGCCIE 198 (476)
Q Consensus 120 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~ 198 (476)
.++|++.+.||+|+||.||+|++.. .+|+.||||++..... .....+.+|+.+|++++||||+++++++.+
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~--------~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 150 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRN--------VNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEH 150 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGG--------GTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcC--------CCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEee
Confidence 4689999999999999999997652 1577899999875432 234567899999999999999999999998
Q ss_pred CCe-----eEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEe
Q 011851 199 DDQ-----RLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLS 273 (476)
Q Consensus 199 ~~~-----~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~ 273 (476)
.+. .||||||++|++|.+++.. .+++..++.++.||+.||.|||+++ ||||||||+||||+.+ .+||+
T Consensus 151 ~~~~~~~~~~lv~E~~~g~~L~~~~~~---~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~ 223 (681)
T 2pzi_A 151 TDRHGDPVGYIVMEYVGGQSLKRSKGQ---KLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLI 223 (681)
T ss_dssp ECTTSCEEEEEEEECCCCEECC----C---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEEC
T ss_pred cCCCCCceeEEEEEeCCCCcHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEE
Confidence 766 7999999999999987743 6999999999999999999999988 9999999999999875 89999
Q ss_pred ecCCcCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhc
Q 011851 274 DFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLG 353 (476)
Q Consensus 274 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~ 353 (476)
|||+++..... ...+||+.|+|||++.+.. +.++|||||||++|+|++|..||.........
T Consensus 224 DFG~a~~~~~~------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~~----------- 285 (681)
T 2pzi_A 224 DLGAVSRINSF------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDGLP----------- 285 (681)
T ss_dssp CCTTCEETTCC------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSSCC-----------
T ss_pred ecccchhcccC------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccccccccc-----------
Confidence 99999875432 3367999999999987764 89999999999999999999888642111000
Q ss_pred cccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011851 354 ERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEA 402 (476)
Q Consensus 354 ~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~ 402 (476)
........+..+.+||.+||+.||++||+..+.+.+
T Consensus 286 -------------~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~ 321 (681)
T 2pzi_A 286 -------------EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSA 321 (681)
T ss_dssp -------------TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred -------------ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHH
Confidence 000111224678899999999999999976665554
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-42 Score=342.76 Aligned_cols=248 Identities=17% Similarity=0.146 Sum_probs=189.4
Q ss_pred ccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCc--------cCHHHHHHHHHHHhCCC------
Q 011851 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL--------QGHKEWLAEVNYLGGLI------ 185 (476)
Q Consensus 120 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~--------~~~~~~~~E~~~l~~l~------ 185 (476)
.++|++.+.||+|+||+||+|++ +|+.||||++..... ...+.+.+|+.+|+.++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-----------~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~ 87 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-----------DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEV 87 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-----------TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCS
T ss_pred cccchheeeecccCceEEEEEEe-----------CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccc
Confidence 35699999999999999999865 467899999976532 23467888999888875
Q ss_pred ---CCceeeEEEEEE------------------------------eCCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHH
Q 011851 186 ---HPNLVKLIGCCI------------------------------EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK 232 (476)
Q Consensus 186 ---hpnIv~l~~~~~------------------------------~~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~ 232 (476)
||||+++++++. +.+.+|||||||++|+|.+.+.+ ..+++..++.
T Consensus 88 ~~~h~niv~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~--~~~~~~~~~~ 165 (336)
T 2vuw_A 88 CNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT--KLSSLATAKS 165 (336)
T ss_dssp SSBCCCBCCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT--TCCCHHHHHH
T ss_pred cccCCchhhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh--cCCCHHHHHH
Confidence 888888877653 26789999999999987777744 4689999999
Q ss_pred HHHHHHHHHHHHH-hcCCCCeEecCCCCCCeeecCCC--------------------ceEEeecCCcCCCCCCCccceee
Q 011851 233 IALDAAKGLAFLH-EEAEKPVIYRDFKTSNILLDGEY--------------------NAKLSDFGLAKDGPEGDKTHVST 291 (476)
Q Consensus 233 i~~qi~~al~~lH-~~~~~~ivHrDlKp~NILl~~~~--------------------~vkl~DFG~a~~~~~~~~~~~~~ 291 (476)
++.||+.||.||| +++ |+||||||+||||+.++ .+||+|||+|+.... .
T Consensus 166 i~~qi~~aL~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~-------~ 235 (336)
T 2vuw_A 166 ILHQLTASLAVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD-------G 235 (336)
T ss_dssp HHHHHHHHHHHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET-------T
T ss_pred HHHHHHHHHHHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC-------C
Confidence 9999999999999 888 99999999999999887 899999999986532 1
Q ss_pred eeecCCCCCCcchhhcCCCCccchhhhhHHH-HHHHHhCCCCCCCCCCCCcchhHHhhhhhhccccccccccCcccCCCC
Q 011851 292 RVMGTYGYAAPEYVMTGHLTAKSDVYSFGVV-LLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRRFYRLIDPCLEGCF 370 (476)
Q Consensus 292 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~-l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 370 (476)
..+||+.|+|||++.+.. +.++||||||++ .+++++|..||... .........+..... .........
T Consensus 236 ~~~gt~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~------~~~~~~~~~~~~~~~----~~~~~~~~~ 304 (336)
T 2vuw_A 236 IVVFCDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNV------LWLHYLTDKMLKQMT----FKTKCNTPA 304 (336)
T ss_dssp EEECCCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHH------HHHHHHHHHHHHTCC----CSSCCCSHH
T ss_pred cEEEeecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcch------hhhhHHHHhhhhhhc----cCcccchhh
Confidence 358999999999998776 899999998777 88899999998421 000000000000000 000001111
Q ss_pred ChHHHHHHHHHHHHhcccCCCCCCCHHHHH-HHhcCCCCcc
Q 011851 371 SIKGAEKTIQLAASCLNRDQKARPRMSEVV-EALKPLPYLK 410 (476)
Q Consensus 371 ~~~~~~~~~~li~~cL~~dP~~RPt~~ell-~~L~~~~~~~ 410 (476)
....+.++.+||.+||+.| |+.|++ +| |||+
T Consensus 305 ~~~~s~~~~dli~~~L~~d-----sa~e~l~~H----p~f~ 336 (336)
T 2vuw_A 305 MKQIKRKIQEFHRTMLNFS-----SATDLLCQH----SLFK 336 (336)
T ss_dssp HHHHHHHHHHHHHHGGGSS-----SHHHHHHHC----GGGC
T ss_pred hhhcCHHHHHHHHHHhccC-----CHHHHHhcC----CCcC
Confidence 2345789999999999977 999999 87 8874
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-34 Score=307.12 Aligned_cols=171 Identities=18% Similarity=0.125 Sum_probs=129.2
Q ss_pred CCCceEEEEEecCCCcc----------CHHHHHHHHHHHhCC-CCCceeeEEEEEEeCCeeEEEEEecCCCCHHHHHhhc
Q 011851 153 GTGLPVAVKTLNHDGLQ----------GHKEWLAEVNYLGGL-IHPNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRR 221 (476)
Q Consensus 153 ~~g~~vAiK~~~~~~~~----------~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lV~E~~~~g~L~~~l~~~ 221 (476)
.+|+.||+|++...... ..+++.+|+++|+++ .|+||+++++++++++.+|||||||+|++|.++|.+
T Consensus 257 ~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVMEyv~G~~L~d~i~~- 335 (569)
T 4azs_A 257 FFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVMEKLPGRLLSDMLAA- 335 (569)
T ss_dssp EECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEEECCCSEEHHHHHHT-
T ss_pred cccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEEecCCCCcHHHHHHh-
Confidence 36888999999765321 234688999999999 699999999999999999999999999999999954
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCcCCCCCCCccceeeeeecCCCCCC
Q 011851 222 SLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAA 301 (476)
Q Consensus 222 ~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~a 301 (476)
..++++. .|+.||+.||+|||++| ||||||||+||||+.+|.+||+|||+|+....... .....+||+.|||
T Consensus 336 ~~~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~--~~~t~vGTp~YmA 407 (569)
T 4azs_A 336 GEEIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCS--WPTNLVQSFFVFV 407 (569)
T ss_dssp TCCCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESCC---C--CSHHHHHHHHHHH
T ss_pred CCCCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeCCCCCc--cccCceechhhcc
Confidence 4567764 58899999999999998 99999999999999999999999999987644222 2344789999999
Q ss_pred cchhhcCCCCccchhhhhHHHHHHHHhCCCCC
Q 011851 302 PEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSM 333 (476)
Q Consensus 302 PE~~~~~~~~~~~DiwslGv~l~elltG~~pf 333 (476)
||++.+ .+..++|+||+|+++++|+++..++
T Consensus 408 PE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~~ 438 (569)
T 4azs_A 408 NELFAE-NKSWNGFWRSAPVHPFNLPQPWSNW 438 (569)
T ss_dssp HHHC------------------CCCCTTHHHH
T ss_pred HHHhCC-CCCCcccccccccchhhhccccchh
Confidence 998875 4677899999999998887765543
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=4.5e-30 Score=270.98 Aligned_cols=186 Identities=18% Similarity=0.208 Sum_probs=146.3
Q ss_pred CccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccC--------HHHHHHHHHHHhCCCCCceeeEEEE
Q 011851 124 RPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQG--------HKEWLAEVNYLGGLIHPNLVKLIGC 195 (476)
Q Consensus 124 ~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~--------~~~~~~E~~~l~~l~hpnIv~l~~~ 195 (476)
...++||+|+||.||+|.. .++.+++|......... .+++.+|+++|++++||||+++..+
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~-----------~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~ 407 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY-----------LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIF 407 (540)
T ss_dssp ---------CCEEEEEEEC-----------SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEE
T ss_pred CCCCEEeeCCCEEEEEEEE-----------CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEE
Confidence 4567899999999999843 45679999875433221 2347899999999999999966666
Q ss_pred EEeCCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeec
Q 011851 196 CIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDF 275 (476)
Q Consensus 196 ~~~~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DF 275 (476)
+...+..||||||+++++|.+++.. +..++.||+.||.|||+++ |+||||||+|||++. .+||+||
T Consensus 408 ~~~~~~~~lVmE~~~ggsL~~~l~~---------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DF 473 (540)
T 3en9_A 408 DVDLDNKRIMMSYINGKLAKDVIED---------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDF 473 (540)
T ss_dssp EEETTTTEEEEECCCSEEHHHHSTT---------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCC
T ss_pred EEeCCccEEEEECCCCCCHHHHHHH---------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEEC
Confidence 6678888999999999999999854 5689999999999999988 999999999999998 9999999
Q ss_pred CCcCCCCCCCccc-----eeeeeecCCCCCCcchhhc--CCCCccchhhhhHHHHHHHHhCCCCCC
Q 011851 276 GLAKDGPEGDKTH-----VSTRVMGTYGYAAPEYVMT--GHLTAKSDVYSFGVVLLEMLTGRRSMD 334 (476)
Q Consensus 276 G~a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslGv~l~elltG~~pf~ 334 (476)
|+++......... ....++||+.|||||++.. ..|+..+|+|+..+-..+.+.++.+|.
T Consensus 474 Gla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 474 GLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp TTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred ccCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 9999865422111 1235789999999999987 678889999999999999888877663
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=3.3e-26 Score=221.93 Aligned_cols=162 Identities=15% Similarity=0.071 Sum_probs=125.7
Q ss_pred HHHhccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCcc------------------CHHHHHHH
Q 011851 116 LKSATKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQ------------------GHKEWLAE 177 (476)
Q Consensus 116 ~~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~------------------~~~~~~~E 177 (476)
+......|.+.+.||+|+||.||+|.+ .+|+.||||+++..... ....+.+|
T Consensus 85 ~~~~~~~~~~~~~iG~G~~g~Vy~~~~----------~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E 154 (282)
T 1zar_A 85 LVRSGKVDAIGKLMGEGKESAVFNCYS----------EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNE 154 (282)
T ss_dssp HHHTTSCSEEEEEEEECSSEEEEEEEE----------TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHH
T ss_pred HHhCCeEEEecCEeccCCCceEEEEEe----------CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHH
Confidence 334455677889999999999999865 26788999999653211 23457899
Q ss_pred HHHHhCCCCCceeeEEEEEEeCCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCC
Q 011851 178 VNYLGGLIHPNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDF 257 (476)
Q Consensus 178 ~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDl 257 (476)
+.+|++++ | +++++++.. +..|+||||++|++|.+ +.. .....++.||+.||.|||+.+ |+||||
T Consensus 155 ~~~l~~l~--~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~-------~~~~~i~~qi~~~l~~lH~~g---iiHrDl 219 (282)
T 1zar_A 155 FRALQKLQ--G-LAVPKVYAW-EGNAVLMELIDAKELYR-VRV-------ENPDEVLDMILEEVAKFYHRG---IVHGDL 219 (282)
T ss_dssp HHHHHHTT--T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC-------SCHHHHHHHHHHHHHHHHHTT---EECSCC
T ss_pred HHHHHhcc--C-CCcCeEEec-cceEEEEEecCCCcHHH-cch-------hhHHHHHHHHHHHHHHHHHCC---CEeCCC
Confidence 99999998 4 566665443 56799999999999988 421 234579999999999999988 999999
Q ss_pred CCCCeeecCCCceEEeecCCcCCCCCCCccceeeeeecCCCCCCcchhhc----------CCCCccchhhh
Q 011851 258 KTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT----------GHLTAKSDVYS 318 (476)
Q Consensus 258 Kp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----------~~~~~~~Diws 318 (476)
||+|||++ ++.+||+|||+++. +..|+|||++.. ..|+..+|+|.
T Consensus 220 kp~NILl~-~~~vkl~DFG~a~~---------------~~~~~a~e~l~rdv~~i~~~f~~~~~~~~~~~~ 274 (282)
T 1zar_A 220 SQYNVLVS-EEGIWIIDFPQSVE---------------VGEEGWREILERDVRNIITYFSRTYRTEKDINS 274 (282)
T ss_dssp STTSEEEE-TTEEEECCCTTCEE---------------TTSTTHHHHHHHHHHHHHHHHHHHHCCCCCHHH
T ss_pred CHHHEEEE-CCcEEEEECCCCeE---------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCChHH
Confidence 99999999 99999999999863 344899998854 34556667665
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=3.6e-22 Score=190.97 Aligned_cols=138 Identities=17% Similarity=0.045 Sum_probs=106.3
Q ss_pred CCCccccccccCCccEEEEEEccCCceeeeCCCCce--EEEEEecCCCccC------------------------HHHHH
Q 011851 122 SFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLP--VAVKTLNHDGLQG------------------------HKEWL 175 (476)
Q Consensus 122 ~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~--vAiK~~~~~~~~~------------------------~~~~~ 175 (476)
-|.+.+.||+|+||.||+|.+. .+|+. ||||+++...... ...+.
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~---------~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 118 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGV---------FDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTE 118 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEE---------ETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEc---------CCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHH
Confidence 3678899999999999999763 25778 9999976432110 12577
Q ss_pred HHHHHHhCCCCCce--eeEEEEEEeCCeeEEEEEecCC-C----CHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHH-hc
Q 011851 176 AEVNYLGGLIHPNL--VKLIGCCIEDDQRLLVYEFMPR-G----SLENHLFRRSLPLPWSIRMKIALDAAKGLAFLH-EE 247 (476)
Q Consensus 176 ~E~~~l~~l~hpnI--v~l~~~~~~~~~~~lV~E~~~~-g----~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH-~~ 247 (476)
+|+.+|.++.|++| ..++++ +..+|||||+.+ | +|.+.+.. .++..+..++.||+.+|.||| +.
T Consensus 119 ~E~~~l~~l~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~----~~~~~~~~i~~qi~~~l~~lH~~~ 190 (258)
T 1zth_A 119 KEFRNLERAKEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE----LKELDVEGIFNDVVENVKRLYQEA 190 (258)
T ss_dssp HHHHHHHHHHHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG----GGGSCHHHHHHHHHHHHHHHHHTS
T ss_pred HHHHHHHHHHhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc----cChHHHHHHHHHHHHHHHHHHHHC
Confidence 89999999988754 444442 367999999942 3 67666532 234567889999999999999 88
Q ss_pred CCCCeEecCCCCCCeeecCCCceEEeecCCcCCC
Q 011851 248 AEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDG 281 (476)
Q Consensus 248 ~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~ 281 (476)
+ |+||||||+|||++. .++|+|||+|...
T Consensus 191 g---ivHrDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 191 E---LVHADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp C---EECSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred C---EEeCCCCHHHEEEcC--cEEEEECcccccC
Confidence 8 999999999999998 8999999999764
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.74 E-value=4.3e-19 Score=177.28 Aligned_cols=136 Identities=13% Similarity=0.109 Sum_probs=99.8
Q ss_pred CCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCc-----c---------CHHH--------HHHHHH
Q 011851 122 SFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL-----Q---------GHKE--------WLAEVN 179 (476)
Q Consensus 122 ~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~-----~---------~~~~--------~~~E~~ 179 (476)
-|++...||+|+||.||+|.+. +|+.||||+++.... . .... ..+|..
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d~----------~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~ 165 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVADE----------KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFA 165 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEECT----------TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHH
T ss_pred EEEecCEeeeCCceEEEEEECC----------CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHH
Confidence 4999999999999999998653 688999999864211 0 0111 234677
Q ss_pred HHhCCCCCcee--eEEEEEEeCCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCC
Q 011851 180 YLGGLIHPNLV--KLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDF 257 (476)
Q Consensus 180 ~l~~l~hpnIv--~l~~~~~~~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDl 257 (476)
.|.+|.+.++. ..+++ ...+|||||++|+.|.++.. . .....++.||+.+|.|||+.+ ||||||
T Consensus 166 nL~rL~~~gv~vp~p~~~----~~~~LVME~i~G~~L~~l~~-----~--~~~~~l~~qll~~l~~lH~~g---IVHrDL 231 (397)
T 4gyi_A 166 FMKALYEEGFPVPEPIAQ----SRHTIVMSLVDALPMRQVSS-----V--PDPASLYADLIALILRLAKHG---LIHGDF 231 (397)
T ss_dssp HHHHHHHTTCSCCCEEEE----ETTEEEEECCSCEEGGGCCC-----C--SCHHHHHHHHHHHHHHHHHTT---EECSCC
T ss_pred HHHHHHhcCCCCCeeeec----cCceEEEEecCCccHhhhcc-----c--HHHHHHHHHHHHHHHHHHHCC---CcCCCC
Confidence 77777555442 22322 23479999999988865431 1 234567899999999999988 999999
Q ss_pred CCCCeeecCCC----------ceEEeecCCcCCC
Q 011851 258 KTSNILLDGEY----------NAKLSDFGLAKDG 281 (476)
Q Consensus 258 Kp~NILl~~~~----------~vkl~DFG~a~~~ 281 (476)
||.||||++++ .+.|+||+-+...
T Consensus 232 Kp~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 232 NEFNILIREEKDAEDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp STTSEEEEEEECSSCTTSEEEEEEECCCTTCEET
T ss_pred CHHHEEEeCCCCcccccccccceEEEEeCCcccC
Confidence 99999998776 3899999988653
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.48 E-value=1.1e-13 Score=131.88 Aligned_cols=145 Identities=14% Similarity=-0.038 Sum_probs=111.9
Q ss_pred HhccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCCC-CCceeeEEEEE
Q 011851 118 SATKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLI-HPNLVKLIGCC 196 (476)
Q Consensus 118 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~ 196 (476)
.....|++...++.|+++.||++.. .+..+++|+...........+.+|+.+|+.|. +..+.++++++
T Consensus 11 ~~l~~~~~~~~~~g~s~~~v~~~~~-----------~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~ 79 (263)
T 3tm0_A 11 KLIEKYRCVKDTEGMSPAKVYKLVG-----------ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFE 79 (263)
T ss_dssp HHHTTSEEEECCSCCSSSEEEEEEC-----------SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEE
T ss_pred HHhccceeEeeccCCCCCeEEEEEC-----------CCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEE
Confidence 3445788899999999999998642 25679999987532222345778999998884 67788999999
Q ss_pred EeCCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcC----------------------------
Q 011851 197 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEA---------------------------- 248 (476)
Q Consensus 197 ~~~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---------------------------- 248 (476)
.+.+..|+||||++|.+|.+.+. +......++.+++.+|..||+..
T Consensus 80 ~~~~~~~lv~e~i~G~~l~~~~~------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (263)
T 3tm0_A 80 RHDGWSNLLMSEADGVLCSEEYE------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADV 153 (263)
T ss_dssp EETTEEEEEEECCSSEEHHHHCC------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCC
T ss_pred ecCCceEEEEEecCCeehhhccC------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccc
Confidence 99999999999999999987641 11223477889999999999811
Q ss_pred ----------------------------CCCeEecCCCCCCeeecCCCceEEeecCCcC
Q 011851 249 ----------------------------EKPVIYRDFKTSNILLDGEYNAKLSDFGLAK 279 (476)
Q Consensus 249 ----------------------------~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~ 279 (476)
...++|+|++|.|||++++..+.|+||+.+.
T Consensus 154 ~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 154 DCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp SGGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred ccccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 0238999999999999876556799998874
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.29 E-value=4.7e-12 Score=119.81 Aligned_cols=137 Identities=16% Similarity=0.036 Sum_probs=98.2
Q ss_pred CCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCCCCCc--eeeEEEEEEeC
Q 011851 122 SFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHPN--LVKLIGCCIED 199 (476)
Q Consensus 122 ~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~hpn--Iv~l~~~~~~~ 199 (476)
.|.+..+.+.|..+.||++.. .+|..+++|+..... ...+.+|+.+|+.+.+.+ +.+++++...+
T Consensus 21 ~~~~~~~~~gg~~~~v~~~~~----------~~g~~~vlK~~~~~~---~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~ 87 (264)
T 1nd4_A 21 GYDWAQQTIGCSDAAVFRLSA----------QGRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEA 87 (264)
T ss_dssp TCEEEECSCTTSSCEEEEEEC----------TTSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECS
T ss_pred CCceEecccCCCCceEEEEec----------CCCCeEEEEeCCccc---chhhhHHHHHHHHHHhCCCCCCeEEEeccCC
Confidence 455444445666799998642 246679999986542 234678888888875434 56789888888
Q ss_pred CeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcC-------------------------------
Q 011851 200 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEA------------------------------- 248 (476)
Q Consensus 200 ~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~------------------------------- 248 (476)
+..++||||++|.+|. ... .. ...++.+++..|..||...
T Consensus 88 ~~~~~v~e~i~G~~l~--~~~----~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (264)
T 1nd4_A 88 GRDWLLLGEVPGQDLL--SSH----LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDL 158 (264)
T ss_dssp SCEEEEEECCSSEETT--TSC----CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSC
T ss_pred CCCEEEEEecCCcccC--cCc----CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhh
Confidence 8899999999998883 211 11 2356677788888888643
Q ss_pred ------------------------CCCeEecCCCCCCeeecCCCceEEeecCCcCC
Q 011851 249 ------------------------EKPVIYRDFKTSNILLDGEYNAKLSDFGLAKD 280 (476)
Q Consensus 249 ------------------------~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~ 280 (476)
...++|+|++|.|||+++++.+.|+|||.+..
T Consensus 159 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 159 DEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp CGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred hhhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 11299999999999998776677999998743
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.19 E-value=4.9e-11 Score=118.91 Aligned_cols=142 Identities=13% Similarity=0.166 Sum_probs=104.5
Q ss_pred ccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEec--CCCc-cCHHHHHHHHHHHhCCC--CCceeeEEEEEEeC
Q 011851 125 PECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLN--HDGL-QGHKEWLAEVNYLGGLI--HPNLVKLIGCCIED 199 (476)
Q Consensus 125 ~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~--~~~~-~~~~~~~~E~~~l~~l~--hpnIv~l~~~~~~~ 199 (476)
..+.|+.|.++.||+.... +..+++|+.. .... .....+.+|+.+|+.|. +..+.+++.++.+.
T Consensus 42 ~~~~l~~G~sn~~y~v~~~-----------~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~ 110 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTP-----------GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDE 110 (359)
T ss_dssp EEEECCC-CCSCEEEEECS-----------SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCT
T ss_pred eEEEcCCcccceEEEEEEC-----------CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCC
Confidence 4567899999999986432 3468888876 3221 22345778999998886 45678899888766
Q ss_pred ---CeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcC----------------------------
Q 011851 200 ---DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEA---------------------------- 248 (476)
Q Consensus 200 ---~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---------------------------- 248 (476)
+..|+||||++|..|.+.. ...++...+..++.+++..|..||...
T Consensus 111 ~~~g~~~~vme~v~G~~l~~~~---~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 187 (359)
T 3dxp_A 111 SVIGRAFYIMEFVSGRVLWDQS---LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYK 187 (359)
T ss_dssp TTTSSCEEEEECCCCBCCCCTT---CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHH
T ss_pred CccCCeEEEEEecCCeecCCCc---cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHH
Confidence 4589999999998775422 224678888899999999999999831
Q ss_pred ---------------------------CCCeEecCCCCCCeeecCCCc--eEEeecCCcCC
Q 011851 249 ---------------------------EKPVIYRDFKTSNILLDGEYN--AKLSDFGLAKD 280 (476)
Q Consensus 249 ---------------------------~~~ivHrDlKp~NILl~~~~~--vkl~DFG~a~~ 280 (476)
...++|+|+++.|||++.++. +.|+||+.+..
T Consensus 188 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 188 LSETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHCCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred hcCCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 135999999999999987753 68999998864
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.12 E-value=6.2e-11 Score=115.39 Aligned_cols=183 Identities=21% Similarity=0.208 Sum_probs=122.0
Q ss_pred cccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCCC-CCc--eeeEEEEEEeCC--
Q 011851 126 ECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLI-HPN--LVKLIGCCIEDD-- 200 (476)
Q Consensus 126 ~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~-hpn--Iv~l~~~~~~~~-- 200 (476)
.+.++.|.+..||+. +..+++|+.... .....+.+|..+|+.+. +.. +.+++......+
T Consensus 25 i~~~~~G~~n~v~~v--------------~~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~ 88 (304)
T 3sg8_A 25 IEISGEGNDCIAYEI--------------NRDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETY 88 (304)
T ss_dssp CCEEEECSSEEEEES--------------TTSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSC
T ss_pred eEecCCCCcceEEEE--------------CCEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCC
Confidence 456899999999973 145889986533 23456788999998773 322 445554433333
Q ss_pred -eeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcC-------------------------------
Q 011851 201 -QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEA------------------------------- 248 (476)
Q Consensus 201 -~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~------------------------------- 248 (476)
..|+|||+++|..|.+... ..++...+..++.+++..|..||+..
T Consensus 89 ~~~~~vm~~i~G~~l~~~~~---~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (304)
T 3sg8_A 89 QMSFAGFTKIKGVPLTPLLL---NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSREL 165 (304)
T ss_dssp SCSCEEEECCCCEECCHHHH---HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTS
T ss_pred CcceEEEcccCCeECCcccc---ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccC
Confidence 3589999999988875442 23677888888899999999998621
Q ss_pred ------------------------CCCeEecCCCCCCeeecC--CCceEEeecCCcCCCCCCCccceeeeeecCCCC---
Q 011851 249 ------------------------EKPVIYRDFKTSNILLDG--EYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGY--- 299 (476)
Q Consensus 249 ------------------------~~~ivHrDlKp~NILl~~--~~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y--- 299 (476)
...++|+|++|.|||++. ...+.|+||+.+........ ......+
T Consensus 166 ~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~D------l~~~~~~~~~ 239 (304)
T 3sg8_A 166 KGPQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDND------FISLMEDDEE 239 (304)
T ss_dssp CHHHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHH------HHTTCCTTTS
T ss_pred CcccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHH------HHHHHhhccc
Confidence 123799999999999988 45678999999865322100 0011111
Q ss_pred CCcchhhc-----CCC---------CccchhhhhHHHHHHHHhCCCCC
Q 011851 300 AAPEYVMT-----GHL---------TAKSDVYSFGVVLLEMLTGRRSM 333 (476)
Q Consensus 300 ~aPE~~~~-----~~~---------~~~~DiwslGv~l~elltG~~pf 333 (476)
..|+.... +.. ....+.|+++.++|.+.+|..+|
T Consensus 240 ~~~~~~~~~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 240 YGMEFVSKILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp CCHHHHHHHHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred cCHHHHHHHHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 23332211 111 12258999999999999998776
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.57 E-value=2.7e-07 Score=89.65 Aligned_cols=136 Identities=20% Similarity=0.128 Sum_probs=93.4
Q ss_pred cccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCCCCC---ceeeEEEEEE-eCCe
Q 011851 126 ECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHP---NLVKLIGCCI-EDDQ 201 (476)
Q Consensus 126 ~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~hp---nIv~l~~~~~-~~~~ 201 (476)
.+.++.|....||+. |..+++|+-... .....+.+|..+|+.|.+. .|.+++.+.. ..+.
T Consensus 24 v~~l~~G~~n~v~~v--------------g~~~VlR~~~~~--~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~ 87 (306)
T 3tdw_A 24 VESLGEGFRNYAILV--------------NGDWVFRFPKSQ--QGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGN 87 (306)
T ss_dssp EEEEEECSSEEEEEE--------------TTTEEEEEESSH--HHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSC
T ss_pred eeecCCCcceeEEEE--------------CCEEEEEecCCc--hHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCc
Confidence 356788888899974 345889985321 2235678899999988642 3566676664 4556
Q ss_pred eEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcC---------------------------------
Q 011851 202 RLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEA--------------------------------- 248 (476)
Q Consensus 202 ~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~--------------------------------- 248 (476)
.|+||||++|..|.+.... .++......++.++...|..||+..
T Consensus 88 ~~~v~e~i~G~~l~~~~~~---~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l 164 (306)
T 3tdw_A 88 PFVGYRKVQGQILGEDGMA---VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLL 164 (306)
T ss_dssp EEEEEECCCSEECHHHHHT---TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGS
T ss_pred eEEEEeccCCeECchhhhh---hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhccccc
Confidence 7899999999888763211 2345555555555655555555432
Q ss_pred ------------------------CCCeEecCCCCCCeeecC---CCce-EEeecCCcCC
Q 011851 249 ------------------------EKPVIYRDFKTSNILLDG---EYNA-KLSDFGLAKD 280 (476)
Q Consensus 249 ------------------------~~~ivHrDlKp~NILl~~---~~~v-kl~DFG~a~~ 280 (476)
...++|+|+++.|||++. ++.+ .|+||+.+..
T Consensus 165 ~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 165 DESLRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp CHHHHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred chhhHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 123699999999999987 4554 8999998865
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.54 E-value=2.8e-07 Score=87.47 Aligned_cols=135 Identities=18% Similarity=0.062 Sum_probs=92.9
Q ss_pred ccccCCc-cEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCCC-CCceeeEEEEEEeCCeeEEEE
Q 011851 129 LGEGGFG-CVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLI-HPNLVKLIGCCIEDDQRLLVY 206 (476)
Q Consensus 129 LG~G~fg-~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~~lV~ 206 (476)
+..|..+ .||+.... ..+..+.+|+-... ....+.+|..+|+.|. +--+.+++.++.+++..|+||
T Consensus 32 ~~~G~S~~~v~rl~~~---------~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvm 99 (272)
T 4gkh_A 32 DNVGQSGATIYRLYGK---------PNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLT 99 (272)
T ss_dssp EECSSSSCEEEEEECC---------TTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEE
T ss_pred ccCCCcCCeEEEEEec---------CCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEE
Confidence 4445554 58874322 34567899987543 2345778988888774 333678889999999999999
Q ss_pred EecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcC--------------------------------------
Q 011851 207 EFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEA-------------------------------------- 248 (476)
Q Consensus 207 E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~-------------------------------------- 248 (476)
|+++|.++.+..... ......+..++...|..||...
T Consensus 100 e~l~G~~~~~~~~~~-----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 174 (272)
T 4gkh_A 100 TAIPGKTAFQVLEEY-----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGW 174 (272)
T ss_dssp ECCCSEEHHHHHHHC-----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTC
T ss_pred EeeCCccccccccCC-----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccch
Confidence 999998887665321 1223345556666666666421
Q ss_pred -----------------CCCeEecCCCCCCeeecCCCceEEeecCCcCC
Q 011851 249 -----------------EKPVIYRDFKTSNILLDGEYNAKLSDFGLAKD 280 (476)
Q Consensus 249 -----------------~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~ 280 (476)
...++|+|+.+.|||+++++.+-|+||+.+..
T Consensus 175 ~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 175 PVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp CHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 01279999999999999877777999998753
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.38 E-value=2.6e-07 Score=91.61 Aligned_cols=85 Identities=4% Similarity=-0.101 Sum_probs=53.3
Q ss_pred cccc-cccCCccEEEEEEcc--CCceeeeCCCCceEEEEEecCCC---ccCHHHHHHHHHHHhCCC-C--CceeeEEEEE
Q 011851 126 ECLL-GEGGFGCVYKGWINM--NGTATVKPGTGLPVAVKTLNHDG---LQGHKEWLAEVNYLGGLI-H--PNLVKLIGCC 196 (476)
Q Consensus 126 ~~~L-G~G~fg~Vy~a~~~~--~~~~~~~~~~g~~vAiK~~~~~~---~~~~~~~~~E~~~l~~l~-h--pnIv~l~~~~ 196 (476)
.+.| +.|....+|+..... ++. .++..+++|+..... ......+.+|+.+|+.|. + -.+.+++.++
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~-----~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~ 99 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGR-----SIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIE 99 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTE-----EEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEE
T ss_pred EEECCCCCccceEEEEEEecccCCC-----CCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEc
Confidence 3567 888889999864320 000 014568899875432 111234667888887774 2 3467788776
Q ss_pred EeC---CeeEEEEEecCCCCHH
Q 011851 197 IED---DQRLLVYEFMPRGSLE 215 (476)
Q Consensus 197 ~~~---~~~~lV~E~~~~g~L~ 215 (476)
.+. +..|+||||++|..|.
T Consensus 100 ~~~~~~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 100 TTGDVLGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp CSSTTTSSCEEEEECCCCBCCC
T ss_pred cCCCccCCceEEEEecCCCChh
Confidence 554 3578999999887654
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.32 E-value=1.4e-06 Score=87.62 Aligned_cols=76 Identities=12% Similarity=0.044 Sum_probs=48.7
Q ss_pred cccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCc-------cCHHHHHHHHHHHhCCCC--C-ceeeEEEE
Q 011851 126 ECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL-------QGHKEWLAEVNYLGGLIH--P-NLVKLIGC 195 (476)
Q Consensus 126 ~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~-------~~~~~~~~E~~~l~~l~h--p-nIv~l~~~ 195 (476)
.+.||.|.++.||++... .+++.|+||....... ....++..|.++|+.+.. + .+.+++.+
T Consensus 35 ~~~lg~G~~n~vyrv~~~---------~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~ 105 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQ---------EHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS 105 (397)
T ss_dssp EEECCSSSSEEEEEEEC-------------CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE
T ss_pred EEECCCCceEEEEEEEEC---------CCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE
Confidence 467999999999997543 1356799998653211 123456778888886632 3 34456643
Q ss_pred EEeCCeeEEEEEecCCC
Q 011851 196 CIEDDQRLLVYEFMPRG 212 (476)
Q Consensus 196 ~~~~~~~~lV~E~~~~g 212 (476)
+.+..++||||+++.
T Consensus 106 --d~~~~~lvmE~l~g~ 120 (397)
T 2olc_A 106 --DTEMAVTVMEDLSHL 120 (397)
T ss_dssp --ETTTTEEEECCCTTS
T ss_pred --cCCccEEEEEeCCCc
Confidence 455678999999764
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.21 E-value=7.7e-06 Score=80.01 Aligned_cols=31 Identities=19% Similarity=0.178 Sum_probs=27.4
Q ss_pred CCeEecCCCCCCeeecCCCceEEeecCCcCC
Q 011851 250 KPVIYRDFKTSNILLDGEYNAKLSDFGLAKD 280 (476)
Q Consensus 250 ~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~ 280 (476)
..++|+|+++.|||++.++.+.|+||+.+..
T Consensus 222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp CCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred CceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 4599999999999998788899999998754
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.85 E-value=5e-05 Score=76.96 Aligned_cols=77 Identities=16% Similarity=0.198 Sum_probs=45.8
Q ss_pred CCeEecCCCCCCeeecCCCceEEeecCCcCCCCCCCccceeeeeec--CCCCCCcchhhcCC---CCccchhhhhHHHHH
Q 011851 250 KPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMG--TYGYAAPEYVMTGH---LTAKSDVYSFGVVLL 324 (476)
Q Consensus 250 ~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~---~~~~~DiwslGv~l~ 324 (476)
..++|+|+++.|||++.++ +.|+||+.+........ .. .... ...|++|+...... -....++..+...+|
T Consensus 232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~D--la-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (420)
T 2pyw_A 232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFD--IG-AYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTW 307 (420)
T ss_dssp CEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHH--HH-HHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHH
T ss_pred CeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHH--HH-HHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHH
Confidence 4499999999999998776 99999999875321100 00 0000 12355555443111 112244557777788
Q ss_pred HHHhCC
Q 011851 325 EMLTGR 330 (476)
Q Consensus 325 elltG~ 330 (476)
+++++.
T Consensus 308 ~~y~~~ 313 (420)
T 2pyw_A 308 NLFNKR 313 (420)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 777653
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.81 E-value=8.7e-05 Score=72.02 Aligned_cols=75 Identities=17% Similarity=0.072 Sum_probs=57.6
Q ss_pred cccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCCC---CCceeeEEEEEEeCCee
Q 011851 126 ECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLI---HPNLVKLIGCCIEDDQR 202 (476)
Q Consensus 126 ~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~---hpnIv~l~~~~~~~~~~ 202 (476)
.+.|+.|.+..+|+... .+..+++|+.... ....+..|...|+.|. ...+.+++.+....+..
T Consensus 41 ~~~l~gG~~n~~y~v~~-----------~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~ 106 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLIND-----------EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHS 106 (312)
T ss_dssp EEEECCSSSSEEEEEES-----------SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEE
T ss_pred eEEeCCccceeeeEEEE-----------CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCce
Confidence 45689999999998542 3456889987643 2456778988888773 35688889888888899
Q ss_pred EEEEEecCCCCH
Q 011851 203 LLVYEFMPRGSL 214 (476)
Q Consensus 203 ~lV~E~~~~g~L 214 (476)
|+||||++|..+
T Consensus 107 ~lvme~l~G~~~ 118 (312)
T 3jr1_A 107 FLLLEALNKSKN 118 (312)
T ss_dssp EEEEECCCCCCC
T ss_pred EEEEEeccCCCC
Confidence 999999998764
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.63 E-value=0.00016 Score=69.12 Aligned_cols=79 Identities=22% Similarity=0.183 Sum_probs=54.3
Q ss_pred CCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCCCC---CceeeEEEEEEe
Q 011851 122 SFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIH---PNLVKLIGCCIE 198 (476)
Q Consensus 122 ~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~h---pnIv~l~~~~~~ 198 (476)
...-.+.+|.|..+.||+.... +|+.|.+|+...........+..|...|+.|.- --+.+++.+
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l~----------DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--- 82 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVELA----------DGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW--- 82 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEET----------TSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE---
T ss_pred CeEEEEecCCCCCeEEEEEEEC----------CCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec---
Confidence 3445677999999999997543 678899998765544434457789888887632 234555554
Q ss_pred CCeeEEEEEecCCCCH
Q 011851 199 DDQRLLVYEFMPRGSL 214 (476)
Q Consensus 199 ~~~~~lV~E~~~~g~L 214 (476)
+.-++||||++++..
T Consensus 83 -~~~~lv~e~l~~~~~ 97 (288)
T 3f7w_A 83 -DDRTLAMEWVDERPP 97 (288)
T ss_dssp -ETTEEEEECCCCCCC
T ss_pred -cCceEEEEeecccCC
Confidence 234889999987643
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.61 E-value=8e-05 Score=72.27 Aligned_cols=157 Identities=14% Similarity=0.154 Sum_probs=83.8
Q ss_pred cChhHHHHhccCCCc-----cccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCCC
Q 011851 111 FSFNELKSATKSFRP-----ECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLI 185 (476)
Q Consensus 111 ~~~~~~~~~~~~y~~-----~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~ 185 (476)
++.+++.....+|.+ .+.|+.|....+|+.... .| .+++|+..... ....+..|+.++..|.
T Consensus 7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~----------~g-~~vlk~~~~~~--~~~~l~~e~~~l~~L~ 73 (322)
T 2ppq_A 7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTT----------KD-PLILTLYEKRV--EKNDLPFFLGLMQHLA 73 (322)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEES----------SC-CEEEEEECC-----CCHHHHHHHHHHHHH
T ss_pred CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeC----------Cc-cEEEEEeCCCC--CHHHHHHHHHHHHHHH
Confidence 344555555555655 234667888889986432 23 58899987531 1234556777666553
Q ss_pred -----CCceeeEE-E--EEEeCCeeEEEEEecCCCCHHH--------------HHhhc--C--CC----CC---HHHHHH
Q 011851 186 -----HPNLVKLI-G--CCIEDDQRLLVYEFMPRGSLEN--------------HLFRR--S--LP----LP---WSIRMK 232 (476)
Q Consensus 186 -----hpnIv~l~-~--~~~~~~~~~lV~E~~~~g~L~~--------------~l~~~--~--~~----l~---~~~~~~ 232 (476)
-|.++... + +....+..++||+|++|..+.. .++.. . .+ .. |.....
T Consensus 74 ~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~ 153 (322)
T 2ppq_A 74 AKGLSCPLPLPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWD 153 (322)
T ss_dssp HTTCCCCCBCCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHH
T ss_pred HCCCCCCcccCCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHH
Confidence 23333210 0 1223467799999998865311 01111 1 01 11 111000
Q ss_pred ------------HHHHHHHHHHHHHhcC----CCCeEecCCCCCCeeecCCCceEEeecCCcCC
Q 011851 233 ------------IALDAAKGLAFLHEEA----EKPVIYRDFKTSNILLDGEYNAKLSDFGLAKD 280 (476)
Q Consensus 233 ------------i~~qi~~al~~lH~~~----~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~ 280 (476)
+...+...+.+++... ...++|+|+.+.|||++++..+.|+||+.+..
T Consensus 154 ~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 154 KSEERADEVEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp HHGGGGGGTSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHHhhhhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 0112344555565321 23489999999999998876568999997743
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.48 E-value=0.00061 Score=61.68 Aligned_cols=99 Identities=14% Similarity=0.070 Sum_probs=66.7
Q ss_pred CCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCcCCCCCCCccceee
Q 011851 212 GSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVST 291 (476)
Q Consensus 212 g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~ 291 (476)
-+|.+.|...+.+++++++|.++.|.+.+|.-+-... . -..+=+-|..|+|..+|.|-+.+ +.+.
T Consensus 33 vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~-~-~~~~i~~~~~i~l~~dG~V~f~~-~~s~------------ 97 (229)
T 2yle_A 33 LSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRR-Q-PRHRVRSAAQIRVWRDGAVTLAP-AADD------------ 97 (229)
T ss_dssp EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT-C-CCCCCCSGGGEEEETTSCEEECC-C---------------
T ss_pred ccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcc-c-CCceecCCcceEEecCCceeccc-cccc------------
Confidence 3899999888999999999999999999987762211 0 11233456889999999988764 2111
Q ss_pred eeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHh
Q 011851 292 RVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLT 328 (476)
Q Consensus 292 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~ellt 328 (476)
.....+.|||... ...+.+.=|||||++||..+-
T Consensus 98 --~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALD 131 (229)
T 2yle_A 98 --AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALD 131 (229)
T ss_dssp -----------CCSS-SSSCHHHHHHHHHHHHHHHHT
T ss_pred --ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhh
Confidence 0122367888653 345677889999999999985
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.41 E-value=0.00073 Score=65.55 Aligned_cols=140 Identities=14% Similarity=0.078 Sum_probs=77.8
Q ss_pred ccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCCCCC--ceeeEEEE-----EEeC
Q 011851 127 CLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHP--NLVKLIGC-----CIED 199 (476)
Q Consensus 127 ~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~hp--nIv~l~~~-----~~~~ 199 (476)
..|+ |....||+... .+|+.+++|+.+... .....+..|..+++.|... .+.+++.. ...+
T Consensus 32 ~~l~-g~~n~~y~v~~----------~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~ 99 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQD----------EDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQ 99 (328)
T ss_dssp EEEC-CSSSEEEEECC----------TTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEET
T ss_pred Eeec-CcccceEEEEc----------CCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEEC
Confidence 3466 77888997532 245679999986432 2345666787777766321 23444332 2235
Q ss_pred CeeEEEEEecCCCCHH-----HH---------Hhh--cC------CCCCHHHH----HHH---------------HHHHH
Q 011851 200 DQRLLVYEFMPRGSLE-----NH---------LFR--RS------LPLPWSIR----MKI---------------ALDAA 238 (476)
Q Consensus 200 ~~~~lV~E~~~~g~L~-----~~---------l~~--~~------~~l~~~~~----~~i---------------~~qi~ 238 (476)
+..++||||++|..+. .. ++. .. ...+.... ..+ ...+-
T Consensus 100 g~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 179 (328)
T 1zyl_A 100 GFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATD 179 (328)
T ss_dssp TEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHH
T ss_pred CEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHH
Confidence 5678999999875432 11 111 00 01121110 001 11111
Q ss_pred HHHHHHHhc----CCCCeEecCCCCCCeeecCCCceEEeecCCcCC
Q 011851 239 KGLAFLHEE----AEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKD 280 (476)
Q Consensus 239 ~al~~lH~~----~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~ 280 (476)
..++.+... ....++|+|+++.|||++ + .+.|+||+.+..
T Consensus 180 ~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 180 ELIAAVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp HHHHHHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred HHHHHHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 223333221 223489999999999999 4 899999998754
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.34 E-value=0.0011 Score=64.51 Aligned_cols=32 Identities=34% Similarity=0.371 Sum_probs=27.4
Q ss_pred CCeEecCCCCCCeeecCC----CceEEeecCCcCCC
Q 011851 250 KPVIYRDFKTSNILLDGE----YNAKLSDFGLAKDG 281 (476)
Q Consensus 250 ~~ivHrDlKp~NILl~~~----~~vkl~DFG~a~~~ 281 (476)
..++|+|+.+.|||++.+ +.+.|+||+.+...
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 449999999999999874 67999999988653
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.32 E-value=0.00022 Score=68.65 Aligned_cols=136 Identities=8% Similarity=0.016 Sum_probs=72.9
Q ss_pred cccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCCCCCce-eeEEEEEEeCCeeEE
Q 011851 126 ECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHPNL-VKLIGCCIEDDQRLL 204 (476)
Q Consensus 126 ~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~hpnI-v~l~~~~~~~~~~~l 204 (476)
.+.|+.|....+|+. ..+++|+........ -...+|+.+++.+...++ .+++.+ +.+.-++
T Consensus 23 i~~l~gG~tN~~~~~---------------~~~vlR~~~~~~~~~-~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~ 84 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA---------------GDLCLRIPGKGTEEY-INRANEAVAAREAAKAGVSPEVLHV--DPATGVM 84 (301)
T ss_dssp CEEEESCSSEEEEEE---------------TTEEEEEECC----C-CCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCE
T ss_pred eeEcCCcccccccee---------------eeEEEECCCCCccce-eCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEE
Confidence 677888999999985 238888876532111 112357766665532222 455543 4445689
Q ss_pred EEEec-CCCCHHHH------------------HhhcCCCC----C-HHHHHHHHH--------------HHHHHHHHH--
Q 011851 205 VYEFM-PRGSLENH------------------LFRRSLPL----P-WSIRMKIAL--------------DAAKGLAFL-- 244 (476)
Q Consensus 205 V~E~~-~~g~L~~~------------------l~~~~~~l----~-~~~~~~i~~--------------qi~~al~~l-- 244 (476)
|+||+ +|.+|... ++.....+ . +.....+.. .+...+..+
T Consensus 85 v~e~i~~g~~l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~ 164 (301)
T 3dxq_A 85 VTRYIAGAQTMSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRS 164 (301)
T ss_dssp EEECCTTCEECCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHH
T ss_pred EEeecCCCccCCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHH
Confidence 99999 66544311 01111111 1 111111111 011111111
Q ss_pred --Hh-cCCCCeEecCCCCCCeeecCCCceEEeecCCcCC
Q 011851 245 --HE-EAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKD 280 (476)
Q Consensus 245 --H~-~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~ 280 (476)
.. .....++|+|+.+.||| ..++.+.|+||..+..
T Consensus 165 ~l~~~~~~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 165 ALAAHPLPLAACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp HHHSSCCCCEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred HHHhcCCCceeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 11 11234899999999999 5567889999998764
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.16 E-value=0.00082 Score=66.91 Aligned_cols=147 Identities=15% Similarity=0.094 Sum_probs=80.9
Q ss_pred ccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCCC-CCceeeEEEEEEeCCeeEEE
Q 011851 127 CLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLI-HPNLVKLIGCCIEDDQRLLV 205 (476)
Q Consensus 127 ~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~~lV 205 (476)
+.|..|-...+|+........ .....+..|.+|+.... ......+.+|..+++.|. +.-..++++++.+ .+|
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~--~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v 128 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLP--SVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRL 128 (379)
T ss_dssp EEC-----CCEEEEECCTTSC--CCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEE
T ss_pred EEcCCcccccEEEEEeCCCcc--ccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccE
Confidence 457678888999875431100 00123567999986432 233455668988888774 2223566665432 299
Q ss_pred EEecCCCCHHH----------HH-------hhcC----CCCC--HHHHHHHHHHHHH-------------------HHHH
Q 011851 206 YEFMPRGSLEN----------HL-------FRRS----LPLP--WSIRMKIALDAAK-------------------GLAF 243 (476)
Q Consensus 206 ~E~~~~g~L~~----------~l-------~~~~----~~l~--~~~~~~i~~qi~~-------------------al~~ 243 (476)
|||++|..|.. .+ +... .... +..+..+..++.. .+..
T Consensus 129 ~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 208 (379)
T 3feg_A 129 EQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGN 208 (379)
T ss_dssp EECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHH
T ss_pred EEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHH
Confidence 99998865431 11 1111 1111 3445555544322 2333
Q ss_pred HH----hcC-CCCeEecCCCCCCeeecCC----CceEEeecCCcCC
Q 011851 244 LH----EEA-EKPVIYRDFKTSNILLDGE----YNAKLSDFGLAKD 280 (476)
Q Consensus 244 lH----~~~-~~~ivHrDlKp~NILl~~~----~~vkl~DFG~a~~ 280 (476)
|. ... ...++|+|+.+.|||++.+ +.+.|+||..+..
T Consensus 209 L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 209 LRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 32 211 2348999999999999876 7899999988743
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.12 E-value=0.00042 Score=70.30 Aligned_cols=81 Identities=15% Similarity=0.074 Sum_probs=49.1
Q ss_pred cccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCCCCCce-eeEEEEEEeCCeeEE
Q 011851 126 ECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHPNL-VKLIGCCIEDDQRLL 204 (476)
Q Consensus 126 ~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~hpnI-v~l~~~~~~~~~~~l 204 (476)
.+.|+.|....||+........ .....+..+.+|+.... .....+..|..+++.|...++ .++++.+. + .+
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~--~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~--~--g~ 149 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYP--PIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFS--G--GR 149 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSC--CSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEET--T--EE
T ss_pred EEEeCCCcccceEEEEeCCCcc--ccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeC--C--CE
Confidence 3567888889999976432100 00113567999988432 112455678888887743333 56666543 2 38
Q ss_pred EEEecCCCCH
Q 011851 205 VYEFMPRGSL 214 (476)
Q Consensus 205 V~E~~~~g~L 214 (476)
||||++|.+|
T Consensus 150 v~e~l~G~~l 159 (429)
T 1nw1_A 150 LEEYIPSRPL 159 (429)
T ss_dssp EECCCCEEEC
T ss_pred EEEEeCCccc
Confidence 9999987443
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.87 E-value=0.0014 Score=64.88 Aligned_cols=83 Identities=7% Similarity=-0.026 Sum_probs=42.5
Q ss_pred cccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCCCCCc-eeeEEEEEEeCCeeEE
Q 011851 126 ECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHPN-LVKLIGCCIEDDQRLL 204 (476)
Q Consensus 126 ~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~hpn-Iv~l~~~~~~~~~~~l 204 (476)
.+.|+.|....+|+........ ......+..+++|+....... ......|..+++.|...+ +.++++.+ . -++
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~-~~~~~~~~~~vlRi~~~~~~~-~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~ 111 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETA-NNYNSIRTRVLFRIYGKHVDE-LYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGR 111 (369)
T ss_dssp EEEC----CCEEEEEEECHHHH-TTCTTSCCEEEEEECCTTGGG-TSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEE
T ss_pred EEEeCCcccceEEEEEeCCCCc-ccccCCCceEEEEecCCCccc-eecHHHHHHHHHHHHhcCCCCceEEec--C--CcE
Confidence 3467788888999875431000 000012356888987543211 112346777777664223 34666543 2 378
Q ss_pred EEEecCCCCH
Q 011851 205 VYEFMPRGSL 214 (476)
Q Consensus 205 V~E~~~~g~L 214 (476)
||||++|..|
T Consensus 112 v~e~i~G~~l 121 (369)
T 3c5i_A 112 IEEWLYGDPL 121 (369)
T ss_dssp EEECCCSEEC
T ss_pred EEEEecCCcC
Confidence 9999987543
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.84 E-value=0.0024 Score=65.21 Aligned_cols=75 Identities=13% Similarity=-0.061 Sum_probs=44.6
Q ss_pred cccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCCCCCce-eeEEEEEEeCCeeEE
Q 011851 126 ECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHPNL-VKLIGCCIEDDQRLL 204 (476)
Q Consensus 126 ~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~hpnI-v~l~~~~~~~~~~~l 204 (476)
.+.|+.|-...+|+..... .+..+++|+......... ...+|..+|+.|...++ .++++++. + .+
T Consensus 113 i~~lsgG~tN~~y~v~~~~---------~~~~~vLRi~g~~~~~~i-dR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~ 178 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMS---------KQAKYLIRLYGPKTDEII-NREREKKISCILYNKNIAKKIYVFFT--N--GR 178 (458)
T ss_dssp EEEECC--CEEEEEEEETT---------TTEEEEEEEECC-CCSCS-CHHHHHHHHHHHTTSSSBCCEEEEET--T--EE
T ss_pred EEEcCCCeEeEEEEEEECC---------CCceEEEEECCCChhhhc-CHHHHHHHHHHHHhcCCCCCEEEEeC--C--eE
Confidence 3467778888999865431 246788998754321111 12468888887754444 56776652 2 35
Q ss_pred EEEecCCCCH
Q 011851 205 VYEFMPRGSL 214 (476)
Q Consensus 205 V~E~~~~g~L 214 (476)
||||++|..|
T Consensus 179 v~e~I~G~~l 188 (458)
T 2qg7_A 179 IEEFMDGYAL 188 (458)
T ss_dssp EEECCCSEEC
T ss_pred EEEeeCCccC
Confidence 9999987544
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.80 E-value=0.0076 Score=58.88 Aligned_cols=31 Identities=16% Similarity=0.167 Sum_probs=27.1
Q ss_pred CCeEecCCCCCCeeecCCCceEEeecCCcCC
Q 011851 250 KPVIYRDFKTSNILLDGEYNAKLSDFGLAKD 280 (476)
Q Consensus 250 ~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~ 280 (476)
..++|+|+.+.|||++.++.+.|+||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 3489999999999999888899999987754
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=94.53 E-value=0.08 Score=53.26 Aligned_cols=81 Identities=10% Similarity=-0.081 Sum_probs=45.0
Q ss_pred ccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCCC-CCceeeEEEEEEeCCeeEEE
Q 011851 127 CLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLI-HPNLVKLIGCCIEDDQRLLV 205 (476)
Q Consensus 127 ~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~~lV 205 (476)
+.|..|-...+|+......... ....+..|++|+........ -...+|..+++.|. +.-..++++.+ . -++|
T Consensus 76 ~~lsGG~TN~~y~v~~~~~~~~--~~~~~~~~vlRi~g~~t~~~-idR~~E~~~l~~L~~~gi~P~l~~~~--~--~~~I 148 (424)
T 3mes_A 76 KQIFSGLTNQLFVVSIVNESMS--LSLKHPRILFRIYGKHVGKF-YDSKVELDVFRYLSNINIAPNIIADF--P--EGRI 148 (424)
T ss_dssp EEECCCSSSEEEEEEECCC-------CCCSEEEEEECCCCC-CC-CCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEE
T ss_pred EEcCCCcccceEEEEeCCCccc--ccCCCCeEEEEECCCCcchh-cCHHHHHHHHHHHHhcCCCCCEEEEc--C--CCEE
Confidence 4566788888998765321100 01125779999865432111 12246777777664 22234555432 2 3789
Q ss_pred EEecCCCCH
Q 011851 206 YEFMPRGSL 214 (476)
Q Consensus 206 ~E~~~~g~L 214 (476)
|||++|..|
T Consensus 149 ~efI~G~~l 157 (424)
T 3mes_A 149 EEFIDGEPL 157 (424)
T ss_dssp EECCCSEEC
T ss_pred EEEeCCccC
Confidence 999998653
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=89.80 E-value=0.62 Score=42.06 Aligned_cols=115 Identities=10% Similarity=0.113 Sum_probs=78.5
Q ss_pred CCCceeeEEEEEEeCCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHH-HHHhcCCCCeEecCCCCCCee
Q 011851 185 IHPNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLA-FLHEEAEKPVIYRDFKTSNIL 263 (476)
Q Consensus 185 ~hpnIv~l~~~~~~~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~-~lH~~~~~~ivHrDlKp~NIL 263 (476)
.||++ -..+-.+++.+.+.++.-+++.=+..+. .++...+++++.+|+.... +++. -+|--|.|+||+
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~----~~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P~NL~ 116 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIR----KTTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCPENLM 116 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHH----TSCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCGGGEE
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHH----hcCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeCceEE
Confidence 57877 4444577788888887765544344442 3778899999998888777 5554 688899999999
Q ss_pred ecCCCceEEeecCCcCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCC
Q 011851 264 LDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMD 334 (476)
Q Consensus 264 l~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~ 334 (476)
++.++.++|.-.|+-.. ++|.- ++..-=+-.+=|++..++.++..|+
T Consensus 117 f~~~~~p~i~hRGi~~~-------------------lpP~e-----~~ee~fl~qyKali~all~~K~~Fe 163 (219)
T 4ano_A 117 FNRALEPFFLHVGVKES-------------------LPPDE-----WDDERLLREVKATVLALTEGEYRFD 163 (219)
T ss_dssp ECTTCCEEESCCEETTT-------------------BSSCS-----CCHHHHHHHHHHHHHHHTTCSSCHH
T ss_pred EeCCCcEEEEEcCCccc-------------------CCCCC-----CCHHHHHHHHHHHHHHHHcCCCCHH
Confidence 99999999987775432 22221 1111112346688888998887774
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=87.97 E-value=0.52 Score=42.37 Aligned_cols=124 Identities=8% Similarity=0.060 Sum_probs=82.9
Q ss_pred HHHHHHhCCCCCceeeEEEEEEeCCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEec
Q 011851 176 AEVNYLGGLIHPNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYR 255 (476)
Q Consensus 176 ~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHr 255 (476)
.|+.+|.. .||+++.. .+-.+++.+.+.++.-+.+.=+..+ ..++...+++++.+|+....+++. -+|-
T Consensus 35 ~el~LL~~-~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~i----k~~~~~eKlr~l~ni~~l~~~~~~-----r~tf 103 (215)
T 4ann_A 35 HLMYLLEQ-HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDNI----KSFTKNEKLRYLLNIKNLEEVNRT-----RYTF 103 (215)
T ss_dssp GGGGGGGS-CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGGG----GGSCHHHHHHHHHHGGGGGGGGGS-----SEEC
T ss_pred HHHHHHhc-cCCcccce-EEEEcccEEEEEEEcCcccCCHHHH----HhcCHHHHHHHHHHHHHHHHHhcC-----ceEE
Confidence 34554443 58888876 5666777777777665433222223 236788999999999988866654 5888
Q ss_pred CCCCCCeeecCCCceEEeecCCcCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCC
Q 011851 256 DFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMD 334 (476)
Q Consensus 256 DlKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~ 334 (476)
-|.|+||+++.++.+++.-.|+-... +|. .++...=+-.+=|++..+++++..|+
T Consensus 104 ~L~P~NL~f~~~~~p~i~~RGik~~l-------------------~P~-----~~~ee~fL~qyKAliiall~~K~~Fe 158 (215)
T 4ann_A 104 VLAPDELFFTRDGLPIAKTRGLQNVV-------------------DPL-----PVSEAEFLTRYKALVICAFNEKQSFD 158 (215)
T ss_dssp CCSGGGEEECTTSCEEESCCEETTTB-------------------SCC-----CCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred EEecceEEEcCCCCEEEEEccCccCC-------------------CCC-----CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence 99999999999999999877764322 121 11111123346688889999988874
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=80.69 E-value=0.25 Score=50.31 Aligned_cols=62 Identities=11% Similarity=0.113 Sum_probs=18.1
Q ss_pred CccccccccCCccEEEEEEccCCceeeeCCCCceEEE------EEecCCCc--cCHHHHHHHHHHHhCCCCCceeeEEEE
Q 011851 124 RPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAV------KTLNHDGL--QGHKEWLAEVNYLGGLIHPNLVKLIGC 195 (476)
Q Consensus 124 ~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAi------K~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~ 195 (476)
.+.+.|| ||.||+|.+.. +..+||+ |..+.... +....+.+|..+++.++|||+++.+.+
T Consensus 145 ~l~~~lG---fG~v~~g~~~~---------~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f 212 (463)
T 3cxl_A 145 PIYEHVG---YTTLNREPAYK---------KHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNF 212 (463)
T ss_dssp CSTTTSS---BCCC------------------CCBGGGC-----------------------------------CBCCCE
T ss_pred cccccCC---chhhhcccccc---------cCCchhhhhccCccccccccccccccccccccccccccccccccCCCcce
Confidence 4567787 99999997752 1235777 66543222 223457889999999999999999887
Q ss_pred EE
Q 011851 196 CI 197 (476)
Q Consensus 196 ~~ 197 (476)
..
T Consensus 213 ~~ 214 (463)
T 3cxl_A 213 KV 214 (463)
T ss_dssp EE
T ss_pred EE
Confidence 54
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 476 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 6e-75 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-69 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-67 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 5e-67 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 6e-67 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 9e-67 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 3e-66 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-64 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 1e-64 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-64 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 3e-64 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 3e-64 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 3e-64 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 4e-64 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 4e-64 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-63 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 4e-62 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 5e-62 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 5e-62 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-60 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 3e-60 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 4e-60 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-59 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 3e-59 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 3e-59 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 4e-59 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 5e-59 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 5e-58 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 1e-56 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 4e-56 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 2e-55 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 5e-54 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 1e-53 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 2e-53 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 9e-51 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 5e-50 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 4e-49 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 1e-48 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-48 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 2e-48 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-46 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 3e-46 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 3e-46 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 4e-46 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 4e-45 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 5e-45 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 7e-45 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 1e-43 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 3e-43 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 3e-43 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 4e-43 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-42 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-41 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 2e-39 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-38 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 4e-38 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 1e-37 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 6e-36 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 1e-33 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 3e-31 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-30 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 6e-27 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 9e-17 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 234 bits (599), Expect = 6e-75
Identities = 75/284 (26%), Positives = 122/284 (42%), Gaps = 33/284 (11%)
Query: 128 LLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL--QGHKEWLAEVNYLGGLI 185
+G G FG VYKG + + VAVK LN Q + + EV L
Sbjct: 15 RIGSGSFGTVYKGKWHGD------------VAVKMLNVTAPTPQQLQAFKNEVGVLRKTR 62
Query: 186 HPNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLH 245
H N++ +G Q +V ++ SL +HL + IA A+G+ +LH
Sbjct: 63 HVNILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH 121
Query: 246 EEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYV 305
K +I+RD K++NI L + K+ DFGLA +H ++ G+ + APE +
Sbjct: 122 A---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI 178
Query: 306 MT---GHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRRFYRLI 362
+ +SDVY+FG+VL E++TG+ P N + +G L
Sbjct: 179 RMQDKNPYSFQSDVYAFGIVLYELMTGQ------LPYSNINNRDQIIFMVGRGYLSPDL- 231
Query: 363 DPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPL 406
C + +L A CL + + RP +++ +++ L
Sbjct: 232 SKVRSNC-----PKAMKRLMAECLKKKRDERPLFPQILASIELL 270
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 221 bits (565), Expect = 2e-69
Identities = 90/341 (26%), Positives = 140/341 (41%), Gaps = 44/341 (12%)
Query: 87 NAESTTPSTPKIGEELKISPQLRKFSFNELKSATKSFRPECLLGEGGFGCVYKGWINMNG 146
+ + P + + + I P FNE+ +G G FGCVY G + N
Sbjct: 5 DLSALNPELVQAVQHVVIGPSSLIVHFNEV------------IGRGHFGCVYHGTLLDND 52
Query: 147 TATVKPGTGLPVAVKTLNHDGLQGH-KEWLAEVNYLGGLIHPNLVKLIGCCIEDDQR-LL 204
G + AVK+LN G ++L E + HPN++ L+G C+ + L+
Sbjct: 53 ------GKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 106
Query: 205 VYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILL 264
V +M G L N + + + L AKG+ FL K ++RD N +L
Sbjct: 107 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCML 163
Query: 265 DGEYNAKLSDFGLAKD--GPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVV 322
D ++ K++DFGLA+D E D H T + A E + T T KSDV+SFGV+
Sbjct: 164 DEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVL 223
Query: 323 LLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLA 382
L E++T P + N + L + RL+ P E C + ++
Sbjct: 224 LWELMTRGA-----PPYPDVNTFDITVYLL----QGRRLLQP--EYC-----PDPLYEVM 267
Query: 383 ASCLNRDQKARPRMSEVVEALKPLPYLKDMASSSSYVQAMQ 423
C + + RP SE+V + + YV
Sbjct: 268 LKCWHPKAEMRPSFSELVSRISAI--FSTF-IGEHYVHVNA 305
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 216 bits (550), Expect = 2e-67
Identities = 69/309 (22%), Positives = 127/309 (41%), Gaps = 38/309 (12%)
Query: 111 FSFNELKSATKSFRPEC---------LLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVK 161
F+F + A + F E ++G G FG V G + + G + VA+K
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPG------KREIFVAIK 60
Query: 162 TLNHDGL-QGHKEWLAEVNYLGGLIHPNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFR 220
TL + +++L+E + +G HPN++ L G + +++ EFM GSL++ L +
Sbjct: 61 TLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQ 120
Query: 221 RSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKD 280
+ + A G+ +L + ++RD NIL++ K+SDFGL++
Sbjct: 121 NDGQFTVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRF 177
Query: 281 GPEGDKTHVSTRV---MGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNR 337
+ T + APE + T+ SDV+S+G+V+ E+++ R
Sbjct: 178 LEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGE-----R 232
Query: 338 PNGEHNLVEWARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMS 397
P + + I+ + QL C +D+ RP+
Sbjct: 233 PYWDMTNQDV-----------INAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFG 281
Query: 398 EVVEALKPL 406
++V L +
Sbjct: 282 QIVNTLDKM 290
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 214 bits (545), Expect = 5e-67
Identities = 78/287 (27%), Positives = 126/287 (43%), Gaps = 33/287 (11%)
Query: 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNY 180
++ + LG G FG V+ G+ N VAVK+L +LAE N
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYN----------GHTKVAVKSLKQGS-MSPDAFLAEANL 61
Query: 181 LGGLIHPNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALDAAK 239
+ L H LV+L + ++ E+M GSL + L S + L + + +A A+
Sbjct: 62 MKQLQHQRLVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAE 120
Query: 240 GLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGY 299
G+AF+ E+ I+RD + +NIL+ + K++DFGLA+ + ++ +
Sbjct: 121 GMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIED-NEYTAREGAKFPIKW 176
Query: 300 AAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRRFY 359
APE + G T KSDV+SFG++L E++T R N E + R Y
Sbjct: 177 TAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE---------VIQNLERGY 227
Query: 360 RLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPL 406
R++ P + C E+ QL C + RP + L+
Sbjct: 228 RMVRP--DNC-----PEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 213 bits (543), Expect = 6e-67
Identities = 61/284 (21%), Positives = 108/284 (38%), Gaps = 31/284 (10%)
Query: 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNY 180
K LG G FG V G VA+K + E++ E
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWR----------GQYDVAIKMIKEGS-MSEDEFIEEAKV 52
Query: 181 LGGLIHPNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKG 240
+ L H LV+L G C + ++ E+M G L N+L +++ D +
Sbjct: 53 MMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEA 112
Query: 241 LAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYA 300
+ +L K ++RD N L++ + K+SDFGL++ + D+ S ++
Sbjct: 113 MEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD-DEYTSSVGSKFPVRWS 168
Query: 301 APEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRRFYR 360
PE +M ++KSD+++FGV++ E+ + + + N E
Sbjct: 169 PPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE----------------TAE 212
Query: 361 LIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALK 404
I L +EK + SC + RP ++ +
Sbjct: 213 HIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNIL 256
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 215 bits (548), Expect = 9e-67
Identities = 70/343 (20%), Positives = 128/343 (37%), Gaps = 49/343 (14%)
Query: 115 ELKSATKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQG-HKE 173
ELK F LG G G V+K +GL +A K ++ + +
Sbjct: 2 ELK--DDDFEKISELGAGNGGVVFKV---------SHKPSGLVMARKLIHLEIKPAIRNQ 50
Query: 174 WLAEVNYLGGLIHPNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKI 233
+ E+ L P +V G D + + E M GSL+ L + +P I K+
Sbjct: 51 IIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG-RIPEQILGKV 109
Query: 234 ALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRV 293
++ KGL +L E+ +++RD K SNIL++ KL DFG++ + ++
Sbjct: 110 SIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----SMANSF 163
Query: 294 MGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRR---------------------- 331
+GT Y +PE + H + +SD++S G+ L+EM GR
Sbjct: 164 VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDA 223
Query: 332 ----SMDKNRPNGEHNLVEWARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLN 387
+ + +RP + +++ S + + CL
Sbjct: 224 AETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLI 283
Query: 388 RDQKARPRMSEVVEALKPLPYLKDMASSSSYVQAMQAERVRLN 430
++ R + +++ ++K + + LN
Sbjct: 284 KNPAERADLKQLMV----HAFIKRSDAEEVDFAGWLCSTIGLN 322
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 212 bits (540), Expect = 3e-66
Identities = 74/286 (25%), Positives = 122/286 (42%), Gaps = 31/286 (10%)
Query: 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNY 180
+G G FG V+ G+ VA+KT+ ++++ E
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWL----------NKDKVAIKTIREGA-MSEEDFIEEAEV 53
Query: 181 LGGLIHPNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKG 240
+ L HP LV+L G C+E LV+EFM G L ++L + + + LD +G
Sbjct: 54 MMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEG 113
Query: 241 LAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYA 300
+A+L E VI+RD N L+ K+SDFG+ + + D+ ST +A
Sbjct: 114 MAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD-DQYTSSTGTKFPVKWA 169
Query: 301 APEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRRFYR 360
+PE ++KSDV+SFGV++ E+ + + +NR N E + + +R
Sbjct: 170 SPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE---------VVEDISTGFR 220
Query: 361 LIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPL 406
L P L + Q+ C + RP S ++ L +
Sbjct: 221 LYKPRLA-------STHVYQIMNHCWKERPEDRPAFSRLLRQLAEI 259
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 208 bits (531), Expect = 1e-64
Identities = 72/299 (24%), Positives = 128/299 (42%), Gaps = 31/299 (10%)
Query: 109 RKFSFNELKSATKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL 168
++++ + + LG G +G VY+G V L VAVKTL D +
Sbjct: 5 SSPNYDKWEMERTDITMKHKLGGGQYGEVYEG---------VWKKYSLTVAVKTLKEDTM 55
Query: 169 QGHKEWLAEVNYLGGLIHPNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRS-LPLPW 227
+ +E+L E + + HPNLV+L+G C + ++ EFM G+L ++L + +
Sbjct: 56 EV-EEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSA 114
Query: 228 SIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKT 287
+ + +A + + +L + K I+RD N L+ + K++DFGL++ GD
Sbjct: 115 VVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTY 170
Query: 288 HVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEW 347
+ APE + + KSDV++FGV+L E+ T S +
Sbjct: 171 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ------ 224
Query: 348 ARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPL 406
Y L++ EK +L +C + RP +E+ +A + +
Sbjct: 225 ----------VYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 273
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 209 bits (532), Expect = 1e-64
Identities = 67/299 (22%), Positives = 113/299 (37%), Gaps = 35/299 (11%)
Query: 129 LGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHPN 188
+G+G FG V++G G VAVK + + AE+ L H N
Sbjct: 11 IGKGRFGEVWRGKW-----------RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHEN 58
Query: 189 LVKLIGCCIEDD----QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFL 244
++ I +D+ Q LV ++ GSL ++L R + +K+AL A GLA L
Sbjct: 59 ILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHL 116
Query: 245 HEEA-----EKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKT--HVSTRVMGTY 297
H E + + +RD K+ NIL+ ++D GLA T +GT
Sbjct: 117 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTK 176
Query: 298 GYAAPEYVMT------GHLTAKSDVYSFGVVLLEMLTGRR----SMDKNRPNGEHNLVEW 347
Y APE + ++D+Y+ G+V E+ D P + +
Sbjct: 177 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236
Query: 348 ARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPL 406
+ ++ + +L S + ++ C + AR + + L L
Sbjct: 237 SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 295
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 208 bits (530), Expect = 2e-64
Identities = 68/327 (20%), Positives = 118/327 (36%), Gaps = 52/327 (15%)
Query: 104 ISPQLRKFSFNELKSATKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTL 163
++P+L + + +GEG FG V++ + VAVK L
Sbjct: 1 LNPKLLSLEY-----PRNNIEYVRDIGEGAFGRVFQARA----PGLLPYEPFTMVAVKML 51
Query: 164 NHDGLQG-HKEWLAEVNYLGGLIHPNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRS 222
+ ++ E + +PN+VKL+G C L++E+M G L L S
Sbjct: 52 KEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMS 111
Query: 223 L-----------------------PLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKT 259
PL + ++ IA A G+A+L E + ++RD T
Sbjct: 112 PHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLAT 168
Query: 260 SNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSF 319
N L+ K++DFGL+++ D + PE + T +SDV+++
Sbjct: 169 RNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAY 228
Query: 320 GVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRRFYRLIDPCLEGCFSIKGAEKTI 379
GVVL E+ + + E ++ + R G L
Sbjct: 229 GVVLWEIFSYGLQPYYGMAHEE--VIYYVRD--GNILACPENCPLEL------------Y 272
Query: 380 QLAASCLNRDQKARPRMSEVVEALKPL 406
L C ++ RP + L+ +
Sbjct: 273 NLMRLCWSKLPADRPSFCSIHRILQRM 299
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (528), Expect = 3e-64
Identities = 70/279 (25%), Positives = 117/279 (41%), Gaps = 31/279 (11%)
Query: 129 LGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGH-KEWLAEVNYLGGLIHP 187
LG G FG V +G M + VA+K L + +E + E + L +P
Sbjct: 17 LGCGNFGSVRQGVYRMRKK-------QIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNP 69
Query: 188 NLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEE 247
+V+LIG C + + +LV E G L L + +P S ++ + G+ +L E
Sbjct: 70 YIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEE- 127
Query: 248 AEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKD-GPEGDKTHVSTRVMGTYGYAAPEYVM 306
K ++RD N+LL + AK+SDFGL+K G + + + APE +
Sbjct: 128 --KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECIN 185
Query: 307 TGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVE-WARPQLGERRRFYRLIDPC 365
+++SDV+S+GV + E L+ + +P + E A + G+R P
Sbjct: 186 FRKFSSRSDVWSYGVTMWEALSYGQ-----KPYKKMKGPEVMAFIEQGKRMECPPECPPE 240
Query: 366 LEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALK 404
L L + C + RP V + ++
Sbjct: 241 L------------YALMSDCWIYKWEDRPDFLTVEQRMR 267
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (525), Expect = 3e-64
Identities = 73/286 (25%), Positives = 125/286 (43%), Gaps = 39/286 (13%)
Query: 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNY 180
K + +G+G FG V G G VAVK + +D + +LAE +
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDY-----------RGNKVAVKCIKNDATA--QAFLAEASV 53
Query: 181 LGGLIHPNLVKLIGCCIEDDQRL-LVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALDAA 238
+ L H NLV+L+G +E+ L +V E+M +GSL ++L R L +K +LD
Sbjct: 54 MTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVC 113
Query: 239 KGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYG 298
+ + +L ++RD N+L+ + AK+SDFGL K+ T
Sbjct: 114 EAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDT-----GKLPVK 165
Query: 299 YAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRRF 358
+ APE + + KSDV+SFG++L E+ + R ++ P++ + +
Sbjct: 166 WTAPEALREKKFSTKSDVWSFGILLWEIYSFG------RVPYPRIPLKDVVPRVEKGYKM 219
Query: 359 YRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALK 404
+GC ++ +C + D RP ++ E L+
Sbjct: 220 -----DAPDGC-----PPAVYEVMKNCWHLDAAMRPSFLQLREQLE 255
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (529), Expect = 3e-64
Identities = 76/309 (24%), Positives = 118/309 (38%), Gaps = 46/309 (14%)
Query: 128 LLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKE-WLAEVNYLGGLI- 185
LG G FG V + +K + VAVK L +E ++E+ L L
Sbjct: 30 TLGAGAFGKVVEATA----YGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGN 85
Query: 186 HPNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRR-----------------SLPLPWS 228
H N+V L+G C L++ E+ G L N L R+ L L
Sbjct: 86 HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLE 145
Query: 229 IRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTH 288
+ + AKG+AFL K I+RD NILL K+ DFGLA+D
Sbjct: 146 DLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYV 202
Query: 289 VSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA 348
V + APE + T +SDV+S+G+ L E+ + S P
Sbjct: 203 VKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK------ 256
Query: 349 RPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPY 408
FY++I + + +C + D RP ++V+ ++
Sbjct: 257 ---------FYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIE---- 303
Query: 409 LKDMASSSS 417
K ++ S++
Sbjct: 304 -KQISESTN 311
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (526), Expect = 4e-64
Identities = 68/294 (23%), Positives = 124/294 (42%), Gaps = 31/294 (10%)
Query: 120 TKSFRPEC-----LLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHK-E 173
T P C ++G G FG VYKG + + +PVA+KTL + + +
Sbjct: 1 TTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKK-----EVPVAIKTLKAGYTEKQRVD 55
Query: 174 WLAEVNYLGGLIHPNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKI 233
+L E +G H N+++L G + +++ E+M G+L+ L + + +
Sbjct: 56 FLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGM 115
Query: 234 ALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEG-DKTHVSTR 292
A G+ +L ++RD NIL++ K+SDFGL++ + + T+ ++
Sbjct: 116 LRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSG 172
Query: 293 VMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQL 352
+ APE + T+ SDV+SFG+V+ E++T N E
Sbjct: 173 GKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE----------- 221
Query: 353 GERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPL 406
+ I+ + QL C +++ RP+ +++V L L
Sbjct: 222 -----VMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL 270
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (530), Expect = 4e-64
Identities = 73/306 (23%), Positives = 112/306 (36%), Gaps = 46/306 (15%)
Query: 123 FRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKE-WLAEVNYL 181
+LG G FG V K G + VAVK L +E ++E+ +
Sbjct: 39 LEFGKVLGSGAFGKVMNATAYGIS----KTGVSIQVAVKMLKEKADSSEREALMSELKMM 94
Query: 182 GGLI-HPNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSL----------------- 223
L H N+V L+G C L++E+ G L N+L +
Sbjct: 95 TQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEE 154
Query: 224 -----PLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLA 278
L + + A AKG+ FL K ++RD N+L+ K+ DFGLA
Sbjct: 155 EEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLA 211
Query: 279 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRP 338
+D V + APE + G T KSDV+S+G++L E+ + + P
Sbjct: 212 RDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 271
Query: 339 NGEHNLVEWARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSE 398
+ FY+LI + E+ + SC D + RP
Sbjct: 272 VDAN---------------FYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPN 316
Query: 399 VVEALK 404
+ L
Sbjct: 317 LTSFLG 322
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (520), Expect = 2e-63
Identities = 76/288 (26%), Positives = 115/288 (39%), Gaps = 29/288 (10%)
Query: 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL---QGHKEWLAE 177
K R LG+G FG V +G + G + VAVK L D L + +++ E
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPS------GKTVSVAVKCLKPDVLSQPEAMDDFIRE 61
Query: 178 VNYLGGLIHPNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDA 237
VN + L H NL++L G + ++ V E P GSL + L + + A+
Sbjct: 62 VNAMHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQV 120
Query: 238 AKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHV-STRVMGT 296
A+G+ +L K I+RD N+LL K+ DFGL + P+ D +V
Sbjct: 121 AEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVP 177
Query: 297 YGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERR 356
+ + APE + T + SD + FGV L EM T + P N + E
Sbjct: 178 FAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQ-----EPWIGLNGSQILHKIDKEGE 232
Query: 357 RFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALK 404
R P E C + + C + RP + + L
Sbjct: 233 RL-----PRPEDC-----PQDIYNVMVQCWAHKPEDRPTFVALRDFLL 270
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (514), Expect = 4e-62
Identities = 63/284 (22%), Positives = 110/284 (38%), Gaps = 34/284 (11%)
Query: 123 FRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLG 182
+ LG+G FG VYK T + A K ++ + ++++ E++ L
Sbjct: 14 WEIIGELGDGAFGKVYKA---------QNKETSVLAAAKVIDTKSEEELEDYMVEIDILA 64
Query: 183 GLIHPNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLA 242
HPN+VKL+ ++ ++ EF G+++ + PL S + L
Sbjct: 65 SCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALN 124
Query: 243 FLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAP 302
+LH + +I+RD K NIL + + KL+DFG++ + +GT + AP
Sbjct: 125 YLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRR--DSFIGTPYWMAP 179
Query: 303 EYVMT-----GHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRR 357
E VM K+DV+S G+ L+EM P+ E N +
Sbjct: 180 EVVMCETSKDRPYDYKADVWSLGITLIEMAEIE------PPHHELNPMRVLLKIAKSEPP 233
Query: 358 FYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVE 401
CL ++ AR S++++
Sbjct: 234 TLAQPSRWSSNF---------KDFLKKCLEKNVDARWTTSQLLQ 268
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (512), Expect = 5e-62
Identities = 77/293 (26%), Positives = 122/293 (41%), Gaps = 33/293 (11%)
Query: 129 LGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQG--HKEWLAEVNYLGGLIH 186
LG G FG V KG+ M VAVK L ++ E LAE N + L +
Sbjct: 15 LGSGNFGTVKKGYYQMKKV-------VKTVAVKILKNEANDPALKDELLAEANVMQQLDN 67
Query: 187 PNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHE 246
P +V++IG C E + +LV E G L +L + + +++ + G+ +L E
Sbjct: 68 PYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNR-HVKDKNIIELVHQVSMGMKYLEE 125
Query: 247 EAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEG-DKTHVSTRVMGTYGYAAPEYV 305
++RD N+LL ++ AK+SDFGL+K + T + APE +
Sbjct: 126 ---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI 182
Query: 306 MTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRRFYRLIDPC 365
++KSDV+SFGV++ E + + +P E L + R C
Sbjct: 183 NYYKFSSKSDVWSFGVLMWEAFSYGQ-----KPYRGMKGSEVTA-MLEKGERM-----GC 231
Query: 366 LEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDMASSSSY 418
GC + L C D + RP + V L+ Y D+ + +
Sbjct: 232 PAGC-----PREMYDLMNLCWTYDVENRPGFAAVELRLR--NYYYDVVNEGHH 277
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (515), Expect = 5e-62
Identities = 63/285 (22%), Positives = 119/285 (41%), Gaps = 26/285 (9%)
Query: 123 FRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDG-LQGHKEWLAEVNYL 181
F+ +LG G FG VYKG G +PVA+K L + +KE L E +
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKV-----KIPVAIKELREATSPKANKEILDEAYVM 65
Query: 182 GGLIHPNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGL 241
+ +P++ +L+G C+ +L + + MP G L +++ + + + AKG+
Sbjct: 66 ASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGM 124
Query: 242 AFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAA 301
+L + + +++RD N+L+ + K++DFGLAK +K + + + A
Sbjct: 125 NYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 181
Query: 302 PEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRRFYRL 361
E ++ T +SDV+S+GV + E++T P E +
Sbjct: 182 LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE----------------ISSI 225
Query: 362 IDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPL 406
++ + C D +RP+ E++ +
Sbjct: 226 LEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 270
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (504), Expect = 2e-60
Identities = 69/301 (22%), Positives = 118/301 (39%), Gaps = 46/301 (15%)
Query: 123 FRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL-QGHKEWLAEVNYL 181
+ + ++GEG FG V K I K G + A+K + H+++ E+ L
Sbjct: 12 IKFQDVIGEGNFGQVLKARIK-------KDGLRMDAAIKRMKEYASKDDHRDFAGELEVL 64
Query: 182 GGLI-HPNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSL---------------PL 225
L HPN++ L+G C L E+ P G+L + L + + L
Sbjct: 65 CKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTL 124
Query: 226 PWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGD 285
+ A D A+G+ +L + K I+RD NIL+ Y AK++DFGL++
Sbjct: 125 SSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYV 181
Query: 286 KTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV 345
K T + A E + T SDV+S+GV+L E+++ + P
Sbjct: 182 KK---TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT-----PYCGMTCA 233
Query: 346 EWARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKP 405
E Y + + ++ L C RP ++++ +L
Sbjct: 234 EL-----------YEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNR 282
Query: 406 L 406
+
Sbjct: 283 M 283
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (499), Expect = 3e-60
Identities = 68/296 (22%), Positives = 110/296 (37%), Gaps = 45/296 (15%)
Query: 109 RKFSFNELKSATKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL 168
R+++ + F LG+G FG VY + + +A+K L L
Sbjct: 1 RQWALED-------FEIGRPLGKGKFGNVYLA---------REKQSKFILALKVLFKAQL 44
Query: 169 ---QGHKEWLAEVNYLGGLIHPNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPL 225
+ EV L HPN+++L G + + L+ E+ P G++ L + S
Sbjct: 45 EKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS-KF 103
Query: 226 PWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGD 285
+ A L++ H K VI+RD K N+LL K++DFG + P
Sbjct: 104 DEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR 160
Query: 286 KTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV 345
+T + GT Y PE + K D++S GV+ E L G+ P +
Sbjct: 161 RTTL----CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK------PPFEANTYQ 210
Query: 346 EWARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVE 401
E + F + L + L + RP + EV+E
Sbjct: 211 ETYKRISRVEFTFPDFVTEGA------------RDLISRLLKHNPSQRPMLREVLE 254
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (498), Expect = 4e-60
Identities = 65/281 (23%), Positives = 106/281 (37%), Gaps = 30/281 (10%)
Query: 123 FRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLN-HDGLQGHKEWLAEVNYL 181
+ LGEG +G V V T VAVK ++ + + E+
Sbjct: 7 WDLVQTLGEGAYGEVQLA---------VNRVTEEAVAVKIVDMKRAVDCPENIKKEICIN 57
Query: 182 GGLIHPNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGL 241
L H N+VK G E + + L E+ G L + + +P + G+
Sbjct: 58 KMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI-GMPEPDAQRFFHQLMAGV 116
Query: 242 AFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAA 301
+LH + +RD K N+LLD N K+SDFGLA ++ + ++ GT Y A
Sbjct: 117 VYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVA 173
Query: 302 PEYVMTGHL-TAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRRFYR 360
PE + DV+S G+VL ML G D+ + + + ++
Sbjct: 174 PELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKK---TYLNPWK 230
Query: 361 LIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVE 401
ID + L L + AR + ++ +
Sbjct: 231 KIDSAP------------LALLHKILVENPSARITIPDIKK 259
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (494), Expect = 2e-59
Identities = 66/295 (22%), Positives = 110/295 (37%), Gaps = 42/295 (14%)
Query: 123 FRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL--QGHKEWLAEVNY 180
+ + +G G F VYKG + T + VA L L + + E
Sbjct: 11 LKFDIEIGRGSFKTVYKG---------LDTETTVEVAWCELQDRKLTKSERQRFKEEAEM 61
Query: 181 LGGLIHPNLVKLIGCCIE----DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALD 236
L GL HPN+V+ +LV E M G+L+ +L R + +
Sbjct: 62 LKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK-VMKIKVLRSWCRQ 120
Query: 237 AAKGLAFLHEEAEKPVIYRDFKTSNILLDGE-YNAKLSDFGLAKDGPEGDKTHVSTRVMG 295
KGL FLH P+I+RD K NI + G + K+ D GLA + + V+G
Sbjct: 121 ILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATL----KRASFAKAVIG 175
Query: 296 TYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGER 355
T + APE + DVY+FG+ +LEM T P E ++
Sbjct: 176 TPEFMAPE-MYEEKYDESVDVYAFGMCMLEMATSE------YPYSECQNAAQIYRRVTSG 228
Query: 356 RRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLK 410
+ + ++ C+ +++ R + +++ + +
Sbjct: 229 VKPASFDKVAIPEV---------KEIIEGCIRQNKDERYSIKDLLN----HAFFQ 270
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (493), Expect = 3e-59
Identities = 64/288 (22%), Positives = 109/288 (37%), Gaps = 37/288 (12%)
Query: 123 FRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL--QGHKEWLAEVNY 180
+ +G G +G K + G + K L++ + + ++EVN
Sbjct: 6 YEVLYTIGTGSYGRCQKI---------RRKSDGKILVWKELDYGSMTEAEKQMLVSEVNL 56
Query: 181 LGGLIHPNLVKLIGCCIEDDQRLL--VYEFMPRGSLENHLFRRSL---PLPWSIRMKIAL 235
L L HPN+V+ I+ L V E+ G L + + + + L +++
Sbjct: 57 LRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMT 116
Query: 236 DAAKGLAFLHE--EAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRV 293
L H + V++RD K +N+ LDG+ N KL DFGLA+ T +
Sbjct: 117 QLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI--LNHDTSFAKAF 174
Query: 294 MGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLG 353
+GT Y +PE + KSD++S G +L E+ + + G
Sbjct: 175 VGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFT-----AFSQKELAGKIREG 229
Query: 354 ERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVE 401
+ RR L ++ LN RP + E++E
Sbjct: 230 KFRRIPYRYSDEL------------NEIITRMLNLKDYHRPSVEEILE 265
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (493), Expect = 3e-59
Identities = 70/281 (24%), Positives = 112/281 (39%), Gaps = 30/281 (10%)
Query: 128 LLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKE-WLAEVNYLGGLIH 186
+GEG FG V++G L VA+KT + +E +L E + H
Sbjct: 14 CIGEGQFGDVHQG------IYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDH 67
Query: 187 PNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHE 246
P++VKLIG ++ ++ E G L + L R L + + A + LA+L
Sbjct: 68 PHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLES 126
Query: 247 EAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM 306
K ++RD N+L+ KL DFGL++ + + +++ + APE +
Sbjct: 127 ---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST-YYKASKGKLPIKWMAPESIN 182
Query: 307 TGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVE-WARPQLGERRRFYRLIDPC 365
T+ SDV+ FGV + E+L +P + R + GER P
Sbjct: 183 FRRFTSASDVWMFGVCMWEILMHGV-----KPFQGVKNNDVIGRIENGERLPMPPNCPPT 237
Query: 366 LEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPL 406
L L C D RPR +E+ L +
Sbjct: 238 L------------YSLMTKCWAYDPSRRPRFTELKAQLSTI 266
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 194 bits (495), Expect = 4e-59
Identities = 74/325 (22%), Positives = 128/325 (39%), Gaps = 49/325 (15%)
Query: 106 PQLRKFSFNELKSATKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNH 165
P + + F + K F +G G FG VY VA+K +++
Sbjct: 2 PDVAELFFKD--DPEKLFSDLREIGHGSFGAVYFA---------RDVRNSEVVAIKKMSY 50
Query: 166 DGLQGHKEW---LAEVNYLGGLIHPNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRS 222
G Q +++W + EV +L L HPN ++ GC + + LV E+ + + +
Sbjct: 51 SGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKK 110
Query: 223 LPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGP 282
PL + A +GLA+LH +I+RD K NILL KL DFG A
Sbjct: 111 -PLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA 166
Query: 283 EGDKTHVSTRVMGTYGYAAPEYVMT---GHLTAKSDVYSFGVVLLEMLTGRRSM-DKNRP 338
+ +GT + APE ++ G K DV+S G+ +E+ + + + N
Sbjct: 167 P------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM 220
Query: 339 NGEHNLVEWARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSE 398
+ +++ + P L G +S E SCL + + RP
Sbjct: 221 SALYHIAQNESPAL-------------QSGHWS----EYFRNFVDSCLQKIPQDRPTSEV 263
Query: 399 VVEALKPLPYLKDMASSSSYVQAMQ 423
+++ ++ + + +Q
Sbjct: 264 LLK----HRFVLRERPPTVIMDLIQ 284
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (492), Expect = 5e-59
Identities = 70/287 (24%), Positives = 114/287 (39%), Gaps = 33/287 (11%)
Query: 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNY 180
+S R E LG+G FG V+ G N VA+KTL + +L E
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWN----------GTTRVAIKTLKPG-TMSPEAFLQEAQV 65
Query: 181 LGGLIHPNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLF-RRSLPLPWSIRMKIALDAAK 239
+ L H LV+L ++ +V E+M +GSL + L L + +A A
Sbjct: 66 MKKLRHEKLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIAS 124
Query: 240 GLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGY 299
G+A++ ++RD + +NIL+ K++DFGLA+ + ++ +
Sbjct: 125 GMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIED-NEYTARQGAKFPIKW 180
Query: 300 AAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRRFY 359
APE + G T KSDV+SFG++L E+ T R N E
Sbjct: 181 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE----------------VL 224
Query: 360 RLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPL 406
++ + E L C ++ + RP + L+
Sbjct: 225 DQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 271
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (487), Expect = 5e-58
Identities = 72/309 (23%), Positives = 131/309 (42%), Gaps = 35/309 (11%)
Query: 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDG-LQGHKEWLAEVN 179
+ LG+G FG VY+G VK VA+KT+N ++ E+L E +
Sbjct: 20 EKITMSRELGQGSFGMVYEGVA----KGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 75
Query: 180 YLGGLIHPNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLF---------RRSLPLPWSIR 230
+ ++V+L+G + L++ E M RG L+++L P S
Sbjct: 76 VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKM 135
Query: 231 MKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVS 290
+++A + A G+A+L+ ++RD N ++ ++ K+ DFG+ +D E D
Sbjct: 136 IQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKG 192
Query: 291 TRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP 350
+ + + +PE + G T SDV+SFGVVL E+ T + N + ++ +
Sbjct: 193 GKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ--VLRFVM- 249
Query: 351 QLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPL--PY 408
D C + +L C + K RP E++ ++K P
Sbjct: 250 ----EGGLLDKPDNCPDML---------FELMRMCWQYNPKMRPSFLEIISSIKEEMEPG 296
Query: 409 LKDMASSSS 417
++++ S
Sbjct: 297 FREVSFYYS 305
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (476), Expect = 1e-56
Identities = 68/323 (21%), Positives = 121/323 (37%), Gaps = 37/323 (11%)
Query: 104 ISPQLRKFSFNELKSATKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTL 163
I +LR S + K + +G+G G VY + TG VA++ +
Sbjct: 5 ILEKLR--SIVSVGDPKKKYTRFEKIGQGASGTVYTA---------MDVATGQEVAIRQM 53
Query: 164 NHDGLQGHKEWLAEVNYLGGLIHPNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSL 223
N + + E+ + +PN+V + + D+ +V E++ GSL + +
Sbjct: 54 NLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET-- 111
Query: 224 PLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPE 283
+ + + + L FLH VI+RD K+ NILL + + KL+DFG
Sbjct: 112 CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 168
Query: 284 GDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHN 343
+ ++GT + APE V K D++S G++ +EM+ G P N
Sbjct: 169 EQSKR--STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE------PPYLNEN 220
Query: 344 LVEWARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEAL 403
+ + + CL+ D + R E+++
Sbjct: 221 PLRALYLIATNGTPELQNPEKLSAIF---------RDFLNRCLDMDVEKRGSAKELLQH- 270
Query: 404 KPLPYLKDMASSSSYVQAMQAER 426
+LK SS + A +
Sbjct: 271 ---QFLKIAKPLSSLTPLIAAAK 290
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (473), Expect = 4e-56
Identities = 79/302 (26%), Positives = 115/302 (38%), Gaps = 40/302 (13%)
Query: 123 FRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQG-HKEWLAEVNYL 181
+ LG G FG V + K T VAVK L H+ ++E+ L
Sbjct: 15 LKLGKPLGRGAFGQVIEADAF----GIDKTATCRTVAVKMLKEGATHSEHRALMSELKIL 70
Query: 182 GGLIH-PNLVKLIGCCIEDDQRL-LVYEFMPRGSLENHLFRR---------------SLP 224
+ H N+V L+G C + L ++ EF G+L +L +
Sbjct: 71 IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF 130
Query: 225 LPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEG 284
L + + AKG+ FL + I+RD NILL + K+ DFGLA+D +
Sbjct: 131 LTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD 187
Query: 285 DKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNL 344
+ APE + T +SDV+SFGV+L E+ + S P +
Sbjct: 188 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS-----PYPGVKI 242
Query: 345 VEWARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALK 404
E +L E R R D Q C + + RP SE+VE L
Sbjct: 243 DEEFCRRLKEGTRM-RAPDYTTPEM---------YQTMLDCWHGEPSQRPTFSELVEHLG 292
Query: 405 PL 406
L
Sbjct: 293 NL 294
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (468), Expect = 2e-55
Identities = 73/296 (24%), Positives = 117/296 (39%), Gaps = 38/296 (12%)
Query: 128 LLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGH-KEWLAEVNYLGGLI- 185
LGEG FG V G KP VAVK L D + + ++E+ + +
Sbjct: 20 PLGEGAFGQVVLAE--AIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 77
Query: 186 HPNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLP---------------LPWSIR 230
H N++ L+G C +D ++ E+ +G+L +L R P L
Sbjct: 78 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 137
Query: 231 MKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVS 290
+ A A+G+ +L K I+RD N+L+ + K++DFGLA+D D +
Sbjct: 138 VSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 194
Query: 291 TRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP 350
T + APE + T +SDV+SFGV+L E+ T S P E
Sbjct: 195 TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE--------- 245
Query: 351 QLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPL 406
++L+ + + C + RP ++VE L +
Sbjct: 246 -------LFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 294
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (458), Expect = 5e-54
Identities = 61/295 (20%), Positives = 104/295 (35%), Gaps = 36/295 (12%)
Query: 123 FRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL---QGHKEWLAEVN 179
F+ +LGEG F V + T A+K L + E +
Sbjct: 10 FKFGKILGEGSFSTVVLA---------RELATSREYAIKILEKRHIIKENKVPYVTRERD 60
Query: 180 YLGGLIHPNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAK 239
+ L HP VKL +D++ + G L ++ + + +
Sbjct: 61 VMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG-SFDETCTRFYTAEIVS 119
Query: 240 GLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGY 299
L +LH K +I+RD K NILL+ + + +++DFG AK K + +GT Y
Sbjct: 120 ALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQY 176
Query: 300 AAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRRFY 359
+PE + SD+++ G ++ +++ G P N + + F
Sbjct: 177 VSPELLTEKSACKSSDLWALGCIIYQLVAGL------PPFRAGNEYLIFQKIIKLEYDFP 230
Query: 360 RLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEV--VEALKPLPYLKDM 412
P K L L D R E+ LK P+ + +
Sbjct: 231 EKFFP------------KARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 273
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 181 bits (461), Expect = 1e-53
Identities = 63/344 (18%), Positives = 128/344 (37%), Gaps = 36/344 (10%)
Query: 123 FRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLG 182
+ LG G FG V++ V+ TG K +N E++ +
Sbjct: 31 YDILEELGSGAFGVVHRC---------VEKATGRVFVAKFINTPYPLDKYTVKNEISIMN 81
Query: 183 GLIHPNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLA 242
L HP L+ L + + +L+ EF+ G L + + + + + A +GL
Sbjct: 82 QLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLK 141
Query: 243 FLHEEAEKPVIYRDFKTSNILLDGEYNA--KLSDFGLAKDGPEGDKTHVSTRVMGTYGYA 300
+H E +++ D K NI+ + + + K+ DFGLA + T +A
Sbjct: 142 HMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVK---VTTATAEFA 195
Query: 301 APEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRRFYR 360
APE V + +D+++ GV+ +L+G P + +E + F
Sbjct: 196 APEIVDREPVGFYTDMWAIGVLGYVLLSGL------SPFAGEDDLETLQNVKRCDWEFDE 249
Query: 361 LIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLK-DMASSSSYV 419
+ + + L ++ + R + + +E P+LK D ++ +S +
Sbjct: 250 DAFSSVS--------PEAKDFIKNLLQKEPRKRLTVHDALE----HPWLKGDHSNLTSRI 297
Query: 420 QAMQAERVRLNLNAKHGSRVPRKGQPTRSLSIPNAPHVSPYHLN 463
+ + ++R + K+ + R + + P
Sbjct: 298 PSSRYNKIRQKIKEKYADWPAPQPAIGRIANFSSLRKHRPQEYQ 341
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 181 bits (459), Expect = 2e-53
Identities = 62/291 (21%), Positives = 103/291 (35%), Gaps = 35/291 (12%)
Query: 123 FRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLG 182
+ LG G FG V++ + TG A K + + E+ +
Sbjct: 28 YDIHEELGTGAFGVVHRV---------TERATGNNFAAKFVMTPHESDKETVRKEIQTMS 78
Query: 183 GLIHPNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLA 242
L HP LV L +D++ +++YEFM G L + + ++ KGL
Sbjct: 79 VLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLC 138
Query: 243 FLHEEAEKPVIYRDFKTSNILLDGEYN--AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYA 300
+H E ++ D K NI+ + + KL DFGL V GT +A
Sbjct: 139 HMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKV---TTGTAEFA 192
Query: 301 APEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRRFYR 360
APE + +D++S GV+ +L+G + V + +
Sbjct: 193 APEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNV---------KSCDWN 243
Query: 361 LIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKD 411
+ D G +E L D R + + +E P+L
Sbjct: 244 MDDSAFSGI-----SEDGKDFIRKLLLADPNTRMTIHQALE----HPWLTP 285
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 174 bits (442), Expect = 9e-51
Identities = 72/298 (24%), Positives = 115/298 (38%), Gaps = 40/298 (13%)
Query: 123 FRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL---QGHKEWLAEVN 179
F ++G GGFG VY K TG A+K L+ + QG L E
Sbjct: 6 FSVHRIIGRGGFGEVYGC---------RKADTGKMYAMKCLDKKRIKMKQGETLALNERI 56
Query: 180 ---YLGGLIHPNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALD 236
+ P +V + D+ + + M G L HL + + +R A +
Sbjct: 57 MLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMR-FYAAE 115
Query: 237 AAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGT 296
GL +H + V+YRD K +NILLD + ++SD GLA D + +GT
Sbjct: 116 IILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA----SVGT 168
Query: 297 YGYAAPEYVMTG-HLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGER 355
+GY APE + G + +D +S G +L ++L G +++ +H + L
Sbjct: 169 HGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM---TLTMA 225
Query: 356 RRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPR-MSEVVEALKPLPYLKDM 412
P L L L RD R + + +K P+ + +
Sbjct: 226 VELPDSFSPEL------------RSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSL 271
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 169 bits (430), Expect = 5e-50
Identities = 65/290 (22%), Positives = 111/290 (38%), Gaps = 36/290 (12%)
Query: 123 FRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQG---HKEWLAEVN 179
+ +LG GG V+ VAVK L D + + + E
Sbjct: 9 YELGEILGFGGMSEVHLA---------RDLRLHRDVAVKVLRADLARDPSFYLRFRREAQ 59
Query: 180 YLGGLIHPNLVKLIGCCIEDDQRL----LVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 235
L HP +V + + +V E++ +L + + P+ +++
Sbjct: 60 NAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIA 118
Query: 236 DAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKD-GPEGDKTHVSTRVM 294
DA + L F H+ +I+RD K +NI++ K+ DFG+A+ G+ + V+
Sbjct: 119 DACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVI 175
Query: 295 GTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGE 354
GT Y +PE + A+SDVYS G VL E+LTG P + V A + E
Sbjct: 176 GTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE------PPFTGDSPVSVAYQHVRE 229
Query: 355 RRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPR-MSEVVEAL 403
L + + L ++ + R + +E+ L
Sbjct: 230 DPIPPSARHEGL--------SADLDAVVLKALAKNPENRYQTAAEMRADL 271
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 168 bits (426), Expect = 4e-49
Identities = 55/311 (17%), Positives = 104/311 (33%), Gaps = 32/311 (10%)
Query: 123 FRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKE-WLAEVNYL 181
+ +LG G F V T VA+K + L+G + E+ L
Sbjct: 11 YDFRDVLGTGAFSEVILA---------EDKRTQKLVAIKCIAKKALEGKEGSMENEIAVL 61
Query: 182 GGLIHPNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGL 241
+ HPN+V L L+ + + G L + + + ++ +
Sbjct: 62 HKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG-FYTERDASRLIFQVLDAV 120
Query: 242 AFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAA 301
+LH+ + LD + +SDFGL+K D V + GT GY A
Sbjct: 121 KYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK---MEDPGSVLSTACGTPGYVA 177
Query: 302 PEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRRFYRL 361
PE + + D +S GV+ +L G P + N + L F
Sbjct: 178 PEVLAQKPYSKAVDCWSIGVIAYILLCGY------PPFYDENDAKLFEQILKAEYEFDSP 231
Query: 362 IDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDMASSSSYVQA 421
+ ++ + +D + R + ++ P++ + +
Sbjct: 232 YWDDI--------SDSAKDFIRHLMEKDPEKRFTCEQALQ----HPWIAGDTALDKNIHQ 279
Query: 422 MQAERVRLNLN 432
+E+++ N
Sbjct: 280 SVSEQIKKNFA 290
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (424), Expect = 1e-48
Identities = 56/335 (16%), Positives = 118/335 (35%), Gaps = 43/335 (12%)
Query: 123 FRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLG 182
+ LG G FG V++ V+ + K + G E++ L
Sbjct: 7 YMIAEDLGRGEFGIVHRC---------VETSSKKTYMAKFVKVKGTD-QVLVKKEISILN 56
Query: 183 GLIHPNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLA 242
H N++ L ++ ++++EF+ + + + L + + L
Sbjct: 57 IARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQ 116
Query: 243 FLHEEAEKPVIYRDFKTSNILLD--GEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYA 300
FLH + + D + NI+ K+ +FG A+ GD + + Y
Sbjct: 117 FLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL---LFTAPEYY 170
Query: 301 APEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRRFYR 360
APE ++ +D++S G ++ +L+G P + + F
Sbjct: 171 APEVHQHDVVSTATDMWSLGTLVYVLLSGI------NPFLAETNQQIIENIMNAEYTFDE 224
Query: 361 LIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDMAS--SSSY 418
+ + + + L +++K+R SE ++ P+LK S+
Sbjct: 225 EAFKEI--------SIEAMDFVDRLLVKERKSRMTASEALQH----PWLKQKIERVSTKV 272
Query: 419 VQAMQAER-----VRLNLNAKHGSRVPRKGQPTRS 448
++ ++ R ++ +LN + G RS
Sbjct: 273 IRTLKHRRYYHTLIKKDLNMVVSAARISCGGAIRS 307
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (423), Expect = 2e-48
Identities = 69/294 (23%), Positives = 108/294 (36%), Gaps = 40/294 (13%)
Query: 123 FRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEW---LAEVN 179
F +LG+G FG V+ T A+K L D + + + E
Sbjct: 4 FILHKMLGKGSFGKVFLA---------EFKKTNQFFAIKALKKDVVLMDDDVECTMVEKR 54
Query: 180 YLGGLI-HPNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAA 238
L HP L + + V E++ G L H+ S A +
Sbjct: 55 VLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCH-KFDLSRATFYAAEII 113
Query: 239 KGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYG 298
GL FLH K ++YRD K NILLD + + K++DFG+ K+ GD GT
Sbjct: 114 LGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT--NTFCGTPD 168
Query: 299 YAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRRF 358
Y APE ++ D +SFGV+L EML G+ P + E + +
Sbjct: 169 YIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQ------SPFHGQDEEELFHSIRMDNPFY 222
Query: 359 YRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDM 412
R ++ L R+ + R + ++ P +++
Sbjct: 223 PRWLEKEA------------KDLLVKLFVREPEKRLGVR---GDIRQHPLFREI 261
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 165 bits (419), Expect = 2e-48
Identities = 65/304 (21%), Positives = 115/304 (37%), Gaps = 50/304 (16%)
Query: 123 FRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL---------QGHKE 173
+ P+ +LG G V + + T AVK ++ G + +
Sbjct: 5 YEPKEILGRGVSSVVRRC---------IHKPTCKEYAVKIIDVTGGGSFSAEEVQELREA 55
Query: 174 WLAEVNYLGGL-IHPNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK 232
L EV+ L + HPN+++L + LV++ M +G L ++L + L K
Sbjct: 56 TLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV-TLSEKETRK 114
Query: 233 IALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTR 292
I + + LH+ +++RD K NILLD + N KL+DFG + G+K
Sbjct: 115 IMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL---RE 168
Query: 293 VMGTYGYAAPEYVMTGHL------TAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVE 346
V GT Y APE + + D++S GV++ +L G + ++
Sbjct: 169 VCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMI- 227
Query: 347 WARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPL 406
Y+ P + ++ L + L + R E +
Sbjct: 228 --------MSGNYQFGSPEWDDY-----SDTVKDLVSRFLVVQPQKRYTAEEALA----H 270
Query: 407 PYLK 410
P+ +
Sbjct: 271 PFFQ 274
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 161 bits (408), Expect = 2e-46
Identities = 75/294 (25%), Positives = 117/294 (39%), Gaps = 40/294 (13%)
Query: 123 FRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKE---WLAEVN 179
F+ LG G FG V+ G A+K L + + K+ E
Sbjct: 6 FQILRTLGTGSFGRVHLI---------RSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERL 56
Query: 180 YLGGLIHPNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAK 239
L + HP ++++ G + Q ++ +++ G L R+S P + A +
Sbjct: 57 MLSIVTHPFIIRMWGTFQDAQQIFMIMDYIE-GGELFSLLRKSQRFPNPVAKFYAAEVCL 115
Query: 240 GLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGY 299
L +LH K +IYRD K NILLD + K++DFG AK P+ T GT Y
Sbjct: 116 ALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLC-----GTPDY 167
Query: 300 AAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRRFY 359
APE V T D +SFG+++ EML G P + N ++ L RF
Sbjct: 168 IAPEVVSTKPYNKSIDWWSFGILIYEMLAGY------TPFYDSNTMKTYEKILNAELRFP 221
Query: 360 RLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPR-MSEVVEALKPLPYLKDM 412
+ + L + + RD R + E +K P+ K++
Sbjct: 222 PFFNEDV------------KDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEV 263
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 160 bits (406), Expect = 3e-46
Identities = 51/290 (17%), Positives = 89/290 (30%), Gaps = 32/290 (11%)
Query: 123 FRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLG 182
+R +G G FG +Y G G VA+K H + E
Sbjct: 9 YRLGRKIGSGSFGDIYLG---------TDIAAGEEVAIKLECVK--TKHPQLHIESKIYK 57
Query: 183 GLIHPNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLA 242
+ + I C + ++ + SLE+ S + +A +
Sbjct: 58 MMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIE 117
Query: 243 FLHEEAEKPVIYRDFKTSNIL---LDGEYNAKLSDFGLAKDGPEGD-----KTHVSTRVM 294
++H K I+RD K N L + DFGLAK + + +
Sbjct: 118 YIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLT 174
Query: 295 GTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGE 354
GT YA+ + + + D+ S G VL+ G + + E
Sbjct: 175 GTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKY--------E 226
Query: 355 RRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALK 404
R ++ P C + C + +P S + + +
Sbjct: 227 RISEKKMSTPIEVLCKGY--PSEFATYLNFCRSLRFDDKPDYSYLRQLFR 274
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (405), Expect = 3e-46
Identities = 68/300 (22%), Positives = 112/300 (37%), Gaps = 35/300 (11%)
Query: 128 LLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKE-----WLAEVNYLG 182
LGEG F VYK T VA+K + K+ L E+ L
Sbjct: 5 FLGEGQFATVYKA---------RDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQ 55
Query: 183 GLIHPNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLA 242
L HPN++ L+ LV++FM LE + SL L S L +GL
Sbjct: 56 ELSHPNIIGLLDAFGHKSNISLVFDFME-TDLEVIIKDNSLVLTPSHIKAYMLMTLQGLE 114
Query: 243 FLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAP 302
+LH + +++RD K +N+LLD KL+DFGLAK ++ + T + T Y AP
Sbjct: 115 YLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAY--THQVVTRWYRAP 169
Query: 303 EYVMTGHL-TAKSDVYSFGVVLLEMLTGRRSMDKNRP----------NGEHNLVEWARPQ 351
E + + D+++ G +L E+L + + G +W
Sbjct: 170 ELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMC 229
Query: 352 LGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKD 411
++ + + L + AR ++ ++ + Y +
Sbjct: 230 SLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK----MKYFSN 285
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (405), Expect = 4e-46
Identities = 68/314 (21%), Positives = 111/314 (35%), Gaps = 39/314 (12%)
Query: 119 ATKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEW---- 174
A + + +GEG +G V+K A G VA+K + +
Sbjct: 5 ADQQYECVAEIGEGAYGKVFK--------ARDLKNGGRFVALKRVRVQTGEEGMPLSTIR 56
Query: 175 -LAEVNYLGGLIHPNLVKLIGCCIEDDQR-----LLVYEFMPRGSLENHLFRRSLPLPWS 228
+A + +L HPN+V+L C LV+E + + +P
Sbjct: 57 EVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTE 116
Query: 229 IRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTH 288
+ +GL FLH V++RD K NIL+ KL+DFGLA+
Sbjct: 117 TIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLAR---IYSFQM 170
Query: 289 VSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV--- 345
T V+ T Y APE ++ D++S G + EM + + + +
Sbjct: 171 ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDV 230
Query: 346 -------EWARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSE 398
+W R R+ F+ +E + E L CL + R
Sbjct: 231 IGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVT-DIDELGKDLLLKCLTFNPAKRISAYS 289
Query: 399 VVEALKPLPYLKDM 412
+ PY +D+
Sbjct: 290 ALS----HPYFQDL 299
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (397), Expect = 4e-45
Identities = 69/307 (22%), Positives = 119/307 (38%), Gaps = 32/307 (10%)
Query: 123 FRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL--QGHKEWLAEVNY 180
F+ +GEG +G VYK TG VA+K + D + E++
Sbjct: 4 FQKVEKIGEGTYGVVYKA---------RNKLTGEVVALKKIRLDTETEGVPSTAIREISL 54
Query: 181 LGGLIHPNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKG 240
L L HPN+VKL+ +++ LV+EF+ + + +P + +G
Sbjct: 55 LKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQG 114
Query: 241 LAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYA 300
LAF H V++RD K N+L++ E KL+DFGLA+ +T+ + V+ + A
Sbjct: 115 LAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY-THEVVTLWYRA 170
Query: 301 APEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRRFYR 360
+ + + D++S G + EM+T R + + + E
Sbjct: 171 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGV 230
Query: 361 LIDPCLEGCFSIKGA-----------EKTIQLAASCLNRDQKARPRMSEVV------EAL 403
P + F E L + L+ D R + +
Sbjct: 231 TSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 290
Query: 404 KPLPYLK 410
KP+P+L+
Sbjct: 291 KPVPHLR 297
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (401), Expect = 5e-45
Identities = 60/307 (19%), Positives = 111/307 (36%), Gaps = 34/307 (11%)
Query: 123 FRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGH-KEWLAEVNYL 181
+ +GEG +G V + + VA+K ++ Q + + L E+ L
Sbjct: 10 YTNLSYIGEGAYGMVCSAY---------DNVNKVRVAIKKISPFEHQTYCQRTLREIKIL 60
Query: 182 GGLIHPNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFR--RSLPLPWSIRMKIALDAAK 239
H N++ + + ++ + L++ ++ L +
Sbjct: 61 LRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILR 120
Query: 240 GLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKD-GPEGDKTHVSTRVMGTYG 298
GL ++H V++RD K SN+LL+ + K+ DFGLA+ P+ D T T + T
Sbjct: 121 GLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 177
Query: 299 YAAPEYVMTGHL-TAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRR 357
Y APE ++ T D++S G +L EML+ R + N + +
Sbjct: 178 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDL 237
Query: 358 FYRLIDPCLEGCFSIKGAEKT-------------IQLAASCLNRDQKARPRMSEVVEALK 404
+ S+ K + L L + R + + +
Sbjct: 238 NCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH-- 295
Query: 405 PLPYLKD 411
PYL+
Sbjct: 296 --PYLEQ 300
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (396), Expect = 7e-45
Identities = 60/306 (19%), Positives = 106/306 (34%), Gaps = 44/306 (14%)
Query: 128 LLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLA------EVNYL 181
LG G F V K + TGL A K + + + ++ EV+ L
Sbjct: 17 ELGSGQFAVVKKC---------REKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSIL 67
Query: 182 GGLIHPNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGL 241
+ HPN++ L +L+ E + G L + L + L + G+
Sbjct: 68 KEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGV 126
Query: 242 AFLHEEAEKPVIYRDFKTSNILLDGE----YNAKLSDFGLAKDGPEGDKTHVSTRVMGTY 297
+LH + + D K NI+L K+ DFGLA G++ + GT
Sbjct: 127 YYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---KNIFGTP 180
Query: 298 GYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRR 357
+ APE V L ++D++S GV+ +L+G + V +
Sbjct: 181 EFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEF--EDE 238
Query: 358 FYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDMASSSS 417
++ L +D K R + + ++ P++K + +
Sbjct: 239 YFSNTSALA------------KDFIRRLLVKDPKKRMTIQDSLQ----HPWIKPKDTQQA 282
Query: 418 YVQAMQ 423
A
Sbjct: 283 LSSAWS 288
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 153 bits (387), Expect = 1e-43
Identities = 47/294 (15%), Positives = 90/294 (30%), Gaps = 34/294 (11%)
Query: 123 FRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLG 182
++ +GEG FG +++G VA+K + E
Sbjct: 7 YKVGRRIGEGSFGVIFEG---------TNLLNNQQVAIKFEPRR--SDAPQLRDEYRTYK 55
Query: 183 GLIHPNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLA 242
L + + ++ ++ + SLE+ L A +
Sbjct: 56 LLAGCTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQ 115
Query: 243 FLHEEAEKPVIYRDFKTSNILLD-----GEYNAKLSDFGLAKDGPEGD-----KTHVSTR 292
+HE K ++YRD K N L+ + DFG+ K +
Sbjct: 116 SIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKN 172
Query: 293 VMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQL 352
+ GT Y + + + + D+ + G V + L G + E ++
Sbjct: 173 LSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYE----RI 228
Query: 353 GERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPL 406
GE+++ L + C G E+ + N A P + +
Sbjct: 229 GEKKQSTPLRELC-AGF-----PEEFYKYMHYARNLAFDATPDYDYLQGLFSKV 276
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 152 bits (384), Expect = 3e-43
Identities = 64/302 (21%), Positives = 112/302 (37%), Gaps = 32/302 (10%)
Query: 123 FRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL--QGHKEWLAEVNY 180
+ +GEG +G VYK N G A+K + + + E++
Sbjct: 4 YHGLEKIGEGTYGVVYKAQNN----------YGETFALKKIRLEKEDEGIPSTTIREISI 53
Query: 181 LGGLIHPNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKG 240
L L H N+VKL + +LV+E + L+ L L L G
Sbjct: 54 LKELKHSNIVKLYDVIHTKKRLVLVFEHLD-QDLKKLLDVCEGGLESVTAKSFLLQLLNG 112
Query: 241 LAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYA 300
+A+ H+ + V++RD K N+L++ E K++DFGLA+ + + ++ + A
Sbjct: 113 IAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYT-HEIVTLWYRA 168
Query: 301 APEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPN----------GEHNLVEWAR- 349
+ + + D++S G + EM+ G G N W
Sbjct: 169 PDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNV 228
Query: 350 PQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYL 409
+L + + + +P F E I L + L D R + +E Y
Sbjct: 229 TELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE----HAYF 284
Query: 410 KD 411
K+
Sbjct: 285 KE 286
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (388), Expect = 3e-43
Identities = 74/294 (25%), Positives = 104/294 (35%), Gaps = 37/294 (12%)
Query: 123 FRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEW---LAEVN 179
F LLG+G FG V + TG A+K L + + E + E
Sbjct: 7 FDYLKLLGKGTFGKVILV---------REKATGRYYAMKILRKEVIIAKDEVAHTVTESR 57
Query: 180 YLGGLIHPNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAK 239
L HP L L D+ V E+ G L HL R +
Sbjct: 58 VLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHL-SRERVFTEERARFYGAEIVS 116
Query: 240 GLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGY 299
L +LH + V+YRD K N++LD + + K++DFGL K+G T GT Y
Sbjct: 117 ALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM--KTFCGTPEY 171
Query: 300 AAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRRFY 359
APE + D + GVV+ EM+ GR P + L E RF
Sbjct: 172 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR------LPFYNQDHERLFELILMEEIRFP 225
Query: 360 RLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEV-VEALKPLPYLKDM 412
R + P L A L +D K R + + + +
Sbjct: 226 RTLSPEA------------KSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSI 267
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (382), Expect = 4e-43
Identities = 66/300 (22%), Positives = 107/300 (35%), Gaps = 54/300 (18%)
Query: 123 FRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKE------WLA 176
++ LLG GGFG VY G ++ LPVA+K + D + E
Sbjct: 6 YQVGPLLGSGGFGSVYSG---------IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 56
Query: 177 EVNYLGGL--IHPNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 234
EV L + +++L+ D +L+ E L +
Sbjct: 57 EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF 116
Query: 235 LDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGE-YNAKLSDFGLAKDGPEGDKTHVSTRV 293
+ + H V++RD K NIL+D KL DFG K V T
Sbjct: 117 WQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGAL----LKDTVYTDF 169
Query: 294 MGTYGYAAPEYVMTG-HLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQL 352
GT Y+ PE++ + + V+S G++L +M+ G + + E R Q+
Sbjct: 170 DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE--------EIIRGQV 221
Query: 353 GERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDM 412
R+R + + L CL RP E+ P+++D+
Sbjct: 222 FFRQRV----------------SSECQHLIRWCLALRPSDRPTFEEIQN----HPWMQDV 261
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (384), Expect = 1e-42
Identities = 68/343 (19%), Positives = 118/343 (34%), Gaps = 57/343 (16%)
Query: 90 STTPSTPKIGEELKISPQLRKFSFNELKSATKSFRPECLLGEGGFGCVYKGWINMNGTAT 149
+T +TP G + + ++ S+ + K ++G G FG VY+
Sbjct: 4 TTVVATPGQGPD-----RPQEVSYTDTK----------VIGNGSFGVVYQA--------- 39
Query: 150 VKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHPNLVKLIGCCIEDDQR------L 203
+G VA+K + D + E+ + L H N+V+L ++
Sbjct: 40 KLCDSGELVAIKKVLQD----KRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 95
Query: 204 LVYEFMPRGSLEN--HLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSN 261
LV +++P H R LP + LA++H + +RD K N
Sbjct: 96 LVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQN 152
Query: 262 ILLDGE-YNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFG 320
+LLD + KL DFG AK G+ + + Y A T+ DV+S G
Sbjct: 153 LLLDPDTAVLKLCDFGSAKQLVRGEPNV--SYICSRYYRAPELIFGATDYTSSIDVWSAG 210
Query: 321 VVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGE-----------RRRFYRLIDPCLEGC 369
VL E+L G+ + + + +F ++
Sbjct: 211 CVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKV 270
Query: 370 FSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDM 412
F + + I L + L AR E + ++
Sbjct: 271 FRPRTPPEAIALCSRLLEYTPTARLTPLEACAH----SFFDEL 309
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (375), Expect = 2e-41
Identities = 56/293 (19%), Positives = 97/293 (33%), Gaps = 43/293 (14%)
Query: 128 LLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLI-H 186
+LG G G V + T A+K L + EV
Sbjct: 19 VLGLGINGKVLQI---------FNKRTQEKFALKMLQD-----CPKARREVELHWRASQC 64
Query: 187 PNLVKLIGCC----IEDDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALDAAKGL 241
P++V+++ L+V E + G L + + R +I + +
Sbjct: 65 PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAI 124
Query: 242 AFLHEEAEKPVIYRDFKTSNILLDGEYN---AKLSDFGLAKDGPEGDKTHVSTRVMGTYG 298
+LH + +RD K N+L + KL+DFG AK+ + T
Sbjct: 125 QYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLT---TPCYTPY 178
Query: 299 YAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRRF 358
Y APE + D++S GV++ +L G H L + R
Sbjct: 179 YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFY-----SNHGLAISPGMKTRIRMGQ 233
Query: 359 YRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKD 411
Y +P +E+ L + L + R ++E + P++
Sbjct: 234 YEFPNPEWSEV-----SEEVKMLIRNLLKTEPTQRMTITEFMN----HPWIMQ 277
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (359), Expect = 2e-39
Identities = 60/306 (19%), Positives = 102/306 (33%), Gaps = 40/306 (13%)
Query: 123 FRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQG--HKEWLAEVNY 180
+ +G+G FG V+K TG VA+K + + + L E+
Sbjct: 12 YEKLAKIGQGTFGEVFKA---------RHRKTGQKVALKKVLMENEKEGFPITALREIKI 62
Query: 181 LGGLIHPNLVKLIGCCIEDDQR--------LLVYEFMPRGSLENHLFRRSLPLPWSIRMK 232
L L H N+V LI C LV++F S +
Sbjct: 63 LQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLV-KFTLSEIKR 121
Query: 233 IALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVS-- 290
+ GL ++H +++RD K +N+L+ + KL+DFGLA+ + +
Sbjct: 122 VMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRY 178
Query: 291 TRVMGTYGYAAPEYVMTGHL-TAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV---- 345
T + T Y PE ++ D++ G ++ EM T M N + L+
Sbjct: 179 TNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLC 238
Query: 346 ------EWARPQLGERRRFYRLIDPC----LEGCFSIKGAEKTIQLAASCLNRDQKARPR 395
W E L+ + + + L L D R
Sbjct: 239 GSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRID 298
Query: 396 MSEVVE 401
+ +
Sbjct: 299 SDDALN 304
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 141 bits (355), Expect = 2e-38
Identities = 72/337 (21%), Positives = 116/337 (34%), Gaps = 46/337 (13%)
Query: 81 SSSTTSNAESTTPSTPKIGEELKISPQLRKFSFNELKSAT-KSFRPECLLGEGGFGCVYK 139
++ S ES K E+ L+K+ +A F LG G FG V
Sbjct: 5 AAKKGSEQESVKEFLAKAKEDF-----LKKWETPSQNTAQLDQFDRIKTLGTGSFGRVML 59
Query: 140 GWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEW---LAEVNYLGGLIHPNLVKLIGCC 196
+G A+K L+ + K+ L E L + P LVKL
Sbjct: 60 V---------KHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSF 110
Query: 197 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRD 256
++ +V E++ G + +HL R A +LH +IYRD
Sbjct: 111 KDNSNLYMVMEYVAGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYLHS---LDLIYRD 166
Query: 257 FKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDV 316
K N+L+D + +++DFG AK T + GT APE +++ D
Sbjct: 167 LKPENLLIDQQGYIQVTDFGFAKRVKGRTWT-----LCGTPEALAPEIILSKGYNKAVDW 221
Query: 317 YSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRRFYRLIDPCLEGCFSIKGAE 376
++ GV++ EM G P ++ + + RF L+
Sbjct: 222 WALGVLIYEMAAGY------PPFFADQPIQIYEKIVSGKVRFPSHFSSDLK--------- 266
Query: 377 KTIQLAASCLNRDQKAR-PRMSEVVEALKPLPYLKDM 412
L + L D R + V +K +
Sbjct: 267 ---DLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATT 300
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (348), Expect = 4e-38
Identities = 60/303 (19%), Positives = 101/303 (33%), Gaps = 32/303 (10%)
Query: 123 FRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL--QGHKEWLAEVNY 180
+ +GEG +G V+K T VA+K + D L E+
Sbjct: 4 YEKLEKIGEGTYGTVFKA---------KNRETHEIVALKRVRLDDDDEGVPSSALREICL 54
Query: 181 LGGLIHPNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKG 240
L L H N+V+L D + LV+EF + + I KG
Sbjct: 55 LKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDL-DPEIVKSFLFQLLKG 113
Query: 241 LAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYA 300
L F H + V++RD K N+L++ KL++FGLA+ + + S V+ +
Sbjct: 114 LGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY-SAEVVTLWYRP 169
Query: 301 APEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPN-----------GEHNLVEWAR 349
+ D++S G + E+ R + G +W
Sbjct: 170 PDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPS 229
Query: 350 -PQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPY 408
+L + + + K L + L + R E ++ PY
Sbjct: 230 MTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ----HPY 285
Query: 409 LKD 411
D
Sbjct: 286 FSD 288
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (349), Expect = 1e-37
Identities = 64/327 (19%), Positives = 114/327 (34%), Gaps = 48/327 (14%)
Query: 111 FSFNELKSAT----KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHD 166
F E+ +R +G G +G V V TG VA+K L
Sbjct: 4 FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSA---------VDGRTGAKVAIKKLYRP 54
Query: 167 GL--QGHKEWLAEVNYLGGLIHPNLVKLIGCCIEDDQR------LLVYEFMPRGSLENHL 218
K E+ L + H N++ L+ D+ LV FM G+ L
Sbjct: 55 FQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKL 112
Query: 219 FRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLA 278
+ L + KGL ++H +I+RD K N+ ++ + K+ DFGLA
Sbjct: 113 MKHE-KLGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLA 168
Query: 279 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRP 338
+ ++ V+ + A + T D++S G ++ EM+TG+ +
Sbjct: 169 RQADS----EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDH 224
Query: 339 NGEHNLV----------EWARPQLGERRRFYRLIDPCLEGCFS---IKGAEKTIQLAASC 385
+ + R Q E + + + + + F+ + + L
Sbjct: 225 LDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKM 284
Query: 386 LNRDQKARPRMSEVVEALKPLPYLKDM 412
L D + R E + PY + +
Sbjct: 285 LVLDAEQRVTAGEALA----HPYFESL 307
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (335), Expect = 6e-36
Identities = 69/316 (21%), Positives = 114/316 (36%), Gaps = 43/316 (13%)
Query: 114 NELKSATKSFRPECL----------LGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTL 163
+EL++A + E + LG G +G V+ TG A+K L
Sbjct: 7 HELRTANLTGHAEKVGIENFELLKVLGTGAYGKVFLVR------KISGHDTGKLYAMKVL 60
Query: 164 NHDGL----QGHKEWLAEVNYLGGLIH-PNLVKLIGCCIEDDQRLLVYEFMPRGSLENHL 218
+ + + E L + P LV L + + L+ +++ G L HL
Sbjct: 61 KKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHL 120
Query: 219 FRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLA 278
+R + L LH+ +IYRD K NILLD + L+DFGL+
Sbjct: 121 SQRE-RFTEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLS 176
Query: 279 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGH--LTAKSDVYSFGVVLLEMLTGRRSMDKN 336
K+ + + GT Y AP+ V G D +S GV++ E+LTG
Sbjct: 177 KEFVADETER-AYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFT-- 233
Query: 337 RPNGEHNLVEWARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRM 396
+++ E +R L + + + L L +D K R
Sbjct: 234 VDGEKNSQAEISRRILKSEPPYPQEMSALA------------KDLIQRLLMKDPKKRLGC 281
Query: 397 S-EVVEALKPLPYLKD 411
+ +K + +
Sbjct: 282 GPRDADEIKEHLFFQK 297
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 127 bits (319), Expect = 1e-33
Identities = 53/315 (16%), Positives = 102/315 (32%), Gaps = 51/315 (16%)
Query: 123 FRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLG 182
++ LG G + V++ + V VK L K+ E+ L
Sbjct: 37 YQLVRKLGRGKYSEVFEA---------INITNNEKVVVKILKPVK---KKKIKREIKILE 84
Query: 183 GL-IHPNLVKLIGCCIEDDQRL--LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAK 239
L PN++ L + R LV+E + + L + K
Sbjct: 85 NLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT----LTDYDIRFYMYEILK 140
Query: 240 GLAFLHEEAEKPVIYRDFKTSNILLDGE-YNAKLSDFGLAKDGPEGDKTHVSTRVMGTYG 298
L + H +++RD K N+++D E +L D+GLA+ G + + +
Sbjct: 141 ALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY---NVRVASRY 194
Query: 299 YAAPEYVMT-GHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGE---------------- 341
+ PE ++ D++S G +L M+ + N +
Sbjct: 195 FKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYD 254
Query: 342 ----HNLVEWARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMS 397
+N+ R R + + + + + + L D ++R
Sbjct: 255 YIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAR 314
Query: 398 EVVEALKPLPYLKDM 412
E +E PY +
Sbjct: 315 EAMEH----PYFYTV 325
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (304), Expect = 3e-31
Identities = 57/311 (18%), Positives = 100/311 (32%), Gaps = 51/311 (16%)
Query: 123 FRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL--QGHKEWLAEVNY 180
++ +G G G V + VA+K L+ K E+
Sbjct: 19 YQNLKPIGSGAQGIVCAAY---------DAVLDRNVAIKKLSRPFQNQTHAKRAYRELVL 69
Query: 181 LGGLIHPNLVKLIGCCI------EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 234
+ + H N++ L+ E LV E M + +
Sbjct: 70 MKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL----DHERMSYLL 125
Query: 235 LDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVM 294
G+ LH +I+RD K SNI++ + K+ DFGLA+ T +
Sbjct: 126 YQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM---TPYV 179
Query: 295 GTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGR----------------RSMDKNRP 338
T Y APE ++ D++S G ++ EM+ + + P
Sbjct: 180 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCP 239
Query: 339 NGEHNLVEWARPQLGERRRFYRLIDPCL--------EGCFSIKGAEKTIQLAASCLNRDQ 390
L R + R ++ L P L + + A + L + L D
Sbjct: 240 EFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDP 299
Query: 391 KARPRMSEVVE 401
R + + ++
Sbjct: 300 AKRISVDDALQ 310
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (299), Expect = 1e-30
Identities = 60/309 (19%), Positives = 110/309 (35%), Gaps = 42/309 (13%)
Query: 123 FRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL--QGHKEWLAEVNY 180
++ +G G +G V + TGL VAVK L+ K E+
Sbjct: 20 YQNLSPVGSGAYGSVCAAF---------DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 70
Query: 181 LGGLIHPNLVKLIGCC-----IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 235
L + H N++ L+ +E+ + + + L N + + L +
Sbjct: 71 LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ--KLTDDHVQFLIY 128
Query: 236 DAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMG 295
+GL ++H +I+RD K SN+ ++ + K+ DFGLA+ + +V+TR
Sbjct: 129 QILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR--- 182
Query: 296 TYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKN----------RPNGEHNLV 345
+ A + H D++S G ++ E+LTGR R G
Sbjct: 183 -WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE 241
Query: 346 EWARPQLGERRRFYRLIDPCLEGCFS---IKGAEKTIQLAASCLNRDQKARPRMSEVVEA 402
+ R + + + + F+ I + L L D R ++ +
Sbjct: 242 LLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 301
Query: 403 LKPLPYLKD 411
Y
Sbjct: 302 ----AYFAQ 306
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 109 bits (272), Expect = 6e-27
Identities = 54/335 (16%), Positives = 100/335 (29%), Gaps = 62/335 (18%)
Query: 123 FRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLG 182
+ LG G F V+ VA+K + D + + E+ L
Sbjct: 15 YILVRKLGWGHFSTVWLAK---------DMVNNTHVAMKIVRGDKVY-TEAAEDEIKLLQ 64
Query: 183 GLIHPNLVKLIGCCIEDDQRLLVY---------------EFMPRGSLENHLFRRSLPLPW 227
+ + K +LL + E + L +P
Sbjct: 65 RVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPL 124
Query: 228 SIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGE-YNAKLSDFGLAKDGPEGDK 286
+I+ GL ++H +I+ D K N+L++ L +A G
Sbjct: 125 IYVKQISKQLLLGLDYMHRR--CGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWY 182
Query: 287 THVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVE 346
T + T Y +PE ++ +D++S ++ E++TG + + + +
Sbjct: 183 DEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDD 242
Query: 347 WAR------------------------PQLGERRRFYRLIDPCLEGCFSIKG------AE 376
G R +L LE + K A+
Sbjct: 243 HIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAK 302
Query: 377 KTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKD 411
+ + L D + R +V P+LKD
Sbjct: 303 EISDFLSPMLQLDPRKRADAGGLVNH----PWLKD 333
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 76.4 bits (187), Expect = 9e-17
Identities = 21/167 (12%), Positives = 43/167 (25%), Gaps = 36/167 (21%)
Query: 128 LLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL----------QGHKEWLAE 177
L+GEG V+ VK G +
Sbjct: 7 LMGEGKESAVFNC----------YSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVL 56
Query: 178 VNYLGGLIHPNLVKLIGCCIED----DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKI 233
L KL G + + ++ E + L ++
Sbjct: 57 AIRSARNEFRALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRV--------RVENPDEV 108
Query: 234 ALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKD 280
+ +A + + +++ D N+L+ E + DF + +
Sbjct: 109 LDMILEEVAKFY---HRGIVHGDLSQYNVLVS-EEGIWIIDFPQSVE 151
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 476 | |||
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.92 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.74 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.1 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.81 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.83 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.69 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.55 |
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-58 Score=448.72 Aligned_cols=261 Identities=25% Similarity=0.336 Sum_probs=217.7
Q ss_pred cCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCCCCCceeeEEEEEEeCC
Q 011851 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHPNLVKLIGCCIEDD 200 (476)
Q Consensus 121 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 200 (476)
++|++.+.||+|+||+||+|.+. .+|+.||||+++.......+.+.+|+++|++++|||||+++++|.+++
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~---------~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~ 90 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDV---------ATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGD 90 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBT---------TTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred cccEEEEEEecCcCcEEEEEEEC---------CCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECC
Confidence 47999999999999999998654 578899999998766666778999999999999999999999999999
Q ss_pred eeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCcCC
Q 011851 201 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKD 280 (476)
Q Consensus 201 ~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~ 280 (476)
.+|||||||+||+|.+++.+. .+++..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|+.
T Consensus 91 ~~~ivmEy~~gg~L~~~~~~~--~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~ 165 (293)
T d1yhwa1 91 ELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQ 165 (293)
T ss_dssp EEEEEEECCTTCBHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEEEEecCCCcHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhhee
Confidence 999999999999999987553 5999999999999999999999988 99999999999999999999999999987
Q ss_pred CCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhcccccccc
Q 011851 281 GPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRRFYR 360 (476)
Q Consensus 281 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 360 (476)
...... .....+||+.|+|||++.+..|+.++|||||||++|+|++|+.||.......... ...... . ..
T Consensus 166 ~~~~~~--~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~--~~~~~~---~---~~ 235 (293)
T d1yhwa1 166 ITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY--LIATNG---T---PE 235 (293)
T ss_dssp CCSTTC--CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH--HHHHHC---S---CC
T ss_pred eccccc--cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHH--HHHhCC---C---CC
Confidence 644322 2345689999999999999999999999999999999999999997543221111 110000 0 00
Q ss_pred ccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCcccccCcc
Q 011851 361 LIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDMASSS 416 (476)
Q Consensus 361 ~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~~~~~~ 416 (476)
+ ..+...+.++.+||.+||+.||++|||+.|+++| |||+.....+
T Consensus 236 -----~--~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~H----p~~~~~~~~~ 280 (293)
T d1yhwa1 236 -----L--QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH----QFLKIAKPLS 280 (293)
T ss_dssp -----C--SSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTC----GGGGGCCCGG
T ss_pred -----C--CCcccCCHHHHHHHHHHccCChhHCcCHHHHhcC----HhhCCCCCCC
Confidence 0 1122336789999999999999999999999887 9998654433
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-59 Score=448.23 Aligned_cols=260 Identities=25% Similarity=0.326 Sum_probs=212.0
Q ss_pred ccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCcc-CHHHHHHHHHHHhCCCCCceeeEEEEEEe
Q 011851 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQ-GHKEWLAEVNYLGGLIHPNLVKLIGCCIE 198 (476)
Q Consensus 120 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~~ 198 (476)
.++|++.+.||+|+||+||+|++. .+|+.||||+++..... ..+.+.+|+++|++++|||||++++++.+
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~---------~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~ 74 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNR---------VTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRRE 74 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEET---------TTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEEC---------CCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeecc
Confidence 356999999999999999998654 57888999999765432 34568899999999999999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCc
Q 011851 199 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLA 278 (476)
Q Consensus 199 ~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a 278 (476)
++.+|||||||++|+|.+++. ....+++..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|
T Consensus 75 ~~~~~ivmEy~~gg~L~~~l~-~~~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a 150 (271)
T d1nvra_ 75 GNIQYLFLEYCSGGELFDRIE-PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLA 150 (271)
T ss_dssp TTEEEEEEECCTTEEGGGGSB-TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTC
T ss_pred CceeEEEEeccCCCcHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhh
Confidence 999999999999999999984 4457999999999999999999999988 999999999999999999999999999
Q ss_pred CCCCCCCccceeeeeecCCCCCCcchhhcCCC-CccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhccccc
Q 011851 279 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHL-TAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRR 357 (476)
Q Consensus 279 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 357 (476)
+..............+||+.|||||++.+..+ +.++|||||||++|||++|+.||.......... ..+... ..
T Consensus 151 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~-~~~~~~-----~~ 224 (271)
T d1nvra_ 151 TVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY-SDWKEK-----KT 224 (271)
T ss_dssp EECEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHH-HHHHTT-----CT
T ss_pred eeeccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHH-HHHhcC-----CC
Confidence 87654443334455789999999999998876 578999999999999999999997654322111 111000 00
Q ss_pred cccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCccc
Q 011851 358 FYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKD 411 (476)
Q Consensus 358 ~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~ 411 (476)
... .....+.++.+||.+||+.||++|||++|+++| |||+.
T Consensus 225 ----~~~-----~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h----pwf~~ 265 (271)
T d1nvra_ 225 ----YLN-----PWKKIDSAPLALLHKILVENPSARITIPDIKKD----RWYNK 265 (271)
T ss_dssp ----TST-----TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC----TTTTC
T ss_pred ----CCC-----ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC----HhhCc
Confidence 000 011225788999999999999999999999887 99975
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-58 Score=442.35 Aligned_cols=252 Identities=26% Similarity=0.394 Sum_probs=211.7
Q ss_pred cCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCC---ccCHHHHHHHHHHHhCCCCCceeeEEEEEE
Q 011851 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDG---LQGHKEWLAEVNYLGGLIHPNLVKLIGCCI 197 (476)
Q Consensus 121 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~ 197 (476)
++|++.+.||+|+||+||+|++. .+|+.||||++.+.. ....+.+.+|+++|++++|||||++++++.
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~---------~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~ 76 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREK---------QSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH 76 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEET---------TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEEC---------CCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEE
Confidence 35999999999999999998654 578889999986432 233567889999999999999999999999
Q ss_pred eCCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCC
Q 011851 198 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGL 277 (476)
Q Consensus 198 ~~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~ 277 (476)
+++.+|||||||++|+|.+++.+. ..+++..+..++.||+.||+|||+++ ||||||||+||||+.++.+||+|||+
T Consensus 77 ~~~~~~ivmEy~~~g~L~~~l~~~-~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~ 152 (263)
T d2j4za1 77 DATRVYLILEYAPLGTVYRELQKL-SKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGW 152 (263)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCS
T ss_pred ECCEEEEEEeecCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccce
Confidence 999999999999999999999654 46999999999999999999999988 99999999999999999999999999
Q ss_pred cCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhccccc
Q 011851 278 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRR 357 (476)
Q Consensus 278 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 357 (476)
|+...... ....+||+.|||||++.+..|+.++|||||||++|||++|+.||...........+. ....
T Consensus 153 a~~~~~~~----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~------~~~~- 221 (263)
T d2j4za1 153 SVHAPSSR----RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS------RVEF- 221 (263)
T ss_dssp CSCCCCCC----CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH------TTCC-
T ss_pred eeecCCCc----ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHH------cCCC-
Confidence 98764422 234689999999999999999999999999999999999999997643221111110 0000
Q ss_pred cccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCccc
Q 011851 358 FYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKD 411 (476)
Q Consensus 358 ~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~ 411 (476)
.++...++++.+||.+||+.||++|||++|+++| |||..
T Consensus 222 -----------~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~h----p~~~~ 260 (263)
T d2j4za1 222 -----------TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH----PWITA 260 (263)
T ss_dssp -----------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTC----HHHHH
T ss_pred -----------CCCccCCHHHHHHHHHHccCCHhHCcCHHHHHcC----cCcCC
Confidence 1122236789999999999999999999999987 88763
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-59 Score=450.02 Aligned_cols=263 Identities=22% Similarity=0.281 Sum_probs=214.4
Q ss_pred cCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCC---ccCHHHHHHHHHHHhCCCCCceeeEEEEEE
Q 011851 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDG---LQGHKEWLAEVNYLGGLIHPNLVKLIGCCI 197 (476)
Q Consensus 121 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~ 197 (476)
++|++++.||+|+||+||+|.+. .+|+.||||++++.. ....+.+.+|+++|++++|||||+++++|.
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~---------~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~ 78 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLAREL---------ATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQ 78 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET---------TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEEC---------CCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEE
Confidence 46999999999999999998654 478889999997532 233567899999999999999999999999
Q ss_pred eCCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCC
Q 011851 198 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGL 277 (476)
Q Consensus 198 ~~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~ 277 (476)
+++.+|||||||+||+|.+++... ..+++..++.++.||+.||+|||+++ ||||||||+||||+.++.+||+|||+
T Consensus 79 ~~~~~~ivmEy~~gg~L~~~~~~~-~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~ 154 (288)
T d1uu3a_ 79 DDEKLYFGLSYAKNGELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGT 154 (288)
T ss_dssp CSSEEEEEECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTT
T ss_pred ECCEEEEEEEccCCCCHHHhhhcc-CCCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEeccccc
Confidence 999999999999999999988554 57999999999999999999999988 99999999999999999999999999
Q ss_pred cCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhccccc
Q 011851 278 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRR 357 (476)
Q Consensus 278 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 357 (476)
|+..............+||+.|+|||++.+..|+.++|||||||++|||++|+.||...+.......+ .....
T Consensus 155 a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i------~~~~~- 227 (288)
T d1uu3a_ 155 AKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKI------IKLEY- 227 (288)
T ss_dssp CEECC----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH------HTTCC-
T ss_pred ceecccCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHH------HcCCC-
Confidence 98765444333344578999999999999999999999999999999999999999764322111100 00000
Q ss_pred cccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--hcCCCCcccccC
Q 011851 358 FYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEA--LKPLPYLKDMAS 414 (476)
Q Consensus 358 ~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~--L~~~~~~~~~~~ 414 (476)
.++...++++.+||.+||+.||++|||++|++++ +..+|||+++..
T Consensus 228 -----------~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i~w 275 (288)
T d1uu3a_ 228 -----------DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTW 275 (288)
T ss_dssp -----------CCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCC
T ss_pred -----------CCCccCCHHHHHHHHHHccCCHhHCcCHHHHcCCHHHHcCCccCCCCH
Confidence 1122236789999999999999999999997654 567899988653
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-58 Score=445.07 Aligned_cols=258 Identities=25% Similarity=0.406 Sum_probs=215.3
Q ss_pred cCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCCCCCceeeEEEEEEeCC
Q 011851 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHPNLVKLIGCCIEDD 200 (476)
Q Consensus 121 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 200 (476)
+.|++++.||+|+||+||+|++. .+|+.||||+++.......+.+.+|+++|++++|||||++++++.+++
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~---------~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~ 82 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNK---------ETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYEN 82 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEET---------TTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred cCeEEeEEEeeCCCcEEEEEEEC---------CCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCC
Confidence 35899999999999999998754 578889999998776666778999999999999999999999999999
Q ss_pred eeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCcCC
Q 011851 201 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKD 280 (476)
Q Consensus 201 ~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~ 280 (476)
.+|||||||++|+|.+++.+...++++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+|+.
T Consensus 83 ~~~lvmEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~ 159 (288)
T d2jfla1 83 NLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAK 159 (288)
T ss_dssp EEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred eEEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhc
Confidence 999999999999999998777778999999999999999999999988 99999999999999999999999999976
Q ss_pred CCCCCccceeeeeecCCCCCCcchhh-----cCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhccc
Q 011851 281 GPEGDKTHVSTRVMGTYGYAAPEYVM-----TGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGER 355 (476)
Q Consensus 281 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~ 355 (476)
.... .......+||+.|+|||++. +..|+.++|||||||++|||+||+.||.......... ...... .
T Consensus 160 ~~~~--~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~--~i~~~~---~ 232 (288)
T d2jfla1 160 NTRT--IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLL--KIAKSE---P 232 (288)
T ss_dssp CHHH--HHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHH--HHHHSC---C
T ss_pred cCCC--cccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHH--HHHcCC---C
Confidence 4321 11223478999999999984 4568999999999999999999999997654322111 111100 0
Q ss_pred cccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCccc
Q 011851 356 RRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKD 411 (476)
Q Consensus 356 ~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~ 411 (476)
+.+ ..+...++++.+||.+||+.||++|||+.|+++| ||++.
T Consensus 233 --------~~~--~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~h----p~~~~ 274 (288)
T d2jfla1 233 --------PTL--AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQH----PFVTV 274 (288)
T ss_dssp --------CCC--SSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTS----GGGCC
T ss_pred --------CCC--CccccCCHHHHHHHHHHccCChhHCcCHHHHhcC----cccCC
Confidence 000 1122336789999999999999999999999987 99974
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-58 Score=452.46 Aligned_cols=274 Identities=24% Similarity=0.359 Sum_probs=212.9
Q ss_pred ccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccC-HHHHHHHHHHHhCCCCCceeeEEEEEEe
Q 011851 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQG-HKEWLAEVNYLGGLIHPNLVKLIGCCIE 198 (476)
Q Consensus 120 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~-~~~~~~E~~~l~~l~hpnIv~l~~~~~~ 198 (476)
.++|+++++||+|+||+||+|++. .+|+.||+|+++...... ..++.+|+.+|++++|||||+++++|.+
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~---------~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~ 75 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHK---------PSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS 75 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEET---------TTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEEC
T ss_pred ccCCEEEEEEecCCCeEEEEEEEC---------CCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE
Confidence 467999999999999999998654 578899999997654333 4578899999999999999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCCeeecCCCceEEeecCC
Q 011851 199 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHE-EAEKPVIYRDFKTSNILLDGEYNAKLSDFGL 277 (476)
Q Consensus 199 ~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~-~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~ 277 (476)
++++|||||||+||+|.+++.+. ..+++..++.++.||+.||.|||+ ++ |+||||||+||||+.++.+||+|||+
T Consensus 76 ~~~~~iVmEy~~gg~L~~~l~~~-~~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGl 151 (322)
T d1s9ja_ 76 DGEISICMEHMDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGV 151 (322)
T ss_dssp SSEEEEEEECCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCC
T ss_pred CCEEEEEEEcCCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCC
Confidence 99999999999999999999654 469999999999999999999997 47 99999999999999999999999999
Q ss_pred cCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhh-hhhhcc--
Q 011851 278 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA-RPQLGE-- 354 (476)
Q Consensus 278 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~-~~~~~~-- 354 (476)
|+..... .....+||+.|+|||++.+..|+.++|||||||++|||++|+.||............... ......
T Consensus 152 a~~~~~~----~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 227 (322)
T d1s9ja_ 152 SGQLIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETP 227 (322)
T ss_dssp CHHHHHH----TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC------------
T ss_pred ccccCCC----ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCC
Confidence 9864321 233478999999999999999999999999999999999999999765432111000000 000000
Q ss_pred -------c------------ccccc----ccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCccc
Q 011851 355 -------R------------RRFYR----LIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKD 411 (476)
Q Consensus 355 -------~------------~~~~~----~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~ 411 (476)
. ....+ +.............+.++.+||.+||+.||++|||++|+|+| |||++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~H----pf~~~ 303 (322)
T d1s9ja_ 228 PRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH----AFIKR 303 (322)
T ss_dssp ------------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTS----HHHHH
T ss_pred cccccccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC----HhhCc
Confidence 0 00000 000000000011125689999999999999999999999998 99986
Q ss_pred ccC
Q 011851 412 MAS 414 (476)
Q Consensus 412 ~~~ 414 (476)
...
T Consensus 304 ~~~ 306 (322)
T d1s9ja_ 304 SDA 306 (322)
T ss_dssp HHH
T ss_pred CCc
Confidence 543
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.4e-56 Score=438.45 Aligned_cols=261 Identities=21% Similarity=0.309 Sum_probs=198.5
Q ss_pred ccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccC-HHHHHHHHHHHhCCCCCceeeEEEEEEe
Q 011851 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQG-HKEWLAEVNYLGGLIHPNLVKLIGCCIE 198 (476)
Q Consensus 120 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~-~~~~~~E~~~l~~l~hpnIv~l~~~~~~ 198 (476)
.+.|++.++||+|+||+||+|++. .+|+.||||++....... .+.+.+|+.+|++++|||||++++++.+
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~---------~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~ 78 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDK---------RTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYES 78 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEET---------TTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred ccceEEEEEEeeccCeEEEEEEEC---------CCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEE
Confidence 456999999999999999998654 578889999997654332 3457789999999999999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeec---CCCceEEeec
Q 011851 199 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLD---GEYNAKLSDF 275 (476)
Q Consensus 199 ~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~---~~~~vkl~DF 275 (476)
++.+|||||||+||+|.++|.. ...+++..+..++.||+.||+|||+++ |+||||||+|||+. .++.+||+||
T Consensus 79 ~~~~~lvmE~~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DF 154 (307)
T d1a06a_ 79 GGHLYLIMQLVSGGELFDRIVE-KGFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDF 154 (307)
T ss_dssp SSEEEEEECCCCSCBHHHHHHT-CSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC
T ss_pred CCEEEEEEeccCCCcHHHhhhc-ccCCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEecc
Confidence 9999999999999999999954 457999999999999999999999988 99999999999994 5789999999
Q ss_pred CCcCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhccc
Q 011851 276 GLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGER 355 (476)
Q Consensus 276 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~ 355 (476)
|+|+...... .....+||+.|||||++.+..|+.++|||||||++|||++|+.||....... +..... ...
T Consensus 155 G~a~~~~~~~---~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~---~~~~i~---~~~ 225 (307)
T d1a06a_ 155 GLSKMEDPGS---VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAK---LFEQIL---KAE 225 (307)
T ss_dssp ---------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHH---TTC
T ss_pred ceeEEccCCC---eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHH---HHHHHh---ccC
Confidence 9998754332 2334789999999999999999999999999999999999999997543221 111100 000
Q ss_pred cccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCcccccC
Q 011851 356 RRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDMAS 414 (476)
Q Consensus 356 ~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~~~~ 414 (476)
. . .........++++.+||.+||+.||++|||+.|+++| |||++...
T Consensus 226 ~---~-----~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h----p~~~~~~~ 272 (307)
T d1a06a_ 226 Y---E-----FDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH----PWIAGDTA 272 (307)
T ss_dssp C---C-----CCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS----TTTTSSCC
T ss_pred C---C-----CCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcC----HhhCCCCc
Confidence 0 0 0011112336789999999999999999999999998 99986443
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-56 Score=432.26 Aligned_cols=258 Identities=27% Similarity=0.406 Sum_probs=203.0
Q ss_pred ccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCc--cCHHHHHHHHHHHhCCCCCceeeEEEEEE
Q 011851 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL--QGHKEWLAEVNYLGGLIHPNLVKLIGCCI 197 (476)
Q Consensus 120 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~ 197 (476)
.++|++.+.||+|+||+||+|.++ ..||||+++.... ...+.+.+|+.+|++++|||||++++++.
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~------------~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~ 74 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH------------GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST 74 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS------------SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC------------CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe
Confidence 457999999999999999999643 2499999975432 33567899999999999999999999864
Q ss_pred eCCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCC
Q 011851 198 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGL 277 (476)
Q Consensus 198 ~~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~ 277 (476)
++.+|||||||++|+|.+++......+++..+..++.||+.||+|||+++ ||||||||+||||+.++.+||+|||+
T Consensus 75 -~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGl 150 (276)
T d1uwha_ 75 -APQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGL 150 (276)
T ss_dssp -SSSCEEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCC
T ss_pred -ccEEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccc
Confidence 56789999999999999999877778999999999999999999999988 99999999999999999999999999
Q ss_pred cCCCCCCCccceeeeeecCCCCCCcchhhcC---CCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhcc
Q 011851 278 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG---HLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGE 354 (476)
Q Consensus 278 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~ 354 (476)
|+...............||+.|||||++.+. .|+.++|||||||+||||+||+.||.......... ......
T Consensus 151 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~--~~~~~~--- 225 (276)
T d1uwha_ 151 ATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQII--FMVGRG--- 225 (276)
T ss_dssp SCC------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHH--HHHHHT---
T ss_pred eeeccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHH--HHHhcC---
Confidence 9876544443344567899999999999753 58999999999999999999999997654322111 111100
Q ss_pred ccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 011851 355 RRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKP 405 (476)
Q Consensus 355 ~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~ 405 (476)
...+.+. ..+...++++.+||.+||+.||++|||+.+|+++|+.
T Consensus 226 ------~~~p~~~-~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~ 269 (276)
T d1uwha_ 226 ------YLSPDLS-KVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIEL 269 (276)
T ss_dssp ------SCCCCGG-GSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ------CCCCcch-hccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 0001000 0112236789999999999999999999999999763
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.2e-56 Score=446.38 Aligned_cols=260 Identities=23% Similarity=0.290 Sum_probs=217.1
Q ss_pred ccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCCCCCceeeEEEEEEeC
Q 011851 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHPNLVKLIGCCIED 199 (476)
Q Consensus 120 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~ 199 (476)
.++|++.+.||+|+||+||+|++. .+|+.||||++........+.+.+|+.+|++|+|||||++++++.++
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~---------~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~ 95 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTER---------ATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDD 95 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEET---------TTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEET
T ss_pred ccCeEEEEEEecCcCeEEEEEEEC---------CCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEEC
Confidence 357999999999999999998654 57889999999877666667789999999999999999999999999
Q ss_pred CeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeec--CCCceEEeecCC
Q 011851 200 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLD--GEYNAKLSDFGL 277 (476)
Q Consensus 200 ~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~--~~~~vkl~DFG~ 277 (476)
+.+|||||||+||+|.+++.+....+++..++.|+.||+.||.|||+++ ||||||||+||||+ .++.+||+|||+
T Consensus 96 ~~~~ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~ 172 (350)
T d1koaa2 96 NEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGL 172 (350)
T ss_dssp TEEEEEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTT
T ss_pred CEEEEEEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecch
Confidence 9999999999999999999777778999999999999999999999988 99999999999995 467899999999
Q ss_pred cCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhccccc
Q 011851 278 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRR 357 (476)
Q Consensus 278 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 357 (476)
|+...... .....+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.........+. .. ...
T Consensus 173 a~~~~~~~---~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~--~~----~~~ 243 (350)
T d1koaa2 173 TAHLDPKQ---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVK--SC----DWN 243 (350)
T ss_dssp CEECCTTS---CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH--HT----CCC
T ss_pred heeccccc---ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHH--hC----CCC
Confidence 98764432 2345789999999999999999999999999999999999999997543221111110 00 000
Q ss_pred cccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCcccc
Q 011851 358 FYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDM 412 (476)
Q Consensus 358 ~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~~ 412 (476)
+... .....++++.+||.+||+.||++|||+.|+++| |||+..
T Consensus 244 ---~~~~-----~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h----p~~~~~ 286 (350)
T d1koaa2 244 ---MDDS-----AFSGISEDGKDFIRKLLLADPNTRMTIHQALEH----PWLTPG 286 (350)
T ss_dssp ---SCCG-----GGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS----TTTSCT
T ss_pred ---CCcc-----cccCCCHHHHHHHHHHccCChhHCcCHHHHhcC----cccCCC
Confidence 0000 111236789999999999999999999999998 888754
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-57 Score=434.07 Aligned_cols=257 Identities=24% Similarity=0.370 Sum_probs=198.7
Q ss_pred cCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCcc--CHHHHHHHHHHHhCCCCCceeeEEEEEEe
Q 011851 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQ--GHKEWLAEVNYLGGLIHPNLVKLIGCCIE 198 (476)
Q Consensus 121 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~l~~~~~~ 198 (476)
++|++.+.||+|+||+||+|++. .+|+.||||++...... ..+.+.+|+++|++++|||||++++++.+
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~---------~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~ 74 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRK---------SDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIID 74 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEET---------TTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC
T ss_pred hhCEEeEEEecCCCeEEEEEEEC---------CCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEe
Confidence 46999999999999999998654 57888999999766443 23568899999999999999999999865
Q ss_pred --CCeeEEEEEecCCCCHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHHhcC--CCCeEecCCCCCCeeecCCCceE
Q 011851 199 --DDQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALDAAKGLAFLHEEA--EKPVIYRDFKTSNILLDGEYNAK 271 (476)
Q Consensus 199 --~~~~~lV~E~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~al~~lH~~~--~~~ivHrDlKp~NILl~~~~~vk 271 (476)
++.+|||||||++|+|.+++.+ ....+++..++.++.||+.||.|||+.+ ..+||||||||+||||+.++.+|
T Consensus 75 ~~~~~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vk 154 (269)
T d2java1 75 RTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVK 154 (269)
T ss_dssp ----CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEE
T ss_pred CCCCEEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEE
Confidence 4568999999999999999864 3567999999999999999999999865 23499999999999999999999
Q ss_pred EeecCCcCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhh
Q 011851 272 LSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQ 351 (476)
Q Consensus 272 l~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~ 351 (476)
|+|||+|+....... .....+||+.|||||++.+..|+.++|||||||++|||+||+.||...... .+......
T Consensus 155 l~DFG~a~~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~---~~~~~i~~- 228 (269)
T d2java1 155 LGDFGLARILNHDTS--FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK---ELAGKIRE- 228 (269)
T ss_dssp ECCHHHHHHC-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHH-
T ss_pred EeeccceeecccCCC--ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHH---HHHHHHHc-
Confidence 999999987644222 234578999999999999999999999999999999999999999754322 11111100
Q ss_pred hccccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCc
Q 011851 352 LGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYL 409 (476)
Q Consensus 352 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~ 409 (476)
..+. ..+...++++.+||.+||+.||++|||+.|+++| ||+
T Consensus 229 ----~~~~---------~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~h----p~i 269 (269)
T d2java1 229 ----GKFR---------RIPYRYSDELNEIITRMLNLKDYHRPSVEEILEN----PLI 269 (269)
T ss_dssp ----TCCC---------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS----TTC
T ss_pred ----CCCC---------CCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhC----CcC
Confidence 0000 0112236789999999999999999999999997 874
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-56 Score=430.74 Aligned_cols=253 Identities=26% Similarity=0.429 Sum_probs=202.6
Q ss_pred CCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCc--cCHHHHHHHHHHHhCCCCCceeeEEEEEEe--
Q 011851 123 FRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL--QGHKEWLAEVNYLGGLIHPNLVKLIGCCIE-- 198 (476)
Q Consensus 123 y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~-- 198 (476)
|++.++||+|+||+||+|.+. .+++.||+|++..... ...+.+.+|+++|++++|||||+++++|.+
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~---------~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~ 81 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDT---------ETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV 81 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEET---------TTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEES
T ss_pred EEeeeEEecCcCcEEEEEEEC---------CCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeecc
Confidence 467788999999999998654 4788899999875432 234568899999999999999999999875
Q ss_pred --CCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeec-CCCceEEeec
Q 011851 199 --DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLD-GEYNAKLSDF 275 (476)
Q Consensus 199 --~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~-~~~~vkl~DF 275 (476)
+..+|||||||++|+|.+++.+. ..+++..++.++.||+.||+|||+++ .+|+||||||+||||+ .++.+||+||
T Consensus 82 ~~~~~~~ivmE~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DF 159 (270)
T d1t4ha_ 82 KGKKCIVLVTELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDL 159 (270)
T ss_dssp SSCEEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCT
T ss_pred ccCCEEEEEEeCCCCCcHHHHHhcc-ccccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeec
Confidence 35689999999999999999654 57999999999999999999999865 4599999999999996 5789999999
Q ss_pred CCcCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhccc
Q 011851 276 GLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGER 355 (476)
Q Consensus 276 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~ 355 (476)
|+|+..... .....+||+.|||||++.+ .|+.++|||||||++|||++|+.||....... .+...... .
T Consensus 160 Gla~~~~~~----~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~--~~~~~i~~----~ 228 (270)
T d1t4ha_ 160 GLATLKRAS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA--QIYRRVTS----G 228 (270)
T ss_dssp TGGGGCCTT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH--HHHHHHTT----T
T ss_pred CcceeccCC----ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHH--HHHHHHHc----C
Confidence 999864322 2345789999999998865 69999999999999999999999997543211 11111100 0
Q ss_pred cccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCcc
Q 011851 356 RRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLK 410 (476)
Q Consensus 356 ~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~ 410 (476)
. .+ ..++...++++.+||.+||+.||++|||+.|+++| |||+
T Consensus 229 ~------~~---~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~H----p~fk 270 (270)
T d1t4ha_ 229 V------KP---ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH----AFFQ 270 (270)
T ss_dssp C------CC---GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS----GGGC
T ss_pred C------CC---cccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCC----cccC
Confidence 0 00 00111225678999999999999999999999997 9985
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.9e-56 Score=445.38 Aligned_cols=259 Identities=21% Similarity=0.297 Sum_probs=217.0
Q ss_pred cCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCCCCCceeeEEEEEEeCC
Q 011851 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHPNLVKLIGCCIEDD 200 (476)
Q Consensus 121 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 200 (476)
++|++++.||+|+||+||+|++. .+|+.||||+++.......+.+.+|+.+|++|+|||||+++++|.+++
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~---------~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~ 99 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEK---------ATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKY 99 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEET---------TTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSS
T ss_pred cceEEEEEEecCCCeEEEEEEEC---------CCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence 46999999999999999998654 578899999998766555667889999999999999999999999999
Q ss_pred eeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeec--CCCceEEeecCCc
Q 011851 201 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLD--GEYNAKLSDFGLA 278 (476)
Q Consensus 201 ~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~--~~~~vkl~DFG~a 278 (476)
.+|||||||+||+|.+++.....++++..++.|+.||+.||.|||+++ ||||||||+||||+ .++.+||+|||+|
T Consensus 100 ~~~ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla 176 (352)
T d1koba_ 100 EMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLA 176 (352)
T ss_dssp EEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTC
T ss_pred EEEEEEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccc
Confidence 999999999999999988777778999999999999999999999988 99999999999997 6789999999999
Q ss_pred CCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhcccccc
Q 011851 279 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRRF 358 (476)
Q Consensus 279 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 358 (476)
+...... .....+||+.|+|||++.+..|+.++|||||||++|||+||+.||.+.........+. .. ...
T Consensus 177 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~--~~----~~~- 246 (352)
T d1koba_ 177 TKLNPDE---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVK--RC----DWE- 246 (352)
T ss_dssp EECCTTS---CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHH--HC----CCC-
T ss_pred eecCCCC---ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH--hC----CCC-
Confidence 8765432 2345789999999999999999999999999999999999999997543221111110 00 000
Q ss_pred ccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCcccc
Q 011851 359 YRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDM 412 (476)
Q Consensus 359 ~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~~ 412 (476)
.........+.++.+||.+||+.||++|||+.|+++| |||++.
T Consensus 247 -------~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H----p~~~~~ 289 (352)
T d1koba_ 247 -------FDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH----PWLKGD 289 (352)
T ss_dssp -------CCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS----TTTSSC
T ss_pred -------CCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC----HhhCCC
Confidence 0111112236789999999999999999999999997 999754
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-56 Score=439.85 Aligned_cols=256 Identities=29% Similarity=0.359 Sum_probs=214.1
Q ss_pred cCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCC---ccCHHHHHHHHHHHhCCCCCceeeEEEEEE
Q 011851 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDG---LQGHKEWLAEVNYLGGLIHPNLVKLIGCCI 197 (476)
Q Consensus 121 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~ 197 (476)
++|++++.||+|+||+||+|++. .+|+.||||++++.. ....+.+.+|+.+|++++||||++++++|.
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~---------~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~ 75 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREK---------ATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQ 75 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEET---------TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEE
T ss_pred HhcEEEEEEecCcCeEEEEEEEC---------CCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeec
Confidence 46999999999999999998654 578899999997542 234567889999999999999999999999
Q ss_pred eCCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCC
Q 011851 198 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGL 277 (476)
Q Consensus 198 ~~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~ 277 (476)
+++.+|||||||+||+|.+++.+. ..+++..++.++.||+.||+|||+++ ||||||||+||||+.+|.+||+|||+
T Consensus 76 ~~~~~~iv~ey~~gg~L~~~~~~~-~~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~ 151 (337)
T d1o6la_ 76 THDRLCFVMEYANGGELFFHLSRE-RVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGL 151 (337)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTT
T ss_pred cccccccceeccCCCchhhhhhcc-cCCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeeccc
Confidence 999999999999999999998654 57999999999999999999999988 99999999999999999999999999
Q ss_pred cCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhccccc
Q 011851 278 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRR 357 (476)
Q Consensus 278 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 357 (476)
|+....... .....+||+.|+|||++.+..|+.++|||||||++|||++|+.||...+....... .......
T Consensus 152 a~~~~~~~~--~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~------i~~~~~~ 223 (337)
T d1o6la_ 152 CKEGISDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFEL------ILMEEIR 223 (337)
T ss_dssp CBCSCCTTC--CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH------HHHCCCC
T ss_pred ccccccCCc--ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHH------HhcCCCC
Confidence 987543222 23457899999999999999999999999999999999999999986543211111 1111111
Q ss_pred cccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHHhcCCCCccccc
Q 011851 358 FYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPR-----MSEVVEALKPLPYLKDMA 413 (476)
Q Consensus 358 ~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt-----~~ell~~L~~~~~~~~~~ 413 (476)
++...+.++.+||.+||+.||++|++ ++++++| |||+++.
T Consensus 224 ------------~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~H----p~f~~i~ 268 (337)
T d1o6la_ 224 ------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH----RFFLSIN 268 (337)
T ss_dssp ------------CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS----GGGTTCC
T ss_pred ------------CCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcC----cccccCC
Confidence 12233678999999999999999995 7787776 9998763
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-56 Score=426.34 Aligned_cols=253 Identities=28% Similarity=0.428 Sum_probs=199.5
Q ss_pred cCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCCCCCceeeEEEEEEeCC
Q 011851 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHPNLVKLIGCCIEDD 200 (476)
Q Consensus 121 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 200 (476)
++|++.+.||+|+||+||+|.+. +++.||||+++... ...+++.+|+++|++++|||||++++++.+++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~----------~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~ 73 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWL----------NKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQA 73 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEET----------TTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHcEEEEEEeeCCCeEEEEEEEC----------CCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCC
Confidence 46889999999999999999764 45679999997644 44678999999999999999999999999999
Q ss_pred eeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCcCC
Q 011851 201 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKD 280 (476)
Q Consensus 201 ~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~ 280 (476)
.+|||||||++|+|.+++......+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++.
T Consensus 74 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~ 150 (263)
T d1sm2a_ 74 PICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRF 150 (263)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC----
T ss_pred ceEEEEEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchhee
Confidence 999999999999999999877778999999999999999999999988 99999999999999999999999999987
Q ss_pred CCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCC-CCCCCCCCCCcchhHHhhhhhhccccccc
Q 011851 281 GPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGR-RSMDKNRPNGEHNLVEWARPQLGERRRFY 359 (476)
Q Consensus 281 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~-~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 359 (476)
....... ......||+.|+|||++.+..|+.++|||||||++|||+|+. +||..... ..+...... . .
T Consensus 151 ~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~---~~~~~~i~~----~---~ 219 (263)
T d1sm2a_ 151 VLDDQYT-SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN---SEVVEDIST----G---F 219 (263)
T ss_dssp ---------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCH---HHHHHHHHH----T---C
T ss_pred ccCCCce-eecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCH---HHHHHHHHh----c---C
Confidence 6543322 233467999999999999999999999999999999999964 44443221 111111111 0 0
Q ss_pred cccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 011851 360 RLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKP 405 (476)
Q Consensus 360 ~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~ 405 (476)
+.. .+...++++.+||.+||+.||++|||+++|+++|+.
T Consensus 220 ~~~-------~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~ 258 (263)
T d1sm2a_ 220 RLY-------KPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAE 258 (263)
T ss_dssp CCC-------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCC-------CccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHH
Confidence 111 111225789999999999999999999999999764
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.1e-56 Score=431.26 Aligned_cols=257 Identities=26% Similarity=0.370 Sum_probs=212.1
Q ss_pred ccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCCCCCceeeEEEEEEeC
Q 011851 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHPNLVKLIGCCIED 199 (476)
Q Consensus 120 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~ 199 (476)
.++|++.+.||+|+||+||+|.+. .+|+.||||+++... ...+++.+|+++|++++|||||+++++|.++
T Consensus 16 ~~~~~~~~~iG~G~fg~Vy~a~~~---------~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~ 85 (287)
T d1opja_ 16 RTDITMKHKLGGGQYGEVYEGVWK---------KYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE 85 (287)
T ss_dssp GGGEEEEEETTTTTTSSEEEEEEG---------GGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEEC---------CCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeC
Confidence 356899999999999999998765 367789999997654 4467899999999999999999999999999
Q ss_pred CeeEEEEEecCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCc
Q 011851 200 DQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLA 278 (476)
Q Consensus 200 ~~~~lV~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a 278 (476)
+.+|||||||++|+|.+++.+. ...+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|
T Consensus 86 ~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a 162 (287)
T d1opja_ 86 PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLS 162 (287)
T ss_dssp SSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCT
T ss_pred CeeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccccce
Confidence 9999999999999999999753 567999999999999999999999988 999999999999999999999999999
Q ss_pred CCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhcccccc
Q 011851 279 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRRF 358 (476)
Q Consensus 279 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 358 (476)
+...... ........||+.|+|||++.++.|+.++|||||||++|||++|..||...... ..+......
T Consensus 163 ~~~~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~--~~~~~~i~~-------- 231 (287)
T d1opja_ 163 RLMTGDT-YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL--SQVYELLEK-------- 231 (287)
T ss_dssp TTCCSSS-SEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCH--HHHHHHHHT--------
T ss_pred eecCCCC-ceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchH--HHHHHHHhc--------
Confidence 8765432 22333457899999999999999999999999999999999987776433221 111111110
Q ss_pred ccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011851 359 YRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPL 406 (476)
Q Consensus 359 ~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~ 406 (476)
.....++...++++.+||.+||+.||++|||+.+|++.|+.+
T Consensus 232 ------~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~ 273 (287)
T d1opja_ 232 ------DYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 273 (287)
T ss_dssp ------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred ------CCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 011112223367899999999999999999999999987643
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.8e-56 Score=433.77 Aligned_cols=256 Identities=27% Similarity=0.390 Sum_probs=209.4
Q ss_pred CCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccC---HHHHHHHHHHHhCCCCCceeeEEEEEEe
Q 011851 122 SFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQG---HKEWLAEVNYLGGLIHPNLVKLIGCCIE 198 (476)
Q Consensus 122 ~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~---~~~~~~E~~~l~~l~hpnIv~l~~~~~~ 198 (476)
.|+.++.||+|+||+||+|++. .+|+.||||+++...... .+.+.+|+++|++|+|||||++++++.+
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~---------~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~ 86 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDV---------RNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR 86 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEET---------TTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEEC---------CCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEE
Confidence 4999999999999999998654 578889999998665432 3468899999999999999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCc
Q 011851 199 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLA 278 (476)
Q Consensus 199 ~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a 278 (476)
++.+|||||||++|+|..++ ....++++..++.++.||+.||.|||+++ ||||||||+||||+.++.+||+|||+|
T Consensus 87 ~~~~~iv~E~~~~g~l~~~~-~~~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a 162 (309)
T d1u5ra_ 87 EHTAWLVMEYCLGSASDLLE-VHKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSA 162 (309)
T ss_dssp TTEEEEEEECCSEEHHHHHH-HHTSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTC
T ss_pred CCEEEEEEEecCCCchHHHH-HhCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccc
Confidence 99999999999999887665 44467999999999999999999999988 999999999999999999999999999
Q ss_pred CCCCCCCccceeeeeecCCCCCCcchhhc---CCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhccc
Q 011851 279 KDGPEGDKTHVSTRVMGTYGYAAPEYVMT---GHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGER 355 (476)
Q Consensus 279 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~ 355 (476)
+.... ....+||+.|||||++.+ +.|+.++|||||||++|||++|+.||........ +..... .
T Consensus 163 ~~~~~------~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~--~~~i~~----~- 229 (309)
T d1u5ra_ 163 SIMAP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA--LYHIAQ----N- 229 (309)
T ss_dssp BSSSS------BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH--HHHHHH----S-
T ss_pred cccCC------CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHH--HHHHHh----C-
Confidence 87533 233689999999999864 4689999999999999999999999975432111 100000 0
Q ss_pred cccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCcccccCcc
Q 011851 356 RRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDMASSS 416 (476)
Q Consensus 356 ~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~~~~~~ 416 (476)
. .+.+ .+...++++.+||.+||+.||++|||++|+++| ||+.......
T Consensus 230 -~-----~~~~---~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~H----p~~~~~~~~~ 277 (309)
T d1u5ra_ 230 -E-----SPAL---QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH----RFVLRERPPT 277 (309)
T ss_dssp -C-----CCCC---SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC----HHHHSCCCTT
T ss_pred -C-----CCCC---CCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhC----HHhcCCCCch
Confidence 0 0001 111236789999999999999999999999987 9987654443
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-55 Score=428.94 Aligned_cols=260 Identities=23% Similarity=0.324 Sum_probs=212.7
Q ss_pred ccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCcc------CHHHHHHHHHHHhCCCCCceeeEE
Q 011851 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQ------GHKEWLAEVNYLGGLIHPNLVKLI 193 (476)
Q Consensus 120 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~------~~~~~~~E~~~l~~l~hpnIv~l~ 193 (476)
.++|++.+.||+|+||+||+|++. .+|+.||||++++.... ..+.+.+|+.+|++++|||||+++
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~---------~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~ 79 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREK---------STGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLH 79 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEET---------TTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEEC---------CCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEE
Confidence 457999999999999999998654 57889999999754322 356789999999999999999999
Q ss_pred EEEEeCCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCC----c
Q 011851 194 GCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEY----N 269 (476)
Q Consensus 194 ~~~~~~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~----~ 269 (476)
++|.+++.+|||||||++|+|.+++... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++ .
T Consensus 80 ~~~~~~~~~~iv~E~~~gg~L~~~i~~~-~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~ 155 (293)
T d1jksa_ 80 EVYENKTDVILILELVAGGELFDFLAEK-ESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPR 155 (293)
T ss_dssp EEEECSSEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCC
T ss_pred EEEEECCEEEEEEEcCCCccccchhccc-cccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccc
Confidence 9999999999999999999999999654 47999999999999999999999988 99999999999998776 4
Q ss_pred eEEeecCCcCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhh
Q 011851 270 AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR 349 (476)
Q Consensus 270 vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~ 349 (476)
+||+|||+|+....... .....||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.........+. .
T Consensus 156 vkl~DfG~a~~~~~~~~---~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~--~ 230 (293)
T d1jksa_ 156 IKIIDFGLAHKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVS--A 230 (293)
T ss_dssp EEECCCTTCEECTTSCB---CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH--T
T ss_pred eEecchhhhhhcCCCcc---ccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHH--h
Confidence 99999999987654332 334689999999999999999999999999999999999999997643221111110 0
Q ss_pred hhhccccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCccccc
Q 011851 350 PQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDMA 413 (476)
Q Consensus 350 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~~~ 413 (476)
....+.. + .....+.++.+||.+||+.||++|||++|+++| |||++..
T Consensus 231 ----~~~~~~~---~-----~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h----p~~~~~~ 278 (293)
T d1jksa_ 231 ----VNYEFED---E-----YFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH----PWIKPKD 278 (293)
T ss_dssp ----TCCCCCH---H-----HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS----TTTCC--
T ss_pred ----cCCCCCc---h-----hcCCCCHHHHHHHHHHccCChhHCcCHHHHhcC----cccCCCC
Confidence 0000000 0 001225788999999999999999999999997 9998643
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.1e-55 Score=431.75 Aligned_cols=253 Identities=28% Similarity=0.395 Sum_probs=212.2
Q ss_pred cCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCC---ccCHHHHHHHHHHHhCCCCCceeeEEEEEE
Q 011851 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDG---LQGHKEWLAEVNYLGGLIHPNLVKLIGCCI 197 (476)
Q Consensus 121 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~ 197 (476)
++|++++.||+|+||+||+|++. .+|+.||||++++.. ....+.+.+|+.+|++++|||||++++++.
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~---------~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~ 74 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSR---------HNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQ 74 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET---------TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEEC---------CCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEe
Confidence 46999999999999999998654 578899999997532 234567889999999999999999999999
Q ss_pred eCCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCC
Q 011851 198 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGL 277 (476)
Q Consensus 198 ~~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~ 277 (476)
+++.+|+|||||+||+|..++.. ...+++..++.++.||+.||.|||+++ |+||||||+||||+.+|.+||+|||+
T Consensus 75 ~~~~~~ivmE~~~gg~l~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~ 150 (316)
T d1fota_ 75 DAQQIFMIMDYIEGGELFSLLRK-SQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGF 150 (316)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHH-TSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSS
T ss_pred eCCeeeeEeeecCCccccccccc-cccccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCcc
Confidence 99999999999999999988854 456899999999999999999999988 99999999999999999999999999
Q ss_pred cCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhccccc
Q 011851 278 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRR 357 (476)
Q Consensus 278 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 357 (476)
|+..... ....+||+.|||||++.+..|+.++|||||||++|||++|+.||...+.......+ .....
T Consensus 151 a~~~~~~-----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i------~~~~~- 218 (316)
T d1fota_ 151 AKYVPDV-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKI------LNAEL- 218 (316)
T ss_dssp CEECSSC-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH------HHCCC-
T ss_pred ceEeccc-----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHH------HcCCC-
Confidence 9876432 23478999999999999999999999999999999999999999764322111110 00000
Q ss_pred cccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHhcCCCCccccc
Q 011851 358 FYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARP-----RMSEVVEALKPLPYLKDMA 413 (476)
Q Consensus 358 ~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RP-----t~~ell~~L~~~~~~~~~~ 413 (476)
.++...++++.+++.+||..||.+|+ |++++++| |||+++.
T Consensus 219 -----------~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H----p~f~~i~ 264 (316)
T d1fota_ 219 -----------RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH----PWFKEVV 264 (316)
T ss_dssp -----------CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS----GGGSSCC
T ss_pred -----------CCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcC----cccccCC
Confidence 11222367899999999999999996 89998887 9998864
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.7e-55 Score=429.46 Aligned_cols=259 Identities=25% Similarity=0.422 Sum_probs=200.6
Q ss_pred cCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCcc-CHHHHHHHHHHHhCCCCCceeeEEEEEEeC
Q 011851 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQ-GHKEWLAEVNYLGGLIHPNLVKLIGCCIED 199 (476)
Q Consensus 121 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~ 199 (476)
.+|++.++||+|+||+||+|++..++. ....||||.+...... ..+++.+|+++|++++|||||++++++.++
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~ 99 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGK------REIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKS 99 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---------CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCC------EEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeC
Confidence 457888999999999999998764322 2346899998764333 345789999999999999999999999999
Q ss_pred CeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCcC
Q 011851 200 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAK 279 (476)
Q Consensus 200 ~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~ 279 (476)
+.+|||||||++|+|.+++......+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++
T Consensus 100 ~~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~ 176 (299)
T d1jpaa_ 100 TPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSR 176 (299)
T ss_dssp SSCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC----
T ss_pred CEEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccce
Confidence 9999999999999999999777778999999999999999999999988 9999999999999999999999999998
Q ss_pred CCCCCCccc---eeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhhccc
Q 011851 280 DGPEGDKTH---VSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPQLGER 355 (476)
Q Consensus 280 ~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~ 355 (476)
......... ......||+.|||||++.++.|+.++|||||||++|||+| |+.||...... .+...... .
T Consensus 177 ~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~---~~~~~i~~----~ 249 (299)
T d1jpaa_ 177 FLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ---DVINAIEQ----D 249 (299)
T ss_dssp -------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHHHHHHT----T
T ss_pred EccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHH---HHHHHHHc----C
Confidence 764432211 1122468999999999999999999999999999999998 89999765432 11111110 0
Q ss_pred cccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 011851 356 RRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKP 405 (476)
Q Consensus 356 ~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~ 405 (476)
.. ...+...+.++.+||.+||+.||++|||+.+|++.|+.
T Consensus 250 ~~----------~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~ 289 (299)
T d1jpaa_ 250 YR----------LPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDK 289 (299)
T ss_dssp CC----------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred CC----------CCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 00 01122336789999999999999999999999998763
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-55 Score=433.75 Aligned_cols=261 Identities=25% Similarity=0.372 Sum_probs=210.8
Q ss_pred cCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCc-cCHHHHHHHHHHHhCC-CCCceeeEEEEEEe
Q 011851 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL-QGHKEWLAEVNYLGGL-IHPNLVKLIGCCIE 198 (476)
Q Consensus 121 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~-~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~ 198 (476)
++|++.++||+|+||+||+|++...+. ......||+|.+..... .....+.+|+.+|.++ +|||||++++++.+
T Consensus 37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~----~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~ 112 (325)
T d1rjba_ 37 ENLEFGKVLGSGAFGKVMNATAYGISK----TGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTL 112 (325)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSS----SSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred HHeEEeeEEeeCCCeEEEEEEEcCCCc----ccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEee
Confidence 579999999999999999998764322 12345799999865432 3345788999999998 89999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHHhhcC----------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecC
Q 011851 199 DDQRLLVYEFMPRGSLENHLFRRS----------------------LPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRD 256 (476)
Q Consensus 199 ~~~~~lV~E~~~~g~L~~~l~~~~----------------------~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrD 256 (476)
.+.+|||||||++|+|.++|.... ..+++..++.++.||+.||+|||+++ |||||
T Consensus 113 ~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRD 189 (325)
T d1rjba_ 113 SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRD 189 (325)
T ss_dssp SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETT
T ss_pred CCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecc
Confidence 999999999999999999996543 35899999999999999999999988 99999
Q ss_pred CCCCCeeecCCCceEEeecCCcCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHh-CCCCCCC
Q 011851 257 FKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLT-GRRSMDK 335 (476)
Q Consensus 257 lKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~ellt-G~~pf~~ 335 (476)
|||+|||++.++.+||+|||+|+...............||+.|||||++.++.|+.++|||||||++|||+| |+.||.+
T Consensus 190 lKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~ 269 (325)
T d1rjba_ 190 LAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPG 269 (325)
T ss_dssp CSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred CchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCC
Confidence 999999999999999999999987655444444445789999999999999999999999999999999998 8999976
Q ss_pred CCCCCcchhHHhhhhhhccccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 011851 336 NRPNGEHNLVEWARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALK 404 (476)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~ 404 (476)
....... ...... .. ....+...++++.+||.+||+.||++|||++||+++|.
T Consensus 270 ~~~~~~~--~~~~~~----~~----------~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 270 IPVDANF--YKLIQN----GF----------KMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp CCCSHHH--HHHHHT----TC----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCHHHHH--HHHHhc----CC----------CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 5443211 111110 00 00112233678999999999999999999999999974
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-55 Score=415.96 Aligned_cols=254 Identities=24% Similarity=0.391 Sum_probs=214.1
Q ss_pred cCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCCCCCceeeEEEEEEeCC
Q 011851 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHPNLVKLIGCCIEDD 200 (476)
Q Consensus 121 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 200 (476)
++|++.++||+|+||+||+|+++ +++.||||+++.... ..+++.+|+.++++++||||+++++++.+++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~----------~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~ 72 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWR----------GQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQR 72 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEET----------TTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSS
T ss_pred HHCEEeEEEecCCCeEEEEEEEC----------CCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCC
Confidence 57999999999999999999764 567899999987644 4578999999999999999999999999999
Q ss_pred eeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCcCC
Q 011851 201 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKD 280 (476)
Q Consensus 201 ~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~ 280 (476)
.+++||||+++|+|.+++......+++..++.++.||++||+|||+.+ |+||||||+||||+.++.+||+|||+++.
T Consensus 73 ~~~iv~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~ 149 (258)
T d1k2pa_ 73 PIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRY 149 (258)
T ss_dssp SEEEEEECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCB
T ss_pred ceEEEEEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhhee
Confidence 999999999999999998777778999999999999999999999988 99999999999999999999999999987
Q ss_pred CCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhhccccccc
Q 011851 281 GPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPQLGERRRFY 359 (476)
Q Consensus 281 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 359 (476)
....... ......||+.|+|||++.+..|+.++|||||||++|||+| |+.||....... +..... ...
T Consensus 150 ~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~---~~~~i~----~~~--- 218 (258)
T d1k2pa_ 150 VLDDEYT-SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE---TAEHIA----QGL--- 218 (258)
T ss_dssp CSSSSCC-CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH---HHHHHH----TTC---
T ss_pred ccCCCce-eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHH---HHHHHH----hCC---
Confidence 6543322 2334679999999999999999999999999999999998 899997654322 111111 100
Q ss_pred cccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011851 360 RLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPL 406 (476)
Q Consensus 360 ~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~ 406 (476)
+.. .+...++++.+||.+||+.||++|||+++|+++|.++
T Consensus 219 ~~~-------~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 219 RLY-------RPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp CCC-------CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred CCC-------CcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence 111 1122357899999999999999999999999998653
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=9.5e-55 Score=432.92 Aligned_cols=253 Identities=24% Similarity=0.301 Sum_probs=212.4
Q ss_pred cCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCC---ccCHHHHHHHHHHHhCCCCCceeeEEEEEE
Q 011851 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDG---LQGHKEWLAEVNYLGGLIHPNLVKLIGCCI 197 (476)
Q Consensus 121 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~ 197 (476)
++|++++.||+|+||.||+|++. .+|+.||||++.+.. ....+.+.+|+++|+.++|||||++++++.
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~---------~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~ 111 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHK---------ESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK 111 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET---------TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEEC---------CCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccc
Confidence 46999999999999999998654 578899999996532 234567889999999999999999999999
Q ss_pred eCCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCC
Q 011851 198 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGL 277 (476)
Q Consensus 198 ~~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~ 277 (476)
+.+.+|+||||+.+|+|.+++.+. ..+++..++.++.||+.||.|||+++ ||||||||+||||+.++.+||+|||+
T Consensus 112 ~~~~~~~v~e~~~~g~l~~~l~~~-~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~ 187 (350)
T d1rdqe_ 112 DNSNLYMVMEYVAGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGF 187 (350)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTT
T ss_pred cccccccccccccccchhhhHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeecee
Confidence 999999999999999999999654 46999999999999999999999988 99999999999999999999999999
Q ss_pred cCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhccccc
Q 011851 278 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRR 357 (476)
Q Consensus 278 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 357 (476)
|+..... ....+||+.|||||++.+..|+.++|||||||++|||+||+.||....... +.... .....
T Consensus 188 a~~~~~~-----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~---~~~~i---~~~~~- 255 (350)
T d1rdqe_ 188 AKRVKGR-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ---IYEKI---VSGKV- 255 (350)
T ss_dssp CEECSSC-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHH---HHCCC-
T ss_pred eeecccc-----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHH---HHHHH---hcCCC-
Confidence 9876432 234689999999999999999999999999999999999999997543211 11110 00000
Q ss_pred cccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHhcCCCCccccc
Q 011851 358 FYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARP-----RMSEVVEALKPLPYLKDMA 413 (476)
Q Consensus 358 ~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RP-----t~~ell~~L~~~~~~~~~~ 413 (476)
.++...+.++.+||.+||+.||.+|+ |+++|++| |||++..
T Consensus 256 -----------~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~H----p~f~~~~ 301 (350)
T d1rdqe_ 256 -----------RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH----KWFATTD 301 (350)
T ss_dssp -----------CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS----GGGTTCC
T ss_pred -----------CCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcC----ccccCCC
Confidence 01122367899999999999999994 88998886 9998764
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=2e-54 Score=432.84 Aligned_cols=257 Identities=26% Similarity=0.373 Sum_probs=208.7
Q ss_pred cCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCc---cCHHHH---HHHHHHHhCCCCCceeeEEE
Q 011851 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL---QGHKEW---LAEVNYLGGLIHPNLVKLIG 194 (476)
Q Consensus 121 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~---~~~~~~---~~E~~~l~~l~hpnIv~l~~ 194 (476)
++|++.++||+|+||.||+|++. .+|+.||||++.+... .....+ ..|+.+++.++|||||++++
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~---------~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~ 74 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKA---------DTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSY 74 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEET---------TTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEEC---------CCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEE
Confidence 57999999999999999998654 5788999999864322 122233 34578888999999999999
Q ss_pred EEEeCCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEee
Q 011851 195 CCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSD 274 (476)
Q Consensus 195 ~~~~~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~D 274 (476)
+|.+++.+|||||||+||+|.++|.+. ..+++..++.++.||+.||.|||+++ ||||||||+||||+.+|.+||+|
T Consensus 75 ~~~~~~~~~ivmE~~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~D 150 (364)
T d1omwa3 75 AFHTPDKLSFILDLMNGGDLHYHLSQH-GVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISD 150 (364)
T ss_dssp EEECSSEEEEEECCCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECC
T ss_pred EEEECCEEEEEEEecCCCcHHHHHHhc-ccccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEee
Confidence 999999999999999999999999654 57899999999999999999999988 99999999999999999999999
Q ss_pred cCCcCCCCCCCccceeeeeecCCCCCCcchhhc-CCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhc
Q 011851 275 FGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLG 353 (476)
Q Consensus 275 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~ 353 (476)
||+|+...... ....+||+.|+|||++.. ..|+.++|||||||+||||+||+.||..........+... ...
T Consensus 151 FGla~~~~~~~----~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~---~~~ 223 (364)
T d1omwa3 151 LGLACDFSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM---TLT 223 (364)
T ss_dssp CTTCEECSSSC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHH---SSS
T ss_pred eceeeecCCCc----ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh---ccc
Confidence 99998764432 234689999999999975 5799999999999999999999999986544332222111 100
Q ss_pred cccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHHhcCCCCccccc
Q 011851 354 ERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPR-----MSEVVEALKPLPYLKDMA 413 (476)
Q Consensus 354 ~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt-----~~ell~~L~~~~~~~~~~ 413 (476)
.. . .++...++++.+||.+||+.||++||| ++++++| |||+++.
T Consensus 224 ~~--------~----~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~H----p~f~~i~ 272 (364)
T d1omwa3 224 MA--------V----ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES----PFFRSLD 272 (364)
T ss_dssp CC--------C----CCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTS----GGGTTCC
T ss_pred CC--------C----CCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcC----ccccCCC
Confidence 00 0 011123678999999999999999999 6788776 9998764
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-54 Score=419.58 Aligned_cols=257 Identities=25% Similarity=0.408 Sum_probs=207.8
Q ss_pred cCCCcccc-ccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCcc-CHHHHHHHHHHHhCCCCCceeeEEEEEEe
Q 011851 121 KSFRPECL-LGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQ-GHKEWLAEVNYLGGLIHPNLVKLIGCCIE 198 (476)
Q Consensus 121 ~~y~~~~~-LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~~ 198 (476)
++|.+.+. ||+|+||+||+|.+... .++..||||+++..... ..+++.+|+++|++++|||||++++++..
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~-------~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~ 80 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMR-------KKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA 80 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC----------CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES
T ss_pred cCeEECCcEEecccCeEEEEEEEecC-------CCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc
Confidence 35666674 99999999999976532 34667999999765433 34678999999999999999999999864
Q ss_pred CCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCc
Q 011851 199 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLA 278 (476)
Q Consensus 199 ~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a 278 (476)
+.+|||||||++|+|.+++......+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||++
T Consensus 81 -~~~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla 156 (285)
T d1u59a_ 81 -EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLS 156 (285)
T ss_dssp -SSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTC
T ss_pred -CeEEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhh
Confidence 5689999999999999998777778999999999999999999999988 999999999999999999999999999
Q ss_pred CCCCCCCcc-ceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhhcccc
Q 011851 279 KDGPEGDKT-HVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPQLGERR 356 (476)
Q Consensus 279 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~ 356 (476)
+........ .......||+.|+|||++.++.++.++|||||||++|||+| |+.||....... +..... ...
T Consensus 157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~---~~~~i~----~~~ 229 (285)
T d1u59a_ 157 KALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE---VMAFIE----QGK 229 (285)
T ss_dssp EECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH---HHHHHH----TTC
T ss_pred hcccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHH---HHHHHH----cCC
Confidence 876543322 22234578999999999999999999999999999999998 999998654321 111111 100
Q ss_pred ccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 011851 357 RFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKP 405 (476)
Q Consensus 357 ~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~ 405 (476)
+ ...+...+.++.+||.+||+.||++|||+.+|++.|+.
T Consensus 230 ~----------~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~ 268 (285)
T d1u59a_ 230 R----------MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRA 268 (285)
T ss_dssp C----------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred C----------CCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 0 01122336789999999999999999999999988753
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-54 Score=417.90 Aligned_cols=254 Identities=28% Similarity=0.417 Sum_probs=205.0
Q ss_pred ccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCCCCCceeeEEEEEEeC
Q 011851 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHPNLVKLIGCCIED 199 (476)
Q Consensus 120 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~ 199 (476)
.++|++.+.||+|+||+||+|.++ +++.||||+++... ...+.+.+|+++|++++|||||++++++. +
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~----------~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~-~ 79 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYN----------GHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT-Q 79 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET----------TTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-S
T ss_pred HHHeEEeEEEecCCCcEEEEEEEC----------CCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeec-c
Confidence 357899999999999999999764 45679999997654 44678999999999999999999999875 5
Q ss_pred CeeEEEEEecCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCc
Q 011851 200 DQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLA 278 (476)
Q Consensus 200 ~~~~lV~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a 278 (476)
+.+|||||||++|+|.+++... ...+++..++.|+.||+.||.|||+++ |+||||||+||||+.++.+||+|||+|
T Consensus 80 ~~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla 156 (272)
T d1qpca_ 80 EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLA 156 (272)
T ss_dssp SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred CCeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccce
Confidence 6789999999999999987543 346999999999999999999999988 999999999999999999999999999
Q ss_pred CCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhcccccc
Q 011851 279 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRRF 358 (476)
Q Consensus 279 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 358 (476)
+....... .......||+.|||||++.++.|+.++|||||||++|||+||..|+...... ..+..... ...
T Consensus 157 ~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~--~~~~~~i~----~~~-- 227 (272)
T d1qpca_ 157 RLIEDNEY-TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN--PEVIQNLE----RGY-- 227 (272)
T ss_dssp EECSSSCE-ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH--HHHHHHHH----TTC--
T ss_pred EEccCCcc-ccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCH--HHHHHHHH----hcC--
Confidence 87654322 2233467999999999999999999999999999999999976655432211 11111111 000
Q ss_pred ccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 011851 359 YRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKP 405 (476)
Q Consensus 359 ~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~ 405 (476)
.+. .+...++++.+||.+||+.||++|||+++|++.|++
T Consensus 228 ----~~~----~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~ 266 (272)
T d1qpca_ 228 ----RMV----RPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLED 266 (272)
T ss_dssp ----CCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ----CCC----CcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhh
Confidence 000 112235789999999999999999999999998763
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-54 Score=415.41 Aligned_cols=250 Identities=28% Similarity=0.399 Sum_probs=199.0
Q ss_pred ccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCcc--CHHHHHHHHHHHhCCCCCceeeEEEEEEeCCeeEE
Q 011851 127 CLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQ--GHKEWLAEVNYLGGLIHPNLVKLIGCCIEDDQRLL 204 (476)
Q Consensus 127 ~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 204 (476)
++||+|+||+||+|.+.. ..+++.||||+++..... ..+++.+|+++|++++|||||++++++.. +..||
T Consensus 13 k~iG~G~fG~Vy~~~~~~-------~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~l 84 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQM-------KKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWML 84 (277)
T ss_dssp EEEEECSSEEEEEEEEEC-------SSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEE
T ss_pred CCcccCCCeEEEEEEEcc-------CCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEE
Confidence 579999999999997653 235678999999754332 24578999999999999999999999864 56799
Q ss_pred EEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCcCCCCCC
Q 011851 205 VYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPEG 284 (476)
Q Consensus 205 V~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~~ 284 (476)
|||||++|+|.+++.+ ...+++..+..++.||+.||+|||+++ ||||||||+||||+.++.+||+|||+++.....
T Consensus 85 vmE~~~~g~L~~~l~~-~~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~ 160 (277)
T d1xbba_ 85 VMEMAELGPLNKYLQQ-NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRAD 160 (277)
T ss_dssp EEECCTTEEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTT
T ss_pred EEEcCCCCcHHHHHhh-ccCCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhcccc
Confidence 9999999999999854 457999999999999999999999988 999999999999999999999999999876543
Q ss_pred Ccc-ceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhhcccccccccc
Q 011851 285 DKT-HVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPQLGERRRFYRLI 362 (476)
Q Consensus 285 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 362 (476)
... .......||+.|||||++.+..|+.++|||||||++|||+| |+.||....... +..... ...+
T Consensus 161 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~---~~~~i~----~~~~----- 228 (277)
T d1xbba_ 161 ENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE---VTAMLE----KGER----- 228 (277)
T ss_dssp CSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH---HHHHHH----TTCC-----
T ss_pred ccccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHH---HHHHHH----cCCC-----
Confidence 322 22234679999999999999999999999999999999998 899997654321 111111 0000
Q ss_pred CcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 011851 363 DPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKP 405 (476)
Q Consensus 363 d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~ 405 (476)
...+...+.++.+||.+||+.||++|||+++|++.|+.
T Consensus 229 -----~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~ 266 (277)
T d1xbba_ 229 -----MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN 266 (277)
T ss_dssp -----CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred -----CCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhC
Confidence 01112236789999999999999999999999887763
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-54 Score=426.13 Aligned_cols=258 Identities=18% Similarity=0.256 Sum_probs=212.7
Q ss_pred ccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCCCCCceeeEEEEEEeC
Q 011851 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHPNLVKLIGCCIED 199 (476)
Q Consensus 120 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~ 199 (476)
.++|++.+.||+|+||+||+|.+. .+|+.||||+++.... ....+.+|+++|+.++|||||+++++|+++
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~---------~~~~~~AiK~i~~~~~-~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~ 73 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVET---------SSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHESFESM 73 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEET---------TTTEEEEEEEECCCTH-HHHHHHHHHHHHHHSCCTTBCCEEEEEEET
T ss_pred ccceEEEEEEecCCCeEEEEEEEC---------CCCcEEEEEEEcCCcc-cHHHHHHHHHHHHhCCCCCCCeEEEEEEEC
Confidence 467999999999999999998654 5788999999976543 235678999999999999999999999999
Q ss_pred CeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCC--CceEEeecCC
Q 011851 200 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGE--YNAKLSDFGL 277 (476)
Q Consensus 200 ~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~--~~vkl~DFG~ 277 (476)
+++|||||||+||+|.++|......+++..++.|+.||+.||+|||+++ |+||||||+|||++.+ ..+||+|||+
T Consensus 74 ~~~~lvmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~ 150 (321)
T d1tkia_ 74 EELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQ 150 (321)
T ss_dssp TEEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTT
T ss_pred CEEEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccch
Confidence 9999999999999999999776668999999999999999999999988 9999999999999754 5899999999
Q ss_pred cCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhccccc
Q 011851 278 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRR 357 (476)
Q Consensus 278 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 357 (476)
++...... .....+||+.|+|||.+.+..|+.++|||||||++|+|++|+.||...........+. .....
T Consensus 151 ~~~~~~~~---~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~------~~~~~ 221 (321)
T d1tkia_ 151 ARQLKPGD---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIM------NAEYT 221 (321)
T ss_dssp CEECCTTC---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH------HTCCC
T ss_pred hhccccCC---cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHH------hCCCC
Confidence 98764432 2344689999999999999999999999999999999999999997654321111110 00000
Q ss_pred cccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCccc
Q 011851 358 FYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKD 411 (476)
Q Consensus 358 ~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~ 411 (476)
+. ...+ ...+.++.+||.+||..||++|||+.|+++| |||++
T Consensus 222 ~~---~~~~-----~~~s~~~~~li~~~L~~dp~~R~s~~eil~h----p~~~~ 263 (321)
T d1tkia_ 222 FD---EEAF-----KEISIEAMDFVDRLLVKERKSRMTASEALQH----PWLKQ 263 (321)
T ss_dssp CC---HHHH-----TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS----HHHHS
T ss_pred CC---hhhc-----cCCCHHHHHHHHHHccCChhHCcCHHHHhcC----Hhhcc
Confidence 00 0000 0125788999999999999999999999997 88864
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-54 Score=425.98 Aligned_cols=255 Identities=26% Similarity=0.416 Sum_probs=209.8
Q ss_pred cCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCC---ccCHHHHHHHHHHHh-CCCCCceeeEEEEE
Q 011851 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDG---LQGHKEWLAEVNYLG-GLIHPNLVKLIGCC 196 (476)
Q Consensus 121 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~---~~~~~~~~~E~~~l~-~l~hpnIv~l~~~~ 196 (476)
++|++++.||+|+||+||+|.+. .+|+.||||++++.. ....+.+..|..++. .++|||||++++++
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~---------~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~ 72 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFK---------KTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTF 72 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEET---------TTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEEC---------CCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEE
Confidence 47999999999999999998654 578899999997532 233455677777665 68999999999999
Q ss_pred EeCCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecC
Q 011851 197 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFG 276 (476)
Q Consensus 197 ~~~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG 276 (476)
.+++.+|||||||++|+|.+++.. ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||
T Consensus 73 ~~~~~~yivmEy~~~g~L~~~i~~-~~~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG 148 (320)
T d1xjda_ 73 QTKENLFFVMEYLNGGDLMYHIQS-CHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFG 148 (320)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCT
T ss_pred ccCCceeEEEeecCCCcHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccc
Confidence 999999999999999999999954 456999999999999999999999988 9999999999999999999999999
Q ss_pred CcCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhcccc
Q 011851 277 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERR 356 (476)
Q Consensus 277 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~ 356 (476)
+++....... .....+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.........+. ...
T Consensus 149 ~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~------~~~- 219 (320)
T d1xjda_ 149 MCKENMLGDA--KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIR------MDN- 219 (320)
T ss_dssp TCBCCCCTTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH------HCC-
T ss_pred hhhhcccccc--cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHH------cCC-
Confidence 9986543322 2344689999999999999999999999999999999999999997654322111111 000
Q ss_pred ccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHH-HHHHHhcCCCCcccc
Q 011851 357 RFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMS-EVVEALKPLPYLKDM 412 (476)
Q Consensus 357 ~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~-ell~~L~~~~~~~~~ 412 (476)
+ .++...+.++.+||.+||+.||++||++. ++++| |||++.
T Consensus 220 -------~----~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~h----pff~~~ 261 (320)
T d1xjda_ 220 -------P----FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQH----PLFREI 261 (320)
T ss_dssp -------C----CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGS----GGGTTC
T ss_pred -------C----CCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHhC----chhccC
Confidence 0 11122367899999999999999999996 77775 999875
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-54 Score=415.23 Aligned_cols=261 Identities=24% Similarity=0.405 Sum_probs=202.4
Q ss_pred cCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCcc-CHHHHHHHHHHHhCCCCCceeeEEEEEEeC
Q 011851 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQ-GHKEWLAEVNYLGGLIHPNLVKLIGCCIED 199 (476)
Q Consensus 121 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~ 199 (476)
..|++.++||+|+||.||+|.+...+. .....||||+++..... ...++.+|+++|++++|||||++++++.+.
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~-----~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~ 81 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSG-----KKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKY 81 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC--------CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCC-----EEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecC
Confidence 358888999999999999998764321 12356999999765433 234688999999999999999999999999
Q ss_pred CeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCcC
Q 011851 200 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAK 279 (476)
Q Consensus 200 ~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~ 279 (476)
+..++|||||.+++|.+++......+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++
T Consensus 82 ~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~ 158 (283)
T d1mqba_ 82 KPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSR 158 (283)
T ss_dssp SSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred CceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhh
Confidence 9999999999999999998877788999999999999999999999988 9999999999999999999999999998
Q ss_pred CCCCCCc-cceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhcccccc
Q 011851 280 DGPEGDK-THVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRRF 358 (476)
Q Consensus 280 ~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 358 (476)
....... ........||+.|||||++.++.|+.++|||||||++|||++|..|+...... ..+..... ..
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~--~~~~~~i~----~~--- 229 (283)
T d1mqba_ 159 VLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN--HEVMKAIN----DG--- 229 (283)
T ss_dssp ---------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--HHHHHHHH----TT---
T ss_pred cccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCH--HHHHHHHh----cc---
Confidence 7644322 22223457899999999999999999999999999999999976665433221 11111111 10
Q ss_pred ccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 011851 359 YRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKP 405 (476)
Q Consensus 359 ~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~ 405 (476)
.....+...+.++.+||.+||+.||++|||+.+|++.|+.
T Consensus 230 -------~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~ 269 (283)
T d1mqba_ 230 -------FRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDK 269 (283)
T ss_dssp -------CCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred -------CCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHH
Confidence 0111122336789999999999999999999999998753
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=7.1e-54 Score=413.11 Aligned_cols=258 Identities=24% Similarity=0.339 Sum_probs=211.4
Q ss_pred cCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccC---------HHHHHHHHHHHhCCC-CCcee
Q 011851 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQG---------HKEWLAEVNYLGGLI-HPNLV 190 (476)
Q Consensus 121 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~---------~~~~~~E~~~l~~l~-hpnIv 190 (476)
++|++.+.||+|+||+||+|++. .+|+.||||+++...... .+.+.+|+.+|++++ ||||+
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~---------~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv 73 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHK---------PTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNII 73 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEET---------TTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBC
T ss_pred ccCEEceEEecCcCeEEEEEEEC---------CCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeE
Confidence 57999999999999999998654 468889999997654321 235788999999997 99999
Q ss_pred eEEEEEEeCCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCce
Q 011851 191 KLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNA 270 (476)
Q Consensus 191 ~l~~~~~~~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~v 270 (476)
++++++.+++++|||||||++|+|.++|..+ .++++..++.++.||+.||+|||+++ |+||||||+||||+.++.+
T Consensus 74 ~~~~~~~~~~~~~ivmE~~~~g~L~~~l~~~-~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~ 149 (277)
T d1phka_ 74 QLKDTYETNTFFFLVFDLMKKGELFDYLTEK-VTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNI 149 (277)
T ss_dssp CEEEEEECSSEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCE
T ss_pred EEEeecccCcceEEEEEcCCCchHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCe
Confidence 9999999999999999999999999999654 57999999999999999999999988 9999999999999999999
Q ss_pred EEeecCCcCCCCCCCccceeeeeecCCCCCCcchhhc------CCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchh
Q 011851 271 KLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT------GHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNL 344 (476)
Q Consensus 271 kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~ 344 (476)
||+|||+++....... ....+||+.|+|||++.+ ..++.++||||+||++|||++|+.||...........
T Consensus 150 kl~DFG~a~~~~~~~~---~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~ 226 (277)
T d1phka_ 150 KLTDFGFSCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRM 226 (277)
T ss_dssp EECCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred EEccchheeEccCCCc---eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHH
Confidence 9999999987654322 344789999999999874 3578899999999999999999999986542211111
Q ss_pred HHhhhhhhccccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCcccc
Q 011851 345 VEWARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDM 412 (476)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~~ 412 (476)
+. ..... . ........++++.+||.+||+.||++|||+.||++| |||++.
T Consensus 227 i~------~~~~~---~-----~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h----~~~~~~ 276 (277)
T d1phka_ 227 IM------SGNYQ---F-----GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH----PFFQQY 276 (277)
T ss_dssp HH------HTCCC---C-----CTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS----GGGCTT
T ss_pred HH------hCCCC---C-----CCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC----HHHHHh
Confidence 11 00000 0 011112346789999999999999999999999987 998753
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-53 Score=416.13 Aligned_cols=275 Identities=25% Similarity=0.338 Sum_probs=207.3
Q ss_pred cCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCcc--CHHHHHHHHHHHhCCCCCceeeEEEEEEe
Q 011851 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQ--GHKEWLAEVNYLGGLIHPNLVKLIGCCIE 198 (476)
Q Consensus 121 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~l~~~~~~ 198 (476)
++|++++.||+|+||+||+|.+. .+|+.||||+++..... ..+++.+|+++|++++|||||+++++|.+
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~---------~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~ 72 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNK---------LTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT 72 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEET---------TTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEEC---------CCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEecccccc
Confidence 47999999999999999998654 47888999999754332 34678899999999999999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHH-hhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCC
Q 011851 199 DDQRLLVYEFMPRGSLENHL-FRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGL 277 (476)
Q Consensus 199 ~~~~~lV~E~~~~g~L~~~l-~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~ 277 (476)
++++||||||+.+ .+.+++ ......+++..++.++.||+.||+|||+++ ||||||||+|||++.++.+||+|||+
T Consensus 73 ~~~~~iv~e~~~~-~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~ 148 (298)
T d1gz8a_ 73 ENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGL 148 (298)
T ss_dssp TTEEEEEEECCSE-EHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTH
T ss_pred ccceeEEEeecCC-chhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCc
Confidence 9999999999965 444444 345667999999999999999999999988 99999999999999999999999999
Q ss_pred cCCCCCCCccceeeeeecCCCCCCcchhhcCC-CCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhc--c
Q 011851 278 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGH-LTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLG--E 354 (476)
Q Consensus 278 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~--~ 354 (476)
|+....... .....+||+.|+|||++.... ++.++|||||||++|+|++|+.||...+.......+........ .
T Consensus 149 a~~~~~~~~--~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 226 (298)
T d1gz8a_ 149 ARAFGVPVR--TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVV 226 (298)
T ss_dssp HHHHCCCSB--CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred ceeccCCcc--cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhh
Confidence 986543222 223468999999999887765 57899999999999999999999976432211110000000000 0
Q ss_pred ccccccc------cCcccCCC---CChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCcccccC
Q 011851 355 RRRFYRL------IDPCLEGC---FSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDMAS 414 (476)
Q Consensus 355 ~~~~~~~------~d~~l~~~---~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~~~~ 414 (476)
....... ........ .....+.++.+||.+||+.||++|||++|+++| |||+++..
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H----~ff~~~~~ 291 (298)
T d1gz8a_ 227 WPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH----PFFQDVTK 291 (298)
T ss_dssp STTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS----GGGTTCCC
T ss_pred ccccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC----HhhccCCC
Confidence 0000000 00000000 001225788999999999999999999999997 99987654
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-53 Score=410.01 Aligned_cols=257 Identities=26% Similarity=0.394 Sum_probs=199.9
Q ss_pred cCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccC-HHHHHHHHHHHhCCCCCceeeEEEEEEeC
Q 011851 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQG-HKEWLAEVNYLGGLIHPNLVKLIGCCIED 199 (476)
Q Consensus 121 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~-~~~~~~E~~~l~~l~hpnIv~l~~~~~~~ 199 (476)
++|++.+.||+|+||+||+|.+...+ .++..||||.++...... .+.+.+|+++|++++|||||++++++. +
T Consensus 7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~------~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~ 79 (273)
T d1mp8a_ 7 ERIELGRCIGEGQFGDVHQGIYMSPE------NPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-E 79 (273)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECCC--------CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-S
T ss_pred HHeEEEEEEeeCCCcEEEEEEEecCC------ceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-c
Confidence 46999999999999999999875332 245679999987544332 456899999999999999999999985 5
Q ss_pred CeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCcC
Q 011851 200 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAK 279 (476)
Q Consensus 200 ~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~ 279 (476)
+.+|||||||++|+|.+++......+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+|+
T Consensus 80 ~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~ 156 (273)
T d1mp8a_ 80 NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSR 156 (273)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC-----
T ss_pred CeEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchhhe
Confidence 6899999999999999998877778999999999999999999999988 9999999999999999999999999998
Q ss_pred CCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhhcccccc
Q 011851 280 DGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPQLGERRRF 358 (476)
Q Consensus 280 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 358 (476)
...... ........||+.|+|||++.+..|+.++|||||||++|||++ |.+||...........+. .....
T Consensus 157 ~~~~~~-~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~-------~~~~~ 228 (273)
T d1mp8a_ 157 YMEDST-YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE-------NGERL 228 (273)
T ss_dssp ---------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH-------TTCCC
T ss_pred eccCCc-ceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHH-------cCCCC
Confidence 754432 223345678999999999999999999999999999999998 899997654432211111 00000
Q ss_pred ccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 011851 359 YRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKP 405 (476)
Q Consensus 359 ~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~ 405 (476)
+ ++...++++.+||.+||+.||++|||+.+|+++|+.
T Consensus 229 -----~-----~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~ 265 (273)
T d1mp8a_ 229 -----P-----MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLST 265 (273)
T ss_dssp -----C-----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred -----C-----CCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 0 122336789999999999999999999999998764
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-54 Score=418.53 Aligned_cols=269 Identities=25% Similarity=0.304 Sum_probs=201.9
Q ss_pred cccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccC-----HHHHHHHHHHHhCCCCCceeeEEEEEEeCC
Q 011851 126 ECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQG-----HKEWLAEVNYLGGLIHPNLVKLIGCCIEDD 200 (476)
Q Consensus 126 ~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~-----~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 200 (476)
+++||+|+||+||+|++. .+|+.||||+++...... .+.+.+|+.+|++++|||||++++++.+++
T Consensus 3 l~~lG~G~fg~Vy~~~~~---------~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~ 73 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDK---------NTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKS 73 (299)
T ss_dssp EEEEEEETTEEEEEEECS---------SCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred ceEeccCcCeEEEEEEEC---------CCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCC
Confidence 578999999999998654 578899999997543322 246889999999999999999999999999
Q ss_pred eeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCcCC
Q 011851 201 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKD 280 (476)
Q Consensus 201 ~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~ 280 (476)
++|||||||.++++..++ ..+..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+.
T Consensus 74 ~~~ivmE~~~~~~~~~~~-~~~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~ 149 (299)
T d1ua2a_ 74 NISLVFDFMETDLEVIIK-DNSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKS 149 (299)
T ss_dssp CCEEEEECCSEEHHHHHT-TCCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGST
T ss_pred ceeehhhhhcchHHhhhh-hcccCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccc
Confidence 999999999887665444 55667999999999999999999999988 99999999999999999999999999987
Q ss_pred CCCCCccceeeeeecCCCCCCcchhhcC-CCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhh--hhhccccc
Q 011851 281 GPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR--PQLGERRR 357 (476)
Q Consensus 281 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~--~~~~~~~~ 357 (476)
....... ....+||+.|+|||++.+. .|+.++|||||||++|||++|..||...........+.... +.......
T Consensus 150 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~ 227 (299)
T d1ua2a_ 150 FGSPNRA--YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPD 227 (299)
T ss_dssp TTSCCCC--CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSS
T ss_pred cCCCccc--ccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccc
Confidence 6543322 2346899999999998755 68999999999999999999999997654322111110000 00000000
Q ss_pred cccccCc----ccCC----CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCccccc
Q 011851 358 FYRLIDP----CLEG----CFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDMA 413 (476)
Q Consensus 358 ~~~~~d~----~l~~----~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~~~ 413 (476)
....... .... ......++++.+||.+||+.||++|||++|+|+| |||++..
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H----p~f~~~p 287 (299)
T d1ua2a_ 228 MCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM----KYFSNRP 287 (299)
T ss_dssp TTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS----GGGTSSS
T ss_pred hhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCC----HhhCCCC
Confidence 0000000 0000 0001225789999999999999999999999987 9998643
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-53 Score=416.65 Aligned_cols=258 Identities=26% Similarity=0.414 Sum_probs=205.8
Q ss_pred cCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCC-ccCHHHHHHHHHHHhCCCCCceeeEEEEEEeC
Q 011851 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDG-LQGHKEWLAEVNYLGGLIHPNLVKLIGCCIED 199 (476)
Q Consensus 121 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~ 199 (476)
.+|+++++||+|+||+||+|.+..++.. ....||+|.++... ....+++.+|+.+|++++|||||++++++.++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~ 83 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEK-----VKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS 83 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC---------CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCE-----EEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence 3699999999999999999987643321 23469999986543 34567899999999999999999999999865
Q ss_pred CeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCcC
Q 011851 200 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAK 279 (476)
Q Consensus 200 ~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~ 279 (476)
..+++|||+.+++|.+++......+++..++.++.||+.||.|||+++ ||||||||+||||+.++.+||+|||+|+
T Consensus 84 -~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~ 159 (317)
T d1xkka_ 84 -TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAK 159 (317)
T ss_dssp -SEEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHH
T ss_pred -CeeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccce
Confidence 678889999999999999888888999999999999999999999988 9999999999999999999999999998
Q ss_pred CCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhhcccccc
Q 011851 280 DGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPQLGERRRF 358 (476)
Q Consensus 280 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 358 (476)
...............||+.|+|||++.++.|+.++|||||||++|||+| |..||...........+.. ..+
T Consensus 160 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~-------~~~- 231 (317)
T d1xkka_ 160 LLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK-------GER- 231 (317)
T ss_dssp HTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHH-------TCC-
T ss_pred ecccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHc-------CCC-
Confidence 7655444444445679999999999999999999999999999999998 7888876543322211110 000
Q ss_pred ccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 011851 359 YRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALK 404 (476)
Q Consensus 359 ~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~ 404 (476)
. ..+...+.++.+|+.+||+.||++|||+.+|+++|.
T Consensus 232 --~-------~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~ 268 (317)
T d1xkka_ 232 --L-------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFS 268 (317)
T ss_dssp --C-------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred --C-------CCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHH
Confidence 0 011223678999999999999999999999999865
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.3e-52 Score=404.97 Aligned_cols=258 Identities=24% Similarity=0.312 Sum_probs=200.4
Q ss_pred ccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccC---HHHHHHHHHHHhCCCCCceeeEEEEE
Q 011851 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQG---HKEWLAEVNYLGGLIHPNLVKLIGCC 196 (476)
Q Consensus 120 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~---~~~~~~E~~~l~~l~hpnIv~l~~~~ 196 (476)
.++|++.+.||+|+||+||+|++. .+|+.||||+++...... .+.+.+|+++|+.++|||||++++++
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~---------~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~ 76 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDL---------RLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTG 76 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEET---------TTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEEC---------CCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCccccee
Confidence 467999999999999999998654 578899999998765443 34688999999999999999999999
Q ss_pred EeCC----eeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEE
Q 011851 197 IEDD----QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKL 272 (476)
Q Consensus 197 ~~~~----~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl 272 (476)
..++ .+|||||||+|++|.+++... ..+++..++.++.||+.||+|||+++ |+||||||+||||+.++.++|
T Consensus 77 ~~~~~~~~~~~lvmE~~~g~~L~~~~~~~-~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l 152 (277)
T d1o6ya_ 77 EAETPAGPLPYIVMEYVDGVTLRDIVHTE-GPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKV 152 (277)
T ss_dssp EEECSSSEEEEEEEECCCEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEE
T ss_pred eeccCCCceEEEEEECCCCCEehhhhccc-CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCcccccee
Confidence 8754 389999999999999988554 57999999999999999999999988 999999999999999999999
Q ss_pred eecCCcCCCCCCCc-cceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhh
Q 011851 273 SDFGLAKDGPEGDK-THVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQ 351 (476)
Q Consensus 273 ~DFG~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~ 351 (476)
+|||.+........ .......+||+.|+|||++.+..|+.++|||||||++|||+||+.||........ . ...
T Consensus 153 ~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~---~---~~~ 226 (277)
T d1o6ya_ 153 MDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV---A---YQH 226 (277)
T ss_dssp CCCTTCEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---H---HHH
T ss_pred ehhhhhhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHH---H---HHH
Confidence 99999876433222 2223447899999999999999999999999999999999999999975432211 1 111
Q ss_pred hccccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHhc
Q 011851 352 LGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARP-RMSEVVEALK 404 (476)
Q Consensus 352 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RP-t~~ell~~L~ 404 (476)
+....... .......++++.+||.+||+.||++|| |++++++.|.
T Consensus 227 ~~~~~~~~--------~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~ 272 (277)
T d1o6ya_ 227 VREDPIPP--------SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLV 272 (277)
T ss_dssp HHCCCCCG--------GGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred HhcCCCCC--------chhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHH
Confidence 11110000 001112367899999999999999999 8899887654
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-53 Score=420.54 Aligned_cols=258 Identities=21% Similarity=0.244 Sum_probs=203.7
Q ss_pred ccCCCccc-cccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhC-CCCCceeeEEEEEE
Q 011851 120 TKSFRPEC-LLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGG-LIHPNLVKLIGCCI 197 (476)
Q Consensus 120 ~~~y~~~~-~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~-l~hpnIv~l~~~~~ 197 (476)
.++|.+.. .||+|+||+||+|++. .+|+.||||+++.. ..+.+|+.++.+ ++|||||+++++|.
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~---------~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~ 75 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNK---------RTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYE 75 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEET---------TTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEEC---------CCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEe
Confidence 35788764 6999999999998754 47889999999643 567789998654 58999999999997
Q ss_pred e----CCeeEEEEEecCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecC---CCc
Q 011851 198 E----DDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDG---EYN 269 (476)
Q Consensus 198 ~----~~~~~lV~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~---~~~ 269 (476)
+ +..+|||||||+||+|.++|.+. ...+++..++.|+.||+.||+|||+++ |+||||||+|||++. ++.
T Consensus 76 ~~~~~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~ 152 (335)
T d2ozaa1 76 NLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAI 152 (335)
T ss_dssp EEETTEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCC
T ss_pred ecccCCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcC---Ccccccccccccccccccccc
Confidence 6 46789999999999999999764 357999999999999999999999988 999999999999975 567
Q ss_pred eEEeecCCcCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhh
Q 011851 270 AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR 349 (476)
Q Consensus 270 vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~ 349 (476)
+||+|||+|+....... ....+||+.|||||++.+..|+.++|||||||++|+|+||+.||.+.........+.
T Consensus 153 ~Kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~--- 226 (335)
T d2ozaa1 153 LKLTDFGFAKETTSHNS---LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK--- 226 (335)
T ss_dssp EEECCCTTCEECCCCCC---CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC----------
T ss_pred ccccccceeeeccCCCc---cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHH---
Confidence 99999999987654332 234689999999999999999999999999999999999999997654332211110
Q ss_pred hhhccccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCccc
Q 011851 350 PQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKD 411 (476)
Q Consensus 350 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~ 411 (476)
..+.. . ............++++.+||.+||+.||++|||+.|+++| |||.+
T Consensus 227 ~~i~~-~------~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h----p~~~~ 277 (335)
T d2ozaa1 227 TRIRM-G------QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH----PWIMQ 277 (335)
T ss_dssp -CCCS-C------SSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS----HHHHT
T ss_pred HHHhc-C------CCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC----HHhhC
Confidence 00000 0 0000000111236789999999999999999999999997 77754
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-53 Score=412.53 Aligned_cols=276 Identities=24% Similarity=0.297 Sum_probs=208.7
Q ss_pred ccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCcc--CHHHHHHHHHHHhCC---CCCceeeEEE
Q 011851 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQ--GHKEWLAEVNYLGGL---IHPNLVKLIG 194 (476)
Q Consensus 120 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~--~~~~~~~E~~~l~~l---~hpnIv~l~~ 194 (476)
.++|++++.||+|+||+||+|++.. .+++.||||+++..... ....+.+|+.+|+.| +||||+++++
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~--------~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~ 77 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLK--------NGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFD 77 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETT--------TTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEE
T ss_pred cCCEEEEEEEecccCeEEEEEEEEC--------CCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeee
Confidence 4689999999999999999987642 23567999998653222 223456777776655 7999999999
Q ss_pred EEEe-----CCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCc
Q 011851 195 CCIE-----DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYN 269 (476)
Q Consensus 195 ~~~~-----~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~ 269 (476)
+|.. ...+|++||||.++.+..........+++..++.++.||+.||+|||+++ ||||||||+|||++.++.
T Consensus 78 ~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~ 154 (305)
T d1blxa_ 78 VCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQ 154 (305)
T ss_dssp EEEEEECSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCC
T ss_pred eecccccccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCC
Confidence 9864 34689999999887776666566677999999999999999999999988 999999999999999999
Q ss_pred eEEeecCCcCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhh
Q 011851 270 AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR 349 (476)
Q Consensus 270 vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~ 349 (476)
+||+|||+++..... ......+||+.|+|||++.+..|+.++|||||||++|||++|+.||...........+....
T Consensus 155 ~kl~dfg~~~~~~~~---~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~ 231 (305)
T d1blxa_ 155 IKLADFGLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVI 231 (305)
T ss_dssp EEECSCCSCCCCCGG---GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH
T ss_pred eeecchhhhhhhccc---ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhh
Confidence 999999999865332 22345789999999999999999999999999999999999999997654322111111000
Q ss_pred hh-----hcc-----ccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCcccccC
Q 011851 350 PQ-----LGE-----RRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDMAS 414 (476)
Q Consensus 350 ~~-----~~~-----~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~~~~ 414 (476)
.. ... ...+... .......+....++.+.+||.+||+.||++|||+.|+|+| |||+++..
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H----pff~~i~~ 301 (305)
T d1blxa_ 232 GLPGEEDWPRDVALPRQAFHSK-SAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH----PYFQDLER 301 (305)
T ss_dssp CCCCGGGSCTTCSSCGGGSCCC-CCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS----GGGTTCCC
T ss_pred CCCchhcccccccchhhhhccc-cccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC----hhhcCchh
Confidence 00 000 0000000 0000111222336788999999999999999999999997 99998754
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-53 Score=408.69 Aligned_cols=253 Identities=27% Similarity=0.388 Sum_probs=199.8
Q ss_pred cCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCCCCCceeeEEEEEEeCC
Q 011851 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHPNLVKLIGCCIEDD 200 (476)
Q Consensus 121 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 200 (476)
++|++.+.||+|+||.||+|++. +++.||||+++... ...+.+.+|+.+|++++|||||++++++. ++
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~----------~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~ 84 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWN----------GTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EE 84 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET----------TTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SS
T ss_pred HHEEEeeEEeeCCCeEEEEEEEC----------CCCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEe-cC
Confidence 46999999999999999999764 34569999997554 45678999999999999999999999985 55
Q ss_pred eeEEEEEecCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCcC
Q 011851 201 QRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAK 279 (476)
Q Consensus 201 ~~~lV~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~ 279 (476)
..|||||||++|+|..++... ...+++..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++
T Consensus 85 ~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~ 161 (285)
T d1fmka3 85 PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLAR 161 (285)
T ss_dssp SCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC
T ss_pred CeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhh
Confidence 789999999999999888653 456999999999999999999999988 9999999999999999999999999998
Q ss_pred CCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhccccccc
Q 011851 280 DGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRRFY 359 (476)
Q Consensus 280 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 359 (476)
....... .......||+.|+|||++.++.++.++|||||||++|||++|..||...... ..+....... .
T Consensus 162 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~--~~~~~~i~~~----~--- 231 (285)
T d1fmka3 162 LIEDNEY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN--REVLDQVERG----Y--- 231 (285)
T ss_dssp ---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH--HHHHHHHHTT----C---
T ss_pred hccCCCc-eeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCH--HHHHHHHHhc----C---
Confidence 7644322 2234467999999999999999999999999999999999976666443221 1111111100 0
Q ss_pred cccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 011851 360 RLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKP 405 (476)
Q Consensus 360 ~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~ 405 (476)
....+...++++.+||.+||+.||++||++++|++.|+.
T Consensus 232 -------~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~ 270 (285)
T d1fmka3 232 -------RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLED 270 (285)
T ss_dssp -------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred -------CCCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhh
Confidence 000112236789999999999999999999999998774
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-53 Score=412.15 Aligned_cols=264 Identities=28% Similarity=0.359 Sum_probs=200.9
Q ss_pred ccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCcc-CHHHHHHHHHHHhCC-CCCceeeEEEEEE
Q 011851 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQ-GHKEWLAEVNYLGGL-IHPNLVKLIGCCI 197 (476)
Q Consensus 120 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~-~~~~~~~E~~~l~~l-~hpnIv~l~~~~~ 197 (476)
.++|++.++||+|+||.||+|.+...+ +..+++.||||+++..... ..+.+.+|..++.++ +|+||+.+++++.
T Consensus 12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~----~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~ 87 (299)
T d1ywna1 12 RDRLKLGKPLGRGAFGQVIEADAFGID----KTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACT 87 (299)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEESTT----SSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred HHHEEEeeEEeecCCeEEEEEEEcCCC----cccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeec
Confidence 357999999999999999999876432 2346788999999754432 345677888877776 6899999999987
Q ss_pred eC-CeeEEEEEecCCCCHHHHHhhc---------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCC
Q 011851 198 ED-DQRLLVYEFMPRGSLENHLFRR---------------SLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSN 261 (476)
Q Consensus 198 ~~-~~~~lV~E~~~~g~L~~~l~~~---------------~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~N 261 (476)
+. ..+++|||||++|+|.++|... ...+++..+..++.||+.||.|||+++ ||||||||+|
T Consensus 88 ~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDlKp~N 164 (299)
T d1ywna1 88 KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARN 164 (299)
T ss_dssp STTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGG
T ss_pred cCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCcCCccc
Confidence 65 4689999999999999999643 235899999999999999999999988 9999999999
Q ss_pred eeecCCCceEEeecCCcCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCC-CCCCCCCCCC
Q 011851 262 ILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGR-RSMDKNRPNG 340 (476)
Q Consensus 262 ILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~-~pf~~~~~~~ 340 (476)
|||+.++.+||+|||+|+..............+||+.|+|||++.++.|+.++|||||||++|||+||. .||.......
T Consensus 165 ILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~ 244 (299)
T d1ywna1 165 ILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE 244 (299)
T ss_dssp EEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH
T ss_pred eeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHH
Confidence 999999999999999998765544433344578999999999999999999999999999999999975 5776543322
Q ss_pred cchhHHhhhhhhccccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011851 341 EHNLVEWARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPL 406 (476)
Q Consensus 341 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~ 406 (476)
. +..... .... + ..+...++++.+||.+||+.||++|||+.||+++|+.+
T Consensus 245 ~--~~~~~~----~~~~------~----~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~i 294 (299)
T d1ywna1 245 E--FCRRLK----EGTR------M----RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 294 (299)
T ss_dssp H--HHHHHH----HTCC------C----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred H--HHHHHh----cCCC------C----CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 1 111111 0000 0 01112357899999999999999999999999998743
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-53 Score=409.20 Aligned_cols=250 Identities=24% Similarity=0.384 Sum_probs=204.8
Q ss_pred ccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCcc------CHHHHHHHHHHHhCCC--CCceee
Q 011851 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQ------GHKEWLAEVNYLGGLI--HPNLVK 191 (476)
Q Consensus 120 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~------~~~~~~~E~~~l~~l~--hpnIv~ 191 (476)
.++|++.++||+|+||+||+|++. .+|+.||||++++.... ...++.+|+.+|++++ |||||+
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~---------~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~ 73 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRV---------SDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIR 73 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEET---------TTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCC
T ss_pred CCeEEEeEEEeeCCCeEEEEEEEC---------CCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccE
Confidence 457999999999999999998654 57889999999754322 1234668999999886 899999
Q ss_pred EEEEEEeCCeeEEEEEecCC-CCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCC-Cc
Q 011851 192 LIGCCIEDDQRLLVYEFMPR-GSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGE-YN 269 (476)
Q Consensus 192 l~~~~~~~~~~~lV~E~~~~-g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~-~~ 269 (476)
+++++.+++..|+||||+.+ +++.+++.. ...+++..++.++.||+.||+|||+++ |+||||||+|||++.+ +.
T Consensus 74 ~~~~~~~~~~~~lv~e~~~~~~~l~~~~~~-~~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~ 149 (273)
T d1xwsa_ 74 LLDWFERPDSFVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGE 149 (273)
T ss_dssp EEEEEECSSEEEEEEECCSSEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTE
T ss_pred EEEEEeeCCeEEEEEEeccCcchHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCe
Confidence 99999999999999999976 577777744 457999999999999999999999988 9999999999999854 79
Q ss_pred eEEeecCCcCCCCCCCccceeeeeecCCCCCCcchhhcCCC-CccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhh
Q 011851 270 AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHL-TAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA 348 (476)
Q Consensus 270 vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~ 348 (476)
+||+|||+|+...... .+..+||+.|+|||++.+..+ +.++|||||||++|||++|+.||.... .+.
T Consensus 150 vkl~DFG~a~~~~~~~----~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~-----~i~--- 217 (273)
T d1xwsa_ 150 LKLIDFGSGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-----EII--- 217 (273)
T ss_dssp EEECCCTTCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-----HHH---
T ss_pred EEECccccceeccccc----ccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch-----HHh---
Confidence 9999999998654322 334789999999999987765 577999999999999999999996421 110
Q ss_pred hhhhccccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCcccccC
Q 011851 349 RPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDMAS 414 (476)
Q Consensus 349 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~~~~ 414 (476)
.. .. . ++...+.++.+||.+||+.||++|||++|+++| |||++...
T Consensus 218 ~~----~~----~--------~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h----p~~~~~~~ 263 (273)
T d1xwsa_ 218 RG----QV----F--------FRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH----PWMQDVLL 263 (273)
T ss_dssp HC----CC----C--------CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS----GGGSSCCC
T ss_pred hc----cc----C--------CCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcC----HhhCCCCC
Confidence 00 00 0 111236789999999999999999999999987 99987654
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.4e-53 Score=411.84 Aligned_cols=264 Identities=23% Similarity=0.367 Sum_probs=211.6
Q ss_pred hccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCcc-CHHHHHHHHHHHhCCCCCceeeEEEEEE
Q 011851 119 ATKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQ-GHKEWLAEVNYLGGLIHPNLVKLIGCCI 197 (476)
Q Consensus 119 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~ 197 (476)
..++|++.+.||+|+||+||+|++... .+..+++.||||+++..... ..+++.+|+++|++++||||+++++++.
T Consensus 11 p~~~~~~~~~lG~G~fG~Vy~a~~~~~----~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~ 86 (301)
T d1lufa_ 11 PRNNIEYVRDIGEGAFGRVFQARAPGL----LPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA 86 (301)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETS----STTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred CHHHcEEeEEEeeCCCeEEEEEEECCC----ccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeec
Confidence 346799999999999999999987532 12346778999999765433 2457899999999999999999999999
Q ss_pred eCCeeEEEEEecCCCCHHHHHhhc-----------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEe
Q 011851 198 EDDQRLLVYEFMPRGSLENHLFRR-----------------------SLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIY 254 (476)
Q Consensus 198 ~~~~~~lV~E~~~~g~L~~~l~~~-----------------------~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivH 254 (476)
+.+..++||||+++|+|.+++... ...+++..++.|+.||+.||+|||+++ |||
T Consensus 87 ~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---ivH 163 (301)
T d1lufa_ 87 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVH 163 (301)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCC
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---eEe
Confidence 999999999999999999998642 124889999999999999999999988 999
Q ss_pred cCCCCCCeeecCCCceEEeecCCcCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCC-CCC
Q 011851 255 RDFKTSNILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGR-RSM 333 (476)
Q Consensus 255 rDlKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~-~pf 333 (476)
|||||+||||+.++.+||+|||+|+...............||+.|+|||++.+..|+.++|||||||++|||++|. +||
T Consensus 164 rDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~ 243 (301)
T d1lufa_ 164 RDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY 243 (301)
T ss_dssp SCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred eEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCC
Confidence 9999999999999999999999998654433333444578999999999999999999999999999999999996 567
Q ss_pred CCCCCCCcchhHHhhhhhhccccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011851 334 DKNRPNGEHNLVEWARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPL 406 (476)
Q Consensus 334 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~ 406 (476)
....... +..... ... .. + .+...+.++.+||.+||+.||++|||+.||++.|+.+
T Consensus 244 ~~~~~~e---~~~~v~----~~~-~~----~-----~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i 299 (301)
T d1lufa_ 244 YGMAHEE---VIYYVR----DGN-IL----A-----CPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRM 299 (301)
T ss_dssp TTSCHHH---HHHHHH----TTC-CC----C-----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred CCCCHHH---HHHHHH----cCC-CC----C-----CCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 6543221 111111 100 00 0 1122356899999999999999999999999988754
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-53 Score=405.46 Aligned_cols=259 Identities=27% Similarity=0.425 Sum_probs=199.4
Q ss_pred cCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCc---cCHHHHHHHHHHHhCCCCCceeeEEEEEE
Q 011851 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL---QGHKEWLAEVNYLGGLIHPNLVKLIGCCI 197 (476)
Q Consensus 121 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~l~~~~~ 197 (476)
++|++.+.||+|+||.||+|++.... +....||||++..... ...+++.+|+.+|++++|||||++++++.
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~------~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~ 81 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPS------GKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVL 81 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTT------SCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCC------CcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence 56999999999999999999875332 2345799999876433 22457899999999999999999999996
Q ss_pred eCCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCC
Q 011851 198 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGL 277 (476)
Q Consensus 198 ~~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~ 277 (476)
+ +..+||||||++|+|.+++......+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+
T Consensus 82 ~-~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl 157 (273)
T d1u46a_ 82 T-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGL 157 (273)
T ss_dssp S-SSCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTT
T ss_pred e-cchheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchh
Confidence 5 5789999999999999998877778999999999999999999999988 99999999999999999999999999
Q ss_pred cCCCCCCCccc-eeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhhccc
Q 011851 278 AKDGPEGDKTH-VSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPQLGER 355 (476)
Q Consensus 278 a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~ 355 (476)
++......... ......|+..|+|||++.+..++.++|||||||++|||+| |+.||....... ...... ...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~---~~~~i~---~~~ 231 (273)
T d1u46a_ 158 MRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ---ILHKID---KEG 231 (273)
T ss_dssp CEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HHHHHH---TSC
T ss_pred hhhcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHH---HHHHHH---hCC
Confidence 99765443322 2233568889999999999999999999999999999998 899997543321 111111 010
Q ss_pred cccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 011851 356 RRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKP 405 (476)
Q Consensus 356 ~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~ 405 (476)
..+ + .+...+.++.+||.+||+.||++|||+.+|++.|++
T Consensus 232 ~~~-----~-----~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~ 271 (273)
T d1u46a_ 232 ERL-----P-----RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLE 271 (273)
T ss_dssp CCC-----C-----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCC-----C-----CcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence 000 1 111225789999999999999999999999988753
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=3e-52 Score=404.18 Aligned_cols=271 Identities=24% Similarity=0.320 Sum_probs=205.6
Q ss_pred cCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCcc--CHHHHHHHHHHHhCCCCCceeeEEEEEEe
Q 011851 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQ--GHKEWLAEVNYLGGLIHPNLVKLIGCCIE 198 (476)
Q Consensus 121 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~l~~~~~~ 198 (476)
++|+++++||+|+||+||+|.+. +|+.||||+++..... ..+++.+|+.+|++++|||||+++++|.+
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~----------~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~ 71 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNN----------YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHT 71 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET----------TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeC----------CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeeccc
Confidence 57999999999999999998753 6788999999765332 24678999999999999999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCc
Q 011851 199 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLA 278 (476)
Q Consensus 199 ~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a 278 (476)
++..|+||||+.++.+.. +......+++..++.++.||+.||+|||+++ ||||||||+||||+.++.+||+|||++
T Consensus 72 ~~~~~i~~e~~~~~~~~~-~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a 147 (286)
T d1ob3a_ 72 KKRLVLVFEHLDQDLKKL-LDVCEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLA 147 (286)
T ss_dssp SSCEEEEEECCSEEHHHH-HHTSTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHH
T ss_pred CCceeEEEEeehhhhHHH-HHhhcCCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccc
Confidence 999999999997665554 4466678999999999999999999999988 999999999999999999999999999
Q ss_pred CCCCCCCccceeeeeecCCCCCCcchhhcC-CCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhh------
Q 011851 279 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQ------ 351 (476)
Q Consensus 279 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~------ 351 (476)
........ ......|++.|+|||.+.+. .++.++|||||||++|||++|+.||...........+......
T Consensus 148 ~~~~~~~~--~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 225 (286)
T d1ob3a_ 148 RAFGIPVR--KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNW 225 (286)
T ss_dssp HHHCC-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred eecccCcc--ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhc
Confidence 76543222 12335799999999998764 6799999999999999999999999765322111111000000
Q ss_pred --hcccccc---ccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCccc
Q 011851 352 --LGERRRF---YRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKD 411 (476)
Q Consensus 352 --~~~~~~~---~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~ 411 (476)
....... .....+.....+....+..+.+||.+||+.||++|||++|+++| |||++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~H----p~f~~ 286 (286)
T d1ob3a_ 226 PNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH----AYFKE 286 (286)
T ss_dssp TTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS----GGGGC
T ss_pred cchhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcC----cccCc
Confidence 0000000 00001111111122235789999999999999999999999987 99874
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-52 Score=399.62 Aligned_cols=247 Identities=28% Similarity=0.421 Sum_probs=196.2
Q ss_pred cCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCCCCCceeeEEEEEEe-C
Q 011851 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHPNLVKLIGCCIE-D 199 (476)
Q Consensus 121 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~-~ 199 (476)
++|++.+.||+|+||.||+|.++ |..||||+++.+. ..+.+.+|+++|++++||||+++++++.+ +
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~-----------~~~vAvK~i~~~~--~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~ 73 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDYR-----------GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEK 73 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET-----------TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC-
T ss_pred HHeEEeEEEecCCCeEEEEEEEC-----------CeEEEEEEECcHH--HHHHHHHHHHHHHhCCCCCEeeEEEEEEecC
Confidence 45888999999999999999753 5679999997643 34779999999999999999999999865 4
Q ss_pred CeeEEEEEecCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCc
Q 011851 200 DQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLA 278 (476)
Q Consensus 200 ~~~~lV~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a 278 (476)
+.+||||||+++|+|.++|.+. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 74 ~~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s 150 (262)
T d1byga_ 74 GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLT 150 (262)
T ss_dssp -CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC-
T ss_pred CcEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccc
Confidence 6789999999999999999654 345899999999999999999999988 999999999999999999999999999
Q ss_pred CCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhhccccc
Q 011851 279 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPQLGERRR 357 (476)
Q Consensus 279 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 357 (476)
+..... .....+|..|+|||++.++.++.++|||||||++|||+| |+.||....... +...... ..
T Consensus 151 ~~~~~~-----~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~---~~~~i~~----~~- 217 (262)
T d1byga_ 151 KEASST-----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVPRVEK----GY- 217 (262)
T ss_dssp ----------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG---HHHHHTT----TC-
T ss_pred eecCCC-----CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHH---HHHHHHc----CC-
Confidence 875432 223568999999999999999999999999999999998 688886543322 2211110 00
Q ss_pred cccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 011851 358 FYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKP 405 (476)
Q Consensus 358 ~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~ 405 (476)
...++...+.++.+||.+||+.||++|||+.+|+++|+.
T Consensus 218 ---------~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~ 256 (262)
T d1byga_ 218 ---------KMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEH 256 (262)
T ss_dssp ---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ---------CCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHH
Confidence 011222335789999999999999999999999999764
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-52 Score=407.54 Aligned_cols=264 Identities=27% Similarity=0.372 Sum_probs=208.0
Q ss_pred ccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCcc-CHHHHHHHHHHHhCC-CCCceeeEEEEEE
Q 011851 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQ-GHKEWLAEVNYLGGL-IHPNLVKLIGCCI 197 (476)
Q Consensus 120 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~-~~~~~~~E~~~l~~l-~hpnIv~l~~~~~ 197 (476)
.++|++.+.||+|+||.||+|+....+.. ...++..||||+++..... ...++.+|+.++.++ +|||||+++++|.
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~--~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~ 89 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKD--KPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT 89 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC------CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcc--cccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccc
Confidence 35799999999999999999987643321 2234568999999765443 346788899999888 7999999999999
Q ss_pred eCCeeEEEEEecCCCCHHHHHhhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCe
Q 011851 198 EDDQRLLVYEFMPRGSLENHLFRRS---------------LPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNI 262 (476)
Q Consensus 198 ~~~~~~lV~E~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NI 262 (476)
+++..|+|||||++|+|.++|.... ..+++..++.++.||+.||+|||+.+ ||||||||+||
T Consensus 90 ~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~Ni 166 (299)
T d1fgka_ 90 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNV 166 (299)
T ss_dssp SSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGE
T ss_pred cCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeecccce
Confidence 9999999999999999999996442 45899999999999999999999988 99999999999
Q ss_pred eecCCCceEEeecCCcCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHh-CCCCCCCCCCCCc
Q 011851 263 LLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLT-GRRSMDKNRPNGE 341 (476)
Q Consensus 263 Ll~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~ellt-G~~pf~~~~~~~~ 341 (476)
|++.++.+||+|||+++...............||+.|+|||++.++.|+.++|||||||++|||++ |..||.......
T Consensus 167 Ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~- 245 (299)
T d1fgka_ 167 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE- 245 (299)
T ss_dssp EECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH-
T ss_pred eecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHH-
Confidence 999999999999999987655444434445789999999999999999999999999999999998 688886544321
Q ss_pred chhHHhhhhhhccccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 011851 342 HNLVEWARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKP 405 (476)
Q Consensus 342 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~ 405 (476)
+..... .... ..++...++++.+||.+||+.||++|||+.||++.|+.
T Consensus 246 --~~~~i~----~~~~----------~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~ 293 (299)
T d1fgka_ 246 --LFKLLK----EGHR----------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR 293 (299)
T ss_dssp --HHHHHH----TTCC----------CCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred --HHHHHH----cCCC----------CCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHH
Confidence 111111 1110 01112235789999999999999999999999998754
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-52 Score=406.68 Aligned_cols=262 Identities=26% Similarity=0.387 Sum_probs=213.5
Q ss_pred cCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCcc-CHHHHHHHHHHHhCC-CCCceeeEEEEEEe
Q 011851 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQ-GHKEWLAEVNYLGGL-IHPNLVKLIGCCIE 198 (476)
Q Consensus 121 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~-~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~ 198 (476)
++|++.++||+|+||.||+|.+... .+..+++.||||+++..... ...++.+|+.+++++ +|||||++++++.+
T Consensus 23 ~~~~l~~~iG~G~fg~Vy~a~~~~~----~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~ 98 (311)
T d1t46a_ 23 NRLSFGKTLGAGAFGKVVEATAYGL----IKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTI 98 (311)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESS----SSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred HHeEEeeEEeecCCeEEEEEEEecc----ccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEee
Confidence 5789999999999999999987531 23357889999999765433 345688999999999 69999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHHhhcC-----------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCC
Q 011851 199 DDQRLLVYEFMPRGSLENHLFRRS-----------------LPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSN 261 (476)
Q Consensus 199 ~~~~~lV~E~~~~g~L~~~l~~~~-----------------~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~N 261 (476)
.+.+|||||||++|+|.+++.... ..+++..+..++.||+.||+|||+++ ||||||||+|
T Consensus 99 ~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~N 175 (311)
T d1t46a_ 99 GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARN 175 (311)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGG
T ss_pred CCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccccccc
Confidence 999999999999999999996532 35899999999999999999999988 9999999999
Q ss_pred eeecCCCceEEeecCCcCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHh-CCCCCCCCCCCC
Q 011851 262 ILLDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLT-GRRSMDKNRPNG 340 (476)
Q Consensus 262 ILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~ellt-G~~pf~~~~~~~ 340 (476)
||++.++.+||+|||+++..............+||+.|+|||++.++.++.++|||||||++|||+| |.+||.......
T Consensus 176 Il~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~ 255 (311)
T d1t46a_ 176 ILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS 255 (311)
T ss_dssp EEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH
T ss_pred ccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHH
Confidence 9999999999999999998766555555556789999999999999999999999999999999999 555555443322
Q ss_pred cchhHHhhhhhhccccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 011851 341 EHNLVEWARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKP 405 (476)
Q Consensus 341 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~ 405 (476)
.. ....... .....+...+.++.+||.+||+.||++|||+.+|++.|+.
T Consensus 256 ~~--~~~i~~~--------------~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~ 304 (311)
T d1t46a_ 256 KF--YKMIKEG--------------FRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK 304 (311)
T ss_dssp HH--HHHHHHT--------------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HH--HHHHhcC--------------CCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 11 1111110 0001112236789999999999999999999999998753
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-51 Score=403.45 Aligned_cols=255 Identities=26% Similarity=0.412 Sum_probs=201.9
Q ss_pred cCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCC-ccCHHHHHHHHHHHhCC-CCCceeeEEEEEEe
Q 011851 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDG-LQGHKEWLAEVNYLGGL-IHPNLVKLIGCCIE 198 (476)
Q Consensus 121 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~ 198 (476)
++|++.++||+|+||+||+|.+..++. ...||||.++... ....+.+.+|+++|+++ +|||||++++++.+
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~-------~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~ 82 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGL-------RMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH 82 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTE-------EEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCe-------EEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEec
Confidence 468899999999999999998764322 1247888876433 23456789999999999 79999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHHhhc---------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCee
Q 011851 199 DDQRLLVYEFMPRGSLENHLFRR---------------SLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNIL 263 (476)
Q Consensus 199 ~~~~~lV~E~~~~g~L~~~l~~~---------------~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NIL 263 (476)
++.+||||||+++|+|.++|.+. ...+++..++.++.||+.||.|||+.+ |+||||||+|||
T Consensus 83 ~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL 159 (309)
T d1fvra_ 83 RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNIL 159 (309)
T ss_dssp TTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEE
T ss_pred CCeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEE
Confidence 99999999999999999999643 357999999999999999999999988 999999999999
Q ss_pred ecCCCceEEeecCCcCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCC-CCCCCCCCCcc
Q 011851 264 LDGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRR-SMDKNRPNGEH 342 (476)
Q Consensus 264 l~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~-pf~~~~~~~~~ 342 (476)
++.++.+||+|||+++....... .....||..|+|||.+.++.|+.++|||||||++|||++|.. ||......
T Consensus 160 ~~~~~~~kl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~--- 233 (309)
T d1fvra_ 160 VGENYVAKIADFGLSRGQEVYVK---KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA--- 233 (309)
T ss_dssp ECGGGCEEECCTTCEESSCEECC---C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---
T ss_pred EcCCCceEEcccccccccccccc---ccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHH---
Confidence 99999999999999986533221 233579999999999999999999999999999999999765 56543321
Q ss_pred hhHHhhhhhhccccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 011851 343 NLVEWARPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKP 405 (476)
Q Consensus 343 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~ 405 (476)
.+..... ...+ ...+...++++.+||.+||+.||++|||+++|+++|+.
T Consensus 234 ~~~~~i~----~~~~----------~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~ 282 (309)
T d1fvra_ 234 ELYEKLP----QGYR----------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNR 282 (309)
T ss_dssp HHHHHGG----GTCC----------CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHHHH----hcCC----------CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 1111111 1000 01122336789999999999999999999999998764
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-50 Score=397.55 Aligned_cols=256 Identities=29% Similarity=0.476 Sum_probs=203.2
Q ss_pred cccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCC-CccCHHHHHHHHHHHhCCCCCceeeEEEEEEe-CCeeE
Q 011851 126 ECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHD-GLQGHKEWLAEVNYLGGLIHPNLVKLIGCCIE-DDQRL 203 (476)
Q Consensus 126 ~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~-~~~~~ 203 (476)
.++||+|+||+||+|.+..++ ++...||||+++.. .....+++.+|+++|++++|||||++++++.+ ++.++
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~------~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~ 105 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDND------GKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 105 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----------CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEE
T ss_pred ceEEeecCCeEEEEEEEECCC------CEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceE
Confidence 578999999999999875432 23456999999753 33344679999999999999999999999876 46899
Q ss_pred EEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCcCCCCC
Q 011851 204 LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDGPE 283 (476)
Q Consensus 204 lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~~~~ 283 (476)
+|||||++|+|.+++......+++..++.++.||+.||.|||+.+ |+||||||+||||++++.+||+|||+++....
T Consensus 106 lv~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~ 182 (311)
T d1r0pa_ 106 VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYD 182 (311)
T ss_dssp EEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTT
T ss_pred EEEEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhccc
Confidence 999999999999999877778899999999999999999999988 99999999999999999999999999987654
Q ss_pred CCcc--ceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhccccccccc
Q 011851 284 GDKT--HVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLGERRRFYRL 361 (476)
Q Consensus 284 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 361 (476)
.... .......||+.|+|||.+....++.++|||||||++|||+||..||....... .+...... .. +.
T Consensus 183 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~--~~~~~i~~----g~---~~ 253 (311)
T d1r0pa_ 183 KEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF--DITVYLLQ----GR---RL 253 (311)
T ss_dssp TTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------CHHHHHT----TC---CC
T ss_pred cccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHH--HHHHHHHc----CC---CC
Confidence 3221 12223578999999999999999999999999999999999888876533221 11111110 00 01
Q ss_pred cCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011851 362 IDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPL 406 (476)
Q Consensus 362 ~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~ 406 (476)
.. +...++++.+||.+||+.||++||++.||+++|+.+
T Consensus 254 ~~-------p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i 291 (311)
T d1r0pa_ 254 LQ-------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 291 (311)
T ss_dssp CC-------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CC-------cccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 11 112257899999999999999999999999997644
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-51 Score=401.82 Aligned_cols=266 Identities=26% Similarity=0.399 Sum_probs=212.5
Q ss_pred cCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCcc-CHHHHHHHHHHHhCCCCCceeeEEEEEEeC
Q 011851 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQ-GHKEWLAEVNYLGGLIHPNLVKLIGCCIED 199 (476)
Q Consensus 121 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~ 199 (476)
++|.+.+.||+|+||+||+|.+... .+..++..||||+++..... ....+.+|+++|++++|||||++++++..+
T Consensus 20 ~~~~l~~~lG~G~fG~Vy~a~~~~~----~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~ 95 (308)
T d1p4oa_ 20 EKITMSRELGQGSFGMVYEGVAKGV----VKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG 95 (308)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEEEE----ETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSS
T ss_pred HHeEEeeEEeeCCCeEEEEEEECCc----ccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecC
Confidence 5688999999999999999987531 22234578999999754332 234688999999999999999999999999
Q ss_pred CeeEEEEEecCCCCHHHHHhhc---------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCce
Q 011851 200 DQRLLVYEFMPRGSLENHLFRR---------SLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNA 270 (476)
Q Consensus 200 ~~~~lV~E~~~~g~L~~~l~~~---------~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~v 270 (476)
+..+||||||++|+|.+++... ...+++..+..++.||+.||.|||+++ |+||||||+||||+.++++
T Consensus 96 ~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~~~ 172 (308)
T d1p4oa_ 96 QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTV 172 (308)
T ss_dssp SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCE
T ss_pred CceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecCCceE
Confidence 9999999999999999998632 235789999999999999999999988 9999999999999999999
Q ss_pred EEeecCCcCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCC-CCCCCCCCCCcchhHHhhh
Q 011851 271 KLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGR-RSMDKNRPNGEHNLVEWAR 349 (476)
Q Consensus 271 kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~-~pf~~~~~~~~~~~~~~~~ 349 (476)
||+|||+++...............||+.|+|||.+.+..++.++|||||||++|||+||. .||........ .....
T Consensus 173 Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~---~~~i~ 249 (308)
T d1p4oa_ 173 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV---LRFVM 249 (308)
T ss_dssp EECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHH---HHHHH
T ss_pred EEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHH---HHHHH
Confidence 999999998764433333344467999999999999999999999999999999999985 66654322211 11110
Q ss_pred hhhccccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC--CCCcc
Q 011851 350 PQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKP--LPYLK 410 (476)
Q Consensus 350 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~--~~~~~ 410 (476)
.... . + .+...+..+.+||.+||+.||++|||+++|+++|+. .|+|+
T Consensus 250 ----~~~~----~-~-----~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~~~~ 298 (308)
T d1p4oa_ 250 ----EGGL----L-D-----KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFR 298 (308)
T ss_dssp ----TTCC----C-C-----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHH
T ss_pred ----hCCC----C-C-----CcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCc
Confidence 1000 0 0 111225789999999999999999999999999886 44444
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-50 Score=402.69 Aligned_cols=270 Identities=24% Similarity=0.307 Sum_probs=202.2
Q ss_pred CCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCCCCCceeeEEEEEEeC--
Q 011851 122 SFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHPNLVKLIGCCIED-- 199 (476)
Q Consensus 122 ~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~-- 199 (476)
+|+..++||+|+||+||+|++. .+|+.||||++...... ..+|+++|++++||||++++++|...
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~---------~~~~~vAiK~i~~~~~~----~~~Ei~il~~l~h~niv~~~~~~~~~~~ 87 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLC---------DSGELVAIKKVLQDKRF----KNRELQIMRKLDHCNIVRLRYFFYSSGE 87 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEET---------TTCCEEEEEEEECCSSS----CCHHHHHHHHCCCTTBCCEEEEEEEC--
T ss_pred CcEeeeEEeeCcCeEEEEEEEC---------CCCCEEEEEEECccchH----HHHHHHHHHhcCCCCCCcEEEEEEecCc
Confidence 5888899999999999998754 57889999999765422 24799999999999999999998643
Q ss_pred ----CeeEEEEEecCCCCHHHHHh--hcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCC-ceEE
Q 011851 200 ----DQRLLVYEFMPRGSLENHLF--RRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEY-NAKL 272 (476)
Q Consensus 200 ----~~~~lV~E~~~~g~L~~~l~--~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~-~vkl 272 (476)
.++|||||||+++.+..+.. .....+++..++.++.||+.||+|||+++ |+||||||+||||+.++ .+||
T Consensus 88 ~~~~~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl 164 (350)
T d1q5ka_ 88 KKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKL 164 (350)
T ss_dssp CCSCCEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEE
T ss_pred cCCceEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeE
Confidence 35789999997654333322 34667999999999999999999999988 99999999999999775 8999
Q ss_pred eecCCcCCCCCCCccceeeeeecCCCCCCcchhhcC-CCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhh---
Q 011851 273 SDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA--- 348 (476)
Q Consensus 273 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~--- 348 (476)
+|||+++....... ....+||+.|+|||++.+. .|+.++|||||||++|||++|+.||...........+...
T Consensus 165 ~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~ 241 (350)
T d1q5ka_ 165 CDFGSAKQLVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGT 241 (350)
T ss_dssp CCCTTCEECCTTSC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCC
T ss_pred ecccchhhccCCcc---cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCC
Confidence 99999987644332 2346899999999988764 7899999999999999999999999765432211111000
Q ss_pred ------hhhhcc--ccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCcccccC
Q 011851 349 ------RPQLGE--RRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDMAS 414 (476)
Q Consensus 349 ------~~~~~~--~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~~~~ 414 (476)
...... ...+.......+........++++.+||.+||+.||++|||+.|+|+| |||+++..
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H----p~f~~~~~ 311 (350)
T d1q5ka_ 242 PTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH----SFFDELRD 311 (350)
T ss_dssp CCHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS----GGGGGGGC
T ss_pred ChHHhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcC----HhhccccC
Confidence 000000 000001100111111122336789999999999999999999999997 99987643
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-50 Score=393.68 Aligned_cols=276 Identities=21% Similarity=0.278 Sum_probs=203.0
Q ss_pred ccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCc--cCHHHHHHHHHHHhCCCCCceeeEEEEEE
Q 011851 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL--QGHKEWLAEVNYLGGLIHPNLVKLIGCCI 197 (476)
Q Consensus 120 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~ 197 (476)
.++|++++.||+|+||+||+|++. .+|+.||||++..... ...+++.+|+++|++++||||+++++++.
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~---------~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~ 79 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHR---------KTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICR 79 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEET---------TTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred cCCEEEEEEEecCcCeEEEEEEEC---------CCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeee
Confidence 357999999999999999998764 4788999999865433 23467889999999999999999999986
Q ss_pred e--------CCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCc
Q 011851 198 E--------DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYN 269 (476)
Q Consensus 198 ~--------~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~ 269 (476)
. ++++|+|||||.++.+. .+......+++..++.++.||+.||.|||+++ |+||||||+||||+.++.
T Consensus 80 ~~~~~~~~~~~~~~iv~e~~~~~~~~-~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~ 155 (318)
T d3blha1 80 TKASPYNRCKGSIYLVFDFCEHDLAG-LLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGV 155 (318)
T ss_dssp C----------CEEEEEECCCEEHHH-HHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSC
T ss_pred cccccccccCceEEEEEeccCCCccc-hhhhcccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCc
Confidence 5 35689999999766554 44455667999999999999999999999988 999999999999999999
Q ss_pred eEEeecCCcCCCCCCCcc--ceeeeeecCCCCCCcchhhcC-CCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHH
Q 011851 270 AKLSDFGLAKDGPEGDKT--HVSTRVMGTYGYAAPEYVMTG-HLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVE 346 (476)
Q Consensus 270 vkl~DFG~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~ 346 (476)
+||+|||+++........ ......+||+.|+|||++.+. .|+.++|||||||++|||++|+.||...........+.
T Consensus 156 ~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~ 235 (318)
T d3blha1 156 LKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALIS 235 (318)
T ss_dssp EEECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred EEeeecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHH
Confidence 999999999765432221 112235799999999999865 78999999999999999999999997644322211111
Q ss_pred hhhhhhccc-------cccccccCcccCCCCCh-------HHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCcccc
Q 011851 347 WARPQLGER-------RRFYRLIDPCLEGCFSI-------KGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDM 412 (476)
Q Consensus 347 ~~~~~~~~~-------~~~~~~~d~~l~~~~~~-------~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~~ 412 (476)
......... ......+.......... ..+.++.+||.+||+.||++|||++|+++| |||+..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H----pff~~~ 311 (318)
T d3blha1 236 QLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH----DFFWSD 311 (318)
T ss_dssp HHHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS----GGGSSS
T ss_pred HhcCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC----hhhccC
Confidence 111000000 00000000000000000 114577899999999999999999999998 999864
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-50 Score=399.40 Aligned_cols=269 Identities=23% Similarity=0.306 Sum_probs=202.0
Q ss_pred ccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCcc--CHHHHHHHHHHHhCCCCCceeeEEEEEE
Q 011851 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQ--GHKEWLAEVNYLGGLIHPNLVKLIGCCI 197 (476)
Q Consensus 120 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~l~~~~~ 197 (476)
.++|++++.||+|+||+||+|.+. .+|+.||||+++..... ..+.+.+|+++|++++|||||+++++|.
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~---------~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~ 87 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDG---------RTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFT 87 (346)
T ss_dssp BSSEEEEEEC------CEEEEEET---------TTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEEC
T ss_pred CCcEEEEEEEecCCCeEEEEEEEC---------CCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEec
Confidence 568999999999999999998654 57889999999764332 2456889999999999999999999998
Q ss_pred eCC------eeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceE
Q 011851 198 EDD------QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAK 271 (476)
Q Consensus 198 ~~~------~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vk 271 (476)
..+ ++||||||| +.+|..++.. ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+|
T Consensus 88 ~~~~~~~~~~~~lv~e~~-~~~l~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~k 161 (346)
T d1cm8a_ 88 PDETLDDFTDFYLVMPFM-GTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELK 161 (346)
T ss_dssp SCSSTTTCCCCEEEEECC-SEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEE
T ss_pred cCccccccceEEEEEecc-cccHHHHHHh--ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhcccccccc
Confidence 765 579999999 6677776643 36999999999999999999999988 99999999999999999999
Q ss_pred EeecCCcCCCCCCCccceeeeeecCCCCCCcchhhcC-CCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhh
Q 011851 272 LSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP 350 (476)
Q Consensus 272 l~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~ 350 (476)
|+|||+|+..... .+..+||+.|+|||++.+. .++.++|||||||++|||++|+.||.................
T Consensus 162 l~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~ 236 (346)
T d1cm8a_ 162 ILDFGLARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTG 236 (346)
T ss_dssp ECCCTTCEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC
T ss_pred cccccceeccCCc-----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccC
Confidence 9999999875432 2346799999999998875 578999999999999999999999976533211111100000
Q ss_pred hhc--------------cccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCccccc
Q 011851 351 QLG--------------ERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDMA 413 (476)
Q Consensus 351 ~~~--------------~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~~~ 413 (476)
... ....+.......+.. .....+.++.+||.+||..||++|||+.|+|+| |||+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~H----p~f~~~~ 308 (346)
T d1cm8a_ 237 TPPAEFVQRLQSDEAKNYMKGLPELEKKDFAS-ILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH----PYFESLH 308 (346)
T ss_dssp CCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGG-TCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS----GGGTTTC
T ss_pred CCcHHHHhhhcchhhhhhhccCCcccccchHH-hccCCCHHHHHHHHHHCcCChhHCcCHHHHhcC----hhhCcCC
Confidence 000 000000000011111 111235688999999999999999999999998 9998764
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-49 Score=385.50 Aligned_cols=272 Identities=23% Similarity=0.277 Sum_probs=211.4
Q ss_pred cCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCcc--CHHHHHHHHHHHhCCCCCceeeEEEEEEe
Q 011851 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQ--GHKEWLAEVNYLGGLIHPNLVKLIGCCIE 198 (476)
Q Consensus 121 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~l~~~~~~ 198 (476)
++|++++.||+|+||+||+|++. .+|+.||||+++..... ..+++.+|+.+|+.++||||+++++++.+
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~---------~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~ 72 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNR---------ETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS 72 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEET---------TTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred CCCEeeeEEecCcCeEEEEEEEC---------CCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeecccccc
Confidence 47999999999999999998654 47888999999765433 24678899999999999999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeecCCc
Q 011851 199 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLA 278 (476)
Q Consensus 199 ~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a 278 (476)
.+..++|||++.+++|..++ .....+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||.+
T Consensus 73 ~~~~~iv~~~~~~~~l~~~~-~~~~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a 148 (292)
T d1unla_ 73 DKKLTLVFEFCDQDLKKYFD-SCNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLA 148 (292)
T ss_dssp SSEEEEEEECCSEEHHHHHH-HTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTC
T ss_pred ccceeEEeeecccccccccc-ccccccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchh
Confidence 99999999999888887766 55668999999999999999999999988 999999999999999999999999999
Q ss_pred CCCCCCCccceeeeeecCCCCCCcchhhcCC-CCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhc----
Q 011851 279 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGH-LTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLG---- 353 (476)
Q Consensus 279 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~---- 353 (476)
+........ .....+++.|+|||++.... ++.++|||||||++|||++|+.||....... ...........
T Consensus 149 ~~~~~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~--~~~~~~~~~~~~~~~ 224 (292)
T d1unla_ 149 RAFGIPVRC--YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD--DQLKRIFRLLGTPTE 224 (292)
T ss_dssp EECCSCCSC--CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHH--HHHHHHHHHHCCCCT
T ss_pred hcccCCCcc--ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHH--HHHHHHHhhcCCCCh
Confidence 876543322 23356788999999988765 6899999999999999999999975433211 11110000000
Q ss_pred -cccccccccC---------cccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCccccc
Q 011851 354 -ERRRFYRLID---------PCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDMA 413 (476)
Q Consensus 354 -~~~~~~~~~d---------~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~~~ 413 (476)
.........+ ...........+..+.+||.+||+.||++|||++|+|+| |||++..
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H----p~f~~~~ 290 (292)
T d1unla_ 225 EQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH----PYFSDFC 290 (292)
T ss_dssp TTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS----GGGSSCS
T ss_pred hhhhhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC----hhhcCCC
Confidence 0000000000 000111122335788999999999999999999999998 9998754
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-50 Score=394.13 Aligned_cols=264 Identities=25% Similarity=0.339 Sum_probs=197.5
Q ss_pred cCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHH--HHHHHhCCCCCceeeEEEEEEe
Q 011851 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLA--EVNYLGGLIHPNLVKLIGCCIE 198 (476)
Q Consensus 121 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~--E~~~l~~l~hpnIv~l~~~~~~ 198 (476)
++|.+.+.||+|+||.||+|++ +|+.||||+++... .+.+.. |+..+.+++|||||++++++.+
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~-----------~g~~vAvK~~~~~~---~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~ 68 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW-----------RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNK 68 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-----------TTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-----------CCEEEEEEEECccc---hhHHHHHHHHHHHhhCCCCcCcceEEEEEe
Confidence 4688899999999999999975 46789999996542 234444 4555567899999999999987
Q ss_pred CC----eeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcC-----CCCeEecCCCCCCeeecCCCc
Q 011851 199 DD----QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEA-----EKPVIYRDFKTSNILLDGEYN 269 (476)
Q Consensus 199 ~~----~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~-----~~~ivHrDlKp~NILl~~~~~ 269 (476)
++ .+|||||||++|+|.++|.+. .+++..++.++.|++.||.|||+.. .++||||||||+||||+.++.
T Consensus 69 ~~~~~~~~~lv~Ey~~~g~L~~~l~~~--~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~ 146 (303)
T d1vjya_ 69 DNGTWTQLWLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT 146 (303)
T ss_dssp ECSSSEEEEEEEECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSC
T ss_pred CCCcceEEEEEEecccCCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCC
Confidence 54 589999999999999999654 5899999999999999999999741 234999999999999999999
Q ss_pred eEEeecCCcCCCCCCCcc--ceeeeeecCCCCCCcchhhcCC------CCccchhhhhHHHHHHHHhCCCCCCCCCCCCc
Q 011851 270 AKLSDFGLAKDGPEGDKT--HVSTRVMGTYGYAAPEYVMTGH------LTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGE 341 (476)
Q Consensus 270 vkl~DFG~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~------~~~~~DiwslGv~l~elltG~~pf~~~~~~~~ 341 (476)
+||+|||+++........ ......+||+.|+|||++.+.. ++.++|||||||+||||+||..||........
T Consensus 147 ~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~ 226 (303)
T d1vjya_ 147 CCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQL 226 (303)
T ss_dssp EEECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCC
T ss_pred eEEEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCccccccc
Confidence 999999999875443221 1233478999999999987653 57789999999999999999988854332211
Q ss_pred chh--------HHhhhhhhccccccccccCcccCCC-CChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 011851 342 HNL--------VEWARPQLGERRRFYRLIDPCLEGC-FSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKP 405 (476)
Q Consensus 342 ~~~--------~~~~~~~~~~~~~~~~~~d~~l~~~-~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~ 405 (476)
... ........ ....+++.+... .+......+.+|+.+||+.||++|||+.||++.|+.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~-----~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~ 294 (303)
T d1vjya_ 227 PYYDLVPSDPSVEEMRKVV-----CEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 294 (303)
T ss_dssp TTTTTSCSSCCHHHHHHHH-----TTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHH
T ss_pred chhhcccccchHHHHHHHH-----hccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHH
Confidence 110 00000000 001112222111 123345679999999999999999999999998764
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1.1e-49 Score=393.58 Aligned_cols=267 Identities=19% Similarity=0.266 Sum_probs=206.0
Q ss_pred cCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCCC-CCceeeEEEEEEe-
Q 011851 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLI-HPNLVKLIGCCIE- 198 (476)
Q Consensus 121 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~- 198 (476)
++|+++++||+|+||+||+|++. .+|+.||||+++.. ..+++.+|+++|+++. ||||++++++|..
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~---------~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~ 102 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINI---------TNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDP 102 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEET---------TTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECT
T ss_pred cCeEEEEEEecCcCeEEEEEEEC---------CCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEec
Confidence 57999999999999999998654 57889999999754 3467889999999995 9999999999985
Q ss_pred -CCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCC-ceEEeecC
Q 011851 199 -DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEY-NAKLSDFG 276 (476)
Q Consensus 199 -~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~-~vkl~DFG 276 (476)
...+++|||||.+++|..+. ..+++..++.++.||+.||+|||+++ |+||||||+||||+.++ .+||+|||
T Consensus 103 ~~~~~~~v~e~~~~~~L~~~~----~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG 175 (328)
T d3bqca1 103 VSRTPALVFEHVNNTDFKQLY----QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWG 175 (328)
T ss_dssp TTCSEEEEEECCCSCBGGGTT----TSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGG
T ss_pred CCCceeEEEeecCCCcHHHHh----cCCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccc
Confidence 45699999999999987653 45999999999999999999999988 99999999999998655 69999999
Q ss_pred CcCCCCCCCccceeeeeecCCCCCCcchhhcC-CCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcch--hHHh------
Q 011851 277 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHN--LVEW------ 347 (476)
Q Consensus 277 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~--~~~~------ 347 (476)
+|+....... ....+||+.|+|||++.+. .|+.++|||||||++|||++|+.||.......... +...
T Consensus 176 ~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~ 252 (328)
T d3bqca1 176 LAEFYHPGQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDL 252 (328)
T ss_dssp GCEECCTTCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHH
T ss_pred cceeccCCCc---ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchh
Confidence 9987654332 2346799999999998875 58999999999999999999999997654322110 0000
Q ss_pred ---h-hhhhccccccccccC--------cccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCccccc
Q 011851 348 ---A-RPQLGERRRFYRLID--------PCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDMA 413 (476)
Q Consensus 348 ---~-~~~~~~~~~~~~~~d--------~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~~~ 413 (476)
. .........+..... ...........+.++.+||.+||+.||++|||++|+|+| |||+++.
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~H----p~F~~v~ 326 (328)
T d3bqca1 253 YDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH----PYFYTVV 326 (328)
T ss_dssp HHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTS----GGGTTSC
T ss_pred hhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcC----cccCCCC
Confidence 0 000000000001100 001111112235789999999999999999999999987 9998764
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-50 Score=396.77 Aligned_cols=264 Identities=25% Similarity=0.322 Sum_probs=211.9
Q ss_pred cCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCc----cCHHHHHHHHHHHhCCCC-CceeeEEEE
Q 011851 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGL----QGHKEWLAEVNYLGGLIH-PNLVKLIGC 195 (476)
Q Consensus 121 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~----~~~~~~~~E~~~l~~l~h-pnIv~l~~~ 195 (476)
++|++++.||+|+||+||+|++.. .+.+|+.||||+++.... ...+.+.+|+++|++++| |||++++++
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~------~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~ 97 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKIS------GHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYA 97 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECS------STTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEE
T ss_pred hceEEEEEEecCCCeEEEEEEECc------cCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeee
Confidence 469999999999999999997642 345789999999875422 234567889999999976 899999999
Q ss_pred EEeCCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEeec
Q 011851 196 CIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDF 275 (476)
Q Consensus 196 ~~~~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~DF 275 (476)
+.+...+++||||+.+|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+||
T Consensus 98 ~~~~~~~~~v~e~~~~~~L~~~i~~~-~~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DF 173 (322)
T d1vzoa_ 98 FQTETKLHLILDYINGGELFTHLSQR-ERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDF 173 (322)
T ss_dssp EEETTEEEEEECCCCSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCS
T ss_pred eccCCceeeeeecccccHHHHHHHhc-ccccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeec
Confidence 99999999999999999999998554 46789999999999999999999988 999999999999999999999999
Q ss_pred CCcCCCCCCCccceeeeeecCCCCCCcchhhcC--CCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhc
Q 011851 276 GLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG--HLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQLG 353 (476)
Q Consensus 276 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~~ 353 (476)
|+++........ ......|++.|+|||.+.+. .++.++|||||||+||||++|+.||...........+.... ..
T Consensus 174 G~a~~~~~~~~~-~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~--~~ 250 (322)
T d1vzoa_ 174 GLSKEFVADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRI--LK 250 (322)
T ss_dssp SEEEECCGGGGG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHH--HH
T ss_pred cchhhhcccccc-cccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc--cc
Confidence 999876443222 23346899999999999765 47889999999999999999999998765544332221111 10
Q ss_pred cccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHHhcCCCCccccc
Q 011851 354 ERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPR-----MSEVVEALKPLPYLKDMA 413 (476)
Q Consensus 354 ~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt-----~~ell~~L~~~~~~~~~~ 413 (476)
... .++...+.++.+||.+||+.||++||| ++|+++| |||+++.
T Consensus 251 ~~~------------~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~H----pff~~i~ 299 (322)
T d1vzoa_ 251 SEP------------PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH----LFFQKIN 299 (322)
T ss_dssp CCC------------CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS----GGGTTCC
T ss_pred CCC------------CCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcC----HhhcCCC
Confidence 000 012233788999999999999999994 7888876 9998753
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-50 Score=400.06 Aligned_cols=275 Identities=22% Similarity=0.288 Sum_probs=201.2
Q ss_pred ccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCcc-CHHHHHHHHHHHhCCCCCceeeEEEEEEe
Q 011851 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQ-GHKEWLAEVNYLGGLIHPNLVKLIGCCIE 198 (476)
Q Consensus 120 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~~ 198 (476)
+.+|++++.||+|+||+||+|++. .+|+.||||+++..... ..+.+++|+++|++|+||||+++++++..
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~---------~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~ 77 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDN---------VNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRA 77 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEET---------TTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECC
T ss_pred CCCeEEEEEEeeccCeEEEEEEEC---------CCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEee
Confidence 457999999999999999998654 57889999999765432 34578899999999999999999999876
Q ss_pred CC----eeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEEee
Q 011851 199 DD----QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSD 274 (476)
Q Consensus 199 ~~----~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl~D 274 (476)
.. ..+++|+|+.+|+|.+++... .+++..++.++.||+.||+|||+++ ||||||||+||||+.++.+||+|
T Consensus 78 ~~~~~~~~~~l~~~~~~g~L~~~l~~~--~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~D 152 (345)
T d1pmea_ 78 PTIEQMKDVYLVTHLMGADLYKLLKTQ--HLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICD 152 (345)
T ss_dssp SSTTTCCCEEEEEECCCEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECC
T ss_pred ccccccceEEEEEeecCCchhhhhhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcc
Confidence 53 234445566699999999553 5999999999999999999999988 99999999999999999999999
Q ss_pred cCCcCCCCCCCcc-ceeeeeecCCCCCCcchhhc-CCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhh
Q 011851 275 FGLAKDGPEGDKT-HVSTRVMGTYGYAAPEYVMT-GHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQL 352 (476)
Q Consensus 275 FG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~~ 352 (476)
||+++........ ......+||+.|+|||++.. ..++.++||||+||++|||++|+.||...................
T Consensus 153 fG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~ 232 (345)
T d1pmea_ 153 FGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSP 232 (345)
T ss_dssp CTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSC
T ss_pred cCceeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCC
Confidence 9999865432221 11234679999999999854 578999999999999999999999997654321111110000000
Q ss_pred cc-----------ccccccccCcccC--CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCcccc
Q 011851 353 GE-----------RRRFYRLIDPCLE--GCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDM 412 (476)
Q Consensus 353 ~~-----------~~~~~~~~d~~l~--~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~~ 412 (476)
.. ......+...... .......+.++.+|+.+||+.||++|||+.|+|+| |||+..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h----pf~~~~ 301 (345)
T d1pmea_ 233 SQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH----PYLEQY 301 (345)
T ss_dssp CHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS----GGGTTT
T ss_pred ChhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC----HhhccC
Confidence 00 0000000000000 00001124678999999999999999999999997 887743
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=8.7e-49 Score=382.12 Aligned_cols=260 Identities=20% Similarity=0.233 Sum_probs=201.8
Q ss_pred ccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCCCCCc-eeeEEEEEEe
Q 011851 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHPN-LVKLIGCCIE 198 (476)
Q Consensus 120 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~hpn-Iv~l~~~~~~ 198 (476)
.++|++.+.||+|+||+||+|++. .+|+.||||++..... .+++..|+++++.++|+| |+.+.+++.+
T Consensus 6 g~rY~l~~~iG~G~fG~Vy~a~~~---------~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~ 74 (299)
T d1ckia_ 6 GNRYRLGRKIGSGSFGDIYLGTDI---------AAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAE 74 (299)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEET---------TTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEE
T ss_pred CCEEEEeEEEeeCCCcEEEEEEEC---------CCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEec
Confidence 357999999999999999998754 4688899999876533 245788999999997665 5566677788
Q ss_pred CCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeec---CCCceEEeec
Q 011851 199 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLD---GEYNAKLSDF 275 (476)
Q Consensus 199 ~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~---~~~~vkl~DF 275 (476)
.+..++||||+ +++|.+.+......+++..+..++.||+.||+|||+++ ||||||||+|||++ .+..+||+||
T Consensus 75 ~~~~~ivme~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DF 150 (299)
T d1ckia_ 75 GDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDF 150 (299)
T ss_dssp TTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCC
T ss_pred CCEEEEEEEEc-CCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeecc
Confidence 88999999999 66788877777778999999999999999999999988 99999999999975 4557999999
Q ss_pred CCcCCCCCCCcc-----ceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHH-hhh
Q 011851 276 GLAKDGPEGDKT-----HVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVE-WAR 349 (476)
Q Consensus 276 G~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~-~~~ 349 (476)
|+|+........ ......+||+.|||||++.+..++.++|||||||++|||++|+.||............. ...
T Consensus 151 G~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~ 230 (299)
T d1ckia_ 151 GLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISE 230 (299)
T ss_dssp SSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHH
T ss_pred CcceeccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhc
Confidence 999876443221 12334689999999999999999999999999999999999999998765443332221 111
Q ss_pred hhhccccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 011851 350 PQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKP 405 (476)
Q Consensus 350 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~ 405 (476)
..... .. +.+ ....++++.+|+.+||+.||++||+++++.+.|+.
T Consensus 231 ~~~~~--~~-----~~~----~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 275 (299)
T d1ckia_ 231 KKMST--PI-----EVL----CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRN 275 (299)
T ss_dssp HHHHS--CH-----HHH----TTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHH
T ss_pred ccCCC--Ch-----hHh----ccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHH
Confidence 11000 00 000 01125789999999999999999999988877664
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8e-49 Score=391.53 Aligned_cols=270 Identities=23% Similarity=0.274 Sum_probs=197.3
Q ss_pred ccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCcc--CHHHHHHHHHHHhCCCCCceeeEEEEEE
Q 011851 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQ--GHKEWLAEVNYLGGLIHPNLVKLIGCCI 197 (476)
Q Consensus 120 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~l~~~~~ 197 (476)
.++|+++++||+|+||+||+|++. .||+.||||+++..... ..+++.+|+.+|++++|||||+++++|.
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~---------~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~ 86 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDA---------VLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFT 86 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEET---------TTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEC
T ss_pred cCCeEEEEEeecCcCeEEEEEEEC---------CCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEe
Confidence 367999999999999999998654 57889999999765432 2346889999999999999999999996
Q ss_pred e------CCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceE
Q 011851 198 E------DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAK 271 (476)
Q Consensus 198 ~------~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vk 271 (476)
. ..++|+|||||.+ +|.+.+. ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+|
T Consensus 87 ~~~~~~~~~~~~iv~Ey~~~-~l~~~~~---~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~k 159 (355)
T d2b1pa1 87 PQKTLEEFQDVYLVMELMDA-NLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLK 159 (355)
T ss_dssp SCCSTTTCCEEEEEEECCSE-EHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEE
T ss_pred cccccccCceeEEEEeccch-HHHHhhh---cCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCcccccccccccee
Confidence 4 3688999999966 4555552 35899999999999999999999998 99999999999999999999
Q ss_pred EeecCCcCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHH-----
Q 011851 272 LSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVE----- 346 (476)
Q Consensus 272 l~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~----- 346 (476)
|+|||+++...... .....+||+.|+|||++.+..++.++||||+||++|||++|+.||.+.........+.
T Consensus 160 l~df~~~~~~~~~~---~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~ 236 (355)
T d2b1pa1 160 ILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGT 236 (355)
T ss_dssp ECCCCC------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCC
T ss_pred eechhhhhcccccc---ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccC
Confidence 99999988754432 2345689999999999999999999999999999999999999997543211111000
Q ss_pred ----hh-------hhhhccc-----cccccccCcccC---CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCC
Q 011851 347 ----WA-------RPQLGER-----RRFYRLIDPCLE---GCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLP 407 (476)
Q Consensus 347 ----~~-------~~~~~~~-----~~~~~~~d~~l~---~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~ 407 (476)
+. ....... ......+..... .......+.++.+||.+||..||++|||++|+|+| |
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H----p 312 (355)
T d2b1pa1 237 PCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH----P 312 (355)
T ss_dssp CCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS----T
T ss_pred CCHHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC----c
Confidence 00 0000000 000001110110 01122346789999999999999999999999998 9
Q ss_pred Ccccc
Q 011851 408 YLKDM 412 (476)
Q Consensus 408 ~~~~~ 412 (476)
||+..
T Consensus 313 w~~~~ 317 (355)
T d2b1pa1 313 YINVW 317 (355)
T ss_dssp TTGGG
T ss_pred ccCCC
Confidence 99864
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=7.2e-48 Score=374.43 Aligned_cols=260 Identities=17% Similarity=0.170 Sum_probs=207.1
Q ss_pred ccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCCCC-CceeeEEEEEEe
Q 011851 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIH-PNLVKLIGCCIE 198 (476)
Q Consensus 120 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~h-pnIv~l~~~~~~ 198 (476)
.++|+++++||+|+||+||+|++. .+|+.||||++..... ...+.+|+++++.|.| +||+.+++++.+
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~---------~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~ 72 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNL---------LNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQE 72 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEET---------TTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEEC---------CCCCEEEEEEEccccC--cHHHHHHHHHHHHhcCCCCCCEEEEEeec
Confidence 357999999999999999998754 4788899999865432 2456788889988865 899999999999
Q ss_pred CCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecC-----CCceEEe
Q 011851 199 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDG-----EYNAKLS 273 (476)
Q Consensus 199 ~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~-----~~~vkl~ 273 (476)
+...|+||||+ +++|.+++......+++..+..++.|++.||+|||+++ |+||||||+||||+. ++.+||+
T Consensus 73 ~~~~~~vme~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~ 148 (293)
T d1csna_ 73 GLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVV 148 (293)
T ss_dssp TTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEEC
T ss_pred CCccEEEEEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEc
Confidence 99999999999 78999999877778999999999999999999999988 999999999999964 5789999
Q ss_pred ecCCcCCCCCCCcc-----ceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhh
Q 011851 274 DFGLAKDGPEGDKT-----HVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA 348 (476)
Q Consensus 274 DFG~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~ 348 (476)
|||+|+........ .....++||+.|||||++.+..++.++|||||||++|||++|+.||...............
T Consensus 149 DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i 228 (293)
T d1csna_ 149 DFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERI 228 (293)
T ss_dssp CCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHH
T ss_pred ccceeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHH
Confidence 99999865432211 1233468999999999999999999999999999999999999999866554333222111
Q ss_pred hhhhccccccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 011851 349 RPQLGERRRFYRLIDPCLEGCFSIKGAEKTIQLAASCLNRDQKARPRMSEVVEALK 404 (476)
Q Consensus 349 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~ 404 (476)
.... ......++ ....++++.+++..|+..+|++||+++.+.+.|+
T Consensus 229 ~~~~-~~~~~~~l---------~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~ 274 (293)
T d1csna_ 229 GEKK-QSTPLREL---------CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFS 274 (293)
T ss_dssp HHHH-HHSCHHHH---------TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHH
T ss_pred Hhcc-CCCChHHh---------cCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHH
Confidence 1100 00000011 0112568999999999999999999998877654
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-48 Score=388.06 Aligned_cols=271 Identities=23% Similarity=0.326 Sum_probs=202.4
Q ss_pred ccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCcc--CHHHHHHHHHHHhCCCCCceeeEEEEEE
Q 011851 120 TKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQ--GHKEWLAEVNYLGGLIHPNLVKLIGCCI 197 (476)
Q Consensus 120 ~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~l~~~~~ 197 (476)
.++|+++++||+|+||+||+|++. .+|+.||||+++..... ..+++.+|+++|++++|||||++++++.
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~---------~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~ 87 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDT---------KTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFT 87 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEET---------TTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEC
T ss_pred CCCeEEEEEEecCCCeEEEEEEEC---------CCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence 568999999999999999998654 57889999999765432 2356889999999999999999999986
Q ss_pred eC-----CeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCceEE
Q 011851 198 ED-----DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKL 272 (476)
Q Consensus 198 ~~-----~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl~~~~~vkl 272 (476)
.. ...+++|||+.+|+|.+++.. ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||
T Consensus 88 ~~~~~~~~~~~~i~~~~~gg~L~~~~~~--~~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl 162 (348)
T d2gfsa1 88 PARSLEEFNDVYLVTHLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKI 162 (348)
T ss_dssp SCSSTTTCCCCEEEEECCSEEHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEE
T ss_pred eccccccCceEEEEEeecCCchhhhccc--ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccc
Confidence 43 345667778889999998844 36999999999999999999999988 999999999999999999999
Q ss_pred eecCCcCCCCCCCccceeeeeecCCCCCCcchhhcC-CCCccchhhhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhh
Q 011851 273 SDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTAKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPQ 351 (476)
Q Consensus 273 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGv~l~elltG~~pf~~~~~~~~~~~~~~~~~~ 351 (476)
+|||++...... .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+.......+......
T Consensus 163 ~dfg~a~~~~~~-----~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~ 237 (348)
T d2gfsa1 163 LDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 237 (348)
T ss_dssp CCC----CCTGG-----GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred cccchhcccCcc-----cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence 999999765322 2346799999999987776 4688999999999999999999999765432211111100000
Q ss_pred hcc----------ccccccccCcccCCCC---ChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCccccc
Q 011851 352 LGE----------RRRFYRLIDPCLEGCF---SIKGAEKTIQLAASCLNRDQKARPRMSEVVEALKPLPYLKDMA 413 (476)
Q Consensus 352 ~~~----------~~~~~~~~d~~l~~~~---~~~~~~~~~~li~~cL~~dP~~RPt~~ell~~L~~~~~~~~~~ 413 (476)
... ...+...+.......+ ....+.++.+||.+||+.||++|||+.|+|+| |||++..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~H----p~f~~~~ 308 (348)
T d2gfsa1 238 PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH----AYFAQYH 308 (348)
T ss_dssp CCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS----GGGTTTC
T ss_pred CChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcC----HhhCCCC
Confidence 000 0000000000000000 01225678999999999999999999999987 9998653
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=4.1e-44 Score=358.01 Aligned_cols=271 Identities=22% Similarity=0.240 Sum_probs=196.7
Q ss_pred cCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCCC-----------CCce
Q 011851 121 KSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLI-----------HPNL 189 (476)
Q Consensus 121 ~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~-----------hpnI 189 (476)
.+|+++++||+|+||+||+|++. .+|+.||||+++.... ..+.+.+|+.+|+.++ |+||
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~---------~~g~~vAvKvi~~~~~-~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~i 82 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDM---------VNNTHVAMKIVRGDKV-YTEAAEDEIKLLQRVNDADNTKEDSMGANHI 82 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEET---------TTTEEEEEEEECSCHH-HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTB
T ss_pred CcEEEEEEEeeCCCeEEEEEEEC---------CCCCEEEEEEEecccc-chHHHHHHHHHHHHhcchhhhhhhhcCcCce
Confidence 35999999999999999998754 5788999999976532 2356678888888775 5789
Q ss_pred eeEEEEEEe--CCeeEEEEEecCCCCHHHHH--hhcCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCCeee
Q 011851 190 VKLIGCCIE--DDQRLLVYEFMPRGSLENHL--FRRSLPLPWSIRMKIALDAAKGLAFLHE-EAEKPVIYRDFKTSNILL 264 (476)
Q Consensus 190 v~l~~~~~~--~~~~~lV~E~~~~g~L~~~l--~~~~~~l~~~~~~~i~~qi~~al~~lH~-~~~~~ivHrDlKp~NILl 264 (476)
+++++++.. ....+++|+++..+...... ......+++..+..++.||+.||.|||+ .+ |+||||||+||||
T Consensus 83 v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll 159 (362)
T d1q8ya_ 83 LKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLM 159 (362)
T ss_dssp CCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEE
T ss_pred EEEEEEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeee
Confidence 999998865 35667777777555433332 2345678999999999999999999998 66 9999999999999
Q ss_pred cCCC------ceEEeecCCcCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHHHHHHhCCCCCCCCCC
Q 011851 265 DGEY------NAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVLLEMLTGRRSMDKNRP 338 (476)
Q Consensus 265 ~~~~------~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l~elltG~~pf~~~~~ 338 (476)
+.++ .++|+|||.+...... ....+||+.|+|||++.+..|+.++|||||||++++|++|+.||.....
T Consensus 160 ~~~~~~~~~~~~kl~dfg~s~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~ 234 (362)
T d1q8ya_ 160 EIVDSPENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEG 234 (362)
T ss_dssp EEEETTTTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC-----
T ss_pred eccCcccccceeeEeecccccccccc-----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCcc
Confidence 7665 3999999999764332 2346799999999999999999999999999999999999999976543
Q ss_pred CCcchhHHhhh---hhhcc--------c---------cccccccCc----------ccCCCCChHHHHHHHHHHHHhccc
Q 011851 339 NGEHNLVEWAR---PQLGE--------R---------RRFYRLIDP----------CLEGCFSIKGAEKTIQLAASCLNR 388 (476)
Q Consensus 339 ~~~~~~~~~~~---~~~~~--------~---------~~~~~~~d~----------~l~~~~~~~~~~~~~~li~~cL~~ 388 (476)
........... ..++. . ......+.. .....+....+.++.+||.+||..
T Consensus 235 ~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~ 314 (362)
T d1q8ya_ 235 HSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQL 314 (362)
T ss_dssp ----CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCS
T ss_pred ccccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCC
Confidence 22211110000 00000 0 000000000 001123345678999999999999
Q ss_pred CCCCCCCHHHHHHHhcCCCCccccc
Q 011851 389 DQKARPRMSEVVEALKPLPYLKDMA 413 (476)
Q Consensus 389 dP~~RPt~~ell~~L~~~~~~~~~~ 413 (476)
||.+|||++|+|+| |||++..
T Consensus 315 dP~~Rpta~e~L~H----p~f~~~~ 335 (362)
T d1q8ya_ 315 DPRKRADAGGLVNH----PWLKDTL 335 (362)
T ss_dssp STTTCBCHHHHHTC----GGGTTCT
T ss_pred ChhHCcCHHHHhcC----cccCCCC
Confidence 99999999999987 9998553
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.92 E-value=5.6e-26 Score=205.23 Aligned_cols=170 Identities=14% Similarity=0.060 Sum_probs=119.6
Q ss_pred CCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCcc-------------C-----HHHHHHHHHHHhCC
Q 011851 123 FRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQ-------------G-----HKEWLAEVNYLGGL 184 (476)
Q Consensus 123 y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~-------------~-----~~~~~~E~~~l~~l 184 (476)
+.+.++||+|+||+||+|.+. +|+.||||+++..... . ......|...|.++
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~----------~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l 71 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSE----------KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKL 71 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEET----------TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHT
T ss_pred chhCCEeeeCcceEEEEEECC----------CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHc
Confidence 346789999999999998753 6788999997642110 0 12235688999999
Q ss_pred CCCceeeEEEEEEeCCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeee
Q 011851 185 IHPNLVKLIGCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEAEKPVIYRDFKTSNILL 264 (476)
Q Consensus 185 ~hpnIv~l~~~~~~~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ivHrDlKp~NILl 264 (476)
.|.+++..+++. ..+|||||+++..+.+ ++......++.|++.+|.|||+++ |+||||||+|||+
T Consensus 72 ~~~~v~~~~~~~----~~~lvme~~~~~~~~~--------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv 136 (191)
T d1zara2 72 QGLAVPKVYAWE----GNAVLMELIDAKELYR--------VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLV 136 (191)
T ss_dssp TTSSSCCEEEEE----TTEEEEECCCCEEGGG--------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEE
T ss_pred cCCCcceEEEec----CCEEEEEeeccccccc--------hhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheee
Confidence 999999988653 2479999998765432 344456789999999999999988 9999999999999
Q ss_pred cCCCceEEeecCCcCCCCCCCccceeeeeecCCCCCCcchhhcCCCCccchhhhhHHHH
Q 011851 265 DGEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTAKSDVYSFGVVL 323 (476)
Q Consensus 265 ~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv~l 323 (476)
+++ .++|+|||+|.............+-+.. -.| +....|+.++|+||+.--+
T Consensus 137 ~~~-~~~liDFG~a~~~~~~~~~~~l~rd~~~----~~~-~f~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 137 SEE-GIWIIDFPQSVEVGEEGWREILERDVRN----IIT-YFSRTYRTEKDINSAIDRI 189 (191)
T ss_dssp ETT-EEEECCCTTCEETTSTTHHHHHHHHHHH----HHH-HHHHHHCCCCCHHHHHHHH
T ss_pred eCC-CEEEEECCCcccCCCCCcHHHHHHHHHH----HHH-HHcCCCCCcccHHHHHHHH
Confidence 965 5899999999765432211100000000 001 1245788999999975443
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.74 E-value=1.8e-08 Score=93.14 Aligned_cols=149 Identities=17% Similarity=0.022 Sum_probs=100.0
Q ss_pred HHHHhccCCCccccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCCC-CCceeeEE
Q 011851 115 ELKSATKSFRPECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLI-HPNLVKLI 193 (476)
Q Consensus 115 ~~~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~ 193 (476)
+++.....|++.+..+-++.+.||+.. ..+..+.+|+...........+.+|..+|..|. +--+.+++
T Consensus 8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~-----------~~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl 76 (263)
T d1j7la_ 8 ELKKLIEKYRCVKDTEGMSPAKVYKLV-----------GENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVL 76 (263)
T ss_dssp HHHHHHTTSEEEECSCCCSSSEEEEEE-----------CSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEE
T ss_pred HHHHhhhceEEEEcCCCCCCCcEEEEE-----------eCCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEE
Confidence 455666778887776656667899853 245568889886544333345667888777653 33367788
Q ss_pred EEEEeCCeeEEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcC-------------------------
Q 011851 194 GCCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALDAAKGLAFLHEEA------------------------- 248 (476)
Q Consensus 194 ~~~~~~~~~~lV~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~~lH~~~------------------------- 248 (476)
.+..+++..|+||++++|.++.+..... .....++.++...+..||+..
T Consensus 77 ~~~~~~~~~~lv~~~l~G~~~~~~~~~~------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 150 (263)
T d1j7la_ 77 HFERHDGWSNLLMSEADGVLCSEEYEDE------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDL 150 (263)
T ss_dssp EEEEETTEEEEEEECCSSEEHHHHTTTC------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTC
T ss_pred EEEecCCceEEEEEeccccccccccccc------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHh
Confidence 8888889999999999998876544211 112233444455555555321
Q ss_pred -------------------------------CCCeEecCCCCCCeeecCCCceEEeecCCcCC
Q 011851 249 -------------------------------EKPVIYRDFKTSNILLDGEYNAKLSDFGLAKD 280 (476)
Q Consensus 249 -------------------------------~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~ 280 (476)
...++|+|+.|.|||+++++.+-|+||+.+..
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 151 ADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp SCCCGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred hhhhhhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 01278999999999999776667999998753
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.10 E-value=6.7e-06 Score=74.77 Aligned_cols=73 Identities=19% Similarity=0.089 Sum_probs=49.0
Q ss_pred ccccC-CccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCCC--CCceeeEEEEEEeCCeeEEE
Q 011851 129 LGEGG-FGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLI--HPNLVKLIGCCIEDDQRLLV 205 (476)
Q Consensus 129 LG~G~-fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~--hpnIv~l~~~~~~~~~~~lV 205 (476)
+..|. -+.||+... ..+..+.+|........ .+..|...|+.|. .-.+.+++.+..+++..++|
T Consensus 18 ~~~G~s~~~v~r~~~----------~~~~~~vlK~~~~~~~~---~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v 84 (255)
T d1nd4a_ 18 QTIGCSDAAVFRLSA----------QGRPVLFVKTDLSGALN---ELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLL 84 (255)
T ss_dssp CSCTTSSCEEEEEEC----------TTSCCEEEEEECSCTTS---CHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEE
T ss_pred cCCcccCCeEEEEEe----------CCCCEEEEEeCCccCHh---HHHHHHHHHHHHHhcCCCCCceeeecccccceEEE
Confidence 34444 367887543 35667889987655433 3456666666553 23367788888888899999
Q ss_pred EEecCCCCH
Q 011851 206 YEFMPRGSL 214 (476)
Q Consensus 206 ~E~~~~g~L 214 (476)
||+++|.++
T Consensus 85 ~~~i~G~~~ 93 (255)
T d1nd4a_ 85 LGEVPGQDL 93 (255)
T ss_dssp EECCSSEET
T ss_pred EEeeecccc
Confidence 999988665
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.81 E-value=2.7e-05 Score=75.83 Aligned_cols=78 Identities=10% Similarity=0.011 Sum_probs=48.1
Q ss_pred cccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCC------C-ccCHHHHHHHHHHHhCCC---CCceeeEEEE
Q 011851 126 ECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHD------G-LQGHKEWLAEVNYLGGLI---HPNLVKLIGC 195 (476)
Q Consensus 126 ~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~------~-~~~~~~~~~E~~~l~~l~---hpnIv~l~~~ 195 (476)
.+.||.|....||+..+. .+++.|+||.-... . .....+...|.+.|+.+. ...+.+++.+
T Consensus 31 ~~eig~G~~N~vfrV~~~---------~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~ 101 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQ---------EHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS 101 (392)
T ss_dssp EEECCSSSSEEEEEEEC-------------CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE
T ss_pred EEEeCCCceEeEEEEEeC---------CCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE
Confidence 346899999999996543 34667889964321 1 112345566887777552 2345666643
Q ss_pred EEeCCeeEEEEEecCCCCH
Q 011851 196 CIEDDQRLLVYEFMPRGSL 214 (476)
Q Consensus 196 ~~~~~~~~lV~E~~~~g~L 214 (476)
+.+..++|||++++..+
T Consensus 102 --d~~~~~lvmE~L~~~~~ 118 (392)
T d2pula1 102 --DTEMAVTVMEDLSHLKI 118 (392)
T ss_dssp --ETTTTEEEECCCTTSEE
T ss_pred --cCCCCEEEEeccCCccc
Confidence 55667899999977543
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.83 E-value=0.002 Score=60.25 Aligned_cols=133 Identities=14% Similarity=0.101 Sum_probs=74.4
Q ss_pred ccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCCCCCce--eeEE-----EEEEeCCeeEEEEE
Q 011851 135 GCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHPNL--VKLI-----GCCIEDDQRLLVYE 207 (476)
Q Consensus 135 g~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~hpnI--v~l~-----~~~~~~~~~~lV~E 207 (476)
-.||++.. .+|..|++|+.+... ...+++..|+..|..|...+| +..+ ..+..++..+.|++
T Consensus 36 N~vy~v~~----------~dg~~~VlK~~rp~~-~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~ 104 (325)
T d1zyla1 36 NRVYQFQD----------EDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFP 104 (325)
T ss_dssp SEEEEECC----------TTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEE
T ss_pred ceeEEEEc----------CCCCEEEEEEeCCCC-CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEe
Confidence 57887543 367889999987542 345677788888876642221 1111 12345677889999
Q ss_pred ecCCCCHH-----HH------H---hh--c------CCCCCH-------------------HHHHHHHHHHHHHHHHHHh
Q 011851 208 FMPRGSLE-----NH------L---FR--R------SLPLPW-------------------SIRMKIALDAAKGLAFLHE 246 (476)
Q Consensus 208 ~~~~g~L~-----~~------l---~~--~------~~~l~~-------------------~~~~~i~~qi~~al~~lH~ 246 (476)
+++|..+. .+ + +. . ....+. .....+...+...++.+..
T Consensus 105 ~~~G~~~~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~ 184 (325)
T d1zyla1 105 SVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTA 184 (325)
T ss_dssp CCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHH
T ss_pred ecCCcCCCCCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHH
Confidence 99764321 11 0 00 0 011111 1111122222233333332
Q ss_pred c----CCCCeEecCCCCCCeeecCCCceEEeecCCcCC
Q 011851 247 E----AEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKD 280 (476)
Q Consensus 247 ~----~~~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~ 280 (476)
. ....+||+|+.+.|||++++ ..++||+-+..
T Consensus 185 ~~~~~~p~~liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 185 HWREDFTVLRLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp HCCSCSCCEECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred hccccCCceeecCCCCcccEEEeCC--ceEEechhccc
Confidence 2 23458999999999999743 45899998864
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.69 E-value=0.0013 Score=63.47 Aligned_cols=81 Identities=15% Similarity=0.070 Sum_probs=51.4
Q ss_pred cccccccCCccEEEEEEccCCceeeeCCCCceEEEEEecCCCccCHHHHHHHHHHHhCCCCCce-eeEEEEEEeCCeeEE
Q 011851 126 ECLLGEGGFGCVYKGWINMNGTATVKPGTGLPVAVKTLNHDGLQGHKEWLAEVNYLGGLIHPNL-VKLIGCCIEDDQRLL 204 (476)
Q Consensus 126 ~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~g~~vAiK~~~~~~~~~~~~~~~E~~~l~~l~hpnI-v~l~~~~~~~~~~~l 204 (476)
++.|+-|---.+|+........ ..+..++.|.+++.... ...-...+|..+++.+.-.++ .++++++.+ .+
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~--~~~~~~~~vllRi~g~~--~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~ 118 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYP--PIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GR 118 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSC--CSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EE
T ss_pred EEEcCCccccceEEEEeCCCCc--cccCCCCcEEEEecCCc--chhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ce
Confidence 3568888888999987653321 22234566888887532 223345678888887753343 577776532 68
Q ss_pred EEEecCCCCH
Q 011851 205 VYEFMPRGSL 214 (476)
Q Consensus 205 V~E~~~~g~L 214 (476)
||||++|..|
T Consensus 119 I~efi~g~~l 128 (395)
T d1nw1a_ 119 LEEYIPSRPL 128 (395)
T ss_dssp EECCCCEEEC
T ss_pred EEEEeccccC
Confidence 9999987544
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.55 E-value=0.0018 Score=60.11 Aligned_cols=31 Identities=29% Similarity=0.331 Sum_probs=27.1
Q ss_pred CCeEecCCCCCCeeecCCCceEEeecCCcCC
Q 011851 250 KPVIYRDFKTSNILLDGEYNAKLSDFGLAKD 280 (476)
Q Consensus 250 ~~ivHrDlKp~NILl~~~~~vkl~DFG~a~~ 280 (476)
.++||+|+.++||+++++...-|+||+.+..
T Consensus 183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred cccccCCcchhhhhcccccceeEeccccccc
Confidence 4599999999999999887778999998753
|